data_1ydu_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1ydu _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.401 ' N ' ' HD3' ' A' ' 55' ' ' PRO . 42.0 mt . . . . . 0 C--O 1.211 -0.931 0 N-CA-C 114.602 1.334 . . . . 0.0 114.602 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.533 ' O ' ' HG2' ' A' ' 59' ' ' LYS . 20.9 Cg_exo -61.76 -15.93 45.61 Favored 'Trans proline' 0 C--N 1.374 1.907 0 C-N-CA 121.73 1.62 . . . . 0.0 113.412 -165.149 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 31.1 mm-40 -80.35 -30.74 38.01 Favored 'General case' 0 CA--C 1.485 -1.542 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 -178.008 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.473 ' HA ' ' HB3' ' A' ' 60' ' ' GLU . 72.6 mt -75.28 -35.06 61.37 Favored 'General case' 0 N--CA 1.418 -2.054 0 CA-C-N 114.648 -1.16 . . . . 0.0 110.572 -179.218 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.56 ' HB3' ' H ' ' A' ' 75' ' ' TYR . 5.2 mp -64.46 -50.93 65.57 Favored 'General case' 0 CA--C 1.493 -1.229 0 C-N-CA 119.668 -0.813 . . . . 0.0 110.047 -178.28 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.533 ' HG2' ' O ' ' A' ' 55' ' ' PRO . 18.0 ptpt -62.55 -26.48 68.6 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 114.923 -1.035 . . . . 0.0 111.041 175.478 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.473 ' HB3' ' HA ' ' A' ' 57' ' ' LEU . 15.5 tt0 -69.71 -39.44 76.86 Favored 'General case' 0 C--N 1.317 -0.823 0 C-N-CA 123.89 0.876 . . . . 0.0 112.345 176.884 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -74.89 -26.14 59.44 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 120.459 -0.497 . . . . 0.0 110.301 176.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.44 ' CG ' ' H ' ' A' ' 63' ' ' LEU . 17.0 t70 -77.17 -162.22 0.27 Allowed 'General case' 0 CA--C 1.565 1.545 0 CA-C-N 115.206 -0.906 . . . . 0.0 108.563 178.782 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.469 ' HB2' HD13 ' A' ' 65' ' ' ILE . 1.5 mt -95.02 -178.64 0.82 Allowed Pre-proline 0 CA--C 1.569 1.704 0 N-CA-C 106.809 -1.552 . . . . 0.0 106.809 -175.591 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_endo -92.45 14.85 1.63 Allowed 'Trans proline' 0 C--N 1.361 1.202 0 C-N-CA 122.36 2.04 . . . . 0.0 111.547 -174.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.619 ' O ' ' HA3' ' A' ' 159' ' ' GLY . 0.2 OUTLIER -76.12 -42.15 37.93 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.704 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 179.497 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 57.75 8.55 4.27 Favored Glycine 0 N--CA 1.481 1.645 0 CA-C-N 115.925 -0.58 . . . . 0.0 112.771 -178.155 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.549 ' O ' ' HB ' ' A' ' 160' ' ' VAL . 61.6 mt 64.95 -67.39 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.562 0 C-N-CA 126.201 1.8 . . . . 0.0 112.471 -176.623 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.404 ' HB2' ' O ' ' A' ' 67' ' ' ILE . 53.3 t80 179.61 -56.63 0.0 OUTLIER Pre-proline 0 C--N 1.31 -1.119 0 N-CA-C 112.268 0.47 . . . . 0.0 112.268 -177.672 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.456 ' HB2' ' OD2' ' A' ' 71' ' ' ASP . 3.2 Cg_endo -87.67 -22.68 1.5 Allowed 'Trans proline' 0 C--N 1.365 1.416 0 C-N-CA 121.556 1.504 . . . . 0.0 114.185 -170.787 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 88.8 -8.55 79.23 Favored Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 120.525 -0.845 . . . . 0.0 111.456 -175.338 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.456 ' OD2' ' HB2' ' A' ' 69' ' ' PRO . 21.6 m-20 -81.78 -46.65 13.91 Favored 'General case' 0 CA--C 1.501 -0.926 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 177.537 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.486 ' O ' ' HB ' ' A' ' 73' ' ' THR . . . -71.27 178.15 3.51 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 114.164 -1.38 . . . . 0.0 110.273 172.798 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.694 HG23 ' O ' ' A' ' 73' ' ' THR . 81.3 m 83.24 27.86 0.1 Allowed 'General case' 0 C--N 1.354 0.775 0 CA-C-O 124.429 2.062 . . . . 0.0 110.018 174.496 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.684 ' O ' ' HA ' ' A' ' 86' ' ' VAL . 0.7 OUTLIER -81.82 137.76 35.22 Favored 'General case' 0 C--N 1.275 -2.635 0 CA-C-N 114.206 -1.361 . . . . 0.0 109.726 177.706 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.56 ' H ' ' HB3' ' A' ' 58' ' ' LEU . 37.5 t80 -106.73 104.94 14.75 Favored 'General case' 0 C--N 1.273 -2.756 0 CA-C-N 115.234 -0.894 . . . . 0.0 110.074 -173.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.657 ' O ' ' HG ' ' A' ' 84' ' ' LEU . 10.8 mm-40 -137.73 163.33 31.59 Favored 'General case' 0 C--N 1.307 -1.258 0 C-N-CA 124.112 0.965 . . . . 0.0 108.882 177.202 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 50.9 p90 -147.75 150.47 34.33 Favored 'General case' 0 C--N 1.289 -2.035 0 N-CA-C 108.064 -1.088 . . . . 0.0 108.064 177.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.528 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 12.7 m-20 -99.16 165.26 11.8 Favored 'General case' 0 CA--C 1.479 -1.767 0 C-N-CA 118.001 -1.48 . . . . 0.0 110.282 178.549 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -79.55 -59.66 2.66 Favored 'General case' 0 C--N 1.272 -2.802 0 CA-C-N 114.159 -1.382 . . . . 0.0 112.947 -177.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -72.41 -30.41 64.62 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-O 121.58 0.705 . . . . 0.0 110.292 -177.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.528 ' HB ' ' HB2' ' A' ' 78' ' ' ASP . 21.8 m -78.49 -51.07 10.52 Favored 'General case' 0 N--CA 1.411 -2.424 0 CA-C-N 114.824 -1.08 . . . . 0.0 110.48 -178.158 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 65.0 mttp 65.88 12.0 8.06 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.626 0.77 . . . . 0.0 112.172 -177.567 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 5.0 tppp? -100.59 141.97 32.72 Favored 'General case' 0 N--CA 1.428 -1.548 0 N-CA-C 104.449 -2.426 . . . . 0.0 104.449 175.445 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.657 ' HG ' ' O ' ' A' ' 76' ' ' GLU . 9.3 tt -80.83 145.83 31.21 Favored 'General case' 0 C--N 1.295 -1.782 0 C-N-CA 119.39 -0.924 . . . . 0.0 110.488 -178.428 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 10.7 t -126.47 123.84 38.75 Favored 'General case' 0 N--CA 1.4 -2.964 0 CA-C-O 121.896 0.855 . . . . 0.0 111.035 -179.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.684 ' HA ' ' O ' ' A' ' 74' ' ' ASN . 98.5 t -96.84 126.81 49.47 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 CA-C-N 114.932 -1.031 . . . . 0.0 108.4 175.36 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.6 mp -91.64 120.37 32.35 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-O 121.63 0.728 . . . . 0.0 111.046 -179.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 2.1 mp -100.69 132.74 21.85 Favored Pre-proline 0 C--N 1.286 -2.191 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 172.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -51.06 -36.28 53.96 Favored 'Trans proline' 0 C--N 1.356 0.938 0 C-N-CA 124.637 3.558 . . . . 0.0 114.357 -176.131 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' SER . . . . . 0.547 ' HB2' ' HB2' ' A' ' 168' ' ' ASP . 47.9 t -161.99 157.65 23.96 Favored 'General case' 0 CA--C 1.493 -1.221 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -70.4 116.13 11.13 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.711 0 O-C-N 123.991 0.807 . . . . 0.0 109.28 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 41.3 t -112.77 123.51 50.46 Favored 'General case' 0 N--CA 1.427 -1.587 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.934 179.377 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -106.57 114.66 28.9 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 174.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 5.8 p -111.66 118.15 56.86 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.726 0 CA-C-O 121.192 0.52 . . . . 0.0 111.283 -176.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . 0.4 ' HA2' ' HA ' ' A' ' 101' ' ' VAL . . . . . . . . 0 N--CA 1.43 -1.703 0 C-N-CA 120.463 -0.875 . . . . 0.0 112.016 179.155 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 48.8 m . . . . . 0 N--CA 1.452 -0.345 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.4 ' HA ' ' HA2' ' A' ' 95' ' ' GLY . 13.8 p -166.85 147.63 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.796 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 -178.354 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.472 HD21 ' H ' ' A' ' 126' ' ' LYS . 51.6 mt -134.86 133.95 40.25 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 -176.205 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.42 ' O ' ' HA ' ' A' ' 123' ' ' ILE . 27.4 ttpp -110.28 114.05 27.22 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 112.195 0.442 . . . . 0.0 112.195 -177.112 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -101.65 104.54 15.39 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.721 176.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 89.4 m -79.59 165.0 23.39 Favored 'General case' 0 CA--C 1.557 1.215 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.618 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 12.0 p -69.57 -69.68 0.33 Allowed 'General case' 0 N--CA 1.438 -1.063 0 C-N-CA 124.93 1.292 . . . . 0.0 112.886 -175.014 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 25.6 m -96.3 88.51 4.79 Favored 'General case' 0 N--CA 1.416 -2.173 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 -178.195 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.509 HG22 HG13 ' A' ' 123' ' ' ILE . 5.0 p -101.48 144.18 13.43 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.103 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.18 -176.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.57 ' OG1' ' HB3' ' A' ' 121' ' ' GLU . 11.6 p -109.33 165.06 11.92 Favored 'General case' 0 C--N 1.287 -2.139 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 178.183 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 173.39 172.58 38.99 Favored Glycine 0 N--CA 1.427 -1.914 0 N-CA-C 111.485 -0.646 . . . . 0.0 111.485 179.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 47.4 t-80 -93.2 106.47 18.43 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 178.016 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.453 ' CB ' HD13 ' A' ' 84' ' ' LEU . 2.9 tm? -94.42 136.51 34.63 Favored 'General case' 0 CA--C 1.466 -2.261 0 N-CA-C 106.838 -1.542 . . . . 0.0 106.838 -175.388 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . 0.418 ' N ' HD11 ' A' ' 112' ' ' LEU . 0.3 OUTLIER -142.49 153.01 43.26 Favored 'General case' 0 N--CA 1.383 -3.777 0 N-CA-C 105.275 -2.12 . . . . 0.0 105.275 177.837 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 8.1 mmtt -67.92 101.06 1.04 Allowed 'General case' 0 C--N 1.302 -1.464 0 CA-C-O 121.898 0.856 . . . . 0.0 111.691 -178.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . 0.652 ' O ' ' HB ' ' A' ' 138' ' ' THR . . . 131.0 -54.24 0.79 Allowed Glycine 0 N--CA 1.41 -3.049 0 CA-C-N 114.342 -1.299 . . . . 0.0 109.927 -178.765 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.51 141.93 43.47 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 114.006 1.113 . . . . 0.0 114.006 -176.811 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.662 ' O ' ' HB2' ' A' ' 135' ' ' SER . 58.1 tp -104.82 106.82 17.47 Favored 'General case' 0 C--N 1.311 -1.067 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 177.704 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 42.1 p -106.19 142.93 35.06 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 -175.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 28.6 m-20 54.74 98.78 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 125.156 1.382 . . . . 0.0 113.031 177.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 4.3 m -100.58 172.54 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.587 0 CA-C-O 120.983 0.42 . . . . 0.0 110.907 179.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.57 ' HB3' ' OG1' ' A' ' 109' ' ' THR . 14.9 tp10 -140.84 82.77 1.86 Allowed 'General case' 0 N--CA 1.416 -2.165 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.382 178.705 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 150.96 -19.7 0.97 Allowed Glycine 0 C--N 1.308 -1.012 0 CA-C-N 115.153 -0.931 . . . . 0.0 111.979 177.14 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.509 HG13 HG22 ' A' ' 108' ' ' VAL . 96.1 mt -99.61 100.17 9.93 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.63 0 CA-C-O 121.383 0.611 . . . . 0.0 109.514 -179.087 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . 0.448 ' HA ' ' HA ' ' A' ' 132' ' ' LYS . 39.7 ttmt -86.65 119.19 26.62 Favored 'General case' 0 N--CA 1.428 -1.565 0 N-CA-C 107.613 -1.255 . . . . 0.0 107.613 -179.617 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.58 ' HB ' ' OG1' ' A' ' 134' ' ' THR . 89.9 m -121.33 125.14 46.28 Favored 'General case' 0 C--N 1.268 -2.95 0 CA-C-N 114.477 -1.238 . . . . 0.0 110.962 -172.19 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.623 ' HD3' ' C ' ' A' ' 126' ' ' LYS . 0.2 OUTLIER -117.99 105.78 12.24 Favored 'General case' 0 N--CA 1.412 -2.347 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 173.026 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 33.3 m -107.7 -27.61 2.95 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.102 0 CA-C-O 121.872 0.844 . . . . 0.0 110.08 176.314 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' MET . . . . . 0.496 ' C ' HD13 ' A' ' 129' ' ' ILE . 27.3 ttt -158.94 -35.55 0.06 Allowed 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 106.971 -1.492 . . . . 0.0 106.971 -175.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . 0.496 HD13 ' C ' ' A' ' 128' ' ' MET . 2.8 mp -134.94 151.65 31.46 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.72 0 N-CA-C 104.271 -2.492 . . . . 0.0 104.271 171.356 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 16.2 p90 -90.53 116.68 28.62 Favored 'General case' 0 N--CA 1.425 -1.711 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 178.375 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . 0.53 HG11 ' H ' ' A' ' 133' ' ' VAL . 36.0 t -137.69 146.58 27.25 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 -175.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . 0.448 ' HA ' ' HA ' ' A' ' 124' ' ' LYS . 58.9 pttt -103.23 12.0 36.17 Favored 'General case' 0 C--N 1.315 -0.917 0 C-N-CA 120.165 -0.614 . . . . 0.0 111.448 -178.797 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.53 ' H ' HG11 ' A' ' 131' ' ' VAL . 33.5 m -125.55 -1.43 5.14 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.006 0 C-N-CA 120.396 -0.522 . . . . 0.0 111.778 -175.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' THR . . . . . 0.58 ' OG1' ' HB ' ' A' ' 125' ' ' THR . 1.3 p -60.35 111.16 1.45 Allowed 'General case' 0 N--CA 1.43 -1.425 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 175.636 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' SER . . . . . 0.662 ' HB2' ' O ' ' A' ' 117' ' ' LEU . 23.2 p -106.79 172.2 6.95 Favored 'General case' 0 N--CA 1.41 -2.471 0 N-CA-C 114.93 1.455 . . . . 0.0 114.93 -169.166 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . 0.405 ' HB ' ' CG2' ' A' ' 146' ' ' THR . 12.2 tt -101.16 105.23 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.491 0 CA-C-N 114.81 -1.086 . . . . 0.0 110.869 -173.406 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' SER . . . . . 0.496 ' HG ' ' HB2' ' A' ' 144' ' ' TYR . 45.7 p -91.54 114.36 26.87 Favored 'General case' 0 N--CA 1.414 -2.269 0 CA-C-N 115.157 -0.928 . . . . 0.0 109.685 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' THR . . . . . 0.652 ' HB ' ' O ' ' A' ' 115' ' ' GLY . 46.6 m -119.54 153.87 34.74 Favored 'General case' 0 C--N 1.279 -2.476 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 -179.791 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -106.41 35.36 2.98 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 178.326 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . 57.54 34.87 25.15 Favored 'General case' 0 C--N 1.355 0.805 0 CA-C-N 115.046 -0.979 . . . . 0.0 109.065 -177.389 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 47.2 t -173.1 -77.96 0.01 OUTLIER 'General case' 0 C--O 1.211 -0.935 0 CA-C-N 114.731 -1.122 . . . . 0.0 109.683 -174.234 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 81.6 mttt -89.93 150.97 21.94 Favored 'General case' 0 CA--C 1.497 -1.068 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 179.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 13.1 p -118.93 142.91 31.71 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.067 0 CA-C-O 121.416 0.627 . . . . 0.0 111.686 -175.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . 0.496 ' HB2' ' HG ' ' A' ' 137' ' ' SER . 87.4 m-85 -121.55 114.9 21.86 Favored 'General case' 0 N--CA 1.423 -1.799 0 N-CA-C 106.163 -1.791 . . . . 0.0 106.163 171.475 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . 0.493 ' HB3' ' HB2' ' A' ' 151' ' ' LYS . 65.0 t80 -53.74 156.2 2.85 Favored 'General case' 0 C--O 1.252 1.223 0 C-N-CA 124.539 1.135 . . . . 0.0 113.094 -171.831 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' THR . . . . . 0.457 ' O ' HG23 ' A' ' 125' ' ' THR . 33.7 p -51.1 93.65 0.01 OUTLIER 'General case' 0 C--N 1.35 0.609 0 C-N-CA 125.181 1.392 . . . . 0.0 113.793 -175.573 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . 0.422 ' HA ' ' HB ' ' A' ' 134' ' ' THR . . . 163.27 -35.71 0.0 OUTLIER 'General case' 0 CA--C 1.497 -1.061 0 C-N-CA 127.171 2.188 . . . . 0.0 106.31 178.676 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 100.63 79.07 1.4 Allowed Glycine 0 N--CA 1.434 -1.493 0 CA-C-N 114.963 -1.017 . . . . 0.0 111.807 179.016 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 16.3 tpt 72.51 -10.24 0.96 Allowed 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 123.877 0.871 . . . . 0.0 112.698 177.155 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -62.38 -30.53 71.27 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 121.062 0.458 . . . . 0.0 110.023 -179.014 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . 0.493 ' HB2' ' HB3' ' A' ' 145' ' ' PHE . 10.0 mmpt? -121.86 118.76 29.75 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 106.521 -1.659 . . . . 0.0 106.521 175.122 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 32.1 p -91.39 111.66 23.24 Favored 'General case' 0 C--N 1.297 -1.708 0 CA-C-O 120.617 0.246 . . . . 0.0 111.174 -177.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 37.6 mmt180 -134.88 137.3 43.09 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 179.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 20.0 m -90.2 132.47 35.47 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 111.504 0.187 . . . . 0.0 111.504 -176.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' ARG . . . . . 0.473 ' HD3' ' O ' ' A' ' 155' ' ' ARG . 2.0 tmt_? -65.01 -26.5 68.31 Favored 'General case' 0 N--CA 1.483 1.196 0 CA-C-O 121.107 0.479 . . . . 0.0 109.898 177.494 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -38.04 -48.11 1.17 Allowed 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 126.102 1.761 . . . . 0.0 115.576 -175.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -79.33 -54.92 5.47 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 113.899 1.074 . . . . 0.0 113.899 -173.212 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . 0.577 ' HB2' ' NE2' ' A' ' 161' ' ' GLN . 98.3 m-85 -153.19 24.5 0.55 Allowed 'General case' 0 N--CA 1.482 1.151 0 O-C-N 122.242 -0.286 . . . . 0.0 110.536 -176.658 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . 0.619 ' HA3' ' O ' ' A' ' 65' ' ' ILE . . . 87.78 -92.41 1.8 Allowed Glycine 0 CA--C 1.475 -2.46 0 C-N-CA 119.672 -1.252 . . . . 0.0 111.618 -177.597 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.549 ' HB ' ' O ' ' A' ' 67' ' ' ILE . 28.6 t -98.58 121.92 49.68 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.191 0 C-N-CA 119.67 -0.812 . . . . 0.0 108.91 -179.797 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' GLN . . . . . 0.577 ' NE2' ' HB2' ' A' ' 158' ' ' TYR . 25.7 mm-40 -103.88 92.95 4.63 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 115.78 1.77 . . . . 0.0 115.78 -175.188 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 17.0 mmm180 -152.66 150.27 29.29 Favored 'General case' 0 CA--C 1.501 -0.93 0 C-N-CA 125.624 1.57 . . . . 0.0 108.754 170.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 19.7 m120 -89.88 97.69 11.33 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-O 120.964 0.412 . . . . 0.0 111.415 -178.491 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -136.57 156.07 22.91 Favored Glycine 0 C--N 1.308 -1.025 0 N-CA-C 110.615 -0.994 . . . . 0.0 110.615 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -135.83 116.63 14.07 Favored 'General case' 0 N--CA 1.425 -1.703 0 CA-C-O 121.38 0.609 . . . . 0.0 109.5 178.355 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . 0.533 ' HD2' ' N ' ' A' ' 166' ' ' ARG . 3.3 mpt_? -81.3 105.83 12.79 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 106.39 -1.707 . . . . 0.0 106.39 178.63 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 9.2 m -71.43 77.08 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.925 0 N-CA-C 114.976 1.473 . . . . 0.0 114.976 -174.25 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . 0.547 ' HB2' ' HB2' ' A' ' 90' ' ' SER . 15.4 t70 -144.41 -34.01 0.38 Allowed 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 114.072 -1.422 . . . . 0.0 107.279 177.588 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -111.86 157.4 20.66 Favored 'General case' 0 N--CA 1.439 -1.015 0 CA-C-N 114.543 -1.208 . . . . 0.0 108.039 178.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' PHE . . . . . . . . . . . . . 16.0 p90 . . . . . 0 C--N 1.305 -1.366 0 O-C-N 123.248 0.342 . . . . 0.0 111.349 179.405 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 8.4 mp . . . . . 0 CA--C 1.489 -1.383 0 N-CA-C 117.272 2.323 . . . . 0.0 117.272 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.56 ' HA ' ' HG ' ' A' ' 58' ' ' LEU . 13.1 Cg_exo -66.39 -14.51 44.46 Favored 'Trans proline' 0 N--CA 1.416 -3.05 0 CA-C-N 120.183 1.101 . . . . 0.0 111.857 -175.131 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -74.05 -32.19 63.2 Favored 'General case' 0 N--CA 1.426 -1.644 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 -179.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.49 ' HA ' ' HG2' ' A' ' 60' ' ' GLU . 3.7 mm? -73.88 -41.73 61.75 Favored 'General case' 0 N--CA 1.423 -1.825 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 175.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.56 ' HG ' ' HA ' ' A' ' 55' ' ' PRO . 52.0 mt -58.2 -48.08 81.43 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.735 -177.864 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.481 ' HB3' ' HZ3' ' A' ' 59' ' ' LYS . 7.4 mtpm? -70.84 -26.58 63.34 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 115.296 -0.865 . . . . 0.0 112.319 -178.036 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.49 ' HG2' ' HA ' ' A' ' 57' ' ' LEU . 8.6 pt-20 -83.84 -18.49 37.39 Favored 'General case' 0 N--CA 1.444 -0.762 0 C-N-CA 118.957 -1.097 . . . . 0.0 109.854 177.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 61.2 m-85 -89.08 -13.91 37.52 Favored 'General case' 0 C--O 1.24 0.604 0 C-N-CA 119.095 -1.042 . . . . 0.0 112.119 175.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.494 ' CG ' ' H ' ' A' ' 63' ' ' LEU . 23.5 t70 -91.93 -153.95 0.35 Allowed 'General case' 0 C--O 1.253 1.27 0 N-CA-C 105.782 -1.933 . . . . 0.0 105.782 172.698 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.523 ' HB2' HD11 ' A' ' 65' ' ' ILE . 5.1 mt -95.16 158.17 35.26 Favored Pre-proline 0 C--N 1.298 -1.661 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 -178.057 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -93.86 26.6 0.34 Allowed 'Trans proline' 0 N--CA 1.448 -1.19 0 C-N-CA 122.849 2.366 . . . . 0.0 111.143 -168.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.549 HG12 ' H ' ' A' ' 67' ' ' ILE . 0.2 OUTLIER -95.11 -21.58 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.778 0 CA-C-N 115.331 -0.849 . . . . 0.0 108.966 -177.995 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 67.64 8.92 54.33 Favored Glycine 0 C--N 1.353 1.481 0 CA-C-N 115.501 -0.772 . . . . 0.0 112.195 179.548 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.556 ' O ' HG22 ' A' ' 160' ' ' VAL . 73.0 mt 57.79 -70.78 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.203 -1.344 0 C-N-CA 127.184 2.193 . . . . 0.0 112.613 -173.044 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.44 ' HB3' ' HD3' ' A' ' 69' ' ' PRO . 79.5 t80 176.73 -50.53 0.0 OUTLIER Pre-proline 0 C--N 1.303 -1.449 0 C-N-CA 122.853 0.461 . . . . 0.0 110.392 -174.578 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.481 ' HB3' ' HD3' ' A' ' 166' ' ' ARG . 24.8 Cg_exo -67.58 131.69 25.15 Favored 'Trans proline' 0 N--CA 1.436 -1.876 0 N-CA-C 109.046 -1.175 . . . . 0.0 109.046 174.386 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -73.7 64.58 1.84 Allowed Glycine 0 C--N 1.306 -1.102 0 O-C-N 123.439 0.462 . . . . 0.0 113.045 -177.275 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 12.7 t70 177.43 -39.65 0.01 OUTLIER 'General case' 0 C--O 1.21 -0.978 0 N-CA-C 107.737 -1.208 . . . . 0.0 107.737 179.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.644 ' O ' ' HB ' ' A' ' 73' ' ' THR . . . -46.48 166.28 0.02 OUTLIER 'General case' 0 N--CA 1.506 2.365 0 C-N-CA 124.273 1.029 . . . . 0.0 112.753 174.624 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.644 ' HB ' ' O ' ' A' ' 72' ' ' ALA 0.254 1.5 m 88.11 26.22 0.03 OUTLIER 'General case' 0 C--N 1.367 1.346 0 CA-C-O 125.071 2.367 . . . . 0.0 109.665 -178.97 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 40.7 m-80 -82.23 163.88 21.57 Favored 'General case' 0 N--CA 1.411 -2.376 0 CA-C-N 113.725 -1.58 . . . . 0.0 111.033 177.404 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.436 ' H ' ' HB3' ' A' ' 58' ' ' LEU . 33.7 t80 -134.52 95.6 3.41 Favored 'General case' 0 C--N 1.274 -2.702 0 CA-C-N 115.151 -0.932 . . . . 0.0 111.923 -168.893 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.491 ' O ' HD22 ' A' ' 84' ' ' LEU . 41.0 mm-40 -115.89 153.46 31.5 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 173.667 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 69.0 t80 -146.08 114.47 6.71 Favored 'General case' 0 C--N 1.29 -1.98 0 O-C-N 122.046 -0.409 . . . . 0.0 110.04 -177.023 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.58 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 31.7 m-20 -88.67 148.95 23.75 Favored 'General case' 0 CA--C 1.459 -2.535 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 175.622 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -82.37 -41.18 20.31 Favored 'General case' 1 C--N 1.24 -4.172 0 CA-C-N 114.796 -1.093 . . . . 0.0 111.916 179.307 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -61.84 -41.7 98.14 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-O 122.236 1.017 . . . . 0.0 109.332 178.331 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.58 ' HB ' ' HB2' ' A' ' 78' ' ' ASP . 46.2 m -70.76 -51.31 27.9 Favored 'General case' 0 N--CA 1.412 -2.374 0 CA-C-N 113.799 -1.546 . . . . 0.0 108.045 177.14 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 80.0 tttt 68.2 9.01 6.95 Favored 'General case' 0 C--N 1.348 0.533 0 C-N-CA 126.144 1.778 . . . . 0.0 110.398 178.563 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.514 ' HG2' HG23 ' A' ' 109' ' ' THR . 75.5 tttt -117.7 133.86 55.51 Favored 'General case' 0 N--CA 1.409 -2.505 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 179.363 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.491 HD22 ' O ' ' A' ' 76' ' ' GLU . 2.7 tm? -64.44 133.76 53.15 Favored 'General case' 0 C--N 1.317 -0.841 0 C-N-CA 123.101 0.561 . . . . 0.0 110.149 -172.554 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.452 ' HB ' HG22 ' A' ' 109' ' ' THR . 6.0 t -117.1 111.44 19.51 Favored 'General case' 0 N--CA 1.412 -2.372 0 CA-C-O 122.128 0.966 . . . . 0.0 111.577 -177.593 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 58.0 t -92.87 126.01 45.37 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.272 0 CA-C-N 114.89 -1.05 . . . . 0.0 108.433 177.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.475 ' HA ' ' O ' ' A' ' 106' ' ' THR . 1.9 pp -105.02 124.4 49.46 Favored 'General case' 0 N--CA 1.408 -2.572 0 CA-C-N 115.242 -0.89 . . . . 0.0 112.16 178.276 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 3.0 mp -110.06 125.04 31.93 Favored Pre-proline 0 C--N 1.293 -1.855 0 CA-C-N 114.063 -1.426 . . . . 0.0 109.089 178.453 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . 0.425 ' O ' ' HB3' ' A' ' 166' ' ' ARG . 2.6 Cg_endo -52.23 98.59 0.04 OUTLIER 'Trans proline' 0 C--N 1.363 1.306 0 C-N-CA 123.395 2.73 . . . . 0.0 112.206 173.216 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' SER . . . . . 0.481 ' HB2' ' HB2' ' A' ' 168' ' ' ASP . 43.3 t 74.03 141.56 0.07 Allowed 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 124.326 1.05 . . . . 0.0 112.512 -179.534 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.455 HD12 ' HG3' ' A' ' 103' ' ' LYS . 0.0 OUTLIER -76.49 108.37 9.08 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.132 0 CA-C-N 114.999 -1.0 . . . . 0.0 109.005 176.644 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' CYS . . . . . 0.452 ' HG ' ' HB2' ' A' ' 104' ' ' PHE . 25.1 p -91.83 127.22 37.21 Favored 'General case' 0 N--CA 1.431 -1.419 0 CA-C-N 114.838 -1.074 . . . . 0.0 110.56 -179.756 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -107.8 159.59 16.38 Favored 'General case' 0 C--O 1.244 0.766 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.25 -179.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.607 ' O ' ' HA ' ' A' ' 101' ' ' VAL . 2.6 p -156.95 109.01 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.141 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 -178.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . 0.558 ' HA2' ' O ' ' A' ' 100' ' ' SER . . . . . . . . 0 N--CA 1.423 -2.233 0 C-N-CA 119.022 -1.561 . . . . 0.0 114.239 -178.114 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' SER . . . . . 0.558 ' O ' ' HA2' ' A' ' 95' ' ' GLY . 54.3 m . . . . . 0 N--CA 1.429 -1.524 0 CA-C-O 120.634 0.254 . . . . 0.0 110.945 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.607 ' HA ' ' O ' ' A' ' 94' ' ' VAL . 11.3 p -117.27 132.97 65.49 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.507 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 171.771 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.47 ' HG ' ' HA ' ' A' ' 125' ' ' THR . 6.8 tt -152.78 145.41 24.24 Favored 'General case' 0 N--CA 1.405 -2.702 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 -175.642 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.455 ' HG3' HD12 ' A' ' 91' ' ' ILE . 39.8 ttmt -129.99 121.1 25.87 Favored 'General case' 0 C--N 1.291 -1.965 0 N-CA-C 111.937 0.347 . . . . 0.0 111.937 -177.331 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.452 ' HB2' ' HG ' ' A' ' 92' ' ' CYS . 89.4 m-85 -95.36 103.6 15.47 Favored 'General case' 0 N--CA 1.439 -1.008 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 175.293 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 41.1 m -70.82 149.74 46.53 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 109.889 -0.411 . . . . 0.0 109.889 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' THR . . . . . 0.475 ' O ' ' HA ' ' A' ' 87' ' ' LEU . 37.8 p -54.07 -53.75 48.88 Favored 'General case' 0 C--O 1.216 -0.691 0 CA-C-O 121.666 0.746 . . . . 0.0 110.985 -178.26 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 7.5 m -113.73 93.54 4.43 Favored 'General case' 0 N--CA 1.399 -2.994 0 CA-C-N 115.056 -0.974 . . . . 0.0 109.619 -176.408 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.461 HG11 ' CD1' ' A' ' 123' ' ' ILE . 15.1 m -99.46 155.59 4.03 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.546 177.531 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.514 HG23 ' HG2' ' A' ' 83' ' ' LYS . 0.4 OUTLIER -137.24 128.73 28.35 Favored 'General case' 0 N--CA 1.398 -3.072 0 N-CA-C 106.05 -1.833 . . . . 0.0 106.05 -173.831 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . 0.439 ' HA2' ' O ' ' A' ' 119' ' ' ASP . . . -151.12 -174.57 22.15 Favored Glycine 0 C--N 1.286 -2.208 0 C-N-CA 119.979 -1.105 . . . . 0.0 113.714 -175.706 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' HIS . . . . . 0.453 ' O ' HD13 ' A' ' 117' ' ' LEU . 45.0 t60 -91.33 117.93 30.08 Favored 'General case' 0 C--N 1.294 -1.821 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 179.727 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -99.92 117.91 35.22 Favored 'General case' 0 CA--C 1.479 -1.752 0 CA-C-O 121.014 0.435 . . . . 0.0 110.879 -171.132 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -126.74 138.34 53.37 Favored 'General case' 0 CA--C 1.45 -2.881 0 CA-C-N 115.094 -0.957 . . . . 0.0 108.894 167.04 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 6.0 tmtt? -73.47 100.88 3.36 Favored 'General case' 0 N--CA 1.389 -3.482 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 -175.482 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . 0.535 ' O ' HG23 ' A' ' 138' ' ' THR . . . 135.78 -37.63 1.88 Allowed Glycine 0 N--CA 1.419 -2.461 0 N-CA-C 110.169 -1.172 . . . . 0.0 110.169 -176.203 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.547 ' O ' ' HD2' ' A' ' 116' ' ' LYS . 0.0 OUTLIER -154.06 136.96 15.39 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.27 0.628 . . . . 0.0 111.984 -179.441 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.453 HD13 ' O ' ' A' ' 111' ' ' HIS . 64.1 tp -111.43 107.05 16.14 Favored 'General case' 0 C--N 1.308 -1.2 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 -177.274 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 68.1 p -105.56 176.11 5.27 Favored 'General case' 0 C--N 1.296 -1.735 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.637 -179.023 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . 0.439 ' O ' ' HA2' ' A' ' 110' ' ' GLY . 16.2 m-20 56.59 48.66 16.1 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.259 0.623 . . . . 0.0 111.722 172.61 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.466 HG23 ' O ' ' A' ' 133' ' ' VAL . 3.3 m -81.93 96.18 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.656 0 CA-C-O 122.662 1.22 . . . . 0.0 112.29 -176.253 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -75.94 94.12 3.34 Favored 'General case' 0 N--CA 1.401 -2.886 0 CA-C-N 113.253 -1.794 . . . . 0.0 108.438 -178.56 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 134.7 -4.85 4.39 Favored Glycine 0 C--N 1.285 -2.299 0 CA-C-N 115.063 -0.971 . . . . 0.0 111.816 177.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.461 ' CD1' HG11 ' A' ' 108' ' ' VAL . 48.9 mm -99.91 99.58 8.78 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.229 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 177.039 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 53.4 mtmt -93.44 119.26 32.32 Favored 'General case' 0 N--CA 1.411 -2.382 0 CA-C-N 114.355 -1.293 . . . . 0.0 108.605 -179.092 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.47 ' HA ' ' HG ' ' A' ' 102' ' ' LEU . 99.1 m -128.1 131.87 49.01 Favored 'General case' 0 N--CA 1.422 -1.852 0 CA-C-N 114.771 -1.104 . . . . 0.0 112.918 -167.782 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.646 ' HD3' ' C ' ' A' ' 126' ' ' LYS . 0.2 OUTLIER -123.05 119.71 31.16 Favored 'General case' 0 N--CA 1.418 -2.068 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 170.825 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.422 HG21 ' H ' ' A' ' 128' ' ' MET . 4.8 m -139.17 -56.57 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.031 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.388 176.934 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' MET . . . . . 0.422 ' H ' HG21 ' A' ' 127' ' ' VAL . 26.8 ttt -99.57 -34.96 10.02 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 178.168 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . 0.565 ' CD1' ' H ' ' A' ' 130' ' ' TRP . 0.3 OUTLIER -162.57 -177.71 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.418 -2.074 0 N-CA-C 103.499 -2.778 . . . . 0.0 103.499 176.615 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' TRP . . . . . 0.565 ' H ' ' CD1' ' A' ' 129' ' ' ILE . 88.4 t90 -92.29 123.76 35.85 Favored 'General case' 0 C--N 1.296 -1.733 0 CA-C-N 119.55 1.068 . . . . 0.0 109.797 -179.658 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . 0.504 HG12 ' H ' ' A' ' 133' ' ' VAL . 61.1 t -131.55 136.69 56.85 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.08 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 179.631 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . 0.488 ' HD3' ' H ' ' A' ' 132' ' ' LYS . 0.0 OUTLIER -98.89 21.77 11.11 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-O 121.019 0.437 . . . . 0.0 111.237 -178.056 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.504 ' H ' HG12 ' A' ' 131' ' ' VAL . 51.5 t -132.05 -78.73 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.251 0 CA-C-N 116.214 -0.448 . . . . 0.0 109.959 -175.689 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 40.0 p 51.86 -167.01 0.05 OUTLIER 'General case' 0 CA--C 1.555 1.155 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 -177.068 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 27.6 p -164.04 150.39 11.33 Favored 'General case' 0 N--CA 1.429 -1.52 0 C-N-CA 122.637 0.375 . . . . 0.0 110.146 -179.43 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 7.5 tt -105.7 97.41 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.884 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 173.502 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 60.6 p -97.58 142.63 29.16 Favored 'General case' 0 N--CA 1.405 -2.686 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.997 -177.011 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' THR . . . . . 0.535 HG23 ' O ' ' A' ' 115' ' ' GLY . 5.8 t -165.08 175.07 9.72 Favored 'General case' 0 N--CA 1.399 -2.988 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 -177.794 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -110.71 28.52 8.61 Favored 'General case' 0 C--N 1.285 -2.23 0 N-CA-C 106.306 -1.739 . . . . 0.0 106.306 176.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . 61.46 44.06 9.72 Favored 'General case' 0 C--N 1.348 0.529 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 -171.115 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 30.8 t -174.96 -80.29 0.01 OUTLIER 'General case' 0 CA--C 1.555 1.149 0 CA-C-N 114.783 -1.099 . . . . 0.0 110.973 -171.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -83.96 128.6 34.66 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 179.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 88.8 t -105.49 127.83 60.01 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.973 0 CA-C-O 121.516 0.674 . . . . 0.0 112.093 -171.001 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 26.7 m-85 -118.41 141.25 48.74 Favored 'General case' 0 N--CA 1.426 -1.64 0 CA-C-N 115.318 -0.855 . . . . 0.0 111.138 179.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 42.9 m-85 -93.21 98.75 11.48 Favored 'General case' 0 N--CA 1.408 -2.525 0 CA-C-N 114.382 -1.281 . . . . 0.0 108.371 171.377 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . 0.259 2.5 p -98.42 99.71 10.91 Favored 'General case' 0 N--CA 1.406 -2.639 0 N-CA-C 115.061 1.504 . . . . 0.0 115.061 -176.221 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -130.35 29.62 4.84 Favored 'General case' 0 C--N 1.312 -1.031 0 N-CA-C 105.445 -2.057 . . . . 0.0 105.445 174.524 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 133.99 -69.33 0.53 Allowed Glycine 0 N--CA 1.413 -2.847 0 N-CA-C 104.016 -3.633 . . . . 0.0 104.016 -171.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 27.7 ttt 173.3 82.86 0.0 OUTLIER 'General case' 0 C--N 1.314 -0.971 0 C-N-CA 125.885 1.674 . . . . 0.0 108.147 169.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 29.4 mmtt -88.84 -88.74 0.15 Allowed 'General case' 0 C--N 1.308 -1.196 0 N-CA-C 115.09 1.515 . . . . 0.0 115.09 -179.513 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -110.26 149.1 30.65 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 113.354 0.872 . . . . 0.0 113.354 -172.469 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 20.3 m -132.64 137.77 47.12 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.818 -176.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.28 162.84 40.78 Favored 'General case' 0 CA--C 1.477 -1.849 0 CA-C-O 121.317 0.58 . . . . 0.0 111.661 175.129 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 46.4 m -90.18 139.85 30.24 Favored 'General case' 0 C--N 1.274 -2.689 0 CA-C-N 115.284 -0.871 . . . . 0.0 108.858 179.12 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' ARG . . . . . . . . . . . . 0.407 0.0 OUTLIER -58.68 -18.54 31.81 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 114.28 1.215 . . . . 0.0 114.28 -179.783 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -50.06 -32.4 15.46 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 124.632 1.173 . . . . 0.0 111.489 178.494 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -68.04 -54.05 21.26 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 116.576 -0.283 . . . . 0.0 110.827 179.708 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 1.1 t80 177.95 21.6 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.0 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 177.205 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 88.71 -99.41 2.54 Favored Glycine 0 N--CA 1.419 -2.472 0 C-N-CA 119.779 -1.201 . . . . 0.0 111.098 -174.08 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.556 HG22 ' O ' ' A' ' 67' ' ' ILE . 4.2 m -103.09 128.79 55.74 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.304 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 49.9 mt-30 -94.02 92.13 7.19 Favored 'General case' 0 C--N 1.294 -1.824 0 C-N-CA 119.176 -1.01 . . . . 0.0 111.151 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . 0.506 ' CG ' HG11 ' A' ' 94' ' ' VAL . 21.0 tpp180 -152.49 112.2 3.95 Favored 'General case' 0 N--CA 1.414 -2.228 0 N-CA-C 106.857 -1.534 . . . . 0.0 106.857 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 83.7 m-20 -77.05 105.97 8.46 Favored 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 -174.402 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -118.76 -178.22 16.81 Favored Glycine 0 C--N 1.3 -1.434 0 N-CA-C 110.18 -1.168 . . . . 0.0 110.18 176.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . 0.522 ' O ' HD21 ' A' ' 165' ' ' LEU . 0.0 OUTLIER -141.55 131.74 24.89 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 177.431 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . 0.481 ' HD3' ' HB3' ' A' ' 69' ' ' PRO . 9.5 mtm180 -96.05 111.1 23.21 Favored 'General case' 0 CA--C 1.482 -1.667 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 -179.788 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . 0.287 2.6 m -80.84 65.92 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.103 0 CA-C-O 122.906 1.336 . . . . 0.0 111.181 173.32 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . 0.481 ' HB2' ' HB2' ' A' ' 90' ' ' SER . 21.7 t70 -160.87 -27.49 0.06 Allowed 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 112.33 -2.214 . . . . 0.0 108.426 -177.293 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 21.6 pttp -74.85 149.51 39.54 Favored 'General case' 0 C--O 1.244 0.796 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.863 -173.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' PHE . . . . . . . . . . . . . 16.9 p90 . . . . . 0 C--N 1.297 -1.698 0 CA-C-O 118.189 -0.91 . . . . 0.0 110.039 -179.785 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 9.3 mp . . . . . 0 CA--C 1.476 -1.892 0 N-CA-C 116.92 2.193 . . . . 0.0 116.92 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.521 ' O ' ' HG2' ' A' ' 59' ' ' LYS . 25.8 Cg_exo -60.71 -15.53 37.95 Favored 'Trans proline' 0 N--CA 1.45 -1.079 0 C-N-CA 121.613 1.542 . . . . 0.0 111.92 -171.643 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.472 ' O ' ' HB2' ' A' ' 60' ' ' GLU . 22.6 mm-40 -80.27 -37.09 33.55 Favored 'General case' 0 N--CA 1.419 -1.989 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 179.553 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.425 ' HA ' ' HB3' ' A' ' 60' ' ' GLU . 9.3 mp -75.63 -34.27 60.53 Favored 'General case' 0 N--CA 1.438 -1.074 0 N-CA-C 113.557 0.947 . . . . 0.0 113.557 -177.412 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.402 HD11 ' N ' ' A' ' 58' ' ' LEU . 3.5 mp -63.14 -45.74 90.5 Favored 'General case' 0 N--CA 1.499 2.025 0 C-N-CA 119.29 -0.964 . . . . 0.0 109.365 -178.618 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.543 ' O ' ' HB3' ' A' ' 62' ' ' ASP . 0.0 OUTLIER -75.77 -25.85 56.82 Favored 'General case' 0 C--N 1.297 -1.689 0 CA-C-N 114.833 -1.076 . . . . 0.0 112.33 176.395 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.472 ' HB2' ' O ' ' A' ' 56' ' ' GLU . 9.3 tp10 -63.18 -54.47 37.01 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 179.46 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 86.8 m-85 -74.23 3.89 6.54 Favored 'General case' 0 CA--C 1.511 -0.53 0 CA-C-O 121.839 0.828 . . . . 0.0 111.688 -178.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.543 ' HB3' ' O ' ' A' ' 59' ' ' LYS . 9.2 t70 -88.85 -177.03 5.41 Favored 'General case' 0 C--N 1.276 -2.626 0 CA-C-N 113.998 -1.455 . . . . 0.0 109.659 178.651 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.525 ' HB3' HG21 ' A' ' 138' ' ' THR . 3.0 mt -80.2 -168.35 0.17 Allowed Pre-proline 0 CA--C 1.582 2.2 0 N-CA-C 106.215 -1.772 . . . . 0.0 106.215 178.454 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.646 ' HG3' ' N ' ' A' ' 141' ' ' SER . 41.8 Cg_endo -94.26 6.62 2.5 Favored 'Trans proline' 0 N--CA 1.442 -1.505 0 CA-C-N 121.991 1.747 . . . . 0.0 111.539 -176.836 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.567 HG12 ' H ' ' A' ' 67' ' ' ILE . 0.1 OUTLIER -69.45 -46.65 75.78 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.874 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 179.801 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.462 ' H ' HD13 ' A' ' 65' ' ' ILE . . . 57.06 9.55 4.14 Favored Glycine 0 N--CA 1.482 1.735 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.57 -174.286 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.567 ' H ' HG12 ' A' ' 65' ' ' ILE . 68.3 mt 58.11 -70.66 0.07 OUTLIER 'Isoleucine or valine' 0 C--O 1.189 -2.129 0 C-N-CA 128.135 2.574 . . . . 0.0 111.405 -171.25 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.422 ' HB3' ' HD3' ' A' ' 69' ' ' PRO . 77.4 t80 -177.7 -55.83 0.0 OUTLIER Pre-proline 0 C--N 1.306 -1.289 0 CA-C-N 117.805 0.275 . . . . 0.0 111.146 -175.476 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.422 ' HD3' ' HB3' ' A' ' 68' ' ' PHE . 8.5 Cg_endo -96.91 -172.2 0.18 Allowed 'Trans proline' 0 N--CA 1.442 -1.558 0 C-N-CA 122.508 2.139 . . . . 0.0 112.187 -175.683 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -104.17 12.72 52.16 Favored Glycine 0 N--CA 1.436 -1.316 0 N-CA-C 110.62 -0.992 . . . . 0.0 110.62 175.294 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.407 ' H ' ' HB2' ' A' ' 69' ' ' PRO . 1.8 p30 -101.19 -56.68 2.25 Favored 'General case' 0 N--CA 1.419 -2.012 0 CA-C-N 115.422 -0.389 . . . . 0.0 110.421 179.678 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.402 ' O ' ' HB ' ' A' ' 73' ' ' THR . . . -67.37 167.46 12.48 Favored 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 123.379 0.672 . . . . 0.0 111.209 172.366 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.72 HG23 ' O ' ' A' ' 73' ' ' THR . 96.7 m 87.88 27.97 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.813 0 CA-C-O 124.518 2.104 . . . . 0.0 111.128 175.366 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.578 ' O ' ' HA ' ' A' ' 86' ' ' VAL . 0.8 OUTLIER -76.0 145.65 40.11 Favored 'General case' 0 C--N 1.267 -3.017 0 CA-C-N 114.575 -1.193 . . . . 0.0 109.456 174.721 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 42.6 t80 -121.25 98.57 6.04 Favored 'General case' 0 C--N 1.282 -2.341 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.633 -169.206 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 32.8 mm-40 -128.12 115.63 18.71 Favored 'General case' 0 C--O 1.212 -0.878 0 C-N-CA 123.35 0.66 . . . . 0.0 110.151 178.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 36.1 p90 -123.04 143.17 50.13 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 -178.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.47 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 10.5 m-20 -96.27 169.36 9.99 Favored 'General case' 0 CA--C 1.487 -1.452 0 C-N-CA 118.876 -1.13 . . . . 0.0 108.955 178.604 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -79.75 -64.01 1.28 Allowed 'General case' 0 C--N 1.279 -2.477 0 CA-C-N 114.644 -1.162 . . . . 0.0 111.396 -176.543 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -68.21 -45.5 73.17 Favored 'General case' 0 CA--C 1.498 -1.054 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.575 -177.104 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.47 ' HB ' ' HB2' ' A' ' 78' ' ' ASP . 10.5 m -57.68 -49.45 76.45 Favored 'General case' 0 N--CA 1.419 -2.021 0 CA-C-N 114.232 -1.349 . . . . 0.0 111.823 -176.58 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt 65.35 16.19 10.4 Favored 'General case' 0 N--CA 1.488 1.453 0 CA-C-O 121.916 0.865 . . . . 0.0 111.493 -176.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.453 ' HB3' HG21 ' A' ' 81' ' ' THR . 39.4 ttpt -115.18 131.08 57.04 Favored 'General case' 0 N--CA 1.42 -1.953 0 N-CA-C 106.299 -1.741 . . . . 0.0 106.299 177.607 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.523 ' O ' ' HA ' ' A' ' 109' ' ' THR . 7.0 tt -103.59 142.79 33.69 Favored 'General case' 0 C--N 1.284 -2.25 0 O-C-N 123.68 0.612 . . . . 0.0 109.901 -175.657 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.438 ' HA ' ' O ' ' A' ' 108' ' ' VAL . 9.3 t -113.42 121.3 43.92 Favored 'General case' 0 N--CA 1.406 -2.661 0 CA-C-O 121.879 0.847 . . . . 0.0 110.429 178.803 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.578 ' HA ' ' O ' ' A' ' 74' ' ' ASN . 86.7 t -93.34 118.99 40.36 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.746 0 CA-C-N 114.905 -1.043 . . . . 0.0 108.438 174.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 5.4 mp -80.95 116.2 20.8 Favored 'General case' 0 C--O 1.249 1.056 0 O-C-N 123.711 0.632 . . . . 0.0 110.389 -179.094 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.581 ' O ' ' HA ' ' A' ' 106' ' ' THR . 42.1 mm -108.12 128.4 25.8 Favored Pre-proline 0 C--N 1.285 -2.201 0 N-CA-C 106.593 -1.632 . . . . 0.0 106.593 176.614 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -58.84 111.74 0.98 Allowed 'Trans proline' 0 N--CA 1.45 -1.083 0 C-N-CA 122.062 1.841 . . . . 0.0 111.351 176.531 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 22.7 t 67.42 -169.01 0.2 Allowed 'General case' 0 N--CA 1.443 -0.812 0 O-C-N 124.117 0.886 . . . . 0.0 110.847 178.01 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.439 HG12 ' OE2' ' A' ' 93' ' ' GLU . 10.3 tt -112.2 109.4 28.4 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.278 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 176.481 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' CYS . . . . . 0.629 ' SG ' ' HB2' ' A' ' 104' ' ' PHE . 16.1 p -108.89 124.84 51.28 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-N 115.723 -0.672 . . . . 0.0 112.55 -174.057 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.439 ' OE2' HG12 ' A' ' 91' ' ' ILE . 4.9 mp0 -107.27 156.94 18.32 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 174.194 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 3.4 p -128.76 111.9 24.62 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.756 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 173.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.435 -1.417 0 N-CA-C 110.448 -1.061 . . . . 0.0 110.448 -179.826 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 47.4 t . . . . . 0 N--CA 1.43 -1.431 0 N-CA-C 107.102 -1.444 . . . . 0.0 107.102 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 94.5 t -128.28 127.87 67.86 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 -179.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.402 HD22 ' N ' ' A' ' 102' ' ' LEU . 0.7 OUTLIER -158.0 166.88 31.43 Favored 'General case' 0 C--N 1.309 -1.17 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 -175.084 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.434 ' HD2' HD13 ' A' ' 91' ' ' ILE . 38.5 ttpt -132.92 133.56 43.39 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.304 -175.707 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.629 ' HB2' ' SG ' ' A' ' 92' ' ' CYS . 77.9 m-85 -117.2 110.38 18.07 Favored 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 107.567 -1.271 . . . . 0.0 107.567 175.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 12.9 t -88.99 171.57 9.76 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 -177.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' THR . . . . . 0.581 ' HA ' ' O ' ' A' ' 88' ' ' ILE . 32.5 m -58.49 -50.31 74.21 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 112.919 0.711 . . . . 0.0 112.919 -175.249 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 23.3 p -116.78 94.36 4.57 Favored 'General case' 0 C--N 1.296 -1.719 0 C-N-CA 119.414 -0.914 . . . . 0.0 112.458 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.438 ' O ' ' HA ' ' A' ' 85' ' ' THR . 43.5 t -93.16 125.45 45.72 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.486 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 175.437 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.523 ' HA ' ' O ' ' A' ' 84' ' ' LEU . 8.1 p -107.81 154.1 22.03 Favored 'General case' 0 N--CA 1.4 -2.941 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.48 -177.088 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 175.28 -173.98 46.54 Favored Glycine 0 C--N 1.283 -2.364 0 N-CA-C 110.506 -1.038 . . . . 0.0 110.506 178.327 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 59.9 m-70 -99.25 91.53 5.01 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 178.182 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.416 ' HB3' HD12 ' A' ' 84' ' ' LEU . 5.3 tt -97.7 112.56 24.4 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 -175.121 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -116.21 160.25 20.67 Favored 'General case' 0 CA--C 1.458 -2.584 0 CA-C-N 114.9 -1.046 . . . . 0.0 108.569 175.504 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 2.3 tmtp? -71.51 103.72 3.05 Favored 'General case' 0 C--N 1.255 -3.503 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 -177.062 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 116.15 -10.07 17.77 Favored Glycine 0 C--O 1.186 -2.872 0 C-N-CA 120.516 -0.85 . . . . 0.0 111.944 -178.285 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -174.88 134.77 0.36 Allowed 'General case' 0 N--CA 1.488 1.465 0 CA-C-N 118.088 0.944 . . . . 0.0 111.888 176.768 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.3 tt -110.6 114.98 28.79 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 105.772 -1.936 . . . . 0.0 105.772 175.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.406 ' HA ' ' HB3' ' A' ' 135' ' ' SER . 75.1 p -103.35 135.06 45.68 Favored 'General case' 0 C--N 1.278 -2.539 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 -177.079 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . 0.394 4.0 p-10 48.61 97.47 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 115.878 1.807 . . . . 0.0 115.878 -178.63 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.436 HG22 ' O ' ' A' ' 134' ' ' THR . 13.0 m -87.44 118.02 32.54 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.086 0 CA-C-N 114.637 -1.165 . . . . 0.0 110.334 -179.687 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -97.08 92.36 6.02 Favored 'General case' 0 C--N 1.252 -3.67 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 179.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 140.92 -15.93 2.82 Favored Glycine 0 C--N 1.302 -1.323 0 C-N-CA 119.968 -1.111 . . . . 0.0 112.932 177.268 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 80.4 mt -100.37 104.81 16.68 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 CA-C-O 121.767 0.794 . . . . 0.0 111.235 -179.282 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -86.45 121.24 28.72 Favored 'General case' 0 N--CA 1.433 -1.312 0 N-CA-C 106.104 -1.813 . . . . 0.0 106.104 176.447 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 12.8 t -133.37 162.3 32.21 Favored 'General case' 0 N--CA 1.412 -2.347 0 CA-C-O 121.515 0.674 . . . . 0.0 110.644 -176.398 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.482 ' HD3' ' C ' ' A' ' 126' ' ' LYS . 1.0 OUTLIER -126.1 119.92 28.83 Favored 'General case' 0 N--CA 1.396 -3.137 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 173.051 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 59.9 t -109.38 -78.38 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.838 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 179.202 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -96.93 -35.75 10.78 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 105.636 -1.987 . . . . 0.0 105.636 171.771 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . 0.495 HG13 ' H ' ' A' ' 130' ' ' TRP . 9.6 tp -146.98 176.06 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.419 -1.981 0 N-CA-C 106.636 -1.616 . . . . 0.0 106.636 176.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' TRP . . . . . 0.495 ' H ' HG13 ' A' ' 129' ' ' ILE . 6.2 m-90 -74.81 132.61 41.69 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 122.767 0.427 . . . . 0.0 111.041 -177.189 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . 0.436 HG21 ' H ' ' A' ' 133' ' ' VAL . 8.4 p -149.64 147.09 16.61 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.09 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 175.227 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 57.7 pttt -111.09 -4.23 15.15 Favored 'General case' 0 C--N 1.31 -1.128 0 C-N-CA 119.537 -0.865 . . . . 0.0 111.774 178.189 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.436 ' H ' HG21 ' A' ' 131' ' ' VAL . 7.4 p -123.79 103.8 13.25 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 CA-C-O 122.001 0.905 . . . . 0.0 110.862 178.746 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' THR . . . . . 0.436 ' O ' HG22 ' A' ' 120' ' ' VAL . 8.3 t -144.91 169.95 17.09 Favored 'General case' 0 C--N 1.293 -1.863 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 -179.494 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' SER . . . . . 0.406 ' HB3' ' HA ' ' A' ' 118' ' ' THR . 26.9 m -122.65 168.64 11.94 Favored 'General case' 0 N--CA 1.409 -2.508 0 N-CA-C 109.924 -0.398 . . . . 0.0 109.924 178.678 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 11.8 tt -134.92 98.05 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.767 0 CA-C-O 122.382 1.087 . . . . 0.0 108.797 175.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 73.9 p -89.93 158.67 17.3 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-N 114.608 -1.178 . . . . 0.0 110.453 -176.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' THR . . . . . 0.525 HG21 ' HB3' ' A' ' 63' ' ' LEU . 9.8 t -166.01 178.56 6.33 Favored 'General case' 0 N--CA 1.418 -2.069 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 -179.638 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -118.66 26.93 9.23 Favored 'General case' 0 C--N 1.273 -2.718 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 175.187 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . 60.65 36.56 19.58 Favored 'General case' 0 C--N 1.354 0.793 0 CA-C-N 114.379 -1.282 . . . . 0.0 108.274 -173.371 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' SER . . . . . 0.646 ' N ' ' HG3' ' A' ' 64' ' ' PRO . 46.8 t -171.01 -78.68 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 114.092 -1.413 . . . . 0.0 109.825 -173.248 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.1 130.34 36.28 Favored 'General case' 0 CA--C 1.498 -1.029 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 176.352 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.503 ' HB ' ' O ' ' A' ' 153' ' ' ARG . 42.4 t -108.35 143.2 19.15 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 CA-C-O 121.108 0.48 . . . . 0.0 111.47 -171.336 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 91.1 m-85 -135.82 123.32 22.11 Favored 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 178.018 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 42.8 t80 -93.61 117.16 29.73 Favored 'General case' 0 C--N 1.288 -2.088 0 N-CA-C 106.708 -1.59 . . . . 0.0 106.708 -178.493 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' THR . . . . . 0.438 ' C ' ' H ' ' A' ' 148' ' ' GLY . 62.9 p -76.24 -89.87 0.03 OUTLIER 'General case' 0 N--CA 1.425 -1.701 0 N-CA-C 114.94 1.459 . . . . 0.0 114.94 -169.164 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . 67.17 -42.59 0.43 Allowed 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 125.244 1.418 . . . . 0.0 112.047 -175.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . 0.438 ' H ' ' C ' ' A' ' 146' ' ' THR . . . 177.94 44.9 0.07 OUTLIER Glycine 0 N--CA 1.412 -2.937 0 N-CA-C 107.349 -2.3 . . . . 0.0 107.349 178.437 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 65.6 mtt 58.22 40.14 25.1 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 124.003 0.921 . . . . 0.0 109.715 -176.278 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -89.03 -48.55 7.34 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 115.805 1.78 . . . . 0.0 115.805 -169.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . 0.442 ' HA ' ' HE2' ' A' ' 151' ' ' LYS . 8.2 mmpt? -125.44 162.86 23.91 Favored 'General case' 0 N--CA 1.483 1.216 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 -172.227 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 57.3 p -119.73 158.34 26.71 Favored 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 174.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' ARG . . . . . 0.503 ' O ' ' HB ' ' A' ' 143' ' ' VAL . 3.8 tpm_? -149.92 120.5 7.47 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 109.082 -0.711 . . . . 0.0 109.082 -178.028 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 17.8 m -87.91 143.78 26.93 Favored 'General case' 0 C--N 1.308 -1.226 0 C-N-CA 120.122 -0.631 . . . . 0.0 110.835 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' ARG . . . . . 0.416 ' HD3' ' HB2' ' A' ' 64' ' ' PRO . 32.6 ttp180 -70.67 -34.5 72.08 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 115.608 -0.723 . . . . 0.0 110.121 179.06 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -45.85 -40.82 10.4 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 116.706 2.113 . . . . 0.0 116.706 -170.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -70.95 -56.43 6.22 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 119.019 -1.072 . . . . 0.0 112.077 -174.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 67.9 m-85 -171.63 19.16 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.765 0 C-N-CA 124.556 1.143 . . . . 0.0 108.934 -179.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . 0.42 ' HA3' ' O ' ' A' ' 65' ' ' ILE . . . 84.76 -97.19 2.1 Favored Glycine 0 N--CA 1.427 -1.942 0 C-N-CA 119.011 -1.566 . . . . 0.0 110.224 -171.704 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.47 HG23 ' HB ' ' A' ' 65' ' ' ILE . 90.2 t -127.65 113.41 31.31 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.521 0 CA-C-O 121.828 0.823 . . . . 0.0 110.651 -178.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -121.71 107.06 11.91 Favored 'General case' 0 C--N 1.295 -1.804 0 C-N-CA 119.424 -0.91 . . . . 0.0 113.167 -176.005 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 30.4 mmm180 -130.66 137.49 49.6 Favored 'General case' 0 C--N 1.292 -1.92 0 N-CA-C 106.337 -1.727 . . . . 0.0 106.337 172.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -77.25 74.53 3.82 Favored 'General case' 0 C--N 1.289 -2.056 0 N-CA-C 113.699 1.0 . . . . 0.0 113.699 -172.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -111.59 129.02 8.92 Favored Glycine 0 N--CA 1.424 -2.136 0 N-CA-C 109.25 -1.54 . . . . 0.0 109.25 176.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -91.56 112.65 24.65 Favored 'General case' 0 N--CA 1.42 -1.963 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 -177.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . 0.404 ' HA ' ' HB3' ' A' ' 92' ' ' CYS . 65.9 mtt85 -79.45 102.58 8.84 Favored 'General case' 0 N--CA 1.417 -2.12 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 179.027 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 25.2 t -66.01 82.55 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 O-C-N 124.077 0.861 . . . . 0.0 110.063 -178.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 22.1 t70 176.74 -24.65 0.0 OUTLIER 'General case' 0 C--N 1.287 -2.114 0 N-CA-C 106.236 -1.765 . . . . 0.0 106.236 -171.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 2.9 tppp? -79.2 106.48 11.26 Favored 'General case' 0 N--CA 1.425 -1.678 0 CA-C-N 114.145 -1.389 . . . . 0.0 111.899 179.312 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' PHE . . . . . . . . . . . . . 47.3 p90 . . . . . 0 C--N 1.293 -1.888 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 173.632 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.594 ' N ' ' HD3' ' A' ' 55' ' ' PRO . 10.2 mp . . . . . 0 N--CA 1.443 -0.805 0 N-CA-C 116.904 2.187 . . . . 0.0 116.904 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.724 ' HA ' ' CD1' ' A' ' 58' ' ' LEU . 7.6 Cg_exo -66.08 -15.12 47.38 Favored 'Trans proline' 0 N--CA 1.425 -2.507 0 CA-C-N 121.134 1.441 . . . . 0.0 115.568 -161.018 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 32.3 mm-40 -79.34 -29.69 42.36 Favored 'General case' 0 N--CA 1.425 -1.691 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.705 ' O ' ' HB3' ' A' ' 60' ' ' GLU . 10.6 mt -76.41 -31.66 58.06 Favored 'General case' 0 C--O 1.207 -1.14 0 CA-C-N 114.652 -1.158 . . . . 0.0 110.061 -177.582 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.724 ' CD1' ' HA ' ' A' ' 55' ' ' PRO . 8.2 mt -70.41 -54.32 12.87 Favored 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 -174.383 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.623 ' HG2' ' O ' ' A' ' 55' ' ' PRO . 17.1 ptpt -64.02 -25.08 67.96 Favored 'General case' 0 C--O 1.191 -2.009 0 CA-C-N 114.885 -1.052 . . . . 0.0 111.398 176.76 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.705 ' HB3' ' O ' ' A' ' 57' ' ' LEU . 7.1 tp10 -54.95 -56.4 20.11 Favored 'General case' 0 C--N 1.295 -1.773 0 O-C-N 121.954 -0.467 . . . . 0.0 111.13 172.361 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 45.2 m-85 -78.54 -40.2 35.68 Favored 'General case' 0 CA--C 1.489 -1.375 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 -175.321 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.43 ' OD2' ' HG ' ' A' ' 112' ' ' LEU . 5.9 m-20 -87.42 18.34 3.9 Favored 'General case' 0 C--N 1.294 -1.833 0 CA-C-N 113.686 -1.597 . . . . 0.0 113.262 -174.256 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.48 HD13 ' OG1' ' A' ' 138' ' ' THR . 21.5 mt 79.79 151.24 0.12 Allowed Pre-proline 0 N--CA 1.475 0.82 0 C-N-CA 125.184 1.393 . . . . 0.0 112.703 174.303 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_endo -80.65 15.07 1.86 Allowed 'Trans proline' 0 N--CA 1.443 -1.468 0 C-N-CA 122.697 2.265 . . . . 0.0 113.546 -166.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.598 ' O ' ' HA3' ' A' ' 159' ' ' GLY . 0.2 OUTLIER -69.5 -36.73 72.68 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.811 0 N-CA-C 106.753 -1.573 . . . . 0.0 106.753 173.029 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 54.34 8.68 1.24 Allowed Glycine 0 C--N 1.339 0.731 0 CA-C-N 114.771 -1.104 . . . . 0.0 115.287 175.149 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.727 ' O ' ' HB ' ' A' ' 160' ' ' VAL 0.252 27.7 mt 72.71 -45.66 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.031 0 N-CA-C 114.527 1.306 . . . . 0.0 114.527 -179.9 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.557 ' HB2' ' O ' ' A' ' 67' ' ' ILE . 40.2 t80 164.99 -56.4 0.0 OUTLIER Pre-proline 0 CA--C 1.54 0.574 0 C-N-CA 124.155 0.982 . . . . 0.0 110.597 173.826 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -102.07 -160.31 0.04 OUTLIER 'Trans proline' 0 N--CA 1.43 -2.246 0 C-N-CA 122.533 2.155 . . . . 0.0 113.123 -169.58 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -100.96 29.08 13.28 Favored Glycine 0 N--CA 1.428 -1.868 0 N-CA-C 109.656 -1.378 . . . . 0.0 109.656 174.102 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.492 ' OD1' ' HD3' ' A' ' 89' ' ' PRO . 8.8 t0 -140.84 176.67 8.61 Favored 'General case' 0 N--CA 1.42 -1.949 0 N-CA-C 102.928 -2.99 . . . . 0.0 102.928 177.111 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.582 ' O ' HG21 ' A' ' 73' ' ' THR . . . 57.8 -177.73 0.07 Allowed 'General case' 0 N--CA 1.483 1.185 0 CA-C-N 118.977 0.808 . . . . 0.0 109.871 -170.635 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.582 HG21 ' O ' ' A' ' 72' ' ' ALA . 5.2 t 65.36 16.7 10.67 Favored 'General case' 0 N--CA 1.515 2.775 0 C-N-CA 125.06 1.344 . . . . 0.0 109.523 172.256 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.592 ' O ' ' HA ' ' A' ' 86' ' ' VAL . 37.3 m-80 -68.45 135.8 52.25 Favored 'General case' 0 N--CA 1.414 -2.25 0 CA-C-N 113.366 -1.743 . . . . 0.0 114.127 -176.154 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.499 ' CD2' HD12 ' A' ' 84' ' ' LEU . 48.3 t80 -98.88 106.22 18.46 Favored 'General case' 0 C--N 1.272 -2.797 0 CA-C-N 113.247 -1.797 . . . . 0.0 109.949 -177.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -137.81 141.34 40.83 Favored 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 176.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 48.1 p90 -144.49 150.95 38.44 Favored 'General case' 0 C--N 1.301 -1.512 0 C-N-CA 120.283 -0.567 . . . . 0.0 110.675 -177.283 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.545 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 11.0 m-20 -97.1 170.72 8.94 Favored 'General case' 0 CA--C 1.486 -1.489 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 174.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -79.81 -71.46 0.45 Allowed 'General case' 0 C--N 1.278 -2.53 0 CA-C-N 115.283 -0.871 . . . . 0.0 113.021 -175.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -72.94 -42.27 63.62 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 121.583 0.706 . . . . 0.0 110.654 -175.088 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.545 ' HB ' ' HB2' ' A' ' 78' ' ' ASP . 19.8 m -55.7 -41.15 73.38 Favored 'General case' 0 N--CA 1.431 -1.41 0 CA-C-N 114.645 -1.161 . . . . 0.0 110.9 179.54 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 71.8 mmtt 59.85 9.9 1.89 Allowed 'General case' 0 N--CA 1.482 1.165 0 N-CA-C 113.04 0.756 . . . . 0.0 113.04 178.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 27.8 pttt -98.77 134.12 42.11 Favored 'General case' 0 N--CA 1.402 -2.85 0 N-CA-C 105.13 -2.174 . . . . 0.0 105.13 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.511 ' O ' ' HA ' ' A' ' 109' ' ' THR . 6.9 tt -89.36 143.24 26.98 Favored 'General case' 0 C--N 1.282 -2.33 0 C-N-CA 120.142 -0.623 . . . . 0.0 109.492 -174.22 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.501 ' N ' HD22 ' A' ' 84' ' ' LEU . 2.7 t -116.5 107.19 14.45 Favored 'General case' 0 N--CA 1.415 -2.199 0 CA-C-O 121.692 0.758 . . . . 0.0 111.722 -179.61 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.592 ' HA ' ' O ' ' A' ' 74' ' ' ASN . 73.0 t -89.84 108.96 19.95 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.224 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 173.76 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . 0.272 0.8 OUTLIER -96.71 118.2 32.66 Favored 'General case' 0 N--CA 1.394 -3.262 0 CA-C-O 122.605 1.193 . . . . 0.0 111.852 -179.79 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 55.9 mt -97.46 142.42 24.52 Favored Pre-proline 0 C--N 1.277 -2.577 0 N-CA-C 104.399 -2.445 . . . . 0.0 104.399 178.178 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . 0.492 ' HD3' ' OD1' ' A' ' 71' ' ' ASP . 30.9 Cg_endo -59.53 -18.04 44.7 Favored 'Trans proline' 0 C--N 1.328 -0.532 0 C-N-CA 122.968 2.446 . . . . 0.0 112.914 -178.077 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 6.5 m -154.44 167.42 30.08 Favored 'General case' 0 N--CA 1.422 -1.843 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 -172.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 14.2 tt -85.74 108.49 17.41 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.295 0 N-CA-C 105.968 -1.864 . . . . 0.0 105.968 166.614 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' CYS . . . . . 0.502 ' SG ' ' HA3' ' A' ' 164' ' ' GLY . 48.2 t -119.19 123.38 44.19 Favored 'General case' 0 C--N 1.292 -1.916 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 -176.358 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.418 ' CB ' ' HA ' ' A' ' 103' ' ' LYS . 12.7 pt-20 -119.49 150.6 39.97 Favored 'General case' 0 C--N 1.284 -2.277 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.908 -174.182 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.455 ' CG1' ' H ' ' A' ' 163' ' ' ASN . 34.5 m -130.29 102.2 6.67 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.485 0 CA-C-O 121.871 0.843 . . . . 0.0 111.385 179.807 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . 0.499 ' HA2' ' O ' ' A' ' 100' ' ' SER . . . . . . . . 0 CA--C 1.48 -2.117 0 N-CA-C 108.121 -1.992 . . . . 0.0 108.121 172.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' SER . . . . . 0.499 ' O ' ' HA2' ' A' ' 95' ' ' GLY . 34.2 t . . . . . 0 N--CA 1.409 -2.523 0 CA-C-O 121.342 0.592 . . . . 0.0 109.677 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 48.2 t -109.33 99.56 8.93 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 CA-C-N 115.084 -0.962 . . . . 0.0 109.491 176.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.466 ' HG ' ' HA ' ' A' ' 125' ' ' THR . 7.8 mp -110.07 127.93 55.14 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.157 179.617 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.418 ' HA ' ' CB ' ' A' ' 93' ' ' GLU . 23.8 ttmm -106.5 109.01 20.81 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 177.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 78.9 m-85 -94.81 105.68 17.63 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-N 116.068 -0.514 . . . . 0.0 109.788 179.469 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 49.7 m -61.75 151.37 34.21 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 115.276 -0.875 . . . . 0.0 111.006 178.585 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 7.3 m -51.5 -43.69 62.31 Favored 'General case' 0 C--O 1.215 -0.748 0 C-N-CA 125.241 1.417 . . . . 0.0 110.289 179.344 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 85.5 m -120.21 101.19 7.64 Favored 'General case' 0 N--CA 1.423 -1.777 0 CA-C-O 121.137 0.494 . . . . 0.0 109.761 178.46 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 13.5 m -108.71 114.77 47.65 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.059 0 CA-C-O 121.951 0.881 . . . . 0.0 111.176 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.511 ' HA ' ' O ' ' A' ' 84' ' ' LEU . 20.9 p -107.76 166.42 10.71 Favored 'General case' 0 N--CA 1.405 -2.693 0 CA-C-N 114.449 -1.251 . . . . 0.0 111.02 -176.528 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 167.84 -164.06 37.65 Favored Glycine 0 N--CA 1.41 -3.054 0 C-N-CA 120.323 -0.941 . . . . 0.0 111.565 177.052 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 52.0 t60 -103.3 99.81 9.67 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.43 ' HG ' ' OD2' ' A' ' 62' ' ' ASP . 3.0 tm? -103.55 125.29 50.0 Favored 'General case' 0 CA--C 1.483 -1.611 0 CA-C-N 115.635 -0.712 . . . . 0.0 110.2 -172.675 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -122.41 149.24 44.09 Favored 'General case' 0 N--CA 1.402 -2.871 0 CA-C-N 114.75 -1.113 . . . . 0.0 108.994 172.259 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -68.95 100.59 1.23 Allowed 'General case' 0 N--CA 1.402 -2.866 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 -179.091 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . 0.478 ' N ' HD23 ' A' ' 63' ' ' LEU . . . 135.52 -45.44 1.1 Allowed Glycine 0 C--N 1.282 -2.459 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 -175.738 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.417 ' O ' ' HD2' ' A' ' 116' ' ' LYS . 0.7 OUTLIER -150.2 133.5 16.37 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 114.074 1.139 . . . . 0.0 114.074 -178.382 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.521 ' O ' ' HB2' ' A' ' 135' ' ' SER . 40.6 tp -97.51 113.52 25.24 Favored 'General case' 0 C--N 1.309 -1.163 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 175.549 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 19.8 p -114.71 140.81 48.56 Favored 'General case' 0 C--N 1.285 -2.225 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.547 -178.593 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 66.18 100.61 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.93 0.892 . . . . 0.0 111.097 179.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 4.1 m -107.37 103.25 15.18 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.674 0 N-CA-C 113.974 1.102 . . . . 0.0 113.974 -177.355 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -84.66 84.26 7.74 Favored 'General case' 0 C--N 1.29 -2.013 0 CA-C-N 114.632 -1.167 . . . . 0.0 108.534 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 133.6 -12.4 4.87 Favored Glycine 0 N--CA 1.435 -1.384 0 CA-C-N 115.289 -0.869 . . . . 0.0 113.038 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 71.7 mt -100.28 99.95 9.46 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.112 0 CA-C-O 121.817 0.818 . . . . 0.0 109.716 179.213 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -91.18 118.18 30.24 Favored 'General case' 0 C--N 1.29 -2.004 0 CA-C-N 114.791 -1.095 . . . . 0.0 108.429 -177.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.466 ' HA ' ' HG ' ' A' ' 102' ' ' LEU . 62.1 m -115.46 113.53 23.83 Favored 'General case' 0 N--CA 1.426 -1.64 0 N-CA-C 112.913 0.708 . . . . 0.0 112.913 -173.137 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.42 ' O ' ' HA ' ' A' ' 100' ' ' SER . 39.0 tttp -105.13 121.82 44.61 Favored 'General case' 0 N--CA 1.415 -2.203 0 C-N-CA 119.137 -1.025 . . . . 0.0 108.644 169.676 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.487 ' O ' ' HB3' ' A' ' 128' ' ' MET . 27.2 t -144.76 104.09 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.278 -2.534 0 N-CA-C 103.29 -2.856 . . . . 0.0 103.29 170.547 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' MET . . . . . 0.487 ' HB3' ' O ' ' A' ' 127' ' ' VAL . 26.3 ttt 74.17 -52.29 0.69 Allowed 'General case' 0 C--N 1.321 -0.658 0 O-C-N 124.487 1.117 . . . . 0.0 109.55 -172.241 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 8.7 tp -136.88 152.96 29.2 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 N-CA-C 109.063 -0.718 . . . . 0.0 109.063 175.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 20.4 t-105 -81.49 117.8 22.2 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 123.526 0.731 . . . . 0.0 109.863 -177.028 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . 0.415 HG12 ' H ' ' A' ' 133' ' ' VAL . 41.4 t -138.09 120.48 18.85 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.129 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 178.728 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 65.7 pttt -91.46 11.34 24.29 Favored 'General case' 0 C--N 1.312 -1.029 0 O-C-N 121.738 -0.601 . . . . 0.0 111.599 -177.2 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.415 ' H ' HG12 ' A' ' 131' ' ' VAL . 34.1 m -120.59 -1.59 8.21 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.107 0 C-N-CA 119.647 -0.821 . . . . 0.0 112.885 -175.586 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' THR . . . . . 0.689 ' O ' ' HB ' ' A' ' 146' ' ' THR . 18.2 p -74.13 101.63 3.99 Favored 'General case' 0 N--CA 1.425 -1.709 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 176.5 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' SER . . . . . 0.521 ' HB2' ' O ' ' A' ' 117' ' ' LEU . 12.4 p -94.48 170.03 9.78 Favored 'General case' 0 N--CA 1.412 -2.338 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 -177.665 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 15.2 tt -100.77 122.35 52.68 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.155 0 CA-C-O 121.685 0.755 . . . . 0.0 111.555 -170.355 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' SER . . . . . 0.412 ' C ' ' HG1' ' A' ' 138' ' ' THR . 25.9 m -109.32 147.4 32.74 Favored 'General case' 0 N--CA 1.433 -1.297 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.023 -177.726 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' THR . . . . . 0.487 HG22 ' H ' ' A' ' 141' ' ' SER . 33.0 m -146.85 174.03 11.86 Favored 'General case' 0 C--N 1.295 -1.787 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 -174.671 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -110.24 28.75 8.32 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 172.396 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . 59.79 43.74 14.86 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 -172.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' SER . . . . . 0.487 ' H ' HG22 ' A' ' 138' ' ' THR . 35.1 t 176.78 -82.57 0.0 OUTLIER 'General case' 0 CA--C 1.545 0.77 0 CA-C-N 114.755 -1.111 . . . . 0.0 110.338 -173.59 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 24.7 pttm -89.29 150.91 22.39 Favored 'General case' 0 CA--C 1.503 -0.858 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.419 HG21 ' OG1' ' A' ' 138' ' ' THR . 13.8 p -131.52 149.38 33.01 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.337 0 N-CA-C 114.281 1.215 . . . . 0.0 114.281 -168.656 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -112.44 143.48 43.51 Favored 'General case' 0 N--CA 1.428 -1.528 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 169.063 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 48.7 t80 -67.87 165.58 17.31 Favored 'General case' 0 C--N 1.305 -1.353 0 C-N-CA 122.93 0.492 . . . . 0.0 109.987 -173.18 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' THR . . . . . 0.689 ' HB ' ' O ' ' A' ' 134' ' ' THR . 41.6 p -50.88 -53.16 34.88 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 120.985 0.421 . . . . 0.0 111.531 -176.511 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -84.95 97.33 9.73 Favored 'General case' 0 N--CA 1.424 -1.754 0 N-CA-C 105.735 -1.95 . . . . 0.0 105.735 170.227 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -81.71 -18.0 69.19 Favored Glycine 0 CA--C 1.466 -2.978 0 CA-C-O 121.66 0.589 . . . . 0.0 111.666 -167.136 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 66.3 mtt -97.43 5.43 49.74 Favored 'General case' 0 C--N 1.281 -2.389 0 CA-C-N 114.666 -0.767 . . . . 0.0 110.718 178.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . 0.473 ' HA ' ' HE2' ' A' ' 150' ' ' LYS . 6.7 mmpt? -116.4 -49.69 2.66 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.509 -179.396 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 42.4 mmtm -146.14 165.08 30.18 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.3 0.571 . . . . 0.0 112.514 -175.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 42.2 p -130.03 160.37 33.9 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 174.073 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' ARG . . . . . 0.404 ' NE ' ' HA ' ' A' ' 153' ' ' ARG . 3.3 tpm_? -135.95 149.3 48.85 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 106.976 -1.491 . . . . 0.0 106.976 -177.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 8.2 m -88.64 117.37 27.55 Favored 'General case' 0 N--CA 1.436 -1.126 0 C-N-CA 120.212 -0.595 . . . . 0.0 111.763 -175.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' ARG . . . . . 0.508 ' HA ' ' HA2' ' A' ' 159' ' ' GLY . 0.0 OUTLIER -69.75 -31.08 68.85 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 105.457 -2.053 . . . . 0.0 105.457 174.505 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -45.46 -53.99 8.03 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 113.592 -1.64 . . . . 0.0 113.791 -179.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -66.47 -53.21 37.83 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 120.799 0.333 . . . . 0.0 111.476 -177.727 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -148.43 -32.89 0.24 Allowed 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.689 -178.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . 0.598 ' HA3' ' O ' ' A' ' 65' ' ' ILE . . . 130.54 -95.0 0.33 Allowed Glycine 0 CA--C 1.463 -3.215 0 N-CA-C 107.992 -2.043 . . . . 0.0 107.992 -168.627 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.727 ' HB ' ' O ' ' A' ' 67' ' ' ILE . 41.3 t -98.72 125.25 52.17 Favored 'Isoleucine or valine' 0 N--CA 1.398 -3.046 0 N-CA-C 107.273 -1.381 . . . . 0.0 107.273 171.244 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 46.8 mt-30 -90.78 101.38 14.13 Favored 'General case' 0 C--N 1.294 -1.824 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 -176.094 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 20.2 mmt180 -90.86 152.89 20.57 Favored 'General case' 0 C--N 1.278 -2.501 0 CA-C-N 113.584 -1.644 . . . . 0.0 114.151 -172.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' ASN . . . . . 0.455 ' H ' ' CG1' ' A' ' 94' ' ' VAL . 46.7 m-80 -136.82 31.69 2.74 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 104.789 -2.301 . . . . 0.0 104.789 173.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . 0.502 ' HA3' ' SG ' ' A' ' 92' ' ' CYS . . . -110.67 149.34 17.7 Favored Glycine 0 N--CA 1.433 -1.508 0 CA-C-N 114.051 -1.432 . . . . 0.0 113.587 -171.399 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -110.01 117.16 33.03 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 175.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 30.0 mtt180 -78.73 102.14 7.92 Favored 'General case' 0 N--CA 1.422 -1.83 0 N-CA-C 107.378 -1.341 . . . . 0.0 107.378 -178.416 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 40.0 t -75.72 90.6 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 CA-C-O 121.189 0.519 . . . . 0.0 110.848 -177.638 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 21.0 t70 172.85 -33.87 0.0 OUTLIER 'General case' 0 CA--C 1.484 -1.57 0 N-CA-C 106.665 -1.605 . . . . 0.0 106.665 -178.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 15.5 ptmt -157.38 -164.26 1.54 Allowed 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 113.675 -1.602 . . . . 0.0 110.75 -172.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' PHE . . . . . . . . . . . . . 89.1 t80 . . . . . 0 N--CA 1.427 -1.578 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 171.576 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.519 ' O ' ' HG ' ' A' ' 58' ' ' LEU . 14.9 tp . . . . . 0 C--O 1.214 -0.798 0 N-CA-C 114.573 1.323 . . . . 0.0 114.573 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.438 ' O ' ' HE3' ' A' ' 59' ' ' LYS . 0.9 OUTLIER -52.4 -26.41 27.86 Favored 'Trans proline' 0 C--N 1.362 1.253 0 C-N-CA 123.303 2.669 . . . . 0.0 110.952 176.922 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 20.0 mm-40 -82.7 -41.48 19.27 Favored 'General case' 0 N--CA 1.4 -2.928 0 CA-C-N 115.201 -0.909 . . . . 0.0 109.367 -178.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.436 ' O ' ' HB3' ' A' ' 60' ' ' GLU . 3.8 mm? -75.35 -37.38 60.71 Favored 'General case' 0 N--CA 1.44 -0.973 0 N-CA-C 113.47 0.915 . . . . 0.0 113.47 -176.056 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.571 HD23 ' ND2' ' A' ' 74' ' ' ASN 0.261 1.8 pp -58.84 -43.58 90.78 Favored 'General case' 0 C--O 1.217 -0.614 0 C-N-CA 120.088 -0.645 . . . . 0.0 112.179 178.908 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.476 ' H ' HD13 ' A' ' 58' ' ' LEU . 20.8 pttp -77.49 -26.81 51.58 Favored 'General case' 0 C--O 1.208 -1.119 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 175.454 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.48 ' C ' ' H ' ' A' ' 62' ' ' ASP . 8.7 tp10 -61.97 -49.03 77.72 Favored 'General case' 0 C--N 1.313 -0.999 0 C-N-CA 123.895 0.878 . . . . 0.0 111.34 177.402 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 72.5 m-85 -73.62 5.5 3.85 Favored 'General case' 0 C--O 1.243 0.725 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.332 179.181 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.48 ' H ' ' C ' ' A' ' 60' ' ' GLU . 14.9 t70 -125.4 -162.93 1.15 Allowed 'General case' 0 C--N 1.292 -1.918 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 -179.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.512 ' HB2' HD12 ' A' ' 65' ' ' ILE . 2.5 mt -79.11 173.86 7.04 Favored Pre-proline 0 CA--C 1.563 1.467 0 N-CA-C 106.988 -1.486 . . . . 0.0 106.988 -176.421 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -85.8 6.41 5.57 Favored 'Trans proline' 0 CA--C 1.505 -0.967 0 C-N-CA 121.68 1.587 . . . . 0.0 112.103 -171.131 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.512 HD12 ' HB2' ' A' ' 63' ' ' LEU . 0.2 OUTLIER -71.26 -45.46 70.34 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.816 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 179.578 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 58.27 8.91 5.36 Favored Glycine 0 CA--C 1.528 0.885 0 CA-C-N 115.735 -0.666 . . . . 0.0 113.531 -178.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.521 ' O ' ' HB ' ' A' ' 160' ' ' VAL . 48.0 mt 68.58 -68.07 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.832 0 C-N-CA 125.494 1.517 . . . . 0.0 112.364 -176.791 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.452 ' HB3' ' HD3' ' A' ' 69' ' ' PRO . 76.7 t80 178.67 -56.99 0.0 OUTLIER Pre-proline 0 C--N 1.303 -1.417 0 C-N-CA 122.324 0.25 . . . . 0.0 111.078 -177.625 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.452 ' HD3' ' HB3' ' A' ' 68' ' ' PHE . 20.0 Cg_endo -98.15 145.64 0.64 Allowed 'Trans proline' 0 N--CA 1.432 -2.134 0 C-N-CA 122.285 1.99 . . . . 0.0 112.364 -177.026 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -78.57 64.34 3.59 Favored Glycine 0 N--CA 1.442 -0.934 0 N-CA-C 110.517 -1.033 . . . . 0.0 110.517 178.124 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -163.06 -27.38 0.04 OUTLIER 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 -177.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.419 ' HA ' ' CD ' ' A' ' 89' ' ' PRO . . . -83.2 170.52 14.62 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.663 0.785 . . . . 0.0 109.339 173.239 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.661 ' O ' HG22 ' A' ' 73' ' ' THR . 84.1 m 76.8 28.46 0.68 Allowed 'General case' 0 CA--C 1.56 1.339 0 CA-C-O 124.878 2.275 . . . . 0.0 110.866 172.117 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.763 ' O ' ' HA ' ' A' ' 86' ' ' VAL . 0.9 OUTLIER -73.74 108.21 6.44 Favored 'General case' 0 C--N 1.257 -3.439 0 CA-C-N 113.947 -1.479 . . . . 0.0 112.712 -178.175 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.49 ' HB2' HD21 ' A' ' 84' ' ' LEU . 31.3 p90 -79.34 108.71 13.06 Favored 'General case' 0 C--N 1.271 -2.815 0 CA-C-O 122.095 0.95 . . . . 0.0 113.37 -173.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.644 ' HB2' ' O ' ' A' ' 85' ' ' THR . 8.4 mm-40 -105.02 158.35 16.61 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 174.638 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 60.0 t80 -152.87 147.43 25.99 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 -175.274 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.694 ' O ' ' HA ' ' A' ' 82' ' ' LYS . 12.0 m-20 -130.3 -176.46 3.96 Favored 'General case' 0 CA--C 1.489 -1.393 0 CA-C-O 121.325 0.584 . . . . 0.0 111.665 -179.811 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.74 ' O ' ' HB2' ' A' ' 82' ' ' LYS . 45.8 mt-10 -83.88 -62.57 1.54 Allowed 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 117.042 2.238 . . . . 0.0 117.042 175.141 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.404 ' C ' ' H ' ' A' ' 82' ' ' LYS . 9.1 pt-20 -80.6 -34.43 35.17 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 122.775 1.274 . . . . 0.0 108.257 177.818 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.593 ' C ' ' H ' ' A' ' 83' ' ' LYS . 24.7 m -92.63 30.58 1.51 Allowed 'General case' 0 C--N 1.291 -1.969 0 C-N-CA 126.877 2.071 . . . . 0.0 107.496 176.478 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.74 ' HB2' ' O ' ' A' ' 79' ' ' GLU . 72.5 tttt -57.33 32.0 0.0 OUTLIER 'General case' 0 CA--C 1.565 1.542 0 C-N-CA 127.996 2.518 . . . . 0.0 112.617 -179.737 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.593 ' H ' ' C ' ' A' ' 81' ' ' THR . 53.9 pttt -117.96 133.67 55.69 Favored 'General case' 0 N--CA 1.393 -3.315 0 C-N-CA 125.943 1.697 . . . . 0.0 107.179 176.219 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.49 HD21 ' HB2' ' A' ' 75' ' ' TYR . 1.2 tm? -59.82 127.24 30.99 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-O 121.569 0.699 . . . . 0.0 110.743 -171.368 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.644 ' O ' ' HB2' ' A' ' 76' ' ' GLU . 6.2 t -126.77 114.28 17.75 Favored 'General case' 0 N--CA 1.405 -2.687 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.37 -179.851 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.763 ' HA ' ' O ' ' A' ' 74' ' ' ASN . 15.7 m -92.41 140.16 16.7 Favored 'Isoleucine or valine' 0 CA--C 1.474 -1.96 0 O-C-N 121.007 -1.058 . . . . 0.0 111.304 178.542 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.446 ' HA ' ' H ' ' A' ' 107' ' ' THR 0.339 2.0 pp -101.59 103.7 14.54 Favored 'General case' 0 N--CA 1.391 -3.423 0 CA-C-O 122.593 1.187 . . . . 0.0 109.979 176.892 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 35.0 mt -88.65 117.37 68.25 Favored Pre-proline 0 N--CA 1.405 -2.715 0 CA-C-N 113.683 -1.599 . . . . 0.0 107.23 -178.223 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . 0.464 ' HB2' ' HD2' ' A' ' 166' ' ' ARG . 55.1 Cg_exo -55.78 104.15 0.12 Allowed 'Trans proline' 0 N--CA 1.451 -0.992 0 C-N-CA 123.442 2.761 . . . . 0.0 111.737 -178.059 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' SER . . . . . 0.503 ' OG ' ' HB ' ' A' ' 167' ' ' VAL . 25.7 t 71.66 170.22 0.32 Allowed 'General case' 0 N--CA 1.44 -0.942 0 O-C-N 124.715 1.259 . . . . 0.0 110.832 -179.134 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 79.4 mt -85.88 116.78 29.49 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.921 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.227 177.409 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' CYS . . . . . 0.581 ' SG ' ' HB2' ' A' ' 104' ' ' PHE . 12.0 p -109.91 129.05 55.7 Favored 'General case' 0 C--N 1.292 -1.92 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 174.615 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -120.41 120.34 35.66 Favored 'General case' 0 CA--C 1.461 -2.463 0 N-CA-C 108.787 -0.819 . . . . 0.0 108.787 -175.5 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.73 ' O ' ' HA ' ' A' ' 101' ' ' VAL . 49.1 t -111.06 115.79 50.8 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.156 0 CA-C-N 114.443 -1.253 . . . . 0.0 109.398 -172.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.309 -0.944 0 N-CA-C 110.939 -0.864 . . . . 0.0 110.939 179.325 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 39.9 m . . . . . 0 N--CA 1.43 -1.466 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.73 ' HA ' ' O ' ' A' ' 94' ' ' VAL . 9.3 p -94.81 116.37 35.97 Favored 'Isoleucine or valine' 0 C--O 1.244 0.765 0 CA-C-O 122.01 0.909 . . . . 0.0 113.021 -175.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.413 ' CD1' HG21 ' A' ' 125' ' ' THR . 1.5 mm? -110.2 133.23 53.43 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 177.202 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 22.6 ttmm -103.39 105.23 15.44 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 177.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.581 ' HB2' ' SG ' ' A' ' 92' ' ' CYS . 99.3 m-85 -90.15 98.18 11.62 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 176.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 28.0 m -85.81 155.94 20.78 Favored 'General case' 0 C--N 1.296 -1.737 0 CA-C-N 114.686 -1.143 . . . . 0.0 111.062 -175.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 27.0 m -68.79 121.29 16.22 Favored 'General case' 0 N--CA 1.417 -2.094 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 175.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.446 ' H ' ' HA ' ' A' ' 87' ' ' LEU . 23.3 m 71.98 79.56 0.15 Allowed 'General case' 0 C--N 1.317 -0.807 0 C-N-CA 124.212 1.005 . . . . 0.0 110.656 179.238 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.478 ' O ' ' HA ' ' A' ' 85' ' ' THR . 14.9 m -109.25 121.21 61.93 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 CA-C-N 114.995 -1.002 . . . . 0.0 109.45 177.306 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.585 ' CG2' ' HG3' ' A' ' 83' ' ' LYS . 25.7 m -106.57 124.22 49.28 Favored 'General case' 0 N--CA 1.409 -2.492 0 CA-C-N 114.977 -1.01 . . . . 0.0 111.657 -167.599 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -157.1 -168.69 20.02 Favored Glycine 0 C--N 1.309 -0.947 0 C-N-CA 120.452 -0.88 . . . . 0.0 113.733 -179.295 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 12.9 t-80 -99.64 119.62 38.39 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 105.752 -1.944 . . . . 0.0 105.752 179.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.453 HD22 ' HG ' ' A' ' 84' ' ' LEU . 60.7 tp -124.11 118.51 27.08 Favored 'General case' 0 CA--C 1.457 -2.62 0 CA-C-O 121.338 0.59 . . . . 0.0 111.594 -167.496 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 8.1 mp0 -121.04 146.57 46.58 Favored 'General case' 1 N--CA 1.37 -4.459 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 175.323 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 21.2 tptm -66.2 101.14 0.68 Allowed 'General case' 0 C--N 1.291 -1.959 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 179.148 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 137.07 -48.95 0.88 Allowed Glycine 0 C--O 1.192 -2.478 0 N-CA-C 108.361 -1.896 . . . . 0.0 108.361 -173.294 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.488 ' O ' ' HD2' ' A' ' 116' ' ' LYS . 0.0 OUTLIER -148.71 144.22 26.95 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 114.006 1.113 . . . . 0.0 114.006 179.935 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.645 ' O ' ' HB2' ' A' ' 135' ' ' SER . 49.1 tp -110.65 100.91 9.61 Favored 'General case' 0 C--N 1.31 -1.124 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 177.029 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.469 HG23 ' HD3' ' A' ' 116' ' ' LYS . 6.9 p -100.95 138.16 38.37 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 113.064 0.765 . . . . 0.0 113.064 -176.528 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 29.3 t70 64.09 124.52 0.02 OUTLIER 'General case' 0 CA--C 1.45 -2.866 0 C-N-CA 124.882 1.273 . . . . 0.0 111.348 -176.414 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -145.99 145.16 20.37 Favored 'Isoleucine or valine' 1 N--CA 1.351 -5.388 0 C-N-CA 116.475 -2.09 . . . . 0.0 111.082 -169.659 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 14.9 tp10 -111.42 102.87 11.21 Favored 'General case' 0 C--N 1.283 -2.283 0 CA-C-N 115.13 -0.941 . . . . 0.0 109.199 -176.567 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 116.22 -4.85 20.0 Favored Glycine 0 N--CA 1.439 -1.161 0 C-N-CA 119.392 -1.385 . . . . 0.0 114.225 173.294 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 61.4 mt -99.35 105.4 17.39 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.99 0 C-N-CA 118.737 -1.185 . . . . 0.0 110.052 179.746 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 58.0 tttm -85.37 119.67 25.99 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 179.019 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.506 ' O ' ' HA ' ' A' ' 130' ' ' TRP . 92.1 m -116.46 124.08 49.08 Favored 'General case' 0 C--N 1.271 -2.813 0 CA-C-N 114.951 -1.022 . . . . 0.0 110.116 -176.365 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.466 ' HA ' ' O ' ' A' ' 129' ' ' ILE . 0.7 OUTLIER -122.83 100.25 6.81 Favored 'General case' 0 N--CA 1.424 -1.762 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 174.077 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 11.8 p -102.59 -26.84 3.38 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.138 0 CA-C-O 122.255 1.026 . . . . 0.0 109.511 178.299 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 26.6 ttt -161.32 -33.6 0.05 OUTLIER 'General case' 0 C--N 1.282 -2.335 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 -178.089 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . 0.484 ' H ' HD13 ' A' ' 129' ' ' ILE . 0.2 OUTLIER -139.46 165.62 22.59 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 N-CA-C 104.436 -2.431 . . . . 0.0 104.436 176.759 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' TRP . . . . . 0.506 ' HA ' ' O ' ' A' ' 125' ' ' THR . 60.8 p-90 -108.42 127.82 54.24 Favored 'General case' 0 N--CA 1.418 -2.058 0 C-N-CA 118.928 -1.109 . . . . 0.0 111.661 -178.479 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . 0.507 HG12 ' H ' ' A' ' 133' ' ' VAL . 43.0 t -127.99 154.02 38.06 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.914 0 N-CA-C 105.751 -1.944 . . . . 0.0 105.751 177.354 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -115.98 18.71 15.43 Favored 'General case' 0 C--N 1.3 -1.579 0 CA-C-O 121.627 0.727 . . . . 0.0 111.238 -176.441 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.507 ' H ' HG12 ' A' ' 131' ' ' VAL . 33.5 m -138.11 0.2 0.71 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.637 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.962 -178.464 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' THR . . . . . 0.473 ' OG1' ' HB ' ' A' ' 125' ' ' THR . 1.2 p -64.65 120.61 12.73 Favored 'General case' 0 N--CA 1.418 -2.063 0 CA-C-O 122.065 0.936 . . . . 0.0 110.917 178.074 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' SER . . . . . 0.645 ' HB2' ' O ' ' A' ' 117' ' ' LEU . 19.7 p -78.61 171.25 15.4 Favored 'General case' 0 N--CA 1.407 -2.608 0 CA-C-N 113.778 -1.555 . . . . 0.0 114.049 -173.03 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 10.4 tt -119.18 127.54 75.84 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.099 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 175.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 37.9 m -129.45 131.23 46.68 Favored 'General case' 0 C--N 1.293 -1.886 0 C-N-CA 120.351 -0.54 . . . . 0.0 110.995 -174.422 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' THR . . . . . 0.495 ' HB ' ' O ' ' A' ' 142' ' ' LYS . 59.6 p -118.2 176.13 5.37 Favored 'General case' 0 C--N 1.29 -1.983 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 177.182 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -99.93 21.64 12.35 Favored 'General case' 0 C--N 1.281 -2.398 0 N-CA-C 106.185 -1.783 . . . . 0.0 106.185 173.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . 61.71 40.42 13.15 Favored 'General case' 0 C--N 1.352 0.683 0 N-CA-C 107.367 -1.346 . . . . 0.0 107.367 -168.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 35.6 t -174.78 -79.69 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 114.222 -1.354 . . . . 0.0 109.483 -174.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . 0.495 ' O ' ' HB ' ' A' ' 138' ' ' THR . 99.5 mttt -85.41 167.2 15.74 Favored 'General case' 0 CA--C 1.497 -1.095 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 177.141 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.423 ' HA ' HG21 ' A' ' 138' ' ' THR . 10.4 p -126.33 127.7 70.84 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.741 0 N-CA-C 113.484 0.92 . . . . 0.0 113.484 -173.105 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 45.8 m-85 -113.68 147.14 38.71 Favored 'General case' 0 CA--C 1.487 -1.465 0 CA-C-N 115.244 -0.889 . . . . 0.0 109.982 176.041 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -99.19 99.85 10.89 Favored 'General case' 0 C--N 1.263 -3.174 0 CA-C-N 114.456 -1.247 . . . . 0.0 107.922 175.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . 0.363 17.7 p -82.34 69.76 9.15 Favored 'General case' 0 N--CA 1.425 -1.686 0 N-CA-C 115.315 1.598 . . . . 0.0 115.315 -175.215 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -123.85 74.35 1.27 Allowed 'General case' 0 N--CA 1.424 -1.728 0 N-CA-C 104.68 -2.341 . . . . 0.0 104.68 170.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 77.64 16.25 80.4 Favored Glycine 0 N--CA 1.433 -1.567 0 N-CA-C 109.071 -1.611 . . . . 0.0 109.071 -171.271 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 27.5 ptt? 49.03 24.39 0.88 Allowed 'General case' 0 N--CA 1.502 2.149 0 C-N-CA 126.578 1.951 . . . . 0.0 111.416 -173.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 59.5 mttp -62.77 -36.79 84.23 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 115.021 1.489 . . . . 0.0 115.021 -174.099 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . 0.437 ' HA ' ' HE2' ' A' ' 151' ' ' LYS . 6.1 mmpt? -106.3 132.8 51.91 Favored 'General case' 0 C--N 1.319 -0.74 0 C-N-CA 120.473 -0.491 . . . . 0.0 110.897 178.144 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 19.7 m -132.46 128.21 36.96 Favored 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 -179.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 25.2 mmm180 -140.99 172.95 11.97 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-O 121.232 0.539 . . . . 0.0 111.954 -178.138 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 17.8 m -101.15 142.26 32.85 Favored 'General case' 0 N--CA 1.432 -1.331 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 176.434 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' ARG . . . . . 0.527 ' HD3' ' C ' ' A' ' 155' ' ' ARG . 0.2 OUTLIER -78.58 -25.02 45.21 Favored 'General case' 0 C--N 1.299 -1.606 0 CA-C-O 121.255 0.55 . . . . 0.0 109.89 178.976 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -44.17 -36.37 2.62 Favored 'General case' 0 C--N 1.316 -0.854 0 C-N-CA 125.455 1.502 . . . . 0.0 114.905 -175.277 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -66.44 -53.81 31.23 Favored 'General case' 0 CA--C 1.546 0.797 0 N-CA-C 114.277 1.214 . . . . 0.0 114.277 -174.107 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -149.66 5.15 0.6 Allowed 'General case' 0 N--CA 1.491 1.603 0 CA-C-N 117.597 0.18 . . . . 0.0 111.364 -175.411 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . 0.506 ' HA2' ' HG2' ' A' ' 155' ' ' ARG . . . 96.31 -91.55 1.29 Allowed Glycine 0 CA--C 1.461 -3.33 0 N-CA-C 106.231 -2.748 . . . . 0.0 106.231 -166.772 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.521 ' HB ' ' O ' ' A' ' 67' ' ' ILE . 57.7 t -104.96 127.45 59.49 Favored 'Isoleucine or valine' 1 N--CA 1.369 -4.512 0 N-CA-C 105.16 -2.163 . . . . 0.0 105.16 165.1 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 -88.34 106.59 18.34 Favored 'General case' 0 C--N 1.273 -2.754 0 N-CA-C 106.396 -1.705 . . . . 0.0 106.396 -177.055 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . 0.414 ' HD2' ' O ' ' A' ' 164' ' ' GLY . 0.0 OUTLIER -148.64 158.69 44.31 Favored 'General case' 0 N--CA 1.389 -3.519 0 C-N-CA 118.384 -1.326 . . . . 0.0 114.523 -167.359 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -106.29 -24.1 12.38 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 115.073 -0.967 . . . . 0.0 108.792 172.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . 0.414 ' O ' ' HD2' ' A' ' 162' ' ' ARG . . . -58.65 118.61 14.33 Favored Glycine 0 CA--C 1.498 -0.994 0 CA-C-N 115.258 -0.883 . . . . 0.0 112.282 -178.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 2.8 pp -108.7 153.74 23.01 Favored 'General case' 0 N--CA 1.418 -2.047 0 CA-C-O 120.667 0.27 . . . . 0.0 111.161 -174.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . 0.464 ' HD2' ' HB2' ' A' ' 89' ' ' PRO . 58.6 mtm180 -79.12 117.4 20.11 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 178.17 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . 0.503 ' HB ' ' OG ' ' A' ' 90' ' ' SER . 43.6 t -62.28 -18.0 19.26 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.627 0 CA-C-O 121.64 0.733 . . . . 0.0 109.692 176.056 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -56.1 -41.44 75.21 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 124.739 1.215 . . . . 0.0 111.101 176.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 1.9 tmmm? -86.59 109.58 19.23 Favored 'General case' 0 N--CA 1.429 -1.499 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 -178.478 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' PHE . . . . . . . . . . . . . 87.9 t80 . . . . . 0 N--CA 1.423 -1.822 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 178.414 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.656 ' O ' ' HG ' ' A' ' 58' ' ' LEU . 23.3 mt . . . . . 0 C--O 1.208 -1.088 0 CA-C-O 118.826 -0.607 . . . . 0.0 112.068 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.497 ' HA ' ' CD1' ' A' ' 58' ' ' LEU . 36.7 Cg_endo -60.34 -34.96 93.04 Favored 'Trans proline' 0 C--N 1.377 2.063 0 C-N-CA 120.899 1.066 . . . . 0.0 113.768 -169.729 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -78.21 -30.27 48.8 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-O 121.242 0.544 . . . . 0.0 110.633 179.324 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 45.5 tp -74.02 -29.39 61.91 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.242 176.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.656 ' HG ' ' O ' ' A' ' 54' ' ' LEU . 59.6 mt -57.48 -45.9 84.3 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-O 121.375 0.607 . . . . 0.0 110.3 -177.896 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.433 ' HZ2' ' HB2' ' A' ' 60' ' ' GLU . 1.9 pptp? -73.57 -25.0 60.16 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 114.894 -1.048 . . . . 0.0 110.577 -179.183 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.433 ' HB2' ' HZ2' ' A' ' 59' ' ' LYS . 35.0 tt0 -90.48 -22.83 21.17 Favored 'General case' 0 CA--C 1.556 1.181 0 N-CA-C 113.482 0.919 . . . . 0.0 113.482 -174.776 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.537 ' CD2' ' HA ' ' A' ' 58' ' ' LEU . 34.1 m-85 -41.31 -41.08 1.83 Allowed 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 115.193 1.553 . . . . 0.0 115.193 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.489 ' OD2' ' HA ' ' A' ' 114' ' ' LYS . 10.4 t70 -125.96 -82.96 0.63 Allowed 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 117.746 -1.582 . . . . 0.0 112.205 -172.647 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.441 ' H ' HD12 ' A' ' 63' ' ' LEU . 0.0 OUTLIER -90.94 161.07 36.56 Favored Pre-proline 0 N--CA 1.444 -0.752 0 N-CA-C 106.619 -1.623 . . . . 0.0 106.619 -179.742 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -100.55 14.17 0.45 Allowed 'Trans proline' 0 N--CA 1.435 -1.936 0 C-N-CA 122.778 2.319 . . . . 0.0 112.803 -176.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.517 HG12 ' H ' ' A' ' 67' ' ' ILE . 0.2 OUTLIER -67.09 -47.5 81.75 Favored 'Isoleucine or valine' 0 CA--C 1.484 -1.59 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 177.146 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.441 ' HA2' HG21 ' A' ' 73' ' ' THR . . . 49.91 8.7 0.15 Allowed Glycine 0 N--CA 1.472 1.043 0 CA-C-N 114.903 -1.044 . . . . 0.0 113.849 -173.13 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.517 ' H ' HG12 ' A' ' 65' ' ' ILE . 16.6 mm 69.38 -69.34 0.16 Allowed 'Isoleucine or valine' 0 C--O 1.177 -2.739 0 C-N-CA 125.549 1.54 . . . . 0.0 108.555 -173.142 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.489 ' HB3' ' HD3' ' A' ' 69' ' ' PRO . 65.3 t80 -167.4 -56.75 0.01 OUTLIER Pre-proline 0 C--N 1.293 -1.851 0 C-N-CA 120.917 -0.313 . . . . 0.0 110.64 -177.78 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.489 ' HD3' ' HB3' ' A' ' 68' ' ' PHE . 56.0 Cg_endo -102.71 178.91 0.15 Allowed 'Trans proline' 0 N--CA 1.424 -2.61 0 C-N-CA 121.721 1.614 . . . . 0.0 111.108 -179.651 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -102.99 19.32 46.98 Favored Glycine 0 N--CA 1.43 -1.76 0 N-CA-C 109.756 -1.338 . . . . 0.0 109.756 175.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -100.93 -44.43 5.75 Favored 'General case' 0 N--CA 1.432 -1.353 0 N-CA-C 106.401 -1.703 . . . . 0.0 106.401 -178.368 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -80.6 168.04 19.36 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 114.653 -1.158 . . . . 0.0 109.156 167.059 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.711 HG23 ' O ' ' A' ' 73' ' ' THR . 22.3 m 81.8 28.84 0.15 Allowed 'General case' 0 CA--C 1.513 -0.462 0 CA-C-O 123.764 1.745 . . . . 0.0 111.198 171.556 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.713 HD21 ' N ' ' A' ' 74' ' ' ASN . 0.7 OUTLIER -70.47 148.26 48.49 Favored 'General case' 0 C--N 1.262 -3.212 0 CA-C-N 114.264 -1.335 . . . . 0.0 110.01 -179.725 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 40.5 t80 -115.01 91.32 3.58 Favored 'General case' 0 C--N 1.275 -2.644 0 C-N-CA 119.847 -0.741 . . . . 0.0 111.834 -166.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.508 ' O ' HD21 ' A' ' 84' ' ' LEU . 39.6 mm-40 -113.53 153.77 28.19 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.018 177.165 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 46.0 p90 -163.35 147.77 10.95 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 178.409 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.484 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 11.7 m-20 -74.99 165.11 25.79 Favored 'General case' 0 CA--C 1.478 -1.818 0 C-N-CA 119.827 -0.749 . . . . 0.0 109.235 179.77 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -80.78 -62.73 1.58 Allowed 'General case' 0 C--N 1.265 -3.087 0 CA-C-N 114.775 -1.102 . . . . 0.0 111.599 -179.169 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.409 ' H ' ' CD ' ' A' ' 80' ' ' GLU . 0.0 OUTLIER -80.98 -35.15 32.42 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.271 -176.293 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.484 ' HB ' ' HB2' ' A' ' 78' ' ' ASP . 56.8 m -80.49 -40.83 25.4 Favored 'General case' 0 N--CA 1.423 -1.822 0 CA-C-N 115.076 -0.965 . . . . 0.0 110.992 -178.598 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.442 ' H ' ' HB2' ' A' ' 78' ' ' ASP . 61.9 mttp 66.23 13.72 9.3 Favored 'General case' 0 N--CA 1.483 1.184 0 N-CA-C 114.206 1.187 . . . . 0.0 114.206 178.554 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 36.6 ttpt -71.54 116.46 11.91 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 176.336 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.508 HD21 ' O ' ' A' ' 76' ' ' GLU . 2.1 tm? -75.03 131.39 40.57 Favored 'General case' 0 N--CA 1.443 -0.817 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 -176.447 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.568 ' HA ' ' O ' ' A' ' 108' ' ' VAL . 27.4 p -126.66 116.59 21.23 Favored 'General case' 0 N--CA 1.412 -2.353 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.127 177.428 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.565 ' HA ' ' O ' ' A' ' 74' ' ' ASN . 63.2 t -91.92 131.84 37.94 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.054 0 N-CA-C 106.86 -1.533 . . . . 0.0 106.86 173.837 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.595 ' HA ' ' O ' ' A' ' 106' ' ' THR 0.361 2.1 pp -111.08 114.9 28.51 Favored 'General case' 0 N--CA 1.393 -3.28 0 CA-C-O 122.161 0.981 . . . . 0.0 111.869 178.642 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.464 ' O ' HG21 ' A' ' 106' ' ' THR . 70.3 mt -95.88 125.71 47.67 Favored Pre-proline 0 N--CA 1.419 -2.008 0 CA-C-N 113.647 -1.615 . . . . 0.0 109.771 -176.472 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -53.89 95.43 0.04 OUTLIER 'Trans proline' 0 CA--C 1.534 0.489 0 C-N-CA 124.129 3.219 . . . . 0.0 112.492 177.696 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' SER . . . . . 0.529 ' OG ' ' HB ' ' A' ' 167' ' ' VAL . 22.9 t 75.7 158.14 0.2 Allowed 'General case' 0 C--O 1.236 0.387 0 C-N-CA 125.452 1.501 . . . . 0.0 110.394 -177.804 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.423 HD12 ' HD3' ' A' ' 103' ' ' LYS . 15.9 tt -78.57 108.22 11.77 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.598 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 173.871 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' CYS . . . . . 0.672 ' SG ' ' HG2' ' A' ' 166' ' ' ARG . 32.0 m -98.76 127.03 44.56 Favored 'General case' 0 C--N 1.29 -1.99 0 CA-C-N 114.932 -1.031 . . . . 0.0 110.725 -170.817 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -116.79 147.71 41.84 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-N 116.661 -0.245 . . . . 0.0 110.461 -178.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.568 ' O ' ' HA ' ' A' ' 101' ' ' VAL . 6.4 p -137.74 114.11 11.39 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 CA-C-O 120.91 0.386 . . . . 0.0 111.198 -178.745 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.854 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 176.613 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 36.1 p . . . . . 0 N--CA 1.414 -2.27 0 CA-C-O 121.329 0.585 . . . . 0.0 109.973 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.568 ' HA ' ' O ' ' A' ' 94' ' ' VAL . 11.6 p -123.22 119.64 58.17 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 N-CA-C 106.681 -1.599 . . . . 0.0 106.681 174.477 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.446 HD21 ' H ' ' A' ' 126' ' ' LYS . 59.1 mt -124.83 144.12 50.46 Favored 'General case' 0 C--N 1.282 -2.356 0 C-N-CA 120.03 -0.668 . . . . 0.0 110.688 -170.88 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.423 ' HD3' HD12 ' A' ' 91' ' ' ILE . 23.0 ttmm -121.28 104.96 10.11 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 179.551 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -89.92 101.83 14.53 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.767 -178.31 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 82.5 m -60.97 153.09 25.99 Favored 'General case' 0 C--N 1.306 -1.317 0 C-N-CA 124.46 1.104 . . . . 0.0 110.652 177.11 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' THR . . . . . 0.595 ' O ' ' HA ' ' A' ' 87' ' ' LEU . 88.4 m -71.65 -69.24 0.4 Allowed 'General case' 0 C--O 1.205 -1.242 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.302 -174.634 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 32.3 p -99.08 101.71 13.17 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 178.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.568 ' O ' ' HA ' ' A' ' 85' ' ' THR . 4.7 p -112.41 138.42 41.56 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.769 0 C-N-CA 119.27 -0.972 . . . . 0.0 111.751 -177.236 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 76.4 p -94.29 153.07 18.21 Favored 'General case' 0 N--CA 1.413 -2.311 0 CA-C-N 115.344 -0.843 . . . . 0.0 109.666 -177.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . 0.462 ' HA2' ' O ' ' A' ' 119' ' ' ASP . . . -169.8 167.92 40.92 Favored Glycine 0 N--CA 1.423 -2.201 0 C-N-CA 120.787 -0.72 . . . . 0.0 111.979 -179.381 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 9.6 t60 -92.97 108.65 20.17 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 178.31 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -91.52 125.42 36.25 Favored 'General case' 0 C--N 1.296 -1.718 0 CA-C-O 121.075 0.464 . . . . 0.0 110.363 -178.37 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . 0.454 ' HG3' ' HG3' ' A' ' 116' ' ' LYS . 10.5 pt-20 -142.33 136.57 29.8 Favored 'General case' 0 N--CA 1.425 -1.675 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 171.133 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . 0.489 ' HA ' ' OD2' ' A' ' 62' ' ' ASP . 2.3 tmtp? -52.08 117.82 3.04 Favored 'General case' 0 C--O 1.248 0.991 0 CA-C-O 121.726 0.775 . . . . 0.0 111.774 -169.599 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . 0.656 ' O ' ' HB ' ' A' ' 138' ' ' THR . . . 106.53 -28.47 13.32 Favored Glycine 0 N--CA 1.409 -3.126 0 CA-C-N 114.66 -1.155 . . . . 0.0 112.421 176.559 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.454 ' HG3' ' HG3' ' A' ' 113' ' ' GLU . 12.4 ptmm? -147.11 115.38 6.62 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-O 121.784 0.802 . . . . 0.0 111.676 -174.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 59.4 tp -93.55 103.57 15.74 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 106.656 -1.609 . . . . 0.0 106.656 177.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.425 HG23 ' NZ ' ' A' ' 116' ' ' LYS . 39.7 p -103.64 140.38 37.64 Favored 'General case' 0 N--CA 1.403 -2.801 0 N-CA-C 113.572 0.953 . . . . 0.0 113.572 -171.787 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . 0.462 ' O ' ' HA2' ' A' ' 110' ' ' GLY . 12.9 m-20 60.09 85.51 0.11 Allowed 'General case' 0 CA--C 1.493 -1.215 0 CA-C-N 114.611 -1.177 . . . . 0.0 113.788 -179.824 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.8 m -88.02 87.77 2.8 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.985 0 CA-C-N 115.038 -0.983 . . . . 0.0 109.327 174.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -68.51 93.89 0.53 Allowed 'General case' 0 N--CA 1.418 -2.066 0 CA-C-N 113.813 -1.539 . . . . 0.0 108.495 -177.434 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 137.84 -11.26 3.67 Favored Glycine 0 N--CA 1.418 -2.52 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.597 178.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.565 HG12 HG21 ' A' ' 108' ' ' VAL . 36.1 mm -96.64 112.46 28.8 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.176 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 178.779 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 46.6 mtpt -86.35 118.97 26.12 Favored 'General case' 0 N--CA 1.414 -2.253 0 CA-C-N 114.954 -1.021 . . . . 0.0 109.279 -177.282 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.421 HG21 HG23 ' A' ' 134' ' ' THR . 86.5 m -122.9 130.66 53.12 Favored 'General case' 0 N--CA 1.407 -2.604 0 CA-C-N 114.159 -1.382 . . . . 0.0 110.604 -173.894 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.625 ' HD3' ' C ' ' A' ' 126' ' ' LYS . 0.3 OUTLIER -107.72 125.64 51.63 Favored 'General case' 0 N--CA 1.41 -2.454 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 173.705 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.58 HG22 ' H ' ' A' ' 128' ' ' MET . 4.0 m -119.29 -81.0 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.09 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.498 175.844 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' MET . . . . . 0.58 ' H ' HG22 ' A' ' 127' ' ' VAL . 1.1 tmt? -103.1 -20.2 14.26 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 106.277 -1.749 . . . . 0.0 106.277 171.722 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 1.1 pp -152.21 -176.41 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 C-N-CA 126.758 2.023 . . . . 0.0 108.564 -178.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 91.2 m95 -95.28 139.84 31.02 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.06 0.457 . . . . 0.0 111.567 178.585 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . 0.472 HG13 ' H ' ' A' ' 133' ' ' VAL . 31.9 t -138.65 135.43 43.47 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.955 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 174.428 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . 0.487 ' H ' ' HD2' ' A' ' 132' ' ' LYS . 0.0 OUTLIER -93.03 13.31 21.16 Favored 'General case' 0 N--CA 1.487 1.403 0 CA-C-N 118.426 0.557 . . . . 0.0 111.024 -178.029 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.472 ' H ' HG13 ' A' ' 131' ' ' VAL . 5.5 p -166.43 96.31 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.31 -1.129 0 CA-C-O 122.364 1.078 . . . . 0.0 111.578 -172.539 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' THR . . . . . 0.421 HG23 HG21 ' A' ' 125' ' ' THR . 21.8 p -99.03 -172.8 2.35 Favored 'General case' 0 N--CA 1.404 -2.742 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.289 176.334 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 28.4 t -147.97 134.53 19.8 Favored 'General case' 0 C--N 1.282 -2.344 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 -173.569 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 60.9 mt -105.27 103.79 15.92 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.875 0 CA-C-O 121.197 0.522 . . . . 0.0 109.979 -178.415 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 56.3 p -96.54 110.8 23.13 Favored 'General case' 0 N--CA 1.428 -1.549 0 CA-C-O 121.233 0.54 . . . . 0.0 109.597 179.107 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' THR . . . . . 0.656 ' HB ' ' O ' ' A' ' 115' ' ' GLY . 75.5 m -128.44 159.65 34.74 Favored 'General case' 0 C--N 1.274 -2.694 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 -177.591 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -105.72 39.35 1.78 Allowed 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 109.786 -0.449 . . . . 0.0 109.786 175.576 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . 58.74 34.82 24.03 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 115.243 -0.89 . . . . 0.0 109.602 -177.152 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' SER . . . . . 0.442 ' H ' HG23 ' A' ' 138' ' ' THR . 33.5 t 179.45 -78.16 0.01 OUTLIER 'General case' 0 CA--C 1.547 0.859 0 CA-C-N 114.7 -1.137 . . . . 0.0 110.081 -174.634 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -80.67 134.97 35.95 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 110.152 -0.314 . . . . 0.0 110.152 179.392 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 20.3 t -110.22 140.19 30.32 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 N-CA-C 112.793 0.664 . . . . 0.0 112.793 -168.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -133.51 151.84 51.82 Favored 'General case' 0 CA--C 1.483 -1.605 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 170.013 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . 0.445 ' HB2' ' HB2' ' A' ' 151' ' ' LYS . 55.4 m-85 -113.11 99.58 7.94 Favored 'General case' 0 C--N 1.275 -2.659 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.744 179.297 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 16.8 p -84.81 85.72 7.43 Favored 'General case' 0 N--CA 1.408 -2.538 0 CA-C-N 115.133 -0.939 . . . . 0.0 110.97 177.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -113.03 70.52 0.72 Allowed 'General case' 0 N--CA 1.428 -1.559 0 N-CA-C 106.33 -1.73 . . . . 0.0 106.33 174.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 72.64 27.03 70.1 Favored Glycine 0 N--CA 1.439 -1.125 0 N-CA-C 108.619 -1.792 . . . . 0.0 108.619 -171.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 26.8 ttt 60.42 97.51 0.03 OUTLIER 'General case' 0 C--N 1.355 0.807 0 C-N-CA 124.621 1.169 . . . . 0.0 109.3 -171.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . 0.539 ' HA ' ' HZ3' ' A' ' 150' ' ' LYS . 0.0 OUTLIER -144.19 -52.54 0.32 Allowed 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 114.9 1.444 . . . . 0.0 114.9 -174.766 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . 0.445 ' HB2' ' HB2' ' A' ' 145' ' ' PHE . 35.2 mmtp -121.96 163.9 18.52 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 114.236 1.199 . . . . 0.0 114.236 -171.292 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 55.7 p -128.51 160.01 33.67 Favored 'General case' 0 N--CA 1.439 -0.977 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 175.362 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 14.6 tpp180 -154.96 132.84 11.49 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.132 0.491 . . . . 0.0 111.709 179.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 9.2 m -88.64 137.38 32.37 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 177.311 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' ARG . . . . . 0.673 ' HD3' ' O ' ' A' ' 155' ' ' ARG . 2.4 tmt_? -70.12 -22.25 63.03 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 110.282 -0.266 . . . . 0.0 110.282 -176.898 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -50.86 -25.25 4.29 Favored 'General case' 0 N--CA 1.5 2.052 0 C-N-CA 123.482 0.713 . . . . 0.0 112.552 177.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . 0.429 ' HB1' ' HG2' ' A' ' 161' ' ' GLN . . . -76.42 4.01 9.93 Favored 'General case' 0 C--N 1.306 -1.286 0 C-N-CA 124.924 1.29 . . . . 0.0 113.393 -178.311 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . 0.412 ' HB2' ' O ' ' A' ' 157' ' ' ALA . 86.7 m-85 91.53 23.46 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.147 0 C-N-CA 126.186 1.794 . . . . 0.0 109.51 -175.489 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . 0.441 ' HA3' ' O ' ' A' ' 65' ' ' ILE . . . 101.64 -94.4 1.22 Allowed Glycine 0 N--CA 1.398 -3.867 0 N-CA-C 109.224 -1.551 . . . . 0.0 109.224 -175.458 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.484 HG22 ' HB ' ' A' ' 65' ' ' ILE . 79.7 t -128.92 113.74 30.09 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.337 0 CA-C-O 121.505 0.669 . . . . 0.0 111.029 -178.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' GLN . . . . . 0.429 ' HG2' ' HB1' ' A' ' 157' ' ' ALA 0.315 10.0 pt20 -110.52 92.87 4.21 Favored 'General case' 0 C--N 1.302 -1.472 0 C-N-CA 117.203 -1.799 . . . . 0.0 114.54 179.278 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 26.0 tpt180 -146.22 102.14 3.58 Favored 'General case' 0 C--N 1.274 -2.708 0 N-CA-C 101.789 -3.411 . . . . 0.0 101.789 168.454 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 47.8 m-80 -110.67 123.03 49.23 Favored 'General case' 0 C--N 1.292 -1.93 0 N-CA-C 113.453 0.909 . . . . 0.0 113.453 -169.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . 0.444 ' CA ' ' HB ' ' A' ' 94' ' ' VAL . . . -95.11 -169.5 36.35 Favored Glycine 0 N--CA 1.42 -2.422 0 N-CA-C 108.823 -1.711 . . . . 0.0 108.823 172.899 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . 0.495 HD22 ' H ' ' A' ' 165' ' ' LEU . 1.9 pt? -91.37 112.0 23.72 Favored 'General case' 0 C--N 1.296 -1.736 0 C-N-CA 119.113 -1.035 . . . . 0.0 109.648 -178.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . 0.672 ' HG2' ' SG ' ' A' ' 92' ' ' CYS . 78.9 mtt85 -82.74 101.16 10.7 Favored 'General case' 0 CA--C 1.48 -1.738 0 N-CA-C 106.447 -1.686 . . . . 0.0 106.447 174.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . 0.529 ' HB ' ' OG ' ' A' ' 90' ' ' SER . 52.4 t -68.59 -27.84 37.86 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.803 0 CA-C-N 114.942 -1.026 . . . . 0.0 112.25 -175.366 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -90.84 69.69 6.48 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-O 121.975 0.893 . . . . 0.0 110.432 -177.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 39.3 ttpt 177.92 130.54 0.06 Allowed 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 113.474 -1.694 . . . . 0.0 106.81 175.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' PHE . . . . . . . . . . . . . 64.0 m-85 . . . . . 0 C--N 1.288 -2.098 0 CA-C-O 119.148 -0.453 . . . . 0.0 110.302 -175.159 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.458 ' O ' ' HG ' ' A' ' 58' ' ' LEU . 18.4 mt . . . . . 0 N--CA 1.437 -1.115 0 CA-C-O 119.087 -0.482 . . . . 0.0 111.597 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.462 ' HA ' ' CD1' ' A' ' 58' ' ' LEU . 38.6 Cg_exo -58.59 -38.47 89.41 Favored 'Trans proline' 0 C--N 1.384 2.409 0 C-N-CA 121.209 1.273 . . . . 0.0 113.572 -172.059 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.439 ' O ' ' HG3' ' A' ' 59' ' ' LYS . 11.0 pt-20 -70.13 -30.13 67.24 Favored 'General case' 0 C--O 1.214 -0.765 0 CA-C-O 120.826 0.346 . . . . 0.0 110.815 178.317 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 62.4 tp -69.66 -33.38 72.51 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.371 177.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.462 ' CD1' ' HA ' ' A' ' 55' ' ' PRO . 6.3 mt -65.58 -52.59 51.08 Favored 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 -179.042 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.448 ' O ' ' HA ' ' A' ' 64' ' ' PRO . 15.3 ptpt -63.04 -24.04 67.73 Favored 'General case' 0 C--O 1.187 -2.213 0 CA-C-N 114.897 -1.047 . . . . 0.0 113.296 177.149 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -82.53 -54.77 4.92 Favored 'General case' 0 C--N 1.292 -1.898 0 O-C-N 121.848 -0.533 . . . . 0.0 112.283 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 54.0 t80 -56.96 -31.26 64.83 Favored 'General case' 0 C--O 1.245 0.827 0 C-N-CA 124.287 1.035 . . . . 0.0 110.68 -173.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.613 ' OD1' ' HB3' ' A' ' 75' ' ' TYR . 3.4 m-20 -108.56 25.69 11.4 Favored 'General case' 0 C--N 1.283 -2.32 0 CA-C-N 114.19 -1.368 . . . . 0.0 111.681 -172.312 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.572 HD22 ' N ' ' A' ' 115' ' ' GLY . 34.5 mt 80.91 143.33 0.08 OUTLIER Pre-proline 0 N--CA 1.477 0.89 0 C-N-CA 125.056 1.342 . . . . 0.0 108.936 -178.408 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.448 ' HA ' ' O ' ' A' ' 59' ' ' LYS . 10.2 Cg_endo -84.2 21.5 1.06 Allowed 'Trans proline' 0 N--CA 1.439 -1.733 0 C-N-CA 122.837 2.358 . . . . 0.0 113.239 -161.797 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.595 ' O ' ' HA3' ' A' ' 159' ' ' GLY . 0.2 OUTLIER -72.93 -38.13 55.7 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.913 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 175.338 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.422 ' C ' ' H ' ' A' ' 68' ' ' PHE . . . 55.07 8.64 1.57 Allowed Glycine 0 N--CA 1.473 1.106 0 CA-C-N 114.988 -1.005 . . . . 0.0 114.329 178.099 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.738 ' O ' ' HB ' ' A' ' 160' ' ' VAL . 37.9 mt 70.77 -31.93 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 C-N-CA 125.578 1.551 . . . . 0.0 113.911 -179.132 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.537 ' HB2' ' O ' ' A' ' 67' ' ' ILE . 55.6 t80 167.04 -56.89 0.0 OUTLIER Pre-proline 0 C--N 1.312 -1.046 0 C-N-CA 124.743 1.217 . . . . 0.0 108.936 175.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.461 ' HD2' ' H ' ' A' ' 70' ' ' GLY . 19.3 Cg_endo -110.4 -16.73 0.03 OUTLIER 'Trans proline' 0 CA--C 1.569 2.225 0 C-N-CA 122.777 2.318 . . . . 0.0 116.877 -171.701 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.461 ' H ' ' HD2' ' A' ' 69' ' ' PRO . . . 84.09 7.19 85.66 Favored Glycine 0 CA--C 1.533 1.161 0 C-N-CA 119.732 -1.223 . . . . 0.0 110.395 -171.155 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.445 ' HB3' ' HG2' ' A' ' 69' ' ' PRO . 30.0 t70 -82.36 -50.62 8.71 Favored 'General case' 0 CA--C 1.497 -1.086 0 N-CA-C 106.314 -1.735 . . . . 0.0 106.314 177.395 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.406 ' O ' ' HB ' ' A' ' 73' ' ' THR . . . -83.03 176.73 9.02 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 113.732 -1.577 . . . . 0.0 107.48 166.049 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.652 HG23 ' O ' ' A' ' 73' ' ' THR . 89.4 m 82.0 27.86 0.15 Allowed 'General case' 0 N--CA 1.492 1.633 0 CA-C-O 124.363 2.03 . . . . 0.0 109.8 176.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.599 HD21 ' N ' ' A' ' 74' ' ' ASN . 0.8 OUTLIER -87.84 123.53 32.71 Favored 'General case' 0 C--N 1.257 -3.447 0 CA-C-N 114.417 -1.265 . . . . 0.0 110.464 179.434 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.613 ' HB3' ' OD1' ' A' ' 62' ' ' ASP . 46.2 p90 -82.17 141.53 32.97 Favored 'General case' 0 C--N 1.295 -1.771 0 O-C-N 124.243 0.964 . . . . 0.0 112.506 -178.639 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 32.0 mm-40 -159.39 136.84 9.88 Favored 'General case' 0 C--O 1.203 -1.347 0 C-N-CA 126.537 1.935 . . . . 0.0 107.266 174.409 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 49.9 p90 -134.7 148.32 50.28 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 118.538 0.608 . . . . 0.0 110.995 -177.163 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.501 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 4.6 m-20 -89.39 169.88 11.02 Favored 'General case' 0 CA--C 1.478 -1.827 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 177.477 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -81.41 -62.07 1.76 Allowed 'General case' 0 C--N 1.267 -3.013 0 CA-C-N 114.426 -1.261 . . . . 0.0 111.337 177.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.32 -33.59 49.17 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 115.398 -0.819 . . . . 0.0 112.502 -176.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.501 ' HB ' ' HB2' ' A' ' 78' ' ' ASP . 90.1 m -81.46 -47.6 12.97 Favored 'General case' 0 C--N 1.288 -2.093 0 CA-C-N 115.192 -0.913 . . . . 0.0 111.844 178.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.408 ' H ' ' HB2' ' A' ' 78' ' ' ASP . 65.5 mttp 61.73 -5.55 0.14 Allowed 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 115.345 1.609 . . . . 0.0 115.345 -179.238 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.565 ' HG2' HG23 ' A' ' 109' ' ' THR . 32.6 ttmt -75.2 110.22 9.35 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 173.071 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 5.8 tt -66.23 134.02 51.82 Favored 'General case' 0 C--N 1.299 -1.6 0 CA-C-N 114.756 -1.111 . . . . 0.0 111.41 -174.067 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 15.0 t -108.02 126.93 53.31 Favored 'General case' 0 N--CA 1.397 -3.093 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.238 -179.288 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.593 ' HA ' ' O ' ' A' ' 74' ' ' ASN . 79.0 t -96.9 132.24 41.8 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.672 -179.359 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.9 mp -95.4 114.63 26.42 Favored 'General case' 0 N--CA 1.423 -1.787 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.721 -179.444 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 2.4 mp -104.83 110.27 64.22 Favored Pre-proline 0 C--N 1.299 -1.616 0 N-CA-C 105.77 -1.937 . . . . 0.0 105.77 171.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . 0.623 ' O ' ' HB2' ' A' ' 166' ' ' ARG . 51.8 Cg_exo -56.17 94.07 0.05 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.498 0 C-N-CA 122.782 2.321 . . . . 0.0 112.215 178.164 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' SER . . . . . 0.414 ' HB2' ' HB2' ' A' ' 168' ' ' ASP . 40.9 t 74.95 141.53 0.07 Allowed 'General case' 0 C--N 1.343 0.323 0 C-N-CA 125.217 1.407 . . . . 0.0 111.813 -176.777 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 4.5 tt -69.08 121.35 18.27 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.504 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.894 177.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 12.7 p -107.58 145.16 33.59 Favored 'General case' 0 C--N 1.298 -1.657 0 CA-C-N 114.524 -1.216 . . . . 0.0 109.634 176.511 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.455 ' O ' ' HA3' ' A' ' 164' ' ' GLY . 2.2 mp0 -118.1 132.65 56.33 Favored 'General case' 0 CA--C 1.471 -2.087 0 N-CA-C 105.969 -1.863 . . . . 0.0 105.969 178.585 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.502 HG12 ' H ' ' A' ' 163' ' ' ASN . 16.7 t -108.8 104.19 16.69 Favored 'Isoleucine or valine' 0 N--CA 1.398 -3.046 0 C-N-CA 119.366 -0.934 . . . . 0.0 109.132 -178.628 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.404 -3.477 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 -179.102 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' SER . . . . . 0.4 ' HA ' ' O ' ' A' ' 126' ' ' LYS . 46.4 t . . . . . 0 N--CA 1.419 -2.01 0 N-CA-C 104.816 -2.29 . . . . 0.0 104.816 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 54.3 t -126.03 131.21 71.97 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 179.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.467 ' HB2' ' HB ' ' A' ' 94' ' ' VAL . 2.7 mp -126.81 148.42 49.95 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 118.145 0.429 . . . . 0.0 110.126 -177.61 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -138.67 123.73 19.01 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 174.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -120.77 108.05 13.49 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 178.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 12.4 t -81.47 -177.35 6.47 Favored 'General case' 0 N--CA 1.432 -1.339 0 CA-C-O 121.133 0.492 . . . . 0.0 111.266 -178.431 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 39.4 p -66.07 -58.71 4.87 Favored 'General case' 0 C--N 1.301 -1.538 0 C-N-CA 124.833 1.253 . . . . 0.0 112.595 -172.376 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 6.4 m -122.54 97.32 5.4 Favored 'General case' 0 N--CA 1.41 -2.455 0 CA-C-O 121.535 0.683 . . . . 0.0 109.866 -175.571 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 18.1 m -99.02 141.11 17.09 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 CA-C-N 114.978 -1.01 . . . . 0.0 109.545 179.301 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.565 HG23 ' HG2' ' A' ' 83' ' ' LYS . 2.9 m -114.62 119.91 38.36 Favored 'General case' 0 N--CA 1.403 -2.783 0 N-CA-C 104.748 -2.316 . . . . 0.0 104.748 -174.336 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . 0.718 ' HA2' ' O ' ' A' ' 119' ' ' ASP . . . -141.74 159.56 26.9 Favored Glycine 0 N--CA 1.435 -1.38 0 C-N-CA 120.037 -1.078 . . . . 0.0 115.169 -174.258 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 6.8 t60 -88.06 109.28 19.73 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 177.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 65.3 tp -106.96 120.99 43.55 Favored 'General case' 0 C--N 1.302 -1.461 0 C-N-CA 119.885 -0.726 . . . . 0.0 112.458 -175.099 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -115.1 158.05 22.71 Favored 'General case' 0 CA--C 1.448 -2.971 0 N-CA-C 107.505 -1.294 . . . . 0.0 107.505 169.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 2.4 tmtm? -82.25 99.12 9.12 Favored 'General case' 2 N--CA 1.375 -4.202 0 N-CA-C 107.135 -1.432 . . . . 0.0 107.135 -175.854 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . 0.572 ' N ' HD22 ' A' ' 63' ' ' LEU . . . 131.28 -20.24 4.74 Favored Glycine 0 C--O 1.19 -2.631 0 N-CA-C 109.978 -1.249 . . . . 0.0 109.978 -177.257 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -163.23 135.8 5.38 Favored 'General case' 0 C--N 1.314 -0.953 0 O-C-N 122.109 -0.642 . . . . 0.0 110.864 -177.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 3.1 tt -116.8 114.54 24.08 Favored 'General case' 0 C--N 1.286 -2.168 0 N-CA-C 106.246 -1.761 . . . . 0.0 106.246 178.002 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.441 ' HA ' ' CB ' ' A' ' 135' ' ' SER . 49.9 p -116.52 175.77 5.41 Favored 'General case' 0 C--N 1.279 -2.48 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.424 -176.016 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . 0.718 ' O ' ' HA2' ' A' ' 110' ' ' GLY . 7.0 m-20 54.91 83.84 0.08 Allowed 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.629 0.772 . . . . 0.0 111.2 174.85 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.42 ' CG2' ' HB ' ' A' ' 123' ' ' ILE . 13.6 m -119.3 108.47 23.86 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.8 0 CA-C-O 122.303 1.049 . . . . 0.0 112.321 -172.469 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -79.9 100.24 7.95 Favored 'General case' 0 C--N 1.268 -2.943 0 CA-C-N 114.331 -1.304 . . . . 0.0 110.204 174.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 123.94 -14.08 8.01 Favored Glycine 0 N--CA 1.435 -1.428 0 C-N-CA 120.722 -0.751 . . . . 0.0 113.161 176.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.42 ' HB ' ' CG2' ' A' ' 120' ' ' VAL . 63.5 mt -102.46 116.09 45.53 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.914 0 CA-C-O 121.536 0.684 . . . . 0.0 110.116 179.555 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -124.21 141.23 52.24 Favored 'General case' 0 C--N 1.294 -1.847 0 CA-C-N 114.795 -1.093 . . . . 0.0 109.053 178.474 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.408 ' OG1' ' HG ' ' A' ' 102' ' ' LEU . 11.1 t -152.48 162.67 40.88 Favored 'General case' 0 C--O 1.245 0.847 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 178.495 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.441 ' HE2' ' N ' ' A' ' 128' ' ' MET . 8.3 tmtt? -131.18 129.59 41.91 Favored 'General case' 0 N--CA 1.426 -1.635 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.656 176.261 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.455 ' O ' ' HB3' ' A' ' 128' ' ' MET . 41.8 t -150.02 112.81 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.481 -1.699 0 N-CA-C 104.31 -2.478 . . . . 0.0 104.31 172.764 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' MET . . . . . 0.455 ' HB3' ' O ' ' A' ' 127' ' ' VAL . 45.9 ttm 69.48 -54.95 0.58 Allowed 'General case' 0 N--CA 1.473 0.696 0 O-C-N 124.031 0.832 . . . . 0.0 109.978 -172.054 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 8.0 tp -139.18 162.89 27.21 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.716 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 178.38 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 69.5 p-90 -92.67 137.72 32.12 Favored 'General case' 0 N--CA 1.423 -1.823 0 CA-C-O 121.064 0.459 . . . . 0.0 110.861 -178.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 53.4 t -134.31 121.83 38.38 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.154 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 179.343 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 60.1 pttt -98.29 3.16 48.73 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.157 0.503 . . . . 0.0 111.955 -176.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 34.4 m -124.22 25.02 3.47 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.204 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 176.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 9.4 t -55.24 113.24 1.31 Allowed 'General case' 0 N--CA 1.441 -0.906 0 CA-C-N 113.258 -1.792 . . . . 0.0 113.249 -173.178 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' SER . . . . . 0.471 ' O ' ' HA ' ' A' ' 146' ' ' THR . 26.3 p -100.1 149.94 22.99 Favored 'General case' 0 N--CA 1.405 -2.72 0 C-N-CA 119.72 -0.792 . . . . 0.0 113.033 -177.38 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . 0.449 ' HB ' HG22 ' A' ' 146' ' ' THR . 13.2 tt -100.9 138.46 25.05 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.71 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 -179.109 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 14.7 t -120.55 142.71 49.09 Favored 'General case' 0 N--CA 1.408 -2.567 0 N-CA-C 107.052 -1.462 . . . . 0.0 107.052 -178.479 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' THR . . . . . 0.432 ' HB ' HD11 ' A' ' 63' ' ' LEU . 33.2 m -149.02 175.5 11.25 Favored 'General case' 0 C--N 1.27 -2.882 0 N-CA-C 106.523 -1.658 . . . . 0.0 106.523 -176.768 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -118.05 30.45 7.23 Favored 'General case' 0 C--N 1.277 -2.583 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 174.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . 0.43 ' HA ' HD21 ' A' ' 63' ' ' LEU . . . 60.26 36.56 20.75 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-N 114.745 -1.116 . . . . 0.0 110.145 -177.045 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 41.4 t 174.38 -82.68 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 114.283 -1.326 . . . . 0.0 108.353 -172.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 23.0 pttm -77.56 136.79 38.32 Favored 'General case' 0 CA--C 1.505 -0.758 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 177.62 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 12.4 p -109.95 156.58 10.79 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.889 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 -171.23 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -128.98 154.16 46.86 Favored 'General case' 0 N--CA 1.428 -1.539 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 174.613 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 33.9 t80 -73.96 162.92 28.55 Favored 'General case' 0 C--N 1.309 -1.152 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 -175.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' THR . . . . . 0.471 ' HA ' ' O ' ' A' ' 135' ' ' SER . 70.9 p -71.7 -172.73 0.85 Allowed 'General case' 0 N--CA 1.42 -1.966 0 CA-C-O 121.512 0.672 . . . . 0.0 112.609 -175.358 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . 0.415 ' HB3' ' CG ' ' A' ' 150' ' ' LYS . . . 74.78 -29.54 0.19 Allowed 'General case' 0 N--CA 1.463 0.192 0 C-N-CA 126.018 1.727 . . . . 0.0 113.317 177.267 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 147.74 43.63 0.03 OUTLIER Glycine 0 CA--C 1.477 -2.319 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 178.008 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 65.3 mtt 60.96 40.14 15.76 Favored 'General case' 0 C--N 1.344 0.369 0 O-C-N 124.196 0.586 . . . . 0.0 110.224 -177.409 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . 0.51 ' HA ' ' HE2' ' A' ' 150' ' ' LYS . 9.5 mmpt? -65.53 -16.76 64.0 Favored 'General case' 0 N--CA 1.483 1.199 0 CA-C-O 120.816 0.341 . . . . 0.0 111.415 -178.766 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . 0.47 ' HA ' ' HE3' ' A' ' 151' ' ' LYS . 0.0 OUTLIER -147.27 163.43 36.42 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 176.962 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 9.0 p -131.34 111.65 12.04 Favored 'General case' 0 C--N 1.292 -1.904 0 CA-C-O 121.391 0.615 . . . . 0.0 110.483 176.502 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 33.5 mmt180 -113.87 160.51 18.68 Favored 'General case' 0 CA--C 1.501 -0.914 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.001 -179.085 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 51.2 m -96.05 140.49 30.7 Favored 'General case' 0 N--CA 1.42 -1.93 0 CA-C-N 116.253 -0.43 . . . . 0.0 109.905 177.068 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' ARG . . . . . 0.48 ' HG3' ' HA2' ' A' ' 159' ' ' GLY . 9.0 ttp180 -74.99 -21.2 59.28 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.051 175.625 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -34.92 -49.6 0.45 Allowed 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 126.315 1.846 . . . . 0.0 114.806 -174.144 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -77.44 -55.37 5.45 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 113.635 0.976 . . . . 0.0 113.635 -176.198 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -153.52 16.02 0.52 Allowed 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.981 -0.449 . . . . 0.0 111.836 -176.01 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . 0.595 ' HA3' ' O ' ' A' ' 65' ' ' ILE . . . 84.88 -89.35 1.6 Allowed Glycine 0 CA--C 1.466 -2.989 0 C-N-CA 119.646 -1.264 . . . . 0.0 110.735 -174.501 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.738 ' HB ' ' O ' ' A' ' 67' ' ' ILE . 39.1 t -99.6 148.5 6.39 Favored 'Isoleucine or valine' 0 N--CA 1.4 -2.931 0 C-N-CA 119.491 -0.884 . . . . 0.0 109.102 177.575 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 74.8 mt-30 -113.74 108.98 17.84 Favored 'General case' 0 N--CA 1.416 -2.158 0 N-CA-C 106.393 -1.706 . . . . 0.0 106.393 -172.082 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . 0.524 ' C ' ' HD2' ' A' ' 162' ' ' ARG . 5.2 ppt_? -125.9 163.15 23.57 Favored 'General case' 0 C--N 1.275 -2.668 0 CA-C-N 115.167 -0.924 . . . . 0.0 112.919 -169.76 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' ASN . . . . . 0.502 ' H ' HG12 ' A' ' 94' ' ' VAL . 3.1 m-20 -110.4 -59.65 1.91 Allowed 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.875 175.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . 0.493 ' O ' ' HD3' ' A' ' 162' ' ' ARG . . . -61.0 147.38 47.03 Favored Glycine 0 CA--C 1.501 -0.782 0 CA-C-N 115.877 -0.601 . . . . 0.0 113.033 -179.635 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 65.6 tp -107.83 139.23 42.73 Favored 'General case' 0 N--CA 1.422 -1.827 0 CA-C-O 121.169 0.509 . . . . 0.0 109.851 -177.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . 0.623 ' HB2' ' O ' ' A' ' 89' ' ' PRO . 6.5 ptp85 -85.84 103.49 14.64 Favored 'General case' 0 C--N 1.287 -2.146 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 176.471 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 4.8 t -102.9 70.98 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.788 0 CA-C-N 115.184 -0.916 . . . . 0.0 112.46 -170.52 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . 0.414 ' HB2' ' HB2' ' A' ' 90' ' ' SER . 15.8 t70 -109.14 -39.2 5.33 Favored 'General case' 0 CA--C 1.475 -1.918 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 175.304 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' LYS . . . . . 0.504 ' HD3' ' H ' ' A' ' 169' ' ' LYS . 0.0 OUTLIER -93.1 149.65 21.08 Favored 'General case' 0 C--N 1.287 -2.128 0 CA-C-N 113.48 -1.691 . . . . 0.0 109.634 -174.146 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' PHE . . . . . . . . . . . . . 81.6 t80 . . . . . 0 C--N 1.288 -2.082 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 179.719 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.627 ' O ' ' HG ' ' A' ' 58' ' ' LEU . 10.5 tp . . . . . 0 C--O 1.203 -1.349 0 N-CA-C 110.213 -0.292 . . . . 0.0 110.213 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.569 ' HD3' ' HB3' ' A' ' 54' ' ' LEU . 8.1 Cg_exo -50.73 -38.2 55.81 Favored 'Trans proline' 0 C--N 1.388 2.608 0 C-N-CA 123.536 2.824 . . . . 0.0 112.671 -177.444 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -76.95 -31.84 56.88 Favored 'General case' 0 N--CA 1.432 -1.365 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.069 -179.299 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.547 ' HG ' ' O ' ' A' ' 54' ' ' LEU . 2.0 pp -75.74 -28.67 58.59 Favored 'General case' 0 C--O 1.204 -1.293 0 C-N-CA 119.669 -0.812 . . . . 0.0 108.984 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.627 ' HG ' ' O ' ' A' ' 54' ' ' LEU . 63.0 mt -57.34 -48.76 78.14 Favored 'General case' 0 C--O 1.199 -1.571 0 O-C-N 123.938 0.774 . . . . 0.0 110.809 -177.123 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 55.2 mtpt -64.88 -29.53 70.49 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-O 121.846 0.832 . . . . 0.0 110.627 -177.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -96.71 1.71 51.25 Favored 'General case' 0 C--N 1.297 -1.686 0 CA-C-N 114.692 -1.14 . . . . 0.0 111.424 -178.214 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 41.2 t80 -57.15 -42.88 81.86 Favored 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 112.776 0.658 . . . . 0.0 112.776 -170.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.563 ' OD1' ' HA ' ' A' ' 114' ' ' LYS . 11.2 t70 -139.67 -74.56 0.36 Allowed 'General case' 0 C--N 1.315 -0.916 0 C-N-CA 120.031 -0.667 . . . . 0.0 109.989 -177.41 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.448 HD23 ' H ' ' A' ' 115' ' ' GLY . 20.3 mt -96.29 150.17 36.82 Favored Pre-proline 0 N--CA 1.445 -0.719 0 N-CA-C 106.23 -1.767 . . . . 0.0 106.23 175.489 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_endo -99.9 18.22 0.35 Allowed 'Trans proline' 0 N--CA 1.443 -1.497 0 C-N-CA 123.77 2.98 . . . . 0.0 113.539 -169.391 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.409 ' HB ' HG22 ' A' ' 160' ' ' VAL . 0.2 OUTLIER -69.78 -45.01 78.6 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.872 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 176.743 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 52.83 9.53 0.8 Allowed Glycine 0 N--CA 1.486 2.011 0 CA-C-N 114.908 -1.042 . . . . 0.0 114.266 178.401 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.666 ' HA ' ' CG2' ' A' ' 160' ' ' VAL 0.288 20.2 mt 62.17 -68.37 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 C-N-CA 126.413 1.885 . . . . 0.0 112.835 -170.948 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 69.6 t80 177.97 -55.41 0.0 OUTLIER Pre-proline 0 C--N 1.301 -1.528 0 O-C-N 123.69 0.619 . . . . 0.0 111.674 -177.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -82.9 -70.35 0.01 OUTLIER 'Trans proline' 0 C--N 1.369 1.647 0 C-N-CA 121.763 1.642 . . . . 0.0 113.003 -175.402 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 153.73 -40.53 0.67 Allowed Glycine 0 CA--C 1.492 -1.38 0 N-CA-C 110.092 -1.203 . . . . 0.0 110.092 -176.114 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.416 ' O ' ' ND2' ' A' ' 74' ' ' ASN . 3.2 t70 -74.84 -55.25 6.01 Favored 'General case' 0 C--O 1.184 -2.352 0 N-CA-C 104.745 -2.317 . . . . 0.0 104.745 175.757 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -66.08 99.57 0.52 Allowed 'General case' 0 C--N 1.31 -1.132 0 C-N-CA 117.082 -1.847 . . . . 0.0 107.556 163.216 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.402 ' O ' HG21 ' A' ' 73' ' ' THR 1.619 6.3 m 115.26 30.8 0.0 OUTLIER 'General case' 0 N--CA 1.439 -1.012 1 N-CA-C 123.299 4.555 . . . . 0.0 123.299 -178.542 . . . . . . . . 4 3 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.579 ' O ' HG22 ' A' ' 86' ' ' VAL . 3.5 p30 -89.11 178.28 6.42 Favored 'General case' 0 C--N 1.293 -1.882 0 CA-C-N 114.708 -1.133 . . . . 0.0 108.003 167.419 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.469 ' CD1' HD21 ' A' ' 112' ' ' LEU . 93.4 m-85 -136.73 101.56 4.64 Favored 'General case' 0 C--N 1.281 -2.395 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 -178.248 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -108.59 114.15 27.72 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 -178.253 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 87.8 t80 -112.94 126.73 55.8 Favored 'General case' 0 C--N 1.282 -2.363 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 -176.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.555 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 7.3 m-20 -91.09 164.44 13.94 Favored 'General case' 0 CA--C 1.478 -1.799 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 177.001 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -80.27 -64.77 1.11 Allowed 'General case' 0 C--N 1.278 -2.515 0 CA-C-N 115.055 -0.975 . . . . 0.0 112.662 -175.541 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -71.91 -30.36 65.28 Favored 'General case' 0 CA--C 1.506 -0.736 0 CA-C-O 121.437 0.637 . . . . 0.0 110.538 -176.033 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.555 ' HB ' ' HB2' ' A' ' 78' ' ' ASP . 17.7 m -66.29 -46.81 75.7 Favored 'General case' 0 N--CA 1.417 -2.125 0 CA-C-N 115.082 -0.963 . . . . 0.0 110.295 -178.218 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 97.3 mttt 64.58 17.59 10.96 Favored 'General case' 0 N--CA 1.486 1.363 0 CA-C-O 121.982 0.896 . . . . 0.0 111.486 178.345 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 47.0 tptt -116.03 124.62 50.91 Favored 'General case' 0 N--CA 1.394 -3.248 0 N-CA-C 105.242 -2.133 . . . . 0.0 105.242 -178.607 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.449 HD12 ' N ' ' A' ' 85' ' ' THR . 3.1 tm? -76.46 137.38 39.64 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 179.794 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.449 ' N ' HD12 ' A' ' 84' ' ' LEU . 54.1 p -125.94 144.8 50.54 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.579 HG22 ' O ' ' A' ' 74' ' ' ASN . 92.9 t -112.98 130.39 66.92 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.512 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 172.337 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 18.5 mt -96.4 102.16 13.91 Favored 'General case' 0 C--N 1.282 -2.355 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 -179.447 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 62.6 mt -104.15 135.1 19.39 Favored Pre-proline 0 C--N 1.306 -1.313 0 N-CA-C 109.63 -0.508 . . . . 0.0 109.63 -178.378 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . 0.418 ' O ' ' HB2' ' A' ' 90' ' ' SER . 37.9 Cg_endo -84.04 110.34 1.54 Allowed 'Trans proline' 0 N--CA 1.43 -2.264 0 C-N-CA 122.548 2.165 . . . . 0.0 110.483 177.606 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' SER . . . . . 0.418 ' HB2' ' O ' ' A' ' 89' ' ' PRO . 59.9 m 71.41 156.25 0.16 Allowed 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 122.146 0.974 . . . . 0.0 113.181 -179.748 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.448 HG12 ' HA ' ' A' ' 105' ' ' THR . 96.5 mt -80.72 125.69 39.4 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.861 0 CA-C-N 114.807 -1.088 . . . . 0.0 110.038 177.058 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 8.9 p -118.13 145.92 44.54 Favored 'General case' 0 C--N 1.293 -1.87 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 173.292 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -131.18 130.84 43.53 Favored 'General case' 0 C--N 1.282 -2.334 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 -174.099 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.534 HG11 ' H ' ' A' ' 163' ' ' ASN . 55.7 t -118.67 109.43 26.92 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.296 0 CA-C-O 121.266 0.555 . . . . 0.0 111.87 -173.779 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.408 -3.209 0 N-CA-C 109.357 -1.497 . . . . 0.0 109.357 175.306 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' SER . . . . . 0.636 ' HB3' ' O ' ' A' ' 126' ' ' LYS . 23.3 m . . . . . 0 N--CA 1.402 -2.856 0 CA-C-O 120.512 0.196 . . . . 0.0 110.489 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 86.6 t -128.68 102.64 8.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 N-CA-C 107.313 -1.365 . . . . 0.0 107.313 175.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.564 ' CD2' HG23 ' A' ' 125' ' ' THR . 55.2 mt -109.39 130.86 55.48 Favored 'General case' 0 C--N 1.285 -2.205 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.989 -171.144 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 35.2 tttp -103.63 115.57 30.74 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 110.237 -0.282 . . . . 0.0 110.237 -175.391 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -96.89 95.73 8.05 Favored 'General case' 0 N--CA 1.413 -2.285 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 173.303 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' THR . . . . . 0.556 ' H ' HG21 ' A' ' 123' ' ' ILE . 19.6 m -66.35 179.56 0.97 Allowed 'General case' 0 N--CA 1.423 -1.803 0 CA-C-N 113.587 -1.642 . . . . 0.0 110.186 177.318 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' THR . . . . . 0.549 ' H ' HG22 ' A' ' 105' ' ' THR . 22.1 p -79.56 -74.09 0.31 Allowed 'General case' 0 C--N 1.301 -1.527 0 C-N-CA 123.814 0.846 . . . . 0.0 112.408 -173.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 11.5 p -96.04 101.59 13.28 Favored 'General case' 0 N--CA 1.406 -2.642 0 CA-C-O 121.295 0.569 . . . . 0.0 110.25 -178.412 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.436 ' CG2' HG23 ' A' ' 123' ' ' ILE . 1.1 p -97.45 159.01 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.03 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 -179.778 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 63.6 m -144.71 120.38 10.47 Favored 'General case' 0 C--N 1.293 -1.876 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 -173.103 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . 0.524 ' HA3' ' O ' ' A' ' 119' ' ' ASP . . . -160.69 -157.45 8.71 Favored Glycine 0 C--O 1.202 -1.897 0 C-N-CA 121.091 -0.576 . . . . 0.0 113.88 -174.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 36.4 m80 -124.64 117.34 24.06 Favored 'General case' 0 C--N 1.305 -1.358 0 O-C-N 122.269 -0.548 . . . . 0.0 109.687 177.277 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.469 HD21 ' CD1' ' A' ' 75' ' ' TYR . 67.0 tp -100.68 129.61 46.61 Favored 'General case' 0 C--N 1.293 -1.885 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.267 -177.605 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -127.32 153.29 46.36 Favored 'General case' 0 CA--C 1.441 -3.239 0 CA-C-N 115.018 -0.992 . . . . 0.0 109.507 174.115 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . 0.563 ' HA ' ' OD1' ' A' ' 62' ' ' ASP . 56.6 tptt -67.54 101.52 1.01 Allowed 'General case' 0 N--CA 1.388 -3.539 0 O-C-N 124.672 1.233 . . . . 0.0 107.896 176.816 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . 0.523 ' O ' ' HB ' ' A' ' 138' ' ' THR . . . 135.78 -55.3 0.72 Allowed Glycine 0 N--CA 1.401 -3.657 0 N-CA-C 109.272 -1.531 . . . . 0.0 109.272 -175.209 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.458 ' HD3' HG23 ' A' ' 118' ' ' THR . 0.0 OUTLIER -148.98 152.73 36.84 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 -177.485 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.505 ' O ' ' HB2' ' A' ' 135' ' ' SER . 47.9 tp -108.47 102.77 11.83 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-N 115.337 -0.847 . . . . 0.0 108.96 177.616 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.458 HG23 ' HD3' ' A' ' 116' ' ' LYS . 6.1 p -103.22 167.09 10.05 Favored 'General case' 0 C--N 1.299 -1.619 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.048 178.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . 0.524 ' O ' ' HA3' ' A' ' 110' ' ' GLY . 5.8 m-20 67.94 107.22 0.05 OUTLIER 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.665 0.786 . . . . 0.0 109.12 -176.041 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.452 ' HB ' HG12 ' A' ' 123' ' ' ILE 0.354 4.1 m -125.7 72.79 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.401 -2.92 0 N-CA-C 114.243 1.201 . . . . 0.0 114.243 179.514 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -82.04 86.39 6.58 Favored 'General case' 0 N--CA 1.425 -1.682 0 CA-C-N 114.271 -1.331 . . . . 0.0 110.449 176.121 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 161.92 -40.77 0.39 Allowed Glycine 0 C--N 1.262 -3.533 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 175.141 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.556 HG21 ' H ' ' A' ' 105' ' ' THR . 25.2 pt -100.12 152.2 4.83 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.737 0 C-N-CA 119.09 -1.044 . . . . 0.0 108.813 -178.041 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . 0.586 ' HB2' ' HZ2' ' A' ' 124' ' ' LYS . 4.1 ttmp? -128.79 138.0 51.83 Favored 'General case' 0 C--N 1.27 -2.854 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 -176.468 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.564 HG23 ' CD2' ' A' ' 102' ' ' LEU . 13.3 m -124.13 115.45 21.16 Favored 'General case' 0 C--N 1.283 -2.296 0 CA-C-N 115.517 -0.765 . . . . 0.0 112.928 -169.561 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.636 ' O ' ' HB3' ' A' ' 100' ' ' SER . 0.2 OUTLIER -100.85 115.66 30.89 Favored 'General case' 0 N--CA 1.413 -2.289 0 N-CA-C 107.154 -1.424 . . . . 0.0 107.154 169.572 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.648 HG11 ' SD ' ' A' ' 128' ' ' MET 0.25 1.0 OUTLIER -120.47 -78.46 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.128 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.353 176.739 . . . . . . . . 4 4 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' MET . . . . . 0.648 ' SD ' HG11 ' A' ' 127' ' ' VAL . 0.0 OUTLIER -103.69 -9.15 19.36 Favored 'General case' 0 N--CA 1.412 -2.362 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 176.67 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 8.9 tp -164.06 164.48 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.41 -2.437 0 N-CA-C 106.297 -1.742 . . . . 0.0 106.297 177.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 31.0 t90 -85.33 114.93 22.77 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 -178.436 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 15.7 m -148.74 -175.27 0.38 Allowed 'Isoleucine or valine' 0 C--O 1.211 -0.953 0 C-N-CA 125.125 1.37 . . . . 0.0 109.452 -176.381 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . 0.506 ' HG3' ' N ' ' A' ' 133' ' ' VAL . 38.6 pttt -131.06 -36.62 1.32 Allowed 'General case' 0 C--N 1.305 -1.334 0 C-N-CA 120.227 -0.589 . . . . 0.0 112.038 176.163 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.506 ' N ' ' HG3' ' A' ' 132' ' ' LYS . 25.6 m -69.81 -8.0 9.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 N-CA-C 115.389 1.626 . . . . 0.0 115.389 -165.484 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' THR . . . . . 0.411 ' O ' ' HB ' ' A' ' 146' ' ' THR . 37.9 p -75.57 90.3 2.77 Favored 'General case' 0 N--CA 1.42 -1.951 0 CA-C-O 121.767 0.794 . . . . 0.0 110.48 179.464 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' SER . . . . . 0.505 ' HB2' ' O ' ' A' ' 117' ' ' LEU . 30.0 p -86.13 174.27 9.27 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-N 114.404 -1.271 . . . . 0.0 112.757 -175.554 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 9.4 tt -98.33 122.46 50.01 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.798 0 CA-C-O 122.027 0.918 . . . . 0.0 111.889 -171.38 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 34.0 p -96.56 148.11 23.17 Favored 'General case' 0 N--CA 1.417 -2.113 0 CA-C-N 114.886 -1.052 . . . . 0.0 108.69 176.473 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' THR . . . . . 0.538 HG21 ' N ' ' A' ' 140' ' ' ALA . 93.6 m -154.03 164.09 39.03 Favored 'General case' 0 C--N 1.289 -2.043 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 -172.565 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 63.7 m-20 -99.64 22.97 10.13 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 172.457 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . 0.538 ' N ' HG21 ' A' ' 138' ' ' THR . . . 58.86 36.36 24.62 Favored 'General case' 0 C--N 1.351 0.661 0 N-CA-C 106.525 -1.657 . . . . 0.0 106.525 -167.331 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' SER . . . . . 0.488 ' H ' HG21 ' A' ' 138' ' ' THR . 35.3 t -167.54 -75.36 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.841 0 CA-C-N 113.741 -1.572 . . . . 0.0 110.341 -170.124 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . 0.514 ' O ' HG23 ' A' ' 138' ' ' THR . 96.7 mttt -98.65 163.58 12.59 Favored 'General case' 0 N--CA 1.484 1.268 0 CA-C-N 117.924 0.329 . . . . 0.0 110.581 -179.306 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 92.1 t -106.7 135.14 46.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-O 121.431 0.634 . . . . 0.0 111.1 -178.389 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 62.5 m-85 -119.76 156.53 30.4 Favored 'General case' 0 C--N 1.296 -1.732 0 CA-C-N 115.483 -0.781 . . . . 0.0 109.501 179.143 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 46.9 p90 -42.03 133.17 3.04 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 124.558 1.143 . . . . 0.0 113.92 -176.288 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' THR . . . . . 0.476 ' HA ' ' O ' ' A' ' 135' ' ' SER . 74.5 p -78.71 -40.46 33.66 Favored 'General case' 0 N--CA 1.433 -1.311 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.101 177.699 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . 0.405 ' CB ' HG13 ' A' ' 127' ' ' VAL . . . -112.09 157.71 20.47 Favored 'General case' 0 N--CA 1.433 -1.292 0 CA-C-N 115.091 -0.958 . . . . 0.0 108.739 178.618 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -67.41 -27.78 73.57 Favored Glycine 0 C--N 1.309 -0.945 0 O-C-N 123.543 0.527 . . . . 0.0 113.153 -176.266 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 1.6 tmt? -78.25 -24.27 46.99 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-O 121.271 0.558 . . . . 0.0 110.429 178.259 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . 0.533 ' HE2' ' CG2' ' A' ' 127' ' ' VAL . 21.5 ttmm -80.14 166.45 21.46 Favored 'General case' 0 N--CA 1.433 -1.317 0 CA-C-N 115.289 -0.869 . . . . 0.0 110.155 -176.03 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -110.49 161.92 15.2 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 -177.381 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 44.2 m -76.17 155.41 34.58 Favored 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 176.136 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 24.4 tpt180 -142.77 138.69 30.63 Favored 'General case' 0 N--CA 1.435 -1.187 0 C-N-CA 119.104 -1.039 . . . . 0.0 112.077 -172.001 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 28.5 p -68.25 118.62 11.6 Favored 'General case' 0 N--CA 1.44 -0.958 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.668 177.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' ARG . . . . . 0.529 ' HB2' ' O ' ' A' ' 159' ' ' GLY 0.315 0.0 OUTLIER -83.35 -20.6 33.99 Favored 'General case' 0 C--O 1.204 -1.336 0 C-N-CA 119.357 -0.937 . . . . 0.0 113.476 -178.787 . . . . . . . . 4 4 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -43.78 -32.03 0.95 Allowed 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 124.774 1.23 . . . . 0.0 113.425 -178.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -61.53 -38.53 87.76 Favored 'General case' 0 CA--C 1.553 1.095 0 N-CA-C 113.647 0.98 . . . . 0.0 113.647 -179.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 41.1 m-85 -152.55 -21.69 0.17 Allowed 'General case' 0 N--CA 1.504 2.238 0 CA-C-N 118.363 0.529 . . . . 0.0 111.507 -177.432 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . 0.529 ' O ' ' HB2' ' A' ' 155' ' ' ARG . . . 106.34 -91.33 0.72 Allowed Glycine 0 CA--C 1.464 -3.149 0 N-CA-C 105.585 -3.006 . . . . 0.0 105.585 -166.413 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.666 ' CG2' ' HA ' ' A' ' 67' ' ' ILE . 88.9 t -100.66 141.68 17.04 Favored 'Isoleucine or valine' 0 N--CA 1.388 -3.534 0 N-CA-C 105.984 -1.858 . . . . 0.0 105.984 167.291 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 65.5 mt-30 -94.47 92.12 6.97 Favored 'General case' 0 CA--C 1.453 -2.755 0 N-CA-C 106.425 -1.695 . . . . 0.0 106.425 -170.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . 0.608 ' HD2' ' O ' ' A' ' 162' ' ' ARG . 0.0 OUTLIER -101.24 135.89 41.98 Favored 'General case' 1 N--CA 1.379 -4.016 0 CA-C-N 114.573 -1.194 . . . . 0.0 111.648 -170.685 . . . . . . . . 4 4 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' ASN . . . . . 0.534 ' H ' HG11 ' A' ' 94' ' ' VAL . 7.5 t30 -114.77 -13.63 12.03 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 177.537 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . 0.433 ' O ' ' HD3' ' A' ' 162' ' ' ARG . . . -100.38 157.78 19.43 Favored Glycine 0 N--CA 1.428 -1.863 0 CA-C-N 114.225 -1.352 . . . . 0.0 110.609 178.853 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . 0.409 ' O ' HD12 ' A' ' 165' ' ' LEU . 2.1 pp -121.38 153.78 37.35 Favored 'General case' 0 C--N 1.287 -2.144 0 C-N-CA 123.234 0.614 . . . . 0.0 109.935 -177.234 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.38 129.75 39.61 Favored 'General case' 0 N--CA 1.432 -1.326 0 N-CA-C 106.856 -1.535 . . . . 0.0 106.856 173.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 46.8 t -57.54 -29.65 34.55 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 CA-C-O 121.444 0.64 . . . . 0.0 109.684 174.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -70.29 -34.6 72.95 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 123.475 0.71 . . . . 0.0 111.378 178.054 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 64.8 tttp -96.99 109.63 22.34 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 113.248 0.832 . . . . 0.0 113.248 -174.462 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 . . . . . 0 C--N 1.293 -1.885 0 N-CA-C 107.099 -1.445 . . . . 0.0 107.099 173.914 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.48 ' HB3' ' HD3' ' A' ' 55' ' ' PRO . 14.8 tp . . . . . 0 C--O 1.199 -1.59 0 CA-C-O 118.895 -0.574 . . . . 0.0 111.65 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.48 ' HD3' ' HB3' ' A' ' 54' ' ' LEU . 0.1 OUTLIER -38.3 -45.58 2.2 Favored 'Trans proline' 0 C--N 1.388 2.613 0 C-N-CA 124.143 3.229 . . . . 0.0 113.476 177.185 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -69.76 -37.9 76.56 Favored 'General case' 0 N--CA 1.438 -1.069 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.668 179.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.429 ' HG ' ' CE1' ' A' ' 61' ' ' TYR . 3.7 tt -75.64 -35.4 60.45 Favored 'General case' 0 N--CA 1.436 -1.166 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.845 -177.817 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.493 HD12 ' N ' ' A' ' 59' ' ' LYS . 4.0 pp -66.88 -41.11 87.8 Favored 'General case' 0 C--N 1.314 -0.937 0 C-N-CA 120.412 -0.515 . . . . 0.0 112.276 -178.273 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.493 ' N ' HD12 ' A' ' 58' ' ' LEU . 62.0 pttt -75.13 -26.0 58.84 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.788 0.804 . . . . 0.0 109.823 176.649 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -66.27 -53.8 32.54 Favored 'General case' 0 N--CA 1.439 -0.979 0 CA-C-N 115.146 -0.934 . . . . 0.0 111.393 176.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.429 ' CE1' ' HG ' ' A' ' 57' ' ' LEU . 14.5 m-85 -60.34 -52.96 63.04 Favored 'General case' 0 CA--C 1.504 -0.815 0 N-CA-C 114.681 1.363 . . . . 0.0 114.681 -178.847 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.555 ' O ' HD13 ' A' ' 63' ' ' LEU . 19.6 m-20 -79.91 -98.04 0.03 OUTLIER 'General case' 0 C--N 1.316 -0.86 0 C-N-CA 118.918 -1.113 . . . . 0.0 110.44 -179.737 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.555 HD13 ' O ' ' A' ' 62' ' ' ASP . 0.8 OUTLIER -142.41 158.68 60.21 Favored Pre-proline 0 N--CA 1.43 -1.426 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 -177.723 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.501 ' HB2' ' NH1' ' A' ' 155' ' ' ARG . 12.9 Cg_endo -93.27 28.68 0.31 Allowed 'Trans proline' 0 N--CA 1.439 -1.679 0 C-N-CA 123.47 2.78 . . . . 0.0 112.176 -173.565 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.482 ' O ' ' HA3' ' A' ' 159' ' ' GLY . 0.2 OUTLIER -69.96 -29.92 42.16 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.343 0 N-CA-C 107.764 -1.199 . . . . 0.0 107.764 173.863 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.407 ' O ' ' HB ' ' A' ' 67' ' ' ILE . . . 62.01 -9.71 0.11 Allowed Glycine 0 CA--C 1.54 1.651 0 CA-C-N 114.515 -1.22 . . . . 0.0 115.268 177.596 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.6 ' O ' ' HB ' ' A' ' 160' ' ' VAL . 38.4 mt 76.33 -38.53 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.51 -0.592 0 C-N-CA 125.171 1.389 . . . . 0.0 113.217 179.315 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.531 ' HB2' ' O ' ' A' ' 67' ' ' ILE . 39.0 t80 166.07 -57.72 0.0 OUTLIER Pre-proline 0 C--N 1.321 -0.636 0 C-N-CA 125.009 1.323 . . . . 0.0 109.007 173.131 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.445 ' HD2' ' H ' ' A' ' 70' ' ' GLY . 19.6 Cg_endo -102.56 -16.85 0.09 OUTLIER 'Trans proline' 0 C--N 1.378 2.129 0 C-N-CA 122.209 1.94 . . . . 0.0 114.985 -172.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.445 ' H ' ' HD2' ' A' ' 69' ' ' PRO . . . 80.36 9.72 86.2 Favored Glycine 0 N--CA 1.441 -0.986 0 C-N-CA 119.924 -1.132 . . . . 0.0 111.633 -173.565 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.649 ' OD1' ' HG3' ' A' ' 89' ' ' PRO . 10.4 t70 -92.0 -43.56 9.36 Favored 'General case' 0 C--O 1.201 -1.455 0 N-CA-C 106.474 -1.676 . . . . 0.0 106.474 176.304 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.454 ' O ' ' HB ' ' A' ' 73' ' ' THR . . . -72.02 -178.77 2.5 Favored 'General case' 0 CA--C 1.552 1.043 0 CA-C-N 114.537 -1.21 . . . . 0.0 108.104 165.195 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.581 ' O ' HG22 ' A' ' 73' ' ' THR . 56.8 m 83.52 26.97 0.1 Allowed 'General case' 0 N--CA 1.498 1.948 0 CA-C-O 123.469 1.604 . . . . 0.0 108.398 179.28 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.431 ' ND2' HD23 ' A' ' 58' ' ' LEU . 3.5 m120 -81.7 111.15 17.69 Favored 'General case' 0 N--CA 1.41 -2.474 0 C-N-CA 118.528 -1.269 . . . . 0.0 110.962 -175.601 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 66.1 t80 -71.71 94.2 1.34 Allowed 'General case' 0 C--N 1.293 -1.874 0 CA-C-N 114.074 -1.421 . . . . 0.0 112.081 -176.195 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.505 ' HB2' ' HG1' ' A' ' 85' ' ' THR . 23.5 mm-40 -110.62 111.57 22.88 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 171.692 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -125.76 127.28 45.92 Favored 'General case' 0 C--N 1.291 -1.966 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.985 -170.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.455 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 3.3 m-20 -91.32 163.48 14.2 Favored 'General case' 0 CA--C 1.475 -1.933 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 178.238 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -81.67 -58.38 3.03 Favored 'General case' 0 C--N 1.26 -3.29 0 CA-C-N 114.237 -1.347 . . . . 0.0 113.176 -178.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -75.97 -46.92 27.14 Favored 'General case' 0 N--CA 1.429 -1.499 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.596 -176.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.455 ' HB ' ' HB2' ' A' ' 78' ' ' ASP . 96.8 m -67.98 -52.08 39.9 Favored 'General case' 0 C--N 1.293 -1.882 0 CA-C-N 114.4 -1.273 . . . . 0.0 112.369 -177.677 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 99.4 mttt 66.6 3.76 3.06 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 114.501 1.297 . . . . 0.0 114.501 178.334 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.696 ' HG2' ' OG1' ' A' ' 109' ' ' THR . 38.2 ttpt -91.17 92.49 8.69 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-O 121.856 0.836 . . . . 0.0 109.24 176.485 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.441 HD21 ' O ' ' A' ' 76' ' ' GLU . 3.0 tm? -51.21 135.1 26.65 Favored 'General case' 0 C--N 1.32 -0.706 0 C-N-CA 126.376 1.87 . . . . 0.0 111.728 -173.82 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.505 ' HG1' ' HB2' ' A' ' 76' ' ' GLU . 46.1 p -117.34 110.04 17.57 Favored 'General case' 0 N--CA 1.419 -1.981 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.021 179.805 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.409 HG23 ' CD1' ' A' ' 84' ' ' LEU . 53.5 t -91.9 127.44 44.18 Favored 'Isoleucine or valine' 0 CA--C 1.478 -1.822 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 172.574 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.454 ' HA ' ' O ' ' A' ' 106' ' ' THR 0.286 0.0 OUTLIER -114.57 129.85 56.71 Favored 'General case' 0 N--CA 1.392 -3.349 0 CA-C-N 115.105 -0.952 . . . . 0.0 111.227 178.902 . . . . . . . . 4 4 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.454 ' O ' HG21 ' A' ' 106' ' ' THR . 3.1 mp -95.69 136.21 22.5 Favored Pre-proline 0 C--N 1.275 -2.66 0 CA-C-N 114.069 -1.423 . . . . 0.0 108.411 178.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . 0.649 ' HG3' ' OD1' ' A' ' 71' ' ' ASP . 7.1 Cg_exo -25.3 -55.45 0.08 OUTLIER 'Trans proline' 0 C--N 1.374 1.878 1 C-N-CA 125.719 4.279 . . . . 0.0 114.065 174.825 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' SER . . . . . 0.471 ' HB2' ' HB2' ' A' ' 168' ' ' ASP . 45.1 t -154.1 161.45 41.89 Favored 'General case' 0 N--CA 1.426 -1.631 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 177.179 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.407 HD11 ' HD2' ' A' ' 103' ' ' LYS . 10.0 tt -64.64 114.65 2.48 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 O-C-N 123.939 0.774 . . . . 0.0 110.524 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' CYS . . . . . 0.483 ' HB2' ' HA ' ' A' ' 166' ' ' ARG . 44.2 t -116.03 123.08 47.06 Favored 'General case' 0 N--CA 1.417 -2.122 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.01 -179.161 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -99.05 169.82 9.14 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.25 -179.148 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.409 ' HB ' HH11 ' A' ' 162' ' ' ARG . 3.5 p -148.31 106.08 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.674 0 C-N-CA 123.325 0.65 . . . . 0.0 110.073 174.372 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.296 -1.686 0 N-CA-C 108.643 -1.783 . . . . 0.0 108.643 175.831 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 43.6 p . . . . . 0 N--CA 1.411 -2.388 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 96.1 t -94.68 115.96 34.8 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.993 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.776 176.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.442 ' HG ' ' HA ' ' A' ' 125' ' ' THR . 6.9 tt -137.66 134.83 35.91 Favored 'General case' 0 C--N 1.286 -2.195 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 -178.199 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.407 ' HD2' HD11 ' A' ' 91' ' ' ILE . 39.0 ttpt -110.11 106.51 16.0 Favored 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 178.62 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 14.1 t80 -96.36 96.83 9.01 Favored 'General case' 0 N--CA 1.421 -1.904 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 -177.579 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' THR . . . . . 0.468 HG23 ' H ' ' A' ' 106' ' ' THR . 10.6 m -57.98 172.29 0.43 Allowed 'General case' 0 CA--C 1.568 1.66 0 C-N-CA 126.415 1.886 . . . . 0.0 112.307 -178.777 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' THR . . . . . 0.468 ' H ' HG23 ' A' ' 105' ' ' THR . 38.4 m -78.29 -72.41 0.37 Allowed 'General case' 0 C--N 1.316 -0.887 0 C-N-CA 123.562 0.745 . . . . 0.0 111.79 -173.445 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 43.9 m -103.62 110.34 22.36 Favored 'General case' 0 N--CA 1.431 -1.412 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 179.498 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.563 HG22 HG12 ' A' ' 123' ' ' ILE . 3.6 p -109.03 167.08 4.31 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.419 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 178.48 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.696 ' OG1' ' HG2' ' A' ' 83' ' ' LYS . 15.1 t -139.39 131.94 28.74 Favored 'General case' 0 N--CA 1.4 -2.945 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 -175.788 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -147.32 172.18 27.8 Favored Glycine 0 N--CA 1.413 -2.86 0 C-N-CA 119.273 -1.441 . . . . 0.0 113.162 -177.65 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 35.8 m80 -77.35 121.57 23.93 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 -179.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.42 ' HB2' ' CB ' ' A' ' 84' ' ' LEU . 3.2 tm? -94.57 110.71 22.5 Favored 'General case' 0 N--CA 1.422 -1.845 0 CA-C-O 121.213 0.53 . . . . 0.0 110.532 -174.214 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -128.18 130.15 47.59 Favored 'General case' 0 CA--C 1.439 -3.307 0 CA-C-N 114.549 -1.205 . . . . 0.0 108.913 168.221 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 54.8 tptt -66.47 116.37 7.39 Favored 'General case' 0 N--CA 1.38 -3.962 0 CA-C-N 114.54 -1.209 . . . . 0.0 109.142 -178.209 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . 0.474 ' C ' ' HE2' ' A' ' 116' ' ' LYS . . . 118.42 -27.56 7.23 Favored Glycine 0 C--O 1.177 -3.459 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 -174.169 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.726 ' HE2' ' N ' ' A' ' 116' ' ' LYS . 0.0 OUTLIER -165.19 122.23 1.51 Allowed 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 117.393 0.597 . . . . 0.0 111.898 -178.246 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 64.4 tp -93.6 105.44 17.49 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 176.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 34.2 p -105.9 134.64 48.71 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 114.094 1.146 . . . . 0.0 114.094 -172.534 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 67.1 88.15 0.11 Allowed 'General case' 0 CA--C 1.49 -1.327 0 C-N-CA 124.871 1.268 . . . . 0.0 112.887 178.211 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.419 HG22 ' O ' ' A' ' 134' ' ' THR . 12.4 m -95.78 92.35 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.302 0 CA-C-O 122.912 1.339 . . . . 0.0 108.679 178.824 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -73.57 99.76 3.14 Favored 'General case' 0 C--N 1.264 -3.145 0 CA-C-N 113.072 -1.876 . . . . 0.0 111.769 -174.307 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 145.67 -8.62 1.58 Allowed Glycine 0 N--CA 1.423 -2.194 0 CA-C-N 114.41 -1.268 . . . . 0.0 111.631 177.011 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.563 HG12 HG22 ' A' ' 108' ' ' VAL . 46.4 mm -100.21 118.46 46.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-O 121.623 0.725 . . . . 0.0 111.18 -178.171 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt -85.4 119.31 25.63 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 106.294 -1.743 . . . . 0.0 106.294 175.169 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.442 ' HA ' ' HG ' ' A' ' 102' ' ' LEU . 89.5 m -125.47 128.07 47.48 Favored 'General case' 0 C--N 1.283 -2.299 0 CA-C-N 115.764 -0.653 . . . . 0.0 112.526 -169.624 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.526 ' HD3' ' C ' ' A' ' 126' ' ' LYS . 0.5 OUTLIER -137.85 123.45 19.75 Favored 'General case' 0 N--CA 1.428 -1.561 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 168.82 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.459 ' N ' ' HD3' ' A' ' 126' ' ' LYS . 7.1 p -150.55 -44.52 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.284 -2.266 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 177.556 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 15.5 tpt -103.72 -42.7 5.55 Favored 'General case' 0 N--CA 1.416 -2.16 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 173.371 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . 0.414 HG13 ' H ' ' A' ' 130' ' ' TRP . 9.3 tp -164.51 175.33 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.889 0 N-CA-C 105.808 -1.923 . . . . 0.0 105.808 178.507 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' TRP . . . . . 0.46 ' CE3' ' HB2' ' A' ' 126' ' ' LYS . 97.7 m95 -69.66 122.81 19.85 Favored 'General case' 0 C--O 1.241 0.642 0 CA-C-O 121.716 0.769 . . . . 0.0 112.285 178.725 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 97.0 t -130.96 149.03 33.08 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.031 0 C-N-CA 125.481 1.512 . . . . 0.0 107.348 179.347 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 18.0 ptmt -122.75 -12.37 8.07 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-O 121.381 0.61 . . . . 0.0 110.71 177.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 15.8 m -138.39 75.28 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 CA-C-O 122.115 0.96 . . . . 0.0 110.266 -178.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' THR . . . . . 0.419 ' O ' HG22 ' A' ' 120' ' ' VAL . 7.7 t -84.01 168.92 15.49 Favored 'General case' 0 N--CA 1.414 -2.265 0 CA-C-N 115.062 -0.972 . . . . 0.0 109.328 179.022 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 16.6 p -131.47 151.69 51.35 Favored 'General case' 0 N--CA 1.387 -3.593 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 14.1 tt -118.28 97.61 5.55 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.272 0 CA-C-O 122.253 1.025 . . . . 0.0 108.768 176.405 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' SER . . . . . 0.476 ' OG ' ' HB2' ' A' ' 144' ' ' TYR . 36.2 p -91.44 152.48 20.36 Favored 'General case' 0 N--CA 1.407 -2.577 0 CA-C-N 115.019 -0.991 . . . . 0.0 110.575 -177.204 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' THR . . . . . 0.417 HG21 ' O ' ' A' ' 115' ' ' GLY . 4.4 t -165.42 178.08 7.05 Favored 'General case' 0 N--CA 1.396 -3.137 0 N-CA-C 107.337 -1.356 . . . . 0.0 107.337 -176.378 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -112.7 28.43 8.79 Favored 'General case' 0 C--N 1.269 -2.891 0 N-CA-C 106.848 -1.538 . . . . 0.0 106.848 174.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . 71.44 35.76 1.44 Allowed 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 114.284 -1.325 . . . . 0.0 109.569 -175.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 39.3 t 177.66 -80.9 0.0 OUTLIER 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 114.299 -1.319 . . . . 0.0 109.37 -178.17 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -78.26 135.94 37.66 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 -178.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 47.7 t -105.48 144.5 14.96 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 -165.062 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . 0.476 ' HB2' ' OG ' ' A' ' 137' ' ' SER . 83.6 m-85 -119.69 121.42 39.18 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 106.499 -1.667 . . . . 0.0 106.499 173.826 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 32.3 t80 -96.86 99.13 10.71 Favored 'General case' 0 C--N 1.286 -2.163 0 CA-C-O 121.812 0.815 . . . . 0.0 109.117 -173.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 15.2 p -97.95 31.35 2.71 Favored 'General case' 0 C--N 1.298 -1.668 0 CA-C-N 115.288 -0.869 . . . . 0.0 112.571 -175.137 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -76.13 82.45 2.96 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-O 121.856 0.836 . . . . 0.0 111.265 178.364 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 94.79 -58.13 1.84 Allowed Glycine 0 CA--C 1.477 -2.34 0 N-CA-C 108.749 -1.74 . . . . 0.0 108.749 178.213 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 19.6 ttt 169.93 88.93 0.0 OUTLIER 'General case' 0 N--CA 1.435 -1.214 0 C-N-CA 126.518 1.927 . . . . 0.0 107.351 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . 0.407 ' HD3' ' HA ' ' A' ' 150' ' ' LYS . 63.2 mmtt -133.07 176.32 8.6 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 113.64 0.978 . . . . 0.0 113.64 178.878 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -85.59 161.34 19.34 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.296 -0.866 . . . . 0.0 112.205 -173.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 53.6 p -78.31 160.8 27.66 Favored 'General case' 0 N--CA 1.438 -1.058 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.189 -179.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 30.4 ttm180 -145.7 152.09 39.05 Favored 'General case' 0 N--CA 1.438 -1.073 0 CA-C-O 121.014 0.435 . . . . 0.0 110.257 -176.074 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 61.8 p -89.11 135.05 33.77 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 177.186 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' ARG . . . . . 0.501 ' NH1' ' HB2' ' A' ' 64' ' ' PRO . 15.1 ptt180 -78.45 -19.18 53.71 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 120.091 -0.644 . . . . 0.0 110.449 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -48.68 -30.54 5.61 Favored 'General case' 0 C--N 1.316 -0.858 0 C-N-CA 124.375 1.07 . . . . 0.0 112.837 -177.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -75.33 -53.83 8.08 Favored 'General case' 0 N--CA 1.441 -0.902 0 C-N-CA 120.838 -0.345 . . . . 0.0 111.043 178.422 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . 0.444 ' HB2' ' HB3' ' A' ' 161' ' ' GLN . 95.4 m-85 -157.1 -5.25 0.1 Allowed 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 111.592 0.219 . . . . 0.0 111.592 -178.417 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . 0.482 ' HA3' ' O ' ' A' ' 65' ' ' ILE . . . 79.14 -84.71 1.24 Allowed Glycine 0 CA--C 1.475 -2.446 0 N-CA-C 109.01 -1.636 . . . . 0.0 109.01 -169.47 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.6 ' HB ' ' O ' ' A' ' 67' ' ' ILE . 16.3 t -109.85 134.11 53.02 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.505 0 N-CA-C 107.513 -1.292 . . . . 0.0 107.513 174.297 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' GLN . . . . . 0.444 ' HB3' ' HB2' ' A' ' 158' ' ' TYR . 1.1 pp0? -148.17 116.39 6.51 Favored 'General case' 0 N--CA 1.416 -2.169 0 CA-C-O 121.497 0.665 . . . . 0.0 110.721 -175.002 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . 0.458 ' NH1' ' HA3' ' A' ' 164' ' ' GLY . 1.9 ppt_? -154.74 162.32 41.16 Favored 'General case' 0 C--N 1.266 -3.034 0 CA-C-N 113.935 -1.484 . . . . 0.0 109.074 175.57 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -76.8 91.98 3.56 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 121.716 0.77 . . . . 0.0 112.718 -177.478 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . 0.458 ' HA3' ' NH1' ' A' ' 162' ' ' ARG . . . -146.25 142.4 10.48 Favored Glycine 0 N--CA 1.421 -2.312 0 CA-C-N 115.67 -0.696 . . . . 0.0 111.591 178.128 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . 0.407 HD22 ' H ' ' A' ' 165' ' ' LEU . 1.5 pt? -117.7 112.05 19.95 Favored 'General case' 0 N--CA 1.416 -2.133 0 N-CA-C 106.802 -1.555 . . . . 0.0 106.802 173.575 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . 0.483 ' HA ' ' HB2' ' A' ' 92' ' ' CYS . 10.8 ptp180 -80.02 110.21 15.2 Favored 'General case' 0 N--CA 1.416 -2.161 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 -179.06 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 5.7 m -69.88 26.31 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.292 -1.897 0 N-CA-C 116.082 1.882 . . . . 0.0 116.082 -171.537 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . 0.471 ' HB2' ' HB2' ' A' ' 90' ' ' SER . 31.7 t70 -135.37 69.15 1.44 Allowed 'General case' 0 CA--C 1.497 -1.092 0 N-CA-C 108.064 -1.088 . . . . 0.0 108.064 170.183 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' LYS . . . . . 0.422 ' HB2' ' O ' ' A' ' 168' ' ' ASP . 25.0 ttpp 167.87 145.86 0.02 OUTLIER 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 113.878 -1.51 . . . . 0.0 107.344 179.465 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' PHE . . . . . . . . . . . . . 74.5 t80 . . . . . 0 N--CA 1.412 -2.346 0 N-CA-C 105.37 -2.085 . . . . 0.0 105.37 170.378 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.427 ' N ' ' HD2' ' A' ' 55' ' ' PRO . 3.4 mm? . . . . . 0 CA--C 1.491 -1.301 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.427 ' HD2' ' N ' ' A' ' 54' ' ' LEU . 27.3 Cg_endo -60.82 -14.97 35.09 Favored 'Trans proline' 0 N--CA 1.434 -2.017 0 C-N-CA 121.914 1.743 . . . . 0.0 113.129 -170.789 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -76.26 -34.4 59.16 Favored 'General case' 0 CA--C 1.493 -1.228 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 -179.597 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.418 ' HA ' ' HB3' ' A' ' 60' ' ' GLU . 88.1 mt -74.44 -36.52 63.4 Favored 'General case' 0 N--CA 1.42 -1.971 0 CA-C-N 114.946 -1.025 . . . . 0.0 109.48 178.459 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 8.3 mp -62.59 -42.11 99.37 Favored 'General case' 0 CA--C 1.494 -1.187 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -178.088 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.413 ' HD2' ' N ' ' A' ' 60' ' ' GLU . 0.0 OUTLIER -75.39 -28.1 59.32 Favored 'General case' 0 N--CA 1.435 -1.204 0 C-N-CA 118.839 -1.144 . . . . 0.0 110.375 176.228 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.418 ' HB3' ' HA ' ' A' ' 57' ' ' LEU . 7.5 tt0 -60.47 -38.64 84.86 Favored 'General case' 0 C--O 1.25 1.094 0 CA-C-N 114.952 -1.022 . . . . 0.0 113.124 178.835 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 73.8 m-85 -60.43 -42.24 95.64 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.944 0.72 . . . . 0.0 112.944 179.39 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . 0.265 24.8 m-20 -121.64 -82.77 0.65 Allowed 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 115.92 1.822 . . . . 0.0 115.92 -174.416 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.501 ' HB2' HD12 ' A' ' 65' ' ' ILE . 0.0 OUTLIER -114.04 138.72 22.99 Favored Pre-proline 0 C--N 1.318 -0.793 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 -177.747 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 63' ' ' LEU . 32.2 Cg_endo -98.93 27.94 0.15 Allowed 'Trans proline' 0 N--CA 1.431 -2.178 0 C-N-CA 123.858 3.038 . . . . 0.0 111.753 -170.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.668 ' O ' ' HA3' ' A' ' 159' ' ' GLY . 0.2 OUTLIER -61.63 -39.59 83.69 Favored 'Isoleucine or valine' 0 CA--C 1.484 -1.592 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 173.787 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 54.83 8.79 1.49 Allowed Glycine 0 CA--C 1.547 2.086 0 CA-C-N 115.263 -0.88 . . . . 0.0 113.737 -177.66 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.466 ' O ' ' HB ' ' A' ' 160' ' ' VAL . 47.8 mt 62.35 -68.15 0.12 Allowed 'Isoleucine or valine' 0 C--O 1.193 -1.904 0 C-N-CA 126.669 1.988 . . . . 0.0 113.812 -177.307 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 89.2 t80 -176.74 -54.19 0.0 OUTLIER Pre-proline 0 C--N 1.307 -1.273 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -173.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -92.05 -2.9 4.08 Favored 'Trans proline' 0 C--N 1.366 1.447 0 C-N-CA 121.74 1.626 . . . . 0.0 113.085 -172.507 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 82.77 -2.64 85.78 Favored Glycine 0 N--CA 1.429 -1.773 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.15 -179.196 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -102.75 -71.06 0.73 Allowed 'General case' 0 CA--C 1.497 -1.083 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 179.297 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.402 ' CB ' HG22 ' A' ' 88' ' ' ILE . . . -49.77 137.78 15.66 Favored 'General case' 0 CA--C 1.509 -0.604 0 CA-C-N 115.037 -0.983 . . . . 0.0 108.812 173.25 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 8.1 t 118.53 4.19 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.167 0 C-N-CA 126.735 2.014 . . . . 0.0 108.475 -169.112 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.514 ' O ' HG13 ' A' ' 86' ' ' VAL . 18.5 m-80 -72.31 -173.13 1.03 Allowed 'General case' 0 CA--C 1.497 -1.081 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 174.667 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.449 ' HB2' HD11 ' A' ' 84' ' ' LEU . 50.5 p90 -170.87 143.46 2.06 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 114.286 1.217 . . . . 0.0 114.286 178.326 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.429 ' HG3' HD12 ' A' ' 87' ' ' LEU . 52.8 mt-10 -133.11 173.34 11.53 Favored 'General case' 0 C--N 1.288 -2.074 0 C-N-CA 127.479 2.312 . . . . 0.0 105.021 174.393 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 47.2 p90 -148.45 149.54 31.89 Favored 'General case' 0 C--N 1.29 -2.017 0 CA-C-N 118.904 0.775 . . . . 0.0 110.544 178.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.709 ' OD1' ' HB ' ' A' ' 81' ' ' THR . 5.5 p30 -87.91 158.07 18.79 Favored 'General case' 0 C--N 1.306 -1.301 0 C-N-CA 119.682 -0.807 . . . . 0.0 111.109 174.507 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -82.59 -66.86 0.84 Allowed 'General case' 0 C--N 1.28 -2.454 0 N-CA-C 115.915 1.82 . . . . 0.0 115.915 -170.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.69 -21.3 63.52 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.832 -173.074 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.709 ' HB ' ' OD1' ' A' ' 78' ' ' ASP . 85.0 m -101.57 -51.01 3.56 Favored 'General case' 0 N--CA 1.408 -2.546 0 CA-C-N 114.973 -1.012 . . . . 0.0 110.52 -178.212 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.566 ' HA ' ' O ' ' A' ' 78' ' ' ASP . 39.6 mtpt 77.39 31.13 0.48 Allowed 'General case' 0 C--O 1.243 0.757 0 C-N-CA 125.959 1.703 . . . . 0.0 112.438 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.482 ' CG ' HG22 ' A' ' 109' ' ' THR . 16.4 tptm -88.8 139.3 30.6 Favored 'General case' 0 N--CA 1.404 -2.767 0 N-CA-C 106.007 -1.849 . . . . 0.0 106.007 175.845 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.593 ' O ' ' HA ' ' A' ' 109' ' ' THR . 16.0 tp -76.07 135.57 39.89 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 -176.587 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 3.0 t -124.86 111.57 15.64 Favored 'General case' 0 C--N 1.272 -2.777 0 CA-C-O 121.927 0.87 . . . . 0.0 109.915 178.073 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.514 HG13 ' O ' ' A' ' 74' ' ' ASN . 86.7 t -92.01 124.65 44.57 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.691 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.675 -177.501 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.499 ' H ' HD11 ' A' ' 87' ' ' LEU . 0.0 OUTLIER -90.48 117.77 29.43 Favored 'General case' 0 N--CA 1.398 -3.064 0 CA-C-N 114.944 -1.026 . . . . 0.0 108.754 176.497 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.635 HG23 ' NH1' ' A' ' 166' ' ' ARG . 48.8 mt -117.82 120.29 32.94 Favored Pre-proline 0 C--N 1.277 -2.576 0 CA-C-N 114.122 -1.399 . . . . 0.0 107.926 -175.629 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -58.19 91.36 0.06 OUTLIER 'Trans proline' 0 C--N 1.358 1.053 0 C-N-CA 123.794 2.996 . . . . 0.0 113.475 -177.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 70.0 m 73.39 -169.92 0.12 Allowed 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.003 0.921 . . . . 0.0 112.205 -179.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.497 HG12 ' HA ' ' A' ' 105' ' ' THR . 66.5 mt -102.58 150.04 6.67 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.12 0 CA-C-O 120.722 0.296 . . . . 0.0 110.344 178.677 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 23.5 p -141.4 141.44 33.76 Favored 'General case' 0 CA--C 1.48 -1.734 0 N-CA-C 105.715 -1.957 . . . . 0.0 105.715 168.296 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.471 ' HB3' ' HA ' ' A' ' 103' ' ' LYS . 7.9 pt-20 -150.16 168.19 24.68 Favored 'General case' 0 C--N 1.259 -3.356 0 O-C-N 123.508 0.505 . . . . 0.0 111.022 177.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.463 ' O ' ' HA ' ' A' ' 101' ' ' VAL . 5.2 p -137.33 123.9 28.51 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.158 0 C-N-CA 120.587 -0.445 . . . . 0.0 111.34 -172.637 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.433 -1.542 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 177.306 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 20.3 m . . . . . 0 N--CA 1.406 -2.626 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.463 ' HA ' ' O ' ' A' ' 94' ' ' VAL . 7.6 p -113.69 103.13 14.9 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.355 0 CA-C-O 121.889 0.852 . . . . 0.0 110.497 176.853 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.422 ' HG ' ' CG2' ' A' ' 125' ' ' THR . 4.3 mp -116.92 134.15 55.12 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 114.698 -1.137 . . . . 0.0 109.001 -177.587 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.471 ' HA ' ' HB3' ' A' ' 93' ' ' GLU . 4.4 ttmp? -103.01 111.95 24.55 Favored 'General case' 0 C--N 1.312 -1.046 0 N-CA-C 109.57 -0.529 . . . . 0.0 109.57 175.824 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.448 ' O ' ' HA ' ' A' ' 91' ' ' ILE . 98.3 m-85 -95.34 101.45 13.18 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 176.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' THR . . . . . 0.497 ' HA ' HG12 ' A' ' 91' ' ' ILE . 14.7 t -87.56 179.7 6.49 Favored 'General case' 0 N--CA 1.443 -0.784 0 O-C-N 123.63 0.581 . . . . 0.0 111.612 -173.732 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' THR . . . . . 0.44 ' HA ' ' O ' ' A' ' 88' ' ' ILE . 37.3 p -67.6 -35.66 79.4 Favored 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 124.051 0.94 . . . . 0.0 113.293 -176.322 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 27.8 p -133.13 110.2 10.01 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-O 120.811 0.339 . . . . 0.0 111.14 178.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 61.5 t -109.6 131.38 60.65 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.699 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 176.067 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.593 ' HA ' ' O ' ' A' ' 84' ' ' LEU . 11.5 m -114.15 122.01 45.52 Favored 'General case' 0 N--CA 1.42 -1.962 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 -172.094 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . 0.543 ' HA3' ' O ' ' A' ' 119' ' ' ASP . . . -155.16 -158.42 8.74 Favored Glycine 0 N--CA 1.442 -0.904 0 C-N-CA 120.305 -0.95 . . . . 0.0 114.058 -175.654 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 78.7 t60 -120.09 127.17 52.3 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-O 121.337 0.589 . . . . 0.0 110.532 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.462 ' HA ' HD22 ' A' ' 117' ' ' LEU . 1.2 tt -95.35 128.08 41.91 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 115.542 -0.753 . . . . 0.0 109.675 -174.571 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . 0.516 ' HB2' ' O ' ' A' ' 116' ' ' LYS . 35.1 mm-40 -131.04 165.31 23.5 Favored 'General case' 0 CA--C 1.495 -1.144 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 171.736 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 57.2 tptt -84.15 101.36 11.78 Favored 'General case' 0 N--CA 1.414 -2.243 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 178.401 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . 0.681 ' O ' ' HB ' ' A' ' 138' ' ' THR . . . 120.18 -56.54 0.59 Allowed Glycine 0 N--CA 1.418 -2.51 0 C-N-CA 120.027 -1.082 . . . . 0.0 111.494 179.547 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.516 ' O ' ' HB2' ' A' ' 113' ' ' GLU . 0.0 OUTLIER -126.23 127.51 45.76 Favored 'General case' 0 C--N 1.298 -1.654 0 CA-C-O 121.577 0.704 . . . . 0.0 112.542 -177.663 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.462 HD22 ' HA ' ' A' ' 112' ' ' LEU . 1.8 tm? -100.95 107.54 19.05 Favored 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 106.989 -1.485 . . . . 0.0 106.989 -176.69 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.478 ' HA ' ' HB2' ' A' ' 135' ' ' SER . 12.4 p -110.47 153.63 24.78 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 -178.559 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . 0.543 ' O ' ' HA3' ' A' ' 110' ' ' GLY . 20.7 m-20 69.53 115.92 0.04 OUTLIER 'General case' 0 C--O 1.206 -1.224 0 C-N-CA 124.379 1.071 . . . . 0.0 109.828 -174.836 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 8.5 m -140.37 85.38 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.115 0 CA-C-O 122.398 1.094 . . . . 0.0 111.312 179.258 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -79.05 101.95 8.11 Favored 'General case' 0 C--N 1.289 -2.026 0 CA-C-N 114.474 -1.239 . . . . 0.0 107.8 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 139.38 -22.48 2.88 Favored Glycine 0 C--N 1.297 -1.608 0 N-CA-C 110.525 -1.03 . . . . 0.0 110.525 -177.371 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 89.9 mt -100.09 107.71 21.45 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.059 0 CA-C-O 121.918 0.866 . . . . 0.0 109.403 178.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 57.5 mttp -107.1 122.9 47.41 Favored 'General case' 0 C--N 1.288 -2.104 0 CA-C-N 114.304 -1.317 . . . . 0.0 108.756 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.422 ' CG2' ' HG ' ' A' ' 102' ' ' LEU . 72.1 m -130.89 130.04 43.03 Favored 'General case' 0 N--CA 1.431 -1.385 0 O-C-N 123.851 0.72 . . . . 0.0 112.633 -172.298 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.543 ' HD3' ' C ' ' A' ' 126' ' ' LYS . 0.4 OUTLIER -113.48 126.52 55.41 Favored 'General case' 0 N--CA 1.42 -1.962 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 167.996 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.56 HG13 ' SD ' ' A' ' 128' ' ' MET . 2.3 p -135.74 -65.05 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.873 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.517 177.239 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' MET . . . . . 0.56 ' SD ' HG13 ' A' ' 127' ' ' VAL . 0.0 OUTLIER -106.59 -29.76 9.44 Favored 'General case' 0 N--CA 1.399 -3.017 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 177.556 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 42.5 mm -148.92 162.31 5.05 Favored 'Isoleucine or valine' 0 C--O 1.248 1.0 0 N-CA-C 104.315 -2.476 . . . . 0.0 104.315 177.135 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 87.4 t90 -81.47 117.46 21.91 Favored 'General case' 0 N--CA 1.443 -0.786 0 N-CA-C 108.234 -1.025 . . . . 0.0 108.234 175.208 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . 0.483 HG11 ' H ' ' A' ' 133' ' ' VAL . 47.5 t -123.04 141.64 42.62 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.903 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 -177.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 64.4 pttt -100.85 21.95 12.84 Favored 'General case' 0 C--N 1.306 -1.306 0 C-N-CA 119.326 -0.949 . . . . 0.0 111.876 -177.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.483 ' H ' HG11 ' A' ' 131' ' ' VAL . 61.5 t -133.82 -82.12 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 C-N-CA 120.712 -0.395 . . . . 0.0 110.548 176.768 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' THR . . . . . 0.472 ' O ' ' HB ' ' A' ' 146' ' ' THR . 70.5 p 49.9 76.93 0.12 Allowed 'General case' 0 CA--C 1.536 0.414 0 CA-C-O 121.619 0.724 . . . . 0.0 111.097 -171.184 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' SER . . . . . 0.594 ' O ' ' HA ' ' A' ' 146' ' ' THR . 12.5 p -83.15 153.85 24.59 Favored 'General case' 0 N--CA 1.431 -1.391 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 -176.257 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 14.5 tt -100.84 128.89 52.53 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.396 0 CA-C-O 121.891 0.853 . . . . 0.0 112.259 -170.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 19.8 m -101.3 147.52 26.21 Favored 'General case' 0 N--CA 1.421 -1.894 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 178.081 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' THR . . . . . 0.681 ' HB ' ' O ' ' A' ' 115' ' ' GLY . 98.8 m -155.77 152.31 28.32 Favored 'General case' 0 C--N 1.284 -2.247 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 -178.301 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 73.5 m-20 -87.36 23.07 1.97 Allowed 'General case' 0 N--CA 1.482 1.162 0 O-C-N 121.597 -0.69 . . . . 0.0 109.965 176.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . 61.47 35.95 17.39 Favored 'General case' 0 C--N 1.351 0.631 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 -170.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' SER . . . . . 0.435 ' H ' HG22 ' A' ' 138' ' ' THR . 43.3 t -173.87 -79.18 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 113.972 -1.467 . . . . 0.0 109.492 -173.812 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . 0.456 ' O ' HG21 ' A' ' 138' ' ' THR . 97.9 mttt -88.0 151.46 22.76 Favored 'General case' 0 CA--C 1.509 -0.631 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 -179.48 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.448 ' O ' ' HB3' ' A' ' 152' ' ' SER . 24.4 t -105.97 136.78 38.99 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 O-C-N 123.545 0.528 . . . . 0.0 111.442 -167.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -124.5 155.56 38.74 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-O 120.833 0.349 . . . . 0.0 111.527 -177.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 35.3 p90 -45.93 148.34 0.83 Allowed 'General case' 0 C--O 1.243 0.737 0 N-CA-C 115.346 1.609 . . . . 0.0 115.346 -178.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' THR . . . . . 0.594 ' HA ' ' O ' ' A' ' 135' ' ' SER . 69.3 p -93.05 -16.02 25.47 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-N 114.915 -1.038 . . . . 0.0 110.973 179.176 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -136.36 149.17 48.23 Favored 'General case' 0 N--CA 1.441 -0.876 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 -177.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -83.04 74.71 2.49 Favored Glycine 0 CA--C 1.497 -1.037 0 N-CA-C 111.289 -0.725 . . . . 0.0 111.289 -176.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 1.3 tmt? 174.5 -36.27 0.0 OUTLIER 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 105.87 -1.9 . . . . 0.0 105.87 -177.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 22.8 ttmm -75.43 168.49 19.9 Favored 'General case' 0 N--CA 1.411 -2.425 0 CA-C-N 112.469 -2.15 . . . . 0.0 109.074 -179.141 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 61.0 mttp -119.92 164.03 16.67 Favored 'General case' 0 C--N 1.31 -1.133 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 -171.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' SER . . . . . 0.448 ' HB3' ' O ' ' A' ' 143' ' ' VAL . 35.6 m -85.82 160.86 19.36 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 115.398 -0.819 . . . . 0.0 112.806 -175.69 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' ARG . . . . . 0.424 ' HG2' ' H ' ' A' ' 161' ' ' GLN . 12.0 mpt_? -126.56 164.2 21.73 Favored 'General case' 0 CA--C 1.516 -0.351 0 C-N-CA 123.571 0.748 . . . . 0.0 111.282 -179.883 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 35.0 m -94.38 145.3 24.86 Favored 'General case' 0 C--N 1.296 -1.748 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.784 177.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -61.16 -37.46 82.98 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 176.47 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -58.3 -26.16 62.69 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 123.749 0.82 . . . . 0.0 111.656 177.445 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . 0.418 ' O ' ' HB2' ' A' ' 158' ' ' TYR . . . -79.56 1.21 26.77 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 115.692 -0.685 . . . . 0.0 112.017 -177.608 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . 0.418 ' HB2' ' O ' ' A' ' 157' ' ' ALA . 88.7 m-85 93.54 20.94 0.02 OUTLIER 'General case' 0 CA--C 1.493 -1.241 0 C-N-CA 125.888 1.675 . . . . 0.0 111.189 -176.432 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . 0.668 ' HA3' ' O ' ' A' ' 65' ' ' ILE . . . 87.04 -86.04 1.54 Allowed Glycine 0 N--CA 1.408 -3.219 0 CA-C-N 114.757 -1.111 . . . . 0.0 113.115 175.645 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.466 ' HB ' ' O ' ' A' ' 67' ' ' ILE . 6.8 t -104.57 116.48 48.44 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.138 0 C-N-CA 119.849 -0.74 . . . . 0.0 109.686 -174.758 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' GLN . . . . . 0.424 ' H ' ' HG2' ' A' ' 153' ' ' ARG . 12.5 mm-40 -116.33 99.87 7.5 Favored 'General case' 0 CA--C 1.486 -1.505 0 N-CA-C 116.521 2.045 . . . . 0.0 116.521 -174.847 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . 0.559 ' HA ' ' NE ' ' A' ' 162' ' ' ARG . 1.5 tpm_? -152.66 105.23 2.96 Favored 'General case' 0 N--CA 1.4 -2.933 0 N-CA-C 105.504 -2.035 . . . . 0.0 105.504 170.886 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 19.0 m120 -45.63 104.12 0.04 OUTLIER 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 115.875 1.806 . . . . 0.0 115.875 -172.403 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -151.66 156.21 26.56 Favored Glycine 0 N--CA 1.435 -1.425 0 N-CA-C 108.449 -1.86 . . . . 0.0 108.449 176.18 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -128.19 135.47 49.77 Favored 'General case' 0 N--CA 1.429 -1.508 0 CA-C-N 118.025 0.913 . . . . 0.0 109.929 -179.296 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . 0.635 ' NH1' HG23 ' A' ' 88' ' ' ILE . 3.1 mmp_? -65.76 122.44 17.31 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 106.496 -1.668 . . . . 0.0 106.496 179.541 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 25.1 t -74.18 61.99 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.559 1.308 0 CA-C-O 122.615 1.197 . . . . 0.0 109.596 175.256 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -165.83 -33.82 0.03 OUTLIER 'General case' 0 C--N 1.296 -1.735 0 C-N-CA 126.457 1.903 . . . . 0.0 106.742 -177.237 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 16.4 tppt? -76.37 110.47 10.93 Favored 'General case' 0 N--CA 1.434 -1.25 0 CA-C-N 114.349 -1.296 . . . . 0.0 111.932 -177.153 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' PHE . . . . . . . . . . . . . 69.7 t80 . . . . . 0 N--CA 1.432 -1.352 0 N-CA-C 106.456 -1.683 . . . . 0.0 106.456 176.588 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.523 ' HB3' ' HD3' ' A' ' 55' ' ' PRO . 14.0 tp . . . . . 0 N--CA 1.495 1.778 0 N-CA-C 113.373 0.879 . . . . 0.0 113.373 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.523 ' HD3' ' HB3' ' A' ' 54' ' ' LEU . 80.6 Cg_exo -59.22 -19.99 52.69 Favored 'Trans proline' 0 C--N 1.369 1.607 0 C-N-CA 123.086 2.524 . . . . 0.0 111.544 -178.183 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.416 ' HA ' ' HE2' ' A' ' 59' ' ' LYS . 21.3 mm-40 -81.1 -32.03 34.05 Favored 'General case' 0 N--CA 1.413 -2.312 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 -175.614 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.438 ' HA ' ' HG2' ' A' ' 60' ' ' GLU . 3.8 mm? -75.34 -49.23 19.76 Favored 'General case' 0 CA--C 1.483 -1.617 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.695 177.168 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.427 ' HA ' ' CD1' ' A' ' 75' ' ' TYR 0.323 2.5 pp -61.77 -38.95 89.93 Favored 'General case' 0 C--O 1.21 -1.0 0 C-N-CA 119.375 -0.93 . . . . 0.0 113.032 -176.162 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.416 ' HE2' ' HA ' ' A' ' 56' ' ' GLU . 63.7 pttt -75.5 -26.97 58.57 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 120.017 -0.673 . . . . 0.0 111.002 -179.867 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.438 ' HG2' ' HA ' ' A' ' 57' ' ' LEU . 11.2 pt-20 -79.78 -28.48 40.32 Favored 'General case' 0 C--N 1.351 0.65 0 C-N-CA 119.892 -0.723 . . . . 0.0 110.866 -177.896 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 78.5 m-85 -86.33 -1.58 57.64 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 118.799 -1.16 . . . . 0.0 112.269 175.336 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.448 ' OD2' HD13 ' A' ' 65' ' ' ILE . 15.4 t70 -93.2 -171.91 2.8 Favored 'General case' 0 C--N 1.306 -1.308 0 C-N-CA 125.709 1.603 . . . . 0.0 108.607 178.079 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.462 ' HB2' HD11 ' A' ' 65' ' ' ILE . 17.0 mt -85.47 -153.84 0.0 OUTLIER Pre-proline 0 CA--C 1.576 1.969 0 N-CA-C 103.488 -2.782 . . . . 0.0 103.488 174.175 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.556 ' O ' ' HD2' ' A' ' 155' ' ' ARG . 17.7 Cg_endo -100.87 8.78 0.58 Allowed 'Trans proline' 0 N--CA 1.436 -1.883 0 CA-C-N 123.998 2.464 . . . . 0.0 111.241 176.125 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.597 HG12 ' H ' ' A' ' 67' ' ' ILE . 0.1 OUTLIER -78.69 -38.21 21.5 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.461 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 -176.641 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 60.08 9.39 10.93 Favored Glycine 0 N--CA 1.48 1.579 0 CA-C-O 122.517 1.065 . . . . 0.0 110.702 -176.16 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.695 ' O ' HG12 ' A' ' 160' ' ' VAL . 48.7 mt 63.51 -68.73 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.41 -2.442 0 C-N-CA 128.136 2.574 . . . . 0.0 110.349 -172.516 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.418 ' CD2' ' HD3' ' A' ' 162' ' ' ARG . 91.0 t80 -177.53 -55.72 0.0 OUTLIER Pre-proline 0 C--N 1.308 -1.231 0 N-CA-C 113.702 1.001 . . . . 0.0 113.702 -175.83 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -91.93 -29.31 0.13 Allowed 'Trans proline' 0 C--N 1.361 1.215 0 C-N-CA 121.573 1.516 . . . . 0.0 115.396 -170.083 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 94.22 -16.97 59.82 Favored Glycine 0 N--CA 1.442 -0.943 0 N-CA-C 110.012 -1.235 . . . . 0.0 110.012 -172.009 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.41 ' CB ' ' HG2' ' A' ' 89' ' ' PRO . 30.0 m-20 -78.84 -38.56 37.71 Favored 'General case' 0 CA--C 1.506 -0.726 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 177.617 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.564 ' O ' ' HB ' ' A' ' 73' ' ' THR . . . -78.53 178.61 7.64 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 114.282 -1.326 . . . . 0.0 108.063 170.41 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.564 ' HB ' ' O ' ' A' ' 72' ' ' ALA . 3.0 m 85.25 6.42 0.47 Allowed 'General case' 0 N--CA 1.483 1.182 0 CA-C-O 123.739 1.733 . . . . 0.0 111.534 175.1 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.555 ' O ' ' HA ' ' A' ' 86' ' ' VAL . 0.8 OUTLIER -64.93 132.97 50.78 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-N 114.079 -1.418 . . . . 0.0 110.307 177.603 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.46 ' HB2' HD22 ' A' ' 84' ' ' LEU . 11.5 p90 -108.94 99.21 8.58 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 113.385 0.883 . . . . 0.0 113.385 -173.487 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 58.9 mm-40 -117.69 133.49 55.89 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 174.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 41.2 p90 -144.57 145.24 31.71 Favored 'General case' 0 C--N 1.295 -1.795 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 -179.205 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.471 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 35.3 m-20 -96.02 173.97 7.16 Favored 'General case' 0 CA--C 1.476 -1.87 0 C-N-CA 119.623 -0.831 . . . . 0.0 109.357 178.028 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -79.27 -65.37 1.01 Allowed 'General case' 0 C--N 1.283 -2.319 0 CA-C-N 114.784 -1.098 . . . . 0.0 111.843 -176.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -74.91 -29.75 61.07 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.112 -175.451 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.48 HG23 ' HB3' ' A' ' 83' ' ' LYS . 17.5 m -65.41 -43.27 91.1 Favored 'General case' 0 N--CA 1.428 -1.526 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.581 179.605 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 46.6 mmtm 61.16 14.49 5.55 Favored 'General case' 0 N--CA 1.495 1.778 0 C-N-CA 123.409 0.684 . . . . 0.0 112.098 -177.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.596 ' CD ' HG22 ' A' ' 109' ' ' THR . 31.5 ttmt -116.38 128.4 55.48 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-O 121.247 0.546 . . . . 0.0 110.531 -176.13 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.46 HD22 ' HB2' ' A' ' 75' ' ' TYR . 2.0 tm? -84.65 126.67 33.56 Favored 'General case' 0 C--N 1.296 -1.72 0 CA-C-N 114.388 -1.278 . . . . 0.0 109.163 -173.625 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.518 ' HA ' ' O ' ' A' ' 108' ' ' VAL . 68.1 p -107.06 115.08 29.56 Favored 'General case' 0 N--CA 1.409 -2.483 0 CA-C-N 115.474 -0.785 . . . . 0.0 109.41 178.327 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.555 ' HA ' ' O ' ' A' ' 74' ' ' ASN . 58.6 t -92.57 120.69 42.3 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 179.384 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 5.3 mp -83.34 103.14 12.49 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-O 121.472 0.653 . . . . 0.0 109.467 -179.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.491 ' O ' ' HA ' ' A' ' 106' ' ' THR . 46.7 mm -83.34 115.2 58.0 Favored Pre-proline 0 N--CA 1.412 -2.338 0 N-CA-C 104.793 -2.299 . . . . 0.0 104.793 171.915 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . 0.41 ' HG2' ' CB ' ' A' ' 71' ' ' ASP . 1.0 OUTLIER -37.46 -41.18 0.91 Allowed 'Trans proline' 0 N--CA 1.485 1.017 0 C-N-CA 125.146 3.897 . . . . 0.0 115.715 -175.047 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' SER . . . . . 0.439 ' HB2' ' HB2' ' A' ' 168' ' ' ASP . 47.9 t -157.15 166.1 34.17 Favored 'General case' 0 C--N 1.284 -2.268 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 6.0 tt -71.81 119.83 19.0 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.336 0 CA-C-O 121.642 0.734 . . . . 0.0 109.883 179.763 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' CYS . . . . . 0.448 ' SG ' ' HB2' ' A' ' 104' ' ' PHE . 19.0 p -115.97 123.42 47.99 Favored 'General case' 0 C--N 1.29 -1.995 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 174.383 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -103.66 111.33 23.76 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 107.019 -1.475 . . . . 0.0 107.019 175.532 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.486 HG21 ' HA ' ' A' ' 162' ' ' ARG . 5.2 p -108.5 102.65 14.3 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.03 0 C-N-CA 118.812 -1.155 . . . . 0.0 113.925 -178.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.431 -1.639 0 N-CA-C 108.102 -1.999 . . . . 0.0 108.102 176.075 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 14.1 m . . . . . 0 N--CA 1.42 -1.958 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 46.3 t -105.62 116.22 48.97 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.085 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 179.154 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.537 ' HG ' ' CG2' ' A' ' 125' ' ' THR . 5.5 mp -114.42 121.16 42.71 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 110.198 -0.297 . . . . 0.0 110.198 -176.54 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -111.32 109.12 18.98 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-O 121.571 0.701 . . . . 0.0 110.95 178.677 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.448 ' HB2' ' SG ' ' A' ' 92' ' ' CYS . 94.5 m-85 -91.02 125.33 35.78 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 114.825 -1.079 . . . . 0.0 108.5 179.28 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' THR . . . . . 0.469 ' O ' HG12 ' A' ' 108' ' ' VAL . 13.2 m -100.16 147.32 25.82 Favored 'General case' 0 C--N 1.294 -1.817 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.642 -175.155 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' THR . . . . . 0.491 ' HA ' ' O ' ' A' ' 88' ' ' ILE . 14.9 m -56.81 120.82 8.52 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 172.65 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 39.0 m 66.14 78.28 0.27 Allowed 'General case' 0 C--N 1.308 -1.198 0 CA-C-O 122.038 0.923 . . . . 0.0 111.676 -177.461 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.518 ' O ' ' HA ' ' A' ' 85' ' ' THR . 3.7 m -93.45 133.17 35.46 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.161 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.391 175.146 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.596 HG22 ' CD ' ' A' ' 83' ' ' LYS 0.26 7.8 m -105.56 118.0 35.46 Favored 'General case' 0 N--CA 1.406 -2.626 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 -168.239 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . 0.519 ' HA2' ' O ' ' A' ' 119' ' ' ASP . . . -157.97 167.88 34.38 Favored Glycine 0 CA--C 1.494 -1.27 0 C-N-CA 119.945 -1.122 . . . . 0.0 113.316 -177.73 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 14.2 t-80 -90.91 101.89 14.65 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 179.788 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 68.0 tp -96.73 109.02 21.76 Favored 'General case' 0 CA--C 1.484 -1.577 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.739 -174.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -106.15 156.5 18.38 Favored 'General case' 0 CA--C 1.448 -2.96 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 173.037 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 1.6 tmtm? -79.55 100.7 7.89 Favored 'General case' 0 N--CA 1.384 -3.772 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 -176.344 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 138.31 -51.8 0.76 Allowed Glycine 0 C--N 1.296 -1.691 0 N-CA-C 108.419 -1.872 . . . . 0.0 108.419 -174.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.457 ' HB2' ' HA ' ' A' ' 137' ' ' SER . 0.0 OUTLIER -140.83 137.28 33.16 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-O 121.43 0.633 . . . . 0.0 112.149 -179.013 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.529 ' O ' ' HB3' ' A' ' 135' ' ' SER . 46.3 tp -102.25 105.8 16.51 Favored 'General case' 0 C--N 1.305 -1.326 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 175.275 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.469 ' HA ' ' HB3' ' A' ' 135' ' ' SER . 27.7 p -120.53 145.93 46.81 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 112.505 0.557 . . . . 0.0 112.505 -173.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . 0.519 ' O ' ' HA2' ' A' ' 110' ' ' GLY . 34.5 t70 64.4 87.96 0.11 Allowed 'General case' 0 C--O 1.215 -0.715 0 O-C-N 124.117 0.885 . . . . 0.0 110.096 -179.468 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.409 HG12 ' HA3' ' A' ' 110' ' ' GLY . 3.1 m -124.89 104.31 13.48 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.489 0 CA-C-O 122.671 1.224 . . . . 0.0 112.081 -172.779 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -86.41 100.88 12.65 Favored 'General case' 0 C--N 1.26 -3.313 0 CA-C-N 113.292 -1.776 . . . . 0.0 108.401 178.344 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 139.7 -15.5 3.12 Favored Glycine 0 N--CA 1.428 -1.871 0 CA-C-N 115.209 -0.905 . . . . 0.0 112.347 178.729 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 65.3 mt -99.28 102.76 13.83 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.23 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 178.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -106.13 119.26 38.75 Favored 'General case' 0 C--N 1.282 -2.352 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 -176.51 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.537 ' CG2' ' HG ' ' A' ' 102' ' ' LEU . 49.7 m -139.64 148.43 42.43 Favored 'General case' 0 C--N 1.293 -1.878 0 CA-C-N 115.429 -0.805 . . . . 0.0 112.671 -168.917 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.406 ' HA ' ' HA ' ' A' ' 130' ' ' TRP . 40.9 tttp -108.11 122.24 46.49 Favored 'General case' 0 N--CA 1.424 -1.74 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 172.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.411 ' CG1' ' HB3' ' A' ' 150' ' ' LYS . 15.9 t -138.56 101.15 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.208 0 N-CA-C 104.142 -2.54 . . . . 0.0 104.142 169.663 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' MET . . . . . 0.405 ' HB3' ' O ' ' A' ' 127' ' ' VAL . 0.6 OUTLIER 73.67 -52.88 0.7 Allowed 'General case' 0 CA--C 1.544 0.729 0 O-C-N 124.305 1.003 . . . . 0.0 108.594 -171.075 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 9.0 tp -137.51 158.65 34.8 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.264 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 176.615 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' TRP . . . . . 0.406 ' HA ' ' HA ' ' A' ' 126' ' ' LYS . 42.6 t-105 -78.2 122.31 25.51 Favored 'General case' 0 C--O 1.241 0.644 0 CA-C-O 121.185 0.517 . . . . 0.0 110.708 -179.135 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 48.5 t -125.06 132.05 71.76 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 177.619 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 63.1 pttt -88.85 28.6 1.13 Allowed 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 112.268 0.47 . . . . 0.0 112.268 -176.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 44.7 t -132.74 -78.09 0.15 Allowed 'Isoleucine or valine' 0 C--O 1.214 -0.812 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 -179.059 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 38.5 p 46.89 80.21 0.05 Allowed 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 113.615 0.968 . . . . 0.0 113.615 -179.499 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' SER . . . . . 0.529 ' HB3' ' O ' ' A' ' 117' ' ' LEU . 28.3 m -84.68 153.61 23.0 Favored 'General case' 0 N--CA 1.424 -1.729 0 CA-C-N 115.898 -0.592 . . . . 0.0 112.036 -177.653 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 67.5 mt -100.67 97.91 6.3 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.231 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' SER . . . . . 0.61 ' O ' ' HB2' ' A' ' 144' ' ' TYR . 29.1 t -119.89 126.86 51.96 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-N 115.914 -0.584 . . . . 0.0 109.569 -174.187 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' THR . . . . . 0.405 ' HG1' ' C ' ' A' ' 142' ' ' LYS . 9.3 t -162.12 177.58 9.56 Favored 'General case' 0 N--CA 1.424 -1.747 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 -173.871 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -109.9 75.02 0.92 Allowed 'General case' 0 C--N 1.306 -1.324 0 C-N-CA 120.389 -0.524 . . . . 0.0 109.906 176.356 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . 27.43 72.42 0.04 OUTLIER 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 125.603 1.561 . . . . 0.0 113.994 177.303 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 40.2 t 177.68 -63.59 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 -177.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . 0.405 ' C ' ' HG1' ' A' ' 138' ' ' THR . 96.4 mttt -95.09 -169.65 2.03 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 179.31 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 13.2 p -142.66 123.04 10.52 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.347 0 CA-C-O 121.365 0.603 . . . . 0.0 109.894 177.087 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . 0.61 ' HB2' ' O ' ' A' ' 137' ' ' SER . 94.0 m-85 -128.97 155.61 45.09 Favored 'General case' 0 CA--C 1.487 -1.473 0 CA-C-O 121.41 0.624 . . . . 0.0 110.574 -179.587 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 81.7 m-85 -112.72 113.81 26.1 Favored 'General case' 0 N--CA 1.407 -2.579 0 CA-C-N 114.565 -1.198 . . . . 0.0 109.145 176.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' THR . . . . . 0.455 ' CG2' ' HB2' ' A' ' 135' ' ' SER . 9.1 t -79.82 33.41 0.27 Allowed 'General case' 0 CA--C 1.56 1.337 0 CA-C-O 122.115 0.96 . . . . 0.0 111.404 -174.512 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -75.48 -19.67 59.26 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.349 179.368 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 134.02 50.54 0.08 OUTLIER Glycine 0 CA--C 1.475 -2.428 0 N-CA-C 108.987 -1.645 . . . . 0.0 108.987 179.09 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 66.5 mtt 63.64 12.08 6.25 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.102 0.961 . . . . 0.0 111.787 -177.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . 0.411 ' HB3' ' CG1' ' A' ' 127' ' ' VAL . 47.7 mmtm -69.16 -29.83 67.94 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 115.375 -0.83 . . . . 0.0 112.564 -176.585 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 39.9 mmtm -143.88 122.58 12.59 Favored 'General case' 0 CA--C 1.509 -0.629 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 178.557 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 43.8 m -132.46 128.27 37.07 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 106.136 -1.802 . . . . 0.0 106.136 175.232 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' ARG . . . . . 0.453 ' HG2' ' CG ' ' A' ' 161' ' ' GLN . 26.9 tpt180 -146.6 160.41 42.2 Favored 'General case' 0 N--CA 1.429 -1.491 0 C-N-CA 119.084 -1.046 . . . . 0.0 110.942 -172.814 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 13.6 m -90.47 130.25 36.55 Favored 'General case' 0 N--CA 1.419 -1.992 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 174.378 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' ARG . . . . . 0.556 ' HD2' ' O ' ' A' ' 64' ' ' PRO . 8.6 ttp180 -68.29 -24.92 64.92 Favored 'General case' 0 C--N 1.297 -1.678 0 C-N-CA 123.517 0.727 . . . . 0.0 110.455 179.675 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -42.29 -45.71 4.29 Favored 'General case' 0 C--N 1.313 -0.996 0 N-CA-C 115.257 1.577 . . . . 0.0 115.257 -172.106 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -71.55 -52.62 17.25 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 114.438 1.273 . . . . 0.0 114.438 -173.507 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 -141.89 3.8 1.64 Allowed 'General case' 0 N--CA 1.483 1.18 0 N-CA-C 113.029 0.751 . . . . 0.0 113.029 -174.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 90.85 -88.49 1.43 Allowed Glycine 0 C--N 1.304 -1.223 0 N-CA-C 108.935 -1.666 . . . . 0.0 108.935 -173.078 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.695 HG12 ' O ' ' A' ' 67' ' ' ILE . 11.5 p -98.64 177.03 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.556 1.193 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 171.712 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' GLN . . . . . 0.479 ' H ' HG23 ' A' ' 160' ' ' VAL . 14.3 mm100 -108.36 99.29 8.71 Favored 'General case' 0 CA--C 1.463 -2.378 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 -175.553 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . 0.486 ' HA ' HG21 ' A' ' 94' ' ' VAL . 0.0 OUTLIER -132.1 173.18 11.49 Favored 'General case' 0 N--CA 1.393 -3.287 0 C-N-CA 119.283 -0.967 . . . . 0.0 113.148 -174.722 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 21.9 t-20 -152.76 -48.69 0.1 Allowed 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 106.359 -1.719 . . . . 0.0 106.359 179.55 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -64.0 147.27 50.73 Favored Glycine 0 C--O 1.254 1.373 0 CA-C-N 114.566 -1.197 . . . . 0.0 110.546 170.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . 0.431 ' H ' HD21 ' A' ' 165' ' ' LEU . 1.9 pt? -124.65 154.9 40.05 Favored 'General case' 0 C--N 1.291 -1.973 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 -176.874 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . 0.512 ' HD2' ' N ' ' A' ' 166' ' ' ARG . 5.2 mpt_? -76.43 114.98 15.74 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 -179.219 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 18.2 m -80.75 54.07 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.286 -2.191 0 CA-C-O 122.479 1.133 . . . . 0.0 112.827 -177.335 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . 0.439 ' HB2' ' HB2' ' A' ' 90' ' ' SER . 14.8 t70 -109.94 -39.32 5.1 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 114.069 -1.423 . . . . 0.0 107.766 176.908 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 27.8 ttpp -107.22 8.92 30.23 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 114.012 -1.449 . . . . 0.0 108.749 -177.05 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 170' ' ' PHE . . . . . . . . . . . . . 84.5 t80 . . . . . 0 C--N 1.306 -1.291 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 -178.464 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.522 ' O ' HD11 ' A' ' 58' ' ' LEU . 28.8 mt . . . . . 0 CA--C 1.51 -0.581 0 CA-C-O 119.484 -0.294 . . . . 0.0 110.902 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_exo -64.9 -31.42 56.76 Favored 'Trans proline' 0 N--CA 1.428 -2.366 0 C-N-CA 120.791 0.994 . . . . 0.0 111.88 -170.509 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -75.86 -32.33 59.68 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.282 178.753 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 63.7 tp -69.33 -34.3 74.42 Favored 'General case' 0 CA--C 1.508 -0.656 0 C-N-CA 120.503 -0.479 . . . . 0.0 110.157 178.634 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.589 ' HA ' ' CD1' ' A' ' 75' ' ' TYR . 6.2 mp -61.7 -41.47 97.65 Favored 'General case' 0 CA--C 1.49 -1.334 0 C-N-CA 120.128 -0.629 . . . . 0.0 112.421 179.669 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.479 ' HD2' ' N ' ' A' ' 60' ' ' GLU . 0.1 OUTLIER -76.86 -26.5 54.32 Favored 'General case' 0 C--N 1.298 -1.658 0 CA-C-O 121.491 0.662 . . . . 0.0 112.722 178.477 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.594 ' C ' ' H ' ' A' ' 62' ' ' ASP . 8.5 tp10 -82.51 -41.53 19.58 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 115.344 -0.843 . . . . 0.0 113.145 -171.08 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 56.2 t80 -68.44 3.85 1.6 Allowed 'General case' 0 N--CA 1.494 1.727 0 CA-C-O 122.095 0.95 . . . . 0.0 110.108 -178.303 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.594 ' H ' ' C ' ' A' ' 60' ' ' GLU . 27.9 t70 -109.02 -153.8 0.52 Allowed 'General case' 0 C--N 1.287 -2.113 0 CA-C-N 113.888 -1.505 . . . . 0.0 109.024 -174.783 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.542 ' H ' ' CG ' ' A' ' 62' ' ' ASP . 0.1 OUTLIER -100.54 -167.98 0.15 Allowed Pre-proline 0 CA--C 1.576 1.961 0 N-CA-C 106.187 -1.783 . . . . 0.0 106.187 -177.362 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.482 ' O ' ' HD2' ' A' ' 155' ' ' ARG . 18.2 Cg_endo -100.4 11.49 0.56 Allowed 'Trans proline' 0 C--N 1.368 1.576 0 CA-C-N 122.943 2.087 . . . . 0.0 112.593 -176.292 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.62 ' O ' ' HA3' ' A' ' 159' ' ' GLY . 0.2 OUTLIER -73.03 -43.07 59.21 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.959 0 CA-C-N 115.846 -0.616 . . . . 0.0 109.62 179.53 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 56.94 9.14 3.56 Favored Glycine 0 N--CA 1.484 1.846 0 CA-C-O 121.351 0.417 . . . . 0.0 113.201 -177.582 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.516 ' O ' ' HB ' ' A' ' 160' ' ' VAL . 52.1 mt 67.39 -67.63 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.421 0 C-N-CA 125.877 1.671 . . . . 0.0 112.04 -175.61 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.494 ' HB2' ' O ' ' A' ' 67' ' ' ILE . 26.0 t80 175.01 -56.16 0.0 OUTLIER Pre-proline 0 C--N 1.318 -0.782 0 CA-C-O 119.68 -0.2 . . . . 0.0 111.281 -178.314 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.423 ' HD3' ' HB3' ' A' ' 68' ' ' PHE . 8.4 Cg_exo -73.51 -35.37 4.84 Favored 'Trans proline' 0 C--N 1.379 2.163 0 C-N-CA 121.934 1.756 . . . . 0.0 113.108 -172.226 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 97.28 -17.55 58.93 Favored Glycine 0 N--CA 1.44 -1.069 0 C-N-CA 120.193 -1.004 . . . . 0.0 111.048 -176.253 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -84.93 -48.11 9.62 Favored 'General case' 0 C--O 1.195 -1.769 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 176.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.659 ' O ' ' HB ' ' A' ' 73' ' ' THR . . . -57.7 171.87 0.43 Allowed 'General case' 0 CA--C 1.55 0.981 0 C-N-CA 124.53 1.132 . . . . 0.0 111.675 174.888 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.659 ' HB ' ' O ' ' A' ' 72' ' ' ALA . 8.9 m 94.49 -10.65 0.12 Allowed 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 124.022 0.929 . . . . 0.0 112.035 177.804 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.512 ' O ' ' HA ' ' A' ' 86' ' ' VAL . 35.5 m-80 -46.4 103.25 0.04 OUTLIER 'General case' 0 CA--C 1.45 -2.879 0 C-N-CA 125.062 1.345 . . . . 0.0 113.657 -179.463 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.589 ' CD1' ' HA ' ' A' ' 58' ' ' LEU . 8.3 p90 -92.81 144.0 25.72 Favored 'General case' 1 C--N 1.241 -4.144 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.493 -176.787 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.656 ' HB2' ' O ' ' A' ' 85' ' ' THR . 10.9 mm-40 -136.2 161.78 34.78 Favored 'General case' 0 C--N 1.278 -2.534 0 N-CA-C 105.872 -1.899 . . . . 0.0 105.872 171.522 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 38.8 p90 -162.95 146.83 11.15 Favored 'General case' 0 C--N 1.293 -1.875 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 177.682 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.538 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 25.5 m-20 -105.17 162.31 13.51 Favored 'General case' 0 CA--C 1.459 -2.529 0 C-N-CA 118.955 -1.098 . . . . 0.0 108.799 176.12 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -81.24 -44.47 17.71 Favored 'General case' 0 C--N 1.262 -3.201 0 CA-C-N 114.161 -1.382 . . . . 0.0 111.094 -179.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -69.17 -47.45 64.9 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 178.213 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.538 ' HB ' ' HB2' ' A' ' 78' ' ' ASP . 31.8 m -63.75 -51.74 63.55 Favored 'General case' 0 N--CA 1.418 -2.056 0 CA-C-N 113.93 -1.486 . . . . 0.0 111.951 -178.45 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 99.1 mttt 66.27 18.63 10.96 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-O 121.818 0.818 . . . . 0.0 111.117 -177.042 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.508 ' CD ' ' HB ' ' A' ' 109' ' ' THR . 35.5 ttmt -111.83 135.88 51.86 Favored 'General case' 0 CA--C 1.491 -1.298 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.205 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.561 ' O ' ' HA ' ' A' ' 109' ' ' THR . 1.5 tm? -76.65 124.71 28.06 Favored 'General case' 0 N--CA 1.421 -1.897 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 -179.757 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.656 ' O ' ' HB2' ' A' ' 76' ' ' GLU . 3.8 t -126.82 109.39 11.95 Favored 'General case' 0 C--N 1.265 -3.097 0 CA-C-N 115.844 -0.617 . . . . 0.0 109.622 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.596 ' O ' ' HA ' ' A' ' 107' ' ' THR . 31.0 m -91.84 151.08 3.61 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.943 0 O-C-N 121.375 -0.828 . . . . 0.0 110.575 -179.483 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.496 ' HA ' ' O ' ' A' ' 106' ' ' THR 0.299 1.5 pp -115.59 103.64 10.93 Favored 'General case' 0 N--CA 1.396 -3.153 0 CA-C-O 122.655 1.217 . . . . 0.0 109.736 174.35 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 40.0 mm -89.82 139.01 27.61 Favored Pre-proline 0 C--N 1.289 -2.044 0 CA-C-N 114.08 -1.418 . . . . 0.0 108.37 -174.293 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -54.14 87.5 0.03 OUTLIER 'Trans proline' 0 C--N 1.354 0.868 0 C-N-CA 123.475 2.783 . . . . 0.0 112.431 173.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' SER . . . . . 0.511 ' OG ' ' HB ' ' A' ' 167' ' ' VAL . 22.6 t 66.73 -169.15 0.2 Allowed 'General case' 0 N--CA 1.44 -0.955 0 C-N-CA 124.421 1.088 . . . . 0.0 110.811 178.951 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -93.05 137.36 22.59 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 177.022 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' CYS . . . . . 0.585 ' SG ' ' HG2' ' A' ' 166' ' ' ARG . 33.3 m -129.57 138.61 51.39 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 -176.882 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.615 ' O ' ' HA2' ' A' ' 164' ' ' GLY . 45.6 mt-10 -120.25 135.71 54.9 Favored 'General case' 0 CA--C 1.469 -2.167 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 177.511 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.583 HG13 ' H ' ' A' ' 163' ' ' ASN . 20.3 t -117.91 107.81 22.94 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.482 0 C-N-CA 120.224 -0.59 . . . . 0.0 112.349 -172.215 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.426 -1.988 0 N-CA-C 108.166 -1.974 . . . . 0.0 108.166 169.536 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 67.0 m . . . . . 0 CA--C 1.513 -0.446 0 N-CA-C 105.818 -1.919 . . . . 0.0 105.818 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.451 ' HA ' ' O ' ' A' ' 94' ' ' VAL . 59.9 t -147.59 129.88 7.16 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.919 0 CA-C-N 114.759 -1.11 . . . . 0.0 108.065 177.632 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -126.61 167.37 15.76 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 177.629 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.484 ' HB3' ' HB3' ' A' ' 124' ' ' LYS . 39.0 ttmt -148.54 128.97 13.91 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-O 120.768 0.318 . . . . 0.0 110.462 174.689 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -104.6 123.73 48.08 Favored 'General case' 0 C--N 1.293 -1.87 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 174.31 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 14.4 t -91.09 168.98 11.24 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 179.464 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' THR . . . . . 0.496 ' O ' ' HA ' ' A' ' 87' ' ' LEU . 46.1 m -64.94 -27.97 69.21 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 112.229 0.455 . . . . 0.0 112.229 -175.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.596 ' HA ' ' O ' ' A' ' 86' ' ' VAL . 29.1 m -138.66 108.35 6.25 Favored 'General case' 0 C--N 1.306 -1.314 0 O-C-N 121.687 -0.633 . . . . 0.0 110.74 -179.4 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.468 ' O ' ' HA ' ' A' ' 85' ' ' THR . 34.1 t -108.72 135.97 45.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 N-CA-C 108.631 -0.878 . . . . 0.0 108.631 -179.303 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.561 ' HA ' ' O ' ' A' ' 84' ' ' LEU . 44.5 p -122.43 132.95 54.6 Favored 'General case' 0 N--CA 1.414 -2.237 0 C-N-CA 122.755 0.422 . . . . 0.0 110.785 -173.51 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . 0.642 ' HA3' ' O ' ' A' ' 119' ' ' ASP . . . -168.69 -158.26 12.44 Favored Glycine 0 C--N 1.308 -0.985 0 C-N-CA 121.373 -0.442 . . . . 0.0 113.234 -178.748 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 46.2 m80 -110.65 119.57 39.59 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-O 121.0 0.428 . . . . 0.0 110.562 -178.281 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -89.88 120.78 31.41 Favored 'General case' 0 C--N 1.308 -1.198 0 C-N-CA 123.905 0.882 . . . . 0.0 111.192 -176.264 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -139.56 175.37 9.62 Favored 'General case' 0 CA--C 1.475 -1.928 0 CA-C-N 115.274 -0.876 . . . . 0.0 109.303 170.692 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 1.8 tmtm? -103.81 131.9 50.57 Favored 'General case' 0 N--CA 1.393 -3.287 0 N-CA-C 107.262 -1.385 . . . . 0.0 107.262 -175.494 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 97.13 -25.77 25.58 Favored Glycine 0 C--O 1.189 -2.686 0 N-CA-C 109.862 -1.295 . . . . 0.0 109.862 -176.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . 0.341 0.0 OUTLIER -164.12 134.76 4.3 Favored 'General case' 0 C--N 1.291 -1.952 0 N-CA-C 114.316 1.228 . . . . 0.0 114.316 177.928 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -103.49 109.53 21.21 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 104.932 -2.248 . . . . 0.0 104.932 179.053 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 33.5 p -95.99 136.97 35.73 Favored 'General case' 0 C--N 1.284 -2.27 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.221 -176.49 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . 0.642 ' O ' ' HA3' ' A' ' 110' ' ' GLY . 15.1 m-20 69.03 107.22 0.05 Allowed 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 124.623 1.169 . . . . 0.0 111.621 178.608 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 7.6 m -119.66 86.39 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.901 0 CA-C-O 122.168 0.985 . . . . 0.0 111.129 173.082 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -74.25 100.9 3.84 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-N 114.48 -1.236 . . . . 0.0 109.464 -177.19 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 128.66 -7.86 6.53 Favored Glycine 0 C--N 1.299 -1.482 0 C-N-CA 120.017 -1.087 . . . . 0.0 111.736 177.744 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 66.5 mt -99.3 115.85 41.01 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.699 0 CA-C-O 121.869 0.843 . . . . 0.0 109.525 178.547 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . 0.484 ' HB3' ' HB3' ' A' ' 103' ' ' LYS . 86.7 tttt -84.2 128.06 34.33 Favored 'General case' 0 CA--C 1.475 -1.936 0 CA-C-N 114.317 -1.31 . . . . 0.0 107.711 -176.146 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.49 HG23 ' HZ1' ' A' ' 150' ' ' LYS . 92.1 m -130.16 127.28 39.39 Favored 'General case' 0 N--CA 1.388 -3.571 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.715 -176.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.512 ' HG2' ' N ' ' A' ' 127' ' ' VAL . 85.2 tttt -139.11 143.12 38.13 Favored 'General case' 0 N--CA 1.407 -2.609 0 CA-C-O 121.344 0.592 . . . . 0.0 110.184 167.178 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.512 ' N ' ' HG2' ' A' ' 126' ' ' LYS . 7.0 p -158.84 -37.66 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 N-CA-C 106.286 -1.746 . . . . 0.0 106.286 177.02 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -120.28 -52.83 2.15 Favored 'General case' 0 N--CA 1.381 -3.903 0 CA-C-N 112.173 -2.285 . . . . 0.0 106.531 -177.484 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 9.6 tp -153.04 164.43 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.386 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 177.095 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 62.6 t90 -70.81 117.66 12.6 Favored 'General case' 0 C--N 1.317 -0.826 0 C-N-CA 123.339 0.656 . . . . 0.0 111.406 178.151 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . 0.404 ' O ' ' HB ' ' A' ' 125' ' ' THR . 21.5 t -138.86 119.44 15.37 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 175.696 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 14.8 ptmm? -102.09 17.53 23.05 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-O 121.316 0.579 . . . . 0.0 110.936 -179.123 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 13.7 m -138.33 74.63 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 CA-C-N 114.866 -1.061 . . . . 0.0 110.324 178.612 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' THR . . . . . 0.412 ' C ' ' HG ' ' A' ' 135' ' ' SER . 35.2 p -111.49 -165.97 1.04 Allowed 'General case' 0 C--N 1.288 -2.102 0 CA-C-N 115.166 -0.925 . . . . 0.0 110.374 -177.271 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' SER . . . . . 0.412 ' HG ' ' C ' ' A' ' 134' ' ' THR . 38.3 m -151.65 167.71 27.28 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 176.623 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 11.7 tt -135.11 136.01 52.0 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.234 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 179.375 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 36.6 p -123.51 168.26 12.82 Favored 'General case' 0 N--CA 1.427 -1.579 0 CA-C-O 121.858 0.837 . . . . 0.0 112.885 -177.056 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' THR . . . . . 0.404 HG23 ' H ' ' A' ' 140' ' ' ALA . 5.0 t -165.7 177.53 7.22 Favored 'General case' 0 N--CA 1.413 -2.312 0 N-CA-C 106.97 -1.492 . . . . 0.0 106.97 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -115.22 32.95 5.72 Favored 'General case' 0 C--N 1.265 -3.101 0 N-CA-C 105.352 -2.092 . . . . 0.0 105.352 175.062 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . 0.404 ' H ' HG23 ' A' ' 138' ' ' THR . . . 60.91 42.78 12.51 Favored 'General case' 0 C--N 1.366 1.309 0 CA-C-N 113.759 -1.564 . . . . 0.0 108.97 -172.466 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 47.6 t -173.4 -65.61 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 115.432 -0.803 . . . . 0.0 111.645 -172.735 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . 0.417 ' HE2' ' HA ' ' A' ' 142' ' ' LYS . 9.1 mmpt? -82.4 -154.46 0.13 Allowed 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 -179.599 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 14.6 p -155.25 119.3 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.055 0 CA-C-O 121.408 0.623 . . . . 0.0 110.136 170.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -114.55 155.99 25.46 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-O 121.964 0.888 . . . . 0.0 112.98 -172.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 35.0 p90 -72.78 137.66 45.95 Favored 'General case' 0 N--CA 1.431 -1.388 0 CA-C-N 113.931 -1.486 . . . . 0.0 113.379 178.216 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 25.9 m -157.72 28.73 0.27 Allowed 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 106.451 -1.685 . . . . 0.0 106.451 172.419 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . 0.417 ' HB2' HG22 ' A' ' 125' ' ' THR . . . -132.44 92.62 3.11 Favored 'General case' 0 N--CA 1.422 -1.859 0 C-N-CA 119.552 -0.859 . . . . 0.0 113.227 -173.459 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 66.9 32.28 80.56 Favored Glycine 0 CA--C 1.5 -0.852 0 CA-C-N 115.803 -0.635 . . . . 0.0 112.815 175.707 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 49.5 ttm 60.12 80.13 0.21 Allowed 'General case' 0 C--O 1.236 0.386 0 CA-C-O 122.019 0.914 . . . . 0.0 109.689 -177.065 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . 0.637 ' HG2' ' H ' ' A' ' 151' ' ' LYS . 35.4 ttmt -120.8 -160.32 0.84 Allowed 'General case' 0 C--N 1.297 -1.698 0 CA-C-N 114.915 -1.039 . . . . 0.0 108.995 -174.181 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . 0.637 ' H ' ' HG2' ' A' ' 150' ' ' LYS . 96.4 mttt -121.64 165.12 16.21 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 124.078 0.951 . . . . 0.0 110.016 -178.415 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 22.3 p -83.66 160.11 21.41 Favored 'General case' 0 C--N 1.301 -1.51 0 C-N-CA 123.275 0.63 . . . . 0.0 110.587 177.527 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 4.2 mpt_? -128.18 174.65 9.07 Favored 'General case' 0 CA--C 1.506 -0.736 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 177.272 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 14.7 m -98.9 116.23 30.66 Favored 'General case' 0 N--CA 1.422 -1.862 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 173.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' ARG . . . . . 0.506 ' HG2' ' HA2' ' A' ' 159' ' ' GLY . 0.2 OUTLIER -63.15 -22.98 67.22 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.461 0.648 . . . . 0.0 109.598 -179.559 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -46.51 -37.55 8.07 Favored 'General case' 0 C--N 1.318 -0.797 0 C-N-CA 125.346 1.458 . . . . 0.0 114.476 -177.626 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -69.92 -56.63 6.53 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 119.708 -0.797 . . . . 0.0 112.372 -174.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 58.5 m-85 -165.1 20.52 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 124.025 0.93 . . . . 0.0 110.08 -178.317 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . 0.62 ' HA3' ' O ' ' A' ' 65' ' ' ILE . . . 92.36 -92.79 1.72 Allowed Glycine 0 CA--C 1.47 -2.736 0 C-N-CA 120.016 -1.088 . . . . 0.0 111.195 -174.908 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.516 ' HB ' ' O ' ' A' ' 67' ' ' ILE . 11.5 t -103.42 172.53 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.41 -2.457 0 N-CA-C 106.947 -1.501 . . . . 0.0 106.947 179.102 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' GLN . . . . . 0.428 ' H ' HG11 ' A' ' 160' ' ' VAL . 46.6 mt-30 -123.09 92.9 3.8 Favored 'General case' 0 CA--C 1.483 -1.62 0 CA-C-N 118.973 0.806 . . . . 0.0 109.233 -175.147 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.33 161.83 17.96 Favored 'General case' 0 N--CA 1.401 -2.902 0 C-N-CA 119.012 -1.075 . . . . 0.0 113.251 -176.409 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' ASN . . . . . 0.583 ' H ' HG13 ' A' ' 94' ' ' VAL . 57.7 t30 -129.75 16.56 5.82 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 105.678 -1.971 . . . . 0.0 105.678 172.671 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . 0.615 ' HA2' ' O ' ' A' ' 93' ' ' GLU . . . -58.19 123.09 31.98 Favored Glycine 0 CA--C 1.475 -2.449 0 CA-C-N 113.469 -1.696 . . . . 0.0 112.991 -176.149 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . 0.579 HD11 ' O ' ' A' ' 165' ' ' LEU . 3.9 pp -94.16 121.96 36.2 Favored 'General case' 1 N--CA 1.374 -4.25 0 N-CA-C 105.661 -1.977 . . . . 0.0 105.661 -178.349 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . 0.585 ' HG2' ' SG ' ' A' ' 92' ' ' CYS . 16.0 mtm180 -84.94 129.09 34.86 Favored 'General case' 0 N--CA 1.391 -3.396 0 N-CA-C 105.886 -1.894 . . . . 0.0 105.886 179.483 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . 0.511 ' HB ' ' OG ' ' A' ' 90' ' ' SER . 66.8 t -58.93 -14.98 5.4 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.737 0 CA-C-O 122.104 0.954 . . . . 0.0 110.249 171.679 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -76.25 -13.0 60.18 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 125.795 1.638 . . . . 0.0 109.986 173.162 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 169' ' ' LYS . . . . . 0.465 ' HG2' ' N ' ' A' ' 170' ' ' PHE . 56.1 tttm -134.29 176.99 8.1 Favored 'General case' 0 C--N 1.297 -1.699 0 C-N-CA 124.167 0.987 . . . . 0.0 108.497 -174.247 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 170' ' ' PHE . . . . . 0.465 ' N ' ' HG2' ' A' ' 169' ' ' LYS . 79.4 t80 . . . . . 0 C--N 1.295 -1.762 0 N-CA-C 106.656 -1.609 . . . . 0.0 106.656 170.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 3.4 mm? . . . . . 0 CA--C 1.484 -1.569 0 N-CA-C 113.872 1.064 . . . . 0.0 113.872 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.6 ' O ' ' HG2' ' A' ' 59' ' ' LYS . 19.3 Cg_endo -55.38 -25.74 49.56 Favored 'Trans proline' 0 N--CA 1.429 -2.301 0 C-N-CA 121.94 1.76 . . . . 0.0 113.657 -168.023 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.431 ' HA ' ' CG ' ' A' ' 59' ' ' LYS . 14.0 pt-20 -81.36 -29.51 34.05 Favored 'General case' 0 CA--C 1.479 -1.763 0 CA-C-O 121.093 0.473 . . . . 0.0 110.867 -177.353 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.594 ' O ' ' HB3' ' A' ' 60' ' ' GLU . 93.8 mt -74.29 -31.54 62.54 Favored 'General case' 0 N--CA 1.417 -2.104 0 CA-C-N 115.736 -0.666 . . . . 0.0 109.973 174.867 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.611 ' N ' HD12 ' A' ' 58' ' ' LEU . 4.8 mp -69.76 -35.32 74.83 Favored 'General case' 0 CA--C 1.504 -0.82 0 C-N-CA 118.988 -1.085 . . . . 0.0 110.017 177.852 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.623 ' O ' ' HB3' ' A' ' 62' ' ' ASP 0.279 41.5 pttt -75.1 -25.25 58.36 Favored 'General case' 0 N--CA 1.439 -1.011 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 172.405 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.594 ' HB3' ' O ' ' A' ' 57' ' ' LEU . 7.4 tp10 -59.4 -49.13 78.98 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-O 121.247 0.546 . . . . 0.0 109.98 171.098 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 85.6 m-85 -68.93 -4.28 15.98 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-O 121.313 0.578 . . . . 0.0 111.202 176.468 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.623 ' HB3' ' O ' ' A' ' 59' ' ' LYS . 21.1 t70 -84.65 166.52 17.01 Favored 'General case' 0 C--N 1.298 -1.671 0 CA-C-N 115.102 -0.954 . . . . 0.0 111.813 -176.117 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.465 HD22 ' H ' ' A' ' 115' ' ' GLY . 3.5 mt -85.67 -151.47 0.0 OUTLIER Pre-proline 0 CA--C 1.602 2.95 0 N-CA-C 104.936 -2.246 . . . . 0.0 104.936 178.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.627 ' HG3' ' N ' ' A' ' 141' ' ' SER . 71.3 Cg_endo -101.54 5.07 0.57 Allowed 'Trans proline' 0 N--CA 1.449 -1.114 0 CA-C-N 123.531 2.297 . . . . 0.0 112.125 176.188 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.551 HG12 ' H ' ' A' ' 67' ' ' ILE . 0.1 OUTLIER -70.04 -42.06 79.35 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.832 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.534 -177.435 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.401 ' H ' HD12 ' A' ' 65' ' ' ILE . . . 57.79 8.91 4.63 Favored Glycine 0 N--CA 1.5 2.958 0 CA-C-O 122.228 0.904 . . . . 0.0 112.441 -174.922 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.551 ' H ' HG12 ' A' ' 65' ' ' ILE . 61.1 mt 58.13 -72.47 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 C-N-CA 129.191 2.997 . . . . 0.0 113.162 -174.358 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.427 ' HB3' ' HD3' ' A' ' 69' ' ' PRO . 80.0 t80 171.8 -53.26 0.0 OUTLIER Pre-proline 0 N--CA 1.485 1.303 0 N-CA-C 113.497 0.925 . . . . 0.0 113.497 -172.687 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.427 ' HD3' ' HB3' ' A' ' 68' ' ' PHE . 6.9 Cg_exo -74.1 -28.53 10.8 Favored 'Trans proline' 0 C--N 1.366 1.496 0 C-N-CA 121.288 1.325 . . . . 0.0 113.094 -174.1 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 86.84 -12.7 60.99 Favored Glycine 0 C--N 1.31 -0.905 0 N-CA-C 110.309 -1.117 . . . . 0.0 110.309 -174.274 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -93.12 -53.47 4.11 Favored 'General case' 0 CA--C 1.48 -1.739 0 N-CA-C 106.512 -1.662 . . . . 0.0 106.512 178.374 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.649 ' O ' ' HB ' ' A' ' 73' ' ' THR . . . -52.06 173.37 0.03 OUTLIER 'General case' 0 C--N 1.361 1.079 0 CA-C-N 114.671 -1.15 . . . . 0.0 110.549 169.916 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.649 ' HB ' ' O ' ' A' ' 72' ' ' ALA . 10.6 m 87.63 27.13 0.03 OUTLIER 'General case' 0 CA--C 1.558 1.251 0 CA-C-O 125.331 2.491 . . . . 0.0 109.246 -174.814 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.599 ' O ' ' HA ' ' A' ' 86' ' ' VAL . 37.2 m-80 -83.81 75.12 10.12 Favored 'General case' 0 C--N 1.275 -2.67 0 CA-C-N 113.685 -1.598 . . . . 0.0 112.021 177.77 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.498 ' H ' ' HB3' ' A' ' 58' ' ' LEU . 2.9 m-85 -70.89 98.12 1.53 Allowed 'General case' 0 C--N 1.258 -3.375 0 CA-C-N 113.377 -1.738 . . . . 0.0 113.56 -179.073 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -106.43 115.29 29.95 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 105.452 -2.055 . . . . 0.0 105.452 176.672 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 76.2 t80 -131.35 127.59 37.94 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 112.465 0.543 . . . . 0.0 112.465 -172.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.539 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 19.6 m-20 -94.22 160.45 14.68 Favored 'General case' 0 CA--C 1.483 -1.607 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 173.248 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 13.5 tp10 -80.14 -63.38 1.42 Allowed 'General case' 0 C--N 1.264 -3.125 0 CA-C-N 114.94 -1.027 . . . . 0.0 112.436 -175.455 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -67.08 -40.05 86.92 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.582 0.706 . . . . 0.0 110.088 -173.638 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.539 ' HB ' ' HB2' ' A' ' 78' ' ' ASP . 62.7 m -62.77 -40.85 98.57 Favored 'General case' 0 C--N 1.289 -2.049 0 CA-C-N 114.679 -1.146 . . . . 0.0 111.648 -179.71 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt 65.0 6.83 3.64 Favored 'General case' 0 N--CA 1.484 1.247 0 N-CA-C 113.308 0.855 . . . . 0.0 113.308 -179.249 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -116.14 109.64 17.75 Favored 'General case' 0 N--CA 1.399 -2.991 0 CA-C-O 121.54 0.686 . . . . 0.0 109.21 -179.059 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.508 ' O ' ' HA ' ' A' ' 109' ' ' THR . 3.4 tt -82.41 150.03 27.33 Favored 'General case' 0 C--N 1.289 -2.055 0 CA-C-N 114.044 -1.435 . . . . 0.0 110.121 -178.415 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.43 ' HA ' ' O ' ' A' ' 108' ' ' VAL . 7.1 t -126.14 131.27 52.09 Favored 'General case' 0 N--CA 1.405 -2.72 0 N-CA-C 106.667 -1.605 . . . . 0.0 106.667 174.38 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.599 ' HA ' ' O ' ' A' ' 74' ' ' ASN . 9.8 p -107.13 134.26 49.35 Favored 'Isoleucine or valine' 0 N--CA 1.398 -3.03 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 -177.57 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 5.1 mp -86.98 116.65 25.18 Favored 'General case' 0 C--N 1.293 -1.851 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.439 178.033 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 48.7 mm -103.37 126.8 31.16 Favored Pre-proline 0 C--N 1.274 -2.715 0 N-CA-C 106.418 -1.697 . . . . 0.0 106.418 173.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -40.33 -42.54 3.74 Favored 'Trans proline' 0 C--N 1.372 1.784 0 C-N-CA 124.44 3.426 . . . . 0.0 113.739 -178.432 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 66.5 m -161.79 161.73 29.24 Favored 'General case' 0 CA--C 1.482 -1.664 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 176.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.406 ' HA ' ' O ' ' A' ' 104' ' ' PHE . 0.0 OUTLIER -71.15 108.91 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.148 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 174.683 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' CYS . . . . . 0.492 ' SG ' ' HB2' ' A' ' 104' ' ' PHE . 14.2 p -97.42 124.0 41.46 Favored 'General case' 0 N--CA 1.425 -1.689 0 N-CA-C 108.442 -0.948 . . . . 0.0 108.442 175.642 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -116.47 123.7 48.13 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 177.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.656 ' O ' ' HA ' ' A' ' 101' ' ' VAL . 33.5 m -113.62 130.61 67.37 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.348 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 -179.759 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . 0.511 ' HA2' ' O ' ' A' ' 100' ' ' SER . . . . . . . . 0 C--N 1.3 -1.466 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.232 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' SER . . . . . 0.511 ' O ' ' HA2' ' A' ' 95' ' ' GLY . 18.2 m . . . . . 0 N--CA 1.411 -2.378 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.656 ' HA ' ' O ' ' A' ' 94' ' ' VAL . 93.8 t -127.11 117.74 48.31 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.19 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 173.891 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.499 HD11 ' C ' ' A' ' 101' ' ' VAL . 5.6 mp -134.47 142.32 47.04 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 -178.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 39.6 ttmt -133.5 121.04 21.6 Favored 'General case' 0 C--N 1.291 -1.968 0 CA-C-O 121.002 0.43 . . . . 0.0 110.249 179.175 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.492 ' HB2' ' SG ' ' A' ' 92' ' ' CYS . 94.1 m-85 -101.25 109.24 21.07 Favored 'General case' 0 C--N 1.291 -1.965 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 174.804 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 43.9 m -72.58 151.96 42.08 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.484 -177.147 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 17.1 p -50.28 -42.87 52.97 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 124.134 0.974 . . . . 0.0 112.375 -179.367 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 41.4 p -127.42 93.76 3.81 Favored 'General case' 0 N--CA 1.424 -1.768 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.344 178.324 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.443 HG11 HG13 ' A' ' 123' ' ' ILE . 45.7 t -87.33 144.09 9.98 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.115 0 N-CA-C 106.372 -1.714 . . . . 0.0 106.372 175.479 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.508 ' HA ' ' O ' ' A' ' 84' ' ' LEU . 10.1 t -144.45 134.45 23.98 Favored 'General case' 0 N--CA 1.399 -2.998 0 CA-C-N 118.614 0.643 . . . . 0.0 110.891 -176.205 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -167.22 -166.97 27.2 Favored Glycine 0 N--CA 1.434 -1.491 0 N-CA-C 111.353 -0.699 . . . . 0.0 111.353 179.652 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 45.8 m80 -83.98 143.32 29.88 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 117.696 0.748 . . . . 0.0 110.741 -177.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.481 ' HA ' HD22 ' A' ' 117' ' ' LEU . 0.5 OUTLIER -103.42 118.19 36.2 Favored 'General case' 0 N--CA 1.434 -1.23 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 -174.524 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -132.75 140.23 47.96 Favored 'General case' 0 CA--C 1.461 -2.469 0 O-C-N 123.897 0.748 . . . . 0.0 109.038 167.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 2.5 tmtm? -78.31 100.4 6.71 Favored 'General case' 0 C--N 1.268 -2.964 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 -174.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . 0.465 ' H ' HD22 ' A' ' 63' ' ' LEU . . . 135.02 -63.3 0.6 Allowed Glycine 0 N--CA 1.433 -1.559 0 N-CA-C 108.201 -1.96 . . . . 0.0 108.201 -175.071 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.43 ' HD3' ' H ' ' A' ' 116' ' ' LYS . 0.1 OUTLIER -122.08 130.0 52.88 Favored 'General case' 0 C--N 1.291 -1.945 0 O-C-N 121.848 -0.795 . . . . 0.0 110.492 179.407 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.481 HD22 ' HA ' ' A' ' 112' ' ' LEU . 0.3 OUTLIER -108.19 105.34 15.02 Favored 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 105.165 -2.161 . . . . 0.0 105.165 -179.502 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 48.1 p -106.05 166.75 10.28 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 113.103 0.779 . . . . 0.0 113.103 -172.748 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 28.0 m-20 64.43 40.53 6.27 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.976 0.91 . . . . 0.0 109.75 175.109 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.466 ' CG1' HD13 ' A' ' 117' ' ' LEU . 15.6 m -83.83 83.07 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.415 -2.197 0 CA-C-O 122.216 1.007 . . . . 0.0 112.117 -172.595 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -68.63 96.39 0.71 Allowed 'General case' 0 N--CA 1.406 -2.64 0 CA-C-N 113.742 -1.572 . . . . 0.0 109.004 176.054 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 147.53 -15.11 1.43 Allowed Glycine 0 C--N 1.292 -1.87 0 C-N-CA 120.28 -0.962 . . . . 0.0 112.059 177.753 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.443 HG13 HG11 ' A' ' 108' ' ' VAL . 93.2 mt -100.17 99.52 8.64 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.833 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 176.636 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . 0.49 ' HA ' ' O ' ' A' ' 131' ' ' VAL . 47.9 mtpt -107.23 148.63 28.69 Favored 'General case' 0 N--CA 1.419 -1.99 0 CA-C-N 113.999 -1.455 . . . . 0.0 109.666 -173.145 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 13.3 t -154.76 157.62 38.27 Favored 'General case' 0 C--N 1.285 -2.23 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 176.236 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.614 ' HD3' ' N ' ' A' ' 127' ' ' VAL . 0.5 OUTLIER -128.8 138.02 51.84 Favored 'General case' 0 N--CA 1.385 -3.713 0 N-CA-C 106.686 -1.598 . . . . 0.0 106.686 172.184 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.614 ' N ' ' HD3' ' A' ' 126' ' ' LYS . 7.4 p -160.21 -38.04 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.289 -2.054 0 N-CA-C 105.766 -1.939 . . . . 0.0 105.766 177.327 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 13.8 tpt -115.74 -50.62 2.69 Favored 'General case' 0 N--CA 1.39 -3.434 0 CA-C-N 112.605 -2.089 . . . . 0.0 108.129 177.711 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 8.7 tp -162.25 172.71 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 N-CA-C 105.511 -2.033 . . . . 0.0 105.511 174.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 14.3 m-90 -71.66 117.38 13.17 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 118.834 0.743 . . . . 0.0 110.344 177.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . 0.49 ' O ' ' HA ' ' A' ' 124' ' ' LYS . 45.9 t -122.84 133.01 70.21 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.661 0 N-CA-C 106.559 -1.645 . . . . 0.0 106.559 174.691 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 62.8 pttt -108.61 5.24 24.81 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 -173.293 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 35.8 m -126.05 14.94 4.02 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 N-CA-C 112.439 0.533 . . . . 0.0 112.439 -177.538 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 38.4 p -51.58 102.13 0.04 OUTLIER 'General case' 0 C--N 1.347 0.458 0 CA-C-O 121.502 0.668 . . . . 0.0 112.059 179.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 38.5 m -86.54 152.44 22.63 Favored 'General case' 0 N--CA 1.418 -2.038 0 CA-C-N 115.073 -0.967 . . . . 0.0 111.669 -174.747 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 11.5 tt -110.27 132.32 58.93 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.513 0 CA-C-N 114.973 -1.012 . . . . 0.0 109.558 -179.256 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 26.0 t -122.13 116.95 25.12 Favored 'General case' 0 N--CA 1.426 -1.657 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 -179.812 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 3.0 t -136.35 114.62 11.62 Favored 'General case' 0 C--N 1.277 -2.57 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 178.393 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -78.33 73.06 4.89 Favored 'General case' 0 C--N 1.305 -1.369 0 C-N-CA 119.16 -1.016 . . . . 0.0 111.586 -174.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . 49.86 32.23 5.28 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 125.482 1.513 . . . . 0.0 112.039 178.479 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' SER . . . . . 0.627 ' N ' ' HG3' ' A' ' 64' ' ' PRO . 22.9 t -176.96 -76.73 0.01 OUTLIER 'General case' 0 C--O 1.215 -0.727 0 CA-C-O 120.886 0.374 . . . . 0.0 111.102 -175.902 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -98.48 150.47 21.63 Favored 'General case' 0 C--N 1.306 -1.291 0 O-C-N 122.287 -0.258 . . . . 0.0 110.443 -172.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.676 ' HB ' ' O ' ' A' ' 153' ' ' ARG . 47.9 t -106.16 136.06 42.08 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 CA-C-O 121.143 0.497 . . . . 0.0 111.697 -172.772 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . 0.417 ' HA ' ' OG ' ' A' ' 152' ' ' SER . 75.5 m-85 -135.71 143.29 45.3 Favored 'General case' 0 C--O 1.25 1.11 0 C-N-CA 123.894 0.878 . . . . 0.0 109.244 179.488 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 55.5 p90 -64.14 141.28 58.83 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-O 121.423 0.63 . . . . 0.0 112.564 178.575 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 91.4 m -108.63 -28.77 9.09 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 167.56 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . 0.402 ' HB1' ' HB3' ' A' ' 150' ' ' LYS . . . -60.33 129.46 41.76 Favored 'General case' 0 N--CA 1.441 -0.925 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 172.445 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -84.22 -15.61 68.91 Favored Glycine 0 CA--C 1.48 -2.097 0 C-N-CA 119.956 -1.116 . . . . 0.0 112.584 -169.616 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 58.5 mtt -101.45 2.13 39.01 Favored 'General case' 0 C--N 1.291 -1.974 0 CA-C-O 121.453 0.644 . . . . 0.0 110.021 -176.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . 0.499 ' HG3' ' H ' ' A' ' 151' ' ' LYS . 17.3 tppt? -121.28 -178.03 3.67 Favored 'General case' 0 CA--C 1.561 1.374 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 -174.398 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . 0.499 ' H ' ' HG3' ' A' ' 150' ' ' LYS . 75.0 mmtt -137.32 164.52 28.39 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 123.491 0.716 . . . . 0.0 109.071 -172.562 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' SER . . . . . 0.447 ' C ' ' HD2' ' A' ' 153' ' ' ARG . 42.5 m -76.04 153.6 36.31 Favored 'General case' 0 C--N 1.306 -1.326 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 -174.758 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' ARG . . . . . 0.676 ' O ' ' HB ' ' A' ' 143' ' ' VAL . 3.1 mpt_? -126.18 149.98 48.63 Favored 'General case' 0 CA--C 1.494 -1.177 0 N-CA-C 106.18 -1.785 . . . . 0.0 106.18 173.635 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 41.4 m -93.63 142.22 27.59 Favored 'General case' 0 C--N 1.281 -2.382 0 C-N-CA 120.497 -0.481 . . . . 0.0 110.625 -178.352 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 19.1 ttp180 -58.5 -30.38 66.99 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-O 120.66 0.267 . . . . 0.0 111.184 178.541 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -53.44 -21.03 5.37 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 124.058 0.943 . . . . 0.0 112.71 179.531 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -64.96 -53.63 43.3 Favored 'General case' 0 N--CA 1.432 -1.332 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 178.605 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 10.7 t80 170.72 23.57 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 106.744 -1.576 . . . . 0.0 106.744 177.49 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 95.89 -92.52 1.44 Allowed Glycine 0 N--CA 1.416 -2.689 0 C-N-CA 119.082 -1.532 . . . . 0.0 109.376 -170.159 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.455 HG21 ' HB ' ' A' ' 65' ' ' ILE . 2.4 t -130.26 114.5 29.18 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.758 0 N-CA-C 106.333 -1.728 . . . . 0.0 106.333 176.289 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 5.3 pp0? -134.51 130.66 36.96 Favored 'General case' 0 N--CA 1.414 -2.25 0 C-N-CA 117.194 -1.802 . . . . 0.0 115.338 -172.46 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 19.8 tpt180 -152.81 138.68 18.02 Favored 'General case' 0 C--N 1.27 -2.875 0 N-CA-C 104.694 -2.335 . . . . 0.0 104.694 168.102 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -69.81 95.27 0.89 Allowed 'General case' 0 CA--C 1.505 -0.768 0 CA-C-O 121.621 0.724 . . . . 0.0 112.777 -175.579 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -145.6 159.27 27.89 Favored Glycine 0 N--CA 1.423 -2.17 0 N-CA-C 109.2 -1.56 . . . . 0.0 109.2 176.572 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . 0.411 ' HB2' ' OXT' ' A' ' 170' ' ' PHE . 2.0 pt? -130.77 143.74 50.95 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-O 120.992 0.425 . . . . 0.0 110.451 -178.075 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . 0.506 ' HD2' ' N ' ' A' ' 166' ' ' ARG . 4.2 mpt_? -96.85 106.34 18.63 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 178.897 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 43.3 t -37.52 -46.26 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.562 1.44 0 N-CA-C 115.674 1.731 . . . . 0.0 115.674 -172.054 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -60.45 -35.55 76.11 Favored 'General case' 0 N--CA 1.486 1.326 0 CA-C-O 121.178 0.513 . . . . 0.0 111.729 -178.534 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 31.5 tttm -96.22 -81.17 0.42 Allowed 'General case' 0 C--N 1.3 -1.572 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.678 -179.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 170' ' ' PHE . . . . . 0.411 ' OXT' ' HB2' ' A' ' 165' ' ' LEU . 68.6 t80 . . . . . 0 N--CA 1.432 -1.35 0 N-CA-C 101.802 -3.407 . . . . 0.0 101.802 -175.545 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 33.0 mt . . . . . 0 CA--C 1.505 -0.754 0 N-CA-C 112.793 0.664 . . . . 0.0 112.793 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.459 ' O ' ' HG2' ' A' ' 59' ' ' LYS . 7.5 Cg_exo -69.65 -14.34 36.29 Favored 'Trans proline' 0 N--CA 1.427 -2.432 0 C-N-CA 121.61 1.54 . . . . 0.0 112.282 -169.356 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -71.52 -39.88 70.48 Favored 'General case' 0 CA--C 1.49 -1.359 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 -174.069 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.406 ' O ' ' HB3' ' A' ' 60' ' ' GLU . 10.4 mp -68.62 -30.48 69.22 Favored 'General case' 0 N--CA 1.44 -0.925 0 CA-C-N 114.808 -1.087 . . . . 0.0 111.988 178.932 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 6.2 mp -64.5 -48.82 73.74 Favored 'General case' 0 CA--C 1.495 -1.153 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 179.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.459 ' HG2' ' O ' ' A' ' 55' ' ' PRO . 32.3 pttt -75.19 -26.84 59.33 Favored 'General case' 0 C--N 1.299 -1.59 0 CA-C-N 115.143 -0.935 . . . . 0.0 112.986 177.399 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.406 ' HB3' ' O ' ' A' ' 57' ' ' LEU . 8.3 tp10 -59.82 -51.81 68.15 Favored 'General case' 0 C--N 1.306 -1.313 0 C-N-CA 123.927 0.891 . . . . 0.0 111.221 175.018 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 63.4 t80 -68.59 -10.26 54.78 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.6 -176.519 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.581 ' OD2' HG22 ' A' ' 73' ' ' THR . 22.4 t0 -94.71 -179.37 4.84 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.473 -178.495 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.522 ' H ' ' CG ' ' A' ' 62' ' ' ASP . 2.5 mt -76.36 169.03 22.9 Favored Pre-proline 0 CA--C 1.559 1.299 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 -178.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.431 ' HB2' ' HG3' ' A' ' 155' ' ' ARG . 10.9 Cg_endo -91.97 25.7 0.46 Allowed 'Trans proline' 0 N--CA 1.441 -1.576 0 C-N-CA 122.596 2.197 . . . . 0.0 110.853 -176.725 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.728 ' O ' ' HA3' ' A' ' 159' ' ' GLY . 0.2 OUTLIER -73.89 -29.09 25.12 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.432 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 176.915 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 53.11 1.66 0.07 OUTLIER Glycine 0 CA--C 1.544 1.887 0 CA-C-N 114.972 -1.013 . . . . 0.0 115.133 178.086 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.672 ' O ' ' HB ' ' A' ' 160' ' ' VAL . 48.6 mt 67.08 -42.35 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.189 0 C-N-CA 126.441 1.896 . . . . 0.0 114.099 -179.575 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.532 ' HB2' ' O ' ' A' ' 67' ' ' ILE . 71.3 t80 158.0 -51.37 0.0 OUTLIER Pre-proline 0 N--CA 1.489 1.494 0 C-N-CA 125.354 1.462 . . . . 0.0 110.498 177.729 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.436 ' HB2' ' OD2' ' A' ' 71' ' ' ASP . 9.5 Cg_endo -95.82 -24.82 0.12 Allowed 'Trans proline' 0 C--N 1.374 1.878 0 C-N-CA 121.87 1.713 . . . . 0.0 115.052 -172.479 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.406 ' H ' ' HD2' ' A' ' 69' ' ' PRO . . . 82.48 -7.89 63.44 Favored Glycine 0 CA--C 1.526 0.738 0 C-N-CA 120.454 -0.879 . . . . 0.0 111.629 -174.707 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.436 ' OD2' ' HB2' ' A' ' 69' ' ' PRO . 23.2 m-20 -86.16 -30.99 22.05 Favored 'General case' 0 CA--C 1.495 -1.148 0 N-CA-C 106.26 -1.755 . . . . 0.0 106.26 178.062 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.534 ' O ' ' HB ' ' A' ' 73' ' ' THR . . . -82.62 -172.26 3.95 Favored 'General case' 0 N--CA 1.442 -0.825 0 CA-C-N 113.556 -1.657 . . . . 0.0 107.103 171.81 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.711 HG23 ' O ' ' A' ' 73' ' ' THR . 60.7 m 79.94 27.35 0.32 Allowed 'General case' 0 N--CA 1.474 0.742 0 CA-C-O 124.807 2.241 . . . . 0.0 109.483 175.015 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 35.8 m-80 -84.48 -177.3 6.58 Favored 'General case' 0 N--CA 1.386 -3.641 0 CA-C-N 113.759 -1.564 . . . . 0.0 110.479 178.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 42.6 t80 -149.21 94.9 2.3 Favored 'General case' 0 C--N 1.276 -2.628 0 C-N-CA 119.352 -0.939 . . . . 0.0 110.935 -169.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.646 ' OE1' ' HG ' ' A' ' 87' ' ' LEU . 4.2 mp0 -107.26 96.09 6.17 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 176.777 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 81.9 t80 -102.73 124.31 48.03 Favored 'General case' 0 C--N 1.297 -1.704 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.255 -176.264 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.58 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 10.4 m-20 -93.9 155.77 16.99 Favored 'General case' 0 CA--C 1.47 -2.1 0 C-N-CA 118.819 -1.152 . . . . 0.0 108.712 175.017 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -80.43 -53.35 6.68 Favored 'General case' 0 C--N 1.25 -3.756 0 CA-C-N 113.412 -1.722 . . . . 0.0 109.026 179.323 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -66.77 -21.33 66.06 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 113.726 -1.579 . . . . 0.0 110.754 -176.498 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.58 ' HB ' ' HB2' ' A' ' 78' ' ' ASP . 27.2 m -101.63 -53.01 3.07 Favored 'General case' 0 N--CA 1.41 -2.455 0 CA-C-N 115.0 -1.0 . . . . 0.0 111.192 -174.612 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 99.7 mttt 70.26 4.15 4.74 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 123.85 0.86 . . . . 0.0 111.995 -174.616 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.503 ' HG2' ' CG2' ' A' ' 109' ' ' THR . 36.2 ttmt -104.91 107.41 18.36 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 176.655 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -68.01 133.73 49.52 Favored 'General case' 0 C--N 1.292 -1.929 0 CA-C-N 113.833 -1.53 . . . . 0.0 110.447 -175.56 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.441 ' HA ' ' HA ' ' A' ' 109' ' ' THR . 8.9 t -120.85 137.79 54.38 Favored 'General case' 0 N--CA 1.403 -2.812 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 177.422 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 61.0 t -111.32 118.62 57.88 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 C-N-CA 123.811 0.844 . . . . 0.0 109.44 -179.205 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.646 ' HG ' ' OE1' ' A' ' 76' ' ' GLU 0.293 0.5 OUTLIER -79.44 124.41 28.43 Favored 'General case' 0 N--CA 1.403 -2.82 0 CA-C-O 122.578 1.18 . . . . 0.0 112.37 172.879 . . . . . . . . 4 4 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 50.4 mm -102.36 125.8 35.18 Favored Pre-proline 0 C--N 1.279 -2.482 0 CA-C-N 113.711 -1.586 . . . . 0.0 107.805 178.638 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -59.61 96.93 0.1 Allowed 'Trans proline' 0 C--O 1.248 1.018 0 C-N-CA 122.62 2.214 . . . . 0.0 111.516 175.476 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' SER . . . . . 0.479 ' OG ' ' HB2' ' A' ' 168' ' ' ASP . 68.4 m 65.21 176.74 0.2 Allowed 'General case' 0 C--O 1.236 0.356 0 C-N-CA 124.483 1.113 . . . . 0.0 112.844 -178.711 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.423 HG12 ' HA ' ' A' ' 105' ' ' THR . 39.7 mt -88.5 131.15 36.7 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.623 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.793 178.705 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' CYS . . . . . 0.403 ' SG ' ' HA3' ' A' ' 164' ' ' GLY . 16.0 t -116.16 122.71 45.87 Favored 'General case' 0 N--CA 1.41 -2.452 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 173.764 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -116.96 127.29 54.06 Favored 'General case' 0 C--N 1.29 -2.017 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 178.628 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 3.9 p -105.14 103.94 16.14 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.27 0 CA-C-O 122.024 0.916 . . . . 0.0 109.578 177.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.423 -2.229 0 N-CA-C 108.226 -1.95 . . . . 0.0 108.226 179.111 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 35.0 m . . . . . 0 N--CA 1.423 -1.789 0 CA-C-O 121.322 0.582 . . . . 0.0 109.645 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.45 ' C ' HD11 ' A' ' 102' ' ' LEU . 60.8 t -113.0 128.86 69.52 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.201 0 N-CA-C 108.142 -1.058 . . . . 0.0 108.142 176.374 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.474 ' HA ' ' O ' ' A' ' 124' ' ' LYS . 5.3 mp -129.9 136.2 49.23 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-O 120.746 0.308 . . . . 0.0 110.796 -178.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -112.43 110.09 20.08 Favored 'General case' 0 C--N 1.31 -1.146 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 177.132 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -89.82 103.5 16.15 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 176.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' THR . . . . . 0.423 ' HA ' HG12 ' A' ' 91' ' ' ILE . 35.1 m -82.41 157.81 23.54 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.967 -175.099 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 20.3 p -55.84 -38.13 69.64 Favored 'General case' 0 C--N 1.319 -0.725 0 C-N-CA 125.898 1.679 . . . . 0.0 113.037 -177.406 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 14.0 m -128.13 98.73 5.21 Favored 'General case' 0 N--CA 1.419 -1.983 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 -179.412 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 16.9 m -108.4 133.69 52.59 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 179.108 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.503 ' CG2' ' HG2' ' A' ' 83' ' ' LYS . 37.0 m -130.35 132.53 45.87 Favored 'General case' 0 N--CA 1.394 -3.268 0 CA-C-N 116.767 -0.197 . . . . 0.0 110.813 -164.338 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . 0.6 ' HA3' ' O ' ' A' ' 119' ' ' ASP . . . -161.98 -158.25 9.41 Favored Glycine 0 C--O 1.217 -0.916 0 C-N-CA 121.288 -0.482 . . . . 0.0 112.635 -177.274 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 53.3 m80 -117.56 108.06 15.02 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 122.165 -0.609 . . . . 0.0 109.606 176.038 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 5.9 tt -104.4 127.82 52.14 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.73 -172.071 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -131.59 168.1 18.27 Favored 'General case' 0 CA--C 1.464 -2.355 0 CA-C-N 115.243 -0.889 . . . . 0.0 109.71 173.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 54.2 tptt -84.35 101.11 11.71 Favored 'General case' 0 N--CA 1.389 -3.522 0 CA-C-N 115.179 -0.918 . . . . 0.0 108.809 -177.017 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . 0.408 ' H ' ' CD2' ' A' ' 63' ' ' LEU . . . 126.24 -11.68 7.22 Favored Glycine 0 C--O 1.205 -1.697 0 CA-C-N 115.159 -0.928 . . . . 0.0 111.164 -176.868 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 179.53 147.89 0.24 Allowed 'General case' 0 N--CA 1.487 1.393 0 CA-C-N 117.052 0.426 . . . . 0.0 111.219 178.295 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.6 tt -124.11 113.67 18.68 Favored 'General case' 0 N--CA 1.429 -1.497 0 N-CA-C 106.013 -1.847 . . . . 0.0 106.013 176.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 71.8 p -97.58 122.58 40.82 Favored 'General case' 0 C--N 1.265 -3.071 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.609 -177.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . 0.6 ' O ' ' HA3' ' A' ' 110' ' ' GLY . 31.3 m-20 73.13 129.76 0.04 OUTLIER 'General case' 0 C--O 1.207 -1.146 0 C-N-CA 125.484 1.514 . . . . 0.0 111.651 -179.155 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 10.8 m -135.5 78.75 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 CA-C-O 122.639 1.209 . . . . 0.0 108.72 173.744 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -67.17 111.53 3.97 Favored 'General case' 0 N--CA 1.424 -1.757 0 CA-C-N 113.668 -1.605 . . . . 0.0 108.85 -175.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 133.27 -13.75 4.89 Favored Glycine 0 N--CA 1.424 -2.1 0 C-N-CA 120.31 -0.948 . . . . 0.0 112.115 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.427 ' O ' ' HA ' ' A' ' 132' ' ' LYS . 67.5 mt -99.55 113.57 35.14 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.17 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 179.178 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . 0.474 ' O ' ' HA ' ' A' ' 102' ' ' LEU . 23.1 tptm -85.07 117.9 24.31 Favored 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 104.967 -2.234 . . . . 0.0 104.967 -179.261 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 95.1 m -126.85 124.93 40.74 Favored 'General case' 0 C--N 1.288 -2.085 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 -170.347 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.518 ' HG2' ' N ' ' A' ' 127' ' ' VAL . 84.2 tttt -119.37 145.59 46.06 Favored 'General case' 0 N--CA 1.429 -1.499 0 CA-C-O 121.255 0.55 . . . . 0.0 110.203 169.548 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.518 ' N ' ' HG2' ' A' ' 126' ' ' LYS . 7.2 p -159.21 -35.68 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 175.782 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -125.25 -51.67 1.64 Allowed 'General case' 0 N--CA 1.399 -3.006 0 N-CA-C 105.621 -1.992 . . . . 0.0 105.621 -179.729 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 7.9 tp -149.94 169.9 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.285 0 N-CA-C 105.574 -2.01 . . . . 0.0 105.574 176.516 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' TRP . . . . . 0.421 ' CD1' ' HB2' ' A' ' 126' ' ' LYS . 30.6 m-90 -80.12 126.32 30.94 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-O 121.32 0.581 . . . . 0.0 111.241 177.52 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 7.3 p -137.35 137.0 46.51 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.247 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 176.636 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . 0.427 ' HA ' ' O ' ' A' ' 123' ' ' ILE . 0.0 OUTLIER -112.07 20.19 17.11 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 113.708 1.003 . . . . 0.0 113.708 -174.687 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 17.8 m -124.17 -60.55 1.86 Allowed 'Isoleucine or valine' 0 C--O 1.21 -1.014 0 CA-C-N 116.101 -0.499 . . . . 0.0 112.15 179.357 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' THR . . . . . 0.448 ' O ' ' HA ' ' A' ' 119' ' ' ASP . 77.5 p 51.71 -171.64 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 124.118 0.967 . . . . 0.0 113.465 179.386 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 23.2 p -166.0 152.9 9.73 Favored 'General case' 0 N--CA 1.427 -1.612 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 176.06 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 14.1 tt -131.29 134.0 61.61 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.322 0 CA-C-O 121.254 0.549 . . . . 0.0 109.549 -179.264 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 39.9 t -124.81 159.61 30.62 Favored 'General case' 0 C--N 1.289 -2.041 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 -176.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' THR . . . . . 0.435 HG23 ' H ' ' A' ' 140' ' ' ALA . 9.7 t -165.15 175.97 8.88 Favored 'General case' 0 N--CA 1.41 -2.436 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 -178.008 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -112.49 30.57 6.99 Favored 'General case' 0 C--N 1.275 -2.659 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 173.128 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . 0.435 ' H ' HG23 ' A' ' 138' ' ' THR . . . 62.84 38.37 11.56 Favored 'General case' 0 C--N 1.35 0.596 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 -172.462 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' SER . . . . . 0.635 ' O ' ' HB3' ' A' ' 155' ' ' ARG . 46.9 t -174.57 -79.95 0.01 OUTLIER 'General case' 0 C--O 1.219 -0.527 0 CA-C-N 114.585 -1.189 . . . . 0.0 111.312 -175.064 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -75.53 134.94 40.63 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 -178.48 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 59.4 t -106.0 130.37 57.67 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.969 0 CA-C-O 120.998 0.428 . . . . 0.0 111.556 -170.155 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -131.76 150.17 52.24 Favored 'General case' 0 CA--C 1.481 -1.699 0 CA-C-O 121.589 0.709 . . . . 0.0 110.631 176.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 60.7 m-85 -109.91 103.12 11.85 Favored 'General case' 0 C--N 1.268 -2.967 0 CA-C-N 115.026 -0.988 . . . . 0.0 111.424 179.205 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 6.6 p -81.75 19.69 1.04 Allowed 'General case' 0 C--N 1.305 -1.37 0 CA-C-N 115.073 -0.967 . . . . 0.0 113.269 -176.229 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -68.79 -15.4 63.49 Favored 'General case' 0 C--O 1.218 -0.574 0 CA-C-O 121.773 0.796 . . . . 0.0 109.812 175.209 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 166.39 29.53 0.02 OUTLIER Glycine 0 N--CA 1.43 -1.715 0 N-CA-C 108.868 -1.693 . . . . 0.0 108.868 175.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 15.6 tpt 57.59 23.5 9.38 Favored 'General case' 0 N--CA 1.486 1.328 0 CA-C-O 122.322 1.058 . . . . 0.0 108.498 -173.481 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . 0.446 ' CD ' HG11 ' A' ' 127' ' ' VAL . 0.0 OUTLIER -76.19 -9.46 58.65 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 115.942 1.83 . . . . 0.0 115.942 -169.492 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 5.2 mmpt? -147.21 138.33 23.83 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 120.514 0.197 . . . . 0.0 111.278 178.556 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 72.2 p -126.53 132.41 51.37 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 174.343 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 22.8 tpt180 -147.91 157.37 43.49 Favored 'General case' 0 C--N 1.31 -1.148 0 N-CA-C 109.554 -0.535 . . . . 0.0 109.554 -176.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 68.3 m -98.1 143.71 28.36 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 108.434 -0.951 . . . . 0.0 108.434 173.019 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' ARG . . . . . 0.635 ' HB3' ' O ' ' A' ' 141' ' ' SER . 0.0 OUTLIER -67.44 -18.29 65.04 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 118.756 -1.177 . . . . 0.0 112.758 176.837 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -41.86 -56.97 2.54 Favored 'General case' 0 N--CA 1.482 1.174 0 N-CA-C 115.128 1.529 . . . . 0.0 115.128 -173.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -56.32 -37.96 70.65 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 112.012 0.375 . . . . 0.0 112.012 -176.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 6.7 t80 176.15 -26.25 0.0 OUTLIER 'General case' 0 CA--C 1.506 -0.731 0 N-CA-C 106.913 -1.514 . . . . 0.0 106.913 174.374 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . 0.728 ' HA3' ' O ' ' A' ' 65' ' ' ILE . . . 132.03 -87.33 0.28 Allowed Glycine 0 N--CA 1.407 -3.251 0 N-CA-C 110.506 -1.037 . . . . 0.0 110.506 -174.014 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.672 ' HB ' ' O ' ' A' ' 67' ' ' ILE . 12.0 t -98.54 116.91 42.6 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.238 0 C-N-CA 119.338 -0.945 . . . . 0.0 108.701 178.593 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 75.9 mm-40 -119.61 108.94 15.08 Favored 'General case' 0 CA--C 1.501 -0.931 0 N-CA-C 113.979 1.103 . . . . 0.0 113.979 -176.638 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 22.4 mmm180 -149.71 148.43 29.25 Favored 'General case' 0 C--N 1.308 -1.234 0 C-N-CA 125.508 1.523 . . . . 0.0 107.466 172.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -74.31 89.38 2.07 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-O 121.514 0.673 . . . . 0.0 110.874 -177.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . 0.403 ' HA3' ' SG ' ' A' ' 92' ' ' CYS . . . -122.8 168.05 15.12 Favored Glycine 0 N--CA 1.432 -1.568 0 CA-C-N 115.151 -0.931 . . . . 0.0 110.952 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 49.9 tp -141.19 114.58 8.77 Favored 'General case' 0 N--CA 1.414 -2.251 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 178.537 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 81.3 mtt85 -87.4 103.97 16.0 Favored 'General case' 0 CA--C 1.476 -1.882 0 CA-C-O 122.07 0.938 . . . . 0.0 110.672 178.131 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 18.6 m -77.09 53.04 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.294 -1.809 0 CA-C-N 113.378 -1.737 . . . . 0.0 114.444 -173.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . 0.479 ' HB2' ' OG ' ' A' ' 90' ' ' SER . 32.8 t70 -135.36 -0.33 2.7 Favored 'General case' 0 N--CA 1.475 0.825 0 CA-C-O 122.271 1.034 . . . . 0.0 108.435 175.932 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -149.88 162.41 40.37 Favored 'General case' 0 N--CA 1.443 -0.817 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 -177.693 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 170' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 . . . . . 0 C--O 1.247 0.927 0 CA-C-O 118.958 -0.544 . . . . 0.0 110.162 176.784 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.65 ' O ' ' HG ' ' A' ' 58' ' ' LEU 0.261 7.9 mp . . . . . 0 CA--C 1.476 -1.886 0 N-CA-C 117.79 2.515 . . . . 0.0 117.79 . . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.6 ' O ' ' HE2' ' A' ' 59' ' ' LYS . 52.8 Cg_exo -57.44 -25.76 67.88 Favored 'Trans proline' 0 N--CA 1.445 -1.342 0 C-N-CA 121.52 1.48 . . . . 0.0 111.418 -176.371 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -81.74 -32.04 31.71 Favored 'General case' 0 N--CA 1.417 -2.124 0 CA-C-N 115.021 -0.99 . . . . 0.0 108.898 -178.279 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.473 ' HA ' ' HB3' ' A' ' 60' ' ' GLU . 15.4 mt -74.98 -29.69 60.97 Favored 'General case' 0 CA--C 1.487 -1.454 0 CA-C-N 115.004 -0.998 . . . . 0.0 110.333 -174.436 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.65 ' HG ' ' O ' ' A' ' 54' ' ' LEU . 15.5 mt -59.71 -52.4 65.67 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 -178.687 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.6 ' HE2' ' O ' ' A' ' 55' ' ' PRO . 49.5 mtmt -64.93 -23.91 67.36 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 113.955 -1.475 . . . . 0.0 110.57 177.689 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.473 ' HB3' ' HA ' ' A' ' 57' ' ' LEU . 28.3 tt0 -82.58 -19.09 39.14 Favored 'General case' 0 C--N 1.291 -1.976 0 C-N-CA 124.844 1.257 . . . . 0.0 111.679 178.456 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 36.6 m-85 -85.9 -33.21 21.28 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 113.56 0.948 . . . . 0.0 113.56 -177.669 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.468 ' OD2' HD12 ' A' ' 65' ' ' ILE . 4.6 p-10 -78.47 -165.19 0.66 Allowed 'General case' 0 C--N 1.292 -1.92 0 N-CA-C 113.116 0.784 . . . . 0.0 113.116 -167.458 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.472 HD21 ' H ' ' A' ' 115' ' ' GLY . 6.6 mt -77.16 -154.23 0.0 OUTLIER Pre-proline 0 CA--C 1.599 2.845 0 N-CA-C 104.494 -2.41 . . . . 0.0 104.494 178.146 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.476 ' O ' ' HD2' ' A' ' 155' ' ' ARG . 7.5 Cg_endo -96.77 10.9 1.25 Allowed 'Trans proline' 0 N--CA 1.441 -1.585 0 CA-C-N 123.667 2.345 . . . . 0.0 111.067 177.127 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.666 ' O ' ' HA3' ' A' ' 159' ' ' GLY . 0.2 OUTLIER -78.9 -40.31 22.77 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.92 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.68 -176.81 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 59.9 8.14 7.62 Favored Glycine 0 CA--C 1.542 1.73 0 CA-C-N 116.287 -0.415 . . . . 0.0 113.638 -177.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.505 ' H ' HG12 ' A' ' 65' ' ' ILE . 55.9 mt 59.01 -70.4 0.07 OUTLIER 'Isoleucine or valine' 0 C--O 1.211 -0.94 0 C-N-CA 127.418 2.287 . . . . 0.0 114.126 -178.72 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.501 ' HB3' ' HD3' ' A' ' 69' ' ' PRO . 34.3 t80 173.5 -56.57 0.0 OUTLIER Pre-proline 0 CA--C 1.563 1.446 0 CA-C-N 118.024 0.375 . . . . 0.0 110.571 -176.55 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.501 ' HD3' ' HB3' ' A' ' 68' ' ' PHE . 6.9 Cg_endo -98.89 157.97 0.67 Allowed 'Trans proline' 0 C--N 1.386 2.533 0 C-N-CA 123.205 2.603 . . . . 0.0 112.598 179.39 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -89.45 -8.24 68.39 Favored Glycine 0 CA--C 1.524 0.648 0 C-N-CA 121.379 -0.438 . . . . 0.0 112.39 179.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.569 ' OD2' ' HG3' ' A' ' 89' ' ' PRO . 20.8 t70 -89.6 -19.96 24.3 Favored 'General case' 0 C--O 1.213 -0.852 0 CA-C-O 122.17 0.986 . . . . 0.0 108.635 177.045 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.492 ' C ' HG21 ' A' ' 73' ' ' THR . . . -84.33 -166.13 1.35 Allowed 'General case' 0 CA--C 1.487 -1.48 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 167.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.492 HG21 ' C ' ' A' ' 72' ' ' ALA . 18.2 p 67.71 18.06 9.81 Favored 'General case' 0 CA--C 1.47 -2.11 0 CA-C-O 123.582 1.658 . . . . 0.0 110.668 172.234 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.733 ' O ' ' HA ' ' A' ' 86' ' ' VAL . 1.6 m-80 -75.87 100.49 4.81 Favored 'General case' 2 N--CA 1.365 -4.694 0 CA-C-N 111.704 -2.498 . . . . 0.0 110.513 -178.639 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -99.03 91.86 5.22 Favored 'General case' 0 C--N 1.274 -2.71 0 CA-C-N 114.572 -1.194 . . . . 0.0 113.33 -176.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.45 ' HB2' HG23 ' A' ' 85' ' ' THR . 19.2 mm-40 -97.5 133.8 41.58 Favored 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 106.729 -1.582 . . . . 0.0 106.729 175.735 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.44 ' HB2' ' CD2' ' A' ' 84' ' ' LEU . 90.6 t80 -146.57 127.28 14.3 Favored 'General case' 0 C--N 1.301 -1.511 0 C-N-CA 120.256 -0.578 . . . . 0.0 112.193 -173.477 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.596 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 5.8 m-20 -95.2 156.5 16.29 Favored 'General case' 0 CA--C 1.472 -2.043 0 N-CA-C 105.44 -2.059 . . . . 0.0 105.44 170.184 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -80.1 -60.63 2.26 Favored 'General case' 0 C--N 1.255 -3.521 0 N-CA-C 113.557 0.947 . . . . 0.0 113.557 -175.027 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -71.04 -29.94 65.98 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-O 121.415 0.626 . . . . 0.0 111.1 -175.695 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.596 ' HB ' ' HB2' ' A' ' 78' ' ' ASP . 24.6 m -68.6 -45.13 72.77 Favored 'General case' 0 N--CA 1.421 -1.886 0 CA-C-N 114.898 -1.046 . . . . 0.0 109.873 179.561 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 99.6 mttt 68.12 8.13 6.33 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.139 0.976 . . . . 0.0 113.319 -179.016 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 1.9 mptm? -89.22 106.23 18.31 Favored 'General case' 0 CA--C 1.494 -1.193 0 CA-C-O 121.551 0.691 . . . . 0.0 110.662 173.712 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.44 ' CD2' ' HB2' ' A' ' 77' ' ' PHE . 2.1 tm? -81.81 126.4 31.81 Favored 'General case' 0 C--N 1.285 -2.229 0 N-CA-C 105.426 -2.064 . . . . 0.0 105.426 174.909 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.583 ' HA ' ' O ' ' A' ' 108' ' ' VAL . 9.5 t -116.5 127.42 54.54 Favored 'General case' 0 N--CA 1.392 -3.327 0 C-N-CA 120.196 -0.602 . . . . 0.0 110.632 -178.937 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.733 ' HA ' ' O ' ' A' ' 74' ' ' ASN . 32.3 t -104.75 122.65 58.06 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.108 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.404 -178.588 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 5.6 mp -90.49 104.4 16.99 Favored 'General case' 0 C--N 1.29 -2.01 0 CA-C-N 114.981 -1.008 . . . . 0.0 109.328 177.352 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 3.5 mp -93.93 137.53 23.03 Favored Pre-proline 0 C--N 1.302 -1.489 0 N-CA-C 106.561 -1.644 . . . . 0.0 106.561 175.114 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . 0.609 ' O ' ' HB2' ' A' ' 166' ' ' ARG . 43.4 Cg_exo -59.76 97.32 0.11 Allowed 'Trans proline' 0 N--CA 1.455 -0.781 0 C-N-CA 122.58 2.187 . . . . 0.0 110.34 176.364 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' SER . . . . . 0.554 ' OG ' ' HB ' ' A' ' 167' ' ' VAL . 73.4 m 66.57 177.82 0.22 Allowed 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 123.654 0.781 . . . . 0.0 110.862 -174.531 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 14.8 tt -94.78 109.06 21.66 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.763 0 C-N-CA 119.792 -0.763 . . . . 0.0 109.185 175.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 27.1 p -98.77 149.15 23.17 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.366 -179.072 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -116.56 121.32 41.42 Favored 'General case' 0 CA--C 1.476 -1.88 0 N-CA-C 107.513 -1.291 . . . . 0.0 107.513 -179.053 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.501 HG22 ' HD3' ' A' ' 162' ' ' ARG . 25.0 t -112.04 103.27 15.18 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.62 0 C-N-CA 119.614 -0.834 . . . . 0.0 111.293 -176.227 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.435 -1.426 0 N-CA-C 108.285 -1.926 . . . . 0.0 108.285 178.043 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 36.1 m . . . . . 0 N--CA 1.424 -1.746 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.481 ' HA ' ' O ' ' A' ' 94' ' ' VAL . 52.0 t -97.64 119.24 45.4 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.257 0 CA-C-N 115.23 -0.895 . . . . 0.0 110.653 -176.851 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 6.5 mp -109.19 126.76 53.6 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 176.619 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 38.9 ttmt -109.46 115.16 29.41 Favored 'General case' 0 C--N 1.289 -2.035 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 -178.743 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -89.95 97.06 10.97 Favored 'General case' 0 N--CA 1.426 -1.651 0 CA-C-N 115.949 -0.569 . . . . 0.0 112.264 -175.16 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 87.9 m -56.88 122.36 12.05 Favored 'General case' 0 N--CA 1.422 -1.844 0 CA-C-N 114.062 -1.426 . . . . 0.0 109.535 174.621 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 8.0 t -71.9 117.7 13.82 Favored 'General case' 0 N--CA 1.435 -1.197 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 -179.588 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 52.3 m 70.68 68.71 0.19 Allowed 'General case' 0 N--CA 1.439 -0.984 0 CA-C-O 122.76 1.266 . . . . 0.0 108.812 -173.353 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.583 ' O ' ' HA ' ' A' ' 85' ' ' THR . 9.8 p -103.93 159.83 4.89 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.127 0 CA-C-N 113.627 -1.624 . . . . 0.0 106.812 -179.124 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 15.8 p -115.53 170.72 8.21 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-N 118.735 0.698 . . . . 0.0 111.504 -178.334 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 176.54 -175.59 47.59 Favored Glycine 0 N--CA 1.439 -1.107 0 N-CA-C 110.506 -1.038 . . . . 0.0 110.506 179.362 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 46.7 t-80 -105.77 131.39 53.18 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 -179.29 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -97.08 107.78 20.38 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-O 121.803 0.811 . . . . 0.0 112.678 -172.18 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -123.53 143.64 50.06 Favored 'General case' 0 CA--C 1.453 -2.756 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 171.064 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 3.7 tmtp? -92.01 101.06 13.6 Favored 'General case' 0 N--CA 1.384 -3.742 0 CA-C-O 122.321 1.058 . . . . 0.0 108.57 -171.556 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . 0.623 ' O ' ' HB ' ' A' ' 138' ' ' THR . . . 143.94 -58.53 0.53 Allowed Glycine 0 C--N 1.283 -2.397 0 N-CA-C 106.736 -2.546 . . . . 0.0 106.736 -175.163 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.421 ' HB2' ' HA ' ' A' ' 137' ' ' SER . 0.0 OUTLIER -132.72 130.37 39.94 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 178.989 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -91.92 105.57 17.8 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 105.569 -2.011 . . . . 0.0 105.569 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 21.4 p -99.26 175.33 5.92 Favored 'General case' 0 C--N 1.294 -1.839 0 C-N-CA 123.355 0.662 . . . . 0.0 112.069 -174.213 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 27.4 m-20 50.89 45.72 27.12 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 123.529 0.732 . . . . 0.0 111.125 173.6 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.459 ' CG2' ' HA ' ' A' ' 135' ' ' SER . 2.1 t -77.52 99.17 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.863 0 CA-C-O 122.416 1.103 . . . . 0.0 109.807 -169.863 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 46.6 tt0 -79.79 87.58 5.27 Favored 'General case' 0 N--CA 1.4 -2.928 0 CA-C-N 113.819 -1.537 . . . . 0.0 111.275 -173.641 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 126.39 7.61 5.26 Favored Glycine 0 N--CA 1.412 -2.957 0 C-N-CA 119.604 -1.284 . . . . 0.0 112.439 171.601 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 8.5 tp -98.09 116.62 41.25 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.271 0 C-N-CA 117.402 -1.719 . . . . 0.0 108.223 -176.488 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -85.73 117.65 24.74 Favored 'General case' 0 C--N 1.274 -2.68 0 CA-C-N 113.816 -1.538 . . . . 0.0 109.227 -177.155 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 80.8 m -136.02 126.95 27.65 Favored 'General case' 0 N--CA 1.415 -2.215 0 CA-C-N 114.756 -1.111 . . . . 0.0 110.914 -173.428 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.51 ' HD3' ' C ' ' A' ' 126' ' ' LYS . 0.4 OUTLIER -112.36 128.33 56.26 Favored 'General case' 0 N--CA 1.419 -1.986 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 171.255 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.464 ' N ' ' HD3' ' A' ' 126' ' ' LYS . 7.7 p -143.36 -45.58 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.805 0 CA-C-O 121.538 0.685 . . . . 0.0 109.164 176.84 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 26.5 ptm -120.5 -26.43 5.36 Favored 'General case' 0 N--CA 1.423 -1.808 0 CA-C-N 115.037 -0.983 . . . . 0.0 108.528 173.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 9.3 tp -164.13 171.51 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.416 -2.172 0 N-CA-C 104.249 -2.5 . . . . 0.0 104.249 177.324 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 88.6 t90 -85.21 120.26 26.5 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 179.57 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . 0.443 HG13 ' H ' ' A' ' 133' ' ' VAL . 45.4 t -128.08 146.05 34.26 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 N-CA-C 107.262 -1.385 . . . . 0.0 107.262 178.724 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 22.5 pttp -111.71 31.3 6.27 Favored 'General case' 0 C--O 1.246 0.882 0 CA-C-O 121.76 0.79 . . . . 0.0 110.731 -179.646 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.443 ' H ' HG13 ' A' ' 131' ' ' VAL . 21.9 t -131.27 -80.1 0.14 Allowed 'Isoleucine or valine' 0 C--O 1.208 -1.102 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 178.834 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 41.3 p 47.57 -156.41 0.05 Allowed 'General case' 0 C--O 1.258 1.551 0 C-N-CA 123.639 0.776 . . . . 0.0 112.602 179.363 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' SER . . . . . 0.459 ' HA ' ' CG2' ' A' ' 120' ' ' VAL . 34.1 t -170.42 144.16 2.42 Favored 'General case' 0 N--CA 1.419 -1.993 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 -179.571 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 12.2 tt -99.64 96.95 5.33 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.28 0 N-CA-C 105.318 -2.105 . . . . 0.0 105.318 172.13 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' SER . . . . . 0.421 ' HA ' ' HB2' ' A' ' 116' ' ' LYS . 25.6 m -90.55 142.95 27.22 Favored 'General case' 0 N--CA 1.389 -3.509 0 CA-C-N 113.588 -1.642 . . . . 0.0 109.303 -174.533 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' THR . . . . . 0.623 ' HB ' ' O ' ' A' ' 115' ' ' GLY . 92.4 m -153.89 147.66 25.35 Favored 'General case' 0 C--N 1.256 -3.478 0 N-CA-C 105.743 -1.947 . . . . 0.0 105.743 -179.013 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -95.62 28.9 2.8 Favored 'General case' 0 C--N 1.276 -2.596 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 177.351 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . 0.448 ' N ' HG22 ' A' ' 138' ' ' THR . . . 58.16 39.54 25.86 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 -171.433 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 24.6 t -168.67 -70.95 0.02 OUTLIER 'General case' 0 N--CA 1.441 -0.876 0 CA-C-N 114.625 -1.17 . . . . 0.0 110.803 -175.287 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . 0.433 ' O ' HG21 ' A' ' 138' ' ' THR . 40.1 mmtm -106.42 159.7 15.95 Favored 'General case' 0 CA--C 1.51 -0.588 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 -179.45 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 48.0 t -106.21 139.32 27.93 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 CA-C-O 121.111 0.482 . . . . 0.0 110.855 -174.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 38.3 m-85 -129.5 150.28 50.91 Favored 'General case' 0 CA--C 1.498 -1.052 0 CA-C-O 122.089 0.947 . . . . 0.0 111.657 177.169 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -108.72 103.03 12.04 Favored 'General case' 0 C--N 1.277 -2.555 0 CA-C-N 113.723 -1.58 . . . . 0.0 108.98 178.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' THR . . . . . 0.432 ' OG1' ' HB3' ' A' ' 135' ' ' SER . 36.7 p -104.46 104.83 14.75 Favored 'General case' 0 N--CA 1.41 -2.438 0 N-CA-C 114.212 1.19 . . . . 0.0 114.212 -175.132 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -111.5 26.6 10.48 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 104.888 -2.264 . . . . 0.0 104.888 169.553 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 140.92 -74.28 0.36 Allowed Glycine 0 N--CA 1.399 -3.789 1 N-CA-C 103.049 -4.02 . . . . 0.0 103.049 -169.908 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 28.2 ttt -175.15 88.13 0.04 OUTLIER 'General case' 0 C--N 1.315 -0.934 0 C-N-CA 124.703 1.201 . . . . 0.0 108.103 170.352 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . 0.282 72.4 mmtt -106.42 -93.23 0.38 Allowed 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 116.1 1.889 . . . . 0.0 116.1 -177.605 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -93.42 161.59 14.32 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 113.7 1.0 . . . . 0.0 113.7 -172.188 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 33.0 t -133.72 156.64 47.58 Favored 'General case' 0 C--N 1.31 -1.126 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 175.561 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 20.4 tpt180 -149.62 151.13 33.27 Favored 'General case' 0 N--CA 1.441 -0.899 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 178.618 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 20.2 m -73.59 133.54 43.53 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 176.687 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' ARG . . . . . 0.476 ' HD2' ' O ' ' A' ' 64' ' ' PRO . 14.9 ttp85 -75.88 -21.43 57.17 Favored 'General case' 0 C--N 1.299 -1.597 0 CA-C-O 121.617 0.722 . . . . 0.0 109.534 176.72 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -35.11 -47.64 0.39 Allowed 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 116.923 2.194 . . . . 0.0 116.923 -172.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -76.38 -53.45 8.15 Favored 'General case' 0 CA--C 1.548 0.878 0 N-CA-C 115.041 1.497 . . . . 0.0 115.041 -171.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -140.39 7.14 2.15 Favored 'General case' 0 N--CA 1.484 1.257 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -178.03 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . 0.666 ' HA3' ' O ' ' A' ' 65' ' ' ILE . . . 96.07 -81.88 0.8 Allowed Glycine 0 CA--C 1.462 -3.223 0 N-CA-C 108.712 -1.755 . . . . 0.0 108.712 -172.004 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.503 ' CG2' ' HA ' ' A' ' 67' ' ' ILE . 17.8 t -111.62 135.02 52.17 Favored 'Isoleucine or valine' 0 N--CA 1.401 -2.916 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 172.275 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -84.76 91.68 8.03 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 -177.601 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . 0.501 ' HD3' HG22 ' A' ' 94' ' ' VAL . 3.5 mmp_? -106.59 140.79 38.91 Favored 'General case' 0 C--N 1.29 -1.978 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.897 -176.816 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' ASN . . . . . 0.434 ' H ' HG13 ' A' ' 94' ' ' VAL . 16.8 m120 -127.3 5.91 6.36 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 114.762 -1.108 . . . . 0.0 111.011 -174.895 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -81.47 167.29 48.63 Favored Glycine 0 CA--C 1.498 -1.019 0 C-N-CA 120.343 -0.932 . . . . 0.0 111.912 -175.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . 0.404 HD22 ' H ' ' A' ' 165' ' ' LEU . 1.2 pt? -116.92 112.34 20.9 Favored 'General case' 0 N--CA 1.417 -2.106 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 -179.873 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . 0.609 ' HB2' ' O ' ' A' ' 89' ' ' PRO . 5.8 ptp85 -82.91 118.84 23.74 Favored 'General case' 0 N--CA 1.41 -2.461 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 -177.095 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . 0.554 ' HB ' ' OG ' ' A' ' 90' ' ' SER . 41.1 t -51.61 -46.52 37.55 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 CA-C-N 115.107 -0.951 . . . . 0.0 111.484 -179.776 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -79.31 81.32 5.59 Favored 'General case' 0 CA--C 1.498 -1.05 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 171.224 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 27.0 tptp -99.57 106.63 18.64 Favored 'General case' 0 C--N 1.279 -2.475 0 N-CA-C 114.046 1.128 . . . . 0.0 114.046 -179.377 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 170' ' ' PHE . . . . . . . . . . . . . 79.5 t80 . . . . . 0 N--CA 1.424 -1.765 0 N-CA-C 106.311 -1.737 . . . . 0.0 106.311 173.173 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 8.9 mp . . . . . 0 CA--C 1.498 -1.027 0 N-CA-C 116.377 1.992 . . . . 0.0 116.377 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -62.29 -12.86 29.15 Favored 'Trans proline' 0 N--CA 1.449 -1.095 0 C-N-CA 122.336 2.024 . . . . 0.0 112.462 -170.584 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 17.8 mm-40 -72.52 -32.4 66.11 Favored 'General case' 0 N--CA 1.418 -2.028 0 N-CA-C 107.513 -1.291 . . . . 0.0 107.513 -178.491 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.475 ' O ' ' HG2' ' A' ' 60' ' ' GLU . 3.5 mm? -74.48 -44.28 52.22 Favored 'General case' 0 N--CA 1.423 -1.805 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 175.743 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.434 ' N ' HD12 ' A' ' 58' ' ' LEU . 6.9 mp -59.05 -38.55 79.63 Favored 'General case' 0 CA--C 1.495 -1.15 0 CA-C-N 114.842 -1.072 . . . . 0.0 111.646 -176.563 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.43 ' HD2' ' N ' ' A' ' 60' ' ' GLU . 0.0 OUTLIER -76.14 -29.12 57.67 Favored 'General case' 0 N--CA 1.419 -2.005 0 C-N-CA 119.345 -0.942 . . . . 0.0 112.697 177.842 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.475 ' HG2' ' O ' ' A' ' 57' ' ' LEU . 11.6 pt-20 -77.68 -27.09 50.71 Favored 'General case' 0 N--CA 1.445 -0.706 0 C-N-CA 119.212 -0.995 . . . . 0.0 111.321 -175.595 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 58.6 m-85 -57.02 -47.71 80.25 Favored 'General case' 0 C--O 1.242 0.667 0 C-N-CA 120.17 -0.612 . . . . 0.0 112.515 176.455 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -108.78 -86.05 0.52 Allowed 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 114.722 1.378 . . . . 0.0 114.722 -174.348 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.501 ' CD1' ' H ' ' A' ' 115' ' ' GLY . 0.0 OUTLIER -115.31 137.58 23.13 Favored Pre-proline 0 C--N 1.317 -0.81 0 C-N-CA 118.489 -1.284 . . . . 0.0 107.751 -179.215 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -91.49 21.26 0.8 Allowed 'Trans proline' 0 N--CA 1.429 -2.313 0 C-N-CA 123.653 2.902 . . . . 0.0 111.257 -170.332 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.535 ' C ' ' H ' ' A' ' 67' ' ' ILE . 0.2 OUTLIER -58.9 -40.33 79.96 Favored 'Isoleucine or valine' 0 CA--C 1.473 -2.007 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 176.544 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 59.2 -0.29 0.59 Allowed Glycine 0 N--CA 1.483 1.794 0 CA-C-N 114.363 -1.29 . . . . 0.0 112.182 -176.176 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.54 ' HA ' ' HB ' ' A' ' 160' ' ' VAL . 56.4 mt 62.73 -69.36 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.414 -2.238 0 C-N-CA 127.539 2.336 . . . . 0.0 111.076 -171.606 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 75.1 t80 -177.54 -52.87 0.0 OUTLIER Pre-proline 0 C--N 1.306 -1.287 0 N-CA-C 113.541 0.941 . . . . 0.0 113.541 -174.451 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.444 ' HB2' ' OD1' ' A' ' 71' ' ' ASP . 18.6 Cg_endo -90.21 -28.0 0.27 Allowed 'Trans proline' 0 N--CA 1.444 -1.432 0 C-N-CA 121.073 1.182 . . . . 0.0 115.136 -170.919 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 94.68 -18.42 57.19 Favored Glycine 0 C--O 1.216 -0.993 0 N-CA-C 110.537 -1.025 . . . . 0.0 110.537 -174.108 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.582 ' HB3' ' HG2' ' A' ' 89' ' ' PRO . 8.2 m-20 -75.48 -50.73 14.84 Favored 'General case' 0 N--CA 1.437 -1.11 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 177.272 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.406 ' HA ' ' O ' ' A' ' 87' ' ' LEU . . . -73.86 170.86 14.48 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 114.106 -1.406 . . . . 0.0 109.95 174.082 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.676 ' O ' HG21 ' A' ' 73' ' ' THR . 28.8 m 89.79 28.46 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.836 0 CA-C-O 124.11 1.909 . . . . 0.0 112.559 170.929 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.425 ' HB2' ' HB2' ' A' ' 87' ' ' LEU . 27.5 m-80 -91.25 -174.9 4.1 Favored 'General case' 0 C--N 1.247 -3.855 0 CA-C-N 114.823 -1.08 . . . . 0.0 109.973 178.133 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.464 ' HB2' HD21 ' A' ' 84' ' ' LEU . 28.4 p90 -148.9 136.14 20.13 Favored 'General case' 0 C--N 1.3 -1.545 0 C-N-CA 119.206 -0.998 . . . . 0.0 113.299 -179.387 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.48 ' O ' HD23 ' A' ' 84' ' ' LEU . 70.5 mm-40 -144.13 146.07 32.53 Favored 'General case' 0 C--N 1.306 -1.322 0 C-N-CA 126.251 1.82 . . . . 0.0 106.784 175.324 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 50.2 p90 -149.65 150.93 32.91 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-N 118.249 0.477 . . . . 0.0 111.95 -176.572 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.497 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 11.5 m-20 -95.35 163.1 13.39 Favored 'General case' 0 CA--C 1.489 -1.378 0 N-CA-C 106.857 -1.534 . . . . 0.0 106.857 173.814 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -81.11 -62.43 1.66 Allowed 'General case' 0 C--N 1.278 -2.524 0 N-CA-C 113.633 0.975 . . . . 0.0 113.633 -178.202 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -77.56 -40.39 42.63 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 121.309 0.576 . . . . 0.0 109.519 -176.236 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.497 ' HB ' ' HB2' ' A' ' 78' ' ' ASP . 81.5 m -66.67 -38.54 87.03 Favored 'General case' 0 N--CA 1.429 -1.521 0 CA-C-N 114.949 -1.023 . . . . 0.0 111.892 178.638 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 98.8 mttt 61.54 7.5 1.86 Allowed 'General case' 0 N--CA 1.5 2.036 0 N-CA-C 114.037 1.125 . . . . 0.0 114.037 177.3 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.459 ' HD3' ' HB ' ' A' ' 109' ' ' THR . 35.8 ttmt -83.26 113.33 20.61 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 108.847 -0.798 . . . . 0.0 108.847 178.74 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.48 HD23 ' O ' ' A' ' 76' ' ' GLU . 2.2 tm? -79.87 134.64 36.32 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 -176.194 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.596 ' HA ' ' O ' ' A' ' 108' ' ' VAL . 8.9 t -120.91 129.7 53.59 Favored 'General case' 0 N--CA 1.403 -2.823 0 CA-C-O 121.643 0.735 . . . . 0.0 110.309 178.763 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.412 HG11 ' O ' ' A' ' 74' ' ' ASN . 98.8 t -102.92 134.07 44.98 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.611 -177.28 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.425 ' HB2' ' HB2' ' A' ' 74' ' ' ASN . 2.5 mm? -81.95 115.92 21.34 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-N 114.676 -1.147 . . . . 0.0 110.819 -179.76 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.614 ' O ' ' HA ' ' A' ' 106' ' ' THR . 64.0 mt -124.8 103.81 30.83 Favored Pre-proline 0 C--N 1.29 -1.982 0 N-CA-C 107.375 -1.343 . . . . 0.0 107.375 173.91 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . 0.582 ' HG2' ' HB3' ' A' ' 71' ' ' ASP . 70.9 Cg_exo -56.63 110.9 0.65 Allowed 'Trans proline' 0 C--O 1.199 -1.45 0 C-N-CA 123.136 2.557 . . . . 0.0 111.814 178.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' SER . . . . . 0.475 ' HB2' ' O ' ' A' ' 89' ' ' PRO . 36.7 m 75.34 149.47 0.1 Allowed 'General case' 0 CA--C 1.485 -1.52 0 CA-C-O 122.091 0.948 . . . . 0.0 113.324 -175.511 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.428 ' HA ' ' O ' ' A' ' 104' ' ' PHE . 3.3 mp -80.79 120.7 32.93 Favored 'Isoleucine or valine' 0 N--CA 1.392 -3.33 0 N-CA-C 107.594 -1.261 . . . . 0.0 107.594 173.582 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 40.4 t -96.15 121.57 38.06 Favored 'General case' 0 N--CA 1.405 -2.688 0 N-CA-C 106.625 -1.62 . . . . 0.0 106.625 171.594 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -116.82 121.6 42.0 Favored 'General case' 0 CA--C 1.466 -2.267 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 177.263 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 33.3 m -115.28 103.63 15.58 Favored 'Isoleucine or valine' 0 C--N 1.267 -2.989 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 177.754 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . 0.75 ' HA2' ' O ' ' A' ' 100' ' ' SER . . . . . . . . 0 CA--C 1.478 -2.226 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 -178.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' SER . . . . . 0.75 ' O ' ' HA2' ' A' ' 95' ' ' GLY . 69.3 p . . . . . 0 N--CA 1.41 -2.456 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 60.5 t -115.72 99.72 9.02 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.237 0 CA-C-O 121.23 0.538 . . . . 0.0 109.755 175.817 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.447 HD13 HG22 ' A' ' 125' ' ' THR . 1.8 mm? -111.79 129.62 56.07 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 178.693 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -116.51 107.2 14.45 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-O 120.924 0.392 . . . . 0.0 111.106 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.428 ' O ' ' HA ' ' A' ' 91' ' ' ILE . 89.0 m-85 -93.06 102.36 14.69 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 107.518 -1.289 . . . . 0.0 107.518 176.69 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' THR . . . . . 0.524 ' O ' ' HB ' ' A' ' 88' ' ' ILE . 13.5 t -77.07 -178.37 4.96 Favored 'General case' 0 CA--C 1.551 1.019 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.532 -175.697 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' THR . . . . . 0.614 ' HA ' ' O ' ' A' ' 88' ' ' ILE . 15.0 p -84.13 -50.32 8.04 Favored 'General case' 0 C--N 1.309 -1.162 0 C-N-CA 123.513 0.725 . . . . 0.0 111.716 -173.9 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 26.3 p -115.82 84.76 2.16 Favored 'General case' 0 N--CA 1.406 -2.644 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 175.251 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.596 ' O ' ' HA ' ' A' ' 85' ' ' THR . 14.7 p -81.58 129.58 37.27 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.296 0 CA-C-N 114.94 -1.027 . . . . 0.0 109.922 -177.317 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.48 ' OG1' ' HB3' ' A' ' 121' ' ' GLU . 17.5 p -104.98 149.0 26.12 Favored 'General case' 0 N--CA 1.4 -2.955 0 CA-C-N 116.191 -0.459 . . . . 0.0 109.771 -176.05 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 178.98 -159.41 24.3 Favored Glycine 0 N--CA 1.424 -2.135 0 N-CA-C 110.944 -0.862 . . . . 0.0 110.944 -179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' HIS . . . . . 0.429 ' HB2' ' O ' ' A' ' 118' ' ' THR . 74.1 m80 -123.68 121.22 34.96 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 177.593 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.46 ' HB3' ' HG ' ' A' ' 84' ' ' LEU . 6.4 tt -123.43 136.58 54.68 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-O 121.277 0.56 . . . . 0.0 110.427 -171.717 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -130.67 171.09 13.47 Favored 'General case' 0 CA--C 1.456 -2.64 0 CA-C-N 114.941 -1.027 . . . . 0.0 110.189 177.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 2.7 tmtm? -86.24 100.84 12.53 Favored 'General case' 1 N--CA 1.376 -4.155 0 N-CA-C 103.779 -2.674 . . . . 0.0 103.779 173.461 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . 0.62 ' O ' HG21 ' A' ' 138' ' ' THR . . . 143.2 -62.09 0.51 Allowed Glycine 0 C--N 1.273 -2.96 0 N-CA-C 109.252 -1.539 . . . . 0.0 109.252 -174.85 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.02 164.7 35.8 Favored 'General case' 0 CA--C 1.508 -0.647 0 C-N-CA 122.766 0.426 . . . . 0.0 110.087 -179.697 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 3.7 tt -121.31 109.76 15.3 Favored 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 106.252 -1.758 . . . . 0.0 106.252 176.608 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.615 ' HA ' ' OG ' ' A' ' 135' ' ' SER . 66.9 p -112.14 131.22 55.58 Favored 'General case' 0 C--N 1.277 -2.566 0 N-CA-C 114.109 1.151 . . . . 0.0 114.109 -177.263 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . 0.467 ' H ' ' HB2' ' A' ' 135' ' ' SER . 17.5 t70 70.42 107.81 0.06 Allowed 'General case' 0 CA--C 1.507 -0.71 0 N-CA-C 114.294 1.22 . . . . 0.0 114.294 175.215 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 35.8 m -112.58 166.07 6.92 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.194 0 CA-C-N 115.002 -0.999 . . . . 0.0 110.566 177.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.48 ' HB3' ' OG1' ' A' ' 109' ' ' THR . 12.0 tp10 -127.75 -8.32 5.59 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.747 -178.316 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -105.7 -19.11 10.65 Favored Glycine 0 N--CA 1.432 -1.587 0 C-N-CA 119.706 -1.235 . . . . 0.0 112.39 -173.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.484 HG13 ' CG2' ' A' ' 108' ' ' VAL . 96.2 mt -100.82 100.6 10.71 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.62 0 CA-C-O 121.98 0.895 . . . . 0.0 111.272 -178.553 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -86.27 141.89 28.94 Favored 'General case' 0 C--N 1.295 -1.77 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 172.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.447 HG22 HD13 ' A' ' 102' ' ' LEU . 17.9 m -150.5 143.04 24.47 Favored 'General case' 0 N--CA 1.421 -1.925 0 N-CA-C 112.998 0.74 . . . . 0.0 112.998 -172.561 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.537 ' HD3' ' C ' ' A' ' 126' ' ' LYS . 0.4 OUTLIER -131.07 105.24 7.58 Favored 'General case' 0 N--CA 1.423 -1.798 0 N-CA-C 105.3 -2.111 . . . . 0.0 105.3 168.56 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 7.4 p -113.47 -53.58 5.01 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.441 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 179.193 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 45.5 ttm -114.29 -27.49 7.59 Favored 'General case' 0 N--CA 1.398 -3.059 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 172.295 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 8.5 tp -161.51 171.13 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.551 1.008 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 173.77 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 8.5 m-90 -70.66 117.52 12.28 Favored 'General case' 0 CA--C 1.509 -0.605 0 CA-C-N 118.572 0.623 . . . . 0.0 110.431 179.309 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 88.6 t -147.94 111.04 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.139 0 C-N-CA 122.956 0.502 . . . . 0.0 109.783 179.62 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 54.6 pttt -106.78 114.33 28.36 Favored 'General case' 0 N--CA 1.442 -0.841 0 C-N-CA 119.31 -0.956 . . . . 0.0 109.364 173.523 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 13.5 p 173.57 -21.23 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.296 -1.755 0 N-CA-C 107.362 -1.347 . . . . 0.0 107.362 -178.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' THR . . . . . 0.444 HG22 ' HA3' ' A' ' 148' ' ' GLY . 66.4 p -7.51 88.84 0.0 OUTLIER 'General case' 0 C--N 1.366 1.295 0 C-N-CA 127.921 2.488 . . . . 0.0 114.345 177.89 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' SER . . . . . 0.615 ' OG ' ' HA ' ' A' ' 118' ' ' THR . 30.2 t -101.64 146.43 27.73 Favored 'General case' 0 N--CA 1.408 -2.571 0 CA-C-N 114.252 -1.34 . . . . 0.0 109.978 -176.505 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 8.9 tt -115.36 122.85 70.14 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.567 0 O-C-N 124.136 0.897 . . . . 0.0 109.681 179.464 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 34.7 p -105.77 135.96 46.25 Favored 'General case' 0 N--CA 1.398 -3.051 0 CA-C-O 122.239 1.018 . . . . 0.0 110.306 178.382 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' THR . . . . . 0.62 HG21 ' O ' ' A' ' 115' ' ' GLY . 3.0 t -151.08 175.68 11.88 Favored 'General case' 0 N--CA 1.385 -3.724 0 N-CA-C 105.7 -1.963 . . . . 0.0 105.7 -179.599 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -122.2 33.76 5.37 Favored 'General case' 0 C--N 1.271 -2.827 0 N-CA-C 106.272 -1.751 . . . . 0.0 106.272 177.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . 63.33 46.15 4.59 Favored 'General case' 0 C--N 1.351 0.646 0 CA-C-N 113.971 -1.468 . . . . 0.0 109.274 -176.751 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 36.2 t -178.45 -78.87 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 114.878 -1.055 . . . . 0.0 110.065 -177.702 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 66.2 mttm -88.91 143.72 26.68 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 -178.44 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.516 ' HB ' ' O ' ' A' ' 153' ' ' ARG . 47.6 t -106.86 138.4 32.81 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 CA-C-O 120.899 0.381 . . . . 0.0 111.693 -173.569 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 57.6 m-85 -136.11 141.58 44.19 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 178.463 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 51.5 p90 -66.94 161.87 23.16 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.531 0.681 . . . . 0.0 112.19 177.683 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' THR . . . . . 0.491 ' HB ' ' O ' ' A' ' 135' ' ' SER . 92.7 m -149.0 -58.87 0.22 Allowed 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.298 174.9 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . 0.408 ' HB2' ' HA ' ' A' ' 134' ' ' THR . . . -141.38 137.04 32.01 Favored 'General case' 0 CA--C 1.507 -0.691 0 N-CA-C 110.062 -0.348 . . . . 0.0 110.062 178.803 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . 0.444 ' HA3' HG22 ' A' ' 134' ' ' THR . . . 79.89 -54.59 4.45 Favored Glycine 0 C--O 1.219 -0.817 0 O-C-N 123.539 0.524 . . . . 0.0 113.129 177.585 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 26.4 ttt -60.98 -48.49 81.57 Favored 'General case' 0 C--N 1.3 -1.577 0 C-N-CA 123.159 0.584 . . . . 0.0 109.799 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . 0.257 27.3 mtpp 49.0 17.46 0.16 Allowed 'General case' 0 N--CA 1.486 1.348 0 N-CA-C 115.985 1.846 . . . . 0.0 115.985 177.943 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -143.95 140.98 29.97 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 175.608 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 20.6 p -87.72 111.28 21.16 Favored 'General case' 0 N--CA 1.421 -1.916 0 CA-C-O 121.392 0.615 . . . . 0.0 110.119 177.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' ARG . . . . . 0.516 ' O ' ' HB ' ' A' ' 143' ' ' VAL . 2.6 tpm_? -105.9 105.77 15.97 Favored 'General case' 0 N--CA 1.432 -1.361 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 176.657 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 48.1 m -68.71 146.23 53.14 Favored 'General case' 0 C--N 1.285 -2.209 0 C-N-CA 120.841 -0.344 . . . . 0.0 111.742 -177.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' ARG . . . . . 0.429 ' HA ' ' HA2' ' A' ' 159' ' ' GLY . 29.0 tpt180 -57.81 -31.01 66.17 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-O 121.278 0.561 . . . . 0.0 109.532 175.732 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -47.16 -41.85 18.58 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 114.298 -1.319 . . . . 0.0 112.084 175.583 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -82.41 -53.87 5.66 Favored 'General case' 0 N--CA 1.437 -1.097 0 C-N-CA 120.692 -0.403 . . . . 0.0 111.622 -179.321 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -152.99 -18.97 0.15 Allowed 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 112.815 0.672 . . . . 0.0 112.815 -175.588 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . 0.429 ' HA2' ' HA ' ' A' ' 155' ' ' ARG . . . 107.99 -93.16 0.79 Allowed Glycine 0 N--CA 1.418 -2.555 0 N-CA-C 108.062 -2.015 . . . . 0.0 108.062 -165.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.54 ' HB ' ' HA ' ' A' ' 67' ' ' ILE . 83.8 t -133.57 115.86 23.32 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 CA-C-O 121.705 0.764 . . . . 0.0 110.399 -179.761 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' GLN . . . . . 0.405 ' H ' ' HG2' ' A' ' 153' ' ' ARG . 2.5 mm-40 -134.99 135.31 41.31 Favored 'General case' 0 N--CA 1.412 -2.36 0 N-CA-C 115.158 1.54 . . . . 0.0 115.158 -177.767 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 10.9 tpt180 -150.53 110.52 4.11 Favored 'General case' 0 C--N 1.263 -3.183 0 N-CA-C 101.72 -3.437 . . . . 0.0 101.72 170.197 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -43.71 95.29 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 113.975 1.102 . . . . 0.0 113.975 -169.519 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -157.39 161.09 31.04 Favored Glycine 0 N--CA 1.433 -1.552 0 CA-C-N 114.302 -1.317 . . . . 0.0 110.439 -178.54 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . 0.48 HD11 ' O ' ' A' ' 165' ' ' LEU . 3.5 pp -141.37 139.09 33.44 Favored 'General case' 0 N--CA 1.411 -2.399 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 178.216 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . 0.514 ' HB3' ' O ' ' A' ' 89' ' ' PRO . 0.0 OUTLIER -70.49 134.76 48.03 Favored 'General case' 0 C--N 1.295 -1.778 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 175.869 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 32.7 t -62.11 -31.36 51.13 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.845 0 O-C-N 123.755 0.66 . . . . 0.0 112.681 176.577 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -73.83 77.49 1.61 Allowed 'General case' 0 N--CA 1.485 1.308 0 CA-C-O 122.25 1.024 . . . . 0.0 111.114 174.753 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 19.3 ttpp -152.95 156.39 38.8 Favored 'General case' 0 C--N 1.276 -2.606 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 -178.619 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 170' ' ' PHE . . . . . . . . . . . . . 28.3 p90 . . . . . 0 C--N 1.304 -1.378 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 174.321 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.619 ' O ' ' HG ' ' A' ' 58' ' ' LEU . 3.5 mm? . . . . . 0 N--CA 1.498 1.935 0 N-CA-C 116.658 2.096 . . . . 0.0 116.658 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.493 ' HA ' HD12 ' A' ' 58' ' ' LEU . 26.2 Cg_exo -59.65 -21.09 61.2 Favored 'Trans proline' 0 N--CA 1.426 -2.464 0 C-N-CA 121.275 1.317 . . . . 0.0 112.029 -172.19 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -84.3 -41.39 16.89 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 123.456 0.702 . . . . 0.0 110.73 -179.196 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -69.7 -51.42 34.57 Favored 'General case' 0 CA--C 1.488 -1.407 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.962 178.214 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.619 ' HG ' ' O ' ' A' ' 54' ' ' LEU 0.294 1.7 pp -62.19 -26.77 68.54 Favored 'General case' 0 C--O 1.208 -1.082 0 C-N-CA 119.745 -0.782 . . . . 0.0 111.029 179.284 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.431 ' HB2' ' O ' ' A' ' 55' ' ' PRO . 37.1 ttmt -69.45 -41.52 76.14 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 114.671 -1.15 . . . . 0.0 111.842 174.785 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -80.18 -16.18 55.41 Favored 'General case' 0 N--CA 1.441 -0.908 0 C-N-CA 119.418 -0.913 . . . . 0.0 109.122 -179.49 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 26.0 m-85 -84.29 -31.92 24.64 Favored 'General case' 0 C--N 1.321 -0.644 0 C-N-CA 119.437 -0.905 . . . . 0.0 111.456 177.665 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.489 ' CG ' ' H ' ' A' ' 63' ' ' LEU . 20.7 t70 -87.11 -155.46 0.28 Allowed 'General case' 0 CA--C 1.545 0.773 0 N-CA-C 106.486 -1.672 . . . . 0.0 106.486 173.09 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.491 ' HB2' HD11 ' A' ' 65' ' ' ILE . 13.4 mt -84.03 155.4 64.14 Favored Pre-proline 0 C--N 1.299 -1.618 0 N-CA-C 107.248 -1.39 . . . . 0.0 107.248 -178.685 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -80.61 10.21 3.4 Favored 'Trans proline' 0 N--CA 1.453 -0.868 0 C-N-CA 122.2 1.933 . . . . 0.0 113.27 -166.102 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.589 HG12 ' H ' ' A' ' 67' ' ' ILE . 0.2 OUTLIER -81.34 -26.22 10.31 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.311 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 179.708 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 68.42 9.98 59.22 Favored Glycine 0 C--N 1.357 1.742 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.29 179.808 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.609 ' O ' HG23 ' A' ' 160' ' ' VAL . 55.8 mt 64.3 -68.01 0.14 Allowed 'Isoleucine or valine' 0 C--O 1.181 -2.506 0 C-N-CA 126.259 1.824 . . . . 0.0 111.653 -171.845 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.421 ' HB2' HG23 ' A' ' 160' ' ' VAL . 39.7 t80 -170.58 -57.81 0.0 OUTLIER Pre-proline 0 C--N 1.275 -2.632 0 CA-C-N 118.078 0.399 . . . . 0.0 111.177 -175.409 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.402 ' HG2' ' OD1' ' A' ' 71' ' ' ASP . 8.6 Cg_endo -100.57 -10.41 0.27 Allowed 'Trans proline' 0 N--CA 1.449 -1.116 0 C-N-CA 122.505 2.137 . . . . 0.0 114.793 -172.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 73.83 10.65 80.59 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.369 -0.92 . . . . 0.0 111.561 -175.2 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.442 ' HB2' ' CG ' ' A' ' 89' ' ' PRO . 13.3 p30 -95.96 -50.3 4.93 Favored 'General case' 0 N--CA 1.421 -1.905 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 178.438 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.555 ' O ' ' HB ' ' A' ' 73' ' ' THR . . . -64.01 178.45 0.65 Allowed 'General case' 0 C--N 1.318 -0.77 0 C-N-CA 124.302 1.041 . . . . 0.0 109.08 164.028 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.643 ' O ' HG21 ' A' ' 73' ' ' THR . 65.0 m 84.33 27.89 0.08 Allowed 'General case' 0 C--N 1.349 0.578 0 CA-C-O 124.052 1.882 . . . . 0.0 109.773 171.217 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.634 HD21 ' N ' ' A' ' 74' ' ' ASN . 0.5 OUTLIER -80.93 176.33 9.91 Favored 'General case' 0 C--N 1.288 -2.072 0 C-N-CA 118.002 -1.479 . . . . 0.0 109.803 -178.768 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.446 ' CD2' HD11 ' A' ' 84' ' ' LEU . 13.7 t80 -147.12 109.84 4.66 Favored 'General case' 0 C--N 1.289 -2.051 0 C-N-CA 119.273 -0.971 . . . . 0.0 111.498 -171.387 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -131.24 116.99 18.37 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.988 172.568 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 88.5 t80 -115.03 132.6 56.55 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.007 -173.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.433 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 26.1 m-20 -92.02 178.71 5.8 Favored 'General case' 0 CA--C 1.488 -1.436 0 CA-C-O 121.387 0.613 . . . . 0.0 111.048 -179.447 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -79.74 -74.11 0.31 Allowed 'General case' 0 C--N 1.294 -1.819 0 CA-C-N 114.503 -1.226 . . . . 0.0 112.244 -177.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -92.1 -22.35 19.95 Favored 'General case' 0 CA--C 1.503 -0.862 0 CA-C-N 115.823 -0.626 . . . . 0.0 112.402 -174.798 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.433 ' HB ' ' HB2' ' A' ' 78' ' ' ASP . 59.7 m -68.64 -51.7 39.27 Favored 'General case' 0 N--CA 1.427 -1.602 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.535 178.677 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 98.0 mttt 63.18 2.77 1.15 Allowed 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 124.16 0.984 . . . . 0.0 113.255 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.426 ' HG2' ' CG2' ' A' ' 109' ' ' THR . 35.6 ttmt -94.45 94.53 8.29 Favored 'General case' 0 N--CA 1.427 -1.598 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 173.933 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.446 HD11 ' CD2' ' A' ' 75' ' ' TYR . 6.9 tt -66.15 144.11 56.87 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-N 113.191 -1.822 . . . . 0.0 111.845 -172.37 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.413 ' HA ' ' O ' ' A' ' 108' ' ' VAL . 10.1 t -110.03 125.54 53.03 Favored 'General case' 0 N--CA 1.411 -2.38 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.148 179.212 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 86.1 t -99.53 127.85 51.89 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.363 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.265 178.116 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.568 ' HA ' ' O ' ' A' ' 106' ' ' THR . 1.2 mm? -97.25 142.11 29.54 Favored 'General case' 0 N--CA 1.418 -2.055 0 CA-C-N 113.707 -1.588 . . . . 0.0 109.507 -177.235 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 58.8 mt -137.28 119.96 11.44 Favored Pre-proline 0 C--N 1.252 -3.633 0 CA-C-N 112.854 -1.975 . . . . 0.0 105.685 174.413 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . 0.442 ' CG ' ' HB2' ' A' ' 71' ' ' ASP . 6.2 Cg_exo -22.41 -52.72 0.04 OUTLIER 'Trans proline' 0 C--N 1.37 1.691 1 C-N-CA 126.133 4.555 . . . . 0.0 116.445 -178.769 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 41.3 t -151.55 165.35 34.53 Favored 'General case' 0 N--CA 1.425 -1.695 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 -179.743 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.471 HD11 ' HD2' ' A' ' 103' ' ' LYS . 6.1 tt -72.3 112.38 7.88 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.979 0 CA-C-O 121.647 0.737 . . . . 0.0 110.37 178.41 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' CYS . . . . . 0.535 ' HB3' ' CE2' ' A' ' 104' ' ' PHE . 48.0 t -118.09 128.54 54.85 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 178.625 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -122.33 139.32 53.95 Favored 'General case' 0 C--N 1.292 -1.931 0 C-N-CA 119.218 -0.993 . . . . 0.0 110.158 176.614 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 34.4 m -124.28 106.67 17.2 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.168 -175.219 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.317 -0.518 0 C-N-CA 120.035 -1.079 . . . . 0.0 113.153 176.527 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' SER . . . . . 0.42 ' HA ' ' O ' ' A' ' 126' ' ' LYS . 73.6 p . . . . . 0 N--CA 1.394 -3.248 0 CA-C-O 121.221 0.534 . . . . 0.0 110.692 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 65.1 t -93.65 105.39 16.8 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.069 0 N-CA-C 107.03 -1.47 . . . . 0.0 107.03 172.02 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.416 HD23 ' H ' ' A' ' 126' ' ' LYS . 83.3 mt -118.53 114.63 23.11 Favored 'General case' 0 C--N 1.286 -2.187 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.99 -173.678 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.471 ' HD2' HD11 ' A' ' 91' ' ' ILE . 34.9 ttpt -103.55 113.17 26.47 Favored 'General case' 0 N--CA 1.427 -1.576 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.091 -179.313 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.535 ' CE2' ' HB3' ' A' ' 92' ' ' CYS 0.288 38.9 p90 -111.07 107.72 17.19 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-O 122.191 0.996 . . . . 0.0 112.538 179.467 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' THR . . . . . 0.546 ' H ' HG22 ' A' ' 123' ' ' ILE . 12.2 t -72.11 -175.74 1.57 Allowed 'General case' 0 N--CA 1.436 -1.151 0 CA-C-N 113.843 -1.526 . . . . 0.0 111.958 -177.378 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' THR . . . . . 0.568 ' O ' ' HA ' ' A' ' 87' ' ' LEU . 4.7 t -93.18 -27.64 16.76 Favored 'General case' 0 C--N 1.288 -2.102 0 CA-C-N 114.624 -1.171 . . . . 0.0 112.682 -173.26 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 25.0 m -139.73 95.35 2.9 Favored 'General case' 0 C--N 1.275 -2.672 0 N-CA-C 107.672 -1.232 . . . . 0.0 107.672 -178.478 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.413 ' O ' ' HA ' ' A' ' 85' ' ' THR . 3.4 p -103.83 160.36 4.73 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.52 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 -177.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.426 ' CG2' ' HG2' ' A' ' 83' ' ' LYS . 61.1 m -132.4 120.56 22.18 Favored 'General case' 0 N--CA 1.415 -2.219 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 -169.769 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -163.83 -159.43 10.8 Favored Glycine 0 C--O 1.208 -1.517 0 C-N-CA 120.474 -0.87 . . . . 0.0 113.097 -178.543 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 41.0 m80 -114.59 122.75 47.48 Favored 'General case' 0 CA--C 1.482 -1.664 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 178.47 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.415 HD21 ' HA ' ' A' ' 62' ' ' ASP . 5.2 tt -102.47 110.41 22.35 Favored 'General case' 0 C--N 1.285 -2.228 0 C-N-CA 119.965 -0.694 . . . . 0.0 109.278 -176.237 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -118.77 157.98 26.49 Favored 'General case' 0 CA--C 1.455 -2.678 0 CA-C-O 121.827 0.823 . . . . 0.0 109.445 174.122 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 16.5 mmtp -75.31 101.47 4.72 Favored 'General case' 0 C--N 1.245 -3.936 0 CA-C-O 122.687 1.232 . . . . 0.0 112.567 -178.492 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 121.59 -11.91 9.55 Favored Glycine 0 N--CA 1.411 -2.982 0 CA-C-N 113.195 -1.82 . . . . 0.0 110.021 -177.033 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -172.37 129.94 0.57 Allowed 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 113.363 0.875 . . . . 0.0 113.363 177.752 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.403 ' HB3' ' CG2' ' A' ' 136' ' ' ILE . 59.7 tp -97.39 104.23 16.23 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 106.46 -1.682 . . . . 0.0 106.46 172.664 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.458 ' HA ' ' CB ' ' A' ' 135' ' ' SER . 82.4 p -104.0 172.25 6.9 Favored 'General case' 0 C--N 1.311 -1.074 0 N-CA-C 111.803 0.297 . . . . 0.0 111.803 -173.301 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 57.76 46.17 17.59 Favored 'General case' 0 CA--C 1.496 -1.115 0 O-C-N 123.997 0.811 . . . . 0.0 110.7 172.71 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . 0.263 8.5 m -84.52 77.01 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.414 -2.266 0 CA-C-O 123.224 1.488 . . . . 0.0 111.962 -173.413 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -73.38 89.03 1.59 Allowed 'General case' 0 N--CA 1.394 -3.246 0 CA-C-N 112.287 -2.233 . . . . 0.0 110.293 -177.678 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 160.85 -22.91 0.24 Allowed Glycine 0 N--CA 1.413 -2.895 0 CA-C-N 115.085 -0.961 . . . . 0.0 110.801 176.504 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.546 HG22 ' H ' ' A' ' 105' ' ' THR . 18.6 pt -110.53 141.1 26.85 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.313 0 C-N-CA 119.62 -0.832 . . . . 0.0 111.657 -179.768 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -101.92 126.88 48.92 Favored 'General case' 0 C--N 1.294 -1.821 0 CA-C-N 114.795 -1.093 . . . . 0.0 110.331 177.479 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 97.4 m -115.49 109.74 18.27 Favored 'General case' 0 C--N 1.281 -2.394 0 CA-C-N 114.797 -1.092 . . . . 0.0 109.575 -178.297 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.457 ' HE2' ' C ' ' A' ' 127' ' ' VAL . 6.6 tmtt? -114.56 134.73 54.82 Favored 'General case' 0 N--CA 1.421 -1.878 0 C-N-CA 120.441 -0.503 . . . . 0.0 110.45 174.102 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.457 ' C ' ' HE2' ' A' ' 126' ' ' LYS . 89.7 t -130.19 -57.74 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.289 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 176.242 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 16.9 tpt -115.66 -34.86 4.71 Favored 'General case' 0 C--N 1.291 -1.971 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 173.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 7.8 tp -138.55 155.01 27.73 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.933 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.303 177.016 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 72.6 m95 -79.43 117.51 20.46 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 123.095 0.558 . . . . 0.0 110.872 179.343 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 17.5 m -129.93 157.16 42.54 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 174.107 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 48.0 pttt -126.84 28.48 5.83 Favored 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 -174.348 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 46.1 t -122.07 -83.07 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.15 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 175.472 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' THR . . . . . 0.408 ' HB ' ' H ' ' A' ' 135' ' ' SER . 33.8 p 42.6 -161.71 0.01 OUTLIER 'General case' 0 CA--C 1.559 1.324 0 N-CA-C 114.288 1.218 . . . . 0.0 114.288 -178.54 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' SER . . . . . 0.458 ' CB ' ' HA ' ' A' ' 118' ' ' THR . 89.6 p -171.81 157.75 4.66 Favored 'General case' 0 N--CA 1.414 -2.24 0 N-CA-C 106.801 -1.555 . . . . 0.0 106.801 176.167 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . 0.403 ' CG2' ' HB3' ' A' ' 117' ' ' LEU . 9.7 tt -100.44 113.02 34.87 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.94 0 N-CA-C 106.12 -1.808 . . . . 0.0 106.12 173.284 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 23.3 m -105.04 155.08 19.3 Favored 'General case' 0 N--CA 1.418 -2.074 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.676 -172.115 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' THR . . . . . 0.44 HG23 ' HB3' ' A' ' 63' ' ' LEU . 9.4 t -164.09 166.19 21.57 Favored 'General case' 0 C--N 1.282 -2.333 0 N-CA-C 106.922 -1.51 . . . . 0.0 106.922 178.59 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -111.86 64.77 0.62 Allowed 'General case' 0 C--N 1.268 -2.94 0 C-N-CA 117.682 -1.607 . . . . 0.0 106.808 170.296 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . 50.88 41.64 27.03 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 113.568 -1.651 . . . . 0.0 111.69 -178.036 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' SER . . . . . 0.547 ' O ' ' HD2' ' A' ' 155' ' ' ARG . 47.4 t 171.05 -84.78 0.0 OUTLIER 'General case' 0 C--N 1.346 0.447 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.387 -175.486 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 61.5 pttt -78.91 135.58 37.02 Favored 'General case' 0 CA--C 1.491 -1.326 0 C-N-CA 120.158 -0.617 . . . . 0.0 109.881 -177.31 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 5.3 p -105.52 147.02 11.75 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.91 0 CA-C-O 121.122 0.487 . . . . 0.0 111.474 -166.377 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -139.17 155.91 47.49 Favored 'General case' 0 CA--C 1.499 -0.983 0 CA-C-N 115.417 -0.81 . . . . 0.0 109.935 -179.058 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . 0.423 ' HB2' ' HB2' ' A' ' 151' ' ' LYS . 62.7 m-85 -105.8 114.67 28.96 Favored 'General case' 0 C--N 1.282 -2.345 0 CA-C-N 115.195 -0.912 . . . . 0.0 110.006 172.934 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' THR . . . . . 0.427 HG21 ' OG ' ' A' ' 135' ' ' SER . 8.8 t -70.44 2.79 3.52 Favored 'General case' 0 CA--C 1.554 1.115 0 CA-C-N 114.739 -1.119 . . . . 0.0 113.051 -172.089 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -63.16 -17.04 61.95 Favored 'General case' 0 C--O 1.221 -0.407 0 CA-C-O 121.332 0.587 . . . . 0.0 111.0 -178.259 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 156.3 31.53 0.03 OUTLIER Glycine 0 CA--C 1.492 -1.399 0 N-CA-C 110.107 -1.197 . . . . 0.0 110.107 172.505 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 53.1 ttm 58.83 19.72 7.26 Favored 'General case' 0 C--N 1.361 1.081 0 CA-C-O 122.42 1.105 . . . . 0.0 108.482 -173.099 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . 0.461 ' O ' ' HE3' ' A' ' 151' ' ' LYS . 17.5 ptpt -85.13 1.78 46.43 Favored 'General case' 0 N--CA 1.44 -0.972 0 CA-C-N 114.628 -1.169 . . . . 0.0 113.634 -172.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . 0.461 ' HE3' ' O ' ' A' ' 150' ' ' LYS . 5.1 mmpt? -147.16 118.34 7.78 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 123.218 0.607 . . . . 0.0 109.818 176.247 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 23.7 p -133.01 132.96 42.47 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 177.081 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 25.4 mmt180 -138.7 155.18 48.46 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 122.154 0.181 . . . . 0.0 110.539 179.499 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 70.1 p -79.11 119.91 22.9 Favored 'General case' 0 C--O 1.25 1.086 0 N-CA-C 113.528 0.936 . . . . 0.0 113.528 -175.552 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' ARG . . . . . 0.547 ' HD2' ' O ' ' A' ' 141' ' ' SER . 28.7 ttt180 -71.07 -35.92 72.08 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.073 0.463 . . . . 0.0 111.021 176.327 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -50.11 -41.81 49.22 Favored 'General case' 0 C--N 1.314 -0.943 0 C-N-CA 123.721 0.809 . . . . 0.0 112.528 -175.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -71.1 -52.36 19.79 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.921 -178.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . 0.445 ' HB2' HE22 ' A' ' 161' ' ' GLN . 99.1 m-85 -149.36 -23.13 0.29 Allowed 'General case' 0 N--CA 1.484 1.254 0 N-CA-C 112.028 0.381 . . . . 0.0 112.028 -179.191 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . 0.411 ' CA ' ' HA ' ' A' ' 155' ' ' ARG . . . 128.73 -90.41 0.32 Allowed Glycine 0 N--CA 1.446 -0.646 0 N-CA-C 109.008 -1.637 . . . . 0.0 109.008 -172.901 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.609 HG23 ' O ' ' A' ' 67' ' ' ILE . 22.8 m -98.45 144.78 10.97 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.764 0 N-CA-C 106.285 -1.746 . . . . 0.0 106.285 173.194 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 161' ' ' GLN . . . . . 0.445 HE22 ' HB2' ' A' ' 158' ' ' TYR . 27.1 mm-40 -113.62 90.1 3.26 Favored 'General case' 0 C--N 1.3 -1.572 0 C-N-CA 119.022 -1.071 . . . . 0.0 111.447 -176.526 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -154.75 150.03 27.14 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 173.5 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 50.0 t30 -88.61 104.81 17.2 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-O 121.254 0.55 . . . . 0.0 110.553 177.566 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -142.63 150.51 22.27 Favored Glycine 0 CA--C 1.484 -1.876 0 N-CA-C 108.937 -1.665 . . . . 0.0 108.937 177.561 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -142.74 118.98 10.8 Favored 'General case' 0 N--CA 1.419 -2.018 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 176.784 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.05 136.13 57.1 Favored 'General case' 0 N--CA 1.427 -1.577 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 173.31 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 48.6 t -53.28 -40.66 40.37 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.925 0 O-C-N 123.947 0.78 . . . . 0.0 110.148 175.127 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -86.07 70.79 10.62 Favored 'General case' 0 CA--C 1.503 -0.832 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.598 174.535 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 169' ' ' LYS . . . . . 0.402 ' O ' ' HB2' ' A' ' 170' ' ' PHE . 59.7 tttp -152.93 119.09 5.49 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.411 177.491 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 170' ' ' PHE . . . . . 0.402 ' HB2' ' O ' ' A' ' 169' ' ' LYS . 59.4 t80 . . . . . 0 C--O 1.252 1.194 0 N-CA-C 106.667 -1.605 . . . . 0.0 106.667 174.366 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.67 ' O ' ' HG ' ' A' ' 58' ' ' LEU . 1.8 mm? . . . . . 0 CA--C 1.495 -1.163 0 CA-C-O 118.938 -0.553 . . . . 0.0 111.139 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.506 ' O ' ' HG2' ' A' ' 59' ' ' LYS . 24.7 Cg_exo -60.84 -25.44 81.23 Favored 'Trans proline' 0 C--N 1.386 2.53 0 C-N-CA 121.103 1.202 . . . . 0.0 111.185 -172.581 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -76.18 -47.69 23.23 Favored 'General case' 0 N--CA 1.433 -1.303 0 CA-C-N 114.884 -1.053 . . . . 0.0 109.031 179.681 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.407 ' HA ' ' HG2' ' A' ' 60' ' ' GLU . 52.1 tp -63.83 -48.86 75.11 Favored 'General case' 0 C--N 1.313 -1.021 0 C-N-CA 124.562 1.145 . . . . 0.0 111.497 -179.164 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.67 ' HG ' ' O ' ' A' ' 54' ' ' LEU 0.339 2.4 pp -67.1 -33.85 76.36 Favored 'General case' 0 N--CA 1.428 -1.547 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 -177.995 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.506 ' HG2' ' O ' ' A' ' 55' ' ' PRO . 23.1 pttp -76.56 -30.9 57.26 Favored 'General case' 0 C--O 1.222 -0.367 0 C-N-CA 119.442 -0.903 . . . . 0.0 111.875 175.363 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.407 ' HG2' ' HA ' ' A' ' 57' ' ' LEU . 12.7 pt-20 -76.69 -40.18 49.65 Favored 'General case' 0 CA--C 1.509 -0.601 0 C-N-CA 120.038 -0.665 . . . . 0.0 111.737 -177.368 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 27.7 m-85 -68.64 -19.37 64.41 Favored 'General case' 0 C--O 1.24 0.582 0 C-N-CA 119.0 -1.08 . . . . 0.0 113.035 174.3 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.476 ' O ' ' HE3' ' A' ' 114' ' ' LYS . 12.1 t0 -95.39 176.12 6.31 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.132 178.267 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.51 ' HB2' HD13 ' A' ' 65' ' ' ILE . 13.8 mt -71.39 179.81 0.88 Allowed Pre-proline 0 CA--C 1.577 1.985 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 -177.184 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_endo -88.03 12.66 2.79 Favored 'Trans proline' 0 N--CA 1.45 -1.035 0 C-N-CA 122.211 1.941 . . . . 0.0 111.801 -175.613 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.594 HG12 ' H ' ' A' ' 67' ' ' ILE . 0.2 OUTLIER -68.84 -42.02 82.46 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 178.017 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 58.87 8.79 6.16 Favored Glycine 0 N--CA 1.496 2.644 0 CA-C-O 121.956 0.753 . . . . 0.0 112.163 -176.412 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.594 ' H ' HG12 ' A' ' 65' ' ' ILE . 62.6 mt 56.63 -70.05 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.192 -1.973 0 C-N-CA 128.294 2.638 . . . . 0.0 112.307 -173.544 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.445 ' HB3' ' HD3' ' A' ' 69' ' ' PRO . 88.2 t80 175.2 -61.24 0.0 OUTLIER Pre-proline 0 CA--C 1.543 0.692 0 N-CA-C 112.762 0.653 . . . . 0.0 112.762 -174.539 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.445 ' HD3' ' HB3' ' A' ' 68' ' ' PHE . 3.4 Cg_endo -84.49 -21.23 3.62 Favored 'Trans proline' 0 N--CA 1.447 -1.232 0 C-N-CA 121.409 1.406 . . . . 0.0 114.584 -168.004 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 83.38 -11.5 55.28 Favored Glycine 0 C--O 1.224 -0.497 0 N-CA-C 111.006 -0.837 . . . . 0.0 111.006 -175.576 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.524 ' HB3' ' HG2' ' A' ' 89' ' ' PRO . 20.1 m-20 -83.21 -42.0 17.77 Favored 'General case' 0 N--CA 1.438 -1.038 0 N-CA-C 105.587 -2.005 . . . . 0.0 105.587 177.955 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.518 ' O ' ' HB ' ' A' ' 73' ' ' THR . . . -75.89 -178.35 4.27 Favored 'General case' 0 CA--C 1.546 0.793 0 CA-C-N 113.695 -1.593 . . . . 0.0 109.719 175.217 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.598 ' O ' HG21 ' A' ' 73' ' ' THR . 41.3 m 84.44 26.11 0.09 Allowed 'General case' 0 N--CA 1.49 1.554 0 CA-C-O 124.544 2.116 . . . . 0.0 110.178 175.131 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.607 HD21 ' N ' ' A' ' 74' ' ' ASN . 0.7 OUTLIER -81.07 136.86 36.0 Favored 'General case' 0 C--N 1.272 -2.791 0 CA-C-N 114.527 -1.215 . . . . 0.0 110.16 -178.988 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 43.1 t80 -113.11 90.2 3.28 Favored 'General case' 0 C--N 1.277 -2.552 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.693 -169.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.531 ' O ' HD21 ' A' ' 84' ' ' LEU . 13.2 mm-40 -122.85 150.98 42.16 Favored 'General case' 0 C--O 1.202 -1.415 0 N-CA-C 106.934 -1.506 . . . . 0.0 106.934 179.073 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 46.8 p90 -146.89 144.26 29.13 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-N 119.514 1.052 . . . . 0.0 111.334 176.804 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.472 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 10.8 m-20 -92.01 165.83 13.0 Favored 'General case' 0 CA--C 1.481 -1.705 0 CA-C-O 121.258 0.551 . . . . 0.0 109.542 -178.341 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.406 ' O ' ' HG3' ' A' ' 82' ' ' LYS . 48.8 mt-10 -82.35 -43.79 16.98 Favored 'General case' 0 C--N 1.281 -2.383 0 CA-C-N 114.859 -1.064 . . . . 0.0 112.414 176.25 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -65.25 -33.09 75.18 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 122.62 1.2 . . . . 0.0 109.424 -179.81 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.543 ' CG2' ' HG2' ' A' ' 83' ' ' LYS . 29.7 m -85.23 -52.96 5.55 Favored 'General case' 0 N--CA 1.404 -2.766 0 CA-C-N 113.04 -1.891 . . . . 0.0 110.54 -178.056 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.406 ' HG3' ' O ' ' A' ' 79' ' ' GLU . 62.9 mttp 64.16 8.85 4.32 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 124.211 1.004 . . . . 0.0 109.892 -173.152 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.543 ' HG2' ' CG2' ' A' ' 81' ' ' THR 0.25 14.1 pttt -117.48 146.99 43.14 Favored 'General case' 0 N--CA 1.404 -2.773 0 CA-C-N 114.612 -1.176 . . . . 0.0 109.156 -177.459 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.531 HD21 ' O ' ' A' ' 76' ' ' GLU . 1.8 tm? -73.96 130.19 39.37 Favored 'General case' 0 C--N 1.279 -2.481 0 CA-C-N 115.288 -0.869 . . . . 0.0 111.82 -167.26 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.417 ' HA ' ' O ' ' A' ' 108' ' ' VAL . 74.5 p -111.3 111.95 23.37 Favored 'General case' 0 N--CA 1.411 -2.399 0 CA-C-N 114.892 -1.049 . . . . 0.0 109.063 177.549 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.548 ' HA ' ' O ' ' A' ' 74' ' ' ASN . 86.2 t -91.19 122.46 42.62 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.253 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 177.546 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.506 ' HA ' ' O ' ' A' ' 106' ' ' THR 0.388 1.0 OUTLIER -104.04 102.46 12.22 Favored 'General case' 0 N--CA 1.389 -3.483 0 CA-C-O 122.923 1.344 . . . . 0.0 112.782 -179.042 . . . . . . . . 4 4 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.473 ' O ' HG22 ' A' ' 106' ' ' THR . 69.0 mt -85.56 128.54 58.62 Favored Pre-proline 0 C--N 1.279 -2.487 0 CA-C-N 113.038 -1.892 . . . . 0.0 108.888 -176.824 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . 0.524 ' HG2' ' HB3' ' A' ' 71' ' ' ASP . 50.6 Cg_exo -61.97 109.71 0.86 Allowed 'Trans proline' 0 CA--C 1.504 -0.988 0 C-N-CA 122.708 2.272 . . . . 0.0 110.563 177.926 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 30.4 t 69.26 179.55 0.24 Allowed 'General case' 0 CA--C 1.552 1.037 0 O-C-N 124.019 0.824 . . . . 0.0 110.357 -177.494 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.518 HD13 ' HG3' ' A' ' 103' ' ' LYS . 0.0 OUTLIER -112.58 132.35 61.58 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.784 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.007 177.692 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' CYS . . . . . 0.616 ' SG ' ' HB2' ' A' ' 104' ' ' PHE . 28.1 p -112.28 124.42 52.42 Favored 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 175.618 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.439 ' OE1' ' HE2' ' A' ' 103' ' ' LYS . 35.9 tt0 -124.2 129.72 51.29 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 178.823 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.549 ' O ' ' HA ' ' A' ' 101' ' ' VAL . 20.8 m -122.36 114.63 43.31 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.994 0 CA-C-O 121.234 0.54 . . . . 0.0 111.074 179.132 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.427 -1.941 0 N-CA-C 108.332 -1.907 . . . . 0.0 108.332 178.107 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 31.1 p . . . . . 0 N--CA 1.398 -3.039 0 CA-C-O 121.221 0.534 . . . . 0.0 110.555 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.549 ' HA ' ' O ' ' A' ' 94' ' ' VAL . 17.2 m -125.9 101.09 7.62 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 CA-C-N 115.079 -0.964 . . . . 0.0 108.89 172.154 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.585 ' HG ' ' OG1' ' A' ' 125' ' ' THR . 5.4 mp -123.45 125.69 45.4 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.829 -173.467 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.518 ' HG3' HD13 ' A' ' 91' ' ' ILE . 39.3 ttmt -112.46 113.1 25.11 Favored 'General case' 0 C--N 1.317 -0.82 0 O-C-N 123.127 0.267 . . . . 0.0 110.371 176.738 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.616 ' HB2' ' SG ' ' A' ' 92' ' ' CYS . 96.1 m-85 -103.67 98.94 8.73 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 175.315 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 87.1 m -74.37 159.96 31.66 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 115.095 -0.957 . . . . 0.0 111.378 -178.173 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' THR . . . . . 0.506 ' O ' ' HA ' ' A' ' 87' ' ' LEU . 90.2 m -57.93 -67.94 0.29 Allowed 'General case' 0 N--CA 1.431 -1.381 0 C-N-CA 124.665 1.186 . . . . 0.0 111.373 178.616 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 37.4 p -96.12 90.23 5.45 Favored 'General case' 0 N--CA 1.431 -1.4 0 C-N-CA 119.512 -0.875 . . . . 0.0 111.961 179.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.417 ' O ' ' HA ' ' A' ' 85' ' ' THR . 17.6 m -95.17 132.21 39.82 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 CA-C-N 115.538 -0.756 . . . . 0.0 109.649 176.443 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 30.3 m -114.94 120.06 38.64 Favored 'General case' 0 N--CA 1.413 -2.29 0 N-CA-C 108.712 -0.848 . . . . 0.0 108.712 -173.648 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . 0.542 ' HA2' ' O ' ' A' ' 119' ' ' ASP . . . -150.99 161.79 29.18 Favored Glycine 0 N--CA 1.435 -1.393 0 C-N-CA 121.132 -0.556 . . . . 0.0 111.967 -177.626 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 84.2 t60 -84.81 90.8 7.84 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 178.524 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.453 ' HB2' HD12 ' A' ' 117' ' ' LEU . 5.4 tt -89.52 107.81 19.29 Favored 'General case' 0 N--CA 1.417 -2.1 0 N-CA-C 106.649 -1.611 . . . . 0.0 106.649 179.218 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -108.36 153.12 23.72 Favored 'General case' 0 N--CA 1.385 -3.705 0 N-CA-C 104.655 -2.35 . . . . 0.0 104.655 174.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . 0.476 ' HE3' ' O ' ' A' ' 62' ' ' ASP . 21.4 tptm -75.2 101.5 4.65 Favored 'General case' 0 C--N 1.277 -2.566 0 C-N-CA 117.781 -1.568 . . . . 0.0 109.015 -176.221 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . 0.447 ' O ' HG21 ' A' ' 138' ' ' THR . . . 140.64 -24.42 2.62 Favored Glycine 0 C--O 1.19 -2.649 0 CA-C-N 114.043 -1.435 . . . . 0.0 110.236 -175.228 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 19.7 ptmt -173.98 151.2 1.71 Allowed 'General case' 0 N--CA 1.492 1.632 0 CA-C-N 117.643 0.721 . . . . 0.0 111.919 -179.038 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.466 ' HB3' ' CG2' ' A' ' 136' ' ' ILE . 27.3 tp -118.07 105.35 11.76 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 178.729 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 33.4 p -109.31 144.84 36.93 Favored 'General case' 0 C--N 1.295 -1.787 0 N-CA-C 113.681 0.993 . . . . 0.0 113.681 -176.26 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . 0.542 ' O ' ' HA2' ' A' ' 110' ' ' GLY . 31.5 m-20 60.81 94.06 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 124.885 1.274 . . . . 0.0 111.131 177.447 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 11.2 m -116.53 91.09 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.425 -1.715 0 CA-C-O 122.493 1.139 . . . . 0.0 113.009 -173.284 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -66.77 103.43 1.11 Allowed 'General case' 0 C--N 1.29 -1.999 0 CA-C-N 113.785 -1.552 . . . . 0.0 110.251 175.697 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 139.6 -20.68 2.92 Favored Glycine 0 N--CA 1.432 -1.607 0 CA-C-N 115.11 -0.95 . . . . 0.0 112.008 178.736 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 73.9 mt -101.56 108.17 23.02 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 CA-C-O 120.937 0.399 . . . . 0.0 110.267 -179.333 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 29.0 ttpp -101.23 130.93 47.44 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 176.033 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.585 ' OG1' ' HG ' ' A' ' 102' ' ' LEU . 15.1 t -157.53 163.81 38.01 Favored 'General case' 0 C--N 1.302 -1.498 0 C-N-CA 120.27 -0.572 . . . . 0.0 110.217 -175.822 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.409 ' HB2' ' CD1' ' A' ' 130' ' ' TRP . 74.3 tttt -127.51 142.83 51.28 Favored 'General case' 0 C--N 1.276 -2.609 0 CA-C-N 115.52 -0.763 . . . . 0.0 109.354 174.964 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.401 HG13 ' CB ' ' A' ' 150' ' ' LYS . 83.6 t -110.92 -78.93 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.421 -1.918 0 N-CA-C 107.227 -1.398 . . . . 0.0 107.227 167.679 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' MET . . . . . 0.488 ' C ' HD13 ' A' ' 129' ' ' ILE . 26.3 ttt -105.49 -32.16 8.65 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 176.287 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . 0.488 HD13 ' C ' ' A' ' 128' ' ' MET . 2.7 mp -130.83 154.42 40.66 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.747 0 N-CA-C 107.057 -1.461 . . . . 0.0 107.057 175.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' TRP . . . . . 0.409 ' CD1' ' HB2' ' A' ' 126' ' ' LYS . 12.7 m-90 -70.95 134.12 46.95 Favored 'General case' 0 C--O 1.242 0.696 0 CA-C-O 120.845 0.355 . . . . 0.0 110.969 178.895 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 3.7 m -135.34 162.5 37.7 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 C-N-CA 123.803 0.841 . . . . 0.0 111.282 177.79 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . 0.458 ' HZ2' ' HB3' ' A' ' 132' ' ' LYS . 0.1 OUTLIER -137.77 9.87 2.86 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 112.265 0.468 . . . . 0.0 112.265 -175.673 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 59.1 t -118.12 -69.12 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 C-N-CA 120.307 -0.557 . . . . 0.0 110.04 178.664 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 76.4 p 54.96 -178.6 0.03 OUTLIER 'General case' 0 C--O 1.247 0.944 0 N-CA-C 114.987 1.477 . . . . 0.0 114.987 177.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 36.1 p -164.96 146.84 7.94 Favored 'General case' 0 N--CA 1.422 -1.861 0 CA-C-N 114.955 -1.02 . . . . 0.0 109.056 177.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . 0.466 ' CG2' ' HB3' ' A' ' 117' ' ' LEU . 10.7 tt -113.68 107.95 24.25 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 175.377 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 33.3 p -100.6 148.93 24.27 Favored 'General case' 0 N--CA 1.398 -3.042 0 CA-C-O 121.713 0.768 . . . . 0.0 110.926 -177.166 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' THR . . . . . 0.447 HG21 ' O ' ' A' ' 115' ' ' GLY . 6.1 t -165.31 176.12 8.61 Favored 'General case' 0 N--CA 1.4 -2.958 0 N-CA-C 106.765 -1.569 . . . . 0.0 106.765 -176.778 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -115.26 29.05 8.28 Favored 'General case' 0 C--N 1.277 -2.544 0 N-CA-C 105.859 -1.904 . . . . 0.0 105.859 172.567 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . 66.04 54.72 0.97 Allowed 'General case' 0 C--O 1.242 0.685 0 CA-C-N 113.886 -1.507 . . . . 0.0 107.321 -171.497 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 44.4 t -168.0 -81.41 0.02 OUTLIER 'General case' 0 N--CA 1.443 -0.785 0 CA-C-N 114.405 -1.271 . . . . 0.0 111.327 -174.772 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -95.59 150.03 20.79 Favored 'General case' 0 C--O 1.203 -1.383 0 C-N-CA 122.913 0.485 . . . . 0.0 110.477 -176.429 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.659 ' HB ' ' O ' ' A' ' 153' ' ' ARG . 67.8 t -105.65 114.48 45.19 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.118 0 CA-C-O 121.749 0.785 . . . . 0.0 112.477 -173.081 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 82.0 m-85 -117.89 113.29 21.53 Favored 'General case' 0 N--CA 1.422 -1.858 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 174.469 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 69.2 t80 -83.37 106.7 15.34 Favored 'General case' 0 C--N 1.288 -2.08 0 N-CA-C 108.582 -0.895 . . . . 0.0 108.582 -177.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . 0.406 5.6 p -86.52 78.1 9.28 Favored 'General case' 0 N--CA 1.389 -3.517 0 N-CA-C 116.658 2.095 . . . . 0.0 116.658 -173.802 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -126.7 76.17 1.61 Allowed 'General case' 0 N--CA 1.417 -2.124 0 N-CA-C 104.737 -2.32 . . . . 0.0 104.737 168.115 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 78.75 7.12 88.38 Favored Glycine 0 N--CA 1.441 -1.027 0 CA-C-N 114.195 -1.366 . . . . 0.0 111.274 -174.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' MET . . . . . 0.413 ' O ' ' HG2' ' A' ' 149' ' ' MET . 27.3 ttt 63.67 15.75 9.19 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 124.538 1.135 . . . . 0.0 109.397 -175.682 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . 0.401 ' CB ' HG13 ' A' ' 127' ' ' VAL . 64.3 mttp -66.21 -26.95 67.62 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 114.993 -1.003 . . . . 0.0 113.476 -175.24 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . 0.522 ' HA ' ' HE2' ' A' ' 151' ' ' LYS . 8.2 mmpt? -114.13 136.73 52.61 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.012 0.434 . . . . 0.0 110.472 179.247 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 43.3 m -132.18 126.26 33.18 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 178.58 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' ARG . . . . . 0.659 ' O ' ' HB ' ' A' ' 143' ' ' VAL . 7.0 tpm_? -133.37 108.46 8.71 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 -176.86 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 16.2 m -61.08 128.96 38.99 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 175.524 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' ARG . . . . . 0.437 ' HD3' ' C ' ' A' ' 155' ' ' ARG . 2.5 tmt_? -59.24 -29.47 67.56 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 123.516 0.727 . . . . 0.0 109.299 -179.664 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -41.1 -41.12 1.66 Allowed 'General case' 0 C--N 1.314 -0.936 0 C-N-CA 125.615 1.566 . . . . 0.0 113.735 178.286 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -57.45 -53.11 61.84 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -176.397 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -178.88 20.46 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.172 0 N-CA-C 107.721 -1.214 . . . . 0.0 107.721 -179.202 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . 0.488 ' HA3' ' O ' ' A' ' 65' ' ' ILE . . . 95.85 -98.21 2.19 Favored Glycine 0 N--CA 1.405 -3.429 0 N-CA-C 108.901 -1.679 . . . . 0.0 108.901 -170.631 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.439 ' CG2' ' HB ' ' A' ' 65' ' ' ILE . 3.5 t -121.99 114.14 41.61 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.769 0 N-CA-C 105.793 -1.928 . . . . 0.0 105.793 176.385 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -132.51 98.3 4.32 Favored 'General case' 0 C--N 1.29 -2.02 0 C-N-CA 118.033 -1.467 . . . . 0.0 110.295 -171.012 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 39.8 ttm180 -153.26 100.61 2.47 Favored 'General case' 0 N--CA 1.428 -1.544 0 C-N-CA 120.441 -0.504 . . . . 0.0 109.89 170.816 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 51.41 -33.55 0.01 OUTLIER 'General case' 0 N--CA 1.509 2.477 0 N-CA-C 119.179 3.029 . . . . 0.0 119.179 171.415 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -60.75 111.39 3.7 Favored Glycine 0 C--N 1.315 -0.637 0 N-CA-C 115.647 1.019 . . . . 0.0 115.647 -173.637 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 44.9 tp -124.22 118.78 27.61 Favored 'General case' 0 N--CA 1.425 -1.681 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 176.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . 0.43 ' HB3' ' O ' ' A' ' 89' ' ' PRO . 6.3 mpt_? -78.14 117.6 19.58 Favored 'General case' 0 CA--C 1.479 -1.771 0 CA-C-O 121.112 0.482 . . . . 0.0 110.196 -177.531 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 4.3 m -78.05 62.34 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.947 0 CA-C-O 122.3 1.048 . . . . 0.0 113.233 179.145 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -111.65 -21.7 11.57 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 106.871 -1.529 . . . . 0.0 106.871 172.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 23.7 ttmm -91.12 101.92 14.66 Favored 'General case' 0 N--CA 1.425 -1.715 0 CA-C-N 113.551 -1.658 . . . . 0.0 110.413 -175.642 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 170' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 . . . . . 0 C--N 1.309 -1.193 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 177.268 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.503 ' O ' HD12 ' A' ' 58' ' ' LEU . 19.0 mt . . . . . 0 N--CA 1.475 0.789 0 N-CA-C 113.724 1.009 . . . . 0.0 113.724 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_exo -62.98 -15.57 48.64 Favored 'Trans proline' 0 C--N 1.372 1.795 0 C-N-CA 121.577 1.518 . . . . 0.0 113.068 -168.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 15.2 mm-40 -78.9 -36.97 41.14 Favored 'General case' 0 N--CA 1.423 -1.813 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 -174.083 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -76.05 -32.58 59.38 Favored 'General case' 0 N--CA 1.431 -1.397 0 CA-C-N 115.019 -0.991 . . . . 0.0 110.74 176.699 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.533 ' HG ' ' CE1' ' A' ' 75' ' ' TYR 0.253 4.6 mp -71.12 -44.21 66.08 Favored 'General case' 0 CA--C 1.487 -1.462 0 C-N-CA 120.346 -0.542 . . . . 0.0 111.722 -177.824 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.41 -25.79 66.93 Favored 'General case' 0 C--O 1.218 -0.579 0 CA-C-O 122.536 1.16 . . . . 0.0 109.972 176.432 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 18.5 tt0 -71.97 -28.58 63.52 Favored 'General case' 0 N--CA 1.428 -1.562 0 CA-C-N 114.024 -1.444 . . . . 0.0 112.251 175.807 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 72.6 t80 -83.74 -36.31 23.75 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 176.084 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 55.4 t0 -78.4 -171.05 2.27 Favored 'General case' 0 C--O 1.255 1.363 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 177.698 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.479 ' HB2' HD12 ' A' ' 65' ' ' ILE . 7.0 mt -82.82 -178.9 1.29 Allowed Pre-proline 0 CA--C 1.575 1.923 0 N-CA-C 106.384 -1.709 . . . . 0.0 106.384 179.4 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.464 ' HD3' ' HB3' ' A' ' 63' ' ' LEU . 3.4 Cg_endo -89.66 16.74 1.69 Allowed 'Trans proline' 0 N--CA 1.451 -1.011 0 CA-C-N 121.752 1.662 . . . . 0.0 110.669 -173.485 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.565 ' O ' ' HA3' ' A' ' 159' ' ' GLY . 0.2 OUTLIER -72.64 -38.05 57.76 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.867 0 CA-C-N 114.73 -1.123 . . . . 0.0 109.29 -179.107 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 59.09 4.34 2.35 Favored Glycine 0 N--CA 1.484 1.839 0 CA-C-N 115.495 -0.775 . . . . 0.0 112.769 -177.661 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.541 ' H ' HG12 ' A' ' 65' ' ' ILE . 20.3 mt 65.66 -68.65 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.224 0 C-N-CA 127.663 2.385 . . . . 0.0 112.025 -176.837 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.568 ' HA ' ' CD2' ' A' ' 158' ' ' TYR . 70.5 t80 169.34 -52.87 0.0 OUTLIER Pre-proline 0 C--N 1.322 -0.619 0 C-N-CA 124.013 0.925 . . . . 0.0 110.192 179.657 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.442 ' HB3' ' CZ ' ' A' ' 166' ' ' ARG . 7.1 Cg_exo -81.29 143.48 13.97 Favored 'Trans proline' 0 C--N 1.369 1.637 0 C-N-CA 121.636 1.558 . . . . 0.0 110.229 177.444 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -71.85 -17.13 76.64 Favored Glycine 0 C--N 1.314 -0.644 0 C-N-CA 121.177 -0.535 . . . . 0.0 113.061 -177.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -90.7 -10.69 42.16 Favored 'General case' 0 C--O 1.201 -1.449 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 179.531 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.602 ' HA ' ' O ' ' A' ' 87' ' ' LEU . . . -82.89 -171.48 3.57 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.147 173.21 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.602 HG22 ' O ' ' A' ' 72' ' ' ALA . 6.0 t 72.39 26.9 2.54 Favored 'General case' 0 N--CA 1.501 2.121 0 C-N-CA 126.184 1.794 . . . . 0.0 109.53 169.2 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 28.2 m-80 -87.53 -169.48 2.62 Favored 'General case' 0 N--CA 1.417 -2.076 0 CA-C-N 113.599 -1.637 . . . . 0.0 108.852 -179.746 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.533 ' CE1' ' HG ' ' A' ' 58' ' ' LEU . 49.9 p90 -158.98 119.71 3.25 Favored 'General case' 0 C--N 1.311 -1.106 0 C-N-CA 118.889 -1.125 . . . . 0.0 113.649 -176.623 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.683 ' O ' HG23 ' A' ' 85' ' ' THR . 51.8 mt-10 -146.55 92.2 2.13 Favored 'General case' 0 CA--C 1.577 2.001 0 N-CA-C 114.58 1.326 . . . . 0.0 114.58 175.365 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.544 ' HB2' ' N ' ' A' ' 84' ' ' LEU 0.437 30.3 m-85 -169.45 154.76 5.84 Favored 'General case' 0 N--CA 1.506 2.362 0 C-N-CA 128.105 2.562 . . . . 0.0 110.894 165.859 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.454 ' HB2' ' HB ' ' A' ' 81' ' ' THR 0.259 8.3 m-20 -50.99 142.96 11.06 Favored 'General case' 0 CA--C 1.48 -1.748 0 CA-C-O 122.074 0.94 . . . . 0.0 110.42 -179.874 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -81.11 -31.23 34.37 Favored 'General case' 1 C--N 1.24 -4.185 0 CA-C-N 113.867 -1.515 . . . . 0.0 111.753 178.493 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -65.9 -30.08 70.62 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 122.227 1.013 . . . . 0.0 108.626 177.227 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.454 ' HB ' ' HB2' ' A' ' 78' ' ' ASP . 95.5 m -78.73 -39.13 37.13 Favored 'General case' 0 N--CA 1.414 -2.268 0 CA-C-N 113.5 -1.682 . . . . 0.0 109.571 177.546 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.53 ' HA ' ' CE ' ' A' ' 82' ' ' LYS . 3.3 mmpt? 71.95 15.29 5.7 Favored 'General case' 0 CA--C 1.494 -1.188 0 C-N-CA 124.067 0.947 . . . . 0.0 112.864 -177.492 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.478 ' O ' ' HB2' ' A' ' 84' ' ' LEU . 37.2 ttpt -93.81 173.02 7.88 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 104.212 -2.514 . . . . 0.0 104.212 172.299 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.544 ' N ' ' HB2' ' A' ' 77' ' ' PHE . 20.8 tp 176.24 121.93 0.03 OUTLIER 'General case' 0 CA--C 1.475 -1.912 0 CA-C-N 119.134 0.879 . . . . 0.0 108.99 -169.181 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.683 HG23 ' O ' ' A' ' 76' ' ' GLU . 14.5 t -92.2 129.93 38.03 Favored 'General case' 0 N--CA 1.392 -3.344 0 C-N-CA 118.976 -1.09 . . . . 0.0 108.252 174.537 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 62.3 t -103.92 116.61 48.01 Favored 'Isoleucine or valine' 0 N--CA 1.4 -2.975 0 CA-C-N 115.264 -0.88 . . . . 0.0 108.655 179.623 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.602 ' O ' ' HA ' ' A' ' 72' ' ' ALA . 2.0 mm? -75.1 123.16 24.72 Favored 'General case' 0 N--CA 1.41 -2.456 0 CA-C-N 113.783 -1.553 . . . . 0.0 110.673 -176.337 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 74.8 mt -107.51 137.16 19.6 Favored Pre-proline 0 C--N 1.281 -2.375 0 N-CA-C 105.225 -2.139 . . . . 0.0 105.225 170.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . 0.456 ' O ' ' HB2' ' A' ' 166' ' ' ARG . 17.9 Cg_endo -58.21 84.87 0.05 OUTLIER 'Trans proline' 0 CA--C 1.541 0.825 0 C-N-CA 123.275 2.65 . . . . 0.0 112.523 178.175 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 24.2 m 69.33 163.89 0.24 Allowed 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 125.489 1.516 . . . . 0.0 112.46 -179.385 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 9.3 tt -62.82 135.34 27.34 Favored 'Isoleucine or valine' 0 C--O 1.242 0.69 0 CA-C-O 121.361 0.601 . . . . 0.0 109.864 177.383 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' CYS . . . . . 0.515 ' SG ' ' HB2' ' A' ' 104' ' ' PHE . 3.7 p -132.76 139.17 47.45 Favored 'General case' 0 C--N 1.282 -2.332 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.916 -179.295 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -119.79 142.41 48.62 Favored 'General case' 0 CA--C 1.454 -2.735 0 N-CA-C 106.048 -1.834 . . . . 0.0 106.048 178.637 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.411 ' HB ' ' CD2' ' A' ' 102' ' ' LEU . 17.9 t -118.49 104.38 16.0 Favored 'Isoleucine or valine' 0 N--CA 1.392 -3.365 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 -175.649 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.418 -2.549 0 N-CA-C 109.469 -1.453 . . . . 0.0 109.469 176.875 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 36.4 t . . . . . 0 N--CA 1.408 -2.566 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 9.5 p -119.23 140.4 43.31 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 177.818 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.482 ' N ' HD21 ' A' ' 102' ' ' LEU . 0.4 OUTLIER -151.72 167.08 29.32 Favored 'General case' 0 C--N 1.294 -1.843 0 N-CA-C 112.641 0.608 . . . . 0.0 112.641 -171.364 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -142.59 129.13 20.22 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.413 0.625 . . . . 0.0 111.63 -175.703 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.515 ' HB2' ' SG ' ' A' ' 92' ' ' CYS . 61.0 m-85 -109.86 122.03 46.6 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 178.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' THR . . . . . 0.441 HG23 ' H ' ' A' ' 107' ' ' THR . 32.0 m -71.23 151.7 44.04 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 178.623 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 8.3 m -52.47 -38.5 59.53 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.967 0.907 . . . . 0.0 109.838 176.52 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.441 ' H ' HG23 ' A' ' 105' ' ' THR . 68.2 p -121.42 99.66 6.6 Favored 'General case' 0 N--CA 1.425 -1.678 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.144 179.021 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.531 ' O ' ' HA ' ' A' ' 85' ' ' THR . 61.9 t -99.65 138.22 24.69 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.285 0 N-CA-C 106.779 -1.563 . . . . 0.0 106.779 174.137 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.432 ' HA ' ' O ' ' A' ' 84' ' ' LEU . 9.1 t -125.8 137.13 53.76 Favored 'General case' 0 N--CA 1.395 -3.222 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 -175.814 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -157.16 176.98 34.24 Favored Glycine 0 N--CA 1.403 -3.529 0 C-N-CA 119.834 -1.174 . . . . 0.0 112.053 179.674 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' HIS . . . . . 0.495 ' HA ' ' O ' ' A' ' 82' ' ' LYS . 10.5 t60 -86.81 93.24 9.23 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 178.808 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.444 HD13 HD21 ' A' ' 84' ' ' LEU . 7.2 tt -97.98 120.41 38.32 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-O 121.656 0.741 . . . . 0.0 110.841 -174.062 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . 0.5 ' OE1' ' HE2' ' A' ' 116' ' ' LYS . 44.4 mt-10 -123.41 -177.06 3.6 Favored 'General case' 0 CA--C 1.457 -2.611 0 CA-C-N 114.667 -1.151 . . . . 0.0 108.973 175.05 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . 0.42 ' HD3' ' HA ' ' A' ' 114' ' ' LYS . 29.4 mmtt -83.07 101.84 11.4 Favored 'General case' 1 N--CA 1.371 -4.412 0 CA-C-N 114.834 -1.076 . . . . 0.0 113.536 179.926 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 125.27 -45.1 1.19 Allowed Glycine 0 N--CA 1.406 -3.336 0 CA-C-N 113.148 -1.842 . . . . 0.0 110.425 178.1 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.5 ' HE2' ' OE1' ' A' ' 113' ' ' GLU . 0.3 OUTLIER -135.2 147.59 49.41 Favored 'General case' 0 C--N 1.313 -0.984 0 C-N-CA 123.102 0.561 . . . . 0.0 112.492 -178.151 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.2 tt -120.64 105.06 10.43 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 105.346 -2.094 . . . . 0.0 105.346 178.079 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.498 ' HA ' ' OG ' ' A' ' 135' ' ' SER . 44.9 p -100.89 135.53 42.19 Favored 'General case' 0 C--N 1.267 -2.995 0 N-CA-C 114.465 1.283 . . . . 0.0 114.465 -172.174 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 64.92 97.47 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 125.235 1.414 . . . . 0.0 111.586 -179.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 6.1 m -104.52 93.53 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.018 0 CA-C-O 122.764 1.269 . . . . 0.0 111.348 -177.041 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -82.86 95.03 7.81 Favored 'General case' 0 N--CA 1.397 -3.107 0 CA-C-N 113.26 -1.791 . . . . 0.0 108.829 -179.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 145.91 -14.58 1.74 Allowed Glycine 0 C--N 1.305 -1.154 0 CA-C-N 114.375 -1.284 . . . . 0.0 111.188 -178.519 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.414 HG13 HG13 ' A' ' 108' ' ' VAL . 86.8 mt -100.64 99.41 8.38 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.25 0 CA-C-O 121.81 0.814 . . . . 0.0 111.042 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -89.18 127.71 35.76 Favored 'General case' 0 N--CA 1.433 -1.295 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 178.103 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.461 ' HA ' ' CB ' ' A' ' 102' ' ' LEU . 9.0 t -140.77 152.75 45.48 Favored 'General case' 0 C--N 1.278 -2.536 0 C-N-CA 119.734 -0.786 . . . . 0.0 111.002 -177.754 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.554 ' HD3' ' C ' ' A' ' 126' ' ' LYS . 3.8 tmtt? -140.85 127.17 19.81 Favored 'General case' 0 N--CA 1.389 -3.51 0 CA-C-N 115.168 -0.924 . . . . 0.0 108.695 175.055 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.478 HG13 ' H ' ' A' ' 128' ' ' MET . 2.6 p -135.55 -57.42 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 CA-C-N 114.709 -1.132 . . . . 0.0 109.057 -179.017 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' MET . . . . . 0.478 ' H ' HG13 ' A' ' 127' ' ' VAL . 24.3 ttt -101.19 -57.92 1.99 Allowed 'General case' 0 N--CA 1.421 -1.876 0 N-CA-C 106.293 -1.743 . . . . 0.0 106.293 176.495 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 2.2 pp -132.9 -179.48 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.637 0 CA-C-N 113.508 -1.678 . . . . 0.0 108.721 177.537 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 85.7 t90 -88.13 126.61 35.21 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 123.652 0.595 . . . . 0.0 110.518 -175.236 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 44.3 t -132.3 137.43 54.49 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 178.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 25.2 pttm -102.62 -24.54 13.76 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 112.328 0.492 . . . . 0.0 112.328 179.156 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 19.1 m -130.37 103.69 8.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-O 121.845 0.831 . . . . 0.0 111.417 -179.43 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 23.3 p -109.09 -165.5 1.02 Allowed 'General case' 0 C--N 1.292 -1.908 0 CA-C-N 115.342 -0.845 . . . . 0.0 109.166 177.091 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' SER . . . . . 0.498 ' OG ' ' HA ' ' A' ' 118' ' ' THR . 27.5 t -144.96 158.64 43.74 Favored 'General case' 0 N--CA 1.422 -1.837 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 176.715 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 68.1 mt -126.32 96.82 3.8 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 179.749 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' SER . . . . . 0.571 ' O ' ' HB2' ' A' ' 144' ' ' TYR . 46.9 t -121.48 136.53 54.95 Favored 'General case' 0 C--N 1.298 -1.663 0 O-C-N 121.816 -0.553 . . . . 0.0 110.324 -175.755 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' THR . . . . . 0.49 ' HG1' ' C ' ' A' ' 142' ' ' LYS . 8.8 t -165.16 178.33 7.05 Favored 'General case' 0 N--CA 1.42 -1.935 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 -174.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -110.25 68.33 0.67 Allowed 'General case' 0 C--N 1.312 -1.045 0 C-N-CA 119.215 -0.994 . . . . 0.0 112.599 -179.263 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . 48.79 33.35 4.28 Favored 'General case' 0 N--CA 1.496 1.848 0 C-N-CA 124.586 1.154 . . . . 0.0 113.828 173.009 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' SER . . . . . 0.46 ' O ' ' HG3' ' A' ' 155' ' ' ARG . 48.1 t -154.32 -67.03 0.14 Allowed 'General case' 0 C--N 1.307 -1.265 0 C-N-CA 120.342 -0.543 . . . . 0.0 110.378 -174.717 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . 0.49 ' C ' ' HG1' ' A' ' 138' ' ' THR . 55.3 mtpt -89.87 -162.79 0.92 Allowed 'General case' 0 CA--C 1.507 -0.709 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 179.125 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.535 HG12 ' O ' ' A' ' 159' ' ' GLY . 8.8 p -144.42 145.34 21.56 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 176.211 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . 0.571 ' HB2' ' O ' ' A' ' 137' ' ' SER . 91.6 m-85 -143.04 144.62 32.34 Favored 'General case' 0 CA--C 1.483 -1.6 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 174.219 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . 0.451 ' HB2' ' HA ' ' A' ' 151' ' ' LYS . 26.5 m-85 -95.53 156.37 16.35 Favored 'General case' 0 CA--C 1.454 -2.733 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 173.775 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 19.0 m -137.03 93.92 2.89 Favored 'General case' 1 N--CA 1.374 -4.226 0 C-N-CA 119.799 -0.761 . . . . 0.0 109.477 174.595 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . 0.428 ' HB2' ' HG3' ' A' ' 150' ' ' LYS . . . -111.56 6.99 20.43 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.168 -0.924 . . . . 0.0 109.361 177.783 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . 0.485 ' C ' ' H ' ' A' ' 150' ' ' LYS . . . 111.98 75.41 0.75 Allowed Glycine 0 CA--C 1.48 -2.103 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 -179.377 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER 74.31 -33.72 0.26 Allowed 'General case' 0 N--CA 1.494 1.755 0 C-N-CA 125.145 1.378 . . . . 0.0 110.534 -176.754 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . 0.485 ' H ' ' C ' ' A' ' 148' ' ' GLY . 12.0 pttm -79.88 121.22 25.15 Favored 'General case' 0 C--N 1.315 -0.904 0 C-N-CA 124.292 1.037 . . . . 0.0 112.047 179.518 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . 0.451 ' HA ' ' HB2' ' A' ' 145' ' ' PHE . 21.4 pttm -148.38 119.88 7.95 Favored 'General case' 0 N--CA 1.419 -1.983 0 CA-C-N 114.262 -1.335 . . . . 0.0 110.479 -175.074 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 42.9 m -110.41 111.82 23.34 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 106.54 -1.652 . . . . 0.0 106.54 173.53 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' ARG . . . . . 0.411 ' HG3' ' HA ' ' A' ' 144' ' ' TYR . 0.0 OUTLIER -154.69 99.57 2.17 Favored 'General case' 0 N--CA 1.435 -1.184 0 N-CA-C 116.397 1.999 . . . . 0.0 116.397 -165.745 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 4.9 m -108.99 109.57 20.65 Favored 'General case' 0 C--N 1.261 -3.279 0 O-C-N 121.423 -0.798 . . . . 0.0 109.051 165.489 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' ARG . . . . . 0.551 ' HD3' ' O ' ' A' ' 155' ' ' ARG . 0.2 OUTLIER -72.75 -23.45 60.83 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 120.633 1.561 . . . . 0.0 107.055 173.329 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -48.13 -43.72 31.46 Favored 'General case' 0 C--N 1.298 -1.666 0 C-N-CA 126.859 2.064 . . . . 0.0 115.536 -178.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . 0.523 ' HB1' ' NE2' ' A' ' 161' ' ' GLN . . . -79.28 -19.5 50.38 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 113.318 0.859 . . . . 0.0 113.318 -175.893 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . 0.568 ' CD2' ' HA ' ' A' ' 68' ' ' PHE . 44.0 t80 176.51 -34.49 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 CA-C-O 121.297 0.57 . . . . 0.0 109.831 178.482 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . 0.565 ' HA3' ' O ' ' A' ' 65' ' ' ILE . . . 150.52 -88.92 0.14 Allowed Glycine 0 CA--C 1.464 -3.134 0 N-CA-C 109.168 -1.573 . . . . 0.0 109.168 -172.194 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.473 ' CG2' ' HA ' ' A' ' 67' ' ' ILE . 10.9 t -98.06 153.39 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.642 0 N-CA-C 107.146 -1.428 . . . . 0.0 107.146 178.772 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 161' ' ' GLN . . . . . 0.523 ' NE2' ' HB1' ' A' ' 157' ' ' ALA . 79.3 mm-40 -116.32 90.05 3.25 Favored 'General case' 0 CA--C 1.453 -2.755 0 CA-C-O 122.435 1.112 . . . . 0.0 110.823 -172.469 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.28 147.59 24.9 Favored 'General case' 0 N--CA 1.387 -3.603 0 CA-C-N 112.555 -2.111 . . . . 0.0 108.828 179.327 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 9.4 t30 -113.13 -86.12 0.57 Allowed 'General case' 0 C--N 1.29 -2.014 0 C-N-CA 119.544 -0.862 . . . . 0.0 109.693 173.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 73.02 164.93 8.65 Favored Glycine 0 CA--C 1.502 -0.765 0 C-N-CA 120.424 -0.893 . . . . 0.0 113.256 179.088 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . 0.518 HD23 ' O ' ' A' ' 165' ' ' LEU . 0.0 OUTLIER -100.95 114.69 28.82 Favored 'General case' 0 N--CA 1.413 -2.316 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 177.367 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . 0.456 ' HB2' ' O ' ' A' ' 89' ' ' PRO . 6.2 ptp180 -90.03 105.67 17.96 Favored 'General case' 0 N--CA 1.412 -2.369 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 -179.694 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 57.5 t -43.83 -28.19 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 C-N-CA 124.333 1.053 . . . . 0.0 112.812 -177.662 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -49.64 -43.06 46.57 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 124.242 1.017 . . . . 0.0 111.813 177.042 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -128.49 8.79 5.96 Favored 'General case' 0 CA--C 1.546 0.825 0 CA-C-O 121.635 0.731 . . . . 0.0 110.887 -176.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 170' ' ' PHE . . . . . . . . . . . . . 67.3 t80 . . . . . 0 C--N 1.303 -1.439 0 N-CA-C 108.771 -0.825 . . . . 0.0 108.771 178.603 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.553 ' CG ' ' HD3' ' A' ' 55' ' ' PRO 0.352 0.5 OUTLIER . . . . . 0 N--CA 1.439 -1.003 0 N-CA-C 113.384 0.883 . . . . 0.0 113.384 . . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.553 ' HD3' ' CG ' ' A' ' 54' ' ' LEU . 88.9 Cg_exo -55.33 -35.33 91.34 Favored 'Trans proline' 0 C--N 1.362 1.238 0 C-N-CA 123.376 2.717 . . . . 0.0 112.461 -176.88 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -66.33 -30.88 71.37 Favored 'General case' 0 C--O 1.217 -0.615 0 C-N-CA 120.389 -0.525 . . . . 0.0 110.349 179.392 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 59.8 tp -74.8 -31.77 61.8 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.017 178.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.405 ' HB3' ' H ' ' A' ' 75' ' ' TYR . 7.9 mp -58.39 -49.8 75.96 Favored 'General case' 0 CA--C 1.482 -1.657 0 CA-C-O 121.675 0.75 . . . . 0.0 109.484 178.916 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.467 ' HG2' ' O ' ' A' ' 55' ' ' PRO . 17.2 ptmt -74.64 -26.63 60.0 Favored 'General case' 0 C--N 1.28 -2.425 0 CA-C-N 114.089 -1.414 . . . . 0.0 112.41 179.653 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.425 ' C ' ' H ' ' A' ' 62' ' ' ASP . 9.1 tp10 -70.75 -35.14 72.51 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.934 178.819 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 61.5 m-85 -48.46 -22.6 0.75 Allowed 'General case' 0 N--CA 1.5 2.072 0 CA-C-O 120.944 0.402 . . . . 0.0 111.442 174.494 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.48 ' CG ' ' H ' ' A' ' 63' ' ' LEU . 17.1 t70 -107.25 -156.38 0.58 Allowed 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 -172.799 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.552 HD22 ' H ' ' A' ' 115' ' ' GLY . 53.3 mt -91.71 172.8 6.01 Favored Pre-proline 0 CA--C 1.568 1.651 0 O-C-N 121.394 -0.816 . . . . 0.0 110.419 -174.773 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.461 ' HD3' ' HB3' ' A' ' 63' ' ' LEU . 3.5 Cg_endo -88.12 19.8 1.27 Allowed 'Trans proline' 0 C--N 1.356 0.968 0 C-N-CA 123.335 2.69 . . . . 0.0 111.367 -172.21 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.719 ' O ' ' HA3' ' A' ' 159' ' ' GLY . 0.2 OUTLIER -73.25 -37.92 53.07 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.708 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.401 179.69 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 55.58 8.51 1.95 Allowed Glycine 0 N--CA 1.49 2.25 0 CA-C-N 115.489 -0.778 . . . . 0.0 113.351 -178.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.645 ' O ' ' HB ' ' A' ' 160' ' ' VAL . 40.6 mt 69.37 -63.89 0.23 Allowed 'Isoleucine or valine' 0 C--O 1.197 -1.682 0 C-N-CA 126.053 1.741 . . . . 0.0 113.627 -178.726 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.5 ' HB2' ' O ' ' A' ' 67' ' ' ILE . 63.7 t80 171.24 -48.0 0.0 OUTLIER Pre-proline 0 C--N 1.314 -0.944 0 C-N-CA 122.729 0.412 . . . . 0.0 110.637 -177.446 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.443 ' HB3' ' HD3' ' A' ' 166' ' ' ARG . 17.1 Cg_exo -74.61 -31.62 6.75 Favored 'Trans proline' 0 C--N 1.377 2.035 0 C-N-CA 121.388 1.392 . . . . 0.0 112.109 179.666 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 88.37 -29.16 5.8 Favored Glycine 0 N--CA 1.437 -1.281 0 C-N-CA 120.448 -0.882 . . . . 0.0 110.999 -175.22 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.409 ' HB3' ' HG3' ' A' ' 89' ' ' PRO . 17.5 t70 -81.86 -19.02 41.83 Favored 'General case' 0 C--O 1.2 -1.545 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 177.52 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.501 ' O ' ' HB ' ' A' ' 73' ' ' THR . . . -78.25 175.04 10.57 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 114.95 -1.023 . . . . 0.0 110.375 170.511 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.597 ' O ' HG22 ' A' ' 73' ' ' THR . 51.9 m 86.29 21.27 0.08 Allowed 'General case' 0 C--N 1.355 0.836 0 CA-C-O 124.069 1.89 . . . . 0.0 110.763 172.451 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.554 ' O ' ' HA ' ' A' ' 86' ' ' VAL . 37.3 m-80 -80.33 158.9 25.96 Favored 'General case' 0 C--N 1.272 -2.793 0 CA-C-N 114.641 -1.163 . . . . 0.0 112.632 -179.572 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.405 ' H ' ' HB3' ' A' ' 58' ' ' LEU . 53.5 t80 -118.38 123.1 44.44 Favored 'General case' 0 C--N 1.284 -2.266 0 CA-C-N 114.716 -1.129 . . . . 0.0 112.998 -169.748 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.584 ' O ' HD12 ' A' ' 84' ' ' LEU . 26.7 mm-40 -146.59 151.2 36.91 Favored 'General case' 0 C--O 1.215 -0.73 0 C-N-CA 125.984 1.714 . . . . 0.0 108.165 173.254 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 52.4 p90 -139.28 150.58 45.61 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-N 118.228 0.467 . . . . 0.0 110.651 -178.501 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.476 ' CB ' ' HB ' ' A' ' 81' ' ' THR . 21.6 m-20 -78.56 164.39 24.72 Favored 'General case' 0 CA--C 1.48 -1.729 0 CA-C-O 121.589 0.709 . . . . 0.0 110.227 179.002 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -80.82 -65.87 0.96 Allowed 'General case' 0 C--N 1.279 -2.476 0 CA-C-N 114.312 -1.313 . . . . 0.0 110.835 -179.629 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -81.06 -33.22 33.63 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.378 -176.604 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.476 ' HB ' ' CB ' ' A' ' 78' ' ' ASP . 91.6 m -82.67 -29.03 30.24 Favored 'General case' 0 N--CA 1.425 -1.715 0 CA-C-N 115.048 -0.978 . . . . 0.0 111.64 -176.794 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt 58.88 15.41 3.86 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 113.021 0.749 . . . . 0.0 113.021 178.173 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.433 ' CG ' ' HB ' ' A' ' 109' ' ' THR . 16.4 tppt? -88.54 141.76 28.26 Favored 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 -177.635 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.584 HD12 ' O ' ' A' ' 76' ' ' GLU . 37.5 tp -75.96 138.72 41.15 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.26 177.037 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 9.4 t -126.31 116.97 22.06 Favored 'General case' 0 N--CA 1.412 -2.351 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 173.269 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.554 ' HA ' ' O ' ' A' ' 74' ' ' ASN . 74.2 t -92.92 127.01 45.29 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.808 0 CA-C-N 115.133 -0.94 . . . . 0.0 110.781 -178.463 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.451 ' HB2' ' HB2' ' A' ' 74' ' ' ASN . 3.9 mp -88.6 109.54 20.18 Favored 'General case' 0 N--CA 1.433 -1.294 0 CA-C-N 115.287 -0.87 . . . . 0.0 109.596 179.844 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 65.7 mt -96.86 137.93 21.35 Favored Pre-proline 0 C--N 1.286 -2.186 0 N-CA-C 105.957 -1.868 . . . . 0.0 105.957 171.073 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . 0.594 ' O ' ' HB2' ' A' ' 166' ' ' ARG . 41.5 Cg_endo -63.19 107.44 0.66 Allowed 'Trans proline' 0 N--CA 1.437 -1.842 0 C-N-CA 122.109 1.873 . . . . 0.0 110.14 175.849 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' SER . . . . . 0.499 ' HB2' ' HB2' ' A' ' 168' ' ' ASP . 33.2 t 63.65 -163.92 0.26 Allowed 'General case' 0 CA--C 1.557 1.248 0 CA-C-O 121.272 0.558 . . . . 0.0 110.891 179.614 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 5.7 tt -106.06 119.63 55.71 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 CA-C-O 121.52 0.676 . . . . 0.0 109.496 177.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' CYS . . . . . 0.465 ' O ' ' HB2' ' A' ' 104' ' ' PHE . 21.0 p -117.47 124.59 49.15 Favored 'General case' 0 C--N 1.296 -1.753 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 -179.441 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -116.41 166.17 12.38 Favored 'General case' 0 C--N 1.306 -1.31 0 O-C-N 122.072 -0.392 . . . . 0.0 111.775 -174.045 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 3.0 p -149.95 104.93 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.609 177.757 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.68 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.994 176.627 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' SER . . . . . 0.438 ' HA ' ' O ' ' A' ' 126' ' ' LYS . 34.8 t . . . . . 0 N--CA 1.411 -2.391 0 N-CA-C 106.696 -1.594 . . . . 0.0 106.696 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.433 ' C ' HD11 ' A' ' 102' ' ' LEU . 97.9 t -130.45 119.35 45.89 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.108 0 CA-C-N 114.633 -1.167 . . . . 0.0 108.414 177.22 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.481 ' HG ' ' HA ' ' A' ' 125' ' ' THR . 4.8 mp -124.6 138.59 54.31 Favored 'General case' 0 N--CA 1.424 -1.759 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.346 -179.645 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 27.3 ttpp -117.19 110.35 18.03 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.33 177.759 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.469 ' HA ' HD12 ' A' ' 123' ' ' ILE . 51.1 m-85 -91.13 97.14 10.97 Favored 'General case' 0 N--CA 1.422 -1.871 0 CA-C-O 122.19 0.995 . . . . 0.0 111.756 177.764 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 31.6 m -56.05 146.4 22.85 Favored 'General case' 0 N--CA 1.424 -1.762 0 CA-C-N 112.276 -2.238 . . . . 0.0 110.916 177.325 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 66.9 m -56.95 -67.8 0.28 Allowed 'General case' 0 C--O 1.218 -0.593 0 C-N-CA 123.738 0.815 . . . . 0.0 111.123 -179.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.41 ' HA ' ' O ' ' A' ' 86' ' ' VAL . 7.3 p -107.56 99.88 9.34 Favored 'General case' 0 N--CA 1.423 -1.825 0 CA-C-O 121.654 0.74 . . . . 0.0 110.054 176.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.541 HG23 HG12 ' A' ' 123' ' ' ILE . 4.3 p -110.07 148.38 13.69 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.433 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.805 -176.894 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.519 ' HA ' ' O ' ' A' ' 84' ' ' LEU . 35.6 p -97.95 156.26 16.7 Favored 'General case' 0 N--CA 1.432 -1.369 0 N-CA-C 112.895 0.702 . . . . 0.0 112.895 -176.131 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . 0.65 ' HA2' ' O ' ' A' ' 119' ' ' ASP . . . -172.99 174.42 45.86 Favored Glycine 0 CA--C 1.52 0.353 0 N-CA-C 111.714 -0.554 . . . . 0.0 111.714 -179.84 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 34.2 t-80 -109.75 121.96 46.41 Favored 'General case' 0 CA--C 1.508 -0.658 0 N-CA-C 107.934 -1.135 . . . . 0.0 107.934 177.347 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.47 ' HB2' HD22 ' A' ' 84' ' ' LEU . 2.9 tt -91.99 116.86 29.28 Favored 'General case' 0 C--N 1.307 -1.261 0 C-N-CA 120.324 -0.55 . . . . 0.0 110.395 -172.541 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -127.57 143.99 51.12 Favored 'General case' 0 CA--C 1.459 -2.542 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 171.748 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 42.7 tptt -80.15 100.24 8.16 Favored 'General case' 0 N--CA 1.387 -3.581 0 CA-C-O 122.194 0.997 . . . . 0.0 108.911 -171.627 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . 0.552 ' H ' HD22 ' A' ' 63' ' ' LEU . . . 136.5 -31.92 2.53 Favored Glycine 0 N--CA 1.426 -1.999 0 N-CA-C 108.245 -1.942 . . . . 0.0 108.245 -176.681 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -157.87 127.0 5.77 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 121.379 0.609 . . . . 0.0 111.985 -178.744 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -94.59 107.14 19.14 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 105.656 -1.979 . . . . 0.0 105.656 174.72 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.435 ' HA ' ' CB ' ' A' ' 135' ' ' SER . 49.4 p -109.61 172.44 6.85 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.963 -175.188 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . 0.65 ' O ' ' HA2' ' A' ' 110' ' ' GLY . 12.2 m-20 56.97 63.14 2.0 Favored 'General case' 0 CA--C 1.473 -1.983 0 O-C-N 124.468 1.105 . . . . 0.0 109.55 178.531 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.415 HG23 ' O ' ' A' ' 134' ' ' THR . 4.5 t -86.75 78.1 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.399 -2.98 0 C-N-CA 117.983 -1.487 . . . . 0.0 108.335 -175.798 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.421 ' HB3' ' OG1' ' A' ' 109' ' ' THR . 11.6 tp10 -68.92 96.47 0.77 Allowed 'General case' 0 N--CA 1.414 -2.252 0 CA-C-N 113.011 -1.904 . . . . 0.0 110.601 -174.39 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 130.56 -2.18 5.69 Favored Glycine 0 N--CA 1.424 -2.104 0 C-N-CA 120.152 -1.023 . . . . 0.0 112.995 174.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.541 HG12 HG23 ' A' ' 108' ' ' VAL . 26.6 mm -99.2 112.25 30.93 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 176.743 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -84.3 119.38 25.0 Favored 'General case' 0 N--CA 1.429 -1.51 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 -178.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.481 ' HA ' ' HG ' ' A' ' 102' ' ' LEU . 58.9 m -131.38 119.44 21.68 Favored 'General case' 0 N--CA 1.405 -2.716 0 CA-C-N 114.976 -1.011 . . . . 0.0 111.33 -175.889 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.438 ' O ' ' HA ' ' A' ' 100' ' ' SER . 83.1 tttt -110.08 141.94 42.22 Favored 'General case' 0 N--CA 1.41 -2.451 0 C-N-CA 119.083 -1.047 . . . . 0.0 109.452 168.225 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.419 ' N ' ' HG2' ' A' ' 126' ' ' LYS . 7.5 p -149.01 -35.0 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.296 -1.757 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 175.431 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 26.4 ptm -137.52 -29.23 0.88 Allowed 'General case' 0 N--CA 1.404 -2.758 0 CA-C-N 113.922 -1.49 . . . . 0.0 107.986 -176.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 7.0 tp -161.97 159.52 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.565 0 N-CA-C 103.684 -2.71 . . . . 0.0 103.684 175.278 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 63.6 p-90 -83.82 126.52 33.02 Favored 'General case' 0 N--CA 1.409 -2.476 0 CA-C-O 121.351 0.596 . . . . 0.0 109.547 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . 0.402 HG23 ' H ' ' A' ' 133' ' ' VAL . 13.1 p -130.92 149.01 33.07 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.147 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 179.022 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 20.8 pttp -103.48 12.94 34.52 Favored 'General case' 0 C--N 1.308 -1.201 0 C-N-CA 120.536 -0.466 . . . . 0.0 110.99 -179.643 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.402 ' H ' HG23 ' A' ' 131' ' ' VAL . 10.8 m -146.92 94.17 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.936 0.874 . . . . 0.0 112.529 -174.916 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' THR . . . . . 0.449 HG22 HG21 ' A' ' 125' ' ' THR . 25.5 p -107.59 -160.73 0.74 Allowed 'General case' 0 N--CA 1.404 -2.73 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 174.026 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' SER . . . . . 0.435 ' CB ' ' HA ' ' A' ' 118' ' ' THR . 51.8 p -173.35 142.66 1.01 Allowed 'General case' 0 N--CA 1.44 -0.941 0 N-CA-C 111.327 0.121 . . . . 0.0 111.327 -178.352 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . 0.427 HG13 ' O ' ' A' ' 144' ' ' TYR . 10.1 tt -103.18 111.23 32.18 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 CA-C-O 121.397 0.618 . . . . 0.0 109.396 177.574 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' SER . . . . . 0.45 ' O ' ' HB2' ' A' ' 144' ' ' TYR . 43.5 m -111.75 139.35 47.29 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.739 -178.279 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' THR . . . . . 0.431 ' HG1' ' C ' ' A' ' 142' ' ' LYS . 7.5 t -166.09 178.11 6.56 Favored 'General case' 0 N--CA 1.428 -1.559 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 -177.709 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -83.61 28.69 0.55 Allowed 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 176.441 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . 60.23 35.73 20.91 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.352 0.661 . . . . 0.0 109.598 -174.246 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' SER . . . . . 0.466 ' O ' ' HG3' ' A' ' 155' ' ' ARG . 33.4 t -153.62 -65.73 0.15 Allowed 'General case' 0 C--O 1.214 -0.784 0 CA-C-N 115.795 -0.638 . . . . 0.0 111.426 -171.505 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . 0.431 ' C ' ' HG1' ' A' ' 138' ' ' THR . 51.2 mtpt -80.11 -169.16 1.92 Allowed 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 179.871 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.499 HG23 ' O ' ' A' ' 159' ' ' GLY . 91.7 t -135.71 119.77 25.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-O 121.663 0.744 . . . . 0.0 112.673 179.11 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . 0.45 ' HB2' ' O ' ' A' ' 137' ' ' SER . 96.2 m-85 -113.64 114.59 26.64 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 106.297 -1.742 . . . . 0.0 106.297 171.13 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 29.5 t80 -59.35 143.2 50.22 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 114.866 -1.061 . . . . 0.0 111.701 -169.12 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' THR . . . . . 0.421 ' C ' ' HB ' ' A' ' 134' ' ' THR . 75.1 p -46.88 104.27 0.05 OUTLIER 'General case' 0 C--O 1.245 0.823 0 N-CA-C 115.553 1.686 . . . . 0.0 115.553 -169.795 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . 161.23 -65.47 0.0 OUTLIER 'General case' 0 CA--C 1.487 -1.457 0 C-N-CA 129.674 3.19 . . . . 0.0 104.824 174.036 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 154.57 -75.22 0.23 Allowed Glycine 0 CA--C 1.48 -2.139 0 C-N-CA 119.557 -1.306 . . . . 0.0 112.282 170.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 27.3 ptt? -97.36 -11.59 23.81 Favored 'General case' 0 C--N 1.29 -1.992 0 CA-C-N 115.396 -0.402 . . . . 0.0 111.938 -175.585 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . 0.416 ' HE2' HG11 ' A' ' 127' ' ' VAL 0.352 0.0 OUTLIER -77.37 -28.71 52.97 Favored 'General case' 0 C--O 1.213 -0.823 0 N-CA-C 116.656 2.095 . . . . 0.0 116.656 -170.597 . . . . . . . . 4 4 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . 0.467 ' HA ' ' HE2' ' A' ' 151' ' ' LYS . 4.8 mmpt? -147.52 129.32 15.24 Favored 'General case' 0 CA--C 1.503 -0.829 0 CA-C-N 118.074 0.397 . . . . 0.0 110.767 179.453 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 40.6 p -106.72 145.91 31.46 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 175.461 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 4.1 mmp_? -130.75 166.69 20.23 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 -179.313 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 19.0 m -101.15 121.76 42.41 Favored 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 177.201 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' ARG . . . . . 0.466 ' HG3' ' O ' ' A' ' 141' ' ' SER . 1.6 tmm_? -63.19 -25.79 68.5 Favored 'General case' 0 C--O 1.206 -1.198 0 N-CA-C 106.898 -1.519 . . . . 0.0 106.898 178.548 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -52.7 -25.94 12.47 Favored 'General case' 0 C--N 1.302 -1.499 0 C-N-CA 126.339 1.855 . . . . 0.0 113.009 -179.665 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -71.76 -32.66 67.93 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 120.703 0.287 . . . . 0.0 111.192 -179.268 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 44.0 t80 169.39 -31.94 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 106.333 -1.729 . . . . 0.0 106.333 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . 0.719 ' HA3' ' O ' ' A' ' 65' ' ' ILE . . . 156.87 -90.11 0.12 Allowed Glycine 0 N--CA 1.4 -3.729 0 N-CA-C 108.299 -1.92 . . . . 0.0 108.299 -173.361 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.645 ' HB ' ' O ' ' A' ' 67' ' ' ILE . 11.1 t -103.35 148.17 8.74 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.756 0 N-CA-C 105.372 -2.084 . . . . 0.0 105.372 179.231 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -137.07 102.69 4.92 Favored 'General case' 0 N--CA 1.408 -2.566 0 C-N-CA 118.102 -1.439 . . . . 0.0 109.179 -173.251 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 34.7 ptt85 -152.78 173.76 14.9 Favored 'General case' 0 C--N 1.275 -2.632 0 CA-C-N 113.214 -1.812 . . . . 0.0 106.515 -177.102 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -67.63 126.03 28.06 Favored 'General case' 0 C--O 1.248 1.007 0 C-N-CA 119.087 -1.045 . . . . 0.0 108.475 169.254 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -159.23 60.9 0.31 Allowed Glycine 0 N--CA 1.411 -3.032 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.311 -179.651 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 47.1 tp -81.62 111.54 18.0 Favored 'General case' 0 N--CA 1.418 -2.038 0 N-CA-C 105.509 -2.034 . . . . 0.0 105.509 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . 0.594 ' HB2' ' O ' ' A' ' 89' ' ' PRO . 0.0 OUTLIER -84.15 105.94 15.4 Favored 'General case' 0 N--CA 1.398 -3.055 0 C-N-CA 118.382 -1.327 . . . . 0.0 110.788 -178.189 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 4.8 m -74.74 63.93 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.29 -2.012 0 CA-C-O 122.833 1.301 . . . . 0.0 111.204 176.505 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . 0.499 ' HB2' ' HB2' ' A' ' 90' ' ' SER . 35.6 t70 -133.49 -32.69 1.14 Allowed 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 112.772 -2.013 . . . . 0.0 107.724 -177.635 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 21.7 ttpp -140.03 -67.19 0.44 Allowed 'General case' 0 N--CA 1.427 -1.584 0 CA-C-N 113.764 -1.562 . . . . 0.0 107.763 -177.172 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 170' ' ' PHE . . . . . . . . . . . . . 68.3 t80 . . . . . 0 C--O 1.249 1.026 0 N-CA-C 105.004 -2.221 . . . . 0.0 105.004 -178.82 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 25.6 m . . . . . 0 N--CA 1.444 -0.737 0 N-CA-C 109.225 -0.658 . . . . 0.0 109.225 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -141.14 138.17 33.27 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.396 0.617 . . . . 0.0 112.1 -177.174 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -146.3 27.45 1.14 Allowed 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 177.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 10.3 tt -72.0 127.67 34.2 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 CA-C-N 115.3 -0.864 . . . . 0.0 112.068 -176.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 34.3 p90 -145.12 112.04 5.93 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.683 177.037 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 44.3 t-20 -126.69 99.17 5.67 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 179.196 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -96.56 122.89 39.96 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-N 115.235 -0.893 . . . . 0.0 109.294 -178.167 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.7 p -110.09 126.19 67.32 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.833 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 176.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -88.84 153.59 23.95 Favored Glycine 0 N--CA 1.427 -1.929 0 C-N-CA 120.798 -0.715 . . . . 0.0 111.692 -178.48 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 32.5 t -135.38 124.31 24.13 Favored 'General case' 0 C--N 1.292 -1.906 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 179.108 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -108.8 156.53 19.53 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 178.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 71.3 t-105 -137.76 131.53 31.4 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-O 121.273 0.558 . . . . 0.0 111.56 179.217 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -144.51 145.42 31.84 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-N 115.072 -0.967 . . . . 0.0 109.58 175.01 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -132.05 105.02 0.59 Allowed Glycine 0 N--CA 1.434 -1.485 0 C-N-CA 120.205 -0.997 . . . . 0.0 111.971 -177.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 16.9 mp0 -73.48 108.67 6.47 Favored 'General case' 0 C--N 1.308 -1.196 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 179.27 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -111.71 114.29 27.21 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.77 178.053 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -155.03 146.6 23.17 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -149.96 127.8 11.77 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-O 121.077 0.465 . . . . 0.0 111.586 -179.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -139.68 103.63 4.72 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.207 175.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -126.42 95.0 4.22 Favored 'General case' 0 C--N 1.292 -1.906 0 CA-C-O 121.836 0.827 . . . . 0.0 111.734 -178.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 88.9 t80 -100.0 127.33 46.22 Favored 'General case' 0 C--N 1.296 -1.735 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.515 179.085 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -127.2 165.83 18.88 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 174.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 32.0 t -124.47 136.98 54.46 Favored 'General case' 0 C--N 1.297 -1.688 0 CA-C-O 120.989 0.423 . . . . 0.0 110.461 -175.328 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 55.7 t -92.49 128.06 44.29 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.092 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 -179.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -98.06 170.23 24.75 Favored Glycine 0 N--CA 1.437 -1.276 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.671 -178.073 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 29.9 p-10 -153.34 153.86 33.41 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 177.534 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -128.42 157.85 39.92 Favored 'General case' 0 C--N 1.305 -1.337 0 C-N-CA 120.612 -0.435 . . . . 0.0 110.987 -179.397 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 89.8 mt -96.34 153.47 17.8 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.491 -177.18 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 28.8 p-10 -141.43 131.73 25.05 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.995 -179.173 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 38.0 t -161.27 111.03 1.64 Allowed 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 179.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 28.6 m -127.68 130.83 70.36 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-N 116.281 -0.418 . . . . 0.0 109.899 178.436 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 46.1 m -155.38 152.12 28.7 Favored 'General case' 0 C--N 1.31 -1.134 0 O-C-N 122.304 -0.248 . . . . 0.0 110.376 -177.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 10.2 t -161.14 176.21 11.55 Favored 'General case' 0 C--O 1.246 0.882 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 177.272 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 32.1 t -163.96 158.62 19.89 Favored 'General case' 0 N--CA 1.438 -1.044 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 -179.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 29.8 pt -133.56 -177.12 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.953 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 178.408 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -131.04 134.4 46.62 Favored 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 179.02 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -156.03 48.43 0.48 Allowed Glycine 0 C--N 1.308 -1.024 0 N-CA-C 111.115 -0.794 . . . . 0.0 111.115 -179.012 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -78.48 -36.19 30.8 Favored Glycine 0 N--CA 1.442 -0.962 0 C-N-CA 121.138 -0.553 . . . . 0.0 112.024 -177.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 29.1 p -84.88 121.06 27.2 Favored 'General case' 0 N--CA 1.429 -1.524 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 177.535 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -143.65 107.07 4.57 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-O 121.053 0.454 . . . . 0.0 111.155 -177.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 28.9 p-90 -150.09 100.85 2.96 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 115.045 -0.979 . . . . 0.0 111.461 179.1 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.46 HD23 ' H ' ' A' ' 42' ' ' LEU . 2.0 pt? -79.78 -12.32 59.79 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 121.801 0.81 . . . . 0.0 110.142 179.387 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 34.5 m -104.02 138.67 27.63 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.806 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 175.026 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 5.6 p30 -111.0 85.7 2.17 Favored 'General case' 0 C--N 1.295 -1.763 0 CA-C-O 122.307 1.051 . . . . 0.0 111.505 179.028 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 58.8 tptt -105.72 101.73 11.23 Favored 'General case' 0 N--CA 1.418 -2.062 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 178.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 10.0 tt -64.52 89.95 0.08 OUTLIER 'Isoleucine or valine' 0 C--O 1.248 1.018 0 CA-C-O 122.301 1.048 . . . . 0.0 113.11 -174.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 50.0 tptt -173.07 151.78 2.19 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 105.546 -2.02 . . . . 0.0 105.546 178.339 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -75.26 54.74 2.76 Favored Glycine 0 CA--C 1.525 0.691 0 C-N-CA 121.62 -0.324 . . . . 0.0 113.782 -176.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -135.32 -35.38 0.83 Allowed 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 177.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 1.8 mpt? 66.88 -87.3 0.03 OUTLIER 'General case' 0 C--O 1.242 0.676 0 CA-C-N 114.692 -1.14 . . . . 0.0 109.891 -174.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -143.52 -0.18 1.1 Allowed 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 120.671 0.272 . . . . 0.0 111.32 177.151 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -136.81 155.22 76.63 Favored Pre-proline 0 C--O 1.208 -1.106 0 CA-C-O 120.513 0.197 . . . . 0.0 110.528 -178.249 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -84.14 28.2 0.58 Allowed 'Trans proline' 0 C--O 1.241 0.625 0 C-N-CA 122.864 2.376 . . . . 0.0 111.246 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.401 ' N ' ' HD3' ' A' ' 55' ' ' PRO . 42.0 mt -74.63 -45.24 5.51 Favored Pre-proline 0 C--N 1.307 -1.262 0 N-CA-C 114.602 1.334 . . . . 0.0 114.602 -174.646 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.533 ' O ' ' HG2' ' A' ' 59' ' ' LYS . 20.9 Cg_exo -61.76 -15.93 45.61 Favored 'Trans proline' 0 C--N 1.374 1.907 0 C-N-CA 121.73 1.62 . . . . 0.0 113.412 -165.149 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 31.1 mm-40 -80.35 -30.74 38.01 Favored 'General case' 0 CA--C 1.485 -1.542 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 -178.008 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.473 ' HA ' ' HB3' ' A' ' 60' ' ' GLU . 72.6 mt -75.28 -35.06 61.37 Favored 'General case' 0 N--CA 1.418 -2.054 0 CA-C-N 114.648 -1.16 . . . . 0.0 110.572 -179.218 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.56 ' HB3' ' H ' ' A' ' 75' ' ' TYR . 5.2 mp -64.46 -50.93 65.57 Favored 'General case' 0 CA--C 1.493 -1.229 0 C-N-CA 119.668 -0.813 . . . . 0.0 110.047 -178.28 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.533 ' HG2' ' O ' ' A' ' 55' ' ' PRO . 18.0 ptpt -62.55 -26.48 68.6 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 114.923 -1.035 . . . . 0.0 111.041 175.478 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.473 ' HB3' ' HA ' ' A' ' 57' ' ' LEU . 15.5 tt0 -69.71 -39.44 76.86 Favored 'General case' 0 C--N 1.317 -0.823 0 C-N-CA 123.89 0.876 . . . . 0.0 112.345 176.884 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -74.89 -26.14 59.44 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 120.459 -0.497 . . . . 0.0 110.301 176.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.44 ' CG ' ' H ' ' A' ' 63' ' ' LEU . 17.0 t70 -77.17 -162.22 0.27 Allowed 'General case' 0 CA--C 1.565 1.545 0 CA-C-N 115.206 -0.906 . . . . 0.0 108.563 178.782 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.469 ' HB2' HD13 ' A' ' 65' ' ' ILE . 1.5 mt -95.02 -178.64 0.82 Allowed Pre-proline 0 CA--C 1.569 1.704 0 N-CA-C 106.809 -1.552 . . . . 0.0 106.809 -175.591 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_endo -92.45 14.85 1.63 Allowed 'Trans proline' 0 C--N 1.361 1.202 0 C-N-CA 122.36 2.04 . . . . 0.0 111.547 -174.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.619 ' O ' ' HA3' ' A' ' 159' ' ' GLY . 0.2 OUTLIER -76.12 -42.15 37.93 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.704 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 179.497 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 57.75 8.55 4.27 Favored Glycine 0 N--CA 1.481 1.645 0 CA-C-N 115.925 -0.58 . . . . 0.0 112.771 -178.155 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.549 ' O ' ' HB ' ' A' ' 160' ' ' VAL . 61.6 mt 64.95 -67.39 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.562 0 C-N-CA 126.201 1.8 . . . . 0.0 112.471 -176.623 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.404 ' HB2' ' O ' ' A' ' 67' ' ' ILE . 53.3 t80 179.61 -56.63 0.0 OUTLIER Pre-proline 0 C--N 1.31 -1.119 0 N-CA-C 112.268 0.47 . . . . 0.0 112.268 -177.672 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.456 ' HB2' ' OD2' ' A' ' 71' ' ' ASP . 3.2 Cg_endo -87.67 -22.68 1.5 Allowed 'Trans proline' 0 C--N 1.365 1.416 0 C-N-CA 121.556 1.504 . . . . 0.0 114.185 -170.787 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 88.8 -8.55 79.23 Favored Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 120.525 -0.845 . . . . 0.0 111.456 -175.338 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.456 ' OD2' ' HB2' ' A' ' 69' ' ' PRO . 21.6 m-20 -81.78 -46.65 13.91 Favored 'General case' 0 CA--C 1.501 -0.926 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 177.537 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.486 ' O ' ' HB ' ' A' ' 73' ' ' THR . . . -71.27 178.15 3.51 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 114.164 -1.38 . . . . 0.0 110.273 172.798 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.694 HG23 ' O ' ' A' ' 73' ' ' THR . 81.3 m 83.24 27.86 0.1 Allowed 'General case' 0 C--N 1.354 0.775 0 CA-C-O 124.429 2.062 . . . . 0.0 110.018 174.496 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.684 ' O ' ' HA ' ' A' ' 86' ' ' VAL . 0.7 OUTLIER -81.82 137.76 35.22 Favored 'General case' 0 C--N 1.275 -2.635 0 CA-C-N 114.206 -1.361 . . . . 0.0 109.726 177.706 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.56 ' H ' ' HB3' ' A' ' 58' ' ' LEU . 37.5 t80 -106.73 104.94 14.75 Favored 'General case' 0 C--N 1.273 -2.756 0 CA-C-N 115.234 -0.894 . . . . 0.0 110.074 -173.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.657 ' O ' ' HG ' ' A' ' 84' ' ' LEU . 10.8 mm-40 -137.73 163.33 31.59 Favored 'General case' 0 C--N 1.307 -1.258 0 C-N-CA 124.112 0.965 . . . . 0.0 108.882 177.202 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 50.9 p90 -147.75 150.47 34.33 Favored 'General case' 0 C--N 1.289 -2.035 0 N-CA-C 108.064 -1.088 . . . . 0.0 108.064 177.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.528 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 12.7 m-20 -99.16 165.26 11.8 Favored 'General case' 0 CA--C 1.479 -1.767 0 C-N-CA 118.001 -1.48 . . . . 0.0 110.282 178.549 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -79.55 -59.66 2.66 Favored 'General case' 0 C--N 1.272 -2.802 0 CA-C-N 114.159 -1.382 . . . . 0.0 112.947 -177.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -72.41 -30.41 64.62 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-O 121.58 0.705 . . . . 0.0 110.292 -177.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.528 ' HB ' ' HB2' ' A' ' 78' ' ' ASP . 21.8 m -78.49 -51.07 10.52 Favored 'General case' 0 N--CA 1.411 -2.424 0 CA-C-N 114.824 -1.08 . . . . 0.0 110.48 -178.158 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 65.0 mttp 65.88 12.0 8.06 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.626 0.77 . . . . 0.0 112.172 -177.567 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 5.0 tppp? -100.59 141.97 32.72 Favored 'General case' 0 N--CA 1.428 -1.548 0 N-CA-C 104.449 -2.426 . . . . 0.0 104.449 175.445 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.657 ' HG ' ' O ' ' A' ' 76' ' ' GLU . 9.3 tt -80.83 145.83 31.21 Favored 'General case' 0 C--N 1.295 -1.782 0 C-N-CA 119.39 -0.924 . . . . 0.0 110.488 -178.428 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 10.7 t -126.47 123.84 38.75 Favored 'General case' 0 N--CA 1.4 -2.964 0 CA-C-O 121.896 0.855 . . . . 0.0 111.035 -179.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.684 ' HA ' ' O ' ' A' ' 74' ' ' ASN . 98.5 t -96.84 126.81 49.47 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 CA-C-N 114.932 -1.031 . . . . 0.0 108.4 175.36 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.6 mp -91.64 120.37 32.35 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-O 121.63 0.728 . . . . 0.0 111.046 -179.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 2.1 mp -100.69 132.74 21.85 Favored Pre-proline 0 C--N 1.286 -2.191 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 172.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -51.06 -36.28 53.96 Favored 'Trans proline' 0 C--N 1.356 0.938 0 C-N-CA 124.637 3.558 . . . . 0.0 114.357 -176.131 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.547 ' HB2' ' HB2' ' A' ' 168' ' ' ASP . 47.9 t -161.99 157.65 23.96 Favored 'General case' 0 CA--C 1.493 -1.221 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -70.4 116.13 11.13 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.711 0 O-C-N 123.991 0.807 . . . . 0.0 109.28 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 41.3 t -112.77 123.51 50.46 Favored 'General case' 0 N--CA 1.427 -1.587 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.934 179.377 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -106.57 114.66 28.9 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 174.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 5.8 p -111.66 118.15 56.86 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.726 0 CA-C-O 121.192 0.52 . . . . 0.0 111.283 -176.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . 0.4 ' HA2' ' HA ' ' A' ' 101' ' ' VAL . . . -131.26 140.28 11.65 Favored Glycine 0 N--CA 1.43 -1.703 0 C-N-CA 120.463 -0.875 . . . . 0.0 112.016 179.155 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . 0.464 ' C ' ' H ' ' A' ' 98' ' ' ASP . 51.9 t80 -159.98 175.16 13.34 Favored 'General case' 0 N--CA 1.402 -2.868 0 N-CA-C 102.791 -3.04 . . . . 0.0 102.791 179.224 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.99 1.75 2.5 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 118.755 0.707 . . . . 0.0 111.305 177.543 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.464 ' H ' ' C ' ' A' ' 96' ' ' TYR . 9.4 t70 -45.26 -52.33 9.74 Favored 'General case' 0 CA--C 1.502 -0.898 0 C-N-CA 125.362 1.465 . . . . 0.0 110.07 176.449 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.43 ' OG ' ' HD2' ' A' ' 151' ' ' LYS . 45.1 m -146.89 -68.52 0.26 Allowed 'General case' 0 N--CA 1.408 -2.563 0 N-CA-C 106.653 -1.61 . . . . 0.0 106.653 175.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 48.8 m -164.15 -74.19 0.04 OUTLIER 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 176.014 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.4 ' HA ' ' HA2' ' A' ' 95' ' ' GLY . 13.8 p -166.85 147.63 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.796 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 -178.354 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.472 HD21 ' H ' ' A' ' 126' ' ' LYS . 51.6 mt -134.86 133.95 40.25 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 -176.205 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.42 ' O ' ' HA ' ' A' ' 123' ' ' ILE . 27.4 ttpp -110.28 114.05 27.22 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 112.195 0.442 . . . . 0.0 112.195 -177.112 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -101.65 104.54 15.39 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.721 176.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 89.4 m -79.59 165.0 23.39 Favored 'General case' 0 CA--C 1.557 1.215 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.618 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 12.0 p -69.57 -69.68 0.33 Allowed 'General case' 0 N--CA 1.438 -1.063 0 C-N-CA 124.93 1.292 . . . . 0.0 112.886 -175.014 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 25.6 m -96.3 88.51 4.79 Favored 'General case' 0 N--CA 1.416 -2.173 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 -178.195 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.509 HG22 HG13 ' A' ' 123' ' ' ILE . 5.0 p -101.48 144.18 13.43 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.103 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.18 -176.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.57 ' OG1' ' HB3' ' A' ' 121' ' ' GLU . 11.6 p -109.33 165.06 11.92 Favored 'General case' 0 C--N 1.287 -2.139 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 178.183 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 173.39 172.58 38.99 Favored Glycine 0 N--CA 1.427 -1.914 0 N-CA-C 111.485 -0.646 . . . . 0.0 111.485 179.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 47.4 t-80 -93.2 106.47 18.43 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 178.016 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.453 ' CB ' HD13 ' A' ' 84' ' ' LEU . 2.9 tm? -94.42 136.51 34.63 Favored 'General case' 0 CA--C 1.466 -2.261 0 N-CA-C 106.838 -1.542 . . . . 0.0 106.838 -175.388 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . 0.418 ' N ' HD11 ' A' ' 112' ' ' LEU . 0.3 OUTLIER -142.49 153.01 43.26 Favored 'General case' 0 N--CA 1.383 -3.777 0 N-CA-C 105.275 -2.12 . . . . 0.0 105.275 177.837 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 8.1 mmtt -67.92 101.06 1.04 Allowed 'General case' 0 C--N 1.302 -1.464 0 CA-C-O 121.898 0.856 . . . . 0.0 111.691 -178.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . 0.652 ' O ' ' HB ' ' A' ' 138' ' ' THR . . . 131.0 -54.24 0.79 Allowed Glycine 0 N--CA 1.41 -3.049 0 CA-C-N 114.342 -1.299 . . . . 0.0 109.927 -178.765 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.51 141.93 43.47 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 114.006 1.113 . . . . 0.0 114.006 -176.811 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.662 ' O ' ' HB2' ' A' ' 135' ' ' SER . 58.1 tp -104.82 106.82 17.47 Favored 'General case' 0 C--N 1.311 -1.067 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 177.704 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 42.1 p -106.19 142.93 35.06 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 -175.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 28.6 m-20 54.74 98.78 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 125.156 1.382 . . . . 0.0 113.031 177.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 4.3 m -100.58 172.54 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.587 0 CA-C-O 120.983 0.42 . . . . 0.0 110.907 179.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.57 ' HB3' ' OG1' ' A' ' 109' ' ' THR . 14.9 tp10 -140.84 82.77 1.86 Allowed 'General case' 0 N--CA 1.416 -2.165 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.382 178.705 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 150.96 -19.7 0.97 Allowed Glycine 0 C--N 1.308 -1.012 0 CA-C-N 115.153 -0.931 . . . . 0.0 111.979 177.14 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.509 HG13 HG22 ' A' ' 108' ' ' VAL . 96.1 mt -99.61 100.17 9.93 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.63 0 CA-C-O 121.383 0.611 . . . . 0.0 109.514 -179.087 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.448 ' HA ' ' HA ' ' A' ' 132' ' ' LYS . 39.7 ttmt -86.65 119.19 26.62 Favored 'General case' 0 N--CA 1.428 -1.565 0 N-CA-C 107.613 -1.255 . . . . 0.0 107.613 -179.617 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.58 ' HB ' ' OG1' ' A' ' 134' ' ' THR . 89.9 m -121.33 125.14 46.28 Favored 'General case' 0 C--N 1.268 -2.95 0 CA-C-N 114.477 -1.238 . . . . 0.0 110.962 -172.19 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.623 ' HD3' ' C ' ' A' ' 126' ' ' LYS . 0.2 OUTLIER -117.99 105.78 12.24 Favored 'General case' 0 N--CA 1.412 -2.347 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 173.026 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 33.3 m -107.7 -27.61 2.95 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.102 0 CA-C-O 121.872 0.844 . . . . 0.0 110.08 176.314 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' MET . . . . . 0.496 ' C ' HD13 ' A' ' 129' ' ' ILE . 27.3 ttt -158.94 -35.55 0.06 Allowed 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 106.971 -1.492 . . . . 0.0 106.971 -175.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . 0.496 HD13 ' C ' ' A' ' 128' ' ' MET . 2.8 mp -134.94 151.65 31.46 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.72 0 N-CA-C 104.271 -2.492 . . . . 0.0 104.271 171.356 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 16.2 p90 -90.53 116.68 28.62 Favored 'General case' 0 N--CA 1.425 -1.711 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 178.375 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.53 HG11 ' H ' ' A' ' 133' ' ' VAL . 36.0 t -137.69 146.58 27.25 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 -175.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . 0.448 ' HA ' ' HA ' ' A' ' 124' ' ' LYS . 58.9 pttt -103.23 12.0 36.17 Favored 'General case' 0 C--N 1.315 -0.917 0 C-N-CA 120.165 -0.614 . . . . 0.0 111.448 -178.797 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.53 ' H ' HG11 ' A' ' 131' ' ' VAL . 33.5 m -125.55 -1.43 5.14 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.006 0 C-N-CA 120.396 -0.522 . . . . 0.0 111.778 -175.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' THR . . . . . 0.58 ' OG1' ' HB ' ' A' ' 125' ' ' THR . 1.3 p -60.35 111.16 1.45 Allowed 'General case' 0 N--CA 1.43 -1.425 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 175.636 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' SER . . . . . 0.662 ' HB2' ' O ' ' A' ' 117' ' ' LEU . 23.2 p -106.79 172.2 6.95 Favored 'General case' 0 N--CA 1.41 -2.471 0 N-CA-C 114.93 1.455 . . . . 0.0 114.93 -169.166 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . 0.405 ' HB ' ' CG2' ' A' ' 146' ' ' THR . 12.2 tt -101.16 105.23 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.491 0 CA-C-N 114.81 -1.086 . . . . 0.0 110.869 -173.406 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' SER . . . . . 0.496 ' HG ' ' HB2' ' A' ' 144' ' ' TYR . 45.7 p -91.54 114.36 26.87 Favored 'General case' 0 N--CA 1.414 -2.269 0 CA-C-N 115.157 -0.928 . . . . 0.0 109.685 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' THR . . . . . 0.652 ' HB ' ' O ' ' A' ' 115' ' ' GLY . 46.6 m -119.54 153.87 34.74 Favored 'General case' 0 C--N 1.279 -2.476 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 -179.791 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -106.41 35.36 2.98 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 178.326 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . 57.54 34.87 25.15 Favored 'General case' 0 C--N 1.355 0.805 0 CA-C-N 115.046 -0.979 . . . . 0.0 109.065 -177.389 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 47.2 t -173.1 -77.96 0.01 OUTLIER 'General case' 0 C--O 1.211 -0.935 0 CA-C-N 114.731 -1.122 . . . . 0.0 109.683 -174.234 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 81.6 mttt -89.93 150.97 21.94 Favored 'General case' 0 CA--C 1.497 -1.068 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 179.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 13.1 p -118.93 142.91 31.71 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.067 0 CA-C-O 121.416 0.627 . . . . 0.0 111.686 -175.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . 0.496 ' HB2' ' HG ' ' A' ' 137' ' ' SER . 87.4 m-85 -121.55 114.9 21.86 Favored 'General case' 0 N--CA 1.423 -1.799 0 N-CA-C 106.163 -1.791 . . . . 0.0 106.163 171.475 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . 0.493 ' HB3' ' HB2' ' A' ' 151' ' ' LYS . 65.0 t80 -53.74 156.2 2.85 Favored 'General case' 0 C--O 1.252 1.223 0 C-N-CA 124.539 1.135 . . . . 0.0 113.094 -171.831 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.457 ' O ' HG23 ' A' ' 125' ' ' THR . 33.7 p -51.1 93.65 0.01 OUTLIER 'General case' 0 C--N 1.35 0.609 0 C-N-CA 125.181 1.392 . . . . 0.0 113.793 -175.573 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . 0.422 ' HA ' ' HB ' ' A' ' 134' ' ' THR . . . 163.27 -35.71 0.0 OUTLIER 'General case' 0 CA--C 1.497 -1.061 0 C-N-CA 127.171 2.188 . . . . 0.0 106.31 178.676 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 100.63 79.07 1.4 Allowed Glycine 0 N--CA 1.434 -1.493 0 CA-C-N 114.963 -1.017 . . . . 0.0 111.807 179.016 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 16.3 tpt 72.51 -10.24 0.96 Allowed 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 123.877 0.871 . . . . 0.0 112.698 177.155 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -62.38 -30.53 71.27 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 121.062 0.458 . . . . 0.0 110.023 -179.014 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . 0.493 ' HB2' ' HB3' ' A' ' 145' ' ' PHE . 10.0 mmpt? -121.86 118.76 29.75 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 106.521 -1.659 . . . . 0.0 106.521 175.122 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 32.1 p -91.39 111.66 23.24 Favored 'General case' 0 C--N 1.297 -1.708 0 CA-C-O 120.617 0.246 . . . . 0.0 111.174 -177.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 37.6 mmt180 -134.88 137.3 43.09 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 179.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 20.0 m -90.2 132.47 35.47 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 111.504 0.187 . . . . 0.0 111.504 -176.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' ARG . . . . . 0.473 ' HD3' ' O ' ' A' ' 155' ' ' ARG . 2.0 tmt_? -65.01 -26.5 68.31 Favored 'General case' 0 N--CA 1.483 1.196 0 CA-C-O 121.107 0.479 . . . . 0.0 109.898 177.494 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -38.04 -48.11 1.17 Allowed 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 126.102 1.761 . . . . 0.0 115.576 -175.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -79.33 -54.92 5.47 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 113.899 1.074 . . . . 0.0 113.899 -173.212 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . 0.577 ' HB2' ' NE2' ' A' ' 161' ' ' GLN . 98.3 m-85 -153.19 24.5 0.55 Allowed 'General case' 0 N--CA 1.482 1.151 0 O-C-N 122.242 -0.286 . . . . 0.0 110.536 -176.658 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . 0.619 ' HA3' ' O ' ' A' ' 65' ' ' ILE . . . 87.78 -92.41 1.8 Allowed Glycine 0 CA--C 1.475 -2.46 0 C-N-CA 119.672 -1.252 . . . . 0.0 111.618 -177.597 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.549 ' HB ' ' O ' ' A' ' 67' ' ' ILE . 28.6 t -98.58 121.92 49.68 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.191 0 C-N-CA 119.67 -0.812 . . . . 0.0 108.91 -179.797 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' GLN . . . . . 0.577 ' NE2' ' HB2' ' A' ' 158' ' ' TYR . 25.7 mm-40 -103.88 92.95 4.63 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 115.78 1.77 . . . . 0.0 115.78 -175.188 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 17.0 mmm180 -152.66 150.27 29.29 Favored 'General case' 0 CA--C 1.501 -0.93 0 C-N-CA 125.624 1.57 . . . . 0.0 108.754 170.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 19.7 m120 -89.88 97.69 11.33 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-O 120.964 0.412 . . . . 0.0 111.415 -178.491 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -136.57 156.07 22.91 Favored Glycine 0 C--N 1.308 -1.025 0 N-CA-C 110.615 -0.994 . . . . 0.0 110.615 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -135.83 116.63 14.07 Favored 'General case' 0 N--CA 1.425 -1.703 0 CA-C-O 121.38 0.609 . . . . 0.0 109.5 178.355 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . 0.533 ' HD2' ' N ' ' A' ' 166' ' ' ARG . 3.3 mpt_? -81.3 105.83 12.79 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 106.39 -1.707 . . . . 0.0 106.39 178.63 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 9.2 m -71.43 77.08 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.925 0 N-CA-C 114.976 1.473 . . . . 0.0 114.976 -174.25 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . 0.547 ' HB2' ' HB2' ' A' ' 90' ' ' SER . 15.4 t70 -144.41 -34.01 0.38 Allowed 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 114.072 -1.422 . . . . 0.0 107.279 177.588 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -111.86 157.4 20.66 Favored 'General case' 0 N--CA 1.439 -1.015 0 CA-C-N 114.543 -1.208 . . . . 0.0 108.039 178.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' PHE . . . . . . . . . . . . . 16.0 p90 . . . . . 0 C--N 1.305 -1.366 0 O-C-N 123.248 0.342 . . . . 0.0 111.349 179.405 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 20.4 m . . . . . 0 N--CA 1.44 -0.955 0 N-CA-C 109.022 -0.732 . . . . 0.0 109.022 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 57.74 79.63 0.19 Allowed 'General case' 0 C--O 1.248 1.026 0 C-N-CA 123.396 0.678 . . . . 0.0 111.18 179.357 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 52.9 mt-30 -85.07 106.06 16.27 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-N 115.516 -0.766 . . . . 0.0 111.354 -176.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 7.0 tt -145.14 118.68 2.69 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.816 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.282 178.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 30.8 p90 -147.14 106.35 3.88 Favored 'General case' 0 C--N 1.298 -1.66 0 CA-C-O 121.411 0.624 . . . . 0.0 110.145 -179.063 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 28.3 p-10 -160.73 149.42 16.57 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.325 -178.547 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.13 92.46 2.49 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-O 121.8 0.809 . . . . 0.0 111.575 178.007 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 9.6 p -101.64 145.35 11.77 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 CA-C-N 115.01 -0.995 . . . . 0.0 108.773 178.248 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 95.87 31.66 7.24 Favored Glycine 0 N--CA 1.435 -1.381 0 N-CA-C 110.564 -1.014 . . . . 0.0 110.564 -178.223 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 28.1 t -93.3 101.55 13.8 Favored 'General case' 0 N--CA 1.42 -1.948 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 -179.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 90.3 m-85 -106.38 103.06 12.43 Favored 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 109.414 -0.588 . . . . 0.0 109.414 179.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 85.5 t90 -99.66 120.04 39.06 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.468 -178.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -160.76 154.75 22.76 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 107.783 -1.192 . . . . 0.0 107.783 177.191 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 159.53 46.63 0.01 OUTLIER Glycine 0 N--CA 1.433 -1.513 0 C-N-CA 119.768 -1.206 . . . . 0.0 112.947 178.335 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -86.73 95.68 9.9 Favored 'General case' 0 C--N 1.312 -1.051 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 177.062 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -119.44 104.2 10.13 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 115.925 -0.579 . . . . 0.0 109.683 -178.26 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -93.16 96.72 10.2 Favored 'General case' 0 C--N 1.296 -1.735 0 CA-C-O 121.11 0.481 . . . . 0.0 109.841 178.125 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -116.09 105.0 12.12 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.147 -179.424 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 37.8 ttpt -119.04 101.76 8.26 Favored 'General case' 0 C--N 1.292 -1.907 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.127 -176.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -136.3 108.78 7.39 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.645 -176.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 48.8 p90 -155.98 148.24 23.53 Favored 'General case' 0 C--N 1.292 -1.91 0 N-CA-C 106.505 -1.665 . . . . 0.0 106.505 175.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -118.74 99.04 6.52 Favored 'General case' 0 C--N 1.292 -1.908 0 C-N-CA 120.125 -0.63 . . . . 0.0 109.705 -177.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 54.3 p -76.79 96.62 4.3 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.572 -178.135 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 12.6 p -151.08 148.98 14.54 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 178.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 130.16 78.13 0.19 Allowed Glycine 0 N--CA 1.435 -1.43 0 N-CA-C 110.86 -0.896 . . . . 0.0 110.86 -179.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -112.75 114.68 27.35 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 -178.617 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 31.8 m-20 -85.03 115.86 23.09 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-O 121.23 0.538 . . . . 0.0 110.88 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 89.3 mt -123.91 144.78 49.56 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.44 178.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 32.7 p30 -156.84 155.83 32.16 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.245 177.232 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 21.4 m -114.85 162.72 16.52 Favored 'General case' 0 C--N 1.295 -1.799 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.4 -178.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 58.6 t -88.52 110.49 21.25 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.244 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 -178.411 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 42.1 t -104.52 112.07 24.98 Favored 'General case' 0 C--N 1.311 -1.104 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 177.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 8.7 t -156.95 154.89 30.42 Favored 'General case' 0 N--CA 1.428 -1.571 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 9.5 t -163.32 90.95 0.68 Allowed 'General case' 0 N--CA 1.424 -1.729 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 176.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 62.0 mt -111.77 112.34 40.11 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 177.708 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -146.22 159.71 42.96 Favored 'General case' 0 C--N 1.293 -1.878 0 C-N-CA 120.55 -0.46 . . . . 0.0 110.126 -178.174 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -165.89 -154.28 8.1 Favored Glycine 0 N--CA 1.42 -2.386 0 N-CA-C 110.665 -0.974 . . . . 0.0 110.665 179.43 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -133.32 -174.88 13.71 Favored Glycine 0 N--CA 1.419 -2.445 0 N-CA-C 111.656 -0.578 . . . . 0.0 111.656 -178.339 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 9.3 t -145.05 176.35 9.56 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 59.9 mttp -63.08 119.81 10.22 Favored 'General case' 0 C--N 1.322 -0.59 0 O-C-N 123.424 0.452 . . . . 0.0 110.16 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 57.1 t90 -68.55 -77.89 0.07 Allowed 'General case' 0 C--N 1.306 -1.324 0 CA-C-N 115.204 -0.907 . . . . 0.0 112.396 -176.425 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.4 tt -170.76 34.72 0.02 OUTLIER 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 104.48 -2.415 . . . . 0.0 104.48 -175.138 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 12.6 p -70.02 146.17 12.5 Favored 'Isoleucine or valine' 0 C--O 1.245 0.835 0 CA-C-N 115.072 -0.967 . . . . 0.0 111.46 -173.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 57.8 t30 76.73 11.33 2.59 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 125.079 1.352 . . . . 0.0 110.022 -179.033 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 28.1 mtpp -145.19 128.4 16.72 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.242 -0.89 . . . . 0.0 108.896 -179.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -137.55 163.03 31.79 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.17 0 O-C-N 122.005 -0.434 . . . . 0.0 111.295 178.615 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -139.79 155.36 47.33 Favored 'General case' 0 C--N 1.312 -1.043 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 176.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -178.36 151.61 10.72 Favored Glycine 0 N--CA 1.43 -1.758 0 C-N-CA 119.755 -1.212 . . . . 0.0 112.242 177.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 58.9 tptt -104.82 -51.11 3.12 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 106.66 -1.607 . . . . 0.0 106.66 175.069 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 26.3 ttt -146.05 80.4 1.57 Allowed 'General case' 0 N--CA 1.432 -1.372 0 CA-C-N 114.654 -1.157 . . . . 0.0 108.793 177.319 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER 72.53 -46.86 0.66 Allowed 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 124.872 1.269 . . . . 0.0 111.291 179.782 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 25.0 ttmm 75.07 92.24 0.05 OUTLIER Pre-proline 0 C--O 1.219 -0.504 0 C-N-CA 125.117 1.367 . . . . 0.0 108.146 -174.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -68.7 3.68 2.15 Favored 'Trans proline' 0 N--CA 1.481 0.776 0 C-N-CA 123.593 2.862 . . . . 0.0 115.506 -170.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 8.4 mp -54.75 -47.05 99.16 Favored Pre-proline 0 CA--C 1.489 -1.383 0 N-CA-C 117.272 2.323 . . . . 0.0 117.272 -177.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.56 ' HA ' ' HG ' ' A' ' 58' ' ' LEU . 13.1 Cg_exo -66.39 -14.51 44.46 Favored 'Trans proline' 0 N--CA 1.416 -3.05 0 CA-C-N 120.183 1.101 . . . . 0.0 111.857 -175.131 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -74.05 -32.19 63.2 Favored 'General case' 0 N--CA 1.426 -1.644 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 -179.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.49 ' HA ' ' HG2' ' A' ' 60' ' ' GLU . 3.7 mm? -73.88 -41.73 61.75 Favored 'General case' 0 N--CA 1.423 -1.825 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 175.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.56 ' HG ' ' HA ' ' A' ' 55' ' ' PRO . 52.0 mt -58.2 -48.08 81.43 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.735 -177.864 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.481 ' HB3' ' HZ3' ' A' ' 59' ' ' LYS . 7.4 mtpm? -70.84 -26.58 63.34 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 115.296 -0.865 . . . . 0.0 112.319 -178.036 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.49 ' HG2' ' HA ' ' A' ' 57' ' ' LEU . 8.6 pt-20 -83.84 -18.49 37.39 Favored 'General case' 0 N--CA 1.444 -0.762 0 C-N-CA 118.957 -1.097 . . . . 0.0 109.854 177.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 61.2 m-85 -89.08 -13.91 37.52 Favored 'General case' 0 C--O 1.24 0.604 0 C-N-CA 119.095 -1.042 . . . . 0.0 112.119 175.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.494 ' CG ' ' H ' ' A' ' 63' ' ' LEU . 23.5 t70 -91.93 -153.95 0.35 Allowed 'General case' 0 C--O 1.253 1.27 0 N-CA-C 105.782 -1.933 . . . . 0.0 105.782 172.698 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.523 ' HB2' HD11 ' A' ' 65' ' ' ILE . 5.1 mt -95.16 158.17 35.26 Favored Pre-proline 0 C--N 1.298 -1.661 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 -178.057 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -93.86 26.6 0.34 Allowed 'Trans proline' 0 N--CA 1.448 -1.19 0 C-N-CA 122.849 2.366 . . . . 0.0 111.143 -168.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.549 HG12 ' H ' ' A' ' 67' ' ' ILE . 0.2 OUTLIER -95.11 -21.58 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.778 0 CA-C-N 115.331 -0.849 . . . . 0.0 108.966 -177.995 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 67.64 8.92 54.33 Favored Glycine 0 C--N 1.353 1.481 0 CA-C-N 115.501 -0.772 . . . . 0.0 112.195 179.548 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.556 ' O ' HG22 ' A' ' 160' ' ' VAL . 73.0 mt 57.79 -70.78 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.203 -1.344 0 C-N-CA 127.184 2.193 . . . . 0.0 112.613 -173.044 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.44 ' HB3' ' HD3' ' A' ' 69' ' ' PRO . 79.5 t80 176.73 -50.53 0.0 OUTLIER Pre-proline 0 C--N 1.303 -1.449 0 C-N-CA 122.853 0.461 . . . . 0.0 110.392 -174.578 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.481 ' HB3' ' HD3' ' A' ' 166' ' ' ARG . 24.8 Cg_exo -67.58 131.69 25.15 Favored 'Trans proline' 0 N--CA 1.436 -1.876 0 N-CA-C 109.046 -1.175 . . . . 0.0 109.046 174.386 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -73.7 64.58 1.84 Allowed Glycine 0 C--N 1.306 -1.102 0 O-C-N 123.439 0.462 . . . . 0.0 113.045 -177.275 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 12.7 t70 177.43 -39.65 0.01 OUTLIER 'General case' 0 C--O 1.21 -0.978 0 N-CA-C 107.737 -1.208 . . . . 0.0 107.737 179.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.644 ' O ' ' HB ' ' A' ' 73' ' ' THR . . . -46.48 166.28 0.02 OUTLIER 'General case' 0 N--CA 1.506 2.365 0 C-N-CA 124.273 1.029 . . . . 0.0 112.753 174.624 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.644 ' HB ' ' O ' ' A' ' 72' ' ' ALA 0.254 1.5 m 88.11 26.22 0.03 OUTLIER 'General case' 0 C--N 1.367 1.346 0 CA-C-O 125.071 2.367 . . . . 0.0 109.665 -178.97 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 40.7 m-80 -82.23 163.88 21.57 Favored 'General case' 0 N--CA 1.411 -2.376 0 CA-C-N 113.725 -1.58 . . . . 0.0 111.033 177.404 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.436 ' H ' ' HB3' ' A' ' 58' ' ' LEU . 33.7 t80 -134.52 95.6 3.41 Favored 'General case' 0 C--N 1.274 -2.702 0 CA-C-N 115.151 -0.932 . . . . 0.0 111.923 -168.893 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.491 ' O ' HD22 ' A' ' 84' ' ' LEU . 41.0 mm-40 -115.89 153.46 31.5 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 173.667 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 69.0 t80 -146.08 114.47 6.71 Favored 'General case' 0 C--N 1.29 -1.98 0 O-C-N 122.046 -0.409 . . . . 0.0 110.04 -177.023 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.58 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 31.7 m-20 -88.67 148.95 23.75 Favored 'General case' 0 CA--C 1.459 -2.535 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 175.622 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -82.37 -41.18 20.31 Favored 'General case' 1 C--N 1.24 -4.172 0 CA-C-N 114.796 -1.093 . . . . 0.0 111.916 179.307 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -61.84 -41.7 98.14 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-O 122.236 1.017 . . . . 0.0 109.332 178.331 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.58 ' HB ' ' HB2' ' A' ' 78' ' ' ASP . 46.2 m -70.76 -51.31 27.9 Favored 'General case' 0 N--CA 1.412 -2.374 0 CA-C-N 113.799 -1.546 . . . . 0.0 108.045 177.14 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 80.0 tttt 68.2 9.01 6.95 Favored 'General case' 0 C--N 1.348 0.533 0 C-N-CA 126.144 1.778 . . . . 0.0 110.398 178.563 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.514 ' HG2' HG23 ' A' ' 109' ' ' THR . 75.5 tttt -117.7 133.86 55.51 Favored 'General case' 0 N--CA 1.409 -2.505 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 179.363 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.491 HD22 ' O ' ' A' ' 76' ' ' GLU . 2.7 tm? -64.44 133.76 53.15 Favored 'General case' 0 C--N 1.317 -0.841 0 C-N-CA 123.101 0.561 . . . . 0.0 110.149 -172.554 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.452 ' HB ' HG22 ' A' ' 109' ' ' THR . 6.0 t -117.1 111.44 19.51 Favored 'General case' 0 N--CA 1.412 -2.372 0 CA-C-O 122.128 0.966 . . . . 0.0 111.577 -177.593 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 58.0 t -92.87 126.01 45.37 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.272 0 CA-C-N 114.89 -1.05 . . . . 0.0 108.433 177.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.475 ' HA ' ' O ' ' A' ' 106' ' ' THR . 1.9 pp -105.02 124.4 49.46 Favored 'General case' 0 N--CA 1.408 -2.572 0 CA-C-N 115.242 -0.89 . . . . 0.0 112.16 178.276 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 3.0 mp -110.06 125.04 31.93 Favored Pre-proline 0 C--N 1.293 -1.855 0 CA-C-N 114.063 -1.426 . . . . 0.0 109.089 178.453 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.425 ' O ' ' HB3' ' A' ' 166' ' ' ARG . 2.6 Cg_endo -52.23 98.59 0.04 OUTLIER 'Trans proline' 0 C--N 1.363 1.306 0 C-N-CA 123.395 2.73 . . . . 0.0 112.206 173.216 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.481 ' HB2' ' HB2' ' A' ' 168' ' ' ASP . 43.3 t 74.03 141.56 0.07 Allowed 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 124.326 1.05 . . . . 0.0 112.512 -179.534 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.455 HD12 ' HG3' ' A' ' 103' ' ' LYS . 0.0 OUTLIER -76.49 108.37 9.08 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.132 0 CA-C-N 114.999 -1.0 . . . . 0.0 109.005 176.644 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' CYS . . . . . 0.452 ' HG ' ' HB2' ' A' ' 104' ' ' PHE . 25.1 p -91.83 127.22 37.21 Favored 'General case' 0 N--CA 1.431 -1.419 0 CA-C-N 114.838 -1.074 . . . . 0.0 110.56 -179.756 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -107.8 159.59 16.38 Favored 'General case' 0 C--O 1.244 0.766 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.25 -179.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.607 ' O ' ' HA ' ' A' ' 101' ' ' VAL . 2.6 p -156.95 109.01 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.141 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 -178.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . 0.558 ' HA2' ' O ' ' A' ' 100' ' ' SER . . . -145.94 170.89 27.04 Favored Glycine 0 N--CA 1.423 -2.233 0 C-N-CA 119.022 -1.561 . . . . 0.0 114.239 -178.114 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 87.6 m-85 -127.22 -157.1 0.79 Allowed 'General case' 0 N--CA 1.404 -2.741 0 N-CA-C 102.776 -3.046 . . . . 0.0 102.776 170.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.15 -11.72 61.05 Favored 'General case' 0 C--N 1.293 -1.861 0 C-N-CA 118.675 -1.21 . . . . 0.0 111.158 175.414 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 25.9 t70 177.93 -53.93 0.01 OUTLIER 'General case' 0 C--N 1.382 1.998 0 N-CA-C 114.33 1.233 . . . . 0.0 114.33 177.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 49.9 m -44.98 -28.52 0.69 Allowed 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 115.201 1.556 . . . . 0.0 115.201 -168.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.558 ' O ' ' HA2' ' A' ' 95' ' ' GLY . 54.3 m -152.77 83.53 1.22 Allowed 'General case' 0 C--N 1.287 -2.143 0 C-N-CA 120.952 -0.299 . . . . 0.0 110.945 177.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.607 ' HA ' ' O ' ' A' ' 94' ' ' VAL . 11.3 p -117.27 132.97 65.49 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.507 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 171.771 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.47 ' HG ' ' HA ' ' A' ' 125' ' ' THR . 6.8 tt -152.78 145.41 24.24 Favored 'General case' 0 N--CA 1.405 -2.702 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 -175.642 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.455 ' HG3' HD12 ' A' ' 91' ' ' ILE . 39.8 ttmt -129.99 121.1 25.87 Favored 'General case' 0 C--N 1.291 -1.965 0 N-CA-C 111.937 0.347 . . . . 0.0 111.937 -177.331 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.452 ' HB2' ' HG ' ' A' ' 92' ' ' CYS . 89.4 m-85 -95.36 103.6 15.47 Favored 'General case' 0 N--CA 1.439 -1.008 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 175.293 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 41.1 m -70.82 149.74 46.53 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 109.889 -0.411 . . . . 0.0 109.889 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' THR . . . . . 0.475 ' O ' ' HA ' ' A' ' 87' ' ' LEU . 37.8 p -54.07 -53.75 48.88 Favored 'General case' 0 C--O 1.216 -0.691 0 CA-C-O 121.666 0.746 . . . . 0.0 110.985 -178.26 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 7.5 m -113.73 93.54 4.43 Favored 'General case' 0 N--CA 1.399 -2.994 0 CA-C-N 115.056 -0.974 . . . . 0.0 109.619 -176.408 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.461 HG11 ' CD1' ' A' ' 123' ' ' ILE . 15.1 m -99.46 155.59 4.03 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.546 177.531 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.514 HG23 ' HG2' ' A' ' 83' ' ' LYS . 0.4 OUTLIER -137.24 128.73 28.35 Favored 'General case' 0 N--CA 1.398 -3.072 0 N-CA-C 106.05 -1.833 . . . . 0.0 106.05 -173.831 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . 0.439 ' HA2' ' O ' ' A' ' 119' ' ' ASP . . . -151.12 -174.57 22.15 Favored Glycine 0 C--N 1.286 -2.208 0 C-N-CA 119.979 -1.105 . . . . 0.0 113.714 -175.706 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . 0.453 ' O ' HD13 ' A' ' 117' ' ' LEU . 45.0 t60 -91.33 117.93 30.08 Favored 'General case' 0 C--N 1.294 -1.821 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 179.727 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -99.92 117.91 35.22 Favored 'General case' 0 CA--C 1.479 -1.752 0 CA-C-O 121.014 0.435 . . . . 0.0 110.879 -171.132 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -126.74 138.34 53.37 Favored 'General case' 0 CA--C 1.45 -2.881 0 CA-C-N 115.094 -0.957 . . . . 0.0 108.894 167.04 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 6.0 tmtt? -73.47 100.88 3.36 Favored 'General case' 0 N--CA 1.389 -3.482 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 -175.482 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . 0.535 ' O ' HG23 ' A' ' 138' ' ' THR . . . 135.78 -37.63 1.88 Allowed Glycine 0 N--CA 1.419 -2.461 0 N-CA-C 110.169 -1.172 . . . . 0.0 110.169 -176.203 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.547 ' O ' ' HD2' ' A' ' 116' ' ' LYS . 0.0 OUTLIER -154.06 136.96 15.39 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.27 0.628 . . . . 0.0 111.984 -179.441 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.453 HD13 ' O ' ' A' ' 111' ' ' HIS . 64.1 tp -111.43 107.05 16.14 Favored 'General case' 0 C--N 1.308 -1.2 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 -177.274 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 68.1 p -105.56 176.11 5.27 Favored 'General case' 0 C--N 1.296 -1.735 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.637 -179.023 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . 0.439 ' O ' ' HA2' ' A' ' 110' ' ' GLY . 16.2 m-20 56.59 48.66 16.1 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.259 0.623 . . . . 0.0 111.722 172.61 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.466 HG23 ' O ' ' A' ' 133' ' ' VAL . 3.3 m -81.93 96.18 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.656 0 CA-C-O 122.662 1.22 . . . . 0.0 112.29 -176.253 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -75.94 94.12 3.34 Favored 'General case' 0 N--CA 1.401 -2.886 0 CA-C-N 113.253 -1.794 . . . . 0.0 108.438 -178.56 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 134.7 -4.85 4.39 Favored Glycine 0 C--N 1.285 -2.299 0 CA-C-N 115.063 -0.971 . . . . 0.0 111.816 177.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.461 ' CD1' HG11 ' A' ' 108' ' ' VAL . 48.9 mm -99.91 99.58 8.78 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.229 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 177.039 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 53.4 mtmt -93.44 119.26 32.32 Favored 'General case' 0 N--CA 1.411 -2.382 0 CA-C-N 114.355 -1.293 . . . . 0.0 108.605 -179.092 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.47 ' HA ' ' HG ' ' A' ' 102' ' ' LEU . 99.1 m -128.1 131.87 49.01 Favored 'General case' 0 N--CA 1.422 -1.852 0 CA-C-N 114.771 -1.104 . . . . 0.0 112.918 -167.782 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.646 ' HD3' ' C ' ' A' ' 126' ' ' LYS . 0.2 OUTLIER -123.05 119.71 31.16 Favored 'General case' 0 N--CA 1.418 -2.068 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 170.825 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.422 HG21 ' H ' ' A' ' 128' ' ' MET . 4.8 m -139.17 -56.57 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.031 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.388 176.934 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' MET . . . . . 0.422 ' H ' HG21 ' A' ' 127' ' ' VAL . 26.8 ttt -99.57 -34.96 10.02 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 178.168 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . 0.565 ' CD1' ' H ' ' A' ' 130' ' ' TRP . 0.3 OUTLIER -162.57 -177.71 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.418 -2.074 0 N-CA-C 103.499 -2.778 . . . . 0.0 103.499 176.615 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' TRP . . . . . 0.565 ' H ' ' CD1' ' A' ' 129' ' ' ILE . 88.4 t90 -92.29 123.76 35.85 Favored 'General case' 0 C--N 1.296 -1.733 0 CA-C-N 119.55 1.068 . . . . 0.0 109.797 -179.658 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.504 HG12 ' H ' ' A' ' 133' ' ' VAL . 61.1 t -131.55 136.69 56.85 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.08 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 179.631 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . 0.488 ' HD3' ' H ' ' A' ' 132' ' ' LYS . 0.0 OUTLIER -98.89 21.77 11.11 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-O 121.019 0.437 . . . . 0.0 111.237 -178.056 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.504 ' H ' HG12 ' A' ' 131' ' ' VAL . 51.5 t -132.05 -78.73 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.251 0 CA-C-N 116.214 -0.448 . . . . 0.0 109.959 -175.689 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 40.0 p 51.86 -167.01 0.05 OUTLIER 'General case' 0 CA--C 1.555 1.155 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 -177.068 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 27.6 p -164.04 150.39 11.33 Favored 'General case' 0 N--CA 1.429 -1.52 0 C-N-CA 122.637 0.375 . . . . 0.0 110.146 -179.43 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 7.5 tt -105.7 97.41 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.884 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 173.502 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 60.6 p -97.58 142.63 29.16 Favored 'General case' 0 N--CA 1.405 -2.686 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.997 -177.011 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' THR . . . . . 0.535 HG23 ' O ' ' A' ' 115' ' ' GLY . 5.8 t -165.08 175.07 9.72 Favored 'General case' 0 N--CA 1.399 -2.988 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 -177.794 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -110.71 28.52 8.61 Favored 'General case' 0 C--N 1.285 -2.23 0 N-CA-C 106.306 -1.739 . . . . 0.0 106.306 176.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . 61.46 44.06 9.72 Favored 'General case' 0 C--N 1.348 0.529 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 -171.115 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 30.8 t -174.96 -80.29 0.01 OUTLIER 'General case' 0 CA--C 1.555 1.149 0 CA-C-N 114.783 -1.099 . . . . 0.0 110.973 -171.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -83.96 128.6 34.66 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 179.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 88.8 t -105.49 127.83 60.01 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.973 0 CA-C-O 121.516 0.674 . . . . 0.0 112.093 -171.001 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 26.7 m-85 -118.41 141.25 48.74 Favored 'General case' 0 N--CA 1.426 -1.64 0 CA-C-N 115.318 -0.855 . . . . 0.0 111.138 179.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 42.9 m-85 -93.21 98.75 11.48 Favored 'General case' 0 N--CA 1.408 -2.525 0 CA-C-N 114.382 -1.281 . . . . 0.0 108.371 171.377 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . 0.259 2.5 p -98.42 99.71 10.91 Favored 'General case' 0 N--CA 1.406 -2.639 0 N-CA-C 115.061 1.504 . . . . 0.0 115.061 -176.221 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -130.35 29.62 4.84 Favored 'General case' 0 C--N 1.312 -1.031 0 N-CA-C 105.445 -2.057 . . . . 0.0 105.445 174.524 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 133.99 -69.33 0.53 Allowed Glycine 0 N--CA 1.413 -2.847 0 N-CA-C 104.016 -3.633 . . . . 0.0 104.016 -171.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 27.7 ttt 173.3 82.86 0.0 OUTLIER 'General case' 0 C--N 1.314 -0.971 0 C-N-CA 125.885 1.674 . . . . 0.0 108.147 169.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 29.4 mmtt -88.84 -88.74 0.15 Allowed 'General case' 0 C--N 1.308 -1.196 0 N-CA-C 115.09 1.515 . . . . 0.0 115.09 -179.513 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -110.26 149.1 30.65 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 113.354 0.872 . . . . 0.0 113.354 -172.469 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 20.3 m -132.64 137.77 47.12 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.818 -176.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.28 162.84 40.78 Favored 'General case' 0 CA--C 1.477 -1.849 0 CA-C-O 121.317 0.58 . . . . 0.0 111.661 175.129 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 46.4 m -90.18 139.85 30.24 Favored 'General case' 0 C--N 1.274 -2.689 0 CA-C-N 115.284 -0.871 . . . . 0.0 108.858 179.12 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . 0.407 0.0 OUTLIER -58.68 -18.54 31.81 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 114.28 1.215 . . . . 0.0 114.28 -179.783 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -50.06 -32.4 15.46 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 124.632 1.173 . . . . 0.0 111.489 178.494 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -68.04 -54.05 21.26 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 116.576 -0.283 . . . . 0.0 110.827 179.708 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 1.1 t80 177.95 21.6 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.0 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 177.205 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 88.71 -99.41 2.54 Favored Glycine 0 N--CA 1.419 -2.472 0 C-N-CA 119.779 -1.201 . . . . 0.0 111.098 -174.08 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.556 HG22 ' O ' ' A' ' 67' ' ' ILE . 4.2 m -103.09 128.79 55.74 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.304 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 49.9 mt-30 -94.02 92.13 7.19 Favored 'General case' 0 C--N 1.294 -1.824 0 C-N-CA 119.176 -1.01 . . . . 0.0 111.151 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . 0.506 ' CG ' HG11 ' A' ' 94' ' ' VAL . 21.0 tpp180 -152.49 112.2 3.95 Favored 'General case' 0 N--CA 1.414 -2.228 0 N-CA-C 106.857 -1.534 . . . . 0.0 106.857 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 83.7 m-20 -77.05 105.97 8.46 Favored 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 -174.402 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -118.76 -178.22 16.81 Favored Glycine 0 C--N 1.3 -1.434 0 N-CA-C 110.18 -1.168 . . . . 0.0 110.18 176.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.522 ' O ' HD21 ' A' ' 165' ' ' LEU . 0.0 OUTLIER -141.55 131.74 24.89 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 177.431 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . 0.481 ' HD3' ' HB3' ' A' ' 69' ' ' PRO . 9.5 mtm180 -96.05 111.1 23.21 Favored 'General case' 0 CA--C 1.482 -1.667 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 -179.788 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . 0.287 2.6 m -80.84 65.92 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.103 0 CA-C-O 122.906 1.336 . . . . 0.0 111.181 173.32 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . 0.481 ' HB2' ' HB2' ' A' ' 90' ' ' SER . 21.7 t70 -160.87 -27.49 0.06 Allowed 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 112.33 -2.214 . . . . 0.0 108.426 -177.293 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 21.6 pttp -74.85 149.51 39.54 Favored 'General case' 0 C--O 1.244 0.796 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.863 -173.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' PHE . . . . . . . . . . . . . 16.9 p90 . . . . . 0 C--N 1.297 -1.698 0 CA-C-O 118.189 -0.91 . . . . 0.0 110.039 -179.785 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 39.5 t . . . . . 0 N--CA 1.452 -0.344 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -88.96 101.24 13.88 Favored 'General case' 0 CA--C 1.495 -1.157 0 CA-C-O 120.807 0.337 . . . . 0.0 110.11 179.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 29.2 tt0 -155.52 85.86 1.06 Allowed 'General case' 0 N--CA 1.422 -1.828 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 177.053 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 7.1 tp -151.42 87.83 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 CA-C-O 122.414 1.102 . . . . 0.0 109.505 177.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 86.0 m-85 -112.65 126.5 55.44 Favored 'General case' 0 C--N 1.293 -1.889 0 CA-C-N 114.971 -1.013 . . . . 0.0 109.604 -177.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 43.8 t30 -77.39 92.72 3.98 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 177.493 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 35.1 mmtp -95.18 107.79 19.89 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.433 -179.467 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 6.0 p -80.94 118.6 29.0 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.244 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.685 177.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -91.69 150.97 20.62 Favored Glycine 0 N--CA 1.427 -1.913 0 N-CA-C 110.918 -0.873 . . . . 0.0 110.918 179.285 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 19.9 m -66.95 131.76 46.55 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 179.505 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 42.5 p90 -100.5 102.19 13.31 Favored 'General case' 0 N--CA 1.433 -1.288 0 CA-C-O 121.674 0.75 . . . . 0.0 110.868 179.028 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 14.8 m-90 -83.3 146.23 28.64 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 178.39 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -137.62 146.32 43.8 Favored 'General case' 0 C--N 1.302 -1.458 0 C-N-CA 120.396 -0.522 . . . . 0.0 111.597 -175.184 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -88.76 67.19 3.02 Favored Glycine 0 N--CA 1.433 -1.549 0 N-CA-C 110.746 -0.942 . . . . 0.0 110.746 178.256 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -82.89 166.84 18.59 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-O 120.759 0.314 . . . . 0.0 111.499 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 61.3 mttp 63.66 64.48 0.79 Allowed 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.37 -177.143 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -95.89 91.22 5.92 Favored 'General case' 0 N--CA 1.418 -2.048 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 175.276 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -92.76 139.5 30.49 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.155 -177.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.469 ' HD3' ' N ' ' A' ' 19' ' ' LYS . 0.1 OUTLIER -139.08 154.56 48.19 Favored 'General case' 0 C--N 1.29 -2.009 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 -177.151 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -144.12 100.24 3.52 Favored 'General case' 0 C--N 1.287 -2.133 0 N-CA-C 106.026 -1.842 . . . . 0.0 106.026 176.169 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 47.0 p90 -70.0 138.6 52.36 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-O 121.22 0.533 . . . . 0.0 111.939 -174.491 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -82.05 144.2 30.99 Favored 'General case' 0 C--N 1.291 -1.961 0 CA-C-N 115.397 -0.819 . . . . 0.0 108.854 178.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 33.1 m -128.2 101.78 6.41 Favored 'General case' 0 C--N 1.281 -2.382 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 179.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 41.9 t -101.13 154.02 4.76 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 -179.476 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -75.0 61.18 2.6 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 121.683 -0.294 . . . . 0.0 112.577 -179.436 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 -98.28 77.13 2.36 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-O 121.125 0.488 . . . . 0.0 109.81 -179.472 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.445 ' CG ' ' H ' ' A' ' 28' ' ' LEU . 21.6 t70 -172.67 -168.2 0.49 Allowed 'General case' 0 C--N 1.31 -1.149 0 N-CA-C 105.856 -1.905 . . . . 0.0 105.856 -179.209 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.445 ' H ' ' CG ' ' A' ' 27' ' ' ASP . 54.7 tp 62.77 82.7 0.17 Allowed 'General case' 0 C--O 1.237 0.398 0 CA-C-O 121.885 0.85 . . . . 0.0 109.907 -176.509 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -121.48 -173.75 2.7 Favored 'General case' 0 C--N 1.294 -1.817 0 CA-C-N 115.099 -0.955 . . . . 0.0 110.264 -176.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 20.3 m -92.42 125.88 37.27 Favored 'General case' 0 C--N 1.299 -1.627 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.031 179.132 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 64.5 t -79.78 100.68 4.42 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 174.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 48.2 p -79.72 -25.65 41.08 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.658 -174.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 11.7 t -159.91 144.93 15.12 Favored 'General case' 0 N--CA 1.424 -1.754 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 179.528 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 20.4 m -112.54 111.28 21.99 Favored 'General case' 0 C--N 1.294 -1.832 0 N-CA-C 106.574 -1.639 . . . . 0.0 106.574 175.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 63.0 mt -76.04 108.75 8.85 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 CA-C-O 120.949 0.404 . . . . 0.0 111.355 -174.013 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -113.18 163.74 14.39 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.548 179.063 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 149.94 -176.39 28.62 Favored Glycine 0 N--CA 1.427 -1.963 0 N-CA-C 109.102 -1.599 . . . . 0.0 109.102 -178.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 167.02 -130.83 2.2 Favored Glycine 0 N--CA 1.426 -2.028 0 C-N-CA 119.357 -1.402 . . . . 0.0 112.889 179.034 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 48.1 m 67.19 87.51 0.12 Allowed 'General case' 0 C--N 1.312 -1.026 0 C-N-CA 123.91 0.884 . . . . 0.0 110.029 -175.144 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 18.1 ptpt -90.36 125.75 35.64 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 115.096 -0.956 . . . . 0.0 109.55 178.36 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 25.2 m-90 -85.8 99.22 11.21 Favored 'General case' 0 C--N 1.304 -1.406 0 CA-C-O 122.011 0.91 . . . . 0.0 112.093 -177.254 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 80.3 mt -100.85 -166.53 1.32 Allowed 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 114.581 -1.19 . . . . 0.0 108.205 178.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 70.2 t 73.19 93.81 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.244 0.77 0 CA-C-O 121.542 0.687 . . . . 0.0 109.411 -178.646 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 51.5 t-20 -140.52 124.81 17.66 Favored 'General case' 0 C--N 1.308 -1.239 0 CA-C-N 115.423 -0.808 . . . . 0.0 108.978 -175.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 64.2 mttp -123.74 -178.6 4.09 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-O 120.77 0.319 . . . . 0.0 111.723 179.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.437 HD11 ' OE1' ' A' ' 60' ' ' GLU . 62.0 mt 75.88 122.95 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 C-N-CA 125.482 1.513 . . . . 0.0 111.216 179.626 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 4.0 mptp? -86.14 -60.54 1.98 Allowed 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 108.542 -0.911 . . . . 0.0 108.542 174.646 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 116.94 144.66 7.94 Favored Glycine 0 N--CA 1.428 -1.891 0 C-N-CA 120.349 -0.929 . . . . 0.0 111.206 -179.553 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.403 ' HB3' ' HG2' ' A' ' 51' ' ' GLN . 1.0 OUTLIER -112.02 138.33 48.81 Favored 'General case' 0 C--N 1.298 -1.643 0 C-N-CA 122.514 0.326 . . . . 0.0 110.185 179.986 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 27.0 ptt? -90.19 -0.89 57.83 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-O 121.4 0.619 . . . . 0.0 110.363 -178.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . 0.403 ' HG2' ' HB3' ' A' ' 49' ' ' LYS . 13.5 pt20 -97.43 34.22 1.85 Allowed 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 175.754 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 97.1 mttt 84.79 134.6 0.04 OUTLIER Pre-proline 0 N--CA 1.468 0.436 0 C-N-CA 126.133 1.773 . . . . 0.0 109.744 -172.383 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -78.66 4.55 6.31 Favored 'Trans proline' 0 CA--C 1.511 -0.651 0 C-N-CA 122.571 2.181 . . . . 0.0 112.898 -178.553 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 9.3 mp -53.54 -51.92 71.62 Favored Pre-proline 0 CA--C 1.476 -1.892 0 N-CA-C 116.92 2.193 . . . . 0.0 116.92 -176.371 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.521 ' O ' ' HG2' ' A' ' 59' ' ' LYS . 25.8 Cg_exo -60.71 -15.53 37.95 Favored 'Trans proline' 0 N--CA 1.45 -1.079 0 C-N-CA 121.613 1.542 . . . . 0.0 111.92 -171.643 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.472 ' O ' ' HB2' ' A' ' 60' ' ' GLU . 22.6 mm-40 -80.27 -37.09 33.55 Favored 'General case' 0 N--CA 1.419 -1.989 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 179.553 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.425 ' HA ' ' HB3' ' A' ' 60' ' ' GLU . 9.3 mp -75.63 -34.27 60.53 Favored 'General case' 0 N--CA 1.438 -1.074 0 N-CA-C 113.557 0.947 . . . . 0.0 113.557 -177.412 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.402 HD11 ' N ' ' A' ' 58' ' ' LEU . 3.5 mp -63.14 -45.74 90.5 Favored 'General case' 0 N--CA 1.499 2.025 0 C-N-CA 119.29 -0.964 . . . . 0.0 109.365 -178.618 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.543 ' O ' ' HB3' ' A' ' 62' ' ' ASP . 0.0 OUTLIER -75.77 -25.85 56.82 Favored 'General case' 0 C--N 1.297 -1.689 0 CA-C-N 114.833 -1.076 . . . . 0.0 112.33 176.395 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.472 ' HB2' ' O ' ' A' ' 56' ' ' GLU . 9.3 tp10 -63.18 -54.47 37.01 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 179.46 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 86.8 m-85 -74.23 3.89 6.54 Favored 'General case' 0 CA--C 1.511 -0.53 0 CA-C-O 121.839 0.828 . . . . 0.0 111.688 -178.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.543 ' HB3' ' O ' ' A' ' 59' ' ' LYS . 9.2 t70 -88.85 -177.03 5.41 Favored 'General case' 0 C--N 1.276 -2.626 0 CA-C-N 113.998 -1.455 . . . . 0.0 109.659 178.651 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.525 ' HB3' HG21 ' A' ' 138' ' ' THR . 3.0 mt -80.2 -168.35 0.17 Allowed Pre-proline 0 CA--C 1.582 2.2 0 N-CA-C 106.215 -1.772 . . . . 0.0 106.215 178.454 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.646 ' HG3' ' N ' ' A' ' 141' ' ' SER . 41.8 Cg_endo -94.26 6.62 2.5 Favored 'Trans proline' 0 N--CA 1.442 -1.505 0 CA-C-N 121.991 1.747 . . . . 0.0 111.539 -176.836 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.567 HG12 ' H ' ' A' ' 67' ' ' ILE . 0.1 OUTLIER -69.45 -46.65 75.78 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.874 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 179.801 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.462 ' H ' HD13 ' A' ' 65' ' ' ILE . . . 57.06 9.55 4.14 Favored Glycine 0 N--CA 1.482 1.735 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.57 -174.286 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.567 ' H ' HG12 ' A' ' 65' ' ' ILE . 68.3 mt 58.11 -70.66 0.07 OUTLIER 'Isoleucine or valine' 0 C--O 1.189 -2.129 0 C-N-CA 128.135 2.574 . . . . 0.0 111.405 -171.25 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.422 ' HB3' ' HD3' ' A' ' 69' ' ' PRO . 77.4 t80 -177.7 -55.83 0.0 OUTLIER Pre-proline 0 C--N 1.306 -1.289 0 CA-C-N 117.805 0.275 . . . . 0.0 111.146 -175.476 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.422 ' HD3' ' HB3' ' A' ' 68' ' ' PHE . 8.5 Cg_endo -96.91 -172.2 0.18 Allowed 'Trans proline' 0 N--CA 1.442 -1.558 0 C-N-CA 122.508 2.139 . . . . 0.0 112.187 -175.683 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -104.17 12.72 52.16 Favored Glycine 0 N--CA 1.436 -1.316 0 N-CA-C 110.62 -0.992 . . . . 0.0 110.62 175.294 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.407 ' H ' ' HB2' ' A' ' 69' ' ' PRO . 1.8 p30 -101.19 -56.68 2.25 Favored 'General case' 0 N--CA 1.419 -2.012 0 CA-C-N 115.422 -0.389 . . . . 0.0 110.421 179.678 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.402 ' O ' ' HB ' ' A' ' 73' ' ' THR . . . -67.37 167.46 12.48 Favored 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 123.379 0.672 . . . . 0.0 111.209 172.366 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.72 HG23 ' O ' ' A' ' 73' ' ' THR . 96.7 m 87.88 27.97 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.813 0 CA-C-O 124.518 2.104 . . . . 0.0 111.128 175.366 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.578 ' O ' ' HA ' ' A' ' 86' ' ' VAL . 0.8 OUTLIER -76.0 145.65 40.11 Favored 'General case' 0 C--N 1.267 -3.017 0 CA-C-N 114.575 -1.193 . . . . 0.0 109.456 174.721 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 42.6 t80 -121.25 98.57 6.04 Favored 'General case' 0 C--N 1.282 -2.341 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.633 -169.206 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 32.8 mm-40 -128.12 115.63 18.71 Favored 'General case' 0 C--O 1.212 -0.878 0 C-N-CA 123.35 0.66 . . . . 0.0 110.151 178.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 36.1 p90 -123.04 143.17 50.13 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 -178.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.47 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 10.5 m-20 -96.27 169.36 9.99 Favored 'General case' 0 CA--C 1.487 -1.452 0 C-N-CA 118.876 -1.13 . . . . 0.0 108.955 178.604 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -79.75 -64.01 1.28 Allowed 'General case' 0 C--N 1.279 -2.477 0 CA-C-N 114.644 -1.162 . . . . 0.0 111.396 -176.543 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -68.21 -45.5 73.17 Favored 'General case' 0 CA--C 1.498 -1.054 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.575 -177.104 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.47 ' HB ' ' HB2' ' A' ' 78' ' ' ASP . 10.5 m -57.68 -49.45 76.45 Favored 'General case' 0 N--CA 1.419 -2.021 0 CA-C-N 114.232 -1.349 . . . . 0.0 111.823 -176.58 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt 65.35 16.19 10.4 Favored 'General case' 0 N--CA 1.488 1.453 0 CA-C-O 121.916 0.865 . . . . 0.0 111.493 -176.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.453 ' HB3' HG21 ' A' ' 81' ' ' THR . 39.4 ttpt -115.18 131.08 57.04 Favored 'General case' 0 N--CA 1.42 -1.953 0 N-CA-C 106.299 -1.741 . . . . 0.0 106.299 177.607 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.523 ' O ' ' HA ' ' A' ' 109' ' ' THR . 7.0 tt -103.59 142.79 33.69 Favored 'General case' 0 C--N 1.284 -2.25 0 O-C-N 123.68 0.612 . . . . 0.0 109.901 -175.657 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.438 ' HA ' ' O ' ' A' ' 108' ' ' VAL . 9.3 t -113.42 121.3 43.92 Favored 'General case' 0 N--CA 1.406 -2.661 0 CA-C-O 121.879 0.847 . . . . 0.0 110.429 178.803 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.578 ' HA ' ' O ' ' A' ' 74' ' ' ASN . 86.7 t -93.34 118.99 40.36 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.746 0 CA-C-N 114.905 -1.043 . . . . 0.0 108.438 174.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 5.4 mp -80.95 116.2 20.8 Favored 'General case' 0 C--O 1.249 1.056 0 O-C-N 123.711 0.632 . . . . 0.0 110.389 -179.094 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.581 ' O ' ' HA ' ' A' ' 106' ' ' THR . 42.1 mm -108.12 128.4 25.8 Favored Pre-proline 0 C--N 1.285 -2.201 0 N-CA-C 106.593 -1.632 . . . . 0.0 106.593 176.614 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -58.84 111.74 0.98 Allowed 'Trans proline' 0 N--CA 1.45 -1.083 0 C-N-CA 122.062 1.841 . . . . 0.0 111.351 176.531 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 22.7 t 67.42 -169.01 0.2 Allowed 'General case' 0 N--CA 1.443 -0.812 0 O-C-N 124.117 0.886 . . . . 0.0 110.847 178.01 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.439 HG12 ' OE2' ' A' ' 93' ' ' GLU . 10.3 tt -112.2 109.4 28.4 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.278 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 176.481 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' CYS . . . . . 0.629 ' SG ' ' HB2' ' A' ' 104' ' ' PHE . 16.1 p -108.89 124.84 51.28 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-N 115.723 -0.672 . . . . 0.0 112.55 -174.057 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.439 ' OE2' HG12 ' A' ' 91' ' ' ILE . 4.9 mp0 -107.27 156.94 18.32 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 174.194 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 3.4 p -128.76 111.9 24.62 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.756 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 173.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -103.42 154.7 18.0 Favored Glycine 0 N--CA 1.435 -1.417 0 N-CA-C 110.448 -1.061 . . . . 0.0 110.448 -179.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 44.9 t80 -159.16 -172.47 3.78 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 105.579 -2.008 . . . . 0.0 105.579 -174.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.453 ' O ' ' HB3' ' A' ' 98' ' ' ASP . 10.9 ptmt -64.1 -13.19 45.89 Favored 'General case' 0 N--CA 1.483 1.208 0 CA-C-N 119.108 0.867 . . . . 0.0 109.266 175.473 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.453 ' HB3' ' O ' ' A' ' 97' ' ' LYS 0.294 25.6 t70 92.11 100.03 0.02 OUTLIER 'General case' 0 N--CA 1.427 -1.59 0 C-N-CA 126.487 1.915 . . . . 0.0 113.724 -179.421 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 20.3 m -149.77 -39.79 0.14 Allowed 'General case' 0 C--N 1.286 -2.18 0 N-CA-C 104.761 -2.311 . . . . 0.0 104.761 177.117 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 47.4 t -146.02 104.28 3.82 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-N 113.765 -1.561 . . . . 0.0 107.102 174.003 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 94.5 t -128.28 127.87 67.86 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 -179.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.402 HD22 ' N ' ' A' ' 102' ' ' LEU . 0.7 OUTLIER -158.0 166.88 31.43 Favored 'General case' 0 C--N 1.309 -1.17 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 -175.084 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.434 ' HD2' HD13 ' A' ' 91' ' ' ILE . 38.5 ttpt -132.92 133.56 43.39 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.304 -175.707 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.629 ' HB2' ' SG ' ' A' ' 92' ' ' CYS . 77.9 m-85 -117.2 110.38 18.07 Favored 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 107.567 -1.271 . . . . 0.0 107.567 175.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 12.9 t -88.99 171.57 9.76 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 -177.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' THR . . . . . 0.581 ' HA ' ' O ' ' A' ' 88' ' ' ILE . 32.5 m -58.49 -50.31 74.21 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 112.919 0.711 . . . . 0.0 112.919 -175.249 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 23.3 p -116.78 94.36 4.57 Favored 'General case' 0 C--N 1.296 -1.719 0 C-N-CA 119.414 -0.914 . . . . 0.0 112.458 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.438 ' O ' ' HA ' ' A' ' 85' ' ' THR . 43.5 t -93.16 125.45 45.72 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.486 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 175.437 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.523 ' HA ' ' O ' ' A' ' 84' ' ' LEU . 8.1 p -107.81 154.1 22.03 Favored 'General case' 0 N--CA 1.4 -2.941 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.48 -177.088 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 175.28 -173.98 46.54 Favored Glycine 0 C--N 1.283 -2.364 0 N-CA-C 110.506 -1.038 . . . . 0.0 110.506 178.327 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 59.9 m-70 -99.25 91.53 5.01 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 178.182 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.416 ' HB3' HD12 ' A' ' 84' ' ' LEU . 5.3 tt -97.7 112.56 24.4 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 -175.121 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -116.21 160.25 20.67 Favored 'General case' 0 CA--C 1.458 -2.584 0 CA-C-N 114.9 -1.046 . . . . 0.0 108.569 175.504 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 2.3 tmtp? -71.51 103.72 3.05 Favored 'General case' 0 C--N 1.255 -3.503 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 -177.062 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 116.15 -10.07 17.77 Favored Glycine 0 C--O 1.186 -2.872 0 C-N-CA 120.516 -0.85 . . . . 0.0 111.944 -178.285 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -174.88 134.77 0.36 Allowed 'General case' 0 N--CA 1.488 1.465 0 CA-C-N 118.088 0.944 . . . . 0.0 111.888 176.768 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.3 tt -110.6 114.98 28.79 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 105.772 -1.936 . . . . 0.0 105.772 175.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.406 ' HA ' ' HB3' ' A' ' 135' ' ' SER . 75.1 p -103.35 135.06 45.68 Favored 'General case' 0 C--N 1.278 -2.539 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 -177.079 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . 0.394 4.0 p-10 48.61 97.47 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 115.878 1.807 . . . . 0.0 115.878 -178.63 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.436 HG22 ' O ' ' A' ' 134' ' ' THR . 13.0 m -87.44 118.02 32.54 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.086 0 CA-C-N 114.637 -1.165 . . . . 0.0 110.334 -179.687 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -97.08 92.36 6.02 Favored 'General case' 0 C--N 1.252 -3.67 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 179.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 140.92 -15.93 2.82 Favored Glycine 0 C--N 1.302 -1.323 0 C-N-CA 119.968 -1.111 . . . . 0.0 112.932 177.268 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 80.4 mt -100.37 104.81 16.68 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 CA-C-O 121.767 0.794 . . . . 0.0 111.235 -179.282 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -86.45 121.24 28.72 Favored 'General case' 0 N--CA 1.433 -1.312 0 N-CA-C 106.104 -1.813 . . . . 0.0 106.104 176.447 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 12.8 t -133.37 162.3 32.21 Favored 'General case' 0 N--CA 1.412 -2.347 0 CA-C-O 121.515 0.674 . . . . 0.0 110.644 -176.398 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.482 ' HD3' ' C ' ' A' ' 126' ' ' LYS . 1.0 OUTLIER -126.1 119.92 28.83 Favored 'General case' 0 N--CA 1.396 -3.137 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 173.051 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 59.9 t -109.38 -78.38 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.838 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 179.202 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -96.93 -35.75 10.78 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 105.636 -1.987 . . . . 0.0 105.636 171.771 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . 0.495 HG13 ' H ' ' A' ' 130' ' ' TRP . 9.6 tp -146.98 176.06 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.419 -1.981 0 N-CA-C 106.636 -1.616 . . . . 0.0 106.636 176.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' TRP . . . . . 0.495 ' H ' HG13 ' A' ' 129' ' ' ILE . 6.2 m-90 -74.81 132.61 41.69 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 122.767 0.427 . . . . 0.0 111.041 -177.189 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.436 HG21 ' H ' ' A' ' 133' ' ' VAL . 8.4 p -149.64 147.09 16.61 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.09 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 175.227 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 57.7 pttt -111.09 -4.23 15.15 Favored 'General case' 0 C--N 1.31 -1.128 0 C-N-CA 119.537 -0.865 . . . . 0.0 111.774 178.189 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.436 ' H ' HG21 ' A' ' 131' ' ' VAL . 7.4 p -123.79 103.8 13.25 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 CA-C-O 122.001 0.905 . . . . 0.0 110.862 178.746 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' THR . . . . . 0.436 ' O ' HG22 ' A' ' 120' ' ' VAL . 8.3 t -144.91 169.95 17.09 Favored 'General case' 0 C--N 1.293 -1.863 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 -179.494 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' SER . . . . . 0.406 ' HB3' ' HA ' ' A' ' 118' ' ' THR . 26.9 m -122.65 168.64 11.94 Favored 'General case' 0 N--CA 1.409 -2.508 0 N-CA-C 109.924 -0.398 . . . . 0.0 109.924 178.678 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 11.8 tt -134.92 98.05 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.767 0 CA-C-O 122.382 1.087 . . . . 0.0 108.797 175.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 73.9 p -89.93 158.67 17.3 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-N 114.608 -1.178 . . . . 0.0 110.453 -176.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' THR . . . . . 0.525 HG21 ' HB3' ' A' ' 63' ' ' LEU . 9.8 t -166.01 178.56 6.33 Favored 'General case' 0 N--CA 1.418 -2.069 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 -179.638 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -118.66 26.93 9.23 Favored 'General case' 0 C--N 1.273 -2.718 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 175.187 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . 60.65 36.56 19.58 Favored 'General case' 0 C--N 1.354 0.793 0 CA-C-N 114.379 -1.282 . . . . 0.0 108.274 -173.371 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' SER . . . . . 0.646 ' N ' ' HG3' ' A' ' 64' ' ' PRO . 46.8 t -171.01 -78.68 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 114.092 -1.413 . . . . 0.0 109.825 -173.248 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.1 130.34 36.28 Favored 'General case' 0 CA--C 1.498 -1.029 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 176.352 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.503 ' HB ' ' O ' ' A' ' 153' ' ' ARG . 42.4 t -108.35 143.2 19.15 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 CA-C-O 121.108 0.48 . . . . 0.0 111.47 -171.336 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 91.1 m-85 -135.82 123.32 22.11 Favored 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 178.018 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 42.8 t80 -93.61 117.16 29.73 Favored 'General case' 0 C--N 1.288 -2.088 0 N-CA-C 106.708 -1.59 . . . . 0.0 106.708 -178.493 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.438 ' C ' ' H ' ' A' ' 148' ' ' GLY . 62.9 p -76.24 -89.87 0.03 OUTLIER 'General case' 0 N--CA 1.425 -1.701 0 N-CA-C 114.94 1.459 . . . . 0.0 114.94 -169.164 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . 67.17 -42.59 0.43 Allowed 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 125.244 1.418 . . . . 0.0 112.047 -175.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . 0.438 ' H ' ' C ' ' A' ' 146' ' ' THR . . . 177.94 44.9 0.07 OUTLIER Glycine 0 N--CA 1.412 -2.937 0 N-CA-C 107.349 -2.3 . . . . 0.0 107.349 178.437 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 65.6 mtt 58.22 40.14 25.1 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 124.003 0.921 . . . . 0.0 109.715 -176.278 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -89.03 -48.55 7.34 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 115.805 1.78 . . . . 0.0 115.805 -169.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . 0.442 ' HA ' ' HE2' ' A' ' 151' ' ' LYS . 8.2 mmpt? -125.44 162.86 23.91 Favored 'General case' 0 N--CA 1.483 1.216 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 -172.227 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 57.3 p -119.73 158.34 26.71 Favored 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 174.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' ARG . . . . . 0.503 ' O ' ' HB ' ' A' ' 143' ' ' VAL . 3.8 tpm_? -149.92 120.5 7.47 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 109.082 -0.711 . . . . 0.0 109.082 -178.028 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 17.8 m -87.91 143.78 26.93 Favored 'General case' 0 C--N 1.308 -1.226 0 C-N-CA 120.122 -0.631 . . . . 0.0 110.835 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' ARG . . . . . 0.416 ' HD3' ' HB2' ' A' ' 64' ' ' PRO . 32.6 ttp180 -70.67 -34.5 72.08 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 115.608 -0.723 . . . . 0.0 110.121 179.06 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -45.85 -40.82 10.4 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 116.706 2.113 . . . . 0.0 116.706 -170.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -70.95 -56.43 6.22 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 119.019 -1.072 . . . . 0.0 112.077 -174.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 67.9 m-85 -171.63 19.16 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.765 0 C-N-CA 124.556 1.143 . . . . 0.0 108.934 -179.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . 0.42 ' HA3' ' O ' ' A' ' 65' ' ' ILE . . . 84.76 -97.19 2.1 Favored Glycine 0 N--CA 1.427 -1.942 0 C-N-CA 119.011 -1.566 . . . . 0.0 110.224 -171.704 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.47 HG23 ' HB ' ' A' ' 65' ' ' ILE . 90.2 t -127.65 113.41 31.31 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.521 0 CA-C-O 121.828 0.823 . . . . 0.0 110.651 -178.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -121.71 107.06 11.91 Favored 'General case' 0 C--N 1.295 -1.804 0 C-N-CA 119.424 -0.91 . . . . 0.0 113.167 -176.005 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 30.4 mmm180 -130.66 137.49 49.6 Favored 'General case' 0 C--N 1.292 -1.92 0 N-CA-C 106.337 -1.727 . . . . 0.0 106.337 172.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -77.25 74.53 3.82 Favored 'General case' 0 C--N 1.289 -2.056 0 N-CA-C 113.699 1.0 . . . . 0.0 113.699 -172.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -111.59 129.02 8.92 Favored Glycine 0 N--CA 1.424 -2.136 0 N-CA-C 109.25 -1.54 . . . . 0.0 109.25 176.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -91.56 112.65 24.65 Favored 'General case' 0 N--CA 1.42 -1.963 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 -177.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . 0.404 ' HA ' ' HB3' ' A' ' 92' ' ' CYS . 65.9 mtt85 -79.45 102.58 8.84 Favored 'General case' 0 N--CA 1.417 -2.12 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 179.027 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 25.2 t -66.01 82.55 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 O-C-N 124.077 0.861 . . . . 0.0 110.063 -178.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 22.1 t70 176.74 -24.65 0.0 OUTLIER 'General case' 0 C--N 1.287 -2.114 0 N-CA-C 106.236 -1.765 . . . . 0.0 106.236 -171.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 2.9 tppp? -79.2 106.48 11.26 Favored 'General case' 0 N--CA 1.425 -1.678 0 CA-C-N 114.145 -1.389 . . . . 0.0 111.899 179.312 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' PHE . . . . . . . . . . . . . 47.3 p90 . . . . . 0 C--N 1.293 -1.888 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 173.632 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 33.8 t . . . . . 0 CA--C 1.531 0.228 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -150.73 155.18 38.77 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-O 121.067 0.46 . . . . 0.0 110.621 -178.388 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 25.8 pt20 -159.13 126.96 4.97 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 175.582 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 28.7 pt -108.34 97.94 6.34 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.104 0 CA-C-O 122.37 1.081 . . . . 0.0 112.707 -177.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -132.34 21.07 4.38 Favored 'General case' 0 C--N 1.294 -1.817 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 177.014 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 22.8 p-10 -98.82 147.54 24.81 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 114.579 -1.191 . . . . 0.0 110.677 -178.373 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 87.6 tttt 71.49 124.41 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 125.043 1.337 . . . . 0.0 113.175 178.348 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 8.4 p -83.51 136.12 23.44 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.213 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 175.249 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -80.16 56.23 4.61 Favored Glycine 0 N--CA 1.445 -0.708 0 C-N-CA 121.44 -0.41 . . . . 0.0 112.787 -178.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 36.0 m -130.65 97.52 4.39 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 177.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 88.5 t80 -137.41 129.23 28.8 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 -178.316 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 79.4 m95 -95.7 95.92 8.65 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 179.03 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 60.5 tp -73.2 131.16 41.66 Favored 'General case' 0 C--O 1.25 1.127 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 179.266 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 93.48 86.43 1.6 Allowed Glycine 0 N--CA 1.423 -2.21 0 N-CA-C 110.504 -1.039 . . . . 0.0 110.504 -179.04 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 47.2 tt0 -69.95 -29.18 66.24 Favored 'General case' 0 C--O 1.246 0.879 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 -179.169 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 28.0 tptp 71.6 84.04 0.13 Allowed 'General case' 0 N--CA 1.441 -0.882 0 CA-C-N 114.727 -1.124 . . . . 0.0 110.32 -177.538 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -138.9 122.18 17.04 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-N 114.274 -1.33 . . . . 0.0 107.468 178.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -95.55 111.65 23.52 Favored 'General case' 0 C--N 1.291 -1.964 0 CA-C-O 121.101 0.477 . . . . 0.0 110.558 -174.392 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -113.55 118.58 34.82 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.518 -178.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 51.3 tt0 -129.64 140.64 51.1 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 178.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -88.44 86.43 7.04 Favored 'General case' 0 N--CA 1.435 -1.177 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 175.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 -78.74 111.31 14.73 Favored 'General case' 0 C--N 1.299 -1.6 0 CA-C-N 114.531 -1.213 . . . . 0.0 111.328 -176.259 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 32.0 m -82.4 99.53 9.46 Favored 'General case' 0 N--CA 1.423 -1.786 0 CA-C-N 114.944 -1.025 . . . . 0.0 109.923 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 35.8 m -88.66 -17.74 8.25 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.935 0 CA-C-O 120.866 0.365 . . . . 0.0 110.674 179.455 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -170.64 178.38 43.26 Favored Glycine 0 N--CA 1.43 -1.742 0 N-CA-C 110.927 -0.869 . . . . 0.0 110.927 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 36.2 t30 67.46 98.66 0.05 Allowed 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.43 1.092 . . . . 0.0 112.628 179.439 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -105.52 87.64 2.65 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 178.301 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.9 mm? 57.19 19.18 4.67 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 123.787 0.835 . . . . 0.0 112.337 179.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -90.72 110.41 21.6 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-O 121.007 0.432 . . . . 0.0 111.258 -174.173 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 29.6 t -82.38 103.68 12.13 Favored 'General case' 0 N--CA 1.418 -2.026 0 N-CA-C 107.864 -1.161 . . . . 0.0 107.864 177.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 7.3 p -103.18 109.46 26.95 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.188 0 CA-C-O 121.659 0.743 . . . . 0.0 110.424 -179.411 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 20.2 m -133.64 98.05 4.09 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 179.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 87.7 m -64.8 127.82 33.16 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.385 -179.571 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 13.5 p -74.19 106.86 6.04 Favored 'General case' 0 N--CA 1.425 -1.676 0 CA-C-O 121.391 0.615 . . . . 0.0 110.472 178.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 46.9 mm -62.25 127.09 21.65 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 115.097 -0.956 . . . . 0.0 111.427 -176.449 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -70.05 101.76 1.89 Allowed 'General case' 0 N--CA 1.435 -1.221 0 CA-C-N 114.869 -1.06 . . . . 0.0 109.538 -178.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -83.55 -28.16 36.7 Favored Glycine 0 CA--C 1.494 -1.268 0 N-CA-C 110.959 -0.856 . . . . 0.0 110.959 -178.448 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -80.3 59.25 4.6 Favored Glycine 0 N--CA 1.436 -1.344 0 N-CA-C 111.961 -0.455 . . . . 0.0 111.961 179.419 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 10.1 t -68.3 124.76 24.38 Favored 'General case' 0 N--CA 1.433 -1.317 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 178.436 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -97.01 108.85 21.67 Favored 'General case' 0 N--CA 1.438 -1.045 0 N-CA-C 112.984 0.735 . . . . 0.0 112.984 -174.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 83.0 m95 -118.48 84.69 2.22 Favored 'General case' 0 N--CA 1.427 -1.582 0 CA-C-N 114.89 -1.05 . . . . 0.0 108.939 173.461 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 5.5 mp -96.57 75.47 2.83 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 176.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.6 p -172.93 132.53 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.426 -1.634 0 CA-C-N 114.099 -1.41 . . . . 0.0 108.951 -176.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 43.7 t30 -148.12 92.66 2.07 Favored 'General case' 0 C--N 1.29 -1.985 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 175.165 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -92.58 102.73 15.17 Favored 'General case' 0 N--CA 1.418 -2.053 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 -177.311 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 25.5 pt -98.89 160.76 3.18 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.772 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.245 177.167 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 64.87 81.62 0.2 Allowed 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.012 0.82 . . . . 0.0 110.225 -175.039 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -124.4 37.68 2.57 Favored Glycine 0 N--CA 1.428 -1.876 0 C-N-CA 120.412 -0.899 . . . . 0.0 112.093 -177.562 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 55.5 pttt -141.62 19.65 2.19 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-O 121.288 0.566 . . . . 0.0 110.903 178.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 23.2 ptt? -92.64 83.91 4.96 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 122.368 1.08 . . . . 0.0 112.969 -178.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 80.7 mt-30 -156.07 -58.53 0.1 Allowed 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 105.848 -1.908 . . . . 0.0 105.848 177.362 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.13 112.92 1.27 Allowed Pre-proline 0 N--CA 1.43 -1.469 0 N-CA-C 105.632 -1.988 . . . . 0.0 105.632 174.775 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_endo -67.69 81.9 0.44 Allowed 'Trans proline' 0 N--CA 1.457 -0.618 0 C-N-CA 122.324 2.016 . . . . 0.0 116.846 -174.054 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.594 ' N ' ' HD3' ' A' ' 55' ' ' PRO . 10.2 mp -82.07 -33.2 0.62 Allowed Pre-proline 0 C--N 1.296 -1.743 0 N-CA-C 116.904 2.187 . . . . 0.0 116.904 169.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.724 ' HA ' ' CD1' ' A' ' 58' ' ' LEU . 7.6 Cg_exo -66.08 -15.12 47.38 Favored 'Trans proline' 0 N--CA 1.425 -2.507 0 CA-C-N 121.134 1.441 . . . . 0.0 115.568 -161.018 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 32.3 mm-40 -79.34 -29.69 42.36 Favored 'General case' 0 N--CA 1.425 -1.691 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.705 ' O ' ' HB3' ' A' ' 60' ' ' GLU . 10.6 mt -76.41 -31.66 58.06 Favored 'General case' 0 C--O 1.207 -1.14 0 CA-C-N 114.652 -1.158 . . . . 0.0 110.061 -177.582 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.724 ' CD1' ' HA ' ' A' ' 55' ' ' PRO . 8.2 mt -70.41 -54.32 12.87 Favored 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 -174.383 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.623 ' HG2' ' O ' ' A' ' 55' ' ' PRO . 17.1 ptpt -64.02 -25.08 67.96 Favored 'General case' 0 C--O 1.191 -2.009 0 CA-C-N 114.885 -1.052 . . . . 0.0 111.398 176.76 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.705 ' HB3' ' O ' ' A' ' 57' ' ' LEU . 7.1 tp10 -54.95 -56.4 20.11 Favored 'General case' 0 C--N 1.295 -1.773 0 O-C-N 121.954 -0.467 . . . . 0.0 111.13 172.361 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 45.2 m-85 -78.54 -40.2 35.68 Favored 'General case' 0 CA--C 1.489 -1.375 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 -175.321 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.43 ' OD2' ' HG ' ' A' ' 112' ' ' LEU . 5.9 m-20 -87.42 18.34 3.9 Favored 'General case' 0 C--N 1.294 -1.833 0 CA-C-N 113.686 -1.597 . . . . 0.0 113.262 -174.256 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.48 HD13 ' OG1' ' A' ' 138' ' ' THR . 21.5 mt 79.79 151.24 0.12 Allowed Pre-proline 0 N--CA 1.475 0.82 0 C-N-CA 125.184 1.393 . . . . 0.0 112.703 174.303 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_endo -80.65 15.07 1.86 Allowed 'Trans proline' 0 N--CA 1.443 -1.468 0 C-N-CA 122.697 2.265 . . . . 0.0 113.546 -166.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.598 ' O ' ' HA3' ' A' ' 159' ' ' GLY . 0.2 OUTLIER -69.5 -36.73 72.68 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.811 0 N-CA-C 106.753 -1.573 . . . . 0.0 106.753 173.029 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 54.34 8.68 1.24 Allowed Glycine 0 C--N 1.339 0.731 0 CA-C-N 114.771 -1.104 . . . . 0.0 115.287 175.149 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.727 ' O ' ' HB ' ' A' ' 160' ' ' VAL 0.252 27.7 mt 72.71 -45.66 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.031 0 N-CA-C 114.527 1.306 . . . . 0.0 114.527 -179.9 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.557 ' HB2' ' O ' ' A' ' 67' ' ' ILE . 40.2 t80 164.99 -56.4 0.0 OUTLIER Pre-proline 0 CA--C 1.54 0.574 0 C-N-CA 124.155 0.982 . . . . 0.0 110.597 173.826 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -102.07 -160.31 0.04 OUTLIER 'Trans proline' 0 N--CA 1.43 -2.246 0 C-N-CA 122.533 2.155 . . . . 0.0 113.123 -169.58 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -100.96 29.08 13.28 Favored Glycine 0 N--CA 1.428 -1.868 0 N-CA-C 109.656 -1.378 . . . . 0.0 109.656 174.102 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.492 ' OD1' ' HD3' ' A' ' 89' ' ' PRO . 8.8 t0 -140.84 176.67 8.61 Favored 'General case' 0 N--CA 1.42 -1.949 0 N-CA-C 102.928 -2.99 . . . . 0.0 102.928 177.111 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.582 ' O ' HG21 ' A' ' 73' ' ' THR . . . 57.8 -177.73 0.07 Allowed 'General case' 0 N--CA 1.483 1.185 0 CA-C-N 118.977 0.808 . . . . 0.0 109.871 -170.635 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.582 HG21 ' O ' ' A' ' 72' ' ' ALA . 5.2 t 65.36 16.7 10.67 Favored 'General case' 0 N--CA 1.515 2.775 0 C-N-CA 125.06 1.344 . . . . 0.0 109.523 172.256 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.592 ' O ' ' HA ' ' A' ' 86' ' ' VAL . 37.3 m-80 -68.45 135.8 52.25 Favored 'General case' 0 N--CA 1.414 -2.25 0 CA-C-N 113.366 -1.743 . . . . 0.0 114.127 -176.154 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.499 ' CD2' HD12 ' A' ' 84' ' ' LEU . 48.3 t80 -98.88 106.22 18.46 Favored 'General case' 0 C--N 1.272 -2.797 0 CA-C-N 113.247 -1.797 . . . . 0.0 109.949 -177.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -137.81 141.34 40.83 Favored 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 176.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 48.1 p90 -144.49 150.95 38.44 Favored 'General case' 0 C--N 1.301 -1.512 0 C-N-CA 120.283 -0.567 . . . . 0.0 110.675 -177.283 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.545 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 11.0 m-20 -97.1 170.72 8.94 Favored 'General case' 0 CA--C 1.486 -1.489 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 174.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -79.81 -71.46 0.45 Allowed 'General case' 0 C--N 1.278 -2.53 0 CA-C-N 115.283 -0.871 . . . . 0.0 113.021 -175.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -72.94 -42.27 63.62 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 121.583 0.706 . . . . 0.0 110.654 -175.088 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.545 ' HB ' ' HB2' ' A' ' 78' ' ' ASP . 19.8 m -55.7 -41.15 73.38 Favored 'General case' 0 N--CA 1.431 -1.41 0 CA-C-N 114.645 -1.161 . . . . 0.0 110.9 179.54 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 71.8 mmtt 59.85 9.9 1.89 Allowed 'General case' 0 N--CA 1.482 1.165 0 N-CA-C 113.04 0.756 . . . . 0.0 113.04 178.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 27.8 pttt -98.77 134.12 42.11 Favored 'General case' 0 N--CA 1.402 -2.85 0 N-CA-C 105.13 -2.174 . . . . 0.0 105.13 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.511 ' O ' ' HA ' ' A' ' 109' ' ' THR . 6.9 tt -89.36 143.24 26.98 Favored 'General case' 0 C--N 1.282 -2.33 0 C-N-CA 120.142 -0.623 . . . . 0.0 109.492 -174.22 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.501 ' N ' HD22 ' A' ' 84' ' ' LEU . 2.7 t -116.5 107.19 14.45 Favored 'General case' 0 N--CA 1.415 -2.199 0 CA-C-O 121.692 0.758 . . . . 0.0 111.722 -179.61 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.592 ' HA ' ' O ' ' A' ' 74' ' ' ASN . 73.0 t -89.84 108.96 19.95 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.224 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 173.76 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . 0.272 0.8 OUTLIER -96.71 118.2 32.66 Favored 'General case' 0 N--CA 1.394 -3.262 0 CA-C-O 122.605 1.193 . . . . 0.0 111.852 -179.79 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 55.9 mt -97.46 142.42 24.52 Favored Pre-proline 0 C--N 1.277 -2.577 0 N-CA-C 104.399 -2.445 . . . . 0.0 104.399 178.178 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.492 ' HD3' ' OD1' ' A' ' 71' ' ' ASP . 30.9 Cg_endo -59.53 -18.04 44.7 Favored 'Trans proline' 0 C--N 1.328 -0.532 0 C-N-CA 122.968 2.446 . . . . 0.0 112.914 -178.077 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 6.5 m -154.44 167.42 30.08 Favored 'General case' 0 N--CA 1.422 -1.843 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 -172.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 14.2 tt -85.74 108.49 17.41 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.295 0 N-CA-C 105.968 -1.864 . . . . 0.0 105.968 166.614 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' CYS . . . . . 0.502 ' SG ' ' HA3' ' A' ' 164' ' ' GLY . 48.2 t -119.19 123.38 44.19 Favored 'General case' 0 C--N 1.292 -1.916 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 -176.358 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.418 ' CB ' ' HA ' ' A' ' 103' ' ' LYS . 12.7 pt-20 -119.49 150.6 39.97 Favored 'General case' 0 C--N 1.284 -2.277 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.908 -174.182 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.455 ' CG1' ' H ' ' A' ' 163' ' ' ASN . 34.5 m -130.29 102.2 6.67 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.485 0 CA-C-O 121.871 0.843 . . . . 0.0 111.385 179.807 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . 0.499 ' HA2' ' O ' ' A' ' 100' ' ' SER . . . -148.2 122.62 1.54 Allowed Glycine 0 CA--C 1.48 -2.117 0 N-CA-C 108.121 -1.992 . . . . 0.0 108.121 172.757 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 62.9 t80 -152.29 -67.03 0.17 Allowed 'General case' 0 CA--C 1.46 -2.503 0 C-N-CA 116.388 -2.125 . . . . 0.0 111.1 -178.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.484 ' HD2' ' O ' ' A' ' 97' ' ' LYS . 2.0 tmmm? -86.46 -37.31 18.42 Favored 'General case' 1 N--CA 1.378 -4.051 0 CA-C-N 113.625 -1.625 . . . . 0.0 113.002 -164.276 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.413 ' C ' ' H ' ' A' ' 100' ' ' SER . 29.1 t70 -157.35 83.23 0.91 Allowed 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 115.718 1.747 . . . . 0.0 115.718 -169.805 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 50.3 m 64.09 -27.98 0.09 Allowed 'General case' 0 N--CA 1.481 1.112 0 N-CA-C 115.679 1.733 . . . . 0.0 115.679 169.177 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.499 ' O ' ' HA2' ' A' ' 95' ' ' GLY . 34.2 t -79.07 86.46 4.9 Favored 'General case' 0 N--CA 1.409 -2.523 0 C-N-CA 123.463 0.705 . . . . 0.0 109.677 -179.394 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 48.2 t -109.33 99.56 8.93 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 CA-C-N 115.084 -0.962 . . . . 0.0 109.491 176.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.466 ' HG ' ' HA ' ' A' ' 125' ' ' THR . 7.8 mp -110.07 127.93 55.14 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.157 179.617 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.418 ' HA ' ' CB ' ' A' ' 93' ' ' GLU . 23.8 ttmm -106.5 109.01 20.81 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 177.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 78.9 m-85 -94.81 105.68 17.63 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-N 116.068 -0.514 . . . . 0.0 109.788 179.469 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 49.7 m -61.75 151.37 34.21 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 115.276 -0.875 . . . . 0.0 111.006 178.585 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 7.3 m -51.5 -43.69 62.31 Favored 'General case' 0 C--O 1.215 -0.748 0 C-N-CA 125.241 1.417 . . . . 0.0 110.289 179.344 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 85.5 m -120.21 101.19 7.64 Favored 'General case' 0 N--CA 1.423 -1.777 0 CA-C-O 121.137 0.494 . . . . 0.0 109.761 178.46 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 13.5 m -108.71 114.77 47.65 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.059 0 CA-C-O 121.951 0.881 . . . . 0.0 111.176 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.511 ' HA ' ' O ' ' A' ' 84' ' ' LEU . 20.9 p -107.76 166.42 10.71 Favored 'General case' 0 N--CA 1.405 -2.693 0 CA-C-N 114.449 -1.251 . . . . 0.0 111.02 -176.528 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 167.84 -164.06 37.65 Favored Glycine 0 N--CA 1.41 -3.054 0 C-N-CA 120.323 -0.941 . . . . 0.0 111.565 177.052 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 52.0 t60 -103.3 99.81 9.67 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.43 ' HG ' ' OD2' ' A' ' 62' ' ' ASP . 3.0 tm? -103.55 125.29 50.0 Favored 'General case' 0 CA--C 1.483 -1.611 0 CA-C-N 115.635 -0.712 . . . . 0.0 110.2 -172.675 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -122.41 149.24 44.09 Favored 'General case' 0 N--CA 1.402 -2.871 0 CA-C-N 114.75 -1.113 . . . . 0.0 108.994 172.259 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -68.95 100.59 1.23 Allowed 'General case' 0 N--CA 1.402 -2.866 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 -179.091 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . 0.478 ' N ' HD23 ' A' ' 63' ' ' LEU . . . 135.52 -45.44 1.1 Allowed Glycine 0 C--N 1.282 -2.459 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 -175.738 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.417 ' O ' ' HD2' ' A' ' 116' ' ' LYS . 0.7 OUTLIER -150.2 133.5 16.37 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 114.074 1.139 . . . . 0.0 114.074 -178.382 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.521 ' O ' ' HB2' ' A' ' 135' ' ' SER . 40.6 tp -97.51 113.52 25.24 Favored 'General case' 0 C--N 1.309 -1.163 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 175.549 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 19.8 p -114.71 140.81 48.56 Favored 'General case' 0 C--N 1.285 -2.225 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.547 -178.593 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 66.18 100.61 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.93 0.892 . . . . 0.0 111.097 179.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 4.1 m -107.37 103.25 15.18 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.674 0 N-CA-C 113.974 1.102 . . . . 0.0 113.974 -177.355 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -84.66 84.26 7.74 Favored 'General case' 0 C--N 1.29 -2.013 0 CA-C-N 114.632 -1.167 . . . . 0.0 108.534 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 133.6 -12.4 4.87 Favored Glycine 0 N--CA 1.435 -1.384 0 CA-C-N 115.289 -0.869 . . . . 0.0 113.038 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 71.7 mt -100.28 99.95 9.46 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.112 0 CA-C-O 121.817 0.818 . . . . 0.0 109.716 179.213 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -91.18 118.18 30.24 Favored 'General case' 0 C--N 1.29 -2.004 0 CA-C-N 114.791 -1.095 . . . . 0.0 108.429 -177.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.466 ' HA ' ' HG ' ' A' ' 102' ' ' LEU . 62.1 m -115.46 113.53 23.83 Favored 'General case' 0 N--CA 1.426 -1.64 0 N-CA-C 112.913 0.708 . . . . 0.0 112.913 -173.137 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.42 ' O ' ' HA ' ' A' ' 100' ' ' SER . 39.0 tttp -105.13 121.82 44.61 Favored 'General case' 0 N--CA 1.415 -2.203 0 C-N-CA 119.137 -1.025 . . . . 0.0 108.644 169.676 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.487 ' O ' ' HB3' ' A' ' 128' ' ' MET . 27.2 t -144.76 104.09 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.278 -2.534 0 N-CA-C 103.29 -2.856 . . . . 0.0 103.29 170.547 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' MET . . . . . 0.487 ' HB3' ' O ' ' A' ' 127' ' ' VAL . 26.3 ttt 74.17 -52.29 0.69 Allowed 'General case' 0 C--N 1.321 -0.658 0 O-C-N 124.487 1.117 . . . . 0.0 109.55 -172.241 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 8.7 tp -136.88 152.96 29.2 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 N-CA-C 109.063 -0.718 . . . . 0.0 109.063 175.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 20.4 t-105 -81.49 117.8 22.2 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 123.526 0.731 . . . . 0.0 109.863 -177.028 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.415 HG12 ' H ' ' A' ' 133' ' ' VAL . 41.4 t -138.09 120.48 18.85 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.129 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 178.728 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 65.7 pttt -91.46 11.34 24.29 Favored 'General case' 0 C--N 1.312 -1.029 0 O-C-N 121.738 -0.601 . . . . 0.0 111.599 -177.2 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.415 ' H ' HG12 ' A' ' 131' ' ' VAL . 34.1 m -120.59 -1.59 8.21 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.107 0 C-N-CA 119.647 -0.821 . . . . 0.0 112.885 -175.586 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' THR . . . . . 0.689 ' O ' ' HB ' ' A' ' 146' ' ' THR . 18.2 p -74.13 101.63 3.99 Favored 'General case' 0 N--CA 1.425 -1.709 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 176.5 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' SER . . . . . 0.521 ' HB2' ' O ' ' A' ' 117' ' ' LEU . 12.4 p -94.48 170.03 9.78 Favored 'General case' 0 N--CA 1.412 -2.338 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 -177.665 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 15.2 tt -100.77 122.35 52.68 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.155 0 CA-C-O 121.685 0.755 . . . . 0.0 111.555 -170.355 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' SER . . . . . 0.412 ' C ' ' HG1' ' A' ' 138' ' ' THR . 25.9 m -109.32 147.4 32.74 Favored 'General case' 0 N--CA 1.433 -1.297 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.023 -177.726 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' THR . . . . . 0.487 HG22 ' H ' ' A' ' 141' ' ' SER . 33.0 m -146.85 174.03 11.86 Favored 'General case' 0 C--N 1.295 -1.787 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 -174.671 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -110.24 28.75 8.32 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 172.396 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . 59.79 43.74 14.86 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 -172.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' SER . . . . . 0.487 ' H ' HG22 ' A' ' 138' ' ' THR . 35.1 t 176.78 -82.57 0.0 OUTLIER 'General case' 0 CA--C 1.545 0.77 0 CA-C-N 114.755 -1.111 . . . . 0.0 110.338 -173.59 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 24.7 pttm -89.29 150.91 22.39 Favored 'General case' 0 CA--C 1.503 -0.858 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.419 HG21 ' OG1' ' A' ' 138' ' ' THR . 13.8 p -131.52 149.38 33.01 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.337 0 N-CA-C 114.281 1.215 . . . . 0.0 114.281 -168.656 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -112.44 143.48 43.51 Favored 'General case' 0 N--CA 1.428 -1.528 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 169.063 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 48.7 t80 -67.87 165.58 17.31 Favored 'General case' 0 C--N 1.305 -1.353 0 C-N-CA 122.93 0.492 . . . . 0.0 109.987 -173.18 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.689 ' HB ' ' O ' ' A' ' 134' ' ' THR . 41.6 p -50.88 -53.16 34.88 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 120.985 0.421 . . . . 0.0 111.531 -176.511 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -84.95 97.33 9.73 Favored 'General case' 0 N--CA 1.424 -1.754 0 N-CA-C 105.735 -1.95 . . . . 0.0 105.735 170.227 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -81.71 -18.0 69.19 Favored Glycine 0 CA--C 1.466 -2.978 0 CA-C-O 121.66 0.589 . . . . 0.0 111.666 -167.136 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 66.3 mtt -97.43 5.43 49.74 Favored 'General case' 0 C--N 1.281 -2.389 0 CA-C-N 114.666 -0.767 . . . . 0.0 110.718 178.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . 0.473 ' HA ' ' HE2' ' A' ' 150' ' ' LYS . 6.7 mmpt? -116.4 -49.69 2.66 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.509 -179.396 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 42.4 mmtm -146.14 165.08 30.18 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.3 0.571 . . . . 0.0 112.514 -175.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 42.2 p -130.03 160.37 33.9 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 174.073 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' ARG . . . . . 0.404 ' NE ' ' HA ' ' A' ' 153' ' ' ARG . 3.3 tpm_? -135.95 149.3 48.85 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 106.976 -1.491 . . . . 0.0 106.976 -177.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 8.2 m -88.64 117.37 27.55 Favored 'General case' 0 N--CA 1.436 -1.126 0 C-N-CA 120.212 -0.595 . . . . 0.0 111.763 -175.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' ARG . . . . . 0.508 ' HA ' ' HA2' ' A' ' 159' ' ' GLY . 0.0 OUTLIER -69.75 -31.08 68.85 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 105.457 -2.053 . . . . 0.0 105.457 174.505 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -45.46 -53.99 8.03 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 113.592 -1.64 . . . . 0.0 113.791 -179.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -66.47 -53.21 37.83 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 120.799 0.333 . . . . 0.0 111.476 -177.727 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -148.43 -32.89 0.24 Allowed 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.689 -178.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . 0.598 ' HA3' ' O ' ' A' ' 65' ' ' ILE . . . 130.54 -95.0 0.33 Allowed Glycine 0 CA--C 1.463 -3.215 0 N-CA-C 107.992 -2.043 . . . . 0.0 107.992 -168.627 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.727 ' HB ' ' O ' ' A' ' 67' ' ' ILE . 41.3 t -98.72 125.25 52.17 Favored 'Isoleucine or valine' 0 N--CA 1.398 -3.046 0 N-CA-C 107.273 -1.381 . . . . 0.0 107.273 171.244 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 46.8 mt-30 -90.78 101.38 14.13 Favored 'General case' 0 C--N 1.294 -1.824 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 -176.094 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 20.2 mmt180 -90.86 152.89 20.57 Favored 'General case' 0 C--N 1.278 -2.501 0 CA-C-N 113.584 -1.644 . . . . 0.0 114.151 -172.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' ASN . . . . . 0.455 ' H ' ' CG1' ' A' ' 94' ' ' VAL . 46.7 m-80 -136.82 31.69 2.74 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 104.789 -2.301 . . . . 0.0 104.789 173.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . 0.502 ' HA3' ' SG ' ' A' ' 92' ' ' CYS . . . -110.67 149.34 17.7 Favored Glycine 0 N--CA 1.433 -1.508 0 CA-C-N 114.051 -1.432 . . . . 0.0 113.587 -171.399 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -110.01 117.16 33.03 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 175.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 30.0 mtt180 -78.73 102.14 7.92 Favored 'General case' 0 N--CA 1.422 -1.83 0 N-CA-C 107.378 -1.341 . . . . 0.0 107.378 -178.416 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 40.0 t -75.72 90.6 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 CA-C-O 121.189 0.519 . . . . 0.0 110.848 -177.638 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 21.0 t70 172.85 -33.87 0.0 OUTLIER 'General case' 0 CA--C 1.484 -1.57 0 N-CA-C 106.665 -1.605 . . . . 0.0 106.665 -178.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 15.5 ptmt -157.38 -164.26 1.54 Allowed 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 113.675 -1.602 . . . . 0.0 110.75 -172.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' PHE . . . . . . . . . . . . . 89.1 t80 . . . . . 0 N--CA 1.427 -1.578 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 171.576 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 33.3 m . . . . . 0 N--CA 1.443 -0.782 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -85.27 149.01 25.78 Favored 'General case' 0 C--N 1.31 -1.141 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 178.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 -131.3 89.9 2.79 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-O 121.284 0.564 . . . . 0.0 110.675 -177.496 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.534 HD11 ' O ' ' A' ' 4' ' ' ILE . 2.4 pp -126.4 113.88 35.66 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.265 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.089 177.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -138.2 108.26 6.38 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-O 121.228 0.537 . . . . 0.0 110.836 -178.156 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -135.8 94.74 3.11 Favored 'General case' 0 C--N 1.293 -1.853 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 178.575 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 24.7 ttmm -90.96 116.13 28.52 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 178.127 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 8.7 p -80.45 130.22 36.3 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.678 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 177.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 178.51 80.06 0.06 OUTLIER Glycine 0 N--CA 1.439 -1.137 0 C-N-CA 120.303 -0.951 . . . . 0.0 112.322 -178.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 14.9 p -93.66 104.93 17.0 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-O 121.428 0.632 . . . . 0.0 109.835 177.119 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 76.9 t80 -84.16 101.29 11.73 Favored 'General case' 0 N--CA 1.434 -1.269 0 CA-C-O 121.466 0.651 . . . . 0.0 111.936 -174.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 68.5 p-90 -155.09 160.29 40.87 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 107.686 -1.228 . . . . 0.0 107.686 173.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.461 ' H ' HD21 ' A' ' 13' ' ' LEU . 1.9 pt? -116.93 156.36 27.53 Favored 'General case' 0 C--N 1.305 -1.368 0 C-N-CA 120.649 -0.421 . . . . 0.0 111.267 -175.876 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -103.63 20.22 42.45 Favored Glycine 0 N--CA 1.446 -0.66 0 N-CA-C 111.577 -0.609 . . . . 0.0 111.577 -179.394 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 84.1 mm-40 -115.37 127.85 55.67 Favored 'General case' 0 C--N 1.309 -1.16 0 C-N-CA 122.72 0.408 . . . . 0.0 110.136 179.191 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 60.7 pttt -121.79 153.95 37.63 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 178.256 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -112.67 93.07 4.25 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-O 120.917 0.389 . . . . 0.0 111.984 -177.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 -135.86 112.6 10.15 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-O 121.807 0.813 . . . . 0.0 110.754 177.552 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.524 ' HA ' ' HE3' ' A' ' 19' ' ' LYS . 0.5 OUTLIER -140.89 105.29 4.85 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 115.197 -0.911 . . . . 0.0 108.997 178.703 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 9.0 pm0 -83.57 101.87 11.76 Favored 'General case' 0 N--CA 1.424 -1.743 0 CA-C-O 121.532 0.682 . . . . 0.0 109.77 178.17 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 73.8 t80 -118.18 110.33 17.45 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.702 -177.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -125.73 108.32 11.4 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-O 121.494 0.664 . . . . 0.0 110.276 178.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 47.6 m -155.39 127.28 7.53 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 109.038 -0.726 . . . . 0.0 109.038 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.428 HG21 ' H ' ' A' ' 26' ' ' ASN . 32.3 m -90.02 -24.44 5.81 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-O 121.236 0.541 . . . . 0.0 110.281 179.226 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 103.07 -25.44 27.27 Favored Glycine 0 CA--C 1.499 -0.952 0 CA-C-N 115.751 -0.658 . . . . 0.0 112.055 176.13 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.428 ' H ' HG21 ' A' ' 24' ' ' VAL . 58.0 t30 -103.04 7.79 38.95 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-O 122.294 1.045 . . . . 0.0 108.93 179.703 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.439 ' OD2' ' HB2' ' A' ' 29' ' ' ASN . 9.4 p-10 -93.12 153.28 18.75 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.54 178.616 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 93.0 mt -66.88 102.38 0.95 Allowed 'General case' 0 CA--C 1.499 -0.995 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 175.028 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.439 ' HB2' ' OD2' ' A' ' 27' ' ' ASP . 45.4 t-20 -141.08 139.45 34.04 Favored 'General case' 0 N--CA 1.416 -2.127 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.763 -170.646 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 32.5 t -74.72 -152.02 0.03 OUTLIER 'General case' 0 CA--C 1.557 1.222 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 175.068 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.492 ' HB ' ' O ' ' A' ' 42' ' ' LEU . 7.4 p -69.29 90.91 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 CA-C-O 122.15 0.976 . . . . 0.0 112.323 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 33.0 p -76.35 103.8 6.54 Favored 'General case' 0 N--CA 1.42 -1.931 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 174.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 53.5 p -80.02 80.12 6.47 Favored 'General case' 0 N--CA 1.432 -1.373 0 N-CA-C 113.271 0.841 . . . . 0.0 113.271 -174.508 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 22.3 p -83.4 -61.2 1.91 Allowed 'General case' 0 N--CA 1.431 -1.401 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 175.487 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 51.1 mm -98.7 -69.06 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 175.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -169.72 -63.85 0.02 OUTLIER 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 -179.111 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 133.62 -33.1 2.61 Favored Glycine 0 N--CA 1.437 -1.242 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.864 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 142.38 -128.16 3.44 Favored Glycine 0 CA--C 1.495 -1.185 0 N-CA-C 108.63 -1.788 . . . . 0.0 108.63 -177.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 7.9 t -70.4 -32.22 69.77 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 106.983 -1.488 . . . . 0.0 106.983 171.663 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 53.55 88.04 0.04 OUTLIER 'General case' 0 N--CA 1.439 -0.976 0 C-N-CA 125.82 1.648 . . . . 0.0 114.241 173.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 82.2 m95 -94.6 -53.68 3.79 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 104.739 -2.319 . . . . 0.0 104.739 167.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.492 ' O ' ' HB ' ' A' ' 31' ' ' VAL . 4.2 tt -107.88 -53.98 2.55 Favored 'General case' 0 C--O 1.21 -1.025 0 N-CA-C 103.389 -2.819 . . . . 0.0 103.389 168.869 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.44 HG12 ' H ' ' A' ' 44' ' ' ASN . 7.4 p -165.29 -68.5 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.86 0 CA-C-N 114.998 -1.001 . . . . 0.0 110.575 174.787 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.44 ' H ' HG12 ' A' ' 43' ' ' VAL . 54.0 t30 -169.0 86.05 0.16 Allowed 'General case' 0 C--O 1.236 0.363 0 CA-C-O 121.114 0.483 . . . . 0.0 110.987 178.47 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 4.4 mptp? -132.33 149.2 52.41 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 115.903 -0.59 . . . . 0.0 109.918 177.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 29.0 pt -121.36 -51.34 3.22 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.709 175.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 35.0 mmtp 60.33 174.39 0.09 Allowed 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 124.404 1.082 . . . . 0.0 112.77 177.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 131.32 123.54 2.49 Favored Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 119.319 -1.419 . . . . 0.0 115.901 173.169 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 12.7 mptt -144.63 159.77 42.26 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 107.1 -1.444 . . . . 0.0 107.1 171.354 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 1.1 mpt? -83.15 -167.81 1.83 Allowed 'General case' 0 C--N 1.305 -1.335 0 O-C-N 123.026 0.204 . . . . 0.0 110.559 176.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . 0.268 11.6 pt20 -76.21 75.26 3.03 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 115.948 1.833 . . . . 0.0 115.948 -173.565 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.556 ' HB2' ' HD3' ' A' ' 53' ' ' PRO . 98.9 mttt -135.93 -58.66 0.02 OUTLIER Pre-proline 0 C--N 1.315 -0.903 0 CA-C-N 114.352 -1.294 . . . . 0.0 108.228 169.684 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.556 ' HD3' ' HB2' ' A' ' 52' ' ' LYS . 1.4 Cg_endo -95.72 29.88 0.2 Allowed 'Trans proline' 0 C--N 1.383 2.376 0 C-N-CA 122.879 2.386 . . . . 0.0 108.609 174.436 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.519 ' O ' ' HG ' ' A' ' 58' ' ' LEU . 14.9 tp -54.23 -39.96 78.54 Favored Pre-proline 0 C--N 1.303 -1.435 0 N-CA-C 114.573 1.323 . . . . 0.0 114.573 -171.504 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.438 ' O ' ' HE3' ' A' ' 59' ' ' LYS . 0.9 OUTLIER -52.4 -26.41 27.86 Favored 'Trans proline' 0 C--N 1.362 1.253 0 C-N-CA 123.303 2.669 . . . . 0.0 110.952 176.922 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.419 ' HB2' ' O ' ' A' ' 53' ' ' PRO . 20.0 mm-40 -82.7 -41.48 19.27 Favored 'General case' 0 N--CA 1.4 -2.928 0 CA-C-N 115.201 -0.909 . . . . 0.0 109.367 -178.648 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.436 ' O ' ' HB3' ' A' ' 60' ' ' GLU . 3.8 mm? -75.35 -37.38 60.71 Favored 'General case' 0 N--CA 1.44 -0.973 0 N-CA-C 113.47 0.915 . . . . 0.0 113.47 -176.056 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.571 HD23 ' ND2' ' A' ' 74' ' ' ASN 0.261 1.8 pp -58.84 -43.58 90.78 Favored 'General case' 0 C--O 1.217 -0.614 0 C-N-CA 120.088 -0.645 . . . . 0.0 112.179 178.908 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.476 ' H ' HD13 ' A' ' 58' ' ' LEU . 20.8 pttp -77.49 -26.81 51.58 Favored 'General case' 0 C--O 1.208 -1.119 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 175.454 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.48 ' C ' ' H ' ' A' ' 62' ' ' ASP . 8.7 tp10 -61.97 -49.03 77.72 Favored 'General case' 0 C--N 1.313 -0.999 0 C-N-CA 123.895 0.878 . . . . 0.0 111.34 177.402 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 72.5 m-85 -73.62 5.5 3.85 Favored 'General case' 0 C--O 1.243 0.725 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.332 179.181 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.48 ' H ' ' C ' ' A' ' 60' ' ' GLU . 14.9 t70 -125.4 -162.93 1.15 Allowed 'General case' 0 C--N 1.292 -1.918 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 -179.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.512 ' HB2' HD12 ' A' ' 65' ' ' ILE . 2.5 mt -79.11 173.86 7.04 Favored Pre-proline 0 CA--C 1.563 1.467 0 N-CA-C 106.988 -1.486 . . . . 0.0 106.988 -176.421 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -85.8 6.41 5.57 Favored 'Trans proline' 0 CA--C 1.505 -0.967 0 C-N-CA 121.68 1.587 . . . . 0.0 112.103 -171.131 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.512 HD12 ' HB2' ' A' ' 63' ' ' LEU . 0.2 OUTLIER -71.26 -45.46 70.34 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.816 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 179.578 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 58.27 8.91 5.36 Favored Glycine 0 CA--C 1.528 0.885 0 CA-C-N 115.735 -0.666 . . . . 0.0 113.531 -178.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.521 ' O ' ' HB ' ' A' ' 160' ' ' VAL . 48.0 mt 68.58 -68.07 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.832 0 C-N-CA 125.494 1.517 . . . . 0.0 112.364 -176.791 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.452 ' HB3' ' HD3' ' A' ' 69' ' ' PRO . 76.7 t80 178.67 -56.99 0.0 OUTLIER Pre-proline 0 C--N 1.303 -1.417 0 C-N-CA 122.324 0.25 . . . . 0.0 111.078 -177.625 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.452 ' HD3' ' HB3' ' A' ' 68' ' ' PHE . 20.0 Cg_endo -98.15 145.64 0.64 Allowed 'Trans proline' 0 N--CA 1.432 -2.134 0 C-N-CA 122.285 1.99 . . . . 0.0 112.364 -177.026 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -78.57 64.34 3.59 Favored Glycine 0 N--CA 1.442 -0.934 0 N-CA-C 110.517 -1.033 . . . . 0.0 110.517 178.124 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -163.06 -27.38 0.04 OUTLIER 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 -177.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.419 ' HA ' ' CD ' ' A' ' 89' ' ' PRO . . . -83.2 170.52 14.62 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.663 0.785 . . . . 0.0 109.339 173.239 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.661 ' O ' HG22 ' A' ' 73' ' ' THR . 84.1 m 76.8 28.46 0.68 Allowed 'General case' 0 CA--C 1.56 1.339 0 CA-C-O 124.878 2.275 . . . . 0.0 110.866 172.117 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.763 ' O ' ' HA ' ' A' ' 86' ' ' VAL . 0.9 OUTLIER -73.74 108.21 6.44 Favored 'General case' 0 C--N 1.257 -3.439 0 CA-C-N 113.947 -1.479 . . . . 0.0 112.712 -178.175 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.49 ' HB2' HD21 ' A' ' 84' ' ' LEU . 31.3 p90 -79.34 108.71 13.06 Favored 'General case' 0 C--N 1.271 -2.815 0 CA-C-O 122.095 0.95 . . . . 0.0 113.37 -173.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.644 ' HB2' ' O ' ' A' ' 85' ' ' THR . 8.4 mm-40 -105.02 158.35 16.61 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 174.638 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 60.0 t80 -152.87 147.43 25.99 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 -175.274 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.694 ' O ' ' HA ' ' A' ' 82' ' ' LYS . 12.0 m-20 -130.3 -176.46 3.96 Favored 'General case' 0 CA--C 1.489 -1.393 0 CA-C-O 121.325 0.584 . . . . 0.0 111.665 -179.811 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.74 ' O ' ' HB2' ' A' ' 82' ' ' LYS . 45.8 mt-10 -83.88 -62.57 1.54 Allowed 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 117.042 2.238 . . . . 0.0 117.042 175.141 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.404 ' C ' ' H ' ' A' ' 82' ' ' LYS . 9.1 pt-20 -80.6 -34.43 35.17 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 122.775 1.274 . . . . 0.0 108.257 177.818 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.593 ' C ' ' H ' ' A' ' 83' ' ' LYS . 24.7 m -92.63 30.58 1.51 Allowed 'General case' 0 C--N 1.291 -1.969 0 C-N-CA 126.877 2.071 . . . . 0.0 107.496 176.478 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.74 ' HB2' ' O ' ' A' ' 79' ' ' GLU . 72.5 tttt -57.33 32.0 0.0 OUTLIER 'General case' 0 CA--C 1.565 1.542 0 C-N-CA 127.996 2.518 . . . . 0.0 112.617 -179.737 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.593 ' H ' ' C ' ' A' ' 81' ' ' THR . 53.9 pttt -117.96 133.67 55.69 Favored 'General case' 0 N--CA 1.393 -3.315 0 C-N-CA 125.943 1.697 . . . . 0.0 107.179 176.219 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.49 HD21 ' HB2' ' A' ' 75' ' ' TYR . 1.2 tm? -59.82 127.24 30.99 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-O 121.569 0.699 . . . . 0.0 110.743 -171.368 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.644 ' O ' ' HB2' ' A' ' 76' ' ' GLU . 6.2 t -126.77 114.28 17.75 Favored 'General case' 0 N--CA 1.405 -2.687 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.37 -179.851 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.763 ' HA ' ' O ' ' A' ' 74' ' ' ASN . 15.7 m -92.41 140.16 16.7 Favored 'Isoleucine or valine' 0 CA--C 1.474 -1.96 0 O-C-N 121.007 -1.058 . . . . 0.0 111.304 178.542 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.446 ' HA ' ' H ' ' A' ' 107' ' ' THR 0.339 2.0 pp -101.59 103.7 14.54 Favored 'General case' 0 N--CA 1.391 -3.423 0 CA-C-O 122.593 1.187 . . . . 0.0 109.979 176.892 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 35.0 mt -88.65 117.37 68.25 Favored Pre-proline 0 N--CA 1.405 -2.715 0 CA-C-N 113.683 -1.599 . . . . 0.0 107.23 -178.223 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.464 ' HB2' ' HD2' ' A' ' 166' ' ' ARG . 55.1 Cg_exo -55.78 104.15 0.12 Allowed 'Trans proline' 0 N--CA 1.451 -0.992 0 C-N-CA 123.442 2.761 . . . . 0.0 111.737 -178.059 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.503 ' OG ' ' HB ' ' A' ' 167' ' ' VAL . 25.7 t 71.66 170.22 0.32 Allowed 'General case' 0 N--CA 1.44 -0.942 0 O-C-N 124.715 1.259 . . . . 0.0 110.832 -179.134 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 79.4 mt -85.88 116.78 29.49 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.921 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.227 177.409 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' CYS . . . . . 0.581 ' SG ' ' HB2' ' A' ' 104' ' ' PHE . 12.0 p -109.91 129.05 55.7 Favored 'General case' 0 C--N 1.292 -1.92 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 174.615 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -120.41 120.34 35.66 Favored 'General case' 0 CA--C 1.461 -2.463 0 N-CA-C 108.787 -0.819 . . . . 0.0 108.787 -175.5 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.73 ' O ' ' HA ' ' A' ' 101' ' ' VAL . 49.1 t -111.06 115.79 50.8 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.156 0 CA-C-N 114.443 -1.253 . . . . 0.0 109.398 -172.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -137.99 -168.57 11.36 Favored Glycine 0 C--N 1.309 -0.944 0 N-CA-C 110.939 -0.864 . . . . 0.0 110.939 179.325 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 56.4 t80 -141.34 -91.38 0.15 Allowed 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 179.137 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -88.33 -35.41 17.21 Favored 'General case' 0 N--CA 1.434 -1.249 0 C-N-CA 119.401 -0.92 . . . . 0.0 109.013 171.012 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 15.9 t70 177.42 -67.38 0.01 OUTLIER 'General case' 0 C--N 1.353 0.733 0 CA-C-N 115.327 -0.851 . . . . 0.0 111.804 -178.371 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.451 ' HB3' ' O ' ' A' ' 127' ' ' VAL . 29.6 m -77.98 44.56 0.48 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 122.089 0.947 . . . . 0.0 112.935 -171.821 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 39.9 m -149.72 25.23 0.85 Allowed 'General case' 0 C--N 1.287 -2.129 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 175.485 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.73 ' HA ' ' O ' ' A' ' 94' ' ' VAL . 9.3 p -94.81 116.37 35.97 Favored 'Isoleucine or valine' 0 C--O 1.244 0.765 0 CA-C-O 122.01 0.909 . . . . 0.0 113.021 -175.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.413 ' CD1' HG21 ' A' ' 125' ' ' THR . 1.5 mm? -110.2 133.23 53.43 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 177.202 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 22.6 ttmm -103.39 105.23 15.44 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 177.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.581 ' HB2' ' SG ' ' A' ' 92' ' ' CYS . 99.3 m-85 -90.15 98.18 11.62 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 176.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 28.0 m -85.81 155.94 20.78 Favored 'General case' 0 C--N 1.296 -1.737 0 CA-C-N 114.686 -1.143 . . . . 0.0 111.062 -175.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 27.0 m -68.79 121.29 16.22 Favored 'General case' 0 N--CA 1.417 -2.094 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 175.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.446 ' H ' ' HA ' ' A' ' 87' ' ' LEU . 23.3 m 71.98 79.56 0.15 Allowed 'General case' 0 C--N 1.317 -0.807 0 C-N-CA 124.212 1.005 . . . . 0.0 110.656 179.238 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.478 ' O ' ' HA ' ' A' ' 85' ' ' THR . 14.9 m -109.25 121.21 61.93 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 CA-C-N 114.995 -1.002 . . . . 0.0 109.45 177.306 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.585 ' CG2' ' HG3' ' A' ' 83' ' ' LYS . 25.7 m -106.57 124.22 49.28 Favored 'General case' 0 N--CA 1.409 -2.492 0 CA-C-N 114.977 -1.01 . . . . 0.0 111.657 -167.599 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -157.1 -168.69 20.02 Favored Glycine 0 C--N 1.309 -0.947 0 C-N-CA 120.452 -0.88 . . . . 0.0 113.733 -179.295 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 12.9 t-80 -99.64 119.62 38.39 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 105.752 -1.944 . . . . 0.0 105.752 179.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.453 HD22 ' HG ' ' A' ' 84' ' ' LEU . 60.7 tp -124.11 118.51 27.08 Favored 'General case' 0 CA--C 1.457 -2.62 0 CA-C-O 121.338 0.59 . . . . 0.0 111.594 -167.496 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 8.1 mp0 -121.04 146.57 46.58 Favored 'General case' 1 N--CA 1.37 -4.459 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 175.323 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 21.2 tptm -66.2 101.14 0.68 Allowed 'General case' 0 C--N 1.291 -1.959 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 179.148 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 137.07 -48.95 0.88 Allowed Glycine 0 C--O 1.192 -2.478 0 N-CA-C 108.361 -1.896 . . . . 0.0 108.361 -173.294 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.488 ' O ' ' HD2' ' A' ' 116' ' ' LYS . 0.0 OUTLIER -148.71 144.22 26.95 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 114.006 1.113 . . . . 0.0 114.006 179.935 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.645 ' O ' ' HB2' ' A' ' 135' ' ' SER . 49.1 tp -110.65 100.91 9.61 Favored 'General case' 0 C--N 1.31 -1.124 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 177.029 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.469 HG23 ' HD3' ' A' ' 116' ' ' LYS . 6.9 p -100.95 138.16 38.37 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 113.064 0.765 . . . . 0.0 113.064 -176.528 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 29.3 t70 64.09 124.52 0.02 OUTLIER 'General case' 0 CA--C 1.45 -2.866 0 C-N-CA 124.882 1.273 . . . . 0.0 111.348 -176.414 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -145.99 145.16 20.37 Favored 'Isoleucine or valine' 1 N--CA 1.351 -5.388 0 C-N-CA 116.475 -2.09 . . . . 0.0 111.082 -169.659 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 14.9 tp10 -111.42 102.87 11.21 Favored 'General case' 0 C--N 1.283 -2.283 0 CA-C-N 115.13 -0.941 . . . . 0.0 109.199 -176.567 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 116.22 -4.85 20.0 Favored Glycine 0 N--CA 1.439 -1.161 0 C-N-CA 119.392 -1.385 . . . . 0.0 114.225 173.294 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 61.4 mt -99.35 105.4 17.39 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.99 0 C-N-CA 118.737 -1.185 . . . . 0.0 110.052 179.746 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 58.0 tttm -85.37 119.67 25.99 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 179.019 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.506 ' O ' ' HA ' ' A' ' 130' ' ' TRP . 92.1 m -116.46 124.08 49.08 Favored 'General case' 0 C--N 1.271 -2.813 0 CA-C-N 114.951 -1.022 . . . . 0.0 110.116 -176.365 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.466 ' HA ' ' O ' ' A' ' 129' ' ' ILE . 0.7 OUTLIER -122.83 100.25 6.81 Favored 'General case' 0 N--CA 1.424 -1.762 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 174.077 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.451 ' O ' ' HB3' ' A' ' 99' ' ' SER . 11.8 p -102.59 -26.84 3.38 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.138 0 CA-C-O 122.255 1.026 . . . . 0.0 109.511 178.299 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 26.6 ttt -161.32 -33.6 0.05 OUTLIER 'General case' 0 C--N 1.282 -2.335 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 -178.089 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . 0.484 ' H ' HD13 ' A' ' 129' ' ' ILE . 0.2 OUTLIER -139.46 165.62 22.59 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 N-CA-C 104.436 -2.431 . . . . 0.0 104.436 176.759 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' TRP . . . . . 0.506 ' HA ' ' O ' ' A' ' 125' ' ' THR . 60.8 p-90 -108.42 127.82 54.24 Favored 'General case' 0 N--CA 1.418 -2.058 0 C-N-CA 118.928 -1.109 . . . . 0.0 111.661 -178.479 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.507 HG12 ' H ' ' A' ' 133' ' ' VAL . 43.0 t -127.99 154.02 38.06 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.914 0 N-CA-C 105.751 -1.944 . . . . 0.0 105.751 177.354 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -115.98 18.71 15.43 Favored 'General case' 0 C--N 1.3 -1.579 0 CA-C-O 121.627 0.727 . . . . 0.0 111.238 -176.441 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.507 ' H ' HG12 ' A' ' 131' ' ' VAL . 33.5 m -138.11 0.2 0.71 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.637 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.962 -178.464 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' THR . . . . . 0.473 ' OG1' ' HB ' ' A' ' 125' ' ' THR . 1.2 p -64.65 120.61 12.73 Favored 'General case' 0 N--CA 1.418 -2.063 0 CA-C-O 122.065 0.936 . . . . 0.0 110.917 178.074 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' SER . . . . . 0.645 ' HB2' ' O ' ' A' ' 117' ' ' LEU . 19.7 p -78.61 171.25 15.4 Favored 'General case' 0 N--CA 1.407 -2.608 0 CA-C-N 113.778 -1.555 . . . . 0.0 114.049 -173.03 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 10.4 tt -119.18 127.54 75.84 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.099 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 175.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 37.9 m -129.45 131.23 46.68 Favored 'General case' 0 C--N 1.293 -1.886 0 C-N-CA 120.351 -0.54 . . . . 0.0 110.995 -174.422 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' THR . . . . . 0.495 ' HB ' ' O ' ' A' ' 142' ' ' LYS . 59.6 p -118.2 176.13 5.37 Favored 'General case' 0 C--N 1.29 -1.983 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 177.182 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -99.93 21.64 12.35 Favored 'General case' 0 C--N 1.281 -2.398 0 N-CA-C 106.185 -1.783 . . . . 0.0 106.185 173.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . 61.71 40.42 13.15 Favored 'General case' 0 C--N 1.352 0.683 0 N-CA-C 107.367 -1.346 . . . . 0.0 107.367 -168.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 35.6 t -174.78 -79.69 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 114.222 -1.354 . . . . 0.0 109.483 -174.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . 0.495 ' O ' ' HB ' ' A' ' 138' ' ' THR . 99.5 mttt -85.41 167.2 15.74 Favored 'General case' 0 CA--C 1.497 -1.095 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 177.141 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.423 ' HA ' HG21 ' A' ' 138' ' ' THR . 10.4 p -126.33 127.7 70.84 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.741 0 N-CA-C 113.484 0.92 . . . . 0.0 113.484 -173.105 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 45.8 m-85 -113.68 147.14 38.71 Favored 'General case' 0 CA--C 1.487 -1.465 0 CA-C-N 115.244 -0.889 . . . . 0.0 109.982 176.041 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -99.19 99.85 10.89 Favored 'General case' 0 C--N 1.263 -3.174 0 CA-C-N 114.456 -1.247 . . . . 0.0 107.922 175.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . 0.363 17.7 p -82.34 69.76 9.15 Favored 'General case' 0 N--CA 1.425 -1.686 0 N-CA-C 115.315 1.598 . . . . 0.0 115.315 -175.215 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -123.85 74.35 1.27 Allowed 'General case' 0 N--CA 1.424 -1.728 0 N-CA-C 104.68 -2.341 . . . . 0.0 104.68 170.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 77.64 16.25 80.4 Favored Glycine 0 N--CA 1.433 -1.567 0 N-CA-C 109.071 -1.611 . . . . 0.0 109.071 -171.271 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 27.5 ptt? 49.03 24.39 0.88 Allowed 'General case' 0 N--CA 1.502 2.149 0 C-N-CA 126.578 1.951 . . . . 0.0 111.416 -173.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 59.5 mttp -62.77 -36.79 84.23 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 115.021 1.489 . . . . 0.0 115.021 -174.099 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . 0.437 ' HA ' ' HE2' ' A' ' 151' ' ' LYS . 6.1 mmpt? -106.3 132.8 51.91 Favored 'General case' 0 C--N 1.319 -0.74 0 C-N-CA 120.473 -0.491 . . . . 0.0 110.897 178.144 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 19.7 m -132.46 128.21 36.96 Favored 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 -179.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 25.2 mmm180 -140.99 172.95 11.97 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-O 121.232 0.539 . . . . 0.0 111.954 -178.138 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 17.8 m -101.15 142.26 32.85 Favored 'General case' 0 N--CA 1.432 -1.331 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 176.434 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' ARG . . . . . 0.527 ' HD3' ' C ' ' A' ' 155' ' ' ARG . 0.2 OUTLIER -78.58 -25.02 45.21 Favored 'General case' 0 C--N 1.299 -1.606 0 CA-C-O 121.255 0.55 . . . . 0.0 109.89 178.976 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -44.17 -36.37 2.62 Favored 'General case' 0 C--N 1.316 -0.854 0 C-N-CA 125.455 1.502 . . . . 0.0 114.905 -175.277 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -66.44 -53.81 31.23 Favored 'General case' 0 CA--C 1.546 0.797 0 N-CA-C 114.277 1.214 . . . . 0.0 114.277 -174.107 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -149.66 5.15 0.6 Allowed 'General case' 0 N--CA 1.491 1.603 0 CA-C-N 117.597 0.18 . . . . 0.0 111.364 -175.411 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . 0.506 ' HA2' ' HG2' ' A' ' 155' ' ' ARG . . . 96.31 -91.55 1.29 Allowed Glycine 0 CA--C 1.461 -3.33 0 N-CA-C 106.231 -2.748 . . . . 0.0 106.231 -166.772 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.521 ' HB ' ' O ' ' A' ' 67' ' ' ILE . 57.7 t -104.96 127.45 59.49 Favored 'Isoleucine or valine' 1 N--CA 1.369 -4.512 0 N-CA-C 105.16 -2.163 . . . . 0.0 105.16 165.1 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 -88.34 106.59 18.34 Favored 'General case' 0 C--N 1.273 -2.754 0 N-CA-C 106.396 -1.705 . . . . 0.0 106.396 -177.055 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . 0.414 ' HD2' ' O ' ' A' ' 164' ' ' GLY . 0.0 OUTLIER -148.64 158.69 44.31 Favored 'General case' 0 N--CA 1.389 -3.519 0 C-N-CA 118.384 -1.326 . . . . 0.0 114.523 -167.359 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -106.29 -24.1 12.38 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 115.073 -0.967 . . . . 0.0 108.792 172.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . 0.414 ' O ' ' HD2' ' A' ' 162' ' ' ARG . . . -58.65 118.61 14.33 Favored Glycine 0 CA--C 1.498 -0.994 0 CA-C-N 115.258 -0.883 . . . . 0.0 112.282 -178.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 2.8 pp -108.7 153.74 23.01 Favored 'General case' 0 N--CA 1.418 -2.047 0 CA-C-O 120.667 0.27 . . . . 0.0 111.161 -174.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . 0.464 ' HD2' ' HB2' ' A' ' 89' ' ' PRO . 58.6 mtm180 -79.12 117.4 20.11 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 178.17 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . 0.503 ' HB ' ' OG ' ' A' ' 90' ' ' SER . 43.6 t -62.28 -18.0 19.26 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.627 0 CA-C-O 121.64 0.733 . . . . 0.0 109.692 176.056 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -56.1 -41.44 75.21 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 124.739 1.215 . . . . 0.0 111.101 176.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 1.9 tmmm? -86.59 109.58 19.23 Favored 'General case' 0 N--CA 1.429 -1.499 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 -178.478 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' PHE . . . . . . . . . . . . . 87.9 t80 . . . . . 0 N--CA 1.423 -1.822 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 178.414 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 44.1 m . . . . . 0 N--CA 1.443 -0.813 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -90.43 94.09 9.58 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-O 122.1 0.952 . . . . 0.0 111.8 -177.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 29.6 tt0 -114.18 100.4 8.34 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 178.055 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.1 mp -78.61 127.76 38.69 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.094 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.261 -175.48 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -102.45 157.22 17.07 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.61 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 83.8 m-20 -112.25 165.4 12.2 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 177.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.486 ' HD3' ' H ' ' A' ' 7' ' ' LYS . 0.1 OUTLIER -83.55 83.07 8.03 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-O 121.958 0.885 . . . . 0.0 111.193 178.885 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 29.9 m -137.17 169.7 19.17 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 CA-C-N 115.146 -0.934 . . . . 0.0 109.105 179.422 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -103.49 150.31 17.59 Favored Glycine 0 N--CA 1.418 -2.553 0 N-CA-C 107.477 -2.249 . . . . 0.0 107.477 172.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 32.1 t -66.23 159.14 27.12 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-N 117.957 0.879 . . . . 0.0 109.235 -179.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 37.9 p90 -63.11 129.77 41.75 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-O 120.917 0.389 . . . . 0.0 110.688 -177.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 12.3 p90 -92.44 137.09 32.66 Favored 'General case' 0 C--N 1.304 -1.392 0 C-N-CA 120.411 -0.516 . . . . 0.0 110.257 177.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 53.5 tp -154.37 100.73 2.31 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 109.101 -0.704 . . . . 0.0 109.101 -179.294 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -92.68 115.57 4.89 Favored Glycine 0 N--CA 1.43 -1.715 0 N-CA-C 111.185 -0.766 . . . . 0.0 111.185 -179.54 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -136.95 153.21 50.76 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 18.0 ptpt -125.06 82.52 2.06 Favored 'General case' 0 C--N 1.292 -1.898 0 CA-C-O 122.143 0.973 . . . . 0.0 110.686 173.486 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -136.29 91.95 2.73 Favored 'General case' 0 N--CA 1.426 -1.662 0 CA-C-N 114.43 -1.259 . . . . 0.0 107.635 178.271 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 46.1 t30 -72.48 108.36 5.51 Favored 'General case' 0 C--N 1.299 -1.62 0 CA-C-N 115.085 -0.961 . . . . 0.0 111.517 -175.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 6.0 tmtm? -84.72 -60.23 2.12 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 104.683 -2.34 . . . . 0.0 104.683 171.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -168.36 75.71 0.12 Allowed 'General case' 0 N--CA 1.435 -1.223 0 CA-C-N 115.197 -0.91 . . . . 0.0 109.492 173.132 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -93.83 90.53 6.56 Favored 'General case' 0 CA--C 1.496 -1.125 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.61 178.102 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -109.63 -25.82 10.22 Favored 'General case' 0 C--N 1.291 -1.968 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 176.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 38.4 t 68.71 159.63 0.17 Allowed 'General case' 0 C--N 1.349 0.574 0 C-N-CA 124.578 1.151 . . . . 0.0 111.04 179.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 47.0 t -90.52 102.36 13.26 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.78 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 176.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -54.34 114.95 4.71 Favored Glycine 0 CA--C 1.506 -0.507 0 O-C-N 124.187 0.929 . . . . 0.0 113.278 -175.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -83.27 131.41 35.09 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 -179.109 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -96.19 134.96 38.64 Favored 'General case' 0 C--N 1.295 -1.794 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 175.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . 0.334 1.0 OUTLIER -77.58 72.67 4.13 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 115.607 1.706 . . . . 0.0 115.607 -175.693 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -91.82 131.25 37.31 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.446 177.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 47.3 t -140.95 101.91 4.15 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 -179.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 40.4 t -123.45 74.28 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 178.453 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 26.8 t 173.37 95.56 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 124.608 1.163 . . . . 0.0 108.075 177.086 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 7.1 t -131.18 91.2 2.99 Favored 'General case' 0 C--N 1.295 -1.796 0 CA-C-O 122.117 0.96 . . . . 0.0 110.148 179.037 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 61.7 m -157.8 153.3 26.23 Favored 'General case' 0 N--CA 1.44 -0.966 0 CA-C-N 115.069 -0.969 . . . . 0.0 109.134 179.623 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 6.4 tp -136.84 112.2 11.18 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 175.412 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -120.7 -172.69 2.43 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 113.005 0.743 . . . . 0.0 113.005 -175.685 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -140.95 142.11 11.91 Favored Glycine 0 N--CA 1.415 -2.735 0 N-CA-C 108.952 -1.659 . . . . 0.0 108.952 176.082 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -82.29 69.01 3.41 Favored Glycine 0 C--N 1.302 -1.321 0 N-CA-C 110.935 -0.866 . . . . 0.0 110.935 179.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 7.4 t -160.5 158.35 29.11 Favored 'General case' 0 N--CA 1.426 -1.658 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 -178.336 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 55.7 tptt -87.67 -14.06 40.93 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-O 121.409 0.623 . . . . 0.0 109.546 178.081 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 87.5 t90 -91.16 100.83 13.59 Favored 'General case' 0 N--CA 1.437 -1.086 0 CA-C-O 121.205 0.526 . . . . 0.0 109.649 179.169 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.474 ' O ' HD12 ' A' ' 42' ' ' LEU 0.261 2.3 pp -157.5 108.55 2.28 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-O 121.952 0.882 . . . . 0.0 111.37 176.578 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 8.5 p -165.23 138.29 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.97 0 CA-C-N 114.921 -1.036 . . . . 0.0 109.45 -178.424 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 37.6 t30 -101.25 107.36 18.72 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 179.03 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -98.98 107.7 20.2 Favored 'General case' 0 C--N 1.308 -1.218 0 C-N-CA 120.227 -0.589 . . . . 0.0 111.155 -177.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 63.8 mt -112.84 94.41 3.11 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 173.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 54.6 tttp -87.07 114.36 23.61 Favored 'General case' 0 C--N 1.309 -1.167 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 -176.575 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.423 ' HA2' ' HB2' ' A' ' 51' ' ' GLN . . . -99.48 25.16 29.33 Favored Glycine 0 C--N 1.302 -1.32 0 C-N-CA 121.188 -0.529 . . . . 0.0 113.346 -176.406 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 61.8 tttm -77.48 -52.72 8.61 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 178.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 27.9 ttt -126.79 82.37 2.08 Favored 'General case' 0 C--N 1.308 -1.196 0 N-CA-C 106.163 -1.791 . . . . 0.0 106.163 171.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . 0.423 ' HB2' ' HA2' ' A' ' 48' ' ' GLY . 53.1 tt0 -89.44 -63.09 1.34 Allowed 'General case' 0 C--N 1.302 -1.489 0 CA-C-N 114.999 -1.0 . . . . 0.0 112.146 -170.783 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 68.7 mttm 68.12 132.45 0.04 OUTLIER Pre-proline 0 N--CA 1.467 0.424 0 O-C-N 124.389 1.055 . . . . 0.0 110.212 -171.338 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -78.28 -13.28 15.36 Favored 'Trans proline' 0 N--CA 1.454 -0.844 0 C-N-CA 121.506 1.47 . . . . 0.0 111.482 179.28 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.656 ' O ' ' HG ' ' A' ' 58' ' ' LEU . 23.3 mt -57.08 -59.09 13.74 Favored Pre-proline 0 C--O 1.208 -1.088 0 CA-C-N 115.535 -0.757 . . . . 0.0 112.068 -174.786 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.497 ' HA ' ' CD1' ' A' ' 58' ' ' LEU . 36.7 Cg_endo -60.34 -34.96 93.04 Favored 'Trans proline' 0 C--N 1.377 2.063 0 C-N-CA 120.899 1.066 . . . . 0.0 113.768 -169.729 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -78.21 -30.27 48.8 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-O 121.242 0.544 . . . . 0.0 110.633 179.324 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 45.5 tp -74.02 -29.39 61.91 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.242 176.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.656 ' HG ' ' O ' ' A' ' 54' ' ' LEU . 59.6 mt -57.48 -45.9 84.3 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-O 121.375 0.607 . . . . 0.0 110.3 -177.896 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.433 ' HZ2' ' HB2' ' A' ' 60' ' ' GLU . 1.9 pptp? -73.57 -25.0 60.16 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 114.894 -1.048 . . . . 0.0 110.577 -179.183 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.433 ' HB2' ' HZ2' ' A' ' 59' ' ' LYS . 35.0 tt0 -90.48 -22.83 21.17 Favored 'General case' 0 CA--C 1.556 1.181 0 N-CA-C 113.482 0.919 . . . . 0.0 113.482 -174.776 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.537 ' CD2' ' HA ' ' A' ' 58' ' ' LEU . 34.1 m-85 -41.31 -41.08 1.83 Allowed 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 115.193 1.553 . . . . 0.0 115.193 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.489 ' OD2' ' HA ' ' A' ' 114' ' ' LYS . 10.4 t70 -125.96 -82.96 0.63 Allowed 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 117.746 -1.582 . . . . 0.0 112.205 -172.647 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.441 ' H ' HD12 ' A' ' 63' ' ' LEU . 0.0 OUTLIER -90.94 161.07 36.56 Favored Pre-proline 0 N--CA 1.444 -0.752 0 N-CA-C 106.619 -1.623 . . . . 0.0 106.619 -179.742 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -100.55 14.17 0.45 Allowed 'Trans proline' 0 N--CA 1.435 -1.936 0 C-N-CA 122.778 2.319 . . . . 0.0 112.803 -176.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.517 HG12 ' H ' ' A' ' 67' ' ' ILE . 0.2 OUTLIER -67.09 -47.5 81.75 Favored 'Isoleucine or valine' 0 CA--C 1.484 -1.59 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 177.146 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.441 ' HA2' HG21 ' A' ' 73' ' ' THR . . . 49.91 8.7 0.15 Allowed Glycine 0 N--CA 1.472 1.043 0 CA-C-N 114.903 -1.044 . . . . 0.0 113.849 -173.13 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.517 ' H ' HG12 ' A' ' 65' ' ' ILE . 16.6 mm 69.38 -69.34 0.16 Allowed 'Isoleucine or valine' 0 C--O 1.177 -2.739 0 C-N-CA 125.549 1.54 . . . . 0.0 108.555 -173.142 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.489 ' HB3' ' HD3' ' A' ' 69' ' ' PRO . 65.3 t80 -167.4 -56.75 0.01 OUTLIER Pre-proline 0 C--N 1.293 -1.851 0 C-N-CA 120.917 -0.313 . . . . 0.0 110.64 -177.78 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.489 ' HD3' ' HB3' ' A' ' 68' ' ' PHE . 56.0 Cg_endo -102.71 178.91 0.15 Allowed 'Trans proline' 0 N--CA 1.424 -2.61 0 C-N-CA 121.721 1.614 . . . . 0.0 111.108 -179.651 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -102.99 19.32 46.98 Favored Glycine 0 N--CA 1.43 -1.76 0 N-CA-C 109.756 -1.338 . . . . 0.0 109.756 175.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -100.93 -44.43 5.75 Favored 'General case' 0 N--CA 1.432 -1.353 0 N-CA-C 106.401 -1.703 . . . . 0.0 106.401 -178.368 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -80.6 168.04 19.36 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 114.653 -1.158 . . . . 0.0 109.156 167.059 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.711 HG23 ' O ' ' A' ' 73' ' ' THR . 22.3 m 81.8 28.84 0.15 Allowed 'General case' 0 CA--C 1.513 -0.462 0 CA-C-O 123.764 1.745 . . . . 0.0 111.198 171.556 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.713 HD21 ' N ' ' A' ' 74' ' ' ASN . 0.7 OUTLIER -70.47 148.26 48.49 Favored 'General case' 0 C--N 1.262 -3.212 0 CA-C-N 114.264 -1.335 . . . . 0.0 110.01 -179.725 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 40.5 t80 -115.01 91.32 3.58 Favored 'General case' 0 C--N 1.275 -2.644 0 C-N-CA 119.847 -0.741 . . . . 0.0 111.834 -166.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.508 ' O ' HD21 ' A' ' 84' ' ' LEU . 39.6 mm-40 -113.53 153.77 28.19 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.018 177.165 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 46.0 p90 -163.35 147.77 10.95 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 178.409 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.484 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 11.7 m-20 -74.99 165.11 25.79 Favored 'General case' 0 CA--C 1.478 -1.818 0 C-N-CA 119.827 -0.749 . . . . 0.0 109.235 179.77 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -80.78 -62.73 1.58 Allowed 'General case' 0 C--N 1.265 -3.087 0 CA-C-N 114.775 -1.102 . . . . 0.0 111.599 -179.169 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.409 ' H ' ' CD ' ' A' ' 80' ' ' GLU . 0.0 OUTLIER -80.98 -35.15 32.42 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.271 -176.293 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.484 ' HB ' ' HB2' ' A' ' 78' ' ' ASP . 56.8 m -80.49 -40.83 25.4 Favored 'General case' 0 N--CA 1.423 -1.822 0 CA-C-N 115.076 -0.965 . . . . 0.0 110.992 -178.598 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.442 ' H ' ' HB2' ' A' ' 78' ' ' ASP . 61.9 mttp 66.23 13.72 9.3 Favored 'General case' 0 N--CA 1.483 1.184 0 N-CA-C 114.206 1.187 . . . . 0.0 114.206 178.554 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 36.6 ttpt -71.54 116.46 11.91 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 176.336 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.508 HD21 ' O ' ' A' ' 76' ' ' GLU . 2.1 tm? -75.03 131.39 40.57 Favored 'General case' 0 N--CA 1.443 -0.817 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 -176.447 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.568 ' HA ' ' O ' ' A' ' 108' ' ' VAL . 27.4 p -126.66 116.59 21.23 Favored 'General case' 0 N--CA 1.412 -2.353 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.127 177.428 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.565 ' HA ' ' O ' ' A' ' 74' ' ' ASN . 63.2 t -91.92 131.84 37.94 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.054 0 N-CA-C 106.86 -1.533 . . . . 0.0 106.86 173.837 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.595 ' HA ' ' O ' ' A' ' 106' ' ' THR 0.361 2.1 pp -111.08 114.9 28.51 Favored 'General case' 0 N--CA 1.393 -3.28 0 CA-C-O 122.161 0.981 . . . . 0.0 111.869 178.642 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.464 ' O ' HG21 ' A' ' 106' ' ' THR . 70.3 mt -95.88 125.71 47.67 Favored Pre-proline 0 N--CA 1.419 -2.008 0 CA-C-N 113.647 -1.615 . . . . 0.0 109.771 -176.472 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -53.89 95.43 0.04 OUTLIER 'Trans proline' 0 CA--C 1.534 0.489 0 C-N-CA 124.129 3.219 . . . . 0.0 112.492 177.696 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.529 ' OG ' ' HB ' ' A' ' 167' ' ' VAL . 22.9 t 75.7 158.14 0.2 Allowed 'General case' 0 C--O 1.236 0.387 0 C-N-CA 125.452 1.501 . . . . 0.0 110.394 -177.804 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.423 HD12 ' HD3' ' A' ' 103' ' ' LYS . 15.9 tt -78.57 108.22 11.77 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.598 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 173.871 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' CYS . . . . . 0.672 ' SG ' ' HG2' ' A' ' 166' ' ' ARG . 32.0 m -98.76 127.03 44.56 Favored 'General case' 0 C--N 1.29 -1.99 0 CA-C-N 114.932 -1.031 . . . . 0.0 110.725 -170.817 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -116.79 147.71 41.84 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-N 116.661 -0.245 . . . . 0.0 110.461 -178.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.568 ' O ' ' HA ' ' A' ' 101' ' ' VAL . 6.4 p -137.74 114.11 11.39 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 CA-C-O 120.91 0.386 . . . . 0.0 111.198 -178.745 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -145.43 163.31 28.19 Favored Glycine 0 N--CA 1.443 -0.854 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 176.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 78.1 t80 -171.1 -79.49 0.01 OUTLIER 'General case' 0 CA--C 1.522 -0.11 0 CA-C-N 118.102 0.951 . . . . 0.0 111.263 179.113 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 13.0 ptmt -85.84 -16.25 39.27 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 112.316 0.487 . . . . 0.0 112.316 -176.692 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 23.0 t70 75.25 106.33 0.07 Allowed 'General case' 0 N--CA 1.471 0.578 0 O-C-N 124.304 1.003 . . . . 0.0 112.702 -175.08 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 66.0 m 172.45 -29.87 0.0 OUTLIER 'General case' 0 C--N 1.31 -1.121 0 C-N-CA 128.235 2.614 . . . . 0.0 105.872 -178.325 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 36.1 p -147.92 102.53 3.41 Favored 'General case' 0 N--CA 1.414 -2.27 0 CA-C-N 114.033 -1.44 . . . . 0.0 109.973 178.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.568 ' HA ' ' O ' ' A' ' 94' ' ' VAL . 11.6 p -123.22 119.64 58.17 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 N-CA-C 106.681 -1.599 . . . . 0.0 106.681 174.477 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.446 HD21 ' H ' ' A' ' 126' ' ' LYS . 59.1 mt -124.83 144.12 50.46 Favored 'General case' 0 C--N 1.282 -2.356 0 C-N-CA 120.03 -0.668 . . . . 0.0 110.688 -170.88 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.423 ' HD3' HD12 ' A' ' 91' ' ' ILE . 23.0 ttmm -121.28 104.96 10.11 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 179.551 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -89.92 101.83 14.53 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.767 -178.31 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 82.5 m -60.97 153.09 25.99 Favored 'General case' 0 C--N 1.306 -1.317 0 C-N-CA 124.46 1.104 . . . . 0.0 110.652 177.11 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' THR . . . . . 0.595 ' O ' ' HA ' ' A' ' 87' ' ' LEU . 88.4 m -71.65 -69.24 0.4 Allowed 'General case' 0 C--O 1.205 -1.242 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.302 -174.634 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 32.3 p -99.08 101.71 13.17 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 178.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.568 ' O ' ' HA ' ' A' ' 85' ' ' THR . 4.7 p -112.41 138.42 41.56 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.769 0 C-N-CA 119.27 -0.972 . . . . 0.0 111.751 -177.236 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 76.4 p -94.29 153.07 18.21 Favored 'General case' 0 N--CA 1.413 -2.311 0 CA-C-N 115.344 -0.843 . . . . 0.0 109.666 -177.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . 0.462 ' HA2' ' O ' ' A' ' 119' ' ' ASP . . . -169.8 167.92 40.92 Favored Glycine 0 N--CA 1.423 -2.201 0 C-N-CA 120.787 -0.72 . . . . 0.0 111.979 -179.381 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 9.6 t60 -92.97 108.65 20.17 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 178.31 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -91.52 125.42 36.25 Favored 'General case' 0 C--N 1.296 -1.718 0 CA-C-O 121.075 0.464 . . . . 0.0 110.363 -178.37 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . 0.454 ' HG3' ' HG3' ' A' ' 116' ' ' LYS . 10.5 pt-20 -142.33 136.57 29.8 Favored 'General case' 0 N--CA 1.425 -1.675 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 171.133 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.489 ' HA ' ' OD2' ' A' ' 62' ' ' ASP . 2.3 tmtp? -52.08 117.82 3.04 Favored 'General case' 0 C--O 1.248 0.991 0 CA-C-O 121.726 0.775 . . . . 0.0 111.774 -169.599 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . 0.656 ' O ' ' HB ' ' A' ' 138' ' ' THR . . . 106.53 -28.47 13.32 Favored Glycine 0 N--CA 1.409 -3.126 0 CA-C-N 114.66 -1.155 . . . . 0.0 112.421 176.559 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.454 ' HG3' ' HG3' ' A' ' 113' ' ' GLU . 12.4 ptmm? -147.11 115.38 6.62 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-O 121.784 0.802 . . . . 0.0 111.676 -174.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 59.4 tp -93.55 103.57 15.74 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 106.656 -1.609 . . . . 0.0 106.656 177.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.425 HG23 ' NZ ' ' A' ' 116' ' ' LYS . 39.7 p -103.64 140.38 37.64 Favored 'General case' 0 N--CA 1.403 -2.801 0 N-CA-C 113.572 0.953 . . . . 0.0 113.572 -171.787 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . 0.462 ' O ' ' HA2' ' A' ' 110' ' ' GLY . 12.9 m-20 60.09 85.51 0.11 Allowed 'General case' 0 CA--C 1.493 -1.215 0 CA-C-N 114.611 -1.177 . . . . 0.0 113.788 -179.824 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.8 m -88.02 87.77 2.8 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.985 0 CA-C-N 115.038 -0.983 . . . . 0.0 109.327 174.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -68.51 93.89 0.53 Allowed 'General case' 0 N--CA 1.418 -2.066 0 CA-C-N 113.813 -1.539 . . . . 0.0 108.495 -177.434 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 137.84 -11.26 3.67 Favored Glycine 0 N--CA 1.418 -2.52 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.597 178.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.565 HG12 HG21 ' A' ' 108' ' ' VAL . 36.1 mm -96.64 112.46 28.8 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.176 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 178.779 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 46.6 mtpt -86.35 118.97 26.12 Favored 'General case' 0 N--CA 1.414 -2.253 0 CA-C-N 114.954 -1.021 . . . . 0.0 109.279 -177.282 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.421 HG21 HG23 ' A' ' 134' ' ' THR . 86.5 m -122.9 130.66 53.12 Favored 'General case' 0 N--CA 1.407 -2.604 0 CA-C-N 114.159 -1.382 . . . . 0.0 110.604 -173.894 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.625 ' HD3' ' C ' ' A' ' 126' ' ' LYS . 0.3 OUTLIER -107.72 125.64 51.63 Favored 'General case' 0 N--CA 1.41 -2.454 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 173.705 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.58 HG22 ' H ' ' A' ' 128' ' ' MET . 4.0 m -119.29 -81.0 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.09 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.498 175.844 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' MET . . . . . 0.58 ' H ' HG22 ' A' ' 127' ' ' VAL . 1.1 tmt? -103.1 -20.2 14.26 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 106.277 -1.749 . . . . 0.0 106.277 171.722 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 1.1 pp -152.21 -176.41 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 C-N-CA 126.758 2.023 . . . . 0.0 108.564 -178.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 91.2 m95 -95.28 139.84 31.02 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.06 0.457 . . . . 0.0 111.567 178.585 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.472 HG13 ' H ' ' A' ' 133' ' ' VAL . 31.9 t -138.65 135.43 43.47 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.955 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 174.428 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . 0.487 ' H ' ' HD2' ' A' ' 132' ' ' LYS . 0.0 OUTLIER -93.03 13.31 21.16 Favored 'General case' 0 N--CA 1.487 1.403 0 CA-C-N 118.426 0.557 . . . . 0.0 111.024 -178.029 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.472 ' H ' HG13 ' A' ' 131' ' ' VAL . 5.5 p -166.43 96.31 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.31 -1.129 0 CA-C-O 122.364 1.078 . . . . 0.0 111.578 -172.539 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' THR . . . . . 0.421 HG23 HG21 ' A' ' 125' ' ' THR . 21.8 p -99.03 -172.8 2.35 Favored 'General case' 0 N--CA 1.404 -2.742 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.289 176.334 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 28.4 t -147.97 134.53 19.8 Favored 'General case' 0 C--N 1.282 -2.344 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 -173.569 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 60.9 mt -105.27 103.79 15.92 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.875 0 CA-C-O 121.197 0.522 . . . . 0.0 109.979 -178.415 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 56.3 p -96.54 110.8 23.13 Favored 'General case' 0 N--CA 1.428 -1.549 0 CA-C-O 121.233 0.54 . . . . 0.0 109.597 179.107 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' THR . . . . . 0.656 ' HB ' ' O ' ' A' ' 115' ' ' GLY . 75.5 m -128.44 159.65 34.74 Favored 'General case' 0 C--N 1.274 -2.694 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 -177.591 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -105.72 39.35 1.78 Allowed 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 109.786 -0.449 . . . . 0.0 109.786 175.576 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . 58.74 34.82 24.03 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 115.243 -0.89 . . . . 0.0 109.602 -177.152 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' SER . . . . . 0.442 ' H ' HG23 ' A' ' 138' ' ' THR . 33.5 t 179.45 -78.16 0.01 OUTLIER 'General case' 0 CA--C 1.547 0.859 0 CA-C-N 114.7 -1.137 . . . . 0.0 110.081 -174.634 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -80.67 134.97 35.95 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 110.152 -0.314 . . . . 0.0 110.152 179.392 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 20.3 t -110.22 140.19 30.32 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 N-CA-C 112.793 0.664 . . . . 0.0 112.793 -168.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -133.51 151.84 51.82 Favored 'General case' 0 CA--C 1.483 -1.605 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 170.013 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . 0.445 ' HB2' ' HB2' ' A' ' 151' ' ' LYS . 55.4 m-85 -113.11 99.58 7.94 Favored 'General case' 0 C--N 1.275 -2.659 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.744 179.297 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 16.8 p -84.81 85.72 7.43 Favored 'General case' 0 N--CA 1.408 -2.538 0 CA-C-N 115.133 -0.939 . . . . 0.0 110.97 177.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -113.03 70.52 0.72 Allowed 'General case' 0 N--CA 1.428 -1.559 0 N-CA-C 106.33 -1.73 . . . . 0.0 106.33 174.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 72.64 27.03 70.1 Favored Glycine 0 N--CA 1.439 -1.125 0 N-CA-C 108.619 -1.792 . . . . 0.0 108.619 -171.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 26.8 ttt 60.42 97.51 0.03 OUTLIER 'General case' 0 C--N 1.355 0.807 0 C-N-CA 124.621 1.169 . . . . 0.0 109.3 -171.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . 0.539 ' HA ' ' HZ3' ' A' ' 150' ' ' LYS . 0.0 OUTLIER -144.19 -52.54 0.32 Allowed 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 114.9 1.444 . . . . 0.0 114.9 -174.766 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . 0.445 ' HB2' ' HB2' ' A' ' 145' ' ' PHE . 35.2 mmtp -121.96 163.9 18.52 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 114.236 1.199 . . . . 0.0 114.236 -171.292 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 55.7 p -128.51 160.01 33.67 Favored 'General case' 0 N--CA 1.439 -0.977 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 175.362 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 14.6 tpp180 -154.96 132.84 11.49 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.132 0.491 . . . . 0.0 111.709 179.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 9.2 m -88.64 137.38 32.37 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 177.311 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' ARG . . . . . 0.673 ' HD3' ' O ' ' A' ' 155' ' ' ARG . 2.4 tmt_? -70.12 -22.25 63.03 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 110.282 -0.266 . . . . 0.0 110.282 -176.898 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -50.86 -25.25 4.29 Favored 'General case' 0 N--CA 1.5 2.052 0 C-N-CA 123.482 0.713 . . . . 0.0 112.552 177.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . 0.429 ' HB1' ' HG2' ' A' ' 161' ' ' GLN . . . -76.42 4.01 9.93 Favored 'General case' 0 C--N 1.306 -1.286 0 C-N-CA 124.924 1.29 . . . . 0.0 113.393 -178.311 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . 0.412 ' HB2' ' O ' ' A' ' 157' ' ' ALA . 86.7 m-85 91.53 23.46 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.147 0 C-N-CA 126.186 1.794 . . . . 0.0 109.51 -175.489 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . 0.441 ' HA3' ' O ' ' A' ' 65' ' ' ILE . . . 101.64 -94.4 1.22 Allowed Glycine 0 N--CA 1.398 -3.867 0 N-CA-C 109.224 -1.551 . . . . 0.0 109.224 -175.458 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.484 HG22 ' HB ' ' A' ' 65' ' ' ILE . 79.7 t -128.92 113.74 30.09 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.337 0 CA-C-O 121.505 0.669 . . . . 0.0 111.029 -178.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' GLN . . . . . 0.429 ' HG2' ' HB1' ' A' ' 157' ' ' ALA 0.315 10.0 pt20 -110.52 92.87 4.21 Favored 'General case' 0 C--N 1.302 -1.472 0 C-N-CA 117.203 -1.799 . . . . 0.0 114.54 179.278 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 26.0 tpt180 -146.22 102.14 3.58 Favored 'General case' 0 C--N 1.274 -2.708 0 N-CA-C 101.789 -3.411 . . . . 0.0 101.789 168.454 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 47.8 m-80 -110.67 123.03 49.23 Favored 'General case' 0 C--N 1.292 -1.93 0 N-CA-C 113.453 0.909 . . . . 0.0 113.453 -169.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . 0.444 ' CA ' ' HB ' ' A' ' 94' ' ' VAL . . . -95.11 -169.5 36.35 Favored Glycine 0 N--CA 1.42 -2.422 0 N-CA-C 108.823 -1.711 . . . . 0.0 108.823 172.899 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.495 HD22 ' H ' ' A' ' 165' ' ' LEU . 1.9 pt? -91.37 112.0 23.72 Favored 'General case' 0 C--N 1.296 -1.736 0 C-N-CA 119.113 -1.035 . . . . 0.0 109.648 -178.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . 0.672 ' HG2' ' SG ' ' A' ' 92' ' ' CYS . 78.9 mtt85 -82.74 101.16 10.7 Favored 'General case' 0 CA--C 1.48 -1.738 0 N-CA-C 106.447 -1.686 . . . . 0.0 106.447 174.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . 0.529 ' HB ' ' OG ' ' A' ' 90' ' ' SER . 52.4 t -68.59 -27.84 37.86 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.803 0 CA-C-N 114.942 -1.026 . . . . 0.0 112.25 -175.366 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -90.84 69.69 6.48 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-O 121.975 0.893 . . . . 0.0 110.432 -177.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 39.3 ttpt 177.92 130.54 0.06 Allowed 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 113.474 -1.694 . . . . 0.0 106.81 175.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' PHE . . . . . . . . . . . . . 64.0 m-85 . . . . . 0 C--N 1.288 -2.098 0 CA-C-O 119.148 -0.453 . . . . 0.0 110.302 -175.159 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 26.0 t . . . . . 0 N--CA 1.445 -0.719 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -118.05 97.54 5.86 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-O 121.27 0.557 . . . . 0.0 112.417 -177.548 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 93.9 mt-30 -122.75 113.72 19.57 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 174.083 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.409 ' N ' HD13 ' A' ' 4' ' ' ILE . 2.4 mp -85.22 110.76 19.79 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.936 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 -179.402 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 47.8 p90 -122.56 118.18 27.63 Favored 'General case' 0 N--CA 1.421 -1.878 0 CA-C-O 121.653 0.739 . . . . 0.0 110.646 179.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 63.4 t30 -105.09 19.67 20.19 Favored 'General case' 0 C--N 1.291 -1.96 0 N-CA-C 106.209 -1.774 . . . . 0.0 106.209 176.089 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -72.1 106.81 4.48 Favored 'General case' 0 N--CA 1.436 -1.143 0 CA-C-N 113.34 -1.755 . . . . 0.0 110.584 -178.474 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.7 p -149.73 100.94 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 CA-C-O 122.479 1.133 . . . . 0.0 111.695 178.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -109.64 27.21 12.59 Favored Glycine 0 N--CA 1.432 -1.577 0 CA-C-N 114.782 -1.099 . . . . 0.0 110.381 177.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 20.4 m -84.22 90.9 7.6 Favored 'General case' 0 N--CA 1.427 -1.598 0 CA-C-O 121.233 0.54 . . . . 0.0 110.402 -179.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -106.47 96.46 6.48 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 177.465 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 59.2 p-90 -80.78 147.15 30.63 Favored 'General case' 0 C--N 1.297 -1.694 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.357 -174.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.477 HD13 ' O ' ' A' ' 13' ' ' LEU . 1.9 pp -113.28 115.49 28.25 Favored 'General case' 0 C--N 1.29 -2.011 0 CA-C-O 121.753 0.787 . . . . 0.0 111.84 179.301 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -160.56 48.53 0.38 Allowed Glycine 0 N--CA 1.431 -1.683 0 N-CA-C 110.761 -0.936 . . . . 0.0 110.761 -179.259 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -128.22 131.01 48.84 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 -179.849 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 28.2 tptp -92.55 -28.42 16.77 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.648 -177.635 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 59.22 83.92 0.12 Allowed 'General case' 0 C--O 1.236 0.394 0 CA-C-O 122.024 0.916 . . . . 0.0 111.147 -178.445 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 42.0 t30 -139.52 102.7 4.53 Favored 'General case' 0 C--N 1.295 -1.791 0 CA-C-N 115.183 -0.917 . . . . 0.0 109.129 -178.25 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -147.24 124.01 11.21 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.399 -177.349 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -93.51 122.97 36.49 Favored 'General case' 0 N--CA 1.42 -1.948 0 N-CA-C 104.73 -2.322 . . . . 0.0 104.73 167.136 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 49.2 p90 -94.08 139.38 31.05 Favored 'General case' 0 C--N 1.289 -2.026 0 C-N-CA 119.626 -0.829 . . . . 0.0 111.21 -174.472 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -119.43 80.82 1.62 Allowed 'General case' 0 C--N 1.286 -2.158 0 CA-C-O 122.175 0.988 . . . . 0.0 110.154 176.156 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 20.2 m -148.67 87.73 1.58 Allowed 'General case' 0 N--CA 1.428 -1.546 0 CA-C-N 113.858 -1.519 . . . . 0.0 108.02 -179.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 41.0 t -137.98 170.95 16.36 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.268 0 N-CA-C 105.973 -1.862 . . . . 0.0 105.973 -177.256 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -51.54 119.9 9.15 Favored Glycine 0 C--O 1.245 0.824 0 N-CA-C 110.861 -0.896 . . . . 0.0 110.861 176.121 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 40.2 m-80 -61.29 143.59 55.4 Favored 'General case' 0 C--O 1.247 0.958 0 CA-C-O 120.954 0.406 . . . . 0.0 110.973 -177.075 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -78.82 84.61 4.87 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 122.031 0.919 . . . . 0.0 110.762 -179.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -169.29 -47.32 0.02 OUTLIER 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 104.711 -2.329 . . . . 0.0 104.711 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 41.0 m-80 64.48 90.46 0.09 Allowed 'General case' 0 CA--C 1.5 -0.952 0 CA-C-N 114.162 -1.381 . . . . 0.0 112.04 176.456 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 34.7 t -72.63 -65.87 0.73 Allowed 'General case' 0 N--CA 1.431 -1.418 0 N-CA-C 106.408 -1.701 . . . . 0.0 106.408 174.486 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 29.7 m 44.67 -171.92 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 N-CA-C 116.074 1.879 . . . . 0.0 116.074 172.102 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 27.1 t 70.5 16.65 6.98 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 114.533 -1.212 . . . . 0.0 110.618 176.217 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 40.2 p -72.04 -16.99 62.05 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 122.361 1.077 . . . . 0.0 110.1 -179.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.563 ' HB3' ' OE1' ' A' ' 79' ' ' GLU . 70.7 m -147.72 171.24 15.98 Favored 'General case' 0 N--CA 1.416 -2.155 0 N-CA-C 107.219 -1.4 . . . . 0.0 107.219 176.107 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 32.8 pt -94.59 -25.25 4.69 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.283 0 C-N-CA 120.475 -0.49 . . . . 0.0 111.075 -178.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 32.5 mm-40 68.92 177.1 0.27 Allowed 'General case' 0 C--O 1.239 0.552 0 C-N-CA 123.808 0.843 . . . . 0.0 112.555 178.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -74.14 107.65 2.31 Favored Glycine 0 N--CA 1.434 -1.492 0 N-CA-C 110.667 -0.973 . . . . 0.0 110.667 177.37 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -95.66 -2.29 61.55 Favored Glycine 0 N--CA 1.441 -0.994 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.169 -177.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.446 ' HB ' ' OE1' ' A' ' 76' ' ' GLU . 11.8 t -81.11 129.31 34.5 Favored 'General case' 0 N--CA 1.424 -1.742 0 CA-C-O 121.663 0.744 . . . . 0.0 111.081 -179.385 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -144.46 11.96 1.51 Allowed 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 115.11 -0.95 . . . . 0.0 109.876 177.193 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 41.0 t-105 66.92 91.7 0.08 Allowed 'General case' 0 C--O 1.243 0.741 0 C-N-CA 124.306 1.042 . . . . 0.0 112.319 -178.131 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 81.3 mt -90.29 110.3 21.36 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-N 114.751 -1.113 . . . . 0.0 108.701 177.189 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 59.6 t -72.75 -46.97 51.84 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.278 0 CA-C-N 115.738 -0.665 . . . . 0.0 109.572 179.167 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 78.4 m-20 67.14 83.55 0.17 Allowed 'General case' 0 CA--C 1.511 -0.522 0 CA-C-N 114.808 -1.087 . . . . 0.0 109.756 -177.404 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 20.5 ptmt -88.82 95.85 10.45 Favored 'General case' 0 C--N 1.297 -1.692 0 CA-C-N 115.093 -0.958 . . . . 0.0 111.876 -175.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 6.1 tp 179.82 -52.91 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.31 -1.119 0 CA-C-N 114.915 -1.038 . . . . 0.0 109.586 177.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt 65.46 94.69 0.06 Allowed 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 124.216 1.006 . . . . 0.0 109.76 -175.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -94.66 178.72 36.74 Favored Glycine 0 N--CA 1.426 -2.008 0 C-N-CA 120.351 -0.928 . . . . 0.0 111.041 -179.095 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -76.21 -25.45 55.12 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-O 121.299 0.571 . . . . 0.0 109.64 178.197 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 65.3 mtm -89.92 99.32 12.36 Favored 'General case' 0 N--CA 1.439 -0.985 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 175.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 62.3 tt0 -106.63 -37.74 6.35 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.469 -177.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 66.6 mttm 73.88 148.38 0.12 Allowed Pre-proline 0 CA--C 1.551 1.001 0 C-N-CA 124.507 1.123 . . . . 0.0 110.281 -177.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -71.76 37.35 0.33 Allowed 'Trans proline' 0 N--CA 1.496 1.647 0 C-N-CA 123.568 2.845 . . . . 0.0 113.34 -177.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.458 ' O ' ' HG ' ' A' ' 58' ' ' LEU . 18.4 mt -71.29 -48.44 12.96 Favored Pre-proline 0 C--N 1.291 -1.971 0 CA-C-O 119.087 -0.482 . . . . 0.0 111.597 -177.088 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.462 ' HA ' ' CD1' ' A' ' 58' ' ' LEU . 38.6 Cg_exo -58.59 -38.47 89.41 Favored 'Trans proline' 0 C--N 1.384 2.409 0 C-N-CA 121.209 1.273 . . . . 0.0 113.572 -172.059 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.439 ' O ' ' HG3' ' A' ' 59' ' ' LYS . 11.0 pt-20 -70.13 -30.13 67.24 Favored 'General case' 0 C--O 1.214 -0.765 0 CA-C-O 120.826 0.346 . . . . 0.0 110.815 178.317 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 62.4 tp -69.66 -33.38 72.51 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.371 177.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.462 ' CD1' ' HA ' ' A' ' 55' ' ' PRO . 6.3 mt -65.58 -52.59 51.08 Favored 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 -179.042 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.448 ' O ' ' HA ' ' A' ' 64' ' ' PRO . 15.3 ptpt -63.04 -24.04 67.73 Favored 'General case' 0 C--O 1.187 -2.213 0 CA-C-N 114.897 -1.047 . . . . 0.0 113.296 177.149 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -82.53 -54.77 4.92 Favored 'General case' 0 C--N 1.292 -1.898 0 O-C-N 121.848 -0.533 . . . . 0.0 112.283 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 54.0 t80 -56.96 -31.26 64.83 Favored 'General case' 0 C--O 1.245 0.827 0 C-N-CA 124.287 1.035 . . . . 0.0 110.68 -173.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.613 ' OD1' ' HB3' ' A' ' 75' ' ' TYR . 3.4 m-20 -108.56 25.69 11.4 Favored 'General case' 0 C--N 1.283 -2.32 0 CA-C-N 114.19 -1.368 . . . . 0.0 111.681 -172.312 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.572 HD22 ' N ' ' A' ' 115' ' ' GLY . 34.5 mt 80.91 143.33 0.08 OUTLIER Pre-proline 0 N--CA 1.477 0.89 0 C-N-CA 125.056 1.342 . . . . 0.0 108.936 -178.408 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.448 ' HA ' ' O ' ' A' ' 59' ' ' LYS . 10.2 Cg_endo -84.2 21.5 1.06 Allowed 'Trans proline' 0 N--CA 1.439 -1.733 0 C-N-CA 122.837 2.358 . . . . 0.0 113.239 -161.797 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.595 ' O ' ' HA3' ' A' ' 159' ' ' GLY . 0.2 OUTLIER -72.93 -38.13 55.7 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.913 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 175.338 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.422 ' C ' ' H ' ' A' ' 68' ' ' PHE . . . 55.07 8.64 1.57 Allowed Glycine 0 N--CA 1.473 1.106 0 CA-C-N 114.988 -1.005 . . . . 0.0 114.329 178.099 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.738 ' O ' ' HB ' ' A' ' 160' ' ' VAL . 37.9 mt 70.77 -31.93 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 C-N-CA 125.578 1.551 . . . . 0.0 113.911 -179.132 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.537 ' HB2' ' O ' ' A' ' 67' ' ' ILE . 55.6 t80 167.04 -56.89 0.0 OUTLIER Pre-proline 0 C--N 1.312 -1.046 0 C-N-CA 124.743 1.217 . . . . 0.0 108.936 175.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.461 ' HD2' ' H ' ' A' ' 70' ' ' GLY . 19.3 Cg_endo -110.4 -16.73 0.03 OUTLIER 'Trans proline' 0 CA--C 1.569 2.225 0 C-N-CA 122.777 2.318 . . . . 0.0 116.877 -171.701 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.461 ' H ' ' HD2' ' A' ' 69' ' ' PRO . . . 84.09 7.19 85.66 Favored Glycine 0 CA--C 1.533 1.161 0 C-N-CA 119.732 -1.223 . . . . 0.0 110.395 -171.155 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.445 ' HB3' ' HG2' ' A' ' 69' ' ' PRO . 30.0 t70 -82.36 -50.62 8.71 Favored 'General case' 0 CA--C 1.497 -1.086 0 N-CA-C 106.314 -1.735 . . . . 0.0 106.314 177.395 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.406 ' O ' ' HB ' ' A' ' 73' ' ' THR . . . -83.03 176.73 9.02 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 113.732 -1.577 . . . . 0.0 107.48 166.049 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.652 HG23 ' O ' ' A' ' 73' ' ' THR . 89.4 m 82.0 27.86 0.15 Allowed 'General case' 0 N--CA 1.492 1.633 0 CA-C-O 124.363 2.03 . . . . 0.0 109.8 176.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.599 HD21 ' N ' ' A' ' 74' ' ' ASN . 0.8 OUTLIER -87.84 123.53 32.71 Favored 'General case' 0 C--N 1.257 -3.447 0 CA-C-N 114.417 -1.265 . . . . 0.0 110.464 179.434 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.613 ' HB3' ' OD1' ' A' ' 62' ' ' ASP . 46.2 p90 -82.17 141.53 32.97 Favored 'General case' 0 C--N 1.295 -1.771 0 O-C-N 124.243 0.964 . . . . 0.0 112.506 -178.639 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.446 ' OE1' ' HB ' ' A' ' 39' ' ' THR . 32.0 mm-40 -159.39 136.84 9.88 Favored 'General case' 0 C--O 1.203 -1.347 0 C-N-CA 126.537 1.935 . . . . 0.0 107.266 174.409 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 49.9 p90 -134.7 148.32 50.28 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 118.538 0.608 . . . . 0.0 110.995 -177.163 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.501 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 4.6 m-20 -89.39 169.88 11.02 Favored 'General case' 0 CA--C 1.478 -1.827 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 177.477 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.563 ' OE1' ' HB3' ' A' ' 34' ' ' SER . 44.7 mt-10 -81.41 -62.07 1.76 Allowed 'General case' 0 C--N 1.267 -3.013 0 CA-C-N 114.426 -1.261 . . . . 0.0 111.337 177.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.32 -33.59 49.17 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 115.398 -0.819 . . . . 0.0 112.502 -176.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.501 ' HB ' ' HB2' ' A' ' 78' ' ' ASP . 90.1 m -81.46 -47.6 12.97 Favored 'General case' 0 C--N 1.288 -2.093 0 CA-C-N 115.192 -0.913 . . . . 0.0 111.844 178.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.408 ' H ' ' HB2' ' A' ' 78' ' ' ASP . 65.5 mttp 61.73 -5.55 0.14 Allowed 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 115.345 1.609 . . . . 0.0 115.345 -179.238 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.565 ' HG2' HG23 ' A' ' 109' ' ' THR . 32.6 ttmt -75.2 110.22 9.35 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 173.071 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 5.8 tt -66.23 134.02 51.82 Favored 'General case' 0 C--N 1.299 -1.6 0 CA-C-N 114.756 -1.111 . . . . 0.0 111.41 -174.067 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 15.0 t -108.02 126.93 53.31 Favored 'General case' 0 N--CA 1.397 -3.093 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.238 -179.288 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.593 ' HA ' ' O ' ' A' ' 74' ' ' ASN . 79.0 t -96.9 132.24 41.8 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.672 -179.359 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.9 mp -95.4 114.63 26.42 Favored 'General case' 0 N--CA 1.423 -1.787 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.721 -179.444 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 2.4 mp -104.83 110.27 64.22 Favored Pre-proline 0 C--N 1.299 -1.616 0 N-CA-C 105.77 -1.937 . . . . 0.0 105.77 171.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.623 ' O ' ' HB2' ' A' ' 166' ' ' ARG . 51.8 Cg_exo -56.17 94.07 0.05 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.498 0 C-N-CA 122.782 2.321 . . . . 0.0 112.215 178.164 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.414 ' HB2' ' HB2' ' A' ' 168' ' ' ASP . 40.9 t 74.95 141.53 0.07 Allowed 'General case' 0 C--N 1.343 0.323 0 C-N-CA 125.217 1.407 . . . . 0.0 111.813 -176.777 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 4.5 tt -69.08 121.35 18.27 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.504 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.894 177.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 12.7 p -107.58 145.16 33.59 Favored 'General case' 0 C--N 1.298 -1.657 0 CA-C-N 114.524 -1.216 . . . . 0.0 109.634 176.511 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.455 ' O ' ' HA3' ' A' ' 164' ' ' GLY . 2.2 mp0 -118.1 132.65 56.33 Favored 'General case' 0 CA--C 1.471 -2.087 0 N-CA-C 105.969 -1.863 . . . . 0.0 105.969 178.585 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.502 HG12 ' H ' ' A' ' 163' ' ' ASN . 16.7 t -108.8 104.19 16.69 Favored 'Isoleucine or valine' 0 N--CA 1.398 -3.046 0 C-N-CA 119.366 -0.934 . . . . 0.0 109.132 -178.628 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . 0.417 ' C ' ' H ' ' A' ' 97' ' ' LYS . . . -138.45 -157.79 7.53 Favored Glycine 0 N--CA 1.404 -3.477 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 -179.102 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . 0.469 ' C ' ' H ' ' A' ' 98' ' ' ASP . 72.4 t80 76.22 -44.38 0.49 Allowed 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 124.57 1.148 . . . . 0.0 110.293 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.539 ' HB2' ' HZ2' ' A' ' 97' ' ' LYS . 0.0 OUTLIER -72.48 11.03 0.68 Allowed 'General case' 0 C--N 1.31 -1.147 0 C-N-CA 127.003 2.121 . . . . 0.0 111.292 177.298 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.469 ' H ' ' C ' ' A' ' 96' ' ' TYR . 25.1 t70 -36.42 90.46 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 117.397 2.369 . . . . 0.0 117.397 -169.563 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 31.4 t -152.26 10.53 0.52 Allowed 'General case' 0 C--N 1.281 -2.391 0 N-CA-C 103.024 -2.954 . . . . 0.0 103.024 169.405 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.4 ' HA ' ' O ' ' A' ' 126' ' ' LYS . 46.4 t 170.6 139.97 0.03 OUTLIER 'General case' 0 N--CA 1.419 -2.01 0 C-N-CA 127.528 2.331 . . . . 0.0 104.816 -174.394 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 54.3 t -126.03 131.21 71.97 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 179.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.467 ' HB2' ' HB ' ' A' ' 94' ' ' VAL . 2.7 mp -126.81 148.42 49.95 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 118.145 0.429 . . . . 0.0 110.126 -177.61 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -138.67 123.73 19.01 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 174.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -120.77 108.05 13.49 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 178.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 12.4 t -81.47 -177.35 6.47 Favored 'General case' 0 N--CA 1.432 -1.339 0 CA-C-O 121.133 0.492 . . . . 0.0 111.266 -178.431 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 39.4 p -66.07 -58.71 4.87 Favored 'General case' 0 C--N 1.301 -1.538 0 C-N-CA 124.833 1.253 . . . . 0.0 112.595 -172.376 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 6.4 m -122.54 97.32 5.4 Favored 'General case' 0 N--CA 1.41 -2.455 0 CA-C-O 121.535 0.683 . . . . 0.0 109.866 -175.571 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 18.1 m -99.02 141.11 17.09 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 CA-C-N 114.978 -1.01 . . . . 0.0 109.545 179.301 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.565 HG23 ' HG2' ' A' ' 83' ' ' LYS . 2.9 m -114.62 119.91 38.36 Favored 'General case' 0 N--CA 1.403 -2.783 0 N-CA-C 104.748 -2.316 . . . . 0.0 104.748 -174.336 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . 0.718 ' HA2' ' O ' ' A' ' 119' ' ' ASP . . . -141.74 159.56 26.9 Favored Glycine 0 N--CA 1.435 -1.38 0 C-N-CA 120.037 -1.078 . . . . 0.0 115.169 -174.258 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 6.8 t60 -88.06 109.28 19.73 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 177.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 65.3 tp -106.96 120.99 43.55 Favored 'General case' 0 C--N 1.302 -1.461 0 C-N-CA 119.885 -0.726 . . . . 0.0 112.458 -175.099 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -115.1 158.05 22.71 Favored 'General case' 0 CA--C 1.448 -2.971 0 N-CA-C 107.505 -1.294 . . . . 0.0 107.505 169.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 2.4 tmtm? -82.25 99.12 9.12 Favored 'General case' 2 N--CA 1.375 -4.202 0 N-CA-C 107.135 -1.432 . . . . 0.0 107.135 -175.854 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . 0.572 ' N ' HD22 ' A' ' 63' ' ' LEU . . . 131.28 -20.24 4.74 Favored Glycine 0 C--O 1.19 -2.631 0 N-CA-C 109.978 -1.249 . . . . 0.0 109.978 -177.257 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -163.23 135.8 5.38 Favored 'General case' 0 C--N 1.314 -0.953 0 O-C-N 122.109 -0.642 . . . . 0.0 110.864 -177.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 3.1 tt -116.8 114.54 24.08 Favored 'General case' 0 C--N 1.286 -2.168 0 N-CA-C 106.246 -1.761 . . . . 0.0 106.246 178.002 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.441 ' HA ' ' CB ' ' A' ' 135' ' ' SER . 49.9 p -116.52 175.77 5.41 Favored 'General case' 0 C--N 1.279 -2.48 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.424 -176.016 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . 0.718 ' O ' ' HA2' ' A' ' 110' ' ' GLY . 7.0 m-20 54.91 83.84 0.08 Allowed 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.629 0.772 . . . . 0.0 111.2 174.85 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.42 ' CG2' ' HB ' ' A' ' 123' ' ' ILE . 13.6 m -119.3 108.47 23.86 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.8 0 CA-C-O 122.303 1.049 . . . . 0.0 112.321 -172.469 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -79.9 100.24 7.95 Favored 'General case' 0 C--N 1.268 -2.943 0 CA-C-N 114.331 -1.304 . . . . 0.0 110.204 174.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 123.94 -14.08 8.01 Favored Glycine 0 N--CA 1.435 -1.428 0 C-N-CA 120.722 -0.751 . . . . 0.0 113.161 176.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.42 ' HB ' ' CG2' ' A' ' 120' ' ' VAL . 63.5 mt -102.46 116.09 45.53 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.914 0 CA-C-O 121.536 0.684 . . . . 0.0 110.116 179.555 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -124.21 141.23 52.24 Favored 'General case' 0 C--N 1.294 -1.847 0 CA-C-N 114.795 -1.093 . . . . 0.0 109.053 178.474 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.408 ' OG1' ' HG ' ' A' ' 102' ' ' LEU . 11.1 t -152.48 162.67 40.88 Favored 'General case' 0 C--O 1.245 0.847 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 178.495 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.441 ' HE2' ' N ' ' A' ' 128' ' ' MET . 8.3 tmtt? -131.18 129.59 41.91 Favored 'General case' 0 N--CA 1.426 -1.635 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.656 176.261 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.455 ' O ' ' HB3' ' A' ' 128' ' ' MET . 41.8 t -150.02 112.81 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.481 -1.699 0 N-CA-C 104.31 -2.478 . . . . 0.0 104.31 172.764 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' MET . . . . . 0.455 ' HB3' ' O ' ' A' ' 127' ' ' VAL . 45.9 ttm 69.48 -54.95 0.58 Allowed 'General case' 0 N--CA 1.473 0.696 0 O-C-N 124.031 0.832 . . . . 0.0 109.978 -172.054 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 8.0 tp -139.18 162.89 27.21 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.716 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 178.38 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 69.5 p-90 -92.67 137.72 32.12 Favored 'General case' 0 N--CA 1.423 -1.823 0 CA-C-O 121.064 0.459 . . . . 0.0 110.861 -178.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 53.4 t -134.31 121.83 38.38 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.154 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 179.343 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 60.1 pttt -98.29 3.16 48.73 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.157 0.503 . . . . 0.0 111.955 -176.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 34.4 m -124.22 25.02 3.47 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.204 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 176.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 9.4 t -55.24 113.24 1.31 Allowed 'General case' 0 N--CA 1.441 -0.906 0 CA-C-N 113.258 -1.792 . . . . 0.0 113.249 -173.178 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' SER . . . . . 0.471 ' O ' ' HA ' ' A' ' 146' ' ' THR . 26.3 p -100.1 149.94 22.99 Favored 'General case' 0 N--CA 1.405 -2.72 0 C-N-CA 119.72 -0.792 . . . . 0.0 113.033 -177.38 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . 0.449 ' HB ' HG22 ' A' ' 146' ' ' THR . 13.2 tt -100.9 138.46 25.05 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.71 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 -179.109 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 14.7 t -120.55 142.71 49.09 Favored 'General case' 0 N--CA 1.408 -2.567 0 N-CA-C 107.052 -1.462 . . . . 0.0 107.052 -178.479 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' THR . . . . . 0.432 ' HB ' HD11 ' A' ' 63' ' ' LEU . 33.2 m -149.02 175.5 11.25 Favored 'General case' 0 C--N 1.27 -2.882 0 N-CA-C 106.523 -1.658 . . . . 0.0 106.523 -176.768 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -118.05 30.45 7.23 Favored 'General case' 0 C--N 1.277 -2.583 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 174.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . 0.43 ' HA ' HD21 ' A' ' 63' ' ' LEU . . . 60.26 36.56 20.75 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-N 114.745 -1.116 . . . . 0.0 110.145 -177.045 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 41.4 t 174.38 -82.68 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 114.283 -1.326 . . . . 0.0 108.353 -172.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 23.0 pttm -77.56 136.79 38.32 Favored 'General case' 0 CA--C 1.505 -0.758 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 177.62 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 12.4 p -109.95 156.58 10.79 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.889 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 -171.23 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -128.98 154.16 46.86 Favored 'General case' 0 N--CA 1.428 -1.539 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 174.613 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 33.9 t80 -73.96 162.92 28.55 Favored 'General case' 0 C--N 1.309 -1.152 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 -175.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.471 ' HA ' ' O ' ' A' ' 135' ' ' SER . 70.9 p -71.7 -172.73 0.85 Allowed 'General case' 0 N--CA 1.42 -1.966 0 CA-C-O 121.512 0.672 . . . . 0.0 112.609 -175.358 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . 0.415 ' HB3' ' CG ' ' A' ' 150' ' ' LYS . . . 74.78 -29.54 0.19 Allowed 'General case' 0 N--CA 1.463 0.192 0 C-N-CA 126.018 1.727 . . . . 0.0 113.317 177.267 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 147.74 43.63 0.03 OUTLIER Glycine 0 CA--C 1.477 -2.319 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 178.008 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 65.3 mtt 60.96 40.14 15.76 Favored 'General case' 0 C--N 1.344 0.369 0 O-C-N 124.196 0.586 . . . . 0.0 110.224 -177.409 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . 0.51 ' HA ' ' HE2' ' A' ' 150' ' ' LYS . 9.5 mmpt? -65.53 -16.76 64.0 Favored 'General case' 0 N--CA 1.483 1.199 0 CA-C-O 120.816 0.341 . . . . 0.0 111.415 -178.766 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . 0.47 ' HA ' ' HE3' ' A' ' 151' ' ' LYS . 0.0 OUTLIER -147.27 163.43 36.42 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 176.962 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 9.0 p -131.34 111.65 12.04 Favored 'General case' 0 C--N 1.292 -1.904 0 CA-C-O 121.391 0.615 . . . . 0.0 110.483 176.502 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 33.5 mmt180 -113.87 160.51 18.68 Favored 'General case' 0 CA--C 1.501 -0.914 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.001 -179.085 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 51.2 m -96.05 140.49 30.7 Favored 'General case' 0 N--CA 1.42 -1.93 0 CA-C-N 116.253 -0.43 . . . . 0.0 109.905 177.068 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' ARG . . . . . 0.48 ' HG3' ' HA2' ' A' ' 159' ' ' GLY . 9.0 ttp180 -74.99 -21.2 59.28 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.051 175.625 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -34.92 -49.6 0.45 Allowed 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 126.315 1.846 . . . . 0.0 114.806 -174.144 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -77.44 -55.37 5.45 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 113.635 0.976 . . . . 0.0 113.635 -176.198 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -153.52 16.02 0.52 Allowed 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.981 -0.449 . . . . 0.0 111.836 -176.01 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . 0.595 ' HA3' ' O ' ' A' ' 65' ' ' ILE . . . 84.88 -89.35 1.6 Allowed Glycine 0 CA--C 1.466 -2.989 0 C-N-CA 119.646 -1.264 . . . . 0.0 110.735 -174.501 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.738 ' HB ' ' O ' ' A' ' 67' ' ' ILE . 39.1 t -99.6 148.5 6.39 Favored 'Isoleucine or valine' 0 N--CA 1.4 -2.931 0 C-N-CA 119.491 -0.884 . . . . 0.0 109.102 177.575 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 74.8 mt-30 -113.74 108.98 17.84 Favored 'General case' 0 N--CA 1.416 -2.158 0 N-CA-C 106.393 -1.706 . . . . 0.0 106.393 -172.082 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . 0.524 ' C ' ' HD2' ' A' ' 162' ' ' ARG . 5.2 ppt_? -125.9 163.15 23.57 Favored 'General case' 0 C--N 1.275 -2.668 0 CA-C-N 115.167 -0.924 . . . . 0.0 112.919 -169.76 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' ASN . . . . . 0.502 ' H ' HG12 ' A' ' 94' ' ' VAL . 3.1 m-20 -110.4 -59.65 1.91 Allowed 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.875 175.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . 0.493 ' O ' ' HD3' ' A' ' 162' ' ' ARG . . . -61.0 147.38 47.03 Favored Glycine 0 CA--C 1.501 -0.782 0 CA-C-N 115.877 -0.601 . . . . 0.0 113.033 -179.635 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 65.6 tp -107.83 139.23 42.73 Favored 'General case' 0 N--CA 1.422 -1.827 0 CA-C-O 121.169 0.509 . . . . 0.0 109.851 -177.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . 0.623 ' HB2' ' O ' ' A' ' 89' ' ' PRO . 6.5 ptp85 -85.84 103.49 14.64 Favored 'General case' 0 C--N 1.287 -2.146 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 176.471 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 4.8 t -102.9 70.98 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.788 0 CA-C-N 115.184 -0.916 . . . . 0.0 112.46 -170.52 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . 0.414 ' HB2' ' HB2' ' A' ' 90' ' ' SER . 15.8 t70 -109.14 -39.2 5.33 Favored 'General case' 0 CA--C 1.475 -1.918 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 175.304 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' LYS . . . . . 0.504 ' HD3' ' H ' ' A' ' 169' ' ' LYS . 0.0 OUTLIER -93.1 149.65 21.08 Favored 'General case' 0 C--N 1.287 -2.128 0 CA-C-N 113.48 -1.691 . . . . 0.0 109.634 -174.146 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' PHE . . . . . . . . . . . . . 81.6 t80 . . . . . 0 C--N 1.288 -2.082 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 179.719 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 25.2 p . . . . . 0 N--CA 1.442 -0.844 0 CA-C-O 121.279 0.562 . . . . 0.0 111.095 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -133.7 103.92 6.1 Favored 'General case' 0 CA--C 1.498 -1.056 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 179.238 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -82.99 86.48 6.98 Favored 'General case' 0 C--N 1.309 -1.166 0 C-N-CA 118.575 -1.25 . . . . 0.0 112.223 179.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 8.1 tt -140.21 95.74 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.149 0 CA-C-N 113.734 -1.575 . . . . 0.0 106.757 176.171 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 62.9 t80 -142.49 139.6 31.58 Favored 'General case' 0 C--N 1.299 -1.629 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.167 -173.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -146.91 154.99 41.95 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 178.4 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -120.79 132.53 55.08 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 176.005 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.5 p -122.39 103.14 12.9 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.721 0 CA-C-O 121.906 0.86 . . . . 0.0 112.9 -175.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -114.9 109.39 2.11 Favored Glycine 0 N--CA 1.427 -1.905 0 N-CA-C 109.309 -1.516 . . . . 0.0 109.309 175.383 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 48.5 m -83.31 128.18 34.28 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-O 120.888 0.375 . . . . 0.0 111.1 -177.473 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -130.44 104.57 7.32 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 177.182 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 37.6 p90 -116.51 149.87 38.86 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 -178.541 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 5.3 tt 179.99 -50.64 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 -179.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 105.67 42.79 1.65 Allowed Glycine 0 N--CA 1.436 -1.358 0 CA-C-N 115.384 -0.825 . . . . 0.0 111.588 -179.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 47.2 mt-30 -79.98 154.92 27.91 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-O 120.59 0.233 . . . . 0.0 110.607 -179.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 95.5 mttt 65.83 -176.73 0.18 Allowed 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 124.122 0.969 . . . . 0.0 111.835 178.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 62.65 26.96 15.95 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.557 0.743 . . . . 0.0 111.222 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 52.6 m-80 -86.75 -171.7 3.65 Favored 'General case' 0 C--O 1.244 0.812 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.642 -178.553 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.6 tmmm? -69.49 108.17 3.67 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 179.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -108.65 109.24 20.38 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 84.0 t80 -154.22 117.81 4.62 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 -179.093 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -94.95 -69.47 0.75 Allowed 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 176.23 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 34.2 t -168.58 151.92 5.48 Favored 'General case' 0 N--CA 1.442 -0.841 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 179.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 17.4 m -98.53 90.97 2.24 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.913 0 CA-C-O 121.78 0.8 . . . . 0.0 112.18 178.04 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -115.96 84.87 0.38 Allowed Glycine 0 N--CA 1.436 -1.309 0 N-CA-C 110.409 -1.076 . . . . 0.0 110.409 178.249 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -145.16 111.91 5.87 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-O 120.89 0.376 . . . . 0.0 110.376 -178.239 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -129.33 143.53 50.88 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 115.467 -0.788 . . . . 0.0 108.928 -178.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 50.8 tp -88.77 145.53 25.55 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-O 120.806 0.336 . . . . 0.0 110.399 -177.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 28.2 p-10 -93.26 179.79 5.31 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.388 179.411 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 21.1 m 72.12 175.45 0.28 Allowed 'General case' 0 C--O 1.248 1.018 0 C-N-CA 124.667 1.187 . . . . 0.0 111.137 -179.476 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 23.8 m -86.77 83.36 2.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-O 122.407 1.099 . . . . 0.0 113.115 -177.098 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 49.9 m -157.62 138.73 13.45 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 177.25 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 39.4 p -79.1 110.96 14.84 Favored 'General case' 0 C--N 1.308 -1.212 0 C-N-CA 120.939 -0.304 . . . . 0.0 111.054 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 24.6 t -160.25 92.53 0.99 Allowed 'General case' 0 N--CA 1.435 -1.2 0 CA-C-O 121.475 0.655 . . . . 0.0 110.874 179.321 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 54.9 mt 56.66 84.33 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.241 0.64 0 C-N-CA 126.025 1.73 . . . . 0.0 114.311 176.463 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.495 ' O ' ' HA ' ' A' ' 97' ' ' LYS . 0.4 OUTLIER -176.29 112.62 0.11 Allowed 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 106.272 -1.751 . . . . 0.0 106.272 175.733 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -109.89 39.24 2.97 Favored Glycine 0 C--O 1.215 -1.041 0 C-N-CA 120.376 -0.916 . . . . 0.0 113.915 -176.302 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 84.2 0.5 89.54 Favored Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 120.565 -0.826 . . . . 0.0 112.139 177.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 23.8 m 58.65 90.54 0.05 OUTLIER 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 124.912 1.285 . . . . 0.0 112.471 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.476 ' HZ2' ' HB3' ' A' ' 40' ' ' LYS . 0.0 OUTLIER -169.81 136.51 1.57 Allowed 'General case' 0 CA--C 1.508 -0.66 0 CA-C-O 120.941 0.401 . . . . 0.0 110.116 174.179 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 28.3 m-90 -108.52 95.4 5.63 Favored 'General case' 0 C--N 1.287 -2.134 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 175.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 48.0 tp -74.35 95.93 2.76 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-N 115.189 -0.914 . . . . 0.0 111.904 -174.563 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 6.5 p -103.01 84.73 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.421 -1.887 0 CA-C-O 122.719 1.247 . . . . 0.0 109.069 175.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -141.32 102.25 4.18 Favored 'General case' 0 C--N 1.295 -1.776 0 CA-C-N 114.298 -1.319 . . . . 0.0 108.698 -178.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 63.0 pttt -117.42 129.61 55.96 Favored 'General case' 0 C--N 1.292 -1.891 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 179.204 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.418 ' N ' HD11 ' A' ' 46' ' ' ILE . 2.8 mp -81.72 -56.14 6.69 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.05 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 179.372 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 23.1 tptm 46.37 83.11 0.03 OUTLIER 'General case' 0 C--O 1.245 0.864 0 O-C-N 124.966 1.416 . . . . 0.0 110.551 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -63.62 141.72 45.92 Favored Glycine 0 N--CA 1.444 -0.779 0 CA-C-N 115.157 -0.929 . . . . 0.0 114.237 -173.275 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -112.39 157.13 21.41 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 177.533 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 28.0 ttt 66.19 16.11 10.33 Favored 'General case' 0 N--CA 1.482 1.174 0 CA-C-O 122.5 1.143 . . . . 0.0 110.497 177.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -109.05 170.43 8.06 Favored 'General case' 0 N--CA 1.432 -1.336 0 CA-C-N 115.107 -0.952 . . . . 0.0 109.166 178.097 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.453 ' O ' ' HD2' ' A' ' 55' ' ' PRO . 59.6 tptt -64.46 123.96 84.45 Favored Pre-proline 0 N--CA 1.435 -1.221 0 N-CA-C 106.021 -1.844 . . . . 0.0 106.021 174.342 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -77.86 18.1 0.91 Allowed 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 122.162 1.908 . . . . 0.0 113.823 -175.592 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.627 ' O ' ' HG ' ' A' ' 58' ' ' LEU . 10.5 tp -72.36 -56.7 3.98 Favored Pre-proline 0 C--O 1.203 -1.349 0 C-N-CA 120.367 -0.533 . . . . 0.0 110.213 -179.363 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.569 ' HD3' ' HB3' ' A' ' 54' ' ' LEU . 8.1 Cg_exo -50.73 -38.2 55.81 Favored 'Trans proline' 0 C--N 1.388 2.608 0 C-N-CA 123.536 2.824 . . . . 0.0 112.671 -177.444 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -76.95 -31.84 56.88 Favored 'General case' 0 N--CA 1.432 -1.365 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.069 -179.299 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.547 ' HG ' ' O ' ' A' ' 54' ' ' LEU . 2.0 pp -75.74 -28.67 58.59 Favored 'General case' 0 C--O 1.204 -1.293 0 C-N-CA 119.669 -0.812 . . . . 0.0 108.984 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.627 ' HG ' ' O ' ' A' ' 54' ' ' LEU . 63.0 mt -57.34 -48.76 78.14 Favored 'General case' 0 C--O 1.199 -1.571 0 O-C-N 123.938 0.774 . . . . 0.0 110.809 -177.123 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 55.2 mtpt -64.88 -29.53 70.49 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-O 121.846 0.832 . . . . 0.0 110.627 -177.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -96.71 1.71 51.25 Favored 'General case' 0 C--N 1.297 -1.686 0 CA-C-N 114.692 -1.14 . . . . 0.0 111.424 -178.214 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 41.2 t80 -57.15 -42.88 81.86 Favored 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 112.776 0.658 . . . . 0.0 112.776 -170.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.563 ' OD1' ' HA ' ' A' ' 114' ' ' LYS . 11.2 t70 -139.67 -74.56 0.36 Allowed 'General case' 0 C--N 1.315 -0.916 0 C-N-CA 120.031 -0.667 . . . . 0.0 109.989 -177.41 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.448 HD23 ' H ' ' A' ' 115' ' ' GLY . 20.3 mt -96.29 150.17 36.82 Favored Pre-proline 0 N--CA 1.445 -0.719 0 N-CA-C 106.23 -1.767 . . . . 0.0 106.23 175.489 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_endo -99.9 18.22 0.35 Allowed 'Trans proline' 0 N--CA 1.443 -1.497 0 C-N-CA 123.77 2.98 . . . . 0.0 113.539 -169.391 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.409 ' HB ' HG22 ' A' ' 160' ' ' VAL . 0.2 OUTLIER -69.78 -45.01 78.6 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.872 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 176.743 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 52.83 9.53 0.8 Allowed Glycine 0 N--CA 1.486 2.011 0 CA-C-N 114.908 -1.042 . . . . 0.0 114.266 178.401 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.666 ' HA ' ' CG2' ' A' ' 160' ' ' VAL 0.288 20.2 mt 62.17 -68.37 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 C-N-CA 126.413 1.885 . . . . 0.0 112.835 -170.948 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 69.6 t80 177.97 -55.41 0.0 OUTLIER Pre-proline 0 C--N 1.301 -1.528 0 O-C-N 123.69 0.619 . . . . 0.0 111.674 -177.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -82.9 -70.35 0.01 OUTLIER 'Trans proline' 0 C--N 1.369 1.647 0 C-N-CA 121.763 1.642 . . . . 0.0 113.003 -175.402 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 153.73 -40.53 0.67 Allowed Glycine 0 CA--C 1.492 -1.38 0 N-CA-C 110.092 -1.203 . . . . 0.0 110.092 -176.114 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.416 ' O ' ' ND2' ' A' ' 74' ' ' ASN . 3.2 t70 -74.84 -55.25 6.01 Favored 'General case' 0 C--O 1.184 -2.352 0 N-CA-C 104.745 -2.317 . . . . 0.0 104.745 175.757 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -66.08 99.57 0.52 Allowed 'General case' 0 C--N 1.31 -1.132 0 C-N-CA 117.082 -1.847 . . . . 0.0 107.556 163.216 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.402 ' O ' HG21 ' A' ' 73' ' ' THR 1.619 6.3 m 115.26 30.8 0.0 OUTLIER 'General case' 0 N--CA 1.439 -1.012 1 N-CA-C 123.299 4.555 . . . . 0.0 123.299 -178.542 . . . . . . . . 4 3 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.579 ' O ' HG22 ' A' ' 86' ' ' VAL . 3.5 p30 -89.11 178.28 6.42 Favored 'General case' 0 C--N 1.293 -1.882 0 CA-C-N 114.708 -1.133 . . . . 0.0 108.003 167.419 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.469 ' CD1' HD21 ' A' ' 112' ' ' LEU . 93.4 m-85 -136.73 101.56 4.64 Favored 'General case' 0 C--N 1.281 -2.395 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 -178.248 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -108.59 114.15 27.72 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 -178.253 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 87.8 t80 -112.94 126.73 55.8 Favored 'General case' 0 C--N 1.282 -2.363 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 -176.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.555 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 7.3 m-20 -91.09 164.44 13.94 Favored 'General case' 0 CA--C 1.478 -1.799 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 177.001 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -80.27 -64.77 1.11 Allowed 'General case' 0 C--N 1.278 -2.515 0 CA-C-N 115.055 -0.975 . . . . 0.0 112.662 -175.541 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -71.91 -30.36 65.28 Favored 'General case' 0 CA--C 1.506 -0.736 0 CA-C-O 121.437 0.637 . . . . 0.0 110.538 -176.033 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.555 ' HB ' ' HB2' ' A' ' 78' ' ' ASP . 17.7 m -66.29 -46.81 75.7 Favored 'General case' 0 N--CA 1.417 -2.125 0 CA-C-N 115.082 -0.963 . . . . 0.0 110.295 -178.218 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 97.3 mttt 64.58 17.59 10.96 Favored 'General case' 0 N--CA 1.486 1.363 0 CA-C-O 121.982 0.896 . . . . 0.0 111.486 178.345 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 47.0 tptt -116.03 124.62 50.91 Favored 'General case' 0 N--CA 1.394 -3.248 0 N-CA-C 105.242 -2.133 . . . . 0.0 105.242 -178.607 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.449 HD12 ' N ' ' A' ' 85' ' ' THR . 3.1 tm? -76.46 137.38 39.64 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 179.794 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.449 ' N ' HD12 ' A' ' 84' ' ' LEU . 54.1 p -125.94 144.8 50.54 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.579 HG22 ' O ' ' A' ' 74' ' ' ASN . 92.9 t -112.98 130.39 66.92 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.512 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 172.337 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 18.5 mt -96.4 102.16 13.91 Favored 'General case' 0 C--N 1.282 -2.355 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 -179.447 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 62.6 mt -104.15 135.1 19.39 Favored Pre-proline 0 C--N 1.306 -1.313 0 N-CA-C 109.63 -0.508 . . . . 0.0 109.63 -178.378 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.418 ' O ' ' HB2' ' A' ' 90' ' ' SER . 37.9 Cg_endo -84.04 110.34 1.54 Allowed 'Trans proline' 0 N--CA 1.43 -2.264 0 C-N-CA 122.548 2.165 . . . . 0.0 110.483 177.606 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.418 ' HB2' ' O ' ' A' ' 89' ' ' PRO . 59.9 m 71.41 156.25 0.16 Allowed 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 122.146 0.974 . . . . 0.0 113.181 -179.748 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.448 HG12 ' HA ' ' A' ' 105' ' ' THR . 96.5 mt -80.72 125.69 39.4 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.861 0 CA-C-N 114.807 -1.088 . . . . 0.0 110.038 177.058 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 8.9 p -118.13 145.92 44.54 Favored 'General case' 0 C--N 1.293 -1.87 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 173.292 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -131.18 130.84 43.53 Favored 'General case' 0 C--N 1.282 -2.334 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 -174.099 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.534 HG11 ' H ' ' A' ' 163' ' ' ASN . 55.7 t -118.67 109.43 26.92 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.296 0 CA-C-O 121.266 0.555 . . . . 0.0 111.87 -173.779 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -145.76 -169.31 13.78 Favored Glycine 0 N--CA 1.408 -3.209 0 N-CA-C 109.357 -1.497 . . . . 0.0 109.357 175.306 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 44.4 t80 79.23 -50.76 0.43 Allowed 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.341 1.056 . . . . 0.0 112.062 168.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.539 ' C ' ' HD2' ' A' ' 97' ' ' LYS . 0.1 OUTLIER -71.79 -22.48 61.57 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 177.439 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.413 ' N ' ' HD2' ' A' ' 97' ' ' LYS . 16.0 t70 -99.57 -82.98 0.43 Allowed 'General case' 0 N--CA 1.42 -1.955 0 CA-C-N 114.375 -1.284 . . . . 0.0 112.626 -169.82 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 51.9 p 170.26 -38.14 0.0 OUTLIER 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 106.375 -1.713 . . . . 0.0 106.375 -176.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.636 ' HB3' ' O ' ' A' ' 126' ' ' LYS . 23.3 m -96.02 176.85 5.95 Favored 'General case' 0 N--CA 1.402 -2.856 0 CA-C-N 113.053 -1.885 . . . . 0.0 110.489 -179.2 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 86.6 t -128.68 102.64 8.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 N-CA-C 107.313 -1.365 . . . . 0.0 107.313 175.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.564 ' CD2' HG23 ' A' ' 125' ' ' THR . 55.2 mt -109.39 130.86 55.48 Favored 'General case' 0 C--N 1.285 -2.205 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.989 -171.144 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 35.2 tttp -103.63 115.57 30.74 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 110.237 -0.282 . . . . 0.0 110.237 -175.391 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -96.89 95.73 8.05 Favored 'General case' 0 N--CA 1.413 -2.285 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 173.303 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.556 ' H ' HG21 ' A' ' 123' ' ' ILE . 19.6 m -66.35 179.56 0.97 Allowed 'General case' 0 N--CA 1.423 -1.803 0 CA-C-N 113.587 -1.642 . . . . 0.0 110.186 177.318 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' THR . . . . . 0.549 ' H ' HG22 ' A' ' 105' ' ' THR . 22.1 p -79.56 -74.09 0.31 Allowed 'General case' 0 C--N 1.301 -1.527 0 C-N-CA 123.814 0.846 . . . . 0.0 112.408 -173.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 11.5 p -96.04 101.59 13.28 Favored 'General case' 0 N--CA 1.406 -2.642 0 CA-C-O 121.295 0.569 . . . . 0.0 110.25 -178.412 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.436 ' CG2' HG23 ' A' ' 123' ' ' ILE . 1.1 p -97.45 159.01 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.03 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 -179.778 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 63.6 m -144.71 120.38 10.47 Favored 'General case' 0 C--N 1.293 -1.876 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 -173.103 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . 0.524 ' HA3' ' O ' ' A' ' 119' ' ' ASP . . . -160.69 -157.45 8.71 Favored Glycine 0 C--O 1.202 -1.897 0 C-N-CA 121.091 -0.576 . . . . 0.0 113.88 -174.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 36.4 m80 -124.64 117.34 24.06 Favored 'General case' 0 C--N 1.305 -1.358 0 O-C-N 122.269 -0.548 . . . . 0.0 109.687 177.277 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.469 HD21 ' CD1' ' A' ' 75' ' ' TYR . 67.0 tp -100.68 129.61 46.61 Favored 'General case' 0 C--N 1.293 -1.885 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.267 -177.605 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -127.32 153.29 46.36 Favored 'General case' 0 CA--C 1.441 -3.239 0 CA-C-N 115.018 -0.992 . . . . 0.0 109.507 174.115 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.563 ' HA ' ' OD1' ' A' ' 62' ' ' ASP . 56.6 tptt -67.54 101.52 1.01 Allowed 'General case' 0 N--CA 1.388 -3.539 0 O-C-N 124.672 1.233 . . . . 0.0 107.896 176.816 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . 0.523 ' O ' ' HB ' ' A' ' 138' ' ' THR . . . 135.78 -55.3 0.72 Allowed Glycine 0 N--CA 1.401 -3.657 0 N-CA-C 109.272 -1.531 . . . . 0.0 109.272 -175.209 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.458 ' HD3' HG23 ' A' ' 118' ' ' THR . 0.0 OUTLIER -148.98 152.73 36.84 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 -177.485 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.505 ' O ' ' HB2' ' A' ' 135' ' ' SER . 47.9 tp -108.47 102.77 11.83 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-N 115.337 -0.847 . . . . 0.0 108.96 177.616 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.458 HG23 ' HD3' ' A' ' 116' ' ' LYS . 6.1 p -103.22 167.09 10.05 Favored 'General case' 0 C--N 1.299 -1.619 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.048 178.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . 0.524 ' O ' ' HA3' ' A' ' 110' ' ' GLY . 5.8 m-20 67.94 107.22 0.05 OUTLIER 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.665 0.786 . . . . 0.0 109.12 -176.041 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.452 ' HB ' HG12 ' A' ' 123' ' ' ILE 0.354 4.1 m -125.7 72.79 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.401 -2.92 0 N-CA-C 114.243 1.201 . . . . 0.0 114.243 179.514 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -82.04 86.39 6.58 Favored 'General case' 0 N--CA 1.425 -1.682 0 CA-C-N 114.271 -1.331 . . . . 0.0 110.449 176.121 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 161.92 -40.77 0.39 Allowed Glycine 0 C--N 1.262 -3.533 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 175.141 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.556 HG21 ' H ' ' A' ' 105' ' ' THR . 25.2 pt -100.12 152.2 4.83 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.737 0 C-N-CA 119.09 -1.044 . . . . 0.0 108.813 -178.041 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.586 ' HB2' ' HZ2' ' A' ' 124' ' ' LYS . 4.1 ttmp? -128.79 138.0 51.83 Favored 'General case' 0 C--N 1.27 -2.854 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 -176.468 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.564 HG23 ' CD2' ' A' ' 102' ' ' LEU . 13.3 m -124.13 115.45 21.16 Favored 'General case' 0 C--N 1.283 -2.296 0 CA-C-N 115.517 -0.765 . . . . 0.0 112.928 -169.561 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.636 ' O ' ' HB3' ' A' ' 100' ' ' SER . 0.2 OUTLIER -100.85 115.66 30.89 Favored 'General case' 0 N--CA 1.413 -2.289 0 N-CA-C 107.154 -1.424 . . . . 0.0 107.154 169.572 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.648 HG11 ' SD ' ' A' ' 128' ' ' MET 0.25 1.0 OUTLIER -120.47 -78.46 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.128 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.353 176.739 . . . . . . . . 4 4 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' MET . . . . . 0.648 ' SD ' HG11 ' A' ' 127' ' ' VAL . 0.0 OUTLIER -103.69 -9.15 19.36 Favored 'General case' 0 N--CA 1.412 -2.362 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 176.67 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 8.9 tp -164.06 164.48 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.41 -2.437 0 N-CA-C 106.297 -1.742 . . . . 0.0 106.297 177.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 31.0 t90 -85.33 114.93 22.77 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 -178.436 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 15.7 m -148.74 -175.27 0.38 Allowed 'Isoleucine or valine' 0 C--O 1.211 -0.953 0 C-N-CA 125.125 1.37 . . . . 0.0 109.452 -176.381 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . 0.506 ' HG3' ' N ' ' A' ' 133' ' ' VAL . 38.6 pttt -131.06 -36.62 1.32 Allowed 'General case' 0 C--N 1.305 -1.334 0 C-N-CA 120.227 -0.589 . . . . 0.0 112.038 176.163 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.506 ' N ' ' HG3' ' A' ' 132' ' ' LYS . 25.6 m -69.81 -8.0 9.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 N-CA-C 115.389 1.626 . . . . 0.0 115.389 -165.484 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' THR . . . . . 0.411 ' O ' ' HB ' ' A' ' 146' ' ' THR . 37.9 p -75.57 90.3 2.77 Favored 'General case' 0 N--CA 1.42 -1.951 0 CA-C-O 121.767 0.794 . . . . 0.0 110.48 179.464 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' SER . . . . . 0.505 ' HB2' ' O ' ' A' ' 117' ' ' LEU . 30.0 p -86.13 174.27 9.27 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-N 114.404 -1.271 . . . . 0.0 112.757 -175.554 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 9.4 tt -98.33 122.46 50.01 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.798 0 CA-C-O 122.027 0.918 . . . . 0.0 111.889 -171.38 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 34.0 p -96.56 148.11 23.17 Favored 'General case' 0 N--CA 1.417 -2.113 0 CA-C-N 114.886 -1.052 . . . . 0.0 108.69 176.473 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' THR . . . . . 0.538 HG21 ' N ' ' A' ' 140' ' ' ALA . 93.6 m -154.03 164.09 39.03 Favored 'General case' 0 C--N 1.289 -2.043 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 -172.565 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 63.7 m-20 -99.64 22.97 10.13 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 172.457 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . 0.538 ' N ' HG21 ' A' ' 138' ' ' THR . . . 58.86 36.36 24.62 Favored 'General case' 0 C--N 1.351 0.661 0 N-CA-C 106.525 -1.657 . . . . 0.0 106.525 -167.331 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' SER . . . . . 0.488 ' H ' HG21 ' A' ' 138' ' ' THR . 35.3 t -167.54 -75.36 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.841 0 CA-C-N 113.741 -1.572 . . . . 0.0 110.341 -170.124 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . 0.514 ' O ' HG23 ' A' ' 138' ' ' THR . 96.7 mttt -98.65 163.58 12.59 Favored 'General case' 0 N--CA 1.484 1.268 0 CA-C-N 117.924 0.329 . . . . 0.0 110.581 -179.306 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 92.1 t -106.7 135.14 46.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-O 121.431 0.634 . . . . 0.0 111.1 -178.389 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 62.5 m-85 -119.76 156.53 30.4 Favored 'General case' 0 C--N 1.296 -1.732 0 CA-C-N 115.483 -0.781 . . . . 0.0 109.501 179.143 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 46.9 p90 -42.03 133.17 3.04 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 124.558 1.143 . . . . 0.0 113.92 -176.288 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.476 ' HA ' ' O ' ' A' ' 135' ' ' SER . 74.5 p -78.71 -40.46 33.66 Favored 'General case' 0 N--CA 1.433 -1.311 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.101 177.699 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . 0.405 ' CB ' HG13 ' A' ' 127' ' ' VAL . . . -112.09 157.71 20.47 Favored 'General case' 0 N--CA 1.433 -1.292 0 CA-C-N 115.091 -0.958 . . . . 0.0 108.739 178.618 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -67.41 -27.78 73.57 Favored Glycine 0 C--N 1.309 -0.945 0 O-C-N 123.543 0.527 . . . . 0.0 113.153 -176.266 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 1.6 tmt? -78.25 -24.27 46.99 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-O 121.271 0.558 . . . . 0.0 110.429 178.259 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . 0.533 ' HE2' ' CG2' ' A' ' 127' ' ' VAL . 21.5 ttmm -80.14 166.45 21.46 Favored 'General case' 0 N--CA 1.433 -1.317 0 CA-C-N 115.289 -0.869 . . . . 0.0 110.155 -176.03 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -110.49 161.92 15.2 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 -177.381 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 44.2 m -76.17 155.41 34.58 Favored 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 176.136 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 24.4 tpt180 -142.77 138.69 30.63 Favored 'General case' 0 N--CA 1.435 -1.187 0 C-N-CA 119.104 -1.039 . . . . 0.0 112.077 -172.001 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 28.5 p -68.25 118.62 11.6 Favored 'General case' 0 N--CA 1.44 -0.958 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.668 177.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' ARG . . . . . 0.529 ' HB2' ' O ' ' A' ' 159' ' ' GLY 0.315 0.0 OUTLIER -83.35 -20.6 33.99 Favored 'General case' 0 C--O 1.204 -1.336 0 C-N-CA 119.357 -0.937 . . . . 0.0 113.476 -178.787 . . . . . . . . 4 4 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -43.78 -32.03 0.95 Allowed 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 124.774 1.23 . . . . 0.0 113.425 -178.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -61.53 -38.53 87.76 Favored 'General case' 0 CA--C 1.553 1.095 0 N-CA-C 113.647 0.98 . . . . 0.0 113.647 -179.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 41.1 m-85 -152.55 -21.69 0.17 Allowed 'General case' 0 N--CA 1.504 2.238 0 CA-C-N 118.363 0.529 . . . . 0.0 111.507 -177.432 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . 0.529 ' O ' ' HB2' ' A' ' 155' ' ' ARG . . . 106.34 -91.33 0.72 Allowed Glycine 0 CA--C 1.464 -3.149 0 N-CA-C 105.585 -3.006 . . . . 0.0 105.585 -166.413 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.666 ' CG2' ' HA ' ' A' ' 67' ' ' ILE . 88.9 t -100.66 141.68 17.04 Favored 'Isoleucine or valine' 0 N--CA 1.388 -3.534 0 N-CA-C 105.984 -1.858 . . . . 0.0 105.984 167.291 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 65.5 mt-30 -94.47 92.12 6.97 Favored 'General case' 0 CA--C 1.453 -2.755 0 N-CA-C 106.425 -1.695 . . . . 0.0 106.425 -170.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . 0.608 ' HD2' ' O ' ' A' ' 162' ' ' ARG . 0.0 OUTLIER -101.24 135.89 41.98 Favored 'General case' 1 N--CA 1.379 -4.016 0 CA-C-N 114.573 -1.194 . . . . 0.0 111.648 -170.685 . . . . . . . . 4 4 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' ASN . . . . . 0.534 ' H ' HG11 ' A' ' 94' ' ' VAL . 7.5 t30 -114.77 -13.63 12.03 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 177.537 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . 0.433 ' O ' ' HD3' ' A' ' 162' ' ' ARG . . . -100.38 157.78 19.43 Favored Glycine 0 N--CA 1.428 -1.863 0 CA-C-N 114.225 -1.352 . . . . 0.0 110.609 178.853 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.409 ' O ' HD12 ' A' ' 165' ' ' LEU . 2.1 pp -121.38 153.78 37.35 Favored 'General case' 0 C--N 1.287 -2.144 0 C-N-CA 123.234 0.614 . . . . 0.0 109.935 -177.234 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.38 129.75 39.61 Favored 'General case' 0 N--CA 1.432 -1.326 0 N-CA-C 106.856 -1.535 . . . . 0.0 106.856 173.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 46.8 t -57.54 -29.65 34.55 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 CA-C-O 121.444 0.64 . . . . 0.0 109.684 174.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -70.29 -34.6 72.95 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 123.475 0.71 . . . . 0.0 111.378 178.054 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 64.8 tttp -96.99 109.63 22.34 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 113.248 0.832 . . . . 0.0 113.248 -174.462 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 . . . . . 0 C--N 1.293 -1.885 0 N-CA-C 107.099 -1.445 . . . . 0.0 107.099 173.914 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 40.8 m . . . . . 0 C--O 1.241 0.645 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 66.29 -173.96 0.19 Allowed 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.42 0.688 . . . . 0.0 110.853 -178.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 63.01 18.61 11.05 Favored 'General case' 0 C--O 1.238 0.499 0 C-N-CA 123.589 0.755 . . . . 0.0 111.419 179.125 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 12.2 tt -84.22 142.2 13.7 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.208 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 -178.424 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 51.1 p90 -149.6 166.4 29.36 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 -178.016 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -153.48 115.51 4.32 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-O 120.883 0.373 . . . . 0.0 110.957 176.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.35 95.41 1.24 Allowed 'General case' 0 C--N 1.309 -1.161 0 CA-C-O 121.665 0.745 . . . . 0.0 110.76 171.231 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 13.2 p -73.62 150.95 7.57 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.097 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 177.63 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -78.32 68.26 2.94 Favored Glycine 0 N--CA 1.439 -1.129 0 C-N-CA 120.979 -0.629 . . . . 0.0 113.879 -176.341 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 33.0 t -76.79 -33.99 57.99 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 106.59 -1.633 . . . . 0.0 106.59 174.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 83.9 t80 -82.04 100.92 10.02 Favored 'General case' 0 N--CA 1.425 -1.693 0 CA-C-N 114.494 -1.23 . . . . 0.0 108.672 174.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 68.7 p-90 -113.77 148.86 35.77 Favored 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 177.145 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -149.22 153.19 37.25 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 179.388 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 93.11 71.33 1.16 Allowed Glycine 0 N--CA 1.424 -2.133 0 C-N-CA 120.256 -0.973 . . . . 0.0 111.953 178.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -81.49 118.73 22.96 Favored 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 174.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.51 ' HA ' ' HE3' ' A' ' 16' ' ' LYS . 0.3 OUTLIER 63.83 77.34 0.32 Allowed 'General case' 0 C--N 1.326 -0.435 0 O-C-N 124.096 0.872 . . . . 0.0 108.761 -174.293 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -133.44 90.65 2.75 Favored 'General case' 0 N--CA 1.433 -1.29 0 CA-C-O 121.629 0.728 . . . . 0.0 111.497 -178.404 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -128.62 85.67 2.36 Favored 'General case' 0 C--N 1.29 -1.984 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 176.009 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 47.2 mtmt -84.53 88.33 7.31 Favored 'General case' 0 CA--C 1.502 -0.882 0 C-N-CA 119.883 -0.727 . . . . 0.0 111.207 -176.36 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -145.44 92.91 2.29 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-N 114.801 -1.09 . . . . 0.0 109.717 177.333 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 43.4 p90 -159.27 156.95 29.67 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-N 115.177 -0.92 . . . . 0.0 108.537 -178.388 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -102.82 -71.97 0.71 Allowed 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 177.329 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 23.0 t 66.48 -59.41 0.35 Allowed 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 124.603 1.161 . . . . 0.0 111.12 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 7.5 p -115.41 107.06 21.76 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.531 0 CA-C-O 121.84 0.829 . . . . 0.0 109.33 177.296 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 177.93 164.43 31.21 Favored Glycine 0 N--CA 1.424 -2.111 0 N-CA-C 109.92 -1.272 . . . . 0.0 109.92 -178.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 6.2 t30 57.84 83.75 0.11 Allowed 'General case' 0 C--O 1.24 0.605 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 -175.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -89.13 128.04 35.75 Favored 'General case' 0 C--N 1.29 -1.999 0 CA-C-O 121.903 0.859 . . . . 0.0 112.817 -172.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 48.5 tp -147.66 98.09 2.92 Favored 'General case' 0 C--N 1.293 -1.851 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 171.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 38.3 m-80 -133.99 97.59 3.92 Favored 'General case' 0 C--N 1.288 -2.069 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 -179.291 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 32.2 t -145.72 88.97 1.87 Allowed 'General case' 0 N--CA 1.413 -2.318 0 CA-C-O 121.608 0.718 . . . . 0.0 109.506 179.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 57.3 t -126.18 -64.56 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 N-CA-C 106.037 -1.838 . . . . 0.0 106.037 175.08 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 37.2 m -103.62 104.01 14.01 Favored 'General case' 0 N--CA 1.414 -2.236 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 175.61 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 37.1 p -77.98 84.73 4.24 Favored 'General case' 0 N--CA 1.429 -1.495 0 CA-C-O 122.091 0.948 . . . . 0.0 110.603 179.203 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 38.1 m -122.85 121.78 37.05 Favored 'General case' 0 N--CA 1.418 -2.07 0 CA-C-N 114.536 -1.211 . . . . 0.0 108.268 178.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 51.1 mm -89.65 112.95 25.2 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.765 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 -178.308 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 68.77 -62.76 0.38 Allowed 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 124.551 1.14 . . . . 0.0 112.386 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 132.45 -150.62 19.71 Favored Glycine 0 N--CA 1.422 -2.241 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 -176.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -117.0 3.85 18.96 Favored Glycine 0 C--N 1.299 -1.521 0 C-N-CA 120.752 -0.737 . . . . 0.0 111.746 178.343 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 23.7 p -109.22 103.47 12.45 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-O 121.365 0.602 . . . . 0.0 112.622 -179.512 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -90.26 -42.98 10.68 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 106.082 -1.821 . . . . 0.0 106.082 172.237 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 32.5 p90 -159.3 165.39 33.54 Favored 'General case' 0 N--CA 1.434 -1.264 0 N-CA-C 106.317 -1.734 . . . . 0.0 106.317 175.389 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 56.0 tp -136.77 108.71 7.13 Favored 'General case' 0 C--N 1.292 -1.926 0 C-N-CA 120.322 -0.551 . . . . 0.0 110.836 -179.135 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 61.3 t -86.9 116.34 29.24 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.029 0 N-CA-C 106.934 -1.506 . . . . 0.0 106.934 175.257 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 40.7 t30 -78.08 91.03 4.25 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-O 121.772 0.796 . . . . 0.0 112.436 -175.521 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 41.0 ttmt -126.65 75.26 1.54 Allowed 'General case' 0 N--CA 1.424 -1.774 0 CA-C-N 115.093 -0.958 . . . . 0.0 108.467 175.141 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 7.4 tp -176.2 -47.04 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 CA-C-N 113.444 -1.707 . . . . 0.0 106.48 -178.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 96.1 mttt 67.66 168.55 0.26 Allowed 'General case' 0 C--N 1.346 0.422 0 C-N-CA 125.008 1.323 . . . . 0.0 113.279 175.492 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -85.05 36.8 3.02 Favored Glycine 0 N--CA 1.438 -1.226 0 C-N-CA 121.053 -0.594 . . . . 0.0 114.405 -174.048 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.457 ' HG3' ' SD ' ' A' ' 50' ' ' MET . 62.8 pttt -90.84 -16.82 27.59 Favored 'General case' 0 C--N 1.318 -0.786 0 C-N-CA 120.03 -0.668 . . . . 0.0 109.797 176.736 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' MET . . . . . 0.457 ' SD ' ' HG3' ' A' ' 49' ' ' LYS . 1.7 mpt? -94.36 126.91 39.91 Favored 'General case' 0 N--CA 1.441 -0.91 0 N-CA-C 106.613 -1.625 . . . . 0.0 106.613 171.614 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 28.3 pt20 -74.19 131.89 41.68 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-O 121.588 0.708 . . . . 0.0 112.272 -176.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.469 ' O ' ' HD2' ' A' ' 55' ' ' PRO . 68.6 mttm -129.39 168.72 15.26 Favored Pre-proline 0 C--N 1.302 -1.457 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 179.084 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -84.76 15.55 2.17 Favored 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 122.25 1.967 . . . . 0.0 111.551 175.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.48 ' HB3' ' HD3' ' A' ' 55' ' ' PRO . 14.8 tp -80.02 -49.53 1.26 Allowed Pre-proline 0 C--O 1.199 -1.59 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.65 -179.83 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.48 ' HD3' ' HB3' ' A' ' 54' ' ' LEU . 0.1 OUTLIER -38.3 -45.58 2.2 Favored 'Trans proline' 0 C--N 1.388 2.613 0 C-N-CA 124.143 3.229 . . . . 0.0 113.476 177.185 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -69.76 -37.9 76.56 Favored 'General case' 0 N--CA 1.438 -1.069 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.668 179.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.429 ' HG ' ' CE1' ' A' ' 61' ' ' TYR . 3.7 tt -75.64 -35.4 60.45 Favored 'General case' 0 N--CA 1.436 -1.166 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.845 -177.817 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.493 HD12 ' N ' ' A' ' 59' ' ' LYS . 4.0 pp -66.88 -41.11 87.8 Favored 'General case' 0 C--N 1.314 -0.937 0 C-N-CA 120.412 -0.515 . . . . 0.0 112.276 -178.273 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.493 ' N ' HD12 ' A' ' 58' ' ' LEU . 62.0 pttt -75.13 -26.0 58.84 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.788 0.804 . . . . 0.0 109.823 176.649 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -66.27 -53.8 32.54 Favored 'General case' 0 N--CA 1.439 -0.979 0 CA-C-N 115.146 -0.934 . . . . 0.0 111.393 176.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.429 ' CE1' ' HG ' ' A' ' 57' ' ' LEU . 14.5 m-85 -60.34 -52.96 63.04 Favored 'General case' 0 CA--C 1.504 -0.815 0 N-CA-C 114.681 1.363 . . . . 0.0 114.681 -178.847 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.555 ' O ' HD13 ' A' ' 63' ' ' LEU . 19.6 m-20 -79.91 -98.04 0.03 OUTLIER 'General case' 0 C--N 1.316 -0.86 0 C-N-CA 118.918 -1.113 . . . . 0.0 110.44 -179.737 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.555 HD13 ' O ' ' A' ' 62' ' ' ASP . 0.8 OUTLIER -142.41 158.68 60.21 Favored Pre-proline 0 N--CA 1.43 -1.426 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 -177.723 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.501 ' HB2' ' NH1' ' A' ' 155' ' ' ARG . 12.9 Cg_endo -93.27 28.68 0.31 Allowed 'Trans proline' 0 N--CA 1.439 -1.679 0 C-N-CA 123.47 2.78 . . . . 0.0 112.176 -173.565 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.482 ' O ' ' HA3' ' A' ' 159' ' ' GLY . 0.2 OUTLIER -69.96 -29.92 42.16 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.343 0 N-CA-C 107.764 -1.199 . . . . 0.0 107.764 173.863 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.407 ' O ' ' HB ' ' A' ' 67' ' ' ILE . . . 62.01 -9.71 0.11 Allowed Glycine 0 CA--C 1.54 1.651 0 CA-C-N 114.515 -1.22 . . . . 0.0 115.268 177.596 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.6 ' O ' ' HB ' ' A' ' 160' ' ' VAL . 38.4 mt 76.33 -38.53 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.51 -0.592 0 C-N-CA 125.171 1.389 . . . . 0.0 113.217 179.315 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.531 ' HB2' ' O ' ' A' ' 67' ' ' ILE . 39.0 t80 166.07 -57.72 0.0 OUTLIER Pre-proline 0 C--N 1.321 -0.636 0 C-N-CA 125.009 1.323 . . . . 0.0 109.007 173.131 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.445 ' HD2' ' H ' ' A' ' 70' ' ' GLY . 19.6 Cg_endo -102.56 -16.85 0.09 OUTLIER 'Trans proline' 0 C--N 1.378 2.129 0 C-N-CA 122.209 1.94 . . . . 0.0 114.985 -172.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.445 ' H ' ' HD2' ' A' ' 69' ' ' PRO . . . 80.36 9.72 86.2 Favored Glycine 0 N--CA 1.441 -0.986 0 C-N-CA 119.924 -1.132 . . . . 0.0 111.633 -173.565 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.649 ' OD1' ' HG3' ' A' ' 89' ' ' PRO . 10.4 t70 -92.0 -43.56 9.36 Favored 'General case' 0 C--O 1.201 -1.455 0 N-CA-C 106.474 -1.676 . . . . 0.0 106.474 176.304 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.454 ' O ' ' HB ' ' A' ' 73' ' ' THR . . . -72.02 -178.77 2.5 Favored 'General case' 0 CA--C 1.552 1.043 0 CA-C-N 114.537 -1.21 . . . . 0.0 108.104 165.195 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.581 ' O ' HG22 ' A' ' 73' ' ' THR . 56.8 m 83.52 26.97 0.1 Allowed 'General case' 0 N--CA 1.498 1.948 0 CA-C-O 123.469 1.604 . . . . 0.0 108.398 179.28 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.431 ' ND2' HD23 ' A' ' 58' ' ' LEU . 3.5 m120 -81.7 111.15 17.69 Favored 'General case' 0 N--CA 1.41 -2.474 0 C-N-CA 118.528 -1.269 . . . . 0.0 110.962 -175.601 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 66.1 t80 -71.71 94.2 1.34 Allowed 'General case' 0 C--N 1.293 -1.874 0 CA-C-N 114.074 -1.421 . . . . 0.0 112.081 -176.195 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.505 ' HB2' ' HG1' ' A' ' 85' ' ' THR . 23.5 mm-40 -110.62 111.57 22.88 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 171.692 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -125.76 127.28 45.92 Favored 'General case' 0 C--N 1.291 -1.966 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.985 -170.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.455 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 3.3 m-20 -91.32 163.48 14.2 Favored 'General case' 0 CA--C 1.475 -1.933 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 178.238 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -81.67 -58.38 3.03 Favored 'General case' 0 C--N 1.26 -3.29 0 CA-C-N 114.237 -1.347 . . . . 0.0 113.176 -178.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -75.97 -46.92 27.14 Favored 'General case' 0 N--CA 1.429 -1.499 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.596 -176.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.455 ' HB ' ' HB2' ' A' ' 78' ' ' ASP . 96.8 m -67.98 -52.08 39.9 Favored 'General case' 0 C--N 1.293 -1.882 0 CA-C-N 114.4 -1.273 . . . . 0.0 112.369 -177.677 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 99.4 mttt 66.6 3.76 3.06 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 114.501 1.297 . . . . 0.0 114.501 178.334 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.696 ' HG2' ' OG1' ' A' ' 109' ' ' THR . 38.2 ttpt -91.17 92.49 8.69 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-O 121.856 0.836 . . . . 0.0 109.24 176.485 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.441 HD21 ' O ' ' A' ' 76' ' ' GLU . 3.0 tm? -51.21 135.1 26.65 Favored 'General case' 0 C--N 1.32 -0.706 0 C-N-CA 126.376 1.87 . . . . 0.0 111.728 -173.82 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.505 ' HG1' ' HB2' ' A' ' 76' ' ' GLU . 46.1 p -117.34 110.04 17.57 Favored 'General case' 0 N--CA 1.419 -1.981 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.021 179.805 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.409 HG23 ' CD1' ' A' ' 84' ' ' LEU . 53.5 t -91.9 127.44 44.18 Favored 'Isoleucine or valine' 0 CA--C 1.478 -1.822 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 172.574 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.454 ' HA ' ' O ' ' A' ' 106' ' ' THR 0.286 0.0 OUTLIER -114.57 129.85 56.71 Favored 'General case' 0 N--CA 1.392 -3.349 0 CA-C-N 115.105 -0.952 . . . . 0.0 111.227 178.902 . . . . . . . . 4 4 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.454 ' O ' HG21 ' A' ' 106' ' ' THR . 3.1 mp -95.69 136.21 22.5 Favored Pre-proline 0 C--N 1.275 -2.66 0 CA-C-N 114.069 -1.423 . . . . 0.0 108.411 178.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.649 ' HG3' ' OD1' ' A' ' 71' ' ' ASP . 7.1 Cg_exo -25.3 -55.45 0.08 OUTLIER 'Trans proline' 0 C--N 1.374 1.878 1 C-N-CA 125.719 4.279 . . . . 0.0 114.065 174.825 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.471 ' HB2' ' HB2' ' A' ' 168' ' ' ASP . 45.1 t -154.1 161.45 41.89 Favored 'General case' 0 N--CA 1.426 -1.631 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 177.179 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.407 HD11 ' HD2' ' A' ' 103' ' ' LYS . 10.0 tt -64.64 114.65 2.48 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 O-C-N 123.939 0.774 . . . . 0.0 110.524 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' CYS . . . . . 0.483 ' HB2' ' HA ' ' A' ' 166' ' ' ARG . 44.2 t -116.03 123.08 47.06 Favored 'General case' 0 N--CA 1.417 -2.122 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.01 -179.161 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -99.05 169.82 9.14 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.25 -179.148 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.409 ' HB ' HH11 ' A' ' 162' ' ' ARG . 3.5 p -148.31 106.08 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.674 0 C-N-CA 123.325 0.65 . . . . 0.0 110.073 174.372 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -145.77 114.71 0.77 Allowed Glycine 0 C--N 1.296 -1.686 0 N-CA-C 108.643 -1.783 . . . . 0.0 108.643 175.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . 0.514 ' CD2' ' HG3' ' A' ' 97' ' ' LYS . 12.1 t80 -139.78 -156.67 0.7 Allowed 'General case' 0 N--CA 1.414 -2.253 0 N-CA-C 106.048 -1.834 . . . . 0.0 106.048 -176.607 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.514 ' HG3' ' CD2' ' A' ' 96' ' ' TYR . 0.1 OUTLIER -72.63 -6.07 41.76 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-O 122.185 0.993 . . . . 0.0 111.049 -175.442 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.488 ' OD1' ' HB3' ' A' ' 96' ' ' TYR . 5.9 m-20 -74.38 -15.01 60.94 Favored 'General case' 0 N--CA 1.422 -1.868 0 CA-C-N 113.486 -1.688 . . . . 0.0 111.704 -175.488 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 34.5 t 77.62 -10.0 1.42 Allowed 'General case' 0 C--O 1.238 0.449 0 C-N-CA 124.476 1.111 . . . . 0.0 111.86 177.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 43.6 p -82.9 93.71 7.56 Favored 'General case' 0 N--CA 1.411 -2.388 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 176.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 96.1 t -94.68 115.96 34.8 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.993 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.776 176.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.442 ' HG ' ' HA ' ' A' ' 125' ' ' THR . 6.9 tt -137.66 134.83 35.91 Favored 'General case' 0 C--N 1.286 -2.195 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 -178.199 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.407 ' HD2' HD11 ' A' ' 91' ' ' ILE . 39.0 ttpt -110.11 106.51 16.0 Favored 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 178.62 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 14.1 t80 -96.36 96.83 9.01 Favored 'General case' 0 N--CA 1.421 -1.904 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 -177.579 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.468 HG23 ' H ' ' A' ' 106' ' ' THR . 10.6 m -57.98 172.29 0.43 Allowed 'General case' 0 CA--C 1.568 1.66 0 C-N-CA 126.415 1.886 . . . . 0.0 112.307 -178.777 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' THR . . . . . 0.468 ' H ' HG23 ' A' ' 105' ' ' THR . 38.4 m -78.29 -72.41 0.37 Allowed 'General case' 0 C--N 1.316 -0.887 0 C-N-CA 123.562 0.745 . . . . 0.0 111.79 -173.445 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 43.9 m -103.62 110.34 22.36 Favored 'General case' 0 N--CA 1.431 -1.412 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 179.498 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.563 HG22 HG12 ' A' ' 123' ' ' ILE . 3.6 p -109.03 167.08 4.31 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.419 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 178.48 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.696 ' OG1' ' HG2' ' A' ' 83' ' ' LYS . 15.1 t -139.39 131.94 28.74 Favored 'General case' 0 N--CA 1.4 -2.945 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 -175.788 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -147.32 172.18 27.8 Favored Glycine 0 N--CA 1.413 -2.86 0 C-N-CA 119.273 -1.441 . . . . 0.0 113.162 -177.65 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 35.8 m80 -77.35 121.57 23.93 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 -179.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.42 ' HB2' ' CB ' ' A' ' 84' ' ' LEU . 3.2 tm? -94.57 110.71 22.5 Favored 'General case' 0 N--CA 1.422 -1.845 0 CA-C-O 121.213 0.53 . . . . 0.0 110.532 -174.214 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -128.18 130.15 47.59 Favored 'General case' 0 CA--C 1.439 -3.307 0 CA-C-N 114.549 -1.205 . . . . 0.0 108.913 168.221 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 54.8 tptt -66.47 116.37 7.39 Favored 'General case' 0 N--CA 1.38 -3.962 0 CA-C-N 114.54 -1.209 . . . . 0.0 109.142 -178.209 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . 0.474 ' C ' ' HE2' ' A' ' 116' ' ' LYS . . . 118.42 -27.56 7.23 Favored Glycine 0 C--O 1.177 -3.459 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 -174.169 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.726 ' HE2' ' N ' ' A' ' 116' ' ' LYS . 0.0 OUTLIER -165.19 122.23 1.51 Allowed 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 117.393 0.597 . . . . 0.0 111.898 -178.246 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 64.4 tp -93.6 105.44 17.49 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 176.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 34.2 p -105.9 134.64 48.71 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 114.094 1.146 . . . . 0.0 114.094 -172.534 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 67.1 88.15 0.11 Allowed 'General case' 0 CA--C 1.49 -1.327 0 C-N-CA 124.871 1.268 . . . . 0.0 112.887 178.211 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.419 HG22 ' O ' ' A' ' 134' ' ' THR . 12.4 m -95.78 92.35 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.302 0 CA-C-O 122.912 1.339 . . . . 0.0 108.679 178.824 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -73.57 99.76 3.14 Favored 'General case' 0 C--N 1.264 -3.145 0 CA-C-N 113.072 -1.876 . . . . 0.0 111.769 -174.307 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 145.67 -8.62 1.58 Allowed Glycine 0 N--CA 1.423 -2.194 0 CA-C-N 114.41 -1.268 . . . . 0.0 111.631 177.011 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.563 HG12 HG22 ' A' ' 108' ' ' VAL . 46.4 mm -100.21 118.46 46.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-O 121.623 0.725 . . . . 0.0 111.18 -178.171 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt -85.4 119.31 25.63 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 106.294 -1.743 . . . . 0.0 106.294 175.169 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.442 ' HA ' ' HG ' ' A' ' 102' ' ' LEU . 89.5 m -125.47 128.07 47.48 Favored 'General case' 0 C--N 1.283 -2.299 0 CA-C-N 115.764 -0.653 . . . . 0.0 112.526 -169.624 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.526 ' HD3' ' C ' ' A' ' 126' ' ' LYS . 0.5 OUTLIER -137.85 123.45 19.75 Favored 'General case' 0 N--CA 1.428 -1.561 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 168.82 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.459 ' N ' ' HD3' ' A' ' 126' ' ' LYS . 7.1 p -150.55 -44.52 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.284 -2.266 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 177.556 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 15.5 tpt -103.72 -42.7 5.55 Favored 'General case' 0 N--CA 1.416 -2.16 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 173.371 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . 0.414 HG13 ' H ' ' A' ' 130' ' ' TRP . 9.3 tp -164.51 175.33 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.889 0 N-CA-C 105.808 -1.923 . . . . 0.0 105.808 178.507 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' TRP . . . . . 0.46 ' CE3' ' HB2' ' A' ' 126' ' ' LYS . 97.7 m95 -69.66 122.81 19.85 Favored 'General case' 0 C--O 1.241 0.642 0 CA-C-O 121.716 0.769 . . . . 0.0 112.285 178.725 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 97.0 t -130.96 149.03 33.08 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.031 0 C-N-CA 125.481 1.512 . . . . 0.0 107.348 179.347 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 18.0 ptmt -122.75 -12.37 8.07 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-O 121.381 0.61 . . . . 0.0 110.71 177.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 15.8 m -138.39 75.28 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 CA-C-O 122.115 0.96 . . . . 0.0 110.266 -178.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' THR . . . . . 0.419 ' O ' HG22 ' A' ' 120' ' ' VAL . 7.7 t -84.01 168.92 15.49 Favored 'General case' 0 N--CA 1.414 -2.265 0 CA-C-N 115.062 -0.972 . . . . 0.0 109.328 179.022 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 16.6 p -131.47 151.69 51.35 Favored 'General case' 0 N--CA 1.387 -3.593 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 14.1 tt -118.28 97.61 5.55 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.272 0 CA-C-O 122.253 1.025 . . . . 0.0 108.768 176.405 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' SER . . . . . 0.476 ' OG ' ' HB2' ' A' ' 144' ' ' TYR . 36.2 p -91.44 152.48 20.36 Favored 'General case' 0 N--CA 1.407 -2.577 0 CA-C-N 115.019 -0.991 . . . . 0.0 110.575 -177.204 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' THR . . . . . 0.417 HG21 ' O ' ' A' ' 115' ' ' GLY . 4.4 t -165.42 178.08 7.05 Favored 'General case' 0 N--CA 1.396 -3.137 0 N-CA-C 107.337 -1.356 . . . . 0.0 107.337 -176.378 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -112.7 28.43 8.79 Favored 'General case' 0 C--N 1.269 -2.891 0 N-CA-C 106.848 -1.538 . . . . 0.0 106.848 174.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . 71.44 35.76 1.44 Allowed 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 114.284 -1.325 . . . . 0.0 109.569 -175.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 39.3 t 177.66 -80.9 0.0 OUTLIER 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 114.299 -1.319 . . . . 0.0 109.37 -178.17 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -78.26 135.94 37.66 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 -178.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 47.7 t -105.48 144.5 14.96 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 -165.062 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . 0.476 ' HB2' ' OG ' ' A' ' 137' ' ' SER . 83.6 m-85 -119.69 121.42 39.18 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 106.499 -1.667 . . . . 0.0 106.499 173.826 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 32.3 t80 -96.86 99.13 10.71 Favored 'General case' 0 C--N 1.286 -2.163 0 CA-C-O 121.812 0.815 . . . . 0.0 109.117 -173.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 15.2 p -97.95 31.35 2.71 Favored 'General case' 0 C--N 1.298 -1.668 0 CA-C-N 115.288 -0.869 . . . . 0.0 112.571 -175.137 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -76.13 82.45 2.96 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-O 121.856 0.836 . . . . 0.0 111.265 178.364 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 94.79 -58.13 1.84 Allowed Glycine 0 CA--C 1.477 -2.34 0 N-CA-C 108.749 -1.74 . . . . 0.0 108.749 178.213 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 19.6 ttt 169.93 88.93 0.0 OUTLIER 'General case' 0 N--CA 1.435 -1.214 0 C-N-CA 126.518 1.927 . . . . 0.0 107.351 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . 0.407 ' HD3' ' HA ' ' A' ' 150' ' ' LYS . 63.2 mmtt -133.07 176.32 8.6 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 113.64 0.978 . . . . 0.0 113.64 178.878 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -85.59 161.34 19.34 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.296 -0.866 . . . . 0.0 112.205 -173.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 53.6 p -78.31 160.8 27.66 Favored 'General case' 0 N--CA 1.438 -1.058 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.189 -179.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 30.4 ttm180 -145.7 152.09 39.05 Favored 'General case' 0 N--CA 1.438 -1.073 0 CA-C-O 121.014 0.435 . . . . 0.0 110.257 -176.074 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 61.8 p -89.11 135.05 33.77 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 177.186 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' ARG . . . . . 0.501 ' NH1' ' HB2' ' A' ' 64' ' ' PRO . 15.1 ptt180 -78.45 -19.18 53.71 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 120.091 -0.644 . . . . 0.0 110.449 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -48.68 -30.54 5.61 Favored 'General case' 0 C--N 1.316 -0.858 0 C-N-CA 124.375 1.07 . . . . 0.0 112.837 -177.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -75.33 -53.83 8.08 Favored 'General case' 0 N--CA 1.441 -0.902 0 C-N-CA 120.838 -0.345 . . . . 0.0 111.043 178.422 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . 0.444 ' HB2' ' HB3' ' A' ' 161' ' ' GLN . 95.4 m-85 -157.1 -5.25 0.1 Allowed 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 111.592 0.219 . . . . 0.0 111.592 -178.417 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . 0.482 ' HA3' ' O ' ' A' ' 65' ' ' ILE . . . 79.14 -84.71 1.24 Allowed Glycine 0 CA--C 1.475 -2.446 0 N-CA-C 109.01 -1.636 . . . . 0.0 109.01 -169.47 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.6 ' HB ' ' O ' ' A' ' 67' ' ' ILE . 16.3 t -109.85 134.11 53.02 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.505 0 N-CA-C 107.513 -1.292 . . . . 0.0 107.513 174.297 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' GLN . . . . . 0.444 ' HB3' ' HB2' ' A' ' 158' ' ' TYR . 1.1 pp0? -148.17 116.39 6.51 Favored 'General case' 0 N--CA 1.416 -2.169 0 CA-C-O 121.497 0.665 . . . . 0.0 110.721 -175.002 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . 0.458 ' NH1' ' HA3' ' A' ' 164' ' ' GLY . 1.9 ppt_? -154.74 162.32 41.16 Favored 'General case' 0 C--N 1.266 -3.034 0 CA-C-N 113.935 -1.484 . . . . 0.0 109.074 175.57 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -76.8 91.98 3.56 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 121.716 0.77 . . . . 0.0 112.718 -177.478 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . 0.458 ' HA3' ' NH1' ' A' ' 162' ' ' ARG . . . -146.25 142.4 10.48 Favored Glycine 0 N--CA 1.421 -2.312 0 CA-C-N 115.67 -0.696 . . . . 0.0 111.591 178.128 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.407 HD22 ' H ' ' A' ' 165' ' ' LEU . 1.5 pt? -117.7 112.05 19.95 Favored 'General case' 0 N--CA 1.416 -2.133 0 N-CA-C 106.802 -1.555 . . . . 0.0 106.802 173.575 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . 0.483 ' HA ' ' HB2' ' A' ' 92' ' ' CYS . 10.8 ptp180 -80.02 110.21 15.2 Favored 'General case' 0 N--CA 1.416 -2.161 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 -179.06 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 5.7 m -69.88 26.31 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.292 -1.897 0 N-CA-C 116.082 1.882 . . . . 0.0 116.082 -171.537 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . 0.471 ' HB2' ' HB2' ' A' ' 90' ' ' SER . 31.7 t70 -135.37 69.15 1.44 Allowed 'General case' 0 CA--C 1.497 -1.092 0 N-CA-C 108.064 -1.088 . . . . 0.0 108.064 170.183 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' LYS . . . . . 0.422 ' HB2' ' O ' ' A' ' 168' ' ' ASP . 25.0 ttpp 167.87 145.86 0.02 OUTLIER 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 113.878 -1.51 . . . . 0.0 107.344 179.465 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' PHE . . . . . . . . . . . . . 74.5 t80 . . . . . 0 N--CA 1.412 -2.346 0 N-CA-C 105.37 -2.085 . . . . 0.0 105.37 170.378 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 46.7 t . . . . . 0 C--O 1.241 0.656 0 N-CA-C 110.214 -0.291 . . . . 0.0 110.214 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 58.47 178.15 0.07 Allowed 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 113.571 0.952 . . . . 0.0 113.571 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -172.21 130.19 0.6 Allowed 'General case' 0 C--N 1.311 -1.073 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 177.527 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 50.8 mm -83.28 92.06 2.69 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 C-N-CA 120.472 -0.491 . . . . 0.0 110.542 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -149.8 170.13 19.46 Favored 'General case' 0 C--N 1.312 -1.035 0 C-N-CA 124.68 1.192 . . . . 0.0 107.951 176.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 48.0 t30 -147.56 143.53 27.84 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 179.119 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 23.6 pttm -81.76 97.77 8.12 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-O 122.029 0.919 . . . . 0.0 109.731 175.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.2 p -145.4 138.46 21.34 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.699 0 CA-C-N 114.78 -1.1 . . . . 0.0 109.529 -176.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -165.03 82.25 0.11 Allowed Glycine 0 N--CA 1.426 -1.988 0 N-CA-C 110.137 -1.185 . . . . 0.0 110.137 179.468 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 23.6 p -83.08 80.03 9.18 Favored 'General case' 0 N--CA 1.429 -1.486 0 CA-C-O 121.683 0.754 . . . . 0.0 112.347 -178.435 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 55.1 p90 -145.13 156.81 44.1 Favored 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 106.452 -1.685 . . . . 0.0 106.452 177.463 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 76.6 t-105 -159.73 127.39 4.74 Favored 'General case' 0 C--N 1.307 -1.283 0 C-N-CA 119.74 -0.784 . . . . 0.0 112.72 -179.012 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 57.6 tp -134.11 94.19 3.2 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 107.141 -1.429 . . . . 0.0 107.141 172.613 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -88.13 -9.24 70.73 Favored Glycine 0 CA--C 1.498 -1.012 0 CA-C-N 115.416 -0.811 . . . . 0.0 112.367 -176.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 93.6 mt-30 -65.81 102.83 0.81 Allowed 'General case' 0 CA--C 1.502 -0.882 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 177.259 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 23.8 tptm -150.92 93.14 1.9 Allowed 'General case' 0 C--N 1.291 -1.962 0 N-CA-C 107.021 -1.474 . . . . 0.0 107.021 -178.517 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -151.5 121.85 7.3 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.241 -177.035 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 43.8 t30 -162.75 129.43 3.52 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 -179.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.41 95.73 4.22 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-O 121.904 0.859 . . . . 0.0 108.85 176.519 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 19.2 pt20 -95.64 82.84 3.66 Favored 'General case' 0 C--N 1.292 -1.927 0 CA-C-O 121.732 0.777 . . . . 0.0 112.289 -177.146 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 53.1 p90 -163.56 125.87 2.52 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-N 114.772 -1.103 . . . . 0.0 109.202 175.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -167.76 167.53 13.08 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 -179.155 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 34.3 m -67.77 124.68 23.97 Favored 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 110.081 -0.34 . . . . 0.0 110.081 179.342 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 35.7 m -81.56 153.4 4.15 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.09 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.662 -177.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -116.24 172.47 14.24 Favored Glycine 0 N--CA 1.429 -1.822 0 N-CA-C 110.825 -0.91 . . . . 0.0 110.825 -179.626 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 19.1 m120 -132.88 -179.86 5.74 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 -179.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 -72.98 104.45 4.1 Favored 'General case' 0 C--N 1.31 -1.143 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 177.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -109.53 110.51 21.63 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 105.831 -1.914 . . . . 0.0 105.831 -179.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 44.2 t30 -152.2 132.82 13.93 Favored 'General case' 0 C--N 1.307 -1.258 0 C-N-CA 120.626 -0.43 . . . . 0.0 111.333 -175.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 21.4 p -88.43 119.22 28.66 Favored 'General case' 0 N--CA 1.423 -1.793 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 175.006 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.447 ' O ' ' HB2' ' A' ' 32' ' ' SER . 51.4 t -74.82 -72.65 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.96 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 179.301 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.447 ' HB2' ' O ' ' A' ' 31' ' ' VAL . 20.9 t 169.1 126.87 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.172 0 O-C-N 124.128 0.892 . . . . 0.0 109.028 176.779 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 8.0 t -165.31 90.39 0.49 Allowed 'General case' 0 C--N 1.313 -1.012 0 CA-C-O 121.875 0.845 . . . . 0.0 109.18 175.614 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 69.1 m -155.36 120.34 4.84 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 112.748 0.647 . . . . 0.0 112.748 -175.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 47.9 mm 69.58 125.9 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 C-N-CA 124.897 1.279 . . . . 0.0 114.403 170.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -137.24 100.44 4.26 Favored 'General case' 0 N--CA 1.44 -0.965 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 175.055 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 178.84 167.81 37.05 Favored Glycine 0 C--N 1.308 -0.985 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.113 -178.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 157.93 171.84 24.36 Favored Glycine 0 N--CA 1.436 -1.332 0 N-CA-C 110.642 -0.983 . . . . 0.0 110.642 -179.443 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 18.0 p -76.35 97.19 4.17 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 112.826 0.676 . . . . 0.0 112.826 -179.478 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 29.4 mtpp -111.56 -39.9 4.5 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 172.131 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 12.7 m-90 -133.92 152.37 51.83 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 106.074 -1.824 . . . . 0.0 106.074 175.364 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 5.4 mp -90.5 146.58 24.0 Favored 'General case' 0 C--N 1.301 -1.5 0 C-N-CA 120.151 -0.62 . . . . 0.0 109.919 179.391 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 8.5 p -46.93 132.63 3.65 Favored 'Isoleucine or valine' 0 C--O 1.245 0.827 0 C-N-CA 124.3 1.04 . . . . 0.0 112.152 179.293 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -93.15 159.81 15.12 Favored 'General case' 0 C--N 1.297 -1.699 0 CA-C-N 115.4 -0.818 . . . . 0.0 108.908 -179.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 60.4 pttt -72.24 172.87 9.46 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 116.212 -0.449 . . . . 0.0 109.894 176.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 24.2 pt -67.05 160.69 4.07 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 N-CA-C 111.648 0.24 . . . . 0.0 111.648 -178.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 12.5 mptt 66.98 93.51 0.07 Allowed 'General case' 0 C--O 1.245 0.821 0 C-N-CA 123.883 0.873 . . . . 0.0 111.077 -173.195 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 137.67 -85.98 0.23 Allowed Glycine 0 N--CA 1.433 -1.559 0 N-CA-C 111.184 -0.766 . . . . 0.0 111.184 179.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 9.7 mptt -114.03 117.94 32.7 Favored 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 179.153 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 84.5 mtp -103.23 -64.28 1.1 Allowed 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 176.423 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . 0.497 ' HG3' ' H ' ' A' ' 52' ' ' LYS . 23.1 tp60 -157.97 -179.63 8.32 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 106.429 -1.693 . . . . 0.0 106.429 -179.011 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.497 ' H ' ' HG3' ' A' ' 51' ' ' GLN . 31.6 mmmt -67.64 154.92 92.48 Favored Pre-proline 0 C--N 1.316 -0.866 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 -178.772 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -73.56 -4.9 16.21 Favored 'Trans proline' 0 N--CA 1.473 0.313 0 C-N-CA 122.532 2.154 . . . . 0.0 115.821 -176.08 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.427 ' N ' ' HD2' ' A' ' 55' ' ' PRO . 3.4 mm? -79.03 -58.68 0.68 Allowed Pre-proline 0 C--N 1.301 -1.514 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 178.055 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.473 ' HD2' ' O ' ' A' ' 52' ' ' LYS . 27.3 Cg_endo -60.82 -14.97 35.09 Favored 'Trans proline' 0 N--CA 1.434 -2.017 0 C-N-CA 121.914 1.743 . . . . 0.0 113.129 -170.789 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -76.26 -34.4 59.16 Favored 'General case' 0 CA--C 1.493 -1.228 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 -179.597 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.418 ' HA ' ' HB3' ' A' ' 60' ' ' GLU . 88.1 mt -74.44 -36.52 63.4 Favored 'General case' 0 N--CA 1.42 -1.971 0 CA-C-N 114.946 -1.025 . . . . 0.0 109.48 178.459 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 8.3 mp -62.59 -42.11 99.37 Favored 'General case' 0 CA--C 1.494 -1.187 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -178.088 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.413 ' HD2' ' N ' ' A' ' 60' ' ' GLU . 0.0 OUTLIER -75.39 -28.1 59.32 Favored 'General case' 0 N--CA 1.435 -1.204 0 C-N-CA 118.839 -1.144 . . . . 0.0 110.375 176.228 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.418 ' HB3' ' HA ' ' A' ' 57' ' ' LEU . 7.5 tt0 -60.47 -38.64 84.86 Favored 'General case' 0 C--O 1.25 1.094 0 CA-C-N 114.952 -1.022 . . . . 0.0 113.124 178.835 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 73.8 m-85 -60.43 -42.24 95.64 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.944 0.72 . . . . 0.0 112.944 179.39 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . 0.265 24.8 m-20 -121.64 -82.77 0.65 Allowed 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 115.92 1.822 . . . . 0.0 115.92 -174.416 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.501 ' HB2' HD12 ' A' ' 65' ' ' ILE . 0.0 OUTLIER -114.04 138.72 22.99 Favored Pre-proline 0 C--N 1.318 -0.793 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 -177.747 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 63' ' ' LEU . 32.2 Cg_endo -98.93 27.94 0.15 Allowed 'Trans proline' 0 N--CA 1.431 -2.178 0 C-N-CA 123.858 3.038 . . . . 0.0 111.753 -170.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.668 ' O ' ' HA3' ' A' ' 159' ' ' GLY . 0.2 OUTLIER -61.63 -39.59 83.69 Favored 'Isoleucine or valine' 0 CA--C 1.484 -1.592 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 173.787 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 54.83 8.79 1.49 Allowed Glycine 0 CA--C 1.547 2.086 0 CA-C-N 115.263 -0.88 . . . . 0.0 113.737 -177.66 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.466 ' O ' ' HB ' ' A' ' 160' ' ' VAL . 47.8 mt 62.35 -68.15 0.12 Allowed 'Isoleucine or valine' 0 C--O 1.193 -1.904 0 C-N-CA 126.669 1.988 . . . . 0.0 113.812 -177.307 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 89.2 t80 -176.74 -54.19 0.0 OUTLIER Pre-proline 0 C--N 1.307 -1.273 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -173.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -92.05 -2.9 4.08 Favored 'Trans proline' 0 C--N 1.366 1.447 0 C-N-CA 121.74 1.626 . . . . 0.0 113.085 -172.507 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 82.77 -2.64 85.78 Favored Glycine 0 N--CA 1.429 -1.773 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.15 -179.196 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -102.75 -71.06 0.73 Allowed 'General case' 0 CA--C 1.497 -1.083 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 179.297 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.402 ' CB ' HG22 ' A' ' 88' ' ' ILE . . . -49.77 137.78 15.66 Favored 'General case' 0 CA--C 1.509 -0.604 0 CA-C-N 115.037 -0.983 . . . . 0.0 108.812 173.25 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 8.1 t 118.53 4.19 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.167 0 C-N-CA 126.735 2.014 . . . . 0.0 108.475 -169.112 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.514 ' O ' HG13 ' A' ' 86' ' ' VAL . 18.5 m-80 -72.31 -173.13 1.03 Allowed 'General case' 0 CA--C 1.497 -1.081 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 174.667 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.449 ' HB2' HD11 ' A' ' 84' ' ' LEU . 50.5 p90 -170.87 143.46 2.06 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 114.286 1.217 . . . . 0.0 114.286 178.326 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.429 ' HG3' HD12 ' A' ' 87' ' ' LEU . 52.8 mt-10 -133.11 173.34 11.53 Favored 'General case' 0 C--N 1.288 -2.074 0 C-N-CA 127.479 2.312 . . . . 0.0 105.021 174.393 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 47.2 p90 -148.45 149.54 31.89 Favored 'General case' 0 C--N 1.29 -2.017 0 CA-C-N 118.904 0.775 . . . . 0.0 110.544 178.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.709 ' OD1' ' HB ' ' A' ' 81' ' ' THR . 5.5 p30 -87.91 158.07 18.79 Favored 'General case' 0 C--N 1.306 -1.301 0 C-N-CA 119.682 -0.807 . . . . 0.0 111.109 174.507 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -82.59 -66.86 0.84 Allowed 'General case' 0 C--N 1.28 -2.454 0 N-CA-C 115.915 1.82 . . . . 0.0 115.915 -170.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.69 -21.3 63.52 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.832 -173.074 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.709 ' HB ' ' OD1' ' A' ' 78' ' ' ASP . 85.0 m -101.57 -51.01 3.56 Favored 'General case' 0 N--CA 1.408 -2.546 0 CA-C-N 114.973 -1.012 . . . . 0.0 110.52 -178.212 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.566 ' HA ' ' O ' ' A' ' 78' ' ' ASP . 39.6 mtpt 77.39 31.13 0.48 Allowed 'General case' 0 C--O 1.243 0.757 0 C-N-CA 125.959 1.703 . . . . 0.0 112.438 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.482 ' CG ' HG22 ' A' ' 109' ' ' THR . 16.4 tptm -88.8 139.3 30.6 Favored 'General case' 0 N--CA 1.404 -2.767 0 N-CA-C 106.007 -1.849 . . . . 0.0 106.007 175.845 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.593 ' O ' ' HA ' ' A' ' 109' ' ' THR . 16.0 tp -76.07 135.57 39.89 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 -176.587 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 3.0 t -124.86 111.57 15.64 Favored 'General case' 0 C--N 1.272 -2.777 0 CA-C-O 121.927 0.87 . . . . 0.0 109.915 178.073 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.514 HG13 ' O ' ' A' ' 74' ' ' ASN . 86.7 t -92.01 124.65 44.57 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.691 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.675 -177.501 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.499 ' H ' HD11 ' A' ' 87' ' ' LEU . 0.0 OUTLIER -90.48 117.77 29.43 Favored 'General case' 0 N--CA 1.398 -3.064 0 CA-C-N 114.944 -1.026 . . . . 0.0 108.754 176.497 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.635 HG23 ' NH1' ' A' ' 166' ' ' ARG . 48.8 mt -117.82 120.29 32.94 Favored Pre-proline 0 C--N 1.277 -2.576 0 CA-C-N 114.122 -1.399 . . . . 0.0 107.926 -175.629 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -58.19 91.36 0.06 OUTLIER 'Trans proline' 0 C--N 1.358 1.053 0 C-N-CA 123.794 2.996 . . . . 0.0 113.475 -177.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 70.0 m 73.39 -169.92 0.12 Allowed 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.003 0.921 . . . . 0.0 112.205 -179.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.497 HG12 ' HA ' ' A' ' 105' ' ' THR . 66.5 mt -102.58 150.04 6.67 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.12 0 CA-C-O 120.722 0.296 . . . . 0.0 110.344 178.677 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 23.5 p -141.4 141.44 33.76 Favored 'General case' 0 CA--C 1.48 -1.734 0 N-CA-C 105.715 -1.957 . . . . 0.0 105.715 168.296 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.471 ' HB3' ' HA ' ' A' ' 103' ' ' LYS . 7.9 pt-20 -150.16 168.19 24.68 Favored 'General case' 0 C--N 1.259 -3.356 0 O-C-N 123.508 0.505 . . . . 0.0 111.022 177.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.463 ' O ' ' HA ' ' A' ' 101' ' ' VAL . 5.2 p -137.33 123.9 28.51 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.158 0 C-N-CA 120.587 -0.445 . . . . 0.0 111.34 -172.637 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -137.03 113.27 1.01 Allowed Glycine 0 N--CA 1.433 -1.542 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 177.306 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . 0.414 ' C ' ' H ' ' A' ' 98' ' ' ASP . 48.7 t80 -149.4 -166.77 2.64 Favored 'General case' 0 N--CA 1.411 -2.414 0 N-CA-C 103.145 -2.909 . . . . 0.0 103.145 -176.848 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.55 6.62 9.99 Favored 'General case' 0 C--N 1.289 -2.04 0 CA-C-N 119.009 0.822 . . . . 0.0 109.743 174.861 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.414 ' H ' ' C ' ' A' ' 96' ' ' TYR . 20.8 t70 -68.05 -20.11 64.94 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-N 115.05 -0.977 . . . . 0.0 111.875 -174.216 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.628 ' O ' ' HA ' ' A' ' 127' ' ' VAL . 33.1 t 72.83 20.34 3.64 Favored 'General case' 0 C--N 1.347 0.458 0 C-N-CA 123.638 0.775 . . . . 0.0 109.498 177.509 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 20.3 m -126.31 94.75 4.16 Favored 'General case' 0 N--CA 1.406 -2.626 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 -179.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.463 ' HA ' ' O ' ' A' ' 94' ' ' VAL . 7.6 p -113.69 103.13 14.9 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.355 0 CA-C-O 121.889 0.852 . . . . 0.0 110.497 176.853 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.422 ' HG ' ' CG2' ' A' ' 125' ' ' THR . 4.3 mp -116.92 134.15 55.12 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 114.698 -1.137 . . . . 0.0 109.001 -177.587 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.471 ' HA ' ' HB3' ' A' ' 93' ' ' GLU . 4.4 ttmp? -103.01 111.95 24.55 Favored 'General case' 0 C--N 1.312 -1.046 0 N-CA-C 109.57 -0.529 . . . . 0.0 109.57 175.824 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.448 ' O ' ' HA ' ' A' ' 91' ' ' ILE . 98.3 m-85 -95.34 101.45 13.18 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 176.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.497 ' HA ' HG12 ' A' ' 91' ' ' ILE . 14.7 t -87.56 179.7 6.49 Favored 'General case' 0 N--CA 1.443 -0.784 0 O-C-N 123.63 0.581 . . . . 0.0 111.612 -173.732 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' THR . . . . . 0.44 ' HA ' ' O ' ' A' ' 88' ' ' ILE . 37.3 p -67.6 -35.66 79.4 Favored 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 124.051 0.94 . . . . 0.0 113.293 -176.322 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 27.8 p -133.13 110.2 10.01 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-O 120.811 0.339 . . . . 0.0 111.14 178.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 61.5 t -109.6 131.38 60.65 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.699 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 176.067 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.593 ' HA ' ' O ' ' A' ' 84' ' ' LEU . 11.5 m -114.15 122.01 45.52 Favored 'General case' 0 N--CA 1.42 -1.962 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 -172.094 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . 0.543 ' HA3' ' O ' ' A' ' 119' ' ' ASP . . . -155.16 -158.42 8.74 Favored Glycine 0 N--CA 1.442 -0.904 0 C-N-CA 120.305 -0.95 . . . . 0.0 114.058 -175.654 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 78.7 t60 -120.09 127.17 52.3 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-O 121.337 0.589 . . . . 0.0 110.532 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.462 ' HA ' HD22 ' A' ' 117' ' ' LEU . 1.2 tt -95.35 128.08 41.91 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 115.542 -0.753 . . . . 0.0 109.675 -174.571 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . 0.516 ' HB2' ' O ' ' A' ' 116' ' ' LYS . 35.1 mm-40 -131.04 165.31 23.5 Favored 'General case' 0 CA--C 1.495 -1.144 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 171.736 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 57.2 tptt -84.15 101.36 11.78 Favored 'General case' 0 N--CA 1.414 -2.243 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 178.401 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . 0.681 ' O ' ' HB ' ' A' ' 138' ' ' THR . . . 120.18 -56.54 0.59 Allowed Glycine 0 N--CA 1.418 -2.51 0 C-N-CA 120.027 -1.082 . . . . 0.0 111.494 179.547 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.516 ' O ' ' HB2' ' A' ' 113' ' ' GLU . 0.0 OUTLIER -126.23 127.51 45.76 Favored 'General case' 0 C--N 1.298 -1.654 0 CA-C-O 121.577 0.704 . . . . 0.0 112.542 -177.663 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.462 HD22 ' HA ' ' A' ' 112' ' ' LEU . 1.8 tm? -100.95 107.54 19.05 Favored 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 106.989 -1.485 . . . . 0.0 106.989 -176.69 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.478 ' HA ' ' HB2' ' A' ' 135' ' ' SER . 12.4 p -110.47 153.63 24.78 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 -178.559 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . 0.543 ' O ' ' HA3' ' A' ' 110' ' ' GLY . 20.7 m-20 69.53 115.92 0.04 OUTLIER 'General case' 0 C--O 1.206 -1.224 0 C-N-CA 124.379 1.071 . . . . 0.0 109.828 -174.836 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 8.5 m -140.37 85.38 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.115 0 CA-C-O 122.398 1.094 . . . . 0.0 111.312 179.258 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -79.05 101.95 8.11 Favored 'General case' 0 C--N 1.289 -2.026 0 CA-C-N 114.474 -1.239 . . . . 0.0 107.8 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 139.38 -22.48 2.88 Favored Glycine 0 C--N 1.297 -1.608 0 N-CA-C 110.525 -1.03 . . . . 0.0 110.525 -177.371 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 89.9 mt -100.09 107.71 21.45 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.059 0 CA-C-O 121.918 0.866 . . . . 0.0 109.403 178.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 57.5 mttp -107.1 122.9 47.41 Favored 'General case' 0 C--N 1.288 -2.104 0 CA-C-N 114.304 -1.317 . . . . 0.0 108.756 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.422 ' CG2' ' HG ' ' A' ' 102' ' ' LEU . 72.1 m -130.89 130.04 43.03 Favored 'General case' 0 N--CA 1.431 -1.385 0 O-C-N 123.851 0.72 . . . . 0.0 112.633 -172.298 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.543 ' HD3' ' C ' ' A' ' 126' ' ' LYS . 0.4 OUTLIER -113.48 126.52 55.41 Favored 'General case' 0 N--CA 1.42 -1.962 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 167.996 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.628 ' HA ' ' O ' ' A' ' 99' ' ' SER . 2.3 p -135.74 -65.05 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.873 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.517 177.239 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' MET . . . . . 0.56 ' SD ' HG13 ' A' ' 127' ' ' VAL . 0.0 OUTLIER -106.59 -29.76 9.44 Favored 'General case' 0 N--CA 1.399 -3.017 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 177.556 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 42.5 mm -148.92 162.31 5.05 Favored 'Isoleucine or valine' 0 C--O 1.248 1.0 0 N-CA-C 104.315 -2.476 . . . . 0.0 104.315 177.135 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 87.4 t90 -81.47 117.46 21.91 Favored 'General case' 0 N--CA 1.443 -0.786 0 N-CA-C 108.234 -1.025 . . . . 0.0 108.234 175.208 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.483 HG11 ' H ' ' A' ' 133' ' ' VAL . 47.5 t -123.04 141.64 42.62 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.903 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 -177.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 64.4 pttt -100.85 21.95 12.84 Favored 'General case' 0 C--N 1.306 -1.306 0 C-N-CA 119.326 -0.949 . . . . 0.0 111.876 -177.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.483 ' H ' HG11 ' A' ' 131' ' ' VAL . 61.5 t -133.82 -82.12 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 C-N-CA 120.712 -0.395 . . . . 0.0 110.548 176.768 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' THR . . . . . 0.472 ' O ' ' HB ' ' A' ' 146' ' ' THR . 70.5 p 49.9 76.93 0.12 Allowed 'General case' 0 CA--C 1.536 0.414 0 CA-C-O 121.619 0.724 . . . . 0.0 111.097 -171.184 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' SER . . . . . 0.594 ' O ' ' HA ' ' A' ' 146' ' ' THR . 12.5 p -83.15 153.85 24.59 Favored 'General case' 0 N--CA 1.431 -1.391 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 -176.257 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 14.5 tt -100.84 128.89 52.53 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.396 0 CA-C-O 121.891 0.853 . . . . 0.0 112.259 -170.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 19.8 m -101.3 147.52 26.21 Favored 'General case' 0 N--CA 1.421 -1.894 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 178.081 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' THR . . . . . 0.681 ' HB ' ' O ' ' A' ' 115' ' ' GLY . 98.8 m -155.77 152.31 28.32 Favored 'General case' 0 C--N 1.284 -2.247 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 -178.301 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 73.5 m-20 -87.36 23.07 1.97 Allowed 'General case' 0 N--CA 1.482 1.162 0 O-C-N 121.597 -0.69 . . . . 0.0 109.965 176.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . 61.47 35.95 17.39 Favored 'General case' 0 C--N 1.351 0.631 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 -170.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' SER . . . . . 0.435 ' H ' HG22 ' A' ' 138' ' ' THR . 43.3 t -173.87 -79.18 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 113.972 -1.467 . . . . 0.0 109.492 -173.812 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . 0.456 ' O ' HG21 ' A' ' 138' ' ' THR . 97.9 mttt -88.0 151.46 22.76 Favored 'General case' 0 CA--C 1.509 -0.631 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 -179.48 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.448 ' O ' ' HB3' ' A' ' 152' ' ' SER . 24.4 t -105.97 136.78 38.99 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 O-C-N 123.545 0.528 . . . . 0.0 111.442 -167.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -124.5 155.56 38.74 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-O 120.833 0.349 . . . . 0.0 111.527 -177.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 35.3 p90 -45.93 148.34 0.83 Allowed 'General case' 0 C--O 1.243 0.737 0 N-CA-C 115.346 1.609 . . . . 0.0 115.346 -178.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.594 ' HA ' ' O ' ' A' ' 135' ' ' SER . 69.3 p -93.05 -16.02 25.47 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-N 114.915 -1.038 . . . . 0.0 110.973 179.176 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -136.36 149.17 48.23 Favored 'General case' 0 N--CA 1.441 -0.876 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 -177.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -83.04 74.71 2.49 Favored Glycine 0 CA--C 1.497 -1.037 0 N-CA-C 111.289 -0.725 . . . . 0.0 111.289 -176.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 1.3 tmt? 174.5 -36.27 0.0 OUTLIER 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 105.87 -1.9 . . . . 0.0 105.87 -177.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 22.8 ttmm -75.43 168.49 19.9 Favored 'General case' 0 N--CA 1.411 -2.425 0 CA-C-N 112.469 -2.15 . . . . 0.0 109.074 -179.141 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 61.0 mttp -119.92 164.03 16.67 Favored 'General case' 0 C--N 1.31 -1.133 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 -171.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' SER . . . . . 0.448 ' HB3' ' O ' ' A' ' 143' ' ' VAL . 35.6 m -85.82 160.86 19.36 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 115.398 -0.819 . . . . 0.0 112.806 -175.69 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' ARG . . . . . 0.424 ' HG2' ' H ' ' A' ' 161' ' ' GLN . 12.0 mpt_? -126.56 164.2 21.73 Favored 'General case' 0 CA--C 1.516 -0.351 0 C-N-CA 123.571 0.748 . . . . 0.0 111.282 -179.883 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 35.0 m -94.38 145.3 24.86 Favored 'General case' 0 C--N 1.296 -1.748 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.784 177.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -61.16 -37.46 82.98 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 176.47 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -58.3 -26.16 62.69 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 123.749 0.82 . . . . 0.0 111.656 177.445 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . 0.418 ' O ' ' HB2' ' A' ' 158' ' ' TYR . . . -79.56 1.21 26.77 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 115.692 -0.685 . . . . 0.0 112.017 -177.608 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . 0.418 ' HB2' ' O ' ' A' ' 157' ' ' ALA . 88.7 m-85 93.54 20.94 0.02 OUTLIER 'General case' 0 CA--C 1.493 -1.241 0 C-N-CA 125.888 1.675 . . . . 0.0 111.189 -176.432 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . 0.668 ' HA3' ' O ' ' A' ' 65' ' ' ILE . . . 87.04 -86.04 1.54 Allowed Glycine 0 N--CA 1.408 -3.219 0 CA-C-N 114.757 -1.111 . . . . 0.0 113.115 175.645 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.466 ' HB ' ' O ' ' A' ' 67' ' ' ILE . 6.8 t -104.57 116.48 48.44 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.138 0 C-N-CA 119.849 -0.74 . . . . 0.0 109.686 -174.758 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' GLN . . . . . 0.424 ' H ' ' HG2' ' A' ' 153' ' ' ARG . 12.5 mm-40 -116.33 99.87 7.5 Favored 'General case' 0 CA--C 1.486 -1.505 0 N-CA-C 116.521 2.045 . . . . 0.0 116.521 -174.847 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . 0.559 ' HA ' ' NE ' ' A' ' 162' ' ' ARG . 1.5 tpm_? -152.66 105.23 2.96 Favored 'General case' 0 N--CA 1.4 -2.933 0 N-CA-C 105.504 -2.035 . . . . 0.0 105.504 170.886 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 19.0 m120 -45.63 104.12 0.04 OUTLIER 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 115.875 1.806 . . . . 0.0 115.875 -172.403 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -151.66 156.21 26.56 Favored Glycine 0 N--CA 1.435 -1.425 0 N-CA-C 108.449 -1.86 . . . . 0.0 108.449 176.18 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -128.19 135.47 49.77 Favored 'General case' 0 N--CA 1.429 -1.508 0 CA-C-N 118.025 0.913 . . . . 0.0 109.929 -179.296 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . 0.635 ' NH1' HG23 ' A' ' 88' ' ' ILE . 3.1 mmp_? -65.76 122.44 17.31 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 106.496 -1.668 . . . . 0.0 106.496 179.541 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 25.1 t -74.18 61.99 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.559 1.308 0 CA-C-O 122.615 1.197 . . . . 0.0 109.596 175.256 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -165.83 -33.82 0.03 OUTLIER 'General case' 0 C--N 1.296 -1.735 0 C-N-CA 126.457 1.903 . . . . 0.0 106.742 -177.237 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 16.4 tppt? -76.37 110.47 10.93 Favored 'General case' 0 N--CA 1.434 -1.25 0 CA-C-N 114.349 -1.296 . . . . 0.0 111.932 -177.153 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' PHE . . . . . . . . . . . . . 69.7 t80 . . . . . 0 N--CA 1.432 -1.352 0 N-CA-C 106.456 -1.683 . . . . 0.0 106.456 176.588 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 58.0 p . . . . . 0 C--O 1.247 0.966 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -137.94 89.78 2.43 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 116.7 -0.227 . . . . 0.0 111.031 179.27 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 5.5 pm0 -154.48 148.88 26.16 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 177.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 6.9 tp -139.47 118.85 13.12 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.181 0 CA-C-O 121.157 0.503 . . . . 0.0 110.009 178.101 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 83.7 m-85 -104.73 126.18 51.55 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.198 0.523 . . . . 0.0 111.074 -179.018 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -123.33 136.25 54.58 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 115.298 -0.865 . . . . 0.0 109.134 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -138.56 95.88 3.06 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-O 120.692 0.282 . . . . 0.0 111.35 -178.774 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 11.6 p 173.41 146.55 0.02 OUTLIER 'Isoleucine or valine' 0 C--O 1.237 0.425 0 C-N-CA 124.566 1.146 . . . . 0.0 108.501 177.209 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -137.84 -167.95 11.19 Favored Glycine 0 N--CA 1.429 -1.8 0 N-CA-C 110.125 -1.19 . . . . 0.0 110.125 178.549 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 41.6 t -84.19 100.62 11.29 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 178.556 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 76.2 t80 -131.66 100.58 5.17 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 -179.154 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 88.8 m95 -136.66 139.09 41.76 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.068 -177.269 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 5.6 mp -107.95 136.06 48.28 Favored 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 177.281 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -127.21 138.4 10.5 Favored Glycine 0 N--CA 1.432 -1.605 0 C-N-CA 120.648 -0.787 . . . . 0.0 111.56 179.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 16.3 tm0? -153.79 110.73 3.4 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 178.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 59.4 pttt -140.19 80.33 1.76 Allowed 'General case' 0 C--N 1.296 -1.751 0 CA-C-O 121.991 0.9 . . . . 0.0 109.549 175.078 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -147.48 88.81 1.73 Allowed 'General case' 0 C--N 1.299 -1.62 0 CA-C-N 115.009 -0.996 . . . . 0.0 109.777 -178.232 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -143.29 94.17 2.58 Favored 'General case' 0 C--N 1.286 -2.17 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 177.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 61.9 tttp -82.28 99.61 9.43 Favored 'General case' 0 N--CA 1.422 -1.847 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.642 -179.577 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 47.3 tt0 -58.1 -64.1 1.03 Allowed 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.257 -0.883 . . . . 0.0 109.754 177.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 85.6 t80 57.86 90.4 0.04 OUTLIER 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 114.966 1.469 . . . . 0.0 114.966 175.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -143.98 136.54 26.97 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 105.983 -1.858 . . . . 0.0 105.983 169.764 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 25.8 t -150.55 110.88 4.18 Favored 'General case' 0 C--N 1.293 -1.863 0 C-N-CA 120.275 -0.57 . . . . 0.0 110.382 -176.428 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 10.8 p -103.75 -17.03 7.4 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 CA-C-O 122.068 0.937 . . . . 0.0 108.507 177.54 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 90.55 -125.1 7.79 Favored Glycine 0 N--CA 1.419 -2.445 0 CA-C-N 114.885 -1.052 . . . . 0.0 111.367 -179.409 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -152.93 -62.16 0.15 Allowed 'General case' 0 C--N 1.31 -1.144 0 CA-C-O 119.744 -0.17 . . . . 0.0 110.839 179.581 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -153.53 -78.53 0.1 Allowed 'General case' 0 CA--C 1.518 -0.277 0 C-N-CA 119.774 -0.77 . . . . 0.0 112.872 177.436 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.479 ' O ' HD12 ' A' ' 28' ' ' LEU . 2.6 tm? -115.89 -28.9 6.53 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 -177.671 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 43.1 t-20 77.2 -55.01 0.55 Allowed 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 124.483 1.113 . . . . 0.0 111.991 176.204 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 25.4 m -71.33 109.55 5.41 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-O 121.315 0.578 . . . . 0.0 111.914 -177.732 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 12.3 p -109.02 -15.42 9.49 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.043 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 175.071 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 35.6 t 77.0 129.7 0.05 OUTLIER 'General case' 0 C--O 1.24 0.604 0 C-N-CA 125.468 1.507 . . . . 0.0 112.271 179.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 91.0 m -155.14 128.73 8.52 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.431 -0.804 . . . . 0.0 108.996 179.062 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 44.4 p -139.05 114.45 9.71 Favored 'General case' 0 C--N 1.311 -1.085 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 178.392 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 67.9 mt -128.48 119.19 49.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 O-C-N 122.416 -0.177 . . . . 0.0 110.546 -176.48 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -134.48 160.03 39.27 Favored 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 179.349 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -84.55 -70.8 1.33 Allowed Glycine 0 N--CA 1.428 -1.839 0 N-CA-C 108.433 -1.867 . . . . 0.0 108.433 172.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 108.33 -111.61 3.37 Favored Glycine 0 N--CA 1.426 -2.02 0 C-N-CA 120.806 -0.711 . . . . 0.0 113.073 175.25 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 27.3 p -81.15 146.83 30.34 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 -175.231 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 64.9 mttp -143.28 123.29 13.58 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 175.596 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.409 ' C ' HD12 ' A' ' 42' ' ' LEU . 88.6 t90 -125.99 126.96 45.16 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 179.883 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.409 HD12 ' C ' ' A' ' 41' ' ' TRP . 5.2 mp -131.68 152.3 50.98 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.2 p -108.15 130.77 60.12 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 175.6 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 56.9 t30 -165.08 168.91 16.83 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 -175.688 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.506 ' HB2' ' HZ2' ' A' ' 45' ' ' LYS . 10.3 mtmp? 75.37 118.63 0.05 Allowed 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 125.124 1.37 . . . . 0.0 113.905 175.678 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 60.7 mt 67.64 102.7 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.244 0.777 0 C-N-CA 125.119 1.368 . . . . 0.0 112.207 178.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -128.49 130.11 47.04 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 -179.039 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -96.07 -156.71 31.43 Favored Glycine 0 C--O 1.243 0.707 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.617 -177.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -84.44 91.8 7.91 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.981 0.896 . . . . 0.0 110.066 178.364 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 84.7 mtp -90.69 88.83 7.25 Favored 'General case' 0 C--N 1.298 -1.655 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.405 -177.652 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 28.2 pt20 -128.9 -23.23 3.11 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-N 114.456 -1.247 . . . . 0.0 108.364 177.59 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 62.0 pttt -149.06 160.42 35.05 Favored Pre-proline 0 N--CA 1.425 -1.691 0 N-CA-C 106.251 -1.759 . . . . 0.0 106.251 175.718 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -77.35 -3.74 13.98 Favored 'Trans proline' 0 C--O 1.21 -0.906 0 C-N-CA 122.355 2.036 . . . . 0.0 115.764 -170.723 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.523 ' HB3' ' HD3' ' A' ' 55' ' ' PRO . 14.0 tp -53.5 -50.54 82.5 Favored Pre-proline 0 N--CA 1.495 1.778 0 N-CA-C 113.373 0.879 . . . . 0.0 113.373 -173.572 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.523 ' HD3' ' HB3' ' A' ' 54' ' ' LEU . 80.6 Cg_exo -59.22 -19.99 52.69 Favored 'Trans proline' 0 C--N 1.369 1.607 0 C-N-CA 123.086 2.524 . . . . 0.0 111.544 -178.183 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.416 ' HA ' ' HE2' ' A' ' 59' ' ' LYS . 21.3 mm-40 -81.1 -32.03 34.05 Favored 'General case' 0 N--CA 1.413 -2.312 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 -175.614 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.438 ' HA ' ' HG2' ' A' ' 60' ' ' GLU . 3.8 mm? -75.34 -49.23 19.76 Favored 'General case' 0 CA--C 1.483 -1.617 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.695 177.168 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.427 ' HA ' ' CD1' ' A' ' 75' ' ' TYR 0.323 2.5 pp -61.77 -38.95 89.93 Favored 'General case' 0 C--O 1.21 -1.0 0 C-N-CA 119.375 -0.93 . . . . 0.0 113.032 -176.162 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.416 ' HE2' ' HA ' ' A' ' 56' ' ' GLU . 63.7 pttt -75.5 -26.97 58.57 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 120.017 -0.673 . . . . 0.0 111.002 -179.867 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.438 ' HG2' ' HA ' ' A' ' 57' ' ' LEU . 11.2 pt-20 -79.78 -28.48 40.32 Favored 'General case' 0 C--N 1.351 0.65 0 C-N-CA 119.892 -0.723 . . . . 0.0 110.866 -177.896 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 78.5 m-85 -86.33 -1.58 57.64 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 118.799 -1.16 . . . . 0.0 112.269 175.336 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.448 ' OD2' HD13 ' A' ' 65' ' ' ILE . 15.4 t70 -93.2 -171.91 2.8 Favored 'General case' 0 C--N 1.306 -1.308 0 C-N-CA 125.709 1.603 . . . . 0.0 108.607 178.079 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.462 ' HB2' HD11 ' A' ' 65' ' ' ILE . 17.0 mt -85.47 -153.84 0.0 OUTLIER Pre-proline 0 CA--C 1.576 1.969 0 N-CA-C 103.488 -2.782 . . . . 0.0 103.488 174.175 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.556 ' O ' ' HD2' ' A' ' 155' ' ' ARG . 17.7 Cg_endo -100.87 8.78 0.58 Allowed 'Trans proline' 0 N--CA 1.436 -1.883 0 CA-C-N 123.998 2.464 . . . . 0.0 111.241 176.125 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.597 HG12 ' H ' ' A' ' 67' ' ' ILE . 0.1 OUTLIER -78.69 -38.21 21.5 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.461 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 -176.641 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 60.08 9.39 10.93 Favored Glycine 0 N--CA 1.48 1.579 0 CA-C-O 122.517 1.065 . . . . 0.0 110.702 -176.16 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.695 ' O ' HG12 ' A' ' 160' ' ' VAL . 48.7 mt 63.51 -68.73 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.41 -2.442 0 C-N-CA 128.136 2.574 . . . . 0.0 110.349 -172.516 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.418 ' CD2' ' HD3' ' A' ' 162' ' ' ARG . 91.0 t80 -177.53 -55.72 0.0 OUTLIER Pre-proline 0 C--N 1.308 -1.231 0 N-CA-C 113.702 1.001 . . . . 0.0 113.702 -175.83 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -91.93 -29.31 0.13 Allowed 'Trans proline' 0 C--N 1.361 1.215 0 C-N-CA 121.573 1.516 . . . . 0.0 115.396 -170.083 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 94.22 -16.97 59.82 Favored Glycine 0 N--CA 1.442 -0.943 0 N-CA-C 110.012 -1.235 . . . . 0.0 110.012 -172.009 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.41 ' CB ' ' HG2' ' A' ' 89' ' ' PRO . 30.0 m-20 -78.84 -38.56 37.71 Favored 'General case' 0 CA--C 1.506 -0.726 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 177.617 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.564 ' O ' ' HB ' ' A' ' 73' ' ' THR . . . -78.53 178.61 7.64 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 114.282 -1.326 . . . . 0.0 108.063 170.41 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.564 ' HB ' ' O ' ' A' ' 72' ' ' ALA . 3.0 m 85.25 6.42 0.47 Allowed 'General case' 0 N--CA 1.483 1.182 0 CA-C-O 123.739 1.733 . . . . 0.0 111.534 175.1 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.555 ' O ' ' HA ' ' A' ' 86' ' ' VAL . 0.8 OUTLIER -64.93 132.97 50.78 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-N 114.079 -1.418 . . . . 0.0 110.307 177.603 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.46 ' HB2' HD22 ' A' ' 84' ' ' LEU . 11.5 p90 -108.94 99.21 8.58 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 113.385 0.883 . . . . 0.0 113.385 -173.487 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 58.9 mm-40 -117.69 133.49 55.89 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 174.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 41.2 p90 -144.57 145.24 31.71 Favored 'General case' 0 C--N 1.295 -1.795 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 -179.205 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.471 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 35.3 m-20 -96.02 173.97 7.16 Favored 'General case' 0 CA--C 1.476 -1.87 0 C-N-CA 119.623 -0.831 . . . . 0.0 109.357 178.028 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -79.27 -65.37 1.01 Allowed 'General case' 0 C--N 1.283 -2.319 0 CA-C-N 114.784 -1.098 . . . . 0.0 111.843 -176.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -74.91 -29.75 61.07 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.112 -175.451 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.48 HG23 ' HB3' ' A' ' 83' ' ' LYS . 17.5 m -65.41 -43.27 91.1 Favored 'General case' 0 N--CA 1.428 -1.526 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.581 179.605 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 46.6 mmtm 61.16 14.49 5.55 Favored 'General case' 0 N--CA 1.495 1.778 0 C-N-CA 123.409 0.684 . . . . 0.0 112.098 -177.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.596 ' CD ' HG22 ' A' ' 109' ' ' THR . 31.5 ttmt -116.38 128.4 55.48 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-O 121.247 0.546 . . . . 0.0 110.531 -176.13 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.46 HD22 ' HB2' ' A' ' 75' ' ' TYR . 2.0 tm? -84.65 126.67 33.56 Favored 'General case' 0 C--N 1.296 -1.72 0 CA-C-N 114.388 -1.278 . . . . 0.0 109.163 -173.625 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.518 ' HA ' ' O ' ' A' ' 108' ' ' VAL . 68.1 p -107.06 115.08 29.56 Favored 'General case' 0 N--CA 1.409 -2.483 0 CA-C-N 115.474 -0.785 . . . . 0.0 109.41 178.327 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.555 ' HA ' ' O ' ' A' ' 74' ' ' ASN . 58.6 t -92.57 120.69 42.3 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 179.384 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 5.3 mp -83.34 103.14 12.49 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-O 121.472 0.653 . . . . 0.0 109.467 -179.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.491 ' O ' ' HA ' ' A' ' 106' ' ' THR . 46.7 mm -83.34 115.2 58.0 Favored Pre-proline 0 N--CA 1.412 -2.338 0 N-CA-C 104.793 -2.299 . . . . 0.0 104.793 171.915 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.41 ' HG2' ' CB ' ' A' ' 71' ' ' ASP . 1.0 OUTLIER -37.46 -41.18 0.91 Allowed 'Trans proline' 0 N--CA 1.485 1.017 0 C-N-CA 125.146 3.897 . . . . 0.0 115.715 -175.047 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.439 ' HB2' ' HB2' ' A' ' 168' ' ' ASP . 47.9 t -157.15 166.1 34.17 Favored 'General case' 0 C--N 1.284 -2.268 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 6.0 tt -71.81 119.83 19.0 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.336 0 CA-C-O 121.642 0.734 . . . . 0.0 109.883 179.763 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' CYS . . . . . 0.448 ' SG ' ' HB2' ' A' ' 104' ' ' PHE . 19.0 p -115.97 123.42 47.99 Favored 'General case' 0 C--N 1.29 -1.995 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 174.383 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -103.66 111.33 23.76 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 107.019 -1.475 . . . . 0.0 107.019 175.532 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.486 HG21 ' HA ' ' A' ' 162' ' ' ARG . 5.2 p -108.5 102.65 14.3 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.03 0 C-N-CA 118.812 -1.155 . . . . 0.0 113.925 -178.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -144.82 113.0 0.69 Allowed Glycine 0 N--CA 1.431 -1.639 0 N-CA-C 108.102 -1.999 . . . . 0.0 108.102 176.075 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 43.2 t80 174.31 -51.02 0.01 OUTLIER 'General case' 0 CA--C 1.503 -0.861 0 CA-C-O 122.884 1.325 . . . . 0.0 108.34 -172.323 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.34 8.6 18.12 Favored 'General case' 0 C--N 1.294 -1.825 0 CA-C-N 112.865 -1.97 . . . . 0.0 113.644 -168.486 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -158.55 -79.09 0.07 Allowed 'General case' 0 C--N 1.315 -0.926 0 C-N-CA 119.583 -0.847 . . . . 0.0 111.86 -174.32 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 34.6 t 165.9 -38.66 0.0 OUTLIER 'General case' 0 C--N 1.31 -1.143 0 N-CA-C 104.296 -2.483 . . . . 0.0 104.296 -176.378 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 14.1 m -71.71 125.24 26.62 Favored 'General case' 0 N--CA 1.42 -1.958 0 CA-C-N 113.659 -1.61 . . . . 0.0 109.664 177.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 46.3 t -105.62 116.22 48.97 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.085 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 179.154 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.537 ' HG ' ' CG2' ' A' ' 125' ' ' THR . 5.5 mp -114.42 121.16 42.71 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 110.198 -0.297 . . . . 0.0 110.198 -176.54 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -111.32 109.12 18.98 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-O 121.571 0.701 . . . . 0.0 110.95 178.677 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.448 ' HB2' ' SG ' ' A' ' 92' ' ' CYS . 94.5 m-85 -91.02 125.33 35.78 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 114.825 -1.079 . . . . 0.0 108.5 179.28 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.469 ' O ' HG12 ' A' ' 108' ' ' VAL . 13.2 m -100.16 147.32 25.82 Favored 'General case' 0 C--N 1.294 -1.817 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.642 -175.155 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' THR . . . . . 0.491 ' HA ' ' O ' ' A' ' 88' ' ' ILE . 14.9 m -56.81 120.82 8.52 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 172.65 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 39.0 m 66.14 78.28 0.27 Allowed 'General case' 0 C--N 1.308 -1.198 0 CA-C-O 122.038 0.923 . . . . 0.0 111.676 -177.461 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.518 ' O ' ' HA ' ' A' ' 85' ' ' THR . 3.7 m -93.45 133.17 35.46 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.161 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.391 175.146 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.596 HG22 ' CD ' ' A' ' 83' ' ' LYS 0.26 7.8 m -105.56 118.0 35.46 Favored 'General case' 0 N--CA 1.406 -2.626 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 -168.239 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . 0.519 ' HA2' ' O ' ' A' ' 119' ' ' ASP . . . -157.97 167.88 34.38 Favored Glycine 0 CA--C 1.494 -1.27 0 C-N-CA 119.945 -1.122 . . . . 0.0 113.316 -177.73 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 14.2 t-80 -90.91 101.89 14.65 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 179.788 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 68.0 tp -96.73 109.02 21.76 Favored 'General case' 0 CA--C 1.484 -1.577 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.739 -174.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -106.15 156.5 18.38 Favored 'General case' 0 CA--C 1.448 -2.96 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 173.037 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 1.6 tmtm? -79.55 100.7 7.89 Favored 'General case' 0 N--CA 1.384 -3.772 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 -176.344 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 138.31 -51.8 0.76 Allowed Glycine 0 C--N 1.296 -1.691 0 N-CA-C 108.419 -1.872 . . . . 0.0 108.419 -174.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.457 ' HB2' ' HA ' ' A' ' 137' ' ' SER . 0.0 OUTLIER -140.83 137.28 33.16 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-O 121.43 0.633 . . . . 0.0 112.149 -179.013 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.529 ' O ' ' HB3' ' A' ' 135' ' ' SER . 46.3 tp -102.25 105.8 16.51 Favored 'General case' 0 C--N 1.305 -1.326 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 175.275 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.469 ' HA ' ' HB3' ' A' ' 135' ' ' SER . 27.7 p -120.53 145.93 46.81 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 112.505 0.557 . . . . 0.0 112.505 -173.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . 0.519 ' O ' ' HA2' ' A' ' 110' ' ' GLY . 34.5 t70 64.4 87.96 0.11 Allowed 'General case' 0 C--O 1.215 -0.715 0 O-C-N 124.117 0.885 . . . . 0.0 110.096 -179.468 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.409 HG12 ' HA3' ' A' ' 110' ' ' GLY . 3.1 m -124.89 104.31 13.48 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.489 0 CA-C-O 122.671 1.224 . . . . 0.0 112.081 -172.779 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -86.41 100.88 12.65 Favored 'General case' 0 C--N 1.26 -3.313 0 CA-C-N 113.292 -1.776 . . . . 0.0 108.401 178.344 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 139.7 -15.5 3.12 Favored Glycine 0 N--CA 1.428 -1.871 0 CA-C-N 115.209 -0.905 . . . . 0.0 112.347 178.729 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 65.3 mt -99.28 102.76 13.83 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.23 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 178.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -106.13 119.26 38.75 Favored 'General case' 0 C--N 1.282 -2.352 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 -176.51 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.537 ' CG2' ' HG ' ' A' ' 102' ' ' LEU . 49.7 m -139.64 148.43 42.43 Favored 'General case' 0 C--N 1.293 -1.878 0 CA-C-N 115.429 -0.805 . . . . 0.0 112.671 -168.917 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.406 ' HA ' ' HA ' ' A' ' 130' ' ' TRP . 40.9 tttp -108.11 122.24 46.49 Favored 'General case' 0 N--CA 1.424 -1.74 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 172.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.411 ' CG1' ' HB3' ' A' ' 150' ' ' LYS . 15.9 t -138.56 101.15 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.208 0 N-CA-C 104.142 -2.54 . . . . 0.0 104.142 169.663 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' MET . . . . . 0.405 ' HB3' ' O ' ' A' ' 127' ' ' VAL . 0.6 OUTLIER 73.67 -52.88 0.7 Allowed 'General case' 0 CA--C 1.544 0.729 0 O-C-N 124.305 1.003 . . . . 0.0 108.594 -171.075 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 9.0 tp -137.51 158.65 34.8 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.264 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 176.615 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' TRP . . . . . 0.406 ' HA ' ' HA ' ' A' ' 126' ' ' LYS . 42.6 t-105 -78.2 122.31 25.51 Favored 'General case' 0 C--O 1.241 0.644 0 CA-C-O 121.185 0.517 . . . . 0.0 110.708 -179.135 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 48.5 t -125.06 132.05 71.76 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 177.619 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 63.1 pttt -88.85 28.6 1.13 Allowed 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 112.268 0.47 . . . . 0.0 112.268 -176.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 44.7 t -132.74 -78.09 0.15 Allowed 'Isoleucine or valine' 0 C--O 1.214 -0.812 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 -179.059 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 38.5 p 46.89 80.21 0.05 Allowed 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 113.615 0.968 . . . . 0.0 113.615 -179.499 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' SER . . . . . 0.529 ' HB3' ' O ' ' A' ' 117' ' ' LEU . 28.3 m -84.68 153.61 23.0 Favored 'General case' 0 N--CA 1.424 -1.729 0 CA-C-N 115.898 -0.592 . . . . 0.0 112.036 -177.653 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 67.5 mt -100.67 97.91 6.3 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.231 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' SER . . . . . 0.61 ' O ' ' HB2' ' A' ' 144' ' ' TYR . 29.1 t -119.89 126.86 51.96 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-N 115.914 -0.584 . . . . 0.0 109.569 -174.187 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' THR . . . . . 0.405 ' HG1' ' C ' ' A' ' 142' ' ' LYS . 9.3 t -162.12 177.58 9.56 Favored 'General case' 0 N--CA 1.424 -1.747 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 -173.871 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -109.9 75.02 0.92 Allowed 'General case' 0 C--N 1.306 -1.324 0 C-N-CA 120.389 -0.524 . . . . 0.0 109.906 176.356 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . 27.43 72.42 0.04 OUTLIER 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 125.603 1.561 . . . . 0.0 113.994 177.303 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 40.2 t 177.68 -63.59 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 -177.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . 0.405 ' C ' ' HG1' ' A' ' 138' ' ' THR . 96.4 mttt -95.09 -169.65 2.03 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 179.31 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 13.2 p -142.66 123.04 10.52 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.347 0 CA-C-O 121.365 0.603 . . . . 0.0 109.894 177.087 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . 0.61 ' HB2' ' O ' ' A' ' 137' ' ' SER . 94.0 m-85 -128.97 155.61 45.09 Favored 'General case' 0 CA--C 1.487 -1.473 0 CA-C-O 121.41 0.624 . . . . 0.0 110.574 -179.587 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 81.7 m-85 -112.72 113.81 26.1 Favored 'General case' 0 N--CA 1.407 -2.579 0 CA-C-N 114.565 -1.198 . . . . 0.0 109.145 176.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.455 ' CG2' ' HB2' ' A' ' 135' ' ' SER . 9.1 t -79.82 33.41 0.27 Allowed 'General case' 0 CA--C 1.56 1.337 0 CA-C-O 122.115 0.96 . . . . 0.0 111.404 -174.512 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -75.48 -19.67 59.26 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.349 179.368 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 134.02 50.54 0.08 OUTLIER Glycine 0 CA--C 1.475 -2.428 0 N-CA-C 108.987 -1.645 . . . . 0.0 108.987 179.09 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 66.5 mtt 63.64 12.08 6.25 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.102 0.961 . . . . 0.0 111.787 -177.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . 0.411 ' HB3' ' CG1' ' A' ' 127' ' ' VAL . 47.7 mmtm -69.16 -29.83 67.94 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 115.375 -0.83 . . . . 0.0 112.564 -176.585 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 39.9 mmtm -143.88 122.58 12.59 Favored 'General case' 0 CA--C 1.509 -0.629 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 178.557 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 43.8 m -132.46 128.27 37.07 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 106.136 -1.802 . . . . 0.0 106.136 175.232 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' ARG . . . . . 0.453 ' HG2' ' CG ' ' A' ' 161' ' ' GLN . 26.9 tpt180 -146.6 160.41 42.2 Favored 'General case' 0 N--CA 1.429 -1.491 0 C-N-CA 119.084 -1.046 . . . . 0.0 110.942 -172.814 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 13.6 m -90.47 130.25 36.55 Favored 'General case' 0 N--CA 1.419 -1.992 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 174.378 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' ARG . . . . . 0.556 ' HD2' ' O ' ' A' ' 64' ' ' PRO . 8.6 ttp180 -68.29 -24.92 64.92 Favored 'General case' 0 C--N 1.297 -1.678 0 C-N-CA 123.517 0.727 . . . . 0.0 110.455 179.675 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -42.29 -45.71 4.29 Favored 'General case' 0 C--N 1.313 -0.996 0 N-CA-C 115.257 1.577 . . . . 0.0 115.257 -172.106 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -71.55 -52.62 17.25 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 114.438 1.273 . . . . 0.0 114.438 -173.507 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 -141.89 3.8 1.64 Allowed 'General case' 0 N--CA 1.483 1.18 0 N-CA-C 113.029 0.751 . . . . 0.0 113.029 -174.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 90.85 -88.49 1.43 Allowed Glycine 0 C--N 1.304 -1.223 0 N-CA-C 108.935 -1.666 . . . . 0.0 108.935 -173.078 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.695 HG12 ' O ' ' A' ' 67' ' ' ILE . 11.5 p -98.64 177.03 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.556 1.193 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 171.712 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' GLN . . . . . 0.479 ' H ' HG23 ' A' ' 160' ' ' VAL . 14.3 mm100 -108.36 99.29 8.71 Favored 'General case' 0 CA--C 1.463 -2.378 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 -175.553 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . 0.486 ' HA ' HG21 ' A' ' 94' ' ' VAL . 0.0 OUTLIER -132.1 173.18 11.49 Favored 'General case' 0 N--CA 1.393 -3.287 0 C-N-CA 119.283 -0.967 . . . . 0.0 113.148 -174.722 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 21.9 t-20 -152.76 -48.69 0.1 Allowed 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 106.359 -1.719 . . . . 0.0 106.359 179.55 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -64.0 147.27 50.73 Favored Glycine 0 C--O 1.254 1.373 0 CA-C-N 114.566 -1.197 . . . . 0.0 110.546 170.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.431 ' H ' HD21 ' A' ' 165' ' ' LEU . 1.9 pt? -124.65 154.9 40.05 Favored 'General case' 0 C--N 1.291 -1.973 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 -176.874 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . 0.512 ' HD2' ' N ' ' A' ' 166' ' ' ARG . 5.2 mpt_? -76.43 114.98 15.74 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 -179.219 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 18.2 m -80.75 54.07 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.286 -2.191 0 CA-C-O 122.479 1.133 . . . . 0.0 112.827 -177.335 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . 0.439 ' HB2' ' HB2' ' A' ' 90' ' ' SER . 14.8 t70 -109.94 -39.32 5.1 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 114.069 -1.423 . . . . 0.0 107.766 176.908 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 27.8 ttpp -107.22 8.92 30.23 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 114.012 -1.449 . . . . 0.0 108.749 -177.05 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' PHE . . . . . . . . . . . . . 84.5 t80 . . . . . 0 C--N 1.306 -1.291 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 -178.464 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 30.4 m . . . . . 0 C--O 1.237 0.432 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -128.08 99.31 5.43 Favored 'General case' 0 CA--C 1.5 -0.967 0 CA-C-O 120.722 0.296 . . . . 0.0 110.786 179.458 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -100.85 97.37 7.99 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 175.581 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.1 mp -89.84 104.96 15.64 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 177.352 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 44.0 p90 -120.44 120.65 36.52 Favored 'General case' 0 C--N 1.299 -1.613 0 CA-C-O 121.122 0.487 . . . . 0.0 110.743 -179.503 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 38.7 t30 -142.28 88.12 2.07 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-O 121.544 0.688 . . . . 0.0 110.504 178.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 54.2 mtpt -138.3 20.63 2.77 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 114.922 -1.036 . . . . 0.0 108.254 177.733 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 43.5 t -93.69 134.7 30.5 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.196 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.173 -176.224 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 102.86 117.18 4.29 Favored Glycine 0 N--CA 1.435 -1.387 0 C-N-CA 121.04 -0.6 . . . . 0.0 111.793 179.229 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 23.0 t -120.06 97.35 5.56 Favored 'General case' 0 N--CA 1.431 -1.404 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 178.542 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 81.3 t80 -101.56 127.59 48.2 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.103 -175.426 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 67.1 m95 -131.96 123.81 28.12 Favored 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 -178.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.446 HD21 ' H ' ' A' ' 15' ' ' GLN . 6.0 tt -83.36 110.83 18.47 Favored 'General case' 0 C--N 1.31 -1.132 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 179.32 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -118.01 35.04 4.21 Favored Glycine 0 N--CA 1.442 -0.966 0 CA-C-N 115.944 -0.571 . . . . 0.0 112.057 -176.714 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.446 ' H ' HD21 ' A' ' 13' ' ' LEU . 57.8 tt0 -83.69 115.86 22.38 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 177.216 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 63.2 tttp -105.81 94.95 5.47 Favored 'General case' 0 N--CA 1.424 -1.759 0 N-CA-C 109.797 -0.445 . . . . 0.0 109.797 179.362 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -88.72 90.83 8.57 Favored 'General case' 0 N--CA 1.436 -1.164 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 176.221 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -165.48 131.18 2.59 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 115.219 -0.9 . . . . 0.0 109.729 -176.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 25.0 pttm -129.85 176.56 7.94 Favored 'General case' 0 C--N 1.292 -1.921 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 178.179 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -115.4 150.84 35.75 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 -179.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 80.4 t80 76.63 108.14 0.08 Allowed 'General case' 0 C--O 1.236 0.359 0 C-N-CA 125.165 1.386 . . . . 0.0 112.303 179.641 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -146.42 125.29 12.7 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 115.228 -0.897 . . . . 0.0 108.781 175.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 49.5 m -154.32 174.35 14.94 Favored 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 179.242 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 34.6 m -68.21 144.39 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.939 0 N-CA-C 109.103 -0.702 . . . . 0.0 109.103 175.281 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 145.36 19.0 0.16 Allowed Glycine 0 C--N 1.292 -1.895 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.159 -178.035 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 27.7 p-10 -90.56 149.71 22.04 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 177.465 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -94.73 -29.4 14.81 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.597 -178.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 94.3 mt -138.33 154.83 48.98 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.079 178.782 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 47.8 t-20 -95.86 -47.27 6.22 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 174.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 33.9 m -85.83 93.01 8.8 Favored 'General case' 0 N--CA 1.429 -1.519 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 175.61 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 27.6 m -109.59 -179.45 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.738 -178.134 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 13.1 m -75.36 96.29 3.37 Favored 'General case' 0 N--CA 1.422 -1.831 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 177.477 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 20.1 p -83.5 172.86 11.98 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.854 -177.302 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 42.1 m -72.18 116.36 12.51 Favored 'General case' 0 N--CA 1.438 -1.06 0 CA-C-O 121.144 0.497 . . . . 0.0 110.803 -178.397 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 62.7 mt -124.78 93.82 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.971 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 179.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -76.06 110.16 10.31 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.188 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 175.67 -153.23 14.52 Favored Glycine 0 N--CA 1.442 -0.906 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.07 179.353 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -172.61 -42.95 0.04 OUTLIER Glycine 0 C--N 1.312 -0.772 0 N-CA-C 111.558 -0.617 . . . . 0.0 111.558 179.459 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 62.8 m 77.27 -38.8 0.3 Allowed 'General case' 0 CA--C 1.555 1.142 0 C-N-CA 124.661 1.185 . . . . 0.0 112.869 177.063 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 13.1 mptt -68.42 95.09 0.59 Allowed 'General case' 0 C--O 1.246 0.91 0 N-CA-C 113.547 0.943 . . . . 0.0 113.547 -178.533 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 21.4 t90 -168.68 132.66 1.5 Allowed 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 106.924 -1.51 . . . . 0.0 106.924 174.509 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 86.3 mt 72.28 93.68 0.08 Allowed 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 123.93 0.892 . . . . 0.0 110.716 -174.788 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 59.9 t -124.57 133.92 68.11 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 176.578 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -74.27 97.92 3.1 Favored 'General case' 0 C--N 1.311 -1.094 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 178.045 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 60.9 pttt -146.2 171.7 14.54 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 115.155 -0.929 . . . . 0.0 110.371 -174.138 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 63.1 mt 65.36 87.42 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.243 0.743 0 C-N-CA 124.114 0.966 . . . . 0.0 111.833 177.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -136.58 101.04 4.51 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 115.538 -0.756 . . . . 0.0 109.227 176.06 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -87.5 83.5 1.55 Allowed Glycine 0 N--CA 1.426 -1.973 0 C-N-CA 121.132 -0.556 . . . . 0.0 112.381 -177.613 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.525 ' HA ' ' HE3' ' A' ' 49' ' ' LYS . 0.8 OUTLIER -132.71 94.07 3.33 Favored 'General case' 0 C--N 1.294 -1.821 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 177.202 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 83.4 mtp -88.3 91.06 8.64 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-O 121.838 0.827 . . . . 0.0 111.51 179.535 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 7.2 tp60 -112.4 -62.63 1.55 Allowed 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 107.141 -1.429 . . . . 0.0 107.141 178.263 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 60.3 tttp -176.31 102.67 0.24 Allowed Pre-proline 0 N--CA 1.431 -1.393 0 N-CA-C 104.524 -2.399 . . . . 0.0 104.524 177.646 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -79.11 22.33 0.69 Allowed 'Trans proline' 0 CA--C 1.517 -0.325 0 C-N-CA 122.84 2.36 . . . . 0.0 116.352 -167.053 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.522 ' O ' HD11 ' A' ' 58' ' ' LEU . 28.8 mt -68.39 -57.23 9.02 Favored Pre-proline 0 C--N 1.31 -1.119 0 C-N-CA 119.252 -0.979 . . . . 0.0 110.902 179.572 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_exo -64.9 -31.42 56.76 Favored 'Trans proline' 0 N--CA 1.428 -2.366 0 C-N-CA 120.791 0.994 . . . . 0.0 111.88 -170.509 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -75.86 -32.33 59.68 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.282 178.753 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 63.7 tp -69.33 -34.3 74.42 Favored 'General case' 0 CA--C 1.508 -0.656 0 C-N-CA 120.503 -0.479 . . . . 0.0 110.157 178.634 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.589 ' HA ' ' CD1' ' A' ' 75' ' ' TYR . 6.2 mp -61.7 -41.47 97.65 Favored 'General case' 0 CA--C 1.49 -1.334 0 C-N-CA 120.128 -0.629 . . . . 0.0 112.421 179.669 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.479 ' HD2' ' N ' ' A' ' 60' ' ' GLU . 0.1 OUTLIER -76.86 -26.5 54.32 Favored 'General case' 0 C--N 1.298 -1.658 0 CA-C-O 121.491 0.662 . . . . 0.0 112.722 178.477 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.594 ' C ' ' H ' ' A' ' 62' ' ' ASP . 8.5 tp10 -82.51 -41.53 19.58 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 115.344 -0.843 . . . . 0.0 113.145 -171.08 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 56.2 t80 -68.44 3.85 1.6 Allowed 'General case' 0 N--CA 1.494 1.727 0 CA-C-O 122.095 0.95 . . . . 0.0 110.108 -178.303 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.594 ' H ' ' C ' ' A' ' 60' ' ' GLU . 27.9 t70 -109.02 -153.8 0.52 Allowed 'General case' 0 C--N 1.287 -2.113 0 CA-C-N 113.888 -1.505 . . . . 0.0 109.024 -174.783 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.542 ' H ' ' CG ' ' A' ' 62' ' ' ASP . 0.1 OUTLIER -100.54 -167.98 0.15 Allowed Pre-proline 0 CA--C 1.576 1.961 0 N-CA-C 106.187 -1.783 . . . . 0.0 106.187 -177.362 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.482 ' O ' ' HD2' ' A' ' 155' ' ' ARG . 18.2 Cg_endo -100.4 11.49 0.56 Allowed 'Trans proline' 0 C--N 1.368 1.576 0 CA-C-N 122.943 2.087 . . . . 0.0 112.593 -176.292 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.62 ' O ' ' HA3' ' A' ' 159' ' ' GLY . 0.2 OUTLIER -73.03 -43.07 59.21 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.959 0 CA-C-N 115.846 -0.616 . . . . 0.0 109.62 179.53 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 56.94 9.14 3.56 Favored Glycine 0 N--CA 1.484 1.846 0 CA-C-O 121.351 0.417 . . . . 0.0 113.201 -177.582 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.516 ' O ' ' HB ' ' A' ' 160' ' ' VAL . 52.1 mt 67.39 -67.63 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.421 0 C-N-CA 125.877 1.671 . . . . 0.0 112.04 -175.61 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.494 ' HB2' ' O ' ' A' ' 67' ' ' ILE . 26.0 t80 175.01 -56.16 0.0 OUTLIER Pre-proline 0 C--N 1.318 -0.782 0 CA-C-O 119.68 -0.2 . . . . 0.0 111.281 -178.314 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.423 ' HD3' ' HB3' ' A' ' 68' ' ' PHE . 8.4 Cg_exo -73.51 -35.37 4.84 Favored 'Trans proline' 0 C--N 1.379 2.163 0 C-N-CA 121.934 1.756 . . . . 0.0 113.108 -172.226 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 97.28 -17.55 58.93 Favored Glycine 0 N--CA 1.44 -1.069 0 C-N-CA 120.193 -1.004 . . . . 0.0 111.048 -176.253 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -84.93 -48.11 9.62 Favored 'General case' 0 C--O 1.195 -1.769 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 176.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.659 ' O ' ' HB ' ' A' ' 73' ' ' THR . . . -57.7 171.87 0.43 Allowed 'General case' 0 CA--C 1.55 0.981 0 C-N-CA 124.53 1.132 . . . . 0.0 111.675 174.888 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.659 ' HB ' ' O ' ' A' ' 72' ' ' ALA . 8.9 m 94.49 -10.65 0.12 Allowed 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 124.022 0.929 . . . . 0.0 112.035 177.804 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.512 ' O ' ' HA ' ' A' ' 86' ' ' VAL . 35.5 m-80 -46.4 103.25 0.04 OUTLIER 'General case' 0 CA--C 1.45 -2.879 0 C-N-CA 125.062 1.345 . . . . 0.0 113.657 -179.463 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.589 ' CD1' ' HA ' ' A' ' 58' ' ' LEU . 8.3 p90 -92.81 144.0 25.72 Favored 'General case' 1 C--N 1.241 -4.144 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.493 -176.787 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.656 ' HB2' ' O ' ' A' ' 85' ' ' THR . 10.9 mm-40 -136.2 161.78 34.78 Favored 'General case' 0 C--N 1.278 -2.534 0 N-CA-C 105.872 -1.899 . . . . 0.0 105.872 171.522 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 38.8 p90 -162.95 146.83 11.15 Favored 'General case' 0 C--N 1.293 -1.875 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 177.682 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.538 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 25.5 m-20 -105.17 162.31 13.51 Favored 'General case' 0 CA--C 1.459 -2.529 0 C-N-CA 118.955 -1.098 . . . . 0.0 108.799 176.12 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -81.24 -44.47 17.71 Favored 'General case' 0 C--N 1.262 -3.201 0 CA-C-N 114.161 -1.382 . . . . 0.0 111.094 -179.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -69.17 -47.45 64.9 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 178.213 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.538 ' HB ' ' HB2' ' A' ' 78' ' ' ASP . 31.8 m -63.75 -51.74 63.55 Favored 'General case' 0 N--CA 1.418 -2.056 0 CA-C-N 113.93 -1.486 . . . . 0.0 111.951 -178.45 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 99.1 mttt 66.27 18.63 10.96 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-O 121.818 0.818 . . . . 0.0 111.117 -177.042 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.508 ' CD ' ' HB ' ' A' ' 109' ' ' THR . 35.5 ttmt -111.83 135.88 51.86 Favored 'General case' 0 CA--C 1.491 -1.298 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.205 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.561 ' O ' ' HA ' ' A' ' 109' ' ' THR . 1.5 tm? -76.65 124.71 28.06 Favored 'General case' 0 N--CA 1.421 -1.897 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 -179.757 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.656 ' O ' ' HB2' ' A' ' 76' ' ' GLU . 3.8 t -126.82 109.39 11.95 Favored 'General case' 0 C--N 1.265 -3.097 0 CA-C-N 115.844 -0.617 . . . . 0.0 109.622 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.596 ' O ' ' HA ' ' A' ' 107' ' ' THR . 31.0 m -91.84 151.08 3.61 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.943 0 O-C-N 121.375 -0.828 . . . . 0.0 110.575 -179.483 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.496 ' HA ' ' O ' ' A' ' 106' ' ' THR 0.299 1.5 pp -115.59 103.64 10.93 Favored 'General case' 0 N--CA 1.396 -3.153 0 CA-C-O 122.655 1.217 . . . . 0.0 109.736 174.35 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 40.0 mm -89.82 139.01 27.61 Favored Pre-proline 0 C--N 1.289 -2.044 0 CA-C-N 114.08 -1.418 . . . . 0.0 108.37 -174.293 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -54.14 87.5 0.03 OUTLIER 'Trans proline' 0 C--N 1.354 0.868 0 C-N-CA 123.475 2.783 . . . . 0.0 112.431 173.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.511 ' OG ' ' HB ' ' A' ' 167' ' ' VAL . 22.6 t 66.73 -169.15 0.2 Allowed 'General case' 0 N--CA 1.44 -0.955 0 C-N-CA 124.421 1.088 . . . . 0.0 110.811 178.951 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -93.05 137.36 22.59 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 177.022 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' CYS . . . . . 0.585 ' SG ' ' HG2' ' A' ' 166' ' ' ARG . 33.3 m -129.57 138.61 51.39 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 -176.882 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.615 ' O ' ' HA2' ' A' ' 164' ' ' GLY . 45.6 mt-10 -120.25 135.71 54.9 Favored 'General case' 0 CA--C 1.469 -2.167 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 177.511 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.583 HG13 ' H ' ' A' ' 163' ' ' ASN . 20.3 t -117.91 107.81 22.94 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.482 0 C-N-CA 120.224 -0.59 . . . . 0.0 112.349 -172.215 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -112.15 111.79 2.92 Favored Glycine 0 N--CA 1.426 -1.988 0 N-CA-C 108.166 -1.974 . . . . 0.0 108.166 169.536 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . 0.486 ' C ' ' H ' ' A' ' 98' ' ' ASP . 50.2 t80 -153.56 168.93 24.53 Favored 'General case' 0 N--CA 1.391 -3.416 0 N-CA-C 102.877 -3.008 . . . . 0.0 102.877 -178.829 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.434 ' HE2' ' CE2' ' A' ' 96' ' ' TYR . 0.0 OUTLIER -66.99 3.79 1.02 Allowed 'General case' 0 C--N 1.292 -1.934 0 O-C-N 123.262 0.351 . . . . 0.0 111.735 179.418 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.486 ' H ' ' C ' ' A' ' 96' ' ' TYR . 19.1 t70 -58.65 -74.21 0.07 Allowed 'General case' 0 N--CA 1.427 -1.577 0 CA-C-O 122.07 0.938 . . . . 0.0 110.983 -177.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.489 ' HB3' ' HB ' ' A' ' 127' ' ' VAL . 66.6 m -112.52 -69.93 0.84 Allowed 'General case' 0 C--N 1.281 -2.373 0 CA-C-N 114.565 -1.198 . . . . 0.0 108.942 -178.71 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 67.0 m -177.0 -73.87 0.01 OUTLIER 'General case' 0 C--N 1.31 -1.149 0 C-N-CA 126.577 1.951 . . . . 0.0 105.818 -179.326 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.451 ' HA ' ' O ' ' A' ' 94' ' ' VAL . 59.9 t -147.59 129.88 7.16 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.919 0 CA-C-N 114.759 -1.11 . . . . 0.0 108.065 177.632 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -126.61 167.37 15.76 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 177.629 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.484 ' HB3' ' HB3' ' A' ' 124' ' ' LYS . 39.0 ttmt -148.54 128.97 13.91 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-O 120.768 0.318 . . . . 0.0 110.462 174.689 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -104.6 123.73 48.08 Favored 'General case' 0 C--N 1.293 -1.87 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 174.31 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 14.4 t -91.09 168.98 11.24 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 179.464 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' THR . . . . . 0.496 ' O ' ' HA ' ' A' ' 87' ' ' LEU . 46.1 m -64.94 -27.97 69.21 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 112.229 0.455 . . . . 0.0 112.229 -175.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.596 ' HA ' ' O ' ' A' ' 86' ' ' VAL . 29.1 m -138.66 108.35 6.25 Favored 'General case' 0 C--N 1.306 -1.314 0 O-C-N 121.687 -0.633 . . . . 0.0 110.74 -179.4 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.468 ' O ' ' HA ' ' A' ' 85' ' ' THR . 34.1 t -108.72 135.97 45.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 N-CA-C 108.631 -0.878 . . . . 0.0 108.631 -179.303 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.561 ' HA ' ' O ' ' A' ' 84' ' ' LEU . 44.5 p -122.43 132.95 54.6 Favored 'General case' 0 N--CA 1.414 -2.237 0 C-N-CA 122.755 0.422 . . . . 0.0 110.785 -173.51 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . 0.642 ' HA3' ' O ' ' A' ' 119' ' ' ASP . . . -168.69 -158.26 12.44 Favored Glycine 0 C--N 1.308 -0.985 0 C-N-CA 121.373 -0.442 . . . . 0.0 113.234 -178.748 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 46.2 m80 -110.65 119.57 39.59 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-O 121.0 0.428 . . . . 0.0 110.562 -178.281 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -89.88 120.78 31.41 Favored 'General case' 0 C--N 1.308 -1.198 0 C-N-CA 123.905 0.882 . . . . 0.0 111.192 -176.264 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -139.56 175.37 9.62 Favored 'General case' 0 CA--C 1.475 -1.928 0 CA-C-N 115.274 -0.876 . . . . 0.0 109.303 170.692 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 1.8 tmtm? -103.81 131.9 50.57 Favored 'General case' 0 N--CA 1.393 -3.287 0 N-CA-C 107.262 -1.385 . . . . 0.0 107.262 -175.494 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 97.13 -25.77 25.58 Favored Glycine 0 C--O 1.189 -2.686 0 N-CA-C 109.862 -1.295 . . . . 0.0 109.862 -176.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . 0.341 0.0 OUTLIER -164.12 134.76 4.3 Favored 'General case' 0 C--N 1.291 -1.952 0 N-CA-C 114.316 1.228 . . . . 0.0 114.316 177.928 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -103.49 109.53 21.21 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 104.932 -2.248 . . . . 0.0 104.932 179.053 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 33.5 p -95.99 136.97 35.73 Favored 'General case' 0 C--N 1.284 -2.27 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.221 -176.49 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . 0.642 ' O ' ' HA3' ' A' ' 110' ' ' GLY . 15.1 m-20 69.03 107.22 0.05 Allowed 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 124.623 1.169 . . . . 0.0 111.621 178.608 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 7.6 m -119.66 86.39 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.901 0 CA-C-O 122.168 0.985 . . . . 0.0 111.129 173.082 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -74.25 100.9 3.84 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-N 114.48 -1.236 . . . . 0.0 109.464 -177.19 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 128.66 -7.86 6.53 Favored Glycine 0 C--N 1.299 -1.482 0 C-N-CA 120.017 -1.087 . . . . 0.0 111.736 177.744 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 66.5 mt -99.3 115.85 41.01 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.699 0 CA-C-O 121.869 0.843 . . . . 0.0 109.525 178.547 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.484 ' HB3' ' HB3' ' A' ' 103' ' ' LYS . 86.7 tttt -84.2 128.06 34.33 Favored 'General case' 0 CA--C 1.475 -1.936 0 CA-C-N 114.317 -1.31 . . . . 0.0 107.711 -176.146 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.49 HG23 ' HZ1' ' A' ' 150' ' ' LYS . 92.1 m -130.16 127.28 39.39 Favored 'General case' 0 N--CA 1.388 -3.571 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.715 -176.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.512 ' HG2' ' N ' ' A' ' 127' ' ' VAL . 85.2 tttt -139.11 143.12 38.13 Favored 'General case' 0 N--CA 1.407 -2.609 0 CA-C-O 121.344 0.592 . . . . 0.0 110.184 167.178 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.512 ' N ' ' HG2' ' A' ' 126' ' ' LYS . 7.0 p -158.84 -37.66 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 N-CA-C 106.286 -1.746 . . . . 0.0 106.286 177.02 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -120.28 -52.83 2.15 Favored 'General case' 0 N--CA 1.381 -3.903 0 CA-C-N 112.173 -2.285 . . . . 0.0 106.531 -177.484 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 9.6 tp -153.04 164.43 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.386 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 177.095 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 62.6 t90 -70.81 117.66 12.6 Favored 'General case' 0 C--N 1.317 -0.826 0 C-N-CA 123.339 0.656 . . . . 0.0 111.406 178.151 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.404 ' O ' ' HB ' ' A' ' 125' ' ' THR . 21.5 t -138.86 119.44 15.37 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 175.696 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 14.8 ptmm? -102.09 17.53 23.05 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-O 121.316 0.579 . . . . 0.0 110.936 -179.123 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 13.7 m -138.33 74.63 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 CA-C-N 114.866 -1.061 . . . . 0.0 110.324 178.612 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' THR . . . . . 0.412 ' C ' ' HG ' ' A' ' 135' ' ' SER . 35.2 p -111.49 -165.97 1.04 Allowed 'General case' 0 C--N 1.288 -2.102 0 CA-C-N 115.166 -0.925 . . . . 0.0 110.374 -177.271 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' SER . . . . . 0.412 ' HG ' ' C ' ' A' ' 134' ' ' THR . 38.3 m -151.65 167.71 27.28 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 176.623 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 11.7 tt -135.11 136.01 52.0 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.234 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 179.375 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 36.6 p -123.51 168.26 12.82 Favored 'General case' 0 N--CA 1.427 -1.579 0 CA-C-O 121.858 0.837 . . . . 0.0 112.885 -177.056 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' THR . . . . . 0.404 HG23 ' H ' ' A' ' 140' ' ' ALA . 5.0 t -165.7 177.53 7.22 Favored 'General case' 0 N--CA 1.413 -2.312 0 N-CA-C 106.97 -1.492 . . . . 0.0 106.97 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -115.22 32.95 5.72 Favored 'General case' 0 C--N 1.265 -3.101 0 N-CA-C 105.352 -2.092 . . . . 0.0 105.352 175.062 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . 0.404 ' H ' HG23 ' A' ' 138' ' ' THR . . . 60.91 42.78 12.51 Favored 'General case' 0 C--N 1.366 1.309 0 CA-C-N 113.759 -1.564 . . . . 0.0 108.97 -172.466 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 47.6 t -173.4 -65.61 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 115.432 -0.803 . . . . 0.0 111.645 -172.735 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . 0.417 ' HE2' ' HA ' ' A' ' 142' ' ' LYS . 9.1 mmpt? -82.4 -154.46 0.13 Allowed 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 -179.599 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 14.6 p -155.25 119.3 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.055 0 CA-C-O 121.408 0.623 . . . . 0.0 110.136 170.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -114.55 155.99 25.46 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-O 121.964 0.888 . . . . 0.0 112.98 -172.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 35.0 p90 -72.78 137.66 45.95 Favored 'General case' 0 N--CA 1.431 -1.388 0 CA-C-N 113.931 -1.486 . . . . 0.0 113.379 178.216 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 25.9 m -157.72 28.73 0.27 Allowed 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 106.451 -1.685 . . . . 0.0 106.451 172.419 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . 0.417 ' HB2' HG22 ' A' ' 125' ' ' THR . . . -132.44 92.62 3.11 Favored 'General case' 0 N--CA 1.422 -1.859 0 C-N-CA 119.552 -0.859 . . . . 0.0 113.227 -173.459 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 66.9 32.28 80.56 Favored Glycine 0 CA--C 1.5 -0.852 0 CA-C-N 115.803 -0.635 . . . . 0.0 112.815 175.707 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 49.5 ttm 60.12 80.13 0.21 Allowed 'General case' 0 C--O 1.236 0.386 0 CA-C-O 122.019 0.914 . . . . 0.0 109.689 -177.065 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . 0.637 ' HG2' ' H ' ' A' ' 151' ' ' LYS . 35.4 ttmt -120.8 -160.32 0.84 Allowed 'General case' 0 C--N 1.297 -1.698 0 CA-C-N 114.915 -1.039 . . . . 0.0 108.995 -174.181 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . 0.637 ' H ' ' HG2' ' A' ' 150' ' ' LYS . 96.4 mttt -121.64 165.12 16.21 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 124.078 0.951 . . . . 0.0 110.016 -178.415 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 22.3 p -83.66 160.11 21.41 Favored 'General case' 0 C--N 1.301 -1.51 0 C-N-CA 123.275 0.63 . . . . 0.0 110.587 177.527 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' ARG . . . . . 0.417 HH21 ' CG ' ' A' ' 98' ' ' ASP . 4.2 mpt_? -128.18 174.65 9.07 Favored 'General case' 0 CA--C 1.506 -0.736 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 177.272 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 14.7 m -98.9 116.23 30.66 Favored 'General case' 0 N--CA 1.422 -1.862 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 173.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' ARG . . . . . 0.506 ' HG2' ' HA2' ' A' ' 159' ' ' GLY . 0.2 OUTLIER -63.15 -22.98 67.22 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.461 0.648 . . . . 0.0 109.598 -179.559 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -46.51 -37.55 8.07 Favored 'General case' 0 C--N 1.318 -0.797 0 C-N-CA 125.346 1.458 . . . . 0.0 114.476 -177.626 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -69.92 -56.63 6.53 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 119.708 -0.797 . . . . 0.0 112.372 -174.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 58.5 m-85 -165.1 20.52 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 124.025 0.93 . . . . 0.0 110.08 -178.317 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . 0.62 ' HA3' ' O ' ' A' ' 65' ' ' ILE . . . 92.36 -92.79 1.72 Allowed Glycine 0 CA--C 1.47 -2.736 0 C-N-CA 120.016 -1.088 . . . . 0.0 111.195 -174.908 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.516 ' HB ' ' O ' ' A' ' 67' ' ' ILE . 11.5 t -103.42 172.53 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.41 -2.457 0 N-CA-C 106.947 -1.501 . . . . 0.0 106.947 179.102 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' GLN . . . . . 0.428 ' H ' HG11 ' A' ' 160' ' ' VAL . 46.6 mt-30 -123.09 92.9 3.8 Favored 'General case' 0 CA--C 1.483 -1.62 0 CA-C-N 118.973 0.806 . . . . 0.0 109.233 -175.147 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.33 161.83 17.96 Favored 'General case' 0 N--CA 1.401 -2.902 0 C-N-CA 119.012 -1.075 . . . . 0.0 113.251 -176.409 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' ASN . . . . . 0.583 ' H ' HG13 ' A' ' 94' ' ' VAL . 57.7 t30 -129.75 16.56 5.82 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 105.678 -1.971 . . . . 0.0 105.678 172.671 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . 0.615 ' HA2' ' O ' ' A' ' 93' ' ' GLU . . . -58.19 123.09 31.98 Favored Glycine 0 CA--C 1.475 -2.449 0 CA-C-N 113.469 -1.696 . . . . 0.0 112.991 -176.149 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.579 HD11 ' O ' ' A' ' 165' ' ' LEU . 3.9 pp -94.16 121.96 36.2 Favored 'General case' 1 N--CA 1.374 -4.25 0 N-CA-C 105.661 -1.977 . . . . 0.0 105.661 -178.349 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . 0.585 ' HG2' ' SG ' ' A' ' 92' ' ' CYS . 16.0 mtm180 -84.94 129.09 34.86 Favored 'General case' 0 N--CA 1.391 -3.396 0 N-CA-C 105.886 -1.894 . . . . 0.0 105.886 179.483 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . 0.511 ' HB ' ' OG ' ' A' ' 90' ' ' SER . 66.8 t -58.93 -14.98 5.4 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.737 0 CA-C-O 122.104 0.954 . . . . 0.0 110.249 171.679 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -76.25 -13.0 60.18 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 125.795 1.638 . . . . 0.0 109.986 173.162 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' LYS . . . . . 0.465 ' HG2' ' N ' ' A' ' 170' ' ' PHE . 56.1 tttm -134.29 176.99 8.1 Favored 'General case' 0 C--N 1.297 -1.699 0 C-N-CA 124.167 0.987 . . . . 0.0 108.497 -174.247 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' PHE . . . . . 0.465 ' N ' ' HG2' ' A' ' 169' ' ' LYS . 79.4 t80 . . . . . 0 C--N 1.295 -1.762 0 N-CA-C 106.656 -1.609 . . . . 0.0 106.656 170.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 48.9 m . . . . . 0 N--CA 1.44 -0.926 0 CA-C-O 120.662 0.268 . . . . 0.0 110.631 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -76.32 21.63 0.18 Allowed 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 114.953 1.464 . . . . 0.0 114.953 -173.087 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -86.01 -17.75 34.4 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.466 0.65 . . . . 0.0 109.458 175.313 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 45.3 mm -72.01 135.56 27.59 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.162 0 CA-C-N 115.101 -0.954 . . . . 0.0 108.976 -179.361 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -67.5 -60.55 2.47 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 178.579 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 51.7 t30 -159.77 129.96 5.56 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 177.289 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -86.83 135.44 33.34 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-O 120.956 0.408 . . . . 0.0 110.095 -179.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 11.1 p -110.84 144.09 19.49 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 CA-C-N 116.187 -0.46 . . . . 0.0 109.82 -179.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 159.32 177.03 32.04 Favored Glycine 0 N--CA 1.443 -0.892 0 N-CA-C 110.923 -0.871 . . . . 0.0 110.923 178.587 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 35.9 t -86.22 115.62 23.89 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 179.031 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -97.28 -0.88 45.84 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 112.902 0.704 . . . . 0.0 112.902 -176.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 73.4 t-105 -80.08 107.17 12.66 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 176.565 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 98.9 mt -94.82 164.58 12.87 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.323 -176.565 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -99.5 34.18 5.63 Favored Glycine 0 N--CA 1.44 -1.053 0 N-CA-C 111.172 -0.771 . . . . 0.0 111.172 179.647 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -89.72 110.96 21.82 Favored 'General case' 0 N--CA 1.438 -1.032 0 N-CA-C 105.039 -2.208 . . . . 0.0 105.039 177.756 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 61.3 pttt -137.04 172.36 13.13 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.533 -175.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -80.38 112.11 17.41 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 175.703 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 17.6 m120 -87.1 97.57 10.82 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.304 -177.536 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -155.74 119.47 4.45 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 116.057 -0.519 . . . . 0.0 109.654 179.03 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -135.64 153.29 51.68 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 104.377 -2.453 . . . . 0.0 104.377 177.27 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -64.95 117.99 8.42 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-O 121.373 0.606 . . . . 0.0 110.636 -179.599 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -86.93 -176.02 5.59 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 115.117 -0.947 . . . . 0.0 110.124 -178.194 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 35.1 p -54.38 116.3 2.57 Favored 'General case' 0 C--N 1.314 -0.941 0 C-N-CA 124.256 1.022 . . . . 0.0 113.631 -176.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 7.4 p -146.0 98.96 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.171 0 CA-C-O 121.803 0.811 . . . . 0.0 109.811 175.065 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -121.76 151.25 16.97 Favored Glycine 0 N--CA 1.434 -1.475 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.036 -179.393 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 29.2 p-10 -162.04 171.58 17.32 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 -179.312 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -102.32 -171.93 2.05 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 177.097 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.448 ' H ' HD21 ' A' ' 28' ' ' LEU . 1.7 pt? -76.05 78.82 2.9 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 121.642 0.734 . . . . 0.0 111.819 -178.745 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 52.1 t30 -165.89 162.98 18.61 Favored 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 -179.726 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 34.6 m -70.15 -40.5 74.72 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 118.016 0.371 . . . . 0.0 110.142 179.401 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . 0.259 7.1 p 42.58 99.48 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 C-N-CA 126.123 1.769 . . . . 0.0 115.521 176.109 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 55.2 m -145.36 109.94 5.02 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.062 179.446 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 35.5 p -86.63 130.06 34.63 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.258 178.579 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 32.4 m -82.01 94.13 7.11 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-O 121.322 0.582 . . . . 0.0 109.63 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 49.6 mm -116.0 113.93 44.67 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.322 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 -179.433 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -69.47 148.34 49.66 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 177.216 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 78.48 -104.02 2.01 Favored Glycine 0 N--CA 1.44 -1.05 0 N-CA-C 110.651 -0.98 . . . . 0.0 110.651 -178.504 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 138.23 -41.41 1.37 Allowed Glycine 0 N--CA 1.441 -0.985 0 C-N-CA 120.878 -0.677 . . . . 0.0 111.83 178.643 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 8.9 t -108.72 162.51 14.1 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 -179.019 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 55.1 tptt -113.06 123.82 51.17 Favored 'General case' 0 N--CA 1.433 -1.314 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.073 178.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 47.0 t90 -103.54 126.15 50.51 Favored 'General case' 0 C--N 1.301 -1.516 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.198 177.145 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 5.5 tt -84.45 124.73 31.66 Favored 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 106.663 -1.606 . . . . 0.0 106.663 177.647 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 39.7 t -72.0 91.6 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.138 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 -174.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 48.5 t-20 67.5 102.17 0.05 OUTLIER 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.985 1.314 . . . . 0.0 110.814 177.478 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 54.1 tptt -83.76 -37.01 23.17 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 115.384 -0.825 . . . . 0.0 112.542 -176.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 67.4 mt 66.43 91.72 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 -173.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 23.2 pttm -87.41 -19.56 27.9 Favored 'General case' 0 C--N 1.308 -1.225 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 -175.617 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -167.95 102.81 0.19 Allowed Glycine 0 CA--C 1.491 -1.45 0 C-N-CA 119.641 -1.266 . . . . 0.0 112.411 -179.501 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -177.16 105.76 0.06 Allowed 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 179.043 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 45.3 tpp -159.16 -64.89 0.08 Allowed 'General case' 0 C--N 1.316 -0.862 0 C-N-CA 120.779 -0.368 . . . . 0.0 111.883 -176.308 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 53.9 tt0 -140.65 82.66 1.86 Allowed 'General case' 0 N--CA 1.444 -0.765 0 C-N-CA 119.896 -0.722 . . . . 0.0 112.833 -177.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.633 ' O ' ' HG2' ' A' ' 56' ' ' GLU . 16.6 ptpt 173.44 78.39 0.05 OUTLIER Pre-proline 0 C--N 1.321 -0.647 0 C-N-CA 126.6 1.96 . . . . 0.0 109.315 172.469 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.429 ' O ' ' HG ' ' A' ' 57' ' ' LEU . 9.0 Cg_exo -31.29 -66.67 0.08 OUTLIER 'Trans proline' 0 C--N 1.373 1.822 1 C-N-CA 125.488 4.125 . . . . 0.0 116.792 -170.197 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -63.89 -67.15 1.15 Allowed Pre-proline 0 CA--C 1.484 -1.569 0 N-CA-C 113.872 1.064 . . . . 0.0 113.872 -175.088 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.6 ' O ' ' HG2' ' A' ' 59' ' ' LYS . 19.3 Cg_endo -55.38 -25.74 49.56 Favored 'Trans proline' 0 N--CA 1.429 -2.301 0 C-N-CA 121.94 1.76 . . . . 0.0 113.657 -168.023 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.633 ' HG2' ' O ' ' A' ' 52' ' ' LYS . 14.0 pt-20 -81.36 -29.51 34.05 Favored 'General case' 0 CA--C 1.479 -1.763 0 CA-C-O 121.093 0.473 . . . . 0.0 110.867 -177.353 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.594 ' O ' ' HB3' ' A' ' 60' ' ' GLU . 93.8 mt -74.29 -31.54 62.54 Favored 'General case' 0 N--CA 1.417 -2.104 0 CA-C-N 115.736 -0.666 . . . . 0.0 109.973 174.867 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.611 ' N ' HD12 ' A' ' 58' ' ' LEU . 4.8 mp -69.76 -35.32 74.83 Favored 'General case' 0 CA--C 1.504 -0.82 0 C-N-CA 118.988 -1.085 . . . . 0.0 110.017 177.852 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.623 ' O ' ' HB3' ' A' ' 62' ' ' ASP 0.279 41.5 pttt -75.1 -25.25 58.36 Favored 'General case' 0 N--CA 1.439 -1.011 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 172.405 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.594 ' HB3' ' O ' ' A' ' 57' ' ' LEU . 7.4 tp10 -59.4 -49.13 78.98 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-O 121.247 0.546 . . . . 0.0 109.98 171.098 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 85.6 m-85 -68.93 -4.28 15.98 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-O 121.313 0.578 . . . . 0.0 111.202 176.468 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.623 ' HB3' ' O ' ' A' ' 59' ' ' LYS . 21.1 t70 -84.65 166.52 17.01 Favored 'General case' 0 C--N 1.298 -1.671 0 CA-C-N 115.102 -0.954 . . . . 0.0 111.813 -176.117 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.465 HD22 ' H ' ' A' ' 115' ' ' GLY . 3.5 mt -85.67 -151.47 0.0 OUTLIER Pre-proline 0 CA--C 1.602 2.95 0 N-CA-C 104.936 -2.246 . . . . 0.0 104.936 178.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.627 ' HG3' ' N ' ' A' ' 141' ' ' SER . 71.3 Cg_endo -101.54 5.07 0.57 Allowed 'Trans proline' 0 N--CA 1.449 -1.114 0 CA-C-N 123.531 2.297 . . . . 0.0 112.125 176.188 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.551 HG12 ' H ' ' A' ' 67' ' ' ILE . 0.1 OUTLIER -70.04 -42.06 79.35 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.832 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.534 -177.435 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.401 ' H ' HD12 ' A' ' 65' ' ' ILE . . . 57.79 8.91 4.63 Favored Glycine 0 N--CA 1.5 2.958 0 CA-C-O 122.228 0.904 . . . . 0.0 112.441 -174.922 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.551 ' H ' HG12 ' A' ' 65' ' ' ILE . 61.1 mt 58.13 -72.47 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 C-N-CA 129.191 2.997 . . . . 0.0 113.162 -174.358 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.427 ' HB3' ' HD3' ' A' ' 69' ' ' PRO . 80.0 t80 171.8 -53.26 0.0 OUTLIER Pre-proline 0 N--CA 1.485 1.303 0 N-CA-C 113.497 0.925 . . . . 0.0 113.497 -172.687 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.427 ' HD3' ' HB3' ' A' ' 68' ' ' PHE . 6.9 Cg_exo -74.1 -28.53 10.8 Favored 'Trans proline' 0 C--N 1.366 1.496 0 C-N-CA 121.288 1.325 . . . . 0.0 113.094 -174.1 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 86.84 -12.7 60.99 Favored Glycine 0 C--N 1.31 -0.905 0 N-CA-C 110.309 -1.117 . . . . 0.0 110.309 -174.274 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -93.12 -53.47 4.11 Favored 'General case' 0 CA--C 1.48 -1.739 0 N-CA-C 106.512 -1.662 . . . . 0.0 106.512 178.374 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.649 ' O ' ' HB ' ' A' ' 73' ' ' THR . . . -52.06 173.37 0.03 OUTLIER 'General case' 0 C--N 1.361 1.079 0 CA-C-N 114.671 -1.15 . . . . 0.0 110.549 169.916 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.649 ' HB ' ' O ' ' A' ' 72' ' ' ALA . 10.6 m 87.63 27.13 0.03 OUTLIER 'General case' 0 CA--C 1.558 1.251 0 CA-C-O 125.331 2.491 . . . . 0.0 109.246 -174.814 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.599 ' O ' ' HA ' ' A' ' 86' ' ' VAL . 37.2 m-80 -83.81 75.12 10.12 Favored 'General case' 0 C--N 1.275 -2.67 0 CA-C-N 113.685 -1.598 . . . . 0.0 112.021 177.77 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.498 ' H ' ' HB3' ' A' ' 58' ' ' LEU . 2.9 m-85 -70.89 98.12 1.53 Allowed 'General case' 0 C--N 1.258 -3.375 0 CA-C-N 113.377 -1.738 . . . . 0.0 113.56 -179.073 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -106.43 115.29 29.95 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 105.452 -2.055 . . . . 0.0 105.452 176.672 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 76.2 t80 -131.35 127.59 37.94 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 112.465 0.543 . . . . 0.0 112.465 -172.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.539 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 19.6 m-20 -94.22 160.45 14.68 Favored 'General case' 0 CA--C 1.483 -1.607 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 173.248 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 13.5 tp10 -80.14 -63.38 1.42 Allowed 'General case' 0 C--N 1.264 -3.125 0 CA-C-N 114.94 -1.027 . . . . 0.0 112.436 -175.455 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -67.08 -40.05 86.92 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.582 0.706 . . . . 0.0 110.088 -173.638 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.539 ' HB ' ' HB2' ' A' ' 78' ' ' ASP . 62.7 m -62.77 -40.85 98.57 Favored 'General case' 0 C--N 1.289 -2.049 0 CA-C-N 114.679 -1.146 . . . . 0.0 111.648 -179.71 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt 65.0 6.83 3.64 Favored 'General case' 0 N--CA 1.484 1.247 0 N-CA-C 113.308 0.855 . . . . 0.0 113.308 -179.249 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -116.14 109.64 17.75 Favored 'General case' 0 N--CA 1.399 -2.991 0 CA-C-O 121.54 0.686 . . . . 0.0 109.21 -179.059 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.508 ' O ' ' HA ' ' A' ' 109' ' ' THR . 3.4 tt -82.41 150.03 27.33 Favored 'General case' 0 C--N 1.289 -2.055 0 CA-C-N 114.044 -1.435 . . . . 0.0 110.121 -178.415 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.43 ' HA ' ' O ' ' A' ' 108' ' ' VAL . 7.1 t -126.14 131.27 52.09 Favored 'General case' 0 N--CA 1.405 -2.72 0 N-CA-C 106.667 -1.605 . . . . 0.0 106.667 174.38 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.599 ' HA ' ' O ' ' A' ' 74' ' ' ASN . 9.8 p -107.13 134.26 49.35 Favored 'Isoleucine or valine' 0 N--CA 1.398 -3.03 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 -177.57 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 5.1 mp -86.98 116.65 25.18 Favored 'General case' 0 C--N 1.293 -1.851 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.439 178.033 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 48.7 mm -103.37 126.8 31.16 Favored Pre-proline 0 C--N 1.274 -2.715 0 N-CA-C 106.418 -1.697 . . . . 0.0 106.418 173.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -40.33 -42.54 3.74 Favored 'Trans proline' 0 C--N 1.372 1.784 0 C-N-CA 124.44 3.426 . . . . 0.0 113.739 -178.432 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 66.5 m -161.79 161.73 29.24 Favored 'General case' 0 CA--C 1.482 -1.664 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 176.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.406 ' HA ' ' O ' ' A' ' 104' ' ' PHE . 0.0 OUTLIER -71.15 108.91 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.148 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 174.683 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' CYS . . . . . 0.492 ' SG ' ' HB2' ' A' ' 104' ' ' PHE . 14.2 p -97.42 124.0 41.46 Favored 'General case' 0 N--CA 1.425 -1.689 0 N-CA-C 108.442 -0.948 . . . . 0.0 108.442 175.642 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -116.47 123.7 48.13 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 177.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.656 ' O ' ' HA ' ' A' ' 101' ' ' VAL . 33.5 m -113.62 130.61 67.37 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.348 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 -179.759 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . 0.511 ' HA2' ' O ' ' A' ' 100' ' ' SER . . . -144.63 158.61 27.6 Favored Glycine 0 C--N 1.3 -1.466 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.232 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 27.8 t80 -152.77 -78.72 0.11 Allowed 'General case' 0 CA--C 1.499 -1.001 0 C-N-CA 118.686 -1.206 . . . . 0.0 109.083 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.513 ' O ' ' HB2' ' A' ' 98' ' ' ASP . 50.4 mtpt -86.34 -41.32 14.63 Favored 'General case' 0 CA--C 1.491 -1.318 0 C-N-CA 119.639 -0.824 . . . . 0.0 108.931 178.134 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.513 ' HB2' ' O ' ' A' ' 97' ' ' LYS . 21.6 t70 143.31 -44.08 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.122 0 N-CA-C 105.954 -1.869 . . . . 0.0 105.954 -168.915 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 8.9 m -59.82 -30.14 68.72 Favored 'General case' 0 C--N 1.344 0.347 0 CA-C-N 113.796 -1.547 . . . . 0.0 110.858 -179.028 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.511 ' O ' ' HA2' ' A' ' 95' ' ' GLY . 18.2 m -115.49 82.69 1.8 Allowed 'General case' 0 N--CA 1.411 -2.378 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.713 179.519 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.656 ' HA ' ' O ' ' A' ' 94' ' ' VAL . 93.8 t -127.11 117.74 48.31 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.19 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 173.891 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.499 HD11 ' C ' ' A' ' 101' ' ' VAL . 5.6 mp -134.47 142.32 47.04 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 -178.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 39.6 ttmt -133.5 121.04 21.6 Favored 'General case' 0 C--N 1.291 -1.968 0 CA-C-O 121.002 0.43 . . . . 0.0 110.249 179.175 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.492 ' HB2' ' SG ' ' A' ' 92' ' ' CYS . 94.1 m-85 -101.25 109.24 21.07 Favored 'General case' 0 C--N 1.291 -1.965 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 174.804 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 43.9 m -72.58 151.96 42.08 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.484 -177.147 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 17.1 p -50.28 -42.87 52.97 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 124.134 0.974 . . . . 0.0 112.375 -179.367 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 41.4 p -127.42 93.76 3.81 Favored 'General case' 0 N--CA 1.424 -1.768 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.344 178.324 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.443 HG11 HG13 ' A' ' 123' ' ' ILE . 45.7 t -87.33 144.09 9.98 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.115 0 N-CA-C 106.372 -1.714 . . . . 0.0 106.372 175.479 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.508 ' HA ' ' O ' ' A' ' 84' ' ' LEU . 10.1 t -144.45 134.45 23.98 Favored 'General case' 0 N--CA 1.399 -2.998 0 CA-C-N 118.614 0.643 . . . . 0.0 110.891 -176.205 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -167.22 -166.97 27.2 Favored Glycine 0 N--CA 1.434 -1.491 0 N-CA-C 111.353 -0.699 . . . . 0.0 111.353 179.652 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 45.8 m80 -83.98 143.32 29.88 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 117.696 0.748 . . . . 0.0 110.741 -177.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.481 ' HA ' HD22 ' A' ' 117' ' ' LEU . 0.5 OUTLIER -103.42 118.19 36.2 Favored 'General case' 0 N--CA 1.434 -1.23 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 -174.524 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -132.75 140.23 47.96 Favored 'General case' 0 CA--C 1.461 -2.469 0 O-C-N 123.897 0.748 . . . . 0.0 109.038 167.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 2.5 tmtm? -78.31 100.4 6.71 Favored 'General case' 0 C--N 1.268 -2.964 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 -174.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . 0.465 ' H ' HD22 ' A' ' 63' ' ' LEU . . . 135.02 -63.3 0.6 Allowed Glycine 0 N--CA 1.433 -1.559 0 N-CA-C 108.201 -1.96 . . . . 0.0 108.201 -175.071 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.43 ' HD3' ' H ' ' A' ' 116' ' ' LYS . 0.1 OUTLIER -122.08 130.0 52.88 Favored 'General case' 0 C--N 1.291 -1.945 0 O-C-N 121.848 -0.795 . . . . 0.0 110.492 179.407 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.481 HD22 ' HA ' ' A' ' 112' ' ' LEU . 0.3 OUTLIER -108.19 105.34 15.02 Favored 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 105.165 -2.161 . . . . 0.0 105.165 -179.502 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 48.1 p -106.05 166.75 10.28 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 113.103 0.779 . . . . 0.0 113.103 -172.748 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 28.0 m-20 64.43 40.53 6.27 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.976 0.91 . . . . 0.0 109.75 175.109 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.466 ' CG1' HD13 ' A' ' 117' ' ' LEU . 15.6 m -83.83 83.07 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.415 -2.197 0 CA-C-O 122.216 1.007 . . . . 0.0 112.117 -172.595 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -68.63 96.39 0.71 Allowed 'General case' 0 N--CA 1.406 -2.64 0 CA-C-N 113.742 -1.572 . . . . 0.0 109.004 176.054 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 147.53 -15.11 1.43 Allowed Glycine 0 C--N 1.292 -1.87 0 C-N-CA 120.28 -0.962 . . . . 0.0 112.059 177.753 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.443 HG13 HG11 ' A' ' 108' ' ' VAL . 93.2 mt -100.17 99.52 8.64 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.833 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 176.636 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.49 ' HA ' ' O ' ' A' ' 131' ' ' VAL . 47.9 mtpt -107.23 148.63 28.69 Favored 'General case' 0 N--CA 1.419 -1.99 0 CA-C-N 113.999 -1.455 . . . . 0.0 109.666 -173.145 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 13.3 t -154.76 157.62 38.27 Favored 'General case' 0 C--N 1.285 -2.23 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 176.236 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.614 ' HD3' ' N ' ' A' ' 127' ' ' VAL . 0.5 OUTLIER -128.8 138.02 51.84 Favored 'General case' 0 N--CA 1.385 -3.713 0 N-CA-C 106.686 -1.598 . . . . 0.0 106.686 172.184 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.614 ' N ' ' HD3' ' A' ' 126' ' ' LYS . 7.4 p -160.21 -38.04 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.289 -2.054 0 N-CA-C 105.766 -1.939 . . . . 0.0 105.766 177.327 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 13.8 tpt -115.74 -50.62 2.69 Favored 'General case' 0 N--CA 1.39 -3.434 0 CA-C-N 112.605 -2.089 . . . . 0.0 108.129 177.711 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 8.7 tp -162.25 172.71 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 N-CA-C 105.511 -2.033 . . . . 0.0 105.511 174.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 14.3 m-90 -71.66 117.38 13.17 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 118.834 0.743 . . . . 0.0 110.344 177.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.49 ' O ' ' HA ' ' A' ' 124' ' ' LYS . 45.9 t -122.84 133.01 70.21 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.661 0 N-CA-C 106.559 -1.645 . . . . 0.0 106.559 174.691 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 62.8 pttt -108.61 5.24 24.81 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 -173.293 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 35.8 m -126.05 14.94 4.02 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 N-CA-C 112.439 0.533 . . . . 0.0 112.439 -177.538 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 38.4 p -51.58 102.13 0.04 OUTLIER 'General case' 0 C--N 1.347 0.458 0 CA-C-O 121.502 0.668 . . . . 0.0 112.059 179.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 38.5 m -86.54 152.44 22.63 Favored 'General case' 0 N--CA 1.418 -2.038 0 CA-C-N 115.073 -0.967 . . . . 0.0 111.669 -174.747 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 11.5 tt -110.27 132.32 58.93 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.513 0 CA-C-N 114.973 -1.012 . . . . 0.0 109.558 -179.256 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 26.0 t -122.13 116.95 25.12 Favored 'General case' 0 N--CA 1.426 -1.657 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 -179.812 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 3.0 t -136.35 114.62 11.62 Favored 'General case' 0 C--N 1.277 -2.57 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 178.393 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -78.33 73.06 4.89 Favored 'General case' 0 C--N 1.305 -1.369 0 C-N-CA 119.16 -1.016 . . . . 0.0 111.586 -174.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . 49.86 32.23 5.28 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 125.482 1.513 . . . . 0.0 112.039 178.479 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' SER . . . . . 0.627 ' N ' ' HG3' ' A' ' 64' ' ' PRO . 22.9 t -176.96 -76.73 0.01 OUTLIER 'General case' 0 C--O 1.215 -0.727 0 CA-C-O 120.886 0.374 . . . . 0.0 111.102 -175.902 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -98.48 150.47 21.63 Favored 'General case' 0 C--N 1.306 -1.291 0 O-C-N 122.287 -0.258 . . . . 0.0 110.443 -172.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.676 ' HB ' ' O ' ' A' ' 153' ' ' ARG . 47.9 t -106.16 136.06 42.08 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 CA-C-O 121.143 0.497 . . . . 0.0 111.697 -172.772 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . 0.417 ' HA ' ' OG ' ' A' ' 152' ' ' SER . 75.5 m-85 -135.71 143.29 45.3 Favored 'General case' 0 C--O 1.25 1.11 0 C-N-CA 123.894 0.878 . . . . 0.0 109.244 179.488 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 55.5 p90 -64.14 141.28 58.83 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-O 121.423 0.63 . . . . 0.0 112.564 178.575 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 91.4 m -108.63 -28.77 9.09 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 167.56 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . 0.402 ' HB1' ' HB3' ' A' ' 150' ' ' LYS . . . -60.33 129.46 41.76 Favored 'General case' 0 N--CA 1.441 -0.925 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 172.445 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -84.22 -15.61 68.91 Favored Glycine 0 CA--C 1.48 -2.097 0 C-N-CA 119.956 -1.116 . . . . 0.0 112.584 -169.616 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 58.5 mtt -101.45 2.13 39.01 Favored 'General case' 0 C--N 1.291 -1.974 0 CA-C-O 121.453 0.644 . . . . 0.0 110.021 -176.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . 0.499 ' HG3' ' H ' ' A' ' 151' ' ' LYS . 17.3 tppt? -121.28 -178.03 3.67 Favored 'General case' 0 CA--C 1.561 1.374 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 -174.398 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . 0.499 ' H ' ' HG3' ' A' ' 150' ' ' LYS . 75.0 mmtt -137.32 164.52 28.39 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 123.491 0.716 . . . . 0.0 109.071 -172.562 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' SER . . . . . 0.447 ' C ' ' HD2' ' A' ' 153' ' ' ARG . 42.5 m -76.04 153.6 36.31 Favored 'General case' 0 C--N 1.306 -1.326 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 -174.758 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' ARG . . . . . 0.676 ' O ' ' HB ' ' A' ' 143' ' ' VAL . 3.1 mpt_? -126.18 149.98 48.63 Favored 'General case' 0 CA--C 1.494 -1.177 0 N-CA-C 106.18 -1.785 . . . . 0.0 106.18 173.635 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 41.4 m -93.63 142.22 27.59 Favored 'General case' 0 C--N 1.281 -2.382 0 C-N-CA 120.497 -0.481 . . . . 0.0 110.625 -178.352 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 19.1 ttp180 -58.5 -30.38 66.99 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-O 120.66 0.267 . . . . 0.0 111.184 178.541 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -53.44 -21.03 5.37 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 124.058 0.943 . . . . 0.0 112.71 179.531 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -64.96 -53.63 43.3 Favored 'General case' 0 N--CA 1.432 -1.332 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 178.605 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 10.7 t80 170.72 23.57 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 106.744 -1.576 . . . . 0.0 106.744 177.49 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 95.89 -92.52 1.44 Allowed Glycine 0 N--CA 1.416 -2.689 0 C-N-CA 119.082 -1.532 . . . . 0.0 109.376 -170.159 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.455 HG21 ' HB ' ' A' ' 65' ' ' ILE . 2.4 t -130.26 114.5 29.18 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.758 0 N-CA-C 106.333 -1.728 . . . . 0.0 106.333 176.289 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 5.3 pp0? -134.51 130.66 36.96 Favored 'General case' 0 N--CA 1.414 -2.25 0 C-N-CA 117.194 -1.802 . . . . 0.0 115.338 -172.46 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 19.8 tpt180 -152.81 138.68 18.02 Favored 'General case' 0 C--N 1.27 -2.875 0 N-CA-C 104.694 -2.335 . . . . 0.0 104.694 168.102 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -69.81 95.27 0.89 Allowed 'General case' 0 CA--C 1.505 -0.768 0 CA-C-O 121.621 0.724 . . . . 0.0 112.777 -175.579 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -145.6 159.27 27.89 Favored Glycine 0 N--CA 1.423 -2.17 0 N-CA-C 109.2 -1.56 . . . . 0.0 109.2 176.572 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.411 ' HB2' ' OXT' ' A' ' 170' ' ' PHE . 2.0 pt? -130.77 143.74 50.95 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-O 120.992 0.425 . . . . 0.0 110.451 -178.075 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . 0.506 ' HD2' ' N ' ' A' ' 166' ' ' ARG . 4.2 mpt_? -96.85 106.34 18.63 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 178.897 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 43.3 t -37.52 -46.26 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.562 1.44 0 N-CA-C 115.674 1.731 . . . . 0.0 115.674 -172.054 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -60.45 -35.55 76.11 Favored 'General case' 0 N--CA 1.486 1.326 0 CA-C-O 121.178 0.513 . . . . 0.0 111.729 -178.534 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 31.5 tttm -96.22 -81.17 0.42 Allowed 'General case' 0 C--N 1.3 -1.572 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.678 -179.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' PHE . . . . . 0.411 ' OXT' ' HB2' ' A' ' 165' ' ' LEU . 68.6 t80 . . . . . 0 N--CA 1.432 -1.35 0 N-CA-C 101.802 -3.407 . . . . 0.0 101.802 -175.545 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 38.0 t . . . . . 0 N--CA 1.451 -0.38 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -127.68 91.01 3.21 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-O 121.107 0.48 . . . . 0.0 110.151 177.74 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 94.0 mt-30 -99.92 96.29 7.45 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 177.575 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.3 mp -84.95 109.63 18.25 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 -178.767 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 66.6 m-85 -107.38 107.68 18.69 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 176.354 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 53.0 t-20 -107.5 116.27 31.64 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 -178.251 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -100.97 99.74 10.26 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 109.392 -0.595 . . . . 0.0 109.392 177.628 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 28.6 m -95.17 152.7 3.63 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 CA-C-N 115.802 -0.635 . . . . 0.0 109.675 179.551 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 159.2 124.5 0.76 Allowed Glycine 0 N--CA 1.424 -2.164 0 C-N-CA 120.611 -0.804 . . . . 0.0 111.481 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 44.5 m -94.18 114.77 26.95 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 176.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -109.72 134.58 51.83 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-O 120.828 0.347 . . . . 0.0 111.395 -179.044 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 94.7 m95 -80.68 102.42 9.87 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.554 177.011 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.7 pp -131.11 170.05 15.05 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.803 178.121 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 96.43 24.51 13.96 Favored Glycine 0 C--N 1.299 -1.514 0 C-N-CA 120.512 -0.852 . . . . 0.0 111.354 -179.098 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 56.5 tt0 -78.14 105.91 9.67 Favored 'General case' 0 CA--C 1.504 -0.803 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 177.652 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 62.5 mttp -89.76 79.7 6.68 Favored 'General case' 0 C--N 1.294 -1.831 0 C-N-CA 118.7 -1.2 . . . . 0.0 111.798 178.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -82.63 86.42 6.83 Favored 'General case' 0 N--CA 1.431 -1.395 0 N-CA-C 105.222 -2.14 . . . . 0.0 105.222 171.548 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.41 ' O ' ' HB3' ' A' ' 90' ' ' SER . 7.8 t30 -108.28 114.32 28.09 Favored 'General case' 0 N--CA 1.418 -2.027 0 CA-C-N 114.998 -1.001 . . . . 0.0 112.486 -168.541 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.465 ' HE2' ' CE1' ' A' ' 21' ' ' PHE . 10.2 tmtt? -125.8 96.38 4.75 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 103.571 -2.752 . . . . 0.0 103.571 171.009 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -135.85 90.46 2.59 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 112.372 0.508 . . . . 0.0 112.372 -175.457 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.465 ' CE1' ' HE2' ' A' ' 19' ' ' LYS . 19.1 p90 -164.45 133.0 3.52 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 106.491 -1.67 . . . . 0.0 106.491 172.654 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -122.75 152.92 40.15 Favored 'General case' 0 C--N 1.285 -2.23 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 -179.206 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 35.6 t -83.19 80.35 9.09 Favored 'General case' 0 N--CA 1.422 -1.873 0 C-N-CA 119.622 -0.831 . . . . 0.0 109.203 176.483 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 77.5 t -114.46 -47.42 4.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-N 114.688 -1.142 . . . . 0.0 108.57 177.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 127.88 66.64 0.14 Allowed Glycine 0 N--CA 1.426 -1.979 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.094 178.54 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -58.17 127.0 29.9 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 176.479 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 35.8 m-20 -82.23 103.14 11.61 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 -174.529 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 85.1 mt -85.74 174.17 9.55 Favored 'General case' 0 C--N 1.309 -1.168 0 N-CA-C 106.446 -1.687 . . . . 0.0 106.446 169.751 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.44 ' CG ' ' H ' ' A' ' 30' ' ' SER . 55.1 t30 63.22 -164.45 0.25 Allowed 'General case' 0 N--CA 1.484 1.251 0 N-CA-C 106.544 -1.65 . . . . 0.0 106.544 -172.385 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.44 ' H ' ' CG ' ' A' ' 29' ' ' ASN . 35.4 t 72.37 116.13 0.05 Allowed 'General case' 0 C--O 1.244 0.766 0 CA-C-O 121.552 0.691 . . . . 0.0 111.718 175.3 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 7.3 p -63.13 125.23 19.25 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.906 0 CA-C-O 121.721 0.772 . . . . 0.0 111.346 179.098 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 51.1 m -113.7 93.48 4.4 Favored 'General case' 0 N--CA 1.42 -1.945 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 176.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 11.6 t -102.67 178.3 4.61 Favored 'General case' 0 C--N 1.295 -1.775 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.07 -177.233 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 40.2 m 73.87 -36.46 0.34 Allowed 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.595 1.158 . . . . 0.0 112.424 179.261 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 6.7 tp -81.62 84.57 1.57 Allowed 'Isoleucine or valine' 0 C--O 1.247 0.971 0 CA-C-O 122.299 1.047 . . . . 0.0 110.037 176.185 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -164.41 137.58 5.04 Favored 'General case' 0 C--N 1.31 -1.132 0 N-CA-C 104.983 -2.228 . . . . 0.0 104.983 -178.762 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -164.09 86.4 0.1 Allowed Glycine 0 N--CA 1.429 -1.811 0 C-N-CA 119.4 -1.381 . . . . 0.0 112.291 -179.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 58.87 -111.65 3.48 Favored Glycine 0 C--O 1.238 0.381 0 O-C-N 124.093 0.525 . . . . 0.0 112.751 178.281 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 8.8 t -107.52 116.47 31.99 Favored 'General case' 0 N--CA 1.427 -1.613 0 CA-C-O 121.745 0.783 . . . . 0.0 110.271 179.427 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 47.5 mmtm -133.79 109.93 9.44 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 115.17 -0.923 . . . . 0.0 109.188 179.452 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 36.2 p90 -83.2 89.16 6.93 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-O 122.01 0.909 . . . . 0.0 112.383 -178.766 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 57.4 tp -156.63 150.38 24.76 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 -179.659 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 11.2 p -66.6 142.54 16.58 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.051 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 175.378 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.415 ' ND2' ' HA ' ' A' ' 49' ' ' LYS . 50.6 t30 -76.93 88.7 3.5 Favored 'General case' 0 C--O 1.253 1.252 0 CA-C-O 121.697 0.761 . . . . 0.0 110.846 -177.476 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.502 ' C ' HD13 ' A' ' 46' ' ' ILE . 40.6 ttmt 70.34 -86.37 0.03 OUTLIER 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 113.989 -1.46 . . . . 0.0 109.623 -177.346 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.502 HD13 ' C ' ' A' ' 45' ' ' LYS . 3.1 mp -144.19 -74.26 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 N-CA-C 106.887 -1.523 . . . . 0.0 106.887 174.593 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt -144.95 15.28 1.54 Allowed 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.12 -0.946 . . . . 0.0 108.856 179.342 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -71.42 -43.97 52.51 Favored Glycine 0 N--CA 1.444 -0.809 0 CA-C-N 114.997 -1.001 . . . . 0.0 112.666 -175.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.415 ' HA ' ' ND2' ' A' ' 44' ' ' ASN . 39.7 ttmt 65.61 -83.25 0.03 OUTLIER 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 179.499 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 95.0 mmm 67.7 -62.87 0.33 Allowed 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 124.363 1.065 . . . . 0.0 109.033 -169.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 98.9 mt-30 -139.77 -177.69 5.08 Favored 'General case' 0 C--N 1.313 -0.981 0 C-N-CA 125.24 1.416 . . . . 0.0 107.924 177.697 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 51.5 mtmt 63.54 94.05 0.05 OUTLIER Pre-proline 0 N--CA 1.476 0.827 0 C-N-CA 123.943 0.897 . . . . 0.0 112.443 -179.544 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -80.24 25.98 0.59 Allowed 'Trans proline' 0 N--CA 1.477 0.519 0 C-N-CA 123.578 2.852 . . . . 0.0 112.582 -178.735 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 33.0 mt -54.77 -59.79 9.62 Favored Pre-proline 0 C--N 1.315 -0.927 0 N-CA-C 112.793 0.664 . . . . 0.0 112.793 -173.797 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.459 ' O ' ' HG2' ' A' ' 59' ' ' LYS . 7.5 Cg_exo -69.65 -14.34 36.29 Favored 'Trans proline' 0 N--CA 1.427 -2.432 0 C-N-CA 121.61 1.54 . . . . 0.0 112.282 -169.356 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -71.52 -39.88 70.48 Favored 'General case' 0 CA--C 1.49 -1.359 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 -174.069 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.406 ' O ' ' HB3' ' A' ' 60' ' ' GLU . 10.4 mp -68.62 -30.48 69.22 Favored 'General case' 0 N--CA 1.44 -0.925 0 CA-C-N 114.808 -1.087 . . . . 0.0 111.988 178.932 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 6.2 mp -64.5 -48.82 73.74 Favored 'General case' 0 CA--C 1.495 -1.153 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 179.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.459 ' HG2' ' O ' ' A' ' 55' ' ' PRO . 32.3 pttt -75.19 -26.84 59.33 Favored 'General case' 0 C--N 1.299 -1.59 0 CA-C-N 115.143 -0.935 . . . . 0.0 112.986 177.399 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.406 ' HB3' ' O ' ' A' ' 57' ' ' LEU . 8.3 tp10 -59.82 -51.81 68.15 Favored 'General case' 0 C--N 1.306 -1.313 0 C-N-CA 123.927 0.891 . . . . 0.0 111.221 175.018 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 63.4 t80 -68.59 -10.26 54.78 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.6 -176.519 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.581 ' OD2' HG22 ' A' ' 73' ' ' THR . 22.4 t0 -94.71 -179.37 4.84 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.473 -178.495 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.522 ' H ' ' CG ' ' A' ' 62' ' ' ASP . 2.5 mt -76.36 169.03 22.9 Favored Pre-proline 0 CA--C 1.559 1.299 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 -178.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.431 ' HB2' ' HG3' ' A' ' 155' ' ' ARG . 10.9 Cg_endo -91.97 25.7 0.46 Allowed 'Trans proline' 0 N--CA 1.441 -1.576 0 C-N-CA 122.596 2.197 . . . . 0.0 110.853 -176.725 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.728 ' O ' ' HA3' ' A' ' 159' ' ' GLY . 0.2 OUTLIER -73.89 -29.09 25.12 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.432 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 176.915 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 53.11 1.66 0.07 OUTLIER Glycine 0 CA--C 1.544 1.887 0 CA-C-N 114.972 -1.013 . . . . 0.0 115.133 178.086 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.672 ' O ' ' HB ' ' A' ' 160' ' ' VAL . 48.6 mt 67.08 -42.35 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.189 0 C-N-CA 126.441 1.896 . . . . 0.0 114.099 -179.575 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.532 ' HB2' ' O ' ' A' ' 67' ' ' ILE . 71.3 t80 158.0 -51.37 0.0 OUTLIER Pre-proline 0 N--CA 1.489 1.494 0 C-N-CA 125.354 1.462 . . . . 0.0 110.498 177.729 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.436 ' HB2' ' OD2' ' A' ' 71' ' ' ASP . 9.5 Cg_endo -95.82 -24.82 0.12 Allowed 'Trans proline' 0 C--N 1.374 1.878 0 C-N-CA 121.87 1.713 . . . . 0.0 115.052 -172.479 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.406 ' H ' ' HD2' ' A' ' 69' ' ' PRO . . . 82.48 -7.89 63.44 Favored Glycine 0 CA--C 1.526 0.738 0 C-N-CA 120.454 -0.879 . . . . 0.0 111.629 -174.707 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.436 ' OD2' ' HB2' ' A' ' 69' ' ' PRO . 23.2 m-20 -86.16 -30.99 22.05 Favored 'General case' 0 CA--C 1.495 -1.148 0 N-CA-C 106.26 -1.755 . . . . 0.0 106.26 178.062 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.534 ' O ' ' HB ' ' A' ' 73' ' ' THR . . . -82.62 -172.26 3.95 Favored 'General case' 0 N--CA 1.442 -0.825 0 CA-C-N 113.556 -1.657 . . . . 0.0 107.103 171.81 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.711 HG23 ' O ' ' A' ' 73' ' ' THR . 60.7 m 79.94 27.35 0.32 Allowed 'General case' 0 N--CA 1.474 0.742 0 CA-C-O 124.807 2.241 . . . . 0.0 109.483 175.015 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 35.8 m-80 -84.48 -177.3 6.58 Favored 'General case' 0 N--CA 1.386 -3.641 0 CA-C-N 113.759 -1.564 . . . . 0.0 110.479 178.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 42.6 t80 -149.21 94.9 2.3 Favored 'General case' 0 C--N 1.276 -2.628 0 C-N-CA 119.352 -0.939 . . . . 0.0 110.935 -169.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.646 ' OE1' ' HG ' ' A' ' 87' ' ' LEU . 4.2 mp0 -107.26 96.09 6.17 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 176.777 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 81.9 t80 -102.73 124.31 48.03 Favored 'General case' 0 C--N 1.297 -1.704 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.255 -176.264 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.58 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 10.4 m-20 -93.9 155.77 16.99 Favored 'General case' 0 CA--C 1.47 -2.1 0 C-N-CA 118.819 -1.152 . . . . 0.0 108.712 175.017 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -80.43 -53.35 6.68 Favored 'General case' 0 C--N 1.25 -3.756 0 CA-C-N 113.412 -1.722 . . . . 0.0 109.026 179.323 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -66.77 -21.33 66.06 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 113.726 -1.579 . . . . 0.0 110.754 -176.498 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.58 ' HB ' ' HB2' ' A' ' 78' ' ' ASP . 27.2 m -101.63 -53.01 3.07 Favored 'General case' 0 N--CA 1.41 -2.455 0 CA-C-N 115.0 -1.0 . . . . 0.0 111.192 -174.612 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 99.7 mttt 70.26 4.15 4.74 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 123.85 0.86 . . . . 0.0 111.995 -174.616 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.503 ' HG2' ' CG2' ' A' ' 109' ' ' THR . 36.2 ttmt -104.91 107.41 18.36 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 176.655 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -68.01 133.73 49.52 Favored 'General case' 0 C--N 1.292 -1.929 0 CA-C-N 113.833 -1.53 . . . . 0.0 110.447 -175.56 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.441 ' HA ' ' HA ' ' A' ' 109' ' ' THR . 8.9 t -120.85 137.79 54.38 Favored 'General case' 0 N--CA 1.403 -2.812 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 177.422 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 61.0 t -111.32 118.62 57.88 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 C-N-CA 123.811 0.844 . . . . 0.0 109.44 -179.205 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.646 ' HG ' ' OE1' ' A' ' 76' ' ' GLU 0.293 0.5 OUTLIER -79.44 124.41 28.43 Favored 'General case' 0 N--CA 1.403 -2.82 0 CA-C-O 122.578 1.18 . . . . 0.0 112.37 172.879 . . . . . . . . 4 4 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 50.4 mm -102.36 125.8 35.18 Favored Pre-proline 0 C--N 1.279 -2.482 0 CA-C-N 113.711 -1.586 . . . . 0.0 107.805 178.638 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -59.61 96.93 0.1 Allowed 'Trans proline' 0 C--O 1.248 1.018 0 C-N-CA 122.62 2.214 . . . . 0.0 111.516 175.476 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.479 ' OG ' ' HB2' ' A' ' 168' ' ' ASP . 68.4 m 65.21 176.74 0.2 Allowed 'General case' 0 C--O 1.236 0.356 0 C-N-CA 124.483 1.113 . . . . 0.0 112.844 -178.711 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.423 HG12 ' HA ' ' A' ' 105' ' ' THR . 39.7 mt -88.5 131.15 36.7 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.623 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.793 178.705 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' CYS . . . . . 0.403 ' SG ' ' HA3' ' A' ' 164' ' ' GLY . 16.0 t -116.16 122.71 45.87 Favored 'General case' 0 N--CA 1.41 -2.452 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 173.764 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -116.96 127.29 54.06 Favored 'General case' 0 C--N 1.29 -2.017 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 178.628 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 3.9 p -105.14 103.94 16.14 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.27 0 CA-C-O 122.024 0.916 . . . . 0.0 109.578 177.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -130.53 131.37 6.49 Favored Glycine 0 N--CA 1.423 -2.229 0 N-CA-C 108.226 -1.95 . . . . 0.0 108.226 179.111 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . 0.286 4.9 t80 175.67 -53.41 0.01 OUTLIER 'General case' 0 CA--C 1.476 -1.879 0 N-CA-C 105.041 -2.207 . . . . 0.0 105.041 -171.899 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.541 ' HA ' ' HE3' ' A' ' 97' ' ' LYS . 0.4 OUTLIER -76.13 -18.72 59.02 Favored 'General case' 0 N--CA 1.403 -2.814 0 CA-C-N 110.806 -2.906 . . . . 0.0 112.185 -172.727 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 18.9 t70 70.1 -56.84 0.58 Allowed 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 113.912 1.079 . . . . 0.0 113.912 176.629 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 18.5 m -79.97 -9.97 59.73 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-O 121.661 0.744 . . . . 0.0 109.824 -177.421 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 35.0 m -140.57 89.37 2.27 Favored 'General case' 0 N--CA 1.423 -1.789 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.645 177.429 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.45 ' C ' HD11 ' A' ' 102' ' ' LEU . 60.8 t -113.0 128.86 69.52 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.201 0 N-CA-C 108.142 -1.058 . . . . 0.0 108.142 176.374 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.474 ' HA ' ' O ' ' A' ' 124' ' ' LYS . 5.3 mp -129.9 136.2 49.23 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-O 120.746 0.308 . . . . 0.0 110.796 -178.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -112.43 110.09 20.08 Favored 'General case' 0 C--N 1.31 -1.146 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 177.132 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -89.82 103.5 16.15 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 176.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.423 ' HA ' HG12 ' A' ' 91' ' ' ILE . 35.1 m -82.41 157.81 23.54 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.967 -175.099 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 20.3 p -55.84 -38.13 69.64 Favored 'General case' 0 C--N 1.319 -0.725 0 C-N-CA 125.898 1.679 . . . . 0.0 113.037 -177.406 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 14.0 m -128.13 98.73 5.21 Favored 'General case' 0 N--CA 1.419 -1.983 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 -179.412 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 16.9 m -108.4 133.69 52.59 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 179.108 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.503 ' CG2' ' HG2' ' A' ' 83' ' ' LYS . 37.0 m -130.35 132.53 45.87 Favored 'General case' 0 N--CA 1.394 -3.268 0 CA-C-N 116.767 -0.197 . . . . 0.0 110.813 -164.338 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . 0.6 ' HA3' ' O ' ' A' ' 119' ' ' ASP . . . -161.98 -158.25 9.41 Favored Glycine 0 C--O 1.217 -0.916 0 C-N-CA 121.288 -0.482 . . . . 0.0 112.635 -177.274 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 53.3 m80 -117.56 108.06 15.02 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 122.165 -0.609 . . . . 0.0 109.606 176.038 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 5.9 tt -104.4 127.82 52.14 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.73 -172.071 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -131.59 168.1 18.27 Favored 'General case' 0 CA--C 1.464 -2.355 0 CA-C-N 115.243 -0.889 . . . . 0.0 109.71 173.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 54.2 tptt -84.35 101.11 11.71 Favored 'General case' 0 N--CA 1.389 -3.522 0 CA-C-N 115.179 -0.918 . . . . 0.0 108.809 -177.017 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . 0.408 ' H ' ' CD2' ' A' ' 63' ' ' LEU . . . 126.24 -11.68 7.22 Favored Glycine 0 C--O 1.205 -1.697 0 CA-C-N 115.159 -0.928 . . . . 0.0 111.164 -176.868 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 179.53 147.89 0.24 Allowed 'General case' 0 N--CA 1.487 1.393 0 CA-C-N 117.052 0.426 . . . . 0.0 111.219 178.295 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.6 tt -124.11 113.67 18.68 Favored 'General case' 0 N--CA 1.429 -1.497 0 N-CA-C 106.013 -1.847 . . . . 0.0 106.013 176.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 71.8 p -97.58 122.58 40.82 Favored 'General case' 0 C--N 1.265 -3.071 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.609 -177.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . 0.6 ' O ' ' HA3' ' A' ' 110' ' ' GLY . 31.3 m-20 73.13 129.76 0.04 OUTLIER 'General case' 0 C--O 1.207 -1.146 0 C-N-CA 125.484 1.514 . . . . 0.0 111.651 -179.155 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 10.8 m -135.5 78.75 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 CA-C-O 122.639 1.209 . . . . 0.0 108.72 173.744 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -67.17 111.53 3.97 Favored 'General case' 0 N--CA 1.424 -1.757 0 CA-C-N 113.668 -1.605 . . . . 0.0 108.85 -175.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 133.27 -13.75 4.89 Favored Glycine 0 N--CA 1.424 -2.1 0 C-N-CA 120.31 -0.948 . . . . 0.0 112.115 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.427 ' O ' ' HA ' ' A' ' 132' ' ' LYS . 67.5 mt -99.55 113.57 35.14 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.17 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 179.178 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.474 ' O ' ' HA ' ' A' ' 102' ' ' LEU . 23.1 tptm -85.07 117.9 24.31 Favored 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 104.967 -2.234 . . . . 0.0 104.967 -179.261 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 95.1 m -126.85 124.93 40.74 Favored 'General case' 0 C--N 1.288 -2.085 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 -170.347 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.518 ' HG2' ' N ' ' A' ' 127' ' ' VAL . 84.2 tttt -119.37 145.59 46.06 Favored 'General case' 0 N--CA 1.429 -1.499 0 CA-C-O 121.255 0.55 . . . . 0.0 110.203 169.548 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.518 ' N ' ' HG2' ' A' ' 126' ' ' LYS . 7.2 p -159.21 -35.68 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 175.782 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -125.25 -51.67 1.64 Allowed 'General case' 0 N--CA 1.399 -3.006 0 N-CA-C 105.621 -1.992 . . . . 0.0 105.621 -179.729 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 7.9 tp -149.94 169.9 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.285 0 N-CA-C 105.574 -2.01 . . . . 0.0 105.574 176.516 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' TRP . . . . . 0.421 ' CD1' ' HB2' ' A' ' 126' ' ' LYS . 30.6 m-90 -80.12 126.32 30.94 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-O 121.32 0.581 . . . . 0.0 111.241 177.52 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 7.3 p -137.35 137.0 46.51 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.247 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 176.636 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . 0.427 ' HA ' ' O ' ' A' ' 123' ' ' ILE . 0.0 OUTLIER -112.07 20.19 17.11 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 113.708 1.003 . . . . 0.0 113.708 -174.687 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 17.8 m -124.17 -60.55 1.86 Allowed 'Isoleucine or valine' 0 C--O 1.21 -1.014 0 CA-C-N 116.101 -0.499 . . . . 0.0 112.15 179.357 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' THR . . . . . 0.448 ' O ' ' HA ' ' A' ' 119' ' ' ASP . 77.5 p 51.71 -171.64 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 124.118 0.967 . . . . 0.0 113.465 179.386 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 23.2 p -166.0 152.9 9.73 Favored 'General case' 0 N--CA 1.427 -1.612 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 176.06 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 14.1 tt -131.29 134.0 61.61 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.322 0 CA-C-O 121.254 0.549 . . . . 0.0 109.549 -179.264 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 39.9 t -124.81 159.61 30.62 Favored 'General case' 0 C--N 1.289 -2.041 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 -176.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' THR . . . . . 0.435 HG23 ' H ' ' A' ' 140' ' ' ALA . 9.7 t -165.15 175.97 8.88 Favored 'General case' 0 N--CA 1.41 -2.436 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 -178.008 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -112.49 30.57 6.99 Favored 'General case' 0 C--N 1.275 -2.659 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 173.128 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . 0.435 ' H ' HG23 ' A' ' 138' ' ' THR . . . 62.84 38.37 11.56 Favored 'General case' 0 C--N 1.35 0.596 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 -172.462 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' SER . . . . . 0.635 ' O ' ' HB3' ' A' ' 155' ' ' ARG . 46.9 t -174.57 -79.95 0.01 OUTLIER 'General case' 0 C--O 1.219 -0.527 0 CA-C-N 114.585 -1.189 . . . . 0.0 111.312 -175.064 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -75.53 134.94 40.63 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 -178.48 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 59.4 t -106.0 130.37 57.67 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.969 0 CA-C-O 120.998 0.428 . . . . 0.0 111.556 -170.155 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -131.76 150.17 52.24 Favored 'General case' 0 CA--C 1.481 -1.699 0 CA-C-O 121.589 0.709 . . . . 0.0 110.631 176.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 60.7 m-85 -109.91 103.12 11.85 Favored 'General case' 0 C--N 1.268 -2.967 0 CA-C-N 115.026 -0.988 . . . . 0.0 111.424 179.205 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 6.6 p -81.75 19.69 1.04 Allowed 'General case' 0 C--N 1.305 -1.37 0 CA-C-N 115.073 -0.967 . . . . 0.0 113.269 -176.229 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -68.79 -15.4 63.49 Favored 'General case' 0 C--O 1.218 -0.574 0 CA-C-O 121.773 0.796 . . . . 0.0 109.812 175.209 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 166.39 29.53 0.02 OUTLIER Glycine 0 N--CA 1.43 -1.715 0 N-CA-C 108.868 -1.693 . . . . 0.0 108.868 175.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 15.6 tpt 57.59 23.5 9.38 Favored 'General case' 0 N--CA 1.486 1.328 0 CA-C-O 122.322 1.058 . . . . 0.0 108.498 -173.481 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . 0.446 ' CD ' HG11 ' A' ' 127' ' ' VAL . 0.0 OUTLIER -76.19 -9.46 58.65 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 115.942 1.83 . . . . 0.0 115.942 -169.492 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 5.2 mmpt? -147.21 138.33 23.83 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 120.514 0.197 . . . . 0.0 111.278 178.556 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 72.2 p -126.53 132.41 51.37 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 174.343 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 22.8 tpt180 -147.91 157.37 43.49 Favored 'General case' 0 C--N 1.31 -1.148 0 N-CA-C 109.554 -0.535 . . . . 0.0 109.554 -176.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 68.3 m -98.1 143.71 28.36 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 108.434 -0.951 . . . . 0.0 108.434 173.019 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' ARG . . . . . 0.635 ' HB3' ' O ' ' A' ' 141' ' ' SER . 0.0 OUTLIER -67.44 -18.29 65.04 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 118.756 -1.177 . . . . 0.0 112.758 176.837 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -41.86 -56.97 2.54 Favored 'General case' 0 N--CA 1.482 1.174 0 N-CA-C 115.128 1.529 . . . . 0.0 115.128 -173.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -56.32 -37.96 70.65 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 112.012 0.375 . . . . 0.0 112.012 -176.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 6.7 t80 176.15 -26.25 0.0 OUTLIER 'General case' 0 CA--C 1.506 -0.731 0 N-CA-C 106.913 -1.514 . . . . 0.0 106.913 174.374 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . 0.728 ' HA3' ' O ' ' A' ' 65' ' ' ILE . . . 132.03 -87.33 0.28 Allowed Glycine 0 N--CA 1.407 -3.251 0 N-CA-C 110.506 -1.037 . . . . 0.0 110.506 -174.014 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.672 ' HB ' ' O ' ' A' ' 67' ' ' ILE . 12.0 t -98.54 116.91 42.6 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.238 0 C-N-CA 119.338 -0.945 . . . . 0.0 108.701 178.593 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 75.9 mm-40 -119.61 108.94 15.08 Favored 'General case' 0 CA--C 1.501 -0.931 0 N-CA-C 113.979 1.103 . . . . 0.0 113.979 -176.638 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 22.4 mmm180 -149.71 148.43 29.25 Favored 'General case' 0 C--N 1.308 -1.234 0 C-N-CA 125.508 1.523 . . . . 0.0 107.466 172.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -74.31 89.38 2.07 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-O 121.514 0.673 . . . . 0.0 110.874 -177.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . 0.403 ' HA3' ' SG ' ' A' ' 92' ' ' CYS . . . -122.8 168.05 15.12 Favored Glycine 0 N--CA 1.432 -1.568 0 CA-C-N 115.151 -0.931 . . . . 0.0 110.952 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 49.9 tp -141.19 114.58 8.77 Favored 'General case' 0 N--CA 1.414 -2.251 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 178.537 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 81.3 mtt85 -87.4 103.97 16.0 Favored 'General case' 0 CA--C 1.476 -1.882 0 CA-C-O 122.07 0.938 . . . . 0.0 110.672 178.131 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 18.6 m -77.09 53.04 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.294 -1.809 0 CA-C-N 113.378 -1.737 . . . . 0.0 114.444 -173.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . 0.479 ' HB2' ' OG ' ' A' ' 90' ' ' SER . 32.8 t70 -135.36 -0.33 2.7 Favored 'General case' 0 N--CA 1.475 0.825 0 CA-C-O 122.271 1.034 . . . . 0.0 108.435 175.932 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -149.88 162.41 40.37 Favored 'General case' 0 N--CA 1.443 -0.817 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 -177.693 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 . . . . . 0 C--O 1.247 0.927 0 CA-C-O 118.958 -0.544 . . . . 0.0 110.162 176.784 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 42.5 m . . . . . 0 N--CA 1.446 -0.665 0 CA-C-O 120.624 0.25 . . . . 0.0 110.818 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 67.09 9.21 6.75 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 124.74 1.216 . . . . 0.0 113.364 174.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -90.79 106.9 18.83 Favored 'General case' 0 C--N 1.315 -0.892 0 C-N-CA 119.883 -0.727 . . . . 0.0 111.748 -177.349 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.46 ' H ' HD13 ' A' ' 4' ' ' ILE . 0.2 OUTLIER -116.35 91.84 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.836 0 CA-C-O 122.041 0.924 . . . . 0.0 111.133 179.347 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 44.3 p90 -140.42 113.7 8.51 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-N 115.004 -0.998 . . . . 0.0 109.295 178.54 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 38.1 t30 -160.68 91.31 0.9 Allowed 'General case' 0 C--N 1.299 -1.599 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.907 179.213 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.432 ' HD2' ' N ' ' A' ' 7' ' ' LYS . 0.3 OUTLIER -98.42 91.34 5.14 Favored 'General case' 0 C--N 1.291 -1.939 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 178.114 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.6 p -89.14 125.29 42.18 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 CA-C-N 115.168 -0.924 . . . . 0.0 110.662 -177.326 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -117.94 55.74 0.57 Allowed Glycine 0 N--CA 1.432 -1.588 0 C-N-CA 120.856 -0.688 . . . . 0.0 111.507 -178.576 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 51.0 m -79.05 125.11 28.97 Favored 'General case' 0 N--CA 1.435 -1.217 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 178.706 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 83.2 t80 -106.33 125.76 51.4 Favored 'General case' 0 N--CA 1.425 -1.675 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.831 -175.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 45.1 p90 -144.84 98.24 3.15 Favored 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 171.323 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 64.4 tp -163.24 107.7 1.06 Allowed 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.685 -176.012 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 159.59 -169.99 35.75 Favored Glycine 0 N--CA 1.429 -1.823 0 C-N-CA 120.239 -0.982 . . . . 0.0 111.411 178.823 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 27.6 pt20 -155.86 154.19 30.9 Favored 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 -179.584 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -86.79 113.33 22.53 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 107.956 -1.128 . . . . 0.0 107.956 176.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -76.42 98.82 4.68 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-N 115.976 -0.557 . . . . 0.0 111.072 -178.097 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 50.0 t-20 -87.69 93.58 9.48 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 106.606 -1.627 . . . . 0.0 106.606 174.377 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -99.85 105.81 17.6 Favored 'General case' 0 N--CA 1.419 -1.978 0 CA-C-N 115.956 -0.565 . . . . 0.0 109.557 -178.472 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -90.49 100.94 13.69 Favored 'General case' 0 N--CA 1.423 -1.809 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 177.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 56.6 t80 -100.12 96.38 7.46 Favored 'General case' 0 C--N 1.299 -1.595 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.934 -175.794 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 37.0 m-20 -97.12 85.35 3.69 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.01 179.469 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 32.7 t -169.57 135.56 1.55 Allowed 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 179.145 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 8.3 p -156.21 128.47 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 179.082 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -83.84 75.85 2.32 Favored Glycine 0 N--CA 1.431 -1.694 0 C-N-CA 120.68 -0.772 . . . . 0.0 113.123 -177.724 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -103.16 79.51 1.74 Allowed 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 174.028 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -174.97 152.74 1.54 Allowed 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.296 -177.023 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 58.3 tp 81.55 78.11 0.03 OUTLIER 'General case' 0 C--N 1.314 -0.945 0 C-N-CA 125.348 1.459 . . . . 0.0 112.318 178.722 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 53.1 t30 -159.67 89.02 0.87 Allowed 'General case' 0 C--N 1.305 -1.346 0 CA-C-N 114.19 -1.368 . . . . 0.0 107.669 175.387 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 53.1 p -90.97 93.63 9.28 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.78 -175.488 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 7.3 p -163.53 93.28 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.435 -1.212 0 CA-C-O 122.04 0.924 . . . . 0.0 110.54 178.209 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 33.3 t -86.41 -25.79 25.08 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 177.311 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 10.4 t -173.53 176.94 2.67 Favored 'General case' 0 N--CA 1.423 -1.822 0 N-CA-C 104.762 -2.31 . . . . 0.0 104.762 177.172 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 26.4 t -141.83 127.67 19.33 Favored 'General case' 0 N--CA 1.421 -1.924 0 C-N-CA 119.407 -0.917 . . . . 0.0 110.484 179.746 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 32.8 pt -104.99 -4.5 9.7 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 175.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -69.71 109.55 4.43 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-N 114.377 -1.283 . . . . 0.0 108.153 178.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 145.76 57.17 0.02 OUTLIER Glycine 0 C--N 1.293 -1.834 0 C-N-CA 119.57 -1.3 . . . . 0.0 111.763 -179.487 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -139.06 54.42 0.68 Allowed Glycine 0 N--CA 1.426 -2.012 0 N-CA-C 110.433 -1.067 . . . . 0.0 110.433 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.3 t -85.89 100.99 12.47 Favored 'General case' 0 N--CA 1.425 -1.682 0 CA-C-O 121.771 0.796 . . . . 0.0 110.444 -179.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -87.58 130.78 34.62 Favored 'General case' 0 N--CA 1.423 -1.805 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.278 -178.74 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 77.0 t-105 -128.93 103.52 7.07 Favored 'General case' 0 N--CA 1.422 -1.834 0 N-CA-C 106.96 -1.496 . . . . 0.0 106.96 177.682 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 52.2 tp -87.92 -18.54 28.91 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.812 -174.412 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 47.5 t 70.66 93.2 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.241 0.64 0 C-N-CA 123.996 0.919 . . . . 0.0 110.254 -178.259 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 -92.38 70.39 5.12 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-O 121.455 0.645 . . . . 0.0 110.463 178.746 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 87.5 tttt 176.61 93.95 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.724 0 C-N-CA 125.431 1.493 . . . . 0.0 107.542 179.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 7.2 tp -91.0 77.25 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 CA-C-O 122.174 0.988 . . . . 0.0 111.251 -178.157 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp -135.93 92.96 2.86 Favored 'General case' 0 N--CA 1.438 -1.06 0 CA-C-N 114.363 -1.289 . . . . 0.0 109.179 178.646 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -123.56 -71.4 0.24 Allowed Glycine 0 N--CA 1.42 -2.368 0 N-CA-C 109.792 -1.323 . . . . 0.0 109.792 178.122 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 67.3 mttm 51.24 91.3 0.02 OUTLIER 'General case' 0 CA--C 1.511 -0.556 0 C-N-CA 124.487 1.115 . . . . 0.0 112.166 179.467 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 26.4 ptt? -82.36 83.06 7.6 Favored 'General case' 0 C--N 1.299 -1.615 0 C-N-CA 118.78 -1.168 . . . . 0.0 111.471 -179.219 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 43.7 mt-30 -79.71 108.94 13.66 Favored 'General case' 0 N--CA 1.421 -1.882 0 N-CA-C 105.827 -1.916 . . . . 0.0 105.827 174.53 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.422 ' C ' ' H ' ' A' ' 54' ' ' LEU . 96.0 mttt 78.87 140.9 0.07 OUTLIER Pre-proline 0 CA--C 1.536 0.425 0 O-C-N 125.229 1.581 . . . . 0.0 108.152 -168.231 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.506 ' O ' ' HG ' ' A' ' 57' ' ' LEU . 43.9 Cg_endo -70.65 27.17 0.2 Allowed 'Trans proline' 0 N--CA 1.488 1.206 0 C-N-CA 123.081 2.521 . . . . 0.0 113.924 -177.408 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.65 ' O ' ' HG ' ' A' ' 58' ' ' LEU 0.261 7.9 mp -53.98 -48.71 93.05 Favored Pre-proline 0 CA--C 1.476 -1.886 0 N-CA-C 117.79 2.515 . . . . 0.0 117.79 -174.159 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.6 ' O ' ' HE2' ' A' ' 59' ' ' LYS . 52.8 Cg_exo -57.44 -25.76 67.88 Favored 'Trans proline' 0 N--CA 1.445 -1.342 0 C-N-CA 121.52 1.48 . . . . 0.0 111.418 -176.371 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -81.74 -32.04 31.71 Favored 'General case' 0 N--CA 1.417 -2.124 0 CA-C-N 115.021 -0.99 . . . . 0.0 108.898 -178.279 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.506 ' HG ' ' O ' ' A' ' 53' ' ' PRO . 15.4 mt -74.98 -29.69 60.97 Favored 'General case' 0 CA--C 1.487 -1.454 0 CA-C-N 115.004 -0.998 . . . . 0.0 110.333 -174.436 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.65 ' HG ' ' O ' ' A' ' 54' ' ' LEU . 15.5 mt -59.71 -52.4 65.67 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 -178.687 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.6 ' HE2' ' O ' ' A' ' 55' ' ' PRO . 49.5 mtmt -64.93 -23.91 67.36 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 113.955 -1.475 . . . . 0.0 110.57 177.689 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.473 ' HB3' ' HA ' ' A' ' 57' ' ' LEU . 28.3 tt0 -82.58 -19.09 39.14 Favored 'General case' 0 C--N 1.291 -1.976 0 C-N-CA 124.844 1.257 . . . . 0.0 111.679 178.456 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 36.6 m-85 -85.9 -33.21 21.28 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 113.56 0.948 . . . . 0.0 113.56 -177.669 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.468 ' OD2' HD12 ' A' ' 65' ' ' ILE . 4.6 p-10 -78.47 -165.19 0.66 Allowed 'General case' 0 C--N 1.292 -1.92 0 N-CA-C 113.116 0.784 . . . . 0.0 113.116 -167.458 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.472 HD21 ' H ' ' A' ' 115' ' ' GLY . 6.6 mt -77.16 -154.23 0.0 OUTLIER Pre-proline 0 CA--C 1.599 2.845 0 N-CA-C 104.494 -2.41 . . . . 0.0 104.494 178.146 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.476 ' O ' ' HD2' ' A' ' 155' ' ' ARG . 7.5 Cg_endo -96.77 10.9 1.25 Allowed 'Trans proline' 0 N--CA 1.441 -1.585 0 CA-C-N 123.667 2.345 . . . . 0.0 111.067 177.127 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.666 ' O ' ' HA3' ' A' ' 159' ' ' GLY . 0.2 OUTLIER -78.9 -40.31 22.77 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.92 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.68 -176.81 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 59.9 8.14 7.62 Favored Glycine 0 CA--C 1.542 1.73 0 CA-C-N 116.287 -0.415 . . . . 0.0 113.638 -177.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.505 ' H ' HG12 ' A' ' 65' ' ' ILE . 55.9 mt 59.01 -70.4 0.07 OUTLIER 'Isoleucine or valine' 0 C--O 1.211 -0.94 0 C-N-CA 127.418 2.287 . . . . 0.0 114.126 -178.72 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.501 ' HB3' ' HD3' ' A' ' 69' ' ' PRO . 34.3 t80 173.5 -56.57 0.0 OUTLIER Pre-proline 0 CA--C 1.563 1.446 0 CA-C-N 118.024 0.375 . . . . 0.0 110.571 -176.55 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.501 ' HD3' ' HB3' ' A' ' 68' ' ' PHE . 6.9 Cg_endo -98.89 157.97 0.67 Allowed 'Trans proline' 0 C--N 1.386 2.533 0 C-N-CA 123.205 2.603 . . . . 0.0 112.598 179.39 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -89.45 -8.24 68.39 Favored Glycine 0 CA--C 1.524 0.648 0 C-N-CA 121.379 -0.438 . . . . 0.0 112.39 179.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.569 ' OD2' ' HG3' ' A' ' 89' ' ' PRO . 20.8 t70 -89.6 -19.96 24.3 Favored 'General case' 0 C--O 1.213 -0.852 0 CA-C-O 122.17 0.986 . . . . 0.0 108.635 177.045 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.492 ' C ' HG21 ' A' ' 73' ' ' THR . . . -84.33 -166.13 1.35 Allowed 'General case' 0 CA--C 1.487 -1.48 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 167.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.492 HG21 ' C ' ' A' ' 72' ' ' ALA . 18.2 p 67.71 18.06 9.81 Favored 'General case' 0 CA--C 1.47 -2.11 0 CA-C-O 123.582 1.658 . . . . 0.0 110.668 172.234 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.733 ' O ' ' HA ' ' A' ' 86' ' ' VAL . 1.6 m-80 -75.87 100.49 4.81 Favored 'General case' 2 N--CA 1.365 -4.694 0 CA-C-N 111.704 -2.498 . . . . 0.0 110.513 -178.639 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -99.03 91.86 5.22 Favored 'General case' 0 C--N 1.274 -2.71 0 CA-C-N 114.572 -1.194 . . . . 0.0 113.33 -176.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.45 ' HB2' HG23 ' A' ' 85' ' ' THR . 19.2 mm-40 -97.5 133.8 41.58 Favored 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 106.729 -1.582 . . . . 0.0 106.729 175.735 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.44 ' HB2' ' CD2' ' A' ' 84' ' ' LEU . 90.6 t80 -146.57 127.28 14.3 Favored 'General case' 0 C--N 1.301 -1.511 0 C-N-CA 120.256 -0.578 . . . . 0.0 112.193 -173.477 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.596 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 5.8 m-20 -95.2 156.5 16.29 Favored 'General case' 0 CA--C 1.472 -2.043 0 N-CA-C 105.44 -2.059 . . . . 0.0 105.44 170.184 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -80.1 -60.63 2.26 Favored 'General case' 0 C--N 1.255 -3.521 0 N-CA-C 113.557 0.947 . . . . 0.0 113.557 -175.027 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -71.04 -29.94 65.98 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-O 121.415 0.626 . . . . 0.0 111.1 -175.695 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.596 ' HB ' ' HB2' ' A' ' 78' ' ' ASP . 24.6 m -68.6 -45.13 72.77 Favored 'General case' 0 N--CA 1.421 -1.886 0 CA-C-N 114.898 -1.046 . . . . 0.0 109.873 179.561 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 99.6 mttt 68.12 8.13 6.33 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.139 0.976 . . . . 0.0 113.319 -179.016 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 1.9 mptm? -89.22 106.23 18.31 Favored 'General case' 0 CA--C 1.494 -1.193 0 CA-C-O 121.551 0.691 . . . . 0.0 110.662 173.712 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.44 ' CD2' ' HB2' ' A' ' 77' ' ' PHE . 2.1 tm? -81.81 126.4 31.81 Favored 'General case' 0 C--N 1.285 -2.229 0 N-CA-C 105.426 -2.064 . . . . 0.0 105.426 174.909 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.583 ' HA ' ' O ' ' A' ' 108' ' ' VAL . 9.5 t -116.5 127.42 54.54 Favored 'General case' 0 N--CA 1.392 -3.327 0 C-N-CA 120.196 -0.602 . . . . 0.0 110.632 -178.937 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.733 ' HA ' ' O ' ' A' ' 74' ' ' ASN . 32.3 t -104.75 122.65 58.06 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.108 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.404 -178.588 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 5.6 mp -90.49 104.4 16.99 Favored 'General case' 0 C--N 1.29 -2.01 0 CA-C-N 114.981 -1.008 . . . . 0.0 109.328 177.352 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 3.5 mp -93.93 137.53 23.03 Favored Pre-proline 0 C--N 1.302 -1.489 0 N-CA-C 106.561 -1.644 . . . . 0.0 106.561 175.114 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.609 ' O ' ' HB2' ' A' ' 166' ' ' ARG . 43.4 Cg_exo -59.76 97.32 0.11 Allowed 'Trans proline' 0 N--CA 1.455 -0.781 0 C-N-CA 122.58 2.187 . . . . 0.0 110.34 176.364 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.554 ' OG ' ' HB ' ' A' ' 167' ' ' VAL . 73.4 m 66.57 177.82 0.22 Allowed 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 123.654 0.781 . . . . 0.0 110.862 -174.531 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 14.8 tt -94.78 109.06 21.66 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.763 0 C-N-CA 119.792 -0.763 . . . . 0.0 109.185 175.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 27.1 p -98.77 149.15 23.17 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.366 -179.072 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -116.56 121.32 41.42 Favored 'General case' 0 CA--C 1.476 -1.88 0 N-CA-C 107.513 -1.291 . . . . 0.0 107.513 -179.053 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.501 HG22 ' HD3' ' A' ' 162' ' ' ARG . 25.0 t -112.04 103.27 15.18 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.62 0 C-N-CA 119.614 -0.834 . . . . 0.0 111.293 -176.227 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -144.81 -156.93 7.01 Favored Glycine 0 N--CA 1.435 -1.426 0 N-CA-C 108.285 -1.926 . . . . 0.0 108.285 178.043 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 91.2 t80 75.84 -21.21 0.32 Allowed 'General case' 0 N--CA 1.492 1.631 0 CA-C-N 117.749 0.774 . . . . 0.0 112.989 173.33 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.421 ' HD3' ' OD1' ' A' ' 163' ' ' ASN . 20.9 pttp -86.61 -15.8 38.67 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-O 122.181 0.991 . . . . 0.0 108.914 179.02 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.585 ' CG ' ' H ' ' A' ' 99' ' ' SER . 17.9 t70 -177.43 -151.69 0.03 OUTLIER 'General case' 0 N--CA 1.42 -1.953 0 N-CA-C 104.403 -2.443 . . . . 0.0 104.403 -167.846 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.585 ' H ' ' CG ' ' A' ' 98' ' ' ASP . 25.5 m -123.76 -18.28 6.1 Favored 'General case' 0 C--N 1.265 -3.102 0 C-N-CA 123.839 0.856 . . . . 0.0 109.718 -175.244 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 36.1 m -74.09 96.42 2.71 Favored 'General case' 0 N--CA 1.424 -1.746 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 173.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.481 ' HA ' ' O ' ' A' ' 94' ' ' VAL . 52.0 t -97.64 119.24 45.4 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.257 0 CA-C-N 115.23 -0.895 . . . . 0.0 110.653 -176.851 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 6.5 mp -109.19 126.76 53.6 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 176.619 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 38.9 ttmt -109.46 115.16 29.41 Favored 'General case' 0 C--N 1.289 -2.035 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 -178.743 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -89.95 97.06 10.97 Favored 'General case' 0 N--CA 1.426 -1.651 0 CA-C-N 115.949 -0.569 . . . . 0.0 112.264 -175.16 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 87.9 m -56.88 122.36 12.05 Favored 'General case' 0 N--CA 1.422 -1.844 0 CA-C-N 114.062 -1.426 . . . . 0.0 109.535 174.621 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 8.0 t -71.9 117.7 13.82 Favored 'General case' 0 N--CA 1.435 -1.197 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 -179.588 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 52.3 m 70.68 68.71 0.19 Allowed 'General case' 0 N--CA 1.439 -0.984 0 CA-C-O 122.76 1.266 . . . . 0.0 108.812 -173.353 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.583 ' O ' ' HA ' ' A' ' 85' ' ' THR . 9.8 p -103.93 159.83 4.89 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.127 0 CA-C-N 113.627 -1.624 . . . . 0.0 106.812 -179.124 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 15.8 p -115.53 170.72 8.21 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-N 118.735 0.698 . . . . 0.0 111.504 -178.334 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 176.54 -175.59 47.59 Favored Glycine 0 N--CA 1.439 -1.107 0 N-CA-C 110.506 -1.038 . . . . 0.0 110.506 179.362 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 46.7 t-80 -105.77 131.39 53.18 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 -179.29 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -97.08 107.78 20.38 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-O 121.803 0.811 . . . . 0.0 112.678 -172.18 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -123.53 143.64 50.06 Favored 'General case' 0 CA--C 1.453 -2.756 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 171.064 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 3.7 tmtp? -92.01 101.06 13.6 Favored 'General case' 0 N--CA 1.384 -3.742 0 CA-C-O 122.321 1.058 . . . . 0.0 108.57 -171.556 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . 0.623 ' O ' ' HB ' ' A' ' 138' ' ' THR . . . 143.94 -58.53 0.53 Allowed Glycine 0 C--N 1.283 -2.397 0 N-CA-C 106.736 -2.546 . . . . 0.0 106.736 -175.163 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.421 ' HB2' ' HA ' ' A' ' 137' ' ' SER . 0.0 OUTLIER -132.72 130.37 39.94 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 178.989 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -91.92 105.57 17.8 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 105.569 -2.011 . . . . 0.0 105.569 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 21.4 p -99.26 175.33 5.92 Favored 'General case' 0 C--N 1.294 -1.839 0 C-N-CA 123.355 0.662 . . . . 0.0 112.069 -174.213 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 27.4 m-20 50.89 45.72 27.12 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 123.529 0.732 . . . . 0.0 111.125 173.6 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.459 ' CG2' ' HA ' ' A' ' 135' ' ' SER . 2.1 t -77.52 99.17 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.863 0 CA-C-O 122.416 1.103 . . . . 0.0 109.807 -169.863 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 46.6 tt0 -79.79 87.58 5.27 Favored 'General case' 0 N--CA 1.4 -2.928 0 CA-C-N 113.819 -1.537 . . . . 0.0 111.275 -173.641 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 126.39 7.61 5.26 Favored Glycine 0 N--CA 1.412 -2.957 0 C-N-CA 119.604 -1.284 . . . . 0.0 112.439 171.601 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 8.5 tp -98.09 116.62 41.25 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.271 0 C-N-CA 117.402 -1.719 . . . . 0.0 108.223 -176.488 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -85.73 117.65 24.74 Favored 'General case' 0 C--N 1.274 -2.68 0 CA-C-N 113.816 -1.538 . . . . 0.0 109.227 -177.155 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 80.8 m -136.02 126.95 27.65 Favored 'General case' 0 N--CA 1.415 -2.215 0 CA-C-N 114.756 -1.111 . . . . 0.0 110.914 -173.428 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.51 ' HD3' ' C ' ' A' ' 126' ' ' LYS . 0.4 OUTLIER -112.36 128.33 56.26 Favored 'General case' 0 N--CA 1.419 -1.986 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 171.255 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.464 ' N ' ' HD3' ' A' ' 126' ' ' LYS . 7.7 p -143.36 -45.58 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.805 0 CA-C-O 121.538 0.685 . . . . 0.0 109.164 176.84 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 26.5 ptm -120.5 -26.43 5.36 Favored 'General case' 0 N--CA 1.423 -1.808 0 CA-C-N 115.037 -0.983 . . . . 0.0 108.528 173.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 9.3 tp -164.13 171.51 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.416 -2.172 0 N-CA-C 104.249 -2.5 . . . . 0.0 104.249 177.324 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 88.6 t90 -85.21 120.26 26.5 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 179.57 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.443 HG13 ' H ' ' A' ' 133' ' ' VAL . 45.4 t -128.08 146.05 34.26 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 N-CA-C 107.262 -1.385 . . . . 0.0 107.262 178.724 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 22.5 pttp -111.71 31.3 6.27 Favored 'General case' 0 C--O 1.246 0.882 0 CA-C-O 121.76 0.79 . . . . 0.0 110.731 -179.646 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.443 ' H ' HG13 ' A' ' 131' ' ' VAL . 21.9 t -131.27 -80.1 0.14 Allowed 'Isoleucine or valine' 0 C--O 1.208 -1.102 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 178.834 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 41.3 p 47.57 -156.41 0.05 Allowed 'General case' 0 C--O 1.258 1.551 0 C-N-CA 123.639 0.776 . . . . 0.0 112.602 179.363 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' SER . . . . . 0.459 ' HA ' ' CG2' ' A' ' 120' ' ' VAL . 34.1 t -170.42 144.16 2.42 Favored 'General case' 0 N--CA 1.419 -1.993 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 -179.571 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 12.2 tt -99.64 96.95 5.33 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.28 0 N-CA-C 105.318 -2.105 . . . . 0.0 105.318 172.13 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' SER . . . . . 0.421 ' HA ' ' HB2' ' A' ' 116' ' ' LYS . 25.6 m -90.55 142.95 27.22 Favored 'General case' 0 N--CA 1.389 -3.509 0 CA-C-N 113.588 -1.642 . . . . 0.0 109.303 -174.533 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' THR . . . . . 0.623 ' HB ' ' O ' ' A' ' 115' ' ' GLY . 92.4 m -153.89 147.66 25.35 Favored 'General case' 0 C--N 1.256 -3.478 0 N-CA-C 105.743 -1.947 . . . . 0.0 105.743 -179.013 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -95.62 28.9 2.8 Favored 'General case' 0 C--N 1.276 -2.596 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 177.351 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . 0.448 ' N ' HG22 ' A' ' 138' ' ' THR . . . 58.16 39.54 25.86 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 -171.433 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 24.6 t -168.67 -70.95 0.02 OUTLIER 'General case' 0 N--CA 1.441 -0.876 0 CA-C-N 114.625 -1.17 . . . . 0.0 110.803 -175.287 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . 0.433 ' O ' HG21 ' A' ' 138' ' ' THR . 40.1 mmtm -106.42 159.7 15.95 Favored 'General case' 0 CA--C 1.51 -0.588 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 -179.45 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 48.0 t -106.21 139.32 27.93 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 CA-C-O 121.111 0.482 . . . . 0.0 110.855 -174.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 38.3 m-85 -129.5 150.28 50.91 Favored 'General case' 0 CA--C 1.498 -1.052 0 CA-C-O 122.089 0.947 . . . . 0.0 111.657 177.169 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -108.72 103.03 12.04 Favored 'General case' 0 C--N 1.277 -2.555 0 CA-C-N 113.723 -1.58 . . . . 0.0 108.98 178.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.432 ' OG1' ' HB3' ' A' ' 135' ' ' SER . 36.7 p -104.46 104.83 14.75 Favored 'General case' 0 N--CA 1.41 -2.438 0 N-CA-C 114.212 1.19 . . . . 0.0 114.212 -175.132 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -111.5 26.6 10.48 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 104.888 -2.264 . . . . 0.0 104.888 169.553 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 140.92 -74.28 0.36 Allowed Glycine 0 N--CA 1.399 -3.789 1 N-CA-C 103.049 -4.02 . . . . 0.0 103.049 -169.908 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 28.2 ttt -175.15 88.13 0.04 OUTLIER 'General case' 0 C--N 1.315 -0.934 0 C-N-CA 124.703 1.201 . . . . 0.0 108.103 170.352 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . 0.282 72.4 mmtt -106.42 -93.23 0.38 Allowed 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 116.1 1.889 . . . . 0.0 116.1 -177.605 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -93.42 161.59 14.32 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 113.7 1.0 . . . . 0.0 113.7 -172.188 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 33.0 t -133.72 156.64 47.58 Favored 'General case' 0 C--N 1.31 -1.126 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 175.561 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 20.4 tpt180 -149.62 151.13 33.27 Favored 'General case' 0 N--CA 1.441 -0.899 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 178.618 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 20.2 m -73.59 133.54 43.53 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 176.687 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' ARG . . . . . 0.476 ' HD2' ' O ' ' A' ' 64' ' ' PRO . 14.9 ttp85 -75.88 -21.43 57.17 Favored 'General case' 0 C--N 1.299 -1.597 0 CA-C-O 121.617 0.722 . . . . 0.0 109.534 176.72 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -35.11 -47.64 0.39 Allowed 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 116.923 2.194 . . . . 0.0 116.923 -172.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -76.38 -53.45 8.15 Favored 'General case' 0 CA--C 1.548 0.878 0 N-CA-C 115.041 1.497 . . . . 0.0 115.041 -171.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -140.39 7.14 2.15 Favored 'General case' 0 N--CA 1.484 1.257 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -178.03 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . 0.666 ' HA3' ' O ' ' A' ' 65' ' ' ILE . . . 96.07 -81.88 0.8 Allowed Glycine 0 CA--C 1.462 -3.223 0 N-CA-C 108.712 -1.755 . . . . 0.0 108.712 -172.004 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.503 ' CG2' ' HA ' ' A' ' 67' ' ' ILE . 17.8 t -111.62 135.02 52.17 Favored 'Isoleucine or valine' 0 N--CA 1.401 -2.916 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 172.275 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -84.76 91.68 8.03 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 -177.601 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . 0.501 ' HD3' HG22 ' A' ' 94' ' ' VAL . 3.5 mmp_? -106.59 140.79 38.91 Favored 'General case' 0 C--N 1.29 -1.978 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.897 -176.816 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' ASN . . . . . 0.434 ' H ' HG13 ' A' ' 94' ' ' VAL . 16.8 m120 -127.3 5.91 6.36 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 114.762 -1.108 . . . . 0.0 111.011 -174.895 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -81.47 167.29 48.63 Favored Glycine 0 CA--C 1.498 -1.019 0 C-N-CA 120.343 -0.932 . . . . 0.0 111.912 -175.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.404 HD22 ' H ' ' A' ' 165' ' ' LEU . 1.2 pt? -116.92 112.34 20.9 Favored 'General case' 0 N--CA 1.417 -2.106 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 -179.873 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . 0.609 ' HB2' ' O ' ' A' ' 89' ' ' PRO . 5.8 ptp85 -82.91 118.84 23.74 Favored 'General case' 0 N--CA 1.41 -2.461 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 -177.095 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . 0.554 ' HB ' ' OG ' ' A' ' 90' ' ' SER . 41.1 t -51.61 -46.52 37.55 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 CA-C-N 115.107 -0.951 . . . . 0.0 111.484 -179.776 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -79.31 81.32 5.59 Favored 'General case' 0 CA--C 1.498 -1.05 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 171.224 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 27.0 tptp -99.57 106.63 18.64 Favored 'General case' 0 C--N 1.279 -2.475 0 N-CA-C 114.046 1.128 . . . . 0.0 114.046 -179.377 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' PHE . . . . . . . . . . . . . 79.5 t80 . . . . . 0 N--CA 1.424 -1.765 0 N-CA-C 106.311 -1.737 . . . . 0.0 106.311 173.173 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 36.9 m . . . . . 0 N--CA 1.446 -0.63 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -78.23 109.17 12.11 Favored 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 178.8 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.406 ' C ' HD12 ' A' ' 4' ' ' ILE . 64.2 tt0 -145.52 96.9 2.9 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.753 -177.457 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.406 HD12 ' C ' ' A' ' 3' ' ' GLN . 2.9 mp -128.56 120.8 53.58 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.964 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 178.347 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -106.96 84.8 2.04 Favored 'General case' 0 N--CA 1.432 -1.348 0 CA-C-O 120.955 0.407 . . . . 0.0 109.927 177.075 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 44.6 t30 -89.9 92.75 9.14 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 178.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.521 ' HD3' ' H ' ' A' ' 7' ' ' LYS . 0.0 OUTLIER -102.21 104.55 15.12 Favored 'General case' 0 C--N 1.295 -1.769 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.179 179.213 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 10.5 p -144.08 139.92 24.83 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 CA-C-N 115.171 -0.922 . . . . 0.0 108.996 -179.232 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -141.75 104.77 0.39 Allowed Glycine 0 N--CA 1.423 -2.195 0 N-CA-C 110.209 -1.156 . . . . 0.0 110.209 -179.569 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 47.7 m -75.5 86.45 2.61 Favored 'General case' 0 N--CA 1.426 -1.655 0 CA-C-O 121.575 0.703 . . . . 0.0 111.141 -178.61 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 80.8 t80 -117.76 116.47 27.08 Favored 'General case' 0 N--CA 1.42 -1.969 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 176.729 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . 0.497 ' CZ3' ' HA3' ' A' ' 14' ' ' GLY . 61.2 t90 -85.81 110.33 19.3 Favored 'General case' 0 C--N 1.289 -2.055 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 179.156 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 62.6 tp -83.3 98.17 9.29 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-O 121.318 0.58 . . . . 0.0 109.644 179.68 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.497 ' HA3' ' CZ3' ' A' ' 12' ' ' TRP . . . -127.44 105.2 0.73 Allowed Glycine 0 N--CA 1.42 -2.403 0 N-CA-C 110.143 -1.183 . . . . 0.0 110.143 178.134 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -79.65 93.05 5.44 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-O 121.153 0.501 . . . . 0.0 110.049 179.506 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 14.3 ptmm? -94.26 97.32 10.16 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 174.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -112.27 95.7 5.6 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-N 115.426 -0.807 . . . . 0.0 112.02 -174.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -152.88 77.07 1.15 Allowed 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 173.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 57.9 tptt -171.96 81.88 0.06 Allowed 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 115.095 -0.957 . . . . 0.0 108.499 179.538 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -144.42 141.01 29.35 Favored 'General case' 0 C--N 1.299 -1.608 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.735 179.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -131.41 116.28 17.31 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 177.716 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -83.11 119.62 24.74 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 178.166 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 52.3 p -132.5 143.55 49.83 Favored 'General case' 0 C--N 1.296 -1.733 0 C-N-CA 120.875 -0.33 . . . . 0.0 110.887 -178.22 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 34.7 m -84.41 166.09 2.19 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 CA-C-N 116.191 -0.459 . . . . 0.0 109.834 177.738 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 150.9 171.14 18.75 Favored Glycine 0 N--CA 1.431 -1.679 0 N-CA-C 110.852 -0.899 . . . . 0.0 110.852 -179.034 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -119.54 112.19 19.04 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-O 121.262 0.553 . . . . 0.0 112.091 -177.786 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -136.35 96.57 3.39 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-O 122.056 0.932 . . . . 0.0 109.27 174.099 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -152.68 106.68 3.11 Favored 'General case' 0 C--N 1.294 -1.824 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 -178.31 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 55.2 t-20 -139.86 104.29 4.84 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 178.742 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 47.5 m -92.08 74.44 5.51 Favored 'General case' 0 N--CA 1.438 -1.044 0 N-CA-C 112.953 0.723 . . . . 0.0 112.953 -176.235 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 10.6 p 176.46 103.32 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 C-N-CA 125.796 1.639 . . . . 0.0 108.14 175.373 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.44 ' H ' ' CD ' ' A' ' 76' ' ' GLU . 51.0 p -138.58 -52.6 0.59 Allowed 'General case' 0 C--N 1.282 -2.342 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.388 -175.416 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 17.2 m 63.5 38.95 9.47 Favored 'General case' 0 N--CA 1.442 -0.872 0 CA-C-O 122.568 1.175 . . . . 0.0 108.237 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 58.5 p -67.41 118.51 10.86 Favored 'General case' 0 N--CA 1.434 -1.232 0 CA-C-N 114.319 -1.31 . . . . 0.0 110.089 179.677 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 50.2 mm -81.12 86.33 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.146 0 CA-C-O 121.681 0.753 . . . . 0.0 109.413 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 32.2 mm-40 -120.9 165.5 15.12 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 114.468 -1.242 . . . . 0.0 109.63 -179.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 104.62 131.38 7.11 Favored Glycine 0 N--CA 1.425 -2.095 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.618 176.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 123.64 33.26 0.82 Allowed Glycine 0 C--N 1.298 -1.576 0 C-N-CA 121.043 -0.598 . . . . 0.0 112.015 178.28 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 10.7 m -94.34 109.51 21.34 Favored 'General case' 0 N--CA 1.438 -1.036 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.473 ' HD3' ' N ' ' A' ' 40' ' ' LYS . 0.0 OUTLIER -113.86 90.14 3.27 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-O 121.331 0.586 . . . . 0.0 111.862 -178.49 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 57.8 t-105 -114.71 -56.5 2.37 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.106 -179.297 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 5.9 tt -157.45 137.79 12.81 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 106.522 -1.658 . . . . 0.0 106.522 -179.159 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 62.1 t -82.47 -60.51 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 N-CA-C 111.901 0.334 . . . . 0.0 111.901 -177.03 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 57.3 t30 72.84 144.76 0.07 Allowed 'General case' 0 N--CA 1.504 2.245 0 C-N-CA 123.904 0.882 . . . . 0.0 111.682 177.657 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.511 ' HB2' ' HZ2' ' A' ' 45' ' ' LYS . 10.2 mtmp? -92.22 88.94 6.67 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 -177.493 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.468 HG12 ' H ' ' A' ' 47' ' ' LYS . 15.2 tt 176.78 176.4 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.308 -1.199 0 N-CA-C 104.113 -2.551 . . . . 0.0 104.113 179.581 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.468 ' H ' HG12 ' A' ' 46' ' ' ILE . 0.0 OUTLIER -154.81 172.56 17.79 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 120.408 1.458 . . . . 0.0 111.469 -178.771 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 86.0 81.45 1.13 Allowed Glycine 0 N--CA 1.433 -1.55 0 CA-C-N 115.327 -0.851 . . . . 0.0 114.978 173.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.415 ' HA ' ' CE2' ' A' ' 170' ' ' PHE . 64.9 tttp -77.39 99.2 5.51 Favored 'General case' 0 N--CA 1.442 -0.859 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 172.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 49.1 ttm -65.37 103.61 0.84 Allowed 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 115.373 -0.83 . . . . 0.0 112.781 -172.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 14.8 mm-40 -100.97 -171.3 1.98 Allowed 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 176.661 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 48.8 mtpt -73.58 140.1 78.36 Favored Pre-proline 0 C--N 1.314 -0.966 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 176.829 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -60.92 30.02 0.05 OUTLIER 'Trans proline' 0 N--CA 1.51 2.479 0 C-N-CA 125.187 3.925 . . . . 0.0 117.576 -172.103 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 8.9 mp -65.86 -50.05 55.58 Favored Pre-proline 0 C--N 1.291 -1.972 0 N-CA-C 116.377 1.992 . . . . 0.0 116.377 178.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -62.29 -12.86 29.15 Favored 'Trans proline' 0 N--CA 1.449 -1.095 0 C-N-CA 122.336 2.024 . . . . 0.0 112.462 -170.584 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 17.8 mm-40 -72.52 -32.4 66.11 Favored 'General case' 0 N--CA 1.418 -2.028 0 N-CA-C 107.513 -1.291 . . . . 0.0 107.513 -178.491 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.475 ' O ' ' HG2' ' A' ' 60' ' ' GLU . 3.5 mm? -74.48 -44.28 52.22 Favored 'General case' 0 N--CA 1.423 -1.805 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 175.743 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.434 ' N ' HD12 ' A' ' 58' ' ' LEU . 6.9 mp -59.05 -38.55 79.63 Favored 'General case' 0 CA--C 1.495 -1.15 0 CA-C-N 114.842 -1.072 . . . . 0.0 111.646 -176.563 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.43 ' HD2' ' N ' ' A' ' 60' ' ' GLU . 0.0 OUTLIER -76.14 -29.12 57.67 Favored 'General case' 0 N--CA 1.419 -2.005 0 C-N-CA 119.345 -0.942 . . . . 0.0 112.697 177.842 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.475 ' HG2' ' O ' ' A' ' 57' ' ' LEU . 11.6 pt-20 -77.68 -27.09 50.71 Favored 'General case' 0 N--CA 1.445 -0.706 0 C-N-CA 119.212 -0.995 . . . . 0.0 111.321 -175.595 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 58.6 m-85 -57.02 -47.71 80.25 Favored 'General case' 0 C--O 1.242 0.667 0 C-N-CA 120.17 -0.612 . . . . 0.0 112.515 176.455 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -108.78 -86.05 0.52 Allowed 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 114.722 1.378 . . . . 0.0 114.722 -174.348 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.501 ' CD1' ' H ' ' A' ' 115' ' ' GLY . 0.0 OUTLIER -115.31 137.58 23.13 Favored Pre-proline 0 C--N 1.317 -0.81 0 C-N-CA 118.489 -1.284 . . . . 0.0 107.751 -179.215 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -91.49 21.26 0.8 Allowed 'Trans proline' 0 N--CA 1.429 -2.313 0 C-N-CA 123.653 2.902 . . . . 0.0 111.257 -170.332 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.535 ' C ' ' H ' ' A' ' 67' ' ' ILE . 0.2 OUTLIER -58.9 -40.33 79.96 Favored 'Isoleucine or valine' 0 CA--C 1.473 -2.007 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 176.544 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 59.2 -0.29 0.59 Allowed Glycine 0 N--CA 1.483 1.794 0 CA-C-N 114.363 -1.29 . . . . 0.0 112.182 -176.176 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.54 ' HA ' ' HB ' ' A' ' 160' ' ' VAL . 56.4 mt 62.73 -69.36 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.414 -2.238 0 C-N-CA 127.539 2.336 . . . . 0.0 111.076 -171.606 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 75.1 t80 -177.54 -52.87 0.0 OUTLIER Pre-proline 0 C--N 1.306 -1.287 0 N-CA-C 113.541 0.941 . . . . 0.0 113.541 -174.451 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.444 ' HB2' ' OD1' ' A' ' 71' ' ' ASP . 18.6 Cg_endo -90.21 -28.0 0.27 Allowed 'Trans proline' 0 N--CA 1.444 -1.432 0 C-N-CA 121.073 1.182 . . . . 0.0 115.136 -170.919 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 94.68 -18.42 57.19 Favored Glycine 0 C--O 1.216 -0.993 0 N-CA-C 110.537 -1.025 . . . . 0.0 110.537 -174.108 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.582 ' HB3' ' HG2' ' A' ' 89' ' ' PRO . 8.2 m-20 -75.48 -50.73 14.84 Favored 'General case' 0 N--CA 1.437 -1.11 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 177.272 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.406 ' HA ' ' O ' ' A' ' 87' ' ' LEU . . . -73.86 170.86 14.48 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 114.106 -1.406 . . . . 0.0 109.95 174.082 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.676 ' O ' HG21 ' A' ' 73' ' ' THR . 28.8 m 89.79 28.46 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.836 0 CA-C-O 124.11 1.909 . . . . 0.0 112.559 170.929 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.425 ' HB2' ' HB2' ' A' ' 87' ' ' LEU . 27.5 m-80 -91.25 -174.9 4.1 Favored 'General case' 0 C--N 1.247 -3.855 0 CA-C-N 114.823 -1.08 . . . . 0.0 109.973 178.133 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.464 ' HB2' HD21 ' A' ' 84' ' ' LEU . 28.4 p90 -148.9 136.14 20.13 Favored 'General case' 0 C--N 1.3 -1.545 0 C-N-CA 119.206 -0.998 . . . . 0.0 113.299 -179.387 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.48 ' O ' HD23 ' A' ' 84' ' ' LEU . 70.5 mm-40 -144.13 146.07 32.53 Favored 'General case' 0 C--N 1.306 -1.322 0 C-N-CA 126.251 1.82 . . . . 0.0 106.784 175.324 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 50.2 p90 -149.65 150.93 32.91 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-N 118.249 0.477 . . . . 0.0 111.95 -176.572 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.497 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 11.5 m-20 -95.35 163.1 13.39 Favored 'General case' 0 CA--C 1.489 -1.378 0 N-CA-C 106.857 -1.534 . . . . 0.0 106.857 173.814 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -81.11 -62.43 1.66 Allowed 'General case' 0 C--N 1.278 -2.524 0 N-CA-C 113.633 0.975 . . . . 0.0 113.633 -178.202 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -77.56 -40.39 42.63 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 121.309 0.576 . . . . 0.0 109.519 -176.236 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.497 ' HB ' ' HB2' ' A' ' 78' ' ' ASP . 81.5 m -66.67 -38.54 87.03 Favored 'General case' 0 N--CA 1.429 -1.521 0 CA-C-N 114.949 -1.023 . . . . 0.0 111.892 178.638 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 98.8 mttt 61.54 7.5 1.86 Allowed 'General case' 0 N--CA 1.5 2.036 0 N-CA-C 114.037 1.125 . . . . 0.0 114.037 177.3 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.459 ' HD3' ' HB ' ' A' ' 109' ' ' THR . 35.8 ttmt -83.26 113.33 20.61 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 108.847 -0.798 . . . . 0.0 108.847 178.74 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.48 HD23 ' O ' ' A' ' 76' ' ' GLU . 2.2 tm? -79.87 134.64 36.32 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 -176.194 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.596 ' HA ' ' O ' ' A' ' 108' ' ' VAL . 8.9 t -120.91 129.7 53.59 Favored 'General case' 0 N--CA 1.403 -2.823 0 CA-C-O 121.643 0.735 . . . . 0.0 110.309 178.763 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.412 HG11 ' O ' ' A' ' 74' ' ' ASN . 98.8 t -102.92 134.07 44.98 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.611 -177.28 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.425 ' HB2' ' HB2' ' A' ' 74' ' ' ASN . 2.5 mm? -81.95 115.92 21.34 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-N 114.676 -1.147 . . . . 0.0 110.819 -179.76 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.614 ' O ' ' HA ' ' A' ' 106' ' ' THR . 64.0 mt -124.8 103.81 30.83 Favored Pre-proline 0 C--N 1.29 -1.982 0 N-CA-C 107.375 -1.343 . . . . 0.0 107.375 173.91 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.582 ' HG2' ' HB3' ' A' ' 71' ' ' ASP . 70.9 Cg_exo -56.63 110.9 0.65 Allowed 'Trans proline' 0 C--O 1.199 -1.45 0 C-N-CA 123.136 2.557 . . . . 0.0 111.814 178.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.475 ' HB2' ' O ' ' A' ' 89' ' ' PRO . 36.7 m 75.34 149.47 0.1 Allowed 'General case' 0 CA--C 1.485 -1.52 0 CA-C-O 122.091 0.948 . . . . 0.0 113.324 -175.511 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.428 ' HA ' ' O ' ' A' ' 104' ' ' PHE . 3.3 mp -80.79 120.7 32.93 Favored 'Isoleucine or valine' 0 N--CA 1.392 -3.33 0 N-CA-C 107.594 -1.261 . . . . 0.0 107.594 173.582 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 40.4 t -96.15 121.57 38.06 Favored 'General case' 0 N--CA 1.405 -2.688 0 N-CA-C 106.625 -1.62 . . . . 0.0 106.625 171.594 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -116.82 121.6 42.0 Favored 'General case' 0 CA--C 1.466 -2.267 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 177.263 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 33.3 m -115.28 103.63 15.58 Favored 'Isoleucine or valine' 0 C--N 1.267 -2.989 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 177.754 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . 0.75 ' HA2' ' O ' ' A' ' 100' ' ' SER . . . -145.35 148.63 20.49 Favored Glycine 0 CA--C 1.478 -2.226 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 -178.851 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -125.95 -89.12 0.57 Allowed 'General case' 0 CA--C 1.478 -1.809 0 C-N-CA 118.059 -1.456 . . . . 0.0 109.788 -178.258 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.506 ' O ' ' HB2' ' A' ' 98' ' ' ASP . 57.5 mtpt -87.47 -36.74 17.49 Favored 'General case' 0 N--CA 1.415 -2.186 0 C-N-CA 119.747 -0.781 . . . . 0.0 110.479 176.122 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.506 ' HB2' ' O ' ' A' ' 97' ' ' LYS . 31.3 t70 163.22 -40.62 0.0 OUTLIER 'General case' 0 C--N 1.364 1.238 0 O-C-N 124.21 0.944 . . . . 0.0 111.817 -176.023 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 19.4 m -72.68 15.47 0.19 Allowed 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.353 1.061 . . . . 0.0 113.475 -171.464 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.75 ' O ' ' HA2' ' A' ' 95' ' ' GLY . 69.3 p -167.34 77.0 0.16 Allowed 'General case' 0 N--CA 1.41 -2.456 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 177.065 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 60.5 t -115.72 99.72 9.02 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.237 0 CA-C-O 121.23 0.538 . . . . 0.0 109.755 175.817 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.447 HD13 HG22 ' A' ' 125' ' ' THR . 1.8 mm? -111.79 129.62 56.07 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 178.693 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -116.51 107.2 14.45 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-O 120.924 0.392 . . . . 0.0 111.106 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.428 ' O ' ' HA ' ' A' ' 91' ' ' ILE . 89.0 m-85 -93.06 102.36 14.69 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 107.518 -1.289 . . . . 0.0 107.518 176.69 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.524 ' O ' ' HB ' ' A' ' 88' ' ' ILE . 13.5 t -77.07 -178.37 4.96 Favored 'General case' 0 CA--C 1.551 1.019 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.532 -175.697 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' THR . . . . . 0.614 ' HA ' ' O ' ' A' ' 88' ' ' ILE . 15.0 p -84.13 -50.32 8.04 Favored 'General case' 0 C--N 1.309 -1.162 0 C-N-CA 123.513 0.725 . . . . 0.0 111.716 -173.9 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 26.3 p -115.82 84.76 2.16 Favored 'General case' 0 N--CA 1.406 -2.644 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 175.251 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.596 ' O ' ' HA ' ' A' ' 85' ' ' THR . 14.7 p -81.58 129.58 37.27 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.296 0 CA-C-N 114.94 -1.027 . . . . 0.0 109.922 -177.317 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.48 ' OG1' ' HB3' ' A' ' 121' ' ' GLU . 17.5 p -104.98 149.0 26.12 Favored 'General case' 0 N--CA 1.4 -2.955 0 CA-C-N 116.191 -0.459 . . . . 0.0 109.771 -176.05 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 178.98 -159.41 24.3 Favored Glycine 0 N--CA 1.424 -2.135 0 N-CA-C 110.944 -0.862 . . . . 0.0 110.944 -179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . 0.429 ' HB2' ' O ' ' A' ' 118' ' ' THR . 74.1 m80 -123.68 121.22 34.96 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 177.593 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.46 ' HB3' ' HG ' ' A' ' 84' ' ' LEU . 6.4 tt -123.43 136.58 54.68 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-O 121.277 0.56 . . . . 0.0 110.427 -171.717 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -130.67 171.09 13.47 Favored 'General case' 0 CA--C 1.456 -2.64 0 CA-C-N 114.941 -1.027 . . . . 0.0 110.189 177.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 2.7 tmtm? -86.24 100.84 12.53 Favored 'General case' 1 N--CA 1.376 -4.155 0 N-CA-C 103.779 -2.674 . . . . 0.0 103.779 173.461 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . 0.62 ' O ' HG21 ' A' ' 138' ' ' THR . . . 143.2 -62.09 0.51 Allowed Glycine 0 C--N 1.273 -2.96 0 N-CA-C 109.252 -1.539 . . . . 0.0 109.252 -174.85 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.02 164.7 35.8 Favored 'General case' 0 CA--C 1.508 -0.647 0 C-N-CA 122.766 0.426 . . . . 0.0 110.087 -179.697 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 3.7 tt -121.31 109.76 15.3 Favored 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 106.252 -1.758 . . . . 0.0 106.252 176.608 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.615 ' HA ' ' OG ' ' A' ' 135' ' ' SER . 66.9 p -112.14 131.22 55.58 Favored 'General case' 0 C--N 1.277 -2.566 0 N-CA-C 114.109 1.151 . . . . 0.0 114.109 -177.263 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . 0.467 ' H ' ' HB2' ' A' ' 135' ' ' SER . 17.5 t70 70.42 107.81 0.06 Allowed 'General case' 0 CA--C 1.507 -0.71 0 N-CA-C 114.294 1.22 . . . . 0.0 114.294 175.215 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 35.8 m -112.58 166.07 6.92 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.194 0 CA-C-N 115.002 -0.999 . . . . 0.0 110.566 177.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.48 ' HB3' ' OG1' ' A' ' 109' ' ' THR . 12.0 tp10 -127.75 -8.32 5.59 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.747 -178.316 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -105.7 -19.11 10.65 Favored Glycine 0 N--CA 1.432 -1.587 0 C-N-CA 119.706 -1.235 . . . . 0.0 112.39 -173.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.484 HG13 ' CG2' ' A' ' 108' ' ' VAL . 96.2 mt -100.82 100.6 10.71 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.62 0 CA-C-O 121.98 0.895 . . . . 0.0 111.272 -178.553 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -86.27 141.89 28.94 Favored 'General case' 0 C--N 1.295 -1.77 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 172.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.447 HG22 HD13 ' A' ' 102' ' ' LEU . 17.9 m -150.5 143.04 24.47 Favored 'General case' 0 N--CA 1.421 -1.925 0 N-CA-C 112.998 0.74 . . . . 0.0 112.998 -172.561 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.537 ' HD3' ' C ' ' A' ' 126' ' ' LYS . 0.4 OUTLIER -131.07 105.24 7.58 Favored 'General case' 0 N--CA 1.423 -1.798 0 N-CA-C 105.3 -2.111 . . . . 0.0 105.3 168.56 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 7.4 p -113.47 -53.58 5.01 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.441 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 179.193 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 45.5 ttm -114.29 -27.49 7.59 Favored 'General case' 0 N--CA 1.398 -3.059 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 172.295 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 8.5 tp -161.51 171.13 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.551 1.008 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 173.77 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 8.5 m-90 -70.66 117.52 12.28 Favored 'General case' 0 CA--C 1.509 -0.605 0 CA-C-N 118.572 0.623 . . . . 0.0 110.431 179.309 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 88.6 t -147.94 111.04 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.139 0 C-N-CA 122.956 0.502 . . . . 0.0 109.783 179.62 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 54.6 pttt -106.78 114.33 28.36 Favored 'General case' 0 N--CA 1.442 -0.841 0 C-N-CA 119.31 -0.956 . . . . 0.0 109.364 173.523 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 13.5 p 173.57 -21.23 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.296 -1.755 0 N-CA-C 107.362 -1.347 . . . . 0.0 107.362 -178.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' THR . . . . . 0.444 HG22 ' HA3' ' A' ' 148' ' ' GLY . 66.4 p -7.51 88.84 0.0 OUTLIER 'General case' 0 C--N 1.366 1.295 0 C-N-CA 127.921 2.488 . . . . 0.0 114.345 177.89 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' SER . . . . . 0.615 ' OG ' ' HA ' ' A' ' 118' ' ' THR . 30.2 t -101.64 146.43 27.73 Favored 'General case' 0 N--CA 1.408 -2.571 0 CA-C-N 114.252 -1.34 . . . . 0.0 109.978 -176.505 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 8.9 tt -115.36 122.85 70.14 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.567 0 O-C-N 124.136 0.897 . . . . 0.0 109.681 179.464 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 34.7 p -105.77 135.96 46.25 Favored 'General case' 0 N--CA 1.398 -3.051 0 CA-C-O 122.239 1.018 . . . . 0.0 110.306 178.382 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' THR . . . . . 0.62 HG21 ' O ' ' A' ' 115' ' ' GLY . 3.0 t -151.08 175.68 11.88 Favored 'General case' 0 N--CA 1.385 -3.724 0 N-CA-C 105.7 -1.963 . . . . 0.0 105.7 -179.599 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -122.2 33.76 5.37 Favored 'General case' 0 C--N 1.271 -2.827 0 N-CA-C 106.272 -1.751 . . . . 0.0 106.272 177.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . 63.33 46.15 4.59 Favored 'General case' 0 C--N 1.351 0.646 0 CA-C-N 113.971 -1.468 . . . . 0.0 109.274 -176.751 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 36.2 t -178.45 -78.87 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 114.878 -1.055 . . . . 0.0 110.065 -177.702 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 66.2 mttm -88.91 143.72 26.68 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 -178.44 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.516 ' HB ' ' O ' ' A' ' 153' ' ' ARG . 47.6 t -106.86 138.4 32.81 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 CA-C-O 120.899 0.381 . . . . 0.0 111.693 -173.569 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 57.6 m-85 -136.11 141.58 44.19 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 178.463 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 51.5 p90 -66.94 161.87 23.16 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.531 0.681 . . . . 0.0 112.19 177.683 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.491 ' HB ' ' O ' ' A' ' 135' ' ' SER . 92.7 m -149.0 -58.87 0.22 Allowed 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.298 174.9 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . 0.408 ' HB2' ' HA ' ' A' ' 134' ' ' THR . . . -141.38 137.04 32.01 Favored 'General case' 0 CA--C 1.507 -0.691 0 N-CA-C 110.062 -0.348 . . . . 0.0 110.062 178.803 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . 0.444 ' HA3' HG22 ' A' ' 134' ' ' THR . . . 79.89 -54.59 4.45 Favored Glycine 0 C--O 1.219 -0.817 0 O-C-N 123.539 0.524 . . . . 0.0 113.129 177.585 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 26.4 ttt -60.98 -48.49 81.57 Favored 'General case' 0 C--N 1.3 -1.577 0 C-N-CA 123.159 0.584 . . . . 0.0 109.799 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . 0.257 27.3 mtpp 49.0 17.46 0.16 Allowed 'General case' 0 N--CA 1.486 1.348 0 N-CA-C 115.985 1.846 . . . . 0.0 115.985 177.943 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -143.95 140.98 29.97 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 175.608 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 20.6 p -87.72 111.28 21.16 Favored 'General case' 0 N--CA 1.421 -1.916 0 CA-C-O 121.392 0.615 . . . . 0.0 110.119 177.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' ARG . . . . . 0.516 ' O ' ' HB ' ' A' ' 143' ' ' VAL . 2.6 tpm_? -105.9 105.77 15.97 Favored 'General case' 0 N--CA 1.432 -1.361 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 176.657 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 48.1 m -68.71 146.23 53.14 Favored 'General case' 0 C--N 1.285 -2.209 0 C-N-CA 120.841 -0.344 . . . . 0.0 111.742 -177.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' ARG . . . . . 0.429 ' HA ' ' HA2' ' A' ' 159' ' ' GLY . 29.0 tpt180 -57.81 -31.01 66.17 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-O 121.278 0.561 . . . . 0.0 109.532 175.732 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -47.16 -41.85 18.58 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 114.298 -1.319 . . . . 0.0 112.084 175.583 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -82.41 -53.87 5.66 Favored 'General case' 0 N--CA 1.437 -1.097 0 C-N-CA 120.692 -0.403 . . . . 0.0 111.622 -179.321 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -152.99 -18.97 0.15 Allowed 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 112.815 0.672 . . . . 0.0 112.815 -175.588 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . 0.429 ' HA2' ' HA ' ' A' ' 155' ' ' ARG . . . 107.99 -93.16 0.79 Allowed Glycine 0 N--CA 1.418 -2.555 0 N-CA-C 108.062 -2.015 . . . . 0.0 108.062 -165.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.54 ' HB ' ' HA ' ' A' ' 67' ' ' ILE . 83.8 t -133.57 115.86 23.32 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 CA-C-O 121.705 0.764 . . . . 0.0 110.399 -179.761 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' GLN . . . . . 0.405 ' H ' ' HG2' ' A' ' 153' ' ' ARG . 2.5 mm-40 -134.99 135.31 41.31 Favored 'General case' 0 N--CA 1.412 -2.36 0 N-CA-C 115.158 1.54 . . . . 0.0 115.158 -177.767 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 10.9 tpt180 -150.53 110.52 4.11 Favored 'General case' 0 C--N 1.263 -3.183 0 N-CA-C 101.72 -3.437 . . . . 0.0 101.72 170.197 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -43.71 95.29 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 113.975 1.102 . . . . 0.0 113.975 -169.519 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -157.39 161.09 31.04 Favored Glycine 0 N--CA 1.433 -1.552 0 CA-C-N 114.302 -1.317 . . . . 0.0 110.439 -178.54 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.48 HD11 ' O ' ' A' ' 165' ' ' LEU . 3.5 pp -141.37 139.09 33.44 Favored 'General case' 0 N--CA 1.411 -2.399 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 178.216 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . 0.514 ' HB3' ' O ' ' A' ' 89' ' ' PRO . 0.0 OUTLIER -70.49 134.76 48.03 Favored 'General case' 0 C--N 1.295 -1.778 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 175.869 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 32.7 t -62.11 -31.36 51.13 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.845 0 O-C-N 123.755 0.66 . . . . 0.0 112.681 176.577 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -73.83 77.49 1.61 Allowed 'General case' 0 N--CA 1.485 1.308 0 CA-C-O 122.25 1.024 . . . . 0.0 111.114 174.753 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' LYS . . . . . 0.43 ' HD2' ' HA ' ' A' ' 47' ' ' LYS . 19.3 ttpp -152.95 156.39 38.8 Favored 'General case' 0 C--N 1.276 -2.606 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 -178.619 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' PHE . . . . . 0.415 ' CE2' ' HA ' ' A' ' 49' ' ' LYS . 28.3 p90 . . . . . 0 C--N 1.304 -1.378 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 174.321 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 35.5 t . . . . . 0 N--CA 1.444 -0.734 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -129.47 102.65 6.49 Favored 'General case' 0 CA--C 1.5 -0.953 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 -179.166 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -93.55 94.91 8.91 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 10.6 tt -141.41 112.14 3.36 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 CA-C-O 121.514 0.673 . . . . 0.0 110.438 177.643 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -116.17 119.43 35.77 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 115.052 -0.976 . . . . 0.0 108.871 179.817 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 -102.17 113.33 26.51 Favored 'General case' 0 C--N 1.289 -2.058 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 -174.27 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 13.6 mptt -94.43 92.75 7.29 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 170.194 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 8.3 p -133.27 143.33 39.5 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.753 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 -177.665 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 176.42 72.45 0.05 OUTLIER Glycine 0 N--CA 1.429 -1.789 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.003 -179.243 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 60.5 m -100.06 108.85 21.13 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 177.562 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 40.3 m-85 -110.7 150.81 28.5 Favored 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 -177.398 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 52.0 p-90 -120.07 121.93 39.97 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 175.151 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.476 HD11 ' O ' ' A' ' 13' ' ' LEU 0.261 2.6 pp -82.73 122.18 27.84 Favored 'General case' 0 N--CA 1.428 -1.561 0 N-CA-C 113.592 0.96 . . . . 0.0 113.592 -174.128 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -103.91 35.55 4.96 Favored Glycine 0 N--CA 1.426 -1.989 0 CA-C-N 114.881 -1.054 . . . . 0.0 110.779 178.72 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 29.9 tt0 -83.3 78.77 9.57 Favored 'General case' 0 N--CA 1.436 -1.126 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 178.586 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.483 ' HD3' ' N ' ' A' ' 17' ' ' ALA . 9.5 tmtt? -174.87 133.76 0.35 Allowed 'General case' 0 N--CA 1.443 -0.804 0 N-CA-C 105.861 -1.903 . . . . 0.0 105.861 -177.143 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.483 ' N ' ' HD3' ' A' ' 16' ' ' LYS . . . -123.32 160.75 26.03 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 179.146 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -118.39 128.27 54.47 Favored 'General case' 0 C--N 1.308 -1.203 0 C-N-CA 120.14 -0.624 . . . . 0.0 111.669 -178.396 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 58.0 mttp -94.71 117.2 29.74 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 115.169 -0.923 . . . . 0.0 108.55 178.657 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -138.38 134.61 34.38 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-O 121.064 0.459 . . . . 0.0 111.098 -178.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 38.4 p90 -121.29 166.94 13.3 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.145 -177.476 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -125.89 108.68 11.67 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 176.769 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 58.2 p -142.08 104.47 4.48 Favored 'General case' 0 C--N 1.298 -1.635 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.601 -179.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 33.6 m -108.7 147.45 13.37 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.37 0 CA-C-O 120.72 0.295 . . . . 0.0 110.761 178.526 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -114.72 63.93 0.31 Allowed Glycine 0 N--CA 1.436 -1.321 0 N-CA-C 110.541 -1.024 . . . . 0.0 110.541 179.22 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 79.1 m-20 -94.71 14.33 21.54 Favored 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 -177.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -69.14 145.77 53.05 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 97.0 mt -124.01 111.42 15.97 Favored 'General case' 0 C--N 1.302 -1.478 0 CA-C-O 121.042 0.449 . . . . 0.0 111.205 -176.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 41.5 t30 -94.22 90.59 6.39 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 108.866 -0.791 . . . . 0.0 108.866 175.285 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 55.2 p -97.48 15.07 24.27 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.036 -178.284 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 45.9 t -76.47 90.39 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.054 0 CA-C-O 121.792 0.806 . . . . 0.0 109.827 -179.224 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 33.8 t -148.06 102.72 3.41 Favored 'General case' 0 N--CA 1.412 -2.325 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 178.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 39.4 p -115.86 -4.91 12.05 Favored 'General case' 0 C--N 1.294 -1.812 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.897 -179.614 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 42.1 t 65.88 22.31 11.38 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.301 -178.187 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 7.8 tp -61.05 138.4 21.96 Favored 'Isoleucine or valine' 0 C--O 1.244 0.788 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.906 179.422 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 72.77 16.27 4.64 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 124.078 0.951 . . . . 0.0 110.235 -177.174 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -57.71 -33.38 67.42 Favored Glycine 0 C--N 1.335 0.504 0 CA-C-N 115.611 -0.722 . . . . 0.0 112.817 -179.165 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -162.64 95.82 0.13 Allowed Glycine 0 N--CA 1.435 -1.426 0 N-CA-C 110.672 -0.971 . . . . 0.0 110.672 177.126 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 9.7 t -111.49 112.94 25.03 Favored 'General case' 0 N--CA 1.436 -1.143 0 CA-C-O 122.034 0.921 . . . . 0.0 111.318 -178.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.521 ' HB2' ' HZ3' ' A' ' 40' ' ' LYS . 5.0 ttmp? -139.35 101.19 4.18 Favored 'General case' 0 N--CA 1.427 -1.597 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 178.499 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 19.1 p90 -101.78 86.01 2.83 Favored 'General case' 0 C--N 1.286 -2.168 0 C-N-CA 119.11 -1.036 . . . . 0.0 111.189 -178.243 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 93.6 mt -121.51 92.82 3.83 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-N 114.691 -1.14 . . . . 0.0 107.99 177.002 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 10.0 p -141.01 143.85 27.64 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.93 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.5 -178.454 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 -116.14 110.0 18.24 Favored 'General case' 0 C--N 1.295 -1.781 0 N-CA-C 107.926 -1.138 . . . . 0.0 107.926 179.098 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 8.1 tmtt? -75.08 88.68 2.43 Favored 'General case' 0 C--O 1.244 0.781 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 -177.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 9.0 tp 173.46 -28.23 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 C-N-CA 125.902 1.681 . . . . 0.0 106.743 -177.518 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -102.45 155.03 18.53 Favored 'General case' 0 N--CA 1.437 -1.082 0 N-CA-C 107.448 -1.316 . . . . 0.0 107.448 175.489 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 97.9 53.94 1.25 Allowed Glycine 0 N--CA 1.427 -1.918 0 N-CA-C 107.943 -2.063 . . . . 0.0 107.943 -172.412 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -74.53 142.22 44.78 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 114.435 -0.883 . . . . 0.0 110.988 -175.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 66.6 mtt -78.12 89.75 4.23 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-O 121.506 0.669 . . . . 0.0 110.021 176.814 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 49.4 mt-30 -105.04 151.5 23.88 Favored 'General case' 0 C--N 1.293 -1.85 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 176.657 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.554 ' HZ3' ' HB2' ' A' ' 52' ' ' LYS . 4.8 ttmp? 73.92 132.15 0.04 OUTLIER Pre-proline 0 CA--C 1.556 1.199 0 O-C-N 124.478 1.112 . . . . 0.0 108.785 -176.182 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -68.5 -15.67 41.95 Favored 'Trans proline' 0 N--CA 1.487 1.09 0 C-N-CA 123.133 2.555 . . . . 0.0 116.943 -170.707 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.619 ' O ' ' HG ' ' A' ' 58' ' ' LEU . 3.5 mm? -53.55 -46.64 98.09 Favored Pre-proline 0 N--CA 1.498 1.935 0 N-CA-C 116.658 2.096 . . . . 0.0 116.658 -173.785 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.493 ' HA ' HD12 ' A' ' 58' ' ' LEU . 26.2 Cg_exo -59.65 -21.09 61.2 Favored 'Trans proline' 0 N--CA 1.426 -2.464 0 C-N-CA 121.275 1.317 . . . . 0.0 112.029 -172.19 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -84.3 -41.39 16.89 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 123.456 0.702 . . . . 0.0 110.73 -179.196 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -69.7 -51.42 34.57 Favored 'General case' 0 CA--C 1.488 -1.407 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.962 178.214 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.619 ' HG ' ' O ' ' A' ' 54' ' ' LEU 0.294 1.7 pp -62.19 -26.77 68.54 Favored 'General case' 0 C--O 1.208 -1.082 0 C-N-CA 119.745 -0.782 . . . . 0.0 111.029 179.284 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.431 ' HB2' ' O ' ' A' ' 55' ' ' PRO . 37.1 ttmt -69.45 -41.52 76.14 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 114.671 -1.15 . . . . 0.0 111.842 174.785 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -80.18 -16.18 55.41 Favored 'General case' 0 N--CA 1.441 -0.908 0 C-N-CA 119.418 -0.913 . . . . 0.0 109.122 -179.49 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 26.0 m-85 -84.29 -31.92 24.64 Favored 'General case' 0 C--N 1.321 -0.644 0 C-N-CA 119.437 -0.905 . . . . 0.0 111.456 177.665 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.489 ' CG ' ' H ' ' A' ' 63' ' ' LEU . 20.7 t70 -87.11 -155.46 0.28 Allowed 'General case' 0 CA--C 1.545 0.773 0 N-CA-C 106.486 -1.672 . . . . 0.0 106.486 173.09 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.491 ' HB2' HD11 ' A' ' 65' ' ' ILE . 13.4 mt -84.03 155.4 64.14 Favored Pre-proline 0 C--N 1.299 -1.618 0 N-CA-C 107.248 -1.39 . . . . 0.0 107.248 -178.685 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -80.61 10.21 3.4 Favored 'Trans proline' 0 N--CA 1.453 -0.868 0 C-N-CA 122.2 1.933 . . . . 0.0 113.27 -166.102 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.589 HG12 ' H ' ' A' ' 67' ' ' ILE . 0.2 OUTLIER -81.34 -26.22 10.31 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.311 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 179.708 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 68.42 9.98 59.22 Favored Glycine 0 C--N 1.357 1.742 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.29 179.808 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.609 ' O ' HG23 ' A' ' 160' ' ' VAL . 55.8 mt 64.3 -68.01 0.14 Allowed 'Isoleucine or valine' 0 C--O 1.181 -2.506 0 C-N-CA 126.259 1.824 . . . . 0.0 111.653 -171.845 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.421 ' HB2' HG23 ' A' ' 160' ' ' VAL . 39.7 t80 -170.58 -57.81 0.0 OUTLIER Pre-proline 0 C--N 1.275 -2.632 0 CA-C-N 118.078 0.399 . . . . 0.0 111.177 -175.409 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.402 ' HG2' ' OD1' ' A' ' 71' ' ' ASP . 8.6 Cg_endo -100.57 -10.41 0.27 Allowed 'Trans proline' 0 N--CA 1.449 -1.116 0 C-N-CA 122.505 2.137 . . . . 0.0 114.793 -172.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 73.83 10.65 80.59 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.369 -0.92 . . . . 0.0 111.561 -175.2 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.442 ' HB2' ' CG ' ' A' ' 89' ' ' PRO . 13.3 p30 -95.96 -50.3 4.93 Favored 'General case' 0 N--CA 1.421 -1.905 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 178.438 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.555 ' O ' ' HB ' ' A' ' 73' ' ' THR . . . -64.01 178.45 0.65 Allowed 'General case' 0 C--N 1.318 -0.77 0 C-N-CA 124.302 1.041 . . . . 0.0 109.08 164.028 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.643 ' O ' HG21 ' A' ' 73' ' ' THR . 65.0 m 84.33 27.89 0.08 Allowed 'General case' 0 C--N 1.349 0.578 0 CA-C-O 124.052 1.882 . . . . 0.0 109.773 171.217 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.634 HD21 ' N ' ' A' ' 74' ' ' ASN . 0.5 OUTLIER -80.93 176.33 9.91 Favored 'General case' 0 C--N 1.288 -2.072 0 C-N-CA 118.002 -1.479 . . . . 0.0 109.803 -178.768 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.446 ' CD2' HD11 ' A' ' 84' ' ' LEU . 13.7 t80 -147.12 109.84 4.66 Favored 'General case' 0 C--N 1.289 -2.051 0 C-N-CA 119.273 -0.971 . . . . 0.0 111.498 -171.387 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -131.24 116.99 18.37 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.988 172.568 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 88.5 t80 -115.03 132.6 56.55 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.007 -173.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.433 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 26.1 m-20 -92.02 178.71 5.8 Favored 'General case' 0 CA--C 1.488 -1.436 0 CA-C-O 121.387 0.613 . . . . 0.0 111.048 -179.447 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -79.74 -74.11 0.31 Allowed 'General case' 0 C--N 1.294 -1.819 0 CA-C-N 114.503 -1.226 . . . . 0.0 112.244 -177.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -92.1 -22.35 19.95 Favored 'General case' 0 CA--C 1.503 -0.862 0 CA-C-N 115.823 -0.626 . . . . 0.0 112.402 -174.798 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.433 ' HB ' ' HB2' ' A' ' 78' ' ' ASP . 59.7 m -68.64 -51.7 39.27 Favored 'General case' 0 N--CA 1.427 -1.602 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.535 178.677 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 98.0 mttt 63.18 2.77 1.15 Allowed 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 124.16 0.984 . . . . 0.0 113.255 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.426 ' HG2' ' CG2' ' A' ' 109' ' ' THR . 35.6 ttmt -94.45 94.53 8.29 Favored 'General case' 0 N--CA 1.427 -1.598 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 173.933 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.446 HD11 ' CD2' ' A' ' 75' ' ' TYR . 6.9 tt -66.15 144.11 56.87 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-N 113.191 -1.822 . . . . 0.0 111.845 -172.37 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.413 ' HA ' ' O ' ' A' ' 108' ' ' VAL . 10.1 t -110.03 125.54 53.03 Favored 'General case' 0 N--CA 1.411 -2.38 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.148 179.212 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 86.1 t -99.53 127.85 51.89 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.363 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.265 178.116 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.568 ' HA ' ' O ' ' A' ' 106' ' ' THR . 1.2 mm? -97.25 142.11 29.54 Favored 'General case' 0 N--CA 1.418 -2.055 0 CA-C-N 113.707 -1.588 . . . . 0.0 109.507 -177.235 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 58.8 mt -137.28 119.96 11.44 Favored Pre-proline 0 C--N 1.252 -3.633 0 CA-C-N 112.854 -1.975 . . . . 0.0 105.685 174.413 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.442 ' CG ' ' HB2' ' A' ' 71' ' ' ASP . 6.2 Cg_exo -22.41 -52.72 0.04 OUTLIER 'Trans proline' 0 C--N 1.37 1.691 1 C-N-CA 126.133 4.555 . . . . 0.0 116.445 -178.769 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 41.3 t -151.55 165.35 34.53 Favored 'General case' 0 N--CA 1.425 -1.695 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 -179.743 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.471 HD11 ' HD2' ' A' ' 103' ' ' LYS . 6.1 tt -72.3 112.38 7.88 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.979 0 CA-C-O 121.647 0.737 . . . . 0.0 110.37 178.41 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' CYS . . . . . 0.535 ' HB3' ' CE2' ' A' ' 104' ' ' PHE . 48.0 t -118.09 128.54 54.85 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 178.625 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -122.33 139.32 53.95 Favored 'General case' 0 C--N 1.292 -1.931 0 C-N-CA 119.218 -0.993 . . . . 0.0 110.158 176.614 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 34.4 m -124.28 106.67 17.2 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.168 -175.219 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -146.93 112.72 0.62 Allowed Glycine 0 C--N 1.317 -0.518 0 C-N-CA 120.035 -1.079 . . . . 0.0 113.153 176.527 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 72.7 m-85 -145.2 -107.75 0.1 Allowed 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 113.712 1.005 . . . . 0.0 113.712 175.568 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 1.7 pptp? -87.59 -2.0 58.32 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.974 0.731 . . . . 0.0 112.974 -175.775 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -81.89 -16.43 50.67 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-O 120.972 0.415 . . . . 0.0 110.737 -177.557 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 36.8 t 83.19 -10.94 0.97 Allowed 'General case' 0 CA--C 1.506 -0.747 0 C-N-CA 125.105 1.362 . . . . 0.0 109.801 -179.013 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.42 ' HA ' ' O ' ' A' ' 126' ' ' LYS . 73.6 p -100.02 109.3 21.62 Favored 'General case' 0 N--CA 1.394 -3.248 0 CA-C-O 121.221 0.534 . . . . 0.0 110.692 179.532 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 65.1 t -93.65 105.39 16.8 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.069 0 N-CA-C 107.03 -1.47 . . . . 0.0 107.03 172.02 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.416 HD23 ' H ' ' A' ' 126' ' ' LYS . 83.3 mt -118.53 114.63 23.11 Favored 'General case' 0 C--N 1.286 -2.187 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.99 -173.678 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.471 ' HD2' HD11 ' A' ' 91' ' ' ILE . 34.9 ttpt -103.55 113.17 26.47 Favored 'General case' 0 N--CA 1.427 -1.576 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.091 -179.313 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.535 ' CE2' ' HB3' ' A' ' 92' ' ' CYS 0.288 38.9 p90 -111.07 107.72 17.19 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-O 122.191 0.996 . . . . 0.0 112.538 179.467 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.546 ' H ' HG22 ' A' ' 123' ' ' ILE . 12.2 t -72.11 -175.74 1.57 Allowed 'General case' 0 N--CA 1.436 -1.151 0 CA-C-N 113.843 -1.526 . . . . 0.0 111.958 -177.378 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' THR . . . . . 0.568 ' O ' ' HA ' ' A' ' 87' ' ' LEU . 4.7 t -93.18 -27.64 16.76 Favored 'General case' 0 C--N 1.288 -2.102 0 CA-C-N 114.624 -1.171 . . . . 0.0 112.682 -173.26 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 25.0 m -139.73 95.35 2.9 Favored 'General case' 0 C--N 1.275 -2.672 0 N-CA-C 107.672 -1.232 . . . . 0.0 107.672 -178.478 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.413 ' O ' ' HA ' ' A' ' 85' ' ' THR . 3.4 p -103.83 160.36 4.73 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.52 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 -177.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.426 ' CG2' ' HG2' ' A' ' 83' ' ' LYS . 61.1 m -132.4 120.56 22.18 Favored 'General case' 0 N--CA 1.415 -2.219 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 -169.769 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -163.83 -159.43 10.8 Favored Glycine 0 C--O 1.208 -1.517 0 C-N-CA 120.474 -0.87 . . . . 0.0 113.097 -178.543 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 41.0 m80 -114.59 122.75 47.48 Favored 'General case' 0 CA--C 1.482 -1.664 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 178.47 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.415 HD21 ' HA ' ' A' ' 62' ' ' ASP . 5.2 tt -102.47 110.41 22.35 Favored 'General case' 0 C--N 1.285 -2.228 0 C-N-CA 119.965 -0.694 . . . . 0.0 109.278 -176.237 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -118.77 157.98 26.49 Favored 'General case' 0 CA--C 1.455 -2.678 0 CA-C-O 121.827 0.823 . . . . 0.0 109.445 174.122 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 16.5 mmtp -75.31 101.47 4.72 Favored 'General case' 0 C--N 1.245 -3.936 0 CA-C-O 122.687 1.232 . . . . 0.0 112.567 -178.492 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 121.59 -11.91 9.55 Favored Glycine 0 N--CA 1.411 -2.982 0 CA-C-N 113.195 -1.82 . . . . 0.0 110.021 -177.033 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -172.37 129.94 0.57 Allowed 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 113.363 0.875 . . . . 0.0 113.363 177.752 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.403 ' HB3' ' CG2' ' A' ' 136' ' ' ILE . 59.7 tp -97.39 104.23 16.23 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 106.46 -1.682 . . . . 0.0 106.46 172.664 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.458 ' HA ' ' CB ' ' A' ' 135' ' ' SER . 82.4 p -104.0 172.25 6.9 Favored 'General case' 0 C--N 1.311 -1.074 0 N-CA-C 111.803 0.297 . . . . 0.0 111.803 -173.301 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 57.76 46.17 17.59 Favored 'General case' 0 CA--C 1.496 -1.115 0 O-C-N 123.997 0.811 . . . . 0.0 110.7 172.71 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . 0.263 8.5 m -84.52 77.01 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.414 -2.266 0 CA-C-O 123.224 1.488 . . . . 0.0 111.962 -173.413 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -73.38 89.03 1.59 Allowed 'General case' 0 N--CA 1.394 -3.246 0 CA-C-N 112.287 -2.233 . . . . 0.0 110.293 -177.678 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 160.85 -22.91 0.24 Allowed Glycine 0 N--CA 1.413 -2.895 0 CA-C-N 115.085 -0.961 . . . . 0.0 110.801 176.504 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.546 HG22 ' H ' ' A' ' 105' ' ' THR . 18.6 pt -110.53 141.1 26.85 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.313 0 C-N-CA 119.62 -0.832 . . . . 0.0 111.657 -179.768 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -101.92 126.88 48.92 Favored 'General case' 0 C--N 1.294 -1.821 0 CA-C-N 114.795 -1.093 . . . . 0.0 110.331 177.479 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 97.4 m -115.49 109.74 18.27 Favored 'General case' 0 C--N 1.281 -2.394 0 CA-C-N 114.797 -1.092 . . . . 0.0 109.575 -178.297 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.457 ' HE2' ' C ' ' A' ' 127' ' ' VAL . 6.6 tmtt? -114.56 134.73 54.82 Favored 'General case' 0 N--CA 1.421 -1.878 0 C-N-CA 120.441 -0.503 . . . . 0.0 110.45 174.102 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.457 ' C ' ' HE2' ' A' ' 126' ' ' LYS . 89.7 t -130.19 -57.74 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.289 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 176.242 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 16.9 tpt -115.66 -34.86 4.71 Favored 'General case' 0 C--N 1.291 -1.971 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 173.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 7.8 tp -138.55 155.01 27.73 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.933 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.303 177.016 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 72.6 m95 -79.43 117.51 20.46 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 123.095 0.558 . . . . 0.0 110.872 179.343 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 17.5 m -129.93 157.16 42.54 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 174.107 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 48.0 pttt -126.84 28.48 5.83 Favored 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 -174.348 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 46.1 t -122.07 -83.07 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.15 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 175.472 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' THR . . . . . 0.408 ' HB ' ' H ' ' A' ' 135' ' ' SER . 33.8 p 42.6 -161.71 0.01 OUTLIER 'General case' 0 CA--C 1.559 1.324 0 N-CA-C 114.288 1.218 . . . . 0.0 114.288 -178.54 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' SER . . . . . 0.458 ' CB ' ' HA ' ' A' ' 118' ' ' THR . 89.6 p -171.81 157.75 4.66 Favored 'General case' 0 N--CA 1.414 -2.24 0 N-CA-C 106.801 -1.555 . . . . 0.0 106.801 176.167 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . 0.403 ' CG2' ' HB3' ' A' ' 117' ' ' LEU . 9.7 tt -100.44 113.02 34.87 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.94 0 N-CA-C 106.12 -1.808 . . . . 0.0 106.12 173.284 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 23.3 m -105.04 155.08 19.3 Favored 'General case' 0 N--CA 1.418 -2.074 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.676 -172.115 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' THR . . . . . 0.44 HG23 ' HB3' ' A' ' 63' ' ' LEU . 9.4 t -164.09 166.19 21.57 Favored 'General case' 0 C--N 1.282 -2.333 0 N-CA-C 106.922 -1.51 . . . . 0.0 106.922 178.59 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -111.86 64.77 0.62 Allowed 'General case' 0 C--N 1.268 -2.94 0 C-N-CA 117.682 -1.607 . . . . 0.0 106.808 170.296 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . 50.88 41.64 27.03 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 113.568 -1.651 . . . . 0.0 111.69 -178.036 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' SER . . . . . 0.547 ' O ' ' HD2' ' A' ' 155' ' ' ARG . 47.4 t 171.05 -84.78 0.0 OUTLIER 'General case' 0 C--N 1.346 0.447 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.387 -175.486 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 61.5 pttt -78.91 135.58 37.02 Favored 'General case' 0 CA--C 1.491 -1.326 0 C-N-CA 120.158 -0.617 . . . . 0.0 109.881 -177.31 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 5.3 p -105.52 147.02 11.75 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.91 0 CA-C-O 121.122 0.487 . . . . 0.0 111.474 -166.377 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -139.17 155.91 47.49 Favored 'General case' 0 CA--C 1.499 -0.983 0 CA-C-N 115.417 -0.81 . . . . 0.0 109.935 -179.058 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . 0.423 ' HB2' ' HB2' ' A' ' 151' ' ' LYS . 62.7 m-85 -105.8 114.67 28.96 Favored 'General case' 0 C--N 1.282 -2.345 0 CA-C-N 115.195 -0.912 . . . . 0.0 110.006 172.934 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.427 HG21 ' OG ' ' A' ' 135' ' ' SER . 8.8 t -70.44 2.79 3.52 Favored 'General case' 0 CA--C 1.554 1.115 0 CA-C-N 114.739 -1.119 . . . . 0.0 113.051 -172.089 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -63.16 -17.04 61.95 Favored 'General case' 0 C--O 1.221 -0.407 0 CA-C-O 121.332 0.587 . . . . 0.0 111.0 -178.259 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 156.3 31.53 0.03 OUTLIER Glycine 0 CA--C 1.492 -1.399 0 N-CA-C 110.107 -1.197 . . . . 0.0 110.107 172.505 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 53.1 ttm 58.83 19.72 7.26 Favored 'General case' 0 C--N 1.361 1.081 0 CA-C-O 122.42 1.105 . . . . 0.0 108.482 -173.099 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . 0.461 ' O ' ' HE3' ' A' ' 151' ' ' LYS . 17.5 ptpt -85.13 1.78 46.43 Favored 'General case' 0 N--CA 1.44 -0.972 0 CA-C-N 114.628 -1.169 . . . . 0.0 113.634 -172.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . 0.461 ' HE3' ' O ' ' A' ' 150' ' ' LYS . 5.1 mmpt? -147.16 118.34 7.78 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 123.218 0.607 . . . . 0.0 109.818 176.247 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 23.7 p -133.01 132.96 42.47 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 177.081 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 25.4 mmt180 -138.7 155.18 48.46 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 122.154 0.181 . . . . 0.0 110.539 179.499 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 70.1 p -79.11 119.91 22.9 Favored 'General case' 0 C--O 1.25 1.086 0 N-CA-C 113.528 0.936 . . . . 0.0 113.528 -175.552 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' ARG . . . . . 0.547 ' HD2' ' O ' ' A' ' 141' ' ' SER . 28.7 ttt180 -71.07 -35.92 72.08 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.073 0.463 . . . . 0.0 111.021 176.327 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -50.11 -41.81 49.22 Favored 'General case' 0 C--N 1.314 -0.943 0 C-N-CA 123.721 0.809 . . . . 0.0 112.528 -175.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -71.1 -52.36 19.79 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.921 -178.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . 0.445 ' HB2' HE22 ' A' ' 161' ' ' GLN . 99.1 m-85 -149.36 -23.13 0.29 Allowed 'General case' 0 N--CA 1.484 1.254 0 N-CA-C 112.028 0.381 . . . . 0.0 112.028 -179.191 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . 0.411 ' CA ' ' HA ' ' A' ' 155' ' ' ARG . . . 128.73 -90.41 0.32 Allowed Glycine 0 N--CA 1.446 -0.646 0 N-CA-C 109.008 -1.637 . . . . 0.0 109.008 -172.901 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.609 HG23 ' O ' ' A' ' 67' ' ' ILE . 22.8 m -98.45 144.78 10.97 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.764 0 N-CA-C 106.285 -1.746 . . . . 0.0 106.285 173.194 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' GLN . . . . . 0.445 HE22 ' HB2' ' A' ' 158' ' ' TYR . 27.1 mm-40 -113.62 90.1 3.26 Favored 'General case' 0 C--N 1.3 -1.572 0 C-N-CA 119.022 -1.071 . . . . 0.0 111.447 -176.526 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -154.75 150.03 27.14 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 173.5 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 50.0 t30 -88.61 104.81 17.2 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-O 121.254 0.55 . . . . 0.0 110.553 177.566 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -142.63 150.51 22.27 Favored Glycine 0 CA--C 1.484 -1.876 0 N-CA-C 108.937 -1.665 . . . . 0.0 108.937 177.561 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -142.74 118.98 10.8 Favored 'General case' 0 N--CA 1.419 -2.018 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 176.784 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.05 136.13 57.1 Favored 'General case' 0 N--CA 1.427 -1.577 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 173.31 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 48.6 t -53.28 -40.66 40.37 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.925 0 O-C-N 123.947 0.78 . . . . 0.0 110.148 175.127 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -86.07 70.79 10.62 Favored 'General case' 0 CA--C 1.503 -0.832 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.598 174.535 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' LYS . . . . . 0.402 ' O ' ' HB2' ' A' ' 170' ' ' PHE . 59.7 tttp -152.93 119.09 5.49 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.411 177.491 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' PHE . . . . . 0.402 ' HB2' ' O ' ' A' ' 169' ' ' LYS . 59.4 t80 . . . . . 0 C--O 1.252 1.194 0 N-CA-C 106.667 -1.605 . . . . 0.0 106.667 174.366 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 27.3 p . . . . . 0 N--CA 1.443 -0.818 0 CA-C-O 120.581 0.229 . . . . 0.0 111.242 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -136.3 94.33 3.01 Favored 'General case' 0 CA--C 1.494 -1.183 0 O-C-N 122.245 -0.284 . . . . 0.0 110.49 -179.339 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -96.51 90.38 5.35 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 174.518 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.419 HD11 ' N ' ' A' ' 5' ' ' PHE . 0.0 OUTLIER -136.18 133.77 50.15 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.096 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 -177.483 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.419 ' N ' HD11 ' A' ' 4' ' ' ILE . 43.4 p90 -150.61 134.39 16.64 Favored 'General case' 0 C--N 1.292 -1.93 0 CA-C-O 120.902 0.382 . . . . 0.0 110.703 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -101.83 82.59 2.28 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 173.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -126.86 102.65 7.11 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 -177.201 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 8.4 p -161.31 137.58 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.563 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.957 -178.215 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -153.15 84.58 0.15 Allowed Glycine 0 N--CA 1.424 -2.15 0 N-CA-C 110.436 -1.066 . . . . 0.0 110.436 178.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 18.8 m -79.73 88.17 5.21 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-O 121.112 0.482 . . . . 0.0 110.409 -179.161 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 54.4 p90 -151.63 146.69 26.0 Favored 'General case' 0 N--CA 1.438 -1.073 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 177.401 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 40.8 p90 -161.47 166.74 26.75 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 -179.523 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 4.0 tt -98.92 116.06 30.3 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 -178.082 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -152.08 60.0 0.41 Allowed Glycine 0 N--CA 1.438 -1.187 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 178.088 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -117.69 0.43 12.02 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-O 121.632 0.73 . . . . 0.0 110.633 -174.14 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -108.93 121.61 45.47 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.404 -178.818 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -168.26 168.88 11.24 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 123.704 0.801 . . . . 0.0 109.441 177.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 18.6 m120 62.45 72.95 0.48 Allowed 'General case' 0 C--O 1.243 0.746 0 C-N-CA 124.565 1.146 . . . . 0.0 113.393 178.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 14.6 ptmm? -164.0 120.07 1.62 Allowed 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 115.117 -0.947 . . . . 0.0 109.231 176.505 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -135.38 -70.0 0.49 Allowed 'General case' 0 C--N 1.312 -1.025 0 CA-C-O 121.005 0.431 . . . . 0.0 109.95 -178.466 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 45.2 p90 -139.62 149.04 43.29 Favored 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 108.442 -0.948 . . . . 0.0 108.442 178.591 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -97.79 154.51 17.57 Favored 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 -178.394 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 16.5 m 64.39 102.94 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.245 1.018 . . . . 0.0 113.361 174.434 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 55.4 t -93.16 103.22 14.46 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 177.116 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -149.59 133.04 4.26 Favored Glycine 0 N--CA 1.431 -1.694 0 N-CA-C 110.76 -0.936 . . . . 0.0 110.76 -179.497 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 46.4 m-80 -141.51 167.67 21.61 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-N 116.73 0.265 . . . . 0.0 110.662 -178.156 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 26.4 m-20 -83.86 165.72 18.52 Favored 'General case' 0 C--N 1.313 -1.0 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 177.451 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 90.0 mt -80.76 115.96 20.52 Favored 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 176.607 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -66.41 117.59 8.86 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.12 179.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 21.0 m -102.85 158.39 16.3 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 -179.508 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 54.3 t -84.06 -48.37 17.06 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 175.801 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 50.0 m 69.05 -35.25 0.3 Allowed 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 124.584 1.154 . . . . 0.0 113.411 177.792 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 23.3 m -69.09 -10.81 59.47 Favored 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 123.831 0.852 . . . . 0.0 109.968 178.449 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 19.1 m -64.17 104.83 0.79 Allowed 'General case' 0 N--CA 1.436 -1.152 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.954 179.422 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.506 ' O ' ' HE2' ' A' ' 52' ' ' LYS . 9.2 tp -120.53 -33.79 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 174.838 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 57.64 15.36 2.83 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 124.479 1.112 . . . . 0.0 112.517 177.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -96.91 114.8 5.07 Favored Glycine 0 N--CA 1.423 -2.202 0 N-CA-C 111.617 -0.593 . . . . 0.0 111.617 -178.699 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -75.65 138.36 22.99 Favored Glycine 0 N--CA 1.431 -1.682 0 N-CA-C 110.64 -0.984 . . . . 0.0 110.64 178.638 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 41.1 m -80.62 87.95 5.74 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-O 121.749 0.785 . . . . 0.0 110.395 -178.804 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 5.2 tmtm? -145.87 100.28 3.39 Favored 'General case' 0 C--N 1.311 -1.104 0 N-CA-C 106.384 -1.71 . . . . 0.0 106.384 179.759 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 40.9 p90 -88.73 115.51 26.32 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-O 121.855 0.836 . . . . 0.0 111.187 -177.529 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 61.4 tp -106.53 -40.24 5.62 Favored 'General case' 0 C--N 1.297 -1.685 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.575 -179.221 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 58.3 t -84.57 103.78 12.12 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.968 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.79 -178.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 -93.09 83.61 4.71 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-O 121.27 0.557 . . . . 0.0 109.662 178.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 10.5 tmtt? -160.28 106.45 1.54 Allowed 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 105.428 -2.064 . . . . 0.0 105.428 178.103 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 2.3 pp -80.29 148.94 5.37 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 N-CA-C 113.889 1.07 . . . . 0.0 113.889 -174.783 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 60.2 tttm 61.02 87.87 0.09 Allowed 'General case' 0 C--O 1.25 1.094 0 C-N-CA 124.651 1.181 . . . . 0.0 111.803 178.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 162.46 -161.3 33.5 Favored Glycine 0 N--CA 1.434 -1.494 0 N-CA-C 110.371 -1.092 . . . . 0.0 110.371 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -86.48 95.36 9.68 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 108.542 -0.911 . . . . 0.0 108.542 179.481 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 82.8 mtp -98.08 -79.52 0.47 Allowed 'General case' 0 C--N 1.293 -1.885 0 CA-C-O 121.363 0.601 . . . . 0.0 111.117 -175.362 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 52.6 mt-30 -151.93 -156.8 0.74 Allowed 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 -174.777 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.506 ' HE2' ' O ' ' A' ' 35' ' ' ILE . 50.3 tptt -57.92 137.48 83.51 Favored Pre-proline 0 CA--C 1.556 1.199 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 176.528 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -61.39 32.53 0.06 OUTLIER 'Trans proline' 0 N--CA 1.499 1.827 0 C-N-CA 124.385 3.39 . . . . 0.0 117.72 -174.325 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.67 ' O ' ' HG ' ' A' ' 58' ' ' LEU . 1.8 mm? -63.85 -54.47 41.04 Favored Pre-proline 0 CA--C 1.495 -1.163 0 CA-C-N 119.427 1.012 . . . . 0.0 111.139 178.368 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.506 ' O ' ' HG2' ' A' ' 59' ' ' LYS . 24.7 Cg_exo -60.84 -25.44 81.23 Favored 'Trans proline' 0 C--N 1.386 2.53 0 C-N-CA 121.103 1.202 . . . . 0.0 111.185 -172.581 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -76.18 -47.69 23.23 Favored 'General case' 0 N--CA 1.433 -1.303 0 CA-C-N 114.884 -1.053 . . . . 0.0 109.031 179.681 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.407 ' HA ' ' HG2' ' A' ' 60' ' ' GLU . 52.1 tp -63.83 -48.86 75.11 Favored 'General case' 0 C--N 1.313 -1.021 0 C-N-CA 124.562 1.145 . . . . 0.0 111.497 -179.164 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.67 ' HG ' ' O ' ' A' ' 54' ' ' LEU 0.339 2.4 pp -67.1 -33.85 76.36 Favored 'General case' 0 N--CA 1.428 -1.547 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 -177.995 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.506 ' HG2' ' O ' ' A' ' 55' ' ' PRO . 23.1 pttp -76.56 -30.9 57.26 Favored 'General case' 0 C--O 1.222 -0.367 0 C-N-CA 119.442 -0.903 . . . . 0.0 111.875 175.363 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.407 ' HG2' ' HA ' ' A' ' 57' ' ' LEU . 12.7 pt-20 -76.69 -40.18 49.65 Favored 'General case' 0 CA--C 1.509 -0.601 0 C-N-CA 120.038 -0.665 . . . . 0.0 111.737 -177.368 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 27.7 m-85 -68.64 -19.37 64.41 Favored 'General case' 0 C--O 1.24 0.582 0 C-N-CA 119.0 -1.08 . . . . 0.0 113.035 174.3 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.476 ' O ' ' HE3' ' A' ' 114' ' ' LYS . 12.1 t0 -95.39 176.12 6.31 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.132 178.267 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.51 ' HB2' HD13 ' A' ' 65' ' ' ILE . 13.8 mt -71.39 179.81 0.88 Allowed Pre-proline 0 CA--C 1.577 1.985 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 -177.184 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_endo -88.03 12.66 2.79 Favored 'Trans proline' 0 N--CA 1.45 -1.035 0 C-N-CA 122.211 1.941 . . . . 0.0 111.801 -175.613 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.594 HG12 ' H ' ' A' ' 67' ' ' ILE . 0.2 OUTLIER -68.84 -42.02 82.46 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 178.017 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 58.87 8.79 6.16 Favored Glycine 0 N--CA 1.496 2.644 0 CA-C-O 121.956 0.753 . . . . 0.0 112.163 -176.412 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.594 ' H ' HG12 ' A' ' 65' ' ' ILE . 62.6 mt 56.63 -70.05 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.192 -1.973 0 C-N-CA 128.294 2.638 . . . . 0.0 112.307 -173.544 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.445 ' HB3' ' HD3' ' A' ' 69' ' ' PRO . 88.2 t80 175.2 -61.24 0.0 OUTLIER Pre-proline 0 CA--C 1.543 0.692 0 N-CA-C 112.762 0.653 . . . . 0.0 112.762 -174.539 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.445 ' HD3' ' HB3' ' A' ' 68' ' ' PHE . 3.4 Cg_endo -84.49 -21.23 3.62 Favored 'Trans proline' 0 N--CA 1.447 -1.232 0 C-N-CA 121.409 1.406 . . . . 0.0 114.584 -168.004 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 83.38 -11.5 55.28 Favored Glycine 0 C--O 1.224 -0.497 0 N-CA-C 111.006 -0.837 . . . . 0.0 111.006 -175.576 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.524 ' HB3' ' HG2' ' A' ' 89' ' ' PRO . 20.1 m-20 -83.21 -42.0 17.77 Favored 'General case' 0 N--CA 1.438 -1.038 0 N-CA-C 105.587 -2.005 . . . . 0.0 105.587 177.955 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.518 ' O ' ' HB ' ' A' ' 73' ' ' THR . . . -75.89 -178.35 4.27 Favored 'General case' 0 CA--C 1.546 0.793 0 CA-C-N 113.695 -1.593 . . . . 0.0 109.719 175.217 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.598 ' O ' HG21 ' A' ' 73' ' ' THR . 41.3 m 84.44 26.11 0.09 Allowed 'General case' 0 N--CA 1.49 1.554 0 CA-C-O 124.544 2.116 . . . . 0.0 110.178 175.131 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.607 HD21 ' N ' ' A' ' 74' ' ' ASN . 0.7 OUTLIER -81.07 136.86 36.0 Favored 'General case' 0 C--N 1.272 -2.791 0 CA-C-N 114.527 -1.215 . . . . 0.0 110.16 -178.988 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 43.1 t80 -113.11 90.2 3.28 Favored 'General case' 0 C--N 1.277 -2.552 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.693 -169.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.531 ' O ' HD21 ' A' ' 84' ' ' LEU . 13.2 mm-40 -122.85 150.98 42.16 Favored 'General case' 0 C--O 1.202 -1.415 0 N-CA-C 106.934 -1.506 . . . . 0.0 106.934 179.073 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 46.8 p90 -146.89 144.26 29.13 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-N 119.514 1.052 . . . . 0.0 111.334 176.804 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.472 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 10.8 m-20 -92.01 165.83 13.0 Favored 'General case' 0 CA--C 1.481 -1.705 0 CA-C-O 121.258 0.551 . . . . 0.0 109.542 -178.341 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.406 ' O ' ' HG3' ' A' ' 82' ' ' LYS . 48.8 mt-10 -82.35 -43.79 16.98 Favored 'General case' 0 C--N 1.281 -2.383 0 CA-C-N 114.859 -1.064 . . . . 0.0 112.414 176.25 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -65.25 -33.09 75.18 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 122.62 1.2 . . . . 0.0 109.424 -179.81 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.543 ' CG2' ' HG2' ' A' ' 83' ' ' LYS . 29.7 m -85.23 -52.96 5.55 Favored 'General case' 0 N--CA 1.404 -2.766 0 CA-C-N 113.04 -1.891 . . . . 0.0 110.54 -178.056 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.406 ' HG3' ' O ' ' A' ' 79' ' ' GLU . 62.9 mttp 64.16 8.85 4.32 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 124.211 1.004 . . . . 0.0 109.892 -173.152 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.543 ' HG2' ' CG2' ' A' ' 81' ' ' THR 0.25 14.1 pttt -117.48 146.99 43.14 Favored 'General case' 0 N--CA 1.404 -2.773 0 CA-C-N 114.612 -1.176 . . . . 0.0 109.156 -177.459 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.531 HD21 ' O ' ' A' ' 76' ' ' GLU . 1.8 tm? -73.96 130.19 39.37 Favored 'General case' 0 C--N 1.279 -2.481 0 CA-C-N 115.288 -0.869 . . . . 0.0 111.82 -167.26 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.417 ' HA ' ' O ' ' A' ' 108' ' ' VAL . 74.5 p -111.3 111.95 23.37 Favored 'General case' 0 N--CA 1.411 -2.399 0 CA-C-N 114.892 -1.049 . . . . 0.0 109.063 177.549 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.548 ' HA ' ' O ' ' A' ' 74' ' ' ASN . 86.2 t -91.19 122.46 42.62 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.253 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 177.546 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.506 ' HA ' ' O ' ' A' ' 106' ' ' THR 0.388 1.0 OUTLIER -104.04 102.46 12.22 Favored 'General case' 0 N--CA 1.389 -3.483 0 CA-C-O 122.923 1.344 . . . . 0.0 112.782 -179.042 . . . . . . . . 4 4 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.473 ' O ' HG22 ' A' ' 106' ' ' THR . 69.0 mt -85.56 128.54 58.62 Favored Pre-proline 0 C--N 1.279 -2.487 0 CA-C-N 113.038 -1.892 . . . . 0.0 108.888 -176.824 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.524 ' HG2' ' HB3' ' A' ' 71' ' ' ASP . 50.6 Cg_exo -61.97 109.71 0.86 Allowed 'Trans proline' 0 CA--C 1.504 -0.988 0 C-N-CA 122.708 2.272 . . . . 0.0 110.563 177.926 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 30.4 t 69.26 179.55 0.24 Allowed 'General case' 0 CA--C 1.552 1.037 0 O-C-N 124.019 0.824 . . . . 0.0 110.357 -177.494 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.518 HD13 ' HG3' ' A' ' 103' ' ' LYS . 0.0 OUTLIER -112.58 132.35 61.58 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.784 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.007 177.692 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' CYS . . . . . 0.616 ' SG ' ' HB2' ' A' ' 104' ' ' PHE . 28.1 p -112.28 124.42 52.42 Favored 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 175.618 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.439 ' OE1' ' HE2' ' A' ' 103' ' ' LYS . 35.9 tt0 -124.2 129.72 51.29 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 178.823 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.549 ' O ' ' HA ' ' A' ' 101' ' ' VAL . 20.8 m -122.36 114.63 43.31 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.994 0 CA-C-O 121.234 0.54 . . . . 0.0 111.074 179.132 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -143.77 152.9 24.57 Favored Glycine 0 N--CA 1.427 -1.941 0 N-CA-C 108.332 -1.907 . . . . 0.0 108.332 178.107 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 18.9 t80 175.97 -60.24 0.01 OUTLIER 'General case' 0 CA--C 1.481 -1.678 0 N-CA-C 106.429 -1.693 . . . . 0.0 106.429 -174.609 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.515 ' HA ' ' HE3' ' A' ' 97' ' ' LYS . 0.1 OUTLIER -87.11 -6.81 58.54 Favored 'General case' 0 N--CA 1.409 -2.491 0 CA-C-N 111.327 -2.67 . . . . 0.0 112.055 -172.629 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.442 ' O ' ' HD3' ' A' ' 126' ' ' LYS . 17.3 t70 71.81 -43.86 0.57 Allowed 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 124.407 1.083 . . . . 0.0 112.947 179.765 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 27.3 m -64.01 -30.6 71.66 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 176.576 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 31.1 p -117.31 91.07 3.47 Favored 'General case' 0 N--CA 1.398 -3.039 0 CA-C-N 114.612 -1.177 . . . . 0.0 110.555 177.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.549 ' HA ' ' O ' ' A' ' 94' ' ' VAL . 17.2 m -125.9 101.09 7.62 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 CA-C-N 115.079 -0.964 . . . . 0.0 108.89 172.154 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.585 ' HG ' ' OG1' ' A' ' 125' ' ' THR . 5.4 mp -123.45 125.69 45.4 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.829 -173.467 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.518 ' HG3' HD13 ' A' ' 91' ' ' ILE . 39.3 ttmt -112.46 113.1 25.11 Favored 'General case' 0 C--N 1.317 -0.82 0 O-C-N 123.127 0.267 . . . . 0.0 110.371 176.738 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.616 ' HB2' ' SG ' ' A' ' 92' ' ' CYS . 96.1 m-85 -103.67 98.94 8.73 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 175.315 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 87.1 m -74.37 159.96 31.66 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 115.095 -0.957 . . . . 0.0 111.378 -178.173 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' THR . . . . . 0.506 ' O ' ' HA ' ' A' ' 87' ' ' LEU . 90.2 m -57.93 -67.94 0.29 Allowed 'General case' 0 N--CA 1.431 -1.381 0 C-N-CA 124.665 1.186 . . . . 0.0 111.373 178.616 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 37.4 p -96.12 90.23 5.45 Favored 'General case' 0 N--CA 1.431 -1.4 0 C-N-CA 119.512 -0.875 . . . . 0.0 111.961 179.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.417 ' O ' ' HA ' ' A' ' 85' ' ' THR . 17.6 m -95.17 132.21 39.82 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 CA-C-N 115.538 -0.756 . . . . 0.0 109.649 176.443 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 30.3 m -114.94 120.06 38.64 Favored 'General case' 0 N--CA 1.413 -2.29 0 N-CA-C 108.712 -0.848 . . . . 0.0 108.712 -173.648 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . 0.542 ' HA2' ' O ' ' A' ' 119' ' ' ASP . . . -150.99 161.79 29.18 Favored Glycine 0 N--CA 1.435 -1.393 0 C-N-CA 121.132 -0.556 . . . . 0.0 111.967 -177.626 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 84.2 t60 -84.81 90.8 7.84 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 178.524 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.453 ' HB2' HD12 ' A' ' 117' ' ' LEU . 5.4 tt -89.52 107.81 19.29 Favored 'General case' 0 N--CA 1.417 -2.1 0 N-CA-C 106.649 -1.611 . . . . 0.0 106.649 179.218 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -108.36 153.12 23.72 Favored 'General case' 0 N--CA 1.385 -3.705 0 N-CA-C 104.655 -2.35 . . . . 0.0 104.655 174.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.476 ' HE3' ' O ' ' A' ' 62' ' ' ASP . 21.4 tptm -75.2 101.5 4.65 Favored 'General case' 0 C--N 1.277 -2.566 0 C-N-CA 117.781 -1.568 . . . . 0.0 109.015 -176.221 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . 0.447 ' O ' HG21 ' A' ' 138' ' ' THR . . . 140.64 -24.42 2.62 Favored Glycine 0 C--O 1.19 -2.649 0 CA-C-N 114.043 -1.435 . . . . 0.0 110.236 -175.228 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 19.7 ptmt -173.98 151.2 1.71 Allowed 'General case' 0 N--CA 1.492 1.632 0 CA-C-N 117.643 0.721 . . . . 0.0 111.919 -179.038 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.466 ' HB3' ' CG2' ' A' ' 136' ' ' ILE . 27.3 tp -118.07 105.35 11.76 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 178.729 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 33.4 p -109.31 144.84 36.93 Favored 'General case' 0 C--N 1.295 -1.787 0 N-CA-C 113.681 0.993 . . . . 0.0 113.681 -176.26 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . 0.542 ' O ' ' HA2' ' A' ' 110' ' ' GLY . 31.5 m-20 60.81 94.06 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 124.885 1.274 . . . . 0.0 111.131 177.447 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 11.2 m -116.53 91.09 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.425 -1.715 0 CA-C-O 122.493 1.139 . . . . 0.0 113.009 -173.284 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -66.77 103.43 1.11 Allowed 'General case' 0 C--N 1.29 -1.999 0 CA-C-N 113.785 -1.552 . . . . 0.0 110.251 175.697 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 139.6 -20.68 2.92 Favored Glycine 0 N--CA 1.432 -1.607 0 CA-C-N 115.11 -0.95 . . . . 0.0 112.008 178.736 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 73.9 mt -101.56 108.17 23.02 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 CA-C-O 120.937 0.399 . . . . 0.0 110.267 -179.333 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 29.0 ttpp -101.23 130.93 47.44 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 176.033 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.585 ' OG1' ' HG ' ' A' ' 102' ' ' LEU . 15.1 t -157.53 163.81 38.01 Favored 'General case' 0 C--N 1.302 -1.498 0 C-N-CA 120.27 -0.572 . . . . 0.0 110.217 -175.822 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.442 ' HD3' ' O ' ' A' ' 98' ' ' ASP . 74.3 tttt -127.51 142.83 51.28 Favored 'General case' 0 C--N 1.276 -2.609 0 CA-C-N 115.52 -0.763 . . . . 0.0 109.354 174.964 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.401 HG13 ' CB ' ' A' ' 150' ' ' LYS . 83.6 t -110.92 -78.93 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.421 -1.918 0 N-CA-C 107.227 -1.398 . . . . 0.0 107.227 167.679 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' MET . . . . . 0.488 ' C ' HD13 ' A' ' 129' ' ' ILE . 26.3 ttt -105.49 -32.16 8.65 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 176.287 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . 0.488 HD13 ' C ' ' A' ' 128' ' ' MET . 2.7 mp -130.83 154.42 40.66 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.747 0 N-CA-C 107.057 -1.461 . . . . 0.0 107.057 175.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' TRP . . . . . 0.409 ' CD1' ' HB2' ' A' ' 126' ' ' LYS . 12.7 m-90 -70.95 134.12 46.95 Favored 'General case' 0 C--O 1.242 0.696 0 CA-C-O 120.845 0.355 . . . . 0.0 110.969 178.895 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 3.7 m -135.34 162.5 37.7 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 C-N-CA 123.803 0.841 . . . . 0.0 111.282 177.79 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . 0.458 ' HZ2' ' HB3' ' A' ' 132' ' ' LYS . 0.1 OUTLIER -137.77 9.87 2.86 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 112.265 0.468 . . . . 0.0 112.265 -175.673 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 59.1 t -118.12 -69.12 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 C-N-CA 120.307 -0.557 . . . . 0.0 110.04 178.664 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 76.4 p 54.96 -178.6 0.03 OUTLIER 'General case' 0 C--O 1.247 0.944 0 N-CA-C 114.987 1.477 . . . . 0.0 114.987 177.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 36.1 p -164.96 146.84 7.94 Favored 'General case' 0 N--CA 1.422 -1.861 0 CA-C-N 114.955 -1.02 . . . . 0.0 109.056 177.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . 0.466 ' CG2' ' HB3' ' A' ' 117' ' ' LEU . 10.7 tt -113.68 107.95 24.25 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 175.377 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 33.3 p -100.6 148.93 24.27 Favored 'General case' 0 N--CA 1.398 -3.042 0 CA-C-O 121.713 0.768 . . . . 0.0 110.926 -177.166 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' THR . . . . . 0.447 HG21 ' O ' ' A' ' 115' ' ' GLY . 6.1 t -165.31 176.12 8.61 Favored 'General case' 0 N--CA 1.4 -2.958 0 N-CA-C 106.765 -1.569 . . . . 0.0 106.765 -176.778 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -115.26 29.05 8.28 Favored 'General case' 0 C--N 1.277 -2.544 0 N-CA-C 105.859 -1.904 . . . . 0.0 105.859 172.567 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . 66.04 54.72 0.97 Allowed 'General case' 0 C--O 1.242 0.685 0 CA-C-N 113.886 -1.507 . . . . 0.0 107.321 -171.497 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 44.4 t -168.0 -81.41 0.02 OUTLIER 'General case' 0 N--CA 1.443 -0.785 0 CA-C-N 114.405 -1.271 . . . . 0.0 111.327 -174.772 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -95.59 150.03 20.79 Favored 'General case' 0 C--O 1.203 -1.383 0 C-N-CA 122.913 0.485 . . . . 0.0 110.477 -176.429 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.659 ' HB ' ' O ' ' A' ' 153' ' ' ARG . 67.8 t -105.65 114.48 45.19 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.118 0 CA-C-O 121.749 0.785 . . . . 0.0 112.477 -173.081 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 82.0 m-85 -117.89 113.29 21.53 Favored 'General case' 0 N--CA 1.422 -1.858 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 174.469 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 69.2 t80 -83.37 106.7 15.34 Favored 'General case' 0 C--N 1.288 -2.08 0 N-CA-C 108.582 -0.895 . . . . 0.0 108.582 -177.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . 0.406 5.6 p -86.52 78.1 9.28 Favored 'General case' 0 N--CA 1.389 -3.517 0 N-CA-C 116.658 2.095 . . . . 0.0 116.658 -173.802 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -126.7 76.17 1.61 Allowed 'General case' 0 N--CA 1.417 -2.124 0 N-CA-C 104.737 -2.32 . . . . 0.0 104.737 168.115 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 78.75 7.12 88.38 Favored Glycine 0 N--CA 1.441 -1.027 0 CA-C-N 114.195 -1.366 . . . . 0.0 111.274 -174.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' MET . . . . . 0.413 ' O ' ' HG2' ' A' ' 149' ' ' MET . 27.3 ttt 63.67 15.75 9.19 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 124.538 1.135 . . . . 0.0 109.397 -175.682 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . 0.401 ' CB ' HG13 ' A' ' 127' ' ' VAL . 64.3 mttp -66.21 -26.95 67.62 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 114.993 -1.003 . . . . 0.0 113.476 -175.24 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . 0.522 ' HA ' ' HE2' ' A' ' 151' ' ' LYS . 8.2 mmpt? -114.13 136.73 52.61 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.012 0.434 . . . . 0.0 110.472 179.247 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 43.3 m -132.18 126.26 33.18 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 178.58 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' ARG . . . . . 0.659 ' O ' ' HB ' ' A' ' 143' ' ' VAL . 7.0 tpm_? -133.37 108.46 8.71 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 -176.86 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 16.2 m -61.08 128.96 38.99 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 175.524 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' ARG . . . . . 0.437 ' HD3' ' C ' ' A' ' 155' ' ' ARG . 2.5 tmt_? -59.24 -29.47 67.56 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 123.516 0.727 . . . . 0.0 109.299 -179.664 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -41.1 -41.12 1.66 Allowed 'General case' 0 C--N 1.314 -0.936 0 C-N-CA 125.615 1.566 . . . . 0.0 113.735 178.286 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -57.45 -53.11 61.84 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -176.397 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -178.88 20.46 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.172 0 N-CA-C 107.721 -1.214 . . . . 0.0 107.721 -179.202 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . 0.488 ' HA3' ' O ' ' A' ' 65' ' ' ILE . . . 95.85 -98.21 2.19 Favored Glycine 0 N--CA 1.405 -3.429 0 N-CA-C 108.901 -1.679 . . . . 0.0 108.901 -170.631 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.439 ' CG2' ' HB ' ' A' ' 65' ' ' ILE . 3.5 t -121.99 114.14 41.61 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.769 0 N-CA-C 105.793 -1.928 . . . . 0.0 105.793 176.385 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -132.51 98.3 4.32 Favored 'General case' 0 C--N 1.29 -2.02 0 C-N-CA 118.033 -1.467 . . . . 0.0 110.295 -171.012 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 39.8 ttm180 -153.26 100.61 2.47 Favored 'General case' 0 N--CA 1.428 -1.544 0 C-N-CA 120.441 -0.504 . . . . 0.0 109.89 170.816 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 51.41 -33.55 0.01 OUTLIER 'General case' 0 N--CA 1.509 2.477 0 N-CA-C 119.179 3.029 . . . . 0.0 119.179 171.415 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -60.75 111.39 3.7 Favored Glycine 0 C--N 1.315 -0.637 0 N-CA-C 115.647 1.019 . . . . 0.0 115.647 -173.637 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 44.9 tp -124.22 118.78 27.61 Favored 'General case' 0 N--CA 1.425 -1.681 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 176.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . 0.43 ' HB3' ' O ' ' A' ' 89' ' ' PRO . 6.3 mpt_? -78.14 117.6 19.58 Favored 'General case' 0 CA--C 1.479 -1.771 0 CA-C-O 121.112 0.482 . . . . 0.0 110.196 -177.531 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 4.3 m -78.05 62.34 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.947 0 CA-C-O 122.3 1.048 . . . . 0.0 113.233 179.145 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -111.65 -21.7 11.57 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 106.871 -1.529 . . . . 0.0 106.871 172.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 23.7 ttmm -91.12 101.92 14.66 Favored 'General case' 0 N--CA 1.425 -1.715 0 CA-C-N 113.551 -1.658 . . . . 0.0 110.413 -175.642 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 170' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 . . . . . 0 C--N 1.309 -1.193 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 177.268 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 23.1 m . . . . . 0 N--CA 1.45 -0.425 0 CA-C-O 121.115 0.483 . . . . 0.0 110.103 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -99.39 147.75 24.91 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.143 -175.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 -150.37 152.74 34.86 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 106.465 -1.68 . . . . 0.0 106.465 175.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 73.6 mt -92.96 102.31 13.51 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.722 0 C-N-CA 120.082 -0.647 . . . . 0.0 110.821 -179.535 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -113.97 93.1 4.21 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 173.799 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 32.0 t30 -145.16 119.66 9.7 Favored 'General case' 0 C--N 1.29 -2.004 0 CA-C-O 121.25 0.547 . . . . 0.0 110.583 -178.13 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -116.98 130.71 56.87 Favored 'General case' 0 C--N 1.287 -2.148 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 175.639 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.3 p -73.28 110.24 6.45 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 CA-C-O 121.745 0.784 . . . . 0.0 110.121 178.041 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -92.32 51.57 2.75 Favored Glycine 0 N--CA 1.421 -2.322 0 CA-C-N 115.547 -0.751 . . . . 0.0 112.808 -175.681 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 24.8 p -87.11 97.32 10.68 Favored 'General case' 0 N--CA 1.42 -1.933 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 175.192 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 70.9 m-85 -101.9 112.55 25.21 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.782 -173.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 72.6 t-105 -117.98 100.56 7.64 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.289 176.268 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 5.1 mp -112.67 96.52 6.02 Favored 'General case' 0 N--CA 1.428 -1.544 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 175.529 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 178.78 149.82 8.44 Favored Glycine 0 N--CA 1.423 -2.227 0 N-CA-C 109.159 -1.576 . . . . 0.0 109.159 -178.526 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -152.5 126.96 9.33 Favored 'General case' 0 C--N 1.292 -1.897 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 -178.248 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 60.2 mttp -88.04 96.93 10.7 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-O 121.52 0.676 . . . . 0.0 110.178 -179.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -123.42 129.51 51.38 Favored 'General case' 0 N--CA 1.428 -1.567 0 CA-C-N 115.117 -0.947 . . . . 0.0 109.737 -178.427 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -87.52 147.51 25.33 Favored 'General case' 0 C--N 1.308 -1.2 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 178.352 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -87.51 99.36 11.97 Favored 'General case' 0 N--CA 1.428 -1.566 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 179.517 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -84.86 81.01 9.07 Favored 'General case' 0 N--CA 1.429 -1.512 0 CA-C-O 122.079 0.943 . . . . 0.0 109.742 176.74 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 44.8 t80 -135.89 89.76 2.52 Favored 'General case' 0 N--CA 1.419 -1.989 0 CA-C-N 115.046 -0.979 . . . . 0.0 108.414 179.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -136.31 169.56 17.45 Favored 'General case' 0 C--N 1.281 -2.378 0 N-CA-C 108.042 -1.095 . . . . 0.0 108.042 -178.595 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 23.4 m -109.33 147.95 31.87 Favored 'General case' 0 C--N 1.281 -2.384 0 CA-C-O 120.764 0.316 . . . . 0.0 110.213 -176.755 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 54.2 t -83.6 92.42 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.394 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 177.767 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -100.79 56.02 0.78 Allowed Glycine 0 N--CA 1.429 -1.826 0 N-CA-C 110.897 -0.881 . . . . 0.0 110.897 -178.51 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -58.77 120.3 8.72 Favored 'General case' 0 C--N 1.317 -0.823 0 O-C-N 123.928 0.428 . . . . 0.0 109.972 -179.339 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -79.08 94.3 5.3 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-O 121.219 0.533 . . . . 0.0 111.822 -176.842 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.7 tt 176.48 113.81 0.02 OUTLIER 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 104.376 -2.453 . . . . 0.0 104.376 179.286 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -66.77 109.67 2.97 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 121.341 0.591 . . . . 0.0 111.001 -177.006 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 32.2 t -153.88 -168.12 2.87 Favored 'General case' 0 N--CA 1.419 -1.986 0 N-CA-C 106.437 -1.69 . . . . 0.0 106.437 -178.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 60.7 t -86.26 85.25 2.33 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 CA-C-O 121.508 0.671 . . . . 0.0 109.593 178.605 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 52.3 p -151.49 98.57 2.53 Favored 'General case' 0 N--CA 1.427 -1.601 0 CA-C-N 114.973 -1.012 . . . . 0.0 109.255 -179.618 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 21.3 p -82.5 115.7 21.61 Favored 'General case' 0 N--CA 1.423 -1.814 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.549 -179.674 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 37.2 p -88.98 -18.21 27.88 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-O 121.392 0.615 . . . . 0.0 110.799 -179.459 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 12.0 tt -131.11 149.38 33.36 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 179.097 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -76.92 132.17 38.94 Favored 'General case' 0 N--CA 1.436 -1.134 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 176.319 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -92.2 17.06 58.21 Favored Glycine 0 C--N 1.308 -1.023 0 C-N-CA 121.2 -0.524 . . . . 0.0 112.178 -177.734 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.45 ' HA3' ' CD1' ' A' ' 41' ' ' TRP . . . 152.01 -158.48 27.82 Favored Glycine 0 N--CA 1.416 -2.649 0 N-CA-C 111.226 -0.75 . . . . 0.0 111.226 178.759 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 35.9 p -113.83 -70.75 0.78 Allowed 'General case' 0 C--N 1.302 -1.493 0 CA-C-O 121.124 0.488 . . . . 0.0 110.901 179.599 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 66.6 mttm -99.49 10.13 41.95 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.009 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.45 ' CD1' ' HA3' ' A' ' 38' ' ' GLY . 28.5 p90 -128.62 147.93 50.76 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.173 -178.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 7.1 mp 69.28 114.67 0.04 OUTLIER 'General case' 0 CA--C 1.515 -0.385 0 C-N-CA 125.123 1.369 . . . . 0.0 111.401 -174.649 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 31.3 m -80.56 88.47 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.077 0 CA-C-O 122.541 1.162 . . . . 0.0 110.898 178.663 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -85.26 149.48 25.46 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-N 114.276 -1.329 . . . . 0.0 109.656 -177.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.482 ' HD2' ' N ' ' A' ' 45' ' ' LYS . 11.0 mptt -99.08 101.39 12.73 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 106.838 -1.541 . . . . 0.0 106.838 178.664 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 64.4 mt -111.57 140.61 30.2 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 N-CA-C 113.489 0.922 . . . . 0.0 113.489 -167.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.47 83.25 1.71 Allowed 'General case' 0 N--CA 1.436 -1.175 0 CA-C-N 114.245 -1.343 . . . . 0.0 107.954 168.181 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -160.43 165.32 34.9 Favored Glycine 0 C--N 1.309 -0.937 0 N-CA-C 110.038 -1.225 . . . . 0.0 110.038 -176.361 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 98.8 mttt 63.06 81.43 0.2 Allowed 'General case' 0 CA--C 1.51 -0.586 0 CA-C-O 121.929 0.871 . . . . 0.0 108.826 -173.194 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' MET . . . . . 0.482 ' SD ' ' HA ' ' A' ' 53' ' ' PRO . 50.7 mtt -120.72 132.85 55.29 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-N 114.604 -1.18 . . . . 0.0 110.944 -170.851 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 50.1 tt0 -83.44 -39.63 20.33 Favored 'General case' 0 C--N 1.31 -1.126 0 N-CA-C 104.047 -2.575 . . . . 0.0 104.047 168.146 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 53.2 mtmt -133.89 143.13 46.15 Favored Pre-proline 0 N--CA 1.433 -1.296 0 N-CA-C 106.168 -1.79 . . . . 0.0 106.168 173.521 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.482 ' HA ' ' SD ' ' A' ' 50' ' ' MET . 4.3 Cg_exo -77.85 -20.04 12.11 Favored 'Trans proline' 0 CA--C 1.519 -0.239 0 C-N-CA 121.908 1.739 . . . . 0.0 112.589 -179.013 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.503 ' O ' HD12 ' A' ' 58' ' ' LEU . 19.0 mt -53.7 -51.49 75.99 Favored Pre-proline 0 N--CA 1.475 0.789 0 N-CA-C 113.724 1.009 . . . . 0.0 113.724 -173.213 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_exo -62.98 -15.57 48.64 Favored 'Trans proline' 0 C--N 1.372 1.795 0 C-N-CA 121.577 1.518 . . . . 0.0 113.068 -168.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 15.2 mm-40 -78.9 -36.97 41.14 Favored 'General case' 0 N--CA 1.423 -1.813 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 -174.083 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -76.05 -32.58 59.38 Favored 'General case' 0 N--CA 1.431 -1.397 0 CA-C-N 115.019 -0.991 . . . . 0.0 110.74 176.699 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.533 ' HG ' ' CE1' ' A' ' 75' ' ' TYR 0.253 4.6 mp -71.12 -44.21 66.08 Favored 'General case' 0 CA--C 1.487 -1.462 0 C-N-CA 120.346 -0.542 . . . . 0.0 111.722 -177.824 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.41 -25.79 66.93 Favored 'General case' 0 C--O 1.218 -0.579 0 CA-C-O 122.536 1.16 . . . . 0.0 109.972 176.432 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 18.5 tt0 -71.97 -28.58 63.52 Favored 'General case' 0 N--CA 1.428 -1.562 0 CA-C-N 114.024 -1.444 . . . . 0.0 112.251 175.807 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 72.6 t80 -83.74 -36.31 23.75 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 176.084 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 55.4 t0 -78.4 -171.05 2.27 Favored 'General case' 0 C--O 1.255 1.363 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 177.698 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.479 ' HB2' HD12 ' A' ' 65' ' ' ILE . 7.0 mt -82.82 -178.9 1.29 Allowed Pre-proline 0 CA--C 1.575 1.923 0 N-CA-C 106.384 -1.709 . . . . 0.0 106.384 179.4 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.464 ' HD3' ' HB3' ' A' ' 63' ' ' LEU . 3.4 Cg_endo -89.66 16.74 1.69 Allowed 'Trans proline' 0 N--CA 1.451 -1.011 0 CA-C-N 121.752 1.662 . . . . 0.0 110.669 -173.485 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.565 ' O ' ' HA3' ' A' ' 159' ' ' GLY . 0.2 OUTLIER -72.64 -38.05 57.76 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.867 0 CA-C-N 114.73 -1.123 . . . . 0.0 109.29 -179.107 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 59.09 4.34 2.35 Favored Glycine 0 N--CA 1.484 1.839 0 CA-C-N 115.495 -0.775 . . . . 0.0 112.769 -177.661 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.541 ' H ' HG12 ' A' ' 65' ' ' ILE . 20.3 mt 65.66 -68.65 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.224 0 C-N-CA 127.663 2.385 . . . . 0.0 112.025 -176.837 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.568 ' HA ' ' CD2' ' A' ' 158' ' ' TYR . 70.5 t80 169.34 -52.87 0.0 OUTLIER Pre-proline 0 C--N 1.322 -0.619 0 C-N-CA 124.013 0.925 . . . . 0.0 110.192 179.657 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.442 ' HB3' ' CZ ' ' A' ' 166' ' ' ARG . 7.1 Cg_exo -81.29 143.48 13.97 Favored 'Trans proline' 0 C--N 1.369 1.637 0 C-N-CA 121.636 1.558 . . . . 0.0 110.229 177.444 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -71.85 -17.13 76.64 Favored Glycine 0 C--N 1.314 -0.644 0 C-N-CA 121.177 -0.535 . . . . 0.0 113.061 -177.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -90.7 -10.69 42.16 Favored 'General case' 0 C--O 1.201 -1.449 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 179.531 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.602 ' HA ' ' O ' ' A' ' 87' ' ' LEU . . . -82.89 -171.48 3.57 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.147 173.21 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.602 HG22 ' O ' ' A' ' 72' ' ' ALA . 6.0 t 72.39 26.9 2.54 Favored 'General case' 0 N--CA 1.501 2.121 0 C-N-CA 126.184 1.794 . . . . 0.0 109.53 169.2 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 28.2 m-80 -87.53 -169.48 2.62 Favored 'General case' 0 N--CA 1.417 -2.076 0 CA-C-N 113.599 -1.637 . . . . 0.0 108.852 -179.746 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.533 ' CE1' ' HG ' ' A' ' 58' ' ' LEU . 49.9 p90 -158.98 119.71 3.25 Favored 'General case' 0 C--N 1.311 -1.106 0 C-N-CA 118.889 -1.125 . . . . 0.0 113.649 -176.623 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.683 ' O ' HG23 ' A' ' 85' ' ' THR . 51.8 mt-10 -146.55 92.2 2.13 Favored 'General case' 0 CA--C 1.577 2.001 0 N-CA-C 114.58 1.326 . . . . 0.0 114.58 175.365 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.544 ' HB2' ' N ' ' A' ' 84' ' ' LEU 0.437 30.3 m-85 -169.45 154.76 5.84 Favored 'General case' 0 N--CA 1.506 2.362 0 C-N-CA 128.105 2.562 . . . . 0.0 110.894 165.859 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.454 ' HB2' ' HB ' ' A' ' 81' ' ' THR 0.259 8.3 m-20 -50.99 142.96 11.06 Favored 'General case' 0 CA--C 1.48 -1.748 0 CA-C-O 122.074 0.94 . . . . 0.0 110.42 -179.874 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -81.11 -31.23 34.37 Favored 'General case' 1 C--N 1.24 -4.185 0 CA-C-N 113.867 -1.515 . . . . 0.0 111.753 178.493 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -65.9 -30.08 70.62 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 122.227 1.013 . . . . 0.0 108.626 177.227 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.454 ' HB ' ' HB2' ' A' ' 78' ' ' ASP . 95.5 m -78.73 -39.13 37.13 Favored 'General case' 0 N--CA 1.414 -2.268 0 CA-C-N 113.5 -1.682 . . . . 0.0 109.571 177.546 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.53 ' HA ' ' CE ' ' A' ' 82' ' ' LYS . 3.3 mmpt? 71.95 15.29 5.7 Favored 'General case' 0 CA--C 1.494 -1.188 0 C-N-CA 124.067 0.947 . . . . 0.0 112.864 -177.492 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.478 ' O ' ' HB2' ' A' ' 84' ' ' LEU . 37.2 ttpt -93.81 173.02 7.88 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 104.212 -2.514 . . . . 0.0 104.212 172.299 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.544 ' N ' ' HB2' ' A' ' 77' ' ' PHE . 20.8 tp 176.24 121.93 0.03 OUTLIER 'General case' 0 CA--C 1.475 -1.912 0 CA-C-N 119.134 0.879 . . . . 0.0 108.99 -169.181 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.683 HG23 ' O ' ' A' ' 76' ' ' GLU . 14.5 t -92.2 129.93 38.03 Favored 'General case' 0 N--CA 1.392 -3.344 0 C-N-CA 118.976 -1.09 . . . . 0.0 108.252 174.537 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 62.3 t -103.92 116.61 48.01 Favored 'Isoleucine or valine' 0 N--CA 1.4 -2.975 0 CA-C-N 115.264 -0.88 . . . . 0.0 108.655 179.623 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.602 ' O ' ' HA ' ' A' ' 72' ' ' ALA . 2.0 mm? -75.1 123.16 24.72 Favored 'General case' 0 N--CA 1.41 -2.456 0 CA-C-N 113.783 -1.553 . . . . 0.0 110.673 -176.337 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 74.8 mt -107.51 137.16 19.6 Favored Pre-proline 0 C--N 1.281 -2.375 0 N-CA-C 105.225 -2.139 . . . . 0.0 105.225 170.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.456 ' O ' ' HB2' ' A' ' 166' ' ' ARG . 17.9 Cg_endo -58.21 84.87 0.05 OUTLIER 'Trans proline' 0 CA--C 1.541 0.825 0 C-N-CA 123.275 2.65 . . . . 0.0 112.523 178.175 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 24.2 m 69.33 163.89 0.24 Allowed 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 125.489 1.516 . . . . 0.0 112.46 -179.385 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 9.3 tt -62.82 135.34 27.34 Favored 'Isoleucine or valine' 0 C--O 1.242 0.69 0 CA-C-O 121.361 0.601 . . . . 0.0 109.864 177.383 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' CYS . . . . . 0.515 ' SG ' ' HB2' ' A' ' 104' ' ' PHE . 3.7 p -132.76 139.17 47.45 Favored 'General case' 0 C--N 1.282 -2.332 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.916 -179.295 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -119.79 142.41 48.62 Favored 'General case' 0 CA--C 1.454 -2.735 0 N-CA-C 106.048 -1.834 . . . . 0.0 106.048 178.637 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.411 ' HB ' ' CD2' ' A' ' 102' ' ' LEU . 17.9 t -118.49 104.38 16.0 Favored 'Isoleucine or valine' 0 N--CA 1.392 -3.365 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 -175.649 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -126.2 112.79 1.69 Allowed Glycine 0 N--CA 1.418 -2.549 0 N-CA-C 109.469 -1.453 . . . . 0.0 109.469 176.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 74.1 t80 -158.85 -47.61 0.06 Allowed 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 -177.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.504 ' HE2' ' HA ' ' A' ' 97' ' ' LYS . 7.7 mmpt? -74.43 -21.55 59.56 Favored 'General case' 0 CA--C 1.475 -1.91 0 CA-C-N 115.272 -0.876 . . . . 0.0 109.803 176.404 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 18.1 t70 74.74 -47.85 0.63 Allowed 'General case' 0 C--O 1.219 -0.531 0 O-C-N 124.927 1.392 . . . . 0.0 112.599 169.631 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 37.9 m -84.35 -4.96 59.2 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 175.525 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 36.4 t -135.2 92.46 2.86 Favored 'General case' 0 N--CA 1.408 -2.566 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 173.834 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 9.5 p -119.23 140.4 43.31 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 177.818 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.482 ' N ' HD21 ' A' ' 102' ' ' LEU . 0.4 OUTLIER -151.72 167.08 29.32 Favored 'General case' 0 C--N 1.294 -1.843 0 N-CA-C 112.641 0.608 . . . . 0.0 112.641 -171.364 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -142.59 129.13 20.22 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.413 0.625 . . . . 0.0 111.63 -175.703 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.515 ' HB2' ' SG ' ' A' ' 92' ' ' CYS . 61.0 m-85 -109.86 122.03 46.6 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 178.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.441 HG23 ' H ' ' A' ' 107' ' ' THR . 32.0 m -71.23 151.7 44.04 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 178.623 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 8.3 m -52.47 -38.5 59.53 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.967 0.907 . . . . 0.0 109.838 176.52 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.441 ' H ' HG23 ' A' ' 105' ' ' THR . 68.2 p -121.42 99.66 6.6 Favored 'General case' 0 N--CA 1.425 -1.678 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.144 179.021 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.531 ' O ' ' HA ' ' A' ' 85' ' ' THR . 61.9 t -99.65 138.22 24.69 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.285 0 N-CA-C 106.779 -1.563 . . . . 0.0 106.779 174.137 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.432 ' HA ' ' O ' ' A' ' 84' ' ' LEU . 9.1 t -125.8 137.13 53.76 Favored 'General case' 0 N--CA 1.395 -3.222 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 -175.814 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -157.16 176.98 34.24 Favored Glycine 0 N--CA 1.403 -3.529 0 C-N-CA 119.834 -1.174 . . . . 0.0 112.053 179.674 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . 0.495 ' HA ' ' O ' ' A' ' 82' ' ' LYS . 10.5 t60 -86.81 93.24 9.23 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 178.808 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.444 HD13 HD21 ' A' ' 84' ' ' LEU . 7.2 tt -97.98 120.41 38.32 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-O 121.656 0.741 . . . . 0.0 110.841 -174.062 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . 0.5 ' OE1' ' HE2' ' A' ' 116' ' ' LYS . 44.4 mt-10 -123.41 -177.06 3.6 Favored 'General case' 0 CA--C 1.457 -2.611 0 CA-C-N 114.667 -1.151 . . . . 0.0 108.973 175.05 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.42 ' HD3' ' HA ' ' A' ' 114' ' ' LYS . 29.4 mmtt -83.07 101.84 11.4 Favored 'General case' 1 N--CA 1.371 -4.412 0 CA-C-N 114.834 -1.076 . . . . 0.0 113.536 179.926 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 125.27 -45.1 1.19 Allowed Glycine 0 N--CA 1.406 -3.336 0 CA-C-N 113.148 -1.842 . . . . 0.0 110.425 178.1 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.5 ' HE2' ' OE1' ' A' ' 113' ' ' GLU . 0.3 OUTLIER -135.2 147.59 49.41 Favored 'General case' 0 C--N 1.313 -0.984 0 C-N-CA 123.102 0.561 . . . . 0.0 112.492 -178.151 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.2 tt -120.64 105.06 10.43 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 105.346 -2.094 . . . . 0.0 105.346 178.079 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.498 ' HA ' ' OG ' ' A' ' 135' ' ' SER . 44.9 p -100.89 135.53 42.19 Favored 'General case' 0 C--N 1.267 -2.995 0 N-CA-C 114.465 1.283 . . . . 0.0 114.465 -172.174 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 64.92 97.47 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 125.235 1.414 . . . . 0.0 111.586 -179.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 6.1 m -104.52 93.53 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.018 0 CA-C-O 122.764 1.269 . . . . 0.0 111.348 -177.041 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -82.86 95.03 7.81 Favored 'General case' 0 N--CA 1.397 -3.107 0 CA-C-N 113.26 -1.791 . . . . 0.0 108.829 -179.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 145.91 -14.58 1.74 Allowed Glycine 0 C--N 1.305 -1.154 0 CA-C-N 114.375 -1.284 . . . . 0.0 111.188 -178.519 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.414 HG13 HG13 ' A' ' 108' ' ' VAL . 86.8 mt -100.64 99.41 8.38 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.25 0 CA-C-O 121.81 0.814 . . . . 0.0 111.042 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -89.18 127.71 35.76 Favored 'General case' 0 N--CA 1.433 -1.295 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 178.103 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.461 ' HA ' ' CB ' ' A' ' 102' ' ' LEU . 9.0 t -140.77 152.75 45.48 Favored 'General case' 0 C--N 1.278 -2.536 0 C-N-CA 119.734 -0.786 . . . . 0.0 111.002 -177.754 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.554 ' HD3' ' C ' ' A' ' 126' ' ' LYS . 3.8 tmtt? -140.85 127.17 19.81 Favored 'General case' 0 N--CA 1.389 -3.51 0 CA-C-N 115.168 -0.924 . . . . 0.0 108.695 175.055 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.478 HG13 ' H ' ' A' ' 128' ' ' MET . 2.6 p -135.55 -57.42 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 CA-C-N 114.709 -1.132 . . . . 0.0 109.057 -179.017 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' MET . . . . . 0.478 ' H ' HG13 ' A' ' 127' ' ' VAL . 24.3 ttt -101.19 -57.92 1.99 Allowed 'General case' 0 N--CA 1.421 -1.876 0 N-CA-C 106.293 -1.743 . . . . 0.0 106.293 176.495 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 2.2 pp -132.9 -179.48 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.637 0 CA-C-N 113.508 -1.678 . . . . 0.0 108.721 177.537 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 85.7 t90 -88.13 126.61 35.21 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 123.652 0.595 . . . . 0.0 110.518 -175.236 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 44.3 t -132.3 137.43 54.49 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 178.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 25.2 pttm -102.62 -24.54 13.76 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 112.328 0.492 . . . . 0.0 112.328 179.156 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 19.1 m -130.37 103.69 8.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-O 121.845 0.831 . . . . 0.0 111.417 -179.43 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 23.3 p -109.09 -165.5 1.02 Allowed 'General case' 0 C--N 1.292 -1.908 0 CA-C-N 115.342 -0.845 . . . . 0.0 109.166 177.091 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' SER . . . . . 0.498 ' OG ' ' HA ' ' A' ' 118' ' ' THR . 27.5 t -144.96 158.64 43.74 Favored 'General case' 0 N--CA 1.422 -1.837 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 176.715 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 68.1 mt -126.32 96.82 3.8 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 179.749 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' SER . . . . . 0.571 ' O ' ' HB2' ' A' ' 144' ' ' TYR . 46.9 t -121.48 136.53 54.95 Favored 'General case' 0 C--N 1.298 -1.663 0 O-C-N 121.816 -0.553 . . . . 0.0 110.324 -175.755 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' THR . . . . . 0.49 ' HG1' ' C ' ' A' ' 142' ' ' LYS . 8.8 t -165.16 178.33 7.05 Favored 'General case' 0 N--CA 1.42 -1.935 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 -174.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -110.25 68.33 0.67 Allowed 'General case' 0 C--N 1.312 -1.045 0 C-N-CA 119.215 -0.994 . . . . 0.0 112.599 -179.263 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . 48.79 33.35 4.28 Favored 'General case' 0 N--CA 1.496 1.848 0 C-N-CA 124.586 1.154 . . . . 0.0 113.828 173.009 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' SER . . . . . 0.46 ' O ' ' HG3' ' A' ' 155' ' ' ARG . 48.1 t -154.32 -67.03 0.14 Allowed 'General case' 0 C--N 1.307 -1.265 0 C-N-CA 120.342 -0.543 . . . . 0.0 110.378 -174.717 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . 0.49 ' C ' ' HG1' ' A' ' 138' ' ' THR . 55.3 mtpt -89.87 -162.79 0.92 Allowed 'General case' 0 CA--C 1.507 -0.709 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 179.125 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.535 HG12 ' O ' ' A' ' 159' ' ' GLY . 8.8 p -144.42 145.34 21.56 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 176.211 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . 0.571 ' HB2' ' O ' ' A' ' 137' ' ' SER . 91.6 m-85 -143.04 144.62 32.34 Favored 'General case' 0 CA--C 1.483 -1.6 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 174.219 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . 0.451 ' HB2' ' HA ' ' A' ' 151' ' ' LYS . 26.5 m-85 -95.53 156.37 16.35 Favored 'General case' 0 CA--C 1.454 -2.733 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 173.775 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 19.0 m -137.03 93.92 2.89 Favored 'General case' 1 N--CA 1.374 -4.226 0 C-N-CA 119.799 -0.761 . . . . 0.0 109.477 174.595 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . 0.428 ' HB2' ' HG3' ' A' ' 150' ' ' LYS . . . -111.56 6.99 20.43 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.168 -0.924 . . . . 0.0 109.361 177.783 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . 0.485 ' C ' ' H ' ' A' ' 150' ' ' LYS . . . 111.98 75.41 0.75 Allowed Glycine 0 CA--C 1.48 -2.103 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 -179.377 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER 74.31 -33.72 0.26 Allowed 'General case' 0 N--CA 1.494 1.755 0 C-N-CA 125.145 1.378 . . . . 0.0 110.534 -176.754 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . 0.485 ' H ' ' C ' ' A' ' 148' ' ' GLY . 12.0 pttm -79.88 121.22 25.15 Favored 'General case' 0 C--N 1.315 -0.904 0 C-N-CA 124.292 1.037 . . . . 0.0 112.047 179.518 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . 0.451 ' HA ' ' HB2' ' A' ' 145' ' ' PHE . 21.4 pttm -148.38 119.88 7.95 Favored 'General case' 0 N--CA 1.419 -1.983 0 CA-C-N 114.262 -1.335 . . . . 0.0 110.479 -175.074 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 42.9 m -110.41 111.82 23.34 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 106.54 -1.652 . . . . 0.0 106.54 173.53 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' ARG . . . . . 0.411 ' HG3' ' HA ' ' A' ' 144' ' ' TYR . 0.0 OUTLIER -154.69 99.57 2.17 Favored 'General case' 0 N--CA 1.435 -1.184 0 N-CA-C 116.397 1.999 . . . . 0.0 116.397 -165.745 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 4.9 m -108.99 109.57 20.65 Favored 'General case' 0 C--N 1.261 -3.279 0 O-C-N 121.423 -0.798 . . . . 0.0 109.051 165.489 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' ARG . . . . . 0.551 ' HD3' ' O ' ' A' ' 155' ' ' ARG . 0.2 OUTLIER -72.75 -23.45 60.83 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 120.633 1.561 . . . . 0.0 107.055 173.329 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -48.13 -43.72 31.46 Favored 'General case' 0 C--N 1.298 -1.666 0 C-N-CA 126.859 2.064 . . . . 0.0 115.536 -178.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . 0.523 ' HB1' ' NE2' ' A' ' 161' ' ' GLN . . . -79.28 -19.5 50.38 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 113.318 0.859 . . . . 0.0 113.318 -175.893 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . 0.568 ' CD2' ' HA ' ' A' ' 68' ' ' PHE . 44.0 t80 176.51 -34.49 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 CA-C-O 121.297 0.57 . . . . 0.0 109.831 178.482 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . 0.565 ' HA3' ' O ' ' A' ' 65' ' ' ILE . . . 150.52 -88.92 0.14 Allowed Glycine 0 CA--C 1.464 -3.134 0 N-CA-C 109.168 -1.573 . . . . 0.0 109.168 -172.194 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.473 ' CG2' ' HA ' ' A' ' 67' ' ' ILE . 10.9 t -98.06 153.39 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.642 0 N-CA-C 107.146 -1.428 . . . . 0.0 107.146 178.772 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' GLN . . . . . 0.523 ' NE2' ' HB1' ' A' ' 157' ' ' ALA . 79.3 mm-40 -116.32 90.05 3.25 Favored 'General case' 0 CA--C 1.453 -2.755 0 CA-C-O 122.435 1.112 . . . . 0.0 110.823 -172.469 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.28 147.59 24.9 Favored 'General case' 0 N--CA 1.387 -3.603 0 CA-C-N 112.555 -2.111 . . . . 0.0 108.828 179.327 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 9.4 t30 -113.13 -86.12 0.57 Allowed 'General case' 0 C--N 1.29 -2.014 0 C-N-CA 119.544 -0.862 . . . . 0.0 109.693 173.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 73.02 164.93 8.65 Favored Glycine 0 CA--C 1.502 -0.765 0 C-N-CA 120.424 -0.893 . . . . 0.0 113.256 179.088 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.518 HD23 ' O ' ' A' ' 165' ' ' LEU . 0.0 OUTLIER -100.95 114.69 28.82 Favored 'General case' 0 N--CA 1.413 -2.316 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 177.367 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . 0.456 ' HB2' ' O ' ' A' ' 89' ' ' PRO . 6.2 ptp180 -90.03 105.67 17.96 Favored 'General case' 0 N--CA 1.412 -2.369 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 -179.694 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 57.5 t -43.83 -28.19 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 C-N-CA 124.333 1.053 . . . . 0.0 112.812 -177.662 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -49.64 -43.06 46.57 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 124.242 1.017 . . . . 0.0 111.813 177.042 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -128.49 8.79 5.96 Favored 'General case' 0 CA--C 1.546 0.825 0 CA-C-O 121.635 0.731 . . . . 0.0 110.887 -176.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 170' ' ' PHE . . . . . . . . . . . . . 67.3 t80 . . . . . 0 C--N 1.303 -1.439 0 N-CA-C 108.771 -0.825 . . . . 0.0 108.771 178.603 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 27.7 m . . . . . 0 N--CA 1.443 -0.775 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -92.73 103.43 15.8 Favored 'General case' 0 C--N 1.311 -1.094 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 -179.177 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -117.56 118.49 32.28 Favored 'General case' 0 C--N 1.307 -1.246 0 C-N-CA 120.54 -0.464 . . . . 0.0 111.518 -179.142 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 10.5 tt -137.14 108.21 5.91 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 CA-C-O 121.668 0.747 . . . . 0.0 110.078 174.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 76.5 t80 -109.58 104.32 13.33 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 178.601 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -125.41 99.09 5.89 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-O 121.179 0.514 . . . . 0.0 112.323 -175.389 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 63.8 mttp -133.63 95.94 3.59 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 174.409 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 42.7 t -107.83 138.14 35.72 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 -176.387 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -76.84 71.16 2.2 Favored Glycine 0 N--CA 1.439 -1.134 0 N-CA-C 111.929 -0.468 . . . . 0.0 111.929 179.187 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 17.0 m -83.84 87.35 7.08 Favored 'General case' 0 N--CA 1.425 -1.719 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 178.516 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 50.3 p90 -139.1 135.41 34.09 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.084 179.238 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 30.4 m-90 -132.88 104.85 6.78 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 178.633 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 56.2 tp -90.63 104.9 17.43 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.132 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -97.63 -168.38 32.49 Favored Glycine 0 N--CA 1.437 -1.291 0 C-N-CA 120.786 -0.721 . . . . 0.0 111.855 -179.63 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -93.96 98.61 11.15 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-O 121.537 0.684 . . . . 0.0 110.536 179.53 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.551 ' HD3' ' H ' ' A' ' 16' ' ' LYS . 0.2 OUTLIER -80.69 121.31 25.72 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.871 -179.285 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -165.6 98.26 0.68 Allowed 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.961 178.792 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 44.9 t-20 -147.12 94.78 2.46 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 109.573 -0.528 . . . . 0.0 109.573 178.307 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -138.44 118.66 13.59 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 176.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -83.69 96.85 8.82 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-O 121.53 0.681 . . . . 0.0 112.259 -177.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 33.7 p90 -121.8 96.62 5.14 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-O 121.678 0.752 . . . . 0.0 109.028 175.359 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -151.98 156.75 40.65 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.885 -177.112 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 17.3 m -71.4 127.37 32.35 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-O 120.86 0.362 . . . . 0.0 111.297 -177.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 7.7 p -60.73 138.43 21.64 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.807 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.849 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -89.81 98.3 2.43 Favored Glycine 0 CA--C 1.498 -1.0 0 N-CA-C 110.864 -0.895 . . . . 0.0 110.864 179.78 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 43.7 t30 -76.74 98.36 4.76 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-O 121.502 0.668 . . . . 0.0 112.329 -176.397 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -111.96 116.66 30.96 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 107.143 -1.429 . . . . 0.0 107.143 176.438 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.9 pp -124.53 3.77 8.32 Favored 'General case' 0 C--N 1.31 -1.13 0 N-CA-C 114.574 1.324 . . . . 0.0 114.574 -175.125 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 46.2 t30 -118.45 101.86 8.48 Favored 'General case' 0 C--N 1.314 -0.953 0 C-N-CA 120.334 -0.547 . . . . 0.0 109.902 178.473 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 36.3 p -135.35 14.15 3.5 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 116.145 -0.48 . . . . 0.0 112.29 -178.139 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 20.6 m -76.45 118.57 23.08 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 CA-C-O 121.498 0.666 . . . . 0.0 112.157 179.353 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 40.1 t -141.06 146.68 37.47 Favored 'General case' 0 C--N 1.313 -1.006 0 N-CA-C 108.388 -0.968 . . . . 0.0 108.388 -179.156 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 9.9 t -160.33 138.85 10.25 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-O 121.232 0.539 . . . . 0.0 112.306 -178.268 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 67.5 m -158.18 103.78 1.84 Allowed 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 107.097 -1.446 . . . . 0.0 107.097 174.218 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 11.7 tt -125.24 104.54 13.62 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 N-CA-C 114.2 1.185 . . . . 0.0 114.2 -172.348 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -102.6 122.29 44.1 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 172.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -66.09 127.96 30.66 Favored Glycine 0 N--CA 1.439 -1.147 0 N-CA-C 111.098 -0.801 . . . . 0.0 111.098 -179.556 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -61.12 100.94 0.27 Allowed Glycine 0 CA--C 1.5 -0.884 0 N-CA-C 111.131 -0.788 . . . . 0.0 111.131 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 17.1 m -97.61 70.13 2.21 Favored 'General case' 0 N--CA 1.414 -2.241 0 CA-C-O 122.031 0.92 . . . . 0.0 110.535 -176.284 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 63.3 tttm -145.3 22.05 1.53 Allowed 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 103.621 -2.733 . . . . 0.0 103.621 174.657 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 29.2 t90 -92.51 168.0 11.57 Favored 'General case' 0 N--CA 1.426 -1.666 0 CA-C-N 111.413 -2.63 . . . . 0.0 108.391 -174.189 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.474 ' H ' HD21 ' A' ' 42' ' ' LEU . 2.2 pt? -74.39 176.51 6.69 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 -178.349 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 43.3 t -45.97 120.69 0.6 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.559 0 C-N-CA 124.69 1.196 . . . . 0.0 112.039 -177.127 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 35.5 p30 -93.72 178.08 5.8 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.848 177.152 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.56 ' HE2' ' HA ' ' A' ' 45' ' ' LYS . 10.1 mmpt? -87.09 -34.72 19.04 Favored 'General case' 0 C--N 1.311 -1.085 0 C-N-CA 120.83 -0.348 . . . . 0.0 110.534 -177.447 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . 0.285 7.9 tp 42.76 78.48 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.248 1.02 0 C-N-CA 124.85 1.26 . . . . 0.0 113.124 -177.512 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -87.28 161.25 18.08 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-N 114.96 -1.018 . . . . 0.0 109.599 178.31 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 80.87 59.56 2.44 Favored Glycine 0 N--CA 1.425 -2.037 0 N-CA-C 110.088 -1.205 . . . . 0.0 110.088 -176.751 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 3.7 mptp? -63.29 -41.33 98.97 Favored 'General case' 0 CA--C 1.502 -0.886 0 C-N-CA 122.987 0.515 . . . . 0.0 109.958 -179.297 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 27.5 ttt -175.55 148.75 0.94 Allowed 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 106.339 -1.726 . . . . 0.0 106.339 177.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 79.3 mm-40 -72.69 144.46 47.71 Favored 'General case' 0 C--N 1.296 -1.757 0 C-N-CA 120.463 -0.495 . . . . 0.0 110.983 -178.077 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.603 ' O ' ' HD2' ' A' ' 55' ' ' PRO . 11.3 mptt 76.32 135.42 0.05 OUTLIER Pre-proline 0 CA--C 1.543 0.688 0 C-N-CA 125.507 1.523 . . . . 0.0 109.851 -171.933 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -69.23 -26.52 29.99 Favored 'Trans proline' 0 C--O 1.24 0.58 0 C-N-CA 122.61 2.206 . . . . 0.0 114.91 -173.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.553 ' CG ' ' HD3' ' A' ' 55' ' ' PRO 0.352 0.5 OUTLIER -69.87 -56.42 7.56 Favored Pre-proline 0 C--N 1.307 -1.27 0 C-N-CA 119.367 -0.933 . . . . 0.0 113.384 175.587 . . . . . . . . 4 4 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.603 ' HD2' ' O ' ' A' ' 52' ' ' LYS . 88.9 Cg_exo -55.33 -35.33 91.34 Favored 'Trans proline' 0 C--N 1.362 1.238 0 C-N-CA 123.376 2.717 . . . . 0.0 112.461 -176.88 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -66.33 -30.88 71.37 Favored 'General case' 0 C--O 1.217 -0.615 0 C-N-CA 120.389 -0.525 . . . . 0.0 110.349 179.392 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 59.8 tp -74.8 -31.77 61.8 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.017 178.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.405 ' HB3' ' H ' ' A' ' 75' ' ' TYR . 7.9 mp -58.39 -49.8 75.96 Favored 'General case' 0 CA--C 1.482 -1.657 0 CA-C-O 121.675 0.75 . . . . 0.0 109.484 178.916 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.467 ' HG2' ' O ' ' A' ' 55' ' ' PRO . 17.2 ptmt -74.64 -26.63 60.0 Favored 'General case' 0 C--N 1.28 -2.425 0 CA-C-N 114.089 -1.414 . . . . 0.0 112.41 179.653 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.425 ' C ' ' H ' ' A' ' 62' ' ' ASP . 9.1 tp10 -70.75 -35.14 72.51 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.934 178.819 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 61.5 m-85 -48.46 -22.6 0.75 Allowed 'General case' 0 N--CA 1.5 2.072 0 CA-C-O 120.944 0.402 . . . . 0.0 111.442 174.494 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.48 ' CG ' ' H ' ' A' ' 63' ' ' LEU . 17.1 t70 -107.25 -156.38 0.58 Allowed 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 -172.799 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.552 HD22 ' H ' ' A' ' 115' ' ' GLY . 53.3 mt -91.71 172.8 6.01 Favored Pre-proline 0 CA--C 1.568 1.651 0 O-C-N 121.394 -0.816 . . . . 0.0 110.419 -174.773 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.461 ' HD3' ' HB3' ' A' ' 63' ' ' LEU . 3.5 Cg_endo -88.12 19.8 1.27 Allowed 'Trans proline' 0 C--N 1.356 0.968 0 C-N-CA 123.335 2.69 . . . . 0.0 111.367 -172.21 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.719 ' O ' ' HA3' ' A' ' 159' ' ' GLY . 0.2 OUTLIER -73.25 -37.92 53.07 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.708 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.401 179.69 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 55.58 8.51 1.95 Allowed Glycine 0 N--CA 1.49 2.25 0 CA-C-N 115.489 -0.778 . . . . 0.0 113.351 -178.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.645 ' O ' ' HB ' ' A' ' 160' ' ' VAL . 40.6 mt 69.37 -63.89 0.23 Allowed 'Isoleucine or valine' 0 C--O 1.197 -1.682 0 C-N-CA 126.053 1.741 . . . . 0.0 113.627 -178.726 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.5 ' HB2' ' O ' ' A' ' 67' ' ' ILE . 63.7 t80 171.24 -48.0 0.0 OUTLIER Pre-proline 0 C--N 1.314 -0.944 0 C-N-CA 122.729 0.412 . . . . 0.0 110.637 -177.446 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.443 ' HB3' ' HD3' ' A' ' 166' ' ' ARG . 17.1 Cg_exo -74.61 -31.62 6.75 Favored 'Trans proline' 0 C--N 1.377 2.035 0 C-N-CA 121.388 1.392 . . . . 0.0 112.109 179.666 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 88.37 -29.16 5.8 Favored Glycine 0 N--CA 1.437 -1.281 0 C-N-CA 120.448 -0.882 . . . . 0.0 110.999 -175.22 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.409 ' HB3' ' HG3' ' A' ' 89' ' ' PRO . 17.5 t70 -81.86 -19.02 41.83 Favored 'General case' 0 C--O 1.2 -1.545 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 177.52 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.501 ' O ' ' HB ' ' A' ' 73' ' ' THR . . . -78.25 175.04 10.57 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 114.95 -1.023 . . . . 0.0 110.375 170.511 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.597 ' O ' HG22 ' A' ' 73' ' ' THR . 51.9 m 86.29 21.27 0.08 Allowed 'General case' 0 C--N 1.355 0.836 0 CA-C-O 124.069 1.89 . . . . 0.0 110.763 172.451 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.554 ' O ' ' HA ' ' A' ' 86' ' ' VAL . 37.3 m-80 -80.33 158.9 25.96 Favored 'General case' 0 C--N 1.272 -2.793 0 CA-C-N 114.641 -1.163 . . . . 0.0 112.632 -179.572 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.405 ' H ' ' HB3' ' A' ' 58' ' ' LEU . 53.5 t80 -118.38 123.1 44.44 Favored 'General case' 0 C--N 1.284 -2.266 0 CA-C-N 114.716 -1.129 . . . . 0.0 112.998 -169.748 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.584 ' O ' HD12 ' A' ' 84' ' ' LEU . 26.7 mm-40 -146.59 151.2 36.91 Favored 'General case' 0 C--O 1.215 -0.73 0 C-N-CA 125.984 1.714 . . . . 0.0 108.165 173.254 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 52.4 p90 -139.28 150.58 45.61 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-N 118.228 0.467 . . . . 0.0 110.651 -178.501 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.476 ' CB ' ' HB ' ' A' ' 81' ' ' THR . 21.6 m-20 -78.56 164.39 24.72 Favored 'General case' 0 CA--C 1.48 -1.729 0 CA-C-O 121.589 0.709 . . . . 0.0 110.227 179.002 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -80.82 -65.87 0.96 Allowed 'General case' 0 C--N 1.279 -2.476 0 CA-C-N 114.312 -1.313 . . . . 0.0 110.835 -179.629 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -81.06 -33.22 33.63 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.378 -176.604 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.476 ' HB ' ' CB ' ' A' ' 78' ' ' ASP . 91.6 m -82.67 -29.03 30.24 Favored 'General case' 0 N--CA 1.425 -1.715 0 CA-C-N 115.048 -0.978 . . . . 0.0 111.64 -176.794 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt 58.88 15.41 3.86 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 113.021 0.749 . . . . 0.0 113.021 178.173 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.433 ' CG ' ' HB ' ' A' ' 109' ' ' THR . 16.4 tppt? -88.54 141.76 28.26 Favored 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 -177.635 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.584 HD12 ' O ' ' A' ' 76' ' ' GLU . 37.5 tp -75.96 138.72 41.15 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.26 177.037 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 9.4 t -126.31 116.97 22.06 Favored 'General case' 0 N--CA 1.412 -2.351 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 173.269 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.554 ' HA ' ' O ' ' A' ' 74' ' ' ASN . 74.2 t -92.92 127.01 45.29 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.808 0 CA-C-N 115.133 -0.94 . . . . 0.0 110.781 -178.463 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.451 ' HB2' ' HB2' ' A' ' 74' ' ' ASN . 3.9 mp -88.6 109.54 20.18 Favored 'General case' 0 N--CA 1.433 -1.294 0 CA-C-N 115.287 -0.87 . . . . 0.0 109.596 179.844 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 65.7 mt -96.86 137.93 21.35 Favored Pre-proline 0 C--N 1.286 -2.186 0 N-CA-C 105.957 -1.868 . . . . 0.0 105.957 171.073 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.594 ' O ' ' HB2' ' A' ' 166' ' ' ARG . 41.5 Cg_endo -63.19 107.44 0.66 Allowed 'Trans proline' 0 N--CA 1.437 -1.842 0 C-N-CA 122.109 1.873 . . . . 0.0 110.14 175.849 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.499 ' HB2' ' HB2' ' A' ' 168' ' ' ASP . 33.2 t 63.65 -163.92 0.26 Allowed 'General case' 0 CA--C 1.557 1.248 0 CA-C-O 121.272 0.558 . . . . 0.0 110.891 179.614 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 5.7 tt -106.06 119.63 55.71 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 CA-C-O 121.52 0.676 . . . . 0.0 109.496 177.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' CYS . . . . . 0.465 ' O ' ' HB2' ' A' ' 104' ' ' PHE . 21.0 p -117.47 124.59 49.15 Favored 'General case' 0 C--N 1.296 -1.753 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 -179.441 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -116.41 166.17 12.38 Favored 'General case' 0 C--N 1.306 -1.31 0 O-C-N 122.072 -0.392 . . . . 0.0 111.775 -174.045 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 3.0 p -149.95 104.93 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.609 177.757 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -145.4 151.24 23.46 Favored Glycine 0 N--CA 1.446 -0.68 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.994 176.627 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 78.2 m-85 -161.58 -60.49 0.05 Allowed 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 124.19 0.996 . . . . 0.0 108.508 179.067 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.506 ' HA ' ' HE3' ' A' ' 97' ' ' LYS . 0.4 OUTLIER -71.25 -13.43 61.9 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 114.262 -1.336 . . . . 0.0 110.955 -177.128 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 22.5 t70 71.89 -36.58 0.36 Allowed 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 123.962 0.905 . . . . 0.0 112.145 -179.638 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 68.4 m -77.76 -7.88 57.19 Favored 'General case' 0 N--CA 1.44 -0.937 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 172.399 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.438 ' HA ' ' O ' ' A' ' 126' ' ' LYS . 34.8 t -132.25 91.59 2.97 Favored 'General case' 0 N--CA 1.411 -2.391 0 N-CA-C 106.696 -1.594 . . . . 0.0 106.696 173.824 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.433 ' C ' HD11 ' A' ' 102' ' ' LEU . 97.9 t -130.45 119.35 45.89 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.108 0 CA-C-N 114.633 -1.167 . . . . 0.0 108.414 177.22 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.481 ' HG ' ' HA ' ' A' ' 125' ' ' THR . 4.8 mp -124.6 138.59 54.31 Favored 'General case' 0 N--CA 1.424 -1.759 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.346 -179.645 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 27.3 ttpp -117.19 110.35 18.03 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.33 177.759 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.469 ' HA ' HD12 ' A' ' 123' ' ' ILE . 51.1 m-85 -91.13 97.14 10.97 Favored 'General case' 0 N--CA 1.422 -1.871 0 CA-C-O 122.19 0.995 . . . . 0.0 111.756 177.764 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 31.6 m -56.05 146.4 22.85 Favored 'General case' 0 N--CA 1.424 -1.762 0 CA-C-N 112.276 -2.238 . . . . 0.0 110.916 177.325 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 66.9 m -56.95 -67.8 0.28 Allowed 'General case' 0 C--O 1.218 -0.593 0 C-N-CA 123.738 0.815 . . . . 0.0 111.123 -179.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.41 ' HA ' ' O ' ' A' ' 86' ' ' VAL . 7.3 p -107.56 99.88 9.34 Favored 'General case' 0 N--CA 1.423 -1.825 0 CA-C-O 121.654 0.74 . . . . 0.0 110.054 176.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.541 HG23 HG12 ' A' ' 123' ' ' ILE . 4.3 p -110.07 148.38 13.69 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.433 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.805 -176.894 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.519 ' HA ' ' O ' ' A' ' 84' ' ' LEU . 35.6 p -97.95 156.26 16.7 Favored 'General case' 0 N--CA 1.432 -1.369 0 N-CA-C 112.895 0.702 . . . . 0.0 112.895 -176.131 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . 0.65 ' HA2' ' O ' ' A' ' 119' ' ' ASP . . . -172.99 174.42 45.86 Favored Glycine 0 CA--C 1.52 0.353 0 N-CA-C 111.714 -0.554 . . . . 0.0 111.714 -179.84 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 34.2 t-80 -109.75 121.96 46.41 Favored 'General case' 0 CA--C 1.508 -0.658 0 N-CA-C 107.934 -1.135 . . . . 0.0 107.934 177.347 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.47 ' HB2' HD22 ' A' ' 84' ' ' LEU . 2.9 tt -91.99 116.86 29.28 Favored 'General case' 0 C--N 1.307 -1.261 0 C-N-CA 120.324 -0.55 . . . . 0.0 110.395 -172.541 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -127.57 143.99 51.12 Favored 'General case' 0 CA--C 1.459 -2.542 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 171.748 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 42.7 tptt -80.15 100.24 8.16 Favored 'General case' 0 N--CA 1.387 -3.581 0 CA-C-O 122.194 0.997 . . . . 0.0 108.911 -171.627 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . 0.552 ' H ' HD22 ' A' ' 63' ' ' LEU . . . 136.5 -31.92 2.53 Favored Glycine 0 N--CA 1.426 -1.999 0 N-CA-C 108.245 -1.942 . . . . 0.0 108.245 -176.681 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -157.87 127.0 5.77 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 121.379 0.609 . . . . 0.0 111.985 -178.744 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -94.59 107.14 19.14 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 105.656 -1.979 . . . . 0.0 105.656 174.72 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.435 ' HA ' ' CB ' ' A' ' 135' ' ' SER . 49.4 p -109.61 172.44 6.85 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.963 -175.188 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . 0.65 ' O ' ' HA2' ' A' ' 110' ' ' GLY . 12.2 m-20 56.97 63.14 2.0 Favored 'General case' 0 CA--C 1.473 -1.983 0 O-C-N 124.468 1.105 . . . . 0.0 109.55 178.531 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.415 HG23 ' O ' ' A' ' 134' ' ' THR . 4.5 t -86.75 78.1 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.399 -2.98 0 C-N-CA 117.983 -1.487 . . . . 0.0 108.335 -175.798 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.421 ' HB3' ' OG1' ' A' ' 109' ' ' THR . 11.6 tp10 -68.92 96.47 0.77 Allowed 'General case' 0 N--CA 1.414 -2.252 0 CA-C-N 113.011 -1.904 . . . . 0.0 110.601 -174.39 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 130.56 -2.18 5.69 Favored Glycine 0 N--CA 1.424 -2.104 0 C-N-CA 120.152 -1.023 . . . . 0.0 112.995 174.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.541 HG12 HG23 ' A' ' 108' ' ' VAL . 26.6 mm -99.2 112.25 30.93 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 176.743 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -84.3 119.38 25.0 Favored 'General case' 0 N--CA 1.429 -1.51 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 -178.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.481 ' HA ' ' HG ' ' A' ' 102' ' ' LEU . 58.9 m -131.38 119.44 21.68 Favored 'General case' 0 N--CA 1.405 -2.716 0 CA-C-N 114.976 -1.011 . . . . 0.0 111.33 -175.889 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.438 ' O ' ' HA ' ' A' ' 100' ' ' SER . 83.1 tttt -110.08 141.94 42.22 Favored 'General case' 0 N--CA 1.41 -2.451 0 C-N-CA 119.083 -1.047 . . . . 0.0 109.452 168.225 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.419 ' N ' ' HG2' ' A' ' 126' ' ' LYS . 7.5 p -149.01 -35.0 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.296 -1.757 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 175.431 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 26.4 ptm -137.52 -29.23 0.88 Allowed 'General case' 0 N--CA 1.404 -2.758 0 CA-C-N 113.922 -1.49 . . . . 0.0 107.986 -176.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 7.0 tp -161.97 159.52 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.565 0 N-CA-C 103.684 -2.71 . . . . 0.0 103.684 175.278 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 63.6 p-90 -83.82 126.52 33.02 Favored 'General case' 0 N--CA 1.409 -2.476 0 CA-C-O 121.351 0.596 . . . . 0.0 109.547 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.402 HG23 ' H ' ' A' ' 133' ' ' VAL . 13.1 p -130.92 149.01 33.07 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.147 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 179.022 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 20.8 pttp -103.48 12.94 34.52 Favored 'General case' 0 C--N 1.308 -1.201 0 C-N-CA 120.536 -0.466 . . . . 0.0 110.99 -179.643 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.402 ' H ' HG23 ' A' ' 131' ' ' VAL . 10.8 m -146.92 94.17 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.936 0.874 . . . . 0.0 112.529 -174.916 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' THR . . . . . 0.449 HG22 HG21 ' A' ' 125' ' ' THR . 25.5 p -107.59 -160.73 0.74 Allowed 'General case' 0 N--CA 1.404 -2.73 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 174.026 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' SER . . . . . 0.435 ' CB ' ' HA ' ' A' ' 118' ' ' THR . 51.8 p -173.35 142.66 1.01 Allowed 'General case' 0 N--CA 1.44 -0.941 0 N-CA-C 111.327 0.121 . . . . 0.0 111.327 -178.352 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . 0.427 HG13 ' O ' ' A' ' 144' ' ' TYR . 10.1 tt -103.18 111.23 32.18 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 CA-C-O 121.397 0.618 . . . . 0.0 109.396 177.574 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' SER . . . . . 0.45 ' O ' ' HB2' ' A' ' 144' ' ' TYR . 43.5 m -111.75 139.35 47.29 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.739 -178.279 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' THR . . . . . 0.431 ' HG1' ' C ' ' A' ' 142' ' ' LYS . 7.5 t -166.09 178.11 6.56 Favored 'General case' 0 N--CA 1.428 -1.559 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 -177.709 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -83.61 28.69 0.55 Allowed 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 176.441 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . 60.23 35.73 20.91 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.352 0.661 . . . . 0.0 109.598 -174.246 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' SER . . . . . 0.466 ' O ' ' HG3' ' A' ' 155' ' ' ARG . 33.4 t -153.62 -65.73 0.15 Allowed 'General case' 0 C--O 1.214 -0.784 0 CA-C-N 115.795 -0.638 . . . . 0.0 111.426 -171.505 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . 0.431 ' C ' ' HG1' ' A' ' 138' ' ' THR . 51.2 mtpt -80.11 -169.16 1.92 Allowed 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 179.871 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.499 HG23 ' O ' ' A' ' 159' ' ' GLY . 91.7 t -135.71 119.77 25.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-O 121.663 0.744 . . . . 0.0 112.673 179.11 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . 0.45 ' HB2' ' O ' ' A' ' 137' ' ' SER . 96.2 m-85 -113.64 114.59 26.64 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 106.297 -1.742 . . . . 0.0 106.297 171.13 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 29.5 t80 -59.35 143.2 50.22 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 114.866 -1.061 . . . . 0.0 111.701 -169.12 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.421 ' C ' ' HB ' ' A' ' 134' ' ' THR . 75.1 p -46.88 104.27 0.05 OUTLIER 'General case' 0 C--O 1.245 0.823 0 N-CA-C 115.553 1.686 . . . . 0.0 115.553 -169.795 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . 161.23 -65.47 0.0 OUTLIER 'General case' 0 CA--C 1.487 -1.457 0 C-N-CA 129.674 3.19 . . . . 0.0 104.824 174.036 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 154.57 -75.22 0.23 Allowed Glycine 0 CA--C 1.48 -2.139 0 C-N-CA 119.557 -1.306 . . . . 0.0 112.282 170.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 27.3 ptt? -97.36 -11.59 23.81 Favored 'General case' 0 C--N 1.29 -1.992 0 CA-C-N 115.396 -0.402 . . . . 0.0 111.938 -175.585 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . 0.416 ' HE2' HG11 ' A' ' 127' ' ' VAL 0.352 0.0 OUTLIER -77.37 -28.71 52.97 Favored 'General case' 0 C--O 1.213 -0.823 0 N-CA-C 116.656 2.095 . . . . 0.0 116.656 -170.597 . . . . . . . . 4 4 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . 0.467 ' HA ' ' HE2' ' A' ' 151' ' ' LYS . 4.8 mmpt? -147.52 129.32 15.24 Favored 'General case' 0 CA--C 1.503 -0.829 0 CA-C-N 118.074 0.397 . . . . 0.0 110.767 179.453 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 40.6 p -106.72 145.91 31.46 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 175.461 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 4.1 mmp_? -130.75 166.69 20.23 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 -179.313 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 19.0 m -101.15 121.76 42.41 Favored 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 177.201 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' ARG . . . . . 0.466 ' HG3' ' O ' ' A' ' 141' ' ' SER . 1.6 tmm_? -63.19 -25.79 68.5 Favored 'General case' 0 C--O 1.206 -1.198 0 N-CA-C 106.898 -1.519 . . . . 0.0 106.898 178.548 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -52.7 -25.94 12.47 Favored 'General case' 0 C--N 1.302 -1.499 0 C-N-CA 126.339 1.855 . . . . 0.0 113.009 -179.665 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -71.76 -32.66 67.93 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 120.703 0.287 . . . . 0.0 111.192 -179.268 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 44.0 t80 169.39 -31.94 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 106.333 -1.729 . . . . 0.0 106.333 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . 0.719 ' HA3' ' O ' ' A' ' 65' ' ' ILE . . . 156.87 -90.11 0.12 Allowed Glycine 0 N--CA 1.4 -3.729 0 N-CA-C 108.299 -1.92 . . . . 0.0 108.299 -173.361 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.645 ' HB ' ' O ' ' A' ' 67' ' ' ILE . 11.1 t -103.35 148.17 8.74 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.756 0 N-CA-C 105.372 -2.084 . . . . 0.0 105.372 179.231 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -137.07 102.69 4.92 Favored 'General case' 0 N--CA 1.408 -2.566 0 C-N-CA 118.102 -1.439 . . . . 0.0 109.179 -173.251 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 34.7 ptt85 -152.78 173.76 14.9 Favored 'General case' 0 C--N 1.275 -2.632 0 CA-C-N 113.214 -1.812 . . . . 0.0 106.515 -177.102 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -67.63 126.03 28.06 Favored 'General case' 0 C--O 1.248 1.007 0 C-N-CA 119.087 -1.045 . . . . 0.0 108.475 169.254 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -159.23 60.9 0.31 Allowed Glycine 0 N--CA 1.411 -3.032 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.311 -179.651 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 47.1 tp -81.62 111.54 18.0 Favored 'General case' 0 N--CA 1.418 -2.038 0 N-CA-C 105.509 -2.034 . . . . 0.0 105.509 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . 0.594 ' HB2' ' O ' ' A' ' 89' ' ' PRO . 0.0 OUTLIER -84.15 105.94 15.4 Favored 'General case' 0 N--CA 1.398 -3.055 0 C-N-CA 118.382 -1.327 . . . . 0.0 110.788 -178.189 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 4.8 m -74.74 63.93 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.29 -2.012 0 CA-C-O 122.833 1.301 . . . . 0.0 111.204 176.505 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . 0.499 ' HB2' ' HB2' ' A' ' 90' ' ' SER . 35.6 t70 -133.49 -32.69 1.14 Allowed 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 112.772 -2.013 . . . . 0.0 107.724 -177.635 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 21.7 ttpp -140.03 -67.19 0.44 Allowed 'General case' 0 N--CA 1.427 -1.584 0 CA-C-N 113.764 -1.562 . . . . 0.0 107.763 -177.172 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 170' ' ' PHE . . . . . . . . . . . . . 68.3 t80 . . . . . 0 C--O 1.249 1.026 0 N-CA-C 105.004 -2.221 . . . . 0.0 105.004 -178.82 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 42.0 mt . . . . . 0 C--O 1.211 -0.931 0 N-CA-C 114.602 1.334 . . . . 0.0 114.602 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.519 ' O ' ' HG2' ' A' ' 59' ' ' LYS . 20.9 Cg_exo -61.76 -15.93 45.61 Favored 'Trans proline' 0 C--N 1.374 1.907 0 C-N-CA 121.73 1.62 . . . . 0.0 113.412 -165.149 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 31.1 mm-40 -80.35 -30.74 38.01 Favored 'General case' 0 CA--C 1.485 -1.542 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 -178.008 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.555 ' HA ' ' HB3' ' A' ' 60' ' ' GLU . 72.6 mt -75.28 -35.06 61.37 Favored 'General case' 0 N--CA 1.418 -2.054 0 CA-C-N 114.648 -1.16 . . . . 0.0 110.572 -179.218 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.653 ' HB3' ' H ' ' A' ' 75' ' ' TYR . 5.2 mp -64.46 -50.93 65.57 Favored 'General case' 0 CA--C 1.493 -1.229 0 C-N-CA 119.668 -0.813 . . . . 0.0 110.047 -178.28 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.519 ' HG2' ' O ' ' A' ' 55' ' ' PRO . 18.0 ptpt -62.55 -26.48 68.6 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 114.923 -1.035 . . . . 0.0 111.041 175.478 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.555 ' HB3' ' HA ' ' A' ' 57' ' ' LEU . 15.5 tt0 -69.71 -39.44 76.86 Favored 'General case' 0 C--N 1.317 -0.823 0 C-N-CA 123.89 0.876 . . . . 0.0 112.345 176.884 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -74.89 -26.14 59.44 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 120.459 -0.497 . . . . 0.0 110.301 176.689 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -77.17 -162.22 0.27 Allowed 'General case' 0 CA--C 1.565 1.545 0 CA-C-N 115.206 -0.906 . . . . 0.0 108.563 178.782 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.779 ' HB2' HD12 ' A' ' 65' ' ' ILE . 1.5 mt -95.02 -178.64 0.82 Allowed Pre-proline 0 CA--C 1.569 1.704 0 N-CA-C 106.809 -1.552 . . . . 0.0 106.809 -175.591 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_endo -92.45 14.85 1.63 Allowed 'Trans proline' 0 C--N 1.361 1.202 0 C-N-CA 122.36 2.04 . . . . 0.0 111.547 -174.864 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.779 HD12 ' HB2' ' A' ' 63' ' ' LEU . 0.2 OUTLIER -76.12 -42.15 37.93 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.704 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 179.497 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.402 ' H ' HD13 ' A' ' 65' ' ' ILE . . . 57.75 8.55 4.27 Favored Glycine 0 N--CA 1.481 1.645 0 CA-C-N 115.925 -0.58 . . . . 0.0 112.771 -178.155 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.623 ' H ' HG12 ' A' ' 65' ' ' ILE . 61.6 mt 64.95 -67.39 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.562 0 C-N-CA 126.201 1.8 . . . . 0.0 112.471 -176.623 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.403 ' HB3' ' HD3' ' A' ' 69' ' ' PRO . 53.3 t80 179.61 -56.63 0.0 OUTLIER Pre-proline 0 C--N 1.31 -1.119 0 N-CA-C 112.268 0.47 . . . . 0.0 112.268 -177.672 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.489 ' HB2' ' OD2' ' A' ' 71' ' ' ASP . 3.2 Cg_endo -87.67 -22.68 1.5 Allowed 'Trans proline' 0 C--N 1.365 1.416 0 C-N-CA 121.556 1.504 . . . . 0.0 114.185 -170.787 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 88.8 -8.55 79.23 Favored Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 120.525 -0.845 . . . . 0.0 111.456 -175.338 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.496 ' HB2' ' HG3' ' A' ' 89' ' ' PRO . 21.6 m-20 -81.78 -46.65 13.91 Favored 'General case' 0 CA--C 1.501 -0.926 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 177.537 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.512 ' HB1' HD12 ' A' ' 67' ' ' ILE . . . -71.27 178.15 3.51 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 114.164 -1.38 . . . . 0.0 110.273 172.798 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.541 ' O ' HG22 ' A' ' 73' ' ' THR . 81.3 m 83.24 27.86 0.1 Allowed 'General case' 0 C--N 1.354 0.775 0 CA-C-O 124.429 2.062 . . . . 0.0 110.018 174.496 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.689 ' O ' ' HA ' ' A' ' 86' ' ' VAL . 3.2 m-20 -81.82 137.76 35.22 Favored 'General case' 0 C--N 1.275 -2.635 0 CA-C-N 114.206 -1.361 . . . . 0.0 109.726 177.706 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.653 ' H ' ' HB3' ' A' ' 58' ' ' LEU . 37.5 t80 -106.73 104.94 14.75 Favored 'General case' 0 C--N 1.273 -2.756 0 CA-C-N 115.234 -0.894 . . . . 0.0 110.074 -173.957 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.676 ' O ' ' HG ' ' A' ' 84' ' ' LEU . 10.8 mm-40 -137.73 163.33 31.59 Favored 'General case' 0 C--N 1.307 -1.258 0 C-N-CA 124.112 0.965 . . . . 0.0 108.882 177.202 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 50.9 p90 -147.75 150.47 34.33 Favored 'General case' 0 C--N 1.289 -2.035 0 N-CA-C 108.064 -1.088 . . . . 0.0 108.064 177.766 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.728 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 12.7 m-20 -99.16 165.26 11.8 Favored 'General case' 0 CA--C 1.479 -1.767 0 C-N-CA 118.001 -1.48 . . . . 0.0 110.282 178.549 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -79.55 -59.66 2.66 Favored 'General case' 0 C--N 1.272 -2.802 0 CA-C-N 114.159 -1.382 . . . . 0.0 112.947 -177.968 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -72.41 -30.41 64.62 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-O 121.58 0.705 . . . . 0.0 110.292 -177.616 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.728 ' HB ' ' HB2' ' A' ' 78' ' ' ASP . 21.8 m -78.49 -51.07 10.52 Favored 'General case' 0 N--CA 1.411 -2.424 0 CA-C-N 114.824 -1.08 . . . . 0.0 110.48 -178.158 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 65.0 mttp 65.88 12.0 8.06 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.626 0.77 . . . . 0.0 112.172 -177.567 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 5.0 tppp? -100.59 141.97 32.72 Favored 'General case' 0 N--CA 1.428 -1.548 0 N-CA-C 104.449 -2.426 . . . . 0.0 104.449 175.445 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.676 ' HG ' ' O ' ' A' ' 76' ' ' GLU . 9.3 tt -80.83 145.83 31.21 Favored 'General case' 0 C--N 1.295 -1.782 0 C-N-CA 119.39 -0.924 . . . . 0.0 110.488 -178.428 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.438 ' HB ' HG22 ' A' ' 109' ' ' THR . 10.7 t -126.47 123.84 38.75 Favored 'General case' 0 N--CA 1.4 -2.964 0 CA-C-O 121.896 0.855 . . . . 0.0 111.035 -179.529 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.689 ' HA ' ' O ' ' A' ' 74' ' ' ASN . 98.5 t -96.84 126.81 49.47 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 CA-C-N 114.932 -1.031 . . . . 0.0 108.4 175.36 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.6 mp -91.64 120.37 32.35 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-O 121.63 0.728 . . . . 0.0 111.046 -179.753 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 2.1 mp -100.69 132.74 21.85 Favored Pre-proline 0 C--N 1.286 -2.191 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 172.335 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.496 ' HG3' ' HB2' ' A' ' 71' ' ' ASP . 12.4 Cg_endo -51.06 -36.28 53.96 Favored 'Trans proline' 0 C--N 1.356 0.938 0 C-N-CA 124.637 3.558 . . . . 0.0 114.357 -176.131 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' SER . . . . . 0.637 ' HB2' ' HB2' ' A' ' 168' ' ' ASP . 47.9 t -161.99 157.65 23.96 Favored 'General case' 0 CA--C 1.493 -1.221 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.408 ' CD1' ' HG3' ' A' ' 93' ' ' GLU . 0.0 OUTLIER -70.4 116.13 11.13 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.711 0 O-C-N 123.991 0.807 . . . . 0.0 109.28 179.993 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 41.3 t -112.77 123.51 50.46 Favored 'General case' 0 N--CA 1.427 -1.587 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.934 179.377 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.408 ' HG3' ' CD1' ' A' ' 91' ' ' ILE . 41.4 mt-10 -106.57 114.66 28.9 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 174.782 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 5.8 p -111.66 118.15 56.86 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.726 0 CA-C-O 121.192 0.52 . . . . 0.0 111.283 -176.764 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.466 ' HA2' ' HA ' ' A' ' 101' ' ' VAL . . . . . . . . 0 N--CA 1.43 -1.703 0 C-N-CA 120.463 -0.875 . . . . 0.0 112.016 179.155 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 48.8 m . . . . . 0 N--CA 1.452 -0.345 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.466 ' HA ' ' HA2' ' A' ' 95' ' ' GLY . 13.8 p -166.85 147.63 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.796 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 -178.354 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.524 HD23 ' H ' ' A' ' 126' ' ' LYS . 51.6 mt -134.86 133.95 40.25 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 -176.205 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.446 ' O ' ' HA ' ' A' ' 123' ' ' ILE . 27.4 ttpp -110.28 114.05 27.22 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 112.195 0.442 . . . . 0.0 112.195 -177.112 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.405 ' O ' ' HA ' ' A' ' 91' ' ' ILE . 95.5 m-85 -101.65 104.54 15.39 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.721 176.696 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 89.4 m -79.59 165.0 23.39 Favored 'General case' 0 CA--C 1.557 1.215 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.618 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 12.0 p -69.57 -69.68 0.33 Allowed 'General case' 0 N--CA 1.438 -1.063 0 C-N-CA 124.93 1.292 . . . . 0.0 112.886 -175.014 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 25.6 m -96.3 88.51 4.79 Favored 'General case' 0 N--CA 1.416 -2.173 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 -178.195 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.683 HG21 HG13 ' A' ' 123' ' ' ILE . 5.0 p -101.48 144.18 13.43 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.103 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.18 -176.953 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.592 ' OG1' ' HB3' ' A' ' 121' ' ' GLU . 11.6 p -109.33 165.06 11.92 Favored 'General case' 0 C--N 1.287 -2.139 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 178.183 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 173.39 172.58 38.99 Favored Glycine 0 N--CA 1.427 -1.914 0 N-CA-C 111.485 -0.646 . . . . 0.0 111.485 179.68 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 47.4 t-80 -93.2 106.47 18.43 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 178.016 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.52 ' HB3' HD13 ' A' ' 84' ' ' LEU . 2.9 tm? -94.42 136.51 34.63 Favored 'General case' 0 CA--C 1.466 -2.261 0 N-CA-C 106.838 -1.542 . . . . 0.0 106.838 -175.388 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' GLU . . . . . 0.43 ' N ' HD13 ' A' ' 112' ' ' LEU . 0.3 OUTLIER -142.49 153.01 43.26 Favored 'General case' 0 N--CA 1.383 -3.777 0 N-CA-C 105.275 -2.12 . . . . 0.0 105.275 177.837 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 8.1 mmtt -67.92 101.06 1.04 Allowed 'General case' 0 C--N 1.302 -1.464 0 CA-C-O 121.898 0.856 . . . . 0.0 111.691 -178.607 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' GLY . . . . . 0.685 ' O ' ' HB ' ' A' ' 138' ' ' THR . . . 131.0 -54.24 0.79 Allowed Glycine 0 N--CA 1.41 -3.049 0 CA-C-N 114.342 -1.299 . . . . 0.0 109.927 -178.765 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.491 ' HD3' HG23 ' A' ' 118' ' ' THR . 0.0 OUTLIER -136.51 141.93 43.47 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 114.006 1.113 . . . . 0.0 114.006 -176.811 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.68 ' O ' ' HB2' ' A' ' 135' ' ' SER . 58.1 tp -104.82 106.82 17.47 Favored 'General case' 0 C--N 1.311 -1.067 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 177.704 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.491 HG23 ' HD3' ' A' ' 116' ' ' LYS . 42.1 p -106.19 142.93 35.06 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 -175.594 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 28.6 m-20 54.74 98.78 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 125.156 1.382 . . . . 0.0 113.031 177.891 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 4.3 m -100.58 172.54 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.587 0 CA-C-O 120.983 0.42 . . . . 0.0 110.907 179.529 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.592 ' HB3' ' OG1' ' A' ' 109' ' ' THR . 14.9 tp10 -140.84 82.77 1.86 Allowed 'General case' 0 N--CA 1.416 -2.165 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.382 178.705 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' GLY . . . . . 0.412 ' HA3' HG23 ' A' ' 108' ' ' VAL . . . 150.96 -19.7 0.97 Allowed Glycine 0 C--N 1.308 -1.012 0 CA-C-N 115.153 -0.931 . . . . 0.0 111.979 177.14 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.683 HG13 HG21 ' A' ' 108' ' ' VAL . 96.1 mt -99.61 100.17 9.93 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.63 0 CA-C-O 121.383 0.611 . . . . 0.0 109.514 -179.087 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.461 ' HA ' ' HA ' ' A' ' 132' ' ' LYS . 39.7 ttmt -86.65 119.19 26.62 Favored 'General case' 0 N--CA 1.428 -1.565 0 N-CA-C 107.613 -1.255 . . . . 0.0 107.613 -179.617 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.601 ' HB ' ' OG1' ' A' ' 134' ' ' THR . 89.9 m -121.33 125.14 46.28 Favored 'General case' 0 C--N 1.268 -2.95 0 CA-C-N 114.477 -1.238 . . . . 0.0 110.962 -172.19 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.612 ' C ' ' HD3' ' A' ' 126' ' ' LYS . 0.2 OUTLIER -117.99 105.78 12.24 Favored 'General case' 0 N--CA 1.412 -2.347 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 173.026 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 33.3 m -107.7 -27.61 2.95 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.102 0 CA-C-O 121.872 0.844 . . . . 0.0 110.08 176.314 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' MET . . . . . 0.482 ' C ' HD12 ' A' ' 129' ' ' ILE . 27.3 ttt -158.94 -35.55 0.06 Allowed 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 106.971 -1.492 . . . . 0.0 106.971 -175.0 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 129' ' ' ILE . . . . . 0.482 HD12 ' C ' ' A' ' 128' ' ' MET . 2.8 mp -134.94 151.65 31.46 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.72 0 N-CA-C 104.271 -2.492 . . . . 0.0 104.271 171.356 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 16.2 p90 -90.53 116.68 28.62 Favored 'General case' 0 N--CA 1.425 -1.711 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 178.375 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.623 HG12 ' H ' ' A' ' 133' ' ' VAL . 36.0 t -137.69 146.58 27.25 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 -175.977 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 132' ' ' LYS . . . . . 0.461 ' HA ' ' HA ' ' A' ' 124' ' ' LYS . 58.9 pttt -103.23 12.0 36.17 Favored 'General case' 0 C--N 1.315 -0.917 0 C-N-CA 120.165 -0.614 . . . . 0.0 111.448 -178.797 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.623 ' H ' HG12 ' A' ' 131' ' ' VAL . 33.5 m -125.55 -1.43 5.14 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.006 0 C-N-CA 120.396 -0.522 . . . . 0.0 111.778 -175.942 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 134' ' ' THR . . . . . 0.601 ' OG1' ' HB ' ' A' ' 125' ' ' THR . 1.3 p -60.35 111.16 1.45 Allowed 'General case' 0 N--CA 1.43 -1.425 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 175.636 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 135' ' ' SER . . . . . 0.68 ' HB2' ' O ' ' A' ' 117' ' ' LEU . 23.2 p -106.79 172.2 6.95 Favored 'General case' 0 N--CA 1.41 -2.471 0 N-CA-C 114.93 1.455 . . . . 0.0 114.93 -169.166 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 136' ' ' ILE . . . . . 0.406 ' HB ' ' CG2' ' A' ' 146' ' ' THR . 12.2 tt -101.16 105.23 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.491 0 CA-C-N 114.81 -1.086 . . . . 0.0 110.869 -173.406 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 45.7 p -91.54 114.36 26.87 Favored 'General case' 0 N--CA 1.414 -2.269 0 CA-C-N 115.157 -0.928 . . . . 0.0 109.685 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' THR . . . . . 0.685 ' HB ' ' O ' ' A' ' 115' ' ' GLY . 46.6 m -119.54 153.87 34.74 Favored 'General case' 0 C--N 1.279 -2.476 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 -179.791 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -106.41 35.36 2.98 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 178.326 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . 57.54 34.87 25.15 Favored 'General case' 0 C--N 1.355 0.805 0 CA-C-N 115.046 -0.979 . . . . 0.0 109.065 -177.389 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 47.2 t -173.1 -77.96 0.01 OUTLIER 'General case' 0 C--O 1.211 -0.935 0 CA-C-N 114.731 -1.122 . . . . 0.0 109.683 -174.234 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 81.6 mttt -89.93 150.97 21.94 Favored 'General case' 0 CA--C 1.497 -1.068 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 179.775 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 13.1 p -118.93 142.91 31.71 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.067 0 CA-C-O 121.416 0.627 . . . . 0.0 111.686 -175.85 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -121.55 114.9 21.86 Favored 'General case' 0 N--CA 1.423 -1.799 0 N-CA-C 106.163 -1.791 . . . . 0.0 106.163 171.475 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 145' ' ' PHE . . . . . 0.545 ' HB3' ' HB2' ' A' ' 151' ' ' LYS . 65.0 t80 -53.74 156.2 2.85 Favored 'General case' 0 C--O 1.252 1.223 0 C-N-CA 124.539 1.135 . . . . 0.0 113.094 -171.831 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.516 ' O ' HG21 ' A' ' 125' ' ' THR . 33.7 p -51.1 93.65 0.01 OUTLIER 'General case' 0 C--N 1.35 0.609 0 C-N-CA 125.181 1.392 . . . . 0.0 113.793 -175.573 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 147' ' ' ALA . . . . . 0.521 ' HA ' ' HB ' ' A' ' 134' ' ' THR . . . 163.27 -35.71 0.0 OUTLIER 'General case' 0 CA--C 1.497 -1.061 0 C-N-CA 127.171 2.188 . . . . 0.0 106.31 178.676 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 100.63 79.07 1.4 Allowed Glycine 0 N--CA 1.434 -1.493 0 CA-C-N 114.963 -1.017 . . . . 0.0 111.807 179.016 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 16.3 tpt 72.51 -10.24 0.96 Allowed 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 123.877 0.871 . . . . 0.0 112.698 177.155 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -62.38 -30.53 71.27 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 121.062 0.458 . . . . 0.0 110.023 -179.014 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 151' ' ' LYS . . . . . 0.545 ' HB2' ' HB3' ' A' ' 145' ' ' PHE . 10.0 mmpt? -121.86 118.76 29.75 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 106.521 -1.659 . . . . 0.0 106.521 175.122 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 32.1 p -91.39 111.66 23.24 Favored 'General case' 0 C--N 1.297 -1.708 0 CA-C-O 120.617 0.246 . . . . 0.0 111.174 -177.949 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 37.6 mmt180 -134.88 137.3 43.09 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 179.77 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 20.0 m -90.2 132.47 35.47 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 111.504 0.187 . . . . 0.0 111.504 -176.674 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 155' ' ' ARG . . . . . 0.481 ' HG2' ' HA2' ' A' ' 159' ' ' GLY . 2.0 tmt_? -65.01 -26.5 68.31 Favored 'General case' 0 N--CA 1.483 1.196 0 CA-C-O 121.107 0.479 . . . . 0.0 109.898 177.494 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -38.04 -48.11 1.17 Allowed 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 126.102 1.761 . . . . 0.0 115.576 -175.922 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -79.33 -54.92 5.47 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 113.899 1.074 . . . . 0.0 113.899 -173.212 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 0.43 ' HB2' ' OE1' ' A' ' 161' ' ' GLN . 98.3 m-85 -153.19 24.5 0.55 Allowed 'General case' 0 N--CA 1.482 1.151 0 O-C-N 122.242 -0.286 . . . . 0.0 110.536 -176.658 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 159' ' ' GLY . . . . . 0.634 ' HA3' ' O ' ' A' ' 65' ' ' ILE . . . 87.78 -92.41 1.8 Allowed Glycine 0 CA--C 1.475 -2.46 0 C-N-CA 119.672 -1.252 . . . . 0.0 111.618 -177.597 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.566 ' HB ' ' O ' ' A' ' 67' ' ' ILE . 28.6 t -98.58 121.92 49.68 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.191 0 C-N-CA 119.67 -0.812 . . . . 0.0 108.91 -179.797 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 161' ' ' GLN . . . . . 0.43 ' OE1' ' HB2' ' A' ' 158' ' ' TYR . 15.3 mm100 -103.88 92.95 4.63 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 115.78 1.77 . . . . 0.0 115.78 -175.188 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 17.0 mmm180 -152.66 150.27 29.29 Favored 'General case' 0 CA--C 1.501 -0.93 0 C-N-CA 125.624 1.57 . . . . 0.0 108.754 170.755 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 19.7 m120 -89.88 97.69 11.33 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-O 120.964 0.412 . . . . 0.0 111.415 -178.491 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -136.57 156.07 22.91 Favored Glycine 0 C--N 1.308 -1.025 0 N-CA-C 110.615 -0.994 . . . . 0.0 110.615 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -135.83 116.63 14.07 Favored 'General case' 0 N--CA 1.425 -1.703 0 CA-C-O 121.38 0.609 . . . . 0.0 109.5 178.355 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 166' ' ' ARG . . . . . 0.604 ' H ' ' HD2' ' A' ' 166' ' ' ARG . 3.3 mpt_? -81.3 105.83 12.79 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 106.39 -1.707 . . . . 0.0 106.39 178.63 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 167' ' ' VAL . . . . . 0.4 HG22 ' H ' ' A' ' 167' ' ' VAL . 9.2 m -71.43 77.08 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.925 0 N-CA-C 114.976 1.473 . . . . 0.0 114.976 -174.25 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 168' ' ' ASP . . . . . 0.637 ' HB2' ' HB2' ' A' ' 90' ' ' SER . 15.4 t70 -144.41 -34.01 0.38 Allowed 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 114.072 -1.422 . . . . 0.0 107.279 177.588 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 169' ' ' LYS . . . . . 0.407 ' H ' ' H ' ' A' ' 168' ' ' ASP . 39.1 ttpt -111.86 157.4 20.66 Favored 'General case' 0 N--CA 1.439 -1.015 0 CA-C-N 114.543 -1.208 . . . . 0.0 108.039 178.858 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 170' ' ' PHE . . . . . . . . . . . . . 16.0 p90 . . . . . 0 C--N 1.305 -1.366 0 O-C-N 123.248 0.342 . . . . 0.0 111.349 179.405 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 8.4 mp . . . . . 0 CA--C 1.489 -1.383 0 N-CA-C 117.272 2.323 . . . . 0.0 117.272 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.567 ' HA ' ' HG ' ' A' ' 58' ' ' LEU . 13.1 Cg_exo -66.39 -14.51 44.46 Favored 'Trans proline' 0 N--CA 1.416 -3.05 0 CA-C-N 120.183 1.101 . . . . 0.0 111.857 -175.131 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -74.05 -32.19 63.2 Favored 'General case' 0 N--CA 1.426 -1.644 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 -179.532 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.525 ' HA ' ' HG2' ' A' ' 60' ' ' GLU . 3.7 mm? -73.88 -41.73 61.75 Favored 'General case' 0 N--CA 1.423 -1.825 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 175.941 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.567 ' HG ' ' HA ' ' A' ' 55' ' ' PRO . 52.0 mt -58.2 -48.08 81.43 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.735 -177.864 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 7.4 mtpm? -70.84 -26.58 63.34 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 115.296 -0.865 . . . . 0.0 112.319 -178.036 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.525 ' HG2' ' HA ' ' A' ' 57' ' ' LEU . 8.6 pt-20 -83.84 -18.49 37.39 Favored 'General case' 0 N--CA 1.444 -0.762 0 C-N-CA 118.957 -1.097 . . . . 0.0 109.854 177.913 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 61.2 m-85 -89.08 -13.91 37.52 Favored 'General case' 0 C--O 1.24 0.604 0 C-N-CA 119.095 -1.042 . . . . 0.0 112.119 175.841 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.449 ' HB3' HG23 ' A' ' 73' ' ' THR . 23.5 t70 -91.93 -153.95 0.35 Allowed 'General case' 0 C--O 1.253 1.27 0 N-CA-C 105.782 -1.933 . . . . 0.0 105.782 172.698 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.632 ' HB2' HD12 ' A' ' 65' ' ' ILE . 5.1 mt -95.16 158.17 35.26 Favored Pre-proline 0 C--N 1.298 -1.661 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 -178.057 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -93.86 26.6 0.34 Allowed 'Trans proline' 0 N--CA 1.448 -1.19 0 C-N-CA 122.849 2.366 . . . . 0.0 111.143 -168.729 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.686 HG12 ' H ' ' A' ' 67' ' ' ILE . 0.2 OUTLIER -95.11 -21.58 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.778 0 CA-C-N 115.331 -0.849 . . . . 0.0 108.966 -177.995 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 67.64 8.92 54.33 Favored Glycine 0 C--N 1.353 1.481 0 CA-C-N 115.501 -0.772 . . . . 0.0 112.195 179.548 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.686 ' H ' HG12 ' A' ' 65' ' ' ILE . 73.0 mt 57.79 -70.78 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.203 -1.344 0 C-N-CA 127.184 2.193 . . . . 0.0 112.613 -173.044 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.551 ' HB3' ' HD3' ' A' ' 69' ' ' PRO . 79.5 t80 176.73 -50.53 0.0 OUTLIER Pre-proline 0 C--N 1.303 -1.449 0 C-N-CA 122.853 0.461 . . . . 0.0 110.392 -174.578 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.551 ' HD3' ' HB3' ' A' ' 68' ' ' PHE . 24.8 Cg_exo -67.58 131.69 25.15 Favored 'Trans proline' 0 N--CA 1.436 -1.876 0 N-CA-C 109.046 -1.175 . . . . 0.0 109.046 174.386 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -73.7 64.58 1.84 Allowed Glycine 0 C--N 1.306 -1.102 0 O-C-N 123.439 0.462 . . . . 0.0 113.045 -177.275 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.496 ' HB3' ' HG3' ' A' ' 89' ' ' PRO . 12.7 t70 177.43 -39.65 0.01 OUTLIER 'General case' 0 C--O 1.21 -0.978 0 N-CA-C 107.737 -1.208 . . . . 0.0 107.737 179.379 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.66 ' O ' ' HB ' ' A' ' 73' ' ' THR . . . -46.48 166.28 0.02 OUTLIER 'General case' 0 N--CA 1.506 2.365 0 C-N-CA 124.273 1.029 . . . . 0.0 112.753 174.624 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.66 ' HB ' ' O ' ' A' ' 72' ' ' ALA 0.254 1.5 m 88.11 26.22 0.03 OUTLIER 'General case' 0 C--N 1.367 1.346 0 CA-C-O 125.071 2.367 . . . . 0.0 109.665 -178.97 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 40.7 m-80 -82.23 163.88 21.57 Favored 'General case' 0 N--CA 1.411 -2.376 0 CA-C-N 113.725 -1.58 . . . . 0.0 111.033 177.404 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.496 ' H ' ' HB3' ' A' ' 58' ' ' LEU . 33.7 t80 -134.52 95.6 3.41 Favored 'General case' 0 C--N 1.274 -2.702 0 CA-C-N 115.151 -0.932 . . . . 0.0 111.923 -168.893 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.498 ' O ' HD22 ' A' ' 84' ' ' LEU . 41.0 mm-40 -115.89 153.46 31.5 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 173.667 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 69.0 t80 -146.08 114.47 6.71 Favored 'General case' 0 C--N 1.29 -1.98 0 O-C-N 122.046 -0.409 . . . . 0.0 110.04 -177.023 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.658 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 31.7 m-20 -88.67 148.95 23.75 Favored 'General case' 0 CA--C 1.459 -2.535 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 175.622 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -82.37 -41.18 20.31 Favored 'General case' 1 C--N 1.24 -4.172 0 CA-C-N 114.796 -1.093 . . . . 0.0 111.916 179.307 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.401 ' HG3' ' N ' ' A' ' 81' ' ' THR . 8.7 pt-20 -61.84 -41.7 98.14 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-O 122.236 1.017 . . . . 0.0 109.332 178.331 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.658 ' HB ' ' HB2' ' A' ' 78' ' ' ASP . 46.2 m -70.76 -51.31 27.9 Favored 'General case' 0 N--CA 1.412 -2.374 0 CA-C-N 113.799 -1.546 . . . . 0.0 108.045 177.14 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 80.0 tttt 68.2 9.01 6.95 Favored 'General case' 0 C--N 1.348 0.533 0 C-N-CA 126.144 1.778 . . . . 0.0 110.398 178.563 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.792 ' HG2' HG22 ' A' ' 109' ' ' THR . 75.5 tttt -117.7 133.86 55.51 Favored 'General case' 0 N--CA 1.409 -2.505 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 179.363 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.498 HD22 ' O ' ' A' ' 76' ' ' GLU . 2.7 tm? -64.44 133.76 53.15 Favored 'General case' 0 C--N 1.317 -0.841 0 C-N-CA 123.101 0.561 . . . . 0.0 110.149 -172.554 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.509 ' HB ' HG23 ' A' ' 109' ' ' THR . 6.0 t -117.1 111.44 19.51 Favored 'General case' 0 N--CA 1.412 -2.372 0 CA-C-O 122.128 0.966 . . . . 0.0 111.577 -177.593 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 58.0 t -92.87 126.01 45.37 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.272 0 CA-C-N 114.89 -1.05 . . . . 0.0 108.433 177.853 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.51 ' HA ' ' O ' ' A' ' 106' ' ' THR . 1.9 pp -105.02 124.4 49.46 Favored 'General case' 0 N--CA 1.408 -2.572 0 CA-C-N 115.242 -0.89 . . . . 0.0 112.16 178.276 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 3.0 mp -110.06 125.04 31.93 Favored Pre-proline 0 C--N 1.293 -1.855 0 CA-C-N 114.063 -1.426 . . . . 0.0 109.089 178.453 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.496 ' HG3' ' HB3' ' A' ' 71' ' ' ASP . 2.6 Cg_endo -52.23 98.59 0.04 OUTLIER 'Trans proline' 0 C--N 1.363 1.306 0 C-N-CA 123.395 2.73 . . . . 0.0 112.206 173.216 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' SER . . . . . 0.612 ' HB2' ' HB2' ' A' ' 168' ' ' ASP . 43.3 t 74.03 141.56 0.07 Allowed 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 124.326 1.05 . . . . 0.0 112.512 -179.534 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.532 HD11 ' HG3' ' A' ' 103' ' ' LYS . 0.0 OUTLIER -76.49 108.37 9.08 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.132 0 CA-C-N 114.999 -1.0 . . . . 0.0 109.005 176.644 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 25.1 p -91.83 127.22 37.21 Favored 'General case' 0 N--CA 1.431 -1.419 0 CA-C-N 114.838 -1.074 . . . . 0.0 110.56 -179.756 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -107.8 159.59 16.38 Favored 'General case' 0 C--O 1.244 0.766 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.25 -179.374 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.574 ' O ' ' HA ' ' A' ' 101' ' ' VAL . 2.6 p -156.95 109.01 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.141 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 -178.963 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.552 ' HA2' ' O ' ' A' ' 100' ' ' SER . . . . . . . . 0 N--CA 1.423 -2.233 0 C-N-CA 119.022 -1.561 . . . . 0.0 114.239 -178.114 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' SER . . . . . 0.552 ' O ' ' HA2' ' A' ' 95' ' ' GLY . 54.3 m . . . . . 0 N--CA 1.429 -1.524 0 CA-C-O 120.634 0.254 . . . . 0.0 110.945 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.574 ' HA ' ' O ' ' A' ' 94' ' ' VAL . 11.3 p -117.27 132.97 65.49 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.507 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 171.771 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.41 ' HG ' ' HA ' ' A' ' 125' ' ' THR . 6.8 tt -152.78 145.41 24.24 Favored 'General case' 0 N--CA 1.405 -2.702 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 -175.642 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.532 ' HG3' HD11 ' A' ' 91' ' ' ILE . 39.8 ttmt -129.99 121.1 25.87 Favored 'General case' 0 C--N 1.291 -1.965 0 N-CA-C 111.937 0.347 . . . . 0.0 111.937 -177.331 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -95.36 103.6 15.47 Favored 'General case' 0 N--CA 1.439 -1.008 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 175.293 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 41.1 m -70.82 149.74 46.53 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 109.889 -0.411 . . . . 0.0 109.889 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' THR . . . . . 0.51 ' O ' ' HA ' ' A' ' 87' ' ' LEU . 37.8 p -54.07 -53.75 48.88 Favored 'General case' 0 C--O 1.216 -0.691 0 CA-C-O 121.666 0.746 . . . . 0.0 110.985 -178.26 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 7.5 m -113.73 93.54 4.43 Favored 'General case' 0 N--CA 1.399 -2.994 0 CA-C-N 115.056 -0.974 . . . . 0.0 109.619 -176.408 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.471 HG11 ' CD1' ' A' ' 123' ' ' ILE . 15.1 m -99.46 155.59 4.03 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.546 177.531 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.792 HG22 ' HG2' ' A' ' 83' ' ' LYS . 0.4 OUTLIER -137.24 128.73 28.35 Favored 'General case' 0 N--CA 1.398 -3.072 0 N-CA-C 106.05 -1.833 . . . . 0.0 106.05 -173.831 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 110' ' ' GLY . . . . . 0.453 ' HA2' ' O ' ' A' ' 119' ' ' ASP . . . -151.12 -174.57 22.15 Favored Glycine 0 C--N 1.286 -2.208 0 C-N-CA 119.979 -1.105 . . . . 0.0 113.714 -175.706 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' HIS . . . . . 0.463 ' O ' HD12 ' A' ' 117' ' ' LEU . 45.0 t60 -91.33 117.93 30.08 Favored 'General case' 0 C--N 1.294 -1.821 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 179.727 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -99.92 117.91 35.22 Favored 'General case' 0 CA--C 1.479 -1.752 0 CA-C-O 121.014 0.435 . . . . 0.0 110.879 -171.132 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -126.74 138.34 53.37 Favored 'General case' 0 CA--C 1.45 -2.881 0 CA-C-N 115.094 -0.957 . . . . 0.0 108.894 167.04 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 6.0 tmtt? -73.47 100.88 3.36 Favored 'General case' 0 N--CA 1.389 -3.482 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 -175.482 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' GLY . . . . . 0.543 ' O ' HG23 ' A' ' 138' ' ' THR . . . 135.78 -37.63 1.88 Allowed Glycine 0 N--CA 1.419 -2.461 0 N-CA-C 110.169 -1.172 . . . . 0.0 110.169 -176.203 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.559 ' O ' ' HD2' ' A' ' 116' ' ' LYS . 0.0 OUTLIER -154.06 136.96 15.39 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.27 0.628 . . . . 0.0 111.984 -179.441 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.463 HD12 ' O ' ' A' ' 111' ' ' HIS . 64.1 tp -111.43 107.05 16.14 Favored 'General case' 0 C--N 1.308 -1.2 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 -177.274 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 68.1 p -105.56 176.11 5.27 Favored 'General case' 0 C--N 1.296 -1.735 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.637 -179.023 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' ASP . . . . . 0.453 ' O ' ' HA2' ' A' ' 110' ' ' GLY . 16.2 m-20 56.59 48.66 16.1 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.259 0.623 . . . . 0.0 111.722 172.61 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.454 HG23 ' O ' ' A' ' 133' ' ' VAL . 3.3 m -81.93 96.18 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.656 0 CA-C-O 122.662 1.22 . . . . 0.0 112.29 -176.253 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -75.94 94.12 3.34 Favored 'General case' 0 N--CA 1.401 -2.886 0 CA-C-N 113.253 -1.794 . . . . 0.0 108.438 -178.56 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 134.7 -4.85 4.39 Favored Glycine 0 C--N 1.285 -2.299 0 CA-C-N 115.063 -0.971 . . . . 0.0 111.816 177.909 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.471 ' CD1' HG11 ' A' ' 108' ' ' VAL . 48.9 mm -99.91 99.58 8.78 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.229 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 177.039 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 53.4 mtmt -93.44 119.26 32.32 Favored 'General case' 0 N--CA 1.411 -2.382 0 CA-C-N 114.355 -1.293 . . . . 0.0 108.605 -179.092 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.41 ' HA ' ' HG ' ' A' ' 102' ' ' LEU . 99.1 m -128.1 131.87 49.01 Favored 'General case' 0 N--CA 1.422 -1.852 0 CA-C-N 114.771 -1.104 . . . . 0.0 112.918 -167.782 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.619 ' C ' ' HD3' ' A' ' 126' ' ' LYS . 0.2 OUTLIER -123.05 119.71 31.16 Favored 'General case' 0 N--CA 1.418 -2.068 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 170.825 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.441 HG23 ' H ' ' A' ' 128' ' ' MET . 4.8 m -139.17 -56.57 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.031 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.388 176.934 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 128' ' ' MET . . . . . 0.441 ' H ' HG23 ' A' ' 127' ' ' VAL . 26.8 ttt -99.57 -34.96 10.02 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 178.168 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 129' ' ' ILE . . . . . 0.565 ' CD1' ' H ' ' A' ' 130' ' ' TRP . 0.3 OUTLIER -162.57 -177.71 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.418 -2.074 0 N-CA-C 103.499 -2.778 . . . . 0.0 103.499 176.615 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 130' ' ' TRP . . . . . 0.565 ' H ' ' CD1' ' A' ' 129' ' ' ILE . 88.4 t90 -92.29 123.76 35.85 Favored 'General case' 0 C--N 1.296 -1.733 0 CA-C-N 119.55 1.068 . . . . 0.0 109.797 -179.658 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.626 HG12 ' H ' ' A' ' 133' ' ' VAL . 61.1 t -131.55 136.69 56.85 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.08 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 179.631 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 132' ' ' LYS . . . . . 0.617 ' HD3' ' H ' ' A' ' 132' ' ' LYS . 0.0 OUTLIER -98.89 21.77 11.11 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-O 121.019 0.437 . . . . 0.0 111.237 -178.056 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.626 ' H ' HG12 ' A' ' 131' ' ' VAL . 51.5 t -132.05 -78.73 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.251 0 CA-C-N 116.214 -0.448 . . . . 0.0 109.959 -175.689 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 40.0 p 51.86 -167.01 0.05 OUTLIER 'General case' 0 CA--C 1.555 1.155 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 -177.068 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 27.6 p -164.04 150.39 11.33 Favored 'General case' 0 N--CA 1.429 -1.52 0 C-N-CA 122.637 0.375 . . . . 0.0 110.146 -179.43 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 7.5 tt -105.7 97.41 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.884 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 173.502 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 60.6 p -97.58 142.63 29.16 Favored 'General case' 0 N--CA 1.405 -2.686 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.997 -177.011 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' THR . . . . . 0.543 HG23 ' O ' ' A' ' 115' ' ' GLY . 5.8 t -165.08 175.07 9.72 Favored 'General case' 0 N--CA 1.399 -2.988 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 -177.794 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -110.71 28.52 8.61 Favored 'General case' 0 C--N 1.285 -2.23 0 N-CA-C 106.306 -1.739 . . . . 0.0 106.306 176.669 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . 61.46 44.06 9.72 Favored 'General case' 0 C--N 1.348 0.529 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 -171.115 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 30.8 t -174.96 -80.29 0.01 OUTLIER 'General case' 0 CA--C 1.555 1.149 0 CA-C-N 114.783 -1.099 . . . . 0.0 110.973 -171.52 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -83.96 128.6 34.66 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 179.837 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.421 HG11 HG12 ' A' ' 160' ' ' VAL . 88.8 t -105.49 127.83 60.01 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.973 0 CA-C-O 121.516 0.674 . . . . 0.0 112.093 -171.001 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 26.7 m-85 -118.41 141.25 48.74 Favored 'General case' 0 N--CA 1.426 -1.64 0 CA-C-N 115.318 -0.855 . . . . 0.0 111.138 179.621 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 145' ' ' PHE . . . . . 0.433 ' HB2' ' H ' ' A' ' 151' ' ' LYS . 42.9 m-85 -93.21 98.75 11.48 Favored 'General case' 0 N--CA 1.408 -2.525 0 CA-C-N 114.382 -1.281 . . . . 0.0 108.371 171.377 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . 0.259 2.5 p -98.42 99.71 10.91 Favored 'General case' 0 N--CA 1.406 -2.639 0 N-CA-C 115.061 1.504 . . . . 0.0 115.061 -176.221 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -130.35 29.62 4.84 Favored 'General case' 0 C--N 1.312 -1.031 0 N-CA-C 105.445 -2.057 . . . . 0.0 105.445 174.524 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 133.99 -69.33 0.53 Allowed Glycine 0 N--CA 1.413 -2.847 0 N-CA-C 104.016 -3.633 . . . . 0.0 104.016 -171.794 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 27.7 ttt 173.3 82.86 0.0 OUTLIER 'General case' 0 C--N 1.314 -0.971 0 C-N-CA 125.885 1.674 . . . . 0.0 108.147 169.859 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 150' ' ' LYS . . . . . 0.404 ' HG3' ' CG2' ' A' ' 127' ' ' VAL . 29.4 mmtt -88.84 -88.74 0.15 Allowed 'General case' 0 C--N 1.308 -1.196 0 N-CA-C 115.09 1.515 . . . . 0.0 115.09 -179.513 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 151' ' ' LYS . . . . . 0.433 ' H ' ' HB2' ' A' ' 145' ' ' PHE . 98.7 mttt -110.26 149.1 30.65 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 113.354 0.872 . . . . 0.0 113.354 -172.469 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 20.3 m -132.64 137.77 47.12 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.818 -176.898 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.28 162.84 40.78 Favored 'General case' 0 CA--C 1.477 -1.849 0 CA-C-O 121.317 0.58 . . . . 0.0 111.661 175.129 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 46.4 m -90.18 139.85 30.24 Favored 'General case' 0 C--N 1.274 -2.689 0 CA-C-N 115.284 -0.871 . . . . 0.0 108.858 179.12 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 155' ' ' ARG . . . . . . . . . . . . 0.407 0.0 OUTLIER -58.68 -18.54 31.81 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 114.28 1.215 . . . . 0.0 114.28 -179.783 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -50.06 -32.4 15.46 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 124.632 1.173 . . . . 0.0 111.489 178.494 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -68.04 -54.05 21.26 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 116.576 -0.283 . . . . 0.0 110.827 179.708 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 1.1 t80 177.95 21.6 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.0 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 177.205 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 159' ' ' GLY . . . . . 0.4 ' HA2' ' HB ' ' A' ' 65' ' ' ILE . . . 88.71 -99.41 2.54 Favored Glycine 0 N--CA 1.419 -2.472 0 C-N-CA 119.779 -1.201 . . . . 0.0 111.098 -174.08 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.566 HG22 ' O ' ' A' ' 67' ' ' ILE . 4.2 m -103.09 128.79 55.74 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.304 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 49.9 mt-30 -94.02 92.13 7.19 Favored 'General case' 0 C--N 1.294 -1.824 0 C-N-CA 119.176 -1.01 . . . . 0.0 111.151 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 162' ' ' ARG . . . . . 0.522 ' CG ' HG11 ' A' ' 94' ' ' VAL . 21.0 tpp180 -152.49 112.2 3.95 Favored 'General case' 0 N--CA 1.414 -2.228 0 N-CA-C 106.857 -1.534 . . . . 0.0 106.857 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 83.7 m-20 -77.05 105.97 8.46 Favored 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 -174.402 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -118.76 -178.22 16.81 Favored Glycine 0 C--N 1.3 -1.434 0 N-CA-C 110.18 -1.168 . . . . 0.0 110.18 176.651 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.526 ' O ' HD22 ' A' ' 165' ' ' LEU . 0.0 OUTLIER -141.55 131.74 24.89 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 177.431 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 166' ' ' ARG . . . . . 0.483 ' HD3' ' HB3' ' A' ' 69' ' ' PRO . 9.5 mtm180 -96.05 111.1 23.21 Favored 'General case' 0 CA--C 1.482 -1.667 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 -179.788 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 167' ' ' VAL . . . . . 0.414 HG13 HD23 ' A' ' 165' ' ' LEU 0.287 2.6 m -80.84 65.92 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.103 0 CA-C-O 122.906 1.336 . . . . 0.0 111.181 173.32 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 168' ' ' ASP . . . . . 0.612 ' HB2' ' HB2' ' A' ' 90' ' ' SER . 21.7 t70 -160.87 -27.49 0.06 Allowed 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 112.33 -2.214 . . . . 0.0 108.426 -177.293 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 169' ' ' LYS . . . . . 0.412 ' H ' ' H ' ' A' ' 168' ' ' ASP . 21.6 pttp -74.85 149.51 39.54 Favored 'General case' 0 C--O 1.244 0.796 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.863 -173.904 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 170' ' ' PHE . . . . . . . . . . . . . 16.9 p90 . . . . . 0 C--N 1.297 -1.698 0 CA-C-O 118.189 -0.91 . . . . 0.0 110.039 -179.785 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 9.3 mp . . . . . 0 CA--C 1.476 -1.892 0 N-CA-C 116.92 2.193 . . . . 0.0 116.92 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.553 ' O ' ' HG2' ' A' ' 59' ' ' LYS . 25.8 Cg_exo -60.71 -15.53 37.95 Favored 'Trans proline' 0 N--CA 1.45 -1.079 0 C-N-CA 121.613 1.542 . . . . 0.0 111.92 -171.643 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.478 ' O ' ' HB2' ' A' ' 60' ' ' GLU . 22.6 mm-40 -80.27 -37.09 33.55 Favored 'General case' 0 N--CA 1.419 -1.989 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 179.553 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.507 ' HA ' ' HB3' ' A' ' 60' ' ' GLU . 9.3 mp -75.63 -34.27 60.53 Favored 'General case' 0 N--CA 1.438 -1.074 0 N-CA-C 113.557 0.947 . . . . 0.0 113.557 -177.412 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.421 HD12 ' N ' ' A' ' 58' ' ' LEU . 3.5 mp -63.14 -45.74 90.5 Favored 'General case' 0 N--CA 1.499 2.025 0 C-N-CA 119.29 -0.964 . . . . 0.0 109.365 -178.618 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.553 ' HG2' ' O ' ' A' ' 55' ' ' PRO . 0.0 OUTLIER -75.77 -25.85 56.82 Favored 'General case' 0 C--N 1.297 -1.689 0 CA-C-N 114.833 -1.076 . . . . 0.0 112.33 176.395 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.507 ' HB3' ' HA ' ' A' ' 57' ' ' LEU . 9.3 tp10 -63.18 -54.47 37.01 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 179.46 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 86.8 m-85 -74.23 3.89 6.54 Favored 'General case' 0 CA--C 1.511 -0.53 0 CA-C-O 121.839 0.828 . . . . 0.0 111.688 -178.954 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.548 ' HB3' ' O ' ' A' ' 59' ' ' LYS . 9.2 t70 -88.85 -177.03 5.41 Favored 'General case' 0 C--N 1.276 -2.626 0 CA-C-N 113.998 -1.455 . . . . 0.0 109.659 178.651 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.739 ' HB2' HD12 ' A' ' 65' ' ' ILE . 3.0 mt -80.2 -168.35 0.17 Allowed Pre-proline 0 CA--C 1.582 2.2 0 N-CA-C 106.215 -1.772 . . . . 0.0 106.215 178.454 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.651 ' HG3' ' N ' ' A' ' 141' ' ' SER . 41.8 Cg_endo -94.26 6.62 2.5 Favored 'Trans proline' 0 N--CA 1.442 -1.505 0 CA-C-N 121.991 1.747 . . . . 0.0 111.539 -176.836 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.739 HD12 ' HB2' ' A' ' 63' ' ' LEU . 0.1 OUTLIER -69.45 -46.65 75.78 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.874 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 179.801 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.507 ' H ' HD13 ' A' ' 65' ' ' ILE . . . 57.06 9.55 4.14 Favored Glycine 0 N--CA 1.482 1.735 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.57 -174.286 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.702 ' H ' HG12 ' A' ' 65' ' ' ILE . 68.3 mt 58.11 -70.66 0.07 OUTLIER 'Isoleucine or valine' 0 C--O 1.189 -2.129 0 C-N-CA 128.135 2.574 . . . . 0.0 111.405 -171.25 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.464 ' HB3' ' HD3' ' A' ' 69' ' ' PRO . 77.4 t80 -177.7 -55.83 0.0 OUTLIER Pre-proline 0 C--N 1.306 -1.289 0 CA-C-N 117.805 0.275 . . . . 0.0 111.146 -175.476 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.464 ' HD3' ' HB3' ' A' ' 68' ' ' PHE . 8.5 Cg_endo -96.91 -172.2 0.18 Allowed 'Trans proline' 0 N--CA 1.442 -1.558 0 C-N-CA 122.508 2.139 . . . . 0.0 112.187 -175.683 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -104.17 12.72 52.16 Favored Glycine 0 N--CA 1.436 -1.316 0 N-CA-C 110.62 -0.992 . . . . 0.0 110.62 175.294 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.425 ' H ' ' HB2' ' A' ' 69' ' ' PRO . 1.8 p30 -101.19 -56.68 2.25 Favored 'General case' 0 N--CA 1.419 -2.012 0 CA-C-N 115.422 -0.389 . . . . 0.0 110.421 179.678 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.41 ' O ' ' HB ' ' A' ' 73' ' ' THR . . . -67.37 167.46 12.48 Favored 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 123.379 0.672 . . . . 0.0 111.209 172.366 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.591 ' O ' HG22 ' A' ' 73' ' ' THR . 96.7 m 87.88 27.97 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.813 0 CA-C-O 124.518 2.104 . . . . 0.0 111.128 175.366 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.593 ' O ' ' HA ' ' A' ' 86' ' ' VAL . 5.0 m-20 -76.0 145.65 40.11 Favored 'General case' 0 C--N 1.267 -3.017 0 CA-C-N 114.575 -1.193 . . . . 0.0 109.456 174.721 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 42.6 t80 -121.25 98.57 6.04 Favored 'General case' 0 C--N 1.282 -2.341 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.633 -169.206 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 32.8 mm-40 -128.12 115.63 18.71 Favored 'General case' 0 C--O 1.212 -0.878 0 C-N-CA 123.35 0.66 . . . . 0.0 110.151 178.73 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.403 ' HA ' ' HA ' ' A' ' 84' ' ' LEU . 36.1 p90 -123.04 143.17 50.13 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 -178.852 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.61 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 10.5 m-20 -96.27 169.36 9.99 Favored 'General case' 0 CA--C 1.487 -1.452 0 C-N-CA 118.876 -1.13 . . . . 0.0 108.955 178.604 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -79.75 -64.01 1.28 Allowed 'General case' 0 C--N 1.279 -2.477 0 CA-C-N 114.644 -1.162 . . . . 0.0 111.396 -176.543 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -68.21 -45.5 73.17 Favored 'General case' 0 CA--C 1.498 -1.054 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.575 -177.104 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.61 ' HB ' ' HB2' ' A' ' 78' ' ' ASP . 10.5 m -57.68 -49.45 76.45 Favored 'General case' 0 N--CA 1.419 -2.021 0 CA-C-N 114.232 -1.349 . . . . 0.0 111.823 -176.58 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.414 ' HD3' ' HA ' ' A' ' 82' ' ' LYS . 74.2 mmtt 65.35 16.19 10.4 Favored 'General case' 0 N--CA 1.488 1.453 0 CA-C-O 121.916 0.865 . . . . 0.0 111.493 -176.975 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.597 ' HB3' HG22 ' A' ' 81' ' ' THR . 39.4 ttpt -115.18 131.08 57.04 Favored 'General case' 0 N--CA 1.42 -1.953 0 N-CA-C 106.299 -1.741 . . . . 0.0 106.299 177.607 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.552 ' O ' ' HA ' ' A' ' 109' ' ' THR . 7.0 tt -103.59 142.79 33.69 Favored 'General case' 0 C--N 1.284 -2.25 0 O-C-N 123.68 0.612 . . . . 0.0 109.901 -175.657 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.446 ' HA ' ' O ' ' A' ' 108' ' ' VAL . 9.3 t -113.42 121.3 43.92 Favored 'General case' 0 N--CA 1.406 -2.661 0 CA-C-O 121.879 0.847 . . . . 0.0 110.429 178.803 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.593 ' HA ' ' O ' ' A' ' 74' ' ' ASN . 86.7 t -93.34 118.99 40.36 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.746 0 CA-C-N 114.905 -1.043 . . . . 0.0 108.438 174.923 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 5.4 mp -80.95 116.2 20.8 Favored 'General case' 0 C--O 1.249 1.056 0 O-C-N 123.711 0.632 . . . . 0.0 110.389 -179.094 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.58 ' O ' ' HA ' ' A' ' 106' ' ' THR . 42.1 mm -108.12 128.4 25.8 Favored Pre-proline 0 C--N 1.285 -2.201 0 N-CA-C 106.593 -1.632 . . . . 0.0 106.593 176.614 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -58.84 111.74 0.98 Allowed 'Trans proline' 0 N--CA 1.45 -1.083 0 C-N-CA 122.062 1.841 . . . . 0.0 111.351 176.531 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 22.7 t 67.42 -169.01 0.2 Allowed 'General case' 0 N--CA 1.443 -0.812 0 O-C-N 124.117 0.886 . . . . 0.0 110.847 178.01 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.489 HD11 ' HD2' ' A' ' 103' ' ' LYS . 10.3 tt -112.2 109.4 28.4 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.278 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 176.481 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' CYS . . . . . 0.639 ' SG ' ' HB2' ' A' ' 104' ' ' PHE . 16.1 p -108.89 124.84 51.28 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-N 115.723 -0.672 . . . . 0.0 112.55 -174.057 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.445 ' OE2' HG12 ' A' ' 91' ' ' ILE . 4.9 mp0 -107.27 156.94 18.32 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 174.194 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 3.4 p -128.76 111.9 24.62 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.756 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 173.939 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.435 -1.417 0 N-CA-C 110.448 -1.061 . . . . 0.0 110.448 -179.826 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 47.4 t . . . . . 0 N--CA 1.43 -1.431 0 N-CA-C 107.102 -1.444 . . . . 0.0 107.102 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 94.5 t -128.28 127.87 67.86 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 -179.745 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -158.0 166.88 31.43 Favored 'General case' 0 C--N 1.309 -1.17 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 -175.084 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.489 ' HD2' HD11 ' A' ' 91' ' ' ILE . 38.5 ttpt -132.92 133.56 43.39 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.304 -175.707 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.639 ' HB2' ' SG ' ' A' ' 92' ' ' CYS . 77.9 m-85 -117.2 110.38 18.07 Favored 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 107.567 -1.271 . . . . 0.0 107.567 175.879 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 12.9 t -88.99 171.57 9.76 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 -177.801 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' THR . . . . . 0.58 ' HA ' ' O ' ' A' ' 88' ' ' ILE . 32.5 m -58.49 -50.31 74.21 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 112.919 0.711 . . . . 0.0 112.919 -175.249 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 23.3 p -116.78 94.36 4.57 Favored 'General case' 0 C--N 1.296 -1.719 0 C-N-CA 119.414 -0.914 . . . . 0.0 112.458 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.446 ' O ' ' HA ' ' A' ' 85' ' ' THR . 43.5 t -93.16 125.45 45.72 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.486 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 175.437 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.552 ' HA ' ' O ' ' A' ' 84' ' ' LEU . 8.1 p -107.81 154.1 22.03 Favored 'General case' 0 N--CA 1.4 -2.941 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.48 -177.088 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 175.28 -173.98 46.54 Favored Glycine 0 C--N 1.283 -2.364 0 N-CA-C 110.506 -1.038 . . . . 0.0 110.506 178.327 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 59.9 m-70 -99.25 91.53 5.01 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 178.182 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.468 ' HB3' HD13 ' A' ' 84' ' ' LEU . 5.3 tt -97.7 112.56 24.4 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 -175.121 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -116.21 160.25 20.67 Favored 'General case' 0 CA--C 1.458 -2.584 0 CA-C-N 114.9 -1.046 . . . . 0.0 108.569 175.504 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 2.3 tmtp? -71.51 103.72 3.05 Favored 'General case' 0 C--N 1.255 -3.503 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 -177.062 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 116.15 -10.07 17.77 Favored Glycine 0 C--O 1.186 -2.872 0 C-N-CA 120.516 -0.85 . . . . 0.0 111.944 -178.285 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -174.88 134.77 0.36 Allowed 'General case' 0 N--CA 1.488 1.465 0 CA-C-N 118.088 0.944 . . . . 0.0 111.888 176.768 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.405 ' HA ' ' HA ' ' A' ' 112' ' ' LEU . 2.3 tt -110.6 114.98 28.79 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 105.772 -1.936 . . . . 0.0 105.772 175.552 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.404 ' HA ' ' HB3' ' A' ' 135' ' ' SER . 75.1 p -103.35 135.06 45.68 Favored 'General case' 0 C--N 1.278 -2.539 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 -177.079 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . 0.394 4.0 p-10 48.61 97.47 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 115.878 1.807 . . . . 0.0 115.878 -178.63 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.446 HG22 ' O ' ' A' ' 134' ' ' THR . 13.0 m -87.44 118.02 32.54 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.086 0 CA-C-N 114.637 -1.165 . . . . 0.0 110.334 -179.687 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -97.08 92.36 6.02 Favored 'General case' 0 C--N 1.252 -3.67 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 179.776 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 140.92 -15.93 2.82 Favored Glycine 0 C--N 1.302 -1.323 0 C-N-CA 119.968 -1.111 . . . . 0.0 112.932 177.268 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 80.4 mt -100.37 104.81 16.68 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 CA-C-O 121.767 0.794 . . . . 0.0 111.235 -179.282 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -86.45 121.24 28.72 Favored 'General case' 0 N--CA 1.433 -1.312 0 N-CA-C 106.104 -1.813 . . . . 0.0 106.104 176.447 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 12.8 t -133.37 162.3 32.21 Favored 'General case' 0 N--CA 1.412 -2.347 0 CA-C-O 121.515 0.674 . . . . 0.0 110.644 -176.398 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.469 ' C ' ' HD3' ' A' ' 126' ' ' LYS . 1.0 OUTLIER -126.1 119.92 28.83 Favored 'General case' 0 N--CA 1.396 -3.137 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 173.051 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 59.9 t -109.38 -78.38 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.838 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 179.202 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -96.93 -35.75 10.78 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 105.636 -1.987 . . . . 0.0 105.636 171.771 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 129' ' ' ILE . . . . . 0.498 HG13 ' H ' ' A' ' 130' ' ' TRP . 9.6 tp -146.98 176.06 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.419 -1.981 0 N-CA-C 106.636 -1.616 . . . . 0.0 106.636 176.958 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 130' ' ' TRP . . . . . 0.498 ' H ' HG13 ' A' ' 129' ' ' ILE . 6.2 m-90 -74.81 132.61 41.69 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 122.767 0.427 . . . . 0.0 111.041 -177.189 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.495 HG22 ' H ' ' A' ' 133' ' ' VAL . 8.4 p -149.64 147.09 16.61 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.09 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 175.227 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 57.7 pttt -111.09 -4.23 15.15 Favored 'General case' 0 C--N 1.31 -1.128 0 C-N-CA 119.537 -0.865 . . . . 0.0 111.774 178.189 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.495 ' H ' HG22 ' A' ' 131' ' ' VAL . 7.4 p -123.79 103.8 13.25 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 CA-C-O 122.001 0.905 . . . . 0.0 110.862 178.746 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 134' ' ' THR . . . . . 0.446 ' O ' HG22 ' A' ' 120' ' ' VAL . 8.3 t -144.91 169.95 17.09 Favored 'General case' 0 C--N 1.293 -1.863 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 -179.494 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 135' ' ' SER . . . . . 0.404 ' HB3' ' HA ' ' A' ' 118' ' ' THR . 26.9 m -122.65 168.64 11.94 Favored 'General case' 0 N--CA 1.409 -2.508 0 N-CA-C 109.924 -0.398 . . . . 0.0 109.924 178.678 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 11.8 tt -134.92 98.05 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.767 0 CA-C-O 122.382 1.087 . . . . 0.0 108.797 175.776 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 73.9 p -89.93 158.67 17.3 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-N 114.608 -1.178 . . . . 0.0 110.453 -176.634 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' THR . . . . . 0.658 HG21 ' HB3' ' A' ' 63' ' ' LEU . 9.8 t -166.01 178.56 6.33 Favored 'General case' 0 N--CA 1.418 -2.069 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 -179.638 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -118.66 26.93 9.23 Favored 'General case' 0 C--N 1.273 -2.718 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 175.187 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . 60.65 36.56 19.58 Favored 'General case' 0 C--N 1.354 0.793 0 CA-C-N 114.379 -1.282 . . . . 0.0 108.274 -173.371 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' SER . . . . . 0.651 ' N ' ' HG3' ' A' ' 64' ' ' PRO . 46.8 t -171.01 -78.68 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 114.092 -1.413 . . . . 0.0 109.825 -173.248 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 142' ' ' LYS . . . . . 0.483 ' H ' ' HD3' ' A' ' 142' ' ' LYS . 0.0 OUTLIER -90.1 130.34 36.28 Favored 'General case' 0 CA--C 1.498 -1.029 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 176.352 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.511 ' HB ' ' O ' ' A' ' 153' ' ' ARG . 42.4 t -108.35 143.2 19.15 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 CA-C-O 121.108 0.48 . . . . 0.0 111.47 -171.336 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 91.1 m-85 -135.82 123.32 22.11 Favored 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 178.018 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 42.8 t80 -93.61 117.16 29.73 Favored 'General case' 0 C--N 1.288 -2.088 0 N-CA-C 106.708 -1.59 . . . . 0.0 106.708 -178.493 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.42 ' C ' ' H ' ' A' ' 148' ' ' GLY . 62.9 p -76.24 -89.87 0.03 OUTLIER 'General case' 0 N--CA 1.425 -1.701 0 N-CA-C 114.94 1.459 . . . . 0.0 114.94 -169.164 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . 67.17 -42.59 0.43 Allowed 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 125.244 1.418 . . . . 0.0 112.047 -175.991 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 148' ' ' GLY . . . . . 0.42 ' H ' ' C ' ' A' ' 146' ' ' THR . . . 177.94 44.9 0.07 OUTLIER Glycine 0 N--CA 1.412 -2.937 0 N-CA-C 107.349 -2.3 . . . . 0.0 107.349 178.437 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 65.6 mtt 58.22 40.14 25.1 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 124.003 0.921 . . . . 0.0 109.715 -176.278 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -89.03 -48.55 7.34 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 115.805 1.78 . . . . 0.0 115.805 -169.987 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 151' ' ' LYS . . . . . 0.472 ' HE2' ' HA ' ' A' ' 151' ' ' LYS . 8.2 mmpt? -125.44 162.86 23.91 Favored 'General case' 0 N--CA 1.483 1.216 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 -172.227 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 57.3 p -119.73 158.34 26.71 Favored 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 174.642 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 153' ' ' ARG . . . . . 0.511 ' O ' ' HB ' ' A' ' 143' ' ' VAL . 3.8 tpm_? -149.92 120.5 7.47 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 109.082 -0.711 . . . . 0.0 109.082 -178.028 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 17.8 m -87.91 143.78 26.93 Favored 'General case' 0 C--N 1.308 -1.226 0 C-N-CA 120.122 -0.631 . . . . 0.0 110.835 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 155' ' ' ARG . . . . . 0.522 ' HD3' ' HB2' ' A' ' 64' ' ' PRO . 32.6 ttp180 -70.67 -34.5 72.08 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 115.608 -0.723 . . . . 0.0 110.121 179.06 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -45.85 -40.82 10.4 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 116.706 2.113 . . . . 0.0 116.706 -170.843 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -70.95 -56.43 6.22 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 119.019 -1.072 . . . . 0.0 112.077 -174.795 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 67.9 m-85 -171.63 19.16 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.765 0 C-N-CA 124.556 1.143 . . . . 0.0 108.934 -179.796 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 159' ' ' GLY . . . . . 0.444 ' HA3' ' O ' ' A' ' 65' ' ' ILE . . . 84.76 -97.19 2.1 Favored Glycine 0 N--CA 1.427 -1.942 0 C-N-CA 119.011 -1.566 . . . . 0.0 110.224 -171.704 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.547 HG23 ' HB ' ' A' ' 65' ' ' ILE . 90.2 t -127.65 113.41 31.31 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.521 0 CA-C-O 121.828 0.823 . . . . 0.0 110.651 -178.953 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -121.71 107.06 11.91 Favored 'General case' 0 C--N 1.295 -1.804 0 C-N-CA 119.424 -0.91 . . . . 0.0 113.167 -176.005 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 30.4 mmm180 -130.66 137.49 49.6 Favored 'General case' 0 C--N 1.292 -1.92 0 N-CA-C 106.337 -1.727 . . . . 0.0 106.337 172.862 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -77.25 74.53 3.82 Favored 'General case' 0 C--N 1.289 -2.056 0 N-CA-C 113.699 1.0 . . . . 0.0 113.699 -172.565 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -111.59 129.02 8.92 Favored Glycine 0 N--CA 1.424 -2.136 0 N-CA-C 109.25 -1.54 . . . . 0.0 109.25 176.82 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -91.56 112.65 24.65 Favored 'General case' 0 N--CA 1.42 -1.963 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 -177.565 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 166' ' ' ARG . . . . . 0.409 ' HA ' ' HB3' ' A' ' 92' ' ' CYS . 65.9 mtt85 -79.45 102.58 8.84 Favored 'General case' 0 N--CA 1.417 -2.12 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 179.027 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 25.2 t -66.01 82.55 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 O-C-N 124.077 0.861 . . . . 0.0 110.063 -178.422 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 22.1 t70 176.74 -24.65 0.0 OUTLIER 'General case' 0 C--N 1.287 -2.114 0 N-CA-C 106.236 -1.765 . . . . 0.0 106.236 -171.422 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 2.9 tppp? -79.2 106.48 11.26 Favored 'General case' 0 N--CA 1.425 -1.678 0 CA-C-N 114.145 -1.389 . . . . 0.0 111.899 179.312 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 170' ' ' PHE . . . . . . . . . . . . . 47.3 p90 . . . . . 0 C--N 1.293 -1.888 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 173.632 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.569 ' N ' ' HD3' ' A' ' 55' ' ' PRO . 10.2 mp . . . . . 0 N--CA 1.443 -0.805 0 N-CA-C 116.904 2.187 . . . . 0.0 116.904 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.742 ' HA ' ' CD1' ' A' ' 58' ' ' LEU . 7.6 Cg_exo -66.08 -15.12 47.38 Favored 'Trans proline' 0 N--CA 1.425 -2.507 0 CA-C-N 121.134 1.441 . . . . 0.0 115.568 -161.018 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 32.3 mm-40 -79.34 -29.69 42.36 Favored 'General case' 0 N--CA 1.425 -1.691 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.718 ' O ' ' HB3' ' A' ' 60' ' ' GLU . 10.6 mt -76.41 -31.66 58.06 Favored 'General case' 0 C--O 1.207 -1.14 0 CA-C-N 114.652 -1.158 . . . . 0.0 110.061 -177.582 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.742 ' CD1' ' HA ' ' A' ' 55' ' ' PRO . 8.2 mt -70.41 -54.32 12.87 Favored 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 -174.383 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.636 ' HG2' ' O ' ' A' ' 55' ' ' PRO . 17.1 ptpt -64.02 -25.08 67.96 Favored 'General case' 0 C--O 1.191 -2.009 0 CA-C-N 114.885 -1.052 . . . . 0.0 111.398 176.76 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.718 ' HB3' ' O ' ' A' ' 57' ' ' LEU . 7.1 tp10 -54.95 -56.4 20.11 Favored 'General case' 0 C--N 1.295 -1.773 0 O-C-N 121.954 -0.467 . . . . 0.0 111.13 172.361 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 45.2 m-85 -78.54 -40.2 35.68 Favored 'General case' 0 CA--C 1.489 -1.375 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 -175.321 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.424 ' OD2' ' HG ' ' A' ' 112' ' ' LEU . 5.9 m-20 -87.42 18.34 3.9 Favored 'General case' 0 C--N 1.294 -1.833 0 CA-C-N 113.686 -1.597 . . . . 0.0 113.262 -174.256 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.623 HD21 ' H ' ' A' ' 115' ' ' GLY . 21.5 mt 79.79 151.24 0.12 Allowed Pre-proline 0 N--CA 1.475 0.82 0 C-N-CA 125.184 1.393 . . . . 0.0 112.703 174.303 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.429 ' HB2' ' HD2' ' A' ' 155' ' ' ARG . 7.4 Cg_endo -80.65 15.07 1.86 Allowed 'Trans proline' 0 N--CA 1.443 -1.468 0 C-N-CA 122.697 2.265 . . . . 0.0 113.546 -166.873 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.587 ' O ' ' HA3' ' A' ' 159' ' ' GLY . 0.2 OUTLIER -69.5 -36.73 72.68 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.811 0 N-CA-C 106.753 -1.573 . . . . 0.0 106.753 173.029 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 54.34 8.68 1.24 Allowed Glycine 0 C--N 1.339 0.731 0 CA-C-N 114.771 -1.104 . . . . 0.0 115.287 175.149 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.736 ' O ' ' HB ' ' A' ' 160' ' ' VAL 0.252 27.7 mt 72.71 -45.66 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.031 0 N-CA-C 114.527 1.306 . . . . 0.0 114.527 -179.9 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.546 ' HB2' ' O ' ' A' ' 67' ' ' ILE . 40.2 t80 164.99 -56.4 0.0 OUTLIER Pre-proline 0 CA--C 1.54 0.574 0 C-N-CA 124.155 0.982 . . . . 0.0 110.597 173.826 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -102.07 -160.31 0.04 OUTLIER 'Trans proline' 0 N--CA 1.43 -2.246 0 C-N-CA 122.533 2.155 . . . . 0.0 113.123 -169.58 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -100.96 29.08 13.28 Favored Glycine 0 N--CA 1.428 -1.868 0 N-CA-C 109.656 -1.378 . . . . 0.0 109.656 174.102 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.48 ' OD1' ' HD3' ' A' ' 89' ' ' PRO . 8.8 t0 -140.84 176.67 8.61 Favored 'General case' 0 N--CA 1.42 -1.949 0 N-CA-C 102.928 -2.99 . . . . 0.0 102.928 177.111 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.561 ' O ' HG22 ' A' ' 73' ' ' THR . . . 57.8 -177.73 0.07 Allowed 'General case' 0 N--CA 1.483 1.185 0 CA-C-N 118.977 0.808 . . . . 0.0 109.871 -170.635 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.561 HG22 ' O ' ' A' ' 72' ' ' ALA . 5.2 t 65.36 16.7 10.67 Favored 'General case' 0 N--CA 1.515 2.775 0 C-N-CA 125.06 1.344 . . . . 0.0 109.523 172.256 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.623 ' O ' ' HA ' ' A' ' 86' ' ' VAL . 37.3 m-80 -68.45 135.8 52.25 Favored 'General case' 0 N--CA 1.414 -2.25 0 CA-C-N 113.366 -1.743 . . . . 0.0 114.127 -176.154 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.514 ' CD2' HD11 ' A' ' 84' ' ' LEU . 48.3 t80 -98.88 106.22 18.46 Favored 'General case' 0 C--N 1.272 -2.797 0 CA-C-N 113.247 -1.797 . . . . 0.0 109.949 -177.926 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.454 ' HB2' HG23 ' A' ' 85' ' ' THR . 8.9 mm-40 -137.81 141.34 40.83 Favored 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 176.583 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 48.1 p90 -144.49 150.95 38.44 Favored 'General case' 0 C--N 1.301 -1.512 0 C-N-CA 120.283 -0.567 . . . . 0.0 110.675 -177.283 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.642 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 11.0 m-20 -97.1 170.72 8.94 Favored 'General case' 0 CA--C 1.486 -1.489 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 174.976 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -79.81 -71.46 0.45 Allowed 'General case' 0 C--N 1.278 -2.53 0 CA-C-N 115.283 -0.871 . . . . 0.0 113.021 -175.966 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -72.94 -42.27 63.62 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 121.583 0.706 . . . . 0.0 110.654 -175.088 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.642 ' HB ' ' HB2' ' A' ' 78' ' ' ASP . 19.8 m -55.7 -41.15 73.38 Favored 'General case' 0 N--CA 1.431 -1.41 0 CA-C-N 114.645 -1.161 . . . . 0.0 110.9 179.54 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 71.8 mmtt 59.85 9.9 1.89 Allowed 'General case' 0 N--CA 1.482 1.165 0 N-CA-C 113.04 0.756 . . . . 0.0 113.04 178.714 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.416 ' HE3' HG21 ' A' ' 109' ' ' THR . 27.8 pttt -98.77 134.12 42.11 Favored 'General case' 0 N--CA 1.402 -2.85 0 N-CA-C 105.13 -2.174 . . . . 0.0 105.13 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.514 HD11 ' CD2' ' A' ' 75' ' ' TYR . 6.9 tt -89.36 143.24 26.98 Favored 'General case' 0 C--N 1.282 -2.33 0 C-N-CA 120.142 -0.623 . . . . 0.0 109.492 -174.22 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.507 ' N ' HD23 ' A' ' 84' ' ' LEU . 2.7 t -116.5 107.19 14.45 Favored 'General case' 0 N--CA 1.415 -2.199 0 CA-C-O 121.692 0.758 . . . . 0.0 111.722 -179.61 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.623 ' HA ' ' O ' ' A' ' 74' ' ' ASN . 73.0 t -89.84 108.96 19.95 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.224 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 173.76 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.438 HD12 ' HB2' ' A' ' 74' ' ' ASN 0.272 0.8 OUTLIER -96.71 118.2 32.66 Favored 'General case' 0 N--CA 1.394 -3.262 0 CA-C-O 122.605 1.193 . . . . 0.0 111.852 -179.79 . . . . . . . . 4 4 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.412 HG23 ' HB2' ' A' ' 72' ' ' ALA . 55.9 mt -97.46 142.42 24.52 Favored Pre-proline 0 C--N 1.277 -2.577 0 N-CA-C 104.399 -2.445 . . . . 0.0 104.399 178.178 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.48 ' HD3' ' OD1' ' A' ' 71' ' ' ASP . 30.9 Cg_endo -59.53 -18.04 44.7 Favored 'Trans proline' 0 C--N 1.328 -0.532 0 C-N-CA 122.968 2.446 . . . . 0.0 112.914 -178.077 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 6.5 m -154.44 167.42 30.08 Favored 'General case' 0 N--CA 1.422 -1.843 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 -172.532 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.483 HD11 ' HD3' ' A' ' 103' ' ' LYS . 14.2 tt -85.74 108.49 17.41 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.295 0 N-CA-C 105.968 -1.864 . . . . 0.0 105.968 166.614 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' CYS . . . . . 0.52 ' SG ' ' HA3' ' A' ' 164' ' ' GLY . 48.2 t -119.19 123.38 44.19 Favored 'General case' 0 C--N 1.292 -1.916 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 -176.358 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.448 ' CB ' ' HA ' ' A' ' 103' ' ' LYS . 12.7 pt-20 -119.49 150.6 39.97 Favored 'General case' 0 C--N 1.284 -2.277 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.908 -174.182 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.504 ' CG1' ' H ' ' A' ' 163' ' ' ASN . 34.5 m -130.29 102.2 6.67 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.485 0 CA-C-O 121.871 0.843 . . . . 0.0 111.385 179.807 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.51 ' HA2' ' O ' ' A' ' 100' ' ' SER . . . . . . . . 0 CA--C 1.48 -2.117 0 N-CA-C 108.121 -1.992 . . . . 0.0 108.121 172.757 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' SER . . . . . 0.51 ' O ' ' HA2' ' A' ' 95' ' ' GLY . 34.2 t . . . . . 0 N--CA 1.409 -2.523 0 CA-C-O 121.342 0.592 . . . . 0.0 109.677 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 48.2 t -109.33 99.56 8.93 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 CA-C-N 115.084 -0.962 . . . . 0.0 109.491 176.968 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.452 ' HG ' ' HA ' ' A' ' 125' ' ' THR . 7.8 mp -110.07 127.93 55.14 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.157 179.617 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.483 ' HD3' HD11 ' A' ' 91' ' ' ILE . 23.8 ttmm -106.5 109.01 20.81 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 177.981 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 78.9 m-85 -94.81 105.68 17.63 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-N 116.068 -0.514 . . . . 0.0 109.788 179.469 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 49.7 m -61.75 151.37 34.21 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 115.276 -0.875 . . . . 0.0 111.006 178.585 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 7.3 m -51.5 -43.69 62.31 Favored 'General case' 0 C--O 1.215 -0.748 0 C-N-CA 125.241 1.417 . . . . 0.0 110.289 179.344 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 85.5 m -120.21 101.19 7.64 Favored 'General case' 0 N--CA 1.423 -1.777 0 CA-C-O 121.137 0.494 . . . . 0.0 109.761 178.46 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 13.5 m -108.71 114.77 47.65 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.059 0 CA-C-O 121.951 0.881 . . . . 0.0 111.176 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.511 ' HA ' ' O ' ' A' ' 84' ' ' LEU . 20.9 p -107.76 166.42 10.71 Favored 'General case' 0 N--CA 1.405 -2.693 0 CA-C-N 114.449 -1.251 . . . . 0.0 111.02 -176.528 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 167.84 -164.06 37.65 Favored Glycine 0 N--CA 1.41 -3.054 0 C-N-CA 120.323 -0.941 . . . . 0.0 111.565 177.052 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 52.0 t60 -103.3 99.81 9.67 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.424 ' HG ' ' OD2' ' A' ' 62' ' ' ASP . 3.0 tm? -103.55 125.29 50.0 Favored 'General case' 0 CA--C 1.483 -1.611 0 CA-C-N 115.635 -0.712 . . . . 0.0 110.2 -172.675 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -122.41 149.24 44.09 Favored 'General case' 0 N--CA 1.402 -2.871 0 CA-C-N 114.75 -1.113 . . . . 0.0 108.994 172.259 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -68.95 100.59 1.23 Allowed 'General case' 0 N--CA 1.402 -2.866 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 -179.091 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' GLY . . . . . 0.623 ' H ' HD21 ' A' ' 63' ' ' LEU . . . 135.52 -45.44 1.1 Allowed Glycine 0 C--N 1.282 -2.459 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 -175.738 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.48 ' HD3' HG23 ' A' ' 118' ' ' THR . 0.7 OUTLIER -150.2 133.5 16.37 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 114.074 1.139 . . . . 0.0 114.074 -178.382 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.524 ' O ' ' HB2' ' A' ' 135' ' ' SER . 40.6 tp -97.51 113.52 25.24 Favored 'General case' 0 C--N 1.309 -1.163 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 175.549 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.48 HG23 ' HD3' ' A' ' 116' ' ' LYS . 19.8 p -114.71 140.81 48.56 Favored 'General case' 0 C--N 1.285 -2.225 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.547 -178.593 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 66.18 100.61 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.93 0.892 . . . . 0.0 111.097 179.52 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.431 HG11 HD12 ' A' ' 123' ' ' ILE . 4.1 m -107.37 103.25 15.18 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.674 0 N-CA-C 113.974 1.102 . . . . 0.0 113.974 -177.355 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -84.66 84.26 7.74 Favored 'General case' 0 C--N 1.29 -2.013 0 CA-C-N 114.632 -1.167 . . . . 0.0 108.534 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 133.6 -12.4 4.87 Favored Glycine 0 N--CA 1.435 -1.384 0 CA-C-N 115.289 -0.869 . . . . 0.0 113.038 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.431 HD12 HG11 ' A' ' 120' ' ' VAL . 71.7 mt -100.28 99.95 9.46 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.112 0 CA-C-O 121.817 0.818 . . . . 0.0 109.716 179.213 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -91.18 118.18 30.24 Favored 'General case' 0 C--N 1.29 -2.004 0 CA-C-N 114.791 -1.095 . . . . 0.0 108.429 -177.965 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.452 ' HA ' ' HG ' ' A' ' 102' ' ' LEU . 62.1 m -115.46 113.53 23.83 Favored 'General case' 0 N--CA 1.426 -1.64 0 N-CA-C 112.913 0.708 . . . . 0.0 112.913 -173.137 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.433 ' O ' ' HA ' ' A' ' 100' ' ' SER . 39.0 tttp -105.13 121.82 44.61 Favored 'General case' 0 N--CA 1.415 -2.203 0 C-N-CA 119.137 -1.025 . . . . 0.0 108.644 169.676 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.437 ' O ' ' HB3' ' A' ' 128' ' ' MET . 27.2 t -144.76 104.09 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.278 -2.534 0 N-CA-C 103.29 -2.856 . . . . 0.0 103.29 170.547 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 128' ' ' MET . . . . . 0.437 ' HB3' ' O ' ' A' ' 127' ' ' VAL . 26.3 ttt 74.17 -52.29 0.69 Allowed 'General case' 0 C--N 1.321 -0.658 0 O-C-N 124.487 1.117 . . . . 0.0 109.55 -172.241 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 8.7 tp -136.88 152.96 29.2 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 N-CA-C 109.063 -0.718 . . . . 0.0 109.063 175.92 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' TRP . . . . . 0.431 ' HA ' ' HA ' ' A' ' 126' ' ' LYS . 20.4 t-105 -81.49 117.8 22.2 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 123.526 0.731 . . . . 0.0 109.863 -177.028 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.533 HG12 ' H ' ' A' ' 133' ' ' VAL . 41.4 t -138.09 120.48 18.85 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.129 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 178.728 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 65.7 pttt -91.46 11.34 24.29 Favored 'General case' 0 C--N 1.312 -1.029 0 O-C-N 121.738 -0.601 . . . . 0.0 111.599 -177.2 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.533 ' H ' HG12 ' A' ' 131' ' ' VAL . 34.1 m -120.59 -1.59 8.21 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.107 0 C-N-CA 119.647 -0.821 . . . . 0.0 112.885 -175.586 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 134' ' ' THR . . . . . 0.694 ' O ' ' HB ' ' A' ' 146' ' ' THR . 18.2 p -74.13 101.63 3.99 Favored 'General case' 0 N--CA 1.425 -1.709 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 176.5 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 135' ' ' SER . . . . . 0.524 ' HB2' ' O ' ' A' ' 117' ' ' LEU . 12.4 p -94.48 170.03 9.78 Favored 'General case' 0 N--CA 1.412 -2.338 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 -177.665 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 136' ' ' ILE . . . . . 0.424 HD11 HG21 ' A' ' 65' ' ' ILE . 15.2 tt -100.77 122.35 52.68 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.155 0 CA-C-O 121.685 0.755 . . . . 0.0 111.555 -170.355 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 25.9 m -109.32 147.4 32.74 Favored 'General case' 0 N--CA 1.433 -1.297 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.023 -177.726 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' THR . . . . . 0.535 HG22 ' H ' ' A' ' 141' ' ' SER . 33.0 m -146.85 174.03 11.86 Favored 'General case' 0 C--N 1.295 -1.787 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 -174.671 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -110.24 28.75 8.32 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 172.396 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . 59.79 43.74 14.86 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 -172.577 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' SER . . . . . 0.535 ' H ' HG22 ' A' ' 138' ' ' THR . 35.1 t 176.78 -82.57 0.0 OUTLIER 'General case' 0 CA--C 1.545 0.77 0 CA-C-N 114.755 -1.111 . . . . 0.0 110.338 -173.59 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 24.7 pttm -89.29 150.91 22.39 Favored 'General case' 0 CA--C 1.503 -0.858 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.515 HG12 ' HB2' ' A' ' 155' ' ' ARG . 13.8 p -131.52 149.38 33.01 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.337 0 N-CA-C 114.281 1.215 . . . . 0.0 114.281 -168.656 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -112.44 143.48 43.51 Favored 'General case' 0 N--CA 1.428 -1.528 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 169.063 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 48.7 t80 -67.87 165.58 17.31 Favored 'General case' 0 C--N 1.305 -1.353 0 C-N-CA 122.93 0.492 . . . . 0.0 109.987 -173.18 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.694 ' HB ' ' O ' ' A' ' 134' ' ' THR . 41.6 p -50.88 -53.16 34.88 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 120.985 0.421 . . . . 0.0 111.531 -176.511 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -84.95 97.33 9.73 Favored 'General case' 0 N--CA 1.424 -1.754 0 N-CA-C 105.735 -1.95 . . . . 0.0 105.735 170.227 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -81.71 -18.0 69.19 Favored Glycine 0 CA--C 1.466 -2.978 0 CA-C-O 121.66 0.589 . . . . 0.0 111.666 -167.136 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 66.3 mtt -97.43 5.43 49.74 Favored 'General case' 0 C--N 1.281 -2.389 0 CA-C-N 114.666 -0.767 . . . . 0.0 110.718 178.931 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 150' ' ' LYS . . . . . 0.552 ' HE2' ' HA ' ' A' ' 150' ' ' LYS . 6.7 mmpt? -116.4 -49.69 2.66 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.509 -179.396 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 42.4 mmtm -146.14 165.08 30.18 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.3 0.571 . . . . 0.0 112.514 -175.863 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 42.2 p -130.03 160.37 33.9 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 174.073 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 153' ' ' ARG . . . . . 0.44 ' NE ' ' HA ' ' A' ' 153' ' ' ARG . 3.3 tpm_? -135.95 149.3 48.85 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 106.976 -1.491 . . . . 0.0 106.976 -177.984 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 8.2 m -88.64 117.37 27.55 Favored 'General case' 0 N--CA 1.436 -1.126 0 C-N-CA 120.212 -0.595 . . . . 0.0 111.763 -175.787 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 155' ' ' ARG . . . . . 0.639 ' HA ' ' HA2' ' A' ' 159' ' ' GLY . 0.0 OUTLIER -69.75 -31.08 68.85 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 105.457 -2.053 . . . . 0.0 105.457 174.505 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -45.46 -53.99 8.03 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 113.592 -1.64 . . . . 0.0 113.791 -179.742 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -66.47 -53.21 37.83 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 120.799 0.333 . . . . 0.0 111.476 -177.727 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -148.43 -32.89 0.24 Allowed 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.689 -178.759 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 159' ' ' GLY . . . . . 0.639 ' HA2' ' HA ' ' A' ' 155' ' ' ARG . . . 130.54 -95.0 0.33 Allowed Glycine 0 CA--C 1.463 -3.215 0 N-CA-C 107.992 -2.043 . . . . 0.0 107.992 -168.627 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.736 ' HB ' ' O ' ' A' ' 67' ' ' ILE . 41.3 t -98.72 125.25 52.17 Favored 'Isoleucine or valine' 0 N--CA 1.398 -3.046 0 N-CA-C 107.273 -1.381 . . . . 0.0 107.273 171.244 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 161' ' ' GLN . . . . . 0.407 ' HB2' ' HD3' ' A' ' 153' ' ' ARG . 46.8 mt-30 -90.78 101.38 14.13 Favored 'General case' 0 C--N 1.294 -1.824 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 -176.094 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 162' ' ' ARG . . . . . 0.433 HH21 HG23 ' A' ' 67' ' ' ILE . 20.2 mmt180 -90.86 152.89 20.57 Favored 'General case' 0 C--N 1.278 -2.501 0 CA-C-N 113.584 -1.644 . . . . 0.0 114.151 -172.879 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 163' ' ' ASN . . . . . 0.504 ' H ' ' CG1' ' A' ' 94' ' ' VAL . 46.7 m-80 -136.82 31.69 2.74 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 104.789 -2.301 . . . . 0.0 104.789 173.935 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 164' ' ' GLY . . . . . 0.52 ' HA3' ' SG ' ' A' ' 92' ' ' CYS . . . -110.67 149.34 17.7 Favored Glycine 0 N--CA 1.433 -1.508 0 CA-C-N 114.051 -1.432 . . . . 0.0 113.587 -171.399 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -110.01 117.16 33.03 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 175.937 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 166' ' ' ARG . . . . . 0.41 HH11 ' HD2' ' A' ' 166' ' ' ARG . 30.0 mtt180 -78.73 102.14 7.92 Favored 'General case' 0 N--CA 1.422 -1.83 0 N-CA-C 107.378 -1.341 . . . . 0.0 107.378 -178.416 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 40.0 t -75.72 90.6 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 CA-C-O 121.189 0.519 . . . . 0.0 110.848 -177.638 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 21.0 t70 172.85 -33.87 0.0 OUTLIER 'General case' 0 CA--C 1.484 -1.57 0 N-CA-C 106.665 -1.605 . . . . 0.0 106.665 -178.751 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 15.5 ptmt -157.38 -164.26 1.54 Allowed 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 113.675 -1.602 . . . . 0.0 110.75 -172.792 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 170' ' ' PHE . . . . . . . . . . . . . 89.1 t80 . . . . . 0 N--CA 1.427 -1.578 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 171.576 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.53 ' O ' ' HG ' ' A' ' 58' ' ' LEU . 14.9 tp . . . . . 0 C--O 1.214 -0.798 0 N-CA-C 114.573 1.323 . . . . 0.0 114.573 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.435 ' O ' ' HE3' ' A' ' 59' ' ' LYS . 0.9 OUTLIER -52.4 -26.41 27.86 Favored 'Trans proline' 0 C--N 1.362 1.253 0 C-N-CA 123.303 2.669 . . . . 0.0 110.952 176.922 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 20.0 mm-40 -82.7 -41.48 19.27 Favored 'General case' 0 N--CA 1.4 -2.928 0 CA-C-N 115.201 -0.909 . . . . 0.0 109.367 -178.648 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.489 ' HA ' ' HB3' ' A' ' 60' ' ' GLU . 3.8 mm? -75.35 -37.38 60.71 Favored 'General case' 0 N--CA 1.44 -0.973 0 N-CA-C 113.47 0.915 . . . . 0.0 113.47 -176.056 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.53 ' HG ' ' O ' ' A' ' 54' ' ' LEU 0.261 1.8 pp -58.84 -43.58 90.78 Favored 'General case' 0 C--O 1.217 -0.614 0 C-N-CA 120.088 -0.645 . . . . 0.0 112.179 178.908 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.493 ' N ' HD12 ' A' ' 58' ' ' LEU . 20.8 pttp -77.49 -26.81 51.58 Favored 'General case' 0 C--O 1.208 -1.119 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 175.454 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.489 ' HB3' ' HA ' ' A' ' 57' ' ' LEU . 8.7 tp10 -61.97 -49.03 77.72 Favored 'General case' 0 C--N 1.313 -0.999 0 C-N-CA 123.895 0.878 . . . . 0.0 111.34 177.402 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 72.5 m-85 -73.62 5.5 3.85 Favored 'General case' 0 C--O 1.243 0.725 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.332 179.181 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -125.4 -162.93 1.15 Allowed 'General case' 0 C--N 1.292 -1.918 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.737 ' HB2' HD12 ' A' ' 65' ' ' ILE . 2.5 mt -79.11 173.86 7.04 Favored Pre-proline 0 CA--C 1.563 1.467 0 N-CA-C 106.988 -1.486 . . . . 0.0 106.988 -176.421 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -85.8 6.41 5.57 Favored 'Trans proline' 0 CA--C 1.505 -0.967 0 C-N-CA 121.68 1.587 . . . . 0.0 112.103 -171.131 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.737 HD12 ' HB2' ' A' ' 63' ' ' LEU . 0.2 OUTLIER -71.26 -45.46 70.34 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.816 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 179.578 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.415 ' H ' HD13 ' A' ' 65' ' ' ILE . . . 58.27 8.91 5.36 Favored Glycine 0 CA--C 1.528 0.885 0 CA-C-N 115.735 -0.666 . . . . 0.0 113.531 -178.954 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.544 ' O ' ' HB ' ' A' ' 160' ' ' VAL . 48.0 mt 68.58 -68.07 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.832 0 C-N-CA 125.494 1.517 . . . . 0.0 112.364 -176.791 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.542 ' HB3' ' HD3' ' A' ' 69' ' ' PRO . 76.7 t80 178.67 -56.99 0.0 OUTLIER Pre-proline 0 C--N 1.303 -1.417 0 C-N-CA 122.324 0.25 . . . . 0.0 111.078 -177.625 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.542 ' HD3' ' HB3' ' A' ' 68' ' ' PHE . 20.0 Cg_endo -98.15 145.64 0.64 Allowed 'Trans proline' 0 N--CA 1.432 -2.134 0 C-N-CA 122.285 1.99 . . . . 0.0 112.364 -177.026 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -78.57 64.34 3.59 Favored Glycine 0 N--CA 1.442 -0.934 0 N-CA-C 110.517 -1.033 . . . . 0.0 110.517 178.124 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -163.06 -27.38 0.04 OUTLIER 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 -177.471 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.43 ' HA ' ' CD ' ' A' ' 89' ' ' PRO . . . -83.2 170.52 14.62 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.663 0.785 . . . . 0.0 109.339 173.239 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.56 ' O ' HG22 ' A' ' 73' ' ' THR . 84.1 m 76.8 28.46 0.68 Allowed 'General case' 0 CA--C 1.56 1.339 0 CA-C-O 124.878 2.275 . . . . 0.0 110.866 172.117 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.686 ' O ' ' HA ' ' A' ' 86' ' ' VAL . 4.6 m-20 -73.74 108.21 6.44 Favored 'General case' 0 C--N 1.257 -3.439 0 CA-C-N 113.947 -1.479 . . . . 0.0 112.712 -178.175 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.576 ' HB2' HD21 ' A' ' 84' ' ' LEU . 31.3 p90 -79.34 108.71 13.06 Favored 'General case' 0 C--N 1.271 -2.815 0 CA-C-O 122.095 0.95 . . . . 0.0 113.37 -173.951 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.582 ' HB2' ' O ' ' A' ' 85' ' ' THR . 8.4 mm-40 -105.02 158.35 16.61 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 174.638 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 60.0 t80 -152.87 147.43 25.99 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 -175.274 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.638 ' O ' ' HA ' ' A' ' 82' ' ' LYS . 12.0 m-20 -130.3 -176.46 3.96 Favored 'General case' 0 CA--C 1.489 -1.393 0 CA-C-O 121.325 0.584 . . . . 0.0 111.665 -179.811 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.753 ' O ' ' HB2' ' A' ' 82' ' ' LYS . 45.8 mt-10 -83.88 -62.57 1.54 Allowed 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 117.042 2.238 . . . . 0.0 117.042 175.141 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -80.6 -34.43 35.17 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 122.775 1.274 . . . . 0.0 108.257 177.818 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.589 ' C ' ' H ' ' A' ' 83' ' ' LYS . 24.7 m -92.63 30.58 1.51 Allowed 'General case' 0 C--N 1.291 -1.969 0 C-N-CA 126.877 2.071 . . . . 0.0 107.496 176.478 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.753 ' HB2' ' O ' ' A' ' 79' ' ' GLU . 72.5 tttt -57.33 32.0 0.0 OUTLIER 'General case' 0 CA--C 1.565 1.542 0 C-N-CA 127.996 2.518 . . . . 0.0 112.617 -179.737 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.676 ' HG3' HG22 ' A' ' 109' ' ' THR . 53.9 pttt -117.96 133.67 55.69 Favored 'General case' 0 N--CA 1.393 -3.315 0 C-N-CA 125.943 1.697 . . . . 0.0 107.179 176.219 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.576 HD21 ' HB2' ' A' ' 75' ' ' TYR . 1.2 tm? -59.82 127.24 30.99 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-O 121.569 0.699 . . . . 0.0 110.743 -171.368 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.582 ' O ' ' HB2' ' A' ' 76' ' ' GLU . 6.2 t -126.77 114.28 17.75 Favored 'General case' 0 N--CA 1.405 -2.687 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.37 -179.851 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.686 ' HA ' ' O ' ' A' ' 74' ' ' ASN . 15.7 m -92.41 140.16 16.7 Favored 'Isoleucine or valine' 0 CA--C 1.474 -1.96 0 O-C-N 121.007 -1.058 . . . . 0.0 111.304 178.542 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.543 ' HA ' ' H ' ' A' ' 107' ' ' THR 0.339 2.0 pp -101.59 103.7 14.54 Favored 'General case' 0 N--CA 1.391 -3.423 0 CA-C-O 122.593 1.187 . . . . 0.0 109.979 176.892 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 35.0 mt -88.65 117.37 68.25 Favored Pre-proline 0 N--CA 1.405 -2.715 0 CA-C-N 113.683 -1.599 . . . . 0.0 107.23 -178.223 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.455 ' HB2' ' HD2' ' A' ' 166' ' ' ARG . 55.1 Cg_exo -55.78 104.15 0.12 Allowed 'Trans proline' 0 N--CA 1.451 -0.992 0 C-N-CA 123.442 2.761 . . . . 0.0 111.737 -178.059 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' SER . . . . . 0.512 ' OG ' ' HB ' ' A' ' 167' ' ' VAL . 25.7 t 71.66 170.22 0.32 Allowed 'General case' 0 N--CA 1.44 -0.942 0 O-C-N 124.715 1.259 . . . . 0.0 110.832 -179.134 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 79.4 mt -85.88 116.78 29.49 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.921 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.227 177.409 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' CYS . . . . . 0.597 ' SG ' ' HB2' ' A' ' 104' ' ' PHE . 12.0 p -109.91 129.05 55.7 Favored 'General case' 0 C--N 1.292 -1.92 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 174.615 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -120.41 120.34 35.66 Favored 'General case' 0 CA--C 1.461 -2.463 0 N-CA-C 108.787 -0.819 . . . . 0.0 108.787 -175.5 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.719 ' O ' ' HA ' ' A' ' 101' ' ' VAL . 49.1 t -111.06 115.79 50.8 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.156 0 CA-C-N 114.443 -1.253 . . . . 0.0 109.398 -172.933 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.309 -0.944 0 N-CA-C 110.939 -0.864 . . . . 0.0 110.939 179.325 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 39.9 m . . . . . 0 N--CA 1.43 -1.466 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.719 ' HA ' ' O ' ' A' ' 94' ' ' VAL . 9.3 p -94.81 116.37 35.97 Favored 'Isoleucine or valine' 0 C--O 1.244 0.765 0 CA-C-O 122.01 0.909 . . . . 0.0 113.021 -175.969 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.427 ' CD1' HG23 ' A' ' 125' ' ' THR . 1.5 mm? -110.2 133.23 53.43 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 177.202 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 22.6 ttmm -103.39 105.23 15.44 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 177.924 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.597 ' HB2' ' SG ' ' A' ' 92' ' ' CYS . 99.3 m-85 -90.15 98.18 11.62 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 176.983 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 28.0 m -85.81 155.94 20.78 Favored 'General case' 0 C--N 1.296 -1.737 0 CA-C-N 114.686 -1.143 . . . . 0.0 111.062 -175.863 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 27.0 m -68.79 121.29 16.22 Favored 'General case' 0 N--CA 1.417 -2.094 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 175.892 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.543 ' H ' ' HA ' ' A' ' 87' ' ' LEU . 23.3 m 71.98 79.56 0.15 Allowed 'General case' 0 C--N 1.317 -0.807 0 C-N-CA 124.212 1.005 . . . . 0.0 110.656 179.238 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.506 ' O ' ' HA ' ' A' ' 85' ' ' THR . 14.9 m -109.25 121.21 61.93 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 CA-C-N 114.995 -1.002 . . . . 0.0 109.45 177.306 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.676 HG22 ' HG3' ' A' ' 83' ' ' LYS . 25.7 m -106.57 124.22 49.28 Favored 'General case' 0 N--CA 1.409 -2.492 0 CA-C-N 114.977 -1.01 . . . . 0.0 111.657 -167.599 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -157.1 -168.69 20.02 Favored Glycine 0 C--N 1.309 -0.947 0 C-N-CA 120.452 -0.88 . . . . 0.0 113.733 -179.295 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 12.9 t-80 -99.64 119.62 38.39 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 105.752 -1.944 . . . . 0.0 105.752 179.632 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.559 HD23 ' HG ' ' A' ' 84' ' ' LEU . 60.7 tp -124.11 118.51 27.08 Favored 'General case' 0 CA--C 1.457 -2.62 0 CA-C-O 121.338 0.59 . . . . 0.0 111.594 -167.496 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 8.1 mp0 -121.04 146.57 46.58 Favored 'General case' 1 N--CA 1.37 -4.459 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 175.323 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 21.2 tptm -66.2 101.14 0.68 Allowed 'General case' 0 C--N 1.291 -1.959 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 179.148 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 137.07 -48.95 0.88 Allowed Glycine 0 C--O 1.192 -2.478 0 N-CA-C 108.361 -1.896 . . . . 0.0 108.361 -173.294 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.63 ' HD3' HG23 ' A' ' 118' ' ' THR . 0.0 OUTLIER -148.71 144.22 26.95 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 114.006 1.113 . . . . 0.0 114.006 179.935 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.666 ' O ' ' HB2' ' A' ' 135' ' ' SER . 49.1 tp -110.65 100.91 9.61 Favored 'General case' 0 C--N 1.31 -1.124 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 177.029 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.63 HG23 ' HD3' ' A' ' 116' ' ' LYS . 6.9 p -100.95 138.16 38.37 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 113.064 0.765 . . . . 0.0 113.064 -176.528 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' ASP . . . . . 0.418 ' H ' ' HB3' ' A' ' 135' ' ' SER . 29.3 t70 64.09 124.52 0.02 OUTLIER 'General case' 0 CA--C 1.45 -2.866 0 C-N-CA 124.882 1.273 . . . . 0.0 111.348 -176.414 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.431 HG21 HD12 ' A' ' 123' ' ' ILE . 0.8 OUTLIER -145.99 145.16 20.37 Favored 'Isoleucine or valine' 1 N--CA 1.351 -5.388 0 C-N-CA 116.475 -2.09 . . . . 0.0 111.082 -169.659 . . . . . . . . 4 4 . 1 . 005 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.466 ' HB3' ' HB ' ' A' ' 109' ' ' THR . 14.9 tp10 -111.42 102.87 11.21 Favored 'General case' 0 C--N 1.283 -2.283 0 CA-C-N 115.13 -0.941 . . . . 0.0 109.199 -176.567 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 116.22 -4.85 20.0 Favored Glycine 0 N--CA 1.439 -1.161 0 C-N-CA 119.392 -1.385 . . . . 0.0 114.225 173.294 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.431 HD12 HG21 ' A' ' 120' ' ' VAL . 61.4 mt -99.35 105.4 17.39 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.99 0 C-N-CA 118.737 -1.185 . . . . 0.0 110.052 179.746 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 58.0 tttm -85.37 119.67 25.99 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 179.019 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.523 ' O ' ' HA ' ' A' ' 130' ' ' TRP . 92.1 m -116.46 124.08 49.08 Favored 'General case' 0 C--N 1.271 -2.813 0 CA-C-N 114.951 -1.022 . . . . 0.0 110.116 -176.365 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.482 ' HA ' ' O ' ' A' ' 129' ' ' ILE . 0.7 OUTLIER -122.83 100.25 6.81 Favored 'General case' 0 N--CA 1.424 -1.762 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 174.077 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 11.8 p -102.59 -26.84 3.38 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.138 0 CA-C-O 122.255 1.026 . . . . 0.0 109.511 178.299 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 26.6 ttt -161.32 -33.6 0.05 OUTLIER 'General case' 0 C--N 1.282 -2.335 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 -178.089 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' ILE . . . . . 0.516 ' H ' HD13 ' A' ' 129' ' ' ILE . 0.2 OUTLIER -139.46 165.62 22.59 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 N-CA-C 104.436 -2.431 . . . . 0.0 104.436 176.759 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 130' ' ' TRP . . . . . 0.523 ' HA ' ' O ' ' A' ' 125' ' ' THR . 60.8 p-90 -108.42 127.82 54.24 Favored 'General case' 0 N--CA 1.418 -2.058 0 C-N-CA 118.928 -1.109 . . . . 0.0 111.661 -178.479 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.595 HG12 ' H ' ' A' ' 133' ' ' VAL . 43.0 t -127.99 154.02 38.06 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.914 0 N-CA-C 105.751 -1.944 . . . . 0.0 105.751 177.354 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -115.98 18.71 15.43 Favored 'General case' 0 C--N 1.3 -1.579 0 CA-C-O 121.627 0.727 . . . . 0.0 111.238 -176.441 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.595 ' H ' HG12 ' A' ' 131' ' ' VAL . 33.5 m -138.11 0.2 0.71 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.637 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.962 -178.464 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 134' ' ' THR . . . . . 0.463 ' OG1' ' HB ' ' A' ' 125' ' ' THR . 1.2 p -64.65 120.61 12.73 Favored 'General case' 0 N--CA 1.418 -2.063 0 CA-C-O 122.065 0.936 . . . . 0.0 110.917 178.074 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 135' ' ' SER . . . . . 0.666 ' HB2' ' O ' ' A' ' 117' ' ' LEU . 19.7 p -78.61 171.25 15.4 Favored 'General case' 0 N--CA 1.407 -2.608 0 CA-C-N 113.778 -1.555 . . . . 0.0 114.049 -173.03 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 10.4 tt -119.18 127.54 75.84 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.099 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 175.84 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 37.9 m -129.45 131.23 46.68 Favored 'General case' 0 C--N 1.293 -1.886 0 C-N-CA 120.351 -0.54 . . . . 0.0 110.995 -174.422 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' THR . . . . . 0.516 ' HB ' ' O ' ' A' ' 142' ' ' LYS . 59.6 p -118.2 176.13 5.37 Favored 'General case' 0 C--N 1.29 -1.983 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 177.182 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -99.93 21.64 12.35 Favored 'General case' 0 C--N 1.281 -2.398 0 N-CA-C 106.185 -1.783 . . . . 0.0 106.185 173.732 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . 61.71 40.42 13.15 Favored 'General case' 0 C--N 1.352 0.683 0 N-CA-C 107.367 -1.346 . . . . 0.0 107.367 -168.969 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 35.6 t -174.78 -79.69 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 114.222 -1.354 . . . . 0.0 109.483 -174.921 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' LYS . . . . . 0.516 ' O ' ' HB ' ' A' ' 138' ' ' THR . 99.5 mttt -85.41 167.2 15.74 Favored 'General case' 0 CA--C 1.497 -1.095 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 177.141 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.449 ' HA ' HG22 ' A' ' 138' ' ' THR . 10.4 p -126.33 127.7 70.84 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.741 0 N-CA-C 113.484 0.92 . . . . 0.0 113.484 -173.105 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 45.8 m-85 -113.68 147.14 38.71 Favored 'General case' 0 CA--C 1.487 -1.465 0 CA-C-N 115.244 -0.889 . . . . 0.0 109.982 176.041 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 145' ' ' PHE . . . . . 0.505 ' HB2' ' HB2' ' A' ' 151' ' ' LYS . 93.9 m-85 -99.19 99.85 10.89 Favored 'General case' 0 C--N 1.263 -3.174 0 CA-C-N 114.456 -1.247 . . . . 0.0 107.922 175.738 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . 0.363 17.7 p -82.34 69.76 9.15 Favored 'General case' 0 N--CA 1.425 -1.686 0 N-CA-C 115.315 1.598 . . . . 0.0 115.315 -175.215 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 147' ' ' ALA . . . . . 0.411 ' HB2' HG21 ' A' ' 125' ' ' THR . . . -123.85 74.35 1.27 Allowed 'General case' 0 N--CA 1.424 -1.728 0 N-CA-C 104.68 -2.341 . . . . 0.0 104.68 170.869 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 77.64 16.25 80.4 Favored Glycine 0 N--CA 1.433 -1.567 0 N-CA-C 109.071 -1.611 . . . . 0.0 109.071 -171.271 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 27.5 ptt? 49.03 24.39 0.88 Allowed 'General case' 0 N--CA 1.502 2.149 0 C-N-CA 126.578 1.951 . . . . 0.0 111.416 -173.731 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 59.5 mttp -62.77 -36.79 84.23 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 115.021 1.489 . . . . 0.0 115.021 -174.099 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 151' ' ' LYS . . . . . 0.547 ' HE2' ' HA ' ' A' ' 151' ' ' LYS . 6.1 mmpt? -106.3 132.8 51.91 Favored 'General case' 0 C--N 1.319 -0.74 0 C-N-CA 120.473 -0.491 . . . . 0.0 110.897 178.144 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 19.7 m -132.46 128.21 36.96 Favored 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 -179.727 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 25.2 mmm180 -140.99 172.95 11.97 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-O 121.232 0.539 . . . . 0.0 111.954 -178.138 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 17.8 m -101.15 142.26 32.85 Favored 'General case' 0 N--CA 1.432 -1.331 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 176.434 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 155' ' ' ARG . . . . . 0.531 ' HD3' ' C ' ' A' ' 155' ' ' ARG . 0.2 OUTLIER -78.58 -25.02 45.21 Favored 'General case' 0 C--N 1.299 -1.606 0 CA-C-O 121.255 0.55 . . . . 0.0 109.89 178.976 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -44.17 -36.37 2.62 Favored 'General case' 0 C--N 1.316 -0.854 0 C-N-CA 125.455 1.502 . . . . 0.0 114.905 -175.277 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -66.44 -53.81 31.23 Favored 'General case' 0 CA--C 1.546 0.797 0 N-CA-C 114.277 1.214 . . . . 0.0 114.277 -174.107 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -149.66 5.15 0.6 Allowed 'General case' 0 N--CA 1.491 1.603 0 CA-C-N 117.597 0.18 . . . . 0.0 111.364 -175.411 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 159' ' ' GLY . . . . . 0.518 ' HA2' ' HG2' ' A' ' 155' ' ' ARG . . . 96.31 -91.55 1.29 Allowed Glycine 0 CA--C 1.461 -3.33 0 N-CA-C 106.231 -2.748 . . . . 0.0 106.231 -166.772 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.544 ' HB ' ' O ' ' A' ' 67' ' ' ILE . 57.7 t -104.96 127.45 59.49 Favored 'Isoleucine or valine' 1 N--CA 1.369 -4.512 0 N-CA-C 105.16 -2.163 . . . . 0.0 105.16 165.1 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 -88.34 106.59 18.34 Favored 'General case' 0 C--N 1.273 -2.754 0 N-CA-C 106.396 -1.705 . . . . 0.0 106.396 -177.055 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 162' ' ' ARG . . . . . 0.446 ' HD2' ' O ' ' A' ' 164' ' ' GLY . 0.0 OUTLIER -148.64 158.69 44.31 Favored 'General case' 0 N--CA 1.389 -3.519 0 C-N-CA 118.384 -1.326 . . . . 0.0 114.523 -167.359 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -106.29 -24.1 12.38 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 115.073 -0.967 . . . . 0.0 108.792 172.657 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 164' ' ' GLY . . . . . 0.446 ' O ' ' HD2' ' A' ' 162' ' ' ARG . . . -58.65 118.61 14.33 Favored Glycine 0 CA--C 1.498 -0.994 0 CA-C-N 115.258 -0.883 . . . . 0.0 112.282 -178.914 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 2.8 pp -108.7 153.74 23.01 Favored 'General case' 0 N--CA 1.418 -2.047 0 CA-C-O 120.667 0.27 . . . . 0.0 111.161 -174.991 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 166' ' ' ARG . . . . . 0.455 ' HD2' ' HB2' ' A' ' 89' ' ' PRO . 58.6 mtm180 -79.12 117.4 20.11 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 178.17 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 167' ' ' VAL . . . . . 0.512 ' HB ' ' OG ' ' A' ' 90' ' ' SER . 43.6 t -62.28 -18.0 19.26 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.627 0 CA-C-O 121.64 0.733 . . . . 0.0 109.692 176.056 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -56.1 -41.44 75.21 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 124.739 1.215 . . . . 0.0 111.101 176.736 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 1.9 tmmm? -86.59 109.58 19.23 Favored 'General case' 0 N--CA 1.429 -1.499 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 -178.478 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 170' ' ' PHE . . . . . . . . . . . . . 87.9 t80 . . . . . 0 N--CA 1.423 -1.822 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 178.414 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.676 ' O ' ' HG ' ' A' ' 58' ' ' LEU . 23.3 mt . . . . . 0 C--O 1.208 -1.088 0 CA-C-O 118.826 -0.607 . . . . 0.0 112.068 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.569 ' HA ' ' CD1' ' A' ' 58' ' ' LEU . 36.7 Cg_endo -60.34 -34.96 93.04 Favored 'Trans proline' 0 C--N 1.377 2.063 0 C-N-CA 120.899 1.066 . . . . 0.0 113.768 -169.729 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -78.21 -30.27 48.8 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-O 121.242 0.544 . . . . 0.0 110.633 179.324 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 45.5 tp -74.02 -29.39 61.91 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.242 176.875 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.676 ' HG ' ' O ' ' A' ' 54' ' ' LEU . 59.6 mt -57.48 -45.9 84.3 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-O 121.375 0.607 . . . . 0.0 110.3 -177.896 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.431 ' HD3' ' HA3' ' A' ' 66' ' ' GLY . 1.9 pptp? -73.57 -25.0 60.16 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 114.894 -1.048 . . . . 0.0 110.577 -179.183 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -90.48 -22.83 21.17 Favored 'General case' 0 CA--C 1.556 1.181 0 N-CA-C 113.482 0.919 . . . . 0.0 113.482 -174.776 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.558 ' CD2' ' HA ' ' A' ' 58' ' ' LEU . 34.1 m-85 -41.31 -41.08 1.83 Allowed 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 115.193 1.553 . . . . 0.0 115.193 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.493 ' OD2' ' HA ' ' A' ' 114' ' ' LYS . 10.4 t70 -125.96 -82.96 0.63 Allowed 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 117.746 -1.582 . . . . 0.0 112.205 -172.647 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.554 ' H ' HD12 ' A' ' 63' ' ' LEU . 0.0 OUTLIER -90.94 161.07 36.56 Favored Pre-proline 0 N--CA 1.444 -0.752 0 N-CA-C 106.619 -1.623 . . . . 0.0 106.619 -179.742 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -100.55 14.17 0.45 Allowed 'Trans proline' 0 N--CA 1.435 -1.936 0 C-N-CA 122.778 2.319 . . . . 0.0 112.803 -176.869 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.56 HG12 ' H ' ' A' ' 67' ' ' ILE . 0.2 OUTLIER -67.09 -47.5 81.75 Favored 'Isoleucine or valine' 0 CA--C 1.484 -1.59 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 177.146 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.524 ' HA2' HG21 ' A' ' 73' ' ' THR . . . 49.91 8.7 0.15 Allowed Glycine 0 N--CA 1.472 1.043 0 CA-C-N 114.903 -1.044 . . . . 0.0 113.849 -173.13 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.56 ' H ' HG12 ' A' ' 65' ' ' ILE . 16.6 mm 69.38 -69.34 0.16 Allowed 'Isoleucine or valine' 0 C--O 1.177 -2.739 0 C-N-CA 125.549 1.54 . . . . 0.0 108.555 -173.142 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.577 ' HB3' ' HD3' ' A' ' 69' ' ' PRO . 65.3 t80 -167.4 -56.75 0.01 OUTLIER Pre-proline 0 C--N 1.293 -1.851 0 C-N-CA 120.917 -0.313 . . . . 0.0 110.64 -177.78 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.577 ' HD3' ' HB3' ' A' ' 68' ' ' PHE . 56.0 Cg_endo -102.71 178.91 0.15 Allowed 'Trans proline' 0 N--CA 1.424 -2.61 0 C-N-CA 121.721 1.614 . . . . 0.0 111.108 -179.651 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -102.99 19.32 46.98 Favored Glycine 0 N--CA 1.43 -1.76 0 N-CA-C 109.756 -1.338 . . . . 0.0 109.756 175.381 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -100.93 -44.43 5.75 Favored 'General case' 0 N--CA 1.432 -1.353 0 N-CA-C 106.401 -1.703 . . . . 0.0 106.401 -178.368 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.451 ' HA ' ' HD2' ' A' ' 89' ' ' PRO . . . -80.6 168.04 19.36 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 114.653 -1.158 . . . . 0.0 109.156 167.059 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.559 ' O ' HG22 ' A' ' 73' ' ' THR . 22.3 m 81.8 28.84 0.15 Allowed 'General case' 0 CA--C 1.513 -0.462 0 CA-C-O 123.764 1.745 . . . . 0.0 111.198 171.556 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.565 ' O ' ' HA ' ' A' ' 86' ' ' VAL . 4.3 m-20 -70.47 148.26 48.49 Favored 'General case' 0 C--N 1.262 -3.212 0 CA-C-N 114.264 -1.335 . . . . 0.0 110.01 -179.725 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 40.5 t80 -115.01 91.32 3.58 Favored 'General case' 0 C--N 1.275 -2.644 0 C-N-CA 119.847 -0.741 . . . . 0.0 111.834 -166.556 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.5 ' O ' HD22 ' A' ' 84' ' ' LEU . 39.6 mm-40 -113.53 153.77 28.19 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.018 177.165 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 46.0 p90 -163.35 147.77 10.95 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 178.409 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.574 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 11.7 m-20 -74.99 165.11 25.79 Favored 'General case' 0 CA--C 1.478 -1.818 0 C-N-CA 119.827 -0.749 . . . . 0.0 109.235 179.77 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -80.78 -62.73 1.58 Allowed 'General case' 0 C--N 1.265 -3.087 0 CA-C-N 114.775 -1.102 . . . . 0.0 111.599 -179.169 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.494 ' CD ' ' H ' ' A' ' 80' ' ' GLU . 0.0 OUTLIER -80.98 -35.15 32.42 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.271 -176.293 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.574 ' HB ' ' HB2' ' A' ' 78' ' ' ASP . 56.8 m -80.49 -40.83 25.4 Favored 'General case' 0 N--CA 1.423 -1.822 0 CA-C-N 115.076 -0.965 . . . . 0.0 110.992 -178.598 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.423 ' H ' ' HB2' ' A' ' 78' ' ' ASP . 61.9 mttp 66.23 13.72 9.3 Favored 'General case' 0 N--CA 1.483 1.184 0 N-CA-C 114.206 1.187 . . . . 0.0 114.206 178.554 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 36.6 ttpt -71.54 116.46 11.91 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 176.336 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.5 HD22 ' O ' ' A' ' 76' ' ' GLU . 2.1 tm? -75.03 131.39 40.57 Favored 'General case' 0 N--CA 1.443 -0.817 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 -176.447 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.572 ' HA ' ' O ' ' A' ' 108' ' ' VAL . 27.4 p -126.66 116.59 21.23 Favored 'General case' 0 N--CA 1.412 -2.353 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.127 177.428 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.565 ' HA ' ' O ' ' A' ' 74' ' ' ASN . 63.2 t -91.92 131.84 37.94 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.054 0 N-CA-C 106.86 -1.533 . . . . 0.0 106.86 173.837 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.633 ' HA ' ' O ' ' A' ' 106' ' ' THR 0.361 2.1 pp -111.08 114.9 28.51 Favored 'General case' 0 N--CA 1.393 -3.28 0 CA-C-O 122.161 0.981 . . . . 0.0 111.869 178.642 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.474 ' O ' HG23 ' A' ' 106' ' ' THR . 70.3 mt -95.88 125.71 47.67 Favored Pre-proline 0 N--CA 1.419 -2.008 0 CA-C-N 113.647 -1.615 . . . . 0.0 109.771 -176.472 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.451 ' HD2' ' HA ' ' A' ' 72' ' ' ALA . 9.6 Cg_endo -53.89 95.43 0.04 OUTLIER 'Trans proline' 0 CA--C 1.534 0.489 0 C-N-CA 124.129 3.219 . . . . 0.0 112.492 177.696 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' SER . . . . . 0.533 ' OG ' ' HB ' ' A' ' 167' ' ' VAL . 22.9 t 75.7 158.14 0.2 Allowed 'General case' 0 C--O 1.236 0.387 0 C-N-CA 125.452 1.501 . . . . 0.0 110.394 -177.804 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.476 HD11 ' HD3' ' A' ' 103' ' ' LYS . 15.9 tt -78.57 108.22 11.77 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.598 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 173.871 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' CYS . . . . . 0.683 ' SG ' ' HG2' ' A' ' 166' ' ' ARG . 32.0 m -98.76 127.03 44.56 Favored 'General case' 0 C--N 1.29 -1.99 0 CA-C-N 114.932 -1.031 . . . . 0.0 110.725 -170.817 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -116.79 147.71 41.84 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-N 116.661 -0.245 . . . . 0.0 110.461 -178.745 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.577 ' O ' ' HA ' ' A' ' 101' ' ' VAL . 6.4 p -137.74 114.11 11.39 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 CA-C-O 120.91 0.386 . . . . 0.0 111.198 -178.745 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.854 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 176.613 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 36.1 p . . . . . 0 N--CA 1.414 -2.27 0 CA-C-O 121.329 0.585 . . . . 0.0 109.973 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.577 ' HA ' ' O ' ' A' ' 94' ' ' VAL . 11.6 p -123.22 119.64 58.17 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 N-CA-C 106.681 -1.599 . . . . 0.0 106.681 174.477 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.506 HD23 ' H ' ' A' ' 126' ' ' LYS . 59.1 mt -124.83 144.12 50.46 Favored 'General case' 0 C--N 1.282 -2.356 0 C-N-CA 120.03 -0.668 . . . . 0.0 110.688 -170.88 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.476 ' HD3' HD11 ' A' ' 91' ' ' ILE . 23.0 ttmm -121.28 104.96 10.11 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 179.551 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -89.92 101.83 14.53 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.767 -178.31 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 82.5 m -60.97 153.09 25.99 Favored 'General case' 0 C--N 1.306 -1.317 0 C-N-CA 124.46 1.104 . . . . 0.0 110.652 177.11 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' THR . . . . . 0.633 ' O ' ' HA ' ' A' ' 87' ' ' LEU . 88.4 m -71.65 -69.24 0.4 Allowed 'General case' 0 C--O 1.205 -1.242 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.302 -174.634 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.412 HG22 ' HB3' ' A' ' 87' ' ' LEU . 32.3 p -99.08 101.71 13.17 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 178.907 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.723 HG21 HG12 ' A' ' 123' ' ' ILE . 4.7 p -112.41 138.42 41.56 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.769 0 C-N-CA 119.27 -0.972 . . . . 0.0 111.751 -177.236 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.426 HG22 HG22 ' A' ' 85' ' ' THR . 76.4 p -94.29 153.07 18.21 Favored 'General case' 0 N--CA 1.413 -2.311 0 CA-C-N 115.344 -0.843 . . . . 0.0 109.666 -177.599 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' GLY . . . . . 0.478 ' HA2' ' O ' ' A' ' 119' ' ' ASP . . . -169.8 167.92 40.92 Favored Glycine 0 N--CA 1.423 -2.201 0 C-N-CA 120.787 -0.72 . . . . 0.0 111.979 -179.381 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 9.6 t60 -92.97 108.65 20.17 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 178.31 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -91.52 125.42 36.25 Favored 'General case' 0 C--N 1.296 -1.718 0 CA-C-O 121.075 0.464 . . . . 0.0 110.363 -178.37 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' GLU . . . . . 0.562 ' HG3' ' HG3' ' A' ' 116' ' ' LYS . 10.5 pt-20 -142.33 136.57 29.8 Favored 'General case' 0 N--CA 1.425 -1.675 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 171.133 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.493 ' HA ' ' OD2' ' A' ' 62' ' ' ASP . 2.3 tmtp? -52.08 117.82 3.04 Favored 'General case' 0 C--O 1.248 0.991 0 CA-C-O 121.726 0.775 . . . . 0.0 111.774 -169.599 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' GLY . . . . . 0.671 ' O ' ' HB ' ' A' ' 138' ' ' THR . . . 106.53 -28.47 13.32 Favored Glycine 0 N--CA 1.409 -3.126 0 CA-C-N 114.66 -1.155 . . . . 0.0 112.421 176.559 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.562 ' HG3' ' HG3' ' A' ' 113' ' ' GLU . 12.4 ptmm? -147.11 115.38 6.62 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-O 121.784 0.802 . . . . 0.0 111.676 -174.929 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 59.4 tp -93.55 103.57 15.74 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 106.656 -1.609 . . . . 0.0 106.656 177.856 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.411 HG21 ' NZ ' ' A' ' 116' ' ' LYS . 39.7 p -103.64 140.38 37.64 Favored 'General case' 0 N--CA 1.403 -2.801 0 N-CA-C 113.572 0.953 . . . . 0.0 113.572 -171.787 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' ASP . . . . . 0.478 ' O ' ' HA2' ' A' ' 110' ' ' GLY . 12.9 m-20 60.09 85.51 0.11 Allowed 'General case' 0 CA--C 1.493 -1.215 0 CA-C-N 114.611 -1.177 . . . . 0.0 113.788 -179.824 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.8 m -88.02 87.77 2.8 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.985 0 CA-C-N 115.038 -0.983 . . . . 0.0 109.327 174.848 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -68.51 93.89 0.53 Allowed 'General case' 0 N--CA 1.418 -2.066 0 CA-C-N 113.813 -1.539 . . . . 0.0 108.495 -177.434 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 137.84 -11.26 3.67 Favored Glycine 0 N--CA 1.418 -2.52 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.597 178.899 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.723 HG12 HG21 ' A' ' 108' ' ' VAL . 36.1 mm -96.64 112.46 28.8 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.176 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 178.779 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.413 ' HA ' ' HA ' ' A' ' 132' ' ' LYS . 46.6 mtpt -86.35 118.97 26.12 Favored 'General case' 0 N--CA 1.414 -2.253 0 CA-C-N 114.954 -1.021 . . . . 0.0 109.279 -177.282 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.419 HG23 HD22 ' A' ' 102' ' ' LEU . 86.5 m -122.9 130.66 53.12 Favored 'General case' 0 N--CA 1.407 -2.604 0 CA-C-N 114.159 -1.382 . . . . 0.0 110.604 -173.894 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.617 ' C ' ' HD3' ' A' ' 126' ' ' LYS . 0.3 OUTLIER -107.72 125.64 51.63 Favored 'General case' 0 N--CA 1.41 -2.454 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 173.705 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.638 HG23 ' H ' ' A' ' 128' ' ' MET . 4.0 m -119.29 -81.0 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.09 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.498 175.844 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 128' ' ' MET . . . . . 0.638 ' H ' HG23 ' A' ' 127' ' ' VAL . 1.1 tmt? -103.1 -20.2 14.26 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 106.277 -1.749 . . . . 0.0 106.277 171.722 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 1.1 pp -152.21 -176.41 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 C-N-CA 126.758 2.023 . . . . 0.0 108.564 -178.824 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 91.2 m95 -95.28 139.84 31.02 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.06 0.457 . . . . 0.0 111.567 178.585 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.57 HG12 ' H ' ' A' ' 133' ' ' VAL . 31.9 t -138.65 135.43 43.47 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.955 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 174.428 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 132' ' ' LYS . . . . . 0.593 ' H ' ' HD2' ' A' ' 132' ' ' LYS . 0.0 OUTLIER -93.03 13.31 21.16 Favored 'General case' 0 N--CA 1.487 1.403 0 CA-C-N 118.426 0.557 . . . . 0.0 111.024 -178.029 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.57 ' H ' HG12 ' A' ' 131' ' ' VAL . 5.5 p -166.43 96.31 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.31 -1.129 0 CA-C-O 122.364 1.078 . . . . 0.0 111.578 -172.539 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 134' ' ' THR . . . . . 0.413 ' O ' ' HA ' ' A' ' 119' ' ' ASP . 21.8 p -99.03 -172.8 2.35 Favored 'General case' 0 N--CA 1.404 -2.742 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.289 176.334 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 28.4 t -147.97 134.53 19.8 Favored 'General case' 0 C--N 1.282 -2.344 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 -173.569 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 60.9 mt -105.27 103.79 15.92 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.875 0 CA-C-O 121.197 0.522 . . . . 0.0 109.979 -178.415 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 56.3 p -96.54 110.8 23.13 Favored 'General case' 0 N--CA 1.428 -1.549 0 CA-C-O 121.233 0.54 . . . . 0.0 109.597 179.107 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' THR . . . . . 0.671 ' HB ' ' O ' ' A' ' 115' ' ' GLY . 75.5 m -128.44 159.65 34.74 Favored 'General case' 0 C--N 1.274 -2.694 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 -177.591 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -105.72 39.35 1.78 Allowed 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 109.786 -0.449 . . . . 0.0 109.786 175.576 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . 58.74 34.82 24.03 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 115.243 -0.89 . . . . 0.0 109.602 -177.152 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' SER . . . . . 0.452 ' H ' HG22 ' A' ' 138' ' ' THR . 33.5 t 179.45 -78.16 0.01 OUTLIER 'General case' 0 CA--C 1.547 0.859 0 CA-C-N 114.7 -1.137 . . . . 0.0 110.081 -174.634 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -80.67 134.97 35.95 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 110.152 -0.314 . . . . 0.0 110.152 179.392 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.413 ' CG2' HG22 ' A' ' 65' ' ' ILE . 20.3 t -110.22 140.19 30.32 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 N-CA-C 112.793 0.664 . . . . 0.0 112.793 -168.952 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -133.51 151.84 51.82 Favored 'General case' 0 CA--C 1.483 -1.605 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 170.013 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 145' ' ' PHE . . . . . 0.526 ' HB2' ' HB2' ' A' ' 151' ' ' LYS . 55.4 m-85 -113.11 99.58 7.94 Favored 'General case' 0 C--N 1.275 -2.659 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.744 179.297 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 16.8 p -84.81 85.72 7.43 Favored 'General case' 0 N--CA 1.408 -2.538 0 CA-C-N 115.133 -0.939 . . . . 0.0 110.97 177.747 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -113.03 70.52 0.72 Allowed 'General case' 0 N--CA 1.428 -1.559 0 N-CA-C 106.33 -1.73 . . . . 0.0 106.33 174.72 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 72.64 27.03 70.1 Favored Glycine 0 N--CA 1.439 -1.125 0 N-CA-C 108.619 -1.792 . . . . 0.0 108.619 -171.911 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 26.8 ttt 60.42 97.51 0.03 OUTLIER 'General case' 0 C--N 1.355 0.807 0 C-N-CA 124.621 1.169 . . . . 0.0 109.3 -171.714 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.19 -52.54 0.32 Allowed 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 114.9 1.444 . . . . 0.0 114.9 -174.766 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 151' ' ' LYS . . . . . 0.526 ' HB2' ' HB2' ' A' ' 145' ' ' PHE . 35.2 mmtp -121.96 163.9 18.52 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 114.236 1.199 . . . . 0.0 114.236 -171.292 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 55.7 p -128.51 160.01 33.67 Favored 'General case' 0 N--CA 1.439 -0.977 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 175.362 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 14.6 tpp180 -154.96 132.84 11.49 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.132 0.491 . . . . 0.0 111.709 179.7 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 9.2 m -88.64 137.38 32.37 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 177.311 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 155' ' ' ARG . . . . . 0.677 ' O ' ' HD3' ' A' ' 155' ' ' ARG . 2.4 tmt_? -70.12 -22.25 63.03 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 110.282 -0.266 . . . . 0.0 110.282 -176.898 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -50.86 -25.25 4.29 Favored 'General case' 0 N--CA 1.5 2.052 0 C-N-CA 123.482 0.713 . . . . 0.0 112.552 177.882 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.59 ' HB1' ' HG2' ' A' ' 161' ' ' GLN . . . -76.42 4.01 9.93 Favored 'General case' 0 C--N 1.306 -1.286 0 C-N-CA 124.924 1.29 . . . . 0.0 113.393 -178.311 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 86.7 m-85 91.53 23.46 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.147 0 C-N-CA 126.186 1.794 . . . . 0.0 109.51 -175.489 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 159' ' ' GLY . . . . . 0.464 ' HA3' ' O ' ' A' ' 65' ' ' ILE . . . 101.64 -94.4 1.22 Allowed Glycine 0 N--CA 1.398 -3.867 0 N-CA-C 109.224 -1.551 . . . . 0.0 109.224 -175.458 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.553 HG23 ' HB ' ' A' ' 65' ' ' ILE . 79.7 t -128.92 113.74 30.09 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.337 0 CA-C-O 121.505 0.669 . . . . 0.0 111.029 -178.938 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 161' ' ' GLN . . . . . 0.59 ' HG2' ' HB1' ' A' ' 157' ' ' ALA 0.315 10.0 pt20 -110.52 92.87 4.21 Favored 'General case' 0 C--N 1.302 -1.472 0 C-N-CA 117.203 -1.799 . . . . 0.0 114.54 179.278 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 26.0 tpt180 -146.22 102.14 3.58 Favored 'General case' 0 C--N 1.274 -2.708 0 N-CA-C 101.789 -3.411 . . . . 0.0 101.789 168.454 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 47.8 m-80 -110.67 123.03 49.23 Favored 'General case' 0 C--N 1.292 -1.93 0 N-CA-C 113.453 0.909 . . . . 0.0 113.453 -169.722 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 164' ' ' GLY . . . . . 0.459 ' CA ' ' HB ' ' A' ' 94' ' ' VAL . . . -95.11 -169.5 36.35 Favored Glycine 0 N--CA 1.42 -2.422 0 N-CA-C 108.823 -1.711 . . . . 0.0 108.823 172.899 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.616 ' H ' HD23 ' A' ' 165' ' ' LEU . 1.9 pt? -91.37 112.0 23.72 Favored 'General case' 0 C--N 1.296 -1.736 0 C-N-CA 119.113 -1.035 . . . . 0.0 109.648 -178.948 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 166' ' ' ARG . . . . . 0.683 ' HG2' ' SG ' ' A' ' 92' ' ' CYS . 78.9 mtt85 -82.74 101.16 10.7 Favored 'General case' 0 CA--C 1.48 -1.738 0 N-CA-C 106.447 -1.686 . . . . 0.0 106.447 174.885 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 167' ' ' VAL . . . . . 0.533 ' HB ' ' OG ' ' A' ' 90' ' ' SER . 52.4 t -68.59 -27.84 37.86 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.803 0 CA-C-N 114.942 -1.026 . . . . 0.0 112.25 -175.366 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 168' ' ' ASP . . . . . 0.42 ' HB2' ' HB2' ' A' ' 90' ' ' SER . 18.0 t70 -90.84 69.69 6.48 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-O 121.975 0.893 . . . . 0.0 110.432 -177.642 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 39.3 ttpt 177.92 130.54 0.06 Allowed 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 113.474 -1.694 . . . . 0.0 106.81 175.994 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 170' ' ' PHE . . . . . . . . . . . . . 64.0 m-85 . . . . . 0 C--N 1.288 -2.098 0 CA-C-O 119.148 -0.453 . . . . 0.0 110.302 -175.159 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.471 ' O ' ' HG ' ' A' ' 58' ' ' LEU . 18.4 mt . . . . . 0 N--CA 1.437 -1.115 0 CA-C-O 119.087 -0.482 . . . . 0.0 111.597 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.514 ' HA ' ' CD1' ' A' ' 58' ' ' LEU . 38.6 Cg_exo -58.59 -38.47 89.41 Favored 'Trans proline' 0 C--N 1.384 2.409 0 C-N-CA 121.209 1.273 . . . . 0.0 113.572 -172.059 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.406 ' O ' ' HG3' ' A' ' 59' ' ' LYS . 11.0 pt-20 -70.13 -30.13 67.24 Favored 'General case' 0 C--O 1.214 -0.765 0 CA-C-O 120.826 0.346 . . . . 0.0 110.815 178.317 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 62.4 tp -69.66 -33.38 72.51 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.371 177.818 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.514 ' CD1' ' HA ' ' A' ' 55' ' ' PRO . 6.3 mt -65.58 -52.59 51.08 Favored 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 -179.042 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.462 ' O ' ' HA ' ' A' ' 64' ' ' PRO . 15.3 ptpt -63.04 -24.04 67.73 Favored 'General case' 0 C--O 1.187 -2.213 0 CA-C-N 114.897 -1.047 . . . . 0.0 113.296 177.149 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -82.53 -54.77 4.92 Favored 'General case' 0 C--N 1.292 -1.898 0 O-C-N 121.848 -0.533 . . . . 0.0 112.283 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 54.0 t80 -56.96 -31.26 64.83 Favored 'General case' 0 C--O 1.245 0.827 0 C-N-CA 124.287 1.035 . . . . 0.0 110.68 -173.719 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.624 ' OD1' ' HB3' ' A' ' 75' ' ' TYR . 3.4 m-20 -108.56 25.69 11.4 Favored 'General case' 0 C--N 1.283 -2.32 0 CA-C-N 114.19 -1.368 . . . . 0.0 111.681 -172.312 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.641 HD21 ' H ' ' A' ' 115' ' ' GLY . 34.5 mt 80.91 143.33 0.08 OUTLIER Pre-proline 0 N--CA 1.477 0.89 0 C-N-CA 125.056 1.342 . . . . 0.0 108.936 -178.408 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.462 ' HA ' ' O ' ' A' ' 59' ' ' LYS . 10.2 Cg_endo -84.2 21.5 1.06 Allowed 'Trans proline' 0 N--CA 1.439 -1.733 0 C-N-CA 122.837 2.358 . . . . 0.0 113.239 -161.797 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.596 ' O ' ' HA3' ' A' ' 159' ' ' GLY . 0.2 OUTLIER -72.93 -38.13 55.7 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.913 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 175.338 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 55.07 8.64 1.57 Allowed Glycine 0 N--CA 1.473 1.106 0 CA-C-N 114.988 -1.005 . . . . 0.0 114.329 178.099 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.749 ' O ' ' HB ' ' A' ' 160' ' ' VAL . 37.9 mt 70.77 -31.93 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 C-N-CA 125.578 1.551 . . . . 0.0 113.911 -179.132 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.525 ' HB2' ' O ' ' A' ' 67' ' ' ILE . 55.6 t80 167.04 -56.89 0.0 OUTLIER Pre-proline 0 C--N 1.312 -1.046 0 C-N-CA 124.743 1.217 . . . . 0.0 108.936 175.958 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.476 ' HD3' ' HB3' ' A' ' 68' ' ' PHE . 19.3 Cg_endo -110.4 -16.73 0.03 OUTLIER 'Trans proline' 0 CA--C 1.569 2.225 0 C-N-CA 122.777 2.318 . . . . 0.0 116.877 -171.701 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.474 ' H ' ' HD2' ' A' ' 69' ' ' PRO . . . 84.09 7.19 85.66 Favored Glycine 0 CA--C 1.533 1.161 0 C-N-CA 119.732 -1.223 . . . . 0.0 110.395 -171.155 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.465 ' HB3' ' HG2' ' A' ' 69' ' ' PRO . 30.0 t70 -82.36 -50.62 8.71 Favored 'General case' 0 CA--C 1.497 -1.086 0 N-CA-C 106.314 -1.735 . . . . 0.0 106.314 177.395 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.42 ' HB1' HG13 ' A' ' 88' ' ' ILE . . . -83.03 176.73 9.02 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 113.732 -1.577 . . . . 0.0 107.48 166.049 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.561 ' O ' HG22 ' A' ' 73' ' ' THR . 89.4 m 82.0 27.86 0.15 Allowed 'General case' 0 N--CA 1.492 1.633 0 CA-C-O 124.363 2.03 . . . . 0.0 109.8 176.818 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.582 ' O ' ' HA ' ' A' ' 86' ' ' VAL . 3.5 m-20 -87.84 123.53 32.71 Favored 'General case' 0 C--N 1.257 -3.447 0 CA-C-N 114.417 -1.265 . . . . 0.0 110.464 179.434 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.624 ' HB3' ' OD1' ' A' ' 62' ' ' ASP . 46.2 p90 -82.17 141.53 32.97 Favored 'General case' 0 C--N 1.295 -1.771 0 O-C-N 124.243 0.964 . . . . 0.0 112.506 -178.639 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 32.0 mm-40 -159.39 136.84 9.88 Favored 'General case' 0 C--O 1.203 -1.347 0 C-N-CA 126.537 1.935 . . . . 0.0 107.266 174.409 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 49.9 p90 -134.7 148.32 50.28 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 118.538 0.608 . . . . 0.0 110.995 -177.163 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.619 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 4.6 m-20 -89.39 169.88 11.02 Favored 'General case' 0 CA--C 1.478 -1.827 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 177.477 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -81.41 -62.07 1.76 Allowed 'General case' 0 C--N 1.267 -3.013 0 CA-C-N 114.426 -1.261 . . . . 0.0 111.337 177.912 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.32 -33.59 49.17 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 115.398 -0.819 . . . . 0.0 112.502 -176.99 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.619 ' HB ' ' HB2' ' A' ' 78' ' ' ASP . 90.1 m -81.46 -47.6 12.97 Favored 'General case' 0 C--N 1.288 -2.093 0 CA-C-N 115.192 -0.913 . . . . 0.0 111.844 178.919 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.401 ' H ' ' HB2' ' A' ' 78' ' ' ASP . 65.5 mttp 61.73 -5.55 0.14 Allowed 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 115.345 1.609 . . . . 0.0 115.345 -179.238 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.775 ' HG2' HG22 ' A' ' 109' ' ' THR . 32.6 ttmt -75.2 110.22 9.35 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 173.071 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.543 HD11 ' HB2' ' A' ' 75' ' ' TYR . 5.8 tt -66.23 134.02 51.82 Favored 'General case' 0 C--N 1.299 -1.6 0 CA-C-N 114.756 -1.111 . . . . 0.0 111.41 -174.067 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 15.0 t -108.02 126.93 53.31 Favored 'General case' 0 N--CA 1.397 -3.093 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.238 -179.288 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.582 ' HA ' ' O ' ' A' ' 74' ' ' ASN . 79.0 t -96.9 132.24 41.8 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.672 -179.359 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.9 mp -95.4 114.63 26.42 Favored 'General case' 0 N--CA 1.423 -1.787 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.721 -179.444 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.42 HG13 ' HB1' ' A' ' 72' ' ' ALA . 2.4 mp -104.83 110.27 64.22 Favored Pre-proline 0 C--N 1.299 -1.616 0 N-CA-C 105.77 -1.937 . . . . 0.0 105.77 171.991 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.625 ' O ' ' HB2' ' A' ' 166' ' ' ARG . 51.8 Cg_exo -56.17 94.07 0.05 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.498 0 C-N-CA 122.782 2.321 . . . . 0.0 112.215 178.164 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' SER . . . . . 0.491 ' HB2' ' HB2' ' A' ' 168' ' ' ASP . 40.9 t 74.95 141.53 0.07 Allowed 'General case' 0 C--N 1.343 0.323 0 C-N-CA 125.217 1.407 . . . . 0.0 111.813 -176.777 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.419 HD11 ' HD2' ' A' ' 103' ' ' LYS . 4.5 tt -69.08 121.35 18.27 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.504 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.894 177.94 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 12.7 p -107.58 145.16 33.59 Favored 'General case' 0 C--N 1.298 -1.657 0 CA-C-N 114.524 -1.216 . . . . 0.0 109.634 176.511 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.475 ' O ' ' HA3' ' A' ' 164' ' ' GLY . 2.2 mp0 -118.1 132.65 56.33 Favored 'General case' 0 CA--C 1.471 -2.087 0 N-CA-C 105.969 -1.863 . . . . 0.0 105.969 178.585 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.661 HG13 ' H ' ' A' ' 163' ' ' ASN . 16.7 t -108.8 104.19 16.69 Favored 'Isoleucine or valine' 0 N--CA 1.398 -3.046 0 C-N-CA 119.366 -0.934 . . . . 0.0 109.132 -178.628 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.404 -3.477 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 -179.102 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 100' ' ' SER . . . . . 0.44 ' HA ' ' O ' ' A' ' 126' ' ' LYS . 46.4 t . . . . . 0 N--CA 1.419 -2.01 0 N-CA-C 104.816 -2.29 . . . . 0.0 104.816 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 54.3 t -126.03 131.21 71.97 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 179.68 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.539 ' HB2' ' HB ' ' A' ' 94' ' ' VAL . 2.7 mp -126.81 148.42 49.95 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 118.145 0.429 . . . . 0.0 110.126 -177.61 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.419 ' HD2' HD11 ' A' ' 91' ' ' ILE . 39.5 ttpt -138.67 123.73 19.01 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 174.811 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -120.77 108.05 13.49 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 178.755 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 12.4 t -81.47 -177.35 6.47 Favored 'General case' 0 N--CA 1.432 -1.339 0 CA-C-O 121.133 0.492 . . . . 0.0 111.266 -178.431 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 39.4 p -66.07 -58.71 4.87 Favored 'General case' 0 C--N 1.301 -1.538 0 C-N-CA 124.833 1.253 . . . . 0.0 112.595 -172.376 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 6.4 m -122.54 97.32 5.4 Favored 'General case' 0 N--CA 1.41 -2.455 0 CA-C-O 121.535 0.683 . . . . 0.0 109.866 -175.571 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 18.1 m -99.02 141.11 17.09 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 CA-C-N 114.978 -1.01 . . . . 0.0 109.545 179.301 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.775 HG22 ' HG2' ' A' ' 83' ' ' LYS . 2.9 m -114.62 119.91 38.36 Favored 'General case' 0 N--CA 1.403 -2.783 0 N-CA-C 104.748 -2.316 . . . . 0.0 104.748 -174.336 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' GLY . . . . . 0.734 ' HA2' ' O ' ' A' ' 119' ' ' ASP . . . -141.74 159.56 26.9 Favored Glycine 0 N--CA 1.435 -1.38 0 C-N-CA 120.037 -1.078 . . . . 0.0 115.169 -174.258 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 6.8 t60 -88.06 109.28 19.73 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 177.878 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 65.3 tp -106.96 120.99 43.55 Favored 'General case' 0 C--N 1.302 -1.461 0 C-N-CA 119.885 -0.726 . . . . 0.0 112.458 -175.099 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -115.1 158.05 22.71 Favored 'General case' 0 CA--C 1.448 -2.971 0 N-CA-C 107.505 -1.294 . . . . 0.0 107.505 169.633 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 2.4 tmtm? -82.25 99.12 9.12 Favored 'General case' 2 N--CA 1.375 -4.202 0 N-CA-C 107.135 -1.432 . . . . 0.0 107.135 -175.854 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 115' ' ' GLY . . . . . 0.641 ' H ' HD21 ' A' ' 63' ' ' LEU . . . 131.28 -20.24 4.74 Favored Glycine 0 C--O 1.19 -2.631 0 N-CA-C 109.978 -1.249 . . . . 0.0 109.978 -177.257 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -163.23 135.8 5.38 Favored 'General case' 0 C--N 1.314 -0.953 0 O-C-N 122.109 -0.642 . . . . 0.0 110.864 -177.848 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 3.1 tt -116.8 114.54 24.08 Favored 'General case' 0 C--N 1.286 -2.168 0 N-CA-C 106.246 -1.761 . . . . 0.0 106.246 178.002 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.452 ' HA ' ' CB ' ' A' ' 135' ' ' SER . 49.9 p -116.52 175.77 5.41 Favored 'General case' 0 C--N 1.279 -2.48 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.424 -176.016 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' ASP . . . . . 0.734 ' O ' ' HA2' ' A' ' 110' ' ' GLY . 7.0 m-20 54.91 83.84 0.08 Allowed 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.629 0.772 . . . . 0.0 111.2 174.85 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.431 ' CG2' ' HB ' ' A' ' 123' ' ' ILE . 13.6 m -119.3 108.47 23.86 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.8 0 CA-C-O 122.303 1.049 . . . . 0.0 112.321 -172.469 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -79.9 100.24 7.95 Favored 'General case' 0 C--N 1.268 -2.943 0 CA-C-N 114.331 -1.304 . . . . 0.0 110.204 174.8 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 123.94 -14.08 8.01 Favored Glycine 0 N--CA 1.435 -1.428 0 C-N-CA 120.722 -0.751 . . . . 0.0 113.161 176.959 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.431 ' HB ' ' CG2' ' A' ' 120' ' ' VAL . 63.5 mt -102.46 116.09 45.53 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.914 0 CA-C-O 121.536 0.684 . . . . 0.0 110.116 179.555 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -124.21 141.23 52.24 Favored 'General case' 0 C--N 1.294 -1.847 0 CA-C-N 114.795 -1.093 . . . . 0.0 109.053 178.474 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.433 ' OG1' ' HG ' ' A' ' 102' ' ' LEU . 11.1 t -152.48 162.67 40.88 Favored 'General case' 0 C--O 1.245 0.847 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 178.495 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.454 ' HE2' ' N ' ' A' ' 128' ' ' MET . 8.3 tmtt? -131.18 129.59 41.91 Favored 'General case' 0 N--CA 1.426 -1.635 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.656 176.261 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.408 ' O ' ' HB3' ' A' ' 128' ' ' MET . 41.8 t -150.02 112.81 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.481 -1.699 0 N-CA-C 104.31 -2.478 . . . . 0.0 104.31 172.764 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 128' ' ' MET . . . . . 0.454 ' N ' ' HE2' ' A' ' 126' ' ' LYS . 45.9 ttm 69.48 -54.95 0.58 Allowed 'General case' 0 N--CA 1.473 0.696 0 O-C-N 124.031 0.832 . . . . 0.0 109.978 -172.054 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 8.0 tp -139.18 162.89 27.21 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.716 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 178.38 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 69.5 p-90 -92.67 137.72 32.12 Favored 'General case' 0 N--CA 1.423 -1.823 0 CA-C-O 121.064 0.459 . . . . 0.0 110.861 -178.81 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 53.4 t -134.31 121.83 38.38 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.154 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 179.343 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 60.1 pttt -98.29 3.16 48.73 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.157 0.503 . . . . 0.0 111.955 -176.867 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 34.4 m -124.22 25.02 3.47 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.204 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 176.545 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 9.4 t -55.24 113.24 1.31 Allowed 'General case' 0 N--CA 1.441 -0.906 0 CA-C-N 113.258 -1.792 . . . . 0.0 113.249 -173.178 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' SER . . . . . 0.46 ' O ' ' HA ' ' A' ' 146' ' ' THR . 26.3 p -100.1 149.94 22.99 Favored 'General case' 0 N--CA 1.405 -2.72 0 C-N-CA 119.72 -0.792 . . . . 0.0 113.033 -177.38 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 136' ' ' ILE . . . . . 0.527 ' HB ' HG22 ' A' ' 146' ' ' THR . 13.2 tt -100.9 138.46 25.05 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.71 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 -179.109 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 14.7 t -120.55 142.71 49.09 Favored 'General case' 0 N--CA 1.408 -2.567 0 N-CA-C 107.052 -1.462 . . . . 0.0 107.052 -178.479 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' THR . . . . . 0.453 ' HB ' HD13 ' A' ' 63' ' ' LEU . 33.2 m -149.02 175.5 11.25 Favored 'General case' 0 C--N 1.27 -2.882 0 N-CA-C 106.523 -1.658 . . . . 0.0 106.523 -176.768 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -118.05 30.45 7.23 Favored 'General case' 0 C--N 1.277 -2.583 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 174.802 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' ALA . . . . . 0.499 ' HA ' HD22 ' A' ' 63' ' ' LEU . . . 60.26 36.56 20.75 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-N 114.745 -1.116 . . . . 0.0 110.145 -177.045 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 141' ' ' SER . . . . . 0.407 ' H ' HG22 ' A' ' 138' ' ' THR . 41.4 t 174.38 -82.68 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 114.283 -1.326 . . . . 0.0 108.353 -172.607 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 23.0 pttm -77.56 136.79 38.32 Favored 'General case' 0 CA--C 1.505 -0.758 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 177.62 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.409 HG21 HG21 ' A' ' 65' ' ' ILE . 12.4 p -109.95 156.58 10.79 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.889 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 -171.23 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -128.98 154.16 46.86 Favored 'General case' 0 N--CA 1.428 -1.539 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 174.613 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 33.9 t80 -73.96 162.92 28.55 Favored 'General case' 0 C--N 1.309 -1.152 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 -175.836 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.527 HG22 ' HB ' ' A' ' 136' ' ' ILE . 70.9 p -71.7 -172.73 0.85 Allowed 'General case' 0 N--CA 1.42 -1.966 0 CA-C-O 121.512 0.672 . . . . 0.0 112.609 -175.358 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . 74.78 -29.54 0.19 Allowed 'General case' 0 N--CA 1.463 0.192 0 C-N-CA 126.018 1.727 . . . . 0.0 113.317 177.267 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 147.74 43.63 0.03 OUTLIER Glycine 0 CA--C 1.477 -2.319 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 178.008 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 65.3 mtt 60.96 40.14 15.76 Favored 'General case' 0 C--N 1.344 0.369 0 O-C-N 124.196 0.586 . . . . 0.0 110.224 -177.409 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 150' ' ' LYS . . . . . 0.6 ' HE2' ' HA ' ' A' ' 150' ' ' LYS . 9.5 mmpt? -65.53 -16.76 64.0 Favored 'General case' 0 N--CA 1.483 1.199 0 CA-C-O 120.816 0.341 . . . . 0.0 111.415 -178.766 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 151' ' ' LYS . . . . . 0.543 ' HA ' ' HE3' ' A' ' 151' ' ' LYS . 0.0 OUTLIER -147.27 163.43 36.42 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 176.962 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 9.0 p -131.34 111.65 12.04 Favored 'General case' 0 C--N 1.292 -1.904 0 CA-C-O 121.391 0.615 . . . . 0.0 110.483 176.502 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 33.5 mmt180 -113.87 160.51 18.68 Favored 'General case' 0 CA--C 1.501 -0.914 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.001 -179.085 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 51.2 m -96.05 140.49 30.7 Favored 'General case' 0 N--CA 1.42 -1.93 0 CA-C-N 116.253 -0.43 . . . . 0.0 109.905 177.068 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 155' ' ' ARG . . . . . 0.574 ' HG3' ' HA2' ' A' ' 159' ' ' GLY . 9.0 ttp180 -74.99 -21.2 59.28 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.051 175.625 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -34.92 -49.6 0.45 Allowed 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 126.315 1.846 . . . . 0.0 114.806 -174.144 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -77.44 -55.37 5.45 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 113.635 0.976 . . . . 0.0 113.635 -176.198 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -153.52 16.02 0.52 Allowed 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.981 -0.449 . . . . 0.0 111.836 -176.01 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 159' ' ' GLY . . . . . 0.596 ' HA3' ' O ' ' A' ' 65' ' ' ILE . . . 84.88 -89.35 1.6 Allowed Glycine 0 CA--C 1.466 -2.989 0 C-N-CA 119.646 -1.264 . . . . 0.0 110.735 -174.501 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.749 ' HB ' ' O ' ' A' ' 67' ' ' ILE . 39.1 t -99.6 148.5 6.39 Favored 'Isoleucine or valine' 0 N--CA 1.4 -2.931 0 C-N-CA 119.491 -0.884 . . . . 0.0 109.102 177.575 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 74.8 mt-30 -113.74 108.98 17.84 Favored 'General case' 0 N--CA 1.416 -2.158 0 N-CA-C 106.393 -1.706 . . . . 0.0 106.393 -172.082 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 162' ' ' ARG . . . . . 0.537 ' HD2' ' C ' ' A' ' 162' ' ' ARG . 5.2 ppt_? -125.9 163.15 23.57 Favored 'General case' 0 C--N 1.275 -2.668 0 CA-C-N 115.167 -0.924 . . . . 0.0 112.919 -169.76 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 163' ' ' ASN . . . . . 0.661 ' H ' HG13 ' A' ' 94' ' ' VAL . 3.1 m-20 -110.4 -59.65 1.91 Allowed 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.875 175.903 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 164' ' ' GLY . . . . . 0.503 ' O ' ' HD3' ' A' ' 162' ' ' ARG . . . -61.0 147.38 47.03 Favored Glycine 0 CA--C 1.501 -0.782 0 CA-C-N 115.877 -0.601 . . . . 0.0 113.033 -179.635 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 65.6 tp -107.83 139.23 42.73 Favored 'General case' 0 N--CA 1.422 -1.827 0 CA-C-O 121.169 0.509 . . . . 0.0 109.851 -177.898 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 166' ' ' ARG . . . . . 0.625 ' HB2' ' O ' ' A' ' 89' ' ' PRO . 6.5 ptp85 -85.84 103.49 14.64 Favored 'General case' 0 C--N 1.287 -2.146 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 176.471 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 4.8 t -102.9 70.98 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.788 0 CA-C-N 115.184 -0.916 . . . . 0.0 112.46 -170.52 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 168' ' ' ASP . . . . . 0.491 ' HB2' ' HB2' ' A' ' 90' ' ' SER . 15.8 t70 -109.14 -39.2 5.33 Favored 'General case' 0 CA--C 1.475 -1.918 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 175.304 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 169' ' ' LYS . . . . . 0.645 ' HD3' ' H ' ' A' ' 169' ' ' LYS . 0.0 OUTLIER -93.1 149.65 21.08 Favored 'General case' 0 C--N 1.287 -2.128 0 CA-C-N 113.48 -1.691 . . . . 0.0 109.634 -174.146 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 170' ' ' PHE . . . . . . . . . . . . . 81.6 t80 . . . . . 0 C--N 1.288 -2.082 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 179.719 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.645 ' HB3' ' HD3' ' A' ' 55' ' ' PRO . 10.5 tp . . . . . 0 C--O 1.203 -1.349 0 N-CA-C 110.213 -0.292 . . . . 0.0 110.213 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.645 ' HD3' ' HB3' ' A' ' 54' ' ' LEU . 8.1 Cg_exo -50.73 -38.2 55.81 Favored 'Trans proline' 0 C--N 1.388 2.608 0 C-N-CA 123.536 2.824 . . . . 0.0 112.671 -177.444 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -76.95 -31.84 56.88 Favored 'General case' 0 N--CA 1.432 -1.365 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.069 -179.299 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.564 ' HG ' ' O ' ' A' ' 54' ' ' LEU . 2.0 pp -75.74 -28.67 58.59 Favored 'General case' 0 C--O 1.204 -1.293 0 C-N-CA 119.669 -0.812 . . . . 0.0 108.984 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.639 ' HG ' ' O ' ' A' ' 54' ' ' LEU . 63.0 mt -57.34 -48.76 78.14 Favored 'General case' 0 C--O 1.199 -1.571 0 O-C-N 123.938 0.774 . . . . 0.0 110.809 -177.123 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 55.2 mtpt -64.88 -29.53 70.49 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-O 121.846 0.832 . . . . 0.0 110.627 -177.68 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -96.71 1.71 51.25 Favored 'General case' 0 C--N 1.297 -1.686 0 CA-C-N 114.692 -1.14 . . . . 0.0 111.424 -178.214 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.437 ' HB3' ' CD2' ' A' ' 75' ' ' TYR . 41.2 t80 -57.15 -42.88 81.86 Favored 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 112.776 0.658 . . . . 0.0 112.776 -170.542 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.566 ' OD1' ' HA ' ' A' ' 114' ' ' LYS . 11.2 t70 -139.67 -74.56 0.36 Allowed 'General case' 0 C--N 1.315 -0.916 0 C-N-CA 120.031 -0.667 . . . . 0.0 109.989 -177.41 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.559 HD21 ' H ' ' A' ' 115' ' ' GLY . 20.3 mt -96.29 150.17 36.82 Favored Pre-proline 0 N--CA 1.445 -0.719 0 N-CA-C 106.23 -1.767 . . . . 0.0 106.23 175.489 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_endo -99.9 18.22 0.35 Allowed 'Trans proline' 0 N--CA 1.443 -1.497 0 C-N-CA 123.77 2.98 . . . . 0.0 113.539 -169.391 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.517 ' HB ' HG23 ' A' ' 160' ' ' VAL . 0.2 OUTLIER -69.78 -45.01 78.6 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.872 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 176.743 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 52.83 9.53 0.8 Allowed Glycine 0 N--CA 1.486 2.011 0 CA-C-N 114.908 -1.042 . . . . 0.0 114.266 178.401 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.667 ' HA ' ' CG2' ' A' ' 160' ' ' VAL 0.288 20.2 mt 62.17 -68.37 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 C-N-CA 126.413 1.885 . . . . 0.0 112.835 -170.948 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.418 ' HB3' ' HD3' ' A' ' 69' ' ' PRO . 69.6 t80 177.97 -55.41 0.0 OUTLIER Pre-proline 0 C--N 1.301 -1.528 0 O-C-N 123.69 0.619 . . . . 0.0 111.674 -177.787 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.418 ' HD3' ' HB3' ' A' ' 68' ' ' PHE . 2.9 Cg_endo -82.9 -70.35 0.01 OUTLIER 'Trans proline' 0 C--N 1.369 1.647 0 C-N-CA 121.763 1.642 . . . . 0.0 113.003 -175.402 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 153.73 -40.53 0.67 Allowed Glycine 0 CA--C 1.492 -1.38 0 N-CA-C 110.092 -1.203 . . . . 0.0 110.092 -176.114 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.442 ' HB3' ' HG3' ' A' ' 89' ' ' PRO . 3.2 t70 -74.84 -55.25 6.01 Favored 'General case' 0 C--O 1.184 -2.352 0 N-CA-C 104.745 -2.317 . . . . 0.0 104.745 175.757 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.432 ' HA ' HG12 ' A' ' 88' ' ' ILE . . . -66.08 99.57 0.52 Allowed 'General case' 0 C--N 1.31 -1.132 0 C-N-CA 117.082 -1.847 . . . . 0.0 107.556 163.216 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . 1.619 6.3 m 115.26 30.8 0.0 OUTLIER 'General case' 0 N--CA 1.439 -1.012 1 N-CA-C 123.299 4.555 . . . . 0.0 123.299 -178.542 . . . . . . . . 3 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.582 ' O ' HG22 ' A' ' 86' ' ' VAL . 3.5 p30 -89.11 178.28 6.42 Favored 'General case' 0 C--N 1.293 -1.882 0 CA-C-N 114.708 -1.133 . . . . 0.0 108.003 167.419 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.504 ' HB3' HD21 ' A' ' 84' ' ' LEU . 93.4 m-85 -136.73 101.56 4.64 Favored 'General case' 0 C--N 1.281 -2.395 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 -178.248 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -108.59 114.15 27.72 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 -178.253 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 87.8 t80 -112.94 126.73 55.8 Favored 'General case' 0 C--N 1.282 -2.363 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 -176.879 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.671 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 7.3 m-20 -91.09 164.44 13.94 Favored 'General case' 0 CA--C 1.478 -1.799 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 177.001 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -80.27 -64.77 1.11 Allowed 'General case' 0 C--N 1.278 -2.515 0 CA-C-N 115.055 -0.975 . . . . 0.0 112.662 -175.541 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -71.91 -30.36 65.28 Favored 'General case' 0 CA--C 1.506 -0.736 0 CA-C-O 121.437 0.637 . . . . 0.0 110.538 -176.033 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.671 ' HB ' ' HB2' ' A' ' 78' ' ' ASP . 17.7 m -66.29 -46.81 75.7 Favored 'General case' 0 N--CA 1.417 -2.125 0 CA-C-N 115.082 -0.963 . . . . 0.0 110.295 -178.218 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 97.3 mttt 64.58 17.59 10.96 Favored 'General case' 0 N--CA 1.486 1.363 0 CA-C-O 121.982 0.896 . . . . 0.0 111.486 178.345 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.485 ' HB3' HG22 ' A' ' 81' ' ' THR . 47.0 tptt -116.03 124.62 50.91 Favored 'General case' 0 N--CA 1.394 -3.248 0 N-CA-C 105.242 -2.133 . . . . 0.0 105.242 -178.607 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.504 HD21 ' HB3' ' A' ' 75' ' ' TYR . 3.1 tm? -76.46 137.38 39.64 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 179.794 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.447 ' N ' HD13 ' A' ' 84' ' ' LEU . 54.1 p -125.94 144.8 50.54 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.582 HG22 ' O ' ' A' ' 74' ' ' ASN . 92.9 t -112.98 130.39 66.92 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.512 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 172.337 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 18.5 mt -96.4 102.16 13.91 Favored 'General case' 0 C--N 1.282 -2.355 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 -179.447 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.432 HG12 ' HA ' ' A' ' 72' ' ' ALA . 62.6 mt -104.15 135.1 19.39 Favored Pre-proline 0 C--N 1.306 -1.313 0 N-CA-C 109.63 -0.508 . . . . 0.0 109.63 -178.378 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.442 ' HG3' ' HB3' ' A' ' 71' ' ' ASP . 37.9 Cg_endo -84.04 110.34 1.54 Allowed 'Trans proline' 0 N--CA 1.43 -2.264 0 C-N-CA 122.548 2.165 . . . . 0.0 110.483 177.606 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 59.9 m 71.41 156.25 0.16 Allowed 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 122.146 0.974 . . . . 0.0 113.181 -179.748 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.511 HG12 ' HA ' ' A' ' 105' ' ' THR . 96.5 mt -80.72 125.69 39.4 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.861 0 CA-C-N 114.807 -1.088 . . . . 0.0 110.038 177.058 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 8.9 p -118.13 145.92 44.54 Favored 'General case' 0 C--N 1.293 -1.87 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 173.292 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -131.18 130.84 43.53 Favored 'General case' 0 C--N 1.282 -2.334 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 -174.099 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.614 HG13 ' H ' ' A' ' 163' ' ' ASN . 55.7 t -118.67 109.43 26.92 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.296 0 CA-C-O 121.266 0.555 . . . . 0.0 111.87 -173.779 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.408 -3.209 0 N-CA-C 109.357 -1.497 . . . . 0.0 109.357 175.306 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 100' ' ' SER . . . . . 0.646 ' HB3' ' O ' ' A' ' 126' ' ' LYS . 23.3 m . . . . . 0 N--CA 1.402 -2.856 0 CA-C-O 120.512 0.196 . . . . 0.0 110.489 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 86.6 t -128.68 102.64 8.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 N-CA-C 107.313 -1.365 . . . . 0.0 107.313 175.885 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.657 HD22 HG23 ' A' ' 125' ' ' THR . 55.2 mt -109.39 130.86 55.48 Favored 'General case' 0 C--N 1.285 -2.205 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.989 -171.144 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.443 ' HE3' HD13 ' A' ' 91' ' ' ILE . 35.2 tttp -103.63 115.57 30.74 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 110.237 -0.282 . . . . 0.0 110.237 -175.391 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -96.89 95.73 8.05 Favored 'General case' 0 N--CA 1.413 -2.285 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 173.303 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.636 ' H ' HG22 ' A' ' 123' ' ' ILE . 19.6 m -66.35 179.56 0.97 Allowed 'General case' 0 N--CA 1.423 -1.803 0 CA-C-N 113.587 -1.642 . . . . 0.0 110.186 177.318 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' THR . . . . . 0.631 ' H ' HG22 ' A' ' 105' ' ' THR . 22.1 p -79.56 -74.09 0.31 Allowed 'General case' 0 C--N 1.301 -1.527 0 C-N-CA 123.814 0.846 . . . . 0.0 112.408 -173.972 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 11.5 p -96.04 101.59 13.28 Favored 'General case' 0 N--CA 1.406 -2.642 0 CA-C-O 121.295 0.569 . . . . 0.0 110.25 -178.412 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.444 ' CG2' HG23 ' A' ' 123' ' ' ILE . 1.1 p -97.45 159.01 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.03 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 -179.778 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.483 HG22 ' HG2' ' A' ' 83' ' ' LYS . 63.6 m -144.71 120.38 10.47 Favored 'General case' 0 C--N 1.293 -1.876 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 -173.103 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' GLY . . . . . 0.55 ' HA3' ' O ' ' A' ' 119' ' ' ASP . . . -160.69 -157.45 8.71 Favored Glycine 0 C--O 1.202 -1.897 0 C-N-CA 121.091 -0.576 . . . . 0.0 113.88 -174.95 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 36.4 m80 -124.64 117.34 24.06 Favored 'General case' 0 C--N 1.305 -1.358 0 O-C-N 122.269 -0.548 . . . . 0.0 109.687 177.277 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.478 HD22 ' CD1' ' A' ' 75' ' ' TYR . 67.0 tp -100.68 129.61 46.61 Favored 'General case' 0 C--N 1.293 -1.885 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.267 -177.605 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -127.32 153.29 46.36 Favored 'General case' 0 CA--C 1.441 -3.239 0 CA-C-N 115.018 -0.992 . . . . 0.0 109.507 174.115 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.566 ' HA ' ' OD1' ' A' ' 62' ' ' ASP . 56.6 tptt -67.54 101.52 1.01 Allowed 'General case' 0 N--CA 1.388 -3.539 0 O-C-N 124.672 1.233 . . . . 0.0 107.896 176.816 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' GLY . . . . . 0.573 ' O ' ' HB ' ' A' ' 138' ' ' THR . . . 135.78 -55.3 0.72 Allowed Glycine 0 N--CA 1.401 -3.657 0 N-CA-C 109.272 -1.531 . . . . 0.0 109.272 -175.209 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.611 ' HD3' HG23 ' A' ' 118' ' ' THR . 0.0 OUTLIER -148.98 152.73 36.84 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 -177.485 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.521 ' O ' ' HB2' ' A' ' 135' ' ' SER . 47.9 tp -108.47 102.77 11.83 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-N 115.337 -0.847 . . . . 0.0 108.96 177.616 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.611 HG23 ' HD3' ' A' ' 116' ' ' LYS . 6.1 p -103.22 167.09 10.05 Favored 'General case' 0 C--N 1.299 -1.619 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.048 178.988 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' ASP . . . . . 0.55 ' O ' ' HA3' ' A' ' 110' ' ' GLY . 5.8 m-20 67.94 107.22 0.05 OUTLIER 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.665 0.786 . . . . 0.0 109.12 -176.041 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.527 ' HB ' HG12 ' A' ' 123' ' ' ILE 0.354 4.1 m -125.7 72.79 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.401 -2.92 0 N-CA-C 114.243 1.201 . . . . 0.0 114.243 179.514 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -82.04 86.39 6.58 Favored 'General case' 0 N--CA 1.425 -1.682 0 CA-C-N 114.271 -1.331 . . . . 0.0 110.449 176.121 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 161.92 -40.77 0.39 Allowed Glycine 0 C--N 1.262 -3.533 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 175.141 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.636 HG22 ' H ' ' A' ' 105' ' ' THR . 25.2 pt -100.12 152.2 4.83 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.737 0 C-N-CA 119.09 -1.044 . . . . 0.0 108.813 -178.041 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.423 ' NZ ' ' HB2' ' A' ' 124' ' ' LYS . 4.1 ttmp? -128.79 138.0 51.83 Favored 'General case' 0 C--N 1.27 -2.854 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 -176.468 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.657 HG23 HD22 ' A' ' 102' ' ' LEU . 13.3 m -124.13 115.45 21.16 Favored 'General case' 0 C--N 1.283 -2.296 0 CA-C-N 115.517 -0.765 . . . . 0.0 112.928 -169.561 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.646 ' O ' ' HB3' ' A' ' 100' ' ' SER . 0.2 OUTLIER -100.85 115.66 30.89 Favored 'General case' 0 N--CA 1.413 -2.289 0 N-CA-C 107.154 -1.424 . . . . 0.0 107.154 169.572 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.647 HG13 ' SD ' ' A' ' 128' ' ' MET 0.25 1.0 OUTLIER -120.47 -78.46 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.128 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.353 176.739 . . . . . . . . 4 4 . 1 . 008 nuclear build core ' A' A ' 128' ' ' MET . . . . . 0.647 ' SD ' HG13 ' A' ' 127' ' ' VAL . 0.0 OUTLIER -103.69 -9.15 19.36 Favored 'General case' 0 N--CA 1.412 -2.362 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 176.67 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 129' ' ' ILE . . . . . 0.411 HG23 HG13 ' A' ' 131' ' ' VAL . 8.9 tp -164.06 164.48 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.41 -2.437 0 N-CA-C 106.297 -1.742 . . . . 0.0 106.297 177.834 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 31.0 t90 -85.33 114.93 22.77 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 -178.436 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.411 HG13 HG23 ' A' ' 129' ' ' ILE . 15.7 m -148.74 -175.27 0.38 Allowed 'Isoleucine or valine' 0 C--O 1.211 -0.953 0 C-N-CA 125.125 1.37 . . . . 0.0 109.452 -176.381 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 132' ' ' LYS . . . . . 0.505 ' HG3' ' N ' ' A' ' 133' ' ' VAL . 38.6 pttt -131.06 -36.62 1.32 Allowed 'General case' 0 C--N 1.305 -1.334 0 C-N-CA 120.227 -0.589 . . . . 0.0 112.038 176.163 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.505 ' N ' ' HG3' ' A' ' 132' ' ' LYS . 25.6 m -69.81 -8.0 9.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 N-CA-C 115.389 1.626 . . . . 0.0 115.389 -165.484 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 134' ' ' THR . . . . . 0.416 ' O ' ' HB ' ' A' ' 146' ' ' THR . 37.9 p -75.57 90.3 2.77 Favored 'General case' 0 N--CA 1.42 -1.951 0 CA-C-O 121.767 0.794 . . . . 0.0 110.48 179.464 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 135' ' ' SER . . . . . 0.521 ' HB2' ' O ' ' A' ' 117' ' ' LEU . 30.0 p -86.13 174.27 9.27 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-N 114.404 -1.271 . . . . 0.0 112.757 -175.554 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 9.4 tt -98.33 122.46 50.01 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.798 0 CA-C-O 122.027 0.918 . . . . 0.0 111.889 -171.38 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 34.0 p -96.56 148.11 23.17 Favored 'General case' 0 N--CA 1.417 -2.113 0 CA-C-N 114.886 -1.052 . . . . 0.0 108.69 176.473 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' THR . . . . . 0.573 ' HB ' ' O ' ' A' ' 115' ' ' GLY . 93.6 m -154.03 164.09 39.03 Favored 'General case' 0 C--N 1.289 -2.043 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 -172.565 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 63.7 m-20 -99.64 22.97 10.13 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 172.457 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 140' ' ' ALA . . . . . 0.549 ' N ' HG22 ' A' ' 138' ' ' THR . . . 58.86 36.36 24.62 Favored 'General case' 0 C--N 1.351 0.661 0 N-CA-C 106.525 -1.657 . . . . 0.0 106.525 -167.331 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 141' ' ' SER . . . . . 0.481 ' H ' HG22 ' A' ' 138' ' ' THR . 35.3 t -167.54 -75.36 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.841 0 CA-C-N 113.741 -1.572 . . . . 0.0 110.341 -170.124 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 142' ' ' LYS . . . . . 0.513 ' O ' HG23 ' A' ' 138' ' ' THR . 96.7 mttt -98.65 163.58 12.59 Favored 'General case' 0 N--CA 1.484 1.268 0 CA-C-N 117.924 0.329 . . . . 0.0 110.581 -179.306 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 92.1 t -106.7 135.14 46.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-O 121.431 0.634 . . . . 0.0 111.1 -178.389 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 62.5 m-85 -119.76 156.53 30.4 Favored 'General case' 0 C--N 1.296 -1.732 0 CA-C-N 115.483 -0.781 . . . . 0.0 109.501 179.143 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 46.9 p90 -42.03 133.17 3.04 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 124.558 1.143 . . . . 0.0 113.92 -176.288 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.495 ' HA ' ' O ' ' A' ' 135' ' ' SER . 74.5 p -78.71 -40.46 33.66 Favored 'General case' 0 N--CA 1.433 -1.311 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.101 177.699 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 147' ' ' ALA . . . . . 0.433 ' CB ' HG11 ' A' ' 127' ' ' VAL . . . -112.09 157.71 20.47 Favored 'General case' 0 N--CA 1.433 -1.292 0 CA-C-N 115.091 -0.958 . . . . 0.0 108.739 178.618 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -67.41 -27.78 73.57 Favored Glycine 0 C--N 1.309 -0.945 0 O-C-N 123.543 0.527 . . . . 0.0 113.153 -176.266 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 1.6 tmt? -78.25 -24.27 46.99 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-O 121.271 0.558 . . . . 0.0 110.429 178.259 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 150' ' ' LYS . . . . . 0.523 ' HE2' ' CG2' ' A' ' 127' ' ' VAL . 21.5 ttmm -80.14 166.45 21.46 Favored 'General case' 0 N--CA 1.433 -1.317 0 CA-C-N 115.289 -0.869 . . . . 0.0 110.155 -176.03 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -110.49 161.92 15.2 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 -177.381 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 44.2 m -76.17 155.41 34.58 Favored 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 176.136 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 24.4 tpt180 -142.77 138.69 30.63 Favored 'General case' 0 N--CA 1.435 -1.187 0 C-N-CA 119.104 -1.039 . . . . 0.0 112.077 -172.001 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 28.5 p -68.25 118.62 11.6 Favored 'General case' 0 N--CA 1.44 -0.958 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.668 177.935 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 155' ' ' ARG . . . . . 0.547 ' HB2' ' O ' ' A' ' 159' ' ' GLY 0.315 0.0 OUTLIER -83.35 -20.6 33.99 Favored 'General case' 0 C--O 1.204 -1.336 0 C-N-CA 119.357 -0.937 . . . . 0.0 113.476 -178.787 . . . . . . . . 4 4 . 1 . 008 nuclear build core ' A' A ' 156' ' ' ASP . . . . . 0.413 ' HA ' HH21 ' A' ' 155' ' ' ARG . 22.7 t70 -43.78 -32.03 0.95 Allowed 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 124.774 1.23 . . . . 0.0 113.425 -178.676 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -61.53 -38.53 87.76 Favored 'General case' 0 CA--C 1.553 1.095 0 N-CA-C 113.647 0.98 . . . . 0.0 113.647 -179.739 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 41.1 m-85 -152.55 -21.69 0.17 Allowed 'General case' 0 N--CA 1.504 2.238 0 CA-C-N 118.363 0.529 . . . . 0.0 111.507 -177.432 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 159' ' ' GLY . . . . . 0.547 ' O ' ' HB2' ' A' ' 155' ' ' ARG . . . 106.34 -91.33 0.72 Allowed Glycine 0 CA--C 1.464 -3.149 0 N-CA-C 105.585 -3.006 . . . . 0.0 105.585 -166.413 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.667 ' CG2' ' HA ' ' A' ' 67' ' ' ILE . 88.9 t -100.66 141.68 17.04 Favored 'Isoleucine or valine' 0 N--CA 1.388 -3.534 0 N-CA-C 105.984 -1.858 . . . . 0.0 105.984 167.291 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 65.5 mt-30 -94.47 92.12 6.97 Favored 'General case' 0 CA--C 1.453 -2.755 0 N-CA-C 106.425 -1.695 . . . . 0.0 106.425 -170.916 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 162' ' ' ARG . . . . . 0.61 ' O ' ' HD2' ' A' ' 162' ' ' ARG . 0.0 OUTLIER -101.24 135.89 41.98 Favored 'General case' 1 N--CA 1.379 -4.016 0 CA-C-N 114.573 -1.194 . . . . 0.0 111.648 -170.685 . . . . . . . . 4 4 . 1 . 008 nuclear build core ' A' A ' 163' ' ' ASN . . . . . 0.614 ' H ' HG13 ' A' ' 94' ' ' VAL . 7.5 t30 -114.77 -13.63 12.03 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 177.537 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 164' ' ' GLY . . . . . 0.446 ' O ' ' HD3' ' A' ' 162' ' ' ARG . . . -100.38 157.78 19.43 Favored Glycine 0 N--CA 1.428 -1.863 0 CA-C-N 114.225 -1.352 . . . . 0.0 110.609 178.853 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.416 ' O ' HD12 ' A' ' 165' ' ' LEU . 2.1 pp -121.38 153.78 37.35 Favored 'General case' 0 C--N 1.287 -2.144 0 C-N-CA 123.234 0.614 . . . . 0.0 109.935 -177.234 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 166' ' ' ARG . . . . . 0.401 ' HG2' ' HG2' ' A' ' 89' ' ' PRO . 0.0 OUTLIER -71.38 129.75 39.61 Favored 'General case' 0 N--CA 1.432 -1.326 0 N-CA-C 106.856 -1.535 . . . . 0.0 106.856 173.899 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 46.8 t -57.54 -29.65 34.55 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 CA-C-O 121.444 0.64 . . . . 0.0 109.684 174.557 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -70.29 -34.6 72.95 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 123.475 0.71 . . . . 0.0 111.378 178.054 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 64.8 tttp -96.99 109.63 22.34 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 113.248 0.832 . . . . 0.0 113.248 -174.462 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 170' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 . . . . . 0 C--N 1.293 -1.885 0 N-CA-C 107.099 -1.445 . . . . 0.0 107.099 173.914 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.515 ' HB3' ' HD3' ' A' ' 55' ' ' PRO . 14.8 tp . . . . . 0 C--O 1.199 -1.59 0 CA-C-O 118.895 -0.574 . . . . 0.0 111.65 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.515 ' HD3' ' HB3' ' A' ' 54' ' ' LEU . 0.1 OUTLIER -38.3 -45.58 2.2 Favored 'Trans proline' 0 C--N 1.388 2.613 0 C-N-CA 124.143 3.229 . . . . 0.0 113.476 177.185 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.435 ' HA ' ' HE2' ' A' ' 59' ' ' LYS . 12.3 pt-20 -69.76 -37.9 76.56 Favored 'General case' 0 N--CA 1.438 -1.069 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.668 179.68 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.421 ' HG ' ' CE1' ' A' ' 61' ' ' TYR . 3.7 tt -75.64 -35.4 60.45 Favored 'General case' 0 N--CA 1.436 -1.166 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.845 -177.817 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.519 HD22 HD22 ' A' ' 74' ' ' ASN . 4.0 pp -66.88 -41.11 87.8 Favored 'General case' 0 C--N 1.314 -0.937 0 C-N-CA 120.412 -0.515 . . . . 0.0 112.276 -178.273 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.499 ' N ' HD12 ' A' ' 58' ' ' LEU . 62.0 pttt -75.13 -26.0 58.84 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.788 0.804 . . . . 0.0 109.823 176.649 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -66.27 -53.8 32.54 Favored 'General case' 0 N--CA 1.439 -0.979 0 CA-C-N 115.146 -0.934 . . . . 0.0 111.393 176.57 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.421 ' CE1' ' HG ' ' A' ' 57' ' ' LEU . 14.5 m-85 -60.34 -52.96 63.04 Favored 'General case' 0 CA--C 1.504 -0.815 0 N-CA-C 114.681 1.363 . . . . 0.0 114.681 -178.847 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.566 ' O ' HD13 ' A' ' 63' ' ' LEU . 19.6 m-20 -79.91 -98.04 0.03 OUTLIER 'General case' 0 C--N 1.316 -0.86 0 C-N-CA 118.918 -1.113 . . . . 0.0 110.44 -179.737 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.613 ' HB2' HD12 ' A' ' 65' ' ' ILE . 0.8 OUTLIER -142.41 158.68 60.21 Favored Pre-proline 0 N--CA 1.43 -1.426 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 -177.723 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.528 ' HB2' ' NH1' ' A' ' 155' ' ' ARG . 12.9 Cg_endo -93.27 28.68 0.31 Allowed 'Trans proline' 0 N--CA 1.439 -1.679 0 C-N-CA 123.47 2.78 . . . . 0.0 112.176 -173.565 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.613 HD12 ' HB2' ' A' ' 63' ' ' LEU . 0.2 OUTLIER -69.96 -29.92 42.16 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.343 0 N-CA-C 107.764 -1.199 . . . . 0.0 107.764 173.863 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 62.01 -9.71 0.11 Allowed Glycine 0 CA--C 1.54 1.651 0 CA-C-N 114.515 -1.22 . . . . 0.0 115.268 177.596 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.607 ' O ' ' HB ' ' A' ' 160' ' ' VAL . 38.4 mt 76.33 -38.53 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.51 -0.592 0 C-N-CA 125.171 1.389 . . . . 0.0 113.217 179.315 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.518 ' HB2' ' O ' ' A' ' 67' ' ' ILE . 39.0 t80 166.07 -57.72 0.0 OUTLIER Pre-proline 0 C--N 1.321 -0.636 0 C-N-CA 125.009 1.323 . . . . 0.0 109.007 173.131 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.454 ' HD3' ' HB3' ' A' ' 68' ' ' PHE . 19.6 Cg_endo -102.56 -16.85 0.09 OUTLIER 'Trans proline' 0 C--N 1.378 2.129 0 C-N-CA 122.209 1.94 . . . . 0.0 114.985 -172.922 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.433 ' H ' ' HD2' ' A' ' 69' ' ' PRO . . . 80.36 9.72 86.2 Favored Glycine 0 N--CA 1.441 -0.986 0 C-N-CA 119.924 -1.132 . . . . 0.0 111.633 -173.565 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.658 ' OD1' ' HG3' ' A' ' 89' ' ' PRO . 10.4 t70 -92.0 -43.56 9.36 Favored 'General case' 0 C--O 1.201 -1.455 0 N-CA-C 106.474 -1.676 . . . . 0.0 106.474 176.304 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.44 ' O ' ' HB ' ' A' ' 73' ' ' THR . . . -72.02 -178.77 2.5 Favored 'General case' 0 CA--C 1.552 1.043 0 CA-C-N 114.537 -1.21 . . . . 0.0 108.104 165.195 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.501 ' O ' HG22 ' A' ' 73' ' ' THR . 56.8 m 83.52 26.97 0.1 Allowed 'General case' 0 N--CA 1.498 1.948 0 CA-C-O 123.469 1.604 . . . . 0.0 108.398 179.28 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.519 HD22 HD22 ' A' ' 58' ' ' LEU . 3.5 m120 -81.7 111.15 17.69 Favored 'General case' 0 N--CA 1.41 -2.474 0 C-N-CA 118.528 -1.269 . . . . 0.0 110.962 -175.601 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 66.1 t80 -71.71 94.2 1.34 Allowed 'General case' 0 C--N 1.293 -1.874 0 CA-C-N 114.074 -1.421 . . . . 0.0 112.081 -176.195 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.448 ' O ' HD22 ' A' ' 84' ' ' LEU . 23.5 mm-40 -110.62 111.57 22.88 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 171.692 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.412 ' HB2' HD23 ' A' ' 84' ' ' LEU . 81.4 t80 -125.76 127.28 45.92 Favored 'General case' 0 C--N 1.291 -1.966 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.985 -170.495 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.554 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 3.3 m-20 -91.32 163.48 14.2 Favored 'General case' 0 CA--C 1.475 -1.933 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 178.238 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -81.67 -58.38 3.03 Favored 'General case' 0 C--N 1.26 -3.29 0 CA-C-N 114.237 -1.347 . . . . 0.0 113.176 -178.548 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -75.97 -46.92 27.14 Favored 'General case' 0 N--CA 1.429 -1.499 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.596 -176.643 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.554 ' HB ' ' HB2' ' A' ' 78' ' ' ASP . 96.8 m -67.98 -52.08 39.9 Favored 'General case' 0 C--N 1.293 -1.882 0 CA-C-N 114.4 -1.273 . . . . 0.0 112.369 -177.677 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 99.4 mttt 66.6 3.76 3.06 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 114.501 1.297 . . . . 0.0 114.501 178.334 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.698 ' HG2' ' OG1' ' A' ' 109' ' ' THR . 38.2 ttpt -91.17 92.49 8.69 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-O 121.856 0.836 . . . . 0.0 109.24 176.485 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.506 ' HB2' ' HB2' ' A' ' 112' ' ' LEU . 3.0 tm? -51.21 135.1 26.65 Favored 'General case' 0 C--N 1.32 -0.706 0 C-N-CA 126.376 1.87 . . . . 0.0 111.728 -173.82 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.467 ' HA ' ' O ' ' A' ' 108' ' ' VAL . 46.1 p -117.34 110.04 17.57 Favored 'General case' 0 N--CA 1.419 -1.981 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.021 179.805 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.423 HG23 ' CD1' ' A' ' 84' ' ' LEU . 53.5 t -91.9 127.44 44.18 Favored 'Isoleucine or valine' 0 CA--C 1.478 -1.822 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 172.574 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.507 ' H ' HD13 ' A' ' 87' ' ' LEU 0.286 0.0 OUTLIER -114.57 129.85 56.71 Favored 'General case' 0 N--CA 1.392 -3.349 0 CA-C-N 115.105 -0.952 . . . . 0.0 111.227 178.902 . . . . . . . . 4 4 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.458 ' O ' HG23 ' A' ' 106' ' ' THR . 3.1 mp -95.69 136.21 22.5 Favored Pre-proline 0 C--N 1.275 -2.66 0 CA-C-N 114.069 -1.423 . . . . 0.0 108.411 178.96 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.658 ' HG3' ' OD1' ' A' ' 71' ' ' ASP . 7.1 Cg_exo -25.3 -55.45 0.08 OUTLIER 'Trans proline' 0 C--N 1.374 1.878 1 C-N-CA 125.719 4.279 . . . . 0.0 114.065 174.825 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 90' ' ' SER . . . . . 0.582 ' HB2' ' HB2' ' A' ' 168' ' ' ASP . 45.1 t -154.1 161.45 41.89 Favored 'General case' 0 N--CA 1.426 -1.631 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 177.179 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.431 HD11 ' HD2' ' A' ' 103' ' ' LYS . 10.0 tt -64.64 114.65 2.48 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 O-C-N 123.939 0.774 . . . . 0.0 110.524 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' CYS . . . . . 0.513 ' HB2' ' HA ' ' A' ' 166' ' ' ARG . 44.2 t -116.03 123.08 47.06 Favored 'General case' 0 N--CA 1.417 -2.122 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.01 -179.161 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -99.05 169.82 9.14 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.25 -179.148 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.416 ' HB ' HH11 ' A' ' 162' ' ' ARG . 3.5 p -148.31 106.08 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.674 0 C-N-CA 123.325 0.65 . . . . 0.0 110.073 174.372 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.296 -1.686 0 N-CA-C 108.643 -1.783 . . . . 0.0 108.643 175.831 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 43.6 p . . . . . 0 N--CA 1.411 -2.388 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 96.1 t -94.68 115.96 34.8 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.993 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.776 176.878 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.415 ' HG ' ' HA ' ' A' ' 125' ' ' THR . 6.9 tt -137.66 134.83 35.91 Favored 'General case' 0 C--N 1.286 -2.195 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 -178.199 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.431 ' HD2' HD11 ' A' ' 91' ' ' ILE . 39.0 ttpt -110.11 106.51 16.0 Favored 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 178.62 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.444 ' HA ' HD12 ' A' ' 123' ' ' ILE . 14.1 t80 -96.36 96.83 9.01 Favored 'General case' 0 N--CA 1.421 -1.904 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 -177.579 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.498 HG22 ' H ' ' A' ' 106' ' ' THR . 10.6 m -57.98 172.29 0.43 Allowed 'General case' 0 CA--C 1.568 1.66 0 C-N-CA 126.415 1.886 . . . . 0.0 112.307 -178.777 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' THR . . . . . 0.498 ' H ' HG22 ' A' ' 105' ' ' THR . 38.4 m -78.29 -72.41 0.37 Allowed 'General case' 0 C--N 1.316 -0.887 0 C-N-CA 123.562 0.745 . . . . 0.0 111.79 -173.445 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 43.9 m -103.62 110.34 22.36 Favored 'General case' 0 N--CA 1.431 -1.412 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 179.498 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.815 HG21 HG12 ' A' ' 123' ' ' ILE . 3.6 p -109.03 167.08 4.31 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.419 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 178.48 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.698 ' OG1' ' HG2' ' A' ' 83' ' ' LYS . 15.1 t -139.39 131.94 28.74 Favored 'General case' 0 N--CA 1.4 -2.945 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 -175.788 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -147.32 172.18 27.8 Favored Glycine 0 N--CA 1.413 -2.86 0 C-N-CA 119.273 -1.441 . . . . 0.0 113.162 -177.65 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 35.8 m80 -77.35 121.57 23.93 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 -179.639 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.506 ' HB2' ' HB2' ' A' ' 84' ' ' LEU . 3.2 tm? -94.57 110.71 22.5 Favored 'General case' 0 N--CA 1.422 -1.845 0 CA-C-O 121.213 0.53 . . . . 0.0 110.532 -174.214 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -128.18 130.15 47.59 Favored 'General case' 0 CA--C 1.439 -3.307 0 CA-C-N 114.549 -1.205 . . . . 0.0 108.913 168.221 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 54.8 tptt -66.47 116.37 7.39 Favored 'General case' 0 N--CA 1.38 -3.962 0 CA-C-N 114.54 -1.209 . . . . 0.0 109.142 -178.209 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' GLY . . . . . 0.477 ' C ' ' HE2' ' A' ' 116' ' ' LYS . . . 118.42 -27.56 7.23 Favored Glycine 0 C--O 1.177 -3.459 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 -174.169 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.739 ' N ' ' HE2' ' A' ' 116' ' ' LYS . 0.0 OUTLIER -165.19 122.23 1.51 Allowed 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 117.393 0.597 . . . . 0.0 111.898 -178.246 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 64.4 tp -93.6 105.44 17.49 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 176.997 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 34.2 p -105.9 134.64 48.71 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 114.094 1.146 . . . . 0.0 114.094 -172.534 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 67.1 88.15 0.11 Allowed 'General case' 0 CA--C 1.49 -1.327 0 C-N-CA 124.871 1.268 . . . . 0.0 112.887 178.211 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.43 HG22 ' O ' ' A' ' 134' ' ' THR . 12.4 m -95.78 92.35 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.302 0 CA-C-O 122.912 1.339 . . . . 0.0 108.679 178.824 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -73.57 99.76 3.14 Favored 'General case' 0 C--N 1.264 -3.145 0 CA-C-N 113.072 -1.876 . . . . 0.0 111.769 -174.307 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 145.67 -8.62 1.58 Allowed Glycine 0 N--CA 1.423 -2.194 0 CA-C-N 114.41 -1.268 . . . . 0.0 111.631 177.011 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.815 HG12 HG21 ' A' ' 108' ' ' VAL . 46.4 mm -100.21 118.46 46.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-O 121.623 0.725 . . . . 0.0 111.18 -178.171 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt -85.4 119.31 25.63 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 106.294 -1.743 . . . . 0.0 106.294 175.169 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.481 ' HB ' ' HB ' ' A' ' 131' ' ' VAL . 89.5 m -125.47 128.07 47.48 Favored 'General case' 0 C--N 1.283 -2.299 0 CA-C-N 115.764 -0.653 . . . . 0.0 112.526 -169.624 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.525 ' C ' ' HD3' ' A' ' 126' ' ' LYS . 0.5 OUTLIER -137.85 123.45 19.75 Favored 'General case' 0 N--CA 1.428 -1.561 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 168.82 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.458 ' N ' ' HD3' ' A' ' 126' ' ' LYS . 7.1 p -150.55 -44.52 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.284 -2.266 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 177.556 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 15.5 tpt -103.72 -42.7 5.55 Favored 'General case' 0 N--CA 1.416 -2.16 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 173.371 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 9.3 tp -164.51 175.33 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.889 0 N-CA-C 105.808 -1.923 . . . . 0.0 105.808 178.507 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' TRP . . . . . 0.469 ' CE3' ' HB2' ' A' ' 126' ' ' LYS . 97.7 m95 -69.66 122.81 19.85 Favored 'General case' 0 C--O 1.241 0.642 0 CA-C-O 121.716 0.769 . . . . 0.0 112.285 178.725 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.481 ' HB ' ' HB ' ' A' ' 125' ' ' THR . 97.0 t -130.96 149.03 33.08 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.031 0 C-N-CA 125.481 1.512 . . . . 0.0 107.348 179.347 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 18.0 ptmt -122.75 -12.37 8.07 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-O 121.381 0.61 . . . . 0.0 110.71 177.713 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 15.8 m -138.39 75.28 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 CA-C-O 122.115 0.96 . . . . 0.0 110.266 -178.742 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' THR . . . . . 0.43 ' O ' HG22 ' A' ' 120' ' ' VAL . 7.7 t -84.01 168.92 15.49 Favored 'General case' 0 N--CA 1.414 -2.265 0 CA-C-N 115.062 -0.972 . . . . 0.0 109.328 179.022 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 16.6 p -131.47 151.69 51.35 Favored 'General case' 0 N--CA 1.387 -3.593 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 14.1 tt -118.28 97.61 5.55 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.272 0 CA-C-O 122.253 1.025 . . . . 0.0 108.768 176.405 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' SER . . . . . 0.487 ' OG ' ' HB2' ' A' ' 144' ' ' TYR . 36.2 p -91.44 152.48 20.36 Favored 'General case' 0 N--CA 1.407 -2.577 0 CA-C-N 115.019 -0.991 . . . . 0.0 110.575 -177.204 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 138' ' ' THR . . . . . 0.413 HG23 ' O ' ' A' ' 115' ' ' GLY . 4.4 t -165.42 178.08 7.05 Favored 'General case' 0 N--CA 1.396 -3.137 0 N-CA-C 107.337 -1.356 . . . . 0.0 107.337 -176.378 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -112.7 28.43 8.79 Favored 'General case' 0 C--N 1.269 -2.891 0 N-CA-C 106.848 -1.538 . . . . 0.0 106.848 174.873 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . 71.44 35.76 1.44 Allowed 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 114.284 -1.325 . . . . 0.0 109.569 -175.749 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 39.3 t 177.66 -80.9 0.0 OUTLIER 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 114.299 -1.319 . . . . 0.0 109.37 -178.17 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -78.26 135.94 37.66 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 -178.937 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 47.7 t -105.48 144.5 14.96 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 -165.062 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 144' ' ' TYR . . . . . 0.487 ' HB2' ' OG ' ' A' ' 137' ' ' SER . 83.6 m-85 -119.69 121.42 39.18 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 106.499 -1.667 . . . . 0.0 106.499 173.826 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 32.3 t80 -96.86 99.13 10.71 Favored 'General case' 0 C--N 1.286 -2.163 0 CA-C-O 121.812 0.815 . . . . 0.0 109.117 -173.871 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 15.2 p -97.95 31.35 2.71 Favored 'General case' 0 C--N 1.298 -1.668 0 CA-C-N 115.288 -0.869 . . . . 0.0 112.571 -175.137 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -76.13 82.45 2.96 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-O 121.856 0.836 . . . . 0.0 111.265 178.364 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 94.79 -58.13 1.84 Allowed Glycine 0 CA--C 1.477 -2.34 0 N-CA-C 108.749 -1.74 . . . . 0.0 108.749 178.213 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 19.6 ttt 169.93 88.93 0.0 OUTLIER 'General case' 0 N--CA 1.435 -1.214 0 C-N-CA 126.518 1.927 . . . . 0.0 107.351 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 150' ' ' LYS . . . . . 0.448 ' HA ' ' HD3' ' A' ' 150' ' ' LYS . 63.2 mmtt -133.07 176.32 8.6 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 113.64 0.978 . . . . 0.0 113.64 178.878 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -85.59 161.34 19.34 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.296 -0.866 . . . . 0.0 112.205 -173.716 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 53.6 p -78.31 160.8 27.66 Favored 'General case' 0 N--CA 1.438 -1.058 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.189 -179.71 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 30.4 ttm180 -145.7 152.09 39.05 Favored 'General case' 0 N--CA 1.438 -1.073 0 CA-C-O 121.014 0.435 . . . . 0.0 110.257 -176.074 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 61.8 p -89.11 135.05 33.77 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 177.186 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 155' ' ' ARG . . . . . 0.528 ' NH1' ' HB2' ' A' ' 64' ' ' PRO . 15.1 ptt180 -78.45 -19.18 53.71 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 120.091 -0.644 . . . . 0.0 110.449 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -48.68 -30.54 5.61 Favored 'General case' 0 C--N 1.316 -0.858 0 C-N-CA 124.375 1.07 . . . . 0.0 112.837 -177.647 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -75.33 -53.83 8.08 Favored 'General case' 0 N--CA 1.441 -0.902 0 C-N-CA 120.838 -0.345 . . . . 0.0 111.043 178.422 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 0.51 ' HB2' ' HB3' ' A' ' 161' ' ' GLN . 95.4 m-85 -157.1 -5.25 0.1 Allowed 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 111.592 0.219 . . . . 0.0 111.592 -178.417 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 159' ' ' GLY . . . . . 0.518 ' HA3' ' O ' ' A' ' 65' ' ' ILE . . . 79.14 -84.71 1.24 Allowed Glycine 0 CA--C 1.475 -2.446 0 N-CA-C 109.01 -1.636 . . . . 0.0 109.01 -169.47 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.607 ' HB ' ' O ' ' A' ' 67' ' ' ILE . 16.3 t -109.85 134.11 53.02 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.505 0 N-CA-C 107.513 -1.292 . . . . 0.0 107.513 174.297 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 161' ' ' GLN . . . . . 0.51 ' HB3' ' HB2' ' A' ' 158' ' ' TYR . 1.1 pp0? -148.17 116.39 6.51 Favored 'General case' 0 N--CA 1.416 -2.169 0 CA-C-O 121.497 0.665 . . . . 0.0 110.721 -175.002 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 162' ' ' ARG . . . . . 0.513 ' NH1' ' HA3' ' A' ' 164' ' ' GLY . 1.9 ppt_? -154.74 162.32 41.16 Favored 'General case' 0 C--N 1.266 -3.034 0 CA-C-N 113.935 -1.484 . . . . 0.0 109.074 175.57 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -76.8 91.98 3.56 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 121.716 0.77 . . . . 0.0 112.718 -177.478 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 164' ' ' GLY . . . . . 0.513 ' HA3' ' NH1' ' A' ' 162' ' ' ARG . . . -146.25 142.4 10.48 Favored Glycine 0 N--CA 1.421 -2.312 0 CA-C-N 115.67 -0.696 . . . . 0.0 111.591 178.128 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.471 ' H ' HD23 ' A' ' 165' ' ' LEU . 1.5 pt? -117.7 112.05 19.95 Favored 'General case' 0 N--CA 1.416 -2.133 0 N-CA-C 106.802 -1.555 . . . . 0.0 106.802 173.575 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 166' ' ' ARG . . . . . 0.513 ' HA ' ' HB2' ' A' ' 92' ' ' CYS . 10.8 ptp180 -80.02 110.21 15.2 Favored 'General case' 0 N--CA 1.416 -2.161 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 -179.06 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 167' ' ' VAL . . . . . 0.452 HG22 ' H ' ' A' ' 167' ' ' VAL . 5.7 m -69.88 26.31 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.292 -1.897 0 N-CA-C 116.082 1.882 . . . . 0.0 116.082 -171.537 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 168' ' ' ASP . . . . . 0.582 ' HB2' ' HB2' ' A' ' 90' ' ' SER . 31.7 t70 -135.37 69.15 1.44 Allowed 'General case' 0 CA--C 1.497 -1.092 0 N-CA-C 108.064 -1.088 . . . . 0.0 108.064 170.183 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 169' ' ' LYS . . . . . 0.426 ' HB2' ' O ' ' A' ' 168' ' ' ASP . 25.0 ttpp 167.87 145.86 0.02 OUTLIER 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 113.878 -1.51 . . . . 0.0 107.344 179.465 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 170' ' ' PHE . . . . . . . . . . . . . 74.5 t80 . . . . . 0 N--CA 1.412 -2.346 0 N-CA-C 105.37 -2.085 . . . . 0.0 105.37 170.378 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.404 ' HB2' ' HD3' ' A' ' 55' ' ' PRO . 3.4 mm? . . . . . 0 CA--C 1.491 -1.301 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.404 ' HD3' ' HB2' ' A' ' 54' ' ' LEU . 27.3 Cg_endo -60.82 -14.97 35.09 Favored 'Trans proline' 0 N--CA 1.434 -2.017 0 C-N-CA 121.914 1.743 . . . . 0.0 113.129 -170.789 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -76.26 -34.4 59.16 Favored 'General case' 0 CA--C 1.493 -1.228 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 -179.597 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.471 ' HA ' ' HB3' ' A' ' 60' ' ' GLU . 88.1 mt -74.44 -36.52 63.4 Favored 'General case' 0 N--CA 1.42 -1.971 0 CA-C-N 114.946 -1.025 . . . . 0.0 109.48 178.459 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 8.3 mp -62.59 -42.11 99.37 Favored 'General case' 0 CA--C 1.494 -1.187 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -178.088 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.416 ' HD2' ' N ' ' A' ' 60' ' ' GLU . 0.0 OUTLIER -75.39 -28.1 59.32 Favored 'General case' 0 N--CA 1.435 -1.204 0 C-N-CA 118.839 -1.144 . . . . 0.0 110.375 176.228 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.471 ' HB3' ' HA ' ' A' ' 57' ' ' LEU . 7.5 tt0 -60.47 -38.64 84.86 Favored 'General case' 0 C--O 1.25 1.094 0 CA-C-N 114.952 -1.022 . . . . 0.0 113.124 178.835 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 73.8 m-85 -60.43 -42.24 95.64 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.944 0.72 . . . . 0.0 112.944 179.39 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . 0.265 24.8 m-20 -121.64 -82.77 0.65 Allowed 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 115.92 1.822 . . . . 0.0 115.92 -174.416 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.524 ' HB2' HD12 ' A' ' 65' ' ' ILE . 0.0 OUTLIER -114.04 138.72 22.99 Favored Pre-proline 0 C--N 1.318 -0.793 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 -177.747 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 63' ' ' LEU . 32.2 Cg_endo -98.93 27.94 0.15 Allowed 'Trans proline' 0 N--CA 1.431 -2.178 0 C-N-CA 123.858 3.038 . . . . 0.0 111.753 -170.931 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.678 ' O ' ' HA3' ' A' ' 159' ' ' GLY . 0.2 OUTLIER -61.63 -39.59 83.69 Favored 'Isoleucine or valine' 0 CA--C 1.484 -1.592 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 173.787 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 54.83 8.79 1.49 Allowed Glycine 0 CA--C 1.547 2.086 0 CA-C-N 115.263 -0.88 . . . . 0.0 113.737 -177.66 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.483 ' O ' ' HB ' ' A' ' 160' ' ' VAL . 47.8 mt 62.35 -68.15 0.12 Allowed 'Isoleucine or valine' 0 C--O 1.193 -1.904 0 C-N-CA 126.669 1.988 . . . . 0.0 113.812 -177.307 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 89.2 t80 -176.74 -54.19 0.0 OUTLIER Pre-proline 0 C--N 1.307 -1.273 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -173.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -92.05 -2.9 4.08 Favored 'Trans proline' 0 C--N 1.366 1.447 0 C-N-CA 121.74 1.626 . . . . 0.0 113.085 -172.507 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 82.77 -2.64 85.78 Favored Glycine 0 N--CA 1.429 -1.773 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.15 -179.196 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -102.75 -71.06 0.73 Allowed 'General case' 0 CA--C 1.497 -1.083 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 179.297 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.435 ' HB2' HG23 ' A' ' 88' ' ' ILE . . . -49.77 137.78 15.66 Favored 'General case' 0 CA--C 1.509 -0.604 0 CA-C-N 115.037 -0.983 . . . . 0.0 108.812 173.25 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 8.1 t 118.53 4.19 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.167 0 C-N-CA 126.735 2.014 . . . . 0.0 108.475 -169.112 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.516 ' O ' HG13 ' A' ' 86' ' ' VAL . 18.5 m-80 -72.31 -173.13 1.03 Allowed 'General case' 0 CA--C 1.497 -1.081 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 174.667 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.568 ' HB2' HD11 ' A' ' 84' ' ' LEU . 50.5 p90 -170.87 143.46 2.06 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 114.286 1.217 . . . . 0.0 114.286 178.326 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.563 ' HG3' HD12 ' A' ' 87' ' ' LEU . 52.8 mt-10 -133.11 173.34 11.53 Favored 'General case' 0 C--N 1.288 -2.074 0 C-N-CA 127.479 2.312 . . . . 0.0 105.021 174.393 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 47.2 p90 -148.45 149.54 31.89 Favored 'General case' 0 C--N 1.29 -2.017 0 CA-C-N 118.904 0.775 . . . . 0.0 110.544 178.894 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.739 ' OD1' ' HB ' ' A' ' 81' ' ' THR . 5.5 p30 -87.91 158.07 18.79 Favored 'General case' 0 C--N 1.306 -1.301 0 C-N-CA 119.682 -0.807 . . . . 0.0 111.109 174.507 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -82.59 -66.86 0.84 Allowed 'General case' 0 C--N 1.28 -2.454 0 N-CA-C 115.915 1.82 . . . . 0.0 115.915 -170.815 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.434 ' CD ' ' H ' ' A' ' 80' ' ' GLU . 0.0 OUTLIER -69.69 -21.3 63.52 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.832 -173.074 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.739 ' HB ' ' OD1' ' A' ' 78' ' ' ASP . 85.0 m -101.57 -51.01 3.56 Favored 'General case' 0 N--CA 1.408 -2.546 0 CA-C-N 114.973 -1.012 . . . . 0.0 110.52 -178.212 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.561 ' HA ' ' O ' ' A' ' 78' ' ' ASP . 39.6 mtpt 77.39 31.13 0.48 Allowed 'General case' 0 C--O 1.243 0.757 0 C-N-CA 125.959 1.703 . . . . 0.0 112.438 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.492 ' CG ' HG22 ' A' ' 109' ' ' THR . 16.4 tptm -88.8 139.3 30.6 Favored 'General case' 0 N--CA 1.404 -2.767 0 N-CA-C 106.007 -1.849 . . . . 0.0 106.007 175.845 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.634 ' O ' ' HA ' ' A' ' 109' ' ' THR . 16.0 tp -76.07 135.57 39.89 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 -176.587 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.506 HG23 ' HB2' ' A' ' 76' ' ' GLU . 3.0 t -124.86 111.57 15.64 Favored 'General case' 0 C--N 1.272 -2.777 0 CA-C-O 121.927 0.87 . . . . 0.0 109.915 178.073 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.516 HG13 ' O ' ' A' ' 74' ' ' ASN . 86.7 t -92.01 124.65 44.57 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.691 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.675 -177.501 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.656 ' H ' HD13 ' A' ' 87' ' ' LEU . 0.0 OUTLIER -90.48 117.77 29.43 Favored 'General case' 0 N--CA 1.398 -3.064 0 CA-C-N 114.944 -1.026 . . . . 0.0 108.754 176.497 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.644 HG22 ' NH1' ' A' ' 166' ' ' ARG . 48.8 mt -117.82 120.29 32.94 Favored Pre-proline 0 C--N 1.277 -2.576 0 CA-C-N 114.122 -1.399 . . . . 0.0 107.926 -175.629 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.419 ' HD2' ' HA ' ' A' ' 88' ' ' ILE . 18.8 Cg_endo -58.19 91.36 0.06 OUTLIER 'Trans proline' 0 C--N 1.358 1.053 0 C-N-CA 123.794 2.996 . . . . 0.0 113.475 -177.752 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 70.0 m 73.39 -169.92 0.12 Allowed 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.003 0.921 . . . . 0.0 112.205 -179.727 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.548 HG12 ' HA ' ' A' ' 105' ' ' THR . 66.5 mt -102.58 150.04 6.67 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.12 0 CA-C-O 120.722 0.296 . . . . 0.0 110.344 178.677 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 23.5 p -141.4 141.44 33.76 Favored 'General case' 0 CA--C 1.48 -1.734 0 N-CA-C 105.715 -1.957 . . . . 0.0 105.715 168.296 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.531 ' HB3' ' HA ' ' A' ' 103' ' ' LYS . 7.9 pt-20 -150.16 168.19 24.68 Favored 'General case' 0 C--N 1.259 -3.356 0 O-C-N 123.508 0.505 . . . . 0.0 111.022 177.916 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.511 ' O ' ' HA ' ' A' ' 101' ' ' VAL . 5.2 p -137.33 123.9 28.51 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.158 0 C-N-CA 120.587 -0.445 . . . . 0.0 111.34 -172.637 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.433 -1.542 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 177.306 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 20.3 m . . . . . 0 N--CA 1.406 -2.626 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.511 ' HA ' ' O ' ' A' ' 94' ' ' VAL . 7.6 p -113.69 103.13 14.9 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.355 0 CA-C-O 121.889 0.852 . . . . 0.0 110.497 176.853 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.526 ' HG ' HG23 ' A' ' 125' ' ' THR . 4.3 mp -116.92 134.15 55.12 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 114.698 -1.137 . . . . 0.0 109.001 -177.587 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.531 ' HA ' ' HB3' ' A' ' 93' ' ' GLU . 4.4 ttmp? -103.01 111.95 24.55 Favored 'General case' 0 C--N 1.312 -1.046 0 N-CA-C 109.57 -0.529 . . . . 0.0 109.57 175.824 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.45 ' O ' ' HA ' ' A' ' 91' ' ' ILE . 98.3 m-85 -95.34 101.45 13.18 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 176.944 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.548 ' HA ' HG12 ' A' ' 91' ' ' ILE . 14.7 t -87.56 179.7 6.49 Favored 'General case' 0 N--CA 1.443 -0.784 0 O-C-N 123.63 0.581 . . . . 0.0 111.612 -173.732 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' THR . . . . . 0.434 ' HA ' ' O ' ' A' ' 88' ' ' ILE . 37.3 p -67.6 -35.66 79.4 Favored 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 124.051 0.94 . . . . 0.0 113.293 -176.322 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 27.8 p -133.13 110.2 10.01 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-O 120.811 0.339 . . . . 0.0 111.14 178.922 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 61.5 t -109.6 131.38 60.65 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.699 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 176.067 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.634 ' HA ' ' O ' ' A' ' 84' ' ' LEU . 11.5 m -114.15 122.01 45.52 Favored 'General case' 0 N--CA 1.42 -1.962 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 -172.094 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' GLY . . . . . 0.563 ' HA3' ' O ' ' A' ' 119' ' ' ASP . . . -155.16 -158.42 8.74 Favored Glycine 0 N--CA 1.442 -0.904 0 C-N-CA 120.305 -0.95 . . . . 0.0 114.058 -175.654 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 78.7 t60 -120.09 127.17 52.3 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-O 121.337 0.589 . . . . 0.0 110.532 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.539 ' HA ' HD22 ' A' ' 117' ' ' LEU . 1.2 tt -95.35 128.08 41.91 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 115.542 -0.753 . . . . 0.0 109.675 -174.571 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' GLU . . . . . 0.527 ' HB2' ' O ' ' A' ' 116' ' ' LYS . 35.1 mm-40 -131.04 165.31 23.5 Favored 'General case' 0 CA--C 1.495 -1.144 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 171.736 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 57.2 tptt -84.15 101.36 11.78 Favored 'General case' 0 N--CA 1.414 -2.243 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 178.401 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' GLY . . . . . 0.701 ' O ' ' HB ' ' A' ' 138' ' ' THR . . . 120.18 -56.54 0.59 Allowed Glycine 0 N--CA 1.418 -2.51 0 C-N-CA 120.027 -1.082 . . . . 0.0 111.494 179.547 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.527 ' O ' ' HB2' ' A' ' 113' ' ' GLU . 0.0 OUTLIER -126.23 127.51 45.76 Favored 'General case' 0 C--N 1.298 -1.654 0 CA-C-O 121.577 0.704 . . . . 0.0 112.542 -177.663 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.539 HD22 ' HA ' ' A' ' 112' ' ' LEU . 1.8 tm? -100.95 107.54 19.05 Favored 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 106.989 -1.485 . . . . 0.0 106.989 -176.69 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.574 ' HA ' ' HB2' ' A' ' 135' ' ' SER . 12.4 p -110.47 153.63 24.78 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 -178.559 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' ASP . . . . . 0.563 ' O ' ' HA3' ' A' ' 110' ' ' GLY . 20.7 m-20 69.53 115.92 0.04 OUTLIER 'General case' 0 C--O 1.206 -1.224 0 C-N-CA 124.379 1.071 . . . . 0.0 109.828 -174.836 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 8.5 m -140.37 85.38 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.115 0 CA-C-O 122.398 1.094 . . . . 0.0 111.312 179.258 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -79.05 101.95 8.11 Favored 'General case' 0 C--N 1.289 -2.026 0 CA-C-N 114.474 -1.239 . . . . 0.0 107.8 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 139.38 -22.48 2.88 Favored Glycine 0 C--N 1.297 -1.608 0 N-CA-C 110.525 -1.03 . . . . 0.0 110.525 -177.371 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 89.9 mt -100.09 107.71 21.45 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.059 0 CA-C-O 121.918 0.866 . . . . 0.0 109.403 178.837 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 57.5 mttp -107.1 122.9 47.41 Favored 'General case' 0 C--N 1.288 -2.104 0 CA-C-N 114.304 -1.317 . . . . 0.0 108.756 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.526 HG23 ' HG ' ' A' ' 102' ' ' LEU . 72.1 m -130.89 130.04 43.03 Favored 'General case' 0 N--CA 1.431 -1.385 0 O-C-N 123.851 0.72 . . . . 0.0 112.633 -172.298 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.541 ' C ' ' HD3' ' A' ' 126' ' ' LYS . 0.4 OUTLIER -113.48 126.52 55.41 Favored 'General case' 0 N--CA 1.42 -1.962 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 167.996 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.567 HG13 ' SD ' ' A' ' 128' ' ' MET . 2.3 p -135.74 -65.05 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.873 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.517 177.239 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 128' ' ' MET . . . . . 0.567 ' SD ' HG13 ' A' ' 127' ' ' VAL . 0.0 OUTLIER -106.59 -29.76 9.44 Favored 'General case' 0 N--CA 1.399 -3.017 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 177.556 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 42.5 mm -148.92 162.31 5.05 Favored 'Isoleucine or valine' 0 C--O 1.248 1.0 0 N-CA-C 104.315 -2.476 . . . . 0.0 104.315 177.135 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 87.4 t90 -81.47 117.46 21.91 Favored 'General case' 0 N--CA 1.443 -0.786 0 N-CA-C 108.234 -1.025 . . . . 0.0 108.234 175.208 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.575 HG12 ' H ' ' A' ' 133' ' ' VAL . 47.5 t -123.04 141.64 42.62 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.903 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 -177.944 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 64.4 pttt -100.85 21.95 12.84 Favored 'General case' 0 C--N 1.306 -1.306 0 C-N-CA 119.326 -0.949 . . . . 0.0 111.876 -177.552 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.575 ' H ' HG12 ' A' ' 131' ' ' VAL . 61.5 t -133.82 -82.12 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 C-N-CA 120.712 -0.395 . . . . 0.0 110.548 176.768 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 134' ' ' THR . . . . . 0.48 ' O ' ' HB ' ' A' ' 146' ' ' THR . 70.5 p 49.9 76.93 0.12 Allowed 'General case' 0 CA--C 1.536 0.414 0 CA-C-O 121.619 0.724 . . . . 0.0 111.097 -171.184 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 135' ' ' SER . . . . . 0.593 ' O ' ' HA ' ' A' ' 146' ' ' THR . 12.5 p -83.15 153.85 24.59 Favored 'General case' 0 N--CA 1.431 -1.391 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 -176.257 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 136' ' ' ILE . . . . . 0.428 ' HB ' HG22 ' A' ' 146' ' ' THR . 14.5 tt -100.84 128.89 52.53 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.396 0 CA-C-O 121.891 0.853 . . . . 0.0 112.259 -170.617 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 19.8 m -101.3 147.52 26.21 Favored 'General case' 0 N--CA 1.421 -1.894 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 178.081 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' THR . . . . . 0.701 ' HB ' ' O ' ' A' ' 115' ' ' GLY . 98.8 m -155.77 152.31 28.32 Favored 'General case' 0 C--N 1.284 -2.247 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 -178.301 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 73.5 m-20 -87.36 23.07 1.97 Allowed 'General case' 0 N--CA 1.482 1.162 0 O-C-N 121.597 -0.69 . . . . 0.0 109.965 176.949 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . 61.47 35.95 17.39 Favored 'General case' 0 C--N 1.351 0.631 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 -170.842 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 141' ' ' SER . . . . . 0.426 ' HA ' ' HG2' ' A' ' 64' ' ' PRO . 43.3 t -173.87 -79.18 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 113.972 -1.467 . . . . 0.0 109.492 -173.812 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 142' ' ' LYS . . . . . 0.453 ' O ' HG23 ' A' ' 138' ' ' THR . 97.9 mttt -88.0 151.46 22.76 Favored 'General case' 0 CA--C 1.509 -0.631 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 -179.48 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.506 HG22 HG22 ' A' ' 65' ' ' ILE . 24.4 t -105.97 136.78 38.99 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 O-C-N 123.545 0.528 . . . . 0.0 111.442 -167.933 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 144' ' ' TYR . . . . . 0.402 ' HD2' ' HG ' ' A' ' 152' ' ' SER . 87.9 m-85 -124.5 155.56 38.74 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-O 120.833 0.349 . . . . 0.0 111.527 -177.97 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 35.3 p90 -45.93 148.34 0.83 Allowed 'General case' 0 C--O 1.243 0.737 0 N-CA-C 115.346 1.609 . . . . 0.0 115.346 -178.961 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.593 ' HA ' ' O ' ' A' ' 135' ' ' SER . 69.3 p -93.05 -16.02 25.47 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-N 114.915 -1.038 . . . . 0.0 110.973 179.176 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -136.36 149.17 48.23 Favored 'General case' 0 N--CA 1.441 -0.876 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 -177.827 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -83.04 74.71 2.49 Favored Glycine 0 CA--C 1.497 -1.037 0 N-CA-C 111.289 -0.725 . . . . 0.0 111.289 -176.67 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 1.3 tmt? 174.5 -36.27 0.0 OUTLIER 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 105.87 -1.9 . . . . 0.0 105.87 -177.616 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 22.8 ttmm -75.43 168.49 19.9 Favored 'General case' 0 N--CA 1.411 -2.425 0 CA-C-N 112.469 -2.15 . . . . 0.0 109.074 -179.141 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 61.0 mttp -119.92 164.03 16.67 Favored 'General case' 0 C--N 1.31 -1.133 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 -171.738 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 152' ' ' SER . . . . . 0.453 ' HB3' ' O ' ' A' ' 143' ' ' VAL . 35.6 m -85.82 160.86 19.36 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 115.398 -0.819 . . . . 0.0 112.806 -175.69 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 153' ' ' ARG . . . . . 0.51 ' HG2' ' H ' ' A' ' 161' ' ' GLN . 12.0 mpt_? -126.56 164.2 21.73 Favored 'General case' 0 CA--C 1.516 -0.351 0 C-N-CA 123.571 0.748 . . . . 0.0 111.282 -179.883 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 35.0 m -94.38 145.3 24.86 Favored 'General case' 0 C--N 1.296 -1.748 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.784 177.768 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -61.16 -37.46 82.98 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 176.47 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -58.3 -26.16 62.69 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 123.749 0.82 . . . . 0.0 111.656 177.445 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.431 ' HB1' ' HG3' ' A' ' 161' ' ' GLN . . . -79.56 1.21 26.77 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 115.692 -0.685 . . . . 0.0 112.017 -177.608 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 88.7 m-85 93.54 20.94 0.02 OUTLIER 'General case' 0 CA--C 1.493 -1.241 0 C-N-CA 125.888 1.675 . . . . 0.0 111.189 -176.432 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 159' ' ' GLY . . . . . 0.678 ' HA3' ' O ' ' A' ' 65' ' ' ILE . . . 87.04 -86.04 1.54 Allowed Glycine 0 N--CA 1.408 -3.219 0 CA-C-N 114.757 -1.111 . . . . 0.0 113.115 175.645 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.483 ' HB ' ' O ' ' A' ' 67' ' ' ILE . 6.8 t -104.57 116.48 48.44 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.138 0 C-N-CA 119.849 -0.74 . . . . 0.0 109.686 -174.758 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 161' ' ' GLN . . . . . 0.51 ' H ' ' HG2' ' A' ' 153' ' ' ARG . 12.5 mm-40 -116.33 99.87 7.5 Favored 'General case' 0 CA--C 1.486 -1.505 0 N-CA-C 116.521 2.045 . . . . 0.0 116.521 -174.847 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 162' ' ' ARG . . . . . 0.635 ' NE ' ' HA ' ' A' ' 162' ' ' ARG . 1.5 tpm_? -152.66 105.23 2.96 Favored 'General case' 0 N--CA 1.4 -2.933 0 N-CA-C 105.504 -2.035 . . . . 0.0 105.504 170.886 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 19.0 m120 -45.63 104.12 0.04 OUTLIER 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 115.875 1.806 . . . . 0.0 115.875 -172.403 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -151.66 156.21 26.56 Favored Glycine 0 N--CA 1.435 -1.425 0 N-CA-C 108.449 -1.86 . . . . 0.0 108.449 176.18 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -128.19 135.47 49.77 Favored 'General case' 0 N--CA 1.429 -1.508 0 CA-C-N 118.025 0.913 . . . . 0.0 109.929 -179.296 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 166' ' ' ARG . . . . . 0.644 ' NH1' HG22 ' A' ' 88' ' ' ILE . 3.1 mmp_? -65.76 122.44 17.31 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 106.496 -1.668 . . . . 0.0 106.496 179.541 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 25.1 t -74.18 61.99 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.559 1.308 0 CA-C-O 122.615 1.197 . . . . 0.0 109.596 175.256 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -165.83 -33.82 0.03 OUTLIER 'General case' 0 C--N 1.296 -1.735 0 C-N-CA 126.457 1.903 . . . . 0.0 106.742 -177.237 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 16.4 tppt? -76.37 110.47 10.93 Favored 'General case' 0 N--CA 1.434 -1.25 0 CA-C-N 114.349 -1.296 . . . . 0.0 111.932 -177.153 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 170' ' ' PHE . . . . . . . . . . . . . 69.7 t80 . . . . . 0 N--CA 1.432 -1.352 0 N-CA-C 106.456 -1.683 . . . . 0.0 106.456 176.588 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.565 ' HB3' ' HD3' ' A' ' 55' ' ' PRO . 14.0 tp . . . . . 0 N--CA 1.495 1.778 0 N-CA-C 113.373 0.879 . . . . 0.0 113.373 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.565 ' HD3' ' HB3' ' A' ' 54' ' ' LEU . 80.6 Cg_exo -59.22 -19.99 52.69 Favored 'Trans proline' 0 C--N 1.369 1.607 0 C-N-CA 123.086 2.524 . . . . 0.0 111.544 -178.183 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.461 ' HA ' ' HE2' ' A' ' 59' ' ' LYS . 21.3 mm-40 -81.1 -32.03 34.05 Favored 'General case' 0 N--CA 1.413 -2.312 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 -175.614 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.455 ' HA ' ' HG2' ' A' ' 60' ' ' GLU . 3.8 mm? -75.34 -49.23 19.76 Favored 'General case' 0 CA--C 1.483 -1.617 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.695 177.168 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.47 ' HA ' ' CD1' ' A' ' 75' ' ' TYR 0.323 2.5 pp -61.77 -38.95 89.93 Favored 'General case' 0 C--O 1.21 -1.0 0 C-N-CA 119.375 -0.93 . . . . 0.0 113.032 -176.162 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.461 ' HE2' ' HA ' ' A' ' 56' ' ' GLU . 63.7 pttt -75.5 -26.97 58.57 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 120.017 -0.673 . . . . 0.0 111.002 -179.867 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.455 ' HG2' ' HA ' ' A' ' 57' ' ' LEU . 11.2 pt-20 -79.78 -28.48 40.32 Favored 'General case' 0 C--N 1.351 0.65 0 C-N-CA 119.892 -0.723 . . . . 0.0 110.866 -177.896 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 78.5 m-85 -86.33 -1.58 57.64 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 118.799 -1.16 . . . . 0.0 112.269 175.336 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.517 ' HB2' HG23 ' A' ' 73' ' ' THR . 15.4 t70 -93.2 -171.91 2.8 Favored 'General case' 0 C--N 1.306 -1.308 0 C-N-CA 125.709 1.603 . . . . 0.0 108.607 178.079 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.617 ' HB2' HD12 ' A' ' 65' ' ' ILE . 17.0 mt -85.47 -153.84 0.0 OUTLIER Pre-proline 0 CA--C 1.576 1.969 0 N-CA-C 103.488 -2.782 . . . . 0.0 103.488 174.175 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.573 ' O ' ' HD2' ' A' ' 155' ' ' ARG . 17.7 Cg_endo -100.87 8.78 0.58 Allowed 'Trans proline' 0 N--CA 1.436 -1.883 0 CA-C-N 123.998 2.464 . . . . 0.0 111.241 176.125 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.824 HG12 ' H ' ' A' ' 67' ' ' ILE . 0.1 OUTLIER -78.69 -38.21 21.5 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.461 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 -176.641 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.419 ' H ' HD13 ' A' ' 65' ' ' ILE . . . 60.08 9.39 10.93 Favored Glycine 0 N--CA 1.48 1.579 0 CA-C-O 122.517 1.065 . . . . 0.0 110.702 -176.16 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.824 ' H ' HG12 ' A' ' 65' ' ' ILE . 48.7 mt 63.51 -68.73 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.41 -2.442 0 C-N-CA 128.136 2.574 . . . . 0.0 110.349 -172.516 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.425 ' CD2' ' HD3' ' A' ' 162' ' ' ARG . 91.0 t80 -177.53 -55.72 0.0 OUTLIER Pre-proline 0 C--N 1.308 -1.231 0 N-CA-C 113.702 1.001 . . . . 0.0 113.702 -175.83 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.412 ' HB2' ' OD2' ' A' ' 71' ' ' ASP . 10.8 Cg_endo -91.93 -29.31 0.13 Allowed 'Trans proline' 0 C--N 1.361 1.215 0 C-N-CA 121.573 1.516 . . . . 0.0 115.396 -170.083 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 94.22 -16.97 59.82 Favored Glycine 0 N--CA 1.442 -0.943 0 N-CA-C 110.012 -1.235 . . . . 0.0 110.012 -172.009 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.465 ' CB ' ' HG2' ' A' ' 89' ' ' PRO . 30.0 m-20 -78.84 -38.56 37.71 Favored 'General case' 0 CA--C 1.506 -0.726 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 177.617 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.6 ' O ' ' HB ' ' A' ' 73' ' ' THR . . . -78.53 178.61 7.64 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 114.282 -1.326 . . . . 0.0 108.063 170.41 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.6 ' HB ' ' O ' ' A' ' 72' ' ' ALA . 3.0 m 85.25 6.42 0.47 Allowed 'General case' 0 N--CA 1.483 1.182 0 CA-C-O 123.739 1.733 . . . . 0.0 111.534 175.1 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.563 ' O ' ' HA ' ' A' ' 86' ' ' VAL . 4.9 m-20 -64.93 132.97 50.78 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-N 114.079 -1.418 . . . . 0.0 110.307 177.603 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.52 ' HB2' HD21 ' A' ' 84' ' ' LEU . 11.5 p90 -108.94 99.21 8.58 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 113.385 0.883 . . . . 0.0 113.385 -173.487 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 58.9 mm-40 -117.69 133.49 55.89 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 174.913 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 41.2 p90 -144.57 145.24 31.71 Favored 'General case' 0 C--N 1.295 -1.795 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 -179.205 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.612 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 35.3 m-20 -96.02 173.97 7.16 Favored 'General case' 0 CA--C 1.476 -1.87 0 C-N-CA 119.623 -0.831 . . . . 0.0 109.357 178.028 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -79.27 -65.37 1.01 Allowed 'General case' 0 C--N 1.283 -2.319 0 CA-C-N 114.784 -1.098 . . . . 0.0 111.843 -176.902 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.406 ' H ' ' CD ' ' A' ' 80' ' ' GLU . 0.1 OUTLIER -74.91 -29.75 61.07 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.112 -175.451 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.612 ' HB ' ' HB2' ' A' ' 78' ' ' ASP . 17.5 m -65.41 -43.27 91.1 Favored 'General case' 0 N--CA 1.428 -1.526 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.581 179.605 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 46.6 mmtm 61.16 14.49 5.55 Favored 'General case' 0 N--CA 1.495 1.778 0 C-N-CA 123.409 0.684 . . . . 0.0 112.098 -177.931 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.601 ' CD ' HG22 ' A' ' 109' ' ' THR . 31.5 ttmt -116.38 128.4 55.48 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-O 121.247 0.546 . . . . 0.0 110.531 -176.13 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.52 HD21 ' HB2' ' A' ' 75' ' ' TYR . 2.0 tm? -84.65 126.67 33.56 Favored 'General case' 0 C--N 1.296 -1.72 0 CA-C-N 114.388 -1.278 . . . . 0.0 109.163 -173.625 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.528 ' HA ' ' O ' ' A' ' 108' ' ' VAL . 68.1 p -107.06 115.08 29.56 Favored 'General case' 0 N--CA 1.409 -2.483 0 CA-C-N 115.474 -0.785 . . . . 0.0 109.41 178.327 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.563 ' HA ' ' O ' ' A' ' 74' ' ' ASN . 58.6 t -92.57 120.69 42.3 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 179.384 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 5.3 mp -83.34 103.14 12.49 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-O 121.472 0.653 . . . . 0.0 109.467 -179.823 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.514 ' O ' ' HA ' ' A' ' 106' ' ' THR . 46.7 mm -83.34 115.2 58.0 Favored Pre-proline 0 N--CA 1.412 -2.338 0 N-CA-C 104.793 -2.299 . . . . 0.0 104.793 171.915 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.465 ' HG2' ' CB ' ' A' ' 71' ' ' ASP . 1.0 OUTLIER -37.46 -41.18 0.91 Allowed 'Trans proline' 0 N--CA 1.485 1.017 0 C-N-CA 125.146 3.897 . . . . 0.0 115.715 -175.047 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 90' ' ' SER . . . . . 0.512 ' HB2' ' HB2' ' A' ' 168' ' ' ASP . 47.9 t -157.15 166.1 34.17 Favored 'General case' 0 C--N 1.284 -2.268 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.439 HG13 ' HD3' ' A' ' 103' ' ' LYS . 6.0 tt -71.81 119.83 19.0 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.336 0 CA-C-O 121.642 0.734 . . . . 0.0 109.883 179.763 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' CYS . . . . . 0.452 ' SG ' ' HB2' ' A' ' 104' ' ' PHE . 19.0 p -115.97 123.42 47.99 Favored 'General case' 0 C--N 1.29 -1.995 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 174.383 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -103.66 111.33 23.76 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 107.019 -1.475 . . . . 0.0 107.019 175.532 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.615 HG21 ' HA ' ' A' ' 162' ' ' ARG . 5.2 p -108.5 102.65 14.3 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.03 0 C-N-CA 118.812 -1.155 . . . . 0.0 113.925 -178.919 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.431 -1.639 0 N-CA-C 108.102 -1.999 . . . . 0.0 108.102 176.075 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 14.1 m . . . . . 0 N--CA 1.42 -1.958 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 46.3 t -105.62 116.22 48.97 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.085 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 179.154 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.566 ' HG ' ' CG2' ' A' ' 125' ' ' THR . 5.5 mp -114.42 121.16 42.71 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 110.198 -0.297 . . . . 0.0 110.198 -176.54 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.439 ' HD3' HG13 ' A' ' 91' ' ' ILE . 0.4 OUTLIER -111.32 109.12 18.98 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-O 121.571 0.701 . . . . 0.0 110.95 178.677 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.452 ' HB2' ' SG ' ' A' ' 92' ' ' CYS . 94.5 m-85 -91.02 125.33 35.78 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 114.825 -1.079 . . . . 0.0 108.5 179.28 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.479 ' O ' HG13 ' A' ' 108' ' ' VAL . 13.2 m -100.16 147.32 25.82 Favored 'General case' 0 C--N 1.294 -1.817 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.642 -175.155 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 106' ' ' THR . . . . . 0.514 ' HA ' ' O ' ' A' ' 88' ' ' ILE . 14.9 m -56.81 120.82 8.52 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 172.65 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 39.0 m 66.14 78.28 0.27 Allowed 'General case' 0 C--N 1.308 -1.198 0 CA-C-O 122.038 0.923 . . . . 0.0 111.676 -177.461 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.528 ' O ' ' HA ' ' A' ' 85' ' ' THR . 3.7 m -93.45 133.17 35.46 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.161 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.391 175.146 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.601 HG22 ' CD ' ' A' ' 83' ' ' LYS 0.26 7.8 m -105.56 118.0 35.46 Favored 'General case' 0 N--CA 1.406 -2.626 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 -168.239 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 110' ' ' GLY . . . . . 0.552 ' HA3' HG12 ' A' ' 120' ' ' VAL . . . -157.97 167.88 34.38 Favored Glycine 0 CA--C 1.494 -1.27 0 C-N-CA 119.945 -1.122 . . . . 0.0 113.316 -177.73 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 14.2 t-80 -90.91 101.89 14.65 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 179.788 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 68.0 tp -96.73 109.02 21.76 Favored 'General case' 0 CA--C 1.484 -1.577 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.739 -174.762 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -106.15 156.5 18.38 Favored 'General case' 0 CA--C 1.448 -2.96 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 173.037 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 1.6 tmtm? -79.55 100.7 7.89 Favored 'General case' 0 N--CA 1.384 -3.772 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 -176.344 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 138.31 -51.8 0.76 Allowed Glycine 0 C--N 1.296 -1.691 0 N-CA-C 108.419 -1.872 . . . . 0.0 108.419 -174.988 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.564 ' HB2' ' HA ' ' A' ' 137' ' ' SER . 0.0 OUTLIER -140.83 137.28 33.16 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-O 121.43 0.633 . . . . 0.0 112.149 -179.013 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.528 ' O ' ' HB3' ' A' ' 135' ' ' SER . 46.3 tp -102.25 105.8 16.51 Favored 'General case' 0 C--N 1.305 -1.326 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 175.275 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.515 ' HA ' ' HB3' ' A' ' 135' ' ' SER . 27.7 p -120.53 145.93 46.81 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 112.505 0.557 . . . . 0.0 112.505 -173.979 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 119' ' ' ASP . . . . . 0.532 ' O ' ' HA2' ' A' ' 110' ' ' GLY . 34.5 t70 64.4 87.96 0.11 Allowed 'General case' 0 C--O 1.215 -0.715 0 O-C-N 124.117 0.885 . . . . 0.0 110.096 -179.468 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.552 HG12 ' HA3' ' A' ' 110' ' ' GLY . 3.1 m -124.89 104.31 13.48 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.489 0 CA-C-O 122.671 1.224 . . . . 0.0 112.081 -172.779 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -86.41 100.88 12.65 Favored 'General case' 0 C--N 1.26 -3.313 0 CA-C-N 113.292 -1.776 . . . . 0.0 108.401 178.344 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 139.7 -15.5 3.12 Favored Glycine 0 N--CA 1.428 -1.871 0 CA-C-N 115.209 -0.905 . . . . 0.0 112.347 178.729 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 65.3 mt -99.28 102.76 13.83 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.23 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 178.978 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.412 ' HA ' ' HA ' ' A' ' 132' ' ' LYS . 95.3 mttt -106.13 119.26 38.75 Favored 'General case' 0 C--N 1.282 -2.352 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 -176.51 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.566 ' CG2' ' HG ' ' A' ' 102' ' ' LEU . 49.7 m -139.64 148.43 42.43 Favored 'General case' 0 C--N 1.293 -1.878 0 CA-C-N 115.429 -0.805 . . . . 0.0 112.671 -168.917 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.468 ' HA ' ' HA ' ' A' ' 130' ' ' TRP . 40.9 tttp -108.11 122.24 46.49 Favored 'General case' 0 N--CA 1.424 -1.74 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 172.963 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.438 ' CG1' ' HB3' ' A' ' 150' ' ' LYS . 15.9 t -138.56 101.15 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.208 0 N-CA-C 104.142 -2.54 . . . . 0.0 104.142 169.663 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER 73.67 -52.88 0.7 Allowed 'General case' 0 CA--C 1.544 0.729 0 O-C-N 124.305 1.003 . . . . 0.0 108.594 -171.075 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 9.0 tp -137.51 158.65 34.8 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.264 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 176.615 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 130' ' ' TRP . . . . . 0.468 ' HA ' ' HA ' ' A' ' 126' ' ' LYS . 42.6 t-105 -78.2 122.31 25.51 Favored 'General case' 0 C--O 1.241 0.644 0 CA-C-O 121.185 0.517 . . . . 0.0 110.708 -179.135 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 48.5 t -125.06 132.05 71.76 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 177.619 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' LYS . . . . . 0.412 ' HA ' ' HA ' ' A' ' 124' ' ' LYS . 63.1 pttt -88.85 28.6 1.13 Allowed 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 112.268 0.47 . . . . 0.0 112.268 -176.989 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 44.7 t -132.74 -78.09 0.15 Allowed 'Isoleucine or valine' 0 C--O 1.214 -0.812 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 -179.059 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 38.5 p 46.89 80.21 0.05 Allowed 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 113.615 0.968 . . . . 0.0 113.615 -179.499 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 135' ' ' SER . . . . . 0.528 ' HB3' ' O ' ' A' ' 117' ' ' LEU . 28.3 m -84.68 153.61 23.0 Favored 'General case' 0 N--CA 1.424 -1.729 0 CA-C-N 115.898 -0.592 . . . . 0.0 112.036 -177.653 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 67.5 mt -100.67 97.91 6.3 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.231 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 137' ' ' SER . . . . . 0.619 ' O ' ' HB2' ' A' ' 144' ' ' TYR . 29.1 t -119.89 126.86 51.96 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-N 115.914 -0.584 . . . . 0.0 109.569 -174.187 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 9.3 t -162.12 177.58 9.56 Favored 'General case' 0 N--CA 1.424 -1.747 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 -173.871 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -109.9 75.02 0.92 Allowed 'General case' 0 C--N 1.306 -1.324 0 C-N-CA 120.389 -0.524 . . . . 0.0 109.906 176.356 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . 27.43 72.42 0.04 OUTLIER 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 125.603 1.561 . . . . 0.0 113.994 177.303 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 40.2 t 177.68 -63.59 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 -177.864 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -95.09 -169.65 2.03 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 179.31 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 13.2 p -142.66 123.04 10.52 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.347 0 CA-C-O 121.365 0.603 . . . . 0.0 109.894 177.087 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 144' ' ' TYR . . . . . 0.619 ' HB2' ' O ' ' A' ' 137' ' ' SER . 94.0 m-85 -128.97 155.61 45.09 Favored 'General case' 0 CA--C 1.487 -1.473 0 CA-C-O 121.41 0.624 . . . . 0.0 110.574 -179.587 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 145' ' ' PHE . . . . . 0.437 ' HB2' ' HB2' ' A' ' 151' ' ' LYS . 81.7 m-85 -112.72 113.81 26.1 Favored 'General case' 0 N--CA 1.407 -2.579 0 CA-C-N 114.565 -1.198 . . . . 0.0 109.145 176.987 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.464 ' CG2' ' HB2' ' A' ' 135' ' ' SER . 9.1 t -79.82 33.41 0.27 Allowed 'General case' 0 CA--C 1.56 1.337 0 CA-C-O 122.115 0.96 . . . . 0.0 111.404 -174.512 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -75.48 -19.67 59.26 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.349 179.368 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 134.02 50.54 0.08 OUTLIER Glycine 0 CA--C 1.475 -2.428 0 N-CA-C 108.987 -1.645 . . . . 0.0 108.987 179.09 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 66.5 mtt 63.64 12.08 6.25 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.102 0.961 . . . . 0.0 111.787 -177.831 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 150' ' ' LYS . . . . . 0.438 ' HB3' ' CG1' ' A' ' 127' ' ' VAL . 47.7 mmtm -69.16 -29.83 67.94 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 115.375 -0.83 . . . . 0.0 112.564 -176.585 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 151' ' ' LYS . . . . . 0.437 ' HB2' ' HB2' ' A' ' 145' ' ' PHE . 39.9 mmtm -143.88 122.58 12.59 Favored 'General case' 0 CA--C 1.509 -0.629 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 178.557 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 43.8 m -132.46 128.27 37.07 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 106.136 -1.802 . . . . 0.0 106.136 175.232 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 153' ' ' ARG . . . . . 0.464 ' HG2' ' CG ' ' A' ' 161' ' ' GLN . 26.9 tpt180 -146.6 160.41 42.2 Favored 'General case' 0 N--CA 1.429 -1.491 0 C-N-CA 119.084 -1.046 . . . . 0.0 110.942 -172.814 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 13.6 m -90.47 130.25 36.55 Favored 'General case' 0 N--CA 1.419 -1.992 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 174.378 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 155' ' ' ARG . . . . . 0.573 ' HD2' ' O ' ' A' ' 64' ' ' PRO . 8.6 ttp180 -68.29 -24.92 64.92 Favored 'General case' 0 C--N 1.297 -1.678 0 C-N-CA 123.517 0.727 . . . . 0.0 110.455 179.675 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -42.29 -45.71 4.29 Favored 'General case' 0 C--N 1.313 -0.996 0 N-CA-C 115.257 1.577 . . . . 0.0 115.257 -172.106 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -71.55 -52.62 17.25 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 114.438 1.273 . . . . 0.0 114.438 -173.507 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 -141.89 3.8 1.64 Allowed 'General case' 0 N--CA 1.483 1.18 0 N-CA-C 113.029 0.751 . . . . 0.0 113.029 -174.969 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 90.85 -88.49 1.43 Allowed Glycine 0 C--N 1.304 -1.223 0 N-CA-C 108.935 -1.666 . . . . 0.0 108.935 -173.078 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.671 HG12 ' O ' ' A' ' 67' ' ' ILE . 11.5 p -98.64 177.03 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.556 1.193 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 171.712 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 161' ' ' GLN . . . . . 0.509 ' H ' HG22 ' A' ' 160' ' ' VAL . 14.3 mm100 -108.36 99.29 8.71 Favored 'General case' 0 CA--C 1.463 -2.378 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 -175.553 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 162' ' ' ARG . . . . . 0.615 ' HA ' HG21 ' A' ' 94' ' ' VAL . 0.0 OUTLIER -132.1 173.18 11.49 Favored 'General case' 0 N--CA 1.393 -3.287 0 C-N-CA 119.283 -0.967 . . . . 0.0 113.148 -174.722 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 21.9 t-20 -152.76 -48.69 0.1 Allowed 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 106.359 -1.719 . . . . 0.0 106.359 179.55 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -64.0 147.27 50.73 Favored Glycine 0 C--O 1.254 1.373 0 CA-C-N 114.566 -1.197 . . . . 0.0 110.546 170.898 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.514 ' H ' HD23 ' A' ' 165' ' ' LEU . 1.9 pt? -124.65 154.9 40.05 Favored 'General case' 0 C--N 1.291 -1.973 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 -176.874 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 166' ' ' ARG . . . . . 0.523 ' HD2' ' N ' ' A' ' 166' ' ' ARG . 5.2 mpt_? -76.43 114.98 15.74 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 -179.219 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 18.2 m -80.75 54.07 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.286 -2.191 0 CA-C-O 122.479 1.133 . . . . 0.0 112.827 -177.335 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 168' ' ' ASP . . . . . 0.512 ' HB2' ' HB2' ' A' ' 90' ' ' SER . 14.8 t70 -109.94 -39.32 5.1 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 114.069 -1.423 . . . . 0.0 107.766 176.908 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 27.8 ttpp -107.22 8.92 30.23 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 114.012 -1.449 . . . . 0.0 108.749 -177.05 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 170' ' ' PHE . . . . . . . . . . . . . 84.5 t80 . . . . . 0 C--N 1.306 -1.291 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 -178.464 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.55 ' O ' HD13 ' A' ' 58' ' ' LEU . 28.8 mt . . . . . 0 CA--C 1.51 -0.581 0 CA-C-O 119.484 -0.294 . . . . 0.0 110.902 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.415 ' HD3' ' HB2' ' A' ' 54' ' ' LEU . 13.8 Cg_exo -64.9 -31.42 56.76 Favored 'Trans proline' 0 N--CA 1.428 -2.366 0 C-N-CA 120.791 0.994 . . . . 0.0 111.88 -170.509 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -75.86 -32.33 59.68 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.282 178.753 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 63.7 tp -69.33 -34.3 74.42 Favored 'General case' 0 CA--C 1.508 -0.656 0 C-N-CA 120.503 -0.479 . . . . 0.0 110.157 178.634 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.62 ' HA ' ' CD1' ' A' ' 75' ' ' TYR . 6.2 mp -61.7 -41.47 97.65 Favored 'General case' 0 CA--C 1.49 -1.334 0 C-N-CA 120.128 -0.629 . . . . 0.0 112.421 179.669 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.48 ' HD2' ' N ' ' A' ' 60' ' ' GLU . 0.1 OUTLIER -76.86 -26.5 54.32 Favored 'General case' 0 C--N 1.298 -1.658 0 CA-C-O 121.491 0.662 . . . . 0.0 112.722 178.477 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.534 ' C ' ' H ' ' A' ' 62' ' ' ASP . 8.5 tp10 -82.51 -41.53 19.58 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 115.344 -0.843 . . . . 0.0 113.145 -171.08 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 56.2 t80 -68.44 3.85 1.6 Allowed 'General case' 0 N--CA 1.494 1.727 0 CA-C-O 122.095 0.95 . . . . 0.0 110.108 -178.303 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.534 ' H ' ' C ' ' A' ' 60' ' ' GLU . 27.9 t70 -109.02 -153.8 0.52 Allowed 'General case' 0 C--N 1.287 -2.113 0 CA-C-N 113.888 -1.505 . . . . 0.0 109.024 -174.783 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.708 ' HB2' HD12 ' A' ' 65' ' ' ILE . 0.1 OUTLIER -100.54 -167.98 0.15 Allowed Pre-proline 0 CA--C 1.576 1.961 0 N-CA-C 106.187 -1.783 . . . . 0.0 106.187 -177.362 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.477 ' O ' ' HD2' ' A' ' 155' ' ' ARG . 18.2 Cg_endo -100.4 11.49 0.56 Allowed 'Trans proline' 0 C--N 1.368 1.576 0 CA-C-N 122.943 2.087 . . . . 0.0 112.593 -176.292 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.708 HD12 ' HB2' ' A' ' 63' ' ' LEU . 0.2 OUTLIER -73.03 -43.07 59.21 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.959 0 CA-C-N 115.846 -0.616 . . . . 0.0 109.62 179.53 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.432 ' H ' HD13 ' A' ' 65' ' ' ILE . . . 56.94 9.14 3.56 Favored Glycine 0 N--CA 1.484 1.846 0 CA-C-O 121.351 0.417 . . . . 0.0 113.201 -177.582 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.524 ' H ' HG12 ' A' ' 65' ' ' ILE . 52.1 mt 67.39 -67.63 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.421 0 C-N-CA 125.877 1.671 . . . . 0.0 112.04 -175.61 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.478 ' HB2' ' O ' ' A' ' 67' ' ' ILE . 26.0 t80 175.01 -56.16 0.0 OUTLIER Pre-proline 0 C--N 1.318 -0.782 0 CA-C-O 119.68 -0.2 . . . . 0.0 111.281 -178.314 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.463 ' HD3' ' HB3' ' A' ' 68' ' ' PHE . 8.4 Cg_exo -73.51 -35.37 4.84 Favored 'Trans proline' 0 C--N 1.379 2.163 0 C-N-CA 121.934 1.756 . . . . 0.0 113.108 -172.226 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 97.28 -17.55 58.93 Favored Glycine 0 N--CA 1.44 -1.069 0 C-N-CA 120.193 -1.004 . . . . 0.0 111.048 -176.253 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -84.93 -48.11 9.62 Favored 'General case' 0 C--O 1.195 -1.769 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 176.808 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.647 ' O ' ' HB ' ' A' ' 73' ' ' THR . . . -57.7 171.87 0.43 Allowed 'General case' 0 CA--C 1.55 0.981 0 C-N-CA 124.53 1.132 . . . . 0.0 111.675 174.888 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.647 ' HB ' ' O ' ' A' ' 72' ' ' ALA . 8.9 m 94.49 -10.65 0.12 Allowed 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 124.022 0.929 . . . . 0.0 112.035 177.804 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.542 ' HA ' ' HB3' ' A' ' 58' ' ' LEU . 35.5 m-80 -46.4 103.25 0.04 OUTLIER 'General case' 0 CA--C 1.45 -2.879 0 C-N-CA 125.062 1.345 . . . . 0.0 113.657 -179.463 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.62 ' CD1' ' HA ' ' A' ' 58' ' ' LEU . 8.3 p90 -92.81 144.0 25.72 Favored 'General case' 1 C--N 1.241 -4.144 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.493 -176.787 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.629 ' HB2' ' O ' ' A' ' 85' ' ' THR . 10.9 mm-40 -136.2 161.78 34.78 Favored 'General case' 0 C--N 1.278 -2.534 0 N-CA-C 105.872 -1.899 . . . . 0.0 105.872 171.522 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 38.8 p90 -162.95 146.83 11.15 Favored 'General case' 0 C--N 1.293 -1.875 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 177.682 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.709 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 25.5 m-20 -105.17 162.31 13.51 Favored 'General case' 0 CA--C 1.459 -2.529 0 C-N-CA 118.955 -1.098 . . . . 0.0 108.799 176.12 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -81.24 -44.47 17.71 Favored 'General case' 0 C--N 1.262 -3.201 0 CA-C-N 114.161 -1.382 . . . . 0.0 111.094 -179.0 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -69.17 -47.45 64.9 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 178.213 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.709 ' HB ' ' HB2' ' A' ' 78' ' ' ASP . 31.8 m -63.75 -51.74 63.55 Favored 'General case' 0 N--CA 1.418 -2.056 0 CA-C-N 113.93 -1.486 . . . . 0.0 111.951 -178.45 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 99.1 mttt 66.27 18.63 10.96 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-O 121.818 0.818 . . . . 0.0 111.117 -177.042 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.617 ' HB3' HG22 ' A' ' 81' ' ' THR . 35.5 ttmt -111.83 135.88 51.86 Favored 'General case' 0 CA--C 1.491 -1.298 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.205 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.592 ' O ' ' HA ' ' A' ' 109' ' ' THR . 1.5 tm? -76.65 124.71 28.06 Favored 'General case' 0 N--CA 1.421 -1.897 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 -179.757 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.629 ' O ' ' HB2' ' A' ' 76' ' ' GLU . 3.8 t -126.82 109.39 11.95 Favored 'General case' 0 C--N 1.265 -3.097 0 CA-C-N 115.844 -0.617 . . . . 0.0 109.622 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.606 ' O ' ' HA ' ' A' ' 107' ' ' THR . 31.0 m -91.84 151.08 3.61 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.943 0 O-C-N 121.375 -0.828 . . . . 0.0 110.575 -179.483 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.535 ' HA ' ' O ' ' A' ' 106' ' ' THR 0.299 1.5 pp -115.59 103.64 10.93 Favored 'General case' 0 N--CA 1.396 -3.153 0 CA-C-O 122.655 1.217 . . . . 0.0 109.736 174.35 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 40.0 mm -89.82 139.01 27.61 Favored Pre-proline 0 C--N 1.289 -2.044 0 CA-C-N 114.08 -1.418 . . . . 0.0 108.37 -174.293 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -54.14 87.5 0.03 OUTLIER 'Trans proline' 0 C--N 1.354 0.868 0 C-N-CA 123.475 2.783 . . . . 0.0 112.431 173.923 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' SER . . . . . 0.533 ' OG ' ' HB ' ' A' ' 167' ' ' VAL . 22.6 t 66.73 -169.15 0.2 Allowed 'General case' 0 N--CA 1.44 -0.955 0 C-N-CA 124.421 1.088 . . . . 0.0 110.811 178.951 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -93.05 137.36 22.59 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 177.022 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' CYS . . . . . 0.578 ' SG ' ' HG2' ' A' ' 166' ' ' ARG . 33.3 m -129.57 138.61 51.39 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 -176.882 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.621 ' O ' ' HA2' ' A' ' 164' ' ' GLY . 45.6 mt-10 -120.25 135.71 54.9 Favored 'General case' 0 CA--C 1.469 -2.167 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 177.511 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.734 HG13 ' H ' ' A' ' 163' ' ' ASN . 20.3 t -117.91 107.81 22.94 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.482 0 C-N-CA 120.224 -0.59 . . . . 0.0 112.349 -172.215 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.426 -1.988 0 N-CA-C 108.166 -1.974 . . . . 0.0 108.166 169.536 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 67.0 m . . . . . 0 CA--C 1.513 -0.446 0 N-CA-C 105.818 -1.919 . . . . 0.0 105.818 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.42 ' HA ' ' O ' ' A' ' 94' ' ' VAL . 59.9 t -147.59 129.88 7.16 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.919 0 CA-C-N 114.759 -1.11 . . . . 0.0 108.065 177.632 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -126.61 167.37 15.76 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 177.629 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.62 ' HB3' ' HB3' ' A' ' 124' ' ' LYS . 39.0 ttmt -148.54 128.97 13.91 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-O 120.768 0.318 . . . . 0.0 110.462 174.689 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -104.6 123.73 48.08 Favored 'General case' 0 C--N 1.293 -1.87 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 174.31 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.417 HG22 HG22 ' A' ' 108' ' ' VAL . 14.4 t -91.09 168.98 11.24 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 179.464 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 106' ' ' THR . . . . . 0.535 ' O ' ' HA ' ' A' ' 87' ' ' LEU . 46.1 m -64.94 -27.97 69.21 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 112.229 0.455 . . . . 0.0 112.229 -175.96 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.606 ' HA ' ' O ' ' A' ' 86' ' ' VAL . 29.1 m -138.66 108.35 6.25 Favored 'General case' 0 C--N 1.306 -1.314 0 O-C-N 121.687 -0.633 . . . . 0.0 110.74 -179.4 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.493 ' O ' ' HA ' ' A' ' 85' ' ' THR . 34.1 t -108.72 135.97 45.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 N-CA-C 108.631 -0.878 . . . . 0.0 108.631 -179.303 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.592 ' HA ' ' O ' ' A' ' 84' ' ' LEU . 44.5 p -122.43 132.95 54.6 Favored 'General case' 0 N--CA 1.414 -2.237 0 C-N-CA 122.755 0.422 . . . . 0.0 110.785 -173.51 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 110' ' ' GLY . . . . . 0.659 ' HA3' ' O ' ' A' ' 119' ' ' ASP . . . -168.69 -158.26 12.44 Favored Glycine 0 C--N 1.308 -0.985 0 C-N-CA 121.373 -0.442 . . . . 0.0 113.234 -178.748 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 46.2 m80 -110.65 119.57 39.59 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-O 121.0 0.428 . . . . 0.0 110.562 -178.281 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.427 ' HB2' ' HG ' ' A' ' 84' ' ' LEU . 2.5 tm? -89.88 120.78 31.41 Favored 'General case' 0 C--N 1.308 -1.198 0 C-N-CA 123.905 0.882 . . . . 0.0 111.192 -176.264 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -139.56 175.37 9.62 Favored 'General case' 0 CA--C 1.475 -1.928 0 CA-C-N 115.274 -0.876 . . . . 0.0 109.303 170.692 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 1.8 tmtm? -103.81 131.9 50.57 Favored 'General case' 0 N--CA 1.393 -3.287 0 N-CA-C 107.262 -1.385 . . . . 0.0 107.262 -175.494 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 97.13 -25.77 25.58 Favored Glycine 0 C--O 1.189 -2.686 0 N-CA-C 109.862 -1.295 . . . . 0.0 109.862 -176.943 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . 0.341 0.0 OUTLIER -164.12 134.76 4.3 Favored 'General case' 0 C--N 1.291 -1.952 0 N-CA-C 114.316 1.228 . . . . 0.0 114.316 177.928 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -103.49 109.53 21.21 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 104.932 -2.248 . . . . 0.0 104.932 179.053 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 33.5 p -95.99 136.97 35.73 Favored 'General case' 0 C--N 1.284 -2.27 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.221 -176.49 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' ASP . . . . . 0.659 ' O ' ' HA3' ' A' ' 110' ' ' GLY . 15.1 m-20 69.03 107.22 0.05 Allowed 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 124.623 1.169 . . . . 0.0 111.621 178.608 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.405 HG22 ' O ' ' A' ' 134' ' ' THR . 7.6 m -119.66 86.39 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.901 0 CA-C-O 122.168 0.985 . . . . 0.0 111.129 173.082 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -74.25 100.9 3.84 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-N 114.48 -1.236 . . . . 0.0 109.464 -177.19 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 128.66 -7.86 6.53 Favored Glycine 0 C--N 1.299 -1.482 0 C-N-CA 120.017 -1.087 . . . . 0.0 111.736 177.744 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 66.5 mt -99.3 115.85 41.01 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.699 0 CA-C-O 121.869 0.843 . . . . 0.0 109.525 178.547 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.62 ' HB3' ' HB3' ' A' ' 103' ' ' LYS . 86.7 tttt -84.2 128.06 34.33 Favored 'General case' 0 CA--C 1.475 -1.936 0 CA-C-N 114.317 -1.31 . . . . 0.0 107.711 -176.146 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.479 HG21 ' HB1' ' A' ' 147' ' ' ALA . 92.1 m -130.16 127.28 39.39 Favored 'General case' 0 N--CA 1.388 -3.571 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.715 -176.979 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.512 ' HG2' ' N ' ' A' ' 127' ' ' VAL . 85.2 tttt -139.11 143.12 38.13 Favored 'General case' 0 N--CA 1.407 -2.609 0 CA-C-O 121.344 0.592 . . . . 0.0 110.184 167.178 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.514 HG21 ' HG3' ' A' ' 150' ' ' LYS . 7.0 p -158.84 -37.66 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 N-CA-C 106.286 -1.746 . . . . 0.0 106.286 177.02 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -120.28 -52.83 2.15 Favored 'General case' 0 N--CA 1.381 -3.903 0 CA-C-N 112.173 -2.285 . . . . 0.0 106.531 -177.484 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 9.6 tp -153.04 164.43 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.386 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 177.095 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 62.6 t90 -70.81 117.66 12.6 Favored 'General case' 0 C--N 1.317 -0.826 0 C-N-CA 123.339 0.656 . . . . 0.0 111.406 178.151 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.464 HG12 ' H ' ' A' ' 133' ' ' VAL . 21.5 t -138.86 119.44 15.37 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 175.696 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 14.8 ptmm? -102.09 17.53 23.05 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-O 121.316 0.579 . . . . 0.0 110.936 -179.123 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.464 ' H ' HG12 ' A' ' 131' ' ' VAL . 13.7 m -138.33 74.63 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 CA-C-N 114.866 -1.061 . . . . 0.0 110.324 178.612 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 134' ' ' THR . . . . . 0.405 ' O ' HG22 ' A' ' 120' ' ' VAL . 35.2 p -111.49 -165.97 1.04 Allowed 'General case' 0 C--N 1.288 -2.102 0 CA-C-N 115.166 -0.925 . . . . 0.0 110.374 -177.271 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 38.3 m -151.65 167.71 27.28 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 176.623 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 11.7 tt -135.11 136.01 52.0 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.234 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 179.375 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 36.6 p -123.51 168.26 12.82 Favored 'General case' 0 N--CA 1.427 -1.579 0 CA-C-O 121.858 0.837 . . . . 0.0 112.885 -177.056 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 138' ' ' THR . . . . . 0.486 HG23 ' H ' ' A' ' 140' ' ' ALA . 5.0 t -165.7 177.53 7.22 Favored 'General case' 0 N--CA 1.413 -2.312 0 N-CA-C 106.97 -1.492 . . . . 0.0 106.97 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -115.22 32.95 5.72 Favored 'General case' 0 C--N 1.265 -3.101 0 N-CA-C 105.352 -2.092 . . . . 0.0 105.352 175.062 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 140' ' ' ALA . . . . . 0.486 ' H ' HG23 ' A' ' 138' ' ' THR . . . 60.91 42.78 12.51 Favored 'General case' 0 C--N 1.366 1.309 0 CA-C-N 113.759 -1.564 . . . . 0.0 108.97 -172.466 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 47.6 t -173.4 -65.61 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 115.432 -0.803 . . . . 0.0 111.645 -172.735 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 142' ' ' LYS . . . . . 0.462 ' HA ' ' HE2' ' A' ' 142' ' ' LYS . 9.1 mmpt? -82.4 -154.46 0.13 Allowed 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 -179.599 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 14.6 p -155.25 119.3 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.055 0 CA-C-O 121.408 0.623 . . . . 0.0 110.136 170.935 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -114.55 155.99 25.46 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-O 121.964 0.888 . . . . 0.0 112.98 -172.986 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 35.0 p90 -72.78 137.66 45.95 Favored 'General case' 0 N--CA 1.431 -1.388 0 CA-C-N 113.931 -1.486 . . . . 0.0 113.379 178.216 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 25.9 m -157.72 28.73 0.27 Allowed 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 106.451 -1.685 . . . . 0.0 106.451 172.419 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 147' ' ' ALA . . . . . 0.479 ' HB1' HG21 ' A' ' 125' ' ' THR . . . -132.44 92.62 3.11 Favored 'General case' 0 N--CA 1.422 -1.859 0 C-N-CA 119.552 -0.859 . . . . 0.0 113.227 -173.459 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 66.9 32.28 80.56 Favored Glycine 0 CA--C 1.5 -0.852 0 CA-C-N 115.803 -0.635 . . . . 0.0 112.815 175.707 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 49.5 ttm 60.12 80.13 0.21 Allowed 'General case' 0 C--O 1.236 0.386 0 CA-C-O 122.019 0.914 . . . . 0.0 109.689 -177.065 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 150' ' ' LYS . . . . . 0.742 ' HG2' ' H ' ' A' ' 151' ' ' LYS . 35.4 ttmt -120.8 -160.32 0.84 Allowed 'General case' 0 C--N 1.297 -1.698 0 CA-C-N 114.915 -1.039 . . . . 0.0 108.995 -174.181 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 151' ' ' LYS . . . . . 0.742 ' H ' ' HG2' ' A' ' 150' ' ' LYS . 96.4 mttt -121.64 165.12 16.21 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 124.078 0.951 . . . . 0.0 110.016 -178.415 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 22.3 p -83.66 160.11 21.41 Favored 'General case' 0 C--N 1.301 -1.51 0 C-N-CA 123.275 0.63 . . . . 0.0 110.587 177.527 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 4.2 mpt_? -128.18 174.65 9.07 Favored 'General case' 0 CA--C 1.506 -0.736 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 177.272 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 14.7 m -98.9 116.23 30.66 Favored 'General case' 0 N--CA 1.422 -1.862 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 173.961 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 155' ' ' ARG . . . . . 0.635 ' HG2' ' HA2' ' A' ' 159' ' ' GLY . 0.2 OUTLIER -63.15 -22.98 67.22 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.461 0.648 . . . . 0.0 109.598 -179.559 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -46.51 -37.55 8.07 Favored 'General case' 0 C--N 1.318 -0.797 0 C-N-CA 125.346 1.458 . . . . 0.0 114.476 -177.626 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -69.92 -56.63 6.53 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 119.708 -0.797 . . . . 0.0 112.372 -174.982 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 58.5 m-85 -165.1 20.52 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 124.025 0.93 . . . . 0.0 110.08 -178.317 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 159' ' ' GLY . . . . . 0.646 ' HA3' ' O ' ' A' ' 65' ' ' ILE . . . 92.36 -92.79 1.72 Allowed Glycine 0 CA--C 1.47 -2.736 0 C-N-CA 120.016 -1.088 . . . . 0.0 111.195 -174.908 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.522 ' HB ' ' O ' ' A' ' 67' ' ' ILE . 11.5 t -103.42 172.53 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.41 -2.457 0 N-CA-C 106.947 -1.501 . . . . 0.0 106.947 179.102 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 161' ' ' GLN . . . . . 0.423 ' H ' HG12 ' A' ' 160' ' ' VAL . 46.6 mt-30 -123.09 92.9 3.8 Favored 'General case' 0 CA--C 1.483 -1.62 0 CA-C-N 118.973 0.806 . . . . 0.0 109.233 -175.147 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.33 161.83 17.96 Favored 'General case' 0 N--CA 1.401 -2.902 0 C-N-CA 119.012 -1.075 . . . . 0.0 113.251 -176.409 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 163' ' ' ASN . . . . . 0.734 ' H ' HG13 ' A' ' 94' ' ' VAL . 57.7 t30 -129.75 16.56 5.82 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 105.678 -1.971 . . . . 0.0 105.678 172.671 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 164' ' ' GLY . . . . . 0.621 ' HA2' ' O ' ' A' ' 93' ' ' GLU . . . -58.19 123.09 31.98 Favored Glycine 0 CA--C 1.475 -2.449 0 CA-C-N 113.469 -1.696 . . . . 0.0 112.991 -176.149 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.585 ' O ' HD12 ' A' ' 165' ' ' LEU . 3.9 pp -94.16 121.96 36.2 Favored 'General case' 1 N--CA 1.374 -4.25 0 N-CA-C 105.661 -1.977 . . . . 0.0 105.661 -178.349 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 166' ' ' ARG . . . . . 0.578 ' HG2' ' SG ' ' A' ' 92' ' ' CYS . 16.0 mtm180 -84.94 129.09 34.86 Favored 'General case' 0 N--CA 1.391 -3.396 0 N-CA-C 105.886 -1.894 . . . . 0.0 105.886 179.483 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 167' ' ' VAL . . . . . 0.533 ' HB ' ' OG ' ' A' ' 90' ' ' SER . 66.8 t -58.93 -14.98 5.4 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.737 0 CA-C-O 122.104 0.954 . . . . 0.0 110.249 171.679 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 168' ' ' ASP . . . . . 0.466 ' HB2' ' HB2' ' A' ' 90' ' ' SER . 11.1 t70 -76.25 -13.0 60.18 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 125.795 1.638 . . . . 0.0 109.986 173.162 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 169' ' ' LYS . . . . . 0.478 ' HG2' ' N ' ' A' ' 170' ' ' PHE . 56.1 tttm -134.29 176.99 8.1 Favored 'General case' 0 C--N 1.297 -1.699 0 C-N-CA 124.167 0.987 . . . . 0.0 108.497 -174.247 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 170' ' ' PHE . . . . . 0.478 ' N ' ' HG2' ' A' ' 169' ' ' LYS . 79.4 t80 . . . . . 0 C--N 1.295 -1.762 0 N-CA-C 106.656 -1.609 . . . . 0.0 106.656 170.833 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.404 ' HB2' ' HD3' ' A' ' 55' ' ' PRO . 3.4 mm? . . . . . 0 CA--C 1.484 -1.569 0 N-CA-C 113.872 1.064 . . . . 0.0 113.872 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.655 ' O ' ' HG2' ' A' ' 59' ' ' LYS . 19.3 Cg_endo -55.38 -25.74 49.56 Favored 'Trans proline' 0 N--CA 1.429 -2.301 0 C-N-CA 121.94 1.76 . . . . 0.0 113.657 -168.023 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.414 ' HA ' ' CG ' ' A' ' 59' ' ' LYS . 14.0 pt-20 -81.36 -29.51 34.05 Favored 'General case' 0 CA--C 1.479 -1.763 0 CA-C-O 121.093 0.473 . . . . 0.0 110.867 -177.353 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.596 ' O ' ' HB3' ' A' ' 60' ' ' GLU . 93.8 mt -74.29 -31.54 62.54 Favored 'General case' 0 N--CA 1.417 -2.104 0 CA-C-N 115.736 -0.666 . . . . 0.0 109.973 174.867 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.581 ' HB3' ' H ' ' A' ' 75' ' ' TYR . 4.8 mp -69.76 -35.32 74.83 Favored 'General case' 0 CA--C 1.504 -0.82 0 C-N-CA 118.988 -1.085 . . . . 0.0 110.017 177.852 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.655 ' HG2' ' O ' ' A' ' 55' ' ' PRO 0.279 41.5 pttt -75.1 -25.25 58.36 Favored 'General case' 0 N--CA 1.439 -1.011 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 172.405 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.596 ' HB3' ' O ' ' A' ' 57' ' ' LEU . 7.4 tp10 -59.4 -49.13 78.98 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-O 121.247 0.546 . . . . 0.0 109.98 171.098 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 85.6 m-85 -68.93 -4.28 15.98 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-O 121.313 0.578 . . . . 0.0 111.202 176.468 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.624 ' HB3' ' O ' ' A' ' 59' ' ' LYS . 21.1 t70 -84.65 166.52 17.01 Favored 'General case' 0 C--N 1.298 -1.671 0 CA-C-N 115.102 -0.954 . . . . 0.0 111.813 -176.117 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.696 ' HB2' HD12 ' A' ' 65' ' ' ILE . 3.5 mt -85.67 -151.47 0.0 OUTLIER Pre-proline 0 CA--C 1.602 2.95 0 N-CA-C 104.936 -2.246 . . . . 0.0 104.936 178.959 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.647 ' HG3' ' N ' ' A' ' 141' ' ' SER . 71.3 Cg_endo -101.54 5.07 0.57 Allowed 'Trans proline' 0 N--CA 1.449 -1.114 0 CA-C-N 123.531 2.297 . . . . 0.0 112.125 176.188 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.72 HG12 ' H ' ' A' ' 67' ' ' ILE . 0.1 OUTLIER -70.04 -42.06 79.35 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.832 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.534 -177.435 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.436 ' H ' HD13 ' A' ' 65' ' ' ILE . . . 57.79 8.91 4.63 Favored Glycine 0 N--CA 1.5 2.958 0 CA-C-O 122.228 0.904 . . . . 0.0 112.441 -174.922 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.72 ' H ' HG12 ' A' ' 65' ' ' ILE . 61.1 mt 58.13 -72.47 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 C-N-CA 129.191 2.997 . . . . 0.0 113.162 -174.358 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.471 ' HB3' ' HD3' ' A' ' 69' ' ' PRO . 80.0 t80 171.8 -53.26 0.0 OUTLIER Pre-proline 0 N--CA 1.485 1.303 0 N-CA-C 113.497 0.925 . . . . 0.0 113.497 -172.687 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.471 ' HD3' ' HB3' ' A' ' 68' ' ' PHE . 6.9 Cg_exo -74.1 -28.53 10.8 Favored 'Trans proline' 0 C--N 1.366 1.496 0 C-N-CA 121.288 1.325 . . . . 0.0 113.094 -174.1 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 86.84 -12.7 60.99 Favored Glycine 0 C--N 1.31 -0.905 0 N-CA-C 110.309 -1.117 . . . . 0.0 110.309 -174.274 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -93.12 -53.47 4.11 Favored 'General case' 0 CA--C 1.48 -1.739 0 N-CA-C 106.512 -1.662 . . . . 0.0 106.512 178.374 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.652 ' O ' ' HB ' ' A' ' 73' ' ' THR . . . -52.06 173.37 0.03 OUTLIER 'General case' 0 C--N 1.361 1.079 0 CA-C-N 114.671 -1.15 . . . . 0.0 110.549 169.916 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.652 ' HB ' ' O ' ' A' ' 72' ' ' ALA . 10.6 m 87.63 27.13 0.03 OUTLIER 'General case' 0 CA--C 1.558 1.251 0 CA-C-O 125.331 2.491 . . . . 0.0 109.246 -174.814 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.62 ' O ' ' HA ' ' A' ' 86' ' ' VAL . 37.2 m-80 -83.81 75.12 10.12 Favored 'General case' 0 C--N 1.275 -2.67 0 CA-C-N 113.685 -1.598 . . . . 0.0 112.021 177.77 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.581 ' H ' ' HB3' ' A' ' 58' ' ' LEU . 2.9 m-85 -70.89 98.12 1.53 Allowed 'General case' 0 C--N 1.258 -3.375 0 CA-C-N 113.377 -1.738 . . . . 0.0 113.56 -179.073 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -106.43 115.29 29.95 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 105.452 -2.055 . . . . 0.0 105.452 176.672 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.4 ' HB2' HD12 ' A' ' 84' ' ' LEU . 76.2 t80 -131.35 127.59 37.94 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 112.465 0.543 . . . . 0.0 112.465 -172.842 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.62 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 19.6 m-20 -94.22 160.45 14.68 Favored 'General case' 0 CA--C 1.483 -1.607 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 173.248 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 13.5 tp10 -80.14 -63.38 1.42 Allowed 'General case' 0 C--N 1.264 -3.125 0 CA-C-N 114.94 -1.027 . . . . 0.0 112.436 -175.455 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -67.08 -40.05 86.92 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.582 0.706 . . . . 0.0 110.088 -173.638 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.62 ' HB ' ' HB2' ' A' ' 78' ' ' ASP . 62.7 m -62.77 -40.85 98.57 Favored 'General case' 0 C--N 1.289 -2.049 0 CA-C-N 114.679 -1.146 . . . . 0.0 111.648 -179.71 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt 65.0 6.83 3.64 Favored 'General case' 0 N--CA 1.484 1.247 0 N-CA-C 113.308 0.855 . . . . 0.0 113.308 -179.249 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.431 ' HB3' HG22 ' A' ' 81' ' ' THR . 87.0 tttt -116.14 109.64 17.75 Favored 'General case' 0 N--CA 1.399 -2.991 0 CA-C-O 121.54 0.686 . . . . 0.0 109.21 -179.059 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.537 ' O ' ' HA ' ' A' ' 109' ' ' THR . 3.4 tt -82.41 150.03 27.33 Favored 'General case' 0 C--N 1.289 -2.055 0 CA-C-N 114.044 -1.435 . . . . 0.0 110.121 -178.415 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.437 ' HA ' ' O ' ' A' ' 108' ' ' VAL . 7.1 t -126.14 131.27 52.09 Favored 'General case' 0 N--CA 1.405 -2.72 0 N-CA-C 106.667 -1.605 . . . . 0.0 106.667 174.38 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.62 ' HA ' ' O ' ' A' ' 74' ' ' ASN . 9.8 p -107.13 134.26 49.35 Favored 'Isoleucine or valine' 0 N--CA 1.398 -3.03 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 -177.57 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 5.1 mp -86.98 116.65 25.18 Favored 'General case' 0 C--N 1.293 -1.851 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.439 178.033 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 48.7 mm -103.37 126.8 31.16 Favored Pre-proline 0 C--N 1.274 -2.715 0 N-CA-C 106.418 -1.697 . . . . 0.0 106.418 173.993 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.41 ' HG2' ' HG2' ' A' ' 166' ' ' ARG . 1.2 Cg_endo -40.33 -42.54 3.74 Favored 'Trans proline' 0 C--N 1.372 1.784 0 C-N-CA 124.44 3.426 . . . . 0.0 113.739 -178.432 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 66.5 m -161.79 161.73 29.24 Favored 'General case' 0 CA--C 1.482 -1.664 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 176.895 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.457 ' HA ' ' O ' ' A' ' 104' ' ' PHE . 0.0 OUTLIER -71.15 108.91 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.148 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 174.683 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 92' ' ' CYS . . . . . 0.494 ' SG ' ' HB2' ' A' ' 104' ' ' PHE . 14.2 p -97.42 124.0 41.46 Favored 'General case' 0 N--CA 1.425 -1.689 0 N-CA-C 108.442 -0.948 . . . . 0.0 108.442 175.642 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -116.47 123.7 48.13 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 177.963 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.642 ' O ' ' HA ' ' A' ' 101' ' ' VAL . 33.5 m -113.62 130.61 67.37 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.348 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 -179.759 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.511 ' HA2' ' O ' ' A' ' 100' ' ' SER . . . . . . . . 0 C--N 1.3 -1.466 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.232 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' SER . . . . . 0.511 ' O ' ' HA2' ' A' ' 95' ' ' GLY . 18.2 m . . . . . 0 N--CA 1.411 -2.378 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.642 ' HA ' ' O ' ' A' ' 94' ' ' VAL . 93.8 t -127.11 117.74 48.31 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.19 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 173.891 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.504 HD12 ' C ' ' A' ' 101' ' ' VAL . 5.6 mp -134.47 142.32 47.04 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 -178.986 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 39.6 ttmt -133.5 121.04 21.6 Favored 'General case' 0 C--N 1.291 -1.968 0 CA-C-O 121.002 0.43 . . . . 0.0 110.249 179.175 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.494 ' HB2' ' SG ' ' A' ' 92' ' ' CYS . 94.1 m-85 -101.25 109.24 21.07 Favored 'General case' 0 C--N 1.291 -1.965 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 174.804 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 43.9 m -72.58 151.96 42.08 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.484 -177.147 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 17.1 p -50.28 -42.87 52.97 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 124.134 0.974 . . . . 0.0 112.375 -179.367 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 41.4 p -127.42 93.76 3.81 Favored 'General case' 0 N--CA 1.424 -1.768 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.344 178.324 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.551 HG11 HG13 ' A' ' 123' ' ' ILE . 45.7 t -87.33 144.09 9.98 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.115 0 N-CA-C 106.372 -1.714 . . . . 0.0 106.372 175.479 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.537 ' HA ' ' O ' ' A' ' 84' ' ' LEU . 10.1 t -144.45 134.45 23.98 Favored 'General case' 0 N--CA 1.399 -2.998 0 CA-C-N 118.614 0.643 . . . . 0.0 110.891 -176.205 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -167.22 -166.97 27.2 Favored Glycine 0 N--CA 1.434 -1.491 0 N-CA-C 111.353 -0.699 . . . . 0.0 111.353 179.652 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 45.8 m80 -83.98 143.32 29.88 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 117.696 0.748 . . . . 0.0 110.741 -177.956 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.568 ' HA ' HD22 ' A' ' 117' ' ' LEU . 0.5 OUTLIER -103.42 118.19 36.2 Favored 'General case' 0 N--CA 1.434 -1.23 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 -174.524 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -132.75 140.23 47.96 Favored 'General case' 0 CA--C 1.461 -2.469 0 O-C-N 123.897 0.748 . . . . 0.0 109.038 167.987 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 2.5 tmtm? -78.31 100.4 6.71 Favored 'General case' 0 C--N 1.268 -2.964 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 -174.723 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' GLY . . . . . 0.584 ' H ' HD22 ' A' ' 63' ' ' LEU . . . 135.02 -63.3 0.6 Allowed Glycine 0 N--CA 1.433 -1.559 0 N-CA-C 108.201 -1.96 . . . . 0.0 108.201 -175.071 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.547 ' H ' ' HD3' ' A' ' 116' ' ' LYS . 0.1 OUTLIER -122.08 130.0 52.88 Favored 'General case' 0 C--N 1.291 -1.945 0 O-C-N 121.848 -0.795 . . . . 0.0 110.492 179.407 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.568 HD22 ' HA ' ' A' ' 112' ' ' LEU . 0.3 OUTLIER -108.19 105.34 15.02 Favored 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 105.165 -2.161 . . . . 0.0 105.165 -179.502 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 48.1 p -106.05 166.75 10.28 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 113.103 0.779 . . . . 0.0 113.103 -172.748 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 28.0 m-20 64.43 40.53 6.27 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.976 0.91 . . . . 0.0 109.75 175.109 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.479 ' CG1' HD12 ' A' ' 117' ' ' LEU . 15.6 m -83.83 83.07 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.415 -2.197 0 CA-C-O 122.216 1.007 . . . . 0.0 112.117 -172.595 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -68.63 96.39 0.71 Allowed 'General case' 0 N--CA 1.406 -2.64 0 CA-C-N 113.742 -1.572 . . . . 0.0 109.004 176.054 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 147.53 -15.11 1.43 Allowed Glycine 0 C--N 1.292 -1.87 0 C-N-CA 120.28 -0.962 . . . . 0.0 112.059 177.753 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.551 HG13 HG11 ' A' ' 108' ' ' VAL . 93.2 mt -100.17 99.52 8.64 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.833 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 176.636 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.489 ' HA ' ' O ' ' A' ' 131' ' ' VAL . 47.9 mtpt -107.23 148.63 28.69 Favored 'General case' 0 N--CA 1.419 -1.99 0 CA-C-N 113.999 -1.455 . . . . 0.0 109.666 -173.145 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.458 HG22 HG21 ' A' ' 134' ' ' THR . 13.3 t -154.76 157.62 38.27 Favored 'General case' 0 C--N 1.285 -2.23 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 176.236 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.61 ' HD3' ' N ' ' A' ' 127' ' ' VAL . 0.5 OUTLIER -128.8 138.02 51.84 Favored 'General case' 0 N--CA 1.385 -3.713 0 N-CA-C 106.686 -1.598 . . . . 0.0 106.686 172.184 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.61 ' N ' ' HD3' ' A' ' 126' ' ' LYS . 7.4 p -160.21 -38.04 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.289 -2.054 0 N-CA-C 105.766 -1.939 . . . . 0.0 105.766 177.327 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 13.8 tpt -115.74 -50.62 2.69 Favored 'General case' 0 N--CA 1.39 -3.434 0 CA-C-N 112.605 -2.089 . . . . 0.0 108.129 177.711 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 8.7 tp -162.25 172.71 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 N-CA-C 105.511 -2.033 . . . . 0.0 105.511 174.815 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 14.3 m-90 -71.66 117.38 13.17 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 118.834 0.743 . . . . 0.0 110.344 177.929 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.489 ' O ' ' HA ' ' A' ' 124' ' ' LYS . 45.9 t -122.84 133.01 70.21 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.661 0 N-CA-C 106.559 -1.645 . . . . 0.0 106.559 174.691 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 62.8 pttt -108.61 5.24 24.81 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 -173.293 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 35.8 m -126.05 14.94 4.02 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 N-CA-C 112.439 0.533 . . . . 0.0 112.439 -177.538 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 134' ' ' THR . . . . . 0.458 HG21 HG22 ' A' ' 125' ' ' THR . 38.4 p -51.58 102.13 0.04 OUTLIER 'General case' 0 C--N 1.347 0.458 0 CA-C-O 121.502 0.668 . . . . 0.0 112.059 179.682 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 38.5 m -86.54 152.44 22.63 Favored 'General case' 0 N--CA 1.418 -2.038 0 CA-C-N 115.073 -0.967 . . . . 0.0 111.669 -174.747 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 11.5 tt -110.27 132.32 58.93 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.513 0 CA-C-N 114.973 -1.012 . . . . 0.0 109.558 -179.256 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 137' ' ' SER . . . . . 0.416 ' HB2' ' OG1' ' A' ' 146' ' ' THR . 26.0 t -122.13 116.95 25.12 Favored 'General case' 0 N--CA 1.426 -1.657 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 -179.812 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 138' ' ' THR . . . . . 0.457 HG21 HG23 ' A' ' 65' ' ' ILE . 3.0 t -136.35 114.62 11.62 Favored 'General case' 0 C--N 1.277 -2.57 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 178.393 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -78.33 73.06 4.89 Favored 'General case' 0 C--N 1.305 -1.369 0 C-N-CA 119.16 -1.016 . . . . 0.0 111.586 -174.827 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . 49.86 32.23 5.28 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 125.482 1.513 . . . . 0.0 112.039 178.479 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 141' ' ' SER . . . . . 0.647 ' N ' ' HG3' ' A' ' 64' ' ' PRO . 22.9 t -176.96 -76.73 0.01 OUTLIER 'General case' 0 C--O 1.215 -0.727 0 CA-C-O 120.886 0.374 . . . . 0.0 111.102 -175.902 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 142' ' ' LYS . . . . . 0.433 ' O ' ' HA ' ' A' ' 138' ' ' THR . 93.3 mttt -98.48 150.47 21.63 Favored 'General case' 0 C--N 1.306 -1.291 0 O-C-N 122.287 -0.258 . . . . 0.0 110.443 -172.95 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.685 ' HB ' ' O ' ' A' ' 153' ' ' ARG . 47.9 t -106.16 136.06 42.08 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 CA-C-O 121.143 0.497 . . . . 0.0 111.697 -172.772 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 144' ' ' TYR . . . . . 0.43 ' HA ' ' OG ' ' A' ' 152' ' ' SER . 75.5 m-85 -135.71 143.29 45.3 Favored 'General case' 0 C--O 1.25 1.11 0 C-N-CA 123.894 0.878 . . . . 0.0 109.244 179.488 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 55.5 p90 -64.14 141.28 58.83 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-O 121.423 0.63 . . . . 0.0 112.564 178.575 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.416 ' OG1' ' HB2' ' A' ' 137' ' ' SER . 91.4 m -108.63 -28.77 9.09 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 167.56 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 147' ' ' ALA . . . . . 0.563 ' HB3' ' HB3' ' A' ' 150' ' ' LYS . . . -60.33 129.46 41.76 Favored 'General case' 0 N--CA 1.441 -0.925 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 172.445 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -84.22 -15.61 68.91 Favored Glycine 0 CA--C 1.48 -2.097 0 C-N-CA 119.956 -1.116 . . . . 0.0 112.584 -169.616 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 58.5 mtt -101.45 2.13 39.01 Favored 'General case' 0 C--N 1.291 -1.974 0 CA-C-O 121.453 0.644 . . . . 0.0 110.021 -176.872 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 150' ' ' LYS . . . . . 0.563 ' HB3' ' HB3' ' A' ' 147' ' ' ALA . 17.3 tppt? -121.28 -178.03 3.67 Favored 'General case' 0 CA--C 1.561 1.374 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 -174.398 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 151' ' ' LYS . . . . . 0.516 ' H ' ' HG3' ' A' ' 150' ' ' LYS . 75.0 mmtt -137.32 164.52 28.39 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 123.491 0.716 . . . . 0.0 109.071 -172.562 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 152' ' ' SER . . . . . 0.457 ' C ' ' HD2' ' A' ' 153' ' ' ARG . 42.5 m -76.04 153.6 36.31 Favored 'General case' 0 C--N 1.306 -1.326 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 -174.758 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 153' ' ' ARG . . . . . 0.685 ' O ' ' HB ' ' A' ' 143' ' ' VAL . 3.1 mpt_? -126.18 149.98 48.63 Favored 'General case' 0 CA--C 1.494 -1.177 0 N-CA-C 106.18 -1.785 . . . . 0.0 106.18 173.635 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 41.4 m -93.63 142.22 27.59 Favored 'General case' 0 C--N 1.281 -2.382 0 C-N-CA 120.497 -0.481 . . . . 0.0 110.625 -178.352 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 19.1 ttp180 -58.5 -30.38 66.99 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-O 120.66 0.267 . . . . 0.0 111.184 178.541 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -53.44 -21.03 5.37 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 124.058 0.943 . . . . 0.0 112.71 179.531 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -64.96 -53.63 43.3 Favored 'General case' 0 N--CA 1.432 -1.332 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 178.605 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 0.404 ' H ' ' H ' ' A' ' 159' ' ' GLY . 10.7 t80 170.72 23.57 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 106.744 -1.576 . . . . 0.0 106.744 177.49 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 159' ' ' GLY . . . . . 0.404 ' H ' ' H ' ' A' ' 158' ' ' TYR . . . 95.89 -92.52 1.44 Allowed Glycine 0 N--CA 1.416 -2.689 0 C-N-CA 119.082 -1.532 . . . . 0.0 109.376 -170.159 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.536 HG23 ' HB ' ' A' ' 65' ' ' ILE . 2.4 t -130.26 114.5 29.18 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.758 0 N-CA-C 106.333 -1.728 . . . . 0.0 106.333 176.289 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 5.3 pp0? -134.51 130.66 36.96 Favored 'General case' 0 N--CA 1.414 -2.25 0 C-N-CA 117.194 -1.802 . . . . 0.0 115.338 -172.46 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 162' ' ' ARG . . . . . 0.428 ' HG2' HG21 ' A' ' 94' ' ' VAL . 19.8 tpt180 -152.81 138.68 18.02 Favored 'General case' 0 C--N 1.27 -2.875 0 N-CA-C 104.694 -2.335 . . . . 0.0 104.694 168.102 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -69.81 95.27 0.89 Allowed 'General case' 0 CA--C 1.505 -0.768 0 CA-C-O 121.621 0.724 . . . . 0.0 112.777 -175.579 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -145.6 159.27 27.89 Favored Glycine 0 N--CA 1.423 -2.17 0 N-CA-C 109.2 -1.56 . . . . 0.0 109.2 176.572 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.426 ' H ' HD23 ' A' ' 165' ' ' LEU . 2.0 pt? -130.77 143.74 50.95 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-O 120.992 0.425 . . . . 0.0 110.451 -178.075 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 166' ' ' ARG . . . . . 0.507 ' HD2' ' N ' ' A' ' 166' ' ' ARG . 4.2 mpt_? -96.85 106.34 18.63 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 178.897 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 43.3 t -37.52 -46.26 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.562 1.44 0 N-CA-C 115.674 1.731 . . . . 0.0 115.674 -172.054 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -60.45 -35.55 76.11 Favored 'General case' 0 N--CA 1.486 1.326 0 CA-C-O 121.178 0.513 . . . . 0.0 111.729 -178.534 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 31.5 tttm -96.22 -81.17 0.42 Allowed 'General case' 0 C--N 1.3 -1.572 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.678 -179.756 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 170' ' ' PHE . . . . . 0.421 ' OXT' ' HB2' ' A' ' 165' ' ' LEU . 68.6 t80 . . . . . 0 N--CA 1.432 -1.35 0 N-CA-C 101.802 -3.407 . . . . 0.0 101.802 -175.545 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.433 ' HB2' ' HD3' ' A' ' 55' ' ' PRO . 33.0 mt . . . . . 0 CA--C 1.505 -0.754 0 N-CA-C 112.793 0.664 . . . . 0.0 112.793 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.512 ' O ' ' HG2' ' A' ' 59' ' ' LYS . 7.5 Cg_exo -69.65 -14.34 36.29 Favored 'Trans proline' 0 N--CA 1.427 -2.432 0 C-N-CA 121.61 1.54 . . . . 0.0 112.282 -169.356 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -71.52 -39.88 70.48 Favored 'General case' 0 CA--C 1.49 -1.359 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 -174.069 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.451 ' HA ' ' HB3' ' A' ' 60' ' ' GLU . 10.4 mp -68.62 -30.48 69.22 Favored 'General case' 0 N--CA 1.44 -0.925 0 CA-C-N 114.808 -1.087 . . . . 0.0 111.988 178.932 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 6.2 mp -64.5 -48.82 73.74 Favored 'General case' 0 CA--C 1.495 -1.153 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 179.897 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.512 ' HG2' ' O ' ' A' ' 55' ' ' PRO . 32.3 pttt -75.19 -26.84 59.33 Favored 'General case' 0 C--N 1.299 -1.59 0 CA-C-N 115.143 -0.935 . . . . 0.0 112.986 177.399 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.451 ' HB3' ' HA ' ' A' ' 57' ' ' LEU . 8.3 tp10 -59.82 -51.81 68.15 Favored 'General case' 0 C--N 1.306 -1.313 0 C-N-CA 123.927 0.891 . . . . 0.0 111.221 175.018 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 63.4 t80 -68.59 -10.26 54.78 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.6 -176.519 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.589 ' OD2' HG23 ' A' ' 73' ' ' THR . 22.4 t0 -94.71 -179.37 4.84 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.473 -178.495 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.738 ' HB2' HD12 ' A' ' 65' ' ' ILE . 2.5 mt -76.36 169.03 22.9 Favored Pre-proline 0 CA--C 1.559 1.299 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 -178.986 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.463 ' HB2' ' HG3' ' A' ' 155' ' ' ARG . 10.9 Cg_endo -91.97 25.7 0.46 Allowed 'Trans proline' 0 N--CA 1.441 -1.576 0 C-N-CA 122.596 2.197 . . . . 0.0 110.853 -176.725 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.738 HD12 ' HB2' ' A' ' 63' ' ' LEU . 0.2 OUTLIER -73.89 -29.09 25.12 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.432 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 176.915 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 53.11 1.66 0.07 OUTLIER Glycine 0 CA--C 1.544 1.887 0 CA-C-N 114.972 -1.013 . . . . 0.0 115.133 178.086 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.683 ' O ' ' HB ' ' A' ' 160' ' ' VAL . 48.6 mt 67.08 -42.35 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.189 0 C-N-CA 126.441 1.896 . . . . 0.0 114.099 -179.575 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.514 ' HB2' ' O ' ' A' ' 67' ' ' ILE . 71.3 t80 158.0 -51.37 0.0 OUTLIER Pre-proline 0 N--CA 1.489 1.494 0 C-N-CA 125.354 1.462 . . . . 0.0 110.498 177.729 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.464 ' HB2' ' OD2' ' A' ' 71' ' ' ASP . 9.5 Cg_endo -95.82 -24.82 0.12 Allowed 'Trans proline' 0 C--N 1.374 1.878 0 C-N-CA 121.87 1.713 . . . . 0.0 115.052 -172.479 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 82.48 -7.89 63.44 Favored Glycine 0 CA--C 1.526 0.738 0 C-N-CA 120.454 -0.879 . . . . 0.0 111.629 -174.707 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.464 ' OD2' ' HB2' ' A' ' 69' ' ' PRO . 23.2 m-20 -86.16 -30.99 22.05 Favored 'General case' 0 CA--C 1.495 -1.148 0 N-CA-C 106.26 -1.755 . . . . 0.0 106.26 178.062 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.527 ' O ' ' HB ' ' A' ' 73' ' ' THR . . . -82.62 -172.26 3.95 Favored 'General case' 0 N--CA 1.442 -0.825 0 CA-C-N 113.556 -1.657 . . . . 0.0 107.103 171.81 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.589 HG23 ' OD2' ' A' ' 62' ' ' ASP . 60.7 m 79.94 27.35 0.32 Allowed 'General case' 0 N--CA 1.474 0.742 0 CA-C-O 124.807 2.241 . . . . 0.0 109.483 175.015 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 35.8 m-80 -84.48 -177.3 6.58 Favored 'General case' 0 N--CA 1.386 -3.641 0 CA-C-N 113.759 -1.564 . . . . 0.0 110.479 178.786 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 42.6 t80 -149.21 94.9 2.3 Favored 'General case' 0 C--N 1.276 -2.628 0 C-N-CA 119.352 -0.939 . . . . 0.0 110.935 -169.784 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.665 ' OE1' ' HG ' ' A' ' 87' ' ' LEU . 4.2 mp0 -107.26 96.09 6.17 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 176.777 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.431 ' HB2' HD23 ' A' ' 84' ' ' LEU . 81.9 t80 -102.73 124.31 48.03 Favored 'General case' 0 C--N 1.297 -1.704 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.255 -176.264 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.724 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 10.4 m-20 -93.9 155.77 16.99 Favored 'General case' 0 CA--C 1.47 -2.1 0 C-N-CA 118.819 -1.152 . . . . 0.0 108.712 175.017 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -80.43 -53.35 6.68 Favored 'General case' 0 C--N 1.25 -3.756 0 CA-C-N 113.412 -1.722 . . . . 0.0 109.026 179.323 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -66.77 -21.33 66.06 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 113.726 -1.579 . . . . 0.0 110.754 -176.498 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.724 ' HB ' ' HB2' ' A' ' 78' ' ' ASP . 27.2 m -101.63 -53.01 3.07 Favored 'General case' 0 N--CA 1.41 -2.455 0 CA-C-N 115.0 -1.0 . . . . 0.0 111.192 -174.612 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 99.7 mttt 70.26 4.15 4.74 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 123.85 0.86 . . . . 0.0 111.995 -174.616 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.719 ' HG2' HG22 ' A' ' 109' ' ' THR . 36.2 ttmt -104.91 107.41 18.36 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 176.655 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.431 HD23 ' HB2' ' A' ' 77' ' ' PHE . 3.1 tm? -68.01 133.73 49.52 Favored 'General case' 0 C--N 1.292 -1.929 0 CA-C-N 113.833 -1.53 . . . . 0.0 110.447 -175.56 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.503 HG23 ' HB2' ' A' ' 76' ' ' GLU . 8.9 t -120.85 137.79 54.38 Favored 'General case' 0 N--CA 1.403 -2.812 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 177.422 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 61.0 t -111.32 118.62 57.88 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 C-N-CA 123.811 0.844 . . . . 0.0 109.44 -179.205 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.665 ' HG ' ' OE1' ' A' ' 76' ' ' GLU 0.293 0.5 OUTLIER -79.44 124.41 28.43 Favored 'General case' 0 N--CA 1.403 -2.82 0 CA-C-O 122.578 1.18 . . . . 0.0 112.37 172.879 . . . . . . . . 4 4 . 1 . 014 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.437 HG23 ' HE ' ' A' ' 166' ' ' ARG . 50.4 mm -102.36 125.8 35.18 Favored Pre-proline 0 C--N 1.279 -2.482 0 CA-C-N 113.711 -1.586 . . . . 0.0 107.805 178.638 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -59.61 96.93 0.1 Allowed 'Trans proline' 0 C--O 1.248 1.018 0 C-N-CA 122.62 2.214 . . . . 0.0 111.516 175.476 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' SER . . . . . 0.485 ' OG ' ' HB2' ' A' ' 168' ' ' ASP . 68.4 m 65.21 176.74 0.2 Allowed 'General case' 0 C--O 1.236 0.356 0 C-N-CA 124.483 1.113 . . . . 0.0 112.844 -178.711 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.457 HG12 ' HA ' ' A' ' 105' ' ' THR . 39.7 mt -88.5 131.15 36.7 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.623 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.793 178.705 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' CYS . . . . . 0.461 ' SG ' ' HA3' ' A' ' 164' ' ' GLY . 16.0 t -116.16 122.71 45.87 Favored 'General case' 0 N--CA 1.41 -2.452 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 173.764 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -116.96 127.29 54.06 Favored 'General case' 0 C--N 1.29 -2.017 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 178.628 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 3.9 p -105.14 103.94 16.14 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.27 0 CA-C-O 122.024 0.916 . . . . 0.0 109.578 177.898 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.423 -2.229 0 N-CA-C 108.226 -1.95 . . . . 0.0 108.226 179.111 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 35.0 m . . . . . 0 N--CA 1.423 -1.789 0 CA-C-O 121.322 0.582 . . . . 0.0 109.645 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.459 ' C ' HD12 ' A' ' 102' ' ' LEU . 60.8 t -113.0 128.86 69.52 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.201 0 N-CA-C 108.142 -1.058 . . . . 0.0 108.142 176.374 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.464 ' HA ' ' O ' ' A' ' 124' ' ' LYS . 5.3 mp -129.9 136.2 49.23 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-O 120.746 0.308 . . . . 0.0 110.796 -178.949 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -112.43 110.09 20.08 Favored 'General case' 0 C--N 1.31 -1.146 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 177.132 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -89.82 103.5 16.15 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 176.862 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.457 ' HA ' HG12 ' A' ' 91' ' ' ILE . 35.1 m -82.41 157.81 23.54 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.967 -175.099 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 20.3 p -55.84 -38.13 69.64 Favored 'General case' 0 C--N 1.319 -0.725 0 C-N-CA 125.898 1.679 . . . . 0.0 113.037 -177.406 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 14.0 m -128.13 98.73 5.21 Favored 'General case' 0 N--CA 1.419 -1.983 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 -179.412 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 16.9 m -108.4 133.69 52.59 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 179.108 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.719 HG22 ' HG2' ' A' ' 83' ' ' LYS . 37.0 m -130.35 132.53 45.87 Favored 'General case' 0 N--CA 1.394 -3.268 0 CA-C-N 116.767 -0.197 . . . . 0.0 110.813 -164.338 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 110' ' ' GLY . . . . . 0.637 ' HA3' ' O ' ' A' ' 119' ' ' ASP . . . -161.98 -158.25 9.41 Favored Glycine 0 C--O 1.217 -0.916 0 C-N-CA 121.288 -0.482 . . . . 0.0 112.635 -177.274 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 53.3 m80 -117.56 108.06 15.02 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 122.165 -0.609 . . . . 0.0 109.606 176.038 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 5.9 tt -104.4 127.82 52.14 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.73 -172.071 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -131.59 168.1 18.27 Favored 'General case' 0 CA--C 1.464 -2.355 0 CA-C-N 115.243 -0.889 . . . . 0.0 109.71 173.783 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 54.2 tptt -84.35 101.11 11.71 Favored 'General case' 0 N--CA 1.389 -3.522 0 CA-C-N 115.179 -0.918 . . . . 0.0 108.809 -177.017 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' GLY . . . . . 0.479 ' H ' ' CD2' ' A' ' 63' ' ' LEU . . . 126.24 -11.68 7.22 Favored Glycine 0 C--O 1.205 -1.697 0 CA-C-N 115.159 -0.928 . . . . 0.0 111.164 -176.868 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 179.53 147.89 0.24 Allowed 'General case' 0 N--CA 1.487 1.393 0 CA-C-N 117.052 0.426 . . . . 0.0 111.219 178.295 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.6 tt -124.11 113.67 18.68 Favored 'General case' 0 N--CA 1.429 -1.497 0 N-CA-C 106.013 -1.847 . . . . 0.0 106.013 176.961 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 71.8 p -97.58 122.58 40.82 Favored 'General case' 0 C--N 1.265 -3.071 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.609 -177.829 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' ASP . . . . . 0.637 ' O ' ' HA3' ' A' ' 110' ' ' GLY . 31.3 m-20 73.13 129.76 0.04 OUTLIER 'General case' 0 C--O 1.207 -1.146 0 C-N-CA 125.484 1.514 . . . . 0.0 111.651 -179.155 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 10.8 m -135.5 78.75 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 CA-C-O 122.639 1.209 . . . . 0.0 108.72 173.744 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -67.17 111.53 3.97 Favored 'General case' 0 N--CA 1.424 -1.757 0 CA-C-N 113.668 -1.605 . . . . 0.0 108.85 -175.893 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 133.27 -13.75 4.89 Favored Glycine 0 N--CA 1.424 -2.1 0 C-N-CA 120.31 -0.948 . . . . 0.0 112.115 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.458 ' O ' ' HA ' ' A' ' 132' ' ' LYS . 67.5 mt -99.55 113.57 35.14 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.17 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 179.178 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.464 ' O ' ' HA ' ' A' ' 102' ' ' LEU . 23.1 tptm -85.07 117.9 24.31 Favored 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 104.967 -2.234 . . . . 0.0 104.967 -179.261 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 95.1 m -126.85 124.93 40.74 Favored 'General case' 0 C--N 1.288 -2.085 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 -170.347 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.522 ' HG2' ' N ' ' A' ' 127' ' ' VAL . 84.2 tttt -119.37 145.59 46.06 Favored 'General case' 0 N--CA 1.429 -1.499 0 CA-C-O 121.255 0.55 . . . . 0.0 110.203 169.548 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.522 ' N ' ' HG2' ' A' ' 126' ' ' LYS . 7.2 p -159.21 -35.68 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 175.782 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -125.25 -51.67 1.64 Allowed 'General case' 0 N--CA 1.399 -3.006 0 N-CA-C 105.621 -1.992 . . . . 0.0 105.621 -179.729 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 7.9 tp -149.94 169.9 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.285 0 N-CA-C 105.574 -2.01 . . . . 0.0 105.574 176.516 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 130' ' ' TRP . . . . . 0.433 ' CD1' ' HB2' ' A' ' 126' ' ' LYS . 30.6 m-90 -80.12 126.32 30.94 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-O 121.32 0.581 . . . . 0.0 111.241 177.52 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 7.3 p -137.35 137.0 46.51 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.247 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 176.636 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 132' ' ' LYS . . . . . 0.458 ' HA ' ' O ' ' A' ' 123' ' ' ILE . 0.0 OUTLIER -112.07 20.19 17.11 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 113.708 1.003 . . . . 0.0 113.708 -174.687 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.442 HG13 ' HD2' ' A' ' 132' ' ' LYS . 17.8 m -124.17 -60.55 1.86 Allowed 'Isoleucine or valine' 0 C--O 1.21 -1.014 0 CA-C-N 116.101 -0.499 . . . . 0.0 112.15 179.357 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 134' ' ' THR . . . . . 0.466 ' O ' ' HA ' ' A' ' 119' ' ' ASP . 77.5 p 51.71 -171.64 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 124.118 0.967 . . . . 0.0 113.465 179.386 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 23.2 p -166.0 152.9 9.73 Favored 'General case' 0 N--CA 1.427 -1.612 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 176.06 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 14.1 tt -131.29 134.0 61.61 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.322 0 CA-C-O 121.254 0.549 . . . . 0.0 109.549 -179.264 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 39.9 t -124.81 159.61 30.62 Favored 'General case' 0 C--N 1.289 -2.041 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 -176.936 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 138' ' ' THR . . . . . 0.53 HG23 ' H ' ' A' ' 140' ' ' ALA . 9.7 t -165.15 175.97 8.88 Favored 'General case' 0 N--CA 1.41 -2.436 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 -178.008 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -112.49 30.57 6.99 Favored 'General case' 0 C--N 1.275 -2.659 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 173.128 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 140' ' ' ALA . . . . . 0.53 ' H ' HG23 ' A' ' 138' ' ' THR . . . 62.84 38.37 11.56 Favored 'General case' 0 C--N 1.35 0.596 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 -172.462 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 141' ' ' SER . . . . . 0.632 ' O ' ' HB3' ' A' ' 155' ' ' ARG . 46.9 t -174.57 -79.95 0.01 OUTLIER 'General case' 0 C--O 1.219 -0.527 0 CA-C-N 114.585 -1.189 . . . . 0.0 111.312 -175.064 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -75.53 134.94 40.63 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 -178.48 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 59.4 t -106.0 130.37 57.67 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.969 0 CA-C-O 120.998 0.428 . . . . 0.0 111.556 -170.155 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -131.76 150.17 52.24 Favored 'General case' 0 CA--C 1.481 -1.699 0 CA-C-O 121.589 0.709 . . . . 0.0 110.631 176.968 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 145' ' ' PHE . . . . . 0.456 ' HB2' ' HB2' ' A' ' 151' ' ' LYS . 60.7 m-85 -109.91 103.12 11.85 Favored 'General case' 0 C--N 1.268 -2.967 0 CA-C-N 115.026 -0.988 . . . . 0.0 111.424 179.205 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 6.6 p -81.75 19.69 1.04 Allowed 'General case' 0 C--N 1.305 -1.37 0 CA-C-N 115.073 -0.967 . . . . 0.0 113.269 -176.229 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -68.79 -15.4 63.49 Favored 'General case' 0 C--O 1.218 -0.574 0 CA-C-O 121.773 0.796 . . . . 0.0 109.812 175.209 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 166.39 29.53 0.02 OUTLIER Glycine 0 N--CA 1.43 -1.715 0 N-CA-C 108.868 -1.693 . . . . 0.0 108.868 175.914 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 15.6 tpt 57.59 23.5 9.38 Favored 'General case' 0 N--CA 1.486 1.328 0 CA-C-O 122.322 1.058 . . . . 0.0 108.498 -173.481 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 150' ' ' LYS . . . . . 0.462 ' CD ' HG11 ' A' ' 127' ' ' VAL . 0.0 OUTLIER -76.19 -9.46 58.65 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 115.942 1.83 . . . . 0.0 115.942 -169.492 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 151' ' ' LYS . . . . . 0.473 ' HE2' ' HA ' ' A' ' 151' ' ' LYS . 5.2 mmpt? -147.21 138.33 23.83 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 120.514 0.197 . . . . 0.0 111.278 178.556 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 72.2 p -126.53 132.41 51.37 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 174.343 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 22.8 tpt180 -147.91 157.37 43.49 Favored 'General case' 0 C--N 1.31 -1.148 0 N-CA-C 109.554 -0.535 . . . . 0.0 109.554 -176.82 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 68.3 m -98.1 143.71 28.36 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 108.434 -0.951 . . . . 0.0 108.434 173.019 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 155' ' ' ARG . . . . . 0.632 ' HB3' ' O ' ' A' ' 141' ' ' SER . 0.0 OUTLIER -67.44 -18.29 65.04 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 118.756 -1.177 . . . . 0.0 112.758 176.837 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -41.86 -56.97 2.54 Favored 'General case' 0 N--CA 1.482 1.174 0 N-CA-C 115.128 1.529 . . . . 0.0 115.128 -173.775 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -56.32 -37.96 70.65 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 112.012 0.375 . . . . 0.0 112.012 -176.856 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 6.7 t80 176.15 -26.25 0.0 OUTLIER 'General case' 0 CA--C 1.506 -0.731 0 N-CA-C 106.913 -1.514 . . . . 0.0 106.913 174.374 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 159' ' ' GLY . . . . . 0.695 ' HA3' ' O ' ' A' ' 65' ' ' ILE . . . 132.03 -87.33 0.28 Allowed Glycine 0 N--CA 1.407 -3.251 0 N-CA-C 110.506 -1.037 . . . . 0.0 110.506 -174.014 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.683 ' HB ' ' O ' ' A' ' 67' ' ' ILE . 12.0 t -98.54 116.91 42.6 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.238 0 C-N-CA 119.338 -0.945 . . . . 0.0 108.701 178.593 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 75.9 mm-40 -119.61 108.94 15.08 Favored 'General case' 0 CA--C 1.501 -0.931 0 N-CA-C 113.979 1.103 . . . . 0.0 113.979 -176.638 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 22.4 mmm180 -149.71 148.43 29.25 Favored 'General case' 0 C--N 1.308 -1.234 0 C-N-CA 125.508 1.523 . . . . 0.0 107.466 172.946 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -74.31 89.38 2.07 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-O 121.514 0.673 . . . . 0.0 110.874 -177.871 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 164' ' ' GLY . . . . . 0.461 ' HA3' ' SG ' ' A' ' 92' ' ' CYS . . . -122.8 168.05 15.12 Favored Glycine 0 N--CA 1.432 -1.568 0 CA-C-N 115.151 -0.931 . . . . 0.0 110.952 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 49.9 tp -141.19 114.58 8.77 Favored 'General case' 0 N--CA 1.414 -2.251 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 178.537 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 166' ' ' ARG . . . . . 0.439 ' HD2' ' HG3' ' A' ' 69' ' ' PRO . 81.3 mtt85 -87.4 103.97 16.0 Favored 'General case' 0 CA--C 1.476 -1.882 0 CA-C-O 122.07 0.938 . . . . 0.0 110.672 178.131 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 18.6 m -77.09 53.04 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.294 -1.809 0 CA-C-N 113.378 -1.737 . . . . 0.0 114.444 -173.91 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 168' ' ' ASP . . . . . 0.485 ' HB2' ' OG ' ' A' ' 90' ' ' SER . 32.8 t70 -135.36 -0.33 2.7 Favored 'General case' 0 N--CA 1.475 0.825 0 CA-C-O 122.271 1.034 . . . . 0.0 108.435 175.932 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -149.88 162.41 40.37 Favored 'General case' 0 N--CA 1.443 -0.817 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 -177.693 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 170' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 . . . . . 0 C--O 1.247 0.927 0 CA-C-O 118.958 -0.544 . . . . 0.0 110.162 176.784 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.661 ' O ' ' HG ' ' A' ' 58' ' ' LEU 0.261 7.9 mp . . . . . 0 CA--C 1.476 -1.886 0 N-CA-C 117.79 2.515 . . . . 0.0 117.79 . . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.617 ' O ' ' HE2' ' A' ' 59' ' ' LYS . 52.8 Cg_exo -57.44 -25.76 67.88 Favored 'Trans proline' 0 N--CA 1.445 -1.342 0 C-N-CA 121.52 1.48 . . . . 0.0 111.418 -176.371 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -81.74 -32.04 31.71 Favored 'General case' 0 N--CA 1.417 -2.124 0 CA-C-N 115.021 -0.99 . . . . 0.0 108.898 -178.279 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.543 ' HA ' ' HB3' ' A' ' 60' ' ' GLU . 15.4 mt -74.98 -29.69 60.97 Favored 'General case' 0 CA--C 1.487 -1.454 0 CA-C-N 115.004 -0.998 . . . . 0.0 110.333 -174.436 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.661 ' HG ' ' O ' ' A' ' 54' ' ' LEU . 15.5 mt -59.71 -52.4 65.67 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 -178.687 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.617 ' HE2' ' O ' ' A' ' 55' ' ' PRO . 49.5 mtmt -64.93 -23.91 67.36 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 113.955 -1.475 . . . . 0.0 110.57 177.689 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.543 ' HB3' ' HA ' ' A' ' 57' ' ' LEU . 28.3 tt0 -82.58 -19.09 39.14 Favored 'General case' 0 C--N 1.291 -1.976 0 C-N-CA 124.844 1.257 . . . . 0.0 111.679 178.456 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 36.6 m-85 -85.9 -33.21 21.28 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 113.56 0.948 . . . . 0.0 113.56 -177.669 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.514 ' OD2' HD13 ' A' ' 65' ' ' ILE . 4.6 p-10 -78.47 -165.19 0.66 Allowed 'General case' 0 C--N 1.292 -1.92 0 N-CA-C 113.116 0.784 . . . . 0.0 113.116 -167.458 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.703 ' HB2' HD12 ' A' ' 65' ' ' ILE . 6.6 mt -77.16 -154.23 0.0 OUTLIER Pre-proline 0 CA--C 1.599 2.845 0 N-CA-C 104.494 -2.41 . . . . 0.0 104.494 178.146 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.493 ' O ' ' HD2' ' A' ' 155' ' ' ARG . 7.5 Cg_endo -96.77 10.9 1.25 Allowed 'Trans proline' 0 N--CA 1.441 -1.585 0 CA-C-N 123.667 2.345 . . . . 0.0 111.067 177.127 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.703 HD12 ' HB2' ' A' ' 63' ' ' LEU . 0.2 OUTLIER -78.9 -40.31 22.77 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.92 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.68 -176.81 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 59.9 8.14 7.62 Favored Glycine 0 CA--C 1.542 1.73 0 CA-C-N 116.287 -0.415 . . . . 0.0 113.638 -177.87 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.635 ' H ' HG12 ' A' ' 65' ' ' ILE . 55.9 mt 59.01 -70.4 0.07 OUTLIER 'Isoleucine or valine' 0 C--O 1.211 -0.94 0 C-N-CA 127.418 2.287 . . . . 0.0 114.126 -178.72 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.597 ' HB3' ' HD3' ' A' ' 69' ' ' PRO . 34.3 t80 173.5 -56.57 0.0 OUTLIER Pre-proline 0 CA--C 1.563 1.446 0 CA-C-N 118.024 0.375 . . . . 0.0 110.571 -176.55 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.597 ' HD3' ' HB3' ' A' ' 68' ' ' PHE . 6.9 Cg_endo -98.89 157.97 0.67 Allowed 'Trans proline' 0 C--N 1.386 2.533 0 C-N-CA 123.205 2.603 . . . . 0.0 112.598 179.39 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -89.45 -8.24 68.39 Favored Glycine 0 CA--C 1.524 0.648 0 C-N-CA 121.379 -0.438 . . . . 0.0 112.39 179.837 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.565 ' OD2' ' HG3' ' A' ' 89' ' ' PRO . 20.8 t70 -89.6 -19.96 24.3 Favored 'General case' 0 C--O 1.213 -0.852 0 CA-C-O 122.17 0.986 . . . . 0.0 108.635 177.045 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.448 ' HB3' ' HD2' ' A' ' 69' ' ' PRO . . . -84.33 -166.13 1.35 Allowed 'General case' 0 CA--C 1.487 -1.48 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 167.942 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 18.2 p 67.71 18.06 9.81 Favored 'General case' 0 CA--C 1.47 -2.11 0 CA-C-O 123.582 1.658 . . . . 0.0 110.668 172.234 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.749 ' O ' ' HA ' ' A' ' 86' ' ' VAL . 1.2 m120 -75.87 100.49 4.81 Favored 'General case' 2 N--CA 1.365 -4.694 0 CA-C-N 111.704 -2.498 . . . . 0.0 110.513 -178.639 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -99.03 91.86 5.22 Favored 'General case' 0 C--N 1.274 -2.71 0 CA-C-N 114.572 -1.194 . . . . 0.0 113.33 -176.836 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.599 ' HB2' HG23 ' A' ' 85' ' ' THR . 19.2 mm-40 -97.5 133.8 41.58 Favored 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 106.729 -1.582 . . . . 0.0 106.729 175.735 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.452 ' HB2' ' CD2' ' A' ' 84' ' ' LEU . 90.6 t80 -146.57 127.28 14.3 Favored 'General case' 0 C--N 1.301 -1.511 0 C-N-CA 120.256 -0.578 . . . . 0.0 112.193 -173.477 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.684 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 5.8 m-20 -95.2 156.5 16.29 Favored 'General case' 0 CA--C 1.472 -2.043 0 N-CA-C 105.44 -2.059 . . . . 0.0 105.44 170.184 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -80.1 -60.63 2.26 Favored 'General case' 0 C--N 1.255 -3.521 0 N-CA-C 113.557 0.947 . . . . 0.0 113.557 -175.027 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -71.04 -29.94 65.98 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-O 121.415 0.626 . . . . 0.0 111.1 -175.695 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.684 ' HB ' ' HB2' ' A' ' 78' ' ' ASP . 24.6 m -68.6 -45.13 72.77 Favored 'General case' 0 N--CA 1.421 -1.886 0 CA-C-N 114.898 -1.046 . . . . 0.0 109.873 179.561 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 99.6 mttt 68.12 8.13 6.33 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.139 0.976 . . . . 0.0 113.319 -179.016 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 1.9 mptm? -89.22 106.23 18.31 Favored 'General case' 0 CA--C 1.494 -1.193 0 CA-C-O 121.551 0.691 . . . . 0.0 110.662 173.712 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.461 ' HB2' ' HB2' ' A' ' 112' ' ' LEU . 2.1 tm? -81.81 126.4 31.81 Favored 'General case' 0 C--N 1.285 -2.229 0 N-CA-C 105.426 -2.064 . . . . 0.0 105.426 174.909 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.63 ' HA ' ' O ' ' A' ' 108' ' ' VAL . 9.5 t -116.5 127.42 54.54 Favored 'General case' 0 N--CA 1.392 -3.327 0 C-N-CA 120.196 -0.602 . . . . 0.0 110.632 -178.937 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.749 ' HA ' ' O ' ' A' ' 74' ' ' ASN . 32.3 t -104.75 122.65 58.06 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.108 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.404 -178.588 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.402 ' O ' ' HA ' ' A' ' 72' ' ' ALA . 5.6 mp -90.49 104.4 16.99 Favored 'General case' 0 C--N 1.29 -2.01 0 CA-C-N 114.981 -1.008 . . . . 0.0 109.328 177.352 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.423 HG12 ' HB3' ' A' ' 104' ' ' PHE . 3.5 mp -93.93 137.53 23.03 Favored Pre-proline 0 C--N 1.302 -1.489 0 N-CA-C 106.561 -1.644 . . . . 0.0 106.561 175.114 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.621 ' O ' ' HB2' ' A' ' 166' ' ' ARG . 43.4 Cg_exo -59.76 97.32 0.11 Allowed 'Trans proline' 0 N--CA 1.455 -0.781 0 C-N-CA 122.58 2.187 . . . . 0.0 110.34 176.364 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' SER . . . . . 0.561 ' OG ' ' HB ' ' A' ' 167' ' ' VAL . 73.4 m 66.57 177.82 0.22 Allowed 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 123.654 0.781 . . . . 0.0 110.862 -174.531 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 14.8 tt -94.78 109.06 21.66 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.763 0 C-N-CA 119.792 -0.763 . . . . 0.0 109.185 175.943 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 27.1 p -98.77 149.15 23.17 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.366 -179.072 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -116.56 121.32 41.42 Favored 'General case' 0 CA--C 1.476 -1.88 0 N-CA-C 107.513 -1.291 . . . . 0.0 107.513 -179.053 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.595 HG13 ' H ' ' A' ' 163' ' ' ASN . 25.0 t -112.04 103.27 15.18 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.62 0 C-N-CA 119.614 -0.834 . . . . 0.0 111.293 -176.227 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.435 -1.426 0 N-CA-C 108.285 -1.926 . . . . 0.0 108.285 178.043 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 100' ' ' SER . . . . . 0.425 ' HA ' ' O ' ' A' ' 126' ' ' LYS . 36.1 m . . . . . 0 N--CA 1.424 -1.746 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.482 ' HA ' ' O ' ' A' ' 94' ' ' VAL . 52.0 t -97.64 119.24 45.4 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.257 0 CA-C-N 115.23 -0.895 . . . . 0.0 110.653 -176.851 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.4 ' HG ' HG23 ' A' ' 125' ' ' THR . 6.5 mp -109.19 126.76 53.6 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 176.619 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.437 ' HB3' ' HB2' ' A' ' 124' ' ' LYS . 38.9 ttmt -109.46 115.16 29.41 Favored 'General case' 0 C--N 1.289 -2.035 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 -178.743 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.471 ' HA ' HD11 ' A' ' 123' ' ' ILE . 93.2 m-85 -89.95 97.06 10.97 Favored 'General case' 0 N--CA 1.426 -1.651 0 CA-C-N 115.949 -0.569 . . . . 0.0 112.264 -175.16 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 87.9 m -56.88 122.36 12.05 Favored 'General case' 0 N--CA 1.422 -1.844 0 CA-C-N 114.062 -1.426 . . . . 0.0 109.535 174.621 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 8.0 t -71.9 117.7 13.82 Favored 'General case' 0 N--CA 1.435 -1.197 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 -179.588 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 52.3 m 70.68 68.71 0.19 Allowed 'General case' 0 N--CA 1.439 -0.984 0 CA-C-O 122.76 1.266 . . . . 0.0 108.812 -173.353 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.63 ' O ' ' HA ' ' A' ' 85' ' ' THR . 9.8 p -103.93 159.83 4.89 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.127 0 CA-C-N 113.627 -1.624 . . . . 0.0 106.812 -179.124 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.401 ' HA ' ' O ' ' A' ' 84' ' ' LEU . 15.8 p -115.53 170.72 8.21 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-N 118.735 0.698 . . . . 0.0 111.504 -178.334 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 176.54 -175.59 47.59 Favored Glycine 0 N--CA 1.439 -1.107 0 N-CA-C 110.506 -1.038 . . . . 0.0 110.506 179.362 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 46.7 t-80 -105.77 131.39 53.18 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 -179.29 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.461 ' HB2' ' HB2' ' A' ' 84' ' ' LEU . 3.2 tm? -97.08 107.78 20.38 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-O 121.803 0.811 . . . . 0.0 112.678 -172.18 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -123.53 143.64 50.06 Favored 'General case' 0 CA--C 1.453 -2.756 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 171.064 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 3.7 tmtp? -92.01 101.06 13.6 Favored 'General case' 0 N--CA 1.384 -3.742 0 CA-C-O 122.321 1.058 . . . . 0.0 108.57 -171.556 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' GLY . . . . . 0.645 ' O ' ' HB ' ' A' ' 138' ' ' THR . . . 143.94 -58.53 0.53 Allowed Glycine 0 C--N 1.283 -2.397 0 N-CA-C 106.736 -2.546 . . . . 0.0 106.736 -175.163 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.5 ' HB2' ' HA ' ' A' ' 137' ' ' SER . 0.0 OUTLIER -132.72 130.37 39.94 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 178.989 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -91.92 105.57 17.8 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 105.569 -2.011 . . . . 0.0 105.569 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 21.4 p -99.26 175.33 5.92 Favored 'General case' 0 C--N 1.294 -1.839 0 C-N-CA 123.355 0.662 . . . . 0.0 112.069 -174.213 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 27.4 m-20 50.89 45.72 27.12 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 123.529 0.732 . . . . 0.0 111.125 173.6 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.469 ' CG2' ' HA ' ' A' ' 135' ' ' SER . 2.1 t -77.52 99.17 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.863 0 CA-C-O 122.416 1.103 . . . . 0.0 109.807 -169.863 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 46.6 tt0 -79.79 87.58 5.27 Favored 'General case' 0 N--CA 1.4 -2.928 0 CA-C-N 113.819 -1.537 . . . . 0.0 111.275 -173.641 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 126.39 7.61 5.26 Favored Glycine 0 N--CA 1.412 -2.957 0 C-N-CA 119.604 -1.284 . . . . 0.0 112.439 171.601 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.471 HD11 ' HA ' ' A' ' 104' ' ' PHE . 8.5 tp -98.09 116.62 41.25 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.271 0 C-N-CA 117.402 -1.719 . . . . 0.0 108.223 -176.488 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.437 ' HB2' ' HB3' ' A' ' 103' ' ' LYS . 96.5 mttt -85.73 117.65 24.74 Favored 'General case' 0 C--N 1.274 -2.68 0 CA-C-N 113.816 -1.538 . . . . 0.0 109.227 -177.155 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.4 HG23 ' HG ' ' A' ' 102' ' ' LEU . 80.8 m -136.02 126.95 27.65 Favored 'General case' 0 N--CA 1.415 -2.215 0 CA-C-N 114.756 -1.111 . . . . 0.0 110.914 -173.428 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.512 ' C ' ' HD3' ' A' ' 126' ' ' LYS . 0.4 OUTLIER -112.36 128.33 56.26 Favored 'General case' 0 N--CA 1.419 -1.986 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 171.255 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.461 ' N ' ' HD3' ' A' ' 126' ' ' LYS . 7.7 p -143.36 -45.58 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.805 0 CA-C-O 121.538 0.685 . . . . 0.0 109.164 176.84 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 26.5 ptm -120.5 -26.43 5.36 Favored 'General case' 0 N--CA 1.423 -1.808 0 CA-C-N 115.037 -0.983 . . . . 0.0 108.528 173.816 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 9.3 tp -164.13 171.51 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.416 -2.172 0 N-CA-C 104.249 -2.5 . . . . 0.0 104.249 177.324 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 88.6 t90 -85.21 120.26 26.5 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 179.57 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.545 HG12 ' H ' ' A' ' 133' ' ' VAL . 45.4 t -128.08 146.05 34.26 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 N-CA-C 107.262 -1.385 . . . . 0.0 107.262 178.724 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 22.5 pttp -111.71 31.3 6.27 Favored 'General case' 0 C--O 1.246 0.882 0 CA-C-O 121.76 0.79 . . . . 0.0 110.731 -179.646 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.545 ' H ' HG12 ' A' ' 131' ' ' VAL . 21.9 t -131.27 -80.1 0.14 Allowed 'Isoleucine or valine' 0 C--O 1.208 -1.102 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 178.834 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 41.3 p 47.57 -156.41 0.05 Allowed 'General case' 0 C--O 1.258 1.551 0 C-N-CA 123.639 0.776 . . . . 0.0 112.602 179.363 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 135' ' ' SER . . . . . 0.469 ' HA ' ' CG2' ' A' ' 120' ' ' VAL . 34.1 t -170.42 144.16 2.42 Favored 'General case' 0 N--CA 1.419 -1.993 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 -179.571 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 12.2 tt -99.64 96.95 5.33 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.28 0 N-CA-C 105.318 -2.105 . . . . 0.0 105.318 172.13 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 137' ' ' SER . . . . . 0.5 ' HA ' ' HB2' ' A' ' 116' ' ' LYS . 25.6 m -90.55 142.95 27.22 Favored 'General case' 0 N--CA 1.389 -3.509 0 CA-C-N 113.588 -1.642 . . . . 0.0 109.303 -174.533 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 138' ' ' THR . . . . . 0.645 ' HB ' ' O ' ' A' ' 115' ' ' GLY . 92.4 m -153.89 147.66 25.35 Favored 'General case' 0 C--N 1.256 -3.478 0 N-CA-C 105.743 -1.947 . . . . 0.0 105.743 -179.013 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -95.62 28.9 2.8 Favored 'General case' 0 C--N 1.276 -2.596 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 177.351 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 140' ' ' ALA . . . . . 0.458 ' N ' HG22 ' A' ' 138' ' ' THR . . . 58.16 39.54 25.86 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 -171.433 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 24.6 t -168.67 -70.95 0.02 OUTLIER 'General case' 0 N--CA 1.441 -0.876 0 CA-C-N 114.625 -1.17 . . . . 0.0 110.803 -175.287 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 142' ' ' LYS . . . . . 0.433 ' O ' HG23 ' A' ' 138' ' ' THR . 40.1 mmtm -106.42 159.7 15.95 Favored 'General case' 0 CA--C 1.51 -0.588 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 -179.45 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 48.0 t -106.21 139.32 27.93 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 CA-C-O 121.111 0.482 . . . . 0.0 110.855 -174.917 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 38.3 m-85 -129.5 150.28 50.91 Favored 'General case' 0 CA--C 1.498 -1.052 0 CA-C-O 122.089 0.947 . . . . 0.0 111.657 177.169 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -108.72 103.03 12.04 Favored 'General case' 0 C--N 1.277 -2.555 0 CA-C-N 113.723 -1.58 . . . . 0.0 108.98 178.898 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.441 ' OG1' ' HB3' ' A' ' 135' ' ' SER . 36.7 p -104.46 104.83 14.75 Favored 'General case' 0 N--CA 1.41 -2.438 0 N-CA-C 114.212 1.19 . . . . 0.0 114.212 -175.132 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -111.5 26.6 10.48 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 104.888 -2.264 . . . . 0.0 104.888 169.553 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 140.92 -74.28 0.36 Allowed Glycine 0 N--CA 1.399 -3.789 1 N-CA-C 103.049 -4.02 . . . . 0.0 103.049 -169.908 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 28.2 ttt -175.15 88.13 0.04 OUTLIER 'General case' 0 C--N 1.315 -0.934 0 C-N-CA 124.703 1.201 . . . . 0.0 108.103 170.352 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . 0.282 72.4 mmtt -106.42 -93.23 0.38 Allowed 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 116.1 1.889 . . . . 0.0 116.1 -177.605 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -93.42 161.59 14.32 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 113.7 1.0 . . . . 0.0 113.7 -172.188 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 33.0 t -133.72 156.64 47.58 Favored 'General case' 0 C--N 1.31 -1.126 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 175.561 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 20.4 tpt180 -149.62 151.13 33.27 Favored 'General case' 0 N--CA 1.441 -0.899 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 178.618 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 20.2 m -73.59 133.54 43.53 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 176.687 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 155' ' ' ARG . . . . . 0.51 ' HG3' ' HA2' ' A' ' 159' ' ' GLY . 14.9 ttp85 -75.88 -21.43 57.17 Favored 'General case' 0 C--N 1.299 -1.597 0 CA-C-O 121.617 0.722 . . . . 0.0 109.534 176.72 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -35.11 -47.64 0.39 Allowed 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 116.923 2.194 . . . . 0.0 116.923 -172.929 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -76.38 -53.45 8.15 Favored 'General case' 0 CA--C 1.548 0.878 0 N-CA-C 115.041 1.497 . . . . 0.0 115.041 -171.86 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -140.39 7.14 2.15 Favored 'General case' 0 N--CA 1.484 1.257 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -178.03 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 159' ' ' GLY . . . . . 0.684 ' HA3' ' O ' ' A' ' 65' ' ' ILE . . . 96.07 -81.88 0.8 Allowed Glycine 0 CA--C 1.462 -3.223 0 N-CA-C 108.712 -1.755 . . . . 0.0 108.712 -172.004 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.566 HG23 ' HB ' ' A' ' 65' ' ' ILE . 17.8 t -111.62 135.02 52.17 Favored 'Isoleucine or valine' 0 N--CA 1.401 -2.916 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 172.275 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -84.76 91.68 8.03 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 -177.601 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 162' ' ' ARG . . . . . 0.551 ' HD3' HG21 ' A' ' 94' ' ' VAL . 3.5 mmp_? -106.59 140.79 38.91 Favored 'General case' 0 C--N 1.29 -1.978 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.897 -176.816 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 163' ' ' ASN . . . . . 0.595 ' H ' HG13 ' A' ' 94' ' ' VAL . 16.8 m120 -127.3 5.91 6.36 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 114.762 -1.108 . . . . 0.0 111.011 -174.895 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -81.47 167.29 48.63 Favored Glycine 0 CA--C 1.498 -1.019 0 C-N-CA 120.343 -0.932 . . . . 0.0 111.912 -175.913 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.485 ' H ' HD23 ' A' ' 165' ' ' LEU . 1.2 pt? -116.92 112.34 20.9 Favored 'General case' 0 N--CA 1.417 -2.106 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 -179.873 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 166' ' ' ARG . . . . . 0.621 ' HB2' ' O ' ' A' ' 89' ' ' PRO . 5.8 ptp85 -82.91 118.84 23.74 Favored 'General case' 0 N--CA 1.41 -2.461 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 -177.095 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 167' ' ' VAL . . . . . 0.561 ' HB ' ' OG ' ' A' ' 90' ' ' SER . 41.1 t -51.61 -46.52 37.55 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 CA-C-N 115.107 -0.951 . . . . 0.0 111.484 -179.776 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -79.31 81.32 5.59 Favored 'General case' 0 CA--C 1.498 -1.05 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 171.224 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 27.0 tptp -99.57 106.63 18.64 Favored 'General case' 0 C--N 1.279 -2.475 0 N-CA-C 114.046 1.128 . . . . 0.0 114.046 -179.377 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 170' ' ' PHE . . . . . . . . . . . . . 79.5 t80 . . . . . 0 N--CA 1.424 -1.765 0 N-CA-C 106.311 -1.737 . . . . 0.0 106.311 173.173 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 8.9 mp . . . . . 0 CA--C 1.498 -1.027 0 N-CA-C 116.377 1.992 . . . . 0.0 116.377 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -62.29 -12.86 29.15 Favored 'Trans proline' 0 N--CA 1.449 -1.095 0 C-N-CA 122.336 2.024 . . . . 0.0 112.462 -170.584 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 17.8 mm-40 -72.52 -32.4 66.11 Favored 'General case' 0 N--CA 1.418 -2.028 0 N-CA-C 107.513 -1.291 . . . . 0.0 107.513 -178.491 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.466 ' O ' ' HG2' ' A' ' 60' ' ' GLU . 3.5 mm? -74.48 -44.28 52.22 Favored 'General case' 0 N--CA 1.423 -1.805 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 175.743 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.456 ' HG ' ' CE2' ' A' ' 75' ' ' TYR . 6.9 mp -59.05 -38.55 79.63 Favored 'General case' 0 CA--C 1.495 -1.15 0 CA-C-N 114.842 -1.072 . . . . 0.0 111.646 -176.563 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.442 ' HD2' ' N ' ' A' ' 60' ' ' GLU . 0.0 OUTLIER -76.14 -29.12 57.67 Favored 'General case' 0 N--CA 1.419 -2.005 0 C-N-CA 119.345 -0.942 . . . . 0.0 112.697 177.842 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.466 ' HG2' ' O ' ' A' ' 57' ' ' LEU . 11.6 pt-20 -77.68 -27.09 50.71 Favored 'General case' 0 N--CA 1.445 -0.706 0 C-N-CA 119.212 -0.995 . . . . 0.0 111.321 -175.595 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 58.6 m-85 -57.02 -47.71 80.25 Favored 'General case' 0 C--O 1.242 0.667 0 C-N-CA 120.17 -0.612 . . . . 0.0 112.515 176.455 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -108.78 -86.05 0.52 Allowed 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 114.722 1.378 . . . . 0.0 114.722 -174.348 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.634 ' HB2' HD12 ' A' ' 65' ' ' ILE . 0.0 OUTLIER -115.31 137.58 23.13 Favored Pre-proline 0 C--N 1.317 -0.81 0 C-N-CA 118.489 -1.284 . . . . 0.0 107.751 -179.215 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 63' ' ' LEU . 9.4 Cg_endo -91.49 21.26 0.8 Allowed 'Trans proline' 0 N--CA 1.429 -2.313 0 C-N-CA 123.653 2.902 . . . . 0.0 111.257 -170.332 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.706 ' HB ' HG23 ' A' ' 160' ' ' VAL . 0.2 OUTLIER -58.9 -40.33 79.96 Favored 'Isoleucine or valine' 0 CA--C 1.473 -2.007 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 176.544 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 59.2 -0.29 0.59 Allowed Glycine 0 N--CA 1.483 1.794 0 CA-C-N 114.363 -1.29 . . . . 0.0 112.182 -176.176 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.579 ' H ' HG12 ' A' ' 65' ' ' ILE . 56.4 mt 62.73 -69.36 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.414 -2.238 0 C-N-CA 127.539 2.336 . . . . 0.0 111.076 -171.606 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 75.1 t80 -177.54 -52.87 0.0 OUTLIER Pre-proline 0 C--N 1.306 -1.287 0 N-CA-C 113.541 0.941 . . . . 0.0 113.541 -174.451 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.453 ' HB2' ' OD1' ' A' ' 71' ' ' ASP . 18.6 Cg_endo -90.21 -28.0 0.27 Allowed 'Trans proline' 0 N--CA 1.444 -1.432 0 C-N-CA 121.073 1.182 . . . . 0.0 115.136 -170.919 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 94.68 -18.42 57.19 Favored Glycine 0 C--O 1.216 -0.993 0 N-CA-C 110.537 -1.025 . . . . 0.0 110.537 -174.108 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.613 ' HB3' ' HG2' ' A' ' 89' ' ' PRO . 8.2 m-20 -75.48 -50.73 14.84 Favored 'General case' 0 N--CA 1.437 -1.11 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 177.272 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.421 ' HA ' ' O ' ' A' ' 87' ' ' LEU . . . -73.86 170.86 14.48 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 114.106 -1.406 . . . . 0.0 109.95 174.082 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.584 ' O ' HG22 ' A' ' 73' ' ' THR . 28.8 m 89.79 28.46 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.836 0 CA-C-O 124.11 1.909 . . . . 0.0 112.559 170.929 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.517 ' HB2' ' HB2' ' A' ' 87' ' ' LEU . 27.5 m-80 -91.25 -174.9 4.1 Favored 'General case' 0 C--N 1.247 -3.855 0 CA-C-N 114.823 -1.08 . . . . 0.0 109.973 178.133 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.551 ' HB2' HD21 ' A' ' 84' ' ' LEU . 28.4 p90 -148.9 136.14 20.13 Favored 'General case' 0 C--N 1.3 -1.545 0 C-N-CA 119.206 -0.998 . . . . 0.0 113.299 -179.387 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.575 ' HB2' HG23 ' A' ' 85' ' ' THR . 70.5 mm-40 -144.13 146.07 32.53 Favored 'General case' 0 C--N 1.306 -1.322 0 C-N-CA 126.251 1.82 . . . . 0.0 106.784 175.324 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 50.2 p90 -149.65 150.93 32.91 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-N 118.249 0.477 . . . . 0.0 111.95 -176.572 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.612 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 11.5 m-20 -95.35 163.1 13.39 Favored 'General case' 0 CA--C 1.489 -1.378 0 N-CA-C 106.857 -1.534 . . . . 0.0 106.857 173.814 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -81.11 -62.43 1.66 Allowed 'General case' 0 C--N 1.278 -2.524 0 N-CA-C 113.633 0.975 . . . . 0.0 113.633 -178.202 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -77.56 -40.39 42.63 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 121.309 0.576 . . . . 0.0 109.519 -176.236 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.612 ' HB ' ' HB2' ' A' ' 78' ' ' ASP . 81.5 m -66.67 -38.54 87.03 Favored 'General case' 0 N--CA 1.429 -1.521 0 CA-C-N 114.949 -1.023 . . . . 0.0 111.892 178.638 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 98.8 mttt 61.54 7.5 1.86 Allowed 'General case' 0 N--CA 1.5 2.036 0 N-CA-C 114.037 1.125 . . . . 0.0 114.037 177.3 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.496 ' HD3' ' HB ' ' A' ' 109' ' ' THR . 35.8 ttmt -83.26 113.33 20.61 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 108.847 -0.798 . . . . 0.0 108.847 178.74 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.551 HD21 ' HB2' ' A' ' 75' ' ' TYR . 2.2 tm? -79.87 134.64 36.32 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 -176.194 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.628 ' HA ' ' O ' ' A' ' 108' ' ' VAL . 8.9 t -120.91 129.7 53.59 Favored 'General case' 0 N--CA 1.403 -2.823 0 CA-C-O 121.643 0.735 . . . . 0.0 110.309 178.763 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.402 HG13 ' O ' ' A' ' 74' ' ' ASN . 98.8 t -102.92 134.07 44.98 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.611 -177.28 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.517 ' HB2' ' HB2' ' A' ' 74' ' ' ASN . 2.5 mm? -81.95 115.92 21.34 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-N 114.676 -1.147 . . . . 0.0 110.819 -179.76 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.617 ' O ' ' HA ' ' A' ' 106' ' ' THR . 64.0 mt -124.8 103.81 30.83 Favored Pre-proline 0 C--N 1.29 -1.982 0 N-CA-C 107.375 -1.343 . . . . 0.0 107.375 173.91 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.613 ' HG2' ' HB3' ' A' ' 71' ' ' ASP . 70.9 Cg_exo -56.63 110.9 0.65 Allowed 'Trans proline' 0 C--O 1.199 -1.45 0 C-N-CA 123.136 2.557 . . . . 0.0 111.814 178.974 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' SER . . . . . 0.429 ' HB2' ' O ' ' A' ' 89' ' ' PRO . 36.7 m 75.34 149.47 0.1 Allowed 'General case' 0 CA--C 1.485 -1.52 0 CA-C-O 122.091 0.948 . . . . 0.0 113.324 -175.511 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.458 HD12 HG23 ' A' ' 106' ' ' THR . 3.3 mp -80.79 120.7 32.93 Favored 'Isoleucine or valine' 0 N--CA 1.392 -3.33 0 N-CA-C 107.594 -1.261 . . . . 0.0 107.594 173.582 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 40.4 t -96.15 121.57 38.06 Favored 'General case' 0 N--CA 1.405 -2.688 0 N-CA-C 106.625 -1.62 . . . . 0.0 106.625 171.594 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.445 ' HG3' HG22 ' A' ' 91' ' ' ILE . 49.9 mt-10 -116.82 121.6 42.0 Favored 'General case' 0 CA--C 1.466 -2.267 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 177.263 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.401 HG23 HD23 ' A' ' 102' ' ' LEU . 33.3 m -115.28 103.63 15.58 Favored 'Isoleucine or valine' 0 C--N 1.267 -2.989 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 177.754 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.756 ' HA2' ' O ' ' A' ' 100' ' ' SER . . . . . . . . 0 CA--C 1.478 -2.226 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 -178.851 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' SER . . . . . 0.756 ' O ' ' HA2' ' A' ' 95' ' ' GLY . 69.3 p . . . . . 0 N--CA 1.41 -2.456 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 60.5 t -115.72 99.72 9.02 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.237 0 CA-C-O 121.23 0.538 . . . . 0.0 109.755 175.817 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.554 HD13 HG23 ' A' ' 125' ' ' THR . 1.8 mm? -111.79 129.62 56.07 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 178.693 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -116.51 107.2 14.45 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-O 120.924 0.392 . . . . 0.0 111.106 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -93.06 102.36 14.69 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 107.518 -1.289 . . . . 0.0 107.518 176.69 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.534 ' O ' ' HB ' ' A' ' 88' ' ' ILE . 13.5 t -77.07 -178.37 4.96 Favored 'General case' 0 CA--C 1.551 1.019 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.532 -175.697 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 106' ' ' THR . . . . . 0.617 ' HA ' ' O ' ' A' ' 88' ' ' ILE . 15.0 p -84.13 -50.32 8.04 Favored 'General case' 0 C--N 1.309 -1.162 0 C-N-CA 123.513 0.725 . . . . 0.0 111.716 -173.9 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 26.3 p -115.82 84.76 2.16 Favored 'General case' 0 N--CA 1.406 -2.644 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 175.251 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.628 ' O ' ' HA ' ' A' ' 85' ' ' THR . 14.7 p -81.58 129.58 37.27 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.296 0 CA-C-N 114.94 -1.027 . . . . 0.0 109.922 -177.317 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.496 ' HB ' ' HD3' ' A' ' 83' ' ' LYS . 17.5 p -104.98 149.0 26.12 Favored 'General case' 0 N--CA 1.4 -2.955 0 CA-C-N 116.191 -0.459 . . . . 0.0 109.771 -176.05 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 178.98 -159.41 24.3 Favored Glycine 0 N--CA 1.424 -2.135 0 N-CA-C 110.944 -0.862 . . . . 0.0 110.944 -179.912 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' HIS . . . . . 0.432 ' HB2' ' O ' ' A' ' 118' ' ' THR . 74.1 m80 -123.68 121.22 34.96 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 177.593 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.538 ' HB3' ' HG ' ' A' ' 84' ' ' LEU . 6.4 tt -123.43 136.58 54.68 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-O 121.277 0.56 . . . . 0.0 110.427 -171.717 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -130.67 171.09 13.47 Favored 'General case' 0 CA--C 1.456 -2.64 0 CA-C-N 114.941 -1.027 . . . . 0.0 110.189 177.896 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 2.7 tmtm? -86.24 100.84 12.53 Favored 'General case' 1 N--CA 1.376 -4.155 0 N-CA-C 103.779 -2.674 . . . . 0.0 103.779 173.461 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 115' ' ' GLY . . . . . 0.631 ' O ' HG23 ' A' ' 138' ' ' THR . . . 143.2 -62.09 0.51 Allowed Glycine 0 C--N 1.273 -2.96 0 N-CA-C 109.252 -1.539 . . . . 0.0 109.252 -174.85 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.433 ' HG2' HG23 ' A' ' 118' ' ' THR . 0.0 OUTLIER -151.02 164.7 35.8 Favored 'General case' 0 CA--C 1.508 -0.647 0 C-N-CA 122.766 0.426 . . . . 0.0 110.087 -179.697 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 3.7 tt -121.31 109.76 15.3 Favored 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 106.252 -1.758 . . . . 0.0 106.252 176.608 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.611 ' HA ' ' OG ' ' A' ' 135' ' ' SER . 66.9 p -112.14 131.22 55.58 Favored 'General case' 0 C--N 1.277 -2.566 0 N-CA-C 114.109 1.151 . . . . 0.0 114.109 -177.263 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 119' ' ' ASP . . . . . 0.504 ' H ' ' HB2' ' A' ' 135' ' ' SER . 17.5 t70 70.42 107.81 0.06 Allowed 'General case' 0 CA--C 1.507 -0.71 0 N-CA-C 114.294 1.22 . . . . 0.0 114.294 175.215 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 35.8 m -112.58 166.07 6.92 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.194 0 CA-C-N 115.002 -0.999 . . . . 0.0 110.566 177.981 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.472 ' HB3' ' OG1' ' A' ' 109' ' ' THR . 12.0 tp10 -127.75 -8.32 5.59 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.747 -178.316 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -105.7 -19.11 10.65 Favored Glycine 0 N--CA 1.432 -1.587 0 C-N-CA 119.706 -1.235 . . . . 0.0 112.39 -173.954 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.496 HG13 ' CG2' ' A' ' 108' ' ' VAL . 96.2 mt -100.82 100.6 10.71 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.62 0 CA-C-O 121.98 0.895 . . . . 0.0 111.272 -178.553 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -86.27 141.89 28.94 Favored 'General case' 0 C--N 1.295 -1.77 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 172.943 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.554 HG23 HD13 ' A' ' 102' ' ' LEU . 17.9 m -150.5 143.04 24.47 Favored 'General case' 0 N--CA 1.421 -1.925 0 N-CA-C 112.998 0.74 . . . . 0.0 112.998 -172.561 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.539 ' C ' ' HD3' ' A' ' 126' ' ' LYS . 0.4 OUTLIER -131.07 105.24 7.58 Favored 'General case' 0 N--CA 1.423 -1.798 0 N-CA-C 105.3 -2.111 . . . . 0.0 105.3 168.56 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 7.4 p -113.47 -53.58 5.01 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.441 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 179.193 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 45.5 ttm -114.29 -27.49 7.59 Favored 'General case' 0 N--CA 1.398 -3.059 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 172.295 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 129' ' ' ILE . . . . . 0.404 HD12 ' HA ' ' A' ' 129' ' ' ILE . 8.5 tp -161.51 171.13 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.551 1.008 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 173.77 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 8.5 m-90 -70.66 117.52 12.28 Favored 'General case' 0 CA--C 1.509 -0.605 0 CA-C-N 118.572 0.623 . . . . 0.0 110.431 179.309 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.436 HG12 HG12 ' A' ' 133' ' ' VAL . 88.6 t -147.94 111.04 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.139 0 C-N-CA 122.956 0.502 . . . . 0.0 109.783 179.62 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 54.6 pttt -106.78 114.33 28.36 Favored 'General case' 0 N--CA 1.442 -0.841 0 C-N-CA 119.31 -0.956 . . . . 0.0 109.364 173.523 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.436 HG12 HG12 ' A' ' 131' ' ' VAL . 13.5 p 173.57 -21.23 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.296 -1.755 0 N-CA-C 107.362 -1.347 . . . . 0.0 107.362 -178.992 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 134' ' ' THR . . . . . 0.577 HG22 ' HA3' ' A' ' 148' ' ' GLY . 66.4 p -7.51 88.84 0.0 OUTLIER 'General case' 0 C--N 1.366 1.295 0 C-N-CA 127.921 2.488 . . . . 0.0 114.345 177.89 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 135' ' ' SER . . . . . 0.611 ' OG ' ' HA ' ' A' ' 118' ' ' THR . 30.2 t -101.64 146.43 27.73 Favored 'General case' 0 N--CA 1.408 -2.571 0 CA-C-N 114.252 -1.34 . . . . 0.0 109.978 -176.505 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 8.9 tt -115.36 122.85 70.14 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.567 0 O-C-N 124.136 0.897 . . . . 0.0 109.681 179.464 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 34.7 p -105.77 135.96 46.25 Favored 'General case' 0 N--CA 1.398 -3.051 0 CA-C-O 122.239 1.018 . . . . 0.0 110.306 178.382 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 138' ' ' THR . . . . . 0.631 HG23 ' O ' ' A' ' 115' ' ' GLY . 3.0 t -151.08 175.68 11.88 Favored 'General case' 0 N--CA 1.385 -3.724 0 N-CA-C 105.7 -1.963 . . . . 0.0 105.7 -179.599 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -122.2 33.76 5.37 Favored 'General case' 0 C--N 1.271 -2.827 0 N-CA-C 106.272 -1.751 . . . . 0.0 106.272 177.919 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . 63.33 46.15 4.59 Favored 'General case' 0 C--N 1.351 0.646 0 CA-C-N 113.971 -1.468 . . . . 0.0 109.274 -176.751 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 36.2 t -178.45 -78.87 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 114.878 -1.055 . . . . 0.0 110.065 -177.702 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 66.2 mttm -88.91 143.72 26.68 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 -178.44 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.528 ' HB ' ' O ' ' A' ' 153' ' ' ARG . 47.6 t -106.86 138.4 32.81 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 CA-C-O 120.899 0.381 . . . . 0.0 111.693 -173.569 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 57.6 m-85 -136.11 141.58 44.19 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 178.463 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 51.5 p90 -66.94 161.87 23.16 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.531 0.681 . . . . 0.0 112.19 177.683 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.497 ' HB ' ' O ' ' A' ' 135' ' ' SER . 92.7 m -149.0 -58.87 0.22 Allowed 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.298 174.9 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 147' ' ' ALA . . . . . 0.485 ' HB3' ' HA ' ' A' ' 134' ' ' THR . . . -141.38 137.04 32.01 Favored 'General case' 0 CA--C 1.507 -0.691 0 N-CA-C 110.062 -0.348 . . . . 0.0 110.062 178.803 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 148' ' ' GLY . . . . . 0.577 ' HA3' HG22 ' A' ' 134' ' ' THR . . . 79.89 -54.59 4.45 Favored Glycine 0 C--O 1.219 -0.817 0 O-C-N 123.539 0.524 . . . . 0.0 113.129 177.585 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 26.4 ttt -60.98 -48.49 81.57 Favored 'General case' 0 C--N 1.3 -1.577 0 C-N-CA 123.159 0.584 . . . . 0.0 109.799 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . 0.257 27.3 mtpp 49.0 17.46 0.16 Allowed 'General case' 0 N--CA 1.486 1.348 0 N-CA-C 115.985 1.846 . . . . 0.0 115.985 177.943 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -143.95 140.98 29.97 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 175.608 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 20.6 p -87.72 111.28 21.16 Favored 'General case' 0 N--CA 1.421 -1.916 0 CA-C-O 121.392 0.615 . . . . 0.0 110.119 177.861 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 153' ' ' ARG . . . . . 0.528 ' O ' ' HB ' ' A' ' 143' ' ' VAL . 2.6 tpm_? -105.9 105.77 15.97 Favored 'General case' 0 N--CA 1.432 -1.361 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 176.657 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 48.1 m -68.71 146.23 53.14 Favored 'General case' 0 C--N 1.285 -2.209 0 C-N-CA 120.841 -0.344 . . . . 0.0 111.742 -177.938 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 155' ' ' ARG . . . . . 0.509 ' HA ' ' HA2' ' A' ' 159' ' ' GLY . 29.0 tpt180 -57.81 -31.01 66.17 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-O 121.278 0.561 . . . . 0.0 109.532 175.732 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -47.16 -41.85 18.58 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 114.298 -1.319 . . . . 0.0 112.084 175.583 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -82.41 -53.87 5.66 Favored 'General case' 0 N--CA 1.437 -1.097 0 C-N-CA 120.692 -0.403 . . . . 0.0 111.622 -179.321 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -152.99 -18.97 0.15 Allowed 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 112.815 0.672 . . . . 0.0 112.815 -175.588 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 159' ' ' GLY . . . . . 0.509 ' HA2' ' HA ' ' A' ' 155' ' ' ARG . . . 107.99 -93.16 0.79 Allowed Glycine 0 N--CA 1.418 -2.555 0 N-CA-C 108.062 -2.015 . . . . 0.0 108.062 -165.998 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.706 HG23 ' HB ' ' A' ' 65' ' ' ILE . 83.8 t -133.57 115.86 23.32 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 CA-C-O 121.705 0.764 . . . . 0.0 110.399 -179.761 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 161' ' ' GLN . . . . . 0.471 ' H ' ' HG2' ' A' ' 153' ' ' ARG . 2.5 mm-40 -134.99 135.31 41.31 Favored 'General case' 0 N--CA 1.412 -2.36 0 N-CA-C 115.158 1.54 . . . . 0.0 115.158 -177.767 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 10.9 tpt180 -150.53 110.52 4.11 Favored 'General case' 0 C--N 1.263 -3.183 0 N-CA-C 101.72 -3.437 . . . . 0.0 101.72 170.197 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -43.71 95.29 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 113.975 1.102 . . . . 0.0 113.975 -169.519 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -157.39 161.09 31.04 Favored Glycine 0 N--CA 1.433 -1.552 0 CA-C-N 114.302 -1.317 . . . . 0.0 110.439 -178.54 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.487 ' O ' HD12 ' A' ' 165' ' ' LEU . 3.5 pp -141.37 139.09 33.44 Favored 'General case' 0 N--CA 1.411 -2.399 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 178.216 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 166' ' ' ARG . . . . . 0.53 ' HB3' ' O ' ' A' ' 89' ' ' PRO . 0.0 OUTLIER -70.49 134.76 48.03 Favored 'General case' 0 C--N 1.295 -1.778 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 175.869 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 32.7 t -62.11 -31.36 51.13 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.845 0 O-C-N 123.755 0.66 . . . . 0.0 112.681 176.577 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -73.83 77.49 1.61 Allowed 'General case' 0 N--CA 1.485 1.308 0 CA-C-O 122.25 1.024 . . . . 0.0 111.114 174.753 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 169' ' ' LYS . . . . . 0.404 ' HB3' ' HE3' ' A' ' 169' ' ' LYS . 19.3 ttpp -152.95 156.39 38.8 Favored 'General case' 0 C--N 1.276 -2.606 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 -178.619 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 170' ' ' PHE . . . . . . . . . . . . . 28.3 p90 . . . . . 0 C--N 1.304 -1.378 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 174.321 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.628 ' O ' ' HG ' ' A' ' 58' ' ' LEU . 3.5 mm? . . . . . 0 N--CA 1.498 1.935 0 N-CA-C 116.658 2.096 . . . . 0.0 116.658 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.717 ' HA ' HD11 ' A' ' 58' ' ' LEU . 26.2 Cg_exo -59.65 -21.09 61.2 Favored 'Trans proline' 0 N--CA 1.426 -2.464 0 C-N-CA 121.275 1.317 . . . . 0.0 112.029 -172.19 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -84.3 -41.39 16.89 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 123.456 0.702 . . . . 0.0 110.73 -179.196 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -69.7 -51.42 34.57 Favored 'General case' 0 CA--C 1.488 -1.407 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.962 178.214 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.717 HD11 ' HA ' ' A' ' 55' ' ' PRO 0.294 1.7 pp -62.19 -26.77 68.54 Favored 'General case' 0 C--O 1.208 -1.082 0 C-N-CA 119.745 -0.782 . . . . 0.0 111.029 179.284 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.458 ' HB2' ' O ' ' A' ' 55' ' ' PRO . 37.1 ttmt -69.45 -41.52 76.14 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 114.671 -1.15 . . . . 0.0 111.842 174.785 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -80.18 -16.18 55.41 Favored 'General case' 0 N--CA 1.441 -0.908 0 C-N-CA 119.418 -0.913 . . . . 0.0 109.122 -179.49 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 26.0 m-85 -84.29 -31.92 24.64 Favored 'General case' 0 C--N 1.321 -0.644 0 C-N-CA 119.437 -0.905 . . . . 0.0 111.456 177.665 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.517 ' HA ' HD11 ' A' ' 112' ' ' LEU . 20.7 t70 -87.11 -155.46 0.28 Allowed 'General case' 0 CA--C 1.545 0.773 0 N-CA-C 106.486 -1.672 . . . . 0.0 106.486 173.09 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.491 ' HB2' HD12 ' A' ' 65' ' ' ILE . 13.4 mt -84.03 155.4 64.14 Favored Pre-proline 0 C--N 1.299 -1.618 0 N-CA-C 107.248 -1.39 . . . . 0.0 107.248 -178.685 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -80.61 10.21 3.4 Favored 'Trans proline' 0 N--CA 1.453 -0.868 0 C-N-CA 122.2 1.933 . . . . 0.0 113.27 -166.102 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.744 HG12 ' H ' ' A' ' 67' ' ' ILE . 0.2 OUTLIER -81.34 -26.22 10.31 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.311 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 179.708 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 68.42 9.98 59.22 Favored Glycine 0 C--N 1.357 1.742 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.29 179.808 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.744 ' H ' HG12 ' A' ' 65' ' ' ILE . 55.8 mt 64.3 -68.01 0.14 Allowed 'Isoleucine or valine' 0 C--O 1.181 -2.506 0 C-N-CA 126.259 1.824 . . . . 0.0 111.653 -171.845 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.525 ' HB2' HG22 ' A' ' 160' ' ' VAL . 39.7 t80 -170.58 -57.81 0.0 OUTLIER Pre-proline 0 C--N 1.275 -2.632 0 CA-C-N 118.078 0.399 . . . . 0.0 111.177 -175.409 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.524 ' HD3' ' HB3' ' A' ' 68' ' ' PHE . 8.6 Cg_endo -100.57 -10.41 0.27 Allowed 'Trans proline' 0 N--CA 1.449 -1.116 0 C-N-CA 122.505 2.137 . . . . 0.0 114.793 -172.972 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 73.83 10.65 80.59 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.369 -0.92 . . . . 0.0 111.561 -175.2 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.455 ' HB2' ' CG ' ' A' ' 89' ' ' PRO . 13.3 p30 -95.96 -50.3 4.93 Favored 'General case' 0 N--CA 1.421 -1.905 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 178.438 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.555 ' O ' ' HB ' ' A' ' 73' ' ' THR . . . -64.01 178.45 0.65 Allowed 'General case' 0 C--N 1.318 -0.77 0 C-N-CA 124.302 1.041 . . . . 0.0 109.08 164.028 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.555 ' HB ' ' O ' ' A' ' 72' ' ' ALA . 65.0 m 84.33 27.89 0.08 Allowed 'General case' 0 C--N 1.349 0.578 0 CA-C-O 124.052 1.882 . . . . 0.0 109.773 171.217 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.491 ' HB2' ' H ' ' A' ' 87' ' ' LEU . 1.5 m-20 -80.93 176.33 9.91 Favored 'General case' 0 C--N 1.288 -2.072 0 C-N-CA 118.002 -1.479 . . . . 0.0 109.803 -178.768 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.458 ' CD2' HD11 ' A' ' 84' ' ' LEU . 13.7 t80 -147.12 109.84 4.66 Favored 'General case' 0 C--N 1.289 -2.051 0 C-N-CA 119.273 -0.971 . . . . 0.0 111.498 -171.387 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.402 ' O ' ' HG ' ' A' ' 84' ' ' LEU . 37.9 mt-10 -131.24 116.99 18.37 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.988 172.568 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 88.5 t80 -115.03 132.6 56.55 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.007 -173.912 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.506 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 26.1 m-20 -92.02 178.71 5.8 Favored 'General case' 0 CA--C 1.488 -1.436 0 CA-C-O 121.387 0.613 . . . . 0.0 111.048 -179.447 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -79.74 -74.11 0.31 Allowed 'General case' 0 C--N 1.294 -1.819 0 CA-C-N 114.503 -1.226 . . . . 0.0 112.244 -177.957 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -92.1 -22.35 19.95 Favored 'General case' 0 CA--C 1.503 -0.862 0 CA-C-N 115.823 -0.626 . . . . 0.0 112.402 -174.798 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.506 ' HB ' ' HB2' ' A' ' 78' ' ' ASP . 59.7 m -68.64 -51.7 39.27 Favored 'General case' 0 N--CA 1.427 -1.602 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.535 178.677 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 98.0 mttt 63.18 2.77 1.15 Allowed 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 124.16 0.984 . . . . 0.0 113.255 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.613 ' HG2' HG22 ' A' ' 109' ' ' THR . 35.6 ttmt -94.45 94.53 8.29 Favored 'General case' 0 N--CA 1.427 -1.598 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 173.933 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.458 HD11 ' CD2' ' A' ' 75' ' ' TYR . 6.9 tt -66.15 144.11 56.87 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-N 113.191 -1.822 . . . . 0.0 111.845 -172.37 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.444 ' HA ' ' O ' ' A' ' 108' ' ' VAL . 10.1 t -110.03 125.54 53.03 Favored 'General case' 0 N--CA 1.411 -2.38 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.148 179.212 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 86.1 t -99.53 127.85 51.89 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.363 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.265 178.116 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.507 ' HA ' ' O ' ' A' ' 106' ' ' THR . 1.2 mm? -97.25 142.11 29.54 Favored 'General case' 0 N--CA 1.418 -2.055 0 CA-C-N 113.707 -1.588 . . . . 0.0 109.507 -177.235 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 58.8 mt -137.28 119.96 11.44 Favored Pre-proline 0 C--N 1.252 -3.633 0 CA-C-N 112.854 -1.975 . . . . 0.0 105.685 174.413 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.455 ' CG ' ' HB2' ' A' ' 71' ' ' ASP . 6.2 Cg_exo -22.41 -52.72 0.04 OUTLIER 'Trans proline' 0 C--N 1.37 1.691 1 C-N-CA 126.133 4.555 . . . . 0.0 116.445 -178.769 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 90' ' ' SER . . . . . 0.436 ' HB3' ' HB3' ' A' ' 166' ' ' ARG . 41.3 t -151.55 165.35 34.53 Favored 'General case' 0 N--CA 1.425 -1.695 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 -179.743 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.541 HD11 ' HD2' ' A' ' 103' ' ' LYS . 6.1 tt -72.3 112.38 7.88 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.979 0 CA-C-O 121.647 0.737 . . . . 0.0 110.37 178.41 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' CYS . . . . . 0.524 ' HB3' ' CE2' ' A' ' 104' ' ' PHE . 48.0 t -118.09 128.54 54.85 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 178.625 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -122.33 139.32 53.95 Favored 'General case' 0 C--N 1.292 -1.931 0 C-N-CA 119.218 -0.993 . . . . 0.0 110.158 176.614 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 34.4 m -124.28 106.67 17.2 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.168 -175.219 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.317 -0.518 0 C-N-CA 120.035 -1.079 . . . . 0.0 113.153 176.527 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 100' ' ' SER . . . . . 0.441 ' HA ' ' O ' ' A' ' 126' ' ' LYS . 73.6 p . . . . . 0 N--CA 1.394 -3.248 0 CA-C-O 121.221 0.534 . . . . 0.0 110.692 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 65.1 t -93.65 105.39 16.8 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.069 0 N-CA-C 107.03 -1.47 . . . . 0.0 107.03 172.02 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.437 HD23 ' H ' ' A' ' 126' ' ' LYS . 83.3 mt -118.53 114.63 23.11 Favored 'General case' 0 C--N 1.286 -2.187 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.99 -173.678 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.541 ' HD2' HD11 ' A' ' 91' ' ' ILE . 34.9 ttpt -103.55 113.17 26.47 Favored 'General case' 0 N--CA 1.427 -1.576 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.091 -179.313 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.524 ' CE2' ' HB3' ' A' ' 92' ' ' CYS 0.288 38.9 p90 -111.07 107.72 17.19 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-O 122.191 0.996 . . . . 0.0 112.538 179.467 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.609 ' H ' HG22 ' A' ' 123' ' ' ILE . 12.2 t -72.11 -175.74 1.57 Allowed 'General case' 0 N--CA 1.436 -1.151 0 CA-C-N 113.843 -1.526 . . . . 0.0 111.958 -177.378 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 106' ' ' THR . . . . . 0.507 ' O ' ' HA ' ' A' ' 87' ' ' LEU . 4.7 t -93.18 -27.64 16.76 Favored 'General case' 0 C--N 1.288 -2.102 0 CA-C-N 114.624 -1.171 . . . . 0.0 112.682 -173.26 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 25.0 m -139.73 95.35 2.9 Favored 'General case' 0 C--N 1.275 -2.672 0 N-CA-C 107.672 -1.232 . . . . 0.0 107.672 -178.478 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.444 ' O ' ' HA ' ' A' ' 85' ' ' THR . 3.4 p -103.83 160.36 4.73 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.52 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 -177.963 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.613 HG22 ' HG2' ' A' ' 83' ' ' LYS . 61.1 m -132.4 120.56 22.18 Favored 'General case' 0 N--CA 1.415 -2.219 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 -169.769 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -163.83 -159.43 10.8 Favored Glycine 0 C--O 1.208 -1.517 0 C-N-CA 120.474 -0.87 . . . . 0.0 113.097 -178.543 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 41.0 m80 -114.59 122.75 47.48 Favored 'General case' 0 CA--C 1.482 -1.664 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 178.47 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.517 HD11 ' HA ' ' A' ' 62' ' ' ASP . 5.2 tt -102.47 110.41 22.35 Favored 'General case' 0 C--N 1.285 -2.228 0 C-N-CA 119.965 -0.694 . . . . 0.0 109.278 -176.237 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -118.77 157.98 26.49 Favored 'General case' 0 CA--C 1.455 -2.678 0 CA-C-O 121.827 0.823 . . . . 0.0 109.445 174.122 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.468 ' HA ' ' HD3' ' A' ' 114' ' ' LYS . 16.5 mmtp -75.31 101.47 4.72 Favored 'General case' 0 C--N 1.245 -3.936 0 CA-C-O 122.687 1.232 . . . . 0.0 112.567 -178.492 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 121.59 -11.91 9.55 Favored Glycine 0 N--CA 1.411 -2.982 0 CA-C-N 113.195 -1.82 . . . . 0.0 110.021 -177.033 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -172.37 129.94 0.57 Allowed 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 113.363 0.875 . . . . 0.0 113.363 177.752 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.413 ' HB3' ' CG2' ' A' ' 136' ' ' ILE . 59.7 tp -97.39 104.23 16.23 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 106.46 -1.682 . . . . 0.0 106.46 172.664 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.458 ' HA ' ' CB ' ' A' ' 135' ' ' SER . 82.4 p -104.0 172.25 6.9 Favored 'General case' 0 C--N 1.311 -1.074 0 N-CA-C 111.803 0.297 . . . . 0.0 111.803 -173.301 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 57.76 46.17 17.59 Favored 'General case' 0 CA--C 1.496 -1.115 0 O-C-N 123.997 0.811 . . . . 0.0 110.7 172.71 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.415 HG21 HD11 ' A' ' 123' ' ' ILE 0.263 8.5 m -84.52 77.01 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.414 -2.266 0 CA-C-O 123.224 1.488 . . . . 0.0 111.962 -173.413 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -73.38 89.03 1.59 Allowed 'General case' 0 N--CA 1.394 -3.246 0 CA-C-N 112.287 -2.233 . . . . 0.0 110.293 -177.678 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 160.85 -22.91 0.24 Allowed Glycine 0 N--CA 1.413 -2.895 0 CA-C-N 115.085 -0.961 . . . . 0.0 110.801 176.504 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.609 HG22 ' H ' ' A' ' 105' ' ' THR . 18.6 pt -110.53 141.1 26.85 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.313 0 C-N-CA 119.62 -0.832 . . . . 0.0 111.657 -179.768 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -101.92 126.88 48.92 Favored 'General case' 0 C--N 1.294 -1.821 0 CA-C-N 114.795 -1.093 . . . . 0.0 110.331 177.479 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.401 HG23 HD22 ' A' ' 102' ' ' LEU . 97.4 m -115.49 109.74 18.27 Favored 'General case' 0 C--N 1.281 -2.394 0 CA-C-N 114.797 -1.092 . . . . 0.0 109.575 -178.297 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.441 ' O ' ' HA ' ' A' ' 100' ' ' SER . 6.6 tmtt? -114.56 134.73 54.82 Favored 'General case' 0 N--CA 1.421 -1.878 0 C-N-CA 120.441 -0.503 . . . . 0.0 110.45 174.102 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 89.7 t -130.19 -57.74 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.289 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 176.242 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 16.9 tpt -115.66 -34.86 4.71 Favored 'General case' 0 C--N 1.291 -1.971 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 173.984 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 7.8 tp -138.55 155.01 27.73 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.933 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.303 177.016 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 72.6 m95 -79.43 117.51 20.46 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 123.095 0.558 . . . . 0.0 110.872 179.343 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 17.5 m -129.93 157.16 42.54 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 174.107 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 48.0 pttt -126.84 28.48 5.83 Favored 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 -174.348 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 46.1 t -122.07 -83.07 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.15 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 175.472 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 134' ' ' THR . . . . . 0.431 ' HB ' ' H ' ' A' ' 135' ' ' SER . 33.8 p 42.6 -161.71 0.01 OUTLIER 'General case' 0 CA--C 1.559 1.324 0 N-CA-C 114.288 1.218 . . . . 0.0 114.288 -178.54 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 135' ' ' SER . . . . . 0.458 ' CB ' ' HA ' ' A' ' 118' ' ' THR . 89.6 p -171.81 157.75 4.66 Favored 'General case' 0 N--CA 1.414 -2.24 0 N-CA-C 106.801 -1.555 . . . . 0.0 106.801 176.167 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 136' ' ' ILE . . . . . 0.413 ' CG2' ' HB3' ' A' ' 117' ' ' LEU . 9.7 tt -100.44 113.02 34.87 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.94 0 N-CA-C 106.12 -1.808 . . . . 0.0 106.12 173.284 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 23.3 m -105.04 155.08 19.3 Favored 'General case' 0 N--CA 1.418 -2.074 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.676 -172.115 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 138' ' ' THR . . . . . 0.489 HG21 ' HB3' ' A' ' 63' ' ' LEU . 9.4 t -164.09 166.19 21.57 Favored 'General case' 0 C--N 1.282 -2.333 0 N-CA-C 106.922 -1.51 . . . . 0.0 106.922 178.59 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -111.86 64.77 0.62 Allowed 'General case' 0 C--N 1.268 -2.94 0 C-N-CA 117.682 -1.607 . . . . 0.0 106.808 170.296 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 140' ' ' ALA . . . . . 0.41 ' H ' HG23 ' A' ' 138' ' ' THR . . . 50.88 41.64 27.03 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 113.568 -1.651 . . . . 0.0 111.69 -178.036 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 141' ' ' SER . . . . . 0.564 ' O ' ' HD2' ' A' ' 155' ' ' ARG . 47.4 t 171.05 -84.78 0.0 OUTLIER 'General case' 0 C--N 1.346 0.447 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.387 -175.486 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 61.5 pttt -78.91 135.58 37.02 Favored 'General case' 0 CA--C 1.491 -1.326 0 C-N-CA 120.158 -0.617 . . . . 0.0 109.881 -177.31 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.433 ' HB ' HG21 ' A' ' 65' ' ' ILE . 5.3 p -105.52 147.02 11.75 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.91 0 CA-C-O 121.122 0.487 . . . . 0.0 111.474 -166.377 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -139.17 155.91 47.49 Favored 'General case' 0 CA--C 1.499 -0.983 0 CA-C-N 115.417 -0.81 . . . . 0.0 109.935 -179.058 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 145' ' ' PHE . . . . . 0.547 ' HB2' ' HB2' ' A' ' 151' ' ' LYS . 62.7 m-85 -105.8 114.67 28.96 Favored 'General case' 0 C--N 1.282 -2.345 0 CA-C-N 115.195 -0.912 . . . . 0.0 110.006 172.934 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.403 HG21 ' OG ' ' A' ' 135' ' ' SER . 8.8 t -70.44 2.79 3.52 Favored 'General case' 0 CA--C 1.554 1.115 0 CA-C-N 114.739 -1.119 . . . . 0.0 113.051 -172.089 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -63.16 -17.04 61.95 Favored 'General case' 0 C--O 1.221 -0.407 0 CA-C-O 121.332 0.587 . . . . 0.0 111.0 -178.259 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 156.3 31.53 0.03 OUTLIER Glycine 0 CA--C 1.492 -1.399 0 N-CA-C 110.107 -1.197 . . . . 0.0 110.107 172.505 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 53.1 ttm 58.83 19.72 7.26 Favored 'General case' 0 C--N 1.361 1.081 0 CA-C-O 122.42 1.105 . . . . 0.0 108.482 -173.099 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 150' ' ' LYS . . . . . 0.472 ' O ' ' HE3' ' A' ' 151' ' ' LYS . 17.5 ptpt -85.13 1.78 46.43 Favored 'General case' 0 N--CA 1.44 -0.972 0 CA-C-N 114.628 -1.169 . . . . 0.0 113.634 -172.991 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 151' ' ' LYS . . . . . 0.547 ' HB2' ' HB2' ' A' ' 145' ' ' PHE . 5.1 mmpt? -147.16 118.34 7.78 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 123.218 0.607 . . . . 0.0 109.818 176.247 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 23.7 p -133.01 132.96 42.47 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 177.081 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 153' ' ' ARG . . . . . 0.425 HH11 ' HD3' ' A' ' 153' ' ' ARG . 25.4 mmt180 -138.7 155.18 48.46 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 122.154 0.181 . . . . 0.0 110.539 179.499 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 70.1 p -79.11 119.91 22.9 Favored 'General case' 0 C--O 1.25 1.086 0 N-CA-C 113.528 0.936 . . . . 0.0 113.528 -175.552 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 155' ' ' ARG . . . . . 0.564 ' HD2' ' O ' ' A' ' 141' ' ' SER . 28.7 ttt180 -71.07 -35.92 72.08 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.073 0.463 . . . . 0.0 111.021 176.327 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -50.11 -41.81 49.22 Favored 'General case' 0 C--N 1.314 -0.943 0 C-N-CA 123.721 0.809 . . . . 0.0 112.528 -175.694 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -71.1 -52.36 19.79 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.921 -178.95 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 99.1 m-85 -149.36 -23.13 0.29 Allowed 'General case' 0 N--CA 1.484 1.254 0 N-CA-C 112.028 0.381 . . . . 0.0 112.028 -179.191 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 159' ' ' GLY . . . . . 0.419 ' HA2' ' HA ' ' A' ' 155' ' ' ARG . . . 128.73 -90.41 0.32 Allowed Glycine 0 N--CA 1.446 -0.646 0 N-CA-C 109.008 -1.637 . . . . 0.0 109.008 -172.901 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.608 HG22 ' O ' ' A' ' 67' ' ' ILE . 22.8 m -98.45 144.78 10.97 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.764 0 N-CA-C 106.285 -1.746 . . . . 0.0 106.285 173.194 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 14.8 mm100 -113.62 90.1 3.26 Favored 'General case' 0 C--N 1.3 -1.572 0 C-N-CA 119.022 -1.071 . . . . 0.0 111.447 -176.526 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -154.75 150.03 27.14 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 173.5 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 50.0 t30 -88.61 104.81 17.2 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-O 121.254 0.55 . . . . 0.0 110.553 177.566 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -142.63 150.51 22.27 Favored Glycine 0 CA--C 1.484 -1.876 0 N-CA-C 108.937 -1.665 . . . . 0.0 108.937 177.561 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -142.74 118.98 10.8 Favored 'General case' 0 N--CA 1.419 -2.018 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 176.784 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 166' ' ' ARG . . . . . 0.436 ' HB3' ' HB3' ' A' ' 90' ' ' SER . 0.0 OUTLIER -58.05 136.13 57.1 Favored 'General case' 0 N--CA 1.427 -1.577 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 173.31 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 48.6 t -53.28 -40.66 40.37 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.925 0 O-C-N 123.947 0.78 . . . . 0.0 110.148 175.127 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -86.07 70.79 10.62 Favored 'General case' 0 CA--C 1.503 -0.832 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.598 174.535 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 169' ' ' LYS . . . . . 0.411 ' O ' ' HB2' ' A' ' 170' ' ' PHE . 59.7 tttp -152.93 119.09 5.49 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.411 177.491 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 170' ' ' PHE . . . . . 0.411 ' HB2' ' O ' ' A' ' 169' ' ' LYS . 59.4 t80 . . . . . 0 C--O 1.252 1.194 0 N-CA-C 106.667 -1.605 . . . . 0.0 106.667 174.366 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.679 ' O ' ' HG ' ' A' ' 58' ' ' LEU . 1.8 mm? . . . . . 0 CA--C 1.495 -1.163 0 CA-C-O 118.938 -0.553 . . . . 0.0 111.139 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.579 ' HA ' HD11 ' A' ' 58' ' ' LEU . 24.7 Cg_exo -60.84 -25.44 81.23 Favored 'Trans proline' 0 C--N 1.386 2.53 0 C-N-CA 121.103 1.202 . . . . 0.0 111.185 -172.581 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -76.18 -47.69 23.23 Favored 'General case' 0 N--CA 1.433 -1.303 0 CA-C-N 114.884 -1.053 . . . . 0.0 109.031 179.681 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.5 ' HA ' ' HG2' ' A' ' 60' ' ' GLU . 52.1 tp -63.83 -48.86 75.11 Favored 'General case' 0 C--N 1.313 -1.021 0 C-N-CA 124.562 1.145 . . . . 0.0 111.497 -179.164 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.679 ' HG ' ' O ' ' A' ' 54' ' ' LEU 0.339 2.4 pp -67.1 -33.85 76.36 Favored 'General case' 0 N--CA 1.428 -1.547 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 -177.995 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.499 ' HG2' ' O ' ' A' ' 55' ' ' PRO . 23.1 pttp -76.56 -30.9 57.26 Favored 'General case' 0 C--O 1.222 -0.367 0 C-N-CA 119.442 -0.903 . . . . 0.0 111.875 175.363 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.5 ' HG2' ' HA ' ' A' ' 57' ' ' LEU . 12.7 pt-20 -76.69 -40.18 49.65 Favored 'General case' 0 CA--C 1.509 -0.601 0 C-N-CA 120.038 -0.665 . . . . 0.0 111.737 -177.368 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 27.7 m-85 -68.64 -19.37 64.41 Favored 'General case' 0 C--O 1.24 0.582 0 C-N-CA 119.0 -1.08 . . . . 0.0 113.035 174.3 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.483 ' O ' ' HE3' ' A' ' 114' ' ' LYS . 12.1 t0 -95.39 176.12 6.31 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.132 178.267 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.727 ' HB2' HD12 ' A' ' 65' ' ' ILE . 13.8 mt -71.39 179.81 0.88 Allowed Pre-proline 0 CA--C 1.577 1.985 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 -177.184 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_endo -88.03 12.66 2.79 Favored 'Trans proline' 0 N--CA 1.45 -1.035 0 C-N-CA 122.211 1.941 . . . . 0.0 111.801 -175.613 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.747 HG12 ' H ' ' A' ' 67' ' ' ILE . 0.2 OUTLIER -68.84 -42.02 82.46 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 178.017 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 58.87 8.79 6.16 Favored Glycine 0 N--CA 1.496 2.644 0 CA-C-O 121.956 0.753 . . . . 0.0 112.163 -176.412 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.747 ' H ' HG12 ' A' ' 65' ' ' ILE . 62.6 mt 56.63 -70.05 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.192 -1.973 0 C-N-CA 128.294 2.638 . . . . 0.0 112.307 -173.544 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.494 ' HB3' ' HD3' ' A' ' 69' ' ' PRO . 88.2 t80 175.2 -61.24 0.0 OUTLIER Pre-proline 0 CA--C 1.543 0.692 0 N-CA-C 112.762 0.653 . . . . 0.0 112.762 -174.539 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.494 ' HD3' ' HB3' ' A' ' 68' ' ' PHE . 3.4 Cg_endo -84.49 -21.23 3.62 Favored 'Trans proline' 0 N--CA 1.447 -1.232 0 C-N-CA 121.409 1.406 . . . . 0.0 114.584 -168.004 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 83.38 -11.5 55.28 Favored Glycine 0 C--O 1.224 -0.497 0 N-CA-C 111.006 -0.837 . . . . 0.0 111.006 -175.576 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.579 ' HB3' ' HG2' ' A' ' 89' ' ' PRO . 20.1 m-20 -83.21 -42.0 17.77 Favored 'General case' 0 N--CA 1.438 -1.038 0 N-CA-C 105.587 -2.005 . . . . 0.0 105.587 177.955 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.52 ' O ' ' HB ' ' A' ' 73' ' ' THR . . . -75.89 -178.35 4.27 Favored 'General case' 0 CA--C 1.546 0.793 0 CA-C-N 113.695 -1.593 . . . . 0.0 109.719 175.217 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.522 ' O ' HG22 ' A' ' 73' ' ' THR . 41.3 m 84.44 26.11 0.09 Allowed 'General case' 0 N--CA 1.49 1.554 0 CA-C-O 124.544 2.116 . . . . 0.0 110.178 175.131 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.584 ' O ' ' HA ' ' A' ' 86' ' ' VAL . 3.1 m-20 -81.07 136.86 36.0 Favored 'General case' 0 C--N 1.272 -2.791 0 CA-C-N 114.527 -1.215 . . . . 0.0 110.16 -178.988 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 43.1 t80 -113.11 90.2 3.28 Favored 'General case' 0 C--N 1.277 -2.552 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.693 -169.965 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.505 ' O ' HD22 ' A' ' 84' ' ' LEU . 13.2 mm-40 -122.85 150.98 42.16 Favored 'General case' 0 C--O 1.202 -1.415 0 N-CA-C 106.934 -1.506 . . . . 0.0 106.934 179.073 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 46.8 p90 -146.89 144.26 29.13 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-N 119.514 1.052 . . . . 0.0 111.334 176.804 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.588 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 10.8 m-20 -92.01 165.83 13.0 Favored 'General case' 0 CA--C 1.481 -1.705 0 CA-C-O 121.258 0.551 . . . . 0.0 109.542 -178.341 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.425 ' O ' ' HG3' ' A' ' 82' ' ' LYS . 48.8 mt-10 -82.35 -43.79 16.98 Favored 'General case' 0 C--N 1.281 -2.383 0 CA-C-N 114.859 -1.064 . . . . 0.0 112.414 176.25 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -65.25 -33.09 75.18 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 122.62 1.2 . . . . 0.0 109.424 -179.81 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.588 ' HB ' ' HB2' ' A' ' 78' ' ' ASP . 29.7 m -85.23 -52.96 5.55 Favored 'General case' 0 N--CA 1.404 -2.766 0 CA-C-N 113.04 -1.891 . . . . 0.0 110.54 -178.056 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.425 ' HG3' ' O ' ' A' ' 79' ' ' GLU . 62.9 mttp 64.16 8.85 4.32 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 124.211 1.004 . . . . 0.0 109.892 -173.152 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.539 ' HG2' ' CG2' ' A' ' 81' ' ' THR 0.25 14.1 pttt -117.48 146.99 43.14 Favored 'General case' 0 N--CA 1.404 -2.773 0 CA-C-N 114.612 -1.176 . . . . 0.0 109.156 -177.459 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.505 HD22 ' O ' ' A' ' 76' ' ' GLU . 1.8 tm? -73.96 130.19 39.37 Favored 'General case' 0 C--N 1.279 -2.481 0 CA-C-N 115.288 -0.869 . . . . 0.0 111.82 -167.26 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.422 ' HA ' ' O ' ' A' ' 108' ' ' VAL . 74.5 p -111.3 111.95 23.37 Favored 'General case' 0 N--CA 1.411 -2.399 0 CA-C-N 114.892 -1.049 . . . . 0.0 109.063 177.549 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.584 ' HA ' ' O ' ' A' ' 74' ' ' ASN . 86.2 t -91.19 122.46 42.62 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.253 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 177.546 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.532 ' HA ' ' O ' ' A' ' 106' ' ' THR 0.388 1.0 OUTLIER -104.04 102.46 12.22 Favored 'General case' 0 N--CA 1.389 -3.483 0 CA-C-O 122.923 1.344 . . . . 0.0 112.782 -179.042 . . . . . . . . 4 4 . 1 . 018 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.48 ' O ' HG23 ' A' ' 106' ' ' THR . 69.0 mt -85.56 128.54 58.62 Favored Pre-proline 0 C--N 1.279 -2.487 0 CA-C-N 113.038 -1.892 . . . . 0.0 108.888 -176.824 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.579 ' HG2' ' HB3' ' A' ' 71' ' ' ASP . 50.6 Cg_exo -61.97 109.71 0.86 Allowed 'Trans proline' 0 CA--C 1.504 -0.988 0 C-N-CA 122.708 2.272 . . . . 0.0 110.563 177.926 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 30.4 t 69.26 179.55 0.24 Allowed 'General case' 0 CA--C 1.552 1.037 0 O-C-N 124.019 0.824 . . . . 0.0 110.357 -177.494 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.583 HD11 ' HG3' ' A' ' 103' ' ' LYS . 0.0 OUTLIER -112.58 132.35 61.58 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.784 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.007 177.692 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 92' ' ' CYS . . . . . 0.623 ' SG ' ' HB2' ' A' ' 104' ' ' PHE . 28.1 p -112.28 124.42 52.42 Favored 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 175.618 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.448 ' OE1' ' HE2' ' A' ' 103' ' ' LYS . 35.9 tt0 -124.2 129.72 51.29 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 178.823 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.505 ' O ' ' HA ' ' A' ' 101' ' ' VAL . 20.8 m -122.36 114.63 43.31 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.994 0 CA-C-O 121.234 0.54 . . . . 0.0 111.074 179.132 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.427 -1.941 0 N-CA-C 108.332 -1.907 . . . . 0.0 108.332 178.107 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 31.1 p . . . . . 0 N--CA 1.398 -3.039 0 CA-C-O 121.221 0.534 . . . . 0.0 110.555 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.507 ' O ' ' HA ' ' A' ' 125' ' ' THR . 17.2 m -125.9 101.09 7.62 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 CA-C-N 115.079 -0.964 . . . . 0.0 108.89 172.154 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.606 ' HG ' ' OG1' ' A' ' 125' ' ' THR . 5.4 mp -123.45 125.69 45.4 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.829 -173.467 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.583 ' HG3' HD11 ' A' ' 91' ' ' ILE . 39.3 ttmt -112.46 113.1 25.11 Favored 'General case' 0 C--N 1.317 -0.82 0 O-C-N 123.127 0.267 . . . . 0.0 110.371 176.738 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.623 ' HB2' ' SG ' ' A' ' 92' ' ' CYS . 96.1 m-85 -103.67 98.94 8.73 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 175.315 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 87.1 m -74.37 159.96 31.66 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 115.095 -0.957 . . . . 0.0 111.378 -178.173 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' THR . . . . . 0.532 ' O ' ' HA ' ' A' ' 87' ' ' LEU . 90.2 m -57.93 -67.94 0.29 Allowed 'General case' 0 N--CA 1.431 -1.381 0 C-N-CA 124.665 1.186 . . . . 0.0 111.373 178.616 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 37.4 p -96.12 90.23 5.45 Favored 'General case' 0 N--CA 1.431 -1.4 0 C-N-CA 119.512 -0.875 . . . . 0.0 111.961 179.839 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.422 ' O ' ' HA ' ' A' ' 85' ' ' THR . 17.6 m -95.17 132.21 39.82 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 CA-C-N 115.538 -0.756 . . . . 0.0 109.649 176.443 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 30.3 m -114.94 120.06 38.64 Favored 'General case' 0 N--CA 1.413 -2.29 0 N-CA-C 108.712 -0.848 . . . . 0.0 108.712 -173.648 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' GLY . . . . . 0.549 ' HA2' ' O ' ' A' ' 119' ' ' ASP . . . -150.99 161.79 29.18 Favored Glycine 0 N--CA 1.435 -1.393 0 C-N-CA 121.132 -0.556 . . . . 0.0 111.967 -177.626 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 84.2 t60 -84.81 90.8 7.84 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 178.524 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.542 ' HB2' HD13 ' A' ' 117' ' ' LEU . 5.4 tt -89.52 107.81 19.29 Favored 'General case' 0 N--CA 1.417 -2.1 0 N-CA-C 106.649 -1.611 . . . . 0.0 106.649 179.218 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -108.36 153.12 23.72 Favored 'General case' 0 N--CA 1.385 -3.705 0 N-CA-C 104.655 -2.35 . . . . 0.0 104.655 174.853 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.483 ' HE3' ' O ' ' A' ' 62' ' ' ASP . 21.4 tptm -75.2 101.5 4.65 Favored 'General case' 0 C--N 1.277 -2.566 0 C-N-CA 117.781 -1.568 . . . . 0.0 109.015 -176.221 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 115' ' ' GLY . . . . . 0.441 ' O ' HG23 ' A' ' 138' ' ' THR . . . 140.64 -24.42 2.62 Favored Glycine 0 C--O 1.19 -2.649 0 CA-C-N 114.043 -1.435 . . . . 0.0 110.236 -175.228 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 19.7 ptmt -173.98 151.2 1.71 Allowed 'General case' 0 N--CA 1.492 1.632 0 CA-C-N 117.643 0.721 . . . . 0.0 111.919 -179.038 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.542 HD13 ' HB2' ' A' ' 112' ' ' LEU . 27.3 tp -118.07 105.35 11.76 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 178.729 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 33.4 p -109.31 144.84 36.93 Favored 'General case' 0 C--N 1.295 -1.787 0 N-CA-C 113.681 0.993 . . . . 0.0 113.681 -176.26 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' ASP . . . . . 0.549 ' O ' ' HA2' ' A' ' 110' ' ' GLY . 31.5 m-20 60.81 94.06 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 124.885 1.274 . . . . 0.0 111.131 177.447 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 11.2 m -116.53 91.09 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.425 -1.715 0 CA-C-O 122.493 1.139 . . . . 0.0 113.009 -173.284 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -66.77 103.43 1.11 Allowed 'General case' 0 C--N 1.29 -1.999 0 CA-C-N 113.785 -1.552 . . . . 0.0 110.251 175.697 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 139.6 -20.68 2.92 Favored Glycine 0 N--CA 1.432 -1.607 0 CA-C-N 115.11 -0.95 . . . . 0.0 112.008 178.736 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 73.9 mt -101.56 108.17 23.02 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 CA-C-O 120.937 0.399 . . . . 0.0 110.267 -179.333 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 29.0 ttpp -101.23 130.93 47.44 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 176.033 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.606 ' OG1' ' HG ' ' A' ' 102' ' ' LEU . 15.1 t -157.53 163.81 38.01 Favored 'General case' 0 C--N 1.302 -1.498 0 C-N-CA 120.27 -0.572 . . . . 0.0 110.217 -175.822 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.42 ' HB2' ' CD1' ' A' ' 130' ' ' TRP . 74.3 tttt -127.51 142.83 51.28 Favored 'General case' 0 C--N 1.276 -2.609 0 CA-C-N 115.52 -0.763 . . . . 0.0 109.354 174.964 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.447 HG11 ' HB2' ' A' ' 150' ' ' LYS . 83.6 t -110.92 -78.93 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.421 -1.918 0 N-CA-C 107.227 -1.398 . . . . 0.0 107.227 167.679 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 128' ' ' MET . . . . . 0.482 ' C ' HD12 ' A' ' 129' ' ' ILE . 26.3 ttt -105.49 -32.16 8.65 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 176.287 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 129' ' ' ILE . . . . . 0.482 HD12 ' C ' ' A' ' 128' ' ' MET . 2.7 mp -130.83 154.42 40.66 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.747 0 N-CA-C 107.057 -1.461 . . . . 0.0 107.057 175.954 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 130' ' ' TRP . . . . . 0.42 ' CD1' ' HB2' ' A' ' 126' ' ' LYS . 12.7 m-90 -70.95 134.12 46.95 Favored 'General case' 0 C--O 1.242 0.696 0 CA-C-O 120.845 0.355 . . . . 0.0 110.969 178.895 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 3.7 m -135.34 162.5 37.7 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 C-N-CA 123.803 0.841 . . . . 0.0 111.282 177.79 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -137.77 9.87 2.86 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 112.265 0.468 . . . . 0.0 112.265 -175.673 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 59.1 t -118.12 -69.12 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 C-N-CA 120.307 -0.557 . . . . 0.0 110.04 178.664 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 76.4 p 54.96 -178.6 0.03 OUTLIER 'General case' 0 C--O 1.247 0.944 0 N-CA-C 114.987 1.477 . . . . 0.0 114.987 177.954 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 36.1 p -164.96 146.84 7.94 Favored 'General case' 0 N--CA 1.422 -1.861 0 CA-C-N 114.955 -1.02 . . . . 0.0 109.056 177.912 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 136' ' ' ILE . . . . . 0.478 ' CG2' ' HB3' ' A' ' 117' ' ' LEU . 10.7 tt -113.68 107.95 24.25 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 175.377 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 33.3 p -100.6 148.93 24.27 Favored 'General case' 0 N--CA 1.398 -3.042 0 CA-C-O 121.713 0.768 . . . . 0.0 110.926 -177.166 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 138' ' ' THR . . . . . 0.441 HG23 ' O ' ' A' ' 115' ' ' GLY . 6.1 t -165.31 176.12 8.61 Favored 'General case' 0 N--CA 1.4 -2.958 0 N-CA-C 106.765 -1.569 . . . . 0.0 106.765 -176.778 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -115.26 29.05 8.28 Favored 'General case' 0 C--N 1.277 -2.544 0 N-CA-C 105.859 -1.904 . . . . 0.0 105.859 172.567 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . 66.04 54.72 0.97 Allowed 'General case' 0 C--O 1.242 0.685 0 CA-C-N 113.886 -1.507 . . . . 0.0 107.321 -171.497 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 44.4 t -168.0 -81.41 0.02 OUTLIER 'General case' 0 N--CA 1.443 -0.785 0 CA-C-N 114.405 -1.271 . . . . 0.0 111.327 -174.772 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -95.59 150.03 20.79 Favored 'General case' 0 C--O 1.203 -1.383 0 C-N-CA 122.913 0.485 . . . . 0.0 110.477 -176.429 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.668 ' HB ' ' O ' ' A' ' 153' ' ' ARG . 67.8 t -105.65 114.48 45.19 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.118 0 CA-C-O 121.749 0.785 . . . . 0.0 112.477 -173.081 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 82.0 m-85 -117.89 113.29 21.53 Favored 'General case' 0 N--CA 1.422 -1.858 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 174.469 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 69.2 t80 -83.37 106.7 15.34 Favored 'General case' 0 C--N 1.288 -2.08 0 N-CA-C 108.582 -0.895 . . . . 0.0 108.582 -177.86 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . 0.406 5.6 p -86.52 78.1 9.28 Favored 'General case' 0 N--CA 1.389 -3.517 0 N-CA-C 116.658 2.095 . . . . 0.0 116.658 -173.802 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -126.7 76.17 1.61 Allowed 'General case' 0 N--CA 1.417 -2.124 0 N-CA-C 104.737 -2.32 . . . . 0.0 104.737 168.115 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 78.75 7.12 88.38 Favored Glycine 0 N--CA 1.441 -1.027 0 CA-C-N 114.195 -1.366 . . . . 0.0 111.274 -174.907 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 149' ' ' MET . . . . . 0.423 ' O ' ' HG2' ' A' ' 149' ' ' MET . 27.3 ttt 63.67 15.75 9.19 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 124.538 1.135 . . . . 0.0 109.397 -175.682 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 150' ' ' LYS . . . . . 0.447 ' HB2' HG11 ' A' ' 127' ' ' VAL . 64.3 mttp -66.21 -26.95 67.62 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 114.993 -1.003 . . . . 0.0 113.476 -175.24 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 151' ' ' LYS . . . . . 0.636 ' HE2' ' HA ' ' A' ' 151' ' ' LYS . 8.2 mmpt? -114.13 136.73 52.61 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.012 0.434 . . . . 0.0 110.472 179.247 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 43.3 m -132.18 126.26 33.18 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 178.58 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 153' ' ' ARG . . . . . 0.668 ' O ' ' HB ' ' A' ' 143' ' ' VAL . 7.0 tpm_? -133.37 108.46 8.71 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 -176.86 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 16.2 m -61.08 128.96 38.99 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 175.524 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 155' ' ' ARG . . . . . 0.442 ' HD3' ' C ' ' A' ' 155' ' ' ARG . 2.5 tmt_? -59.24 -29.47 67.56 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 123.516 0.727 . . . . 0.0 109.299 -179.664 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -41.1 -41.12 1.66 Allowed 'General case' 0 C--N 1.314 -0.936 0 C-N-CA 125.615 1.566 . . . . 0.0 113.735 178.286 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -57.45 -53.11 61.84 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -176.397 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -178.88 20.46 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.172 0 N-CA-C 107.721 -1.214 . . . . 0.0 107.721 -179.202 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 159' ' ' GLY . . . . . 0.562 ' HA3' ' O ' ' A' ' 65' ' ' ILE . . . 95.85 -98.21 2.19 Favored Glycine 0 N--CA 1.405 -3.429 0 N-CA-C 108.901 -1.679 . . . . 0.0 108.901 -170.631 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.546 HG23 ' HB ' ' A' ' 65' ' ' ILE . 3.5 t -121.99 114.14 41.61 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.769 0 N-CA-C 105.793 -1.928 . . . . 0.0 105.793 176.385 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 161' ' ' GLN . . . . . 0.416 ' HG2' ' CE1' ' A' ' 68' ' ' PHE . 0.8 OUTLIER -132.51 98.3 4.32 Favored 'General case' 0 C--N 1.29 -2.02 0 C-N-CA 118.033 -1.467 . . . . 0.0 110.295 -171.012 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 39.8 ttm180 -153.26 100.61 2.47 Favored 'General case' 0 N--CA 1.428 -1.544 0 C-N-CA 120.441 -0.504 . . . . 0.0 109.89 170.816 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 51.41 -33.55 0.01 OUTLIER 'General case' 0 N--CA 1.509 2.477 0 N-CA-C 119.179 3.029 . . . . 0.0 119.179 171.415 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -60.75 111.39 3.7 Favored Glycine 0 C--N 1.315 -0.637 0 N-CA-C 115.647 1.019 . . . . 0.0 115.647 -173.637 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 44.9 tp -124.22 118.78 27.61 Favored 'General case' 0 N--CA 1.425 -1.681 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 176.859 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 166' ' ' ARG . . . . . 0.44 ' HB3' ' O ' ' A' ' 89' ' ' PRO . 6.3 mpt_? -78.14 117.6 19.58 Favored 'General case' 0 CA--C 1.479 -1.771 0 CA-C-O 121.112 0.482 . . . . 0.0 110.196 -177.531 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 4.3 m -78.05 62.34 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.947 0 CA-C-O 122.3 1.048 . . . . 0.0 113.233 179.145 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -111.65 -21.7 11.57 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 106.871 -1.529 . . . . 0.0 106.871 172.861 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 23.7 ttmm -91.12 101.92 14.66 Favored 'General case' 0 N--CA 1.425 -1.715 0 CA-C-N 113.551 -1.658 . . . . 0.0 110.413 -175.642 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 170' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 . . . . . 0 C--N 1.309 -1.193 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 177.268 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.52 ' O ' HD13 ' A' ' 58' ' ' LEU . 19.0 mt . . . . . 0 N--CA 1.475 0.789 0 N-CA-C 113.724 1.009 . . . . 0.0 113.724 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_exo -62.98 -15.57 48.64 Favored 'Trans proline' 0 C--N 1.372 1.795 0 C-N-CA 121.577 1.518 . . . . 0.0 113.068 -168.936 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 15.2 mm-40 -78.9 -36.97 41.14 Favored 'General case' 0 N--CA 1.423 -1.813 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 -174.083 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -76.05 -32.58 59.38 Favored 'General case' 0 N--CA 1.431 -1.397 0 CA-C-N 115.019 -0.991 . . . . 0.0 110.74 176.699 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.551 ' HG ' ' CE1' ' A' ' 75' ' ' TYR 0.253 4.6 mp -71.12 -44.21 66.08 Favored 'General case' 0 CA--C 1.487 -1.462 0 C-N-CA 120.346 -0.542 . . . . 0.0 111.722 -177.824 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.41 -25.79 66.93 Favored 'General case' 0 C--O 1.218 -0.579 0 CA-C-O 122.536 1.16 . . . . 0.0 109.972 176.432 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 18.5 tt0 -71.97 -28.58 63.52 Favored 'General case' 0 N--CA 1.428 -1.562 0 CA-C-N 114.024 -1.444 . . . . 0.0 112.251 175.807 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 72.6 t80 -83.74 -36.31 23.75 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 176.084 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 55.4 t0 -78.4 -171.05 2.27 Favored 'General case' 0 C--O 1.255 1.363 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 177.698 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.729 ' HB2' HD12 ' A' ' 65' ' ' ILE . 7.0 mt -82.82 -178.9 1.29 Allowed Pre-proline 0 CA--C 1.575 1.923 0 N-CA-C 106.384 -1.709 . . . . 0.0 106.384 179.4 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.442 ' HD3' ' HB3' ' A' ' 63' ' ' LEU . 3.4 Cg_endo -89.66 16.74 1.69 Allowed 'Trans proline' 0 N--CA 1.451 -1.011 0 CA-C-N 121.752 1.662 . . . . 0.0 110.669 -173.485 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.729 HD12 ' HB2' ' A' ' 63' ' ' LEU . 0.2 OUTLIER -72.64 -38.05 57.76 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.867 0 CA-C-N 114.73 -1.123 . . . . 0.0 109.29 -179.107 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.405 ' H ' HD13 ' A' ' 65' ' ' ILE . . . 59.09 4.34 2.35 Favored Glycine 0 N--CA 1.484 1.839 0 CA-C-N 115.495 -0.775 . . . . 0.0 112.769 -177.661 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.664 ' H ' HG12 ' A' ' 65' ' ' ILE . 20.3 mt 65.66 -68.65 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.224 0 C-N-CA 127.663 2.385 . . . . 0.0 112.025 -176.837 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.553 ' HA ' ' CD2' ' A' ' 158' ' ' TYR . 70.5 t80 169.34 -52.87 0.0 OUTLIER Pre-proline 0 C--N 1.322 -0.619 0 C-N-CA 124.013 0.925 . . . . 0.0 110.192 179.657 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.51 ' HD3' ' HB3' ' A' ' 68' ' ' PHE . 7.1 Cg_exo -81.29 143.48 13.97 Favored 'Trans proline' 0 C--N 1.369 1.637 0 C-N-CA 121.636 1.558 . . . . 0.0 110.229 177.444 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -71.85 -17.13 76.64 Favored Glycine 0 C--N 1.314 -0.644 0 C-N-CA 121.177 -0.535 . . . . 0.0 113.061 -177.979 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -90.7 -10.69 42.16 Favored 'General case' 0 C--O 1.201 -1.449 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 179.531 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.605 ' HA ' ' O ' ' A' ' 87' ' ' LEU . . . -82.89 -171.48 3.57 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.147 173.21 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.59 HG22 ' O ' ' A' ' 72' ' ' ALA . 6.0 t 72.39 26.9 2.54 Favored 'General case' 0 N--CA 1.501 2.121 0 C-N-CA 126.184 1.794 . . . . 0.0 109.53 169.2 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.445 ' HA ' ' HB3' ' A' ' 58' ' ' LEU . 28.2 m-80 -87.53 -169.48 2.62 Favored 'General case' 0 N--CA 1.417 -2.076 0 CA-C-N 113.599 -1.637 . . . . 0.0 108.852 -179.746 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.667 ' HB2' HD11 ' A' ' 84' ' ' LEU . 49.9 p90 -158.98 119.71 3.25 Favored 'General case' 0 C--N 1.311 -1.106 0 C-N-CA 118.889 -1.125 . . . . 0.0 113.649 -176.623 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.675 ' O ' HG22 ' A' ' 85' ' ' THR . 51.8 mt-10 -146.55 92.2 2.13 Favored 'General case' 0 CA--C 1.577 2.001 0 N-CA-C 114.58 1.326 . . . . 0.0 114.58 175.365 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.662 ' HB2' ' HA ' ' A' ' 84' ' ' LEU 0.437 30.3 m-85 -169.45 154.76 5.84 Favored 'General case' 0 N--CA 1.506 2.362 0 C-N-CA 128.105 2.562 . . . . 0.0 110.894 165.859 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.487 ' HB2' ' HB ' ' A' ' 81' ' ' THR 0.259 8.3 m-20 -50.99 142.96 11.06 Favored 'General case' 0 CA--C 1.48 -1.748 0 CA-C-O 122.074 0.94 . . . . 0.0 110.42 -179.874 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -81.11 -31.23 34.37 Favored 'General case' 1 C--N 1.24 -4.185 0 CA-C-N 113.867 -1.515 . . . . 0.0 111.753 178.493 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.413 ' HG2' ' HB3' ' A' ' 78' ' ' ASP . 12.9 pt-20 -65.9 -30.08 70.62 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 122.227 1.013 . . . . 0.0 108.626 177.227 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.487 ' HB ' ' HB2' ' A' ' 78' ' ' ASP . 95.5 m -78.73 -39.13 37.13 Favored 'General case' 0 N--CA 1.414 -2.268 0 CA-C-N 113.5 -1.682 . . . . 0.0 109.571 177.546 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.68 ' HE2' ' HA ' ' A' ' 82' ' ' LYS . 3.3 mmpt? 71.95 15.29 5.7 Favored 'General case' 0 CA--C 1.494 -1.188 0 C-N-CA 124.067 0.947 . . . . 0.0 112.864 -177.492 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.423 ' C ' ' HB2' ' A' ' 77' ' ' PHE . 37.2 ttpt -93.81 173.02 7.88 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 104.212 -2.514 . . . . 0.0 104.212 172.299 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.679 HD23 HD13 ' A' ' 112' ' ' LEU . 20.8 tp 176.24 121.93 0.03 OUTLIER 'General case' 0 CA--C 1.475 -1.912 0 CA-C-N 119.134 0.879 . . . . 0.0 108.99 -169.181 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.675 HG22 ' O ' ' A' ' 76' ' ' GLU . 14.5 t -92.2 129.93 38.03 Favored 'General case' 0 N--CA 1.392 -3.344 0 C-N-CA 118.976 -1.09 . . . . 0.0 108.252 174.537 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 62.3 t -103.92 116.61 48.01 Favored 'Isoleucine or valine' 0 N--CA 1.4 -2.975 0 CA-C-N 115.264 -0.88 . . . . 0.0 108.655 179.623 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.605 ' O ' ' HA ' ' A' ' 72' ' ' ALA . 2.0 mm? -75.1 123.16 24.72 Favored 'General case' 0 N--CA 1.41 -2.456 0 CA-C-N 113.783 -1.553 . . . . 0.0 110.673 -176.337 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 74.8 mt -107.51 137.16 19.6 Favored Pre-proline 0 C--N 1.281 -2.375 0 N-CA-C 105.225 -2.139 . . . . 0.0 105.225 170.881 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.465 ' O ' ' HB2' ' A' ' 166' ' ' ARG . 17.9 Cg_endo -58.21 84.87 0.05 OUTLIER 'Trans proline' 0 CA--C 1.541 0.825 0 C-N-CA 123.275 2.65 . . . . 0.0 112.523 178.175 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' SER . . . . . 0.438 ' HB3' ' HB ' ' A' ' 167' ' ' VAL . 24.2 m 69.33 163.89 0.24 Allowed 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 125.489 1.516 . . . . 0.0 112.46 -179.385 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 9.3 tt -62.82 135.34 27.34 Favored 'Isoleucine or valine' 0 C--O 1.242 0.69 0 CA-C-O 121.361 0.601 . . . . 0.0 109.864 177.383 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' CYS . . . . . 0.528 ' SG ' ' HB2' ' A' ' 104' ' ' PHE . 3.7 p -132.76 139.17 47.45 Favored 'General case' 0 C--N 1.282 -2.332 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.916 -179.295 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -119.79 142.41 48.62 Favored 'General case' 0 CA--C 1.454 -2.735 0 N-CA-C 106.048 -1.834 . . . . 0.0 106.048 178.637 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.411 ' HB ' ' CD2' ' A' ' 102' ' ' LEU . 17.9 t -118.49 104.38 16.0 Favored 'Isoleucine or valine' 0 N--CA 1.392 -3.365 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 -175.649 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.418 -2.549 0 N-CA-C 109.469 -1.453 . . . . 0.0 109.469 176.875 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 36.4 t . . . . . 0 N--CA 1.408 -2.566 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 9.5 p -119.23 140.4 43.31 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 177.818 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.47 ' CB ' ' HA ' ' A' ' 125' ' ' THR . 0.4 OUTLIER -151.72 167.08 29.32 Favored 'General case' 0 C--N 1.294 -1.843 0 N-CA-C 112.641 0.608 . . . . 0.0 112.641 -171.364 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -142.59 129.13 20.22 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.413 0.625 . . . . 0.0 111.63 -175.703 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.528 ' HB2' ' SG ' ' A' ' 92' ' ' CYS . 61.0 m-85 -109.86 122.03 46.6 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 178.967 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.492 HG22 ' H ' ' A' ' 107' ' ' THR . 32.0 m -71.23 151.7 44.04 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 178.623 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 8.3 m -52.47 -38.5 59.53 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.967 0.907 . . . . 0.0 109.838 176.52 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.492 ' H ' HG22 ' A' ' 105' ' ' THR . 68.2 p -121.42 99.66 6.6 Favored 'General case' 0 N--CA 1.425 -1.678 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.144 179.021 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.542 ' O ' ' HA ' ' A' ' 85' ' ' THR . 61.9 t -99.65 138.22 24.69 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.285 0 N-CA-C 106.779 -1.563 . . . . 0.0 106.779 174.137 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.452 ' HA ' ' O ' ' A' ' 84' ' ' LEU . 9.1 t -125.8 137.13 53.76 Favored 'General case' 0 N--CA 1.395 -3.222 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 -175.814 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -157.16 176.98 34.24 Favored Glycine 0 N--CA 1.403 -3.529 0 C-N-CA 119.834 -1.174 . . . . 0.0 112.053 179.674 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' HIS . . . . . 0.524 ' HA ' ' O ' ' A' ' 82' ' ' LYS . 10.5 t60 -86.81 93.24 9.23 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 178.808 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.679 HD13 HD23 ' A' ' 84' ' ' LEU . 7.2 tt -97.98 120.41 38.32 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-O 121.656 0.741 . . . . 0.0 110.841 -174.062 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 113' ' ' GLU . . . . . 0.504 ' OE1' ' HE2' ' A' ' 116' ' ' LYS . 44.4 mt-10 -123.41 -177.06 3.6 Favored 'General case' 0 CA--C 1.457 -2.611 0 CA-C-N 114.667 -1.151 . . . . 0.0 108.973 175.05 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.493 ' HA ' ' HD3' ' A' ' 114' ' ' LYS . 29.4 mmtt -83.07 101.84 11.4 Favored 'General case' 1 N--CA 1.371 -4.412 0 CA-C-N 114.834 -1.076 . . . . 0.0 113.536 179.926 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 125.27 -45.1 1.19 Allowed Glycine 0 N--CA 1.406 -3.336 0 CA-C-N 113.148 -1.842 . . . . 0.0 110.425 178.1 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.504 ' HE2' ' OE1' ' A' ' 113' ' ' GLU . 0.3 OUTLIER -135.2 147.59 49.41 Favored 'General case' 0 C--N 1.313 -0.984 0 C-N-CA 123.102 0.561 . . . . 0.0 112.492 -178.151 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.445 ' HA ' ' HA ' ' A' ' 112' ' ' LEU . 1.2 tt -120.64 105.06 10.43 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 105.346 -2.094 . . . . 0.0 105.346 178.079 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.513 ' HA ' ' OG ' ' A' ' 135' ' ' SER . 44.9 p -100.89 135.53 42.19 Favored 'General case' 0 C--N 1.267 -2.995 0 N-CA-C 114.465 1.283 . . . . 0.0 114.465 -172.174 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 64.92 97.47 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 125.235 1.414 . . . . 0.0 111.586 -179.887 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 6.1 m -104.52 93.53 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.018 0 CA-C-O 122.764 1.269 . . . . 0.0 111.348 -177.041 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -82.86 95.03 7.81 Favored 'General case' 0 N--CA 1.397 -3.107 0 CA-C-N 113.26 -1.791 . . . . 0.0 108.829 -179.888 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 145.91 -14.58 1.74 Allowed Glycine 0 C--N 1.305 -1.154 0 CA-C-N 114.375 -1.284 . . . . 0.0 111.188 -178.519 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.532 HG13 HG11 ' A' ' 108' ' ' VAL . 86.8 mt -100.64 99.41 8.38 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.25 0 CA-C-O 121.81 0.814 . . . . 0.0 111.042 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -89.18 127.71 35.76 Favored 'General case' 0 N--CA 1.433 -1.295 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 178.103 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.47 ' HA ' ' CB ' ' A' ' 102' ' ' LEU . 9.0 t -140.77 152.75 45.48 Favored 'General case' 0 C--N 1.278 -2.536 0 C-N-CA 119.734 -0.786 . . . . 0.0 111.002 -177.754 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.511 ' C ' ' HD3' ' A' ' 126' ' ' LYS . 3.8 tmtt? -140.85 127.17 19.81 Favored 'General case' 0 N--CA 1.389 -3.51 0 CA-C-N 115.168 -0.924 . . . . 0.0 108.695 175.055 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.513 HG13 ' H ' ' A' ' 128' ' ' MET . 2.6 p -135.55 -57.42 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 CA-C-N 114.709 -1.132 . . . . 0.0 109.057 -179.017 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 128' ' ' MET . . . . . 0.513 ' H ' HG13 ' A' ' 127' ' ' VAL . 24.3 ttt -101.19 -57.92 1.99 Allowed 'General case' 0 N--CA 1.421 -1.876 0 N-CA-C 106.293 -1.743 . . . . 0.0 106.293 176.495 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 2.2 pp -132.9 -179.48 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.637 0 CA-C-N 113.508 -1.678 . . . . 0.0 108.721 177.537 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 85.7 t90 -88.13 126.61 35.21 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 123.652 0.595 . . . . 0.0 110.518 -175.236 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 44.3 t -132.3 137.43 54.49 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 178.897 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 25.2 pttm -102.62 -24.54 13.76 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 112.328 0.492 . . . . 0.0 112.328 179.156 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 19.1 m -130.37 103.69 8.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-O 121.845 0.831 . . . . 0.0 111.417 -179.43 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 23.3 p -109.09 -165.5 1.02 Allowed 'General case' 0 C--N 1.292 -1.908 0 CA-C-N 115.342 -0.845 . . . . 0.0 109.166 177.091 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 135' ' ' SER . . . . . 0.513 ' OG ' ' HA ' ' A' ' 118' ' ' THR . 27.5 t -144.96 158.64 43.74 Favored 'General case' 0 N--CA 1.422 -1.837 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 176.715 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 68.1 mt -126.32 96.82 3.8 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 179.749 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 137' ' ' SER . . . . . 0.58 ' O ' ' HB2' ' A' ' 144' ' ' TYR . 46.9 t -121.48 136.53 54.95 Favored 'General case' 0 C--N 1.298 -1.663 0 O-C-N 121.816 -0.553 . . . . 0.0 110.324 -175.755 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 8.8 t -165.16 178.33 7.05 Favored 'General case' 0 N--CA 1.42 -1.935 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 -174.979 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -110.25 68.33 0.67 Allowed 'General case' 0 C--N 1.312 -1.045 0 C-N-CA 119.215 -0.994 . . . . 0.0 112.599 -179.263 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . 48.79 33.35 4.28 Favored 'General case' 0 N--CA 1.496 1.848 0 C-N-CA 124.586 1.154 . . . . 0.0 113.828 173.009 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 141' ' ' SER . . . . . 0.471 ' O ' ' HG3' ' A' ' 155' ' ' ARG . 48.1 t -154.32 -67.03 0.14 Allowed 'General case' 0 C--N 1.307 -1.265 0 C-N-CA 120.342 -0.543 . . . . 0.0 110.378 -174.717 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 55.3 mtpt -89.87 -162.79 0.92 Allowed 'General case' 0 CA--C 1.507 -0.709 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 179.125 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.516 HG11 ' O ' ' A' ' 159' ' ' GLY . 8.8 p -144.42 145.34 21.56 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 176.211 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 144' ' ' TYR . . . . . 0.58 ' HB2' ' O ' ' A' ' 137' ' ' SER . 91.6 m-85 -143.04 144.62 32.34 Favored 'General case' 0 CA--C 1.483 -1.6 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 174.219 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 145' ' ' PHE . . . . . 0.485 ' HB2' ' HA ' ' A' ' 151' ' ' LYS . 26.5 m-85 -95.53 156.37 16.35 Favored 'General case' 0 CA--C 1.454 -2.733 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 173.775 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 19.0 m -137.03 93.92 2.89 Favored 'General case' 1 N--CA 1.374 -4.226 0 C-N-CA 119.799 -0.761 . . . . 0.0 109.477 174.595 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 147' ' ' ALA . . . . . 0.491 ' HB3' ' HG3' ' A' ' 150' ' ' LYS . . . -111.56 6.99 20.43 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.168 -0.924 . . . . 0.0 109.361 177.783 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 148' ' ' GLY . . . . . 0.52 ' O ' ' HG2' ' A' ' 150' ' ' LYS . . . 111.98 75.41 0.75 Allowed Glycine 0 CA--C 1.48 -2.103 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 -179.377 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER 74.31 -33.72 0.26 Allowed 'General case' 0 N--CA 1.494 1.755 0 C-N-CA 125.145 1.378 . . . . 0.0 110.534 -176.754 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 150' ' ' LYS . . . . . 0.52 ' HG2' ' O ' ' A' ' 148' ' ' GLY . 12.0 pttm -79.88 121.22 25.15 Favored 'General case' 0 C--N 1.315 -0.904 0 C-N-CA 124.292 1.037 . . . . 0.0 112.047 179.518 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 151' ' ' LYS . . . . . 0.485 ' HA ' ' HB2' ' A' ' 145' ' ' PHE . 21.4 pttm -148.38 119.88 7.95 Favored 'General case' 0 N--CA 1.419 -1.983 0 CA-C-N 114.262 -1.335 . . . . 0.0 110.479 -175.074 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 42.9 m -110.41 111.82 23.34 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 106.54 -1.652 . . . . 0.0 106.54 173.53 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 153' ' ' ARG . . . . . 0.46 ' HB2' HG13 ' A' ' 143' ' ' VAL . 0.0 OUTLIER -154.69 99.57 2.17 Favored 'General case' 0 N--CA 1.435 -1.184 0 N-CA-C 116.397 1.999 . . . . 0.0 116.397 -165.745 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 4.9 m -108.99 109.57 20.65 Favored 'General case' 0 C--N 1.261 -3.279 0 O-C-N 121.423 -0.798 . . . . 0.0 109.051 165.489 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 155' ' ' ARG . . . . . 0.556 ' O ' ' HD3' ' A' ' 155' ' ' ARG . 0.2 OUTLIER -72.75 -23.45 60.83 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 120.633 1.561 . . . . 0.0 107.055 173.329 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -48.13 -43.72 31.46 Favored 'General case' 0 C--N 1.298 -1.666 0 C-N-CA 126.859 2.064 . . . . 0.0 115.536 -178.848 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.526 ' HB3' ' NE2' ' A' ' 161' ' ' GLN . . . -79.28 -19.5 50.38 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 113.318 0.859 . . . . 0.0 113.318 -175.893 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 0.553 ' CD2' ' HA ' ' A' ' 68' ' ' PHE . 44.0 t80 176.51 -34.49 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 CA-C-O 121.297 0.57 . . . . 0.0 109.831 178.482 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 159' ' ' GLY . . . . . 0.577 ' HA3' ' O ' ' A' ' 65' ' ' ILE . . . 150.52 -88.92 0.14 Allowed Glycine 0 CA--C 1.464 -3.134 0 N-CA-C 109.168 -1.573 . . . . 0.0 109.168 -172.194 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.558 HG23 ' HB ' ' A' ' 65' ' ' ILE . 10.9 t -98.06 153.39 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.642 0 N-CA-C 107.146 -1.428 . . . . 0.0 107.146 178.772 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 161' ' ' GLN . . . . . 0.526 ' NE2' ' HB3' ' A' ' 157' ' ' ALA . 79.3 mm-40 -116.32 90.05 3.25 Favored 'General case' 0 CA--C 1.453 -2.755 0 CA-C-O 122.435 1.112 . . . . 0.0 110.823 -172.469 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.28 147.59 24.9 Favored 'General case' 0 N--CA 1.387 -3.603 0 CA-C-N 112.555 -2.111 . . . . 0.0 108.828 179.327 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 9.4 t30 -113.13 -86.12 0.57 Allowed 'General case' 0 C--N 1.29 -2.014 0 C-N-CA 119.544 -0.862 . . . . 0.0 109.693 173.946 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 73.02 164.93 8.65 Favored Glycine 0 CA--C 1.502 -0.765 0 C-N-CA 120.424 -0.893 . . . . 0.0 113.256 179.088 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.525 ' O ' HD22 ' A' ' 165' ' ' LEU . 0.0 OUTLIER -100.95 114.69 28.82 Favored 'General case' 0 N--CA 1.413 -2.316 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 177.367 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 166' ' ' ARG . . . . . 0.465 ' HB2' ' O ' ' A' ' 89' ' ' PRO . 6.2 ptp180 -90.03 105.67 17.96 Favored 'General case' 0 N--CA 1.412 -2.369 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 -179.694 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 167' ' ' VAL . . . . . 0.438 ' HB ' ' HB3' ' A' ' 90' ' ' SER . 57.5 t -43.83 -28.19 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 C-N-CA 124.333 1.053 . . . . 0.0 112.812 -177.662 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -49.64 -43.06 46.57 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 124.242 1.017 . . . . 0.0 111.813 177.042 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -128.49 8.79 5.96 Favored 'General case' 0 CA--C 1.546 0.825 0 CA-C-O 121.635 0.731 . . . . 0.0 110.887 -176.943 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 170' ' ' PHE . . . . . . . . . . . . . 67.3 t80 . . . . . 0 C--N 1.303 -1.439 0 N-CA-C 108.771 -0.825 . . . . 0.0 108.771 178.603 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.624 ' HG ' ' HD3' ' A' ' 55' ' ' PRO 0.352 0.5 OUTLIER . . . . . 0 N--CA 1.439 -1.003 0 N-CA-C 113.384 0.883 . . . . 0.0 113.384 . . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.624 ' HD3' ' HG ' ' A' ' 54' ' ' LEU . 88.9 Cg_exo -55.33 -35.33 91.34 Favored 'Trans proline' 0 C--N 1.362 1.238 0 C-N-CA 123.376 2.717 . . . . 0.0 112.461 -176.88 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -66.33 -30.88 71.37 Favored 'General case' 0 C--O 1.217 -0.615 0 C-N-CA 120.389 -0.525 . . . . 0.0 110.349 179.392 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.401 ' HA ' ' HB3' ' A' ' 60' ' ' GLU . 59.8 tp -74.8 -31.77 61.8 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.017 178.967 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.454 ' HB3' ' H ' ' A' ' 75' ' ' TYR . 7.9 mp -58.39 -49.8 75.96 Favored 'General case' 0 CA--C 1.482 -1.657 0 CA-C-O 121.675 0.75 . . . . 0.0 109.484 178.916 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.484 ' HG2' ' O ' ' A' ' 55' ' ' PRO . 17.2 ptmt -74.64 -26.63 60.0 Favored 'General case' 0 C--N 1.28 -2.425 0 CA-C-N 114.089 -1.414 . . . . 0.0 112.41 179.653 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.401 ' HB3' ' HA ' ' A' ' 57' ' ' LEU . 9.1 tp10 -70.75 -35.14 72.51 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.934 178.819 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 61.5 m-85 -48.46 -22.6 0.75 Allowed 'General case' 0 N--CA 1.5 2.072 0 CA-C-O 120.944 0.402 . . . . 0.0 111.442 174.494 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.436 ' CG ' ' H ' ' A' ' 63' ' ' LEU . 17.1 t70 -107.25 -156.38 0.58 Allowed 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 -172.799 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.644 HD21 ' H ' ' A' ' 115' ' ' GLY . 53.3 mt -91.71 172.8 6.01 Favored Pre-proline 0 CA--C 1.568 1.651 0 O-C-N 121.394 -0.816 . . . . 0.0 110.419 -174.773 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.428 ' HD3' ' HB3' ' A' ' 63' ' ' LEU . 3.5 Cg_endo -88.12 19.8 1.27 Allowed 'Trans proline' 0 C--N 1.356 0.968 0 C-N-CA 123.335 2.69 . . . . 0.0 111.367 -172.21 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.734 ' O ' ' HA3' ' A' ' 159' ' ' GLY . 0.2 OUTLIER -73.25 -37.92 53.07 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.708 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.401 179.69 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 55.58 8.51 1.95 Allowed Glycine 0 N--CA 1.49 2.25 0 CA-C-N 115.489 -0.778 . . . . 0.0 113.351 -178.804 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.667 ' O ' ' HB ' ' A' ' 160' ' ' VAL . 40.6 mt 69.37 -63.89 0.23 Allowed 'Isoleucine or valine' 0 C--O 1.197 -1.682 0 C-N-CA 126.053 1.741 . . . . 0.0 113.627 -178.726 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.495 ' HB2' ' O ' ' A' ' 67' ' ' ILE . 63.7 t80 171.24 -48.0 0.0 OUTLIER Pre-proline 0 C--N 1.314 -0.944 0 C-N-CA 122.729 0.412 . . . . 0.0 110.637 -177.446 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.592 ' HB3' ' HD3' ' A' ' 166' ' ' ARG . 17.1 Cg_exo -74.61 -31.62 6.75 Favored 'Trans proline' 0 C--N 1.377 2.035 0 C-N-CA 121.388 1.392 . . . . 0.0 112.109 179.666 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 88.37 -29.16 5.8 Favored Glycine 0 N--CA 1.437 -1.281 0 C-N-CA 120.448 -0.882 . . . . 0.0 110.999 -175.22 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.426 ' HB3' ' HG3' ' A' ' 89' ' ' PRO . 17.5 t70 -81.86 -19.02 41.83 Favored 'General case' 0 C--O 1.2 -1.545 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 177.52 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.511 ' HB2' ' HD2' ' A' ' 89' ' ' PRO . . . -78.25 175.04 10.57 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 114.95 -1.023 . . . . 0.0 110.375 170.511 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.501 ' HB ' ' O ' ' A' ' 72' ' ' ALA . 51.9 m 86.29 21.27 0.08 Allowed 'General case' 0 C--N 1.355 0.836 0 CA-C-O 124.069 1.89 . . . . 0.0 110.763 172.451 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.556 ' O ' ' HA ' ' A' ' 86' ' ' VAL . 37.3 m-80 -80.33 158.9 25.96 Favored 'General case' 0 C--N 1.272 -2.793 0 CA-C-N 114.641 -1.163 . . . . 0.0 112.632 -179.572 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.454 ' H ' ' HB3' ' A' ' 58' ' ' LEU . 53.5 t80 -118.38 123.1 44.44 Favored 'General case' 0 C--N 1.284 -2.266 0 CA-C-N 114.716 -1.129 . . . . 0.0 112.998 -169.748 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.598 ' O ' HD12 ' A' ' 84' ' ' LEU . 26.7 mm-40 -146.59 151.2 36.91 Favored 'General case' 0 C--O 1.215 -0.73 0 C-N-CA 125.984 1.714 . . . . 0.0 108.165 173.254 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 52.4 p90 -139.28 150.58 45.61 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-N 118.228 0.467 . . . . 0.0 110.651 -178.501 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.478 ' CB ' ' HB ' ' A' ' 81' ' ' THR . 21.6 m-20 -78.56 164.39 24.72 Favored 'General case' 0 CA--C 1.48 -1.729 0 CA-C-O 121.589 0.709 . . . . 0.0 110.227 179.002 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -80.82 -65.87 0.96 Allowed 'General case' 0 C--N 1.279 -2.476 0 CA-C-N 114.312 -1.313 . . . . 0.0 110.835 -179.629 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -81.06 -33.22 33.63 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.378 -176.604 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.478 ' HB ' ' CB ' ' A' ' 78' ' ' ASP . 91.6 m -82.67 -29.03 30.24 Favored 'General case' 0 N--CA 1.425 -1.715 0 CA-C-N 115.048 -0.978 . . . . 0.0 111.64 -176.794 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt 58.88 15.41 3.86 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 113.021 0.749 . . . . 0.0 113.021 178.173 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.437 ' CG ' ' HB ' ' A' ' 109' ' ' THR . 16.4 tppt? -88.54 141.76 28.26 Favored 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 -177.635 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.598 HD12 ' O ' ' A' ' 76' ' ' GLU . 37.5 tp -75.96 138.72 41.15 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.26 177.037 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.406 HG23 ' HB2' ' A' ' 76' ' ' GLU . 9.4 t -126.31 116.97 22.06 Favored 'General case' 0 N--CA 1.412 -2.351 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 173.269 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.556 ' HA ' ' O ' ' A' ' 74' ' ' ASN . 74.2 t -92.92 127.01 45.29 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.808 0 CA-C-N 115.133 -0.94 . . . . 0.0 110.781 -178.463 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.469 ' HB2' ' HB2' ' A' ' 74' ' ' ASN . 3.9 mp -88.6 109.54 20.18 Favored 'General case' 0 N--CA 1.433 -1.294 0 CA-C-N 115.287 -0.87 . . . . 0.0 109.596 179.844 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 65.7 mt -96.86 137.93 21.35 Favored Pre-proline 0 C--N 1.286 -2.186 0 N-CA-C 105.957 -1.868 . . . . 0.0 105.957 171.073 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.61 ' O ' ' HB2' ' A' ' 166' ' ' ARG . 41.5 Cg_endo -63.19 107.44 0.66 Allowed 'Trans proline' 0 N--CA 1.437 -1.842 0 C-N-CA 122.109 1.873 . . . . 0.0 110.14 175.849 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' SER . . . . . 0.653 ' HB2' ' HB2' ' A' ' 168' ' ' ASP . 33.2 t 63.65 -163.92 0.26 Allowed 'General case' 0 CA--C 1.557 1.248 0 CA-C-O 121.272 0.558 . . . . 0.0 110.891 179.614 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 5.7 tt -106.06 119.63 55.71 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 CA-C-O 121.52 0.676 . . . . 0.0 109.496 177.854 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' CYS . . . . . 0.467 ' O ' ' HB2' ' A' ' 104' ' ' PHE . 21.0 p -117.47 124.59 49.15 Favored 'General case' 0 C--N 1.296 -1.753 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 -179.441 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -116.41 166.17 12.38 Favored 'General case' 0 C--N 1.306 -1.31 0 O-C-N 122.072 -0.392 . . . . 0.0 111.775 -174.045 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.449 ' HB ' ' HB2' ' A' ' 163' ' ' ASN . 3.0 p -149.95 104.93 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.609 177.757 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.68 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.994 176.627 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 100' ' ' SER . . . . . 0.455 ' HA ' ' O ' ' A' ' 126' ' ' LYS . 34.8 t . . . . . 0 N--CA 1.411 -2.391 0 N-CA-C 106.696 -1.594 . . . . 0.0 106.696 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.444 ' C ' HD12 ' A' ' 102' ' ' LEU . 97.9 t -130.45 119.35 45.89 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.108 0 CA-C-N 114.633 -1.167 . . . . 0.0 108.414 177.22 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.48 ' HG ' ' HA ' ' A' ' 125' ' ' THR . 4.8 mp -124.6 138.59 54.31 Favored 'General case' 0 N--CA 1.424 -1.759 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.346 -179.645 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 27.3 ttpp -117.19 110.35 18.03 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.33 177.759 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.579 ' HA ' HD12 ' A' ' 123' ' ' ILE . 51.1 m-85 -91.13 97.14 10.97 Favored 'General case' 0 N--CA 1.422 -1.871 0 CA-C-O 122.19 0.995 . . . . 0.0 111.756 177.764 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 31.6 m -56.05 146.4 22.85 Favored 'General case' 0 N--CA 1.424 -1.762 0 CA-C-N 112.276 -2.238 . . . . 0.0 110.916 177.325 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 66.9 m -56.95 -67.8 0.28 Allowed 'General case' 0 C--O 1.218 -0.593 0 C-N-CA 123.738 0.815 . . . . 0.0 111.123 -179.0 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.412 ' HA ' ' O ' ' A' ' 86' ' ' VAL . 7.3 p -107.56 99.88 9.34 Favored 'General case' 0 N--CA 1.423 -1.825 0 CA-C-O 121.654 0.74 . . . . 0.0 110.054 176.977 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.781 HG21 HG12 ' A' ' 123' ' ' ILE . 4.3 p -110.07 148.38 13.69 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.433 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.805 -176.894 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.535 ' HA ' ' O ' ' A' ' 84' ' ' LEU . 35.6 p -97.95 156.26 16.7 Favored 'General case' 0 N--CA 1.432 -1.369 0 N-CA-C 112.895 0.702 . . . . 0.0 112.895 -176.131 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 110' ' ' GLY . . . . . 0.667 ' HA2' ' O ' ' A' ' 119' ' ' ASP . . . -172.99 174.42 45.86 Favored Glycine 0 CA--C 1.52 0.353 0 N-CA-C 111.714 -0.554 . . . . 0.0 111.714 -179.84 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 34.2 t-80 -109.75 121.96 46.41 Favored 'General case' 0 CA--C 1.508 -0.658 0 N-CA-C 107.934 -1.135 . . . . 0.0 107.934 177.347 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.572 ' HB2' HD22 ' A' ' 84' ' ' LEU . 2.9 tt -91.99 116.86 29.28 Favored 'General case' 0 C--N 1.307 -1.261 0 C-N-CA 120.324 -0.55 . . . . 0.0 110.395 -172.541 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -127.57 143.99 51.12 Favored 'General case' 0 CA--C 1.459 -2.542 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 171.748 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 42.7 tptt -80.15 100.24 8.16 Favored 'General case' 0 N--CA 1.387 -3.581 0 CA-C-O 122.194 0.997 . . . . 0.0 108.911 -171.627 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' GLY . . . . . 0.644 ' H ' HD21 ' A' ' 63' ' ' LEU . . . 136.5 -31.92 2.53 Favored Glycine 0 N--CA 1.426 -1.999 0 N-CA-C 108.245 -1.942 . . . . 0.0 108.245 -176.681 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -157.87 127.0 5.77 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 121.379 0.609 . . . . 0.0 111.985 -178.744 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -94.59 107.14 19.14 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 105.656 -1.979 . . . . 0.0 105.656 174.72 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.438 ' HA ' ' CB ' ' A' ' 135' ' ' SER . 49.4 p -109.61 172.44 6.85 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.963 -175.188 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 119' ' ' ASP . . . . . 0.667 ' O ' ' HA2' ' A' ' 110' ' ' GLY . 12.2 m-20 56.97 63.14 2.0 Favored 'General case' 0 CA--C 1.473 -1.983 0 O-C-N 124.468 1.105 . . . . 0.0 109.55 178.531 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.423 HG23 ' O ' ' A' ' 134' ' ' THR . 4.5 t -86.75 78.1 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.399 -2.98 0 C-N-CA 117.983 -1.487 . . . . 0.0 108.335 -175.798 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.409 ' HB3' ' OG1' ' A' ' 109' ' ' THR . 11.6 tp10 -68.92 96.47 0.77 Allowed 'General case' 0 N--CA 1.414 -2.252 0 CA-C-N 113.011 -1.904 . . . . 0.0 110.601 -174.39 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 130.56 -2.18 5.69 Favored Glycine 0 N--CA 1.424 -2.104 0 C-N-CA 120.152 -1.023 . . . . 0.0 112.995 174.864 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.781 HG12 HG21 ' A' ' 108' ' ' VAL . 26.6 mm -99.2 112.25 30.93 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 176.743 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -84.3 119.38 25.0 Favored 'General case' 0 N--CA 1.429 -1.51 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 -178.932 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.48 ' HA ' ' HG ' ' A' ' 102' ' ' LEU . 58.9 m -131.38 119.44 21.68 Favored 'General case' 0 N--CA 1.405 -2.716 0 CA-C-N 114.976 -1.011 . . . . 0.0 111.33 -175.889 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.455 ' O ' ' HA ' ' A' ' 100' ' ' SER . 83.1 tttt -110.08 141.94 42.22 Favored 'General case' 0 N--CA 1.41 -2.451 0 C-N-CA 119.083 -1.047 . . . . 0.0 109.452 168.225 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.443 HG11 ' HE2' ' A' ' 150' ' ' LYS . 7.5 p -149.01 -35.0 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.296 -1.757 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 175.431 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 128' ' ' MET . . . . . 0.466 ' HG3' HG22 ' A' ' 129' ' ' ILE . 26.4 ptm -137.52 -29.23 0.88 Allowed 'General case' 0 N--CA 1.404 -2.758 0 CA-C-N 113.922 -1.49 . . . . 0.0 107.986 -176.948 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 129' ' ' ILE . . . . . 0.466 HG22 ' HG3' ' A' ' 128' ' ' MET . 7.0 tp -161.97 159.52 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.565 0 N-CA-C 103.684 -2.71 . . . . 0.0 103.684 175.278 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 63.6 p-90 -83.82 126.52 33.02 Favored 'General case' 0 N--CA 1.409 -2.476 0 CA-C-O 121.351 0.596 . . . . 0.0 109.547 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.503 HG22 ' H ' ' A' ' 133' ' ' VAL . 13.1 p -130.92 149.01 33.07 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.147 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 179.022 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 20.8 pttp -103.48 12.94 34.52 Favored 'General case' 0 C--N 1.308 -1.201 0 C-N-CA 120.536 -0.466 . . . . 0.0 110.99 -179.643 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.503 ' H ' HG22 ' A' ' 131' ' ' VAL . 10.8 m -146.92 94.17 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.936 0.874 . . . . 0.0 112.529 -174.916 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 134' ' ' THR . . . . . 0.476 HG21 HG21 ' A' ' 125' ' ' THR . 25.5 p -107.59 -160.73 0.74 Allowed 'General case' 0 N--CA 1.404 -2.73 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 174.026 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 135' ' ' SER . . . . . 0.438 ' CB ' ' HA ' ' A' ' 118' ' ' THR . 51.8 p -173.35 142.66 1.01 Allowed 'General case' 0 N--CA 1.44 -0.941 0 N-CA-C 111.327 0.121 . . . . 0.0 111.327 -178.352 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 136' ' ' ILE . . . . . 0.437 HG13 ' O ' ' A' ' 144' ' ' TYR . 10.1 tt -103.18 111.23 32.18 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 CA-C-O 121.397 0.618 . . . . 0.0 109.396 177.574 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 137' ' ' SER . . . . . 0.443 ' O ' ' HB2' ' A' ' 144' ' ' TYR . 43.5 m -111.75 139.35 47.29 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.739 -178.279 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 138' ' ' THR . . . . . 0.437 HG23 ' H ' ' A' ' 140' ' ' ALA . 7.5 t -166.09 178.11 6.56 Favored 'General case' 0 N--CA 1.428 -1.559 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 -177.709 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -83.61 28.69 0.55 Allowed 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 176.441 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 140' ' ' ALA . . . . . 0.484 ' HA ' HD22 ' A' ' 63' ' ' LEU . . . 60.23 35.73 20.91 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.352 0.661 . . . . 0.0 109.598 -174.246 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 141' ' ' SER . . . . . 0.468 ' O ' ' HG3' ' A' ' 155' ' ' ARG . 33.4 t -153.62 -65.73 0.15 Allowed 'General case' 0 C--O 1.214 -0.784 0 CA-C-N 115.795 -0.638 . . . . 0.0 111.426 -171.505 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 51.2 mtpt -80.11 -169.16 1.92 Allowed 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 179.871 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.609 HG22 HG22 ' A' ' 65' ' ' ILE . 91.7 t -135.71 119.77 25.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-O 121.663 0.744 . . . . 0.0 112.673 179.11 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 144' ' ' TYR . . . . . 0.443 ' HB2' ' O ' ' A' ' 137' ' ' SER . 96.2 m-85 -113.64 114.59 26.64 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 106.297 -1.742 . . . . 0.0 106.297 171.13 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 145' ' ' PHE . . . . . 0.419 ' HB3' ' HB2' ' A' ' 151' ' ' LYS . 29.5 t80 -59.35 143.2 50.22 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 114.866 -1.061 . . . . 0.0 111.701 -169.12 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.43 ' C ' ' HB ' ' A' ' 134' ' ' THR . 75.1 p -46.88 104.27 0.05 OUTLIER 'General case' 0 C--O 1.245 0.823 0 N-CA-C 115.553 1.686 . . . . 0.0 115.553 -169.795 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 147' ' ' ALA . . . . . 0.492 ' HB3' ' HG3' ' A' ' 150' ' ' LYS . . . 161.23 -65.47 0.0 OUTLIER 'General case' 0 CA--C 1.487 -1.457 0 C-N-CA 129.674 3.19 . . . . 0.0 104.824 174.036 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 154.57 -75.22 0.23 Allowed Glycine 0 CA--C 1.48 -2.139 0 C-N-CA 119.557 -1.306 . . . . 0.0 112.282 170.968 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 27.3 ptt? -97.36 -11.59 23.81 Favored 'General case' 0 C--N 1.29 -1.992 0 CA-C-N 115.396 -0.402 . . . . 0.0 111.938 -175.585 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 150' ' ' LYS . . . . . 0.492 ' HG3' ' HB3' ' A' ' 147' ' ' ALA 0.352 0.0 OUTLIER -77.37 -28.71 52.97 Favored 'General case' 0 C--O 1.213 -0.823 0 N-CA-C 116.656 2.095 . . . . 0.0 116.656 -170.597 . . . . . . . . 4 4 . 1 . 020 nuclear build core ' A' A ' 151' ' ' LYS . . . . . 0.565 ' HE2' ' HA ' ' A' ' 151' ' ' LYS . 4.8 mmpt? -147.52 129.32 15.24 Favored 'General case' 0 CA--C 1.503 -0.829 0 CA-C-N 118.074 0.397 . . . . 0.0 110.767 179.453 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 40.6 p -106.72 145.91 31.46 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 175.461 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 153' ' ' ARG . . . . . 0.413 ' HG2' ' HB2' ' A' ' 145' ' ' PHE . 4.1 mmp_? -130.75 166.69 20.23 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 -179.313 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 19.0 m -101.15 121.76 42.41 Favored 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 177.201 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 155' ' ' ARG . . . . . 0.468 ' HG3' ' O ' ' A' ' 141' ' ' SER . 1.6 tmm_? -63.19 -25.79 68.5 Favored 'General case' 0 C--O 1.206 -1.198 0 N-CA-C 106.898 -1.519 . . . . 0.0 106.898 178.548 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -52.7 -25.94 12.47 Favored 'General case' 0 C--N 1.302 -1.499 0 C-N-CA 126.339 1.855 . . . . 0.0 113.009 -179.665 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -71.76 -32.66 67.93 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 120.703 0.287 . . . . 0.0 111.192 -179.268 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 44.0 t80 169.39 -31.94 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 106.333 -1.729 . . . . 0.0 106.333 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 159' ' ' GLY . . . . . 0.734 ' HA3' ' O ' ' A' ' 65' ' ' ILE . . . 156.87 -90.11 0.12 Allowed Glycine 0 N--CA 1.4 -3.729 0 N-CA-C 108.299 -1.92 . . . . 0.0 108.299 -173.361 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.667 ' HB ' ' O ' ' A' ' 67' ' ' ILE . 11.1 t -103.35 148.17 8.74 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.756 0 N-CA-C 105.372 -2.084 . . . . 0.0 105.372 179.231 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -137.07 102.69 4.92 Favored 'General case' 0 N--CA 1.408 -2.566 0 C-N-CA 118.102 -1.439 . . . . 0.0 109.179 -173.251 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 34.7 ptt85 -152.78 173.76 14.9 Favored 'General case' 0 C--N 1.275 -2.632 0 CA-C-N 113.214 -1.812 . . . . 0.0 106.515 -177.102 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 163' ' ' ASN . . . . . 0.449 ' HB2' ' HB ' ' A' ' 94' ' ' VAL . 4.4 m-20 -67.63 126.03 28.06 Favored 'General case' 0 C--O 1.248 1.007 0 C-N-CA 119.087 -1.045 . . . . 0.0 108.475 169.254 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -159.23 60.9 0.31 Allowed Glycine 0 N--CA 1.411 -3.032 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.311 -179.651 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.429 HD12 HH21 ' A' ' 166' ' ' ARG . 47.1 tp -81.62 111.54 18.0 Favored 'General case' 0 N--CA 1.418 -2.038 0 N-CA-C 105.509 -2.034 . . . . 0.0 105.509 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 166' ' ' ARG . . . . . 0.65 ' H ' ' NE ' ' A' ' 166' ' ' ARG . 0.0 OUTLIER -84.15 105.94 15.4 Favored 'General case' 0 N--CA 1.398 -3.055 0 C-N-CA 118.382 -1.327 . . . . 0.0 110.788 -178.189 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 4.8 m -74.74 63.93 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.29 -2.012 0 CA-C-O 122.833 1.301 . . . . 0.0 111.204 176.505 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 168' ' ' ASP . . . . . 0.653 ' HB2' ' HB2' ' A' ' 90' ' ' SER . 35.6 t70 -133.49 -32.69 1.14 Allowed 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 112.772 -2.013 . . . . 0.0 107.724 -177.635 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 21.7 ttpp -140.03 -67.19 0.44 Allowed 'General case' 0 N--CA 1.427 -1.584 0 CA-C-N 113.764 -1.562 . . . . 0.0 107.763 -177.172 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 170' ' ' PHE . . . . . . . . . . . . . 68.3 t80 . . . . . 0 C--O 1.249 1.026 0 N-CA-C 105.004 -2.221 . . . . 0.0 105.004 -178.82 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 25.6 m . . . . . 0 N--CA 1.444 -0.737 0 N-CA-C 109.225 -0.658 . . . . 0.0 109.225 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -141.14 138.17 33.27 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.396 0.617 . . . . 0.0 112.1 -177.174 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -146.3 27.45 1.14 Allowed 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 177.834 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 10.3 tt -72.0 127.67 34.2 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 CA-C-N 115.3 -0.864 . . . . 0.0 112.068 -176.792 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 34.3 p90 -145.12 112.04 5.93 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.683 177.037 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 44.3 t-20 -126.69 99.17 5.67 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 179.196 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -96.56 122.89 39.96 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-N 115.235 -0.893 . . . . 0.0 109.294 -178.167 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.7 p -110.09 126.19 67.32 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.833 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 176.757 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -88.84 153.59 23.95 Favored Glycine 0 N--CA 1.427 -1.929 0 C-N-CA 120.798 -0.715 . . . . 0.0 111.692 -178.48 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 32.5 t -135.38 124.31 24.13 Favored 'General case' 0 C--N 1.292 -1.906 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 179.108 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -108.8 156.53 19.53 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 178.643 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 71.3 t-105 -137.76 131.53 31.4 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-O 121.273 0.558 . . . . 0.0 111.56 179.217 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -144.51 145.42 31.84 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-N 115.072 -0.967 . . . . 0.0 109.58 175.01 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -132.05 105.02 0.59 Allowed Glycine 0 N--CA 1.434 -1.485 0 C-N-CA 120.205 -0.997 . . . . 0.0 111.971 -177.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 16.9 mp0 -73.48 108.67 6.47 Favored 'General case' 0 C--N 1.308 -1.196 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 179.27 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -111.71 114.29 27.21 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.77 178.053 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -155.03 146.6 23.17 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -149.96 127.8 11.77 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-O 121.077 0.465 . . . . 0.0 111.586 -179.695 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -139.68 103.63 4.72 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.207 175.859 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -126.42 95.0 4.22 Favored 'General case' 0 C--N 1.292 -1.906 0 CA-C-O 121.836 0.827 . . . . 0.0 111.734 -178.67 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 88.9 t80 -100.0 127.33 46.22 Favored 'General case' 0 C--N 1.296 -1.735 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.515 179.085 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -127.2 165.83 18.88 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 174.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 32.0 t -124.47 136.98 54.46 Favored 'General case' 0 C--N 1.297 -1.688 0 CA-C-O 120.989 0.423 . . . . 0.0 110.461 -175.328 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 55.7 t -92.49 128.06 44.29 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.092 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 -179.657 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -98.06 170.23 24.75 Favored Glycine 0 N--CA 1.437 -1.276 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.671 -178.073 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 29.9 p-10 -153.34 153.86 33.41 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 177.534 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -128.42 157.85 39.92 Favored 'General case' 0 C--N 1.305 -1.337 0 C-N-CA 120.612 -0.435 . . . . 0.0 110.987 -179.397 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 89.8 mt -96.34 153.47 17.8 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.491 -177.18 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 28.8 p-10 -141.43 131.73 25.05 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.995 -179.173 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 38.0 t -161.27 111.03 1.64 Allowed 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 179.779 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 28.6 m -127.68 130.83 70.36 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-N 116.281 -0.418 . . . . 0.0 109.899 178.436 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 46.1 m -155.38 152.12 28.7 Favored 'General case' 0 C--N 1.31 -1.134 0 O-C-N 122.304 -0.248 . . . . 0.0 110.376 -177.844 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 10.2 t -161.14 176.21 11.55 Favored 'General case' 0 C--O 1.246 0.882 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 177.272 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 32.1 t -163.96 158.62 19.89 Favored 'General case' 0 N--CA 1.438 -1.044 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 -179.635 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 29.8 pt -133.56 -177.12 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.953 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 178.408 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -131.04 134.4 46.62 Favored 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 179.02 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -156.03 48.43 0.48 Allowed Glycine 0 C--N 1.308 -1.024 0 N-CA-C 111.115 -0.794 . . . . 0.0 111.115 -179.012 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -78.48 -36.19 30.8 Favored Glycine 0 N--CA 1.442 -0.962 0 C-N-CA 121.138 -0.553 . . . . 0.0 112.024 -177.628 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 29.1 p -84.88 121.06 27.2 Favored 'General case' 0 N--CA 1.429 -1.524 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 177.535 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -143.65 107.07 4.57 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-O 121.053 0.454 . . . . 0.0 111.155 -177.483 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 28.9 p-90 -150.09 100.85 2.96 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 115.045 -0.979 . . . . 0.0 111.461 179.1 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.644 HD23 ' H ' ' A' ' 42' ' ' LEU . 2.0 pt? -79.78 -12.32 59.79 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 121.801 0.81 . . . . 0.0 110.142 179.387 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 34.5 m -104.02 138.67 27.63 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.806 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 175.026 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 5.6 p30 -111.0 85.7 2.17 Favored 'General case' 0 C--N 1.295 -1.763 0 CA-C-O 122.307 1.051 . . . . 0.0 111.505 179.028 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 58.8 tptt -105.72 101.73 11.23 Favored 'General case' 0 N--CA 1.418 -2.062 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 178.556 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 10.0 tt -64.52 89.95 0.08 OUTLIER 'Isoleucine or valine' 0 C--O 1.248 1.018 0 CA-C-O 122.301 1.048 . . . . 0.0 113.11 -174.652 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 50.0 tptt -173.07 151.78 2.19 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 105.546 -2.02 . . . . 0.0 105.546 178.339 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -75.26 54.74 2.76 Favored Glycine 0 CA--C 1.525 0.691 0 C-N-CA 121.62 -0.324 . . . . 0.0 113.782 -176.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -135.32 -35.38 0.83 Allowed 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 177.871 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 1.8 mpt? 66.88 -87.3 0.03 OUTLIER 'General case' 0 C--O 1.242 0.676 0 CA-C-N 114.692 -1.14 . . . . 0.0 109.891 -174.859 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -143.52 -0.18 1.1 Allowed 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 120.671 0.272 . . . . 0.0 111.32 177.151 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.419 ' HB3' ' HG ' ' A' ' 54' ' ' LEU . 75.3 mmtt -136.81 155.22 76.63 Favored Pre-proline 0 C--O 1.208 -1.106 0 CA-C-O 120.513 0.197 . . . . 0.0 110.528 -178.249 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -84.14 28.2 0.58 Allowed 'Trans proline' 0 C--O 1.241 0.625 0 C-N-CA 122.864 2.376 . . . . 0.0 111.246 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.419 ' HG ' ' HB3' ' A' ' 52' ' ' LYS . 42.0 mt -74.63 -45.24 5.51 Favored Pre-proline 0 C--N 1.307 -1.262 0 N-CA-C 114.602 1.334 . . . . 0.0 114.602 -174.646 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.519 ' O ' ' HG2' ' A' ' 59' ' ' LYS . 20.9 Cg_exo -61.76 -15.93 45.61 Favored 'Trans proline' 0 C--N 1.374 1.907 0 C-N-CA 121.73 1.62 . . . . 0.0 113.412 -165.149 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 31.1 mm-40 -80.35 -30.74 38.01 Favored 'General case' 0 CA--C 1.485 -1.542 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 -178.008 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.555 ' HA ' ' HB3' ' A' ' 60' ' ' GLU . 72.6 mt -75.28 -35.06 61.37 Favored 'General case' 0 N--CA 1.418 -2.054 0 CA-C-N 114.648 -1.16 . . . . 0.0 110.572 -179.218 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.653 ' HB3' ' H ' ' A' ' 75' ' ' TYR . 5.2 mp -64.46 -50.93 65.57 Favored 'General case' 0 CA--C 1.493 -1.229 0 C-N-CA 119.668 -0.813 . . . . 0.0 110.047 -178.28 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.519 ' HG2' ' O ' ' A' ' 55' ' ' PRO . 18.0 ptpt -62.55 -26.48 68.6 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 114.923 -1.035 . . . . 0.0 111.041 175.478 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.555 ' HB3' ' HA ' ' A' ' 57' ' ' LEU . 15.5 tt0 -69.71 -39.44 76.86 Favored 'General case' 0 C--N 1.317 -0.823 0 C-N-CA 123.89 0.876 . . . . 0.0 112.345 176.884 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -74.89 -26.14 59.44 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 120.459 -0.497 . . . . 0.0 110.301 176.689 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -77.17 -162.22 0.27 Allowed 'General case' 0 CA--C 1.565 1.545 0 CA-C-N 115.206 -0.906 . . . . 0.0 108.563 178.782 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.779 ' HB2' HD12 ' A' ' 65' ' ' ILE . 1.5 mt -95.02 -178.64 0.82 Allowed Pre-proline 0 CA--C 1.569 1.704 0 N-CA-C 106.809 -1.552 . . . . 0.0 106.809 -175.591 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_endo -92.45 14.85 1.63 Allowed 'Trans proline' 0 C--N 1.361 1.202 0 C-N-CA 122.36 2.04 . . . . 0.0 111.547 -174.864 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.779 HD12 ' HB2' ' A' ' 63' ' ' LEU . 0.2 OUTLIER -76.12 -42.15 37.93 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.704 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 179.497 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.402 ' H ' HD13 ' A' ' 65' ' ' ILE . . . 57.75 8.55 4.27 Favored Glycine 0 N--CA 1.481 1.645 0 CA-C-N 115.925 -0.58 . . . . 0.0 112.771 -178.155 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.623 ' H ' HG12 ' A' ' 65' ' ' ILE . 61.6 mt 64.95 -67.39 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.562 0 C-N-CA 126.201 1.8 . . . . 0.0 112.471 -176.623 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.403 ' HB3' ' HD3' ' A' ' 69' ' ' PRO . 53.3 t80 179.61 -56.63 0.0 OUTLIER Pre-proline 0 C--N 1.31 -1.119 0 N-CA-C 112.268 0.47 . . . . 0.0 112.268 -177.672 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.489 ' HB2' ' OD2' ' A' ' 71' ' ' ASP . 3.2 Cg_endo -87.67 -22.68 1.5 Allowed 'Trans proline' 0 C--N 1.365 1.416 0 C-N-CA 121.556 1.504 . . . . 0.0 114.185 -170.787 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 88.8 -8.55 79.23 Favored Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 120.525 -0.845 . . . . 0.0 111.456 -175.338 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.496 ' HB2' ' HG3' ' A' ' 89' ' ' PRO . 21.6 m-20 -81.78 -46.65 13.91 Favored 'General case' 0 CA--C 1.501 -0.926 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 177.537 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.512 ' HB1' HD12 ' A' ' 67' ' ' ILE . . . -71.27 178.15 3.51 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 114.164 -1.38 . . . . 0.0 110.273 172.798 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.541 ' O ' HG22 ' A' ' 73' ' ' THR . 81.3 m 83.24 27.86 0.1 Allowed 'General case' 0 C--N 1.354 0.775 0 CA-C-O 124.429 2.062 . . . . 0.0 110.018 174.496 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.689 ' O ' ' HA ' ' A' ' 86' ' ' VAL . 3.2 m-20 -81.82 137.76 35.22 Favored 'General case' 0 C--N 1.275 -2.635 0 CA-C-N 114.206 -1.361 . . . . 0.0 109.726 177.706 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.653 ' H ' ' HB3' ' A' ' 58' ' ' LEU . 37.5 t80 -106.73 104.94 14.75 Favored 'General case' 0 C--N 1.273 -2.756 0 CA-C-N 115.234 -0.894 . . . . 0.0 110.074 -173.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.676 ' O ' ' HG ' ' A' ' 84' ' ' LEU . 10.8 mm-40 -137.73 163.33 31.59 Favored 'General case' 0 C--N 1.307 -1.258 0 C-N-CA 124.112 0.965 . . . . 0.0 108.882 177.202 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 50.9 p90 -147.75 150.47 34.33 Favored 'General case' 0 C--N 1.289 -2.035 0 N-CA-C 108.064 -1.088 . . . . 0.0 108.064 177.766 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.728 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 12.7 m-20 -99.16 165.26 11.8 Favored 'General case' 0 CA--C 1.479 -1.767 0 C-N-CA 118.001 -1.48 . . . . 0.0 110.282 178.549 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -79.55 -59.66 2.66 Favored 'General case' 0 C--N 1.272 -2.802 0 CA-C-N 114.159 -1.382 . . . . 0.0 112.947 -177.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -72.41 -30.41 64.62 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-O 121.58 0.705 . . . . 0.0 110.292 -177.616 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.728 ' HB ' ' HB2' ' A' ' 78' ' ' ASP . 21.8 m -78.49 -51.07 10.52 Favored 'General case' 0 N--CA 1.411 -2.424 0 CA-C-N 114.824 -1.08 . . . . 0.0 110.48 -178.158 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 65.0 mttp 65.88 12.0 8.06 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.626 0.77 . . . . 0.0 112.172 -177.567 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 5.0 tppp? -100.59 141.97 32.72 Favored 'General case' 0 N--CA 1.428 -1.548 0 N-CA-C 104.449 -2.426 . . . . 0.0 104.449 175.445 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.676 ' HG ' ' O ' ' A' ' 76' ' ' GLU . 9.3 tt -80.83 145.83 31.21 Favored 'General case' 0 C--N 1.295 -1.782 0 C-N-CA 119.39 -0.924 . . . . 0.0 110.488 -178.428 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.438 ' HB ' HG22 ' A' ' 109' ' ' THR . 10.7 t -126.47 123.84 38.75 Favored 'General case' 0 N--CA 1.4 -2.964 0 CA-C-O 121.896 0.855 . . . . 0.0 111.035 -179.529 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.689 ' HA ' ' O ' ' A' ' 74' ' ' ASN . 98.5 t -96.84 126.81 49.47 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 CA-C-N 114.932 -1.031 . . . . 0.0 108.4 175.36 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.6 mp -91.64 120.37 32.35 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-O 121.63 0.728 . . . . 0.0 111.046 -179.753 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 2.1 mp -100.69 132.74 21.85 Favored Pre-proline 0 C--N 1.286 -2.191 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 172.335 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.496 ' HG3' ' HB2' ' A' ' 71' ' ' ASP . 12.4 Cg_endo -51.06 -36.28 53.96 Favored 'Trans proline' 0 C--N 1.356 0.938 0 C-N-CA 124.637 3.558 . . . . 0.0 114.357 -176.131 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.637 ' HB2' ' HB2' ' A' ' 168' ' ' ASP . 47.9 t -161.99 157.65 23.96 Favored 'General case' 0 CA--C 1.493 -1.221 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.408 ' CD1' ' HG3' ' A' ' 93' ' ' GLU . 0.0 OUTLIER -70.4 116.13 11.13 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.711 0 O-C-N 123.991 0.807 . . . . 0.0 109.28 179.993 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 41.3 t -112.77 123.51 50.46 Favored 'General case' 0 N--CA 1.427 -1.587 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.934 179.377 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.408 ' HG3' ' CD1' ' A' ' 91' ' ' ILE . 41.4 mt-10 -106.57 114.66 28.9 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 174.782 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 5.8 p -111.66 118.15 56.86 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.726 0 CA-C-O 121.192 0.52 . . . . 0.0 111.283 -176.764 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.466 ' HA2' ' HA ' ' A' ' 101' ' ' VAL . . . -131.26 140.28 11.65 Favored Glycine 0 N--CA 1.43 -1.703 0 C-N-CA 120.463 -0.875 . . . . 0.0 112.016 179.155 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 0.401 ' C ' ' H ' ' A' ' 98' ' ' ASP . 51.9 t80 -159.98 175.16 13.34 Favored 'General case' 0 N--CA 1.402 -2.868 0 N-CA-C 102.791 -3.04 . . . . 0.0 102.791 179.224 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.99 1.75 2.5 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 118.755 0.707 . . . . 0.0 111.305 177.543 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.401 ' H ' ' C ' ' A' ' 96' ' ' TYR . 9.4 t70 -45.26 -52.33 9.74 Favored 'General case' 0 CA--C 1.502 -0.898 0 C-N-CA 125.362 1.465 . . . . 0.0 110.07 176.449 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.443 ' OG ' ' HD2' ' A' ' 151' ' ' LYS . 45.1 m -146.89 -68.52 0.26 Allowed 'General case' 0 N--CA 1.408 -2.563 0 N-CA-C 106.653 -1.61 . . . . 0.0 106.653 175.897 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 48.8 m -164.15 -74.19 0.04 OUTLIER 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 176.014 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.466 ' HA ' ' HA2' ' A' ' 95' ' ' GLY . 13.8 p -166.85 147.63 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.796 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 -178.354 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.524 HD23 ' H ' ' A' ' 126' ' ' LYS . 51.6 mt -134.86 133.95 40.25 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 -176.205 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.446 ' O ' ' HA ' ' A' ' 123' ' ' ILE . 27.4 ttpp -110.28 114.05 27.22 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 112.195 0.442 . . . . 0.0 112.195 -177.112 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.405 ' O ' ' HA ' ' A' ' 91' ' ' ILE . 95.5 m-85 -101.65 104.54 15.39 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.721 176.696 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 89.4 m -79.59 165.0 23.39 Favored 'General case' 0 CA--C 1.557 1.215 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.618 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 12.0 p -69.57 -69.68 0.33 Allowed 'General case' 0 N--CA 1.438 -1.063 0 C-N-CA 124.93 1.292 . . . . 0.0 112.886 -175.014 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 25.6 m -96.3 88.51 4.79 Favored 'General case' 0 N--CA 1.416 -2.173 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 -178.195 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.683 HG21 HG13 ' A' ' 123' ' ' ILE . 5.0 p -101.48 144.18 13.43 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.103 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.18 -176.953 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.592 ' OG1' ' HB3' ' A' ' 121' ' ' GLU . 11.6 p -109.33 165.06 11.92 Favored 'General case' 0 C--N 1.287 -2.139 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 178.183 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 173.39 172.58 38.99 Favored Glycine 0 N--CA 1.427 -1.914 0 N-CA-C 111.485 -0.646 . . . . 0.0 111.485 179.68 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 47.4 t-80 -93.2 106.47 18.43 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 178.016 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.52 ' HB3' HD13 ' A' ' 84' ' ' LEU . 2.9 tm? -94.42 136.51 34.63 Favored 'General case' 0 CA--C 1.466 -2.261 0 N-CA-C 106.838 -1.542 . . . . 0.0 106.838 -175.388 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.43 ' N ' HD13 ' A' ' 112' ' ' LEU . 0.3 OUTLIER -142.49 153.01 43.26 Favored 'General case' 0 N--CA 1.383 -3.777 0 N-CA-C 105.275 -2.12 . . . . 0.0 105.275 177.837 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 8.1 mmtt -67.92 101.06 1.04 Allowed 'General case' 0 C--N 1.302 -1.464 0 CA-C-O 121.898 0.856 . . . . 0.0 111.691 -178.607 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' GLY . . . . . 0.685 ' O ' ' HB ' ' A' ' 138' ' ' THR . . . 131.0 -54.24 0.79 Allowed Glycine 0 N--CA 1.41 -3.049 0 CA-C-N 114.342 -1.299 . . . . 0.0 109.927 -178.765 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.491 ' HD3' HG23 ' A' ' 118' ' ' THR . 0.0 OUTLIER -136.51 141.93 43.47 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 114.006 1.113 . . . . 0.0 114.006 -176.811 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.68 ' O ' ' HB2' ' A' ' 135' ' ' SER . 58.1 tp -104.82 106.82 17.47 Favored 'General case' 0 C--N 1.311 -1.067 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 177.704 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.491 HG23 ' HD3' ' A' ' 116' ' ' LYS . 42.1 p -106.19 142.93 35.06 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 -175.594 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 28.6 m-20 54.74 98.78 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 125.156 1.382 . . . . 0.0 113.031 177.891 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 4.3 m -100.58 172.54 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.587 0 CA-C-O 120.983 0.42 . . . . 0.0 110.907 179.529 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.592 ' HB3' ' OG1' ' A' ' 109' ' ' THR . 14.9 tp10 -140.84 82.77 1.86 Allowed 'General case' 0 N--CA 1.416 -2.165 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.382 178.705 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' GLY . . . . . 0.412 ' HA3' HG23 ' A' ' 108' ' ' VAL . . . 150.96 -19.7 0.97 Allowed Glycine 0 C--N 1.308 -1.012 0 CA-C-N 115.153 -0.931 . . . . 0.0 111.979 177.14 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.683 HG13 HG21 ' A' ' 108' ' ' VAL . 96.1 mt -99.61 100.17 9.93 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.63 0 CA-C-O 121.383 0.611 . . . . 0.0 109.514 -179.087 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.461 ' HA ' ' HA ' ' A' ' 132' ' ' LYS . 39.7 ttmt -86.65 119.19 26.62 Favored 'General case' 0 N--CA 1.428 -1.565 0 N-CA-C 107.613 -1.255 . . . . 0.0 107.613 -179.617 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.601 ' HB ' ' OG1' ' A' ' 134' ' ' THR . 89.9 m -121.33 125.14 46.28 Favored 'General case' 0 C--N 1.268 -2.95 0 CA-C-N 114.477 -1.238 . . . . 0.0 110.962 -172.19 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.612 ' C ' ' HD3' ' A' ' 126' ' ' LYS . 0.2 OUTLIER -117.99 105.78 12.24 Favored 'General case' 0 N--CA 1.412 -2.347 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 173.026 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 33.3 m -107.7 -27.61 2.95 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.102 0 CA-C-O 121.872 0.844 . . . . 0.0 110.08 176.314 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' MET . . . . . 0.482 ' C ' HD12 ' A' ' 129' ' ' ILE . 27.3 ttt -158.94 -35.55 0.06 Allowed 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 106.971 -1.492 . . . . 0.0 106.971 -175.0 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.482 HD12 ' C ' ' A' ' 128' ' ' MET . 2.8 mp -134.94 151.65 31.46 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.72 0 N-CA-C 104.271 -2.492 . . . . 0.0 104.271 171.356 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 16.2 p90 -90.53 116.68 28.62 Favored 'General case' 0 N--CA 1.425 -1.711 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 178.375 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.623 HG12 ' H ' ' A' ' 133' ' ' VAL . 36.0 t -137.69 146.58 27.25 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 -175.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' LYS . . . . . 0.461 ' HA ' ' HA ' ' A' ' 124' ' ' LYS . 58.9 pttt -103.23 12.0 36.17 Favored 'General case' 0 C--N 1.315 -0.917 0 C-N-CA 120.165 -0.614 . . . . 0.0 111.448 -178.797 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.623 ' H ' HG12 ' A' ' 131' ' ' VAL . 33.5 m -125.55 -1.43 5.14 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.006 0 C-N-CA 120.396 -0.522 . . . . 0.0 111.778 -175.942 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' THR . . . . . 0.601 ' OG1' ' HB ' ' A' ' 125' ' ' THR . 1.3 p -60.35 111.16 1.45 Allowed 'General case' 0 N--CA 1.43 -1.425 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 175.636 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' SER . . . . . 0.68 ' HB2' ' O ' ' A' ' 117' ' ' LEU . 23.2 p -106.79 172.2 6.95 Favored 'General case' 0 N--CA 1.41 -2.471 0 N-CA-C 114.93 1.455 . . . . 0.0 114.93 -169.166 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' ILE . . . . . 0.406 ' HB ' ' CG2' ' A' ' 146' ' ' THR . 12.2 tt -101.16 105.23 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.491 0 CA-C-N 114.81 -1.086 . . . . 0.0 110.869 -173.406 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 45.7 p -91.54 114.36 26.87 Favored 'General case' 0 N--CA 1.414 -2.269 0 CA-C-N 115.157 -0.928 . . . . 0.0 109.685 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' THR . . . . . 0.685 ' HB ' ' O ' ' A' ' 115' ' ' GLY . 46.6 m -119.54 153.87 34.74 Favored 'General case' 0 C--N 1.279 -2.476 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 -179.791 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -106.41 35.36 2.98 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 178.326 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . 57.54 34.87 25.15 Favored 'General case' 0 C--N 1.355 0.805 0 CA-C-N 115.046 -0.979 . . . . 0.0 109.065 -177.389 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 47.2 t -173.1 -77.96 0.01 OUTLIER 'General case' 0 C--O 1.211 -0.935 0 CA-C-N 114.731 -1.122 . . . . 0.0 109.683 -174.234 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 81.6 mttt -89.93 150.97 21.94 Favored 'General case' 0 CA--C 1.497 -1.068 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 179.775 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 13.1 p -118.93 142.91 31.71 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.067 0 CA-C-O 121.416 0.627 . . . . 0.0 111.686 -175.85 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -121.55 114.9 21.86 Favored 'General case' 0 N--CA 1.423 -1.799 0 N-CA-C 106.163 -1.791 . . . . 0.0 106.163 171.475 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' PHE . . . . . 0.545 ' HB3' ' HB2' ' A' ' 151' ' ' LYS . 65.0 t80 -53.74 156.2 2.85 Favored 'General case' 0 C--O 1.252 1.223 0 C-N-CA 124.539 1.135 . . . . 0.0 113.094 -171.831 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.516 ' O ' HG21 ' A' ' 125' ' ' THR . 33.7 p -51.1 93.65 0.01 OUTLIER 'General case' 0 C--N 1.35 0.609 0 C-N-CA 125.181 1.392 . . . . 0.0 113.793 -175.573 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.521 ' HA ' ' HB ' ' A' ' 134' ' ' THR . . . 163.27 -35.71 0.0 OUTLIER 'General case' 0 CA--C 1.497 -1.061 0 C-N-CA 127.171 2.188 . . . . 0.0 106.31 178.676 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 100.63 79.07 1.4 Allowed Glycine 0 N--CA 1.434 -1.493 0 CA-C-N 114.963 -1.017 . . . . 0.0 111.807 179.016 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 16.3 tpt 72.51 -10.24 0.96 Allowed 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 123.877 0.871 . . . . 0.0 112.698 177.155 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -62.38 -30.53 71.27 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 121.062 0.458 . . . . 0.0 110.023 -179.014 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.545 ' HB2' ' HB3' ' A' ' 145' ' ' PHE . 10.0 mmpt? -121.86 118.76 29.75 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 106.521 -1.659 . . . . 0.0 106.521 175.122 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 32.1 p -91.39 111.66 23.24 Favored 'General case' 0 C--N 1.297 -1.708 0 CA-C-O 120.617 0.246 . . . . 0.0 111.174 -177.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 37.6 mmt180 -134.88 137.3 43.09 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 179.77 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 20.0 m -90.2 132.47 35.47 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 111.504 0.187 . . . . 0.0 111.504 -176.674 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' ARG . . . . . 0.481 ' HG2' ' HA2' ' A' ' 159' ' ' GLY . 2.0 tmt_? -65.01 -26.5 68.31 Favored 'General case' 0 N--CA 1.483 1.196 0 CA-C-O 121.107 0.479 . . . . 0.0 109.898 177.494 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -38.04 -48.11 1.17 Allowed 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 126.102 1.761 . . . . 0.0 115.576 -175.922 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -79.33 -54.92 5.47 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 113.899 1.074 . . . . 0.0 113.899 -173.212 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 0.43 ' HB2' ' OE1' ' A' ' 161' ' ' GLN . 98.3 m-85 -153.19 24.5 0.55 Allowed 'General case' 0 N--CA 1.482 1.151 0 O-C-N 122.242 -0.286 . . . . 0.0 110.536 -176.658 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 159' ' ' GLY . . . . . 0.634 ' HA3' ' O ' ' A' ' 65' ' ' ILE . . . 87.78 -92.41 1.8 Allowed Glycine 0 CA--C 1.475 -2.46 0 C-N-CA 119.672 -1.252 . . . . 0.0 111.618 -177.597 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.566 ' HB ' ' O ' ' A' ' 67' ' ' ILE . 28.6 t -98.58 121.92 49.68 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.191 0 C-N-CA 119.67 -0.812 . . . . 0.0 108.91 -179.797 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 161' ' ' GLN . . . . . 0.43 ' OE1' ' HB2' ' A' ' 158' ' ' TYR . 15.3 mm100 -103.88 92.95 4.63 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 115.78 1.77 . . . . 0.0 115.78 -175.188 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 17.0 mmm180 -152.66 150.27 29.29 Favored 'General case' 0 CA--C 1.501 -0.93 0 C-N-CA 125.624 1.57 . . . . 0.0 108.754 170.755 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 19.7 m120 -89.88 97.69 11.33 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-O 120.964 0.412 . . . . 0.0 111.415 -178.491 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -136.57 156.07 22.91 Favored Glycine 0 C--N 1.308 -1.025 0 N-CA-C 110.615 -0.994 . . . . 0.0 110.615 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -135.83 116.63 14.07 Favored 'General case' 0 N--CA 1.425 -1.703 0 CA-C-O 121.38 0.609 . . . . 0.0 109.5 178.355 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 166' ' ' ARG . . . . . 0.604 ' H ' ' HD2' ' A' ' 166' ' ' ARG . 3.3 mpt_? -81.3 105.83 12.79 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 106.39 -1.707 . . . . 0.0 106.39 178.63 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.4 HG22 ' H ' ' A' ' 167' ' ' VAL . 9.2 m -71.43 77.08 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.925 0 N-CA-C 114.976 1.473 . . . . 0.0 114.976 -174.25 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 168' ' ' ASP . . . . . 0.637 ' HB2' ' HB2' ' A' ' 90' ' ' SER . 15.4 t70 -144.41 -34.01 0.38 Allowed 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 114.072 -1.422 . . . . 0.0 107.279 177.588 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 169' ' ' LYS . . . . . 0.407 ' H ' ' H ' ' A' ' 168' ' ' ASP . 39.1 ttpt -111.86 157.4 20.66 Favored 'General case' 0 N--CA 1.439 -1.015 0 CA-C-N 114.543 -1.208 . . . . 0.0 108.039 178.858 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 170' ' ' PHE . . . . . . . . . . . . . 16.0 p90 . . . . . 0 C--N 1.305 -1.366 0 O-C-N 123.248 0.342 . . . . 0.0 111.349 179.405 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 20.4 m . . . . . 0 N--CA 1.44 -0.955 0 N-CA-C 109.022 -0.732 . . . . 0.0 109.022 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 57.74 79.63 0.19 Allowed 'General case' 0 C--O 1.248 1.026 0 C-N-CA 123.396 0.678 . . . . 0.0 111.18 179.357 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 52.9 mt-30 -85.07 106.06 16.27 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-N 115.516 -0.766 . . . . 0.0 111.354 -176.771 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 7.0 tt -145.14 118.68 2.69 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.816 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.282 178.913 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 30.8 p90 -147.14 106.35 3.88 Favored 'General case' 0 C--N 1.298 -1.66 0 CA-C-O 121.411 0.624 . . . . 0.0 110.145 -179.063 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 28.3 p-10 -160.73 149.42 16.57 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.325 -178.547 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.13 92.46 2.49 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-O 121.8 0.809 . . . . 0.0 111.575 178.007 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 9.6 p -101.64 145.35 11.77 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 CA-C-N 115.01 -0.995 . . . . 0.0 108.773 178.248 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 95.87 31.66 7.24 Favored Glycine 0 N--CA 1.435 -1.381 0 N-CA-C 110.564 -1.014 . . . . 0.0 110.564 -178.223 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 28.1 t -93.3 101.55 13.8 Favored 'General case' 0 N--CA 1.42 -1.948 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 -179.522 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 90.3 m-85 -106.38 103.06 12.43 Favored 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 109.414 -0.588 . . . . 0.0 109.414 179.821 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 85.5 t90 -99.66 120.04 39.06 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.468 -178.642 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -160.76 154.75 22.76 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 107.783 -1.192 . . . . 0.0 107.783 177.191 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 159.53 46.63 0.01 OUTLIER Glycine 0 N--CA 1.433 -1.513 0 C-N-CA 119.768 -1.206 . . . . 0.0 112.947 178.335 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -86.73 95.68 9.9 Favored 'General case' 0 C--N 1.312 -1.051 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 177.062 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -119.44 104.2 10.13 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 115.925 -0.579 . . . . 0.0 109.683 -178.26 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -93.16 96.72 10.2 Favored 'General case' 0 C--N 1.296 -1.735 0 CA-C-O 121.11 0.481 . . . . 0.0 109.841 178.125 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -116.09 105.0 12.12 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.147 -179.424 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 37.8 ttpt -119.04 101.76 8.26 Favored 'General case' 0 C--N 1.292 -1.907 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.127 -176.88 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -136.3 108.78 7.39 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.645 -176.689 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 48.8 p90 -155.98 148.24 23.53 Favored 'General case' 0 C--N 1.292 -1.91 0 N-CA-C 106.505 -1.665 . . . . 0.0 106.505 175.785 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -118.74 99.04 6.52 Favored 'General case' 0 C--N 1.292 -1.908 0 C-N-CA 120.125 -0.63 . . . . 0.0 109.705 -177.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 54.3 p -76.79 96.62 4.3 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.572 -178.135 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 12.6 p -151.08 148.98 14.54 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 178.694 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 130.16 78.13 0.19 Allowed Glycine 0 N--CA 1.435 -1.43 0 N-CA-C 110.86 -0.896 . . . . 0.0 110.86 -179.625 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -112.75 114.68 27.35 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 -178.617 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 31.8 m-20 -85.03 115.86 23.09 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-O 121.23 0.538 . . . . 0.0 110.88 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 89.3 mt -123.91 144.78 49.56 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.44 178.725 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 32.7 p30 -156.84 155.83 32.16 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.245 177.232 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 21.4 m -114.85 162.72 16.52 Favored 'General case' 0 C--N 1.295 -1.799 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.4 -178.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 58.6 t -88.52 110.49 21.25 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.244 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 -178.411 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 42.1 t -104.52 112.07 24.98 Favored 'General case' 0 C--N 1.311 -1.104 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 177.842 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 8.7 t -156.95 154.89 30.42 Favored 'General case' 0 N--CA 1.428 -1.571 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 9.5 t -163.32 90.95 0.68 Allowed 'General case' 0 N--CA 1.424 -1.729 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 176.784 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 62.0 mt -111.77 112.34 40.11 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 177.708 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -146.22 159.71 42.96 Favored 'General case' 0 C--N 1.293 -1.878 0 C-N-CA 120.55 -0.46 . . . . 0.0 110.126 -178.174 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -165.89 -154.28 8.1 Favored Glycine 0 N--CA 1.42 -2.386 0 N-CA-C 110.665 -0.974 . . . . 0.0 110.665 179.43 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -133.32 -174.88 13.71 Favored Glycine 0 N--CA 1.419 -2.445 0 N-CA-C 111.656 -0.578 . . . . 0.0 111.656 -178.339 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 9.3 t -145.05 176.35 9.56 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 59.9 mttp -63.08 119.81 10.22 Favored 'General case' 0 C--N 1.322 -0.59 0 O-C-N 123.424 0.452 . . . . 0.0 110.16 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 57.1 t90 -68.55 -77.89 0.07 Allowed 'General case' 0 C--N 1.306 -1.324 0 CA-C-N 115.204 -0.907 . . . . 0.0 112.396 -176.425 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.4 tt -170.76 34.72 0.02 OUTLIER 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 104.48 -2.415 . . . . 0.0 104.48 -175.138 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 12.6 p -70.02 146.17 12.5 Favored 'Isoleucine or valine' 0 C--O 1.245 0.835 0 CA-C-N 115.072 -0.967 . . . . 0.0 111.46 -173.902 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 57.8 t30 76.73 11.33 2.59 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 125.079 1.352 . . . . 0.0 110.022 -179.033 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 28.1 mtpp -145.19 128.4 16.72 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.242 -0.89 . . . . 0.0 108.896 -179.764 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -137.55 163.03 31.79 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.17 0 O-C-N 122.005 -0.434 . . . . 0.0 111.295 178.615 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -139.79 155.36 47.33 Favored 'General case' 0 C--N 1.312 -1.043 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 176.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -178.36 151.61 10.72 Favored Glycine 0 N--CA 1.43 -1.758 0 C-N-CA 119.755 -1.212 . . . . 0.0 112.242 177.713 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 58.9 tptt -104.82 -51.11 3.12 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 106.66 -1.607 . . . . 0.0 106.66 175.069 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 26.3 ttt -146.05 80.4 1.57 Allowed 'General case' 0 N--CA 1.432 -1.372 0 CA-C-N 114.654 -1.157 . . . . 0.0 108.793 177.319 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER 72.53 -46.86 0.66 Allowed 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 124.872 1.269 . . . . 0.0 111.291 179.782 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 25.0 ttmm 75.07 92.24 0.05 OUTLIER Pre-proline 0 C--O 1.219 -0.504 0 C-N-CA 125.117 1.367 . . . . 0.0 108.146 -174.582 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -68.7 3.68 2.15 Favored 'Trans proline' 0 N--CA 1.481 0.776 0 C-N-CA 123.593 2.862 . . . . 0.0 115.506 -170.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 8.4 mp -54.75 -47.05 99.16 Favored Pre-proline 0 CA--C 1.489 -1.383 0 N-CA-C 117.272 2.323 . . . . 0.0 117.272 -177.7 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.567 ' HA ' ' HG ' ' A' ' 58' ' ' LEU . 13.1 Cg_exo -66.39 -14.51 44.46 Favored 'Trans proline' 0 N--CA 1.416 -3.05 0 CA-C-N 120.183 1.101 . . . . 0.0 111.857 -175.131 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -74.05 -32.19 63.2 Favored 'General case' 0 N--CA 1.426 -1.644 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 -179.532 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.525 ' HA ' ' HG2' ' A' ' 60' ' ' GLU . 3.7 mm? -73.88 -41.73 61.75 Favored 'General case' 0 N--CA 1.423 -1.825 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 175.941 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.567 ' HG ' ' HA ' ' A' ' 55' ' ' PRO . 52.0 mt -58.2 -48.08 81.43 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.735 -177.864 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 7.4 mtpm? -70.84 -26.58 63.34 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 115.296 -0.865 . . . . 0.0 112.319 -178.036 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.525 ' HG2' ' HA ' ' A' ' 57' ' ' LEU . 8.6 pt-20 -83.84 -18.49 37.39 Favored 'General case' 0 N--CA 1.444 -0.762 0 C-N-CA 118.957 -1.097 . . . . 0.0 109.854 177.913 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 61.2 m-85 -89.08 -13.91 37.52 Favored 'General case' 0 C--O 1.24 0.604 0 C-N-CA 119.095 -1.042 . . . . 0.0 112.119 175.841 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.449 ' HB3' HG23 ' A' ' 73' ' ' THR . 23.5 t70 -91.93 -153.95 0.35 Allowed 'General case' 0 C--O 1.253 1.27 0 N-CA-C 105.782 -1.933 . . . . 0.0 105.782 172.698 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.632 ' HB2' HD12 ' A' ' 65' ' ' ILE . 5.1 mt -95.16 158.17 35.26 Favored Pre-proline 0 C--N 1.298 -1.661 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 -178.057 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -93.86 26.6 0.34 Allowed 'Trans proline' 0 N--CA 1.448 -1.19 0 C-N-CA 122.849 2.366 . . . . 0.0 111.143 -168.729 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.686 HG12 ' H ' ' A' ' 67' ' ' ILE . 0.2 OUTLIER -95.11 -21.58 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.778 0 CA-C-N 115.331 -0.849 . . . . 0.0 108.966 -177.995 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 67.64 8.92 54.33 Favored Glycine 0 C--N 1.353 1.481 0 CA-C-N 115.501 -0.772 . . . . 0.0 112.195 179.548 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.686 ' H ' HG12 ' A' ' 65' ' ' ILE . 73.0 mt 57.79 -70.78 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.203 -1.344 0 C-N-CA 127.184 2.193 . . . . 0.0 112.613 -173.044 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.551 ' HB3' ' HD3' ' A' ' 69' ' ' PRO . 79.5 t80 176.73 -50.53 0.0 OUTLIER Pre-proline 0 C--N 1.303 -1.449 0 C-N-CA 122.853 0.461 . . . . 0.0 110.392 -174.578 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.551 ' HD3' ' HB3' ' A' ' 68' ' ' PHE . 24.8 Cg_exo -67.58 131.69 25.15 Favored 'Trans proline' 0 N--CA 1.436 -1.876 0 N-CA-C 109.046 -1.175 . . . . 0.0 109.046 174.386 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -73.7 64.58 1.84 Allowed Glycine 0 C--N 1.306 -1.102 0 O-C-N 123.439 0.462 . . . . 0.0 113.045 -177.275 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.496 ' HB3' ' HG3' ' A' ' 89' ' ' PRO . 12.7 t70 177.43 -39.65 0.01 OUTLIER 'General case' 0 C--O 1.21 -0.978 0 N-CA-C 107.737 -1.208 . . . . 0.0 107.737 179.379 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.66 ' O ' ' HB ' ' A' ' 73' ' ' THR . . . -46.48 166.28 0.02 OUTLIER 'General case' 0 N--CA 1.506 2.365 0 C-N-CA 124.273 1.029 . . . . 0.0 112.753 174.624 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.66 ' HB ' ' O ' ' A' ' 72' ' ' ALA 0.254 1.5 m 88.11 26.22 0.03 OUTLIER 'General case' 0 C--N 1.367 1.346 0 CA-C-O 125.071 2.367 . . . . 0.0 109.665 -178.97 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 40.7 m-80 -82.23 163.88 21.57 Favored 'General case' 0 N--CA 1.411 -2.376 0 CA-C-N 113.725 -1.58 . . . . 0.0 111.033 177.404 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.496 ' H ' ' HB3' ' A' ' 58' ' ' LEU . 33.7 t80 -134.52 95.6 3.41 Favored 'General case' 0 C--N 1.274 -2.702 0 CA-C-N 115.151 -0.932 . . . . 0.0 111.923 -168.893 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.498 ' O ' HD22 ' A' ' 84' ' ' LEU . 41.0 mm-40 -115.89 153.46 31.5 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 173.667 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 69.0 t80 -146.08 114.47 6.71 Favored 'General case' 0 C--N 1.29 -1.98 0 O-C-N 122.046 -0.409 . . . . 0.0 110.04 -177.023 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.658 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 31.7 m-20 -88.67 148.95 23.75 Favored 'General case' 0 CA--C 1.459 -2.535 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 175.622 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -82.37 -41.18 20.31 Favored 'General case' 1 C--N 1.24 -4.172 0 CA-C-N 114.796 -1.093 . . . . 0.0 111.916 179.307 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.401 ' HG3' ' N ' ' A' ' 81' ' ' THR . 8.7 pt-20 -61.84 -41.7 98.14 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-O 122.236 1.017 . . . . 0.0 109.332 178.331 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.658 ' HB ' ' HB2' ' A' ' 78' ' ' ASP . 46.2 m -70.76 -51.31 27.9 Favored 'General case' 0 N--CA 1.412 -2.374 0 CA-C-N 113.799 -1.546 . . . . 0.0 108.045 177.14 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 80.0 tttt 68.2 9.01 6.95 Favored 'General case' 0 C--N 1.348 0.533 0 C-N-CA 126.144 1.778 . . . . 0.0 110.398 178.563 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.792 ' HG2' HG22 ' A' ' 109' ' ' THR . 75.5 tttt -117.7 133.86 55.51 Favored 'General case' 0 N--CA 1.409 -2.505 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 179.363 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.498 HD22 ' O ' ' A' ' 76' ' ' GLU . 2.7 tm? -64.44 133.76 53.15 Favored 'General case' 0 C--N 1.317 -0.841 0 C-N-CA 123.101 0.561 . . . . 0.0 110.149 -172.554 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.509 ' HB ' HG23 ' A' ' 109' ' ' THR . 6.0 t -117.1 111.44 19.51 Favored 'General case' 0 N--CA 1.412 -2.372 0 CA-C-O 122.128 0.966 . . . . 0.0 111.577 -177.593 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 58.0 t -92.87 126.01 45.37 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.272 0 CA-C-N 114.89 -1.05 . . . . 0.0 108.433 177.853 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.51 ' HA ' ' O ' ' A' ' 106' ' ' THR . 1.9 pp -105.02 124.4 49.46 Favored 'General case' 0 N--CA 1.408 -2.572 0 CA-C-N 115.242 -0.89 . . . . 0.0 112.16 178.276 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 3.0 mp -110.06 125.04 31.93 Favored Pre-proline 0 C--N 1.293 -1.855 0 CA-C-N 114.063 -1.426 . . . . 0.0 109.089 178.453 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.496 ' HG3' ' HB3' ' A' ' 71' ' ' ASP . 2.6 Cg_endo -52.23 98.59 0.04 OUTLIER 'Trans proline' 0 C--N 1.363 1.306 0 C-N-CA 123.395 2.73 . . . . 0.0 112.206 173.216 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.612 ' HB2' ' HB2' ' A' ' 168' ' ' ASP . 43.3 t 74.03 141.56 0.07 Allowed 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 124.326 1.05 . . . . 0.0 112.512 -179.534 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.532 HD11 ' HG3' ' A' ' 103' ' ' LYS . 0.0 OUTLIER -76.49 108.37 9.08 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.132 0 CA-C-N 114.999 -1.0 . . . . 0.0 109.005 176.644 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 25.1 p -91.83 127.22 37.21 Favored 'General case' 0 N--CA 1.431 -1.419 0 CA-C-N 114.838 -1.074 . . . . 0.0 110.56 -179.756 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -107.8 159.59 16.38 Favored 'General case' 0 C--O 1.244 0.766 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.25 -179.374 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.574 ' O ' ' HA ' ' A' ' 101' ' ' VAL . 2.6 p -156.95 109.01 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.141 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 -178.963 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.552 ' HA2' ' O ' ' A' ' 100' ' ' SER . . . -145.94 170.89 27.04 Favored Glycine 0 N--CA 1.423 -2.233 0 C-N-CA 119.022 -1.561 . . . . 0.0 114.239 -178.114 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 87.6 m-85 -127.22 -157.1 0.79 Allowed 'General case' 0 N--CA 1.404 -2.741 0 N-CA-C 102.776 -3.046 . . . . 0.0 102.776 170.939 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.15 -11.72 61.05 Favored 'General case' 0 C--N 1.293 -1.861 0 C-N-CA 118.675 -1.21 . . . . 0.0 111.158 175.414 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 25.9 t70 177.93 -53.93 0.01 OUTLIER 'General case' 0 C--N 1.382 1.998 0 N-CA-C 114.33 1.233 . . . . 0.0 114.33 177.821 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 49.9 m -44.98 -28.52 0.69 Allowed 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 115.201 1.556 . . . . 0.0 115.201 -168.687 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' SER . . . . . 0.552 ' O ' ' HA2' ' A' ' 95' ' ' GLY . 54.3 m -152.77 83.53 1.22 Allowed 'General case' 0 C--N 1.287 -2.143 0 C-N-CA 120.952 -0.299 . . . . 0.0 110.945 177.936 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.574 ' HA ' ' O ' ' A' ' 94' ' ' VAL . 11.3 p -117.27 132.97 65.49 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.507 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 171.771 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.41 ' HG ' ' HA ' ' A' ' 125' ' ' THR . 6.8 tt -152.78 145.41 24.24 Favored 'General case' 0 N--CA 1.405 -2.702 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 -175.642 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.532 ' HG3' HD11 ' A' ' 91' ' ' ILE . 39.8 ttmt -129.99 121.1 25.87 Favored 'General case' 0 C--N 1.291 -1.965 0 N-CA-C 111.937 0.347 . . . . 0.0 111.937 -177.331 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -95.36 103.6 15.47 Favored 'General case' 0 N--CA 1.439 -1.008 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 175.293 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 41.1 m -70.82 149.74 46.53 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 109.889 -0.411 . . . . 0.0 109.889 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.51 ' O ' ' HA ' ' A' ' 87' ' ' LEU . 37.8 p -54.07 -53.75 48.88 Favored 'General case' 0 C--O 1.216 -0.691 0 CA-C-O 121.666 0.746 . . . . 0.0 110.985 -178.26 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 7.5 m -113.73 93.54 4.43 Favored 'General case' 0 N--CA 1.399 -2.994 0 CA-C-N 115.056 -0.974 . . . . 0.0 109.619 -176.408 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.471 HG11 ' CD1' ' A' ' 123' ' ' ILE . 15.1 m -99.46 155.59 4.03 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.546 177.531 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.792 HG22 ' HG2' ' A' ' 83' ' ' LYS . 0.4 OUTLIER -137.24 128.73 28.35 Favored 'General case' 0 N--CA 1.398 -3.072 0 N-CA-C 106.05 -1.833 . . . . 0.0 106.05 -173.831 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.453 ' HA2' ' O ' ' A' ' 119' ' ' ASP . . . -151.12 -174.57 22.15 Favored Glycine 0 C--N 1.286 -2.208 0 C-N-CA 119.979 -1.105 . . . . 0.0 113.714 -175.706 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' HIS . . . . . 0.463 ' O ' HD12 ' A' ' 117' ' ' LEU . 45.0 t60 -91.33 117.93 30.08 Favored 'General case' 0 C--N 1.294 -1.821 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 179.727 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -99.92 117.91 35.22 Favored 'General case' 0 CA--C 1.479 -1.752 0 CA-C-O 121.014 0.435 . . . . 0.0 110.879 -171.132 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -126.74 138.34 53.37 Favored 'General case' 0 CA--C 1.45 -2.881 0 CA-C-N 115.094 -0.957 . . . . 0.0 108.894 167.04 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 6.0 tmtt? -73.47 100.88 3.36 Favored 'General case' 0 N--CA 1.389 -3.482 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 -175.482 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' GLY . . . . . 0.543 ' O ' HG23 ' A' ' 138' ' ' THR . . . 135.78 -37.63 1.88 Allowed Glycine 0 N--CA 1.419 -2.461 0 N-CA-C 110.169 -1.172 . . . . 0.0 110.169 -176.203 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.559 ' O ' ' HD2' ' A' ' 116' ' ' LYS . 0.0 OUTLIER -154.06 136.96 15.39 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.27 0.628 . . . . 0.0 111.984 -179.441 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.463 HD12 ' O ' ' A' ' 111' ' ' HIS . 64.1 tp -111.43 107.05 16.14 Favored 'General case' 0 C--N 1.308 -1.2 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 -177.274 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 68.1 p -105.56 176.11 5.27 Favored 'General case' 0 C--N 1.296 -1.735 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.637 -179.023 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' ASP . . . . . 0.453 ' O ' ' HA2' ' A' ' 110' ' ' GLY . 16.2 m-20 56.59 48.66 16.1 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.259 0.623 . . . . 0.0 111.722 172.61 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.454 HG23 ' O ' ' A' ' 133' ' ' VAL . 3.3 m -81.93 96.18 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.656 0 CA-C-O 122.662 1.22 . . . . 0.0 112.29 -176.253 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -75.94 94.12 3.34 Favored 'General case' 0 N--CA 1.401 -2.886 0 CA-C-N 113.253 -1.794 . . . . 0.0 108.438 -178.56 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 134.7 -4.85 4.39 Favored Glycine 0 C--N 1.285 -2.299 0 CA-C-N 115.063 -0.971 . . . . 0.0 111.816 177.909 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.471 ' CD1' HG11 ' A' ' 108' ' ' VAL . 48.9 mm -99.91 99.58 8.78 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.229 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 177.039 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 53.4 mtmt -93.44 119.26 32.32 Favored 'General case' 0 N--CA 1.411 -2.382 0 CA-C-N 114.355 -1.293 . . . . 0.0 108.605 -179.092 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.41 ' HA ' ' HG ' ' A' ' 102' ' ' LEU . 99.1 m -128.1 131.87 49.01 Favored 'General case' 0 N--CA 1.422 -1.852 0 CA-C-N 114.771 -1.104 . . . . 0.0 112.918 -167.782 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.619 ' C ' ' HD3' ' A' ' 126' ' ' LYS . 0.2 OUTLIER -123.05 119.71 31.16 Favored 'General case' 0 N--CA 1.418 -2.068 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 170.825 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.441 HG23 ' H ' ' A' ' 128' ' ' MET . 4.8 m -139.17 -56.57 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.031 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.388 176.934 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' MET . . . . . 0.441 ' H ' HG23 ' A' ' 127' ' ' VAL . 26.8 ttt -99.57 -34.96 10.02 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 178.168 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.565 ' CD1' ' H ' ' A' ' 130' ' ' TRP . 0.3 OUTLIER -162.57 -177.71 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.418 -2.074 0 N-CA-C 103.499 -2.778 . . . . 0.0 103.499 176.615 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 130' ' ' TRP . . . . . 0.565 ' H ' ' CD1' ' A' ' 129' ' ' ILE . 88.4 t90 -92.29 123.76 35.85 Favored 'General case' 0 C--N 1.296 -1.733 0 CA-C-N 119.55 1.068 . . . . 0.0 109.797 -179.658 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.626 HG12 ' H ' ' A' ' 133' ' ' VAL . 61.1 t -131.55 136.69 56.85 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.08 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 179.631 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 132' ' ' LYS . . . . . 0.617 ' HD3' ' H ' ' A' ' 132' ' ' LYS . 0.0 OUTLIER -98.89 21.77 11.11 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-O 121.019 0.437 . . . . 0.0 111.237 -178.056 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.626 ' H ' HG12 ' A' ' 131' ' ' VAL . 51.5 t -132.05 -78.73 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.251 0 CA-C-N 116.214 -0.448 . . . . 0.0 109.959 -175.689 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 40.0 p 51.86 -167.01 0.05 OUTLIER 'General case' 0 CA--C 1.555 1.155 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 -177.068 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 27.6 p -164.04 150.39 11.33 Favored 'General case' 0 N--CA 1.429 -1.52 0 C-N-CA 122.637 0.375 . . . . 0.0 110.146 -179.43 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 7.5 tt -105.7 97.41 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.884 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 173.502 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 60.6 p -97.58 142.63 29.16 Favored 'General case' 0 N--CA 1.405 -2.686 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.997 -177.011 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' THR . . . . . 0.543 HG23 ' O ' ' A' ' 115' ' ' GLY . 5.8 t -165.08 175.07 9.72 Favored 'General case' 0 N--CA 1.399 -2.988 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 -177.794 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -110.71 28.52 8.61 Favored 'General case' 0 C--N 1.285 -2.23 0 N-CA-C 106.306 -1.739 . . . . 0.0 106.306 176.669 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . 61.46 44.06 9.72 Favored 'General case' 0 C--N 1.348 0.529 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 -171.115 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 30.8 t -174.96 -80.29 0.01 OUTLIER 'General case' 0 CA--C 1.555 1.149 0 CA-C-N 114.783 -1.099 . . . . 0.0 110.973 -171.52 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -83.96 128.6 34.66 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 179.837 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.421 HG11 HG12 ' A' ' 160' ' ' VAL . 88.8 t -105.49 127.83 60.01 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.973 0 CA-C-O 121.516 0.674 . . . . 0.0 112.093 -171.001 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 26.7 m-85 -118.41 141.25 48.74 Favored 'General case' 0 N--CA 1.426 -1.64 0 CA-C-N 115.318 -0.855 . . . . 0.0 111.138 179.621 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' PHE . . . . . 0.433 ' HB2' ' H ' ' A' ' 151' ' ' LYS . 42.9 m-85 -93.21 98.75 11.48 Favored 'General case' 0 N--CA 1.408 -2.525 0 CA-C-N 114.382 -1.281 . . . . 0.0 108.371 171.377 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . 0.259 2.5 p -98.42 99.71 10.91 Favored 'General case' 0 N--CA 1.406 -2.639 0 N-CA-C 115.061 1.504 . . . . 0.0 115.061 -176.221 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -130.35 29.62 4.84 Favored 'General case' 0 C--N 1.312 -1.031 0 N-CA-C 105.445 -2.057 . . . . 0.0 105.445 174.524 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 133.99 -69.33 0.53 Allowed Glycine 0 N--CA 1.413 -2.847 0 N-CA-C 104.016 -3.633 . . . . 0.0 104.016 -171.794 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 27.7 ttt 173.3 82.86 0.0 OUTLIER 'General case' 0 C--N 1.314 -0.971 0 C-N-CA 125.885 1.674 . . . . 0.0 108.147 169.859 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' LYS . . . . . 0.404 ' HG3' ' CG2' ' A' ' 127' ' ' VAL . 29.4 mmtt -88.84 -88.74 0.15 Allowed 'General case' 0 C--N 1.308 -1.196 0 N-CA-C 115.09 1.515 . . . . 0.0 115.09 -179.513 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.433 ' H ' ' HB2' ' A' ' 145' ' ' PHE . 98.7 mttt -110.26 149.1 30.65 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 113.354 0.872 . . . . 0.0 113.354 -172.469 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 20.3 m -132.64 137.77 47.12 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.818 -176.898 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.28 162.84 40.78 Favored 'General case' 0 CA--C 1.477 -1.849 0 CA-C-O 121.317 0.58 . . . . 0.0 111.661 175.129 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 46.4 m -90.18 139.85 30.24 Favored 'General case' 0 C--N 1.274 -2.689 0 CA-C-N 115.284 -0.871 . . . . 0.0 108.858 179.12 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . 0.407 0.0 OUTLIER -58.68 -18.54 31.81 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 114.28 1.215 . . . . 0.0 114.28 -179.783 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -50.06 -32.4 15.46 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 124.632 1.173 . . . . 0.0 111.489 178.494 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -68.04 -54.05 21.26 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 116.576 -0.283 . . . . 0.0 110.827 179.708 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 1.1 t80 177.95 21.6 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.0 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 177.205 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 159' ' ' GLY . . . . . 0.4 ' HA2' ' HB ' ' A' ' 65' ' ' ILE . . . 88.71 -99.41 2.54 Favored Glycine 0 N--CA 1.419 -2.472 0 C-N-CA 119.779 -1.201 . . . . 0.0 111.098 -174.08 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.566 HG22 ' O ' ' A' ' 67' ' ' ILE . 4.2 m -103.09 128.79 55.74 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.304 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 49.9 mt-30 -94.02 92.13 7.19 Favored 'General case' 0 C--N 1.294 -1.824 0 C-N-CA 119.176 -1.01 . . . . 0.0 111.151 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 162' ' ' ARG . . . . . 0.522 ' CG ' HG11 ' A' ' 94' ' ' VAL . 21.0 tpp180 -152.49 112.2 3.95 Favored 'General case' 0 N--CA 1.414 -2.228 0 N-CA-C 106.857 -1.534 . . . . 0.0 106.857 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 83.7 m-20 -77.05 105.97 8.46 Favored 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 -174.402 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -118.76 -178.22 16.81 Favored Glycine 0 C--N 1.3 -1.434 0 N-CA-C 110.18 -1.168 . . . . 0.0 110.18 176.651 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.526 ' O ' HD22 ' A' ' 165' ' ' LEU . 0.0 OUTLIER -141.55 131.74 24.89 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 177.431 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 166' ' ' ARG . . . . . 0.483 ' HD3' ' HB3' ' A' ' 69' ' ' PRO . 9.5 mtm180 -96.05 111.1 23.21 Favored 'General case' 0 CA--C 1.482 -1.667 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 -179.788 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.414 HG13 HD23 ' A' ' 165' ' ' LEU 0.287 2.6 m -80.84 65.92 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.103 0 CA-C-O 122.906 1.336 . . . . 0.0 111.181 173.32 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 168' ' ' ASP . . . . . 0.612 ' HB2' ' HB2' ' A' ' 90' ' ' SER . 21.7 t70 -160.87 -27.49 0.06 Allowed 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 112.33 -2.214 . . . . 0.0 108.426 -177.293 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 169' ' ' LYS . . . . . 0.412 ' H ' ' H ' ' A' ' 168' ' ' ASP . 21.6 pttp -74.85 149.51 39.54 Favored 'General case' 0 C--O 1.244 0.796 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.863 -173.904 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 170' ' ' PHE . . . . . . . . . . . . . 16.9 p90 . . . . . 0 C--N 1.297 -1.698 0 CA-C-O 118.189 -0.91 . . . . 0.0 110.039 -179.785 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 39.5 t . . . . . 0 N--CA 1.452 -0.344 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -88.96 101.24 13.88 Favored 'General case' 0 CA--C 1.495 -1.157 0 CA-C-O 120.807 0.337 . . . . 0.0 110.11 179.668 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 29.2 tt0 -155.52 85.86 1.06 Allowed 'General case' 0 N--CA 1.422 -1.828 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 177.053 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 7.1 tp -151.42 87.83 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 CA-C-O 122.414 1.102 . . . . 0.0 109.505 177.716 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 86.0 m-85 -112.65 126.5 55.44 Favored 'General case' 0 C--N 1.293 -1.889 0 CA-C-N 114.971 -1.013 . . . . 0.0 109.604 -177.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 43.8 t30 -77.39 92.72 3.98 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 177.493 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 35.1 mmtp -95.18 107.79 19.89 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.433 -179.467 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 6.0 p -80.94 118.6 29.0 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.244 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.685 177.665 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -91.69 150.97 20.62 Favored Glycine 0 N--CA 1.427 -1.913 0 N-CA-C 110.918 -0.873 . . . . 0.0 110.918 179.285 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 19.9 m -66.95 131.76 46.55 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 179.505 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 42.5 p90 -100.5 102.19 13.31 Favored 'General case' 0 N--CA 1.433 -1.288 0 CA-C-O 121.674 0.75 . . . . 0.0 110.868 179.028 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 14.8 m-90 -83.3 146.23 28.64 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 178.39 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -137.62 146.32 43.8 Favored 'General case' 0 C--N 1.302 -1.458 0 C-N-CA 120.396 -0.522 . . . . 0.0 111.597 -175.184 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -88.76 67.19 3.02 Favored Glycine 0 N--CA 1.433 -1.549 0 N-CA-C 110.746 -0.942 . . . . 0.0 110.746 178.256 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -82.89 166.84 18.59 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-O 120.759 0.314 . . . . 0.0 111.499 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 61.3 mttp 63.66 64.48 0.79 Allowed 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.37 -177.143 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -95.89 91.22 5.92 Favored 'General case' 0 N--CA 1.418 -2.048 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 175.276 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -92.76 139.5 30.49 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.155 -177.919 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.476 ' N ' ' HD3' ' A' ' 19' ' ' LYS . 0.1 OUTLIER -139.08 154.56 48.19 Favored 'General case' 0 C--N 1.29 -2.009 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 -177.151 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -144.12 100.24 3.52 Favored 'General case' 0 C--N 1.287 -2.133 0 N-CA-C 106.026 -1.842 . . . . 0.0 106.026 176.169 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 47.0 p90 -70.0 138.6 52.36 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-O 121.22 0.533 . . . . 0.0 111.939 -174.491 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -82.05 144.2 30.99 Favored 'General case' 0 C--N 1.291 -1.961 0 CA-C-N 115.397 -0.819 . . . . 0.0 108.854 178.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 33.1 m -128.2 101.78 6.41 Favored 'General case' 0 C--N 1.281 -2.382 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 179.771 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 41.9 t -101.13 154.02 4.76 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 -179.476 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -75.0 61.18 2.6 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 121.683 -0.294 . . . . 0.0 112.577 -179.436 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 -98.28 77.13 2.36 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-O 121.125 0.488 . . . . 0.0 109.81 -179.472 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.406 ' CG ' ' H ' ' A' ' 28' ' ' LEU . 21.6 t70 -172.67 -168.2 0.49 Allowed 'General case' 0 C--N 1.31 -1.149 0 N-CA-C 105.856 -1.905 . . . . 0.0 105.856 -179.209 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.406 ' H ' ' CG ' ' A' ' 27' ' ' ASP . 54.7 tp 62.77 82.7 0.17 Allowed 'General case' 0 C--O 1.237 0.398 0 CA-C-O 121.885 0.85 . . . . 0.0 109.907 -176.509 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -121.48 -173.75 2.7 Favored 'General case' 0 C--N 1.294 -1.817 0 CA-C-N 115.099 -0.955 . . . . 0.0 110.264 -176.925 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 20.3 m -92.42 125.88 37.27 Favored 'General case' 0 C--N 1.299 -1.627 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.031 179.132 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 64.5 t -79.78 100.68 4.42 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 174.639 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 48.2 p -79.72 -25.65 41.08 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.658 -174.731 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 11.7 t -159.91 144.93 15.12 Favored 'General case' 0 N--CA 1.424 -1.754 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 179.528 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 20.4 m -112.54 111.28 21.99 Favored 'General case' 0 C--N 1.294 -1.832 0 N-CA-C 106.574 -1.639 . . . . 0.0 106.574 175.858 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 63.0 mt -76.04 108.75 8.85 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 CA-C-O 120.949 0.404 . . . . 0.0 111.355 -174.013 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -113.18 163.74 14.39 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.548 179.063 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 149.94 -176.39 28.62 Favored Glycine 0 N--CA 1.427 -1.963 0 N-CA-C 109.102 -1.599 . . . . 0.0 109.102 -178.902 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 167.02 -130.83 2.2 Favored Glycine 0 N--CA 1.426 -2.028 0 C-N-CA 119.357 -1.402 . . . . 0.0 112.889 179.034 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 48.1 m 67.19 87.51 0.12 Allowed 'General case' 0 C--N 1.312 -1.026 0 C-N-CA 123.91 0.884 . . . . 0.0 110.029 -175.144 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 18.1 ptpt -90.36 125.75 35.64 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 115.096 -0.956 . . . . 0.0 109.55 178.36 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 25.2 m-90 -85.8 99.22 11.21 Favored 'General case' 0 C--N 1.304 -1.406 0 CA-C-O 122.011 0.91 . . . . 0.0 112.093 -177.254 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 80.3 mt -100.85 -166.53 1.32 Allowed 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 114.581 -1.19 . . . . 0.0 108.205 178.806 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 70.2 t 73.19 93.81 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.244 0.77 0 CA-C-O 121.542 0.687 . . . . 0.0 109.411 -178.646 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 51.5 t-20 -140.52 124.81 17.66 Favored 'General case' 0 C--N 1.308 -1.239 0 CA-C-N 115.423 -0.808 . . . . 0.0 108.978 -175.727 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 64.2 mttp -123.74 -178.6 4.09 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-O 120.77 0.319 . . . . 0.0 111.723 179.645 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.445 HD11 ' OE1' ' A' ' 60' ' ' GLU . 62.0 mt 75.88 122.95 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 C-N-CA 125.482 1.513 . . . . 0.0 111.216 179.626 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 4.0 mptp? -86.14 -60.54 1.98 Allowed 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 108.542 -0.911 . . . . 0.0 108.542 174.646 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 116.94 144.66 7.94 Favored Glycine 0 N--CA 1.428 -1.891 0 C-N-CA 120.349 -0.929 . . . . 0.0 111.206 -179.553 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.459 ' HB3' ' HG2' ' A' ' 51' ' ' GLN . 1.0 OUTLIER -112.02 138.33 48.81 Favored 'General case' 0 C--N 1.298 -1.643 0 C-N-CA 122.514 0.326 . . . . 0.0 110.185 179.986 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 27.0 ptt? -90.19 -0.89 57.83 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-O 121.4 0.619 . . . . 0.0 110.363 -178.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.459 ' HG2' ' HB3' ' A' ' 49' ' ' LYS . 13.5 pt20 -97.43 34.22 1.85 Allowed 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 175.754 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 97.1 mttt 84.79 134.6 0.04 OUTLIER Pre-proline 0 N--CA 1.468 0.436 0 C-N-CA 126.133 1.773 . . . . 0.0 109.744 -172.383 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -78.66 4.55 6.31 Favored 'Trans proline' 0 CA--C 1.511 -0.651 0 C-N-CA 122.571 2.181 . . . . 0.0 112.898 -178.553 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 9.3 mp -53.54 -51.92 71.62 Favored Pre-proline 0 CA--C 1.476 -1.892 0 N-CA-C 116.92 2.193 . . . . 0.0 116.92 -176.371 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.553 ' O ' ' HG2' ' A' ' 59' ' ' LYS . 25.8 Cg_exo -60.71 -15.53 37.95 Favored 'Trans proline' 0 N--CA 1.45 -1.079 0 C-N-CA 121.613 1.542 . . . . 0.0 111.92 -171.643 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.478 ' O ' ' HB2' ' A' ' 60' ' ' GLU . 22.6 mm-40 -80.27 -37.09 33.55 Favored 'General case' 0 N--CA 1.419 -1.989 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 179.553 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.507 ' HA ' ' HB3' ' A' ' 60' ' ' GLU . 9.3 mp -75.63 -34.27 60.53 Favored 'General case' 0 N--CA 1.438 -1.074 0 N-CA-C 113.557 0.947 . . . . 0.0 113.557 -177.412 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.421 HD12 ' N ' ' A' ' 58' ' ' LEU . 3.5 mp -63.14 -45.74 90.5 Favored 'General case' 0 N--CA 1.499 2.025 0 C-N-CA 119.29 -0.964 . . . . 0.0 109.365 -178.618 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.553 ' HG2' ' O ' ' A' ' 55' ' ' PRO . 0.0 OUTLIER -75.77 -25.85 56.82 Favored 'General case' 0 C--N 1.297 -1.689 0 CA-C-N 114.833 -1.076 . . . . 0.0 112.33 176.395 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.507 ' HB3' ' HA ' ' A' ' 57' ' ' LEU . 9.3 tp10 -63.18 -54.47 37.01 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 179.46 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 86.8 m-85 -74.23 3.89 6.54 Favored 'General case' 0 CA--C 1.511 -0.53 0 CA-C-O 121.839 0.828 . . . . 0.0 111.688 -178.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.548 ' HB3' ' O ' ' A' ' 59' ' ' LYS . 9.2 t70 -88.85 -177.03 5.41 Favored 'General case' 0 C--N 1.276 -2.626 0 CA-C-N 113.998 -1.455 . . . . 0.0 109.659 178.651 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.739 ' HB2' HD12 ' A' ' 65' ' ' ILE . 3.0 mt -80.2 -168.35 0.17 Allowed Pre-proline 0 CA--C 1.582 2.2 0 N-CA-C 106.215 -1.772 . . . . 0.0 106.215 178.454 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.651 ' HG3' ' N ' ' A' ' 141' ' ' SER . 41.8 Cg_endo -94.26 6.62 2.5 Favored 'Trans proline' 0 N--CA 1.442 -1.505 0 CA-C-N 121.991 1.747 . . . . 0.0 111.539 -176.836 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.739 HD12 ' HB2' ' A' ' 63' ' ' LEU . 0.1 OUTLIER -69.45 -46.65 75.78 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.874 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 179.801 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.507 ' H ' HD13 ' A' ' 65' ' ' ILE . . . 57.06 9.55 4.14 Favored Glycine 0 N--CA 1.482 1.735 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.57 -174.286 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.702 ' H ' HG12 ' A' ' 65' ' ' ILE . 68.3 mt 58.11 -70.66 0.07 OUTLIER 'Isoleucine or valine' 0 C--O 1.189 -2.129 0 C-N-CA 128.135 2.574 . . . . 0.0 111.405 -171.25 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.464 ' HB3' ' HD3' ' A' ' 69' ' ' PRO . 77.4 t80 -177.7 -55.83 0.0 OUTLIER Pre-proline 0 C--N 1.306 -1.289 0 CA-C-N 117.805 0.275 . . . . 0.0 111.146 -175.476 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.464 ' HD3' ' HB3' ' A' ' 68' ' ' PHE . 8.5 Cg_endo -96.91 -172.2 0.18 Allowed 'Trans proline' 0 N--CA 1.442 -1.558 0 C-N-CA 122.508 2.139 . . . . 0.0 112.187 -175.683 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -104.17 12.72 52.16 Favored Glycine 0 N--CA 1.436 -1.316 0 N-CA-C 110.62 -0.992 . . . . 0.0 110.62 175.294 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.425 ' H ' ' HB2' ' A' ' 69' ' ' PRO . 1.8 p30 -101.19 -56.68 2.25 Favored 'General case' 0 N--CA 1.419 -2.012 0 CA-C-N 115.422 -0.389 . . . . 0.0 110.421 179.678 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.41 ' O ' ' HB ' ' A' ' 73' ' ' THR . . . -67.37 167.46 12.48 Favored 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 123.379 0.672 . . . . 0.0 111.209 172.366 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.591 ' O ' HG22 ' A' ' 73' ' ' THR . 96.7 m 87.88 27.97 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.813 0 CA-C-O 124.518 2.104 . . . . 0.0 111.128 175.366 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.593 ' O ' ' HA ' ' A' ' 86' ' ' VAL . 5.0 m-20 -76.0 145.65 40.11 Favored 'General case' 0 C--N 1.267 -3.017 0 CA-C-N 114.575 -1.193 . . . . 0.0 109.456 174.721 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 42.6 t80 -121.25 98.57 6.04 Favored 'General case' 0 C--N 1.282 -2.341 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.633 -169.206 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 32.8 mm-40 -128.12 115.63 18.71 Favored 'General case' 0 C--O 1.212 -0.878 0 C-N-CA 123.35 0.66 . . . . 0.0 110.151 178.73 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.403 ' HA ' ' HA ' ' A' ' 84' ' ' LEU . 36.1 p90 -123.04 143.17 50.13 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 -178.852 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.61 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 10.5 m-20 -96.27 169.36 9.99 Favored 'General case' 0 CA--C 1.487 -1.452 0 C-N-CA 118.876 -1.13 . . . . 0.0 108.955 178.604 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -79.75 -64.01 1.28 Allowed 'General case' 0 C--N 1.279 -2.477 0 CA-C-N 114.644 -1.162 . . . . 0.0 111.396 -176.543 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -68.21 -45.5 73.17 Favored 'General case' 0 CA--C 1.498 -1.054 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.575 -177.104 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.61 ' HB ' ' HB2' ' A' ' 78' ' ' ASP . 10.5 m -57.68 -49.45 76.45 Favored 'General case' 0 N--CA 1.419 -2.021 0 CA-C-N 114.232 -1.349 . . . . 0.0 111.823 -176.58 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.414 ' HD3' ' HA ' ' A' ' 82' ' ' LYS . 74.2 mmtt 65.35 16.19 10.4 Favored 'General case' 0 N--CA 1.488 1.453 0 CA-C-O 121.916 0.865 . . . . 0.0 111.493 -176.975 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.597 ' HB3' HG22 ' A' ' 81' ' ' THR . 39.4 ttpt -115.18 131.08 57.04 Favored 'General case' 0 N--CA 1.42 -1.953 0 N-CA-C 106.299 -1.741 . . . . 0.0 106.299 177.607 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.552 ' O ' ' HA ' ' A' ' 109' ' ' THR . 7.0 tt -103.59 142.79 33.69 Favored 'General case' 0 C--N 1.284 -2.25 0 O-C-N 123.68 0.612 . . . . 0.0 109.901 -175.657 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.446 ' HA ' ' O ' ' A' ' 108' ' ' VAL . 9.3 t -113.42 121.3 43.92 Favored 'General case' 0 N--CA 1.406 -2.661 0 CA-C-O 121.879 0.847 . . . . 0.0 110.429 178.803 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.593 ' HA ' ' O ' ' A' ' 74' ' ' ASN . 86.7 t -93.34 118.99 40.36 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.746 0 CA-C-N 114.905 -1.043 . . . . 0.0 108.438 174.923 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 5.4 mp -80.95 116.2 20.8 Favored 'General case' 0 C--O 1.249 1.056 0 O-C-N 123.711 0.632 . . . . 0.0 110.389 -179.094 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.58 ' O ' ' HA ' ' A' ' 106' ' ' THR . 42.1 mm -108.12 128.4 25.8 Favored Pre-proline 0 C--N 1.285 -2.201 0 N-CA-C 106.593 -1.632 . . . . 0.0 106.593 176.614 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -58.84 111.74 0.98 Allowed 'Trans proline' 0 N--CA 1.45 -1.083 0 C-N-CA 122.062 1.841 . . . . 0.0 111.351 176.531 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 22.7 t 67.42 -169.01 0.2 Allowed 'General case' 0 N--CA 1.443 -0.812 0 O-C-N 124.117 0.886 . . . . 0.0 110.847 178.01 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.489 HD11 ' HD2' ' A' ' 103' ' ' LYS . 10.3 tt -112.2 109.4 28.4 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.278 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 176.481 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' CYS . . . . . 0.639 ' SG ' ' HB2' ' A' ' 104' ' ' PHE . 16.1 p -108.89 124.84 51.28 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-N 115.723 -0.672 . . . . 0.0 112.55 -174.057 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.445 ' OE2' HG12 ' A' ' 91' ' ' ILE . 4.9 mp0 -107.27 156.94 18.32 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 174.194 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 3.4 p -128.76 111.9 24.62 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.756 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 173.939 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -103.42 154.7 18.0 Favored Glycine 0 N--CA 1.435 -1.417 0 N-CA-C 110.448 -1.061 . . . . 0.0 110.448 -179.826 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 44.9 t80 -159.16 -172.47 3.78 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 105.579 -2.008 . . . . 0.0 105.579 -174.89 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.406 ' O ' ' HB3' ' A' ' 98' ' ' ASP . 10.9 ptmt -64.1 -13.19 45.89 Favored 'General case' 0 N--CA 1.483 1.208 0 CA-C-N 119.108 0.867 . . . . 0.0 109.266 175.473 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.406 ' HB3' ' O ' ' A' ' 97' ' ' LYS 0.294 25.6 t70 92.11 100.03 0.02 OUTLIER 'General case' 0 N--CA 1.427 -1.59 0 C-N-CA 126.487 1.915 . . . . 0.0 113.724 -179.421 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 20.3 m -149.77 -39.79 0.14 Allowed 'General case' 0 C--N 1.286 -2.18 0 N-CA-C 104.761 -2.311 . . . . 0.0 104.761 177.117 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 47.4 t -146.02 104.28 3.82 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-N 113.765 -1.561 . . . . 0.0 107.102 174.003 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 94.5 t -128.28 127.87 67.86 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 -179.745 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -158.0 166.88 31.43 Favored 'General case' 0 C--N 1.309 -1.17 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 -175.084 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.489 ' HD2' HD11 ' A' ' 91' ' ' ILE . 38.5 ttpt -132.92 133.56 43.39 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.304 -175.707 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.639 ' HB2' ' SG ' ' A' ' 92' ' ' CYS . 77.9 m-85 -117.2 110.38 18.07 Favored 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 107.567 -1.271 . . . . 0.0 107.567 175.879 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 12.9 t -88.99 171.57 9.76 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 -177.801 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.58 ' HA ' ' O ' ' A' ' 88' ' ' ILE . 32.5 m -58.49 -50.31 74.21 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 112.919 0.711 . . . . 0.0 112.919 -175.249 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 23.3 p -116.78 94.36 4.57 Favored 'General case' 0 C--N 1.296 -1.719 0 C-N-CA 119.414 -0.914 . . . . 0.0 112.458 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.446 ' O ' ' HA ' ' A' ' 85' ' ' THR . 43.5 t -93.16 125.45 45.72 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.486 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 175.437 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.552 ' HA ' ' O ' ' A' ' 84' ' ' LEU . 8.1 p -107.81 154.1 22.03 Favored 'General case' 0 N--CA 1.4 -2.941 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.48 -177.088 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 175.28 -173.98 46.54 Favored Glycine 0 C--N 1.283 -2.364 0 N-CA-C 110.506 -1.038 . . . . 0.0 110.506 178.327 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 59.9 m-70 -99.25 91.53 5.01 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 178.182 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.468 ' HB3' HD13 ' A' ' 84' ' ' LEU . 5.3 tt -97.7 112.56 24.4 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 -175.121 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -116.21 160.25 20.67 Favored 'General case' 0 CA--C 1.458 -2.584 0 CA-C-N 114.9 -1.046 . . . . 0.0 108.569 175.504 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 2.3 tmtp? -71.51 103.72 3.05 Favored 'General case' 0 C--N 1.255 -3.503 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 -177.062 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 116.15 -10.07 17.77 Favored Glycine 0 C--O 1.186 -2.872 0 C-N-CA 120.516 -0.85 . . . . 0.0 111.944 -178.285 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -174.88 134.77 0.36 Allowed 'General case' 0 N--CA 1.488 1.465 0 CA-C-N 118.088 0.944 . . . . 0.0 111.888 176.768 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.405 ' HA ' ' HA ' ' A' ' 112' ' ' LEU . 2.3 tt -110.6 114.98 28.79 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 105.772 -1.936 . . . . 0.0 105.772 175.552 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.404 ' HA ' ' HB3' ' A' ' 135' ' ' SER . 75.1 p -103.35 135.06 45.68 Favored 'General case' 0 C--N 1.278 -2.539 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 -177.079 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . 0.394 4.0 p-10 48.61 97.47 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 115.878 1.807 . . . . 0.0 115.878 -178.63 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.446 HG22 ' O ' ' A' ' 134' ' ' THR . 13.0 m -87.44 118.02 32.54 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.086 0 CA-C-N 114.637 -1.165 . . . . 0.0 110.334 -179.687 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -97.08 92.36 6.02 Favored 'General case' 0 C--N 1.252 -3.67 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 179.776 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 140.92 -15.93 2.82 Favored Glycine 0 C--N 1.302 -1.323 0 C-N-CA 119.968 -1.111 . . . . 0.0 112.932 177.268 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 80.4 mt -100.37 104.81 16.68 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 CA-C-O 121.767 0.794 . . . . 0.0 111.235 -179.282 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -86.45 121.24 28.72 Favored 'General case' 0 N--CA 1.433 -1.312 0 N-CA-C 106.104 -1.813 . . . . 0.0 106.104 176.447 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 12.8 t -133.37 162.3 32.21 Favored 'General case' 0 N--CA 1.412 -2.347 0 CA-C-O 121.515 0.674 . . . . 0.0 110.644 -176.398 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.469 ' C ' ' HD3' ' A' ' 126' ' ' LYS . 1.0 OUTLIER -126.1 119.92 28.83 Favored 'General case' 0 N--CA 1.396 -3.137 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 173.051 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 59.9 t -109.38 -78.38 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.838 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 179.202 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -96.93 -35.75 10.78 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 105.636 -1.987 . . . . 0.0 105.636 171.771 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.498 HG13 ' H ' ' A' ' 130' ' ' TRP . 9.6 tp -146.98 176.06 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.419 -1.981 0 N-CA-C 106.636 -1.616 . . . . 0.0 106.636 176.958 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' TRP . . . . . 0.498 ' H ' HG13 ' A' ' 129' ' ' ILE . 6.2 m-90 -74.81 132.61 41.69 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 122.767 0.427 . . . . 0.0 111.041 -177.189 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.495 HG22 ' H ' ' A' ' 133' ' ' VAL . 8.4 p -149.64 147.09 16.61 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.09 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 175.227 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 57.7 pttt -111.09 -4.23 15.15 Favored 'General case' 0 C--N 1.31 -1.128 0 C-N-CA 119.537 -0.865 . . . . 0.0 111.774 178.189 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.495 ' H ' HG22 ' A' ' 131' ' ' VAL . 7.4 p -123.79 103.8 13.25 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 CA-C-O 122.001 0.905 . . . . 0.0 110.862 178.746 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 134' ' ' THR . . . . . 0.446 ' O ' HG22 ' A' ' 120' ' ' VAL . 8.3 t -144.91 169.95 17.09 Favored 'General case' 0 C--N 1.293 -1.863 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 -179.494 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 135' ' ' SER . . . . . 0.404 ' HB3' ' HA ' ' A' ' 118' ' ' THR . 26.9 m -122.65 168.64 11.94 Favored 'General case' 0 N--CA 1.409 -2.508 0 N-CA-C 109.924 -0.398 . . . . 0.0 109.924 178.678 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 11.8 tt -134.92 98.05 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.767 0 CA-C-O 122.382 1.087 . . . . 0.0 108.797 175.776 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 73.9 p -89.93 158.67 17.3 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-N 114.608 -1.178 . . . . 0.0 110.453 -176.634 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' THR . . . . . 0.658 HG21 ' HB3' ' A' ' 63' ' ' LEU . 9.8 t -166.01 178.56 6.33 Favored 'General case' 0 N--CA 1.418 -2.069 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 -179.638 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -118.66 26.93 9.23 Favored 'General case' 0 C--N 1.273 -2.718 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 175.187 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . 60.65 36.56 19.58 Favored 'General case' 0 C--N 1.354 0.793 0 CA-C-N 114.379 -1.282 . . . . 0.0 108.274 -173.371 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' SER . . . . . 0.651 ' N ' ' HG3' ' A' ' 64' ' ' PRO . 46.8 t -171.01 -78.68 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 114.092 -1.413 . . . . 0.0 109.825 -173.248 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.483 ' H ' ' HD3' ' A' ' 142' ' ' LYS . 0.0 OUTLIER -90.1 130.34 36.28 Favored 'General case' 0 CA--C 1.498 -1.029 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 176.352 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.511 ' HB ' ' O ' ' A' ' 153' ' ' ARG . 42.4 t -108.35 143.2 19.15 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 CA-C-O 121.108 0.48 . . . . 0.0 111.47 -171.336 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 91.1 m-85 -135.82 123.32 22.11 Favored 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 178.018 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 42.8 t80 -93.61 117.16 29.73 Favored 'General case' 0 C--N 1.288 -2.088 0 N-CA-C 106.708 -1.59 . . . . 0.0 106.708 -178.493 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.42 ' C ' ' H ' ' A' ' 148' ' ' GLY . 62.9 p -76.24 -89.87 0.03 OUTLIER 'General case' 0 N--CA 1.425 -1.701 0 N-CA-C 114.94 1.459 . . . . 0.0 114.94 -169.164 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . 67.17 -42.59 0.43 Allowed 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 125.244 1.418 . . . . 0.0 112.047 -175.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' GLY . . . . . 0.42 ' H ' ' C ' ' A' ' 146' ' ' THR . . . 177.94 44.9 0.07 OUTLIER Glycine 0 N--CA 1.412 -2.937 0 N-CA-C 107.349 -2.3 . . . . 0.0 107.349 178.437 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 65.6 mtt 58.22 40.14 25.1 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 124.003 0.921 . . . . 0.0 109.715 -176.278 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -89.03 -48.55 7.34 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 115.805 1.78 . . . . 0.0 115.805 -169.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.472 ' HE2' ' HA ' ' A' ' 151' ' ' LYS . 8.2 mmpt? -125.44 162.86 23.91 Favored 'General case' 0 N--CA 1.483 1.216 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 -172.227 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 57.3 p -119.73 158.34 26.71 Favored 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 174.642 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' ARG . . . . . 0.511 ' O ' ' HB ' ' A' ' 143' ' ' VAL . 3.8 tpm_? -149.92 120.5 7.47 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 109.082 -0.711 . . . . 0.0 109.082 -178.028 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 17.8 m -87.91 143.78 26.93 Favored 'General case' 0 C--N 1.308 -1.226 0 C-N-CA 120.122 -0.631 . . . . 0.0 110.835 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' ARG . . . . . 0.522 ' HD3' ' HB2' ' A' ' 64' ' ' PRO . 32.6 ttp180 -70.67 -34.5 72.08 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 115.608 -0.723 . . . . 0.0 110.121 179.06 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -45.85 -40.82 10.4 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 116.706 2.113 . . . . 0.0 116.706 -170.843 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -70.95 -56.43 6.22 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 119.019 -1.072 . . . . 0.0 112.077 -174.795 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 67.9 m-85 -171.63 19.16 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.765 0 C-N-CA 124.556 1.143 . . . . 0.0 108.934 -179.796 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 159' ' ' GLY . . . . . 0.444 ' HA3' ' O ' ' A' ' 65' ' ' ILE . . . 84.76 -97.19 2.1 Favored Glycine 0 N--CA 1.427 -1.942 0 C-N-CA 119.011 -1.566 . . . . 0.0 110.224 -171.704 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.547 HG23 ' HB ' ' A' ' 65' ' ' ILE . 90.2 t -127.65 113.41 31.31 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.521 0 CA-C-O 121.828 0.823 . . . . 0.0 110.651 -178.953 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -121.71 107.06 11.91 Favored 'General case' 0 C--N 1.295 -1.804 0 C-N-CA 119.424 -0.91 . . . . 0.0 113.167 -176.005 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 30.4 mmm180 -130.66 137.49 49.6 Favored 'General case' 0 C--N 1.292 -1.92 0 N-CA-C 106.337 -1.727 . . . . 0.0 106.337 172.862 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -77.25 74.53 3.82 Favored 'General case' 0 C--N 1.289 -2.056 0 N-CA-C 113.699 1.0 . . . . 0.0 113.699 -172.565 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -111.59 129.02 8.92 Favored Glycine 0 N--CA 1.424 -2.136 0 N-CA-C 109.25 -1.54 . . . . 0.0 109.25 176.82 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -91.56 112.65 24.65 Favored 'General case' 0 N--CA 1.42 -1.963 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 -177.565 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 166' ' ' ARG . . . . . 0.409 ' HA ' ' HB3' ' A' ' 92' ' ' CYS . 65.9 mtt85 -79.45 102.58 8.84 Favored 'General case' 0 N--CA 1.417 -2.12 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 179.027 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 25.2 t -66.01 82.55 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 O-C-N 124.077 0.861 . . . . 0.0 110.063 -178.422 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 22.1 t70 176.74 -24.65 0.0 OUTLIER 'General case' 0 C--N 1.287 -2.114 0 N-CA-C 106.236 -1.765 . . . . 0.0 106.236 -171.422 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 2.9 tppp? -79.2 106.48 11.26 Favored 'General case' 0 N--CA 1.425 -1.678 0 CA-C-N 114.145 -1.389 . . . . 0.0 111.899 179.312 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 170' ' ' PHE . . . . . . . . . . . . . 47.3 p90 . . . . . 0 C--N 1.293 -1.888 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 173.632 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 33.8 t . . . . . 0 CA--C 1.531 0.228 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -150.73 155.18 38.77 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-O 121.067 0.46 . . . . 0.0 110.621 -178.388 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 25.8 pt20 -159.13 126.96 4.97 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 175.582 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 28.7 pt -108.34 97.94 6.34 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.104 0 CA-C-O 122.37 1.081 . . . . 0.0 112.707 -177.743 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -132.34 21.07 4.38 Favored 'General case' 0 C--N 1.294 -1.817 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 177.014 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 22.8 p-10 -98.82 147.54 24.81 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 114.579 -1.191 . . . . 0.0 110.677 -178.373 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 87.6 tttt 71.49 124.41 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 125.043 1.337 . . . . 0.0 113.175 178.348 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 8.4 p -83.51 136.12 23.44 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.213 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 175.249 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -80.16 56.23 4.61 Favored Glycine 0 N--CA 1.445 -0.708 0 C-N-CA 121.44 -0.41 . . . . 0.0 112.787 -178.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 36.0 m -130.65 97.52 4.39 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 177.84 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 88.5 t80 -137.41 129.23 28.8 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 -178.316 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 79.4 m95 -95.7 95.92 8.65 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 179.03 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 60.5 tp -73.2 131.16 41.66 Favored 'General case' 0 C--O 1.25 1.127 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 179.266 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 93.48 86.43 1.6 Allowed Glycine 0 N--CA 1.423 -2.21 0 N-CA-C 110.504 -1.039 . . . . 0.0 110.504 -179.04 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 47.2 tt0 -69.95 -29.18 66.24 Favored 'General case' 0 C--O 1.246 0.879 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 -179.169 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 28.0 tptp 71.6 84.04 0.13 Allowed 'General case' 0 N--CA 1.441 -0.882 0 CA-C-N 114.727 -1.124 . . . . 0.0 110.32 -177.538 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -138.9 122.18 17.04 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-N 114.274 -1.33 . . . . 0.0 107.468 178.823 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -95.55 111.65 23.52 Favored 'General case' 0 C--N 1.291 -1.964 0 CA-C-O 121.101 0.477 . . . . 0.0 110.558 -174.392 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -113.55 118.58 34.82 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.518 -178.604 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 51.3 tt0 -129.64 140.64 51.1 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 178.765 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -88.44 86.43 7.04 Favored 'General case' 0 N--CA 1.435 -1.177 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 175.858 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 -78.74 111.31 14.73 Favored 'General case' 0 C--N 1.299 -1.6 0 CA-C-N 114.531 -1.213 . . . . 0.0 111.328 -176.259 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 32.0 m -82.4 99.53 9.46 Favored 'General case' 0 N--CA 1.423 -1.786 0 CA-C-N 114.944 -1.025 . . . . 0.0 109.923 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 35.8 m -88.66 -17.74 8.25 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.935 0 CA-C-O 120.866 0.365 . . . . 0.0 110.674 179.455 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -170.64 178.38 43.26 Favored Glycine 0 N--CA 1.43 -1.742 0 N-CA-C 110.927 -0.869 . . . . 0.0 110.927 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 36.2 t30 67.46 98.66 0.05 Allowed 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.43 1.092 . . . . 0.0 112.628 179.439 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -105.52 87.64 2.65 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 178.301 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.9 mm? 57.19 19.18 4.67 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 123.787 0.835 . . . . 0.0 112.337 179.689 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -90.72 110.41 21.6 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-O 121.007 0.432 . . . . 0.0 111.258 -174.173 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 29.6 t -82.38 103.68 12.13 Favored 'General case' 0 N--CA 1.418 -2.026 0 N-CA-C 107.864 -1.161 . . . . 0.0 107.864 177.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 7.3 p -103.18 109.46 26.95 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.188 0 CA-C-O 121.659 0.743 . . . . 0.0 110.424 -179.411 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 20.2 m -133.64 98.05 4.09 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 179.592 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 87.7 m -64.8 127.82 33.16 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.385 -179.571 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 13.5 p -74.19 106.86 6.04 Favored 'General case' 0 N--CA 1.425 -1.676 0 CA-C-O 121.391 0.615 . . . . 0.0 110.472 178.765 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 46.9 mm -62.25 127.09 21.65 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 115.097 -0.956 . . . . 0.0 111.427 -176.449 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -70.05 101.76 1.89 Allowed 'General case' 0 N--CA 1.435 -1.221 0 CA-C-N 114.869 -1.06 . . . . 0.0 109.538 -178.896 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -83.55 -28.16 36.7 Favored Glycine 0 CA--C 1.494 -1.268 0 N-CA-C 110.959 -0.856 . . . . 0.0 110.959 -178.448 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -80.3 59.25 4.6 Favored Glycine 0 N--CA 1.436 -1.344 0 N-CA-C 111.961 -0.455 . . . . 0.0 111.961 179.419 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 10.1 t -68.3 124.76 24.38 Favored 'General case' 0 N--CA 1.433 -1.317 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 178.436 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -97.01 108.85 21.67 Favored 'General case' 0 N--CA 1.438 -1.045 0 N-CA-C 112.984 0.735 . . . . 0.0 112.984 -174.787 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 83.0 m95 -118.48 84.69 2.22 Favored 'General case' 0 N--CA 1.427 -1.582 0 CA-C-N 114.89 -1.05 . . . . 0.0 108.939 173.461 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 5.5 mp -96.57 75.47 2.83 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 176.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.6 p -172.93 132.53 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.426 -1.634 0 CA-C-N 114.099 -1.41 . . . . 0.0 108.951 -176.662 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 43.7 t30 -148.12 92.66 2.07 Favored 'General case' 0 C--N 1.29 -1.985 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 175.165 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -92.58 102.73 15.17 Favored 'General case' 0 N--CA 1.418 -2.053 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 -177.311 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 25.5 pt -98.89 160.76 3.18 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.772 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.245 177.167 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 64.87 81.62 0.2 Allowed 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.012 0.82 . . . . 0.0 110.225 -175.039 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -124.4 37.68 2.57 Favored Glycine 0 N--CA 1.428 -1.876 0 C-N-CA 120.412 -0.899 . . . . 0.0 112.093 -177.562 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 55.5 pttt -141.62 19.65 2.19 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-O 121.288 0.566 . . . . 0.0 110.903 178.255 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 23.2 ptt? -92.64 83.91 4.96 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 122.368 1.08 . . . . 0.0 112.969 -178.689 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 80.7 mt-30 -156.07 -58.53 0.1 Allowed 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 105.848 -1.908 . . . . 0.0 105.848 177.362 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.412 ' HG2' ' CD1' ' A' ' 54' ' ' LEU . 0.0 OUTLIER -161.13 112.92 1.27 Allowed Pre-proline 0 N--CA 1.43 -1.469 0 N-CA-C 105.632 -1.988 . . . . 0.0 105.632 174.775 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_endo -67.69 81.9 0.44 Allowed 'Trans proline' 0 N--CA 1.457 -0.618 0 C-N-CA 122.324 2.016 . . . . 0.0 116.846 -174.054 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.569 ' N ' ' HD3' ' A' ' 55' ' ' PRO . 10.2 mp -82.07 -33.2 0.62 Allowed Pre-proline 0 C--N 1.296 -1.743 0 N-CA-C 116.904 2.187 . . . . 0.0 116.904 169.865 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.742 ' HA ' ' CD1' ' A' ' 58' ' ' LEU . 7.6 Cg_exo -66.08 -15.12 47.38 Favored 'Trans proline' 0 N--CA 1.425 -2.507 0 CA-C-N 121.134 1.441 . . . . 0.0 115.568 -161.018 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 32.3 mm-40 -79.34 -29.69 42.36 Favored 'General case' 0 N--CA 1.425 -1.691 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.718 ' O ' ' HB3' ' A' ' 60' ' ' GLU . 10.6 mt -76.41 -31.66 58.06 Favored 'General case' 0 C--O 1.207 -1.14 0 CA-C-N 114.652 -1.158 . . . . 0.0 110.061 -177.582 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.742 ' CD1' ' HA ' ' A' ' 55' ' ' PRO . 8.2 mt -70.41 -54.32 12.87 Favored 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 -174.383 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.636 ' HG2' ' O ' ' A' ' 55' ' ' PRO . 17.1 ptpt -64.02 -25.08 67.96 Favored 'General case' 0 C--O 1.191 -2.009 0 CA-C-N 114.885 -1.052 . . . . 0.0 111.398 176.76 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.718 ' HB3' ' O ' ' A' ' 57' ' ' LEU . 7.1 tp10 -54.95 -56.4 20.11 Favored 'General case' 0 C--N 1.295 -1.773 0 O-C-N 121.954 -0.467 . . . . 0.0 111.13 172.361 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 45.2 m-85 -78.54 -40.2 35.68 Favored 'General case' 0 CA--C 1.489 -1.375 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 -175.321 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.424 ' OD2' ' HG ' ' A' ' 112' ' ' LEU . 5.9 m-20 -87.42 18.34 3.9 Favored 'General case' 0 C--N 1.294 -1.833 0 CA-C-N 113.686 -1.597 . . . . 0.0 113.262 -174.256 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.623 HD21 ' H ' ' A' ' 115' ' ' GLY . 21.5 mt 79.79 151.24 0.12 Allowed Pre-proline 0 N--CA 1.475 0.82 0 C-N-CA 125.184 1.393 . . . . 0.0 112.703 174.303 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.429 ' HB2' ' HD2' ' A' ' 155' ' ' ARG . 7.4 Cg_endo -80.65 15.07 1.86 Allowed 'Trans proline' 0 N--CA 1.443 -1.468 0 C-N-CA 122.697 2.265 . . . . 0.0 113.546 -166.873 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.587 ' O ' ' HA3' ' A' ' 159' ' ' GLY . 0.2 OUTLIER -69.5 -36.73 72.68 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.811 0 N-CA-C 106.753 -1.573 . . . . 0.0 106.753 173.029 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 54.34 8.68 1.24 Allowed Glycine 0 C--N 1.339 0.731 0 CA-C-N 114.771 -1.104 . . . . 0.0 115.287 175.149 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.736 ' O ' ' HB ' ' A' ' 160' ' ' VAL 0.252 27.7 mt 72.71 -45.66 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.031 0 N-CA-C 114.527 1.306 . . . . 0.0 114.527 -179.9 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.546 ' HB2' ' O ' ' A' ' 67' ' ' ILE . 40.2 t80 164.99 -56.4 0.0 OUTLIER Pre-proline 0 CA--C 1.54 0.574 0 C-N-CA 124.155 0.982 . . . . 0.0 110.597 173.826 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -102.07 -160.31 0.04 OUTLIER 'Trans proline' 0 N--CA 1.43 -2.246 0 C-N-CA 122.533 2.155 . . . . 0.0 113.123 -169.58 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -100.96 29.08 13.28 Favored Glycine 0 N--CA 1.428 -1.868 0 N-CA-C 109.656 -1.378 . . . . 0.0 109.656 174.102 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.48 ' OD1' ' HD3' ' A' ' 89' ' ' PRO . 8.8 t0 -140.84 176.67 8.61 Favored 'General case' 0 N--CA 1.42 -1.949 0 N-CA-C 102.928 -2.99 . . . . 0.0 102.928 177.111 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.561 ' O ' HG22 ' A' ' 73' ' ' THR . . . 57.8 -177.73 0.07 Allowed 'General case' 0 N--CA 1.483 1.185 0 CA-C-N 118.977 0.808 . . . . 0.0 109.871 -170.635 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.561 HG22 ' O ' ' A' ' 72' ' ' ALA . 5.2 t 65.36 16.7 10.67 Favored 'General case' 0 N--CA 1.515 2.775 0 C-N-CA 125.06 1.344 . . . . 0.0 109.523 172.256 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.623 ' O ' ' HA ' ' A' ' 86' ' ' VAL . 37.3 m-80 -68.45 135.8 52.25 Favored 'General case' 0 N--CA 1.414 -2.25 0 CA-C-N 113.366 -1.743 . . . . 0.0 114.127 -176.154 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.514 ' CD2' HD11 ' A' ' 84' ' ' LEU . 48.3 t80 -98.88 106.22 18.46 Favored 'General case' 0 C--N 1.272 -2.797 0 CA-C-N 113.247 -1.797 . . . . 0.0 109.949 -177.926 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.454 ' HB2' HG23 ' A' ' 85' ' ' THR . 8.9 mm-40 -137.81 141.34 40.83 Favored 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 176.583 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 48.1 p90 -144.49 150.95 38.44 Favored 'General case' 0 C--N 1.301 -1.512 0 C-N-CA 120.283 -0.567 . . . . 0.0 110.675 -177.283 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.642 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 11.0 m-20 -97.1 170.72 8.94 Favored 'General case' 0 CA--C 1.486 -1.489 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 174.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -79.81 -71.46 0.45 Allowed 'General case' 0 C--N 1.278 -2.53 0 CA-C-N 115.283 -0.871 . . . . 0.0 113.021 -175.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -72.94 -42.27 63.62 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 121.583 0.706 . . . . 0.0 110.654 -175.088 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.642 ' HB ' ' HB2' ' A' ' 78' ' ' ASP . 19.8 m -55.7 -41.15 73.38 Favored 'General case' 0 N--CA 1.431 -1.41 0 CA-C-N 114.645 -1.161 . . . . 0.0 110.9 179.54 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 71.8 mmtt 59.85 9.9 1.89 Allowed 'General case' 0 N--CA 1.482 1.165 0 N-CA-C 113.04 0.756 . . . . 0.0 113.04 178.714 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.416 ' HE3' HG21 ' A' ' 109' ' ' THR . 27.8 pttt -98.77 134.12 42.11 Favored 'General case' 0 N--CA 1.402 -2.85 0 N-CA-C 105.13 -2.174 . . . . 0.0 105.13 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.514 HD11 ' CD2' ' A' ' 75' ' ' TYR . 6.9 tt -89.36 143.24 26.98 Favored 'General case' 0 C--N 1.282 -2.33 0 C-N-CA 120.142 -0.623 . . . . 0.0 109.492 -174.22 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.507 ' N ' HD23 ' A' ' 84' ' ' LEU . 2.7 t -116.5 107.19 14.45 Favored 'General case' 0 N--CA 1.415 -2.199 0 CA-C-O 121.692 0.758 . . . . 0.0 111.722 -179.61 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.623 ' HA ' ' O ' ' A' ' 74' ' ' ASN . 73.0 t -89.84 108.96 19.95 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.224 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 173.76 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.438 HD12 ' HB2' ' A' ' 74' ' ' ASN 0.272 0.8 OUTLIER -96.71 118.2 32.66 Favored 'General case' 0 N--CA 1.394 -3.262 0 CA-C-O 122.605 1.193 . . . . 0.0 111.852 -179.79 . . . . . . . . 4 4 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.412 HG23 ' HB2' ' A' ' 72' ' ' ALA . 55.9 mt -97.46 142.42 24.52 Favored Pre-proline 0 C--N 1.277 -2.577 0 N-CA-C 104.399 -2.445 . . . . 0.0 104.399 178.178 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.48 ' HD3' ' OD1' ' A' ' 71' ' ' ASP . 30.9 Cg_endo -59.53 -18.04 44.7 Favored 'Trans proline' 0 C--N 1.328 -0.532 0 C-N-CA 122.968 2.446 . . . . 0.0 112.914 -178.077 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 6.5 m -154.44 167.42 30.08 Favored 'General case' 0 N--CA 1.422 -1.843 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 -172.532 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.483 HD11 ' HD3' ' A' ' 103' ' ' LYS . 14.2 tt -85.74 108.49 17.41 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.295 0 N-CA-C 105.968 -1.864 . . . . 0.0 105.968 166.614 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' CYS . . . . . 0.52 ' SG ' ' HA3' ' A' ' 164' ' ' GLY . 48.2 t -119.19 123.38 44.19 Favored 'General case' 0 C--N 1.292 -1.916 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 -176.358 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.448 ' CB ' ' HA ' ' A' ' 103' ' ' LYS . 12.7 pt-20 -119.49 150.6 39.97 Favored 'General case' 0 C--N 1.284 -2.277 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.908 -174.182 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.504 ' CG1' ' H ' ' A' ' 163' ' ' ASN . 34.5 m -130.29 102.2 6.67 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.485 0 CA-C-O 121.871 0.843 . . . . 0.0 111.385 179.807 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.51 ' HA2' ' O ' ' A' ' 100' ' ' SER . . . -148.2 122.62 1.54 Allowed Glycine 0 CA--C 1.48 -2.117 0 N-CA-C 108.121 -1.992 . . . . 0.0 108.121 172.757 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 62.9 t80 -152.29 -67.03 0.17 Allowed 'General case' 0 CA--C 1.46 -2.503 0 C-N-CA 116.388 -2.125 . . . . 0.0 111.1 -178.802 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.46 ' O ' ' HD2' ' A' ' 97' ' ' LYS . 2.0 tmmm? -86.46 -37.31 18.42 Favored 'General case' 1 N--CA 1.378 -4.051 0 CA-C-N 113.625 -1.625 . . . . 0.0 113.002 -164.276 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -157.35 83.23 0.91 Allowed 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 115.718 1.747 . . . . 0.0 115.718 -169.805 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 50.3 m 64.09 -27.98 0.09 Allowed 'General case' 0 N--CA 1.481 1.112 0 N-CA-C 115.679 1.733 . . . . 0.0 115.679 169.177 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' SER . . . . . 0.51 ' O ' ' HA2' ' A' ' 95' ' ' GLY . 34.2 t -79.07 86.46 4.9 Favored 'General case' 0 N--CA 1.409 -2.523 0 C-N-CA 123.463 0.705 . . . . 0.0 109.677 -179.394 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 48.2 t -109.33 99.56 8.93 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 CA-C-N 115.084 -0.962 . . . . 0.0 109.491 176.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.452 ' HG ' ' HA ' ' A' ' 125' ' ' THR . 7.8 mp -110.07 127.93 55.14 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.157 179.617 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.483 ' HD3' HD11 ' A' ' 91' ' ' ILE . 23.8 ttmm -106.5 109.01 20.81 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 177.981 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 78.9 m-85 -94.81 105.68 17.63 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-N 116.068 -0.514 . . . . 0.0 109.788 179.469 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 49.7 m -61.75 151.37 34.21 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 115.276 -0.875 . . . . 0.0 111.006 178.585 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 7.3 m -51.5 -43.69 62.31 Favored 'General case' 0 C--O 1.215 -0.748 0 C-N-CA 125.241 1.417 . . . . 0.0 110.289 179.344 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 85.5 m -120.21 101.19 7.64 Favored 'General case' 0 N--CA 1.423 -1.777 0 CA-C-O 121.137 0.494 . . . . 0.0 109.761 178.46 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 13.5 m -108.71 114.77 47.65 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.059 0 CA-C-O 121.951 0.881 . . . . 0.0 111.176 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.511 ' HA ' ' O ' ' A' ' 84' ' ' LEU . 20.9 p -107.76 166.42 10.71 Favored 'General case' 0 N--CA 1.405 -2.693 0 CA-C-N 114.449 -1.251 . . . . 0.0 111.02 -176.528 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 167.84 -164.06 37.65 Favored Glycine 0 N--CA 1.41 -3.054 0 C-N-CA 120.323 -0.941 . . . . 0.0 111.565 177.052 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 52.0 t60 -103.3 99.81 9.67 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.424 ' HG ' ' OD2' ' A' ' 62' ' ' ASP . 3.0 tm? -103.55 125.29 50.0 Favored 'General case' 0 CA--C 1.483 -1.611 0 CA-C-N 115.635 -0.712 . . . . 0.0 110.2 -172.675 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -122.41 149.24 44.09 Favored 'General case' 0 N--CA 1.402 -2.871 0 CA-C-N 114.75 -1.113 . . . . 0.0 108.994 172.259 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -68.95 100.59 1.23 Allowed 'General case' 0 N--CA 1.402 -2.866 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 -179.091 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' GLY . . . . . 0.623 ' H ' HD21 ' A' ' 63' ' ' LEU . . . 135.52 -45.44 1.1 Allowed Glycine 0 C--N 1.282 -2.459 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 -175.738 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.48 ' HD3' HG23 ' A' ' 118' ' ' THR . 0.7 OUTLIER -150.2 133.5 16.37 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 114.074 1.139 . . . . 0.0 114.074 -178.382 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.524 ' O ' ' HB2' ' A' ' 135' ' ' SER . 40.6 tp -97.51 113.52 25.24 Favored 'General case' 0 C--N 1.309 -1.163 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 175.549 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.48 HG23 ' HD3' ' A' ' 116' ' ' LYS . 19.8 p -114.71 140.81 48.56 Favored 'General case' 0 C--N 1.285 -2.225 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.547 -178.593 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 66.18 100.61 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.93 0.892 . . . . 0.0 111.097 179.52 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.431 HG11 HD12 ' A' ' 123' ' ' ILE . 4.1 m -107.37 103.25 15.18 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.674 0 N-CA-C 113.974 1.102 . . . . 0.0 113.974 -177.355 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -84.66 84.26 7.74 Favored 'General case' 0 C--N 1.29 -2.013 0 CA-C-N 114.632 -1.167 . . . . 0.0 108.534 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 133.6 -12.4 4.87 Favored Glycine 0 N--CA 1.435 -1.384 0 CA-C-N 115.289 -0.869 . . . . 0.0 113.038 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.431 HD12 HG11 ' A' ' 120' ' ' VAL . 71.7 mt -100.28 99.95 9.46 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.112 0 CA-C-O 121.817 0.818 . . . . 0.0 109.716 179.213 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -91.18 118.18 30.24 Favored 'General case' 0 C--N 1.29 -2.004 0 CA-C-N 114.791 -1.095 . . . . 0.0 108.429 -177.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.452 ' HA ' ' HG ' ' A' ' 102' ' ' LEU . 62.1 m -115.46 113.53 23.83 Favored 'General case' 0 N--CA 1.426 -1.64 0 N-CA-C 112.913 0.708 . . . . 0.0 112.913 -173.137 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.433 ' O ' ' HA ' ' A' ' 100' ' ' SER . 39.0 tttp -105.13 121.82 44.61 Favored 'General case' 0 N--CA 1.415 -2.203 0 C-N-CA 119.137 -1.025 . . . . 0.0 108.644 169.676 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.437 ' O ' ' HB3' ' A' ' 128' ' ' MET . 27.2 t -144.76 104.09 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.278 -2.534 0 N-CA-C 103.29 -2.856 . . . . 0.0 103.29 170.547 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' MET . . . . . 0.437 ' HB3' ' O ' ' A' ' 127' ' ' VAL . 26.3 ttt 74.17 -52.29 0.69 Allowed 'General case' 0 C--N 1.321 -0.658 0 O-C-N 124.487 1.117 . . . . 0.0 109.55 -172.241 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 8.7 tp -136.88 152.96 29.2 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 N-CA-C 109.063 -0.718 . . . . 0.0 109.063 175.92 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' TRP . . . . . 0.431 ' HA ' ' HA ' ' A' ' 126' ' ' LYS . 20.4 t-105 -81.49 117.8 22.2 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 123.526 0.731 . . . . 0.0 109.863 -177.028 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.533 HG12 ' H ' ' A' ' 133' ' ' VAL . 41.4 t -138.09 120.48 18.85 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.129 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 178.728 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 65.7 pttt -91.46 11.34 24.29 Favored 'General case' 0 C--N 1.312 -1.029 0 O-C-N 121.738 -0.601 . . . . 0.0 111.599 -177.2 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.533 ' H ' HG12 ' A' ' 131' ' ' VAL . 34.1 m -120.59 -1.59 8.21 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.107 0 C-N-CA 119.647 -0.821 . . . . 0.0 112.885 -175.586 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' THR . . . . . 0.694 ' O ' ' HB ' ' A' ' 146' ' ' THR . 18.2 p -74.13 101.63 3.99 Favored 'General case' 0 N--CA 1.425 -1.709 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 176.5 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 135' ' ' SER . . . . . 0.524 ' HB2' ' O ' ' A' ' 117' ' ' LEU . 12.4 p -94.48 170.03 9.78 Favored 'General case' 0 N--CA 1.412 -2.338 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 -177.665 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 136' ' ' ILE . . . . . 0.424 HD11 HG21 ' A' ' 65' ' ' ILE . 15.2 tt -100.77 122.35 52.68 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.155 0 CA-C-O 121.685 0.755 . . . . 0.0 111.555 -170.355 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 25.9 m -109.32 147.4 32.74 Favored 'General case' 0 N--CA 1.433 -1.297 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.023 -177.726 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' THR . . . . . 0.535 HG22 ' H ' ' A' ' 141' ' ' SER . 33.0 m -146.85 174.03 11.86 Favored 'General case' 0 C--N 1.295 -1.787 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 -174.671 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -110.24 28.75 8.32 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 172.396 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . 59.79 43.74 14.86 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 -172.577 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' SER . . . . . 0.535 ' H ' HG22 ' A' ' 138' ' ' THR . 35.1 t 176.78 -82.57 0.0 OUTLIER 'General case' 0 CA--C 1.545 0.77 0 CA-C-N 114.755 -1.111 . . . . 0.0 110.338 -173.59 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 24.7 pttm -89.29 150.91 22.39 Favored 'General case' 0 CA--C 1.503 -0.858 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.515 HG12 ' HB2' ' A' ' 155' ' ' ARG . 13.8 p -131.52 149.38 33.01 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.337 0 N-CA-C 114.281 1.215 . . . . 0.0 114.281 -168.656 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -112.44 143.48 43.51 Favored 'General case' 0 N--CA 1.428 -1.528 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 169.063 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 48.7 t80 -67.87 165.58 17.31 Favored 'General case' 0 C--N 1.305 -1.353 0 C-N-CA 122.93 0.492 . . . . 0.0 109.987 -173.18 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.694 ' HB ' ' O ' ' A' ' 134' ' ' THR . 41.6 p -50.88 -53.16 34.88 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 120.985 0.421 . . . . 0.0 111.531 -176.511 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -84.95 97.33 9.73 Favored 'General case' 0 N--CA 1.424 -1.754 0 N-CA-C 105.735 -1.95 . . . . 0.0 105.735 170.227 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -81.71 -18.0 69.19 Favored Glycine 0 CA--C 1.466 -2.978 0 CA-C-O 121.66 0.589 . . . . 0.0 111.666 -167.136 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 66.3 mtt -97.43 5.43 49.74 Favored 'General case' 0 C--N 1.281 -2.389 0 CA-C-N 114.666 -0.767 . . . . 0.0 110.718 178.931 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' LYS . . . . . 0.552 ' HE2' ' HA ' ' A' ' 150' ' ' LYS . 6.7 mmpt? -116.4 -49.69 2.66 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.509 -179.396 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 42.4 mmtm -146.14 165.08 30.18 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.3 0.571 . . . . 0.0 112.514 -175.863 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 42.2 p -130.03 160.37 33.9 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 174.073 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' ARG . . . . . 0.44 ' NE ' ' HA ' ' A' ' 153' ' ' ARG . 3.3 tpm_? -135.95 149.3 48.85 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 106.976 -1.491 . . . . 0.0 106.976 -177.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 8.2 m -88.64 117.37 27.55 Favored 'General case' 0 N--CA 1.436 -1.126 0 C-N-CA 120.212 -0.595 . . . . 0.0 111.763 -175.787 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' ARG . . . . . 0.639 ' HA ' ' HA2' ' A' ' 159' ' ' GLY . 0.0 OUTLIER -69.75 -31.08 68.85 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 105.457 -2.053 . . . . 0.0 105.457 174.505 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -45.46 -53.99 8.03 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 113.592 -1.64 . . . . 0.0 113.791 -179.742 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -66.47 -53.21 37.83 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 120.799 0.333 . . . . 0.0 111.476 -177.727 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -148.43 -32.89 0.24 Allowed 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.689 -178.759 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 159' ' ' GLY . . . . . 0.639 ' HA2' ' HA ' ' A' ' 155' ' ' ARG . . . 130.54 -95.0 0.33 Allowed Glycine 0 CA--C 1.463 -3.215 0 N-CA-C 107.992 -2.043 . . . . 0.0 107.992 -168.627 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.736 ' HB ' ' O ' ' A' ' 67' ' ' ILE . 41.3 t -98.72 125.25 52.17 Favored 'Isoleucine or valine' 0 N--CA 1.398 -3.046 0 N-CA-C 107.273 -1.381 . . . . 0.0 107.273 171.244 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 161' ' ' GLN . . . . . 0.407 ' HB2' ' HD3' ' A' ' 153' ' ' ARG . 46.8 mt-30 -90.78 101.38 14.13 Favored 'General case' 0 C--N 1.294 -1.824 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 -176.094 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 162' ' ' ARG . . . . . 0.433 HH21 HG23 ' A' ' 67' ' ' ILE . 20.2 mmt180 -90.86 152.89 20.57 Favored 'General case' 0 C--N 1.278 -2.501 0 CA-C-N 113.584 -1.644 . . . . 0.0 114.151 -172.879 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 163' ' ' ASN . . . . . 0.504 ' H ' ' CG1' ' A' ' 94' ' ' VAL . 46.7 m-80 -136.82 31.69 2.74 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 104.789 -2.301 . . . . 0.0 104.789 173.935 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 164' ' ' GLY . . . . . 0.52 ' HA3' ' SG ' ' A' ' 92' ' ' CYS . . . -110.67 149.34 17.7 Favored Glycine 0 N--CA 1.433 -1.508 0 CA-C-N 114.051 -1.432 . . . . 0.0 113.587 -171.399 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -110.01 117.16 33.03 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 175.937 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 166' ' ' ARG . . . . . 0.41 HH11 ' HD2' ' A' ' 166' ' ' ARG . 30.0 mtt180 -78.73 102.14 7.92 Favored 'General case' 0 N--CA 1.422 -1.83 0 N-CA-C 107.378 -1.341 . . . . 0.0 107.378 -178.416 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 40.0 t -75.72 90.6 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 CA-C-O 121.189 0.519 . . . . 0.0 110.848 -177.638 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 21.0 t70 172.85 -33.87 0.0 OUTLIER 'General case' 0 CA--C 1.484 -1.57 0 N-CA-C 106.665 -1.605 . . . . 0.0 106.665 -178.751 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 15.5 ptmt -157.38 -164.26 1.54 Allowed 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 113.675 -1.602 . . . . 0.0 110.75 -172.792 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 170' ' ' PHE . . . . . . . . . . . . . 89.1 t80 . . . . . 0 N--CA 1.427 -1.578 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 171.576 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 33.3 m . . . . . 0 N--CA 1.443 -0.782 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -85.27 149.01 25.78 Favored 'General case' 0 C--N 1.31 -1.141 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 178.765 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 -131.3 89.9 2.79 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-O 121.284 0.564 . . . . 0.0 110.675 -177.496 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.536 ' O ' HD12 ' A' ' 4' ' ' ILE . 2.4 pp -126.4 113.88 35.66 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.265 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.089 177.933 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -138.2 108.26 6.38 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-O 121.228 0.537 . . . . 0.0 110.836 -178.156 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -135.8 94.74 3.11 Favored 'General case' 0 C--N 1.293 -1.853 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 178.575 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 24.7 ttmm -90.96 116.13 28.52 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 178.127 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 8.7 p -80.45 130.22 36.3 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.678 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 177.643 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 178.51 80.06 0.06 OUTLIER Glycine 0 N--CA 1.439 -1.137 0 C-N-CA 120.303 -0.951 . . . . 0.0 112.322 -178.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 14.9 p -93.66 104.93 17.0 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-O 121.428 0.632 . . . . 0.0 109.835 177.119 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 76.9 t80 -84.16 101.29 11.73 Favored 'General case' 0 N--CA 1.434 -1.269 0 CA-C-O 121.466 0.651 . . . . 0.0 111.936 -174.648 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 68.5 p-90 -155.09 160.29 40.87 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 107.686 -1.228 . . . . 0.0 107.686 173.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.568 ' H ' HD23 ' A' ' 13' ' ' LEU . 1.9 pt? -116.93 156.36 27.53 Favored 'General case' 0 C--N 1.305 -1.368 0 C-N-CA 120.649 -0.421 . . . . 0.0 111.267 -175.876 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -103.63 20.22 42.45 Favored Glycine 0 N--CA 1.446 -0.66 0 N-CA-C 111.577 -0.609 . . . . 0.0 111.577 -179.394 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 84.1 mm-40 -115.37 127.85 55.67 Favored 'General case' 0 C--N 1.309 -1.16 0 C-N-CA 122.72 0.408 . . . . 0.0 110.136 179.191 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 60.7 pttt -121.79 153.95 37.63 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 178.256 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -112.67 93.07 4.25 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-O 120.917 0.389 . . . . 0.0 111.984 -177.671 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 -135.86 112.6 10.15 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-O 121.807 0.813 . . . . 0.0 110.754 177.552 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.602 ' HA ' ' HE3' ' A' ' 19' ' ' LYS . 0.5 OUTLIER -140.89 105.29 4.85 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 115.197 -0.911 . . . . 0.0 108.997 178.703 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 9.0 pm0 -83.57 101.87 11.76 Favored 'General case' 0 N--CA 1.424 -1.743 0 CA-C-O 121.532 0.682 . . . . 0.0 109.77 178.17 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 73.8 t80 -118.18 110.33 17.45 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.702 -177.519 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -125.73 108.32 11.4 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-O 121.494 0.664 . . . . 0.0 110.276 178.74 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 47.6 m -155.39 127.28 7.53 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 109.038 -0.726 . . . . 0.0 109.038 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.521 HG23 ' H ' ' A' ' 26' ' ' ASN . 32.3 m -90.02 -24.44 5.81 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-O 121.236 0.541 . . . . 0.0 110.281 179.226 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 103.07 -25.44 27.27 Favored Glycine 0 CA--C 1.499 -0.952 0 CA-C-N 115.751 -0.658 . . . . 0.0 112.055 176.13 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.521 ' H ' HG23 ' A' ' 24' ' ' VAL . 58.0 t30 -103.04 7.79 38.95 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-O 122.294 1.045 . . . . 0.0 108.93 179.703 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.441 ' OD2' ' HB2' ' A' ' 29' ' ' ASN . 9.4 p-10 -93.12 153.28 18.75 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.54 178.616 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 93.0 mt -66.88 102.38 0.95 Allowed 'General case' 0 CA--C 1.499 -0.995 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 175.028 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.441 ' HB2' ' OD2' ' A' ' 27' ' ' ASP . 45.4 t-20 -141.08 139.45 34.04 Favored 'General case' 0 N--CA 1.416 -2.127 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.763 -170.646 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 32.5 t -74.72 -152.02 0.03 OUTLIER 'General case' 0 CA--C 1.557 1.222 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 175.068 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.497 ' HB ' ' O ' ' A' ' 42' ' ' LEU . 7.4 p -69.29 90.91 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 CA-C-O 122.15 0.976 . . . . 0.0 112.323 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 33.0 p -76.35 103.8 6.54 Favored 'General case' 0 N--CA 1.42 -1.931 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 174.672 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 53.5 p -80.02 80.12 6.47 Favored 'General case' 0 N--CA 1.432 -1.373 0 N-CA-C 113.271 0.841 . . . . 0.0 113.271 -174.508 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 22.3 p -83.4 -61.2 1.91 Allowed 'General case' 0 N--CA 1.431 -1.401 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 175.487 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 51.1 mm -98.7 -69.06 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 175.849 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -169.72 -63.85 0.02 OUTLIER 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 -179.111 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 133.62 -33.1 2.61 Favored Glycine 0 N--CA 1.437 -1.242 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.864 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 142.38 -128.16 3.44 Favored Glycine 0 CA--C 1.495 -1.185 0 N-CA-C 108.63 -1.788 . . . . 0.0 108.63 -177.87 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 7.9 t -70.4 -32.22 69.77 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 106.983 -1.488 . . . . 0.0 106.983 171.663 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 53.55 88.04 0.04 OUTLIER 'General case' 0 N--CA 1.439 -0.976 0 C-N-CA 125.82 1.648 . . . . 0.0 114.241 173.958 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 82.2 m95 -94.6 -53.68 3.79 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 104.739 -2.319 . . . . 0.0 104.739 167.765 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.497 ' O ' ' HB ' ' A' ' 31' ' ' VAL . 4.2 tt -107.88 -53.98 2.55 Favored 'General case' 0 C--O 1.21 -1.025 0 N-CA-C 103.389 -2.819 . . . . 0.0 103.389 168.869 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.484 HG13 ' H ' ' A' ' 44' ' ' ASN . 7.4 p -165.29 -68.5 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.86 0 CA-C-N 114.998 -1.001 . . . . 0.0 110.575 174.787 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.484 ' H ' HG13 ' A' ' 43' ' ' VAL . 54.0 t30 -169.0 86.05 0.16 Allowed 'General case' 0 C--O 1.236 0.363 0 CA-C-O 121.114 0.483 . . . . 0.0 110.987 178.47 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 4.4 mptp? -132.33 149.2 52.41 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 115.903 -0.59 . . . . 0.0 109.918 177.771 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 29.0 pt -121.36 -51.34 3.22 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.709 175.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 35.0 mmtp 60.33 174.39 0.09 Allowed 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 124.404 1.082 . . . . 0.0 112.77 177.775 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 131.32 123.54 2.49 Favored Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 119.319 -1.419 . . . . 0.0 115.901 173.169 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 12.7 mptt -144.63 159.77 42.26 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 107.1 -1.444 . . . . 0.0 107.1 171.354 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 1.1 mpt? -83.15 -167.81 1.83 Allowed 'General case' 0 C--N 1.305 -1.335 0 O-C-N 123.026 0.204 . . . . 0.0 110.559 176.828 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . 0.268 11.6 pt20 -76.21 75.26 3.03 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 115.948 1.833 . . . . 0.0 115.948 -173.565 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.659 ' HB2' ' HD3' ' A' ' 53' ' ' PRO . 98.9 mttt -135.93 -58.66 0.02 OUTLIER Pre-proline 0 C--N 1.315 -0.903 0 CA-C-N 114.352 -1.294 . . . . 0.0 108.228 169.684 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.659 ' HD3' ' HB2' ' A' ' 52' ' ' LYS . 1.4 Cg_endo -95.72 29.88 0.2 Allowed 'Trans proline' 0 C--N 1.383 2.376 0 C-N-CA 122.879 2.386 . . . . 0.0 108.609 174.436 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.53 ' O ' ' HG ' ' A' ' 58' ' ' LEU . 14.9 tp -54.23 -39.96 78.54 Favored Pre-proline 0 C--N 1.303 -1.435 0 N-CA-C 114.573 1.323 . . . . 0.0 114.573 -171.504 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.435 ' O ' ' HE3' ' A' ' 59' ' ' LYS . 0.9 OUTLIER -52.4 -26.41 27.86 Favored 'Trans proline' 0 C--N 1.362 1.253 0 C-N-CA 123.303 2.669 . . . . 0.0 110.952 176.922 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.402 ' HB2' ' O ' ' A' ' 53' ' ' PRO . 20.0 mm-40 -82.7 -41.48 19.27 Favored 'General case' 0 N--CA 1.4 -2.928 0 CA-C-N 115.201 -0.909 . . . . 0.0 109.367 -178.648 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.489 ' HA ' ' HB3' ' A' ' 60' ' ' GLU . 3.8 mm? -75.35 -37.38 60.71 Favored 'General case' 0 N--CA 1.44 -0.973 0 N-CA-C 113.47 0.915 . . . . 0.0 113.47 -176.056 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.53 ' HG ' ' O ' ' A' ' 54' ' ' LEU 0.261 1.8 pp -58.84 -43.58 90.78 Favored 'General case' 0 C--O 1.217 -0.614 0 C-N-CA 120.088 -0.645 . . . . 0.0 112.179 178.908 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.493 ' N ' HD12 ' A' ' 58' ' ' LEU . 20.8 pttp -77.49 -26.81 51.58 Favored 'General case' 0 C--O 1.208 -1.119 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 175.454 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.489 ' HB3' ' HA ' ' A' ' 57' ' ' LEU . 8.7 tp10 -61.97 -49.03 77.72 Favored 'General case' 0 C--N 1.313 -0.999 0 C-N-CA 123.895 0.878 . . . . 0.0 111.34 177.402 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 72.5 m-85 -73.62 5.5 3.85 Favored 'General case' 0 C--O 1.243 0.725 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.332 179.181 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -125.4 -162.93 1.15 Allowed 'General case' 0 C--N 1.292 -1.918 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.737 ' HB2' HD12 ' A' ' 65' ' ' ILE . 2.5 mt -79.11 173.86 7.04 Favored Pre-proline 0 CA--C 1.563 1.467 0 N-CA-C 106.988 -1.486 . . . . 0.0 106.988 -176.421 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -85.8 6.41 5.57 Favored 'Trans proline' 0 CA--C 1.505 -0.967 0 C-N-CA 121.68 1.587 . . . . 0.0 112.103 -171.131 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.737 HD12 ' HB2' ' A' ' 63' ' ' LEU . 0.2 OUTLIER -71.26 -45.46 70.34 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.816 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 179.578 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.415 ' H ' HD13 ' A' ' 65' ' ' ILE . . . 58.27 8.91 5.36 Favored Glycine 0 CA--C 1.528 0.885 0 CA-C-N 115.735 -0.666 . . . . 0.0 113.531 -178.954 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.544 ' O ' ' HB ' ' A' ' 160' ' ' VAL . 48.0 mt 68.58 -68.07 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.832 0 C-N-CA 125.494 1.517 . . . . 0.0 112.364 -176.791 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.542 ' HB3' ' HD3' ' A' ' 69' ' ' PRO . 76.7 t80 178.67 -56.99 0.0 OUTLIER Pre-proline 0 C--N 1.303 -1.417 0 C-N-CA 122.324 0.25 . . . . 0.0 111.078 -177.625 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.542 ' HD3' ' HB3' ' A' ' 68' ' ' PHE . 20.0 Cg_endo -98.15 145.64 0.64 Allowed 'Trans proline' 0 N--CA 1.432 -2.134 0 C-N-CA 122.285 1.99 . . . . 0.0 112.364 -177.026 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -78.57 64.34 3.59 Favored Glycine 0 N--CA 1.442 -0.934 0 N-CA-C 110.517 -1.033 . . . . 0.0 110.517 178.124 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -163.06 -27.38 0.04 OUTLIER 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 -177.471 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.43 ' HA ' ' CD ' ' A' ' 89' ' ' PRO . . . -83.2 170.52 14.62 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.663 0.785 . . . . 0.0 109.339 173.239 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.56 ' O ' HG22 ' A' ' 73' ' ' THR . 84.1 m 76.8 28.46 0.68 Allowed 'General case' 0 CA--C 1.56 1.339 0 CA-C-O 124.878 2.275 . . . . 0.0 110.866 172.117 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.686 ' O ' ' HA ' ' A' ' 86' ' ' VAL . 4.6 m-20 -73.74 108.21 6.44 Favored 'General case' 0 C--N 1.257 -3.439 0 CA-C-N 113.947 -1.479 . . . . 0.0 112.712 -178.175 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.576 ' HB2' HD21 ' A' ' 84' ' ' LEU . 31.3 p90 -79.34 108.71 13.06 Favored 'General case' 0 C--N 1.271 -2.815 0 CA-C-O 122.095 0.95 . . . . 0.0 113.37 -173.951 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.582 ' HB2' ' O ' ' A' ' 85' ' ' THR . 8.4 mm-40 -105.02 158.35 16.61 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 174.638 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 60.0 t80 -152.87 147.43 25.99 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 -175.274 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.638 ' O ' ' HA ' ' A' ' 82' ' ' LYS . 12.0 m-20 -130.3 -176.46 3.96 Favored 'General case' 0 CA--C 1.489 -1.393 0 CA-C-O 121.325 0.584 . . . . 0.0 111.665 -179.811 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.753 ' O ' ' HB2' ' A' ' 82' ' ' LYS . 45.8 mt-10 -83.88 -62.57 1.54 Allowed 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 117.042 2.238 . . . . 0.0 117.042 175.141 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -80.6 -34.43 35.17 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 122.775 1.274 . . . . 0.0 108.257 177.818 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.589 ' C ' ' H ' ' A' ' 83' ' ' LYS . 24.7 m -92.63 30.58 1.51 Allowed 'General case' 0 C--N 1.291 -1.969 0 C-N-CA 126.877 2.071 . . . . 0.0 107.496 176.478 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.753 ' HB2' ' O ' ' A' ' 79' ' ' GLU . 72.5 tttt -57.33 32.0 0.0 OUTLIER 'General case' 0 CA--C 1.565 1.542 0 C-N-CA 127.996 2.518 . . . . 0.0 112.617 -179.737 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.676 ' HG3' HG22 ' A' ' 109' ' ' THR . 53.9 pttt -117.96 133.67 55.69 Favored 'General case' 0 N--CA 1.393 -3.315 0 C-N-CA 125.943 1.697 . . . . 0.0 107.179 176.219 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.576 HD21 ' HB2' ' A' ' 75' ' ' TYR . 1.2 tm? -59.82 127.24 30.99 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-O 121.569 0.699 . . . . 0.0 110.743 -171.368 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.582 ' O ' ' HB2' ' A' ' 76' ' ' GLU . 6.2 t -126.77 114.28 17.75 Favored 'General case' 0 N--CA 1.405 -2.687 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.37 -179.851 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.686 ' HA ' ' O ' ' A' ' 74' ' ' ASN . 15.7 m -92.41 140.16 16.7 Favored 'Isoleucine or valine' 0 CA--C 1.474 -1.96 0 O-C-N 121.007 -1.058 . . . . 0.0 111.304 178.542 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.543 ' HA ' ' H ' ' A' ' 107' ' ' THR 0.339 2.0 pp -101.59 103.7 14.54 Favored 'General case' 0 N--CA 1.391 -3.423 0 CA-C-O 122.593 1.187 . . . . 0.0 109.979 176.892 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 35.0 mt -88.65 117.37 68.25 Favored Pre-proline 0 N--CA 1.405 -2.715 0 CA-C-N 113.683 -1.599 . . . . 0.0 107.23 -178.223 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.455 ' HB2' ' HD2' ' A' ' 166' ' ' ARG . 55.1 Cg_exo -55.78 104.15 0.12 Allowed 'Trans proline' 0 N--CA 1.451 -0.992 0 C-N-CA 123.442 2.761 . . . . 0.0 111.737 -178.059 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.512 ' OG ' ' HB ' ' A' ' 167' ' ' VAL . 25.7 t 71.66 170.22 0.32 Allowed 'General case' 0 N--CA 1.44 -0.942 0 O-C-N 124.715 1.259 . . . . 0.0 110.832 -179.134 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 79.4 mt -85.88 116.78 29.49 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.921 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.227 177.409 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' CYS . . . . . 0.597 ' SG ' ' HB2' ' A' ' 104' ' ' PHE . 12.0 p -109.91 129.05 55.7 Favored 'General case' 0 C--N 1.292 -1.92 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 174.615 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -120.41 120.34 35.66 Favored 'General case' 0 CA--C 1.461 -2.463 0 N-CA-C 108.787 -0.819 . . . . 0.0 108.787 -175.5 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.719 ' O ' ' HA ' ' A' ' 101' ' ' VAL . 49.1 t -111.06 115.79 50.8 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.156 0 CA-C-N 114.443 -1.253 . . . . 0.0 109.398 -172.933 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -137.99 -168.57 11.36 Favored Glycine 0 C--N 1.309 -0.944 0 N-CA-C 110.939 -0.864 . . . . 0.0 110.939 179.325 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 56.4 t80 -141.34 -91.38 0.15 Allowed 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 179.137 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -88.33 -35.41 17.21 Favored 'General case' 0 N--CA 1.434 -1.249 0 C-N-CA 119.401 -0.92 . . . . 0.0 109.013 171.012 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 15.9 t70 177.42 -67.38 0.01 OUTLIER 'General case' 0 C--N 1.353 0.733 0 CA-C-N 115.327 -0.851 . . . . 0.0 111.804 -178.371 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.474 ' HB3' ' O ' ' A' ' 127' ' ' VAL . 29.6 m -77.98 44.56 0.48 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 122.089 0.947 . . . . 0.0 112.935 -171.821 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 39.9 m -149.72 25.23 0.85 Allowed 'General case' 0 C--N 1.287 -2.129 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 175.485 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.719 ' HA ' ' O ' ' A' ' 94' ' ' VAL . 9.3 p -94.81 116.37 35.97 Favored 'Isoleucine or valine' 0 C--O 1.244 0.765 0 CA-C-O 122.01 0.909 . . . . 0.0 113.021 -175.969 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.427 ' CD1' HG23 ' A' ' 125' ' ' THR . 1.5 mm? -110.2 133.23 53.43 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 177.202 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 22.6 ttmm -103.39 105.23 15.44 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 177.924 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.597 ' HB2' ' SG ' ' A' ' 92' ' ' CYS . 99.3 m-85 -90.15 98.18 11.62 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 176.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 28.0 m -85.81 155.94 20.78 Favored 'General case' 0 C--N 1.296 -1.737 0 CA-C-N 114.686 -1.143 . . . . 0.0 111.062 -175.863 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 27.0 m -68.79 121.29 16.22 Favored 'General case' 0 N--CA 1.417 -2.094 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 175.892 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.543 ' H ' ' HA ' ' A' ' 87' ' ' LEU . 23.3 m 71.98 79.56 0.15 Allowed 'General case' 0 C--N 1.317 -0.807 0 C-N-CA 124.212 1.005 . . . . 0.0 110.656 179.238 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.506 ' O ' ' HA ' ' A' ' 85' ' ' THR . 14.9 m -109.25 121.21 61.93 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 CA-C-N 114.995 -1.002 . . . . 0.0 109.45 177.306 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.676 HG22 ' HG3' ' A' ' 83' ' ' LYS . 25.7 m -106.57 124.22 49.28 Favored 'General case' 0 N--CA 1.409 -2.492 0 CA-C-N 114.977 -1.01 . . . . 0.0 111.657 -167.599 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -157.1 -168.69 20.02 Favored Glycine 0 C--N 1.309 -0.947 0 C-N-CA 120.452 -0.88 . . . . 0.0 113.733 -179.295 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 12.9 t-80 -99.64 119.62 38.39 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 105.752 -1.944 . . . . 0.0 105.752 179.632 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.559 HD23 ' HG ' ' A' ' 84' ' ' LEU . 60.7 tp -124.11 118.51 27.08 Favored 'General case' 0 CA--C 1.457 -2.62 0 CA-C-O 121.338 0.59 . . . . 0.0 111.594 -167.496 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 8.1 mp0 -121.04 146.57 46.58 Favored 'General case' 1 N--CA 1.37 -4.459 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 175.323 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 21.2 tptm -66.2 101.14 0.68 Allowed 'General case' 0 C--N 1.291 -1.959 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 179.148 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 137.07 -48.95 0.88 Allowed Glycine 0 C--O 1.192 -2.478 0 N-CA-C 108.361 -1.896 . . . . 0.0 108.361 -173.294 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.63 ' HD3' HG23 ' A' ' 118' ' ' THR . 0.0 OUTLIER -148.71 144.22 26.95 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 114.006 1.113 . . . . 0.0 114.006 179.935 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.666 ' O ' ' HB2' ' A' ' 135' ' ' SER . 49.1 tp -110.65 100.91 9.61 Favored 'General case' 0 C--N 1.31 -1.124 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 177.029 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.63 HG23 ' HD3' ' A' ' 116' ' ' LYS . 6.9 p -100.95 138.16 38.37 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 113.064 0.765 . . . . 0.0 113.064 -176.528 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' ASP . . . . . 0.418 ' H ' ' HB3' ' A' ' 135' ' ' SER . 29.3 t70 64.09 124.52 0.02 OUTLIER 'General case' 0 CA--C 1.45 -2.866 0 C-N-CA 124.882 1.273 . . . . 0.0 111.348 -176.414 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.431 HG21 HD12 ' A' ' 123' ' ' ILE . 0.8 OUTLIER -145.99 145.16 20.37 Favored 'Isoleucine or valine' 1 N--CA 1.351 -5.388 0 C-N-CA 116.475 -2.09 . . . . 0.0 111.082 -169.659 . . . . . . . . 4 4 . 1 . 005 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.466 ' HB3' ' HB ' ' A' ' 109' ' ' THR . 14.9 tp10 -111.42 102.87 11.21 Favored 'General case' 0 C--N 1.283 -2.283 0 CA-C-N 115.13 -0.941 . . . . 0.0 109.199 -176.567 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 116.22 -4.85 20.0 Favored Glycine 0 N--CA 1.439 -1.161 0 C-N-CA 119.392 -1.385 . . . . 0.0 114.225 173.294 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.431 HD12 HG21 ' A' ' 120' ' ' VAL . 61.4 mt -99.35 105.4 17.39 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.99 0 C-N-CA 118.737 -1.185 . . . . 0.0 110.052 179.746 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 58.0 tttm -85.37 119.67 25.99 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 179.019 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.523 ' O ' ' HA ' ' A' ' 130' ' ' TRP . 92.1 m -116.46 124.08 49.08 Favored 'General case' 0 C--N 1.271 -2.813 0 CA-C-N 114.951 -1.022 . . . . 0.0 110.116 -176.365 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.482 ' HA ' ' O ' ' A' ' 129' ' ' ILE . 0.7 OUTLIER -122.83 100.25 6.81 Favored 'General case' 0 N--CA 1.424 -1.762 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 174.077 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.474 ' O ' ' HB3' ' A' ' 99' ' ' SER . 11.8 p -102.59 -26.84 3.38 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.138 0 CA-C-O 122.255 1.026 . . . . 0.0 109.511 178.299 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 26.6 ttt -161.32 -33.6 0.05 OUTLIER 'General case' 0 C--N 1.282 -2.335 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 -178.089 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.516 ' H ' HD13 ' A' ' 129' ' ' ILE . 0.2 OUTLIER -139.46 165.62 22.59 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 N-CA-C 104.436 -2.431 . . . . 0.0 104.436 176.759 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 130' ' ' TRP . . . . . 0.523 ' HA ' ' O ' ' A' ' 125' ' ' THR . 60.8 p-90 -108.42 127.82 54.24 Favored 'General case' 0 N--CA 1.418 -2.058 0 C-N-CA 118.928 -1.109 . . . . 0.0 111.661 -178.479 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.595 HG12 ' H ' ' A' ' 133' ' ' VAL . 43.0 t -127.99 154.02 38.06 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.914 0 N-CA-C 105.751 -1.944 . . . . 0.0 105.751 177.354 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -115.98 18.71 15.43 Favored 'General case' 0 C--N 1.3 -1.579 0 CA-C-O 121.627 0.727 . . . . 0.0 111.238 -176.441 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.595 ' H ' HG12 ' A' ' 131' ' ' VAL . 33.5 m -138.11 0.2 0.71 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.637 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.962 -178.464 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' THR . . . . . 0.463 ' OG1' ' HB ' ' A' ' 125' ' ' THR . 1.2 p -64.65 120.61 12.73 Favored 'General case' 0 N--CA 1.418 -2.063 0 CA-C-O 122.065 0.936 . . . . 0.0 110.917 178.074 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 135' ' ' SER . . . . . 0.666 ' HB2' ' O ' ' A' ' 117' ' ' LEU . 19.7 p -78.61 171.25 15.4 Favored 'General case' 0 N--CA 1.407 -2.608 0 CA-C-N 113.778 -1.555 . . . . 0.0 114.049 -173.03 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 10.4 tt -119.18 127.54 75.84 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.099 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 175.84 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 37.9 m -129.45 131.23 46.68 Favored 'General case' 0 C--N 1.293 -1.886 0 C-N-CA 120.351 -0.54 . . . . 0.0 110.995 -174.422 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' THR . . . . . 0.516 ' HB ' ' O ' ' A' ' 142' ' ' LYS . 59.6 p -118.2 176.13 5.37 Favored 'General case' 0 C--N 1.29 -1.983 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 177.182 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -99.93 21.64 12.35 Favored 'General case' 0 C--N 1.281 -2.398 0 N-CA-C 106.185 -1.783 . . . . 0.0 106.185 173.732 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . 61.71 40.42 13.15 Favored 'General case' 0 C--N 1.352 0.683 0 N-CA-C 107.367 -1.346 . . . . 0.0 107.367 -168.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 35.6 t -174.78 -79.69 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 114.222 -1.354 . . . . 0.0 109.483 -174.921 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.516 ' O ' ' HB ' ' A' ' 138' ' ' THR . 99.5 mttt -85.41 167.2 15.74 Favored 'General case' 0 CA--C 1.497 -1.095 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 177.141 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.449 ' HA ' HG22 ' A' ' 138' ' ' THR . 10.4 p -126.33 127.7 70.84 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.741 0 N-CA-C 113.484 0.92 . . . . 0.0 113.484 -173.105 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 45.8 m-85 -113.68 147.14 38.71 Favored 'General case' 0 CA--C 1.487 -1.465 0 CA-C-N 115.244 -0.889 . . . . 0.0 109.982 176.041 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' PHE . . . . . 0.505 ' HB2' ' HB2' ' A' ' 151' ' ' LYS . 93.9 m-85 -99.19 99.85 10.89 Favored 'General case' 0 C--N 1.263 -3.174 0 CA-C-N 114.456 -1.247 . . . . 0.0 107.922 175.738 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . 0.363 17.7 p -82.34 69.76 9.15 Favored 'General case' 0 N--CA 1.425 -1.686 0 N-CA-C 115.315 1.598 . . . . 0.0 115.315 -175.215 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.411 ' HB2' HG21 ' A' ' 125' ' ' THR . . . -123.85 74.35 1.27 Allowed 'General case' 0 N--CA 1.424 -1.728 0 N-CA-C 104.68 -2.341 . . . . 0.0 104.68 170.869 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 77.64 16.25 80.4 Favored Glycine 0 N--CA 1.433 -1.567 0 N-CA-C 109.071 -1.611 . . . . 0.0 109.071 -171.271 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 27.5 ptt? 49.03 24.39 0.88 Allowed 'General case' 0 N--CA 1.502 2.149 0 C-N-CA 126.578 1.951 . . . . 0.0 111.416 -173.731 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 59.5 mttp -62.77 -36.79 84.23 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 115.021 1.489 . . . . 0.0 115.021 -174.099 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.547 ' HE2' ' HA ' ' A' ' 151' ' ' LYS . 6.1 mmpt? -106.3 132.8 51.91 Favored 'General case' 0 C--N 1.319 -0.74 0 C-N-CA 120.473 -0.491 . . . . 0.0 110.897 178.144 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 19.7 m -132.46 128.21 36.96 Favored 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 -179.727 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 25.2 mmm180 -140.99 172.95 11.97 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-O 121.232 0.539 . . . . 0.0 111.954 -178.138 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 17.8 m -101.15 142.26 32.85 Favored 'General case' 0 N--CA 1.432 -1.331 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 176.434 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' ARG . . . . . 0.531 ' HD3' ' C ' ' A' ' 155' ' ' ARG . 0.2 OUTLIER -78.58 -25.02 45.21 Favored 'General case' 0 C--N 1.299 -1.606 0 CA-C-O 121.255 0.55 . . . . 0.0 109.89 178.976 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -44.17 -36.37 2.62 Favored 'General case' 0 C--N 1.316 -0.854 0 C-N-CA 125.455 1.502 . . . . 0.0 114.905 -175.277 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -66.44 -53.81 31.23 Favored 'General case' 0 CA--C 1.546 0.797 0 N-CA-C 114.277 1.214 . . . . 0.0 114.277 -174.107 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -149.66 5.15 0.6 Allowed 'General case' 0 N--CA 1.491 1.603 0 CA-C-N 117.597 0.18 . . . . 0.0 111.364 -175.411 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 159' ' ' GLY . . . . . 0.518 ' HA2' ' HG2' ' A' ' 155' ' ' ARG . . . 96.31 -91.55 1.29 Allowed Glycine 0 CA--C 1.461 -3.33 0 N-CA-C 106.231 -2.748 . . . . 0.0 106.231 -166.772 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.544 ' HB ' ' O ' ' A' ' 67' ' ' ILE . 57.7 t -104.96 127.45 59.49 Favored 'Isoleucine or valine' 1 N--CA 1.369 -4.512 0 N-CA-C 105.16 -2.163 . . . . 0.0 105.16 165.1 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 -88.34 106.59 18.34 Favored 'General case' 0 C--N 1.273 -2.754 0 N-CA-C 106.396 -1.705 . . . . 0.0 106.396 -177.055 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 162' ' ' ARG . . . . . 0.446 ' HD2' ' O ' ' A' ' 164' ' ' GLY . 0.0 OUTLIER -148.64 158.69 44.31 Favored 'General case' 0 N--CA 1.389 -3.519 0 C-N-CA 118.384 -1.326 . . . . 0.0 114.523 -167.359 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -106.29 -24.1 12.38 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 115.073 -0.967 . . . . 0.0 108.792 172.657 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 164' ' ' GLY . . . . . 0.446 ' O ' ' HD2' ' A' ' 162' ' ' ARG . . . -58.65 118.61 14.33 Favored Glycine 0 CA--C 1.498 -0.994 0 CA-C-N 115.258 -0.883 . . . . 0.0 112.282 -178.914 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 2.8 pp -108.7 153.74 23.01 Favored 'General case' 0 N--CA 1.418 -2.047 0 CA-C-O 120.667 0.27 . . . . 0.0 111.161 -174.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 166' ' ' ARG . . . . . 0.455 ' HD2' ' HB2' ' A' ' 89' ' ' PRO . 58.6 mtm180 -79.12 117.4 20.11 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 178.17 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.512 ' HB ' ' OG ' ' A' ' 90' ' ' SER . 43.6 t -62.28 -18.0 19.26 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.627 0 CA-C-O 121.64 0.733 . . . . 0.0 109.692 176.056 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -56.1 -41.44 75.21 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 124.739 1.215 . . . . 0.0 111.101 176.736 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 1.9 tmmm? -86.59 109.58 19.23 Favored 'General case' 0 N--CA 1.429 -1.499 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 -178.478 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 170' ' ' PHE . . . . . . . . . . . . . 87.9 t80 . . . . . 0 N--CA 1.423 -1.822 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 178.414 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 44.1 m . . . . . 0 N--CA 1.443 -0.813 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -90.43 94.09 9.58 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-O 122.1 0.952 . . . . 0.0 111.8 -177.688 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 29.6 tt0 -114.18 100.4 8.34 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 178.055 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.1 mp -78.61 127.76 38.69 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.094 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.261 -175.48 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -102.45 157.22 17.07 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.61 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 83.8 m-20 -112.25 165.4 12.2 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 177.81 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.598 ' HD3' ' H ' ' A' ' 7' ' ' LYS . 0.1 OUTLIER -83.55 83.07 8.03 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-O 121.958 0.885 . . . . 0.0 111.193 178.885 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 29.9 m -137.17 169.7 19.17 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 CA-C-N 115.146 -0.934 . . . . 0.0 109.105 179.422 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -103.49 150.31 17.59 Favored Glycine 0 N--CA 1.418 -2.553 0 N-CA-C 107.477 -2.249 . . . . 0.0 107.477 172.934 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 32.1 t -66.23 159.14 27.12 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-N 117.957 0.879 . . . . 0.0 109.235 -179.69 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 37.9 p90 -63.11 129.77 41.75 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-O 120.917 0.389 . . . . 0.0 110.688 -177.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 12.3 p90 -92.44 137.09 32.66 Favored 'General case' 0 C--N 1.304 -1.392 0 C-N-CA 120.411 -0.516 . . . . 0.0 110.257 177.818 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 53.5 tp -154.37 100.73 2.31 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 109.101 -0.704 . . . . 0.0 109.101 -179.294 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -92.68 115.57 4.89 Favored Glycine 0 N--CA 1.43 -1.715 0 N-CA-C 111.185 -0.766 . . . . 0.0 111.185 -179.54 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -136.95 153.21 50.76 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 18.0 ptpt -125.06 82.52 2.06 Favored 'General case' 0 C--N 1.292 -1.898 0 CA-C-O 122.143 0.973 . . . . 0.0 110.686 173.486 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -136.29 91.95 2.73 Favored 'General case' 0 N--CA 1.426 -1.662 0 CA-C-N 114.43 -1.259 . . . . 0.0 107.635 178.271 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 46.1 t30 -72.48 108.36 5.51 Favored 'General case' 0 C--N 1.299 -1.62 0 CA-C-N 115.085 -0.961 . . . . 0.0 111.517 -175.862 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 6.0 tmtm? -84.72 -60.23 2.12 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 104.683 -2.34 . . . . 0.0 104.683 171.752 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -168.36 75.71 0.12 Allowed 'General case' 0 N--CA 1.435 -1.223 0 CA-C-N 115.197 -0.91 . . . . 0.0 109.492 173.132 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -93.83 90.53 6.56 Favored 'General case' 0 CA--C 1.496 -1.125 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.61 178.102 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -109.63 -25.82 10.22 Favored 'General case' 0 C--N 1.291 -1.968 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 176.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 38.4 t 68.71 159.63 0.17 Allowed 'General case' 0 C--N 1.349 0.574 0 C-N-CA 124.578 1.151 . . . . 0.0 111.04 179.691 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 47.0 t -90.52 102.36 13.26 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.78 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 176.791 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -54.34 114.95 4.71 Favored Glycine 0 CA--C 1.506 -0.507 0 O-C-N 124.187 0.929 . . . . 0.0 113.278 -175.381 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -83.27 131.41 35.09 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 -179.109 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -96.19 134.96 38.64 Favored 'General case' 0 C--N 1.295 -1.794 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 175.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . 0.334 1.0 OUTLIER -77.58 72.67 4.13 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 115.607 1.706 . . . . 0.0 115.607 -175.693 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -91.82 131.25 37.31 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.446 177.922 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 47.3 t -140.95 101.91 4.15 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 -179.767 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 40.4 t -123.45 74.28 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 178.453 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 26.8 t 173.37 95.56 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 124.608 1.163 . . . . 0.0 108.075 177.086 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 7.1 t -131.18 91.2 2.99 Favored 'General case' 0 C--N 1.295 -1.796 0 CA-C-O 122.117 0.96 . . . . 0.0 110.148 179.037 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 61.7 m -157.8 153.3 26.23 Favored 'General case' 0 N--CA 1.44 -0.966 0 CA-C-N 115.069 -0.969 . . . . 0.0 109.134 179.623 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 6.4 tp -136.84 112.2 11.18 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 175.412 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -120.7 -172.69 2.43 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 113.005 0.743 . . . . 0.0 113.005 -175.685 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -140.95 142.11 11.91 Favored Glycine 0 N--CA 1.415 -2.735 0 N-CA-C 108.952 -1.659 . . . . 0.0 108.952 176.082 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -82.29 69.01 3.41 Favored Glycine 0 C--N 1.302 -1.321 0 N-CA-C 110.935 -0.866 . . . . 0.0 110.935 179.557 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 7.4 t -160.5 158.35 29.11 Favored 'General case' 0 N--CA 1.426 -1.658 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 -178.336 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 55.7 tptt -87.67 -14.06 40.93 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-O 121.409 0.623 . . . . 0.0 109.546 178.081 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 87.5 t90 -91.16 100.83 13.59 Favored 'General case' 0 N--CA 1.437 -1.086 0 CA-C-O 121.205 0.526 . . . . 0.0 109.649 179.169 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.482 ' O ' HD12 ' A' ' 42' ' ' LEU 0.261 2.3 pp -157.5 108.55 2.28 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-O 121.952 0.882 . . . . 0.0 111.37 176.578 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 8.5 p -165.23 138.29 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.97 0 CA-C-N 114.921 -1.036 . . . . 0.0 109.45 -178.424 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 37.6 t30 -101.25 107.36 18.72 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 179.03 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -98.98 107.7 20.2 Favored 'General case' 0 C--N 1.308 -1.218 0 C-N-CA 120.227 -0.589 . . . . 0.0 111.155 -177.895 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 63.8 mt -112.84 94.41 3.11 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 173.907 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 54.6 tttp -87.07 114.36 23.61 Favored 'General case' 0 C--N 1.309 -1.167 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 -176.575 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.457 ' HA2' ' HB2' ' A' ' 51' ' ' GLN . . . -99.48 25.16 29.33 Favored Glycine 0 C--N 1.302 -1.32 0 C-N-CA 121.188 -0.529 . . . . 0.0 113.346 -176.406 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 61.8 tttm -77.48 -52.72 8.61 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 178.522 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 27.9 ttt -126.79 82.37 2.08 Favored 'General case' 0 C--N 1.308 -1.196 0 N-CA-C 106.163 -1.791 . . . . 0.0 106.163 171.804 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.457 ' HB2' ' HA2' ' A' ' 48' ' ' GLY . 53.1 tt0 -89.44 -63.09 1.34 Allowed 'General case' 0 C--N 1.302 -1.489 0 CA-C-N 114.999 -1.0 . . . . 0.0 112.146 -170.783 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 68.7 mttm 68.12 132.45 0.04 OUTLIER Pre-proline 0 N--CA 1.467 0.424 0 O-C-N 124.389 1.055 . . . . 0.0 110.212 -171.338 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -78.28 -13.28 15.36 Favored 'Trans proline' 0 N--CA 1.454 -0.844 0 C-N-CA 121.506 1.47 . . . . 0.0 111.482 179.28 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.676 ' O ' ' HG ' ' A' ' 58' ' ' LEU . 23.3 mt -57.08 -59.09 13.74 Favored Pre-proline 0 C--O 1.208 -1.088 0 CA-C-N 115.535 -0.757 . . . . 0.0 112.068 -174.786 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.569 ' HA ' ' CD1' ' A' ' 58' ' ' LEU . 36.7 Cg_endo -60.34 -34.96 93.04 Favored 'Trans proline' 0 C--N 1.377 2.063 0 C-N-CA 120.899 1.066 . . . . 0.0 113.768 -169.729 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -78.21 -30.27 48.8 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-O 121.242 0.544 . . . . 0.0 110.633 179.324 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 45.5 tp -74.02 -29.39 61.91 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.242 176.875 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.676 ' HG ' ' O ' ' A' ' 54' ' ' LEU . 59.6 mt -57.48 -45.9 84.3 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-O 121.375 0.607 . . . . 0.0 110.3 -177.896 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.431 ' HD3' ' HA3' ' A' ' 66' ' ' GLY . 1.9 pptp? -73.57 -25.0 60.16 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 114.894 -1.048 . . . . 0.0 110.577 -179.183 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -90.48 -22.83 21.17 Favored 'General case' 0 CA--C 1.556 1.181 0 N-CA-C 113.482 0.919 . . . . 0.0 113.482 -174.776 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.558 ' CD2' ' HA ' ' A' ' 58' ' ' LEU . 34.1 m-85 -41.31 -41.08 1.83 Allowed 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 115.193 1.553 . . . . 0.0 115.193 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.493 ' OD2' ' HA ' ' A' ' 114' ' ' LYS . 10.4 t70 -125.96 -82.96 0.63 Allowed 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 117.746 -1.582 . . . . 0.0 112.205 -172.647 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.554 ' H ' HD12 ' A' ' 63' ' ' LEU . 0.0 OUTLIER -90.94 161.07 36.56 Favored Pre-proline 0 N--CA 1.444 -0.752 0 N-CA-C 106.619 -1.623 . . . . 0.0 106.619 -179.742 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -100.55 14.17 0.45 Allowed 'Trans proline' 0 N--CA 1.435 -1.936 0 C-N-CA 122.778 2.319 . . . . 0.0 112.803 -176.869 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.56 HG12 ' H ' ' A' ' 67' ' ' ILE . 0.2 OUTLIER -67.09 -47.5 81.75 Favored 'Isoleucine or valine' 0 CA--C 1.484 -1.59 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 177.146 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.524 ' HA2' HG21 ' A' ' 73' ' ' THR . . . 49.91 8.7 0.15 Allowed Glycine 0 N--CA 1.472 1.043 0 CA-C-N 114.903 -1.044 . . . . 0.0 113.849 -173.13 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.56 ' H ' HG12 ' A' ' 65' ' ' ILE . 16.6 mm 69.38 -69.34 0.16 Allowed 'Isoleucine or valine' 0 C--O 1.177 -2.739 0 C-N-CA 125.549 1.54 . . . . 0.0 108.555 -173.142 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.577 ' HB3' ' HD3' ' A' ' 69' ' ' PRO . 65.3 t80 -167.4 -56.75 0.01 OUTLIER Pre-proline 0 C--N 1.293 -1.851 0 C-N-CA 120.917 -0.313 . . . . 0.0 110.64 -177.78 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.577 ' HD3' ' HB3' ' A' ' 68' ' ' PHE . 56.0 Cg_endo -102.71 178.91 0.15 Allowed 'Trans proline' 0 N--CA 1.424 -2.61 0 C-N-CA 121.721 1.614 . . . . 0.0 111.108 -179.651 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -102.99 19.32 46.98 Favored Glycine 0 N--CA 1.43 -1.76 0 N-CA-C 109.756 -1.338 . . . . 0.0 109.756 175.381 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -100.93 -44.43 5.75 Favored 'General case' 0 N--CA 1.432 -1.353 0 N-CA-C 106.401 -1.703 . . . . 0.0 106.401 -178.368 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.451 ' HA ' ' HD2' ' A' ' 89' ' ' PRO . . . -80.6 168.04 19.36 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 114.653 -1.158 . . . . 0.0 109.156 167.059 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.559 ' O ' HG22 ' A' ' 73' ' ' THR . 22.3 m 81.8 28.84 0.15 Allowed 'General case' 0 CA--C 1.513 -0.462 0 CA-C-O 123.764 1.745 . . . . 0.0 111.198 171.556 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.565 ' O ' ' HA ' ' A' ' 86' ' ' VAL . 4.3 m-20 -70.47 148.26 48.49 Favored 'General case' 0 C--N 1.262 -3.212 0 CA-C-N 114.264 -1.335 . . . . 0.0 110.01 -179.725 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 40.5 t80 -115.01 91.32 3.58 Favored 'General case' 0 C--N 1.275 -2.644 0 C-N-CA 119.847 -0.741 . . . . 0.0 111.834 -166.556 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.5 ' O ' HD22 ' A' ' 84' ' ' LEU . 39.6 mm-40 -113.53 153.77 28.19 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.018 177.165 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 46.0 p90 -163.35 147.77 10.95 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 178.409 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.574 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 11.7 m-20 -74.99 165.11 25.79 Favored 'General case' 0 CA--C 1.478 -1.818 0 C-N-CA 119.827 -0.749 . . . . 0.0 109.235 179.77 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -80.78 -62.73 1.58 Allowed 'General case' 0 C--N 1.265 -3.087 0 CA-C-N 114.775 -1.102 . . . . 0.0 111.599 -179.169 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.494 ' CD ' ' H ' ' A' ' 80' ' ' GLU . 0.0 OUTLIER -80.98 -35.15 32.42 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.271 -176.293 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.574 ' HB ' ' HB2' ' A' ' 78' ' ' ASP . 56.8 m -80.49 -40.83 25.4 Favored 'General case' 0 N--CA 1.423 -1.822 0 CA-C-N 115.076 -0.965 . . . . 0.0 110.992 -178.598 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.423 ' H ' ' HB2' ' A' ' 78' ' ' ASP . 61.9 mttp 66.23 13.72 9.3 Favored 'General case' 0 N--CA 1.483 1.184 0 N-CA-C 114.206 1.187 . . . . 0.0 114.206 178.554 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 36.6 ttpt -71.54 116.46 11.91 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 176.336 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.5 HD22 ' O ' ' A' ' 76' ' ' GLU . 2.1 tm? -75.03 131.39 40.57 Favored 'General case' 0 N--CA 1.443 -0.817 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 -176.447 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.572 ' HA ' ' O ' ' A' ' 108' ' ' VAL . 27.4 p -126.66 116.59 21.23 Favored 'General case' 0 N--CA 1.412 -2.353 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.127 177.428 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.565 ' HA ' ' O ' ' A' ' 74' ' ' ASN . 63.2 t -91.92 131.84 37.94 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.054 0 N-CA-C 106.86 -1.533 . . . . 0.0 106.86 173.837 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.633 ' HA ' ' O ' ' A' ' 106' ' ' THR 0.361 2.1 pp -111.08 114.9 28.51 Favored 'General case' 0 N--CA 1.393 -3.28 0 CA-C-O 122.161 0.981 . . . . 0.0 111.869 178.642 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.474 ' O ' HG23 ' A' ' 106' ' ' THR . 70.3 mt -95.88 125.71 47.67 Favored Pre-proline 0 N--CA 1.419 -2.008 0 CA-C-N 113.647 -1.615 . . . . 0.0 109.771 -176.472 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.451 ' HD2' ' HA ' ' A' ' 72' ' ' ALA . 9.6 Cg_endo -53.89 95.43 0.04 OUTLIER 'Trans proline' 0 CA--C 1.534 0.489 0 C-N-CA 124.129 3.219 . . . . 0.0 112.492 177.696 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.533 ' OG ' ' HB ' ' A' ' 167' ' ' VAL . 22.9 t 75.7 158.14 0.2 Allowed 'General case' 0 C--O 1.236 0.387 0 C-N-CA 125.452 1.501 . . . . 0.0 110.394 -177.804 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.476 HD11 ' HD3' ' A' ' 103' ' ' LYS . 15.9 tt -78.57 108.22 11.77 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.598 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 173.871 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' CYS . . . . . 0.683 ' SG ' ' HG2' ' A' ' 166' ' ' ARG . 32.0 m -98.76 127.03 44.56 Favored 'General case' 0 C--N 1.29 -1.99 0 CA-C-N 114.932 -1.031 . . . . 0.0 110.725 -170.817 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -116.79 147.71 41.84 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-N 116.661 -0.245 . . . . 0.0 110.461 -178.745 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.577 ' O ' ' HA ' ' A' ' 101' ' ' VAL . 6.4 p -137.74 114.11 11.39 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 CA-C-O 120.91 0.386 . . . . 0.0 111.198 -178.745 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -145.43 163.31 28.19 Favored Glycine 0 N--CA 1.443 -0.854 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 176.613 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 78.1 t80 -171.1 -79.49 0.01 OUTLIER 'General case' 0 CA--C 1.522 -0.11 0 CA-C-N 118.102 0.951 . . . . 0.0 111.263 179.113 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.404 ' HE3' ' HB2' ' A' ' 97' ' ' LYS . 13.0 ptmt -85.84 -16.25 39.27 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 112.316 0.487 . . . . 0.0 112.316 -176.692 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 23.0 t70 75.25 106.33 0.07 Allowed 'General case' 0 N--CA 1.471 0.578 0 O-C-N 124.304 1.003 . . . . 0.0 112.702 -175.08 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 66.0 m 172.45 -29.87 0.0 OUTLIER 'General case' 0 C--N 1.31 -1.121 0 C-N-CA 128.235 2.614 . . . . 0.0 105.872 -178.325 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 36.1 p -147.92 102.53 3.41 Favored 'General case' 0 N--CA 1.414 -2.27 0 CA-C-N 114.033 -1.44 . . . . 0.0 109.973 178.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.577 ' HA ' ' O ' ' A' ' 94' ' ' VAL . 11.6 p -123.22 119.64 58.17 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 N-CA-C 106.681 -1.599 . . . . 0.0 106.681 174.477 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.506 HD23 ' H ' ' A' ' 126' ' ' LYS . 59.1 mt -124.83 144.12 50.46 Favored 'General case' 0 C--N 1.282 -2.356 0 C-N-CA 120.03 -0.668 . . . . 0.0 110.688 -170.88 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.476 ' HD3' HD11 ' A' ' 91' ' ' ILE . 23.0 ttmm -121.28 104.96 10.11 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 179.551 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -89.92 101.83 14.53 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.767 -178.31 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 82.5 m -60.97 153.09 25.99 Favored 'General case' 0 C--N 1.306 -1.317 0 C-N-CA 124.46 1.104 . . . . 0.0 110.652 177.11 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.633 ' O ' ' HA ' ' A' ' 87' ' ' LEU . 88.4 m -71.65 -69.24 0.4 Allowed 'General case' 0 C--O 1.205 -1.242 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.302 -174.634 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.412 HG22 ' HB3' ' A' ' 87' ' ' LEU . 32.3 p -99.08 101.71 13.17 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 178.907 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.723 HG21 HG12 ' A' ' 123' ' ' ILE . 4.7 p -112.41 138.42 41.56 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.769 0 C-N-CA 119.27 -0.972 . . . . 0.0 111.751 -177.236 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.426 HG22 HG22 ' A' ' 85' ' ' THR . 76.4 p -94.29 153.07 18.21 Favored 'General case' 0 N--CA 1.413 -2.311 0 CA-C-N 115.344 -0.843 . . . . 0.0 109.666 -177.599 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.478 ' HA2' ' O ' ' A' ' 119' ' ' ASP . . . -169.8 167.92 40.92 Favored Glycine 0 N--CA 1.423 -2.201 0 C-N-CA 120.787 -0.72 . . . . 0.0 111.979 -179.381 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 9.6 t60 -92.97 108.65 20.17 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 178.31 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -91.52 125.42 36.25 Favored 'General case' 0 C--N 1.296 -1.718 0 CA-C-O 121.075 0.464 . . . . 0.0 110.363 -178.37 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.562 ' HG3' ' HG3' ' A' ' 116' ' ' LYS . 10.5 pt-20 -142.33 136.57 29.8 Favored 'General case' 0 N--CA 1.425 -1.675 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 171.133 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.493 ' HA ' ' OD2' ' A' ' 62' ' ' ASP . 2.3 tmtp? -52.08 117.82 3.04 Favored 'General case' 0 C--O 1.248 0.991 0 CA-C-O 121.726 0.775 . . . . 0.0 111.774 -169.599 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' GLY . . . . . 0.671 ' O ' ' HB ' ' A' ' 138' ' ' THR . . . 106.53 -28.47 13.32 Favored Glycine 0 N--CA 1.409 -3.126 0 CA-C-N 114.66 -1.155 . . . . 0.0 112.421 176.559 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.562 ' HG3' ' HG3' ' A' ' 113' ' ' GLU . 12.4 ptmm? -147.11 115.38 6.62 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-O 121.784 0.802 . . . . 0.0 111.676 -174.929 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 59.4 tp -93.55 103.57 15.74 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 106.656 -1.609 . . . . 0.0 106.656 177.856 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.411 HG21 ' NZ ' ' A' ' 116' ' ' LYS . 39.7 p -103.64 140.38 37.64 Favored 'General case' 0 N--CA 1.403 -2.801 0 N-CA-C 113.572 0.953 . . . . 0.0 113.572 -171.787 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' ASP . . . . . 0.478 ' O ' ' HA2' ' A' ' 110' ' ' GLY . 12.9 m-20 60.09 85.51 0.11 Allowed 'General case' 0 CA--C 1.493 -1.215 0 CA-C-N 114.611 -1.177 . . . . 0.0 113.788 -179.824 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.8 m -88.02 87.77 2.8 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.985 0 CA-C-N 115.038 -0.983 . . . . 0.0 109.327 174.848 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -68.51 93.89 0.53 Allowed 'General case' 0 N--CA 1.418 -2.066 0 CA-C-N 113.813 -1.539 . . . . 0.0 108.495 -177.434 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 137.84 -11.26 3.67 Favored Glycine 0 N--CA 1.418 -2.52 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.597 178.899 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.723 HG12 HG21 ' A' ' 108' ' ' VAL . 36.1 mm -96.64 112.46 28.8 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.176 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 178.779 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.413 ' HA ' ' HA ' ' A' ' 132' ' ' LYS . 46.6 mtpt -86.35 118.97 26.12 Favored 'General case' 0 N--CA 1.414 -2.253 0 CA-C-N 114.954 -1.021 . . . . 0.0 109.279 -177.282 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.419 HG23 HD22 ' A' ' 102' ' ' LEU . 86.5 m -122.9 130.66 53.12 Favored 'General case' 0 N--CA 1.407 -2.604 0 CA-C-N 114.159 -1.382 . . . . 0.0 110.604 -173.894 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.617 ' C ' ' HD3' ' A' ' 126' ' ' LYS . 0.3 OUTLIER -107.72 125.64 51.63 Favored 'General case' 0 N--CA 1.41 -2.454 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 173.705 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.638 HG23 ' H ' ' A' ' 128' ' ' MET . 4.0 m -119.29 -81.0 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.09 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.498 175.844 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' MET . . . . . 0.638 ' H ' HG23 ' A' ' 127' ' ' VAL . 1.1 tmt? -103.1 -20.2 14.26 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 106.277 -1.749 . . . . 0.0 106.277 171.722 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 1.1 pp -152.21 -176.41 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 C-N-CA 126.758 2.023 . . . . 0.0 108.564 -178.824 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 91.2 m95 -95.28 139.84 31.02 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.06 0.457 . . . . 0.0 111.567 178.585 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.57 HG12 ' H ' ' A' ' 133' ' ' VAL . 31.9 t -138.65 135.43 43.47 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.955 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 174.428 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 132' ' ' LYS . . . . . 0.593 ' H ' ' HD2' ' A' ' 132' ' ' LYS . 0.0 OUTLIER -93.03 13.31 21.16 Favored 'General case' 0 N--CA 1.487 1.403 0 CA-C-N 118.426 0.557 . . . . 0.0 111.024 -178.029 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.57 ' H ' HG12 ' A' ' 131' ' ' VAL . 5.5 p -166.43 96.31 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.31 -1.129 0 CA-C-O 122.364 1.078 . . . . 0.0 111.578 -172.539 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 134' ' ' THR . . . . . 0.413 ' O ' ' HA ' ' A' ' 119' ' ' ASP . 21.8 p -99.03 -172.8 2.35 Favored 'General case' 0 N--CA 1.404 -2.742 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.289 176.334 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 28.4 t -147.97 134.53 19.8 Favored 'General case' 0 C--N 1.282 -2.344 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 -173.569 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 60.9 mt -105.27 103.79 15.92 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.875 0 CA-C-O 121.197 0.522 . . . . 0.0 109.979 -178.415 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 56.3 p -96.54 110.8 23.13 Favored 'General case' 0 N--CA 1.428 -1.549 0 CA-C-O 121.233 0.54 . . . . 0.0 109.597 179.107 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' THR . . . . . 0.671 ' HB ' ' O ' ' A' ' 115' ' ' GLY . 75.5 m -128.44 159.65 34.74 Favored 'General case' 0 C--N 1.274 -2.694 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 -177.591 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -105.72 39.35 1.78 Allowed 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 109.786 -0.449 . . . . 0.0 109.786 175.576 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . 58.74 34.82 24.03 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 115.243 -0.89 . . . . 0.0 109.602 -177.152 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' SER . . . . . 0.452 ' H ' HG22 ' A' ' 138' ' ' THR . 33.5 t 179.45 -78.16 0.01 OUTLIER 'General case' 0 CA--C 1.547 0.859 0 CA-C-N 114.7 -1.137 . . . . 0.0 110.081 -174.634 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -80.67 134.97 35.95 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 110.152 -0.314 . . . . 0.0 110.152 179.392 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.413 ' CG2' HG22 ' A' ' 65' ' ' ILE . 20.3 t -110.22 140.19 30.32 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 N-CA-C 112.793 0.664 . . . . 0.0 112.793 -168.952 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -133.51 151.84 51.82 Favored 'General case' 0 CA--C 1.483 -1.605 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 170.013 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' PHE . . . . . 0.526 ' HB2' ' HB2' ' A' ' 151' ' ' LYS . 55.4 m-85 -113.11 99.58 7.94 Favored 'General case' 0 C--N 1.275 -2.659 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.744 179.297 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 16.8 p -84.81 85.72 7.43 Favored 'General case' 0 N--CA 1.408 -2.538 0 CA-C-N 115.133 -0.939 . . . . 0.0 110.97 177.747 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -113.03 70.52 0.72 Allowed 'General case' 0 N--CA 1.428 -1.559 0 N-CA-C 106.33 -1.73 . . . . 0.0 106.33 174.72 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 72.64 27.03 70.1 Favored Glycine 0 N--CA 1.439 -1.125 0 N-CA-C 108.619 -1.792 . . . . 0.0 108.619 -171.911 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 26.8 ttt 60.42 97.51 0.03 OUTLIER 'General case' 0 C--N 1.355 0.807 0 C-N-CA 124.621 1.169 . . . . 0.0 109.3 -171.714 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.19 -52.54 0.32 Allowed 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 114.9 1.444 . . . . 0.0 114.9 -174.766 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.526 ' HB2' ' HB2' ' A' ' 145' ' ' PHE . 35.2 mmtp -121.96 163.9 18.52 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 114.236 1.199 . . . . 0.0 114.236 -171.292 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 55.7 p -128.51 160.01 33.67 Favored 'General case' 0 N--CA 1.439 -0.977 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 175.362 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 14.6 tpp180 -154.96 132.84 11.49 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.132 0.491 . . . . 0.0 111.709 179.7 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 9.2 m -88.64 137.38 32.37 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 177.311 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 155' ' ' ARG . . . . . 0.677 ' O ' ' HD3' ' A' ' 155' ' ' ARG . 2.4 tmt_? -70.12 -22.25 63.03 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 110.282 -0.266 . . . . 0.0 110.282 -176.898 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -50.86 -25.25 4.29 Favored 'General case' 0 N--CA 1.5 2.052 0 C-N-CA 123.482 0.713 . . . . 0.0 112.552 177.882 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.59 ' HB1' ' HG2' ' A' ' 161' ' ' GLN . . . -76.42 4.01 9.93 Favored 'General case' 0 C--N 1.306 -1.286 0 C-N-CA 124.924 1.29 . . . . 0.0 113.393 -178.311 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 86.7 m-85 91.53 23.46 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.147 0 C-N-CA 126.186 1.794 . . . . 0.0 109.51 -175.489 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 159' ' ' GLY . . . . . 0.464 ' HA3' ' O ' ' A' ' 65' ' ' ILE . . . 101.64 -94.4 1.22 Allowed Glycine 0 N--CA 1.398 -3.867 0 N-CA-C 109.224 -1.551 . . . . 0.0 109.224 -175.458 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.553 HG23 ' HB ' ' A' ' 65' ' ' ILE . 79.7 t -128.92 113.74 30.09 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.337 0 CA-C-O 121.505 0.669 . . . . 0.0 111.029 -178.938 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 161' ' ' GLN . . . . . 0.59 ' HG2' ' HB1' ' A' ' 157' ' ' ALA 0.315 10.0 pt20 -110.52 92.87 4.21 Favored 'General case' 0 C--N 1.302 -1.472 0 C-N-CA 117.203 -1.799 . . . . 0.0 114.54 179.278 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 26.0 tpt180 -146.22 102.14 3.58 Favored 'General case' 0 C--N 1.274 -2.708 0 N-CA-C 101.789 -3.411 . . . . 0.0 101.789 168.454 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 47.8 m-80 -110.67 123.03 49.23 Favored 'General case' 0 C--N 1.292 -1.93 0 N-CA-C 113.453 0.909 . . . . 0.0 113.453 -169.722 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 164' ' ' GLY . . . . . 0.459 ' CA ' ' HB ' ' A' ' 94' ' ' VAL . . . -95.11 -169.5 36.35 Favored Glycine 0 N--CA 1.42 -2.422 0 N-CA-C 108.823 -1.711 . . . . 0.0 108.823 172.899 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.616 ' H ' HD23 ' A' ' 165' ' ' LEU . 1.9 pt? -91.37 112.0 23.72 Favored 'General case' 0 C--N 1.296 -1.736 0 C-N-CA 119.113 -1.035 . . . . 0.0 109.648 -178.948 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 166' ' ' ARG . . . . . 0.683 ' HG2' ' SG ' ' A' ' 92' ' ' CYS . 78.9 mtt85 -82.74 101.16 10.7 Favored 'General case' 0 CA--C 1.48 -1.738 0 N-CA-C 106.447 -1.686 . . . . 0.0 106.447 174.885 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.533 ' HB ' ' OG ' ' A' ' 90' ' ' SER . 52.4 t -68.59 -27.84 37.86 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.803 0 CA-C-N 114.942 -1.026 . . . . 0.0 112.25 -175.366 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 168' ' ' ASP . . . . . 0.42 ' HB2' ' HB2' ' A' ' 90' ' ' SER . 18.0 t70 -90.84 69.69 6.48 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-O 121.975 0.893 . . . . 0.0 110.432 -177.642 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 39.3 ttpt 177.92 130.54 0.06 Allowed 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 113.474 -1.694 . . . . 0.0 106.81 175.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 170' ' ' PHE . . . . . . . . . . . . . 64.0 m-85 . . . . . 0 C--N 1.288 -2.098 0 CA-C-O 119.148 -0.453 . . . . 0.0 110.302 -175.159 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 26.0 t . . . . . 0 N--CA 1.445 -0.719 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -118.05 97.54 5.86 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-O 121.27 0.557 . . . . 0.0 112.417 -177.548 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 93.9 mt-30 -122.75 113.72 19.57 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 174.083 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.423 ' N ' HD12 ' A' ' 4' ' ' ILE . 2.4 mp -85.22 110.76 19.79 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.936 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 -179.402 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 47.8 p90 -122.56 118.18 27.63 Favored 'General case' 0 N--CA 1.421 -1.878 0 CA-C-O 121.653 0.739 . . . . 0.0 110.646 179.647 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 63.4 t30 -105.09 19.67 20.19 Favored 'General case' 0 C--N 1.291 -1.96 0 N-CA-C 106.209 -1.774 . . . . 0.0 106.209 176.089 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -72.1 106.81 4.48 Favored 'General case' 0 N--CA 1.436 -1.143 0 CA-C-N 113.34 -1.755 . . . . 0.0 110.584 -178.474 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.7 p -149.73 100.94 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 CA-C-O 122.479 1.133 . . . . 0.0 111.695 178.724 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -109.64 27.21 12.59 Favored Glycine 0 N--CA 1.432 -1.577 0 CA-C-N 114.782 -1.099 . . . . 0.0 110.381 177.573 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 20.4 m -84.22 90.9 7.6 Favored 'General case' 0 N--CA 1.427 -1.598 0 CA-C-O 121.233 0.54 . . . . 0.0 110.402 -179.469 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -106.47 96.46 6.48 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 177.465 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 59.2 p-90 -80.78 147.15 30.63 Favored 'General case' 0 C--N 1.297 -1.694 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.357 -174.819 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.482 ' O ' HD12 ' A' ' 13' ' ' LEU . 1.9 pp -113.28 115.49 28.25 Favored 'General case' 0 C--N 1.29 -2.011 0 CA-C-O 121.753 0.787 . . . . 0.0 111.84 179.301 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -160.56 48.53 0.38 Allowed Glycine 0 N--CA 1.431 -1.683 0 N-CA-C 110.761 -0.936 . . . . 0.0 110.761 -179.259 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.22 131.01 48.84 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 -179.849 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 28.2 tptp -92.55 -28.42 16.77 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.648 -177.635 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 59.22 83.92 0.12 Allowed 'General case' 0 C--O 1.236 0.394 0 CA-C-O 122.024 0.916 . . . . 0.0 111.147 -178.445 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 42.0 t30 -139.52 102.7 4.53 Favored 'General case' 0 C--N 1.295 -1.791 0 CA-C-N 115.183 -0.917 . . . . 0.0 109.129 -178.25 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -147.24 124.01 11.21 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.399 -177.349 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -93.51 122.97 36.49 Favored 'General case' 0 N--CA 1.42 -1.948 0 N-CA-C 104.73 -2.322 . . . . 0.0 104.73 167.136 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 49.2 p90 -94.08 139.38 31.05 Favored 'General case' 0 C--N 1.289 -2.026 0 C-N-CA 119.626 -0.829 . . . . 0.0 111.21 -174.472 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -119.43 80.82 1.62 Allowed 'General case' 0 C--N 1.286 -2.158 0 CA-C-O 122.175 0.988 . . . . 0.0 110.154 176.156 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 20.2 m -148.67 87.73 1.58 Allowed 'General case' 0 N--CA 1.428 -1.546 0 CA-C-N 113.858 -1.519 . . . . 0.0 108.02 -179.8 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.401 HG12 ' N ' ' A' ' 25' ' ' GLY . 41.0 t -137.98 170.95 16.36 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.268 0 N-CA-C 105.973 -1.862 . . . . 0.0 105.973 -177.256 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.401 ' N ' HG12 ' A' ' 24' ' ' VAL . . . -51.54 119.9 9.15 Favored Glycine 0 C--O 1.245 0.824 0 N-CA-C 110.861 -0.896 . . . . 0.0 110.861 176.121 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 40.2 m-80 -61.29 143.59 55.4 Favored 'General case' 0 C--O 1.247 0.958 0 CA-C-O 120.954 0.406 . . . . 0.0 110.973 -177.075 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -78.82 84.61 4.87 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 122.031 0.919 . . . . 0.0 110.762 -179.683 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -169.29 -47.32 0.02 OUTLIER 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 104.711 -2.329 . . . . 0.0 104.711 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 41.0 m-80 64.48 90.46 0.09 Allowed 'General case' 0 CA--C 1.5 -0.952 0 CA-C-N 114.162 -1.381 . . . . 0.0 112.04 176.456 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 34.7 t -72.63 -65.87 0.73 Allowed 'General case' 0 N--CA 1.431 -1.418 0 N-CA-C 106.408 -1.701 . . . . 0.0 106.408 174.486 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 29.7 m 44.67 -171.92 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 N-CA-C 116.074 1.879 . . . . 0.0 116.074 172.102 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 27.1 t 70.5 16.65 6.98 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 114.533 -1.212 . . . . 0.0 110.618 176.217 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 40.2 p -72.04 -16.99 62.05 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 122.361 1.077 . . . . 0.0 110.1 -179.754 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.58 ' HB3' ' OE1' ' A' ' 79' ' ' GLU . 70.7 m -147.72 171.24 15.98 Favored 'General case' 0 N--CA 1.416 -2.155 0 N-CA-C 107.219 -1.4 . . . . 0.0 107.219 176.107 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 32.8 pt -94.59 -25.25 4.69 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.283 0 C-N-CA 120.475 -0.49 . . . . 0.0 111.075 -178.899 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 32.5 mm-40 68.92 177.1 0.27 Allowed 'General case' 0 C--O 1.239 0.552 0 C-N-CA 123.808 0.843 . . . . 0.0 112.555 178.68 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -74.14 107.65 2.31 Favored Glycine 0 N--CA 1.434 -1.492 0 N-CA-C 110.667 -0.973 . . . . 0.0 110.667 177.37 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -95.66 -2.29 61.55 Favored Glycine 0 N--CA 1.441 -0.994 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.169 -177.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.458 ' HB ' ' OE1' ' A' ' 76' ' ' GLU . 11.8 t -81.11 129.31 34.5 Favored 'General case' 0 N--CA 1.424 -1.742 0 CA-C-O 121.663 0.744 . . . . 0.0 111.081 -179.385 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -144.46 11.96 1.51 Allowed 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 115.11 -0.95 . . . . 0.0 109.876 177.193 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 41.0 t-105 66.92 91.7 0.08 Allowed 'General case' 0 C--O 1.243 0.741 0 C-N-CA 124.306 1.042 . . . . 0.0 112.319 -178.131 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 81.3 mt -90.29 110.3 21.36 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-N 114.751 -1.113 . . . . 0.0 108.701 177.189 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 59.6 t -72.75 -46.97 51.84 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.278 0 CA-C-N 115.738 -0.665 . . . . 0.0 109.572 179.167 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 78.4 m-20 67.14 83.55 0.17 Allowed 'General case' 0 CA--C 1.511 -0.522 0 CA-C-N 114.808 -1.087 . . . . 0.0 109.756 -177.404 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 20.5 ptmt -88.82 95.85 10.45 Favored 'General case' 0 C--N 1.297 -1.692 0 CA-C-N 115.093 -0.958 . . . . 0.0 111.876 -175.842 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 6.1 tp 179.82 -52.91 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.31 -1.119 0 CA-C-N 114.915 -1.038 . . . . 0.0 109.586 177.874 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt 65.46 94.69 0.06 Allowed 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 124.216 1.006 . . . . 0.0 109.76 -175.871 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -94.66 178.72 36.74 Favored Glycine 0 N--CA 1.426 -2.008 0 C-N-CA 120.351 -0.928 . . . . 0.0 111.041 -179.095 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -76.21 -25.45 55.12 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-O 121.299 0.571 . . . . 0.0 109.64 178.197 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 65.3 mtm -89.92 99.32 12.36 Favored 'General case' 0 N--CA 1.439 -0.985 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 175.759 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 62.3 tt0 -106.63 -37.74 6.35 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.469 -177.713 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 66.6 mttm 73.88 148.38 0.12 Allowed Pre-proline 0 CA--C 1.551 1.001 0 C-N-CA 124.507 1.123 . . . . 0.0 110.281 -177.484 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -71.76 37.35 0.33 Allowed 'Trans proline' 0 N--CA 1.496 1.647 0 C-N-CA 123.568 2.845 . . . . 0.0 113.34 -177.82 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.471 ' O ' ' HG ' ' A' ' 58' ' ' LEU . 18.4 mt -71.29 -48.44 12.96 Favored Pre-proline 0 C--N 1.291 -1.971 0 CA-C-O 119.087 -0.482 . . . . 0.0 111.597 -177.088 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.514 ' HA ' ' CD1' ' A' ' 58' ' ' LEU . 38.6 Cg_exo -58.59 -38.47 89.41 Favored 'Trans proline' 0 C--N 1.384 2.409 0 C-N-CA 121.209 1.273 . . . . 0.0 113.572 -172.059 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.406 ' O ' ' HG3' ' A' ' 59' ' ' LYS . 11.0 pt-20 -70.13 -30.13 67.24 Favored 'General case' 0 C--O 1.214 -0.765 0 CA-C-O 120.826 0.346 . . . . 0.0 110.815 178.317 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 62.4 tp -69.66 -33.38 72.51 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.371 177.818 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.514 ' CD1' ' HA ' ' A' ' 55' ' ' PRO . 6.3 mt -65.58 -52.59 51.08 Favored 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 -179.042 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.462 ' O ' ' HA ' ' A' ' 64' ' ' PRO . 15.3 ptpt -63.04 -24.04 67.73 Favored 'General case' 0 C--O 1.187 -2.213 0 CA-C-N 114.897 -1.047 . . . . 0.0 113.296 177.149 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -82.53 -54.77 4.92 Favored 'General case' 0 C--N 1.292 -1.898 0 O-C-N 121.848 -0.533 . . . . 0.0 112.283 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 54.0 t80 -56.96 -31.26 64.83 Favored 'General case' 0 C--O 1.245 0.827 0 C-N-CA 124.287 1.035 . . . . 0.0 110.68 -173.719 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.624 ' OD1' ' HB3' ' A' ' 75' ' ' TYR . 3.4 m-20 -108.56 25.69 11.4 Favored 'General case' 0 C--N 1.283 -2.32 0 CA-C-N 114.19 -1.368 . . . . 0.0 111.681 -172.312 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.641 HD21 ' H ' ' A' ' 115' ' ' GLY . 34.5 mt 80.91 143.33 0.08 OUTLIER Pre-proline 0 N--CA 1.477 0.89 0 C-N-CA 125.056 1.342 . . . . 0.0 108.936 -178.408 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.462 ' HA ' ' O ' ' A' ' 59' ' ' LYS . 10.2 Cg_endo -84.2 21.5 1.06 Allowed 'Trans proline' 0 N--CA 1.439 -1.733 0 C-N-CA 122.837 2.358 . . . . 0.0 113.239 -161.797 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.596 ' O ' ' HA3' ' A' ' 159' ' ' GLY . 0.2 OUTLIER -72.93 -38.13 55.7 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.913 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 175.338 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 55.07 8.64 1.57 Allowed Glycine 0 N--CA 1.473 1.106 0 CA-C-N 114.988 -1.005 . . . . 0.0 114.329 178.099 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.749 ' O ' ' HB ' ' A' ' 160' ' ' VAL . 37.9 mt 70.77 -31.93 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 C-N-CA 125.578 1.551 . . . . 0.0 113.911 -179.132 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.525 ' HB2' ' O ' ' A' ' 67' ' ' ILE . 55.6 t80 167.04 -56.89 0.0 OUTLIER Pre-proline 0 C--N 1.312 -1.046 0 C-N-CA 124.743 1.217 . . . . 0.0 108.936 175.958 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.476 ' HD3' ' HB3' ' A' ' 68' ' ' PHE . 19.3 Cg_endo -110.4 -16.73 0.03 OUTLIER 'Trans proline' 0 CA--C 1.569 2.225 0 C-N-CA 122.777 2.318 . . . . 0.0 116.877 -171.701 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.474 ' H ' ' HD2' ' A' ' 69' ' ' PRO . . . 84.09 7.19 85.66 Favored Glycine 0 CA--C 1.533 1.161 0 C-N-CA 119.732 -1.223 . . . . 0.0 110.395 -171.155 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.465 ' HB3' ' HG2' ' A' ' 69' ' ' PRO . 30.0 t70 -82.36 -50.62 8.71 Favored 'General case' 0 CA--C 1.497 -1.086 0 N-CA-C 106.314 -1.735 . . . . 0.0 106.314 177.395 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.42 ' HB1' HG13 ' A' ' 88' ' ' ILE . . . -83.03 176.73 9.02 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 113.732 -1.577 . . . . 0.0 107.48 166.049 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.561 ' O ' HG22 ' A' ' 73' ' ' THR . 89.4 m 82.0 27.86 0.15 Allowed 'General case' 0 N--CA 1.492 1.633 0 CA-C-O 124.363 2.03 . . . . 0.0 109.8 176.818 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.582 ' O ' ' HA ' ' A' ' 86' ' ' VAL . 3.5 m-20 -87.84 123.53 32.71 Favored 'General case' 0 C--N 1.257 -3.447 0 CA-C-N 114.417 -1.265 . . . . 0.0 110.464 179.434 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.624 ' HB3' ' OD1' ' A' ' 62' ' ' ASP . 46.2 p90 -82.17 141.53 32.97 Favored 'General case' 0 C--N 1.295 -1.771 0 O-C-N 124.243 0.964 . . . . 0.0 112.506 -178.639 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.458 ' OE1' ' HB ' ' A' ' 39' ' ' THR . 32.0 mm-40 -159.39 136.84 9.88 Favored 'General case' 0 C--O 1.203 -1.347 0 C-N-CA 126.537 1.935 . . . . 0.0 107.266 174.409 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 49.9 p90 -134.7 148.32 50.28 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 118.538 0.608 . . . . 0.0 110.995 -177.163 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.619 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 4.6 m-20 -89.39 169.88 11.02 Favored 'General case' 0 CA--C 1.478 -1.827 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 177.477 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.58 ' OE1' ' HB3' ' A' ' 34' ' ' SER . 44.7 mt-10 -81.41 -62.07 1.76 Allowed 'General case' 0 C--N 1.267 -3.013 0 CA-C-N 114.426 -1.261 . . . . 0.0 111.337 177.912 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.32 -33.59 49.17 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 115.398 -0.819 . . . . 0.0 112.502 -176.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.619 ' HB ' ' HB2' ' A' ' 78' ' ' ASP . 90.1 m -81.46 -47.6 12.97 Favored 'General case' 0 C--N 1.288 -2.093 0 CA-C-N 115.192 -0.913 . . . . 0.0 111.844 178.919 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.401 ' H ' ' HB2' ' A' ' 78' ' ' ASP . 65.5 mttp 61.73 -5.55 0.14 Allowed 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 115.345 1.609 . . . . 0.0 115.345 -179.238 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.775 ' HG2' HG22 ' A' ' 109' ' ' THR . 32.6 ttmt -75.2 110.22 9.35 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 173.071 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.543 HD11 ' HB2' ' A' ' 75' ' ' TYR . 5.8 tt -66.23 134.02 51.82 Favored 'General case' 0 C--N 1.299 -1.6 0 CA-C-N 114.756 -1.111 . . . . 0.0 111.41 -174.067 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 15.0 t -108.02 126.93 53.31 Favored 'General case' 0 N--CA 1.397 -3.093 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.238 -179.288 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.582 ' HA ' ' O ' ' A' ' 74' ' ' ASN . 79.0 t -96.9 132.24 41.8 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.672 -179.359 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.9 mp -95.4 114.63 26.42 Favored 'General case' 0 N--CA 1.423 -1.787 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.721 -179.444 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.42 HG13 ' HB1' ' A' ' 72' ' ' ALA . 2.4 mp -104.83 110.27 64.22 Favored Pre-proline 0 C--N 1.299 -1.616 0 N-CA-C 105.77 -1.937 . . . . 0.0 105.77 171.991 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.625 ' O ' ' HB2' ' A' ' 166' ' ' ARG . 51.8 Cg_exo -56.17 94.07 0.05 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.498 0 C-N-CA 122.782 2.321 . . . . 0.0 112.215 178.164 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.491 ' HB2' ' HB2' ' A' ' 168' ' ' ASP . 40.9 t 74.95 141.53 0.07 Allowed 'General case' 0 C--N 1.343 0.323 0 C-N-CA 125.217 1.407 . . . . 0.0 111.813 -176.777 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.419 HD11 ' HD2' ' A' ' 103' ' ' LYS . 4.5 tt -69.08 121.35 18.27 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.504 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.894 177.94 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 12.7 p -107.58 145.16 33.59 Favored 'General case' 0 C--N 1.298 -1.657 0 CA-C-N 114.524 -1.216 . . . . 0.0 109.634 176.511 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.475 ' O ' ' HA3' ' A' ' 164' ' ' GLY . 2.2 mp0 -118.1 132.65 56.33 Favored 'General case' 0 CA--C 1.471 -2.087 0 N-CA-C 105.969 -1.863 . . . . 0.0 105.969 178.585 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.661 HG13 ' H ' ' A' ' 163' ' ' ASN . 16.7 t -108.8 104.19 16.69 Favored 'Isoleucine or valine' 0 N--CA 1.398 -3.046 0 C-N-CA 119.366 -0.934 . . . . 0.0 109.132 -178.628 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -138.45 -157.79 7.53 Favored Glycine 0 N--CA 1.404 -3.477 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 -179.102 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 0.44 ' C ' ' H ' ' A' ' 98' ' ' ASP . 72.4 t80 76.22 -44.38 0.49 Allowed 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 124.57 1.148 . . . . 0.0 110.293 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.496 ' HB2' ' NZ ' ' A' ' 97' ' ' LYS . 0.0 OUTLIER -72.48 11.03 0.68 Allowed 'General case' 0 C--N 1.31 -1.147 0 C-N-CA 127.003 2.121 . . . . 0.0 111.292 177.298 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.44 ' H ' ' C ' ' A' ' 96' ' ' TYR . 25.1 t70 -36.42 90.46 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 117.397 2.369 . . . . 0.0 117.397 -169.563 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 31.4 t -152.26 10.53 0.52 Allowed 'General case' 0 C--N 1.281 -2.391 0 N-CA-C 103.024 -2.954 . . . . 0.0 103.024 169.405 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' SER . . . . . 0.44 ' HA ' ' O ' ' A' ' 126' ' ' LYS . 46.4 t 170.6 139.97 0.03 OUTLIER 'General case' 0 N--CA 1.419 -2.01 0 C-N-CA 127.528 2.331 . . . . 0.0 104.816 -174.394 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 54.3 t -126.03 131.21 71.97 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 179.68 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.539 ' HB2' ' HB ' ' A' ' 94' ' ' VAL . 2.7 mp -126.81 148.42 49.95 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 118.145 0.429 . . . . 0.0 110.126 -177.61 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.419 ' HD2' HD11 ' A' ' 91' ' ' ILE . 39.5 ttpt -138.67 123.73 19.01 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 174.811 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -120.77 108.05 13.49 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 178.755 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 12.4 t -81.47 -177.35 6.47 Favored 'General case' 0 N--CA 1.432 -1.339 0 CA-C-O 121.133 0.492 . . . . 0.0 111.266 -178.431 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 39.4 p -66.07 -58.71 4.87 Favored 'General case' 0 C--N 1.301 -1.538 0 C-N-CA 124.833 1.253 . . . . 0.0 112.595 -172.376 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 6.4 m -122.54 97.32 5.4 Favored 'General case' 0 N--CA 1.41 -2.455 0 CA-C-O 121.535 0.683 . . . . 0.0 109.866 -175.571 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 18.1 m -99.02 141.11 17.09 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 CA-C-N 114.978 -1.01 . . . . 0.0 109.545 179.301 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.775 HG22 ' HG2' ' A' ' 83' ' ' LYS . 2.9 m -114.62 119.91 38.36 Favored 'General case' 0 N--CA 1.403 -2.783 0 N-CA-C 104.748 -2.316 . . . . 0.0 104.748 -174.336 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.734 ' HA2' ' O ' ' A' ' 119' ' ' ASP . . . -141.74 159.56 26.9 Favored Glycine 0 N--CA 1.435 -1.38 0 C-N-CA 120.037 -1.078 . . . . 0.0 115.169 -174.258 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 6.8 t60 -88.06 109.28 19.73 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 177.878 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 65.3 tp -106.96 120.99 43.55 Favored 'General case' 0 C--N 1.302 -1.461 0 C-N-CA 119.885 -0.726 . . . . 0.0 112.458 -175.099 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -115.1 158.05 22.71 Favored 'General case' 0 CA--C 1.448 -2.971 0 N-CA-C 107.505 -1.294 . . . . 0.0 107.505 169.633 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 2.4 tmtm? -82.25 99.12 9.12 Favored 'General case' 2 N--CA 1.375 -4.202 0 N-CA-C 107.135 -1.432 . . . . 0.0 107.135 -175.854 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' GLY . . . . . 0.641 ' H ' HD21 ' A' ' 63' ' ' LEU . . . 131.28 -20.24 4.74 Favored Glycine 0 C--O 1.19 -2.631 0 N-CA-C 109.978 -1.249 . . . . 0.0 109.978 -177.257 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -163.23 135.8 5.38 Favored 'General case' 0 C--N 1.314 -0.953 0 O-C-N 122.109 -0.642 . . . . 0.0 110.864 -177.848 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 3.1 tt -116.8 114.54 24.08 Favored 'General case' 0 C--N 1.286 -2.168 0 N-CA-C 106.246 -1.761 . . . . 0.0 106.246 178.002 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.452 ' HA ' ' CB ' ' A' ' 135' ' ' SER . 49.9 p -116.52 175.77 5.41 Favored 'General case' 0 C--N 1.279 -2.48 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.424 -176.016 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' ASP . . . . . 0.734 ' O ' ' HA2' ' A' ' 110' ' ' GLY . 7.0 m-20 54.91 83.84 0.08 Allowed 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.629 0.772 . . . . 0.0 111.2 174.85 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.431 ' CG2' ' HB ' ' A' ' 123' ' ' ILE . 13.6 m -119.3 108.47 23.86 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.8 0 CA-C-O 122.303 1.049 . . . . 0.0 112.321 -172.469 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -79.9 100.24 7.95 Favored 'General case' 0 C--N 1.268 -2.943 0 CA-C-N 114.331 -1.304 . . . . 0.0 110.204 174.8 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 123.94 -14.08 8.01 Favored Glycine 0 N--CA 1.435 -1.428 0 C-N-CA 120.722 -0.751 . . . . 0.0 113.161 176.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.431 ' HB ' ' CG2' ' A' ' 120' ' ' VAL . 63.5 mt -102.46 116.09 45.53 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.914 0 CA-C-O 121.536 0.684 . . . . 0.0 110.116 179.555 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -124.21 141.23 52.24 Favored 'General case' 0 C--N 1.294 -1.847 0 CA-C-N 114.795 -1.093 . . . . 0.0 109.053 178.474 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.433 ' OG1' ' HG ' ' A' ' 102' ' ' LEU . 11.1 t -152.48 162.67 40.88 Favored 'General case' 0 C--O 1.245 0.847 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 178.495 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.454 ' HE2' ' N ' ' A' ' 128' ' ' MET . 8.3 tmtt? -131.18 129.59 41.91 Favored 'General case' 0 N--CA 1.426 -1.635 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.656 176.261 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.408 ' O ' ' HB3' ' A' ' 128' ' ' MET . 41.8 t -150.02 112.81 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.481 -1.699 0 N-CA-C 104.31 -2.478 . . . . 0.0 104.31 172.764 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 128' ' ' MET . . . . . 0.454 ' N ' ' HE2' ' A' ' 126' ' ' LYS . 45.9 ttm 69.48 -54.95 0.58 Allowed 'General case' 0 N--CA 1.473 0.696 0 O-C-N 124.031 0.832 . . . . 0.0 109.978 -172.054 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 8.0 tp -139.18 162.89 27.21 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.716 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 178.38 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 69.5 p-90 -92.67 137.72 32.12 Favored 'General case' 0 N--CA 1.423 -1.823 0 CA-C-O 121.064 0.459 . . . . 0.0 110.861 -178.81 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 53.4 t -134.31 121.83 38.38 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.154 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 179.343 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 60.1 pttt -98.29 3.16 48.73 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.157 0.503 . . . . 0.0 111.955 -176.867 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 34.4 m -124.22 25.02 3.47 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.204 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 176.545 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 9.4 t -55.24 113.24 1.31 Allowed 'General case' 0 N--CA 1.441 -0.906 0 CA-C-N 113.258 -1.792 . . . . 0.0 113.249 -173.178 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' SER . . . . . 0.46 ' O ' ' HA ' ' A' ' 146' ' ' THR . 26.3 p -100.1 149.94 22.99 Favored 'General case' 0 N--CA 1.405 -2.72 0 C-N-CA 119.72 -0.792 . . . . 0.0 113.033 -177.38 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 136' ' ' ILE . . . . . 0.527 ' HB ' HG22 ' A' ' 146' ' ' THR . 13.2 tt -100.9 138.46 25.05 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.71 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 -179.109 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 14.7 t -120.55 142.71 49.09 Favored 'General case' 0 N--CA 1.408 -2.567 0 N-CA-C 107.052 -1.462 . . . . 0.0 107.052 -178.479 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' THR . . . . . 0.453 ' HB ' HD13 ' A' ' 63' ' ' LEU . 33.2 m -149.02 175.5 11.25 Favored 'General case' 0 C--N 1.27 -2.882 0 N-CA-C 106.523 -1.658 . . . . 0.0 106.523 -176.768 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -118.05 30.45 7.23 Favored 'General case' 0 C--N 1.277 -2.583 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 174.802 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.499 ' HA ' HD22 ' A' ' 63' ' ' LEU . . . 60.26 36.56 20.75 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-N 114.745 -1.116 . . . . 0.0 110.145 -177.045 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 141' ' ' SER . . . . . 0.407 ' H ' HG22 ' A' ' 138' ' ' THR . 41.4 t 174.38 -82.68 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 114.283 -1.326 . . . . 0.0 108.353 -172.607 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 23.0 pttm -77.56 136.79 38.32 Favored 'General case' 0 CA--C 1.505 -0.758 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 177.62 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.409 HG21 HG21 ' A' ' 65' ' ' ILE . 12.4 p -109.95 156.58 10.79 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.889 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 -171.23 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -128.98 154.16 46.86 Favored 'General case' 0 N--CA 1.428 -1.539 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 174.613 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 33.9 t80 -73.96 162.92 28.55 Favored 'General case' 0 C--N 1.309 -1.152 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 -175.836 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.527 HG22 ' HB ' ' A' ' 136' ' ' ILE . 70.9 p -71.7 -172.73 0.85 Allowed 'General case' 0 N--CA 1.42 -1.966 0 CA-C-O 121.512 0.672 . . . . 0.0 112.609 -175.358 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . 74.78 -29.54 0.19 Allowed 'General case' 0 N--CA 1.463 0.192 0 C-N-CA 126.018 1.727 . . . . 0.0 113.317 177.267 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 147.74 43.63 0.03 OUTLIER Glycine 0 CA--C 1.477 -2.319 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 178.008 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 65.3 mtt 60.96 40.14 15.76 Favored 'General case' 0 C--N 1.344 0.369 0 O-C-N 124.196 0.586 . . . . 0.0 110.224 -177.409 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' LYS . . . . . 0.6 ' HE2' ' HA ' ' A' ' 150' ' ' LYS . 9.5 mmpt? -65.53 -16.76 64.0 Favored 'General case' 0 N--CA 1.483 1.199 0 CA-C-O 120.816 0.341 . . . . 0.0 111.415 -178.766 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.543 ' HA ' ' HE3' ' A' ' 151' ' ' LYS . 0.0 OUTLIER -147.27 163.43 36.42 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 176.962 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 9.0 p -131.34 111.65 12.04 Favored 'General case' 0 C--N 1.292 -1.904 0 CA-C-O 121.391 0.615 . . . . 0.0 110.483 176.502 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 33.5 mmt180 -113.87 160.51 18.68 Favored 'General case' 0 CA--C 1.501 -0.914 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.001 -179.085 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 51.2 m -96.05 140.49 30.7 Favored 'General case' 0 N--CA 1.42 -1.93 0 CA-C-N 116.253 -0.43 . . . . 0.0 109.905 177.068 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' ARG . . . . . 0.574 ' HG3' ' HA2' ' A' ' 159' ' ' GLY . 9.0 ttp180 -74.99 -21.2 59.28 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.051 175.625 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -34.92 -49.6 0.45 Allowed 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 126.315 1.846 . . . . 0.0 114.806 -174.144 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -77.44 -55.37 5.45 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 113.635 0.976 . . . . 0.0 113.635 -176.198 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -153.52 16.02 0.52 Allowed 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.981 -0.449 . . . . 0.0 111.836 -176.01 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 159' ' ' GLY . . . . . 0.596 ' HA3' ' O ' ' A' ' 65' ' ' ILE . . . 84.88 -89.35 1.6 Allowed Glycine 0 CA--C 1.466 -2.989 0 C-N-CA 119.646 -1.264 . . . . 0.0 110.735 -174.501 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.749 ' HB ' ' O ' ' A' ' 67' ' ' ILE . 39.1 t -99.6 148.5 6.39 Favored 'Isoleucine or valine' 0 N--CA 1.4 -2.931 0 C-N-CA 119.491 -0.884 . . . . 0.0 109.102 177.575 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 74.8 mt-30 -113.74 108.98 17.84 Favored 'General case' 0 N--CA 1.416 -2.158 0 N-CA-C 106.393 -1.706 . . . . 0.0 106.393 -172.082 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 162' ' ' ARG . . . . . 0.537 ' HD2' ' C ' ' A' ' 162' ' ' ARG . 5.2 ppt_? -125.9 163.15 23.57 Favored 'General case' 0 C--N 1.275 -2.668 0 CA-C-N 115.167 -0.924 . . . . 0.0 112.919 -169.76 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 163' ' ' ASN . . . . . 0.661 ' H ' HG13 ' A' ' 94' ' ' VAL . 3.1 m-20 -110.4 -59.65 1.91 Allowed 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.875 175.903 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 164' ' ' GLY . . . . . 0.503 ' O ' ' HD3' ' A' ' 162' ' ' ARG . . . -61.0 147.38 47.03 Favored Glycine 0 CA--C 1.501 -0.782 0 CA-C-N 115.877 -0.601 . . . . 0.0 113.033 -179.635 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 65.6 tp -107.83 139.23 42.73 Favored 'General case' 0 N--CA 1.422 -1.827 0 CA-C-O 121.169 0.509 . . . . 0.0 109.851 -177.898 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 166' ' ' ARG . . . . . 0.625 ' HB2' ' O ' ' A' ' 89' ' ' PRO . 6.5 ptp85 -85.84 103.49 14.64 Favored 'General case' 0 C--N 1.287 -2.146 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 176.471 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 4.8 t -102.9 70.98 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.788 0 CA-C-N 115.184 -0.916 . . . . 0.0 112.46 -170.52 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 168' ' ' ASP . . . . . 0.491 ' HB2' ' HB2' ' A' ' 90' ' ' SER . 15.8 t70 -109.14 -39.2 5.33 Favored 'General case' 0 CA--C 1.475 -1.918 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 175.304 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 169' ' ' LYS . . . . . 0.645 ' HD3' ' H ' ' A' ' 169' ' ' LYS . 0.0 OUTLIER -93.1 149.65 21.08 Favored 'General case' 0 C--N 1.287 -2.128 0 CA-C-N 113.48 -1.691 . . . . 0.0 109.634 -174.146 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 170' ' ' PHE . . . . . . . . . . . . . 81.6 t80 . . . . . 0 C--N 1.288 -2.082 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 179.719 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 25.2 p . . . . . 0 N--CA 1.442 -0.844 0 CA-C-O 121.279 0.562 . . . . 0.0 111.095 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -133.7 103.92 6.1 Favored 'General case' 0 CA--C 1.498 -1.056 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 179.238 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -82.99 86.48 6.98 Favored 'General case' 0 C--N 1.309 -1.166 0 C-N-CA 118.575 -1.25 . . . . 0.0 112.223 179.62 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 8.1 tt -140.21 95.74 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.149 0 CA-C-N 113.734 -1.575 . . . . 0.0 106.757 176.171 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 62.9 t80 -142.49 139.6 31.58 Favored 'General case' 0 C--N 1.299 -1.629 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.167 -173.658 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -146.91 154.99 41.95 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 178.4 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -120.79 132.53 55.08 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 176.005 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.5 p -122.39 103.14 12.9 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.721 0 CA-C-O 121.906 0.86 . . . . 0.0 112.9 -175.851 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -114.9 109.39 2.11 Favored Glycine 0 N--CA 1.427 -1.905 0 N-CA-C 109.309 -1.516 . . . . 0.0 109.309 175.383 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 48.5 m -83.31 128.18 34.28 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-O 120.888 0.375 . . . . 0.0 111.1 -177.473 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -130.44 104.57 7.32 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 177.182 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 37.6 p90 -116.51 149.87 38.86 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 -178.541 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 5.3 tt 179.99 -50.64 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 -179.684 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 105.67 42.79 1.65 Allowed Glycine 0 N--CA 1.436 -1.358 0 CA-C-N 115.384 -0.825 . . . . 0.0 111.588 -179.75 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 47.2 mt-30 -79.98 154.92 27.91 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-O 120.59 0.233 . . . . 0.0 110.607 -179.695 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 95.5 mttt 65.83 -176.73 0.18 Allowed 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 124.122 0.969 . . . . 0.0 111.835 178.908 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 62.65 26.96 15.95 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.557 0.743 . . . . 0.0 111.222 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 52.6 m-80 -86.75 -171.7 3.65 Favored 'General case' 0 C--O 1.244 0.812 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.642 -178.553 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.6 tmmm? -69.49 108.17 3.67 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 179.572 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -108.65 109.24 20.38 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 84.0 t80 -154.22 117.81 4.62 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 -179.093 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -94.95 -69.47 0.75 Allowed 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 176.23 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 34.2 t -168.58 151.92 5.48 Favored 'General case' 0 N--CA 1.442 -0.841 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 179.741 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 17.4 m -98.53 90.97 2.24 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.913 0 CA-C-O 121.78 0.8 . . . . 0.0 112.18 178.04 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -115.96 84.87 0.38 Allowed Glycine 0 N--CA 1.436 -1.309 0 N-CA-C 110.409 -1.076 . . . . 0.0 110.409 178.249 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -145.16 111.91 5.87 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-O 120.89 0.376 . . . . 0.0 110.376 -178.239 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -129.33 143.53 50.88 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 115.467 -0.788 . . . . 0.0 108.928 -178.916 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 50.8 tp -88.77 145.53 25.55 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-O 120.806 0.336 . . . . 0.0 110.399 -177.681 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 28.2 p-10 -93.26 179.79 5.31 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.388 179.411 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 21.1 m 72.12 175.45 0.28 Allowed 'General case' 0 C--O 1.248 1.018 0 C-N-CA 124.667 1.187 . . . . 0.0 111.137 -179.476 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 23.8 m -86.77 83.36 2.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-O 122.407 1.099 . . . . 0.0 113.115 -177.098 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 49.9 m -157.62 138.73 13.45 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 177.25 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 39.4 p -79.1 110.96 14.84 Favored 'General case' 0 C--N 1.308 -1.212 0 C-N-CA 120.939 -0.304 . . . . 0.0 111.054 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 24.6 t -160.25 92.53 0.99 Allowed 'General case' 0 N--CA 1.435 -1.2 0 CA-C-O 121.475 0.655 . . . . 0.0 110.874 179.321 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 54.9 mt 56.66 84.33 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.241 0.64 0 C-N-CA 126.025 1.73 . . . . 0.0 114.311 176.463 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.513 ' O ' ' HA ' ' A' ' 97' ' ' LYS . 0.4 OUTLIER -176.29 112.62 0.11 Allowed 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 106.272 -1.751 . . . . 0.0 106.272 175.733 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -109.89 39.24 2.97 Favored Glycine 0 C--O 1.215 -1.041 0 C-N-CA 120.376 -0.916 . . . . 0.0 113.915 -176.302 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 84.2 0.5 89.54 Favored Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 120.565 -0.826 . . . . 0.0 112.139 177.847 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 23.8 m 58.65 90.54 0.05 OUTLIER 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 124.912 1.285 . . . . 0.0 112.471 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.427 ' NZ ' ' HB3' ' A' ' 40' ' ' LYS . 0.0 OUTLIER -169.81 136.51 1.57 Allowed 'General case' 0 CA--C 1.508 -0.66 0 CA-C-O 120.941 0.401 . . . . 0.0 110.116 174.179 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 28.3 m-90 -108.52 95.4 5.63 Favored 'General case' 0 C--N 1.287 -2.134 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 175.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 48.0 tp -74.35 95.93 2.76 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-N 115.189 -0.914 . . . . 0.0 111.904 -174.563 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 6.5 p -103.01 84.73 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.421 -1.887 0 CA-C-O 122.719 1.247 . . . . 0.0 109.069 175.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -141.32 102.25 4.18 Favored 'General case' 0 C--N 1.295 -1.776 0 CA-C-N 114.298 -1.319 . . . . 0.0 108.698 -178.799 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 63.0 pttt -117.42 129.61 55.96 Favored 'General case' 0 C--N 1.292 -1.891 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 179.204 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.422 HD12 ' N ' ' A' ' 46' ' ' ILE . 2.8 mp -81.72 -56.14 6.69 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.05 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 179.372 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 23.1 tptm 46.37 83.11 0.03 OUTLIER 'General case' 0 C--O 1.245 0.864 0 O-C-N 124.966 1.416 . . . . 0.0 110.551 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -63.62 141.72 45.92 Favored Glycine 0 N--CA 1.444 -0.779 0 CA-C-N 115.157 -0.929 . . . . 0.0 114.237 -173.275 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -112.39 157.13 21.41 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 177.533 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 28.0 ttt 66.19 16.11 10.33 Favored 'General case' 0 N--CA 1.482 1.174 0 CA-C-O 122.5 1.143 . . . . 0.0 110.497 177.655 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -109.05 170.43 8.06 Favored 'General case' 0 N--CA 1.432 -1.336 0 CA-C-N 115.107 -0.952 . . . . 0.0 109.166 178.097 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.504 ' O ' ' HD2' ' A' ' 55' ' ' PRO . 59.6 tptt -64.46 123.96 84.45 Favored Pre-proline 0 N--CA 1.435 -1.221 0 N-CA-C 106.021 -1.844 . . . . 0.0 106.021 174.342 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -77.86 18.1 0.91 Allowed 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 122.162 1.908 . . . . 0.0 113.823 -175.592 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.645 ' HB3' ' HD3' ' A' ' 55' ' ' PRO . 10.5 tp -72.36 -56.7 3.98 Favored Pre-proline 0 C--O 1.203 -1.349 0 C-N-CA 120.367 -0.533 . . . . 0.0 110.213 -179.363 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.645 ' HD3' ' HB3' ' A' ' 54' ' ' LEU . 8.1 Cg_exo -50.73 -38.2 55.81 Favored 'Trans proline' 0 C--N 1.388 2.608 0 C-N-CA 123.536 2.824 . . . . 0.0 112.671 -177.444 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -76.95 -31.84 56.88 Favored 'General case' 0 N--CA 1.432 -1.365 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.069 -179.299 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.564 ' HG ' ' O ' ' A' ' 54' ' ' LEU . 2.0 pp -75.74 -28.67 58.59 Favored 'General case' 0 C--O 1.204 -1.293 0 C-N-CA 119.669 -0.812 . . . . 0.0 108.984 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.639 ' HG ' ' O ' ' A' ' 54' ' ' LEU . 63.0 mt -57.34 -48.76 78.14 Favored 'General case' 0 C--O 1.199 -1.571 0 O-C-N 123.938 0.774 . . . . 0.0 110.809 -177.123 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 55.2 mtpt -64.88 -29.53 70.49 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-O 121.846 0.832 . . . . 0.0 110.627 -177.68 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -96.71 1.71 51.25 Favored 'General case' 0 C--N 1.297 -1.686 0 CA-C-N 114.692 -1.14 . . . . 0.0 111.424 -178.214 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.437 ' HB3' ' CD2' ' A' ' 75' ' ' TYR . 41.2 t80 -57.15 -42.88 81.86 Favored 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 112.776 0.658 . . . . 0.0 112.776 -170.542 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.566 ' OD1' ' HA ' ' A' ' 114' ' ' LYS . 11.2 t70 -139.67 -74.56 0.36 Allowed 'General case' 0 C--N 1.315 -0.916 0 C-N-CA 120.031 -0.667 . . . . 0.0 109.989 -177.41 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.559 HD21 ' H ' ' A' ' 115' ' ' GLY . 20.3 mt -96.29 150.17 36.82 Favored Pre-proline 0 N--CA 1.445 -0.719 0 N-CA-C 106.23 -1.767 . . . . 0.0 106.23 175.489 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_endo -99.9 18.22 0.35 Allowed 'Trans proline' 0 N--CA 1.443 -1.497 0 C-N-CA 123.77 2.98 . . . . 0.0 113.539 -169.391 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.517 ' HB ' HG23 ' A' ' 160' ' ' VAL . 0.2 OUTLIER -69.78 -45.01 78.6 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.872 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 176.743 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 52.83 9.53 0.8 Allowed Glycine 0 N--CA 1.486 2.011 0 CA-C-N 114.908 -1.042 . . . . 0.0 114.266 178.401 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.667 ' HA ' ' CG2' ' A' ' 160' ' ' VAL 0.288 20.2 mt 62.17 -68.37 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 C-N-CA 126.413 1.885 . . . . 0.0 112.835 -170.948 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.418 ' HB3' ' HD3' ' A' ' 69' ' ' PRO . 69.6 t80 177.97 -55.41 0.0 OUTLIER Pre-proline 0 C--N 1.301 -1.528 0 O-C-N 123.69 0.619 . . . . 0.0 111.674 -177.787 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.418 ' HD3' ' HB3' ' A' ' 68' ' ' PHE . 2.9 Cg_endo -82.9 -70.35 0.01 OUTLIER 'Trans proline' 0 C--N 1.369 1.647 0 C-N-CA 121.763 1.642 . . . . 0.0 113.003 -175.402 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 153.73 -40.53 0.67 Allowed Glycine 0 CA--C 1.492 -1.38 0 N-CA-C 110.092 -1.203 . . . . 0.0 110.092 -176.114 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.442 ' HB3' ' HG3' ' A' ' 89' ' ' PRO . 3.2 t70 -74.84 -55.25 6.01 Favored 'General case' 0 C--O 1.184 -2.352 0 N-CA-C 104.745 -2.317 . . . . 0.0 104.745 175.757 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.432 ' HA ' HG12 ' A' ' 88' ' ' ILE . . . -66.08 99.57 0.52 Allowed 'General case' 0 C--N 1.31 -1.132 0 C-N-CA 117.082 -1.847 . . . . 0.0 107.556 163.216 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . 1.619 6.3 m 115.26 30.8 0.0 OUTLIER 'General case' 0 N--CA 1.439 -1.012 1 N-CA-C 123.299 4.555 . . . . 0.0 123.299 -178.542 . . . . . . . . 3 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.582 ' O ' HG22 ' A' ' 86' ' ' VAL . 3.5 p30 -89.11 178.28 6.42 Favored 'General case' 0 C--N 1.293 -1.882 0 CA-C-N 114.708 -1.133 . . . . 0.0 108.003 167.419 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.504 ' HB3' HD21 ' A' ' 84' ' ' LEU . 93.4 m-85 -136.73 101.56 4.64 Favored 'General case' 0 C--N 1.281 -2.395 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 -178.248 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -108.59 114.15 27.72 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 -178.253 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 87.8 t80 -112.94 126.73 55.8 Favored 'General case' 0 C--N 1.282 -2.363 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 -176.879 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.671 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 7.3 m-20 -91.09 164.44 13.94 Favored 'General case' 0 CA--C 1.478 -1.799 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 177.001 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -80.27 -64.77 1.11 Allowed 'General case' 0 C--N 1.278 -2.515 0 CA-C-N 115.055 -0.975 . . . . 0.0 112.662 -175.541 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -71.91 -30.36 65.28 Favored 'General case' 0 CA--C 1.506 -0.736 0 CA-C-O 121.437 0.637 . . . . 0.0 110.538 -176.033 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.671 ' HB ' ' HB2' ' A' ' 78' ' ' ASP . 17.7 m -66.29 -46.81 75.7 Favored 'General case' 0 N--CA 1.417 -2.125 0 CA-C-N 115.082 -0.963 . . . . 0.0 110.295 -178.218 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 97.3 mttt 64.58 17.59 10.96 Favored 'General case' 0 N--CA 1.486 1.363 0 CA-C-O 121.982 0.896 . . . . 0.0 111.486 178.345 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.485 ' HB3' HG22 ' A' ' 81' ' ' THR . 47.0 tptt -116.03 124.62 50.91 Favored 'General case' 0 N--CA 1.394 -3.248 0 N-CA-C 105.242 -2.133 . . . . 0.0 105.242 -178.607 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.504 HD21 ' HB3' ' A' ' 75' ' ' TYR . 3.1 tm? -76.46 137.38 39.64 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 179.794 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.447 ' N ' HD13 ' A' ' 84' ' ' LEU . 54.1 p -125.94 144.8 50.54 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.582 HG22 ' O ' ' A' ' 74' ' ' ASN . 92.9 t -112.98 130.39 66.92 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.512 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 172.337 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 18.5 mt -96.4 102.16 13.91 Favored 'General case' 0 C--N 1.282 -2.355 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 -179.447 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.432 HG12 ' HA ' ' A' ' 72' ' ' ALA . 62.6 mt -104.15 135.1 19.39 Favored Pre-proline 0 C--N 1.306 -1.313 0 N-CA-C 109.63 -0.508 . . . . 0.0 109.63 -178.378 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.442 ' HG3' ' HB3' ' A' ' 71' ' ' ASP . 37.9 Cg_endo -84.04 110.34 1.54 Allowed 'Trans proline' 0 N--CA 1.43 -2.264 0 C-N-CA 122.548 2.165 . . . . 0.0 110.483 177.606 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 59.9 m 71.41 156.25 0.16 Allowed 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 122.146 0.974 . . . . 0.0 113.181 -179.748 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.511 HG12 ' HA ' ' A' ' 105' ' ' THR . 96.5 mt -80.72 125.69 39.4 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.861 0 CA-C-N 114.807 -1.088 . . . . 0.0 110.038 177.058 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 8.9 p -118.13 145.92 44.54 Favored 'General case' 0 C--N 1.293 -1.87 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 173.292 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -131.18 130.84 43.53 Favored 'General case' 0 C--N 1.282 -2.334 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 -174.099 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.614 HG13 ' H ' ' A' ' 163' ' ' ASN . 55.7 t -118.67 109.43 26.92 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.296 0 CA-C-O 121.266 0.555 . . . . 0.0 111.87 -173.779 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -145.76 -169.31 13.78 Favored Glycine 0 N--CA 1.408 -3.209 0 N-CA-C 109.357 -1.497 . . . . 0.0 109.357 175.306 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 44.4 t80 79.23 -50.76 0.43 Allowed 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.341 1.056 . . . . 0.0 112.062 168.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.548 ' HD2' ' C ' ' A' ' 97' ' ' LYS . 0.1 OUTLIER -71.79 -22.48 61.57 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 177.439 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.409 ' N ' ' HD2' ' A' ' 97' ' ' LYS . 16.0 t70 -99.57 -82.98 0.43 Allowed 'General case' 0 N--CA 1.42 -1.955 0 CA-C-N 114.375 -1.284 . . . . 0.0 112.626 -169.82 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 51.9 p 170.26 -38.14 0.0 OUTLIER 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 106.375 -1.713 . . . . 0.0 106.375 -176.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' SER . . . . . 0.646 ' HB3' ' O ' ' A' ' 126' ' ' LYS . 23.3 m -96.02 176.85 5.95 Favored 'General case' 0 N--CA 1.402 -2.856 0 CA-C-N 113.053 -1.885 . . . . 0.0 110.489 -179.2 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 86.6 t -128.68 102.64 8.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 N-CA-C 107.313 -1.365 . . . . 0.0 107.313 175.885 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.657 HD22 HG23 ' A' ' 125' ' ' THR . 55.2 mt -109.39 130.86 55.48 Favored 'General case' 0 C--N 1.285 -2.205 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.989 -171.144 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.443 ' HE3' HD13 ' A' ' 91' ' ' ILE . 35.2 tttp -103.63 115.57 30.74 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 110.237 -0.282 . . . . 0.0 110.237 -175.391 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -96.89 95.73 8.05 Favored 'General case' 0 N--CA 1.413 -2.285 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 173.303 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.636 ' H ' HG22 ' A' ' 123' ' ' ILE . 19.6 m -66.35 179.56 0.97 Allowed 'General case' 0 N--CA 1.423 -1.803 0 CA-C-N 113.587 -1.642 . . . . 0.0 110.186 177.318 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.631 ' H ' HG22 ' A' ' 105' ' ' THR . 22.1 p -79.56 -74.09 0.31 Allowed 'General case' 0 C--N 1.301 -1.527 0 C-N-CA 123.814 0.846 . . . . 0.0 112.408 -173.972 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 11.5 p -96.04 101.59 13.28 Favored 'General case' 0 N--CA 1.406 -2.642 0 CA-C-O 121.295 0.569 . . . . 0.0 110.25 -178.412 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.444 ' CG2' HG23 ' A' ' 123' ' ' ILE . 1.1 p -97.45 159.01 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.03 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 -179.778 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.483 HG22 ' HG2' ' A' ' 83' ' ' LYS . 63.6 m -144.71 120.38 10.47 Favored 'General case' 0 C--N 1.293 -1.876 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 -173.103 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.55 ' HA3' ' O ' ' A' ' 119' ' ' ASP . . . -160.69 -157.45 8.71 Favored Glycine 0 C--O 1.202 -1.897 0 C-N-CA 121.091 -0.576 . . . . 0.0 113.88 -174.95 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 36.4 m80 -124.64 117.34 24.06 Favored 'General case' 0 C--N 1.305 -1.358 0 O-C-N 122.269 -0.548 . . . . 0.0 109.687 177.277 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.478 HD22 ' CD1' ' A' ' 75' ' ' TYR . 67.0 tp -100.68 129.61 46.61 Favored 'General case' 0 C--N 1.293 -1.885 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.267 -177.605 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -127.32 153.29 46.36 Favored 'General case' 0 CA--C 1.441 -3.239 0 CA-C-N 115.018 -0.992 . . . . 0.0 109.507 174.115 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.566 ' HA ' ' OD1' ' A' ' 62' ' ' ASP . 56.6 tptt -67.54 101.52 1.01 Allowed 'General case' 0 N--CA 1.388 -3.539 0 O-C-N 124.672 1.233 . . . . 0.0 107.896 176.816 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' GLY . . . . . 0.573 ' O ' ' HB ' ' A' ' 138' ' ' THR . . . 135.78 -55.3 0.72 Allowed Glycine 0 N--CA 1.401 -3.657 0 N-CA-C 109.272 -1.531 . . . . 0.0 109.272 -175.209 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.611 ' HD3' HG23 ' A' ' 118' ' ' THR . 0.0 OUTLIER -148.98 152.73 36.84 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 -177.485 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.521 ' O ' ' HB2' ' A' ' 135' ' ' SER . 47.9 tp -108.47 102.77 11.83 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-N 115.337 -0.847 . . . . 0.0 108.96 177.616 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.611 HG23 ' HD3' ' A' ' 116' ' ' LYS . 6.1 p -103.22 167.09 10.05 Favored 'General case' 0 C--N 1.299 -1.619 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.048 178.988 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' ASP . . . . . 0.55 ' O ' ' HA3' ' A' ' 110' ' ' GLY . 5.8 m-20 67.94 107.22 0.05 OUTLIER 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.665 0.786 . . . . 0.0 109.12 -176.041 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.527 ' HB ' HG12 ' A' ' 123' ' ' ILE 0.354 4.1 m -125.7 72.79 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.401 -2.92 0 N-CA-C 114.243 1.201 . . . . 0.0 114.243 179.514 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -82.04 86.39 6.58 Favored 'General case' 0 N--CA 1.425 -1.682 0 CA-C-N 114.271 -1.331 . . . . 0.0 110.449 176.121 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 161.92 -40.77 0.39 Allowed Glycine 0 C--N 1.262 -3.533 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 175.141 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.636 HG22 ' H ' ' A' ' 105' ' ' THR . 25.2 pt -100.12 152.2 4.83 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.737 0 C-N-CA 119.09 -1.044 . . . . 0.0 108.813 -178.041 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.423 ' NZ ' ' HB2' ' A' ' 124' ' ' LYS . 4.1 ttmp? -128.79 138.0 51.83 Favored 'General case' 0 C--N 1.27 -2.854 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 -176.468 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.657 HG23 HD22 ' A' ' 102' ' ' LEU . 13.3 m -124.13 115.45 21.16 Favored 'General case' 0 C--N 1.283 -2.296 0 CA-C-N 115.517 -0.765 . . . . 0.0 112.928 -169.561 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.646 ' O ' ' HB3' ' A' ' 100' ' ' SER . 0.2 OUTLIER -100.85 115.66 30.89 Favored 'General case' 0 N--CA 1.413 -2.289 0 N-CA-C 107.154 -1.424 . . . . 0.0 107.154 169.572 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.647 HG13 ' SD ' ' A' ' 128' ' ' MET 0.25 1.0 OUTLIER -120.47 -78.46 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.128 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.353 176.739 . . . . . . . . 4 4 . 1 . 008 nuclear build full ' A' A ' 128' ' ' MET . . . . . 0.647 ' SD ' HG13 ' A' ' 127' ' ' VAL . 0.0 OUTLIER -103.69 -9.15 19.36 Favored 'General case' 0 N--CA 1.412 -2.362 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 176.67 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.411 HG23 HG13 ' A' ' 131' ' ' VAL . 8.9 tp -164.06 164.48 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.41 -2.437 0 N-CA-C 106.297 -1.742 . . . . 0.0 106.297 177.834 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 31.0 t90 -85.33 114.93 22.77 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 -178.436 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.411 HG13 HG23 ' A' ' 129' ' ' ILE . 15.7 m -148.74 -175.27 0.38 Allowed 'Isoleucine or valine' 0 C--O 1.211 -0.953 0 C-N-CA 125.125 1.37 . . . . 0.0 109.452 -176.381 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 132' ' ' LYS . . . . . 0.505 ' HG3' ' N ' ' A' ' 133' ' ' VAL . 38.6 pttt -131.06 -36.62 1.32 Allowed 'General case' 0 C--N 1.305 -1.334 0 C-N-CA 120.227 -0.589 . . . . 0.0 112.038 176.163 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.505 ' N ' ' HG3' ' A' ' 132' ' ' LYS . 25.6 m -69.81 -8.0 9.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 N-CA-C 115.389 1.626 . . . . 0.0 115.389 -165.484 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' THR . . . . . 0.416 ' O ' ' HB ' ' A' ' 146' ' ' THR . 37.9 p -75.57 90.3 2.77 Favored 'General case' 0 N--CA 1.42 -1.951 0 CA-C-O 121.767 0.794 . . . . 0.0 110.48 179.464 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 135' ' ' SER . . . . . 0.521 ' HB2' ' O ' ' A' ' 117' ' ' LEU . 30.0 p -86.13 174.27 9.27 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-N 114.404 -1.271 . . . . 0.0 112.757 -175.554 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 9.4 tt -98.33 122.46 50.01 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.798 0 CA-C-O 122.027 0.918 . . . . 0.0 111.889 -171.38 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 34.0 p -96.56 148.11 23.17 Favored 'General case' 0 N--CA 1.417 -2.113 0 CA-C-N 114.886 -1.052 . . . . 0.0 108.69 176.473 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' THR . . . . . 0.573 ' HB ' ' O ' ' A' ' 115' ' ' GLY . 93.6 m -154.03 164.09 39.03 Favored 'General case' 0 C--N 1.289 -2.043 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 -172.565 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 63.7 m-20 -99.64 22.97 10.13 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 172.457 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.549 ' N ' HG22 ' A' ' 138' ' ' THR . . . 58.86 36.36 24.62 Favored 'General case' 0 C--N 1.351 0.661 0 N-CA-C 106.525 -1.657 . . . . 0.0 106.525 -167.331 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 141' ' ' SER . . . . . 0.481 ' H ' HG22 ' A' ' 138' ' ' THR . 35.3 t -167.54 -75.36 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.841 0 CA-C-N 113.741 -1.572 . . . . 0.0 110.341 -170.124 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.513 ' O ' HG23 ' A' ' 138' ' ' THR . 96.7 mttt -98.65 163.58 12.59 Favored 'General case' 0 N--CA 1.484 1.268 0 CA-C-N 117.924 0.329 . . . . 0.0 110.581 -179.306 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 92.1 t -106.7 135.14 46.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-O 121.431 0.634 . . . . 0.0 111.1 -178.389 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 62.5 m-85 -119.76 156.53 30.4 Favored 'General case' 0 C--N 1.296 -1.732 0 CA-C-N 115.483 -0.781 . . . . 0.0 109.501 179.143 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 46.9 p90 -42.03 133.17 3.04 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 124.558 1.143 . . . . 0.0 113.92 -176.288 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.495 ' HA ' ' O ' ' A' ' 135' ' ' SER . 74.5 p -78.71 -40.46 33.66 Favored 'General case' 0 N--CA 1.433 -1.311 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.101 177.699 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.433 ' CB ' HG11 ' A' ' 127' ' ' VAL . . . -112.09 157.71 20.47 Favored 'General case' 0 N--CA 1.433 -1.292 0 CA-C-N 115.091 -0.958 . . . . 0.0 108.739 178.618 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -67.41 -27.78 73.57 Favored Glycine 0 C--N 1.309 -0.945 0 O-C-N 123.543 0.527 . . . . 0.0 113.153 -176.266 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 1.6 tmt? -78.25 -24.27 46.99 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-O 121.271 0.558 . . . . 0.0 110.429 178.259 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' LYS . . . . . 0.523 ' HE2' ' CG2' ' A' ' 127' ' ' VAL . 21.5 ttmm -80.14 166.45 21.46 Favored 'General case' 0 N--CA 1.433 -1.317 0 CA-C-N 115.289 -0.869 . . . . 0.0 110.155 -176.03 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -110.49 161.92 15.2 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 -177.381 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 44.2 m -76.17 155.41 34.58 Favored 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 176.136 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 24.4 tpt180 -142.77 138.69 30.63 Favored 'General case' 0 N--CA 1.435 -1.187 0 C-N-CA 119.104 -1.039 . . . . 0.0 112.077 -172.001 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 28.5 p -68.25 118.62 11.6 Favored 'General case' 0 N--CA 1.44 -0.958 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.668 177.935 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' ARG . . . . . 0.547 ' HB2' ' O ' ' A' ' 159' ' ' GLY 0.315 0.0 OUTLIER -83.35 -20.6 33.99 Favored 'General case' 0 C--O 1.204 -1.336 0 C-N-CA 119.357 -0.937 . . . . 0.0 113.476 -178.787 . . . . . . . . 4 4 . 1 . 008 nuclear build full ' A' A ' 156' ' ' ASP . . . . . 0.413 ' HA ' HH21 ' A' ' 155' ' ' ARG . 22.7 t70 -43.78 -32.03 0.95 Allowed 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 124.774 1.23 . . . . 0.0 113.425 -178.676 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -61.53 -38.53 87.76 Favored 'General case' 0 CA--C 1.553 1.095 0 N-CA-C 113.647 0.98 . . . . 0.0 113.647 -179.739 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 41.1 m-85 -152.55 -21.69 0.17 Allowed 'General case' 0 N--CA 1.504 2.238 0 CA-C-N 118.363 0.529 . . . . 0.0 111.507 -177.432 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 159' ' ' GLY . . . . . 0.547 ' O ' ' HB2' ' A' ' 155' ' ' ARG . . . 106.34 -91.33 0.72 Allowed Glycine 0 CA--C 1.464 -3.149 0 N-CA-C 105.585 -3.006 . . . . 0.0 105.585 -166.413 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.667 ' CG2' ' HA ' ' A' ' 67' ' ' ILE . 88.9 t -100.66 141.68 17.04 Favored 'Isoleucine or valine' 0 N--CA 1.388 -3.534 0 N-CA-C 105.984 -1.858 . . . . 0.0 105.984 167.291 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 65.5 mt-30 -94.47 92.12 6.97 Favored 'General case' 0 CA--C 1.453 -2.755 0 N-CA-C 106.425 -1.695 . . . . 0.0 106.425 -170.916 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 162' ' ' ARG . . . . . 0.61 ' O ' ' HD2' ' A' ' 162' ' ' ARG . 0.0 OUTLIER -101.24 135.89 41.98 Favored 'General case' 1 N--CA 1.379 -4.016 0 CA-C-N 114.573 -1.194 . . . . 0.0 111.648 -170.685 . . . . . . . . 4 4 . 1 . 008 nuclear build full ' A' A ' 163' ' ' ASN . . . . . 0.614 ' H ' HG13 ' A' ' 94' ' ' VAL . 7.5 t30 -114.77 -13.63 12.03 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 177.537 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 164' ' ' GLY . . . . . 0.446 ' O ' ' HD3' ' A' ' 162' ' ' ARG . . . -100.38 157.78 19.43 Favored Glycine 0 N--CA 1.428 -1.863 0 CA-C-N 114.225 -1.352 . . . . 0.0 110.609 178.853 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.416 ' O ' HD12 ' A' ' 165' ' ' LEU . 2.1 pp -121.38 153.78 37.35 Favored 'General case' 0 C--N 1.287 -2.144 0 C-N-CA 123.234 0.614 . . . . 0.0 109.935 -177.234 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 166' ' ' ARG . . . . . 0.401 ' HG2' ' HG2' ' A' ' 89' ' ' PRO . 0.0 OUTLIER -71.38 129.75 39.61 Favored 'General case' 0 N--CA 1.432 -1.326 0 N-CA-C 106.856 -1.535 . . . . 0.0 106.856 173.899 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 46.8 t -57.54 -29.65 34.55 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 CA-C-O 121.444 0.64 . . . . 0.0 109.684 174.557 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -70.29 -34.6 72.95 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 123.475 0.71 . . . . 0.0 111.378 178.054 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 64.8 tttp -96.99 109.63 22.34 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 113.248 0.832 . . . . 0.0 113.248 -174.462 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 170' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 . . . . . 0 C--N 1.293 -1.885 0 N-CA-C 107.099 -1.445 . . . . 0.0 107.099 173.914 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 40.8 m . . . . . 0 C--O 1.241 0.645 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 66.29 -173.96 0.19 Allowed 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.42 0.688 . . . . 0.0 110.853 -178.75 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 63.01 18.61 11.05 Favored 'General case' 0 C--O 1.238 0.499 0 C-N-CA 123.589 0.755 . . . . 0.0 111.419 179.125 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 12.2 tt -84.22 142.2 13.7 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.208 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 -178.424 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 51.1 p90 -149.6 166.4 29.36 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 -178.016 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -153.48 115.51 4.32 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-O 120.883 0.373 . . . . 0.0 110.957 176.653 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.35 95.41 1.24 Allowed 'General case' 0 C--N 1.309 -1.161 0 CA-C-O 121.665 0.745 . . . . 0.0 110.76 171.231 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 13.2 p -73.62 150.95 7.57 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.097 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 177.63 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -78.32 68.26 2.94 Favored Glycine 0 N--CA 1.439 -1.129 0 C-N-CA 120.979 -0.629 . . . . 0.0 113.879 -176.341 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 33.0 t -76.79 -33.99 57.99 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 106.59 -1.633 . . . . 0.0 106.59 174.852 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 83.9 t80 -82.04 100.92 10.02 Favored 'General case' 0 N--CA 1.425 -1.693 0 CA-C-N 114.494 -1.23 . . . . 0.0 108.672 174.744 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 68.7 p-90 -113.77 148.86 35.77 Favored 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 177.145 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -149.22 153.19 37.25 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 179.388 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 93.11 71.33 1.16 Allowed Glycine 0 N--CA 1.424 -2.133 0 C-N-CA 120.256 -0.973 . . . . 0.0 111.953 178.693 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -81.49 118.73 22.96 Favored 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 174.847 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.621 ' HE3' ' HA ' ' A' ' 16' ' ' LYS . 0.3 OUTLIER 63.83 77.34 0.32 Allowed 'General case' 0 C--N 1.326 -0.435 0 O-C-N 124.096 0.872 . . . . 0.0 108.761 -174.293 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -133.44 90.65 2.75 Favored 'General case' 0 N--CA 1.433 -1.29 0 CA-C-O 121.629 0.728 . . . . 0.0 111.497 -178.404 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -128.62 85.67 2.36 Favored 'General case' 0 C--N 1.29 -1.984 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 176.009 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 47.2 mtmt -84.53 88.33 7.31 Favored 'General case' 0 CA--C 1.502 -0.882 0 C-N-CA 119.883 -0.727 . . . . 0.0 111.207 -176.36 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -145.44 92.91 2.29 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-N 114.801 -1.09 . . . . 0.0 109.717 177.333 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 43.4 p90 -159.27 156.95 29.67 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-N 115.177 -0.92 . . . . 0.0 108.537 -178.388 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -102.82 -71.97 0.71 Allowed 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 177.329 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 23.0 t 66.48 -59.41 0.35 Allowed 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 124.603 1.161 . . . . 0.0 111.12 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 7.5 p -115.41 107.06 21.76 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.531 0 CA-C-O 121.84 0.829 . . . . 0.0 109.33 177.296 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 177.93 164.43 31.21 Favored Glycine 0 N--CA 1.424 -2.111 0 N-CA-C 109.92 -1.272 . . . . 0.0 109.92 -178.727 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 6.2 t30 57.84 83.75 0.11 Allowed 'General case' 0 C--O 1.24 0.605 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 -175.851 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -89.13 128.04 35.75 Favored 'General case' 0 C--N 1.29 -1.999 0 CA-C-O 121.903 0.859 . . . . 0.0 112.817 -172.74 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 48.5 tp -147.66 98.09 2.92 Favored 'General case' 0 C--N 1.293 -1.851 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 171.838 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 38.3 m-80 -133.99 97.59 3.92 Favored 'General case' 0 C--N 1.288 -2.069 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 -179.291 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 32.2 t -145.72 88.97 1.87 Allowed 'General case' 0 N--CA 1.413 -2.318 0 CA-C-O 121.608 0.718 . . . . 0.0 109.506 179.75 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 57.3 t -126.18 -64.56 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 N-CA-C 106.037 -1.838 . . . . 0.0 106.037 175.08 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 37.2 m -103.62 104.01 14.01 Favored 'General case' 0 N--CA 1.414 -2.236 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 175.61 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 37.1 p -77.98 84.73 4.24 Favored 'General case' 0 N--CA 1.429 -1.495 0 CA-C-O 122.091 0.948 . . . . 0.0 110.603 179.203 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 38.1 m -122.85 121.78 37.05 Favored 'General case' 0 N--CA 1.418 -2.07 0 CA-C-N 114.536 -1.211 . . . . 0.0 108.268 178.912 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 51.1 mm -89.65 112.95 25.2 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.765 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 -178.308 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 68.77 -62.76 0.38 Allowed 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 124.551 1.14 . . . . 0.0 112.386 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 132.45 -150.62 19.71 Favored Glycine 0 N--CA 1.422 -2.241 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 -176.916 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -117.0 3.85 18.96 Favored Glycine 0 C--N 1.299 -1.521 0 C-N-CA 120.752 -0.737 . . . . 0.0 111.746 178.343 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 23.7 p -109.22 103.47 12.45 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-O 121.365 0.602 . . . . 0.0 112.622 -179.512 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -90.26 -42.98 10.68 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 106.082 -1.821 . . . . 0.0 106.082 172.237 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 32.5 p90 -159.3 165.39 33.54 Favored 'General case' 0 N--CA 1.434 -1.264 0 N-CA-C 106.317 -1.734 . . . . 0.0 106.317 175.389 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 56.0 tp -136.77 108.71 7.13 Favored 'General case' 0 C--N 1.292 -1.926 0 C-N-CA 120.322 -0.551 . . . . 0.0 110.836 -179.135 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 61.3 t -86.9 116.34 29.24 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.029 0 N-CA-C 106.934 -1.506 . . . . 0.0 106.934 175.257 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 40.7 t30 -78.08 91.03 4.25 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-O 121.772 0.796 . . . . 0.0 112.436 -175.521 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 41.0 ttmt -126.65 75.26 1.54 Allowed 'General case' 0 N--CA 1.424 -1.774 0 CA-C-N 115.093 -0.958 . . . . 0.0 108.467 175.141 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 7.4 tp -176.2 -47.04 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 CA-C-N 113.444 -1.707 . . . . 0.0 106.48 -178.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 96.1 mttt 67.66 168.55 0.26 Allowed 'General case' 0 C--N 1.346 0.422 0 C-N-CA 125.008 1.323 . . . . 0.0 113.279 175.492 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -85.05 36.8 3.02 Favored Glycine 0 N--CA 1.438 -1.226 0 C-N-CA 121.053 -0.594 . . . . 0.0 114.405 -174.048 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.482 ' HG3' ' SD ' ' A' ' 50' ' ' MET . 62.8 pttt -90.84 -16.82 27.59 Favored 'General case' 0 C--N 1.318 -0.786 0 C-N-CA 120.03 -0.668 . . . . 0.0 109.797 176.736 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' MET . . . . . 0.482 ' SD ' ' HG3' ' A' ' 49' ' ' LYS . 1.7 mpt? -94.36 126.91 39.91 Favored 'General case' 0 N--CA 1.441 -0.91 0 N-CA-C 106.613 -1.625 . . . . 0.0 106.613 171.614 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 28.3 pt20 -74.19 131.89 41.68 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-O 121.588 0.708 . . . . 0.0 112.272 -176.788 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.492 ' O ' ' HD2' ' A' ' 55' ' ' PRO . 68.6 mttm -129.39 168.72 15.26 Favored Pre-proline 0 C--N 1.302 -1.457 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 179.084 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -84.76 15.55 2.17 Favored 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 122.25 1.967 . . . . 0.0 111.551 175.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.515 ' HB3' ' HD3' ' A' ' 55' ' ' PRO . 14.8 tp -80.02 -49.53 1.26 Allowed Pre-proline 0 C--O 1.199 -1.59 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.65 -179.83 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.515 ' HD3' ' HB3' ' A' ' 54' ' ' LEU . 0.1 OUTLIER -38.3 -45.58 2.2 Favored 'Trans proline' 0 C--N 1.388 2.613 0 C-N-CA 124.143 3.229 . . . . 0.0 113.476 177.185 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.435 ' HA ' ' HE2' ' A' ' 59' ' ' LYS . 12.3 pt-20 -69.76 -37.9 76.56 Favored 'General case' 0 N--CA 1.438 -1.069 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.668 179.68 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.421 ' HG ' ' CE1' ' A' ' 61' ' ' TYR . 3.7 tt -75.64 -35.4 60.45 Favored 'General case' 0 N--CA 1.436 -1.166 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.845 -177.817 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.519 HD22 HD22 ' A' ' 74' ' ' ASN . 4.0 pp -66.88 -41.11 87.8 Favored 'General case' 0 C--N 1.314 -0.937 0 C-N-CA 120.412 -0.515 . . . . 0.0 112.276 -178.273 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.499 ' N ' HD12 ' A' ' 58' ' ' LEU . 62.0 pttt -75.13 -26.0 58.84 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.788 0.804 . . . . 0.0 109.823 176.649 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -66.27 -53.8 32.54 Favored 'General case' 0 N--CA 1.439 -0.979 0 CA-C-N 115.146 -0.934 . . . . 0.0 111.393 176.57 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.421 ' CE1' ' HG ' ' A' ' 57' ' ' LEU . 14.5 m-85 -60.34 -52.96 63.04 Favored 'General case' 0 CA--C 1.504 -0.815 0 N-CA-C 114.681 1.363 . . . . 0.0 114.681 -178.847 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.566 ' O ' HD13 ' A' ' 63' ' ' LEU . 19.6 m-20 -79.91 -98.04 0.03 OUTLIER 'General case' 0 C--N 1.316 -0.86 0 C-N-CA 118.918 -1.113 . . . . 0.0 110.44 -179.737 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.613 ' HB2' HD12 ' A' ' 65' ' ' ILE . 0.8 OUTLIER -142.41 158.68 60.21 Favored Pre-proline 0 N--CA 1.43 -1.426 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 -177.723 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.528 ' HB2' ' NH1' ' A' ' 155' ' ' ARG . 12.9 Cg_endo -93.27 28.68 0.31 Allowed 'Trans proline' 0 N--CA 1.439 -1.679 0 C-N-CA 123.47 2.78 . . . . 0.0 112.176 -173.565 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.613 HD12 ' HB2' ' A' ' 63' ' ' LEU . 0.2 OUTLIER -69.96 -29.92 42.16 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.343 0 N-CA-C 107.764 -1.199 . . . . 0.0 107.764 173.863 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 62.01 -9.71 0.11 Allowed Glycine 0 CA--C 1.54 1.651 0 CA-C-N 114.515 -1.22 . . . . 0.0 115.268 177.596 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.607 ' O ' ' HB ' ' A' ' 160' ' ' VAL . 38.4 mt 76.33 -38.53 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.51 -0.592 0 C-N-CA 125.171 1.389 . . . . 0.0 113.217 179.315 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.518 ' HB2' ' O ' ' A' ' 67' ' ' ILE . 39.0 t80 166.07 -57.72 0.0 OUTLIER Pre-proline 0 C--N 1.321 -0.636 0 C-N-CA 125.009 1.323 . . . . 0.0 109.007 173.131 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.454 ' HD3' ' HB3' ' A' ' 68' ' ' PHE . 19.6 Cg_endo -102.56 -16.85 0.09 OUTLIER 'Trans proline' 0 C--N 1.378 2.129 0 C-N-CA 122.209 1.94 . . . . 0.0 114.985 -172.922 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.433 ' H ' ' HD2' ' A' ' 69' ' ' PRO . . . 80.36 9.72 86.2 Favored Glycine 0 N--CA 1.441 -0.986 0 C-N-CA 119.924 -1.132 . . . . 0.0 111.633 -173.565 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.658 ' OD1' ' HG3' ' A' ' 89' ' ' PRO . 10.4 t70 -92.0 -43.56 9.36 Favored 'General case' 0 C--O 1.201 -1.455 0 N-CA-C 106.474 -1.676 . . . . 0.0 106.474 176.304 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.44 ' O ' ' HB ' ' A' ' 73' ' ' THR . . . -72.02 -178.77 2.5 Favored 'General case' 0 CA--C 1.552 1.043 0 CA-C-N 114.537 -1.21 . . . . 0.0 108.104 165.195 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.501 ' O ' HG22 ' A' ' 73' ' ' THR . 56.8 m 83.52 26.97 0.1 Allowed 'General case' 0 N--CA 1.498 1.948 0 CA-C-O 123.469 1.604 . . . . 0.0 108.398 179.28 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.519 HD22 HD22 ' A' ' 58' ' ' LEU . 3.5 m120 -81.7 111.15 17.69 Favored 'General case' 0 N--CA 1.41 -2.474 0 C-N-CA 118.528 -1.269 . . . . 0.0 110.962 -175.601 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 66.1 t80 -71.71 94.2 1.34 Allowed 'General case' 0 C--N 1.293 -1.874 0 CA-C-N 114.074 -1.421 . . . . 0.0 112.081 -176.195 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.448 ' O ' HD22 ' A' ' 84' ' ' LEU . 23.5 mm-40 -110.62 111.57 22.88 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 171.692 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.412 ' HB2' HD23 ' A' ' 84' ' ' LEU . 81.4 t80 -125.76 127.28 45.92 Favored 'General case' 0 C--N 1.291 -1.966 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.985 -170.495 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.554 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 3.3 m-20 -91.32 163.48 14.2 Favored 'General case' 0 CA--C 1.475 -1.933 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 178.238 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -81.67 -58.38 3.03 Favored 'General case' 0 C--N 1.26 -3.29 0 CA-C-N 114.237 -1.347 . . . . 0.0 113.176 -178.548 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -75.97 -46.92 27.14 Favored 'General case' 0 N--CA 1.429 -1.499 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.596 -176.643 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.554 ' HB ' ' HB2' ' A' ' 78' ' ' ASP . 96.8 m -67.98 -52.08 39.9 Favored 'General case' 0 C--N 1.293 -1.882 0 CA-C-N 114.4 -1.273 . . . . 0.0 112.369 -177.677 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 99.4 mttt 66.6 3.76 3.06 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 114.501 1.297 . . . . 0.0 114.501 178.334 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.698 ' HG2' ' OG1' ' A' ' 109' ' ' THR . 38.2 ttpt -91.17 92.49 8.69 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-O 121.856 0.836 . . . . 0.0 109.24 176.485 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.506 ' HB2' ' HB2' ' A' ' 112' ' ' LEU . 3.0 tm? -51.21 135.1 26.65 Favored 'General case' 0 C--N 1.32 -0.706 0 C-N-CA 126.376 1.87 . . . . 0.0 111.728 -173.82 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.467 ' HA ' ' O ' ' A' ' 108' ' ' VAL . 46.1 p -117.34 110.04 17.57 Favored 'General case' 0 N--CA 1.419 -1.981 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.021 179.805 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.423 HG23 ' CD1' ' A' ' 84' ' ' LEU . 53.5 t -91.9 127.44 44.18 Favored 'Isoleucine or valine' 0 CA--C 1.478 -1.822 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 172.574 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.507 ' H ' HD13 ' A' ' 87' ' ' LEU 0.286 0.0 OUTLIER -114.57 129.85 56.71 Favored 'General case' 0 N--CA 1.392 -3.349 0 CA-C-N 115.105 -0.952 . . . . 0.0 111.227 178.902 . . . . . . . . 4 4 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.458 ' O ' HG23 ' A' ' 106' ' ' THR . 3.1 mp -95.69 136.21 22.5 Favored Pre-proline 0 C--N 1.275 -2.66 0 CA-C-N 114.069 -1.423 . . . . 0.0 108.411 178.96 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.658 ' HG3' ' OD1' ' A' ' 71' ' ' ASP . 7.1 Cg_exo -25.3 -55.45 0.08 OUTLIER 'Trans proline' 0 C--N 1.374 1.878 1 C-N-CA 125.719 4.279 . . . . 0.0 114.065 174.825 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.582 ' HB2' ' HB2' ' A' ' 168' ' ' ASP . 45.1 t -154.1 161.45 41.89 Favored 'General case' 0 N--CA 1.426 -1.631 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 177.179 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.431 HD11 ' HD2' ' A' ' 103' ' ' LYS . 10.0 tt -64.64 114.65 2.48 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 O-C-N 123.939 0.774 . . . . 0.0 110.524 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' CYS . . . . . 0.513 ' HB2' ' HA ' ' A' ' 166' ' ' ARG . 44.2 t -116.03 123.08 47.06 Favored 'General case' 0 N--CA 1.417 -2.122 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.01 -179.161 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -99.05 169.82 9.14 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.25 -179.148 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.416 ' HB ' HH11 ' A' ' 162' ' ' ARG . 3.5 p -148.31 106.08 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.674 0 C-N-CA 123.325 0.65 . . . . 0.0 110.073 174.372 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -145.77 114.71 0.77 Allowed Glycine 0 C--N 1.296 -1.686 0 N-CA-C 108.643 -1.783 . . . . 0.0 108.643 175.831 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 0.526 ' CD2' ' HG3' ' A' ' 97' ' ' LYS . 12.1 t80 -139.78 -156.67 0.7 Allowed 'General case' 0 N--CA 1.414 -2.253 0 N-CA-C 106.048 -1.834 . . . . 0.0 106.048 -176.607 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.526 ' HG3' ' CD2' ' A' ' 96' ' ' TYR . 0.1 OUTLIER -72.63 -6.07 41.76 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-O 122.185 0.993 . . . . 0.0 111.049 -175.442 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.496 ' OD1' ' HB3' ' A' ' 96' ' ' TYR . 5.9 m-20 -74.38 -15.01 60.94 Favored 'General case' 0 N--CA 1.422 -1.868 0 CA-C-N 113.486 -1.688 . . . . 0.0 111.704 -175.488 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 34.5 t 77.62 -10.0 1.42 Allowed 'General case' 0 C--O 1.238 0.449 0 C-N-CA 124.476 1.111 . . . . 0.0 111.86 177.658 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 43.6 p -82.9 93.71 7.56 Favored 'General case' 0 N--CA 1.411 -2.388 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 176.509 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 96.1 t -94.68 115.96 34.8 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.993 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.776 176.878 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.415 ' HG ' ' HA ' ' A' ' 125' ' ' THR . 6.9 tt -137.66 134.83 35.91 Favored 'General case' 0 C--N 1.286 -2.195 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 -178.199 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.431 ' HD2' HD11 ' A' ' 91' ' ' ILE . 39.0 ttpt -110.11 106.51 16.0 Favored 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 178.62 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.444 ' HA ' HD12 ' A' ' 123' ' ' ILE . 14.1 t80 -96.36 96.83 9.01 Favored 'General case' 0 N--CA 1.421 -1.904 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 -177.579 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.498 HG22 ' H ' ' A' ' 106' ' ' THR . 10.6 m -57.98 172.29 0.43 Allowed 'General case' 0 CA--C 1.568 1.66 0 C-N-CA 126.415 1.886 . . . . 0.0 112.307 -178.777 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.498 ' H ' HG22 ' A' ' 105' ' ' THR . 38.4 m -78.29 -72.41 0.37 Allowed 'General case' 0 C--N 1.316 -0.887 0 C-N-CA 123.562 0.745 . . . . 0.0 111.79 -173.445 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 43.9 m -103.62 110.34 22.36 Favored 'General case' 0 N--CA 1.431 -1.412 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 179.498 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.815 HG21 HG12 ' A' ' 123' ' ' ILE . 3.6 p -109.03 167.08 4.31 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.419 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 178.48 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.698 ' OG1' ' HG2' ' A' ' 83' ' ' LYS . 15.1 t -139.39 131.94 28.74 Favored 'General case' 0 N--CA 1.4 -2.945 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 -175.788 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -147.32 172.18 27.8 Favored Glycine 0 N--CA 1.413 -2.86 0 C-N-CA 119.273 -1.441 . . . . 0.0 113.162 -177.65 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 35.8 m80 -77.35 121.57 23.93 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 -179.639 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.506 ' HB2' ' HB2' ' A' ' 84' ' ' LEU . 3.2 tm? -94.57 110.71 22.5 Favored 'General case' 0 N--CA 1.422 -1.845 0 CA-C-O 121.213 0.53 . . . . 0.0 110.532 -174.214 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -128.18 130.15 47.59 Favored 'General case' 0 CA--C 1.439 -3.307 0 CA-C-N 114.549 -1.205 . . . . 0.0 108.913 168.221 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 54.8 tptt -66.47 116.37 7.39 Favored 'General case' 0 N--CA 1.38 -3.962 0 CA-C-N 114.54 -1.209 . . . . 0.0 109.142 -178.209 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' GLY . . . . . 0.477 ' C ' ' HE2' ' A' ' 116' ' ' LYS . . . 118.42 -27.56 7.23 Favored Glycine 0 C--O 1.177 -3.459 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 -174.169 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.739 ' N ' ' HE2' ' A' ' 116' ' ' LYS . 0.0 OUTLIER -165.19 122.23 1.51 Allowed 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 117.393 0.597 . . . . 0.0 111.898 -178.246 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 64.4 tp -93.6 105.44 17.49 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 176.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 34.2 p -105.9 134.64 48.71 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 114.094 1.146 . . . . 0.0 114.094 -172.534 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 67.1 88.15 0.11 Allowed 'General case' 0 CA--C 1.49 -1.327 0 C-N-CA 124.871 1.268 . . . . 0.0 112.887 178.211 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.43 HG22 ' O ' ' A' ' 134' ' ' THR . 12.4 m -95.78 92.35 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.302 0 CA-C-O 122.912 1.339 . . . . 0.0 108.679 178.824 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -73.57 99.76 3.14 Favored 'General case' 0 C--N 1.264 -3.145 0 CA-C-N 113.072 -1.876 . . . . 0.0 111.769 -174.307 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 145.67 -8.62 1.58 Allowed Glycine 0 N--CA 1.423 -2.194 0 CA-C-N 114.41 -1.268 . . . . 0.0 111.631 177.011 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.815 HG12 HG21 ' A' ' 108' ' ' VAL . 46.4 mm -100.21 118.46 46.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-O 121.623 0.725 . . . . 0.0 111.18 -178.171 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt -85.4 119.31 25.63 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 106.294 -1.743 . . . . 0.0 106.294 175.169 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.481 ' HB ' ' HB ' ' A' ' 131' ' ' VAL . 89.5 m -125.47 128.07 47.48 Favored 'General case' 0 C--N 1.283 -2.299 0 CA-C-N 115.764 -0.653 . . . . 0.0 112.526 -169.624 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.525 ' C ' ' HD3' ' A' ' 126' ' ' LYS . 0.5 OUTLIER -137.85 123.45 19.75 Favored 'General case' 0 N--CA 1.428 -1.561 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 168.82 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.458 ' N ' ' HD3' ' A' ' 126' ' ' LYS . 7.1 p -150.55 -44.52 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.284 -2.266 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 177.556 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 15.5 tpt -103.72 -42.7 5.55 Favored 'General case' 0 N--CA 1.416 -2.16 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 173.371 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 9.3 tp -164.51 175.33 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.889 0 N-CA-C 105.808 -1.923 . . . . 0.0 105.808 178.507 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' TRP . . . . . 0.469 ' CE3' ' HB2' ' A' ' 126' ' ' LYS . 97.7 m95 -69.66 122.81 19.85 Favored 'General case' 0 C--O 1.241 0.642 0 CA-C-O 121.716 0.769 . . . . 0.0 112.285 178.725 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.481 ' HB ' ' HB ' ' A' ' 125' ' ' THR . 97.0 t -130.96 149.03 33.08 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.031 0 C-N-CA 125.481 1.512 . . . . 0.0 107.348 179.347 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 18.0 ptmt -122.75 -12.37 8.07 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-O 121.381 0.61 . . . . 0.0 110.71 177.713 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 15.8 m -138.39 75.28 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 CA-C-O 122.115 0.96 . . . . 0.0 110.266 -178.742 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' THR . . . . . 0.43 ' O ' HG22 ' A' ' 120' ' ' VAL . 7.7 t -84.01 168.92 15.49 Favored 'General case' 0 N--CA 1.414 -2.265 0 CA-C-N 115.062 -0.972 . . . . 0.0 109.328 179.022 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 16.6 p -131.47 151.69 51.35 Favored 'General case' 0 N--CA 1.387 -3.593 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 14.1 tt -118.28 97.61 5.55 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.272 0 CA-C-O 122.253 1.025 . . . . 0.0 108.768 176.405 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' SER . . . . . 0.487 ' OG ' ' HB2' ' A' ' 144' ' ' TYR . 36.2 p -91.44 152.48 20.36 Favored 'General case' 0 N--CA 1.407 -2.577 0 CA-C-N 115.019 -0.991 . . . . 0.0 110.575 -177.204 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 138' ' ' THR . . . . . 0.413 HG23 ' O ' ' A' ' 115' ' ' GLY . 4.4 t -165.42 178.08 7.05 Favored 'General case' 0 N--CA 1.396 -3.137 0 N-CA-C 107.337 -1.356 . . . . 0.0 107.337 -176.378 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -112.7 28.43 8.79 Favored 'General case' 0 C--N 1.269 -2.891 0 N-CA-C 106.848 -1.538 . . . . 0.0 106.848 174.873 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . 71.44 35.76 1.44 Allowed 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 114.284 -1.325 . . . . 0.0 109.569 -175.749 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 39.3 t 177.66 -80.9 0.0 OUTLIER 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 114.299 -1.319 . . . . 0.0 109.37 -178.17 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -78.26 135.94 37.66 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 -178.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 47.7 t -105.48 144.5 14.96 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 -165.062 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' TYR . . . . . 0.487 ' HB2' ' OG ' ' A' ' 137' ' ' SER . 83.6 m-85 -119.69 121.42 39.18 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 106.499 -1.667 . . . . 0.0 106.499 173.826 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 32.3 t80 -96.86 99.13 10.71 Favored 'General case' 0 C--N 1.286 -2.163 0 CA-C-O 121.812 0.815 . . . . 0.0 109.117 -173.871 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 15.2 p -97.95 31.35 2.71 Favored 'General case' 0 C--N 1.298 -1.668 0 CA-C-N 115.288 -0.869 . . . . 0.0 112.571 -175.137 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -76.13 82.45 2.96 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-O 121.856 0.836 . . . . 0.0 111.265 178.364 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 94.79 -58.13 1.84 Allowed Glycine 0 CA--C 1.477 -2.34 0 N-CA-C 108.749 -1.74 . . . . 0.0 108.749 178.213 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 19.6 ttt 169.93 88.93 0.0 OUTLIER 'General case' 0 N--CA 1.435 -1.214 0 C-N-CA 126.518 1.927 . . . . 0.0 107.351 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' LYS . . . . . 0.448 ' HA ' ' HD3' ' A' ' 150' ' ' LYS . 63.2 mmtt -133.07 176.32 8.6 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 113.64 0.978 . . . . 0.0 113.64 178.878 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -85.59 161.34 19.34 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.296 -0.866 . . . . 0.0 112.205 -173.716 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 53.6 p -78.31 160.8 27.66 Favored 'General case' 0 N--CA 1.438 -1.058 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.189 -179.71 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 30.4 ttm180 -145.7 152.09 39.05 Favored 'General case' 0 N--CA 1.438 -1.073 0 CA-C-O 121.014 0.435 . . . . 0.0 110.257 -176.074 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 61.8 p -89.11 135.05 33.77 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 177.186 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' ARG . . . . . 0.528 ' NH1' ' HB2' ' A' ' 64' ' ' PRO . 15.1 ptt180 -78.45 -19.18 53.71 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 120.091 -0.644 . . . . 0.0 110.449 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -48.68 -30.54 5.61 Favored 'General case' 0 C--N 1.316 -0.858 0 C-N-CA 124.375 1.07 . . . . 0.0 112.837 -177.647 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -75.33 -53.83 8.08 Favored 'General case' 0 N--CA 1.441 -0.902 0 C-N-CA 120.838 -0.345 . . . . 0.0 111.043 178.422 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 0.51 ' HB2' ' HB3' ' A' ' 161' ' ' GLN . 95.4 m-85 -157.1 -5.25 0.1 Allowed 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 111.592 0.219 . . . . 0.0 111.592 -178.417 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 159' ' ' GLY . . . . . 0.518 ' HA3' ' O ' ' A' ' 65' ' ' ILE . . . 79.14 -84.71 1.24 Allowed Glycine 0 CA--C 1.475 -2.446 0 N-CA-C 109.01 -1.636 . . . . 0.0 109.01 -169.47 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.607 ' HB ' ' O ' ' A' ' 67' ' ' ILE . 16.3 t -109.85 134.11 53.02 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.505 0 N-CA-C 107.513 -1.292 . . . . 0.0 107.513 174.297 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 161' ' ' GLN . . . . . 0.51 ' HB3' ' HB2' ' A' ' 158' ' ' TYR . 1.1 pp0? -148.17 116.39 6.51 Favored 'General case' 0 N--CA 1.416 -2.169 0 CA-C-O 121.497 0.665 . . . . 0.0 110.721 -175.002 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 162' ' ' ARG . . . . . 0.513 ' NH1' ' HA3' ' A' ' 164' ' ' GLY . 1.9 ppt_? -154.74 162.32 41.16 Favored 'General case' 0 C--N 1.266 -3.034 0 CA-C-N 113.935 -1.484 . . . . 0.0 109.074 175.57 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -76.8 91.98 3.56 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 121.716 0.77 . . . . 0.0 112.718 -177.478 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 164' ' ' GLY . . . . . 0.513 ' HA3' ' NH1' ' A' ' 162' ' ' ARG . . . -146.25 142.4 10.48 Favored Glycine 0 N--CA 1.421 -2.312 0 CA-C-N 115.67 -0.696 . . . . 0.0 111.591 178.128 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.471 ' H ' HD23 ' A' ' 165' ' ' LEU . 1.5 pt? -117.7 112.05 19.95 Favored 'General case' 0 N--CA 1.416 -2.133 0 N-CA-C 106.802 -1.555 . . . . 0.0 106.802 173.575 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 166' ' ' ARG . . . . . 0.513 ' HA ' ' HB2' ' A' ' 92' ' ' CYS . 10.8 ptp180 -80.02 110.21 15.2 Favored 'General case' 0 N--CA 1.416 -2.161 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 -179.06 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.452 HG22 ' H ' ' A' ' 167' ' ' VAL . 5.7 m -69.88 26.31 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.292 -1.897 0 N-CA-C 116.082 1.882 . . . . 0.0 116.082 -171.537 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 168' ' ' ASP . . . . . 0.582 ' HB2' ' HB2' ' A' ' 90' ' ' SER . 31.7 t70 -135.37 69.15 1.44 Allowed 'General case' 0 CA--C 1.497 -1.092 0 N-CA-C 108.064 -1.088 . . . . 0.0 108.064 170.183 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 169' ' ' LYS . . . . . 0.426 ' HB2' ' O ' ' A' ' 168' ' ' ASP . 25.0 ttpp 167.87 145.86 0.02 OUTLIER 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 113.878 -1.51 . . . . 0.0 107.344 179.465 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 170' ' ' PHE . . . . . . . . . . . . . 74.5 t80 . . . . . 0 N--CA 1.412 -2.346 0 N-CA-C 105.37 -2.085 . . . . 0.0 105.37 170.378 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 46.7 t . . . . . 0 C--O 1.241 0.656 0 N-CA-C 110.214 -0.291 . . . . 0.0 110.214 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 58.47 178.15 0.07 Allowed 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 113.571 0.952 . . . . 0.0 113.571 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -172.21 130.19 0.6 Allowed 'General case' 0 C--N 1.311 -1.073 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 177.527 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 50.8 mm -83.28 92.06 2.69 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 C-N-CA 120.472 -0.491 . . . . 0.0 110.542 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -149.8 170.13 19.46 Favored 'General case' 0 C--N 1.312 -1.035 0 C-N-CA 124.68 1.192 . . . . 0.0 107.951 176.726 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 48.0 t30 -147.56 143.53 27.84 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 179.119 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 23.6 pttm -81.76 97.77 8.12 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-O 122.029 0.919 . . . . 0.0 109.731 175.905 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.2 p -145.4 138.46 21.34 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.699 0 CA-C-N 114.78 -1.1 . . . . 0.0 109.529 -176.8 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -165.03 82.25 0.11 Allowed Glycine 0 N--CA 1.426 -1.988 0 N-CA-C 110.137 -1.185 . . . . 0.0 110.137 179.468 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 23.6 p -83.08 80.03 9.18 Favored 'General case' 0 N--CA 1.429 -1.486 0 CA-C-O 121.683 0.754 . . . . 0.0 112.347 -178.435 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 55.1 p90 -145.13 156.81 44.1 Favored 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 106.452 -1.685 . . . . 0.0 106.452 177.463 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 76.6 t-105 -159.73 127.39 4.74 Favored 'General case' 0 C--N 1.307 -1.283 0 C-N-CA 119.74 -0.784 . . . . 0.0 112.72 -179.012 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 57.6 tp -134.11 94.19 3.2 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 107.141 -1.429 . . . . 0.0 107.141 172.613 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -88.13 -9.24 70.73 Favored Glycine 0 CA--C 1.498 -1.012 0 CA-C-N 115.416 -0.811 . . . . 0.0 112.367 -176.775 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 93.6 mt-30 -65.81 102.83 0.81 Allowed 'General case' 0 CA--C 1.502 -0.882 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 177.259 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 23.8 tptm -150.92 93.14 1.9 Allowed 'General case' 0 C--N 1.291 -1.962 0 N-CA-C 107.021 -1.474 . . . . 0.0 107.021 -178.517 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -151.5 121.85 7.3 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.241 -177.035 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 43.8 t30 -162.75 129.43 3.52 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 -179.593 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.451 ' HD3' ' H ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -128.41 95.73 4.22 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-O 121.904 0.859 . . . . 0.0 108.85 176.519 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 19.2 pt20 -95.64 82.84 3.66 Favored 'General case' 0 C--N 1.292 -1.927 0 CA-C-O 121.732 0.777 . . . . 0.0 112.289 -177.146 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 53.1 p90 -163.56 125.87 2.52 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-N 114.772 -1.103 . . . . 0.0 109.202 175.518 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -167.76 167.53 13.08 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 -179.155 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 34.3 m -67.77 124.68 23.97 Favored 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 110.081 -0.34 . . . . 0.0 110.081 179.342 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 35.7 m -81.56 153.4 4.15 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.09 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.662 -177.745 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -116.24 172.47 14.24 Favored Glycine 0 N--CA 1.429 -1.822 0 N-CA-C 110.825 -0.91 . . . . 0.0 110.825 -179.626 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 19.1 m120 -132.88 -179.86 5.74 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 -179.642 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 -72.98 104.45 4.1 Favored 'General case' 0 C--N 1.31 -1.143 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 177.798 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -109.53 110.51 21.63 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 105.831 -1.914 . . . . 0.0 105.831 -179.703 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 44.2 t30 -152.2 132.82 13.93 Favored 'General case' 0 C--N 1.307 -1.258 0 C-N-CA 120.626 -0.43 . . . . 0.0 111.333 -175.919 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 21.4 p -88.43 119.22 28.66 Favored 'General case' 0 N--CA 1.423 -1.793 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 175.006 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.453 ' O ' ' HB2' ' A' ' 32' ' ' SER . 51.4 t -74.82 -72.65 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.96 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 179.301 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.453 ' HB2' ' O ' ' A' ' 31' ' ' VAL . 20.9 t 169.1 126.87 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.172 0 O-C-N 124.128 0.892 . . . . 0.0 109.028 176.779 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 8.0 t -165.31 90.39 0.49 Allowed 'General case' 0 C--N 1.313 -1.012 0 CA-C-O 121.875 0.845 . . . . 0.0 109.18 175.614 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 69.1 m -155.36 120.34 4.84 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 112.748 0.647 . . . . 0.0 112.748 -175.89 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 47.9 mm 69.58 125.9 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 C-N-CA 124.897 1.279 . . . . 0.0 114.403 170.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -137.24 100.44 4.26 Favored 'General case' 0 N--CA 1.44 -0.965 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 175.055 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 178.84 167.81 37.05 Favored Glycine 0 C--N 1.308 -0.985 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.113 -178.0 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 157.93 171.84 24.36 Favored Glycine 0 N--CA 1.436 -1.332 0 N-CA-C 110.642 -0.983 . . . . 0.0 110.642 -179.443 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 18.0 p -76.35 97.19 4.17 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 112.826 0.676 . . . . 0.0 112.826 -179.478 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 29.4 mtpp -111.56 -39.9 4.5 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 172.131 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 12.7 m-90 -133.92 152.37 51.83 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 106.074 -1.824 . . . . 0.0 106.074 175.364 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 5.4 mp -90.5 146.58 24.0 Favored 'General case' 0 C--N 1.301 -1.5 0 C-N-CA 120.151 -0.62 . . . . 0.0 109.919 179.391 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 8.5 p -46.93 132.63 3.65 Favored 'Isoleucine or valine' 0 C--O 1.245 0.827 0 C-N-CA 124.3 1.04 . . . . 0.0 112.152 179.293 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -93.15 159.81 15.12 Favored 'General case' 0 C--N 1.297 -1.699 0 CA-C-N 115.4 -0.818 . . . . 0.0 108.908 -179.678 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 60.4 pttt -72.24 172.87 9.46 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 116.212 -0.449 . . . . 0.0 109.894 176.642 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 24.2 pt -67.05 160.69 4.07 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 N-CA-C 111.648 0.24 . . . . 0.0 111.648 -178.923 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 12.5 mptt 66.98 93.51 0.07 Allowed 'General case' 0 C--O 1.245 0.821 0 C-N-CA 123.883 0.873 . . . . 0.0 111.077 -173.195 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 137.67 -85.98 0.23 Allowed Glycine 0 N--CA 1.433 -1.559 0 N-CA-C 111.184 -0.766 . . . . 0.0 111.184 179.801 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 9.7 mptt -114.03 117.94 32.7 Favored 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 179.153 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 84.5 mtp -103.23 -64.28 1.1 Allowed 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 176.423 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.503 ' HG3' ' H ' ' A' ' 52' ' ' LYS . 23.1 tp60 -157.97 -179.63 8.32 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 106.429 -1.693 . . . . 0.0 106.429 -179.011 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.503 ' H ' ' HG3' ' A' ' 51' ' ' GLN . 31.6 mmmt -67.64 154.92 92.48 Favored Pre-proline 0 C--N 1.316 -0.866 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 -178.772 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -73.56 -4.9 16.21 Favored 'Trans proline' 0 N--CA 1.473 0.313 0 C-N-CA 122.532 2.154 . . . . 0.0 115.821 -176.08 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.404 ' HB2' ' HD3' ' A' ' 55' ' ' PRO . 3.4 mm? -79.03 -58.68 0.68 Allowed Pre-proline 0 C--N 1.301 -1.514 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 178.055 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.472 ' HD2' ' O ' ' A' ' 52' ' ' LYS . 27.3 Cg_endo -60.82 -14.97 35.09 Favored 'Trans proline' 0 N--CA 1.434 -2.017 0 C-N-CA 121.914 1.743 . . . . 0.0 113.129 -170.789 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -76.26 -34.4 59.16 Favored 'General case' 0 CA--C 1.493 -1.228 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 -179.597 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.471 ' HA ' ' HB3' ' A' ' 60' ' ' GLU . 88.1 mt -74.44 -36.52 63.4 Favored 'General case' 0 N--CA 1.42 -1.971 0 CA-C-N 114.946 -1.025 . . . . 0.0 109.48 178.459 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 8.3 mp -62.59 -42.11 99.37 Favored 'General case' 0 CA--C 1.494 -1.187 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -178.088 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.416 ' HD2' ' N ' ' A' ' 60' ' ' GLU . 0.0 OUTLIER -75.39 -28.1 59.32 Favored 'General case' 0 N--CA 1.435 -1.204 0 C-N-CA 118.839 -1.144 . . . . 0.0 110.375 176.228 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.471 ' HB3' ' HA ' ' A' ' 57' ' ' LEU . 7.5 tt0 -60.47 -38.64 84.86 Favored 'General case' 0 C--O 1.25 1.094 0 CA-C-N 114.952 -1.022 . . . . 0.0 113.124 178.835 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 73.8 m-85 -60.43 -42.24 95.64 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.944 0.72 . . . . 0.0 112.944 179.39 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . 0.265 24.8 m-20 -121.64 -82.77 0.65 Allowed 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 115.92 1.822 . . . . 0.0 115.92 -174.416 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.524 ' HB2' HD12 ' A' ' 65' ' ' ILE . 0.0 OUTLIER -114.04 138.72 22.99 Favored Pre-proline 0 C--N 1.318 -0.793 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 -177.747 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 63' ' ' LEU . 32.2 Cg_endo -98.93 27.94 0.15 Allowed 'Trans proline' 0 N--CA 1.431 -2.178 0 C-N-CA 123.858 3.038 . . . . 0.0 111.753 -170.931 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.678 ' O ' ' HA3' ' A' ' 159' ' ' GLY . 0.2 OUTLIER -61.63 -39.59 83.69 Favored 'Isoleucine or valine' 0 CA--C 1.484 -1.592 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 173.787 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 54.83 8.79 1.49 Allowed Glycine 0 CA--C 1.547 2.086 0 CA-C-N 115.263 -0.88 . . . . 0.0 113.737 -177.66 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.483 ' O ' ' HB ' ' A' ' 160' ' ' VAL . 47.8 mt 62.35 -68.15 0.12 Allowed 'Isoleucine or valine' 0 C--O 1.193 -1.904 0 C-N-CA 126.669 1.988 . . . . 0.0 113.812 -177.307 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 89.2 t80 -176.74 -54.19 0.0 OUTLIER Pre-proline 0 C--N 1.307 -1.273 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -173.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -92.05 -2.9 4.08 Favored 'Trans proline' 0 C--N 1.366 1.447 0 C-N-CA 121.74 1.626 . . . . 0.0 113.085 -172.507 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 82.77 -2.64 85.78 Favored Glycine 0 N--CA 1.429 -1.773 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.15 -179.196 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -102.75 -71.06 0.73 Allowed 'General case' 0 CA--C 1.497 -1.083 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 179.297 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.435 ' HB2' HG23 ' A' ' 88' ' ' ILE . . . -49.77 137.78 15.66 Favored 'General case' 0 CA--C 1.509 -0.604 0 CA-C-N 115.037 -0.983 . . . . 0.0 108.812 173.25 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 8.1 t 118.53 4.19 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.167 0 C-N-CA 126.735 2.014 . . . . 0.0 108.475 -169.112 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.516 ' O ' HG13 ' A' ' 86' ' ' VAL . 18.5 m-80 -72.31 -173.13 1.03 Allowed 'General case' 0 CA--C 1.497 -1.081 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 174.667 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.568 ' HB2' HD11 ' A' ' 84' ' ' LEU . 50.5 p90 -170.87 143.46 2.06 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 114.286 1.217 . . . . 0.0 114.286 178.326 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.563 ' HG3' HD12 ' A' ' 87' ' ' LEU . 52.8 mt-10 -133.11 173.34 11.53 Favored 'General case' 0 C--N 1.288 -2.074 0 C-N-CA 127.479 2.312 . . . . 0.0 105.021 174.393 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 47.2 p90 -148.45 149.54 31.89 Favored 'General case' 0 C--N 1.29 -2.017 0 CA-C-N 118.904 0.775 . . . . 0.0 110.544 178.894 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.739 ' OD1' ' HB ' ' A' ' 81' ' ' THR . 5.5 p30 -87.91 158.07 18.79 Favored 'General case' 0 C--N 1.306 -1.301 0 C-N-CA 119.682 -0.807 . . . . 0.0 111.109 174.507 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -82.59 -66.86 0.84 Allowed 'General case' 0 C--N 1.28 -2.454 0 N-CA-C 115.915 1.82 . . . . 0.0 115.915 -170.815 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.434 ' CD ' ' H ' ' A' ' 80' ' ' GLU . 0.0 OUTLIER -69.69 -21.3 63.52 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.832 -173.074 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.739 ' HB ' ' OD1' ' A' ' 78' ' ' ASP . 85.0 m -101.57 -51.01 3.56 Favored 'General case' 0 N--CA 1.408 -2.546 0 CA-C-N 114.973 -1.012 . . . . 0.0 110.52 -178.212 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.561 ' HA ' ' O ' ' A' ' 78' ' ' ASP . 39.6 mtpt 77.39 31.13 0.48 Allowed 'General case' 0 C--O 1.243 0.757 0 C-N-CA 125.959 1.703 . . . . 0.0 112.438 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.492 ' CG ' HG22 ' A' ' 109' ' ' THR . 16.4 tptm -88.8 139.3 30.6 Favored 'General case' 0 N--CA 1.404 -2.767 0 N-CA-C 106.007 -1.849 . . . . 0.0 106.007 175.845 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.634 ' O ' ' HA ' ' A' ' 109' ' ' THR . 16.0 tp -76.07 135.57 39.89 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 -176.587 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.506 HG23 ' HB2' ' A' ' 76' ' ' GLU . 3.0 t -124.86 111.57 15.64 Favored 'General case' 0 C--N 1.272 -2.777 0 CA-C-O 121.927 0.87 . . . . 0.0 109.915 178.073 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.516 HG13 ' O ' ' A' ' 74' ' ' ASN . 86.7 t -92.01 124.65 44.57 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.691 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.675 -177.501 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.656 ' H ' HD13 ' A' ' 87' ' ' LEU . 0.0 OUTLIER -90.48 117.77 29.43 Favored 'General case' 0 N--CA 1.398 -3.064 0 CA-C-N 114.944 -1.026 . . . . 0.0 108.754 176.497 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.644 HG22 ' NH1' ' A' ' 166' ' ' ARG . 48.8 mt -117.82 120.29 32.94 Favored Pre-proline 0 C--N 1.277 -2.576 0 CA-C-N 114.122 -1.399 . . . . 0.0 107.926 -175.629 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.419 ' HD2' ' HA ' ' A' ' 88' ' ' ILE . 18.8 Cg_endo -58.19 91.36 0.06 OUTLIER 'Trans proline' 0 C--N 1.358 1.053 0 C-N-CA 123.794 2.996 . . . . 0.0 113.475 -177.752 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 70.0 m 73.39 -169.92 0.12 Allowed 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.003 0.921 . . . . 0.0 112.205 -179.727 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.548 HG12 ' HA ' ' A' ' 105' ' ' THR . 66.5 mt -102.58 150.04 6.67 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.12 0 CA-C-O 120.722 0.296 . . . . 0.0 110.344 178.677 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 23.5 p -141.4 141.44 33.76 Favored 'General case' 0 CA--C 1.48 -1.734 0 N-CA-C 105.715 -1.957 . . . . 0.0 105.715 168.296 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.531 ' HB3' ' HA ' ' A' ' 103' ' ' LYS . 7.9 pt-20 -150.16 168.19 24.68 Favored 'General case' 0 C--N 1.259 -3.356 0 O-C-N 123.508 0.505 . . . . 0.0 111.022 177.916 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.511 ' O ' ' HA ' ' A' ' 101' ' ' VAL . 5.2 p -137.33 123.9 28.51 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.158 0 C-N-CA 120.587 -0.445 . . . . 0.0 111.34 -172.637 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -137.03 113.27 1.01 Allowed Glycine 0 N--CA 1.433 -1.542 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 177.306 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 48.7 t80 -149.4 -166.77 2.64 Favored 'General case' 0 N--CA 1.411 -2.414 0 N-CA-C 103.145 -2.909 . . . . 0.0 103.145 -176.848 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.41 ' HD2' ' C ' ' A' ' 97' ' ' LYS . 0.0 OUTLIER -79.55 6.62 9.99 Favored 'General case' 0 C--N 1.289 -2.04 0 CA-C-N 119.009 0.822 . . . . 0.0 109.743 174.861 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -68.05 -20.11 64.94 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-N 115.05 -0.977 . . . . 0.0 111.875 -174.216 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.649 ' O ' ' HA ' ' A' ' 127' ' ' VAL . 33.1 t 72.83 20.34 3.64 Favored 'General case' 0 C--N 1.347 0.458 0 C-N-CA 123.638 0.775 . . . . 0.0 109.498 177.509 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 20.3 m -126.31 94.75 4.16 Favored 'General case' 0 N--CA 1.406 -2.626 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 -179.724 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.511 ' HA ' ' O ' ' A' ' 94' ' ' VAL . 7.6 p -113.69 103.13 14.9 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.355 0 CA-C-O 121.889 0.852 . . . . 0.0 110.497 176.853 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.526 ' HG ' HG23 ' A' ' 125' ' ' THR . 4.3 mp -116.92 134.15 55.12 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 114.698 -1.137 . . . . 0.0 109.001 -177.587 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.531 ' HA ' ' HB3' ' A' ' 93' ' ' GLU . 4.4 ttmp? -103.01 111.95 24.55 Favored 'General case' 0 C--N 1.312 -1.046 0 N-CA-C 109.57 -0.529 . . . . 0.0 109.57 175.824 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.45 ' O ' ' HA ' ' A' ' 91' ' ' ILE . 98.3 m-85 -95.34 101.45 13.18 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 176.944 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.548 ' HA ' HG12 ' A' ' 91' ' ' ILE . 14.7 t -87.56 179.7 6.49 Favored 'General case' 0 N--CA 1.443 -0.784 0 O-C-N 123.63 0.581 . . . . 0.0 111.612 -173.732 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.434 ' HA ' ' O ' ' A' ' 88' ' ' ILE . 37.3 p -67.6 -35.66 79.4 Favored 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 124.051 0.94 . . . . 0.0 113.293 -176.322 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 27.8 p -133.13 110.2 10.01 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-O 120.811 0.339 . . . . 0.0 111.14 178.922 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 61.5 t -109.6 131.38 60.65 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.699 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 176.067 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.634 ' HA ' ' O ' ' A' ' 84' ' ' LEU . 11.5 m -114.15 122.01 45.52 Favored 'General case' 0 N--CA 1.42 -1.962 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 -172.094 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.563 ' HA3' ' O ' ' A' ' 119' ' ' ASP . . . -155.16 -158.42 8.74 Favored Glycine 0 N--CA 1.442 -0.904 0 C-N-CA 120.305 -0.95 . . . . 0.0 114.058 -175.654 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 78.7 t60 -120.09 127.17 52.3 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-O 121.337 0.589 . . . . 0.0 110.532 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.539 ' HA ' HD22 ' A' ' 117' ' ' LEU . 1.2 tt -95.35 128.08 41.91 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 115.542 -0.753 . . . . 0.0 109.675 -174.571 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.527 ' HB2' ' O ' ' A' ' 116' ' ' LYS . 35.1 mm-40 -131.04 165.31 23.5 Favored 'General case' 0 CA--C 1.495 -1.144 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 171.736 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 57.2 tptt -84.15 101.36 11.78 Favored 'General case' 0 N--CA 1.414 -2.243 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 178.401 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' GLY . . . . . 0.701 ' O ' ' HB ' ' A' ' 138' ' ' THR . . . 120.18 -56.54 0.59 Allowed Glycine 0 N--CA 1.418 -2.51 0 C-N-CA 120.027 -1.082 . . . . 0.0 111.494 179.547 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.527 ' O ' ' HB2' ' A' ' 113' ' ' GLU . 0.0 OUTLIER -126.23 127.51 45.76 Favored 'General case' 0 C--N 1.298 -1.654 0 CA-C-O 121.577 0.704 . . . . 0.0 112.542 -177.663 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.539 HD22 ' HA ' ' A' ' 112' ' ' LEU . 1.8 tm? -100.95 107.54 19.05 Favored 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 106.989 -1.485 . . . . 0.0 106.989 -176.69 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.574 ' HA ' ' HB2' ' A' ' 135' ' ' SER . 12.4 p -110.47 153.63 24.78 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 -178.559 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' ASP . . . . . 0.563 ' O ' ' HA3' ' A' ' 110' ' ' GLY . 20.7 m-20 69.53 115.92 0.04 OUTLIER 'General case' 0 C--O 1.206 -1.224 0 C-N-CA 124.379 1.071 . . . . 0.0 109.828 -174.836 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 8.5 m -140.37 85.38 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.115 0 CA-C-O 122.398 1.094 . . . . 0.0 111.312 179.258 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -79.05 101.95 8.11 Favored 'General case' 0 C--N 1.289 -2.026 0 CA-C-N 114.474 -1.239 . . . . 0.0 107.8 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 139.38 -22.48 2.88 Favored Glycine 0 C--N 1.297 -1.608 0 N-CA-C 110.525 -1.03 . . . . 0.0 110.525 -177.371 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 89.9 mt -100.09 107.71 21.45 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.059 0 CA-C-O 121.918 0.866 . . . . 0.0 109.403 178.837 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 57.5 mttp -107.1 122.9 47.41 Favored 'General case' 0 C--N 1.288 -2.104 0 CA-C-N 114.304 -1.317 . . . . 0.0 108.756 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.526 HG23 ' HG ' ' A' ' 102' ' ' LEU . 72.1 m -130.89 130.04 43.03 Favored 'General case' 0 N--CA 1.431 -1.385 0 O-C-N 123.851 0.72 . . . . 0.0 112.633 -172.298 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.541 ' C ' ' HD3' ' A' ' 126' ' ' LYS . 0.4 OUTLIER -113.48 126.52 55.41 Favored 'General case' 0 N--CA 1.42 -1.962 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 167.996 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.649 ' HA ' ' O ' ' A' ' 99' ' ' SER . 2.3 p -135.74 -65.05 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.873 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.517 177.239 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 128' ' ' MET . . . . . 0.567 ' SD ' HG13 ' A' ' 127' ' ' VAL . 0.0 OUTLIER -106.59 -29.76 9.44 Favored 'General case' 0 N--CA 1.399 -3.017 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 177.556 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 42.5 mm -148.92 162.31 5.05 Favored 'Isoleucine or valine' 0 C--O 1.248 1.0 0 N-CA-C 104.315 -2.476 . . . . 0.0 104.315 177.135 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 87.4 t90 -81.47 117.46 21.91 Favored 'General case' 0 N--CA 1.443 -0.786 0 N-CA-C 108.234 -1.025 . . . . 0.0 108.234 175.208 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.575 HG12 ' H ' ' A' ' 133' ' ' VAL . 47.5 t -123.04 141.64 42.62 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.903 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 -177.944 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 64.4 pttt -100.85 21.95 12.84 Favored 'General case' 0 C--N 1.306 -1.306 0 C-N-CA 119.326 -0.949 . . . . 0.0 111.876 -177.552 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.575 ' H ' HG12 ' A' ' 131' ' ' VAL . 61.5 t -133.82 -82.12 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 C-N-CA 120.712 -0.395 . . . . 0.0 110.548 176.768 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' THR . . . . . 0.48 ' O ' ' HB ' ' A' ' 146' ' ' THR . 70.5 p 49.9 76.93 0.12 Allowed 'General case' 0 CA--C 1.536 0.414 0 CA-C-O 121.619 0.724 . . . . 0.0 111.097 -171.184 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 135' ' ' SER . . . . . 0.593 ' O ' ' HA ' ' A' ' 146' ' ' THR . 12.5 p -83.15 153.85 24.59 Favored 'General case' 0 N--CA 1.431 -1.391 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 -176.257 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 136' ' ' ILE . . . . . 0.428 ' HB ' HG22 ' A' ' 146' ' ' THR . 14.5 tt -100.84 128.89 52.53 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.396 0 CA-C-O 121.891 0.853 . . . . 0.0 112.259 -170.617 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 19.8 m -101.3 147.52 26.21 Favored 'General case' 0 N--CA 1.421 -1.894 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 178.081 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' THR . . . . . 0.701 ' HB ' ' O ' ' A' ' 115' ' ' GLY . 98.8 m -155.77 152.31 28.32 Favored 'General case' 0 C--N 1.284 -2.247 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 -178.301 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 73.5 m-20 -87.36 23.07 1.97 Allowed 'General case' 0 N--CA 1.482 1.162 0 O-C-N 121.597 -0.69 . . . . 0.0 109.965 176.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . 61.47 35.95 17.39 Favored 'General case' 0 C--N 1.351 0.631 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 -170.842 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' SER . . . . . 0.426 ' HA ' ' HG2' ' A' ' 64' ' ' PRO . 43.3 t -173.87 -79.18 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 113.972 -1.467 . . . . 0.0 109.492 -173.812 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.453 ' O ' HG23 ' A' ' 138' ' ' THR . 97.9 mttt -88.0 151.46 22.76 Favored 'General case' 0 CA--C 1.509 -0.631 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 -179.48 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.506 HG22 HG22 ' A' ' 65' ' ' ILE . 24.4 t -105.97 136.78 38.99 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 O-C-N 123.545 0.528 . . . . 0.0 111.442 -167.933 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 144' ' ' TYR . . . . . 0.402 ' HD2' ' HG ' ' A' ' 152' ' ' SER . 87.9 m-85 -124.5 155.56 38.74 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-O 120.833 0.349 . . . . 0.0 111.527 -177.97 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 35.3 p90 -45.93 148.34 0.83 Allowed 'General case' 0 C--O 1.243 0.737 0 N-CA-C 115.346 1.609 . . . . 0.0 115.346 -178.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.593 ' HA ' ' O ' ' A' ' 135' ' ' SER . 69.3 p -93.05 -16.02 25.47 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-N 114.915 -1.038 . . . . 0.0 110.973 179.176 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -136.36 149.17 48.23 Favored 'General case' 0 N--CA 1.441 -0.876 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 -177.827 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -83.04 74.71 2.49 Favored Glycine 0 CA--C 1.497 -1.037 0 N-CA-C 111.289 -0.725 . . . . 0.0 111.289 -176.67 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 1.3 tmt? 174.5 -36.27 0.0 OUTLIER 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 105.87 -1.9 . . . . 0.0 105.87 -177.616 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 22.8 ttmm -75.43 168.49 19.9 Favored 'General case' 0 N--CA 1.411 -2.425 0 CA-C-N 112.469 -2.15 . . . . 0.0 109.074 -179.141 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 61.0 mttp -119.92 164.03 16.67 Favored 'General case' 0 C--N 1.31 -1.133 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 -171.738 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' SER . . . . . 0.453 ' HB3' ' O ' ' A' ' 143' ' ' VAL . 35.6 m -85.82 160.86 19.36 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 115.398 -0.819 . . . . 0.0 112.806 -175.69 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 153' ' ' ARG . . . . . 0.51 ' HG2' ' H ' ' A' ' 161' ' ' GLN . 12.0 mpt_? -126.56 164.2 21.73 Favored 'General case' 0 CA--C 1.516 -0.351 0 C-N-CA 123.571 0.748 . . . . 0.0 111.282 -179.883 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 35.0 m -94.38 145.3 24.86 Favored 'General case' 0 C--N 1.296 -1.748 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.784 177.768 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -61.16 -37.46 82.98 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 176.47 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -58.3 -26.16 62.69 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 123.749 0.82 . . . . 0.0 111.656 177.445 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.431 ' HB1' ' HG3' ' A' ' 161' ' ' GLN . . . -79.56 1.21 26.77 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 115.692 -0.685 . . . . 0.0 112.017 -177.608 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 88.7 m-85 93.54 20.94 0.02 OUTLIER 'General case' 0 CA--C 1.493 -1.241 0 C-N-CA 125.888 1.675 . . . . 0.0 111.189 -176.432 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 159' ' ' GLY . . . . . 0.678 ' HA3' ' O ' ' A' ' 65' ' ' ILE . . . 87.04 -86.04 1.54 Allowed Glycine 0 N--CA 1.408 -3.219 0 CA-C-N 114.757 -1.111 . . . . 0.0 113.115 175.645 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.483 ' HB ' ' O ' ' A' ' 67' ' ' ILE . 6.8 t -104.57 116.48 48.44 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.138 0 C-N-CA 119.849 -0.74 . . . . 0.0 109.686 -174.758 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 161' ' ' GLN . . . . . 0.51 ' H ' ' HG2' ' A' ' 153' ' ' ARG . 12.5 mm-40 -116.33 99.87 7.5 Favored 'General case' 0 CA--C 1.486 -1.505 0 N-CA-C 116.521 2.045 . . . . 0.0 116.521 -174.847 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 162' ' ' ARG . . . . . 0.635 ' NE ' ' HA ' ' A' ' 162' ' ' ARG . 1.5 tpm_? -152.66 105.23 2.96 Favored 'General case' 0 N--CA 1.4 -2.933 0 N-CA-C 105.504 -2.035 . . . . 0.0 105.504 170.886 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 19.0 m120 -45.63 104.12 0.04 OUTLIER 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 115.875 1.806 . . . . 0.0 115.875 -172.403 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -151.66 156.21 26.56 Favored Glycine 0 N--CA 1.435 -1.425 0 N-CA-C 108.449 -1.86 . . . . 0.0 108.449 176.18 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -128.19 135.47 49.77 Favored 'General case' 0 N--CA 1.429 -1.508 0 CA-C-N 118.025 0.913 . . . . 0.0 109.929 -179.296 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 166' ' ' ARG . . . . . 0.644 ' NH1' HG22 ' A' ' 88' ' ' ILE . 3.1 mmp_? -65.76 122.44 17.31 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 106.496 -1.668 . . . . 0.0 106.496 179.541 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 25.1 t -74.18 61.99 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.559 1.308 0 CA-C-O 122.615 1.197 . . . . 0.0 109.596 175.256 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -165.83 -33.82 0.03 OUTLIER 'General case' 0 C--N 1.296 -1.735 0 C-N-CA 126.457 1.903 . . . . 0.0 106.742 -177.237 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 16.4 tppt? -76.37 110.47 10.93 Favored 'General case' 0 N--CA 1.434 -1.25 0 CA-C-N 114.349 -1.296 . . . . 0.0 111.932 -177.153 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 170' ' ' PHE . . . . . . . . . . . . . 69.7 t80 . . . . . 0 N--CA 1.432 -1.352 0 N-CA-C 106.456 -1.683 . . . . 0.0 106.456 176.588 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 58.0 p . . . . . 0 C--O 1.247 0.966 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -137.94 89.78 2.43 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 116.7 -0.227 . . . . 0.0 111.031 179.27 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 5.5 pm0 -154.48 148.88 26.16 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 177.947 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 6.9 tp -139.47 118.85 13.12 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.181 0 CA-C-O 121.157 0.503 . . . . 0.0 110.009 178.101 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 83.7 m-85 -104.73 126.18 51.55 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.198 0.523 . . . . 0.0 111.074 -179.018 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -123.33 136.25 54.58 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 115.298 -0.865 . . . . 0.0 109.134 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -138.56 95.88 3.06 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-O 120.692 0.282 . . . . 0.0 111.35 -178.774 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 11.6 p 173.41 146.55 0.02 OUTLIER 'Isoleucine or valine' 0 C--O 1.237 0.425 0 C-N-CA 124.566 1.146 . . . . 0.0 108.501 177.209 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -137.84 -167.95 11.19 Favored Glycine 0 N--CA 1.429 -1.8 0 N-CA-C 110.125 -1.19 . . . . 0.0 110.125 178.549 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 41.6 t -84.19 100.62 11.29 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 178.556 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 76.2 t80 -131.66 100.58 5.17 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 -179.154 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 88.8 m95 -136.66 139.09 41.76 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.068 -177.269 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 5.6 mp -107.95 136.06 48.28 Favored 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 177.281 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -127.21 138.4 10.5 Favored Glycine 0 N--CA 1.432 -1.605 0 C-N-CA 120.648 -0.787 . . . . 0.0 111.56 179.768 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 16.3 tm0? -153.79 110.73 3.4 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 178.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 59.4 pttt -140.19 80.33 1.76 Allowed 'General case' 0 C--N 1.296 -1.751 0 CA-C-O 121.991 0.9 . . . . 0.0 109.549 175.078 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -147.48 88.81 1.73 Allowed 'General case' 0 C--N 1.299 -1.62 0 CA-C-N 115.009 -0.996 . . . . 0.0 109.777 -178.232 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -143.29 94.17 2.58 Favored 'General case' 0 C--N 1.286 -2.17 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 177.95 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 61.9 tttp -82.28 99.61 9.43 Favored 'General case' 0 N--CA 1.422 -1.847 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.642 -179.577 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 47.3 tt0 -58.1 -64.1 1.03 Allowed 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.257 -0.883 . . . . 0.0 109.754 177.784 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 85.6 t80 57.86 90.4 0.04 OUTLIER 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 114.966 1.469 . . . . 0.0 114.966 175.78 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -143.98 136.54 26.97 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 105.983 -1.858 . . . . 0.0 105.983 169.764 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 25.8 t -150.55 110.88 4.18 Favored 'General case' 0 C--N 1.293 -1.863 0 C-N-CA 120.275 -0.57 . . . . 0.0 110.382 -176.428 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 10.8 p -103.75 -17.03 7.4 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 CA-C-O 122.068 0.937 . . . . 0.0 108.507 177.54 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 90.55 -125.1 7.79 Favored Glycine 0 N--CA 1.419 -2.445 0 CA-C-N 114.885 -1.052 . . . . 0.0 111.367 -179.409 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -152.93 -62.16 0.15 Allowed 'General case' 0 C--N 1.31 -1.144 0 CA-C-O 119.744 -0.17 . . . . 0.0 110.839 179.581 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -153.53 -78.53 0.1 Allowed 'General case' 0 CA--C 1.518 -0.277 0 C-N-CA 119.774 -0.77 . . . . 0.0 112.872 177.436 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.484 ' O ' HD13 ' A' ' 28' ' ' LEU . 2.6 tm? -115.89 -28.9 6.53 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 -177.671 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 43.1 t-20 77.2 -55.01 0.55 Allowed 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 124.483 1.113 . . . . 0.0 111.991 176.204 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 25.4 m -71.33 109.55 5.41 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-O 121.315 0.578 . . . . 0.0 111.914 -177.732 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 12.3 p -109.02 -15.42 9.49 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.043 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 175.071 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 35.6 t 77.0 129.7 0.05 OUTLIER 'General case' 0 C--O 1.24 0.604 0 C-N-CA 125.468 1.507 . . . . 0.0 112.271 179.711 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 91.0 m -155.14 128.73 8.52 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.431 -0.804 . . . . 0.0 108.996 179.062 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 44.4 p -139.05 114.45 9.71 Favored 'General case' 0 C--N 1.311 -1.085 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 178.392 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 67.9 mt -128.48 119.19 49.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 O-C-N 122.416 -0.177 . . . . 0.0 110.546 -176.48 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -134.48 160.03 39.27 Favored 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 179.349 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -84.55 -70.8 1.33 Allowed Glycine 0 N--CA 1.428 -1.839 0 N-CA-C 108.433 -1.867 . . . . 0.0 108.433 172.929 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 108.33 -111.61 3.37 Favored Glycine 0 N--CA 1.426 -2.02 0 C-N-CA 120.806 -0.711 . . . . 0.0 113.073 175.25 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 27.3 p -81.15 146.83 30.34 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 -175.231 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 64.9 mttp -143.28 123.29 13.58 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 175.596 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.413 ' C ' HD12 ' A' ' 42' ' ' LEU . 88.6 t90 -125.99 126.96 45.16 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 179.883 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.413 HD12 ' C ' ' A' ' 41' ' ' TRP . 5.2 mp -131.68 152.3 50.98 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.2 p -108.15 130.77 60.12 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 175.6 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 56.9 t30 -165.08 168.91 16.83 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 -175.688 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 10.3 mtmp? 75.37 118.63 0.05 Allowed 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 125.124 1.37 . . . . 0.0 113.905 175.678 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 60.7 mt 67.64 102.7 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.244 0.777 0 C-N-CA 125.119 1.368 . . . . 0.0 112.207 178.991 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -128.49 130.11 47.04 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 -179.039 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -96.07 -156.71 31.43 Favored Glycine 0 C--O 1.243 0.707 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.617 -177.751 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -84.44 91.8 7.91 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.981 0.896 . . . . 0.0 110.066 178.364 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 84.7 mtp -90.69 88.83 7.25 Favored 'General case' 0 C--N 1.298 -1.655 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.405 -177.652 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 28.2 pt20 -128.9 -23.23 3.11 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-N 114.456 -1.247 . . . . 0.0 108.364 177.59 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 62.0 pttt -149.06 160.42 35.05 Favored Pre-proline 0 N--CA 1.425 -1.691 0 N-CA-C 106.251 -1.759 . . . . 0.0 106.251 175.718 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -77.35 -3.74 13.98 Favored 'Trans proline' 0 C--O 1.21 -0.906 0 C-N-CA 122.355 2.036 . . . . 0.0 115.764 -170.723 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.565 ' HB3' ' HD3' ' A' ' 55' ' ' PRO . 14.0 tp -53.5 -50.54 82.5 Favored Pre-proline 0 N--CA 1.495 1.778 0 N-CA-C 113.373 0.879 . . . . 0.0 113.373 -173.572 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.565 ' HD3' ' HB3' ' A' ' 54' ' ' LEU . 80.6 Cg_exo -59.22 -19.99 52.69 Favored 'Trans proline' 0 C--N 1.369 1.607 0 C-N-CA 123.086 2.524 . . . . 0.0 111.544 -178.183 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.461 ' HA ' ' HE2' ' A' ' 59' ' ' LYS . 21.3 mm-40 -81.1 -32.03 34.05 Favored 'General case' 0 N--CA 1.413 -2.312 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 -175.614 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.455 ' HA ' ' HG2' ' A' ' 60' ' ' GLU . 3.8 mm? -75.34 -49.23 19.76 Favored 'General case' 0 CA--C 1.483 -1.617 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.695 177.168 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.47 ' HA ' ' CD1' ' A' ' 75' ' ' TYR 0.323 2.5 pp -61.77 -38.95 89.93 Favored 'General case' 0 C--O 1.21 -1.0 0 C-N-CA 119.375 -0.93 . . . . 0.0 113.032 -176.162 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.461 ' HE2' ' HA ' ' A' ' 56' ' ' GLU . 63.7 pttt -75.5 -26.97 58.57 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 120.017 -0.673 . . . . 0.0 111.002 -179.867 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.455 ' HG2' ' HA ' ' A' ' 57' ' ' LEU . 11.2 pt-20 -79.78 -28.48 40.32 Favored 'General case' 0 C--N 1.351 0.65 0 C-N-CA 119.892 -0.723 . . . . 0.0 110.866 -177.896 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 78.5 m-85 -86.33 -1.58 57.64 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 118.799 -1.16 . . . . 0.0 112.269 175.336 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.517 ' HB2' HG23 ' A' ' 73' ' ' THR . 15.4 t70 -93.2 -171.91 2.8 Favored 'General case' 0 C--N 1.306 -1.308 0 C-N-CA 125.709 1.603 . . . . 0.0 108.607 178.079 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.617 ' HB2' HD12 ' A' ' 65' ' ' ILE . 17.0 mt -85.47 -153.84 0.0 OUTLIER Pre-proline 0 CA--C 1.576 1.969 0 N-CA-C 103.488 -2.782 . . . . 0.0 103.488 174.175 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.573 ' O ' ' HD2' ' A' ' 155' ' ' ARG . 17.7 Cg_endo -100.87 8.78 0.58 Allowed 'Trans proline' 0 N--CA 1.436 -1.883 0 CA-C-N 123.998 2.464 . . . . 0.0 111.241 176.125 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.824 HG12 ' H ' ' A' ' 67' ' ' ILE . 0.1 OUTLIER -78.69 -38.21 21.5 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.461 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 -176.641 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.419 ' H ' HD13 ' A' ' 65' ' ' ILE . . . 60.08 9.39 10.93 Favored Glycine 0 N--CA 1.48 1.579 0 CA-C-O 122.517 1.065 . . . . 0.0 110.702 -176.16 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.824 ' H ' HG12 ' A' ' 65' ' ' ILE . 48.7 mt 63.51 -68.73 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.41 -2.442 0 C-N-CA 128.136 2.574 . . . . 0.0 110.349 -172.516 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.425 ' CD2' ' HD3' ' A' ' 162' ' ' ARG . 91.0 t80 -177.53 -55.72 0.0 OUTLIER Pre-proline 0 C--N 1.308 -1.231 0 N-CA-C 113.702 1.001 . . . . 0.0 113.702 -175.83 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.412 ' HB2' ' OD2' ' A' ' 71' ' ' ASP . 10.8 Cg_endo -91.93 -29.31 0.13 Allowed 'Trans proline' 0 C--N 1.361 1.215 0 C-N-CA 121.573 1.516 . . . . 0.0 115.396 -170.083 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 94.22 -16.97 59.82 Favored Glycine 0 N--CA 1.442 -0.943 0 N-CA-C 110.012 -1.235 . . . . 0.0 110.012 -172.009 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.465 ' CB ' ' HG2' ' A' ' 89' ' ' PRO . 30.0 m-20 -78.84 -38.56 37.71 Favored 'General case' 0 CA--C 1.506 -0.726 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 177.617 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.6 ' O ' ' HB ' ' A' ' 73' ' ' THR . . . -78.53 178.61 7.64 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 114.282 -1.326 . . . . 0.0 108.063 170.41 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.6 ' HB ' ' O ' ' A' ' 72' ' ' ALA . 3.0 m 85.25 6.42 0.47 Allowed 'General case' 0 N--CA 1.483 1.182 0 CA-C-O 123.739 1.733 . . . . 0.0 111.534 175.1 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.563 ' O ' ' HA ' ' A' ' 86' ' ' VAL . 4.9 m-20 -64.93 132.97 50.78 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-N 114.079 -1.418 . . . . 0.0 110.307 177.603 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.52 ' HB2' HD21 ' A' ' 84' ' ' LEU . 11.5 p90 -108.94 99.21 8.58 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 113.385 0.883 . . . . 0.0 113.385 -173.487 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 58.9 mm-40 -117.69 133.49 55.89 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 174.913 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 41.2 p90 -144.57 145.24 31.71 Favored 'General case' 0 C--N 1.295 -1.795 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 -179.205 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.612 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 35.3 m-20 -96.02 173.97 7.16 Favored 'General case' 0 CA--C 1.476 -1.87 0 C-N-CA 119.623 -0.831 . . . . 0.0 109.357 178.028 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -79.27 -65.37 1.01 Allowed 'General case' 0 C--N 1.283 -2.319 0 CA-C-N 114.784 -1.098 . . . . 0.0 111.843 -176.902 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.406 ' H ' ' CD ' ' A' ' 80' ' ' GLU . 0.1 OUTLIER -74.91 -29.75 61.07 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.112 -175.451 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.612 ' HB ' ' HB2' ' A' ' 78' ' ' ASP . 17.5 m -65.41 -43.27 91.1 Favored 'General case' 0 N--CA 1.428 -1.526 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.581 179.605 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 46.6 mmtm 61.16 14.49 5.55 Favored 'General case' 0 N--CA 1.495 1.778 0 C-N-CA 123.409 0.684 . . . . 0.0 112.098 -177.931 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.601 ' CD ' HG22 ' A' ' 109' ' ' THR . 31.5 ttmt -116.38 128.4 55.48 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-O 121.247 0.546 . . . . 0.0 110.531 -176.13 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.52 HD21 ' HB2' ' A' ' 75' ' ' TYR . 2.0 tm? -84.65 126.67 33.56 Favored 'General case' 0 C--N 1.296 -1.72 0 CA-C-N 114.388 -1.278 . . . . 0.0 109.163 -173.625 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.528 ' HA ' ' O ' ' A' ' 108' ' ' VAL . 68.1 p -107.06 115.08 29.56 Favored 'General case' 0 N--CA 1.409 -2.483 0 CA-C-N 115.474 -0.785 . . . . 0.0 109.41 178.327 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.563 ' HA ' ' O ' ' A' ' 74' ' ' ASN . 58.6 t -92.57 120.69 42.3 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 179.384 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 5.3 mp -83.34 103.14 12.49 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-O 121.472 0.653 . . . . 0.0 109.467 -179.823 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.514 ' O ' ' HA ' ' A' ' 106' ' ' THR . 46.7 mm -83.34 115.2 58.0 Favored Pre-proline 0 N--CA 1.412 -2.338 0 N-CA-C 104.793 -2.299 . . . . 0.0 104.793 171.915 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.465 ' HG2' ' CB ' ' A' ' 71' ' ' ASP . 1.0 OUTLIER -37.46 -41.18 0.91 Allowed 'Trans proline' 0 N--CA 1.485 1.017 0 C-N-CA 125.146 3.897 . . . . 0.0 115.715 -175.047 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.512 ' HB2' ' HB2' ' A' ' 168' ' ' ASP . 47.9 t -157.15 166.1 34.17 Favored 'General case' 0 C--N 1.284 -2.268 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.439 HG13 ' HD3' ' A' ' 103' ' ' LYS . 6.0 tt -71.81 119.83 19.0 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.336 0 CA-C-O 121.642 0.734 . . . . 0.0 109.883 179.763 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' CYS . . . . . 0.452 ' SG ' ' HB2' ' A' ' 104' ' ' PHE . 19.0 p -115.97 123.42 47.99 Favored 'General case' 0 C--N 1.29 -1.995 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 174.383 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -103.66 111.33 23.76 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 107.019 -1.475 . . . . 0.0 107.019 175.532 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.615 HG21 ' HA ' ' A' ' 162' ' ' ARG . 5.2 p -108.5 102.65 14.3 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.03 0 C-N-CA 118.812 -1.155 . . . . 0.0 113.925 -178.919 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -144.82 113.0 0.69 Allowed Glycine 0 N--CA 1.431 -1.639 0 N-CA-C 108.102 -1.999 . . . . 0.0 108.102 176.075 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 43.2 t80 174.31 -51.02 0.01 OUTLIER 'General case' 0 CA--C 1.503 -0.861 0 CA-C-O 122.884 1.325 . . . . 0.0 108.34 -172.323 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.34 8.6 18.12 Favored 'General case' 0 C--N 1.294 -1.825 0 CA-C-N 112.865 -1.97 . . . . 0.0 113.644 -168.486 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -158.55 -79.09 0.07 Allowed 'General case' 0 C--N 1.315 -0.926 0 C-N-CA 119.583 -0.847 . . . . 0.0 111.86 -174.32 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 34.6 t 165.9 -38.66 0.0 OUTLIER 'General case' 0 C--N 1.31 -1.143 0 N-CA-C 104.296 -2.483 . . . . 0.0 104.296 -176.378 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 14.1 m -71.71 125.24 26.62 Favored 'General case' 0 N--CA 1.42 -1.958 0 CA-C-N 113.659 -1.61 . . . . 0.0 109.664 177.832 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 46.3 t -105.62 116.22 48.97 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.085 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 179.154 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.566 ' HG ' ' CG2' ' A' ' 125' ' ' THR . 5.5 mp -114.42 121.16 42.71 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 110.198 -0.297 . . . . 0.0 110.198 -176.54 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.439 ' HD3' HG13 ' A' ' 91' ' ' ILE . 0.4 OUTLIER -111.32 109.12 18.98 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-O 121.571 0.701 . . . . 0.0 110.95 178.677 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.452 ' HB2' ' SG ' ' A' ' 92' ' ' CYS . 94.5 m-85 -91.02 125.33 35.78 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 114.825 -1.079 . . . . 0.0 108.5 179.28 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.479 ' O ' HG13 ' A' ' 108' ' ' VAL . 13.2 m -100.16 147.32 25.82 Favored 'General case' 0 C--N 1.294 -1.817 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.642 -175.155 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.514 ' HA ' ' O ' ' A' ' 88' ' ' ILE . 14.9 m -56.81 120.82 8.52 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 172.65 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 39.0 m 66.14 78.28 0.27 Allowed 'General case' 0 C--N 1.308 -1.198 0 CA-C-O 122.038 0.923 . . . . 0.0 111.676 -177.461 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.528 ' O ' ' HA ' ' A' ' 85' ' ' THR . 3.7 m -93.45 133.17 35.46 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.161 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.391 175.146 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.601 HG22 ' CD ' ' A' ' 83' ' ' LYS 0.26 7.8 m -105.56 118.0 35.46 Favored 'General case' 0 N--CA 1.406 -2.626 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 -168.239 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.552 ' HA3' HG12 ' A' ' 120' ' ' VAL . . . -157.97 167.88 34.38 Favored Glycine 0 CA--C 1.494 -1.27 0 C-N-CA 119.945 -1.122 . . . . 0.0 113.316 -177.73 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 14.2 t-80 -90.91 101.89 14.65 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 179.788 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 68.0 tp -96.73 109.02 21.76 Favored 'General case' 0 CA--C 1.484 -1.577 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.739 -174.762 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -106.15 156.5 18.38 Favored 'General case' 0 CA--C 1.448 -2.96 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 173.037 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 1.6 tmtm? -79.55 100.7 7.89 Favored 'General case' 0 N--CA 1.384 -3.772 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 -176.344 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 138.31 -51.8 0.76 Allowed Glycine 0 C--N 1.296 -1.691 0 N-CA-C 108.419 -1.872 . . . . 0.0 108.419 -174.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.564 ' HB2' ' HA ' ' A' ' 137' ' ' SER . 0.0 OUTLIER -140.83 137.28 33.16 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-O 121.43 0.633 . . . . 0.0 112.149 -179.013 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.528 ' O ' ' HB3' ' A' ' 135' ' ' SER . 46.3 tp -102.25 105.8 16.51 Favored 'General case' 0 C--N 1.305 -1.326 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 175.275 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.515 ' HA ' ' HB3' ' A' ' 135' ' ' SER . 27.7 p -120.53 145.93 46.81 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 112.505 0.557 . . . . 0.0 112.505 -173.979 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 119' ' ' ASP . . . . . 0.532 ' O ' ' HA2' ' A' ' 110' ' ' GLY . 34.5 t70 64.4 87.96 0.11 Allowed 'General case' 0 C--O 1.215 -0.715 0 O-C-N 124.117 0.885 . . . . 0.0 110.096 -179.468 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.552 HG12 ' HA3' ' A' ' 110' ' ' GLY . 3.1 m -124.89 104.31 13.48 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.489 0 CA-C-O 122.671 1.224 . . . . 0.0 112.081 -172.779 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -86.41 100.88 12.65 Favored 'General case' 0 C--N 1.26 -3.313 0 CA-C-N 113.292 -1.776 . . . . 0.0 108.401 178.344 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 139.7 -15.5 3.12 Favored Glycine 0 N--CA 1.428 -1.871 0 CA-C-N 115.209 -0.905 . . . . 0.0 112.347 178.729 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 65.3 mt -99.28 102.76 13.83 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.23 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 178.978 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.412 ' HA ' ' HA ' ' A' ' 132' ' ' LYS . 95.3 mttt -106.13 119.26 38.75 Favored 'General case' 0 C--N 1.282 -2.352 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 -176.51 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.566 ' CG2' ' HG ' ' A' ' 102' ' ' LEU . 49.7 m -139.64 148.43 42.43 Favored 'General case' 0 C--N 1.293 -1.878 0 CA-C-N 115.429 -0.805 . . . . 0.0 112.671 -168.917 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.468 ' HA ' ' HA ' ' A' ' 130' ' ' TRP . 40.9 tttp -108.11 122.24 46.49 Favored 'General case' 0 N--CA 1.424 -1.74 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 172.963 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.438 ' CG1' ' HB3' ' A' ' 150' ' ' LYS . 15.9 t -138.56 101.15 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.208 0 N-CA-C 104.142 -2.54 . . . . 0.0 104.142 169.663 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER 73.67 -52.88 0.7 Allowed 'General case' 0 CA--C 1.544 0.729 0 O-C-N 124.305 1.003 . . . . 0.0 108.594 -171.075 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 9.0 tp -137.51 158.65 34.8 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.264 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 176.615 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' TRP . . . . . 0.468 ' HA ' ' HA ' ' A' ' 126' ' ' LYS . 42.6 t-105 -78.2 122.31 25.51 Favored 'General case' 0 C--O 1.241 0.644 0 CA-C-O 121.185 0.517 . . . . 0.0 110.708 -179.135 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 48.5 t -125.06 132.05 71.76 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 177.619 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' LYS . . . . . 0.412 ' HA ' ' HA ' ' A' ' 124' ' ' LYS . 63.1 pttt -88.85 28.6 1.13 Allowed 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 112.268 0.47 . . . . 0.0 112.268 -176.989 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 44.7 t -132.74 -78.09 0.15 Allowed 'Isoleucine or valine' 0 C--O 1.214 -0.812 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 -179.059 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 38.5 p 46.89 80.21 0.05 Allowed 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 113.615 0.968 . . . . 0.0 113.615 -179.499 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' SER . . . . . 0.528 ' HB3' ' O ' ' A' ' 117' ' ' LEU . 28.3 m -84.68 153.61 23.0 Favored 'General case' 0 N--CA 1.424 -1.729 0 CA-C-N 115.898 -0.592 . . . . 0.0 112.036 -177.653 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 67.5 mt -100.67 97.91 6.3 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.231 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' SER . . . . . 0.619 ' O ' ' HB2' ' A' ' 144' ' ' TYR . 29.1 t -119.89 126.86 51.96 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-N 115.914 -0.584 . . . . 0.0 109.569 -174.187 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 9.3 t -162.12 177.58 9.56 Favored 'General case' 0 N--CA 1.424 -1.747 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 -173.871 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -109.9 75.02 0.92 Allowed 'General case' 0 C--N 1.306 -1.324 0 C-N-CA 120.389 -0.524 . . . . 0.0 109.906 176.356 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . 27.43 72.42 0.04 OUTLIER 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 125.603 1.561 . . . . 0.0 113.994 177.303 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 40.2 t 177.68 -63.59 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 -177.864 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -95.09 -169.65 2.03 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 179.31 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 13.2 p -142.66 123.04 10.52 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.347 0 CA-C-O 121.365 0.603 . . . . 0.0 109.894 177.087 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' TYR . . . . . 0.619 ' HB2' ' O ' ' A' ' 137' ' ' SER . 94.0 m-85 -128.97 155.61 45.09 Favored 'General case' 0 CA--C 1.487 -1.473 0 CA-C-O 121.41 0.624 . . . . 0.0 110.574 -179.587 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 145' ' ' PHE . . . . . 0.437 ' HB2' ' HB2' ' A' ' 151' ' ' LYS . 81.7 m-85 -112.72 113.81 26.1 Favored 'General case' 0 N--CA 1.407 -2.579 0 CA-C-N 114.565 -1.198 . . . . 0.0 109.145 176.987 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.464 ' CG2' ' HB2' ' A' ' 135' ' ' SER . 9.1 t -79.82 33.41 0.27 Allowed 'General case' 0 CA--C 1.56 1.337 0 CA-C-O 122.115 0.96 . . . . 0.0 111.404 -174.512 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -75.48 -19.67 59.26 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.349 179.368 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 134.02 50.54 0.08 OUTLIER Glycine 0 CA--C 1.475 -2.428 0 N-CA-C 108.987 -1.645 . . . . 0.0 108.987 179.09 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 66.5 mtt 63.64 12.08 6.25 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.102 0.961 . . . . 0.0 111.787 -177.831 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 150' ' ' LYS . . . . . 0.438 ' HB3' ' CG1' ' A' ' 127' ' ' VAL . 47.7 mmtm -69.16 -29.83 67.94 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 115.375 -0.83 . . . . 0.0 112.564 -176.585 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.437 ' HB2' ' HB2' ' A' ' 145' ' ' PHE . 39.9 mmtm -143.88 122.58 12.59 Favored 'General case' 0 CA--C 1.509 -0.629 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 178.557 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 43.8 m -132.46 128.27 37.07 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 106.136 -1.802 . . . . 0.0 106.136 175.232 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 153' ' ' ARG . . . . . 0.464 ' HG2' ' CG ' ' A' ' 161' ' ' GLN . 26.9 tpt180 -146.6 160.41 42.2 Favored 'General case' 0 N--CA 1.429 -1.491 0 C-N-CA 119.084 -1.046 . . . . 0.0 110.942 -172.814 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 13.6 m -90.47 130.25 36.55 Favored 'General case' 0 N--CA 1.419 -1.992 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 174.378 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 155' ' ' ARG . . . . . 0.573 ' HD2' ' O ' ' A' ' 64' ' ' PRO . 8.6 ttp180 -68.29 -24.92 64.92 Favored 'General case' 0 C--N 1.297 -1.678 0 C-N-CA 123.517 0.727 . . . . 0.0 110.455 179.675 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -42.29 -45.71 4.29 Favored 'General case' 0 C--N 1.313 -0.996 0 N-CA-C 115.257 1.577 . . . . 0.0 115.257 -172.106 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -71.55 -52.62 17.25 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 114.438 1.273 . . . . 0.0 114.438 -173.507 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 -141.89 3.8 1.64 Allowed 'General case' 0 N--CA 1.483 1.18 0 N-CA-C 113.029 0.751 . . . . 0.0 113.029 -174.969 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 90.85 -88.49 1.43 Allowed Glycine 0 C--N 1.304 -1.223 0 N-CA-C 108.935 -1.666 . . . . 0.0 108.935 -173.078 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.671 HG12 ' O ' ' A' ' 67' ' ' ILE . 11.5 p -98.64 177.03 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.556 1.193 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 171.712 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 161' ' ' GLN . . . . . 0.509 ' H ' HG22 ' A' ' 160' ' ' VAL . 14.3 mm100 -108.36 99.29 8.71 Favored 'General case' 0 CA--C 1.463 -2.378 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 -175.553 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 162' ' ' ARG . . . . . 0.615 ' HA ' HG21 ' A' ' 94' ' ' VAL . 0.0 OUTLIER -132.1 173.18 11.49 Favored 'General case' 0 N--CA 1.393 -3.287 0 C-N-CA 119.283 -0.967 . . . . 0.0 113.148 -174.722 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 21.9 t-20 -152.76 -48.69 0.1 Allowed 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 106.359 -1.719 . . . . 0.0 106.359 179.55 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -64.0 147.27 50.73 Favored Glycine 0 C--O 1.254 1.373 0 CA-C-N 114.566 -1.197 . . . . 0.0 110.546 170.898 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.514 ' H ' HD23 ' A' ' 165' ' ' LEU . 1.9 pt? -124.65 154.9 40.05 Favored 'General case' 0 C--N 1.291 -1.973 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 -176.874 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 166' ' ' ARG . . . . . 0.523 ' HD2' ' N ' ' A' ' 166' ' ' ARG . 5.2 mpt_? -76.43 114.98 15.74 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 -179.219 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 18.2 m -80.75 54.07 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.286 -2.191 0 CA-C-O 122.479 1.133 . . . . 0.0 112.827 -177.335 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 168' ' ' ASP . . . . . 0.512 ' HB2' ' HB2' ' A' ' 90' ' ' SER . 14.8 t70 -109.94 -39.32 5.1 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 114.069 -1.423 . . . . 0.0 107.766 176.908 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 27.8 ttpp -107.22 8.92 30.23 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 114.012 -1.449 . . . . 0.0 108.749 -177.05 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 170' ' ' PHE . . . . . . . . . . . . . 84.5 t80 . . . . . 0 C--N 1.306 -1.291 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 -178.464 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 30.4 m . . . . . 0 C--O 1.237 0.432 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -128.08 99.31 5.43 Favored 'General case' 0 CA--C 1.5 -0.967 0 CA-C-O 120.722 0.296 . . . . 0.0 110.786 179.458 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -100.85 97.37 7.99 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 175.581 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.1 mp -89.84 104.96 15.64 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 177.352 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 44.0 p90 -120.44 120.65 36.52 Favored 'General case' 0 C--N 1.299 -1.613 0 CA-C-O 121.122 0.487 . . . . 0.0 110.743 -179.503 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 38.7 t30 -142.28 88.12 2.07 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-O 121.544 0.688 . . . . 0.0 110.504 178.861 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 54.2 mtpt -138.3 20.63 2.77 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 114.922 -1.036 . . . . 0.0 108.254 177.733 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 43.5 t -93.69 134.7 30.5 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.196 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.173 -176.224 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 102.86 117.18 4.29 Favored Glycine 0 N--CA 1.435 -1.387 0 C-N-CA 121.04 -0.6 . . . . 0.0 111.793 179.229 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 23.0 t -120.06 97.35 5.56 Favored 'General case' 0 N--CA 1.431 -1.404 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 178.542 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 81.3 t80 -101.56 127.59 48.2 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.103 -175.426 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 67.1 m95 -131.96 123.81 28.12 Favored 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 -178.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.524 HD23 ' H ' ' A' ' 15' ' ' GLN . 6.0 tt -83.36 110.83 18.47 Favored 'General case' 0 C--N 1.31 -1.132 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 179.32 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -118.01 35.04 4.21 Favored Glycine 0 N--CA 1.442 -0.966 0 CA-C-N 115.944 -0.571 . . . . 0.0 112.057 -176.714 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.524 ' H ' HD23 ' A' ' 13' ' ' LEU . 57.8 tt0 -83.69 115.86 22.38 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 177.216 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 63.2 tttp -105.81 94.95 5.47 Favored 'General case' 0 N--CA 1.424 -1.759 0 N-CA-C 109.797 -0.445 . . . . 0.0 109.797 179.362 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -88.72 90.83 8.57 Favored 'General case' 0 N--CA 1.436 -1.164 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 176.221 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -165.48 131.18 2.59 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 115.219 -0.9 . . . . 0.0 109.729 -176.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 25.0 pttm -129.85 176.56 7.94 Favored 'General case' 0 C--N 1.292 -1.921 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 178.179 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -115.4 150.84 35.75 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 -179.825 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 80.4 t80 76.63 108.14 0.08 Allowed 'General case' 0 C--O 1.236 0.359 0 C-N-CA 125.165 1.386 . . . . 0.0 112.303 179.641 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -146.42 125.29 12.7 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 115.228 -0.897 . . . . 0.0 108.781 175.967 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 49.5 m -154.32 174.35 14.94 Favored 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 179.242 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 34.6 m -68.21 144.39 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.939 0 N-CA-C 109.103 -0.702 . . . . 0.0 109.103 175.281 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 145.36 19.0 0.16 Allowed Glycine 0 C--N 1.292 -1.895 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.159 -178.035 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 27.7 p-10 -90.56 149.71 22.04 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 177.465 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -94.73 -29.4 14.81 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.597 -178.823 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 94.3 mt -138.33 154.83 48.98 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.079 178.782 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 47.8 t-20 -95.86 -47.27 6.22 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 174.75 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 33.9 m -85.83 93.01 8.8 Favored 'General case' 0 N--CA 1.429 -1.519 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 175.61 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 27.6 m -109.59 -179.45 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.738 -178.134 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 13.1 m -75.36 96.29 3.37 Favored 'General case' 0 N--CA 1.422 -1.831 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 177.477 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 20.1 p -83.5 172.86 11.98 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.854 -177.302 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 42.1 m -72.18 116.36 12.51 Favored 'General case' 0 N--CA 1.438 -1.06 0 CA-C-O 121.144 0.497 . . . . 0.0 110.803 -178.397 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 62.7 mt -124.78 93.82 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.971 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 179.764 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -76.06 110.16 10.31 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.188 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 175.67 -153.23 14.52 Favored Glycine 0 N--CA 1.442 -0.906 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.07 179.353 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -172.61 -42.95 0.04 OUTLIER Glycine 0 C--N 1.312 -0.772 0 N-CA-C 111.558 -0.617 . . . . 0.0 111.558 179.459 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 62.8 m 77.27 -38.8 0.3 Allowed 'General case' 0 CA--C 1.555 1.142 0 C-N-CA 124.661 1.185 . . . . 0.0 112.869 177.063 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 13.1 mptt -68.42 95.09 0.59 Allowed 'General case' 0 C--O 1.246 0.91 0 N-CA-C 113.547 0.943 . . . . 0.0 113.547 -178.533 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 21.4 t90 -168.68 132.66 1.5 Allowed 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 106.924 -1.51 . . . . 0.0 106.924 174.509 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 86.3 mt 72.28 93.68 0.08 Allowed 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 123.93 0.892 . . . . 0.0 110.716 -174.788 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 59.9 t -124.57 133.92 68.11 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 176.578 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -74.27 97.92 3.1 Favored 'General case' 0 C--N 1.311 -1.094 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 178.045 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 60.9 pttt -146.2 171.7 14.54 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 115.155 -0.929 . . . . 0.0 110.371 -174.138 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 63.1 mt 65.36 87.42 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.243 0.743 0 C-N-CA 124.114 0.966 . . . . 0.0 111.833 177.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -136.58 101.04 4.51 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 115.538 -0.756 . . . . 0.0 109.227 176.06 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -87.5 83.5 1.55 Allowed Glycine 0 N--CA 1.426 -1.973 0 C-N-CA 121.132 -0.556 . . . . 0.0 112.381 -177.613 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.62 ' HA ' ' HE3' ' A' ' 49' ' ' LYS . 0.8 OUTLIER -132.71 94.07 3.33 Favored 'General case' 0 C--N 1.294 -1.821 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 177.202 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 83.4 mtp -88.3 91.06 8.64 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-O 121.838 0.827 . . . . 0.0 111.51 179.535 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 7.2 tp60 -112.4 -62.63 1.55 Allowed 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 107.141 -1.429 . . . . 0.0 107.141 178.263 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 60.3 tttp -176.31 102.67 0.24 Allowed Pre-proline 0 N--CA 1.431 -1.393 0 N-CA-C 104.524 -2.399 . . . . 0.0 104.524 177.646 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -79.11 22.33 0.69 Allowed 'Trans proline' 0 CA--C 1.517 -0.325 0 C-N-CA 122.84 2.36 . . . . 0.0 116.352 -167.053 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.55 ' O ' HD13 ' A' ' 58' ' ' LEU . 28.8 mt -68.39 -57.23 9.02 Favored Pre-proline 0 C--N 1.31 -1.119 0 C-N-CA 119.252 -0.979 . . . . 0.0 110.902 179.572 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.415 ' HD3' ' HB2' ' A' ' 54' ' ' LEU . 13.8 Cg_exo -64.9 -31.42 56.76 Favored 'Trans proline' 0 N--CA 1.428 -2.366 0 C-N-CA 120.791 0.994 . . . . 0.0 111.88 -170.509 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -75.86 -32.33 59.68 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.282 178.753 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 63.7 tp -69.33 -34.3 74.42 Favored 'General case' 0 CA--C 1.508 -0.656 0 C-N-CA 120.503 -0.479 . . . . 0.0 110.157 178.634 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.62 ' HA ' ' CD1' ' A' ' 75' ' ' TYR . 6.2 mp -61.7 -41.47 97.65 Favored 'General case' 0 CA--C 1.49 -1.334 0 C-N-CA 120.128 -0.629 . . . . 0.0 112.421 179.669 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.48 ' HD2' ' N ' ' A' ' 60' ' ' GLU . 0.1 OUTLIER -76.86 -26.5 54.32 Favored 'General case' 0 C--N 1.298 -1.658 0 CA-C-O 121.491 0.662 . . . . 0.0 112.722 178.477 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.534 ' C ' ' H ' ' A' ' 62' ' ' ASP . 8.5 tp10 -82.51 -41.53 19.58 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 115.344 -0.843 . . . . 0.0 113.145 -171.08 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 56.2 t80 -68.44 3.85 1.6 Allowed 'General case' 0 N--CA 1.494 1.727 0 CA-C-O 122.095 0.95 . . . . 0.0 110.108 -178.303 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.534 ' H ' ' C ' ' A' ' 60' ' ' GLU . 27.9 t70 -109.02 -153.8 0.52 Allowed 'General case' 0 C--N 1.287 -2.113 0 CA-C-N 113.888 -1.505 . . . . 0.0 109.024 -174.783 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.708 ' HB2' HD12 ' A' ' 65' ' ' ILE . 0.1 OUTLIER -100.54 -167.98 0.15 Allowed Pre-proline 0 CA--C 1.576 1.961 0 N-CA-C 106.187 -1.783 . . . . 0.0 106.187 -177.362 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.477 ' O ' ' HD2' ' A' ' 155' ' ' ARG . 18.2 Cg_endo -100.4 11.49 0.56 Allowed 'Trans proline' 0 C--N 1.368 1.576 0 CA-C-N 122.943 2.087 . . . . 0.0 112.593 -176.292 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.708 HD12 ' HB2' ' A' ' 63' ' ' LEU . 0.2 OUTLIER -73.03 -43.07 59.21 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.959 0 CA-C-N 115.846 -0.616 . . . . 0.0 109.62 179.53 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.432 ' H ' HD13 ' A' ' 65' ' ' ILE . . . 56.94 9.14 3.56 Favored Glycine 0 N--CA 1.484 1.846 0 CA-C-O 121.351 0.417 . . . . 0.0 113.201 -177.582 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.524 ' H ' HG12 ' A' ' 65' ' ' ILE . 52.1 mt 67.39 -67.63 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.421 0 C-N-CA 125.877 1.671 . . . . 0.0 112.04 -175.61 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.478 ' HB2' ' O ' ' A' ' 67' ' ' ILE . 26.0 t80 175.01 -56.16 0.0 OUTLIER Pre-proline 0 C--N 1.318 -0.782 0 CA-C-O 119.68 -0.2 . . . . 0.0 111.281 -178.314 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.463 ' HD3' ' HB3' ' A' ' 68' ' ' PHE . 8.4 Cg_exo -73.51 -35.37 4.84 Favored 'Trans proline' 0 C--N 1.379 2.163 0 C-N-CA 121.934 1.756 . . . . 0.0 113.108 -172.226 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 97.28 -17.55 58.93 Favored Glycine 0 N--CA 1.44 -1.069 0 C-N-CA 120.193 -1.004 . . . . 0.0 111.048 -176.253 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -84.93 -48.11 9.62 Favored 'General case' 0 C--O 1.195 -1.769 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 176.808 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.647 ' O ' ' HB ' ' A' ' 73' ' ' THR . . . -57.7 171.87 0.43 Allowed 'General case' 0 CA--C 1.55 0.981 0 C-N-CA 124.53 1.132 . . . . 0.0 111.675 174.888 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.647 ' HB ' ' O ' ' A' ' 72' ' ' ALA . 8.9 m 94.49 -10.65 0.12 Allowed 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 124.022 0.929 . . . . 0.0 112.035 177.804 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.542 ' HA ' ' HB3' ' A' ' 58' ' ' LEU . 35.5 m-80 -46.4 103.25 0.04 OUTLIER 'General case' 0 CA--C 1.45 -2.879 0 C-N-CA 125.062 1.345 . . . . 0.0 113.657 -179.463 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.62 ' CD1' ' HA ' ' A' ' 58' ' ' LEU . 8.3 p90 -92.81 144.0 25.72 Favored 'General case' 1 C--N 1.241 -4.144 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.493 -176.787 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.629 ' HB2' ' O ' ' A' ' 85' ' ' THR . 10.9 mm-40 -136.2 161.78 34.78 Favored 'General case' 0 C--N 1.278 -2.534 0 N-CA-C 105.872 -1.899 . . . . 0.0 105.872 171.522 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 38.8 p90 -162.95 146.83 11.15 Favored 'General case' 0 C--N 1.293 -1.875 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 177.682 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.709 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 25.5 m-20 -105.17 162.31 13.51 Favored 'General case' 0 CA--C 1.459 -2.529 0 C-N-CA 118.955 -1.098 . . . . 0.0 108.799 176.12 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -81.24 -44.47 17.71 Favored 'General case' 0 C--N 1.262 -3.201 0 CA-C-N 114.161 -1.382 . . . . 0.0 111.094 -179.0 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -69.17 -47.45 64.9 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 178.213 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.709 ' HB ' ' HB2' ' A' ' 78' ' ' ASP . 31.8 m -63.75 -51.74 63.55 Favored 'General case' 0 N--CA 1.418 -2.056 0 CA-C-N 113.93 -1.486 . . . . 0.0 111.951 -178.45 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 99.1 mttt 66.27 18.63 10.96 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-O 121.818 0.818 . . . . 0.0 111.117 -177.042 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.617 ' HB3' HG22 ' A' ' 81' ' ' THR . 35.5 ttmt -111.83 135.88 51.86 Favored 'General case' 0 CA--C 1.491 -1.298 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.205 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.592 ' O ' ' HA ' ' A' ' 109' ' ' THR . 1.5 tm? -76.65 124.71 28.06 Favored 'General case' 0 N--CA 1.421 -1.897 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 -179.757 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.629 ' O ' ' HB2' ' A' ' 76' ' ' GLU . 3.8 t -126.82 109.39 11.95 Favored 'General case' 0 C--N 1.265 -3.097 0 CA-C-N 115.844 -0.617 . . . . 0.0 109.622 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.606 ' O ' ' HA ' ' A' ' 107' ' ' THR . 31.0 m -91.84 151.08 3.61 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.943 0 O-C-N 121.375 -0.828 . . . . 0.0 110.575 -179.483 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.535 ' HA ' ' O ' ' A' ' 106' ' ' THR 0.299 1.5 pp -115.59 103.64 10.93 Favored 'General case' 0 N--CA 1.396 -3.153 0 CA-C-O 122.655 1.217 . . . . 0.0 109.736 174.35 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 40.0 mm -89.82 139.01 27.61 Favored Pre-proline 0 C--N 1.289 -2.044 0 CA-C-N 114.08 -1.418 . . . . 0.0 108.37 -174.293 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -54.14 87.5 0.03 OUTLIER 'Trans proline' 0 C--N 1.354 0.868 0 C-N-CA 123.475 2.783 . . . . 0.0 112.431 173.923 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.533 ' OG ' ' HB ' ' A' ' 167' ' ' VAL . 22.6 t 66.73 -169.15 0.2 Allowed 'General case' 0 N--CA 1.44 -0.955 0 C-N-CA 124.421 1.088 . . . . 0.0 110.811 178.951 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -93.05 137.36 22.59 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 177.022 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' CYS . . . . . 0.578 ' SG ' ' HG2' ' A' ' 166' ' ' ARG . 33.3 m -129.57 138.61 51.39 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 -176.882 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.621 ' O ' ' HA2' ' A' ' 164' ' ' GLY . 45.6 mt-10 -120.25 135.71 54.9 Favored 'General case' 0 CA--C 1.469 -2.167 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 177.511 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.734 HG13 ' H ' ' A' ' 163' ' ' ASN . 20.3 t -117.91 107.81 22.94 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.482 0 C-N-CA 120.224 -0.59 . . . . 0.0 112.349 -172.215 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -112.15 111.79 2.92 Favored Glycine 0 N--CA 1.426 -1.988 0 N-CA-C 108.166 -1.974 . . . . 0.0 108.166 169.536 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 0.474 ' CD1' ' HB2' ' A' ' 163' ' ' ASN . 50.2 t80 -153.56 168.93 24.53 Favored 'General case' 0 N--CA 1.391 -3.416 0 N-CA-C 102.877 -3.008 . . . . 0.0 102.877 -178.829 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.45 ' HE2' ' CE2' ' A' ' 96' ' ' TYR . 0.0 OUTLIER -66.99 3.79 1.02 Allowed 'General case' 0 C--N 1.292 -1.934 0 O-C-N 123.262 0.351 . . . . 0.0 111.735 179.418 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.43 ' H ' ' C ' ' A' ' 96' ' ' TYR . 19.1 t70 -58.65 -74.21 0.07 Allowed 'General case' 0 N--CA 1.427 -1.577 0 CA-C-O 122.07 0.938 . . . . 0.0 110.983 -177.959 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.563 ' HB3' ' HB ' ' A' ' 127' ' ' VAL . 66.6 m -112.52 -69.93 0.84 Allowed 'General case' 0 C--N 1.281 -2.373 0 CA-C-N 114.565 -1.198 . . . . 0.0 108.942 -178.71 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 67.0 m -177.0 -73.87 0.01 OUTLIER 'General case' 0 C--N 1.31 -1.149 0 C-N-CA 126.577 1.951 . . . . 0.0 105.818 -179.326 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.42 ' HA ' ' O ' ' A' ' 94' ' ' VAL . 59.9 t -147.59 129.88 7.16 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.919 0 CA-C-N 114.759 -1.11 . . . . 0.0 108.065 177.632 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -126.61 167.37 15.76 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 177.629 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.62 ' HB3' ' HB3' ' A' ' 124' ' ' LYS . 39.0 ttmt -148.54 128.97 13.91 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-O 120.768 0.318 . . . . 0.0 110.462 174.689 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -104.6 123.73 48.08 Favored 'General case' 0 C--N 1.293 -1.87 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 174.31 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.417 HG22 HG22 ' A' ' 108' ' ' VAL . 14.4 t -91.09 168.98 11.24 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 179.464 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.535 ' O ' ' HA ' ' A' ' 87' ' ' LEU . 46.1 m -64.94 -27.97 69.21 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 112.229 0.455 . . . . 0.0 112.229 -175.96 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.606 ' HA ' ' O ' ' A' ' 86' ' ' VAL . 29.1 m -138.66 108.35 6.25 Favored 'General case' 0 C--N 1.306 -1.314 0 O-C-N 121.687 -0.633 . . . . 0.0 110.74 -179.4 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.493 ' O ' ' HA ' ' A' ' 85' ' ' THR . 34.1 t -108.72 135.97 45.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 N-CA-C 108.631 -0.878 . . . . 0.0 108.631 -179.303 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.592 ' HA ' ' O ' ' A' ' 84' ' ' LEU . 44.5 p -122.43 132.95 54.6 Favored 'General case' 0 N--CA 1.414 -2.237 0 C-N-CA 122.755 0.422 . . . . 0.0 110.785 -173.51 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.659 ' HA3' ' O ' ' A' ' 119' ' ' ASP . . . -168.69 -158.26 12.44 Favored Glycine 0 C--N 1.308 -0.985 0 C-N-CA 121.373 -0.442 . . . . 0.0 113.234 -178.748 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 46.2 m80 -110.65 119.57 39.59 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-O 121.0 0.428 . . . . 0.0 110.562 -178.281 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.427 ' HB2' ' HG ' ' A' ' 84' ' ' LEU . 2.5 tm? -89.88 120.78 31.41 Favored 'General case' 0 C--N 1.308 -1.198 0 C-N-CA 123.905 0.882 . . . . 0.0 111.192 -176.264 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -139.56 175.37 9.62 Favored 'General case' 0 CA--C 1.475 -1.928 0 CA-C-N 115.274 -0.876 . . . . 0.0 109.303 170.692 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 1.8 tmtm? -103.81 131.9 50.57 Favored 'General case' 0 N--CA 1.393 -3.287 0 N-CA-C 107.262 -1.385 . . . . 0.0 107.262 -175.494 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 97.13 -25.77 25.58 Favored Glycine 0 C--O 1.189 -2.686 0 N-CA-C 109.862 -1.295 . . . . 0.0 109.862 -176.943 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . 0.341 0.0 OUTLIER -164.12 134.76 4.3 Favored 'General case' 0 C--N 1.291 -1.952 0 N-CA-C 114.316 1.228 . . . . 0.0 114.316 177.928 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -103.49 109.53 21.21 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 104.932 -2.248 . . . . 0.0 104.932 179.053 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 33.5 p -95.99 136.97 35.73 Favored 'General case' 0 C--N 1.284 -2.27 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.221 -176.49 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' ASP . . . . . 0.659 ' O ' ' HA3' ' A' ' 110' ' ' GLY . 15.1 m-20 69.03 107.22 0.05 Allowed 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 124.623 1.169 . . . . 0.0 111.621 178.608 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.405 HG22 ' O ' ' A' ' 134' ' ' THR . 7.6 m -119.66 86.39 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.901 0 CA-C-O 122.168 0.985 . . . . 0.0 111.129 173.082 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -74.25 100.9 3.84 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-N 114.48 -1.236 . . . . 0.0 109.464 -177.19 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 128.66 -7.86 6.53 Favored Glycine 0 C--N 1.299 -1.482 0 C-N-CA 120.017 -1.087 . . . . 0.0 111.736 177.744 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 66.5 mt -99.3 115.85 41.01 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.699 0 CA-C-O 121.869 0.843 . . . . 0.0 109.525 178.547 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.62 ' HB3' ' HB3' ' A' ' 103' ' ' LYS . 86.7 tttt -84.2 128.06 34.33 Favored 'General case' 0 CA--C 1.475 -1.936 0 CA-C-N 114.317 -1.31 . . . . 0.0 107.711 -176.146 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.479 HG21 ' HB1' ' A' ' 147' ' ' ALA . 92.1 m -130.16 127.28 39.39 Favored 'General case' 0 N--CA 1.388 -3.571 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.715 -176.979 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.512 ' HG2' ' N ' ' A' ' 127' ' ' VAL . 85.2 tttt -139.11 143.12 38.13 Favored 'General case' 0 N--CA 1.407 -2.609 0 CA-C-O 121.344 0.592 . . . . 0.0 110.184 167.178 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.563 ' HB ' ' HB3' ' A' ' 99' ' ' SER . 7.0 p -158.84 -37.66 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 N-CA-C 106.286 -1.746 . . . . 0.0 106.286 177.02 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -120.28 -52.83 2.15 Favored 'General case' 0 N--CA 1.381 -3.903 0 CA-C-N 112.173 -2.285 . . . . 0.0 106.531 -177.484 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 9.6 tp -153.04 164.43 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.386 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 177.095 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 62.6 t90 -70.81 117.66 12.6 Favored 'General case' 0 C--N 1.317 -0.826 0 C-N-CA 123.339 0.656 . . . . 0.0 111.406 178.151 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.464 HG12 ' H ' ' A' ' 133' ' ' VAL . 21.5 t -138.86 119.44 15.37 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 175.696 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 14.8 ptmm? -102.09 17.53 23.05 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-O 121.316 0.579 . . . . 0.0 110.936 -179.123 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.464 ' H ' HG12 ' A' ' 131' ' ' VAL . 13.7 m -138.33 74.63 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 CA-C-N 114.866 -1.061 . . . . 0.0 110.324 178.612 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 134' ' ' THR . . . . . 0.405 ' O ' HG22 ' A' ' 120' ' ' VAL . 35.2 p -111.49 -165.97 1.04 Allowed 'General case' 0 C--N 1.288 -2.102 0 CA-C-N 115.166 -0.925 . . . . 0.0 110.374 -177.271 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 38.3 m -151.65 167.71 27.28 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 176.623 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 11.7 tt -135.11 136.01 52.0 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.234 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 179.375 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 36.6 p -123.51 168.26 12.82 Favored 'General case' 0 N--CA 1.427 -1.579 0 CA-C-O 121.858 0.837 . . . . 0.0 112.885 -177.056 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' THR . . . . . 0.486 HG23 ' H ' ' A' ' 140' ' ' ALA . 5.0 t -165.7 177.53 7.22 Favored 'General case' 0 N--CA 1.413 -2.312 0 N-CA-C 106.97 -1.492 . . . . 0.0 106.97 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -115.22 32.95 5.72 Favored 'General case' 0 C--N 1.265 -3.101 0 N-CA-C 105.352 -2.092 . . . . 0.0 105.352 175.062 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.486 ' H ' HG23 ' A' ' 138' ' ' THR . . . 60.91 42.78 12.51 Favored 'General case' 0 C--N 1.366 1.309 0 CA-C-N 113.759 -1.564 . . . . 0.0 108.97 -172.466 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 47.6 t -173.4 -65.61 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 115.432 -0.803 . . . . 0.0 111.645 -172.735 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.462 ' HA ' ' HE2' ' A' ' 142' ' ' LYS . 9.1 mmpt? -82.4 -154.46 0.13 Allowed 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 -179.599 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 14.6 p -155.25 119.3 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.055 0 CA-C-O 121.408 0.623 . . . . 0.0 110.136 170.935 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -114.55 155.99 25.46 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-O 121.964 0.888 . . . . 0.0 112.98 -172.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 35.0 p90 -72.78 137.66 45.95 Favored 'General case' 0 N--CA 1.431 -1.388 0 CA-C-N 113.931 -1.486 . . . . 0.0 113.379 178.216 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 25.9 m -157.72 28.73 0.27 Allowed 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 106.451 -1.685 . . . . 0.0 106.451 172.419 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.479 ' HB1' HG21 ' A' ' 125' ' ' THR . . . -132.44 92.62 3.11 Favored 'General case' 0 N--CA 1.422 -1.859 0 C-N-CA 119.552 -0.859 . . . . 0.0 113.227 -173.459 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 66.9 32.28 80.56 Favored Glycine 0 CA--C 1.5 -0.852 0 CA-C-N 115.803 -0.635 . . . . 0.0 112.815 175.707 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 49.5 ttm 60.12 80.13 0.21 Allowed 'General case' 0 C--O 1.236 0.386 0 CA-C-O 122.019 0.914 . . . . 0.0 109.689 -177.065 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 150' ' ' LYS . . . . . 0.742 ' HG2' ' H ' ' A' ' 151' ' ' LYS . 35.4 ttmt -120.8 -160.32 0.84 Allowed 'General case' 0 C--N 1.297 -1.698 0 CA-C-N 114.915 -1.039 . . . . 0.0 108.995 -174.181 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.742 ' H ' ' HG2' ' A' ' 150' ' ' LYS . 96.4 mttt -121.64 165.12 16.21 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 124.078 0.951 . . . . 0.0 110.016 -178.415 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 22.3 p -83.66 160.11 21.41 Favored 'General case' 0 C--N 1.301 -1.51 0 C-N-CA 123.275 0.63 . . . . 0.0 110.587 177.527 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 153' ' ' ARG . . . . . 0.425 HH21 ' CG ' ' A' ' 98' ' ' ASP . 4.2 mpt_? -128.18 174.65 9.07 Favored 'General case' 0 CA--C 1.506 -0.736 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 177.272 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 14.7 m -98.9 116.23 30.66 Favored 'General case' 0 N--CA 1.422 -1.862 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 173.961 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 155' ' ' ARG . . . . . 0.635 ' HG2' ' HA2' ' A' ' 159' ' ' GLY . 0.2 OUTLIER -63.15 -22.98 67.22 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.461 0.648 . . . . 0.0 109.598 -179.559 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -46.51 -37.55 8.07 Favored 'General case' 0 C--N 1.318 -0.797 0 C-N-CA 125.346 1.458 . . . . 0.0 114.476 -177.626 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -69.92 -56.63 6.53 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 119.708 -0.797 . . . . 0.0 112.372 -174.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 58.5 m-85 -165.1 20.52 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 124.025 0.93 . . . . 0.0 110.08 -178.317 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 159' ' ' GLY . . . . . 0.646 ' HA3' ' O ' ' A' ' 65' ' ' ILE . . . 92.36 -92.79 1.72 Allowed Glycine 0 CA--C 1.47 -2.736 0 C-N-CA 120.016 -1.088 . . . . 0.0 111.195 -174.908 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.522 ' HB ' ' O ' ' A' ' 67' ' ' ILE . 11.5 t -103.42 172.53 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.41 -2.457 0 N-CA-C 106.947 -1.501 . . . . 0.0 106.947 179.102 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 161' ' ' GLN . . . . . 0.423 ' H ' HG12 ' A' ' 160' ' ' VAL . 46.6 mt-30 -123.09 92.9 3.8 Favored 'General case' 0 CA--C 1.483 -1.62 0 CA-C-N 118.973 0.806 . . . . 0.0 109.233 -175.147 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.33 161.83 17.96 Favored 'General case' 0 N--CA 1.401 -2.902 0 C-N-CA 119.012 -1.075 . . . . 0.0 113.251 -176.409 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 163' ' ' ASN . . . . . 0.734 ' H ' HG13 ' A' ' 94' ' ' VAL . 57.7 t30 -129.75 16.56 5.82 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 105.678 -1.971 . . . . 0.0 105.678 172.671 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 164' ' ' GLY . . . . . 0.621 ' HA2' ' O ' ' A' ' 93' ' ' GLU . . . -58.19 123.09 31.98 Favored Glycine 0 CA--C 1.475 -2.449 0 CA-C-N 113.469 -1.696 . . . . 0.0 112.991 -176.149 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.585 ' O ' HD12 ' A' ' 165' ' ' LEU . 3.9 pp -94.16 121.96 36.2 Favored 'General case' 1 N--CA 1.374 -4.25 0 N-CA-C 105.661 -1.977 . . . . 0.0 105.661 -178.349 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 166' ' ' ARG . . . . . 0.578 ' HG2' ' SG ' ' A' ' 92' ' ' CYS . 16.0 mtm180 -84.94 129.09 34.86 Favored 'General case' 0 N--CA 1.391 -3.396 0 N-CA-C 105.886 -1.894 . . . . 0.0 105.886 179.483 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.533 ' HB ' ' OG ' ' A' ' 90' ' ' SER . 66.8 t -58.93 -14.98 5.4 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.737 0 CA-C-O 122.104 0.954 . . . . 0.0 110.249 171.679 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 168' ' ' ASP . . . . . 0.466 ' HB2' ' HB2' ' A' ' 90' ' ' SER . 11.1 t70 -76.25 -13.0 60.18 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 125.795 1.638 . . . . 0.0 109.986 173.162 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 169' ' ' LYS . . . . . 0.478 ' HG2' ' N ' ' A' ' 170' ' ' PHE . 56.1 tttm -134.29 176.99 8.1 Favored 'General case' 0 C--N 1.297 -1.699 0 C-N-CA 124.167 0.987 . . . . 0.0 108.497 -174.247 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 170' ' ' PHE . . . . . 0.478 ' N ' ' HG2' ' A' ' 169' ' ' LYS . 79.4 t80 . . . . . 0 C--N 1.295 -1.762 0 N-CA-C 106.656 -1.609 . . . . 0.0 106.656 170.833 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 48.9 m . . . . . 0 N--CA 1.44 -0.926 0 CA-C-O 120.662 0.268 . . . . 0.0 110.631 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -76.32 21.63 0.18 Allowed 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 114.953 1.464 . . . . 0.0 114.953 -173.087 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -86.01 -17.75 34.4 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.466 0.65 . . . . 0.0 109.458 175.313 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 45.3 mm -72.01 135.56 27.59 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.162 0 CA-C-N 115.101 -0.954 . . . . 0.0 108.976 -179.361 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -67.5 -60.55 2.47 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 178.579 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 51.7 t30 -159.77 129.96 5.56 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 177.289 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -86.83 135.44 33.34 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-O 120.956 0.408 . . . . 0.0 110.095 -179.872 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 11.1 p -110.84 144.09 19.49 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 CA-C-N 116.187 -0.46 . . . . 0.0 109.82 -179.833 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 159.32 177.03 32.04 Favored Glycine 0 N--CA 1.443 -0.892 0 N-CA-C 110.923 -0.871 . . . . 0.0 110.923 178.587 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 35.9 t -86.22 115.62 23.89 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 179.031 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -97.28 -0.88 45.84 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 112.902 0.704 . . . . 0.0 112.902 -176.961 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 73.4 t-105 -80.08 107.17 12.66 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 176.565 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 98.9 mt -94.82 164.58 12.87 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.323 -176.565 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -99.5 34.18 5.63 Favored Glycine 0 N--CA 1.44 -1.053 0 N-CA-C 111.172 -0.771 . . . . 0.0 111.172 179.647 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -89.72 110.96 21.82 Favored 'General case' 0 N--CA 1.438 -1.032 0 N-CA-C 105.039 -2.208 . . . . 0.0 105.039 177.756 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 61.3 pttt -137.04 172.36 13.13 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.533 -175.95 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -80.38 112.11 17.41 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 175.703 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 17.6 m120 -87.1 97.57 10.82 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.304 -177.536 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -155.74 119.47 4.45 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 116.057 -0.519 . . . . 0.0 109.654 179.03 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -135.64 153.29 51.68 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 104.377 -2.453 . . . . 0.0 104.377 177.27 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -64.95 117.99 8.42 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-O 121.373 0.606 . . . . 0.0 110.636 -179.599 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -86.93 -176.02 5.59 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 115.117 -0.947 . . . . 0.0 110.124 -178.194 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 35.1 p -54.38 116.3 2.57 Favored 'General case' 0 C--N 1.314 -0.941 0 C-N-CA 124.256 1.022 . . . . 0.0 113.631 -176.761 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 7.4 p -146.0 98.96 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.171 0 CA-C-O 121.803 0.811 . . . . 0.0 109.811 175.065 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -121.76 151.25 16.97 Favored Glycine 0 N--CA 1.434 -1.475 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.036 -179.393 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 29.2 p-10 -162.04 171.58 17.32 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 -179.312 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -102.32 -171.93 2.05 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 177.097 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.588 ' H ' HD23 ' A' ' 28' ' ' LEU . 1.7 pt? -76.05 78.82 2.9 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 121.642 0.734 . . . . 0.0 111.819 -178.745 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 52.1 t30 -165.89 162.98 18.61 Favored 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 -179.726 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 34.6 m -70.15 -40.5 74.72 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 118.016 0.371 . . . . 0.0 110.142 179.401 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . 0.259 7.1 p 42.58 99.48 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 C-N-CA 126.123 1.769 . . . . 0.0 115.521 176.109 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 55.2 m -145.36 109.94 5.02 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.062 179.446 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 35.5 p -86.63 130.06 34.63 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.258 178.579 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 32.4 m -82.01 94.13 7.11 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-O 121.322 0.582 . . . . 0.0 109.63 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 49.6 mm -116.0 113.93 44.67 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.322 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 -179.433 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -69.47 148.34 49.66 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 177.216 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 78.48 -104.02 2.01 Favored Glycine 0 N--CA 1.44 -1.05 0 N-CA-C 110.651 -0.98 . . . . 0.0 110.651 -178.504 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 138.23 -41.41 1.37 Allowed Glycine 0 N--CA 1.441 -0.985 0 C-N-CA 120.878 -0.677 . . . . 0.0 111.83 178.643 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 8.9 t -108.72 162.51 14.1 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 -179.019 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 55.1 tptt -113.06 123.82 51.17 Favored 'General case' 0 N--CA 1.433 -1.314 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.073 178.901 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 47.0 t90 -103.54 126.15 50.51 Favored 'General case' 0 C--N 1.301 -1.516 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.198 177.145 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 5.5 tt -84.45 124.73 31.66 Favored 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 106.663 -1.606 . . . . 0.0 106.663 177.647 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 39.7 t -72.0 91.6 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.138 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 -174.914 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 48.5 t-20 67.5 102.17 0.05 OUTLIER 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.985 1.314 . . . . 0.0 110.814 177.478 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 54.1 tptt -83.76 -37.01 23.17 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 115.384 -0.825 . . . . 0.0 112.542 -176.771 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 67.4 mt 66.43 91.72 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 -173.735 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 23.2 pttm -87.41 -19.56 27.9 Favored 'General case' 0 C--N 1.308 -1.225 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 -175.617 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -167.95 102.81 0.19 Allowed Glycine 0 CA--C 1.491 -1.45 0 C-N-CA 119.641 -1.266 . . . . 0.0 112.411 -179.501 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -177.16 105.76 0.06 Allowed 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 179.043 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 45.3 tpp -159.16 -64.89 0.08 Allowed 'General case' 0 C--N 1.316 -0.862 0 C-N-CA 120.779 -0.368 . . . . 0.0 111.883 -176.308 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 53.9 tt0 -140.65 82.66 1.86 Allowed 'General case' 0 N--CA 1.444 -0.765 0 C-N-CA 119.896 -0.722 . . . . 0.0 112.833 -177.827 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.635 ' O ' ' HG2' ' A' ' 56' ' ' GLU . 16.6 ptpt 173.44 78.39 0.05 OUTLIER Pre-proline 0 C--N 1.321 -0.647 0 C-N-CA 126.6 1.96 . . . . 0.0 109.315 172.469 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.433 ' O ' ' HG ' ' A' ' 57' ' ' LEU . 9.0 Cg_exo -31.29 -66.67 0.08 OUTLIER 'Trans proline' 0 C--N 1.373 1.822 1 C-N-CA 125.488 4.125 . . . . 0.0 116.792 -170.197 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.404 ' HB2' ' HD3' ' A' ' 55' ' ' PRO . 3.4 mm? -63.89 -67.15 1.15 Allowed Pre-proline 0 CA--C 1.484 -1.569 0 N-CA-C 113.872 1.064 . . . . 0.0 113.872 -175.088 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.655 ' O ' ' HG2' ' A' ' 59' ' ' LYS . 19.3 Cg_endo -55.38 -25.74 49.56 Favored 'Trans proline' 0 N--CA 1.429 -2.301 0 C-N-CA 121.94 1.76 . . . . 0.0 113.657 -168.023 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.635 ' HG2' ' O ' ' A' ' 52' ' ' LYS . 14.0 pt-20 -81.36 -29.51 34.05 Favored 'General case' 0 CA--C 1.479 -1.763 0 CA-C-O 121.093 0.473 . . . . 0.0 110.867 -177.353 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.596 ' O ' ' HB3' ' A' ' 60' ' ' GLU . 93.8 mt -74.29 -31.54 62.54 Favored 'General case' 0 N--CA 1.417 -2.104 0 CA-C-N 115.736 -0.666 . . . . 0.0 109.973 174.867 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.581 ' HB3' ' H ' ' A' ' 75' ' ' TYR . 4.8 mp -69.76 -35.32 74.83 Favored 'General case' 0 CA--C 1.504 -0.82 0 C-N-CA 118.988 -1.085 . . . . 0.0 110.017 177.852 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.655 ' HG2' ' O ' ' A' ' 55' ' ' PRO 0.279 41.5 pttt -75.1 -25.25 58.36 Favored 'General case' 0 N--CA 1.439 -1.011 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 172.405 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.596 ' HB3' ' O ' ' A' ' 57' ' ' LEU . 7.4 tp10 -59.4 -49.13 78.98 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-O 121.247 0.546 . . . . 0.0 109.98 171.098 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 85.6 m-85 -68.93 -4.28 15.98 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-O 121.313 0.578 . . . . 0.0 111.202 176.468 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.624 ' HB3' ' O ' ' A' ' 59' ' ' LYS . 21.1 t70 -84.65 166.52 17.01 Favored 'General case' 0 C--N 1.298 -1.671 0 CA-C-N 115.102 -0.954 . . . . 0.0 111.813 -176.117 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.696 ' HB2' HD12 ' A' ' 65' ' ' ILE . 3.5 mt -85.67 -151.47 0.0 OUTLIER Pre-proline 0 CA--C 1.602 2.95 0 N-CA-C 104.936 -2.246 . . . . 0.0 104.936 178.959 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.647 ' HG3' ' N ' ' A' ' 141' ' ' SER . 71.3 Cg_endo -101.54 5.07 0.57 Allowed 'Trans proline' 0 N--CA 1.449 -1.114 0 CA-C-N 123.531 2.297 . . . . 0.0 112.125 176.188 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.72 HG12 ' H ' ' A' ' 67' ' ' ILE . 0.1 OUTLIER -70.04 -42.06 79.35 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.832 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.534 -177.435 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.436 ' H ' HD13 ' A' ' 65' ' ' ILE . . . 57.79 8.91 4.63 Favored Glycine 0 N--CA 1.5 2.958 0 CA-C-O 122.228 0.904 . . . . 0.0 112.441 -174.922 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.72 ' H ' HG12 ' A' ' 65' ' ' ILE . 61.1 mt 58.13 -72.47 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 C-N-CA 129.191 2.997 . . . . 0.0 113.162 -174.358 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.471 ' HB3' ' HD3' ' A' ' 69' ' ' PRO . 80.0 t80 171.8 -53.26 0.0 OUTLIER Pre-proline 0 N--CA 1.485 1.303 0 N-CA-C 113.497 0.925 . . . . 0.0 113.497 -172.687 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.471 ' HD3' ' HB3' ' A' ' 68' ' ' PHE . 6.9 Cg_exo -74.1 -28.53 10.8 Favored 'Trans proline' 0 C--N 1.366 1.496 0 C-N-CA 121.288 1.325 . . . . 0.0 113.094 -174.1 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 86.84 -12.7 60.99 Favored Glycine 0 C--N 1.31 -0.905 0 N-CA-C 110.309 -1.117 . . . . 0.0 110.309 -174.274 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -93.12 -53.47 4.11 Favored 'General case' 0 CA--C 1.48 -1.739 0 N-CA-C 106.512 -1.662 . . . . 0.0 106.512 178.374 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.652 ' O ' ' HB ' ' A' ' 73' ' ' THR . . . -52.06 173.37 0.03 OUTLIER 'General case' 0 C--N 1.361 1.079 0 CA-C-N 114.671 -1.15 . . . . 0.0 110.549 169.916 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.652 ' HB ' ' O ' ' A' ' 72' ' ' ALA . 10.6 m 87.63 27.13 0.03 OUTLIER 'General case' 0 CA--C 1.558 1.251 0 CA-C-O 125.331 2.491 . . . . 0.0 109.246 -174.814 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.62 ' O ' ' HA ' ' A' ' 86' ' ' VAL . 37.2 m-80 -83.81 75.12 10.12 Favored 'General case' 0 C--N 1.275 -2.67 0 CA-C-N 113.685 -1.598 . . . . 0.0 112.021 177.77 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.581 ' H ' ' HB3' ' A' ' 58' ' ' LEU . 2.9 m-85 -70.89 98.12 1.53 Allowed 'General case' 0 C--N 1.258 -3.375 0 CA-C-N 113.377 -1.738 . . . . 0.0 113.56 -179.073 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -106.43 115.29 29.95 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 105.452 -2.055 . . . . 0.0 105.452 176.672 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.4 ' HB2' HD12 ' A' ' 84' ' ' LEU . 76.2 t80 -131.35 127.59 37.94 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 112.465 0.543 . . . . 0.0 112.465 -172.842 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.62 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 19.6 m-20 -94.22 160.45 14.68 Favored 'General case' 0 CA--C 1.483 -1.607 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 173.248 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 13.5 tp10 -80.14 -63.38 1.42 Allowed 'General case' 0 C--N 1.264 -3.125 0 CA-C-N 114.94 -1.027 . . . . 0.0 112.436 -175.455 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -67.08 -40.05 86.92 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.582 0.706 . . . . 0.0 110.088 -173.638 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.62 ' HB ' ' HB2' ' A' ' 78' ' ' ASP . 62.7 m -62.77 -40.85 98.57 Favored 'General case' 0 C--N 1.289 -2.049 0 CA-C-N 114.679 -1.146 . . . . 0.0 111.648 -179.71 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt 65.0 6.83 3.64 Favored 'General case' 0 N--CA 1.484 1.247 0 N-CA-C 113.308 0.855 . . . . 0.0 113.308 -179.249 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.431 ' HB3' HG22 ' A' ' 81' ' ' THR . 87.0 tttt -116.14 109.64 17.75 Favored 'General case' 0 N--CA 1.399 -2.991 0 CA-C-O 121.54 0.686 . . . . 0.0 109.21 -179.059 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.537 ' O ' ' HA ' ' A' ' 109' ' ' THR . 3.4 tt -82.41 150.03 27.33 Favored 'General case' 0 C--N 1.289 -2.055 0 CA-C-N 114.044 -1.435 . . . . 0.0 110.121 -178.415 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.437 ' HA ' ' O ' ' A' ' 108' ' ' VAL . 7.1 t -126.14 131.27 52.09 Favored 'General case' 0 N--CA 1.405 -2.72 0 N-CA-C 106.667 -1.605 . . . . 0.0 106.667 174.38 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.62 ' HA ' ' O ' ' A' ' 74' ' ' ASN . 9.8 p -107.13 134.26 49.35 Favored 'Isoleucine or valine' 0 N--CA 1.398 -3.03 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 -177.57 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 5.1 mp -86.98 116.65 25.18 Favored 'General case' 0 C--N 1.293 -1.851 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.439 178.033 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 48.7 mm -103.37 126.8 31.16 Favored Pre-proline 0 C--N 1.274 -2.715 0 N-CA-C 106.418 -1.697 . . . . 0.0 106.418 173.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.41 ' HG2' ' HG2' ' A' ' 166' ' ' ARG . 1.2 Cg_endo -40.33 -42.54 3.74 Favored 'Trans proline' 0 C--N 1.372 1.784 0 C-N-CA 124.44 3.426 . . . . 0.0 113.739 -178.432 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 66.5 m -161.79 161.73 29.24 Favored 'General case' 0 CA--C 1.482 -1.664 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 176.895 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.457 ' HA ' ' O ' ' A' ' 104' ' ' PHE . 0.0 OUTLIER -71.15 108.91 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.148 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 174.683 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 92' ' ' CYS . . . . . 0.494 ' SG ' ' HB2' ' A' ' 104' ' ' PHE . 14.2 p -97.42 124.0 41.46 Favored 'General case' 0 N--CA 1.425 -1.689 0 N-CA-C 108.442 -0.948 . . . . 0.0 108.442 175.642 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -116.47 123.7 48.13 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 177.963 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.642 ' O ' ' HA ' ' A' ' 101' ' ' VAL . 33.5 m -113.62 130.61 67.37 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.348 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 -179.759 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.511 ' HA2' ' O ' ' A' ' 100' ' ' SER . . . -144.63 158.61 27.6 Favored Glycine 0 C--N 1.3 -1.466 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.232 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 27.8 t80 -152.77 -78.72 0.11 Allowed 'General case' 0 CA--C 1.499 -1.001 0 C-N-CA 118.686 -1.206 . . . . 0.0 109.083 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.426 ' O ' ' HB2' ' A' ' 98' ' ' ASP . 50.4 mtpt -86.34 -41.32 14.63 Favored 'General case' 0 CA--C 1.491 -1.318 0 C-N-CA 119.639 -0.824 . . . . 0.0 108.931 178.134 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.426 ' HB2' ' O ' ' A' ' 97' ' ' LYS . 21.6 t70 143.31 -44.08 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.122 0 N-CA-C 105.954 -1.869 . . . . 0.0 105.954 -168.915 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 8.9 m -59.82 -30.14 68.72 Favored 'General case' 0 C--N 1.344 0.347 0 CA-C-N 113.796 -1.547 . . . . 0.0 110.858 -179.028 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' SER . . . . . 0.511 ' O ' ' HA2' ' A' ' 95' ' ' GLY . 18.2 m -115.49 82.69 1.8 Allowed 'General case' 0 N--CA 1.411 -2.378 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.713 179.519 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.642 ' HA ' ' O ' ' A' ' 94' ' ' VAL . 93.8 t -127.11 117.74 48.31 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.19 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 173.891 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.504 HD12 ' C ' ' A' ' 101' ' ' VAL . 5.6 mp -134.47 142.32 47.04 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 -178.986 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 39.6 ttmt -133.5 121.04 21.6 Favored 'General case' 0 C--N 1.291 -1.968 0 CA-C-O 121.002 0.43 . . . . 0.0 110.249 179.175 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.494 ' HB2' ' SG ' ' A' ' 92' ' ' CYS . 94.1 m-85 -101.25 109.24 21.07 Favored 'General case' 0 C--N 1.291 -1.965 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 174.804 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 43.9 m -72.58 151.96 42.08 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.484 -177.147 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 17.1 p -50.28 -42.87 52.97 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 124.134 0.974 . . . . 0.0 112.375 -179.367 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 41.4 p -127.42 93.76 3.81 Favored 'General case' 0 N--CA 1.424 -1.768 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.344 178.324 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.551 HG11 HG13 ' A' ' 123' ' ' ILE . 45.7 t -87.33 144.09 9.98 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.115 0 N-CA-C 106.372 -1.714 . . . . 0.0 106.372 175.479 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.537 ' HA ' ' O ' ' A' ' 84' ' ' LEU . 10.1 t -144.45 134.45 23.98 Favored 'General case' 0 N--CA 1.399 -2.998 0 CA-C-N 118.614 0.643 . . . . 0.0 110.891 -176.205 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -167.22 -166.97 27.2 Favored Glycine 0 N--CA 1.434 -1.491 0 N-CA-C 111.353 -0.699 . . . . 0.0 111.353 179.652 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 45.8 m80 -83.98 143.32 29.88 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 117.696 0.748 . . . . 0.0 110.741 -177.956 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.568 ' HA ' HD22 ' A' ' 117' ' ' LEU . 0.5 OUTLIER -103.42 118.19 36.2 Favored 'General case' 0 N--CA 1.434 -1.23 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 -174.524 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -132.75 140.23 47.96 Favored 'General case' 0 CA--C 1.461 -2.469 0 O-C-N 123.897 0.748 . . . . 0.0 109.038 167.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 2.5 tmtm? -78.31 100.4 6.71 Favored 'General case' 0 C--N 1.268 -2.964 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 -174.723 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' GLY . . . . . 0.584 ' H ' HD22 ' A' ' 63' ' ' LEU . . . 135.02 -63.3 0.6 Allowed Glycine 0 N--CA 1.433 -1.559 0 N-CA-C 108.201 -1.96 . . . . 0.0 108.201 -175.071 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.547 ' H ' ' HD3' ' A' ' 116' ' ' LYS . 0.1 OUTLIER -122.08 130.0 52.88 Favored 'General case' 0 C--N 1.291 -1.945 0 O-C-N 121.848 -0.795 . . . . 0.0 110.492 179.407 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.568 HD22 ' HA ' ' A' ' 112' ' ' LEU . 0.3 OUTLIER -108.19 105.34 15.02 Favored 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 105.165 -2.161 . . . . 0.0 105.165 -179.502 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 48.1 p -106.05 166.75 10.28 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 113.103 0.779 . . . . 0.0 113.103 -172.748 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 28.0 m-20 64.43 40.53 6.27 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.976 0.91 . . . . 0.0 109.75 175.109 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.479 ' CG1' HD12 ' A' ' 117' ' ' LEU . 15.6 m -83.83 83.07 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.415 -2.197 0 CA-C-O 122.216 1.007 . . . . 0.0 112.117 -172.595 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -68.63 96.39 0.71 Allowed 'General case' 0 N--CA 1.406 -2.64 0 CA-C-N 113.742 -1.572 . . . . 0.0 109.004 176.054 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 147.53 -15.11 1.43 Allowed Glycine 0 C--N 1.292 -1.87 0 C-N-CA 120.28 -0.962 . . . . 0.0 112.059 177.753 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.551 HG13 HG11 ' A' ' 108' ' ' VAL . 93.2 mt -100.17 99.52 8.64 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.833 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 176.636 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.489 ' HA ' ' O ' ' A' ' 131' ' ' VAL . 47.9 mtpt -107.23 148.63 28.69 Favored 'General case' 0 N--CA 1.419 -1.99 0 CA-C-N 113.999 -1.455 . . . . 0.0 109.666 -173.145 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.458 HG22 HG21 ' A' ' 134' ' ' THR . 13.3 t -154.76 157.62 38.27 Favored 'General case' 0 C--N 1.285 -2.23 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 176.236 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.61 ' HD3' ' N ' ' A' ' 127' ' ' VAL . 0.5 OUTLIER -128.8 138.02 51.84 Favored 'General case' 0 N--CA 1.385 -3.713 0 N-CA-C 106.686 -1.598 . . . . 0.0 106.686 172.184 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.61 ' N ' ' HD3' ' A' ' 126' ' ' LYS . 7.4 p -160.21 -38.04 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.289 -2.054 0 N-CA-C 105.766 -1.939 . . . . 0.0 105.766 177.327 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 13.8 tpt -115.74 -50.62 2.69 Favored 'General case' 0 N--CA 1.39 -3.434 0 CA-C-N 112.605 -2.089 . . . . 0.0 108.129 177.711 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 8.7 tp -162.25 172.71 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 N-CA-C 105.511 -2.033 . . . . 0.0 105.511 174.815 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 14.3 m-90 -71.66 117.38 13.17 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 118.834 0.743 . . . . 0.0 110.344 177.929 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.489 ' O ' ' HA ' ' A' ' 124' ' ' LYS . 45.9 t -122.84 133.01 70.21 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.661 0 N-CA-C 106.559 -1.645 . . . . 0.0 106.559 174.691 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 62.8 pttt -108.61 5.24 24.81 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 -173.293 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 35.8 m -126.05 14.94 4.02 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 N-CA-C 112.439 0.533 . . . . 0.0 112.439 -177.538 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' THR . . . . . 0.458 HG21 HG22 ' A' ' 125' ' ' THR . 38.4 p -51.58 102.13 0.04 OUTLIER 'General case' 0 C--N 1.347 0.458 0 CA-C-O 121.502 0.668 . . . . 0.0 112.059 179.682 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 38.5 m -86.54 152.44 22.63 Favored 'General case' 0 N--CA 1.418 -2.038 0 CA-C-N 115.073 -0.967 . . . . 0.0 111.669 -174.747 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 11.5 tt -110.27 132.32 58.93 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.513 0 CA-C-N 114.973 -1.012 . . . . 0.0 109.558 -179.256 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' SER . . . . . 0.416 ' HB2' ' OG1' ' A' ' 146' ' ' THR . 26.0 t -122.13 116.95 25.12 Favored 'General case' 0 N--CA 1.426 -1.657 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 -179.812 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 138' ' ' THR . . . . . 0.457 HG21 HG23 ' A' ' 65' ' ' ILE . 3.0 t -136.35 114.62 11.62 Favored 'General case' 0 C--N 1.277 -2.57 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 178.393 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -78.33 73.06 4.89 Favored 'General case' 0 C--N 1.305 -1.369 0 C-N-CA 119.16 -1.016 . . . . 0.0 111.586 -174.827 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . 49.86 32.23 5.28 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 125.482 1.513 . . . . 0.0 112.039 178.479 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' SER . . . . . 0.647 ' N ' ' HG3' ' A' ' 64' ' ' PRO . 22.9 t -176.96 -76.73 0.01 OUTLIER 'General case' 0 C--O 1.215 -0.727 0 CA-C-O 120.886 0.374 . . . . 0.0 111.102 -175.902 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.433 ' O ' ' HA ' ' A' ' 138' ' ' THR . 93.3 mttt -98.48 150.47 21.63 Favored 'General case' 0 C--N 1.306 -1.291 0 O-C-N 122.287 -0.258 . . . . 0.0 110.443 -172.95 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.685 ' HB ' ' O ' ' A' ' 153' ' ' ARG . 47.9 t -106.16 136.06 42.08 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 CA-C-O 121.143 0.497 . . . . 0.0 111.697 -172.772 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 144' ' ' TYR . . . . . 0.43 ' HA ' ' OG ' ' A' ' 152' ' ' SER . 75.5 m-85 -135.71 143.29 45.3 Favored 'General case' 0 C--O 1.25 1.11 0 C-N-CA 123.894 0.878 . . . . 0.0 109.244 179.488 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 55.5 p90 -64.14 141.28 58.83 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-O 121.423 0.63 . . . . 0.0 112.564 178.575 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.416 ' OG1' ' HB2' ' A' ' 137' ' ' SER . 91.4 m -108.63 -28.77 9.09 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 167.56 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.563 ' HB3' ' HB3' ' A' ' 150' ' ' LYS . . . -60.33 129.46 41.76 Favored 'General case' 0 N--CA 1.441 -0.925 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 172.445 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -84.22 -15.61 68.91 Favored Glycine 0 CA--C 1.48 -2.097 0 C-N-CA 119.956 -1.116 . . . . 0.0 112.584 -169.616 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 58.5 mtt -101.45 2.13 39.01 Favored 'General case' 0 C--N 1.291 -1.974 0 CA-C-O 121.453 0.644 . . . . 0.0 110.021 -176.872 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 150' ' ' LYS . . . . . 0.563 ' HB3' ' HB3' ' A' ' 147' ' ' ALA . 17.3 tppt? -121.28 -178.03 3.67 Favored 'General case' 0 CA--C 1.561 1.374 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 -174.398 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.516 ' H ' ' HG3' ' A' ' 150' ' ' LYS . 75.0 mmtt -137.32 164.52 28.39 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 123.491 0.716 . . . . 0.0 109.071 -172.562 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 152' ' ' SER . . . . . 0.457 ' C ' ' HD2' ' A' ' 153' ' ' ARG . 42.5 m -76.04 153.6 36.31 Favored 'General case' 0 C--N 1.306 -1.326 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 -174.758 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 153' ' ' ARG . . . . . 0.685 ' O ' ' HB ' ' A' ' 143' ' ' VAL . 3.1 mpt_? -126.18 149.98 48.63 Favored 'General case' 0 CA--C 1.494 -1.177 0 N-CA-C 106.18 -1.785 . . . . 0.0 106.18 173.635 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 41.4 m -93.63 142.22 27.59 Favored 'General case' 0 C--N 1.281 -2.382 0 C-N-CA 120.497 -0.481 . . . . 0.0 110.625 -178.352 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 19.1 ttp180 -58.5 -30.38 66.99 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-O 120.66 0.267 . . . . 0.0 111.184 178.541 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -53.44 -21.03 5.37 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 124.058 0.943 . . . . 0.0 112.71 179.531 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -64.96 -53.63 43.3 Favored 'General case' 0 N--CA 1.432 -1.332 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 178.605 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 0.404 ' H ' ' H ' ' A' ' 159' ' ' GLY . 10.7 t80 170.72 23.57 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 106.744 -1.576 . . . . 0.0 106.744 177.49 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 159' ' ' GLY . . . . . 0.404 ' H ' ' H ' ' A' ' 158' ' ' TYR . . . 95.89 -92.52 1.44 Allowed Glycine 0 N--CA 1.416 -2.689 0 C-N-CA 119.082 -1.532 . . . . 0.0 109.376 -170.159 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.536 HG23 ' HB ' ' A' ' 65' ' ' ILE . 2.4 t -130.26 114.5 29.18 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.758 0 N-CA-C 106.333 -1.728 . . . . 0.0 106.333 176.289 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 5.3 pp0? -134.51 130.66 36.96 Favored 'General case' 0 N--CA 1.414 -2.25 0 C-N-CA 117.194 -1.802 . . . . 0.0 115.338 -172.46 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 162' ' ' ARG . . . . . 0.428 ' HG2' HG21 ' A' ' 94' ' ' VAL . 19.8 tpt180 -152.81 138.68 18.02 Favored 'General case' 0 C--N 1.27 -2.875 0 N-CA-C 104.694 -2.335 . . . . 0.0 104.694 168.102 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -69.81 95.27 0.89 Allowed 'General case' 0 CA--C 1.505 -0.768 0 CA-C-O 121.621 0.724 . . . . 0.0 112.777 -175.579 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -145.6 159.27 27.89 Favored Glycine 0 N--CA 1.423 -2.17 0 N-CA-C 109.2 -1.56 . . . . 0.0 109.2 176.572 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.426 ' H ' HD23 ' A' ' 165' ' ' LEU . 2.0 pt? -130.77 143.74 50.95 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-O 120.992 0.425 . . . . 0.0 110.451 -178.075 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 166' ' ' ARG . . . . . 0.507 ' HD2' ' N ' ' A' ' 166' ' ' ARG . 4.2 mpt_? -96.85 106.34 18.63 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 178.897 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 43.3 t -37.52 -46.26 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.562 1.44 0 N-CA-C 115.674 1.731 . . . . 0.0 115.674 -172.054 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -60.45 -35.55 76.11 Favored 'General case' 0 N--CA 1.486 1.326 0 CA-C-O 121.178 0.513 . . . . 0.0 111.729 -178.534 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 31.5 tttm -96.22 -81.17 0.42 Allowed 'General case' 0 C--N 1.3 -1.572 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.678 -179.756 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 170' ' ' PHE . . . . . 0.421 ' OXT' ' HB2' ' A' ' 165' ' ' LEU . 68.6 t80 . . . . . 0 N--CA 1.432 -1.35 0 N-CA-C 101.802 -3.407 . . . . 0.0 101.802 -175.545 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 38.0 t . . . . . 0 N--CA 1.451 -0.38 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -127.68 91.01 3.21 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-O 121.107 0.48 . . . . 0.0 110.151 177.74 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 94.0 mt-30 -99.92 96.29 7.45 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 177.575 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.3 mp -84.95 109.63 18.25 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 -178.767 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 66.6 m-85 -107.38 107.68 18.69 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 176.354 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 53.0 t-20 -107.5 116.27 31.64 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 -178.251 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -100.97 99.74 10.26 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 109.392 -0.595 . . . . 0.0 109.392 177.628 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 28.6 m -95.17 152.7 3.63 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 CA-C-N 115.802 -0.635 . . . . 0.0 109.675 179.551 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 159.2 124.5 0.76 Allowed Glycine 0 N--CA 1.424 -2.164 0 C-N-CA 120.611 -0.804 . . . . 0.0 111.481 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 44.5 m -94.18 114.77 26.95 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 176.882 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -109.72 134.58 51.83 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-O 120.828 0.347 . . . . 0.0 111.395 -179.044 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 94.7 m95 -80.68 102.42 9.87 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.554 177.011 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.7 pp -131.11 170.05 15.05 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.803 178.121 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 96.43 24.51 13.96 Favored Glycine 0 C--N 1.299 -1.514 0 C-N-CA 120.512 -0.852 . . . . 0.0 111.354 -179.098 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 56.5 tt0 -78.14 105.91 9.67 Favored 'General case' 0 CA--C 1.504 -0.803 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 177.652 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 62.5 mttp -89.76 79.7 6.68 Favored 'General case' 0 C--N 1.294 -1.831 0 C-N-CA 118.7 -1.2 . . . . 0.0 111.798 178.907 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.493 ' HA ' HD12 ' A' ' 91' ' ' ILE . . . -82.63 86.42 6.83 Favored 'General case' 0 N--CA 1.431 -1.395 0 N-CA-C 105.222 -2.14 . . . . 0.0 105.222 171.548 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -108.28 114.32 28.09 Favored 'General case' 0 N--CA 1.418 -2.027 0 CA-C-N 114.998 -1.001 . . . . 0.0 112.486 -168.541 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.463 ' HE2' ' CE1' ' A' ' 21' ' ' PHE . 10.2 tmtt? -125.8 96.38 4.75 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 103.571 -2.752 . . . . 0.0 103.571 171.009 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 28.0 mm-40 -135.85 90.46 2.59 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 112.372 0.508 . . . . 0.0 112.372 -175.457 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.463 ' CE1' ' HE2' ' A' ' 19' ' ' LYS . 19.1 p90 -164.45 133.0 3.52 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 106.491 -1.67 . . . . 0.0 106.491 172.654 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -122.75 152.92 40.15 Favored 'General case' 0 C--N 1.285 -2.23 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 -179.206 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 35.6 t -83.19 80.35 9.09 Favored 'General case' 0 N--CA 1.422 -1.873 0 C-N-CA 119.622 -0.831 . . . . 0.0 109.203 176.483 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 77.5 t -114.46 -47.42 4.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-N 114.688 -1.142 . . . . 0.0 108.57 177.864 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 127.88 66.64 0.14 Allowed Glycine 0 N--CA 1.426 -1.979 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.094 178.54 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -58.17 127.0 29.9 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 176.479 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 35.8 m-20 -82.23 103.14 11.61 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 -174.529 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 85.1 mt -85.74 174.17 9.55 Favored 'General case' 0 C--N 1.309 -1.168 0 N-CA-C 106.446 -1.687 . . . . 0.0 106.446 169.751 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.419 ' CG ' ' H ' ' A' ' 30' ' ' SER . 55.1 t30 63.22 -164.45 0.25 Allowed 'General case' 0 N--CA 1.484 1.251 0 N-CA-C 106.544 -1.65 . . . . 0.0 106.544 -172.385 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.419 ' H ' ' CG ' ' A' ' 29' ' ' ASN . 35.4 t 72.37 116.13 0.05 Allowed 'General case' 0 C--O 1.244 0.766 0 CA-C-O 121.552 0.691 . . . . 0.0 111.718 175.3 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 7.3 p -63.13 125.23 19.25 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.906 0 CA-C-O 121.721 0.772 . . . . 0.0 111.346 179.098 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 51.1 m -113.7 93.48 4.4 Favored 'General case' 0 N--CA 1.42 -1.945 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 176.882 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 11.6 t -102.67 178.3 4.61 Favored 'General case' 0 C--N 1.295 -1.775 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.07 -177.233 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 40.2 m 73.87 -36.46 0.34 Allowed 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.595 1.158 . . . . 0.0 112.424 179.261 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 6.7 tp -81.62 84.57 1.57 Allowed 'Isoleucine or valine' 0 C--O 1.247 0.971 0 CA-C-O 122.299 1.047 . . . . 0.0 110.037 176.185 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -164.41 137.58 5.04 Favored 'General case' 0 C--N 1.31 -1.132 0 N-CA-C 104.983 -2.228 . . . . 0.0 104.983 -178.762 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -164.09 86.4 0.1 Allowed Glycine 0 N--CA 1.429 -1.811 0 C-N-CA 119.4 -1.381 . . . . 0.0 112.291 -179.68 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 58.87 -111.65 3.48 Favored Glycine 0 C--O 1.238 0.381 0 O-C-N 124.093 0.525 . . . . 0.0 112.751 178.281 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 8.8 t -107.52 116.47 31.99 Favored 'General case' 0 N--CA 1.427 -1.613 0 CA-C-O 121.745 0.783 . . . . 0.0 110.271 179.427 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 47.5 mmtm -133.79 109.93 9.44 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 115.17 -0.923 . . . . 0.0 109.188 179.452 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 36.2 p90 -83.2 89.16 6.93 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-O 122.01 0.909 . . . . 0.0 112.383 -178.766 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 57.4 tp -156.63 150.38 24.76 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 -179.659 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 11.2 p -66.6 142.54 16.58 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.051 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 175.378 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.421 ' ND2' ' HA ' ' A' ' 49' ' ' LYS . 50.6 t30 -76.93 88.7 3.5 Favored 'General case' 0 C--O 1.253 1.252 0 CA-C-O 121.697 0.761 . . . . 0.0 110.846 -177.476 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.516 ' C ' HD12 ' A' ' 46' ' ' ILE . 40.6 ttmt 70.34 -86.37 0.03 OUTLIER 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 113.989 -1.46 . . . . 0.0 109.623 -177.346 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.516 HD12 ' C ' ' A' ' 45' ' ' LYS . 3.1 mp -144.19 -74.26 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 N-CA-C 106.887 -1.523 . . . . 0.0 106.887 174.593 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt -144.95 15.28 1.54 Allowed 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.12 -0.946 . . . . 0.0 108.856 179.342 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -71.42 -43.97 52.51 Favored Glycine 0 N--CA 1.444 -0.809 0 CA-C-N 114.997 -1.001 . . . . 0.0 112.666 -175.783 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.421 ' HA ' ' ND2' ' A' ' 44' ' ' ASN . 39.7 ttmt 65.61 -83.25 0.03 OUTLIER 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 179.499 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 95.0 mmm 67.7 -62.87 0.33 Allowed 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 124.363 1.065 . . . . 0.0 109.033 -169.899 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 98.9 mt-30 -139.77 -177.69 5.08 Favored 'General case' 0 C--N 1.313 -0.981 0 C-N-CA 125.24 1.416 . . . . 0.0 107.924 177.697 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 51.5 mtmt 63.54 94.05 0.05 OUTLIER Pre-proline 0 N--CA 1.476 0.827 0 C-N-CA 123.943 0.897 . . . . 0.0 112.443 -179.544 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -80.24 25.98 0.59 Allowed 'Trans proline' 0 N--CA 1.477 0.519 0 C-N-CA 123.578 2.852 . . . . 0.0 112.582 -178.735 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.433 ' HB2' ' HD3' ' A' ' 55' ' ' PRO . 33.0 mt -54.77 -59.79 9.62 Favored Pre-proline 0 C--N 1.315 -0.927 0 N-CA-C 112.793 0.664 . . . . 0.0 112.793 -173.797 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.512 ' O ' ' HG2' ' A' ' 59' ' ' LYS . 7.5 Cg_exo -69.65 -14.34 36.29 Favored 'Trans proline' 0 N--CA 1.427 -2.432 0 C-N-CA 121.61 1.54 . . . . 0.0 112.282 -169.356 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -71.52 -39.88 70.48 Favored 'General case' 0 CA--C 1.49 -1.359 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 -174.069 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.451 ' HA ' ' HB3' ' A' ' 60' ' ' GLU . 10.4 mp -68.62 -30.48 69.22 Favored 'General case' 0 N--CA 1.44 -0.925 0 CA-C-N 114.808 -1.087 . . . . 0.0 111.988 178.932 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 6.2 mp -64.5 -48.82 73.74 Favored 'General case' 0 CA--C 1.495 -1.153 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 179.897 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.512 ' HG2' ' O ' ' A' ' 55' ' ' PRO . 32.3 pttt -75.19 -26.84 59.33 Favored 'General case' 0 C--N 1.299 -1.59 0 CA-C-N 115.143 -0.935 . . . . 0.0 112.986 177.399 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.451 ' HB3' ' HA ' ' A' ' 57' ' ' LEU . 8.3 tp10 -59.82 -51.81 68.15 Favored 'General case' 0 C--N 1.306 -1.313 0 C-N-CA 123.927 0.891 . . . . 0.0 111.221 175.018 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 63.4 t80 -68.59 -10.26 54.78 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.6 -176.519 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.589 ' OD2' HG23 ' A' ' 73' ' ' THR . 22.4 t0 -94.71 -179.37 4.84 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.473 -178.495 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.738 ' HB2' HD12 ' A' ' 65' ' ' ILE . 2.5 mt -76.36 169.03 22.9 Favored Pre-proline 0 CA--C 1.559 1.299 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 -178.986 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.463 ' HB2' ' HG3' ' A' ' 155' ' ' ARG . 10.9 Cg_endo -91.97 25.7 0.46 Allowed 'Trans proline' 0 N--CA 1.441 -1.576 0 C-N-CA 122.596 2.197 . . . . 0.0 110.853 -176.725 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.738 HD12 ' HB2' ' A' ' 63' ' ' LEU . 0.2 OUTLIER -73.89 -29.09 25.12 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.432 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 176.915 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 53.11 1.66 0.07 OUTLIER Glycine 0 CA--C 1.544 1.887 0 CA-C-N 114.972 -1.013 . . . . 0.0 115.133 178.086 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.683 ' O ' ' HB ' ' A' ' 160' ' ' VAL . 48.6 mt 67.08 -42.35 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.189 0 C-N-CA 126.441 1.896 . . . . 0.0 114.099 -179.575 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.514 ' HB2' ' O ' ' A' ' 67' ' ' ILE . 71.3 t80 158.0 -51.37 0.0 OUTLIER Pre-proline 0 N--CA 1.489 1.494 0 C-N-CA 125.354 1.462 . . . . 0.0 110.498 177.729 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.464 ' HB2' ' OD2' ' A' ' 71' ' ' ASP . 9.5 Cg_endo -95.82 -24.82 0.12 Allowed 'Trans proline' 0 C--N 1.374 1.878 0 C-N-CA 121.87 1.713 . . . . 0.0 115.052 -172.479 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 82.48 -7.89 63.44 Favored Glycine 0 CA--C 1.526 0.738 0 C-N-CA 120.454 -0.879 . . . . 0.0 111.629 -174.707 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.464 ' OD2' ' HB2' ' A' ' 69' ' ' PRO . 23.2 m-20 -86.16 -30.99 22.05 Favored 'General case' 0 CA--C 1.495 -1.148 0 N-CA-C 106.26 -1.755 . . . . 0.0 106.26 178.062 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.527 ' O ' ' HB ' ' A' ' 73' ' ' THR . . . -82.62 -172.26 3.95 Favored 'General case' 0 N--CA 1.442 -0.825 0 CA-C-N 113.556 -1.657 . . . . 0.0 107.103 171.81 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.589 HG23 ' OD2' ' A' ' 62' ' ' ASP . 60.7 m 79.94 27.35 0.32 Allowed 'General case' 0 N--CA 1.474 0.742 0 CA-C-O 124.807 2.241 . . . . 0.0 109.483 175.015 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 35.8 m-80 -84.48 -177.3 6.58 Favored 'General case' 0 N--CA 1.386 -3.641 0 CA-C-N 113.759 -1.564 . . . . 0.0 110.479 178.786 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 42.6 t80 -149.21 94.9 2.3 Favored 'General case' 0 C--N 1.276 -2.628 0 C-N-CA 119.352 -0.939 . . . . 0.0 110.935 -169.784 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.665 ' OE1' ' HG ' ' A' ' 87' ' ' LEU . 4.2 mp0 -107.26 96.09 6.17 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 176.777 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.431 ' HB2' HD23 ' A' ' 84' ' ' LEU . 81.9 t80 -102.73 124.31 48.03 Favored 'General case' 0 C--N 1.297 -1.704 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.255 -176.264 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.724 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 10.4 m-20 -93.9 155.77 16.99 Favored 'General case' 0 CA--C 1.47 -2.1 0 C-N-CA 118.819 -1.152 . . . . 0.0 108.712 175.017 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -80.43 -53.35 6.68 Favored 'General case' 0 C--N 1.25 -3.756 0 CA-C-N 113.412 -1.722 . . . . 0.0 109.026 179.323 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -66.77 -21.33 66.06 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 113.726 -1.579 . . . . 0.0 110.754 -176.498 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.724 ' HB ' ' HB2' ' A' ' 78' ' ' ASP . 27.2 m -101.63 -53.01 3.07 Favored 'General case' 0 N--CA 1.41 -2.455 0 CA-C-N 115.0 -1.0 . . . . 0.0 111.192 -174.612 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 99.7 mttt 70.26 4.15 4.74 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 123.85 0.86 . . . . 0.0 111.995 -174.616 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.719 ' HG2' HG22 ' A' ' 109' ' ' THR . 36.2 ttmt -104.91 107.41 18.36 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 176.655 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.431 HD23 ' HB2' ' A' ' 77' ' ' PHE . 3.1 tm? -68.01 133.73 49.52 Favored 'General case' 0 C--N 1.292 -1.929 0 CA-C-N 113.833 -1.53 . . . . 0.0 110.447 -175.56 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.503 HG23 ' HB2' ' A' ' 76' ' ' GLU . 8.9 t -120.85 137.79 54.38 Favored 'General case' 0 N--CA 1.403 -2.812 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 177.422 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 61.0 t -111.32 118.62 57.88 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 C-N-CA 123.811 0.844 . . . . 0.0 109.44 -179.205 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.665 ' HG ' ' OE1' ' A' ' 76' ' ' GLU 0.293 0.5 OUTLIER -79.44 124.41 28.43 Favored 'General case' 0 N--CA 1.403 -2.82 0 CA-C-O 122.578 1.18 . . . . 0.0 112.37 172.879 . . . . . . . . 4 4 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.437 HG23 ' HE ' ' A' ' 166' ' ' ARG . 50.4 mm -102.36 125.8 35.18 Favored Pre-proline 0 C--N 1.279 -2.482 0 CA-C-N 113.711 -1.586 . . . . 0.0 107.805 178.638 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -59.61 96.93 0.1 Allowed 'Trans proline' 0 C--O 1.248 1.018 0 C-N-CA 122.62 2.214 . . . . 0.0 111.516 175.476 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.485 ' OG ' ' HB2' ' A' ' 168' ' ' ASP . 68.4 m 65.21 176.74 0.2 Allowed 'General case' 0 C--O 1.236 0.356 0 C-N-CA 124.483 1.113 . . . . 0.0 112.844 -178.711 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.493 HD12 ' HA ' ' A' ' 17' ' ' ALA . 39.7 mt -88.5 131.15 36.7 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.623 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.793 178.705 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' CYS . . . . . 0.461 ' SG ' ' HA3' ' A' ' 164' ' ' GLY . 16.0 t -116.16 122.71 45.87 Favored 'General case' 0 N--CA 1.41 -2.452 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 173.764 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -116.96 127.29 54.06 Favored 'General case' 0 C--N 1.29 -2.017 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 178.628 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 3.9 p -105.14 103.94 16.14 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.27 0 CA-C-O 122.024 0.916 . . . . 0.0 109.578 177.898 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -130.53 131.37 6.49 Favored Glycine 0 N--CA 1.423 -2.229 0 N-CA-C 108.226 -1.95 . . . . 0.0 108.226 179.111 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . 0.286 4.9 t80 175.67 -53.41 0.01 OUTLIER 'General case' 0 CA--C 1.476 -1.879 0 N-CA-C 105.041 -2.207 . . . . 0.0 105.041 -171.899 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.603 ' HA ' ' HE3' ' A' ' 97' ' ' LYS . 0.4 OUTLIER -76.13 -18.72 59.02 Favored 'General case' 0 N--CA 1.403 -2.814 0 CA-C-N 110.806 -2.906 . . . . 0.0 112.185 -172.727 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 18.9 t70 70.1 -56.84 0.58 Allowed 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 113.912 1.079 . . . . 0.0 113.912 176.629 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 18.5 m -79.97 -9.97 59.73 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-O 121.661 0.744 . . . . 0.0 109.824 -177.421 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 35.0 m -140.57 89.37 2.27 Favored 'General case' 0 N--CA 1.423 -1.789 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.645 177.429 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.459 ' C ' HD12 ' A' ' 102' ' ' LEU . 60.8 t -113.0 128.86 69.52 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.201 0 N-CA-C 108.142 -1.058 . . . . 0.0 108.142 176.374 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.464 ' HA ' ' O ' ' A' ' 124' ' ' LYS . 5.3 mp -129.9 136.2 49.23 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-O 120.746 0.308 . . . . 0.0 110.796 -178.949 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -112.43 110.09 20.08 Favored 'General case' 0 C--N 1.31 -1.146 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 177.132 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -89.82 103.5 16.15 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 176.862 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.457 ' HA ' HG12 ' A' ' 91' ' ' ILE . 35.1 m -82.41 157.81 23.54 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.967 -175.099 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 20.3 p -55.84 -38.13 69.64 Favored 'General case' 0 C--N 1.319 -0.725 0 C-N-CA 125.898 1.679 . . . . 0.0 113.037 -177.406 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 14.0 m -128.13 98.73 5.21 Favored 'General case' 0 N--CA 1.419 -1.983 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 -179.412 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 16.9 m -108.4 133.69 52.59 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 179.108 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.719 HG22 ' HG2' ' A' ' 83' ' ' LYS . 37.0 m -130.35 132.53 45.87 Favored 'General case' 0 N--CA 1.394 -3.268 0 CA-C-N 116.767 -0.197 . . . . 0.0 110.813 -164.338 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.637 ' HA3' ' O ' ' A' ' 119' ' ' ASP . . . -161.98 -158.25 9.41 Favored Glycine 0 C--O 1.217 -0.916 0 C-N-CA 121.288 -0.482 . . . . 0.0 112.635 -177.274 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 53.3 m80 -117.56 108.06 15.02 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 122.165 -0.609 . . . . 0.0 109.606 176.038 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 5.9 tt -104.4 127.82 52.14 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.73 -172.071 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -131.59 168.1 18.27 Favored 'General case' 0 CA--C 1.464 -2.355 0 CA-C-N 115.243 -0.889 . . . . 0.0 109.71 173.783 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 54.2 tptt -84.35 101.11 11.71 Favored 'General case' 0 N--CA 1.389 -3.522 0 CA-C-N 115.179 -0.918 . . . . 0.0 108.809 -177.017 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' GLY . . . . . 0.479 ' H ' ' CD2' ' A' ' 63' ' ' LEU . . . 126.24 -11.68 7.22 Favored Glycine 0 C--O 1.205 -1.697 0 CA-C-N 115.159 -0.928 . . . . 0.0 111.164 -176.868 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 179.53 147.89 0.24 Allowed 'General case' 0 N--CA 1.487 1.393 0 CA-C-N 117.052 0.426 . . . . 0.0 111.219 178.295 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.6 tt -124.11 113.67 18.68 Favored 'General case' 0 N--CA 1.429 -1.497 0 N-CA-C 106.013 -1.847 . . . . 0.0 106.013 176.961 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 71.8 p -97.58 122.58 40.82 Favored 'General case' 0 C--N 1.265 -3.071 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.609 -177.829 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' ASP . . . . . 0.637 ' O ' ' HA3' ' A' ' 110' ' ' GLY . 31.3 m-20 73.13 129.76 0.04 OUTLIER 'General case' 0 C--O 1.207 -1.146 0 C-N-CA 125.484 1.514 . . . . 0.0 111.651 -179.155 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 10.8 m -135.5 78.75 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 CA-C-O 122.639 1.209 . . . . 0.0 108.72 173.744 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -67.17 111.53 3.97 Favored 'General case' 0 N--CA 1.424 -1.757 0 CA-C-N 113.668 -1.605 . . . . 0.0 108.85 -175.893 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 133.27 -13.75 4.89 Favored Glycine 0 N--CA 1.424 -2.1 0 C-N-CA 120.31 -0.948 . . . . 0.0 112.115 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.458 ' O ' ' HA ' ' A' ' 132' ' ' LYS . 67.5 mt -99.55 113.57 35.14 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.17 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 179.178 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.464 ' O ' ' HA ' ' A' ' 102' ' ' LEU . 23.1 tptm -85.07 117.9 24.31 Favored 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 104.967 -2.234 . . . . 0.0 104.967 -179.261 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 95.1 m -126.85 124.93 40.74 Favored 'General case' 0 C--N 1.288 -2.085 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 -170.347 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.522 ' HG2' ' N ' ' A' ' 127' ' ' VAL . 84.2 tttt -119.37 145.59 46.06 Favored 'General case' 0 N--CA 1.429 -1.499 0 CA-C-O 121.255 0.55 . . . . 0.0 110.203 169.548 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.522 ' N ' ' HG2' ' A' ' 126' ' ' LYS . 7.2 p -159.21 -35.68 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 175.782 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -125.25 -51.67 1.64 Allowed 'General case' 0 N--CA 1.399 -3.006 0 N-CA-C 105.621 -1.992 . . . . 0.0 105.621 -179.729 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 7.9 tp -149.94 169.9 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.285 0 N-CA-C 105.574 -2.01 . . . . 0.0 105.574 176.516 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' TRP . . . . . 0.433 ' CD1' ' HB2' ' A' ' 126' ' ' LYS . 30.6 m-90 -80.12 126.32 30.94 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-O 121.32 0.581 . . . . 0.0 111.241 177.52 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 7.3 p -137.35 137.0 46.51 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.247 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 176.636 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' LYS . . . . . 0.458 ' HA ' ' O ' ' A' ' 123' ' ' ILE . 0.0 OUTLIER -112.07 20.19 17.11 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 113.708 1.003 . . . . 0.0 113.708 -174.687 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.442 HG13 ' HD2' ' A' ' 132' ' ' LYS . 17.8 m -124.17 -60.55 1.86 Allowed 'Isoleucine or valine' 0 C--O 1.21 -1.014 0 CA-C-N 116.101 -0.499 . . . . 0.0 112.15 179.357 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 134' ' ' THR . . . . . 0.466 ' O ' ' HA ' ' A' ' 119' ' ' ASP . 77.5 p 51.71 -171.64 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 124.118 0.967 . . . . 0.0 113.465 179.386 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 23.2 p -166.0 152.9 9.73 Favored 'General case' 0 N--CA 1.427 -1.612 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 176.06 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 14.1 tt -131.29 134.0 61.61 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.322 0 CA-C-O 121.254 0.549 . . . . 0.0 109.549 -179.264 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 39.9 t -124.81 159.61 30.62 Favored 'General case' 0 C--N 1.289 -2.041 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 -176.936 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' THR . . . . . 0.53 HG23 ' H ' ' A' ' 140' ' ' ALA . 9.7 t -165.15 175.97 8.88 Favored 'General case' 0 N--CA 1.41 -2.436 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 -178.008 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -112.49 30.57 6.99 Favored 'General case' 0 C--N 1.275 -2.659 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 173.128 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.53 ' H ' HG23 ' A' ' 138' ' ' THR . . . 62.84 38.37 11.56 Favored 'General case' 0 C--N 1.35 0.596 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 -172.462 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 141' ' ' SER . . . . . 0.632 ' O ' ' HB3' ' A' ' 155' ' ' ARG . 46.9 t -174.57 -79.95 0.01 OUTLIER 'General case' 0 C--O 1.219 -0.527 0 CA-C-N 114.585 -1.189 . . . . 0.0 111.312 -175.064 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -75.53 134.94 40.63 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 -178.48 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 59.4 t -106.0 130.37 57.67 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.969 0 CA-C-O 120.998 0.428 . . . . 0.0 111.556 -170.155 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -131.76 150.17 52.24 Favored 'General case' 0 CA--C 1.481 -1.699 0 CA-C-O 121.589 0.709 . . . . 0.0 110.631 176.968 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' PHE . . . . . 0.456 ' HB2' ' HB2' ' A' ' 151' ' ' LYS . 60.7 m-85 -109.91 103.12 11.85 Favored 'General case' 0 C--N 1.268 -2.967 0 CA-C-N 115.026 -0.988 . . . . 0.0 111.424 179.205 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 6.6 p -81.75 19.69 1.04 Allowed 'General case' 0 C--N 1.305 -1.37 0 CA-C-N 115.073 -0.967 . . . . 0.0 113.269 -176.229 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -68.79 -15.4 63.49 Favored 'General case' 0 C--O 1.218 -0.574 0 CA-C-O 121.773 0.796 . . . . 0.0 109.812 175.209 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 166.39 29.53 0.02 OUTLIER Glycine 0 N--CA 1.43 -1.715 0 N-CA-C 108.868 -1.693 . . . . 0.0 108.868 175.914 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 15.6 tpt 57.59 23.5 9.38 Favored 'General case' 0 N--CA 1.486 1.328 0 CA-C-O 122.322 1.058 . . . . 0.0 108.498 -173.481 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 150' ' ' LYS . . . . . 0.462 ' CD ' HG11 ' A' ' 127' ' ' VAL . 0.0 OUTLIER -76.19 -9.46 58.65 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 115.942 1.83 . . . . 0.0 115.942 -169.492 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.473 ' HE2' ' HA ' ' A' ' 151' ' ' LYS . 5.2 mmpt? -147.21 138.33 23.83 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 120.514 0.197 . . . . 0.0 111.278 178.556 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 72.2 p -126.53 132.41 51.37 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 174.343 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 22.8 tpt180 -147.91 157.37 43.49 Favored 'General case' 0 C--N 1.31 -1.148 0 N-CA-C 109.554 -0.535 . . . . 0.0 109.554 -176.82 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 68.3 m -98.1 143.71 28.36 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 108.434 -0.951 . . . . 0.0 108.434 173.019 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 155' ' ' ARG . . . . . 0.632 ' HB3' ' O ' ' A' ' 141' ' ' SER . 0.0 OUTLIER -67.44 -18.29 65.04 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 118.756 -1.177 . . . . 0.0 112.758 176.837 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -41.86 -56.97 2.54 Favored 'General case' 0 N--CA 1.482 1.174 0 N-CA-C 115.128 1.529 . . . . 0.0 115.128 -173.775 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -56.32 -37.96 70.65 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 112.012 0.375 . . . . 0.0 112.012 -176.856 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 6.7 t80 176.15 -26.25 0.0 OUTLIER 'General case' 0 CA--C 1.506 -0.731 0 N-CA-C 106.913 -1.514 . . . . 0.0 106.913 174.374 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 159' ' ' GLY . . . . . 0.695 ' HA3' ' O ' ' A' ' 65' ' ' ILE . . . 132.03 -87.33 0.28 Allowed Glycine 0 N--CA 1.407 -3.251 0 N-CA-C 110.506 -1.037 . . . . 0.0 110.506 -174.014 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.683 ' HB ' ' O ' ' A' ' 67' ' ' ILE . 12.0 t -98.54 116.91 42.6 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.238 0 C-N-CA 119.338 -0.945 . . . . 0.0 108.701 178.593 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 75.9 mm-40 -119.61 108.94 15.08 Favored 'General case' 0 CA--C 1.501 -0.931 0 N-CA-C 113.979 1.103 . . . . 0.0 113.979 -176.638 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 22.4 mmm180 -149.71 148.43 29.25 Favored 'General case' 0 C--N 1.308 -1.234 0 C-N-CA 125.508 1.523 . . . . 0.0 107.466 172.946 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -74.31 89.38 2.07 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-O 121.514 0.673 . . . . 0.0 110.874 -177.871 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 164' ' ' GLY . . . . . 0.461 ' HA3' ' SG ' ' A' ' 92' ' ' CYS . . . -122.8 168.05 15.12 Favored Glycine 0 N--CA 1.432 -1.568 0 CA-C-N 115.151 -0.931 . . . . 0.0 110.952 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 49.9 tp -141.19 114.58 8.77 Favored 'General case' 0 N--CA 1.414 -2.251 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 178.537 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 166' ' ' ARG . . . . . 0.439 ' HD2' ' HG3' ' A' ' 69' ' ' PRO . 81.3 mtt85 -87.4 103.97 16.0 Favored 'General case' 0 CA--C 1.476 -1.882 0 CA-C-O 122.07 0.938 . . . . 0.0 110.672 178.131 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 18.6 m -77.09 53.04 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.294 -1.809 0 CA-C-N 113.378 -1.737 . . . . 0.0 114.444 -173.91 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 168' ' ' ASP . . . . . 0.485 ' HB2' ' OG ' ' A' ' 90' ' ' SER . 32.8 t70 -135.36 -0.33 2.7 Favored 'General case' 0 N--CA 1.475 0.825 0 CA-C-O 122.271 1.034 . . . . 0.0 108.435 175.932 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -149.88 162.41 40.37 Favored 'General case' 0 N--CA 1.443 -0.817 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 -177.693 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 170' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 . . . . . 0 C--O 1.247 0.927 0 CA-C-O 118.958 -0.544 . . . . 0.0 110.162 176.784 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 42.5 m . . . . . 0 N--CA 1.446 -0.665 0 CA-C-O 120.624 0.25 . . . . 0.0 110.818 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 67.09 9.21 6.75 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 124.74 1.216 . . . . 0.0 113.364 174.761 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -90.79 106.9 18.83 Favored 'General case' 0 C--N 1.315 -0.892 0 C-N-CA 119.883 -0.727 . . . . 0.0 111.748 -177.349 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.541 HD13 ' H ' ' A' ' 4' ' ' ILE . 0.2 OUTLIER -116.35 91.84 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.836 0 CA-C-O 122.041 0.924 . . . . 0.0 111.133 179.347 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 44.3 p90 -140.42 113.7 8.51 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-N 115.004 -0.998 . . . . 0.0 109.295 178.54 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 38.1 t30 -160.68 91.31 0.9 Allowed 'General case' 0 C--N 1.299 -1.599 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.907 179.213 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.443 ' HD2' ' N ' ' A' ' 7' ' ' LYS . 0.3 OUTLIER -98.42 91.34 5.14 Favored 'General case' 0 C--N 1.291 -1.939 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 178.114 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.6 p -89.14 125.29 42.18 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 CA-C-N 115.168 -0.924 . . . . 0.0 110.662 -177.326 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -117.94 55.74 0.57 Allowed Glycine 0 N--CA 1.432 -1.588 0 C-N-CA 120.856 -0.688 . . . . 0.0 111.507 -178.576 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 51.0 m -79.05 125.11 28.97 Favored 'General case' 0 N--CA 1.435 -1.217 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 178.706 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.402 ' CZ ' ' HB3' ' A' ' 13' ' ' LEU . 83.2 t80 -106.33 125.76 51.4 Favored 'General case' 0 N--CA 1.425 -1.675 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.831 -175.857 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 45.1 p90 -144.84 98.24 3.15 Favored 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 171.323 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.402 ' HB3' ' CZ ' ' A' ' 11' ' ' TYR . 64.4 tp -163.24 107.7 1.06 Allowed 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.685 -176.012 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 159.59 -169.99 35.75 Favored Glycine 0 N--CA 1.429 -1.823 0 C-N-CA 120.239 -0.982 . . . . 0.0 111.411 178.823 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 27.6 pt20 -155.86 154.19 30.9 Favored 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 -179.584 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -86.79 113.33 22.53 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 107.956 -1.128 . . . . 0.0 107.956 176.951 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -76.42 98.82 4.68 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-N 115.976 -0.557 . . . . 0.0 111.072 -178.097 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 50.0 t-20 -87.69 93.58 9.48 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 106.606 -1.627 . . . . 0.0 106.606 174.377 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -99.85 105.81 17.6 Favored 'General case' 0 N--CA 1.419 -1.978 0 CA-C-N 115.956 -0.565 . . . . 0.0 109.557 -178.472 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -90.49 100.94 13.69 Favored 'General case' 0 N--CA 1.423 -1.809 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 177.873 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 56.6 t80 -100.12 96.38 7.46 Favored 'General case' 0 C--N 1.299 -1.595 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.934 -175.794 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 37.0 m-20 -97.12 85.35 3.69 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.01 179.469 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 32.7 t -169.57 135.56 1.55 Allowed 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 179.145 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 8.3 p -156.21 128.47 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 179.082 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -83.84 75.85 2.32 Favored Glycine 0 N--CA 1.431 -1.694 0 C-N-CA 120.68 -0.772 . . . . 0.0 113.123 -177.724 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -103.16 79.51 1.74 Allowed 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 174.028 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -174.97 152.74 1.54 Allowed 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.296 -177.023 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 58.3 tp 81.55 78.11 0.03 OUTLIER 'General case' 0 C--N 1.314 -0.945 0 C-N-CA 125.348 1.459 . . . . 0.0 112.318 178.722 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 53.1 t30 -159.67 89.02 0.87 Allowed 'General case' 0 C--N 1.305 -1.346 0 CA-C-N 114.19 -1.368 . . . . 0.0 107.669 175.387 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 53.1 p -90.97 93.63 9.28 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.78 -175.488 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 7.3 p -163.53 93.28 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.435 -1.212 0 CA-C-O 122.04 0.924 . . . . 0.0 110.54 178.209 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 33.3 t -86.41 -25.79 25.08 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 177.311 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 10.4 t -173.53 176.94 2.67 Favored 'General case' 0 N--CA 1.423 -1.822 0 N-CA-C 104.762 -2.31 . . . . 0.0 104.762 177.172 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 26.4 t -141.83 127.67 19.33 Favored 'General case' 0 N--CA 1.421 -1.924 0 C-N-CA 119.407 -0.917 . . . . 0.0 110.484 179.746 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 32.8 pt -104.99 -4.5 9.7 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 175.895 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -69.71 109.55 4.43 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-N 114.377 -1.283 . . . . 0.0 108.153 178.952 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 145.76 57.17 0.02 OUTLIER Glycine 0 C--N 1.293 -1.834 0 C-N-CA 119.57 -1.3 . . . . 0.0 111.763 -179.487 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -139.06 54.42 0.68 Allowed Glycine 0 N--CA 1.426 -2.012 0 N-CA-C 110.433 -1.067 . . . . 0.0 110.433 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.3 t -85.89 100.99 12.47 Favored 'General case' 0 N--CA 1.425 -1.682 0 CA-C-O 121.771 0.796 . . . . 0.0 110.444 -179.851 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -87.58 130.78 34.62 Favored 'General case' 0 N--CA 1.423 -1.805 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.278 -178.74 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 77.0 t-105 -128.93 103.52 7.07 Favored 'General case' 0 N--CA 1.422 -1.834 0 N-CA-C 106.96 -1.496 . . . . 0.0 106.96 177.682 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 52.2 tp -87.92 -18.54 28.91 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.812 -174.412 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 47.5 t 70.66 93.2 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.241 0.64 0 C-N-CA 123.996 0.919 . . . . 0.0 110.254 -178.259 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 -92.38 70.39 5.12 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-O 121.455 0.645 . . . . 0.0 110.463 178.746 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 87.5 tttt 176.61 93.95 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.724 0 C-N-CA 125.431 1.493 . . . . 0.0 107.542 179.773 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 7.2 tp -91.0 77.25 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 CA-C-O 122.174 0.988 . . . . 0.0 111.251 -178.157 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp -135.93 92.96 2.86 Favored 'General case' 0 N--CA 1.438 -1.06 0 CA-C-N 114.363 -1.289 . . . . 0.0 109.179 178.646 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -123.56 -71.4 0.24 Allowed Glycine 0 N--CA 1.42 -2.368 0 N-CA-C 109.792 -1.323 . . . . 0.0 109.792 178.122 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 67.3 mttm 51.24 91.3 0.02 OUTLIER 'General case' 0 CA--C 1.511 -0.556 0 C-N-CA 124.487 1.115 . . . . 0.0 112.166 179.467 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 26.4 ptt? -82.36 83.06 7.6 Favored 'General case' 0 C--N 1.299 -1.615 0 C-N-CA 118.78 -1.168 . . . . 0.0 111.471 -179.219 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 43.7 mt-30 -79.71 108.94 13.66 Favored 'General case' 0 N--CA 1.421 -1.882 0 N-CA-C 105.827 -1.916 . . . . 0.0 105.827 174.53 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 96.0 mttt 78.87 140.9 0.07 OUTLIER Pre-proline 0 CA--C 1.536 0.425 0 O-C-N 125.229 1.581 . . . . 0.0 108.152 -168.231 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.512 ' O ' ' HG ' ' A' ' 57' ' ' LEU . 43.9 Cg_endo -70.65 27.17 0.2 Allowed 'Trans proline' 0 N--CA 1.488 1.206 0 C-N-CA 123.081 2.521 . . . . 0.0 113.924 -177.408 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.661 ' O ' ' HG ' ' A' ' 58' ' ' LEU 0.261 7.9 mp -53.98 -48.71 93.05 Favored Pre-proline 0 CA--C 1.476 -1.886 0 N-CA-C 117.79 2.515 . . . . 0.0 117.79 -174.159 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.617 ' O ' ' HE2' ' A' ' 59' ' ' LYS . 52.8 Cg_exo -57.44 -25.76 67.88 Favored 'Trans proline' 0 N--CA 1.445 -1.342 0 C-N-CA 121.52 1.48 . . . . 0.0 111.418 -176.371 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -81.74 -32.04 31.71 Favored 'General case' 0 N--CA 1.417 -2.124 0 CA-C-N 115.021 -0.99 . . . . 0.0 108.898 -178.279 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.543 ' HA ' ' HB3' ' A' ' 60' ' ' GLU . 15.4 mt -74.98 -29.69 60.97 Favored 'General case' 0 CA--C 1.487 -1.454 0 CA-C-N 115.004 -0.998 . . . . 0.0 110.333 -174.436 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.661 ' HG ' ' O ' ' A' ' 54' ' ' LEU . 15.5 mt -59.71 -52.4 65.67 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 -178.687 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.617 ' HE2' ' O ' ' A' ' 55' ' ' PRO . 49.5 mtmt -64.93 -23.91 67.36 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 113.955 -1.475 . . . . 0.0 110.57 177.689 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.543 ' HB3' ' HA ' ' A' ' 57' ' ' LEU . 28.3 tt0 -82.58 -19.09 39.14 Favored 'General case' 0 C--N 1.291 -1.976 0 C-N-CA 124.844 1.257 . . . . 0.0 111.679 178.456 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 36.6 m-85 -85.9 -33.21 21.28 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 113.56 0.948 . . . . 0.0 113.56 -177.669 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.514 ' OD2' HD13 ' A' ' 65' ' ' ILE . 4.6 p-10 -78.47 -165.19 0.66 Allowed 'General case' 0 C--N 1.292 -1.92 0 N-CA-C 113.116 0.784 . . . . 0.0 113.116 -167.458 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.703 ' HB2' HD12 ' A' ' 65' ' ' ILE . 6.6 mt -77.16 -154.23 0.0 OUTLIER Pre-proline 0 CA--C 1.599 2.845 0 N-CA-C 104.494 -2.41 . . . . 0.0 104.494 178.146 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.493 ' O ' ' HD2' ' A' ' 155' ' ' ARG . 7.5 Cg_endo -96.77 10.9 1.25 Allowed 'Trans proline' 0 N--CA 1.441 -1.585 0 CA-C-N 123.667 2.345 . . . . 0.0 111.067 177.127 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.703 HD12 ' HB2' ' A' ' 63' ' ' LEU . 0.2 OUTLIER -78.9 -40.31 22.77 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.92 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.68 -176.81 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 59.9 8.14 7.62 Favored Glycine 0 CA--C 1.542 1.73 0 CA-C-N 116.287 -0.415 . . . . 0.0 113.638 -177.87 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.635 ' H ' HG12 ' A' ' 65' ' ' ILE . 55.9 mt 59.01 -70.4 0.07 OUTLIER 'Isoleucine or valine' 0 C--O 1.211 -0.94 0 C-N-CA 127.418 2.287 . . . . 0.0 114.126 -178.72 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.597 ' HB3' ' HD3' ' A' ' 69' ' ' PRO . 34.3 t80 173.5 -56.57 0.0 OUTLIER Pre-proline 0 CA--C 1.563 1.446 0 CA-C-N 118.024 0.375 . . . . 0.0 110.571 -176.55 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.597 ' HD3' ' HB3' ' A' ' 68' ' ' PHE . 6.9 Cg_endo -98.89 157.97 0.67 Allowed 'Trans proline' 0 C--N 1.386 2.533 0 C-N-CA 123.205 2.603 . . . . 0.0 112.598 179.39 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -89.45 -8.24 68.39 Favored Glycine 0 CA--C 1.524 0.648 0 C-N-CA 121.379 -0.438 . . . . 0.0 112.39 179.837 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.565 ' OD2' ' HG3' ' A' ' 89' ' ' PRO . 20.8 t70 -89.6 -19.96 24.3 Favored 'General case' 0 C--O 1.213 -0.852 0 CA-C-O 122.17 0.986 . . . . 0.0 108.635 177.045 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.448 ' HB3' ' HD2' ' A' ' 69' ' ' PRO . . . -84.33 -166.13 1.35 Allowed 'General case' 0 CA--C 1.487 -1.48 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 167.942 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 18.2 p 67.71 18.06 9.81 Favored 'General case' 0 CA--C 1.47 -2.11 0 CA-C-O 123.582 1.658 . . . . 0.0 110.668 172.234 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.749 ' O ' ' HA ' ' A' ' 86' ' ' VAL . 1.2 m120 -75.87 100.49 4.81 Favored 'General case' 2 N--CA 1.365 -4.694 0 CA-C-N 111.704 -2.498 . . . . 0.0 110.513 -178.639 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -99.03 91.86 5.22 Favored 'General case' 0 C--N 1.274 -2.71 0 CA-C-N 114.572 -1.194 . . . . 0.0 113.33 -176.836 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.599 ' HB2' HG23 ' A' ' 85' ' ' THR . 19.2 mm-40 -97.5 133.8 41.58 Favored 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 106.729 -1.582 . . . . 0.0 106.729 175.735 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.452 ' HB2' ' CD2' ' A' ' 84' ' ' LEU . 90.6 t80 -146.57 127.28 14.3 Favored 'General case' 0 C--N 1.301 -1.511 0 C-N-CA 120.256 -0.578 . . . . 0.0 112.193 -173.477 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.684 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 5.8 m-20 -95.2 156.5 16.29 Favored 'General case' 0 CA--C 1.472 -2.043 0 N-CA-C 105.44 -2.059 . . . . 0.0 105.44 170.184 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -80.1 -60.63 2.26 Favored 'General case' 0 C--N 1.255 -3.521 0 N-CA-C 113.557 0.947 . . . . 0.0 113.557 -175.027 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -71.04 -29.94 65.98 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-O 121.415 0.626 . . . . 0.0 111.1 -175.695 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.684 ' HB ' ' HB2' ' A' ' 78' ' ' ASP . 24.6 m -68.6 -45.13 72.77 Favored 'General case' 0 N--CA 1.421 -1.886 0 CA-C-N 114.898 -1.046 . . . . 0.0 109.873 179.561 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 99.6 mttt 68.12 8.13 6.33 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.139 0.976 . . . . 0.0 113.319 -179.016 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 1.9 mptm? -89.22 106.23 18.31 Favored 'General case' 0 CA--C 1.494 -1.193 0 CA-C-O 121.551 0.691 . . . . 0.0 110.662 173.712 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.461 ' HB2' ' HB2' ' A' ' 112' ' ' LEU . 2.1 tm? -81.81 126.4 31.81 Favored 'General case' 0 C--N 1.285 -2.229 0 N-CA-C 105.426 -2.064 . . . . 0.0 105.426 174.909 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.63 ' HA ' ' O ' ' A' ' 108' ' ' VAL . 9.5 t -116.5 127.42 54.54 Favored 'General case' 0 N--CA 1.392 -3.327 0 C-N-CA 120.196 -0.602 . . . . 0.0 110.632 -178.937 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.749 ' HA ' ' O ' ' A' ' 74' ' ' ASN . 32.3 t -104.75 122.65 58.06 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.108 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.404 -178.588 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.402 ' O ' ' HA ' ' A' ' 72' ' ' ALA . 5.6 mp -90.49 104.4 16.99 Favored 'General case' 0 C--N 1.29 -2.01 0 CA-C-N 114.981 -1.008 . . . . 0.0 109.328 177.352 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.423 HG12 ' HB3' ' A' ' 104' ' ' PHE . 3.5 mp -93.93 137.53 23.03 Favored Pre-proline 0 C--N 1.302 -1.489 0 N-CA-C 106.561 -1.644 . . . . 0.0 106.561 175.114 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.621 ' O ' ' HB2' ' A' ' 166' ' ' ARG . 43.4 Cg_exo -59.76 97.32 0.11 Allowed 'Trans proline' 0 N--CA 1.455 -0.781 0 C-N-CA 122.58 2.187 . . . . 0.0 110.34 176.364 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.561 ' OG ' ' HB ' ' A' ' 167' ' ' VAL . 73.4 m 66.57 177.82 0.22 Allowed 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 123.654 0.781 . . . . 0.0 110.862 -174.531 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 14.8 tt -94.78 109.06 21.66 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.763 0 C-N-CA 119.792 -0.763 . . . . 0.0 109.185 175.943 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 27.1 p -98.77 149.15 23.17 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.366 -179.072 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -116.56 121.32 41.42 Favored 'General case' 0 CA--C 1.476 -1.88 0 N-CA-C 107.513 -1.291 . . . . 0.0 107.513 -179.053 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.595 HG13 ' H ' ' A' ' 163' ' ' ASN . 25.0 t -112.04 103.27 15.18 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.62 0 C-N-CA 119.614 -0.834 . . . . 0.0 111.293 -176.227 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -144.81 -156.93 7.01 Favored Glycine 0 N--CA 1.435 -1.426 0 N-CA-C 108.285 -1.926 . . . . 0.0 108.285 178.043 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 91.2 t80 75.84 -21.21 0.32 Allowed 'General case' 0 N--CA 1.492 1.631 0 CA-C-N 117.749 0.774 . . . . 0.0 112.989 173.33 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.441 ' HD3' ' OD1' ' A' ' 163' ' ' ASN . 20.9 pttp -86.61 -15.8 38.67 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-O 122.181 0.991 . . . . 0.0 108.914 179.02 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.509 ' CG ' ' H ' ' A' ' 99' ' ' SER . 17.9 t70 -177.43 -151.69 0.03 OUTLIER 'General case' 0 N--CA 1.42 -1.953 0 N-CA-C 104.403 -2.443 . . . . 0.0 104.403 -167.846 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.509 ' H ' ' CG ' ' A' ' 98' ' ' ASP . 25.5 m -123.76 -18.28 6.1 Favored 'General case' 0 C--N 1.265 -3.102 0 C-N-CA 123.839 0.856 . . . . 0.0 109.718 -175.244 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' SER . . . . . 0.425 ' HA ' ' O ' ' A' ' 126' ' ' LYS . 36.1 m -74.09 96.42 2.71 Favored 'General case' 0 N--CA 1.424 -1.746 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 173.805 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.482 ' HA ' ' O ' ' A' ' 94' ' ' VAL . 52.0 t -97.64 119.24 45.4 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.257 0 CA-C-N 115.23 -0.895 . . . . 0.0 110.653 -176.851 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.4 ' HG ' HG23 ' A' ' 125' ' ' THR . 6.5 mp -109.19 126.76 53.6 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 176.619 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.437 ' HB3' ' HB2' ' A' ' 124' ' ' LYS . 38.9 ttmt -109.46 115.16 29.41 Favored 'General case' 0 C--N 1.289 -2.035 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 -178.743 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.471 ' HA ' HD11 ' A' ' 123' ' ' ILE . 93.2 m-85 -89.95 97.06 10.97 Favored 'General case' 0 N--CA 1.426 -1.651 0 CA-C-N 115.949 -0.569 . . . . 0.0 112.264 -175.16 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 87.9 m -56.88 122.36 12.05 Favored 'General case' 0 N--CA 1.422 -1.844 0 CA-C-N 114.062 -1.426 . . . . 0.0 109.535 174.621 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 8.0 t -71.9 117.7 13.82 Favored 'General case' 0 N--CA 1.435 -1.197 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 -179.588 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 52.3 m 70.68 68.71 0.19 Allowed 'General case' 0 N--CA 1.439 -0.984 0 CA-C-O 122.76 1.266 . . . . 0.0 108.812 -173.353 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.63 ' O ' ' HA ' ' A' ' 85' ' ' THR . 9.8 p -103.93 159.83 4.89 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.127 0 CA-C-N 113.627 -1.624 . . . . 0.0 106.812 -179.124 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.401 ' HA ' ' O ' ' A' ' 84' ' ' LEU . 15.8 p -115.53 170.72 8.21 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-N 118.735 0.698 . . . . 0.0 111.504 -178.334 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 176.54 -175.59 47.59 Favored Glycine 0 N--CA 1.439 -1.107 0 N-CA-C 110.506 -1.038 . . . . 0.0 110.506 179.362 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 46.7 t-80 -105.77 131.39 53.18 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 -179.29 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.461 ' HB2' ' HB2' ' A' ' 84' ' ' LEU . 3.2 tm? -97.08 107.78 20.38 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-O 121.803 0.811 . . . . 0.0 112.678 -172.18 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -123.53 143.64 50.06 Favored 'General case' 0 CA--C 1.453 -2.756 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 171.064 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 3.7 tmtp? -92.01 101.06 13.6 Favored 'General case' 0 N--CA 1.384 -3.742 0 CA-C-O 122.321 1.058 . . . . 0.0 108.57 -171.556 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' GLY . . . . . 0.645 ' O ' ' HB ' ' A' ' 138' ' ' THR . . . 143.94 -58.53 0.53 Allowed Glycine 0 C--N 1.283 -2.397 0 N-CA-C 106.736 -2.546 . . . . 0.0 106.736 -175.163 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.5 ' HB2' ' HA ' ' A' ' 137' ' ' SER . 0.0 OUTLIER -132.72 130.37 39.94 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 178.989 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -91.92 105.57 17.8 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 105.569 -2.011 . . . . 0.0 105.569 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 21.4 p -99.26 175.33 5.92 Favored 'General case' 0 C--N 1.294 -1.839 0 C-N-CA 123.355 0.662 . . . . 0.0 112.069 -174.213 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 27.4 m-20 50.89 45.72 27.12 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 123.529 0.732 . . . . 0.0 111.125 173.6 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.469 ' CG2' ' HA ' ' A' ' 135' ' ' SER . 2.1 t -77.52 99.17 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.863 0 CA-C-O 122.416 1.103 . . . . 0.0 109.807 -169.863 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 46.6 tt0 -79.79 87.58 5.27 Favored 'General case' 0 N--CA 1.4 -2.928 0 CA-C-N 113.819 -1.537 . . . . 0.0 111.275 -173.641 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 126.39 7.61 5.26 Favored Glycine 0 N--CA 1.412 -2.957 0 C-N-CA 119.604 -1.284 . . . . 0.0 112.439 171.601 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.471 HD11 ' HA ' ' A' ' 104' ' ' PHE . 8.5 tp -98.09 116.62 41.25 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.271 0 C-N-CA 117.402 -1.719 . . . . 0.0 108.223 -176.488 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.437 ' HB2' ' HB3' ' A' ' 103' ' ' LYS . 96.5 mttt -85.73 117.65 24.74 Favored 'General case' 0 C--N 1.274 -2.68 0 CA-C-N 113.816 -1.538 . . . . 0.0 109.227 -177.155 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.4 HG23 ' HG ' ' A' ' 102' ' ' LEU . 80.8 m -136.02 126.95 27.65 Favored 'General case' 0 N--CA 1.415 -2.215 0 CA-C-N 114.756 -1.111 . . . . 0.0 110.914 -173.428 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.512 ' C ' ' HD3' ' A' ' 126' ' ' LYS . 0.4 OUTLIER -112.36 128.33 56.26 Favored 'General case' 0 N--CA 1.419 -1.986 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 171.255 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.461 ' N ' ' HD3' ' A' ' 126' ' ' LYS . 7.7 p -143.36 -45.58 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.805 0 CA-C-O 121.538 0.685 . . . . 0.0 109.164 176.84 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 26.5 ptm -120.5 -26.43 5.36 Favored 'General case' 0 N--CA 1.423 -1.808 0 CA-C-N 115.037 -0.983 . . . . 0.0 108.528 173.816 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 9.3 tp -164.13 171.51 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.416 -2.172 0 N-CA-C 104.249 -2.5 . . . . 0.0 104.249 177.324 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 88.6 t90 -85.21 120.26 26.5 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 179.57 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.545 HG12 ' H ' ' A' ' 133' ' ' VAL . 45.4 t -128.08 146.05 34.26 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 N-CA-C 107.262 -1.385 . . . . 0.0 107.262 178.724 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 22.5 pttp -111.71 31.3 6.27 Favored 'General case' 0 C--O 1.246 0.882 0 CA-C-O 121.76 0.79 . . . . 0.0 110.731 -179.646 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.545 ' H ' HG12 ' A' ' 131' ' ' VAL . 21.9 t -131.27 -80.1 0.14 Allowed 'Isoleucine or valine' 0 C--O 1.208 -1.102 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 178.834 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 41.3 p 47.57 -156.41 0.05 Allowed 'General case' 0 C--O 1.258 1.551 0 C-N-CA 123.639 0.776 . . . . 0.0 112.602 179.363 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' SER . . . . . 0.469 ' HA ' ' CG2' ' A' ' 120' ' ' VAL . 34.1 t -170.42 144.16 2.42 Favored 'General case' 0 N--CA 1.419 -1.993 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 -179.571 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 12.2 tt -99.64 96.95 5.33 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.28 0 N-CA-C 105.318 -2.105 . . . . 0.0 105.318 172.13 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' SER . . . . . 0.5 ' HA ' ' HB2' ' A' ' 116' ' ' LYS . 25.6 m -90.55 142.95 27.22 Favored 'General case' 0 N--CA 1.389 -3.509 0 CA-C-N 113.588 -1.642 . . . . 0.0 109.303 -174.533 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 138' ' ' THR . . . . . 0.645 ' HB ' ' O ' ' A' ' 115' ' ' GLY . 92.4 m -153.89 147.66 25.35 Favored 'General case' 0 C--N 1.256 -3.478 0 N-CA-C 105.743 -1.947 . . . . 0.0 105.743 -179.013 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -95.62 28.9 2.8 Favored 'General case' 0 C--N 1.276 -2.596 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 177.351 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.458 ' N ' HG22 ' A' ' 138' ' ' THR . . . 58.16 39.54 25.86 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 -171.433 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 24.6 t -168.67 -70.95 0.02 OUTLIER 'General case' 0 N--CA 1.441 -0.876 0 CA-C-N 114.625 -1.17 . . . . 0.0 110.803 -175.287 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.433 ' O ' HG23 ' A' ' 138' ' ' THR . 40.1 mmtm -106.42 159.7 15.95 Favored 'General case' 0 CA--C 1.51 -0.588 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 -179.45 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 48.0 t -106.21 139.32 27.93 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 CA-C-O 121.111 0.482 . . . . 0.0 110.855 -174.917 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 38.3 m-85 -129.5 150.28 50.91 Favored 'General case' 0 CA--C 1.498 -1.052 0 CA-C-O 122.089 0.947 . . . . 0.0 111.657 177.169 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -108.72 103.03 12.04 Favored 'General case' 0 C--N 1.277 -2.555 0 CA-C-N 113.723 -1.58 . . . . 0.0 108.98 178.898 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.441 ' OG1' ' HB3' ' A' ' 135' ' ' SER . 36.7 p -104.46 104.83 14.75 Favored 'General case' 0 N--CA 1.41 -2.438 0 N-CA-C 114.212 1.19 . . . . 0.0 114.212 -175.132 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -111.5 26.6 10.48 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 104.888 -2.264 . . . . 0.0 104.888 169.553 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 140.92 -74.28 0.36 Allowed Glycine 0 N--CA 1.399 -3.789 1 N-CA-C 103.049 -4.02 . . . . 0.0 103.049 -169.908 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 28.2 ttt -175.15 88.13 0.04 OUTLIER 'General case' 0 C--N 1.315 -0.934 0 C-N-CA 124.703 1.201 . . . . 0.0 108.103 170.352 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . 0.282 72.4 mmtt -106.42 -93.23 0.38 Allowed 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 116.1 1.889 . . . . 0.0 116.1 -177.605 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -93.42 161.59 14.32 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 113.7 1.0 . . . . 0.0 113.7 -172.188 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 33.0 t -133.72 156.64 47.58 Favored 'General case' 0 C--N 1.31 -1.126 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 175.561 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 20.4 tpt180 -149.62 151.13 33.27 Favored 'General case' 0 N--CA 1.441 -0.899 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 178.618 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 20.2 m -73.59 133.54 43.53 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 176.687 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 155' ' ' ARG . . . . . 0.51 ' HG3' ' HA2' ' A' ' 159' ' ' GLY . 14.9 ttp85 -75.88 -21.43 57.17 Favored 'General case' 0 C--N 1.299 -1.597 0 CA-C-O 121.617 0.722 . . . . 0.0 109.534 176.72 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -35.11 -47.64 0.39 Allowed 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 116.923 2.194 . . . . 0.0 116.923 -172.929 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -76.38 -53.45 8.15 Favored 'General case' 0 CA--C 1.548 0.878 0 N-CA-C 115.041 1.497 . . . . 0.0 115.041 -171.86 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -140.39 7.14 2.15 Favored 'General case' 0 N--CA 1.484 1.257 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -178.03 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 159' ' ' GLY . . . . . 0.684 ' HA3' ' O ' ' A' ' 65' ' ' ILE . . . 96.07 -81.88 0.8 Allowed Glycine 0 CA--C 1.462 -3.223 0 N-CA-C 108.712 -1.755 . . . . 0.0 108.712 -172.004 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.566 HG23 ' HB ' ' A' ' 65' ' ' ILE . 17.8 t -111.62 135.02 52.17 Favored 'Isoleucine or valine' 0 N--CA 1.401 -2.916 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 172.275 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -84.76 91.68 8.03 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 -177.601 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 162' ' ' ARG . . . . . 0.551 ' HD3' HG21 ' A' ' 94' ' ' VAL . 3.5 mmp_? -106.59 140.79 38.91 Favored 'General case' 0 C--N 1.29 -1.978 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.897 -176.816 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 163' ' ' ASN . . . . . 0.595 ' H ' HG13 ' A' ' 94' ' ' VAL . 16.8 m120 -127.3 5.91 6.36 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 114.762 -1.108 . . . . 0.0 111.011 -174.895 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -81.47 167.29 48.63 Favored Glycine 0 CA--C 1.498 -1.019 0 C-N-CA 120.343 -0.932 . . . . 0.0 111.912 -175.913 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.485 ' H ' HD23 ' A' ' 165' ' ' LEU . 1.2 pt? -116.92 112.34 20.9 Favored 'General case' 0 N--CA 1.417 -2.106 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 -179.873 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 166' ' ' ARG . . . . . 0.621 ' HB2' ' O ' ' A' ' 89' ' ' PRO . 5.8 ptp85 -82.91 118.84 23.74 Favored 'General case' 0 N--CA 1.41 -2.461 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 -177.095 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.561 ' HB ' ' OG ' ' A' ' 90' ' ' SER . 41.1 t -51.61 -46.52 37.55 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 CA-C-N 115.107 -0.951 . . . . 0.0 111.484 -179.776 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -79.31 81.32 5.59 Favored 'General case' 0 CA--C 1.498 -1.05 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 171.224 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 27.0 tptp -99.57 106.63 18.64 Favored 'General case' 0 C--N 1.279 -2.475 0 N-CA-C 114.046 1.128 . . . . 0.0 114.046 -179.377 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 170' ' ' PHE . . . . . . . . . . . . . 79.5 t80 . . . . . 0 N--CA 1.424 -1.765 0 N-CA-C 106.311 -1.737 . . . . 0.0 106.311 173.173 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 36.9 m . . . . . 0 N--CA 1.446 -0.63 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -78.23 109.17 12.11 Favored 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 178.8 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.416 ' C ' HD12 ' A' ' 4' ' ' ILE . 64.2 tt0 -145.52 96.9 2.9 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.753 -177.457 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.416 HD12 ' C ' ' A' ' 3' ' ' GLN . 2.9 mp -128.56 120.8 53.58 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.964 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 178.347 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -106.96 84.8 2.04 Favored 'General case' 0 N--CA 1.432 -1.348 0 CA-C-O 120.955 0.407 . . . . 0.0 109.927 177.075 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 44.6 t30 -89.9 92.75 9.14 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 178.908 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.635 ' HD3' ' H ' ' A' ' 7' ' ' LYS . 0.0 OUTLIER -102.21 104.55 15.12 Favored 'General case' 0 C--N 1.295 -1.769 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.179 179.213 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 10.5 p -144.08 139.92 24.83 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 CA-C-N 115.171 -0.922 . . . . 0.0 108.996 -179.232 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -141.75 104.77 0.39 Allowed Glycine 0 N--CA 1.423 -2.195 0 N-CA-C 110.209 -1.156 . . . . 0.0 110.209 -179.569 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 47.7 m -75.5 86.45 2.61 Favored 'General case' 0 N--CA 1.426 -1.655 0 CA-C-O 121.575 0.703 . . . . 0.0 111.141 -178.61 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 80.8 t80 -117.76 116.47 27.08 Favored 'General case' 0 N--CA 1.42 -1.969 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 176.729 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' TRP . . . . . 0.507 ' CZ3' ' HA3' ' A' ' 14' ' ' GLY . 61.2 t90 -85.81 110.33 19.3 Favored 'General case' 0 C--N 1.289 -2.055 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 179.156 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 62.6 tp -83.3 98.17 9.29 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-O 121.318 0.58 . . . . 0.0 109.644 179.68 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.507 ' HA3' ' CZ3' ' A' ' 12' ' ' TRP . . . -127.44 105.2 0.73 Allowed Glycine 0 N--CA 1.42 -2.403 0 N-CA-C 110.143 -1.183 . . . . 0.0 110.143 178.134 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -79.65 93.05 5.44 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-O 121.153 0.501 . . . . 0.0 110.049 179.506 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 14.3 ptmm? -94.26 97.32 10.16 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 174.941 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -112.27 95.7 5.6 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-N 115.426 -0.807 . . . . 0.0 112.02 -174.985 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -152.88 77.07 1.15 Allowed 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 173.895 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 57.9 tptt -171.96 81.88 0.06 Allowed 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 115.095 -0.957 . . . . 0.0 108.499 179.538 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -144.42 141.01 29.35 Favored 'General case' 0 C--N 1.299 -1.608 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.735 179.816 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -131.41 116.28 17.31 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 177.716 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -83.11 119.62 24.74 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 178.166 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 52.3 p -132.5 143.55 49.83 Favored 'General case' 0 C--N 1.296 -1.733 0 C-N-CA 120.875 -0.33 . . . . 0.0 110.887 -178.22 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 34.7 m -84.41 166.09 2.19 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 CA-C-N 116.191 -0.459 . . . . 0.0 109.834 177.738 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 150.9 171.14 18.75 Favored Glycine 0 N--CA 1.431 -1.679 0 N-CA-C 110.852 -0.899 . . . . 0.0 110.852 -179.034 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -119.54 112.19 19.04 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-O 121.262 0.553 . . . . 0.0 112.091 -177.786 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -136.35 96.57 3.39 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-O 122.056 0.932 . . . . 0.0 109.27 174.099 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -152.68 106.68 3.11 Favored 'General case' 0 C--N 1.294 -1.824 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 -178.31 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 55.2 t-20 -139.86 104.29 4.84 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 178.742 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 47.5 m -92.08 74.44 5.51 Favored 'General case' 0 N--CA 1.438 -1.044 0 N-CA-C 112.953 0.723 . . . . 0.0 112.953 -176.235 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 10.6 p 176.46 103.32 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 C-N-CA 125.796 1.639 . . . . 0.0 108.14 175.373 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.477 ' H ' ' CD ' ' A' ' 76' ' ' GLU . 51.0 p -138.58 -52.6 0.59 Allowed 'General case' 0 C--N 1.282 -2.342 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.388 -175.416 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 17.2 m 63.5 38.95 9.47 Favored 'General case' 0 N--CA 1.442 -0.872 0 CA-C-O 122.568 1.175 . . . . 0.0 108.237 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 58.5 p -67.41 118.51 10.86 Favored 'General case' 0 N--CA 1.434 -1.232 0 CA-C-N 114.319 -1.31 . . . . 0.0 110.089 179.677 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 50.2 mm -81.12 86.33 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.146 0 CA-C-O 121.681 0.753 . . . . 0.0 109.413 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 32.2 mm-40 -120.9 165.5 15.12 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 114.468 -1.242 . . . . 0.0 109.63 -179.868 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 104.62 131.38 7.11 Favored Glycine 0 N--CA 1.425 -2.095 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.618 176.929 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 123.64 33.26 0.82 Allowed Glycine 0 C--N 1.298 -1.576 0 C-N-CA 121.043 -0.598 . . . . 0.0 112.015 178.28 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 10.7 m -94.34 109.51 21.34 Favored 'General case' 0 N--CA 1.438 -1.036 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.49 ' HD3' ' H ' ' A' ' 40' ' ' LYS . 0.0 OUTLIER -113.86 90.14 3.27 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-O 121.331 0.586 . . . . 0.0 111.862 -178.49 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 57.8 t-105 -114.71 -56.5 2.37 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.106 -179.297 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.4 HD23 ' N ' ' A' ' 43' ' ' VAL . 5.9 tt -157.45 137.79 12.81 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 106.522 -1.658 . . . . 0.0 106.522 -179.159 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.4 ' N ' HD23 ' A' ' 42' ' ' LEU . 62.1 t -82.47 -60.51 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 N-CA-C 111.901 0.334 . . . . 0.0 111.901 -177.03 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 57.3 t30 72.84 144.76 0.07 Allowed 'General case' 0 N--CA 1.504 2.245 0 C-N-CA 123.904 0.882 . . . . 0.0 111.682 177.657 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 10.2 mtmp? -92.22 88.94 6.67 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 -177.493 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.495 HG12 ' H ' ' A' ' 47' ' ' LYS . 15.2 tt 176.78 176.4 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.308 -1.199 0 N-CA-C 104.113 -2.551 . . . . 0.0 104.113 179.581 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.495 ' H ' HG12 ' A' ' 46' ' ' ILE . 0.0 OUTLIER -154.81 172.56 17.79 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 120.408 1.458 . . . . 0.0 111.469 -178.771 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 86.0 81.45 1.13 Allowed Glycine 0 N--CA 1.433 -1.55 0 CA-C-N 115.327 -0.851 . . . . 0.0 114.978 173.919 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.411 ' HA ' ' CE2' ' A' ' 170' ' ' PHE . 64.9 tttp -77.39 99.2 5.51 Favored 'General case' 0 N--CA 1.442 -0.859 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 172.974 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 49.1 ttm -65.37 103.61 0.84 Allowed 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 115.373 -0.83 . . . . 0.0 112.781 -172.97 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 14.8 mm-40 -100.97 -171.3 1.98 Allowed 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 176.661 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 48.8 mtpt -73.58 140.1 78.36 Favored Pre-proline 0 C--N 1.314 -0.966 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 176.829 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -60.92 30.02 0.05 OUTLIER 'Trans proline' 0 N--CA 1.51 2.479 0 C-N-CA 125.187 3.925 . . . . 0.0 117.576 -172.103 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 8.9 mp -65.86 -50.05 55.58 Favored Pre-proline 0 C--N 1.291 -1.972 0 N-CA-C 116.377 1.992 . . . . 0.0 116.377 178.777 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -62.29 -12.86 29.15 Favored 'Trans proline' 0 N--CA 1.449 -1.095 0 C-N-CA 122.336 2.024 . . . . 0.0 112.462 -170.584 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 17.8 mm-40 -72.52 -32.4 66.11 Favored 'General case' 0 N--CA 1.418 -2.028 0 N-CA-C 107.513 -1.291 . . . . 0.0 107.513 -178.491 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.466 ' O ' ' HG2' ' A' ' 60' ' ' GLU . 3.5 mm? -74.48 -44.28 52.22 Favored 'General case' 0 N--CA 1.423 -1.805 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 175.743 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.456 ' HG ' ' CE2' ' A' ' 75' ' ' TYR . 6.9 mp -59.05 -38.55 79.63 Favored 'General case' 0 CA--C 1.495 -1.15 0 CA-C-N 114.842 -1.072 . . . . 0.0 111.646 -176.563 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.442 ' HD2' ' N ' ' A' ' 60' ' ' GLU . 0.0 OUTLIER -76.14 -29.12 57.67 Favored 'General case' 0 N--CA 1.419 -2.005 0 C-N-CA 119.345 -0.942 . . . . 0.0 112.697 177.842 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.466 ' HG2' ' O ' ' A' ' 57' ' ' LEU . 11.6 pt-20 -77.68 -27.09 50.71 Favored 'General case' 0 N--CA 1.445 -0.706 0 C-N-CA 119.212 -0.995 . . . . 0.0 111.321 -175.595 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 58.6 m-85 -57.02 -47.71 80.25 Favored 'General case' 0 C--O 1.242 0.667 0 C-N-CA 120.17 -0.612 . . . . 0.0 112.515 176.455 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -108.78 -86.05 0.52 Allowed 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 114.722 1.378 . . . . 0.0 114.722 -174.348 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.634 ' HB2' HD12 ' A' ' 65' ' ' ILE . 0.0 OUTLIER -115.31 137.58 23.13 Favored Pre-proline 0 C--N 1.317 -0.81 0 C-N-CA 118.489 -1.284 . . . . 0.0 107.751 -179.215 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 63' ' ' LEU . 9.4 Cg_endo -91.49 21.26 0.8 Allowed 'Trans proline' 0 N--CA 1.429 -2.313 0 C-N-CA 123.653 2.902 . . . . 0.0 111.257 -170.332 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.706 ' HB ' HG23 ' A' ' 160' ' ' VAL . 0.2 OUTLIER -58.9 -40.33 79.96 Favored 'Isoleucine or valine' 0 CA--C 1.473 -2.007 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 176.544 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 59.2 -0.29 0.59 Allowed Glycine 0 N--CA 1.483 1.794 0 CA-C-N 114.363 -1.29 . . . . 0.0 112.182 -176.176 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.579 ' H ' HG12 ' A' ' 65' ' ' ILE . 56.4 mt 62.73 -69.36 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.414 -2.238 0 C-N-CA 127.539 2.336 . . . . 0.0 111.076 -171.606 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 75.1 t80 -177.54 -52.87 0.0 OUTLIER Pre-proline 0 C--N 1.306 -1.287 0 N-CA-C 113.541 0.941 . . . . 0.0 113.541 -174.451 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.453 ' HB2' ' OD1' ' A' ' 71' ' ' ASP . 18.6 Cg_endo -90.21 -28.0 0.27 Allowed 'Trans proline' 0 N--CA 1.444 -1.432 0 C-N-CA 121.073 1.182 . . . . 0.0 115.136 -170.919 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 94.68 -18.42 57.19 Favored Glycine 0 C--O 1.216 -0.993 0 N-CA-C 110.537 -1.025 . . . . 0.0 110.537 -174.108 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.613 ' HB3' ' HG2' ' A' ' 89' ' ' PRO . 8.2 m-20 -75.48 -50.73 14.84 Favored 'General case' 0 N--CA 1.437 -1.11 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 177.272 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.421 ' HA ' ' O ' ' A' ' 87' ' ' LEU . . . -73.86 170.86 14.48 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 114.106 -1.406 . . . . 0.0 109.95 174.082 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.584 ' O ' HG22 ' A' ' 73' ' ' THR . 28.8 m 89.79 28.46 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.836 0 CA-C-O 124.11 1.909 . . . . 0.0 112.559 170.929 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.517 ' HB2' ' HB2' ' A' ' 87' ' ' LEU . 27.5 m-80 -91.25 -174.9 4.1 Favored 'General case' 0 C--N 1.247 -3.855 0 CA-C-N 114.823 -1.08 . . . . 0.0 109.973 178.133 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.551 ' HB2' HD21 ' A' ' 84' ' ' LEU . 28.4 p90 -148.9 136.14 20.13 Favored 'General case' 0 C--N 1.3 -1.545 0 C-N-CA 119.206 -0.998 . . . . 0.0 113.299 -179.387 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.575 ' HB2' HG23 ' A' ' 85' ' ' THR . 70.5 mm-40 -144.13 146.07 32.53 Favored 'General case' 0 C--N 1.306 -1.322 0 C-N-CA 126.251 1.82 . . . . 0.0 106.784 175.324 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 50.2 p90 -149.65 150.93 32.91 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-N 118.249 0.477 . . . . 0.0 111.95 -176.572 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.612 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 11.5 m-20 -95.35 163.1 13.39 Favored 'General case' 0 CA--C 1.489 -1.378 0 N-CA-C 106.857 -1.534 . . . . 0.0 106.857 173.814 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -81.11 -62.43 1.66 Allowed 'General case' 0 C--N 1.278 -2.524 0 N-CA-C 113.633 0.975 . . . . 0.0 113.633 -178.202 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -77.56 -40.39 42.63 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 121.309 0.576 . . . . 0.0 109.519 -176.236 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.612 ' HB ' ' HB2' ' A' ' 78' ' ' ASP . 81.5 m -66.67 -38.54 87.03 Favored 'General case' 0 N--CA 1.429 -1.521 0 CA-C-N 114.949 -1.023 . . . . 0.0 111.892 178.638 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 98.8 mttt 61.54 7.5 1.86 Allowed 'General case' 0 N--CA 1.5 2.036 0 N-CA-C 114.037 1.125 . . . . 0.0 114.037 177.3 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.496 ' HD3' ' HB ' ' A' ' 109' ' ' THR . 35.8 ttmt -83.26 113.33 20.61 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 108.847 -0.798 . . . . 0.0 108.847 178.74 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.551 HD21 ' HB2' ' A' ' 75' ' ' TYR . 2.2 tm? -79.87 134.64 36.32 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 -176.194 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.628 ' HA ' ' O ' ' A' ' 108' ' ' VAL . 8.9 t -120.91 129.7 53.59 Favored 'General case' 0 N--CA 1.403 -2.823 0 CA-C-O 121.643 0.735 . . . . 0.0 110.309 178.763 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.402 HG13 ' O ' ' A' ' 74' ' ' ASN . 98.8 t -102.92 134.07 44.98 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.611 -177.28 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.517 ' HB2' ' HB2' ' A' ' 74' ' ' ASN . 2.5 mm? -81.95 115.92 21.34 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-N 114.676 -1.147 . . . . 0.0 110.819 -179.76 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.617 ' O ' ' HA ' ' A' ' 106' ' ' THR . 64.0 mt -124.8 103.81 30.83 Favored Pre-proline 0 C--N 1.29 -1.982 0 N-CA-C 107.375 -1.343 . . . . 0.0 107.375 173.91 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.613 ' HG2' ' HB3' ' A' ' 71' ' ' ASP . 70.9 Cg_exo -56.63 110.9 0.65 Allowed 'Trans proline' 0 C--O 1.199 -1.45 0 C-N-CA 123.136 2.557 . . . . 0.0 111.814 178.974 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.429 ' HB2' ' O ' ' A' ' 89' ' ' PRO . 36.7 m 75.34 149.47 0.1 Allowed 'General case' 0 CA--C 1.485 -1.52 0 CA-C-O 122.091 0.948 . . . . 0.0 113.324 -175.511 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.458 HD12 HG23 ' A' ' 106' ' ' THR . 3.3 mp -80.79 120.7 32.93 Favored 'Isoleucine or valine' 0 N--CA 1.392 -3.33 0 N-CA-C 107.594 -1.261 . . . . 0.0 107.594 173.582 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 40.4 t -96.15 121.57 38.06 Favored 'General case' 0 N--CA 1.405 -2.688 0 N-CA-C 106.625 -1.62 . . . . 0.0 106.625 171.594 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.445 ' HG3' HG22 ' A' ' 91' ' ' ILE . 49.9 mt-10 -116.82 121.6 42.0 Favored 'General case' 0 CA--C 1.466 -2.267 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 177.263 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.401 HG23 HD23 ' A' ' 102' ' ' LEU . 33.3 m -115.28 103.63 15.58 Favored 'Isoleucine or valine' 0 C--N 1.267 -2.989 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 177.754 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.756 ' HA2' ' O ' ' A' ' 100' ' ' SER . . . -145.35 148.63 20.49 Favored Glycine 0 CA--C 1.478 -2.226 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 -178.851 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -125.95 -89.12 0.57 Allowed 'General case' 0 CA--C 1.478 -1.809 0 C-N-CA 118.059 -1.456 . . . . 0.0 109.788 -178.258 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.487 ' O ' ' HB2' ' A' ' 98' ' ' ASP . 57.5 mtpt -87.47 -36.74 17.49 Favored 'General case' 0 N--CA 1.415 -2.186 0 C-N-CA 119.747 -0.781 . . . . 0.0 110.479 176.122 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.487 ' HB2' ' O ' ' A' ' 97' ' ' LYS . 31.3 t70 163.22 -40.62 0.0 OUTLIER 'General case' 0 C--N 1.364 1.238 0 O-C-N 124.21 0.944 . . . . 0.0 111.817 -176.023 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 19.4 m -72.68 15.47 0.19 Allowed 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.353 1.061 . . . . 0.0 113.475 -171.464 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' SER . . . . . 0.756 ' O ' ' HA2' ' A' ' 95' ' ' GLY . 69.3 p -167.34 77.0 0.16 Allowed 'General case' 0 N--CA 1.41 -2.456 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 177.065 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 60.5 t -115.72 99.72 9.02 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.237 0 CA-C-O 121.23 0.538 . . . . 0.0 109.755 175.817 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.554 HD13 HG23 ' A' ' 125' ' ' THR . 1.8 mm? -111.79 129.62 56.07 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 178.693 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -116.51 107.2 14.45 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-O 120.924 0.392 . . . . 0.0 111.106 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -93.06 102.36 14.69 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 107.518 -1.289 . . . . 0.0 107.518 176.69 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.534 ' O ' ' HB ' ' A' ' 88' ' ' ILE . 13.5 t -77.07 -178.37 4.96 Favored 'General case' 0 CA--C 1.551 1.019 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.532 -175.697 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.617 ' HA ' ' O ' ' A' ' 88' ' ' ILE . 15.0 p -84.13 -50.32 8.04 Favored 'General case' 0 C--N 1.309 -1.162 0 C-N-CA 123.513 0.725 . . . . 0.0 111.716 -173.9 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 26.3 p -115.82 84.76 2.16 Favored 'General case' 0 N--CA 1.406 -2.644 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 175.251 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.628 ' O ' ' HA ' ' A' ' 85' ' ' THR . 14.7 p -81.58 129.58 37.27 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.296 0 CA-C-N 114.94 -1.027 . . . . 0.0 109.922 -177.317 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.496 ' HB ' ' HD3' ' A' ' 83' ' ' LYS . 17.5 p -104.98 149.0 26.12 Favored 'General case' 0 N--CA 1.4 -2.955 0 CA-C-N 116.191 -0.459 . . . . 0.0 109.771 -176.05 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 178.98 -159.41 24.3 Favored Glycine 0 N--CA 1.424 -2.135 0 N-CA-C 110.944 -0.862 . . . . 0.0 110.944 -179.912 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' HIS . . . . . 0.432 ' HB2' ' O ' ' A' ' 118' ' ' THR . 74.1 m80 -123.68 121.22 34.96 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 177.593 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.538 ' HB3' ' HG ' ' A' ' 84' ' ' LEU . 6.4 tt -123.43 136.58 54.68 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-O 121.277 0.56 . . . . 0.0 110.427 -171.717 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -130.67 171.09 13.47 Favored 'General case' 0 CA--C 1.456 -2.64 0 CA-C-N 114.941 -1.027 . . . . 0.0 110.189 177.896 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 2.7 tmtm? -86.24 100.84 12.53 Favored 'General case' 1 N--CA 1.376 -4.155 0 N-CA-C 103.779 -2.674 . . . . 0.0 103.779 173.461 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 115' ' ' GLY . . . . . 0.631 ' O ' HG23 ' A' ' 138' ' ' THR . . . 143.2 -62.09 0.51 Allowed Glycine 0 C--N 1.273 -2.96 0 N-CA-C 109.252 -1.539 . . . . 0.0 109.252 -174.85 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.433 ' HG2' HG23 ' A' ' 118' ' ' THR . 0.0 OUTLIER -151.02 164.7 35.8 Favored 'General case' 0 CA--C 1.508 -0.647 0 C-N-CA 122.766 0.426 . . . . 0.0 110.087 -179.697 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 3.7 tt -121.31 109.76 15.3 Favored 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 106.252 -1.758 . . . . 0.0 106.252 176.608 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.611 ' HA ' ' OG ' ' A' ' 135' ' ' SER . 66.9 p -112.14 131.22 55.58 Favored 'General case' 0 C--N 1.277 -2.566 0 N-CA-C 114.109 1.151 . . . . 0.0 114.109 -177.263 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 119' ' ' ASP . . . . . 0.504 ' H ' ' HB2' ' A' ' 135' ' ' SER . 17.5 t70 70.42 107.81 0.06 Allowed 'General case' 0 CA--C 1.507 -0.71 0 N-CA-C 114.294 1.22 . . . . 0.0 114.294 175.215 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 35.8 m -112.58 166.07 6.92 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.194 0 CA-C-N 115.002 -0.999 . . . . 0.0 110.566 177.981 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.472 ' HB3' ' OG1' ' A' ' 109' ' ' THR . 12.0 tp10 -127.75 -8.32 5.59 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.747 -178.316 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -105.7 -19.11 10.65 Favored Glycine 0 N--CA 1.432 -1.587 0 C-N-CA 119.706 -1.235 . . . . 0.0 112.39 -173.954 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.496 HG13 ' CG2' ' A' ' 108' ' ' VAL . 96.2 mt -100.82 100.6 10.71 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.62 0 CA-C-O 121.98 0.895 . . . . 0.0 111.272 -178.553 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -86.27 141.89 28.94 Favored 'General case' 0 C--N 1.295 -1.77 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 172.943 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.554 HG23 HD13 ' A' ' 102' ' ' LEU . 17.9 m -150.5 143.04 24.47 Favored 'General case' 0 N--CA 1.421 -1.925 0 N-CA-C 112.998 0.74 . . . . 0.0 112.998 -172.561 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.539 ' C ' ' HD3' ' A' ' 126' ' ' LYS . 0.4 OUTLIER -131.07 105.24 7.58 Favored 'General case' 0 N--CA 1.423 -1.798 0 N-CA-C 105.3 -2.111 . . . . 0.0 105.3 168.56 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 7.4 p -113.47 -53.58 5.01 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.441 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 179.193 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 45.5 ttm -114.29 -27.49 7.59 Favored 'General case' 0 N--CA 1.398 -3.059 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 172.295 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.404 HD12 ' HA ' ' A' ' 129' ' ' ILE . 8.5 tp -161.51 171.13 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.551 1.008 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 173.77 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 8.5 m-90 -70.66 117.52 12.28 Favored 'General case' 0 CA--C 1.509 -0.605 0 CA-C-N 118.572 0.623 . . . . 0.0 110.431 179.309 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.436 HG12 HG12 ' A' ' 133' ' ' VAL . 88.6 t -147.94 111.04 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.139 0 C-N-CA 122.956 0.502 . . . . 0.0 109.783 179.62 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 54.6 pttt -106.78 114.33 28.36 Favored 'General case' 0 N--CA 1.442 -0.841 0 C-N-CA 119.31 -0.956 . . . . 0.0 109.364 173.523 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.436 HG12 HG12 ' A' ' 131' ' ' VAL . 13.5 p 173.57 -21.23 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.296 -1.755 0 N-CA-C 107.362 -1.347 . . . . 0.0 107.362 -178.992 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 134' ' ' THR . . . . . 0.577 HG22 ' HA3' ' A' ' 148' ' ' GLY . 66.4 p -7.51 88.84 0.0 OUTLIER 'General case' 0 C--N 1.366 1.295 0 C-N-CA 127.921 2.488 . . . . 0.0 114.345 177.89 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 135' ' ' SER . . . . . 0.611 ' OG ' ' HA ' ' A' ' 118' ' ' THR . 30.2 t -101.64 146.43 27.73 Favored 'General case' 0 N--CA 1.408 -2.571 0 CA-C-N 114.252 -1.34 . . . . 0.0 109.978 -176.505 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 8.9 tt -115.36 122.85 70.14 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.567 0 O-C-N 124.136 0.897 . . . . 0.0 109.681 179.464 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 34.7 p -105.77 135.96 46.25 Favored 'General case' 0 N--CA 1.398 -3.051 0 CA-C-O 122.239 1.018 . . . . 0.0 110.306 178.382 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 138' ' ' THR . . . . . 0.631 HG23 ' O ' ' A' ' 115' ' ' GLY . 3.0 t -151.08 175.68 11.88 Favored 'General case' 0 N--CA 1.385 -3.724 0 N-CA-C 105.7 -1.963 . . . . 0.0 105.7 -179.599 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -122.2 33.76 5.37 Favored 'General case' 0 C--N 1.271 -2.827 0 N-CA-C 106.272 -1.751 . . . . 0.0 106.272 177.919 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . 63.33 46.15 4.59 Favored 'General case' 0 C--N 1.351 0.646 0 CA-C-N 113.971 -1.468 . . . . 0.0 109.274 -176.751 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 36.2 t -178.45 -78.87 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 114.878 -1.055 . . . . 0.0 110.065 -177.702 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 66.2 mttm -88.91 143.72 26.68 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 -178.44 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.528 ' HB ' ' O ' ' A' ' 153' ' ' ARG . 47.6 t -106.86 138.4 32.81 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 CA-C-O 120.899 0.381 . . . . 0.0 111.693 -173.569 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 57.6 m-85 -136.11 141.58 44.19 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 178.463 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 51.5 p90 -66.94 161.87 23.16 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.531 0.681 . . . . 0.0 112.19 177.683 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.497 ' HB ' ' O ' ' A' ' 135' ' ' SER . 92.7 m -149.0 -58.87 0.22 Allowed 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.298 174.9 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.485 ' HB3' ' HA ' ' A' ' 134' ' ' THR . . . -141.38 137.04 32.01 Favored 'General case' 0 CA--C 1.507 -0.691 0 N-CA-C 110.062 -0.348 . . . . 0.0 110.062 178.803 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 148' ' ' GLY . . . . . 0.577 ' HA3' HG22 ' A' ' 134' ' ' THR . . . 79.89 -54.59 4.45 Favored Glycine 0 C--O 1.219 -0.817 0 O-C-N 123.539 0.524 . . . . 0.0 113.129 177.585 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 26.4 ttt -60.98 -48.49 81.57 Favored 'General case' 0 C--N 1.3 -1.577 0 C-N-CA 123.159 0.584 . . . . 0.0 109.799 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . 0.257 27.3 mtpp 49.0 17.46 0.16 Allowed 'General case' 0 N--CA 1.486 1.348 0 N-CA-C 115.985 1.846 . . . . 0.0 115.985 177.943 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -143.95 140.98 29.97 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 175.608 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 20.6 p -87.72 111.28 21.16 Favored 'General case' 0 N--CA 1.421 -1.916 0 CA-C-O 121.392 0.615 . . . . 0.0 110.119 177.861 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 153' ' ' ARG . . . . . 0.528 ' O ' ' HB ' ' A' ' 143' ' ' VAL . 2.6 tpm_? -105.9 105.77 15.97 Favored 'General case' 0 N--CA 1.432 -1.361 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 176.657 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 48.1 m -68.71 146.23 53.14 Favored 'General case' 0 C--N 1.285 -2.209 0 C-N-CA 120.841 -0.344 . . . . 0.0 111.742 -177.938 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 155' ' ' ARG . . . . . 0.509 ' HA ' ' HA2' ' A' ' 159' ' ' GLY . 29.0 tpt180 -57.81 -31.01 66.17 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-O 121.278 0.561 . . . . 0.0 109.532 175.732 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -47.16 -41.85 18.58 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 114.298 -1.319 . . . . 0.0 112.084 175.583 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -82.41 -53.87 5.66 Favored 'General case' 0 N--CA 1.437 -1.097 0 C-N-CA 120.692 -0.403 . . . . 0.0 111.622 -179.321 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -152.99 -18.97 0.15 Allowed 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 112.815 0.672 . . . . 0.0 112.815 -175.588 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 159' ' ' GLY . . . . . 0.509 ' HA2' ' HA ' ' A' ' 155' ' ' ARG . . . 107.99 -93.16 0.79 Allowed Glycine 0 N--CA 1.418 -2.555 0 N-CA-C 108.062 -2.015 . . . . 0.0 108.062 -165.998 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.706 HG23 ' HB ' ' A' ' 65' ' ' ILE . 83.8 t -133.57 115.86 23.32 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 CA-C-O 121.705 0.764 . . . . 0.0 110.399 -179.761 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 161' ' ' GLN . . . . . 0.471 ' H ' ' HG2' ' A' ' 153' ' ' ARG . 2.5 mm-40 -134.99 135.31 41.31 Favored 'General case' 0 N--CA 1.412 -2.36 0 N-CA-C 115.158 1.54 . . . . 0.0 115.158 -177.767 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 10.9 tpt180 -150.53 110.52 4.11 Favored 'General case' 0 C--N 1.263 -3.183 0 N-CA-C 101.72 -3.437 . . . . 0.0 101.72 170.197 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -43.71 95.29 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 113.975 1.102 . . . . 0.0 113.975 -169.519 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -157.39 161.09 31.04 Favored Glycine 0 N--CA 1.433 -1.552 0 CA-C-N 114.302 -1.317 . . . . 0.0 110.439 -178.54 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.487 ' O ' HD12 ' A' ' 165' ' ' LEU . 3.5 pp -141.37 139.09 33.44 Favored 'General case' 0 N--CA 1.411 -2.399 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 178.216 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 166' ' ' ARG . . . . . 0.53 ' HB3' ' O ' ' A' ' 89' ' ' PRO . 0.0 OUTLIER -70.49 134.76 48.03 Favored 'General case' 0 C--N 1.295 -1.778 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 175.869 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 32.7 t -62.11 -31.36 51.13 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.845 0 O-C-N 123.755 0.66 . . . . 0.0 112.681 176.577 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -73.83 77.49 1.61 Allowed 'General case' 0 N--CA 1.485 1.308 0 CA-C-O 122.25 1.024 . . . . 0.0 111.114 174.753 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 169' ' ' LYS . . . . . 0.468 ' HD2' ' HA ' ' A' ' 47' ' ' LYS . 19.3 ttpp -152.95 156.39 38.8 Favored 'General case' 0 C--N 1.276 -2.606 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 -178.619 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 170' ' ' PHE . . . . . 0.411 ' CE2' ' HA ' ' A' ' 49' ' ' LYS . 28.3 p90 . . . . . 0 C--N 1.304 -1.378 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 174.321 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 35.5 t . . . . . 0 N--CA 1.444 -0.734 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -129.47 102.65 6.49 Favored 'General case' 0 CA--C 1.5 -0.953 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 -179.166 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -93.55 94.91 8.91 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 10.6 tt -141.41 112.14 3.36 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 CA-C-O 121.514 0.673 . . . . 0.0 110.438 177.643 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -116.17 119.43 35.77 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 115.052 -0.976 . . . . 0.0 108.871 179.817 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 -102.17 113.33 26.51 Favored 'General case' 0 C--N 1.289 -2.058 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 -174.27 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 13.6 mptt -94.43 92.75 7.29 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 170.194 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 8.3 p -133.27 143.33 39.5 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.753 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 -177.665 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 176.42 72.45 0.05 OUTLIER Glycine 0 N--CA 1.429 -1.789 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.003 -179.243 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 60.5 m -100.06 108.85 21.13 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 177.562 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 40.3 m-85 -110.7 150.81 28.5 Favored 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 -177.398 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 52.0 p-90 -120.07 121.93 39.97 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 175.151 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.486 ' O ' HD12 ' A' ' 13' ' ' LEU 0.261 2.6 pp -82.73 122.18 27.84 Favored 'General case' 0 N--CA 1.428 -1.561 0 N-CA-C 113.592 0.96 . . . . 0.0 113.592 -174.128 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -103.91 35.55 4.96 Favored Glycine 0 N--CA 1.426 -1.989 0 CA-C-N 114.881 -1.054 . . . . 0.0 110.779 178.72 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 29.9 tt0 -83.3 78.77 9.57 Favored 'General case' 0 N--CA 1.436 -1.126 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 178.586 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.494 ' HD3' ' N ' ' A' ' 17' ' ' ALA . 9.5 tmtt? -174.87 133.76 0.35 Allowed 'General case' 0 N--CA 1.443 -0.804 0 N-CA-C 105.861 -1.903 . . . . 0.0 105.861 -177.143 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.494 ' N ' ' HD3' ' A' ' 16' ' ' LYS . . . -123.32 160.75 26.03 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 179.146 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -118.39 128.27 54.47 Favored 'General case' 0 C--N 1.308 -1.203 0 C-N-CA 120.14 -0.624 . . . . 0.0 111.669 -178.396 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 58.0 mttp -94.71 117.2 29.74 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 115.169 -0.923 . . . . 0.0 108.55 178.657 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -138.38 134.61 34.38 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-O 121.064 0.459 . . . . 0.0 111.098 -178.871 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 38.4 p90 -121.29 166.94 13.3 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.145 -177.476 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -125.89 108.68 11.67 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 176.769 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 58.2 p -142.08 104.47 4.48 Favored 'General case' 0 C--N 1.298 -1.635 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.601 -179.893 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 33.6 m -108.7 147.45 13.37 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.37 0 CA-C-O 120.72 0.295 . . . . 0.0 110.761 178.526 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -114.72 63.93 0.31 Allowed Glycine 0 N--CA 1.436 -1.321 0 N-CA-C 110.541 -1.024 . . . . 0.0 110.541 179.22 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 79.1 m-20 -94.71 14.33 21.54 Favored 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 -177.891 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -69.14 145.77 53.05 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 97.0 mt -124.01 111.42 15.97 Favored 'General case' 0 C--N 1.302 -1.478 0 CA-C-O 121.042 0.449 . . . . 0.0 111.205 -176.848 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 41.5 t30 -94.22 90.59 6.39 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 108.866 -0.791 . . . . 0.0 108.866 175.285 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 55.2 p -97.48 15.07 24.27 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.036 -178.284 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 45.9 t -76.47 90.39 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.054 0 CA-C-O 121.792 0.806 . . . . 0.0 109.827 -179.224 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 33.8 t -148.06 102.72 3.41 Favored 'General case' 0 N--CA 1.412 -2.325 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 178.837 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 39.4 p -115.86 -4.91 12.05 Favored 'General case' 0 C--N 1.294 -1.812 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.897 -179.614 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 42.1 t 65.88 22.31 11.38 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.301 -178.187 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 7.8 tp -61.05 138.4 21.96 Favored 'Isoleucine or valine' 0 C--O 1.244 0.788 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.906 179.422 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 72.77 16.27 4.64 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 124.078 0.951 . . . . 0.0 110.235 -177.174 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -57.71 -33.38 67.42 Favored Glycine 0 C--N 1.335 0.504 0 CA-C-N 115.611 -0.722 . . . . 0.0 112.817 -179.165 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -162.64 95.82 0.13 Allowed Glycine 0 N--CA 1.435 -1.426 0 N-CA-C 110.672 -0.971 . . . . 0.0 110.672 177.126 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 9.7 t -111.49 112.94 25.03 Favored 'General case' 0 N--CA 1.436 -1.143 0 CA-C-O 122.034 0.921 . . . . 0.0 111.318 -178.906 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 5.0 ttmp? -139.35 101.19 4.18 Favored 'General case' 0 N--CA 1.427 -1.597 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 178.499 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 19.1 p90 -101.78 86.01 2.83 Favored 'General case' 0 C--N 1.286 -2.168 0 C-N-CA 119.11 -1.036 . . . . 0.0 111.189 -178.243 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 93.6 mt -121.51 92.82 3.83 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-N 114.691 -1.14 . . . . 0.0 107.99 177.002 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 10.0 p -141.01 143.85 27.64 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.93 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.5 -178.454 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 -116.14 110.0 18.24 Favored 'General case' 0 C--N 1.295 -1.781 0 N-CA-C 107.926 -1.138 . . . . 0.0 107.926 179.098 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 8.1 tmtt? -75.08 88.68 2.43 Favored 'General case' 0 C--O 1.244 0.781 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 -177.84 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 9.0 tp 173.46 -28.23 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 C-N-CA 125.902 1.681 . . . . 0.0 106.743 -177.518 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -102.45 155.03 18.53 Favored 'General case' 0 N--CA 1.437 -1.082 0 N-CA-C 107.448 -1.316 . . . . 0.0 107.448 175.489 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 97.9 53.94 1.25 Allowed Glycine 0 N--CA 1.427 -1.918 0 N-CA-C 107.943 -2.063 . . . . 0.0 107.943 -172.412 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -74.53 142.22 44.78 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 114.435 -0.883 . . . . 0.0 110.988 -175.885 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 66.6 mtt -78.12 89.75 4.23 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-O 121.506 0.669 . . . . 0.0 110.021 176.814 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 49.4 mt-30 -105.04 151.5 23.88 Favored 'General case' 0 C--N 1.293 -1.85 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 176.657 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 4.8 ttmp? 73.92 132.15 0.04 OUTLIER Pre-proline 0 CA--C 1.556 1.199 0 O-C-N 124.478 1.112 . . . . 0.0 108.785 -176.182 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -68.5 -15.67 41.95 Favored 'Trans proline' 0 N--CA 1.487 1.09 0 C-N-CA 123.133 2.555 . . . . 0.0 116.943 -170.707 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.628 ' O ' ' HG ' ' A' ' 58' ' ' LEU . 3.5 mm? -53.55 -46.64 98.09 Favored Pre-proline 0 N--CA 1.498 1.935 0 N-CA-C 116.658 2.096 . . . . 0.0 116.658 -173.785 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.717 ' HA ' HD11 ' A' ' 58' ' ' LEU . 26.2 Cg_exo -59.65 -21.09 61.2 Favored 'Trans proline' 0 N--CA 1.426 -2.464 0 C-N-CA 121.275 1.317 . . . . 0.0 112.029 -172.19 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -84.3 -41.39 16.89 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 123.456 0.702 . . . . 0.0 110.73 -179.196 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -69.7 -51.42 34.57 Favored 'General case' 0 CA--C 1.488 -1.407 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.962 178.214 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.717 HD11 ' HA ' ' A' ' 55' ' ' PRO 0.294 1.7 pp -62.19 -26.77 68.54 Favored 'General case' 0 C--O 1.208 -1.082 0 C-N-CA 119.745 -0.782 . . . . 0.0 111.029 179.284 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.458 ' HB2' ' O ' ' A' ' 55' ' ' PRO . 37.1 ttmt -69.45 -41.52 76.14 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 114.671 -1.15 . . . . 0.0 111.842 174.785 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -80.18 -16.18 55.41 Favored 'General case' 0 N--CA 1.441 -0.908 0 C-N-CA 119.418 -0.913 . . . . 0.0 109.122 -179.49 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 26.0 m-85 -84.29 -31.92 24.64 Favored 'General case' 0 C--N 1.321 -0.644 0 C-N-CA 119.437 -0.905 . . . . 0.0 111.456 177.665 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.517 ' HA ' HD11 ' A' ' 112' ' ' LEU . 20.7 t70 -87.11 -155.46 0.28 Allowed 'General case' 0 CA--C 1.545 0.773 0 N-CA-C 106.486 -1.672 . . . . 0.0 106.486 173.09 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.491 ' HB2' HD12 ' A' ' 65' ' ' ILE . 13.4 mt -84.03 155.4 64.14 Favored Pre-proline 0 C--N 1.299 -1.618 0 N-CA-C 107.248 -1.39 . . . . 0.0 107.248 -178.685 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -80.61 10.21 3.4 Favored 'Trans proline' 0 N--CA 1.453 -0.868 0 C-N-CA 122.2 1.933 . . . . 0.0 113.27 -166.102 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.744 HG12 ' H ' ' A' ' 67' ' ' ILE . 0.2 OUTLIER -81.34 -26.22 10.31 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.311 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 179.708 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 68.42 9.98 59.22 Favored Glycine 0 C--N 1.357 1.742 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.29 179.808 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.744 ' H ' HG12 ' A' ' 65' ' ' ILE . 55.8 mt 64.3 -68.01 0.14 Allowed 'Isoleucine or valine' 0 C--O 1.181 -2.506 0 C-N-CA 126.259 1.824 . . . . 0.0 111.653 -171.845 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.525 ' HB2' HG22 ' A' ' 160' ' ' VAL . 39.7 t80 -170.58 -57.81 0.0 OUTLIER Pre-proline 0 C--N 1.275 -2.632 0 CA-C-N 118.078 0.399 . . . . 0.0 111.177 -175.409 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.524 ' HD3' ' HB3' ' A' ' 68' ' ' PHE . 8.6 Cg_endo -100.57 -10.41 0.27 Allowed 'Trans proline' 0 N--CA 1.449 -1.116 0 C-N-CA 122.505 2.137 . . . . 0.0 114.793 -172.972 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 73.83 10.65 80.59 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.369 -0.92 . . . . 0.0 111.561 -175.2 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.455 ' HB2' ' CG ' ' A' ' 89' ' ' PRO . 13.3 p30 -95.96 -50.3 4.93 Favored 'General case' 0 N--CA 1.421 -1.905 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 178.438 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.555 ' O ' ' HB ' ' A' ' 73' ' ' THR . . . -64.01 178.45 0.65 Allowed 'General case' 0 C--N 1.318 -0.77 0 C-N-CA 124.302 1.041 . . . . 0.0 109.08 164.028 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.555 ' HB ' ' O ' ' A' ' 72' ' ' ALA . 65.0 m 84.33 27.89 0.08 Allowed 'General case' 0 C--N 1.349 0.578 0 CA-C-O 124.052 1.882 . . . . 0.0 109.773 171.217 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.491 ' HB2' ' H ' ' A' ' 87' ' ' LEU . 1.5 m-20 -80.93 176.33 9.91 Favored 'General case' 0 C--N 1.288 -2.072 0 C-N-CA 118.002 -1.479 . . . . 0.0 109.803 -178.768 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.458 ' CD2' HD11 ' A' ' 84' ' ' LEU . 13.7 t80 -147.12 109.84 4.66 Favored 'General case' 0 C--N 1.289 -2.051 0 C-N-CA 119.273 -0.971 . . . . 0.0 111.498 -171.387 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.402 ' O ' ' HG ' ' A' ' 84' ' ' LEU . 37.9 mt-10 -131.24 116.99 18.37 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.988 172.568 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 88.5 t80 -115.03 132.6 56.55 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.007 -173.912 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.506 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 26.1 m-20 -92.02 178.71 5.8 Favored 'General case' 0 CA--C 1.488 -1.436 0 CA-C-O 121.387 0.613 . . . . 0.0 111.048 -179.447 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -79.74 -74.11 0.31 Allowed 'General case' 0 C--N 1.294 -1.819 0 CA-C-N 114.503 -1.226 . . . . 0.0 112.244 -177.957 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -92.1 -22.35 19.95 Favored 'General case' 0 CA--C 1.503 -0.862 0 CA-C-N 115.823 -0.626 . . . . 0.0 112.402 -174.798 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.506 ' HB ' ' HB2' ' A' ' 78' ' ' ASP . 59.7 m -68.64 -51.7 39.27 Favored 'General case' 0 N--CA 1.427 -1.602 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.535 178.677 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 98.0 mttt 63.18 2.77 1.15 Allowed 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 124.16 0.984 . . . . 0.0 113.255 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.613 ' HG2' HG22 ' A' ' 109' ' ' THR . 35.6 ttmt -94.45 94.53 8.29 Favored 'General case' 0 N--CA 1.427 -1.598 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 173.933 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.458 HD11 ' CD2' ' A' ' 75' ' ' TYR . 6.9 tt -66.15 144.11 56.87 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-N 113.191 -1.822 . . . . 0.0 111.845 -172.37 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.444 ' HA ' ' O ' ' A' ' 108' ' ' VAL . 10.1 t -110.03 125.54 53.03 Favored 'General case' 0 N--CA 1.411 -2.38 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.148 179.212 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 86.1 t -99.53 127.85 51.89 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.363 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.265 178.116 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.507 ' HA ' ' O ' ' A' ' 106' ' ' THR . 1.2 mm? -97.25 142.11 29.54 Favored 'General case' 0 N--CA 1.418 -2.055 0 CA-C-N 113.707 -1.588 . . . . 0.0 109.507 -177.235 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 58.8 mt -137.28 119.96 11.44 Favored Pre-proline 0 C--N 1.252 -3.633 0 CA-C-N 112.854 -1.975 . . . . 0.0 105.685 174.413 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.455 ' CG ' ' HB2' ' A' ' 71' ' ' ASP . 6.2 Cg_exo -22.41 -52.72 0.04 OUTLIER 'Trans proline' 0 C--N 1.37 1.691 1 C-N-CA 126.133 4.555 . . . . 0.0 116.445 -178.769 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.436 ' HB3' ' HB3' ' A' ' 166' ' ' ARG . 41.3 t -151.55 165.35 34.53 Favored 'General case' 0 N--CA 1.425 -1.695 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 -179.743 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.541 HD11 ' HD2' ' A' ' 103' ' ' LYS . 6.1 tt -72.3 112.38 7.88 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.979 0 CA-C-O 121.647 0.737 . . . . 0.0 110.37 178.41 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' CYS . . . . . 0.524 ' HB3' ' CE2' ' A' ' 104' ' ' PHE . 48.0 t -118.09 128.54 54.85 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 178.625 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -122.33 139.32 53.95 Favored 'General case' 0 C--N 1.292 -1.931 0 C-N-CA 119.218 -0.993 . . . . 0.0 110.158 176.614 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 34.4 m -124.28 106.67 17.2 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.168 -175.219 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -146.93 112.72 0.62 Allowed Glycine 0 C--N 1.317 -0.518 0 C-N-CA 120.035 -1.079 . . . . 0.0 113.153 176.527 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 72.7 m-85 -145.2 -107.75 0.1 Allowed 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 113.712 1.005 . . . . 0.0 113.712 175.568 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 1.7 pptp? -87.59 -2.0 58.32 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.974 0.731 . . . . 0.0 112.974 -175.775 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -81.89 -16.43 50.67 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-O 120.972 0.415 . . . . 0.0 110.737 -177.557 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 36.8 t 83.19 -10.94 0.97 Allowed 'General case' 0 CA--C 1.506 -0.747 0 C-N-CA 125.105 1.362 . . . . 0.0 109.801 -179.013 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' SER . . . . . 0.441 ' HA ' ' O ' ' A' ' 126' ' ' LYS . 73.6 p -100.02 109.3 21.62 Favored 'General case' 0 N--CA 1.394 -3.248 0 CA-C-O 121.221 0.534 . . . . 0.0 110.692 179.532 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 65.1 t -93.65 105.39 16.8 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.069 0 N-CA-C 107.03 -1.47 . . . . 0.0 107.03 172.02 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.437 HD23 ' H ' ' A' ' 126' ' ' LYS . 83.3 mt -118.53 114.63 23.11 Favored 'General case' 0 C--N 1.286 -2.187 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.99 -173.678 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.541 ' HD2' HD11 ' A' ' 91' ' ' ILE . 34.9 ttpt -103.55 113.17 26.47 Favored 'General case' 0 N--CA 1.427 -1.576 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.091 -179.313 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.524 ' CE2' ' HB3' ' A' ' 92' ' ' CYS 0.288 38.9 p90 -111.07 107.72 17.19 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-O 122.191 0.996 . . . . 0.0 112.538 179.467 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.609 ' H ' HG22 ' A' ' 123' ' ' ILE . 12.2 t -72.11 -175.74 1.57 Allowed 'General case' 0 N--CA 1.436 -1.151 0 CA-C-N 113.843 -1.526 . . . . 0.0 111.958 -177.378 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.507 ' O ' ' HA ' ' A' ' 87' ' ' LEU . 4.7 t -93.18 -27.64 16.76 Favored 'General case' 0 C--N 1.288 -2.102 0 CA-C-N 114.624 -1.171 . . . . 0.0 112.682 -173.26 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 25.0 m -139.73 95.35 2.9 Favored 'General case' 0 C--N 1.275 -2.672 0 N-CA-C 107.672 -1.232 . . . . 0.0 107.672 -178.478 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.444 ' O ' ' HA ' ' A' ' 85' ' ' THR . 3.4 p -103.83 160.36 4.73 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.52 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 -177.963 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.613 HG22 ' HG2' ' A' ' 83' ' ' LYS . 61.1 m -132.4 120.56 22.18 Favored 'General case' 0 N--CA 1.415 -2.219 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 -169.769 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -163.83 -159.43 10.8 Favored Glycine 0 C--O 1.208 -1.517 0 C-N-CA 120.474 -0.87 . . . . 0.0 113.097 -178.543 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 41.0 m80 -114.59 122.75 47.48 Favored 'General case' 0 CA--C 1.482 -1.664 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 178.47 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.517 HD11 ' HA ' ' A' ' 62' ' ' ASP . 5.2 tt -102.47 110.41 22.35 Favored 'General case' 0 C--N 1.285 -2.228 0 C-N-CA 119.965 -0.694 . . . . 0.0 109.278 -176.237 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -118.77 157.98 26.49 Favored 'General case' 0 CA--C 1.455 -2.678 0 CA-C-O 121.827 0.823 . . . . 0.0 109.445 174.122 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.468 ' HA ' ' HD3' ' A' ' 114' ' ' LYS . 16.5 mmtp -75.31 101.47 4.72 Favored 'General case' 0 C--N 1.245 -3.936 0 CA-C-O 122.687 1.232 . . . . 0.0 112.567 -178.492 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 121.59 -11.91 9.55 Favored Glycine 0 N--CA 1.411 -2.982 0 CA-C-N 113.195 -1.82 . . . . 0.0 110.021 -177.033 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -172.37 129.94 0.57 Allowed 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 113.363 0.875 . . . . 0.0 113.363 177.752 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.413 ' HB3' ' CG2' ' A' ' 136' ' ' ILE . 59.7 tp -97.39 104.23 16.23 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 106.46 -1.682 . . . . 0.0 106.46 172.664 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.458 ' HA ' ' CB ' ' A' ' 135' ' ' SER . 82.4 p -104.0 172.25 6.9 Favored 'General case' 0 C--N 1.311 -1.074 0 N-CA-C 111.803 0.297 . . . . 0.0 111.803 -173.301 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 57.76 46.17 17.59 Favored 'General case' 0 CA--C 1.496 -1.115 0 O-C-N 123.997 0.811 . . . . 0.0 110.7 172.71 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.415 HG21 HD11 ' A' ' 123' ' ' ILE 0.263 8.5 m -84.52 77.01 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.414 -2.266 0 CA-C-O 123.224 1.488 . . . . 0.0 111.962 -173.413 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -73.38 89.03 1.59 Allowed 'General case' 0 N--CA 1.394 -3.246 0 CA-C-N 112.287 -2.233 . . . . 0.0 110.293 -177.678 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 160.85 -22.91 0.24 Allowed Glycine 0 N--CA 1.413 -2.895 0 CA-C-N 115.085 -0.961 . . . . 0.0 110.801 176.504 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.609 HG22 ' H ' ' A' ' 105' ' ' THR . 18.6 pt -110.53 141.1 26.85 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.313 0 C-N-CA 119.62 -0.832 . . . . 0.0 111.657 -179.768 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -101.92 126.88 48.92 Favored 'General case' 0 C--N 1.294 -1.821 0 CA-C-N 114.795 -1.093 . . . . 0.0 110.331 177.479 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.401 HG23 HD22 ' A' ' 102' ' ' LEU . 97.4 m -115.49 109.74 18.27 Favored 'General case' 0 C--N 1.281 -2.394 0 CA-C-N 114.797 -1.092 . . . . 0.0 109.575 -178.297 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.441 ' O ' ' HA ' ' A' ' 100' ' ' SER . 6.6 tmtt? -114.56 134.73 54.82 Favored 'General case' 0 N--CA 1.421 -1.878 0 C-N-CA 120.441 -0.503 . . . . 0.0 110.45 174.102 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 89.7 t -130.19 -57.74 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.289 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 176.242 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 16.9 tpt -115.66 -34.86 4.71 Favored 'General case' 0 C--N 1.291 -1.971 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 173.984 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 7.8 tp -138.55 155.01 27.73 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.933 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.303 177.016 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 72.6 m95 -79.43 117.51 20.46 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 123.095 0.558 . . . . 0.0 110.872 179.343 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 17.5 m -129.93 157.16 42.54 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 174.107 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 48.0 pttt -126.84 28.48 5.83 Favored 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 -174.348 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 46.1 t -122.07 -83.07 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.15 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 175.472 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' THR . . . . . 0.431 ' HB ' ' H ' ' A' ' 135' ' ' SER . 33.8 p 42.6 -161.71 0.01 OUTLIER 'General case' 0 CA--C 1.559 1.324 0 N-CA-C 114.288 1.218 . . . . 0.0 114.288 -178.54 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 135' ' ' SER . . . . . 0.458 ' CB ' ' HA ' ' A' ' 118' ' ' THR . 89.6 p -171.81 157.75 4.66 Favored 'General case' 0 N--CA 1.414 -2.24 0 N-CA-C 106.801 -1.555 . . . . 0.0 106.801 176.167 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 136' ' ' ILE . . . . . 0.413 ' CG2' ' HB3' ' A' ' 117' ' ' LEU . 9.7 tt -100.44 113.02 34.87 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.94 0 N-CA-C 106.12 -1.808 . . . . 0.0 106.12 173.284 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 23.3 m -105.04 155.08 19.3 Favored 'General case' 0 N--CA 1.418 -2.074 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.676 -172.115 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 138' ' ' THR . . . . . 0.489 HG21 ' HB3' ' A' ' 63' ' ' LEU . 9.4 t -164.09 166.19 21.57 Favored 'General case' 0 C--N 1.282 -2.333 0 N-CA-C 106.922 -1.51 . . . . 0.0 106.922 178.59 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -111.86 64.77 0.62 Allowed 'General case' 0 C--N 1.268 -2.94 0 C-N-CA 117.682 -1.607 . . . . 0.0 106.808 170.296 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.41 ' H ' HG23 ' A' ' 138' ' ' THR . . . 50.88 41.64 27.03 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 113.568 -1.651 . . . . 0.0 111.69 -178.036 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 141' ' ' SER . . . . . 0.564 ' O ' ' HD2' ' A' ' 155' ' ' ARG . 47.4 t 171.05 -84.78 0.0 OUTLIER 'General case' 0 C--N 1.346 0.447 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.387 -175.486 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 61.5 pttt -78.91 135.58 37.02 Favored 'General case' 0 CA--C 1.491 -1.326 0 C-N-CA 120.158 -0.617 . . . . 0.0 109.881 -177.31 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.433 ' HB ' HG21 ' A' ' 65' ' ' ILE . 5.3 p -105.52 147.02 11.75 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.91 0 CA-C-O 121.122 0.487 . . . . 0.0 111.474 -166.377 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -139.17 155.91 47.49 Favored 'General case' 0 CA--C 1.499 -0.983 0 CA-C-N 115.417 -0.81 . . . . 0.0 109.935 -179.058 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 145' ' ' PHE . . . . . 0.547 ' HB2' ' HB2' ' A' ' 151' ' ' LYS . 62.7 m-85 -105.8 114.67 28.96 Favored 'General case' 0 C--N 1.282 -2.345 0 CA-C-N 115.195 -0.912 . . . . 0.0 110.006 172.934 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.403 HG21 ' OG ' ' A' ' 135' ' ' SER . 8.8 t -70.44 2.79 3.52 Favored 'General case' 0 CA--C 1.554 1.115 0 CA-C-N 114.739 -1.119 . . . . 0.0 113.051 -172.089 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -63.16 -17.04 61.95 Favored 'General case' 0 C--O 1.221 -0.407 0 CA-C-O 121.332 0.587 . . . . 0.0 111.0 -178.259 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 156.3 31.53 0.03 OUTLIER Glycine 0 CA--C 1.492 -1.399 0 N-CA-C 110.107 -1.197 . . . . 0.0 110.107 172.505 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 53.1 ttm 58.83 19.72 7.26 Favored 'General case' 0 C--N 1.361 1.081 0 CA-C-O 122.42 1.105 . . . . 0.0 108.482 -173.099 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 150' ' ' LYS . . . . . 0.472 ' O ' ' HE3' ' A' ' 151' ' ' LYS . 17.5 ptpt -85.13 1.78 46.43 Favored 'General case' 0 N--CA 1.44 -0.972 0 CA-C-N 114.628 -1.169 . . . . 0.0 113.634 -172.991 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.547 ' HB2' ' HB2' ' A' ' 145' ' ' PHE . 5.1 mmpt? -147.16 118.34 7.78 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 123.218 0.607 . . . . 0.0 109.818 176.247 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 23.7 p -133.01 132.96 42.47 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 177.081 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 153' ' ' ARG . . . . . 0.425 HH11 ' HD3' ' A' ' 153' ' ' ARG . 25.4 mmt180 -138.7 155.18 48.46 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 122.154 0.181 . . . . 0.0 110.539 179.499 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 70.1 p -79.11 119.91 22.9 Favored 'General case' 0 C--O 1.25 1.086 0 N-CA-C 113.528 0.936 . . . . 0.0 113.528 -175.552 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 155' ' ' ARG . . . . . 0.564 ' HD2' ' O ' ' A' ' 141' ' ' SER . 28.7 ttt180 -71.07 -35.92 72.08 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.073 0.463 . . . . 0.0 111.021 176.327 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -50.11 -41.81 49.22 Favored 'General case' 0 C--N 1.314 -0.943 0 C-N-CA 123.721 0.809 . . . . 0.0 112.528 -175.694 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -71.1 -52.36 19.79 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.921 -178.95 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 99.1 m-85 -149.36 -23.13 0.29 Allowed 'General case' 0 N--CA 1.484 1.254 0 N-CA-C 112.028 0.381 . . . . 0.0 112.028 -179.191 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 159' ' ' GLY . . . . . 0.419 ' HA2' ' HA ' ' A' ' 155' ' ' ARG . . . 128.73 -90.41 0.32 Allowed Glycine 0 N--CA 1.446 -0.646 0 N-CA-C 109.008 -1.637 . . . . 0.0 109.008 -172.901 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.608 HG22 ' O ' ' A' ' 67' ' ' ILE . 22.8 m -98.45 144.78 10.97 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.764 0 N-CA-C 106.285 -1.746 . . . . 0.0 106.285 173.194 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 14.8 mm100 -113.62 90.1 3.26 Favored 'General case' 0 C--N 1.3 -1.572 0 C-N-CA 119.022 -1.071 . . . . 0.0 111.447 -176.526 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -154.75 150.03 27.14 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 173.5 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 50.0 t30 -88.61 104.81 17.2 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-O 121.254 0.55 . . . . 0.0 110.553 177.566 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -142.63 150.51 22.27 Favored Glycine 0 CA--C 1.484 -1.876 0 N-CA-C 108.937 -1.665 . . . . 0.0 108.937 177.561 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -142.74 118.98 10.8 Favored 'General case' 0 N--CA 1.419 -2.018 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 176.784 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 166' ' ' ARG . . . . . 0.436 ' HB3' ' HB3' ' A' ' 90' ' ' SER . 0.0 OUTLIER -58.05 136.13 57.1 Favored 'General case' 0 N--CA 1.427 -1.577 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 173.31 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 48.6 t -53.28 -40.66 40.37 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.925 0 O-C-N 123.947 0.78 . . . . 0.0 110.148 175.127 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -86.07 70.79 10.62 Favored 'General case' 0 CA--C 1.503 -0.832 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.598 174.535 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 169' ' ' LYS . . . . . 0.411 ' O ' ' HB2' ' A' ' 170' ' ' PHE . 59.7 tttp -152.93 119.09 5.49 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.411 177.491 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 170' ' ' PHE . . . . . 0.411 ' HB2' ' O ' ' A' ' 169' ' ' LYS . 59.4 t80 . . . . . 0 C--O 1.252 1.194 0 N-CA-C 106.667 -1.605 . . . . 0.0 106.667 174.366 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 27.3 p . . . . . 0 N--CA 1.443 -0.818 0 CA-C-O 120.581 0.229 . . . . 0.0 111.242 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -136.3 94.33 3.01 Favored 'General case' 0 CA--C 1.494 -1.183 0 O-C-N 122.245 -0.284 . . . . 0.0 110.49 -179.339 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -96.51 90.38 5.35 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 174.518 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.428 HD13 ' N ' ' A' ' 5' ' ' PHE . 0.0 OUTLIER -136.18 133.77 50.15 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.096 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 -177.483 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.428 ' N ' HD13 ' A' ' 4' ' ' ILE . 43.4 p90 -150.61 134.39 16.64 Favored 'General case' 0 C--N 1.292 -1.93 0 CA-C-O 120.902 0.382 . . . . 0.0 110.703 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -101.83 82.59 2.28 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 173.983 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -126.86 102.65 7.11 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 -177.201 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 8.4 p -161.31 137.58 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.563 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.957 -178.215 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -153.15 84.58 0.15 Allowed Glycine 0 N--CA 1.424 -2.15 0 N-CA-C 110.436 -1.066 . . . . 0.0 110.436 178.976 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 18.8 m -79.73 88.17 5.21 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-O 121.112 0.482 . . . . 0.0 110.409 -179.161 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 54.4 p90 -151.63 146.69 26.0 Favored 'General case' 0 N--CA 1.438 -1.073 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 177.401 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 40.8 p90 -161.47 166.74 26.75 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 -179.523 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 4.0 tt -98.92 116.06 30.3 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 -178.082 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -152.08 60.0 0.41 Allowed Glycine 0 N--CA 1.438 -1.187 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 178.088 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -117.69 0.43 12.02 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-O 121.632 0.73 . . . . 0.0 110.633 -174.14 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -108.93 121.61 45.47 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.404 -178.818 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -168.26 168.88 11.24 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 123.704 0.801 . . . . 0.0 109.441 177.95 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 18.6 m120 62.45 72.95 0.48 Allowed 'General case' 0 C--O 1.243 0.746 0 C-N-CA 124.565 1.146 . . . . 0.0 113.393 178.95 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 14.6 ptmm? -164.0 120.07 1.62 Allowed 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 115.117 -0.947 . . . . 0.0 109.231 176.505 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -135.38 -70.0 0.49 Allowed 'General case' 0 C--N 1.312 -1.025 0 CA-C-O 121.005 0.431 . . . . 0.0 109.95 -178.466 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 45.2 p90 -139.62 149.04 43.29 Favored 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 108.442 -0.948 . . . . 0.0 108.442 178.591 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -97.79 154.51 17.57 Favored 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 -178.394 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 16.5 m 64.39 102.94 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.245 1.018 . . . . 0.0 113.361 174.434 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 55.4 t -93.16 103.22 14.46 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 177.116 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -149.59 133.04 4.26 Favored Glycine 0 N--CA 1.431 -1.694 0 N-CA-C 110.76 -0.936 . . . . 0.0 110.76 -179.497 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 46.4 m-80 -141.51 167.67 21.61 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-N 116.73 0.265 . . . . 0.0 110.662 -178.156 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 26.4 m-20 -83.86 165.72 18.52 Favored 'General case' 0 C--N 1.313 -1.0 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 177.451 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 90.0 mt -80.76 115.96 20.52 Favored 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 176.607 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -66.41 117.59 8.86 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.12 179.858 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 21.0 m -102.85 158.39 16.3 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 -179.508 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 54.3 t -84.06 -48.37 17.06 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 175.801 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 50.0 m 69.05 -35.25 0.3 Allowed 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 124.584 1.154 . . . . 0.0 113.411 177.792 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 23.3 m -69.09 -10.81 59.47 Favored 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 123.831 0.852 . . . . 0.0 109.968 178.449 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 19.1 m -64.17 104.83 0.79 Allowed 'General case' 0 N--CA 1.436 -1.152 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.954 179.422 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.524 ' O ' ' HE2' ' A' ' 52' ' ' LYS . 9.2 tp -120.53 -33.79 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 174.838 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 57.64 15.36 2.83 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 124.479 1.112 . . . . 0.0 112.517 177.858 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.452 ' HA3' ' HG2' ' A' ' 52' ' ' LYS . . . -96.91 114.8 5.07 Favored Glycine 0 N--CA 1.423 -2.202 0 N-CA-C 111.617 -0.593 . . . . 0.0 111.617 -178.699 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -75.65 138.36 22.99 Favored Glycine 0 N--CA 1.431 -1.682 0 N-CA-C 110.64 -0.984 . . . . 0.0 110.64 178.638 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 41.1 m -80.62 87.95 5.74 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-O 121.749 0.785 . . . . 0.0 110.395 -178.804 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 5.2 tmtm? -145.87 100.28 3.39 Favored 'General case' 0 C--N 1.311 -1.104 0 N-CA-C 106.384 -1.71 . . . . 0.0 106.384 179.759 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 40.9 p90 -88.73 115.51 26.32 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-O 121.855 0.836 . . . . 0.0 111.187 -177.529 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 61.4 tp -106.53 -40.24 5.62 Favored 'General case' 0 C--N 1.297 -1.685 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.575 -179.221 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 58.3 t -84.57 103.78 12.12 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.968 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.79 -178.84 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 -93.09 83.61 4.71 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-O 121.27 0.557 . . . . 0.0 109.662 178.92 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 10.5 tmtt? -160.28 106.45 1.54 Allowed 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 105.428 -2.064 . . . . 0.0 105.428 178.103 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 2.3 pp -80.29 148.94 5.37 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 N-CA-C 113.889 1.07 . . . . 0.0 113.889 -174.783 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 60.2 tttm 61.02 87.87 0.09 Allowed 'General case' 0 C--O 1.25 1.094 0 C-N-CA 124.651 1.181 . . . . 0.0 111.803 178.943 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 162.46 -161.3 33.5 Favored Glycine 0 N--CA 1.434 -1.494 0 N-CA-C 110.371 -1.092 . . . . 0.0 110.371 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -86.48 95.36 9.68 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 108.542 -0.911 . . . . 0.0 108.542 179.481 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 82.8 mtp -98.08 -79.52 0.47 Allowed 'General case' 0 C--N 1.293 -1.885 0 CA-C-O 121.363 0.601 . . . . 0.0 111.117 -175.362 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 52.6 mt-30 -151.93 -156.8 0.74 Allowed 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 -174.777 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.524 ' HE2' ' O ' ' A' ' 35' ' ' ILE . 50.3 tptt -57.92 137.48 83.51 Favored Pre-proline 0 CA--C 1.556 1.199 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 176.528 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.432 ' HD2' ' HD2' ' A' ' 52' ' ' LYS . 19.6 Cg_endo -61.39 32.53 0.06 OUTLIER 'Trans proline' 0 N--CA 1.499 1.827 0 C-N-CA 124.385 3.39 . . . . 0.0 117.72 -174.325 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.679 ' O ' ' HG ' ' A' ' 58' ' ' LEU . 1.8 mm? -63.85 -54.47 41.04 Favored Pre-proline 0 CA--C 1.495 -1.163 0 CA-C-N 119.427 1.012 . . . . 0.0 111.139 178.368 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.579 ' HA ' HD11 ' A' ' 58' ' ' LEU . 24.7 Cg_exo -60.84 -25.44 81.23 Favored 'Trans proline' 0 C--N 1.386 2.53 0 C-N-CA 121.103 1.202 . . . . 0.0 111.185 -172.581 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -76.18 -47.69 23.23 Favored 'General case' 0 N--CA 1.433 -1.303 0 CA-C-N 114.884 -1.053 . . . . 0.0 109.031 179.681 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.5 ' HA ' ' HG2' ' A' ' 60' ' ' GLU . 52.1 tp -63.83 -48.86 75.11 Favored 'General case' 0 C--N 1.313 -1.021 0 C-N-CA 124.562 1.145 . . . . 0.0 111.497 -179.164 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.679 ' HG ' ' O ' ' A' ' 54' ' ' LEU 0.339 2.4 pp -67.1 -33.85 76.36 Favored 'General case' 0 N--CA 1.428 -1.547 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 -177.995 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.499 ' HG2' ' O ' ' A' ' 55' ' ' PRO . 23.1 pttp -76.56 -30.9 57.26 Favored 'General case' 0 C--O 1.222 -0.367 0 C-N-CA 119.442 -0.903 . . . . 0.0 111.875 175.363 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.5 ' HG2' ' HA ' ' A' ' 57' ' ' LEU . 12.7 pt-20 -76.69 -40.18 49.65 Favored 'General case' 0 CA--C 1.509 -0.601 0 C-N-CA 120.038 -0.665 . . . . 0.0 111.737 -177.368 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 27.7 m-85 -68.64 -19.37 64.41 Favored 'General case' 0 C--O 1.24 0.582 0 C-N-CA 119.0 -1.08 . . . . 0.0 113.035 174.3 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.483 ' O ' ' HE3' ' A' ' 114' ' ' LYS . 12.1 t0 -95.39 176.12 6.31 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.132 178.267 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.727 ' HB2' HD12 ' A' ' 65' ' ' ILE . 13.8 mt -71.39 179.81 0.88 Allowed Pre-proline 0 CA--C 1.577 1.985 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 -177.184 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_endo -88.03 12.66 2.79 Favored 'Trans proline' 0 N--CA 1.45 -1.035 0 C-N-CA 122.211 1.941 . . . . 0.0 111.801 -175.613 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.747 HG12 ' H ' ' A' ' 67' ' ' ILE . 0.2 OUTLIER -68.84 -42.02 82.46 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 178.017 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 58.87 8.79 6.16 Favored Glycine 0 N--CA 1.496 2.644 0 CA-C-O 121.956 0.753 . . . . 0.0 112.163 -176.412 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.747 ' H ' HG12 ' A' ' 65' ' ' ILE . 62.6 mt 56.63 -70.05 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.192 -1.973 0 C-N-CA 128.294 2.638 . . . . 0.0 112.307 -173.544 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.494 ' HB3' ' HD3' ' A' ' 69' ' ' PRO . 88.2 t80 175.2 -61.24 0.0 OUTLIER Pre-proline 0 CA--C 1.543 0.692 0 N-CA-C 112.762 0.653 . . . . 0.0 112.762 -174.539 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.494 ' HD3' ' HB3' ' A' ' 68' ' ' PHE . 3.4 Cg_endo -84.49 -21.23 3.62 Favored 'Trans proline' 0 N--CA 1.447 -1.232 0 C-N-CA 121.409 1.406 . . . . 0.0 114.584 -168.004 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 83.38 -11.5 55.28 Favored Glycine 0 C--O 1.224 -0.497 0 N-CA-C 111.006 -0.837 . . . . 0.0 111.006 -175.576 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.579 ' HB3' ' HG2' ' A' ' 89' ' ' PRO . 20.1 m-20 -83.21 -42.0 17.77 Favored 'General case' 0 N--CA 1.438 -1.038 0 N-CA-C 105.587 -2.005 . . . . 0.0 105.587 177.955 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.52 ' O ' ' HB ' ' A' ' 73' ' ' THR . . . -75.89 -178.35 4.27 Favored 'General case' 0 CA--C 1.546 0.793 0 CA-C-N 113.695 -1.593 . . . . 0.0 109.719 175.217 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.522 ' O ' HG22 ' A' ' 73' ' ' THR . 41.3 m 84.44 26.11 0.09 Allowed 'General case' 0 N--CA 1.49 1.554 0 CA-C-O 124.544 2.116 . . . . 0.0 110.178 175.131 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.584 ' O ' ' HA ' ' A' ' 86' ' ' VAL . 3.1 m-20 -81.07 136.86 36.0 Favored 'General case' 0 C--N 1.272 -2.791 0 CA-C-N 114.527 -1.215 . . . . 0.0 110.16 -178.988 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 43.1 t80 -113.11 90.2 3.28 Favored 'General case' 0 C--N 1.277 -2.552 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.693 -169.965 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.505 ' O ' HD22 ' A' ' 84' ' ' LEU . 13.2 mm-40 -122.85 150.98 42.16 Favored 'General case' 0 C--O 1.202 -1.415 0 N-CA-C 106.934 -1.506 . . . . 0.0 106.934 179.073 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 46.8 p90 -146.89 144.26 29.13 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-N 119.514 1.052 . . . . 0.0 111.334 176.804 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.588 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 10.8 m-20 -92.01 165.83 13.0 Favored 'General case' 0 CA--C 1.481 -1.705 0 CA-C-O 121.258 0.551 . . . . 0.0 109.542 -178.341 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.425 ' O ' ' HG3' ' A' ' 82' ' ' LYS . 48.8 mt-10 -82.35 -43.79 16.98 Favored 'General case' 0 C--N 1.281 -2.383 0 CA-C-N 114.859 -1.064 . . . . 0.0 112.414 176.25 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -65.25 -33.09 75.18 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 122.62 1.2 . . . . 0.0 109.424 -179.81 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.588 ' HB ' ' HB2' ' A' ' 78' ' ' ASP . 29.7 m -85.23 -52.96 5.55 Favored 'General case' 0 N--CA 1.404 -2.766 0 CA-C-N 113.04 -1.891 . . . . 0.0 110.54 -178.056 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.425 ' HG3' ' O ' ' A' ' 79' ' ' GLU . 62.9 mttp 64.16 8.85 4.32 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 124.211 1.004 . . . . 0.0 109.892 -173.152 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.539 ' HG2' ' CG2' ' A' ' 81' ' ' THR 0.25 14.1 pttt -117.48 146.99 43.14 Favored 'General case' 0 N--CA 1.404 -2.773 0 CA-C-N 114.612 -1.176 . . . . 0.0 109.156 -177.459 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.505 HD22 ' O ' ' A' ' 76' ' ' GLU . 1.8 tm? -73.96 130.19 39.37 Favored 'General case' 0 C--N 1.279 -2.481 0 CA-C-N 115.288 -0.869 . . . . 0.0 111.82 -167.26 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.422 ' HA ' ' O ' ' A' ' 108' ' ' VAL . 74.5 p -111.3 111.95 23.37 Favored 'General case' 0 N--CA 1.411 -2.399 0 CA-C-N 114.892 -1.049 . . . . 0.0 109.063 177.549 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.584 ' HA ' ' O ' ' A' ' 74' ' ' ASN . 86.2 t -91.19 122.46 42.62 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.253 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 177.546 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.532 ' HA ' ' O ' ' A' ' 106' ' ' THR 0.388 1.0 OUTLIER -104.04 102.46 12.22 Favored 'General case' 0 N--CA 1.389 -3.483 0 CA-C-O 122.923 1.344 . . . . 0.0 112.782 -179.042 . . . . . . . . 4 4 . 1 . 018 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.48 ' O ' HG23 ' A' ' 106' ' ' THR . 69.0 mt -85.56 128.54 58.62 Favored Pre-proline 0 C--N 1.279 -2.487 0 CA-C-N 113.038 -1.892 . . . . 0.0 108.888 -176.824 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.579 ' HG2' ' HB3' ' A' ' 71' ' ' ASP . 50.6 Cg_exo -61.97 109.71 0.86 Allowed 'Trans proline' 0 CA--C 1.504 -0.988 0 C-N-CA 122.708 2.272 . . . . 0.0 110.563 177.926 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 30.4 t 69.26 179.55 0.24 Allowed 'General case' 0 CA--C 1.552 1.037 0 O-C-N 124.019 0.824 . . . . 0.0 110.357 -177.494 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.583 HD11 ' HG3' ' A' ' 103' ' ' LYS . 0.0 OUTLIER -112.58 132.35 61.58 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.784 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.007 177.692 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 92' ' ' CYS . . . . . 0.623 ' SG ' ' HB2' ' A' ' 104' ' ' PHE . 28.1 p -112.28 124.42 52.42 Favored 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 175.618 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.448 ' OE1' ' HE2' ' A' ' 103' ' ' LYS . 35.9 tt0 -124.2 129.72 51.29 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 178.823 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.505 ' O ' ' HA ' ' A' ' 101' ' ' VAL . 20.8 m -122.36 114.63 43.31 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.994 0 CA-C-O 121.234 0.54 . . . . 0.0 111.074 179.132 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -143.77 152.9 24.57 Favored Glycine 0 N--CA 1.427 -1.941 0 N-CA-C 108.332 -1.907 . . . . 0.0 108.332 178.107 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 18.9 t80 175.97 -60.24 0.01 OUTLIER 'General case' 0 CA--C 1.481 -1.678 0 N-CA-C 106.429 -1.693 . . . . 0.0 106.429 -174.609 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.615 ' HA ' ' HE3' ' A' ' 97' ' ' LYS . 0.1 OUTLIER -87.11 -6.81 58.54 Favored 'General case' 0 N--CA 1.409 -2.491 0 CA-C-N 111.327 -2.67 . . . . 0.0 112.055 -172.629 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.457 ' O ' ' HD3' ' A' ' 126' ' ' LYS . 17.3 t70 71.81 -43.86 0.57 Allowed 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 124.407 1.083 . . . . 0.0 112.947 179.765 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 27.3 m -64.01 -30.6 71.66 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 176.576 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 31.1 p -117.31 91.07 3.47 Favored 'General case' 0 N--CA 1.398 -3.039 0 CA-C-N 114.612 -1.177 . . . . 0.0 110.555 177.878 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.507 ' O ' ' HA ' ' A' ' 125' ' ' THR . 17.2 m -125.9 101.09 7.62 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 CA-C-N 115.079 -0.964 . . . . 0.0 108.89 172.154 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.606 ' HG ' ' OG1' ' A' ' 125' ' ' THR . 5.4 mp -123.45 125.69 45.4 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.829 -173.467 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.583 ' HG3' HD11 ' A' ' 91' ' ' ILE . 39.3 ttmt -112.46 113.1 25.11 Favored 'General case' 0 C--N 1.317 -0.82 0 O-C-N 123.127 0.267 . . . . 0.0 110.371 176.738 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.623 ' HB2' ' SG ' ' A' ' 92' ' ' CYS . 96.1 m-85 -103.67 98.94 8.73 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 175.315 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 87.1 m -74.37 159.96 31.66 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 115.095 -0.957 . . . . 0.0 111.378 -178.173 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.532 ' O ' ' HA ' ' A' ' 87' ' ' LEU . 90.2 m -57.93 -67.94 0.29 Allowed 'General case' 0 N--CA 1.431 -1.381 0 C-N-CA 124.665 1.186 . . . . 0.0 111.373 178.616 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 37.4 p -96.12 90.23 5.45 Favored 'General case' 0 N--CA 1.431 -1.4 0 C-N-CA 119.512 -0.875 . . . . 0.0 111.961 179.839 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.422 ' O ' ' HA ' ' A' ' 85' ' ' THR . 17.6 m -95.17 132.21 39.82 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 CA-C-N 115.538 -0.756 . . . . 0.0 109.649 176.443 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 30.3 m -114.94 120.06 38.64 Favored 'General case' 0 N--CA 1.413 -2.29 0 N-CA-C 108.712 -0.848 . . . . 0.0 108.712 -173.648 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.549 ' HA2' ' O ' ' A' ' 119' ' ' ASP . . . -150.99 161.79 29.18 Favored Glycine 0 N--CA 1.435 -1.393 0 C-N-CA 121.132 -0.556 . . . . 0.0 111.967 -177.626 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 84.2 t60 -84.81 90.8 7.84 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 178.524 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.542 ' HB2' HD13 ' A' ' 117' ' ' LEU . 5.4 tt -89.52 107.81 19.29 Favored 'General case' 0 N--CA 1.417 -2.1 0 N-CA-C 106.649 -1.611 . . . . 0.0 106.649 179.218 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -108.36 153.12 23.72 Favored 'General case' 0 N--CA 1.385 -3.705 0 N-CA-C 104.655 -2.35 . . . . 0.0 104.655 174.853 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.483 ' HE3' ' O ' ' A' ' 62' ' ' ASP . 21.4 tptm -75.2 101.5 4.65 Favored 'General case' 0 C--N 1.277 -2.566 0 C-N-CA 117.781 -1.568 . . . . 0.0 109.015 -176.221 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 115' ' ' GLY . . . . . 0.441 ' O ' HG23 ' A' ' 138' ' ' THR . . . 140.64 -24.42 2.62 Favored Glycine 0 C--O 1.19 -2.649 0 CA-C-N 114.043 -1.435 . . . . 0.0 110.236 -175.228 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 19.7 ptmt -173.98 151.2 1.71 Allowed 'General case' 0 N--CA 1.492 1.632 0 CA-C-N 117.643 0.721 . . . . 0.0 111.919 -179.038 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.542 HD13 ' HB2' ' A' ' 112' ' ' LEU . 27.3 tp -118.07 105.35 11.76 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 178.729 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 33.4 p -109.31 144.84 36.93 Favored 'General case' 0 C--N 1.295 -1.787 0 N-CA-C 113.681 0.993 . . . . 0.0 113.681 -176.26 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' ASP . . . . . 0.549 ' O ' ' HA2' ' A' ' 110' ' ' GLY . 31.5 m-20 60.81 94.06 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 124.885 1.274 . . . . 0.0 111.131 177.447 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 11.2 m -116.53 91.09 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.425 -1.715 0 CA-C-O 122.493 1.139 . . . . 0.0 113.009 -173.284 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -66.77 103.43 1.11 Allowed 'General case' 0 C--N 1.29 -1.999 0 CA-C-N 113.785 -1.552 . . . . 0.0 110.251 175.697 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 139.6 -20.68 2.92 Favored Glycine 0 N--CA 1.432 -1.607 0 CA-C-N 115.11 -0.95 . . . . 0.0 112.008 178.736 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 73.9 mt -101.56 108.17 23.02 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 CA-C-O 120.937 0.399 . . . . 0.0 110.267 -179.333 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 29.0 ttpp -101.23 130.93 47.44 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 176.033 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.606 ' OG1' ' HG ' ' A' ' 102' ' ' LEU . 15.1 t -157.53 163.81 38.01 Favored 'General case' 0 C--N 1.302 -1.498 0 C-N-CA 120.27 -0.572 . . . . 0.0 110.217 -175.822 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.457 ' HD3' ' O ' ' A' ' 98' ' ' ASP . 74.3 tttt -127.51 142.83 51.28 Favored 'General case' 0 C--N 1.276 -2.609 0 CA-C-N 115.52 -0.763 . . . . 0.0 109.354 174.964 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.447 HG11 ' HB2' ' A' ' 150' ' ' LYS . 83.6 t -110.92 -78.93 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.421 -1.918 0 N-CA-C 107.227 -1.398 . . . . 0.0 107.227 167.679 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 128' ' ' MET . . . . . 0.482 ' C ' HD12 ' A' ' 129' ' ' ILE . 26.3 ttt -105.49 -32.16 8.65 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 176.287 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.482 HD12 ' C ' ' A' ' 128' ' ' MET . 2.7 mp -130.83 154.42 40.66 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.747 0 N-CA-C 107.057 -1.461 . . . . 0.0 107.057 175.954 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 130' ' ' TRP . . . . . 0.42 ' CD1' ' HB2' ' A' ' 126' ' ' LYS . 12.7 m-90 -70.95 134.12 46.95 Favored 'General case' 0 C--O 1.242 0.696 0 CA-C-O 120.845 0.355 . . . . 0.0 110.969 178.895 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 3.7 m -135.34 162.5 37.7 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 C-N-CA 123.803 0.841 . . . . 0.0 111.282 177.79 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -137.77 9.87 2.86 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 112.265 0.468 . . . . 0.0 112.265 -175.673 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 59.1 t -118.12 -69.12 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 C-N-CA 120.307 -0.557 . . . . 0.0 110.04 178.664 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 76.4 p 54.96 -178.6 0.03 OUTLIER 'General case' 0 C--O 1.247 0.944 0 N-CA-C 114.987 1.477 . . . . 0.0 114.987 177.954 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 36.1 p -164.96 146.84 7.94 Favored 'General case' 0 N--CA 1.422 -1.861 0 CA-C-N 114.955 -1.02 . . . . 0.0 109.056 177.912 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' ILE . . . . . 0.478 ' CG2' ' HB3' ' A' ' 117' ' ' LEU . 10.7 tt -113.68 107.95 24.25 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 175.377 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 33.3 p -100.6 148.93 24.27 Favored 'General case' 0 N--CA 1.398 -3.042 0 CA-C-O 121.713 0.768 . . . . 0.0 110.926 -177.166 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 138' ' ' THR . . . . . 0.441 HG23 ' O ' ' A' ' 115' ' ' GLY . 6.1 t -165.31 176.12 8.61 Favored 'General case' 0 N--CA 1.4 -2.958 0 N-CA-C 106.765 -1.569 . . . . 0.0 106.765 -176.778 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -115.26 29.05 8.28 Favored 'General case' 0 C--N 1.277 -2.544 0 N-CA-C 105.859 -1.904 . . . . 0.0 105.859 172.567 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . 66.04 54.72 0.97 Allowed 'General case' 0 C--O 1.242 0.685 0 CA-C-N 113.886 -1.507 . . . . 0.0 107.321 -171.497 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 44.4 t -168.0 -81.41 0.02 OUTLIER 'General case' 0 N--CA 1.443 -0.785 0 CA-C-N 114.405 -1.271 . . . . 0.0 111.327 -174.772 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -95.59 150.03 20.79 Favored 'General case' 0 C--O 1.203 -1.383 0 C-N-CA 122.913 0.485 . . . . 0.0 110.477 -176.429 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.668 ' HB ' ' O ' ' A' ' 153' ' ' ARG . 67.8 t -105.65 114.48 45.19 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.118 0 CA-C-O 121.749 0.785 . . . . 0.0 112.477 -173.081 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 82.0 m-85 -117.89 113.29 21.53 Favored 'General case' 0 N--CA 1.422 -1.858 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 174.469 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 69.2 t80 -83.37 106.7 15.34 Favored 'General case' 0 C--N 1.288 -2.08 0 N-CA-C 108.582 -0.895 . . . . 0.0 108.582 -177.86 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . 0.406 5.6 p -86.52 78.1 9.28 Favored 'General case' 0 N--CA 1.389 -3.517 0 N-CA-C 116.658 2.095 . . . . 0.0 116.658 -173.802 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -126.7 76.17 1.61 Allowed 'General case' 0 N--CA 1.417 -2.124 0 N-CA-C 104.737 -2.32 . . . . 0.0 104.737 168.115 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 78.75 7.12 88.38 Favored Glycine 0 N--CA 1.441 -1.027 0 CA-C-N 114.195 -1.366 . . . . 0.0 111.274 -174.907 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 149' ' ' MET . . . . . 0.423 ' O ' ' HG2' ' A' ' 149' ' ' MET . 27.3 ttt 63.67 15.75 9.19 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 124.538 1.135 . . . . 0.0 109.397 -175.682 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 150' ' ' LYS . . . . . 0.447 ' HB2' HG11 ' A' ' 127' ' ' VAL . 64.3 mttp -66.21 -26.95 67.62 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 114.993 -1.003 . . . . 0.0 113.476 -175.24 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.636 ' HE2' ' HA ' ' A' ' 151' ' ' LYS . 8.2 mmpt? -114.13 136.73 52.61 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.012 0.434 . . . . 0.0 110.472 179.247 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 43.3 m -132.18 126.26 33.18 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 178.58 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 153' ' ' ARG . . . . . 0.668 ' O ' ' HB ' ' A' ' 143' ' ' VAL . 7.0 tpm_? -133.37 108.46 8.71 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 -176.86 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 16.2 m -61.08 128.96 38.99 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 175.524 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 155' ' ' ARG . . . . . 0.442 ' HD3' ' C ' ' A' ' 155' ' ' ARG . 2.5 tmt_? -59.24 -29.47 67.56 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 123.516 0.727 . . . . 0.0 109.299 -179.664 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -41.1 -41.12 1.66 Allowed 'General case' 0 C--N 1.314 -0.936 0 C-N-CA 125.615 1.566 . . . . 0.0 113.735 178.286 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -57.45 -53.11 61.84 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -176.397 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -178.88 20.46 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.172 0 N-CA-C 107.721 -1.214 . . . . 0.0 107.721 -179.202 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 159' ' ' GLY . . . . . 0.562 ' HA3' ' O ' ' A' ' 65' ' ' ILE . . . 95.85 -98.21 2.19 Favored Glycine 0 N--CA 1.405 -3.429 0 N-CA-C 108.901 -1.679 . . . . 0.0 108.901 -170.631 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.546 HG23 ' HB ' ' A' ' 65' ' ' ILE . 3.5 t -121.99 114.14 41.61 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.769 0 N-CA-C 105.793 -1.928 . . . . 0.0 105.793 176.385 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 161' ' ' GLN . . . . . 0.416 ' HG2' ' CE1' ' A' ' 68' ' ' PHE . 0.8 OUTLIER -132.51 98.3 4.32 Favored 'General case' 0 C--N 1.29 -2.02 0 C-N-CA 118.033 -1.467 . . . . 0.0 110.295 -171.012 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 39.8 ttm180 -153.26 100.61 2.47 Favored 'General case' 0 N--CA 1.428 -1.544 0 C-N-CA 120.441 -0.504 . . . . 0.0 109.89 170.816 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 51.41 -33.55 0.01 OUTLIER 'General case' 0 N--CA 1.509 2.477 0 N-CA-C 119.179 3.029 . . . . 0.0 119.179 171.415 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -60.75 111.39 3.7 Favored Glycine 0 C--N 1.315 -0.637 0 N-CA-C 115.647 1.019 . . . . 0.0 115.647 -173.637 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 44.9 tp -124.22 118.78 27.61 Favored 'General case' 0 N--CA 1.425 -1.681 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 176.859 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 166' ' ' ARG . . . . . 0.44 ' HB3' ' O ' ' A' ' 89' ' ' PRO . 6.3 mpt_? -78.14 117.6 19.58 Favored 'General case' 0 CA--C 1.479 -1.771 0 CA-C-O 121.112 0.482 . . . . 0.0 110.196 -177.531 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 4.3 m -78.05 62.34 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.947 0 CA-C-O 122.3 1.048 . . . . 0.0 113.233 179.145 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -111.65 -21.7 11.57 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 106.871 -1.529 . . . . 0.0 106.871 172.861 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 23.7 ttmm -91.12 101.92 14.66 Favored 'General case' 0 N--CA 1.425 -1.715 0 CA-C-N 113.551 -1.658 . . . . 0.0 110.413 -175.642 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 170' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 . . . . . 0 C--N 1.309 -1.193 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 177.268 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 23.1 m . . . . . 0 N--CA 1.45 -0.425 0 CA-C-O 121.115 0.483 . . . . 0.0 110.103 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -99.39 147.75 24.91 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.143 -175.947 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 -150.37 152.74 34.86 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 106.465 -1.68 . . . . 0.0 106.465 175.889 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 73.6 mt -92.96 102.31 13.51 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.722 0 C-N-CA 120.082 -0.647 . . . . 0.0 110.821 -179.535 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -113.97 93.1 4.21 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 173.799 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 32.0 t30 -145.16 119.66 9.7 Favored 'General case' 0 C--N 1.29 -2.004 0 CA-C-O 121.25 0.547 . . . . 0.0 110.583 -178.13 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -116.98 130.71 56.87 Favored 'General case' 0 C--N 1.287 -2.148 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 175.639 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.3 p -73.28 110.24 6.45 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 CA-C-O 121.745 0.784 . . . . 0.0 110.121 178.041 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -92.32 51.57 2.75 Favored Glycine 0 N--CA 1.421 -2.322 0 CA-C-N 115.547 -0.751 . . . . 0.0 112.808 -175.681 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 24.8 p -87.11 97.32 10.68 Favored 'General case' 0 N--CA 1.42 -1.933 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 175.192 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 70.9 m-85 -101.9 112.55 25.21 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.782 -173.876 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 72.6 t-105 -117.98 100.56 7.64 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.289 176.268 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 5.1 mp -112.67 96.52 6.02 Favored 'General case' 0 N--CA 1.428 -1.544 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 175.529 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 178.78 149.82 8.44 Favored Glycine 0 N--CA 1.423 -2.227 0 N-CA-C 109.159 -1.576 . . . . 0.0 109.159 -178.526 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -152.5 126.96 9.33 Favored 'General case' 0 C--N 1.292 -1.897 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 -178.248 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 60.2 mttp -88.04 96.93 10.7 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-O 121.52 0.676 . . . . 0.0 110.178 -179.859 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -123.42 129.51 51.38 Favored 'General case' 0 N--CA 1.428 -1.567 0 CA-C-N 115.117 -0.947 . . . . 0.0 109.737 -178.427 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -87.52 147.51 25.33 Favored 'General case' 0 C--N 1.308 -1.2 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 178.352 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -87.51 99.36 11.97 Favored 'General case' 0 N--CA 1.428 -1.566 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 179.517 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -84.86 81.01 9.07 Favored 'General case' 0 N--CA 1.429 -1.512 0 CA-C-O 122.079 0.943 . . . . 0.0 109.742 176.74 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 44.8 t80 -135.89 89.76 2.52 Favored 'General case' 0 N--CA 1.419 -1.989 0 CA-C-N 115.046 -0.979 . . . . 0.0 108.414 179.839 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -136.31 169.56 17.45 Favored 'General case' 0 C--N 1.281 -2.378 0 N-CA-C 108.042 -1.095 . . . . 0.0 108.042 -178.595 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 23.4 m -109.33 147.95 31.87 Favored 'General case' 0 C--N 1.281 -2.384 0 CA-C-O 120.764 0.316 . . . . 0.0 110.213 -176.755 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 54.2 t -83.6 92.42 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.394 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 177.767 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -100.79 56.02 0.78 Allowed Glycine 0 N--CA 1.429 -1.826 0 N-CA-C 110.897 -0.881 . . . . 0.0 110.897 -178.51 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -58.77 120.3 8.72 Favored 'General case' 0 C--N 1.317 -0.823 0 O-C-N 123.928 0.428 . . . . 0.0 109.972 -179.339 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -79.08 94.3 5.3 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-O 121.219 0.533 . . . . 0.0 111.822 -176.842 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.7 tt 176.48 113.81 0.02 OUTLIER 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 104.376 -2.453 . . . . 0.0 104.376 179.286 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -66.77 109.67 2.97 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 121.341 0.591 . . . . 0.0 111.001 -177.006 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 32.2 t -153.88 -168.12 2.87 Favored 'General case' 0 N--CA 1.419 -1.986 0 N-CA-C 106.437 -1.69 . . . . 0.0 106.437 -178.966 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 60.7 t -86.26 85.25 2.33 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 CA-C-O 121.508 0.671 . . . . 0.0 109.593 178.605 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 52.3 p -151.49 98.57 2.53 Favored 'General case' 0 N--CA 1.427 -1.601 0 CA-C-N 114.973 -1.012 . . . . 0.0 109.255 -179.618 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 21.3 p -82.5 115.7 21.61 Favored 'General case' 0 N--CA 1.423 -1.814 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.549 -179.674 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 37.2 p -88.98 -18.21 27.88 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-O 121.392 0.615 . . . . 0.0 110.799 -179.459 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 12.0 tt -131.11 149.38 33.36 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 179.097 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -76.92 132.17 38.94 Favored 'General case' 0 N--CA 1.436 -1.134 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 176.319 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -92.2 17.06 58.21 Favored Glycine 0 C--N 1.308 -1.023 0 C-N-CA 121.2 -0.524 . . . . 0.0 112.178 -177.734 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.467 ' HA3' ' CD1' ' A' ' 41' ' ' TRP . . . 152.01 -158.48 27.82 Favored Glycine 0 N--CA 1.416 -2.649 0 N-CA-C 111.226 -0.75 . . . . 0.0 111.226 178.759 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 35.9 p -113.83 -70.75 0.78 Allowed 'General case' 0 C--N 1.302 -1.493 0 CA-C-O 121.124 0.488 . . . . 0.0 110.901 179.599 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 66.6 mttm -99.49 10.13 41.95 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.009 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.467 ' CD1' ' HA3' ' A' ' 38' ' ' GLY . 28.5 p90 -128.62 147.93 50.76 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.173 -178.953 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 7.1 mp 69.28 114.67 0.04 OUTLIER 'General case' 0 CA--C 1.515 -0.385 0 C-N-CA 125.123 1.369 . . . . 0.0 111.401 -174.649 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 31.3 m -80.56 88.47 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.077 0 CA-C-O 122.541 1.162 . . . . 0.0 110.898 178.663 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -85.26 149.48 25.46 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-N 114.276 -1.329 . . . . 0.0 109.656 -177.923 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.498 ' HD2' ' N ' ' A' ' 45' ' ' LYS . 11.0 mptt -99.08 101.39 12.73 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 106.838 -1.541 . . . . 0.0 106.838 178.664 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 64.4 mt -111.57 140.61 30.2 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 N-CA-C 113.489 0.922 . . . . 0.0 113.489 -167.96 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.47 83.25 1.71 Allowed 'General case' 0 N--CA 1.436 -1.175 0 CA-C-N 114.245 -1.343 . . . . 0.0 107.954 168.181 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -160.43 165.32 34.9 Favored Glycine 0 C--N 1.309 -0.937 0 N-CA-C 110.038 -1.225 . . . . 0.0 110.038 -176.361 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 98.8 mttt 63.06 81.43 0.2 Allowed 'General case' 0 CA--C 1.51 -0.586 0 CA-C-O 121.929 0.871 . . . . 0.0 108.826 -173.194 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' MET . . . . . 0.434 ' SD ' ' HA ' ' A' ' 53' ' ' PRO . 50.7 mtt -120.72 132.85 55.29 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-N 114.604 -1.18 . . . . 0.0 110.944 -170.851 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 50.1 tt0 -83.44 -39.63 20.33 Favored 'General case' 0 C--N 1.31 -1.126 0 N-CA-C 104.047 -2.575 . . . . 0.0 104.047 168.146 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 53.2 mtmt -133.89 143.13 46.15 Favored Pre-proline 0 N--CA 1.433 -1.296 0 N-CA-C 106.168 -1.79 . . . . 0.0 106.168 173.521 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.434 ' HA ' ' SD ' ' A' ' 50' ' ' MET . 4.3 Cg_exo -77.85 -20.04 12.11 Favored 'Trans proline' 0 CA--C 1.519 -0.239 0 C-N-CA 121.908 1.739 . . . . 0.0 112.589 -179.013 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.52 ' O ' HD13 ' A' ' 58' ' ' LEU . 19.0 mt -53.7 -51.49 75.99 Favored Pre-proline 0 N--CA 1.475 0.789 0 N-CA-C 113.724 1.009 . . . . 0.0 113.724 -173.213 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_exo -62.98 -15.57 48.64 Favored 'Trans proline' 0 C--N 1.372 1.795 0 C-N-CA 121.577 1.518 . . . . 0.0 113.068 -168.936 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 15.2 mm-40 -78.9 -36.97 41.14 Favored 'General case' 0 N--CA 1.423 -1.813 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 -174.083 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -76.05 -32.58 59.38 Favored 'General case' 0 N--CA 1.431 -1.397 0 CA-C-N 115.019 -0.991 . . . . 0.0 110.74 176.699 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.551 ' HG ' ' CE1' ' A' ' 75' ' ' TYR 0.253 4.6 mp -71.12 -44.21 66.08 Favored 'General case' 0 CA--C 1.487 -1.462 0 C-N-CA 120.346 -0.542 . . . . 0.0 111.722 -177.824 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.41 -25.79 66.93 Favored 'General case' 0 C--O 1.218 -0.579 0 CA-C-O 122.536 1.16 . . . . 0.0 109.972 176.432 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 18.5 tt0 -71.97 -28.58 63.52 Favored 'General case' 0 N--CA 1.428 -1.562 0 CA-C-N 114.024 -1.444 . . . . 0.0 112.251 175.807 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 72.6 t80 -83.74 -36.31 23.75 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 176.084 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 55.4 t0 -78.4 -171.05 2.27 Favored 'General case' 0 C--O 1.255 1.363 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 177.698 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.729 ' HB2' HD12 ' A' ' 65' ' ' ILE . 7.0 mt -82.82 -178.9 1.29 Allowed Pre-proline 0 CA--C 1.575 1.923 0 N-CA-C 106.384 -1.709 . . . . 0.0 106.384 179.4 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.442 ' HD3' ' HB3' ' A' ' 63' ' ' LEU . 3.4 Cg_endo -89.66 16.74 1.69 Allowed 'Trans proline' 0 N--CA 1.451 -1.011 0 CA-C-N 121.752 1.662 . . . . 0.0 110.669 -173.485 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.729 HD12 ' HB2' ' A' ' 63' ' ' LEU . 0.2 OUTLIER -72.64 -38.05 57.76 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.867 0 CA-C-N 114.73 -1.123 . . . . 0.0 109.29 -179.107 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.405 ' H ' HD13 ' A' ' 65' ' ' ILE . . . 59.09 4.34 2.35 Favored Glycine 0 N--CA 1.484 1.839 0 CA-C-N 115.495 -0.775 . . . . 0.0 112.769 -177.661 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.664 ' H ' HG12 ' A' ' 65' ' ' ILE . 20.3 mt 65.66 -68.65 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.224 0 C-N-CA 127.663 2.385 . . . . 0.0 112.025 -176.837 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.553 ' HA ' ' CD2' ' A' ' 158' ' ' TYR . 70.5 t80 169.34 -52.87 0.0 OUTLIER Pre-proline 0 C--N 1.322 -0.619 0 C-N-CA 124.013 0.925 . . . . 0.0 110.192 179.657 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.51 ' HD3' ' HB3' ' A' ' 68' ' ' PHE . 7.1 Cg_exo -81.29 143.48 13.97 Favored 'Trans proline' 0 C--N 1.369 1.637 0 C-N-CA 121.636 1.558 . . . . 0.0 110.229 177.444 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -71.85 -17.13 76.64 Favored Glycine 0 C--N 1.314 -0.644 0 C-N-CA 121.177 -0.535 . . . . 0.0 113.061 -177.979 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -90.7 -10.69 42.16 Favored 'General case' 0 C--O 1.201 -1.449 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 179.531 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.605 ' HA ' ' O ' ' A' ' 87' ' ' LEU . . . -82.89 -171.48 3.57 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.147 173.21 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.59 HG22 ' O ' ' A' ' 72' ' ' ALA . 6.0 t 72.39 26.9 2.54 Favored 'General case' 0 N--CA 1.501 2.121 0 C-N-CA 126.184 1.794 . . . . 0.0 109.53 169.2 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.445 ' HA ' ' HB3' ' A' ' 58' ' ' LEU . 28.2 m-80 -87.53 -169.48 2.62 Favored 'General case' 0 N--CA 1.417 -2.076 0 CA-C-N 113.599 -1.637 . . . . 0.0 108.852 -179.746 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.667 ' HB2' HD11 ' A' ' 84' ' ' LEU . 49.9 p90 -158.98 119.71 3.25 Favored 'General case' 0 C--N 1.311 -1.106 0 C-N-CA 118.889 -1.125 . . . . 0.0 113.649 -176.623 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.675 ' O ' HG22 ' A' ' 85' ' ' THR . 51.8 mt-10 -146.55 92.2 2.13 Favored 'General case' 0 CA--C 1.577 2.001 0 N-CA-C 114.58 1.326 . . . . 0.0 114.58 175.365 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.662 ' HB2' ' HA ' ' A' ' 84' ' ' LEU 0.437 30.3 m-85 -169.45 154.76 5.84 Favored 'General case' 0 N--CA 1.506 2.362 0 C-N-CA 128.105 2.562 . . . . 0.0 110.894 165.859 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.487 ' HB2' ' HB ' ' A' ' 81' ' ' THR 0.259 8.3 m-20 -50.99 142.96 11.06 Favored 'General case' 0 CA--C 1.48 -1.748 0 CA-C-O 122.074 0.94 . . . . 0.0 110.42 -179.874 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -81.11 -31.23 34.37 Favored 'General case' 1 C--N 1.24 -4.185 0 CA-C-N 113.867 -1.515 . . . . 0.0 111.753 178.493 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.413 ' HG2' ' HB3' ' A' ' 78' ' ' ASP . 12.9 pt-20 -65.9 -30.08 70.62 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 122.227 1.013 . . . . 0.0 108.626 177.227 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.487 ' HB ' ' HB2' ' A' ' 78' ' ' ASP . 95.5 m -78.73 -39.13 37.13 Favored 'General case' 0 N--CA 1.414 -2.268 0 CA-C-N 113.5 -1.682 . . . . 0.0 109.571 177.546 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.68 ' HE2' ' HA ' ' A' ' 82' ' ' LYS . 3.3 mmpt? 71.95 15.29 5.7 Favored 'General case' 0 CA--C 1.494 -1.188 0 C-N-CA 124.067 0.947 . . . . 0.0 112.864 -177.492 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.423 ' C ' ' HB2' ' A' ' 77' ' ' PHE . 37.2 ttpt -93.81 173.02 7.88 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 104.212 -2.514 . . . . 0.0 104.212 172.299 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.679 HD23 HD13 ' A' ' 112' ' ' LEU . 20.8 tp 176.24 121.93 0.03 OUTLIER 'General case' 0 CA--C 1.475 -1.912 0 CA-C-N 119.134 0.879 . . . . 0.0 108.99 -169.181 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.675 HG22 ' O ' ' A' ' 76' ' ' GLU . 14.5 t -92.2 129.93 38.03 Favored 'General case' 0 N--CA 1.392 -3.344 0 C-N-CA 118.976 -1.09 . . . . 0.0 108.252 174.537 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 62.3 t -103.92 116.61 48.01 Favored 'Isoleucine or valine' 0 N--CA 1.4 -2.975 0 CA-C-N 115.264 -0.88 . . . . 0.0 108.655 179.623 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.605 ' O ' ' HA ' ' A' ' 72' ' ' ALA . 2.0 mm? -75.1 123.16 24.72 Favored 'General case' 0 N--CA 1.41 -2.456 0 CA-C-N 113.783 -1.553 . . . . 0.0 110.673 -176.337 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 74.8 mt -107.51 137.16 19.6 Favored Pre-proline 0 C--N 1.281 -2.375 0 N-CA-C 105.225 -2.139 . . . . 0.0 105.225 170.881 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.465 ' O ' ' HB2' ' A' ' 166' ' ' ARG . 17.9 Cg_endo -58.21 84.87 0.05 OUTLIER 'Trans proline' 0 CA--C 1.541 0.825 0 C-N-CA 123.275 2.65 . . . . 0.0 112.523 178.175 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.438 ' HB3' ' HB ' ' A' ' 167' ' ' VAL . 24.2 m 69.33 163.89 0.24 Allowed 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 125.489 1.516 . . . . 0.0 112.46 -179.385 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 9.3 tt -62.82 135.34 27.34 Favored 'Isoleucine or valine' 0 C--O 1.242 0.69 0 CA-C-O 121.361 0.601 . . . . 0.0 109.864 177.383 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' CYS . . . . . 0.528 ' SG ' ' HB2' ' A' ' 104' ' ' PHE . 3.7 p -132.76 139.17 47.45 Favored 'General case' 0 C--N 1.282 -2.332 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.916 -179.295 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -119.79 142.41 48.62 Favored 'General case' 0 CA--C 1.454 -2.735 0 N-CA-C 106.048 -1.834 . . . . 0.0 106.048 178.637 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.411 ' HB ' ' CD2' ' A' ' 102' ' ' LEU . 17.9 t -118.49 104.38 16.0 Favored 'Isoleucine or valine' 0 N--CA 1.392 -3.365 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 -175.649 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -126.2 112.79 1.69 Allowed Glycine 0 N--CA 1.418 -2.549 0 N-CA-C 109.469 -1.453 . . . . 0.0 109.469 176.875 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 74.1 t80 -158.85 -47.61 0.06 Allowed 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 -177.993 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.625 ' HE2' ' HA ' ' A' ' 97' ' ' LYS . 7.7 mmpt? -74.43 -21.55 59.56 Favored 'General case' 0 CA--C 1.475 -1.91 0 CA-C-N 115.272 -0.876 . . . . 0.0 109.803 176.404 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 18.1 t70 74.74 -47.85 0.63 Allowed 'General case' 0 C--O 1.219 -0.531 0 O-C-N 124.927 1.392 . . . . 0.0 112.599 169.631 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 37.9 m -84.35 -4.96 59.2 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 175.525 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 36.4 t -135.2 92.46 2.86 Favored 'General case' 0 N--CA 1.408 -2.566 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 173.834 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 9.5 p -119.23 140.4 43.31 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 177.818 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.47 ' CB ' ' HA ' ' A' ' 125' ' ' THR . 0.4 OUTLIER -151.72 167.08 29.32 Favored 'General case' 0 C--N 1.294 -1.843 0 N-CA-C 112.641 0.608 . . . . 0.0 112.641 -171.364 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -142.59 129.13 20.22 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.413 0.625 . . . . 0.0 111.63 -175.703 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.528 ' HB2' ' SG ' ' A' ' 92' ' ' CYS . 61.0 m-85 -109.86 122.03 46.6 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 178.967 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.492 HG22 ' H ' ' A' ' 107' ' ' THR . 32.0 m -71.23 151.7 44.04 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 178.623 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 8.3 m -52.47 -38.5 59.53 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.967 0.907 . . . . 0.0 109.838 176.52 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.492 ' H ' HG22 ' A' ' 105' ' ' THR . 68.2 p -121.42 99.66 6.6 Favored 'General case' 0 N--CA 1.425 -1.678 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.144 179.021 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.542 ' O ' ' HA ' ' A' ' 85' ' ' THR . 61.9 t -99.65 138.22 24.69 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.285 0 N-CA-C 106.779 -1.563 . . . . 0.0 106.779 174.137 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.452 ' HA ' ' O ' ' A' ' 84' ' ' LEU . 9.1 t -125.8 137.13 53.76 Favored 'General case' 0 N--CA 1.395 -3.222 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 -175.814 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -157.16 176.98 34.24 Favored Glycine 0 N--CA 1.403 -3.529 0 C-N-CA 119.834 -1.174 . . . . 0.0 112.053 179.674 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' HIS . . . . . 0.524 ' HA ' ' O ' ' A' ' 82' ' ' LYS . 10.5 t60 -86.81 93.24 9.23 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 178.808 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.679 HD13 HD23 ' A' ' 84' ' ' LEU . 7.2 tt -97.98 120.41 38.32 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-O 121.656 0.741 . . . . 0.0 110.841 -174.062 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.504 ' OE1' ' HE2' ' A' ' 116' ' ' LYS . 44.4 mt-10 -123.41 -177.06 3.6 Favored 'General case' 0 CA--C 1.457 -2.611 0 CA-C-N 114.667 -1.151 . . . . 0.0 108.973 175.05 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.493 ' HA ' ' HD3' ' A' ' 114' ' ' LYS . 29.4 mmtt -83.07 101.84 11.4 Favored 'General case' 1 N--CA 1.371 -4.412 0 CA-C-N 114.834 -1.076 . . . . 0.0 113.536 179.926 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 125.27 -45.1 1.19 Allowed Glycine 0 N--CA 1.406 -3.336 0 CA-C-N 113.148 -1.842 . . . . 0.0 110.425 178.1 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.504 ' HE2' ' OE1' ' A' ' 113' ' ' GLU . 0.3 OUTLIER -135.2 147.59 49.41 Favored 'General case' 0 C--N 1.313 -0.984 0 C-N-CA 123.102 0.561 . . . . 0.0 112.492 -178.151 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.445 ' HA ' ' HA ' ' A' ' 112' ' ' LEU . 1.2 tt -120.64 105.06 10.43 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 105.346 -2.094 . . . . 0.0 105.346 178.079 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.513 ' HA ' ' OG ' ' A' ' 135' ' ' SER . 44.9 p -100.89 135.53 42.19 Favored 'General case' 0 C--N 1.267 -2.995 0 N-CA-C 114.465 1.283 . . . . 0.0 114.465 -172.174 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 64.92 97.47 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 125.235 1.414 . . . . 0.0 111.586 -179.887 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 6.1 m -104.52 93.53 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.018 0 CA-C-O 122.764 1.269 . . . . 0.0 111.348 -177.041 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -82.86 95.03 7.81 Favored 'General case' 0 N--CA 1.397 -3.107 0 CA-C-N 113.26 -1.791 . . . . 0.0 108.829 -179.888 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 145.91 -14.58 1.74 Allowed Glycine 0 C--N 1.305 -1.154 0 CA-C-N 114.375 -1.284 . . . . 0.0 111.188 -178.519 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.532 HG13 HG11 ' A' ' 108' ' ' VAL . 86.8 mt -100.64 99.41 8.38 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.25 0 CA-C-O 121.81 0.814 . . . . 0.0 111.042 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -89.18 127.71 35.76 Favored 'General case' 0 N--CA 1.433 -1.295 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 178.103 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.47 ' HA ' ' CB ' ' A' ' 102' ' ' LEU . 9.0 t -140.77 152.75 45.48 Favored 'General case' 0 C--N 1.278 -2.536 0 C-N-CA 119.734 -0.786 . . . . 0.0 111.002 -177.754 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.511 ' C ' ' HD3' ' A' ' 126' ' ' LYS . 3.8 tmtt? -140.85 127.17 19.81 Favored 'General case' 0 N--CA 1.389 -3.51 0 CA-C-N 115.168 -0.924 . . . . 0.0 108.695 175.055 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.513 HG13 ' H ' ' A' ' 128' ' ' MET . 2.6 p -135.55 -57.42 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 CA-C-N 114.709 -1.132 . . . . 0.0 109.057 -179.017 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 128' ' ' MET . . . . . 0.513 ' H ' HG13 ' A' ' 127' ' ' VAL . 24.3 ttt -101.19 -57.92 1.99 Allowed 'General case' 0 N--CA 1.421 -1.876 0 N-CA-C 106.293 -1.743 . . . . 0.0 106.293 176.495 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 2.2 pp -132.9 -179.48 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.637 0 CA-C-N 113.508 -1.678 . . . . 0.0 108.721 177.537 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 85.7 t90 -88.13 126.61 35.21 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 123.652 0.595 . . . . 0.0 110.518 -175.236 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 44.3 t -132.3 137.43 54.49 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 178.897 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 25.2 pttm -102.62 -24.54 13.76 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 112.328 0.492 . . . . 0.0 112.328 179.156 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 19.1 m -130.37 103.69 8.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-O 121.845 0.831 . . . . 0.0 111.417 -179.43 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 23.3 p -109.09 -165.5 1.02 Allowed 'General case' 0 C--N 1.292 -1.908 0 CA-C-N 115.342 -0.845 . . . . 0.0 109.166 177.091 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' SER . . . . . 0.513 ' OG ' ' HA ' ' A' ' 118' ' ' THR . 27.5 t -144.96 158.64 43.74 Favored 'General case' 0 N--CA 1.422 -1.837 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 176.715 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 68.1 mt -126.32 96.82 3.8 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 179.749 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' SER . . . . . 0.58 ' O ' ' HB2' ' A' ' 144' ' ' TYR . 46.9 t -121.48 136.53 54.95 Favored 'General case' 0 C--N 1.298 -1.663 0 O-C-N 121.816 -0.553 . . . . 0.0 110.324 -175.755 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 8.8 t -165.16 178.33 7.05 Favored 'General case' 0 N--CA 1.42 -1.935 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 -174.979 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -110.25 68.33 0.67 Allowed 'General case' 0 C--N 1.312 -1.045 0 C-N-CA 119.215 -0.994 . . . . 0.0 112.599 -179.263 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . 48.79 33.35 4.28 Favored 'General case' 0 N--CA 1.496 1.848 0 C-N-CA 124.586 1.154 . . . . 0.0 113.828 173.009 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 141' ' ' SER . . . . . 0.471 ' O ' ' HG3' ' A' ' 155' ' ' ARG . 48.1 t -154.32 -67.03 0.14 Allowed 'General case' 0 C--N 1.307 -1.265 0 C-N-CA 120.342 -0.543 . . . . 0.0 110.378 -174.717 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 55.3 mtpt -89.87 -162.79 0.92 Allowed 'General case' 0 CA--C 1.507 -0.709 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 179.125 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.516 HG11 ' O ' ' A' ' 159' ' ' GLY . 8.8 p -144.42 145.34 21.56 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 176.211 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 144' ' ' TYR . . . . . 0.58 ' HB2' ' O ' ' A' ' 137' ' ' SER . 91.6 m-85 -143.04 144.62 32.34 Favored 'General case' 0 CA--C 1.483 -1.6 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 174.219 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 145' ' ' PHE . . . . . 0.485 ' HB2' ' HA ' ' A' ' 151' ' ' LYS . 26.5 m-85 -95.53 156.37 16.35 Favored 'General case' 0 CA--C 1.454 -2.733 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 173.775 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 19.0 m -137.03 93.92 2.89 Favored 'General case' 1 N--CA 1.374 -4.226 0 C-N-CA 119.799 -0.761 . . . . 0.0 109.477 174.595 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.491 ' HB3' ' HG3' ' A' ' 150' ' ' LYS . . . -111.56 6.99 20.43 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.168 -0.924 . . . . 0.0 109.361 177.783 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 148' ' ' GLY . . . . . 0.52 ' O ' ' HG2' ' A' ' 150' ' ' LYS . . . 111.98 75.41 0.75 Allowed Glycine 0 CA--C 1.48 -2.103 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 -179.377 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER 74.31 -33.72 0.26 Allowed 'General case' 0 N--CA 1.494 1.755 0 C-N-CA 125.145 1.378 . . . . 0.0 110.534 -176.754 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 150' ' ' LYS . . . . . 0.52 ' HG2' ' O ' ' A' ' 148' ' ' GLY . 12.0 pttm -79.88 121.22 25.15 Favored 'General case' 0 C--N 1.315 -0.904 0 C-N-CA 124.292 1.037 . . . . 0.0 112.047 179.518 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.485 ' HA ' ' HB2' ' A' ' 145' ' ' PHE . 21.4 pttm -148.38 119.88 7.95 Favored 'General case' 0 N--CA 1.419 -1.983 0 CA-C-N 114.262 -1.335 . . . . 0.0 110.479 -175.074 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 42.9 m -110.41 111.82 23.34 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 106.54 -1.652 . . . . 0.0 106.54 173.53 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 153' ' ' ARG . . . . . 0.46 ' HB2' HG13 ' A' ' 143' ' ' VAL . 0.0 OUTLIER -154.69 99.57 2.17 Favored 'General case' 0 N--CA 1.435 -1.184 0 N-CA-C 116.397 1.999 . . . . 0.0 116.397 -165.745 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 4.9 m -108.99 109.57 20.65 Favored 'General case' 0 C--N 1.261 -3.279 0 O-C-N 121.423 -0.798 . . . . 0.0 109.051 165.489 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 155' ' ' ARG . . . . . 0.556 ' O ' ' HD3' ' A' ' 155' ' ' ARG . 0.2 OUTLIER -72.75 -23.45 60.83 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 120.633 1.561 . . . . 0.0 107.055 173.329 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -48.13 -43.72 31.46 Favored 'General case' 0 C--N 1.298 -1.666 0 C-N-CA 126.859 2.064 . . . . 0.0 115.536 -178.848 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.526 ' HB3' ' NE2' ' A' ' 161' ' ' GLN . . . -79.28 -19.5 50.38 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 113.318 0.859 . . . . 0.0 113.318 -175.893 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 0.553 ' CD2' ' HA ' ' A' ' 68' ' ' PHE . 44.0 t80 176.51 -34.49 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 CA-C-O 121.297 0.57 . . . . 0.0 109.831 178.482 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 159' ' ' GLY . . . . . 0.577 ' HA3' ' O ' ' A' ' 65' ' ' ILE . . . 150.52 -88.92 0.14 Allowed Glycine 0 CA--C 1.464 -3.134 0 N-CA-C 109.168 -1.573 . . . . 0.0 109.168 -172.194 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.558 HG23 ' HB ' ' A' ' 65' ' ' ILE . 10.9 t -98.06 153.39 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.642 0 N-CA-C 107.146 -1.428 . . . . 0.0 107.146 178.772 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 161' ' ' GLN . . . . . 0.526 ' NE2' ' HB3' ' A' ' 157' ' ' ALA . 79.3 mm-40 -116.32 90.05 3.25 Favored 'General case' 0 CA--C 1.453 -2.755 0 CA-C-O 122.435 1.112 . . . . 0.0 110.823 -172.469 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.28 147.59 24.9 Favored 'General case' 0 N--CA 1.387 -3.603 0 CA-C-N 112.555 -2.111 . . . . 0.0 108.828 179.327 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 9.4 t30 -113.13 -86.12 0.57 Allowed 'General case' 0 C--N 1.29 -2.014 0 C-N-CA 119.544 -0.862 . . . . 0.0 109.693 173.946 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 73.02 164.93 8.65 Favored Glycine 0 CA--C 1.502 -0.765 0 C-N-CA 120.424 -0.893 . . . . 0.0 113.256 179.088 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.525 ' O ' HD22 ' A' ' 165' ' ' LEU . 0.0 OUTLIER -100.95 114.69 28.82 Favored 'General case' 0 N--CA 1.413 -2.316 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 177.367 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 166' ' ' ARG . . . . . 0.465 ' HB2' ' O ' ' A' ' 89' ' ' PRO . 6.2 ptp180 -90.03 105.67 17.96 Favored 'General case' 0 N--CA 1.412 -2.369 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 -179.694 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.438 ' HB ' ' HB3' ' A' ' 90' ' ' SER . 57.5 t -43.83 -28.19 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 C-N-CA 124.333 1.053 . . . . 0.0 112.812 -177.662 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -49.64 -43.06 46.57 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 124.242 1.017 . . . . 0.0 111.813 177.042 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -128.49 8.79 5.96 Favored 'General case' 0 CA--C 1.546 0.825 0 CA-C-O 121.635 0.731 . . . . 0.0 110.887 -176.943 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 170' ' ' PHE . . . . . . . . . . . . . 67.3 t80 . . . . . 0 C--N 1.303 -1.439 0 N-CA-C 108.771 -0.825 . . . . 0.0 108.771 178.603 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 27.7 m . . . . . 0 N--CA 1.443 -0.775 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -92.73 103.43 15.8 Favored 'General case' 0 C--N 1.311 -1.094 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 -179.177 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -117.56 118.49 32.28 Favored 'General case' 0 C--N 1.307 -1.246 0 C-N-CA 120.54 -0.464 . . . . 0.0 111.518 -179.142 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 10.5 tt -137.14 108.21 5.91 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 CA-C-O 121.668 0.747 . . . . 0.0 110.078 174.991 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 76.5 t80 -109.58 104.32 13.33 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 178.601 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -125.41 99.09 5.89 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-O 121.179 0.514 . . . . 0.0 112.323 -175.389 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 63.8 mttp -133.63 95.94 3.59 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 174.409 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 42.7 t -107.83 138.14 35.72 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 -176.387 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -76.84 71.16 2.2 Favored Glycine 0 N--CA 1.439 -1.134 0 N-CA-C 111.929 -0.468 . . . . 0.0 111.929 179.187 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 17.0 m -83.84 87.35 7.08 Favored 'General case' 0 N--CA 1.425 -1.719 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 178.516 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 50.3 p90 -139.1 135.41 34.09 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.084 179.238 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 30.4 m-90 -132.88 104.85 6.78 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 178.633 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 56.2 tp -90.63 104.9 17.43 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.132 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -97.63 -168.38 32.49 Favored Glycine 0 N--CA 1.437 -1.291 0 C-N-CA 120.786 -0.721 . . . . 0.0 111.855 -179.63 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -93.96 98.61 11.15 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-O 121.537 0.684 . . . . 0.0 110.536 179.53 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.663 ' HD3' ' H ' ' A' ' 16' ' ' LYS . 0.2 OUTLIER -80.69 121.31 25.72 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.871 -179.285 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -165.6 98.26 0.68 Allowed 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.961 178.792 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 44.9 t-20 -147.12 94.78 2.46 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 109.573 -0.528 . . . . 0.0 109.573 178.307 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -138.44 118.66 13.59 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 176.928 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -83.69 96.85 8.82 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-O 121.53 0.681 . . . . 0.0 112.259 -177.934 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 33.7 p90 -121.8 96.62 5.14 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-O 121.678 0.752 . . . . 0.0 109.028 175.359 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -151.98 156.75 40.65 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.885 -177.112 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 17.3 m -71.4 127.37 32.35 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-O 120.86 0.362 . . . . 0.0 111.297 -177.978 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 7.7 p -60.73 138.43 21.64 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.807 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.849 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -89.81 98.3 2.43 Favored Glycine 0 CA--C 1.498 -1.0 0 N-CA-C 110.864 -0.895 . . . . 0.0 110.864 179.78 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 43.7 t30 -76.74 98.36 4.76 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-O 121.502 0.668 . . . . 0.0 112.329 -176.397 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -111.96 116.66 30.96 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 107.143 -1.429 . . . . 0.0 107.143 176.438 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.9 pp -124.53 3.77 8.32 Favored 'General case' 0 C--N 1.31 -1.13 0 N-CA-C 114.574 1.324 . . . . 0.0 114.574 -175.125 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 46.2 t30 -118.45 101.86 8.48 Favored 'General case' 0 C--N 1.314 -0.953 0 C-N-CA 120.334 -0.547 . . . . 0.0 109.902 178.473 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 36.3 p -135.35 14.15 3.5 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 116.145 -0.48 . . . . 0.0 112.29 -178.139 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 20.6 m -76.45 118.57 23.08 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 CA-C-O 121.498 0.666 . . . . 0.0 112.157 179.353 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 40.1 t -141.06 146.68 37.47 Favored 'General case' 0 C--N 1.313 -1.006 0 N-CA-C 108.388 -0.968 . . . . 0.0 108.388 -179.156 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 9.9 t -160.33 138.85 10.25 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-O 121.232 0.539 . . . . 0.0 112.306 -178.268 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 67.5 m -158.18 103.78 1.84 Allowed 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 107.097 -1.446 . . . . 0.0 107.097 174.218 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 11.7 tt -125.24 104.54 13.62 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 N-CA-C 114.2 1.185 . . . . 0.0 114.2 -172.348 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -102.6 122.29 44.1 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 172.819 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -66.09 127.96 30.66 Favored Glycine 0 N--CA 1.439 -1.147 0 N-CA-C 111.098 -0.801 . . . . 0.0 111.098 -179.556 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -61.12 100.94 0.27 Allowed Glycine 0 CA--C 1.5 -0.884 0 N-CA-C 111.131 -0.788 . . . . 0.0 111.131 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 17.1 m -97.61 70.13 2.21 Favored 'General case' 0 N--CA 1.414 -2.241 0 CA-C-O 122.031 0.92 . . . . 0.0 110.535 -176.284 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 63.3 tttm -145.3 22.05 1.53 Allowed 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 103.621 -2.733 . . . . 0.0 103.621 174.657 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 29.2 t90 -92.51 168.0 11.57 Favored 'General case' 0 N--CA 1.426 -1.666 0 CA-C-N 111.413 -2.63 . . . . 0.0 108.391 -174.189 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.623 HD23 ' H ' ' A' ' 42' ' ' LEU . 2.2 pt? -74.39 176.51 6.69 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 -178.349 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 43.3 t -45.97 120.69 0.6 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.559 0 C-N-CA 124.69 1.196 . . . . 0.0 112.039 -177.127 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 35.5 p30 -93.72 178.08 5.8 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.848 177.152 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.673 ' HE2' ' HA ' ' A' ' 45' ' ' LYS . 10.1 mmpt? -87.09 -34.72 19.04 Favored 'General case' 0 C--N 1.311 -1.085 0 C-N-CA 120.83 -0.348 . . . . 0.0 110.534 -177.447 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . 0.285 7.9 tp 42.76 78.48 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.248 1.02 0 C-N-CA 124.85 1.26 . . . . 0.0 113.124 -177.512 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -87.28 161.25 18.08 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-N 114.96 -1.018 . . . . 0.0 109.599 178.31 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 80.87 59.56 2.44 Favored Glycine 0 N--CA 1.425 -2.037 0 N-CA-C 110.088 -1.205 . . . . 0.0 110.088 -176.751 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 3.7 mptp? -63.29 -41.33 98.97 Favored 'General case' 0 CA--C 1.502 -0.886 0 C-N-CA 122.987 0.515 . . . . 0.0 109.958 -179.297 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' MET . . . . . 0.47 ' HB2' ' HD3' ' A' ' 59' ' ' LYS . 27.5 ttt -175.55 148.75 0.94 Allowed 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 106.339 -1.726 . . . . 0.0 106.339 177.875 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 79.3 mm-40 -72.69 144.46 47.71 Favored 'General case' 0 C--N 1.296 -1.757 0 C-N-CA 120.463 -0.495 . . . . 0.0 110.983 -178.077 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.586 ' O ' ' HD2' ' A' ' 55' ' ' PRO . 11.3 mptt 76.32 135.42 0.05 OUTLIER Pre-proline 0 CA--C 1.543 0.688 0 C-N-CA 125.507 1.523 . . . . 0.0 109.851 -171.933 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -69.23 -26.52 29.99 Favored 'Trans proline' 0 C--O 1.24 0.58 0 C-N-CA 122.61 2.206 . . . . 0.0 114.91 -173.864 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.68 ' H ' HD23 ' A' ' 54' ' ' LEU 0.352 0.5 OUTLIER -69.87 -56.42 7.56 Favored Pre-proline 0 C--N 1.307 -1.27 0 C-N-CA 119.367 -0.933 . . . . 0.0 113.384 175.587 . . . . . . . . 4 4 . 1 . 020 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.624 ' HD3' ' HG ' ' A' ' 54' ' ' LEU . 88.9 Cg_exo -55.33 -35.33 91.34 Favored 'Trans proline' 0 C--N 1.362 1.238 0 C-N-CA 123.376 2.717 . . . . 0.0 112.461 -176.88 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -66.33 -30.88 71.37 Favored 'General case' 0 C--O 1.217 -0.615 0 C-N-CA 120.389 -0.525 . . . . 0.0 110.349 179.392 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.401 ' HA ' ' HB3' ' A' ' 60' ' ' GLU . 59.8 tp -74.8 -31.77 61.8 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.017 178.967 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.454 ' HB3' ' H ' ' A' ' 75' ' ' TYR . 7.9 mp -58.39 -49.8 75.96 Favored 'General case' 0 CA--C 1.482 -1.657 0 CA-C-O 121.675 0.75 . . . . 0.0 109.484 178.916 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.484 ' HG2' ' O ' ' A' ' 55' ' ' PRO . 17.2 ptmt -74.64 -26.63 60.0 Favored 'General case' 0 C--N 1.28 -2.425 0 CA-C-N 114.089 -1.414 . . . . 0.0 112.41 179.653 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.401 ' HB3' ' HA ' ' A' ' 57' ' ' LEU . 9.1 tp10 -70.75 -35.14 72.51 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.934 178.819 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 61.5 m-85 -48.46 -22.6 0.75 Allowed 'General case' 0 N--CA 1.5 2.072 0 CA-C-O 120.944 0.402 . . . . 0.0 111.442 174.494 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.436 ' CG ' ' H ' ' A' ' 63' ' ' LEU . 17.1 t70 -107.25 -156.38 0.58 Allowed 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 -172.799 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.644 HD21 ' H ' ' A' ' 115' ' ' GLY . 53.3 mt -91.71 172.8 6.01 Favored Pre-proline 0 CA--C 1.568 1.651 0 O-C-N 121.394 -0.816 . . . . 0.0 110.419 -174.773 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.428 ' HD3' ' HB3' ' A' ' 63' ' ' LEU . 3.5 Cg_endo -88.12 19.8 1.27 Allowed 'Trans proline' 0 C--N 1.356 0.968 0 C-N-CA 123.335 2.69 . . . . 0.0 111.367 -172.21 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.734 ' O ' ' HA3' ' A' ' 159' ' ' GLY . 0.2 OUTLIER -73.25 -37.92 53.07 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.708 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.401 179.69 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 55.58 8.51 1.95 Allowed Glycine 0 N--CA 1.49 2.25 0 CA-C-N 115.489 -0.778 . . . . 0.0 113.351 -178.804 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.667 ' O ' ' HB ' ' A' ' 160' ' ' VAL . 40.6 mt 69.37 -63.89 0.23 Allowed 'Isoleucine or valine' 0 C--O 1.197 -1.682 0 C-N-CA 126.053 1.741 . . . . 0.0 113.627 -178.726 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.495 ' HB2' ' O ' ' A' ' 67' ' ' ILE . 63.7 t80 171.24 -48.0 0.0 OUTLIER Pre-proline 0 C--N 1.314 -0.944 0 C-N-CA 122.729 0.412 . . . . 0.0 110.637 -177.446 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.592 ' HB3' ' HD3' ' A' ' 166' ' ' ARG . 17.1 Cg_exo -74.61 -31.62 6.75 Favored 'Trans proline' 0 C--N 1.377 2.035 0 C-N-CA 121.388 1.392 . . . . 0.0 112.109 179.666 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 88.37 -29.16 5.8 Favored Glycine 0 N--CA 1.437 -1.281 0 C-N-CA 120.448 -0.882 . . . . 0.0 110.999 -175.22 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.426 ' HB3' ' HG3' ' A' ' 89' ' ' PRO . 17.5 t70 -81.86 -19.02 41.83 Favored 'General case' 0 C--O 1.2 -1.545 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 177.52 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.511 ' HB2' ' HD2' ' A' ' 89' ' ' PRO . . . -78.25 175.04 10.57 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 114.95 -1.023 . . . . 0.0 110.375 170.511 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.501 ' HB ' ' O ' ' A' ' 72' ' ' ALA . 51.9 m 86.29 21.27 0.08 Allowed 'General case' 0 C--N 1.355 0.836 0 CA-C-O 124.069 1.89 . . . . 0.0 110.763 172.451 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.556 ' O ' ' HA ' ' A' ' 86' ' ' VAL . 37.3 m-80 -80.33 158.9 25.96 Favored 'General case' 0 C--N 1.272 -2.793 0 CA-C-N 114.641 -1.163 . . . . 0.0 112.632 -179.572 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.454 ' H ' ' HB3' ' A' ' 58' ' ' LEU . 53.5 t80 -118.38 123.1 44.44 Favored 'General case' 0 C--N 1.284 -2.266 0 CA-C-N 114.716 -1.129 . . . . 0.0 112.998 -169.748 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.598 ' O ' HD12 ' A' ' 84' ' ' LEU . 26.7 mm-40 -146.59 151.2 36.91 Favored 'General case' 0 C--O 1.215 -0.73 0 C-N-CA 125.984 1.714 . . . . 0.0 108.165 173.254 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 52.4 p90 -139.28 150.58 45.61 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-N 118.228 0.467 . . . . 0.0 110.651 -178.501 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.478 ' CB ' ' HB ' ' A' ' 81' ' ' THR . 21.6 m-20 -78.56 164.39 24.72 Favored 'General case' 0 CA--C 1.48 -1.729 0 CA-C-O 121.589 0.709 . . . . 0.0 110.227 179.002 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -80.82 -65.87 0.96 Allowed 'General case' 0 C--N 1.279 -2.476 0 CA-C-N 114.312 -1.313 . . . . 0.0 110.835 -179.629 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -81.06 -33.22 33.63 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.378 -176.604 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.478 ' HB ' ' CB ' ' A' ' 78' ' ' ASP . 91.6 m -82.67 -29.03 30.24 Favored 'General case' 0 N--CA 1.425 -1.715 0 CA-C-N 115.048 -0.978 . . . . 0.0 111.64 -176.794 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt 58.88 15.41 3.86 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 113.021 0.749 . . . . 0.0 113.021 178.173 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.437 ' CG ' ' HB ' ' A' ' 109' ' ' THR . 16.4 tppt? -88.54 141.76 28.26 Favored 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 -177.635 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.598 HD12 ' O ' ' A' ' 76' ' ' GLU . 37.5 tp -75.96 138.72 41.15 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.26 177.037 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.406 HG23 ' HB2' ' A' ' 76' ' ' GLU . 9.4 t -126.31 116.97 22.06 Favored 'General case' 0 N--CA 1.412 -2.351 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 173.269 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.556 ' HA ' ' O ' ' A' ' 74' ' ' ASN . 74.2 t -92.92 127.01 45.29 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.808 0 CA-C-N 115.133 -0.94 . . . . 0.0 110.781 -178.463 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.469 ' HB2' ' HB2' ' A' ' 74' ' ' ASN . 3.9 mp -88.6 109.54 20.18 Favored 'General case' 0 N--CA 1.433 -1.294 0 CA-C-N 115.287 -0.87 . . . . 0.0 109.596 179.844 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 65.7 mt -96.86 137.93 21.35 Favored Pre-proline 0 C--N 1.286 -2.186 0 N-CA-C 105.957 -1.868 . . . . 0.0 105.957 171.073 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.61 ' O ' ' HB2' ' A' ' 166' ' ' ARG . 41.5 Cg_endo -63.19 107.44 0.66 Allowed 'Trans proline' 0 N--CA 1.437 -1.842 0 C-N-CA 122.109 1.873 . . . . 0.0 110.14 175.849 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.653 ' HB2' ' HB2' ' A' ' 168' ' ' ASP . 33.2 t 63.65 -163.92 0.26 Allowed 'General case' 0 CA--C 1.557 1.248 0 CA-C-O 121.272 0.558 . . . . 0.0 110.891 179.614 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 5.7 tt -106.06 119.63 55.71 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 CA-C-O 121.52 0.676 . . . . 0.0 109.496 177.854 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' CYS . . . . . 0.467 ' O ' ' HB2' ' A' ' 104' ' ' PHE . 21.0 p -117.47 124.59 49.15 Favored 'General case' 0 C--N 1.296 -1.753 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 -179.441 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -116.41 166.17 12.38 Favored 'General case' 0 C--N 1.306 -1.31 0 O-C-N 122.072 -0.392 . . . . 0.0 111.775 -174.045 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.449 ' HB ' ' HB2' ' A' ' 163' ' ' ASN . 3.0 p -149.95 104.93 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.609 177.757 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -145.4 151.24 23.46 Favored Glycine 0 N--CA 1.446 -0.68 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.994 176.627 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 78.2 m-85 -161.58 -60.49 0.05 Allowed 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 124.19 0.996 . . . . 0.0 108.508 179.067 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.564 ' HA ' ' HE3' ' A' ' 97' ' ' LYS . 0.4 OUTLIER -71.25 -13.43 61.9 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 114.262 -1.336 . . . . 0.0 110.955 -177.128 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 22.5 t70 71.89 -36.58 0.36 Allowed 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 123.962 0.905 . . . . 0.0 112.145 -179.638 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 68.4 m -77.76 -7.88 57.19 Favored 'General case' 0 N--CA 1.44 -0.937 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 172.399 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' SER . . . . . 0.455 ' HA ' ' O ' ' A' ' 126' ' ' LYS . 34.8 t -132.25 91.59 2.97 Favored 'General case' 0 N--CA 1.411 -2.391 0 N-CA-C 106.696 -1.594 . . . . 0.0 106.696 173.824 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.444 ' C ' HD12 ' A' ' 102' ' ' LEU . 97.9 t -130.45 119.35 45.89 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.108 0 CA-C-N 114.633 -1.167 . . . . 0.0 108.414 177.22 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.48 ' HG ' ' HA ' ' A' ' 125' ' ' THR . 4.8 mp -124.6 138.59 54.31 Favored 'General case' 0 N--CA 1.424 -1.759 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.346 -179.645 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 27.3 ttpp -117.19 110.35 18.03 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.33 177.759 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.579 ' HA ' HD12 ' A' ' 123' ' ' ILE . 51.1 m-85 -91.13 97.14 10.97 Favored 'General case' 0 N--CA 1.422 -1.871 0 CA-C-O 122.19 0.995 . . . . 0.0 111.756 177.764 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 31.6 m -56.05 146.4 22.85 Favored 'General case' 0 N--CA 1.424 -1.762 0 CA-C-N 112.276 -2.238 . . . . 0.0 110.916 177.325 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 66.9 m -56.95 -67.8 0.28 Allowed 'General case' 0 C--O 1.218 -0.593 0 C-N-CA 123.738 0.815 . . . . 0.0 111.123 -179.0 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.412 ' HA ' ' O ' ' A' ' 86' ' ' VAL . 7.3 p -107.56 99.88 9.34 Favored 'General case' 0 N--CA 1.423 -1.825 0 CA-C-O 121.654 0.74 . . . . 0.0 110.054 176.977 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.781 HG21 HG12 ' A' ' 123' ' ' ILE . 4.3 p -110.07 148.38 13.69 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.433 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.805 -176.894 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.535 ' HA ' ' O ' ' A' ' 84' ' ' LEU . 35.6 p -97.95 156.26 16.7 Favored 'General case' 0 N--CA 1.432 -1.369 0 N-CA-C 112.895 0.702 . . . . 0.0 112.895 -176.131 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.667 ' HA2' ' O ' ' A' ' 119' ' ' ASP . . . -172.99 174.42 45.86 Favored Glycine 0 CA--C 1.52 0.353 0 N-CA-C 111.714 -0.554 . . . . 0.0 111.714 -179.84 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 34.2 t-80 -109.75 121.96 46.41 Favored 'General case' 0 CA--C 1.508 -0.658 0 N-CA-C 107.934 -1.135 . . . . 0.0 107.934 177.347 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.572 ' HB2' HD22 ' A' ' 84' ' ' LEU . 2.9 tt -91.99 116.86 29.28 Favored 'General case' 0 C--N 1.307 -1.261 0 C-N-CA 120.324 -0.55 . . . . 0.0 110.395 -172.541 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -127.57 143.99 51.12 Favored 'General case' 0 CA--C 1.459 -2.542 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 171.748 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 42.7 tptt -80.15 100.24 8.16 Favored 'General case' 0 N--CA 1.387 -3.581 0 CA-C-O 122.194 0.997 . . . . 0.0 108.911 -171.627 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' GLY . . . . . 0.644 ' H ' HD21 ' A' ' 63' ' ' LEU . . . 136.5 -31.92 2.53 Favored Glycine 0 N--CA 1.426 -1.999 0 N-CA-C 108.245 -1.942 . . . . 0.0 108.245 -176.681 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -157.87 127.0 5.77 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 121.379 0.609 . . . . 0.0 111.985 -178.744 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -94.59 107.14 19.14 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 105.656 -1.979 . . . . 0.0 105.656 174.72 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.438 ' HA ' ' CB ' ' A' ' 135' ' ' SER . 49.4 p -109.61 172.44 6.85 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.963 -175.188 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 119' ' ' ASP . . . . . 0.667 ' O ' ' HA2' ' A' ' 110' ' ' GLY . 12.2 m-20 56.97 63.14 2.0 Favored 'General case' 0 CA--C 1.473 -1.983 0 O-C-N 124.468 1.105 . . . . 0.0 109.55 178.531 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.423 HG23 ' O ' ' A' ' 134' ' ' THR . 4.5 t -86.75 78.1 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.399 -2.98 0 C-N-CA 117.983 -1.487 . . . . 0.0 108.335 -175.798 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.409 ' HB3' ' OG1' ' A' ' 109' ' ' THR . 11.6 tp10 -68.92 96.47 0.77 Allowed 'General case' 0 N--CA 1.414 -2.252 0 CA-C-N 113.011 -1.904 . . . . 0.0 110.601 -174.39 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 130.56 -2.18 5.69 Favored Glycine 0 N--CA 1.424 -2.104 0 C-N-CA 120.152 -1.023 . . . . 0.0 112.995 174.864 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.781 HG12 HG21 ' A' ' 108' ' ' VAL . 26.6 mm -99.2 112.25 30.93 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 176.743 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -84.3 119.38 25.0 Favored 'General case' 0 N--CA 1.429 -1.51 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 -178.932 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.48 ' HA ' ' HG ' ' A' ' 102' ' ' LEU . 58.9 m -131.38 119.44 21.68 Favored 'General case' 0 N--CA 1.405 -2.716 0 CA-C-N 114.976 -1.011 . . . . 0.0 111.33 -175.889 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.455 ' O ' ' HA ' ' A' ' 100' ' ' SER . 83.1 tttt -110.08 141.94 42.22 Favored 'General case' 0 N--CA 1.41 -2.451 0 C-N-CA 119.083 -1.047 . . . . 0.0 109.452 168.225 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.443 HG11 ' HE2' ' A' ' 150' ' ' LYS . 7.5 p -149.01 -35.0 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.296 -1.757 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 175.431 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 128' ' ' MET . . . . . 0.466 ' HG3' HG22 ' A' ' 129' ' ' ILE . 26.4 ptm -137.52 -29.23 0.88 Allowed 'General case' 0 N--CA 1.404 -2.758 0 CA-C-N 113.922 -1.49 . . . . 0.0 107.986 -176.948 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.466 HG22 ' HG3' ' A' ' 128' ' ' MET . 7.0 tp -161.97 159.52 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.565 0 N-CA-C 103.684 -2.71 . . . . 0.0 103.684 175.278 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 63.6 p-90 -83.82 126.52 33.02 Favored 'General case' 0 N--CA 1.409 -2.476 0 CA-C-O 121.351 0.596 . . . . 0.0 109.547 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.503 HG22 ' H ' ' A' ' 133' ' ' VAL . 13.1 p -130.92 149.01 33.07 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.147 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 179.022 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 20.8 pttp -103.48 12.94 34.52 Favored 'General case' 0 C--N 1.308 -1.201 0 C-N-CA 120.536 -0.466 . . . . 0.0 110.99 -179.643 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.503 ' H ' HG22 ' A' ' 131' ' ' VAL . 10.8 m -146.92 94.17 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.936 0.874 . . . . 0.0 112.529 -174.916 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 134' ' ' THR . . . . . 0.476 HG21 HG21 ' A' ' 125' ' ' THR . 25.5 p -107.59 -160.73 0.74 Allowed 'General case' 0 N--CA 1.404 -2.73 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 174.026 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 135' ' ' SER . . . . . 0.438 ' CB ' ' HA ' ' A' ' 118' ' ' THR . 51.8 p -173.35 142.66 1.01 Allowed 'General case' 0 N--CA 1.44 -0.941 0 N-CA-C 111.327 0.121 . . . . 0.0 111.327 -178.352 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 136' ' ' ILE . . . . . 0.437 HG13 ' O ' ' A' ' 144' ' ' TYR . 10.1 tt -103.18 111.23 32.18 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 CA-C-O 121.397 0.618 . . . . 0.0 109.396 177.574 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 137' ' ' SER . . . . . 0.443 ' O ' ' HB2' ' A' ' 144' ' ' TYR . 43.5 m -111.75 139.35 47.29 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.739 -178.279 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 138' ' ' THR . . . . . 0.437 HG23 ' H ' ' A' ' 140' ' ' ALA . 7.5 t -166.09 178.11 6.56 Favored 'General case' 0 N--CA 1.428 -1.559 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 -177.709 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -83.61 28.69 0.55 Allowed 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 176.441 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.484 ' HA ' HD22 ' A' ' 63' ' ' LEU . . . 60.23 35.73 20.91 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.352 0.661 . . . . 0.0 109.598 -174.246 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 141' ' ' SER . . . . . 0.468 ' O ' ' HG3' ' A' ' 155' ' ' ARG . 33.4 t -153.62 -65.73 0.15 Allowed 'General case' 0 C--O 1.214 -0.784 0 CA-C-N 115.795 -0.638 . . . . 0.0 111.426 -171.505 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 51.2 mtpt -80.11 -169.16 1.92 Allowed 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 179.871 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.609 HG22 HG22 ' A' ' 65' ' ' ILE . 91.7 t -135.71 119.77 25.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-O 121.663 0.744 . . . . 0.0 112.673 179.11 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 144' ' ' TYR . . . . . 0.443 ' HB2' ' O ' ' A' ' 137' ' ' SER . 96.2 m-85 -113.64 114.59 26.64 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 106.297 -1.742 . . . . 0.0 106.297 171.13 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 145' ' ' PHE . . . . . 0.419 ' HB3' ' HB2' ' A' ' 151' ' ' LYS . 29.5 t80 -59.35 143.2 50.22 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 114.866 -1.061 . . . . 0.0 111.701 -169.12 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.43 ' C ' ' HB ' ' A' ' 134' ' ' THR . 75.1 p -46.88 104.27 0.05 OUTLIER 'General case' 0 C--O 1.245 0.823 0 N-CA-C 115.553 1.686 . . . . 0.0 115.553 -169.795 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.492 ' HB3' ' HG3' ' A' ' 150' ' ' LYS . . . 161.23 -65.47 0.0 OUTLIER 'General case' 0 CA--C 1.487 -1.457 0 C-N-CA 129.674 3.19 . . . . 0.0 104.824 174.036 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 154.57 -75.22 0.23 Allowed Glycine 0 CA--C 1.48 -2.139 0 C-N-CA 119.557 -1.306 . . . . 0.0 112.282 170.968 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 27.3 ptt? -97.36 -11.59 23.81 Favored 'General case' 0 C--N 1.29 -1.992 0 CA-C-N 115.396 -0.402 . . . . 0.0 111.938 -175.585 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 150' ' ' LYS . . . . . 0.492 ' HG3' ' HB3' ' A' ' 147' ' ' ALA 0.352 0.0 OUTLIER -77.37 -28.71 52.97 Favored 'General case' 0 C--O 1.213 -0.823 0 N-CA-C 116.656 2.095 . . . . 0.0 116.656 -170.597 . . . . . . . . 4 4 . 1 . 020 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.565 ' HE2' ' HA ' ' A' ' 151' ' ' LYS . 4.8 mmpt? -147.52 129.32 15.24 Favored 'General case' 0 CA--C 1.503 -0.829 0 CA-C-N 118.074 0.397 . . . . 0.0 110.767 179.453 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 40.6 p -106.72 145.91 31.46 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 175.461 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 153' ' ' ARG . . . . . 0.413 ' HG2' ' HB2' ' A' ' 145' ' ' PHE . 4.1 mmp_? -130.75 166.69 20.23 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 -179.313 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 19.0 m -101.15 121.76 42.41 Favored 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 177.201 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 155' ' ' ARG . . . . . 0.468 ' HG3' ' O ' ' A' ' 141' ' ' SER . 1.6 tmm_? -63.19 -25.79 68.5 Favored 'General case' 0 C--O 1.206 -1.198 0 N-CA-C 106.898 -1.519 . . . . 0.0 106.898 178.548 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -52.7 -25.94 12.47 Favored 'General case' 0 C--N 1.302 -1.499 0 C-N-CA 126.339 1.855 . . . . 0.0 113.009 -179.665 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -71.76 -32.66 67.93 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 120.703 0.287 . . . . 0.0 111.192 -179.268 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 44.0 t80 169.39 -31.94 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 106.333 -1.729 . . . . 0.0 106.333 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 159' ' ' GLY . . . . . 0.734 ' HA3' ' O ' ' A' ' 65' ' ' ILE . . . 156.87 -90.11 0.12 Allowed Glycine 0 N--CA 1.4 -3.729 0 N-CA-C 108.299 -1.92 . . . . 0.0 108.299 -173.361 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.667 ' HB ' ' O ' ' A' ' 67' ' ' ILE . 11.1 t -103.35 148.17 8.74 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.756 0 N-CA-C 105.372 -2.084 . . . . 0.0 105.372 179.231 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -137.07 102.69 4.92 Favored 'General case' 0 N--CA 1.408 -2.566 0 C-N-CA 118.102 -1.439 . . . . 0.0 109.179 -173.251 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 34.7 ptt85 -152.78 173.76 14.9 Favored 'General case' 0 C--N 1.275 -2.632 0 CA-C-N 113.214 -1.812 . . . . 0.0 106.515 -177.102 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 163' ' ' ASN . . . . . 0.449 ' HB2' ' HB ' ' A' ' 94' ' ' VAL . 4.4 m-20 -67.63 126.03 28.06 Favored 'General case' 0 C--O 1.248 1.007 0 C-N-CA 119.087 -1.045 . . . . 0.0 108.475 169.254 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -159.23 60.9 0.31 Allowed Glycine 0 N--CA 1.411 -3.032 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.311 -179.651 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.429 HD12 HH21 ' A' ' 166' ' ' ARG . 47.1 tp -81.62 111.54 18.0 Favored 'General case' 0 N--CA 1.418 -2.038 0 N-CA-C 105.509 -2.034 . . . . 0.0 105.509 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 166' ' ' ARG . . . . . 0.65 ' H ' ' NE ' ' A' ' 166' ' ' ARG . 0.0 OUTLIER -84.15 105.94 15.4 Favored 'General case' 0 N--CA 1.398 -3.055 0 C-N-CA 118.382 -1.327 . . . . 0.0 110.788 -178.189 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 4.8 m -74.74 63.93 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.29 -2.012 0 CA-C-O 122.833 1.301 . . . . 0.0 111.204 176.505 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 168' ' ' ASP . . . . . 0.653 ' HB2' ' HB2' ' A' ' 90' ' ' SER . 35.6 t70 -133.49 -32.69 1.14 Allowed 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 112.772 -2.013 . . . . 0.0 107.724 -177.635 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 21.7 ttpp -140.03 -67.19 0.44 Allowed 'General case' 0 N--CA 1.427 -1.584 0 CA-C-N 113.764 -1.562 . . . . 0.0 107.763 -177.172 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 170' ' ' PHE . . . . . . . . . . . . . 68.3 t80 . . . . . 0 C--O 1.249 1.026 0 N-CA-C 105.004 -2.221 . . . . 0.0 105.004 -178.82 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 42.0 mt . . . . . 0 C--O 1.211 -0.931 0 N-CA-C 114.602 1.334 . . . . 0.0 114.602 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.519 ' O ' ' HG2' ' A' ' 59' ' ' LYS . 20.9 Cg_exo -61.76 -15.93 45.61 Favored 'Trans proline' 0 C--N 1.374 1.907 0 C-N-CA 121.73 1.62 . . . . 0.0 113.412 -165.149 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 31.1 mm-40 -80.35 -30.74 38.01 Favored 'General case' 0 CA--C 1.485 -1.542 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 -178.008 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.555 ' HA ' ' HB3' ' A' ' 60' ' ' GLU . 72.6 mt -75.28 -35.06 61.37 Favored 'General case' 0 N--CA 1.418 -2.054 0 CA-C-N 114.648 -1.16 . . . . 0.0 110.572 -179.218 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.653 ' HB3' ' H ' ' A' ' 75' ' ' TYR . 5.2 mp -64.46 -50.93 65.57 Favored 'General case' 0 CA--C 1.493 -1.229 0 C-N-CA 119.668 -0.813 . . . . 0.0 110.047 -178.28 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.519 ' HG2' ' O ' ' A' ' 55' ' ' PRO . 18.0 ptpt -62.55 -26.48 68.6 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 114.923 -1.035 . . . . 0.0 111.041 175.478 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.555 ' HB3' ' HA ' ' A' ' 57' ' ' LEU . 15.5 tt0 -69.71 -39.44 76.86 Favored 'General case' 0 C--N 1.317 -0.823 0 C-N-CA 123.89 0.876 . . . . 0.0 112.345 176.884 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -74.89 -26.14 59.44 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 120.459 -0.497 . . . . 0.0 110.301 176.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -77.17 -162.22 0.27 Allowed 'General case' 0 CA--C 1.565 1.545 0 CA-C-N 115.206 -0.906 . . . . 0.0 108.563 178.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.779 ' HB2' HD12 ' A' ' 65' ' ' ILE . 1.5 mt -95.02 -178.64 0.82 Allowed Pre-proline 0 CA--C 1.569 1.704 0 N-CA-C 106.809 -1.552 . . . . 0.0 106.809 -175.591 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_endo -92.45 14.85 1.63 Allowed 'Trans proline' 0 C--N 1.361 1.202 0 C-N-CA 122.36 2.04 . . . . 0.0 111.547 -174.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.779 HD12 ' HB2' ' A' ' 63' ' ' LEU . 0.2 OUTLIER -76.12 -42.15 37.93 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.704 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 179.497 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.402 ' H ' HD13 ' A' ' 65' ' ' ILE . . . 57.75 8.55 4.27 Favored Glycine 0 N--CA 1.481 1.645 0 CA-C-N 115.925 -0.58 . . . . 0.0 112.771 -178.155 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.623 ' H ' HG12 ' A' ' 65' ' ' ILE . 61.6 mt 64.95 -67.39 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.562 0 C-N-CA 126.201 1.8 . . . . 0.0 112.471 -176.623 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.403 ' HB3' ' HD3' ' A' ' 69' ' ' PRO . 53.3 t80 179.61 -56.63 0.0 OUTLIER Pre-proline 0 C--N 1.31 -1.119 0 N-CA-C 112.268 0.47 . . . . 0.0 112.268 -177.672 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.489 ' HB2' ' OD2' ' A' ' 71' ' ' ASP . 3.2 Cg_endo -87.67 -22.68 1.5 Allowed 'Trans proline' 0 C--N 1.365 1.416 0 C-N-CA 121.556 1.504 . . . . 0.0 114.185 -170.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 88.8 -8.55 79.23 Favored Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 120.525 -0.845 . . . . 0.0 111.456 -175.338 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.496 ' HB2' ' HG3' ' A' ' 89' ' ' PRO . 21.6 m-20 -81.78 -46.65 13.91 Favored 'General case' 0 CA--C 1.501 -0.926 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 177.537 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.512 ' HB1' HD12 ' A' ' 67' ' ' ILE . . . -71.27 178.15 3.51 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 114.164 -1.38 . . . . 0.0 110.273 172.798 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.541 ' O ' HG22 ' A' ' 73' ' ' THR . 81.3 m 83.24 27.86 0.1 Allowed 'General case' 0 C--N 1.354 0.775 0 CA-C-O 124.429 2.062 . . . . 0.0 110.018 174.496 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.689 ' O ' ' HA ' ' A' ' 86' ' ' VAL . 0.7 OUTLIER -81.82 137.76 35.22 Favored 'General case' 0 C--N 1.275 -2.635 0 CA-C-N 114.206 -1.361 . . . . 0.0 109.726 177.706 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.653 ' H ' ' HB3' ' A' ' 58' ' ' LEU . 37.5 t80 -106.73 104.94 14.75 Favored 'General case' 0 C--N 1.273 -2.756 0 CA-C-N 115.234 -0.894 . . . . 0.0 110.074 -173.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.676 ' O ' ' HG ' ' A' ' 84' ' ' LEU . 10.8 mm-40 -137.73 163.33 31.59 Favored 'General case' 0 C--N 1.307 -1.258 0 C-N-CA 124.112 0.965 . . . . 0.0 108.882 177.202 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 50.9 p90 -147.75 150.47 34.33 Favored 'General case' 0 C--N 1.289 -2.035 0 N-CA-C 108.064 -1.088 . . . . 0.0 108.064 177.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.728 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 12.7 m-20 -99.16 165.26 11.8 Favored 'General case' 0 CA--C 1.479 -1.767 0 C-N-CA 118.001 -1.48 . . . . 0.0 110.282 178.549 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -79.55 -59.66 2.66 Favored 'General case' 0 C--N 1.272 -2.802 0 CA-C-N 114.159 -1.382 . . . . 0.0 112.947 -177.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -72.41 -30.41 64.62 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-O 121.58 0.705 . . . . 0.0 110.292 -177.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.728 ' HB ' ' HB2' ' A' ' 78' ' ' ASP . 21.8 m -78.49 -51.07 10.52 Favored 'General case' 0 N--CA 1.411 -2.424 0 CA-C-N 114.824 -1.08 . . . . 0.0 110.48 -178.158 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 65.0 mttp 65.88 12.0 8.06 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.626 0.77 . . . . 0.0 112.172 -177.567 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 5.0 tppp? -100.59 141.97 32.72 Favored 'General case' 0 N--CA 1.428 -1.548 0 N-CA-C 104.449 -2.426 . . . . 0.0 104.449 175.445 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.676 ' HG ' ' O ' ' A' ' 76' ' ' GLU . 9.3 tt -80.83 145.83 31.21 Favored 'General case' 0 C--N 1.295 -1.782 0 C-N-CA 119.39 -0.924 . . . . 0.0 110.488 -178.428 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.438 ' HB ' HG22 ' A' ' 109' ' ' THR . 10.7 t -126.47 123.84 38.75 Favored 'General case' 0 N--CA 1.4 -2.964 0 CA-C-O 121.896 0.855 . . . . 0.0 111.035 -179.529 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.689 ' HA ' ' O ' ' A' ' 74' ' ' ASN . 98.5 t -96.84 126.81 49.47 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 CA-C-N 114.932 -1.031 . . . . 0.0 108.4 175.36 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.6 mp -91.64 120.37 32.35 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-O 121.63 0.728 . . . . 0.0 111.046 -179.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 2.1 mp -100.69 132.74 21.85 Favored Pre-proline 0 C--N 1.286 -2.191 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 172.335 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.496 ' HG3' ' HB2' ' A' ' 71' ' ' ASP . 12.4 Cg_endo -51.06 -36.28 53.96 Favored 'Trans proline' 0 C--N 1.356 0.938 0 C-N-CA 124.637 3.558 . . . . 0.0 114.357 -176.131 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . 0.637 ' HB2' ' HB2' ' A' ' 168' ' ' ASP . 47.9 t -161.99 157.65 23.96 Favored 'General case' 0 CA--C 1.493 -1.221 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.408 ' CD1' ' HG3' ' A' ' 93' ' ' GLU . 0.0 OUTLIER -70.4 116.13 11.13 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.711 0 O-C-N 123.991 0.807 . . . . 0.0 109.28 179.993 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 41.3 t -112.77 123.51 50.46 Favored 'General case' 0 N--CA 1.427 -1.587 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.934 179.377 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.408 ' HG3' ' CD1' ' A' ' 91' ' ' ILE . 41.4 mt-10 -106.57 114.66 28.9 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 174.782 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 5.8 p -111.66 118.15 56.86 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.726 0 CA-C-O 121.192 0.52 . . . . 0.0 111.283 -176.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.466 ' HA2' ' HA ' ' A' ' 101' ' ' VAL . . . . . . . . 0 N--CA 1.43 -1.703 0 C-N-CA 120.463 -0.875 . . . . 0.0 112.016 179.155 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 48.8 m . . . . . 0 N--CA 1.452 -0.345 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.466 ' HA ' ' HA2' ' A' ' 95' ' ' GLY . 13.8 p -166.85 147.63 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.796 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 -178.354 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.524 HD23 ' H ' ' A' ' 126' ' ' LYS . 51.6 mt -134.86 133.95 40.25 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 -176.205 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.446 ' O ' ' HA ' ' A' ' 123' ' ' ILE . 27.4 ttpp -110.28 114.05 27.22 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 112.195 0.442 . . . . 0.0 112.195 -177.112 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.405 ' O ' ' HA ' ' A' ' 91' ' ' ILE . 95.5 m-85 -101.65 104.54 15.39 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.721 176.696 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 89.4 m -79.59 165.0 23.39 Favored 'General case' 0 CA--C 1.557 1.215 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.618 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 12.0 p -69.57 -69.68 0.33 Allowed 'General case' 0 N--CA 1.438 -1.063 0 C-N-CA 124.93 1.292 . . . . 0.0 112.886 -175.014 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 25.6 m -96.3 88.51 4.79 Favored 'General case' 0 N--CA 1.416 -2.173 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 -178.195 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.683 HG21 HG13 ' A' ' 123' ' ' ILE . 5.0 p -101.48 144.18 13.43 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.103 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.18 -176.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.592 ' OG1' ' HB3' ' A' ' 121' ' ' GLU . 11.6 p -109.33 165.06 11.92 Favored 'General case' 0 C--N 1.287 -2.139 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 178.183 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 173.39 172.58 38.99 Favored Glycine 0 N--CA 1.427 -1.914 0 N-CA-C 111.485 -0.646 . . . . 0.0 111.485 179.68 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 47.4 t-80 -93.2 106.47 18.43 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 178.016 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.52 ' HB3' HD13 ' A' ' 84' ' ' LEU . 2.9 tm? -94.42 136.51 34.63 Favored 'General case' 0 CA--C 1.466 -2.261 0 N-CA-C 106.838 -1.542 . . . . 0.0 106.838 -175.388 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . 0.43 ' N ' HD13 ' A' ' 112' ' ' LEU . 0.3 OUTLIER -142.49 153.01 43.26 Favored 'General case' 0 N--CA 1.383 -3.777 0 N-CA-C 105.275 -2.12 . . . . 0.0 105.275 177.837 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 8.1 mmtt -67.92 101.06 1.04 Allowed 'General case' 0 C--N 1.302 -1.464 0 CA-C-O 121.898 0.856 . . . . 0.0 111.691 -178.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . 0.685 ' O ' ' HB ' ' A' ' 138' ' ' THR . . . 131.0 -54.24 0.79 Allowed Glycine 0 N--CA 1.41 -3.049 0 CA-C-N 114.342 -1.299 . . . . 0.0 109.927 -178.765 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.491 ' HD3' HG23 ' A' ' 118' ' ' THR . 0.0 OUTLIER -136.51 141.93 43.47 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 114.006 1.113 . . . . 0.0 114.006 -176.811 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.68 ' O ' ' HB2' ' A' ' 135' ' ' SER . 58.1 tp -104.82 106.82 17.47 Favored 'General case' 0 C--N 1.311 -1.067 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 177.704 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.491 HG23 ' HD3' ' A' ' 116' ' ' LYS . 42.1 p -106.19 142.93 35.06 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 -175.594 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 28.6 m-20 54.74 98.78 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 125.156 1.382 . . . . 0.0 113.031 177.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 4.3 m -100.58 172.54 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.587 0 CA-C-O 120.983 0.42 . . . . 0.0 110.907 179.529 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.592 ' HB3' ' OG1' ' A' ' 109' ' ' THR . 14.9 tp10 -140.84 82.77 1.86 Allowed 'General case' 0 N--CA 1.416 -2.165 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.382 178.705 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . 0.412 ' HA3' HG23 ' A' ' 108' ' ' VAL . . . 150.96 -19.7 0.97 Allowed Glycine 0 C--N 1.308 -1.012 0 CA-C-N 115.153 -0.931 . . . . 0.0 111.979 177.14 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.683 HG13 HG21 ' A' ' 108' ' ' VAL . 96.1 mt -99.61 100.17 9.93 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.63 0 CA-C-O 121.383 0.611 . . . . 0.0 109.514 -179.087 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.461 ' HA ' ' HA ' ' A' ' 132' ' ' LYS . 39.7 ttmt -86.65 119.19 26.62 Favored 'General case' 0 N--CA 1.428 -1.565 0 N-CA-C 107.613 -1.255 . . . . 0.0 107.613 -179.617 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.601 ' HB ' ' OG1' ' A' ' 134' ' ' THR . 89.9 m -121.33 125.14 46.28 Favored 'General case' 0 C--N 1.268 -2.95 0 CA-C-N 114.477 -1.238 . . . . 0.0 110.962 -172.19 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.612 ' C ' ' HD3' ' A' ' 126' ' ' LYS . 0.2 OUTLIER -117.99 105.78 12.24 Favored 'General case' 0 N--CA 1.412 -2.347 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 173.026 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 33.3 m -107.7 -27.61 2.95 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.102 0 CA-C-O 121.872 0.844 . . . . 0.0 110.08 176.314 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . 0.482 ' C ' HD12 ' A' ' 129' ' ' ILE . 27.3 ttt -158.94 -35.55 0.06 Allowed 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 106.971 -1.492 . . . . 0.0 106.971 -175.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . 0.482 HD12 ' C ' ' A' ' 128' ' ' MET . 2.8 mp -134.94 151.65 31.46 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.72 0 N-CA-C 104.271 -2.492 . . . . 0.0 104.271 171.356 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 16.2 p90 -90.53 116.68 28.62 Favored 'General case' 0 N--CA 1.425 -1.711 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 178.375 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.623 HG12 ' H ' ' A' ' 133' ' ' VAL . 36.0 t -137.69 146.58 27.25 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 -175.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . 0.461 ' HA ' ' HA ' ' A' ' 124' ' ' LYS . 58.9 pttt -103.23 12.0 36.17 Favored 'General case' 0 C--N 1.315 -0.917 0 C-N-CA 120.165 -0.614 . . . . 0.0 111.448 -178.797 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.623 ' H ' HG12 ' A' ' 131' ' ' VAL . 33.5 m -125.55 -1.43 5.14 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.006 0 C-N-CA 120.396 -0.522 . . . . 0.0 111.778 -175.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . 0.601 ' OG1' ' HB ' ' A' ' 125' ' ' THR . 1.3 p -60.35 111.16 1.45 Allowed 'General case' 0 N--CA 1.43 -1.425 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 175.636 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . 0.68 ' HB2' ' O ' ' A' ' 117' ' ' LEU . 23.2 p -106.79 172.2 6.95 Favored 'General case' 0 N--CA 1.41 -2.471 0 N-CA-C 114.93 1.455 . . . . 0.0 114.93 -169.166 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . 0.406 ' HB ' ' CG2' ' A' ' 146' ' ' THR . 12.2 tt -101.16 105.23 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.491 0 CA-C-N 114.81 -1.086 . . . . 0.0 110.869 -173.406 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 45.7 p -91.54 114.36 26.87 Favored 'General case' 0 N--CA 1.414 -2.269 0 CA-C-N 115.157 -0.928 . . . . 0.0 109.685 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . 0.685 ' HB ' ' O ' ' A' ' 115' ' ' GLY . 46.6 m -119.54 153.87 34.74 Favored 'General case' 0 C--N 1.279 -2.476 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 -179.791 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -106.41 35.36 2.98 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 178.326 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . 57.54 34.87 25.15 Favored 'General case' 0 C--N 1.355 0.805 0 CA-C-N 115.046 -0.979 . . . . 0.0 109.065 -177.389 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 47.2 t -173.1 -77.96 0.01 OUTLIER 'General case' 0 C--O 1.211 -0.935 0 CA-C-N 114.731 -1.122 . . . . 0.0 109.683 -174.234 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 81.6 mttt -89.93 150.97 21.94 Favored 'General case' 0 CA--C 1.497 -1.068 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 179.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 13.1 p -118.93 142.91 31.71 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.067 0 CA-C-O 121.416 0.627 . . . . 0.0 111.686 -175.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -121.55 114.9 21.86 Favored 'General case' 0 N--CA 1.423 -1.799 0 N-CA-C 106.163 -1.791 . . . . 0.0 106.163 171.475 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . 0.545 ' HB3' ' HB2' ' A' ' 151' ' ' LYS . 65.0 t80 -53.74 156.2 2.85 Favored 'General case' 0 C--O 1.252 1.223 0 C-N-CA 124.539 1.135 . . . . 0.0 113.094 -171.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.516 ' O ' HG21 ' A' ' 125' ' ' THR . 33.7 p -51.1 93.65 0.01 OUTLIER 'General case' 0 C--N 1.35 0.609 0 C-N-CA 125.181 1.392 . . . . 0.0 113.793 -175.573 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . 0.521 ' HA ' ' HB ' ' A' ' 134' ' ' THR . . . 163.27 -35.71 0.0 OUTLIER 'General case' 0 CA--C 1.497 -1.061 0 C-N-CA 127.171 2.188 . . . . 0.0 106.31 178.676 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 100.63 79.07 1.4 Allowed Glycine 0 N--CA 1.434 -1.493 0 CA-C-N 114.963 -1.017 . . . . 0.0 111.807 179.016 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 16.3 tpt 72.51 -10.24 0.96 Allowed 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 123.877 0.871 . . . . 0.0 112.698 177.155 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -62.38 -30.53 71.27 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 121.062 0.458 . . . . 0.0 110.023 -179.014 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . 0.545 ' HB2' ' HB3' ' A' ' 145' ' ' PHE . 10.0 mmpt? -121.86 118.76 29.75 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 106.521 -1.659 . . . . 0.0 106.521 175.122 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 32.1 p -91.39 111.66 23.24 Favored 'General case' 0 C--N 1.297 -1.708 0 CA-C-O 120.617 0.246 . . . . 0.0 111.174 -177.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 37.6 mmt180 -134.88 137.3 43.09 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 179.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 20.0 m -90.2 132.47 35.47 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 111.504 0.187 . . . . 0.0 111.504 -176.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' ARG . . . . . 0.481 ' HG2' ' HA2' ' A' ' 159' ' ' GLY . 2.0 tmt_? -65.01 -26.5 68.31 Favored 'General case' 0 N--CA 1.483 1.196 0 CA-C-O 121.107 0.479 . . . . 0.0 109.898 177.494 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -38.04 -48.11 1.17 Allowed 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 126.102 1.761 . . . . 0.0 115.576 -175.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -79.33 -54.92 5.47 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 113.899 1.074 . . . . 0.0 113.899 -173.212 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 0.577 ' HB2' ' NE2' ' A' ' 161' ' ' GLN . 98.3 m-85 -153.19 24.5 0.55 Allowed 'General case' 0 N--CA 1.482 1.151 0 O-C-N 122.242 -0.286 . . . . 0.0 110.536 -176.658 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . 0.634 ' HA3' ' O ' ' A' ' 65' ' ' ILE . . . 87.78 -92.41 1.8 Allowed Glycine 0 CA--C 1.475 -2.46 0 C-N-CA 119.672 -1.252 . . . . 0.0 111.618 -177.597 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.566 ' HB ' ' O ' ' A' ' 67' ' ' ILE . 28.6 t -98.58 121.92 49.68 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.191 0 C-N-CA 119.67 -0.812 . . . . 0.0 108.91 -179.797 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' GLN . . . . . 0.577 ' NE2' ' HB2' ' A' ' 158' ' ' TYR . 25.7 mm-40 -103.88 92.95 4.63 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 115.78 1.77 . . . . 0.0 115.78 -175.188 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 17.0 mmm180 -152.66 150.27 29.29 Favored 'General case' 0 CA--C 1.501 -0.93 0 C-N-CA 125.624 1.57 . . . . 0.0 108.754 170.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 19.7 m120 -89.88 97.69 11.33 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-O 120.964 0.412 . . . . 0.0 111.415 -178.491 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -136.57 156.07 22.91 Favored Glycine 0 C--N 1.308 -1.025 0 N-CA-C 110.615 -0.994 . . . . 0.0 110.615 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -135.83 116.63 14.07 Favored 'General case' 0 N--CA 1.425 -1.703 0 CA-C-O 121.38 0.609 . . . . 0.0 109.5 178.355 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . 0.604 ' H ' ' HD2' ' A' ' 166' ' ' ARG . 3.3 mpt_? -81.3 105.83 12.79 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 106.39 -1.707 . . . . 0.0 106.39 178.63 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . 0.4 HG22 ' H ' ' A' ' 167' ' ' VAL . 9.2 m -71.43 77.08 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.925 0 N-CA-C 114.976 1.473 . . . . 0.0 114.976 -174.25 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . 0.637 ' HB2' ' HB2' ' A' ' 90' ' ' SER . 15.4 t70 -144.41 -34.01 0.38 Allowed 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 114.072 -1.422 . . . . 0.0 107.279 177.588 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' LYS . . . . . 0.407 ' H ' ' H ' ' A' ' 168' ' ' ASP . 39.1 ttpt -111.86 157.4 20.66 Favored 'General case' 0 N--CA 1.439 -1.015 0 CA-C-N 114.543 -1.208 . . . . 0.0 108.039 178.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' PHE . . . . . . . . . . . . . 16.0 p90 . . . . . 0 C--N 1.305 -1.366 0 O-C-N 123.248 0.342 . . . . 0.0 111.349 179.405 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 8.4 mp . . . . . 0 CA--C 1.489 -1.383 0 N-CA-C 117.272 2.323 . . . . 0.0 117.272 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.567 ' HA ' ' HG ' ' A' ' 58' ' ' LEU . 13.1 Cg_exo -66.39 -14.51 44.46 Favored 'Trans proline' 0 N--CA 1.416 -3.05 0 CA-C-N 120.183 1.101 . . . . 0.0 111.857 -175.131 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -74.05 -32.19 63.2 Favored 'General case' 0 N--CA 1.426 -1.644 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 -179.532 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.525 ' HA ' ' HG2' ' A' ' 60' ' ' GLU . 3.7 mm? -73.88 -41.73 61.75 Favored 'General case' 0 N--CA 1.423 -1.825 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 175.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.567 ' HG ' ' HA ' ' A' ' 55' ' ' PRO . 52.0 mt -58.2 -48.08 81.43 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.735 -177.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 7.4 mtpm? -70.84 -26.58 63.34 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 115.296 -0.865 . . . . 0.0 112.319 -178.036 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.525 ' HG2' ' HA ' ' A' ' 57' ' ' LEU . 8.6 pt-20 -83.84 -18.49 37.39 Favored 'General case' 0 N--CA 1.444 -0.762 0 C-N-CA 118.957 -1.097 . . . . 0.0 109.854 177.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 61.2 m-85 -89.08 -13.91 37.52 Favored 'General case' 0 C--O 1.24 0.604 0 C-N-CA 119.095 -1.042 . . . . 0.0 112.119 175.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.449 ' HB3' HG23 ' A' ' 73' ' ' THR . 23.5 t70 -91.93 -153.95 0.35 Allowed 'General case' 0 C--O 1.253 1.27 0 N-CA-C 105.782 -1.933 . . . . 0.0 105.782 172.698 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.632 ' HB2' HD12 ' A' ' 65' ' ' ILE . 5.1 mt -95.16 158.17 35.26 Favored Pre-proline 0 C--N 1.298 -1.661 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 -178.057 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -93.86 26.6 0.34 Allowed 'Trans proline' 0 N--CA 1.448 -1.19 0 C-N-CA 122.849 2.366 . . . . 0.0 111.143 -168.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.686 HG12 ' H ' ' A' ' 67' ' ' ILE . 0.2 OUTLIER -95.11 -21.58 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.778 0 CA-C-N 115.331 -0.849 . . . . 0.0 108.966 -177.995 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 67.64 8.92 54.33 Favored Glycine 0 C--N 1.353 1.481 0 CA-C-N 115.501 -0.772 . . . . 0.0 112.195 179.548 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.686 ' H ' HG12 ' A' ' 65' ' ' ILE . 73.0 mt 57.79 -70.78 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.203 -1.344 0 C-N-CA 127.184 2.193 . . . . 0.0 112.613 -173.044 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.551 ' HB3' ' HD3' ' A' ' 69' ' ' PRO . 79.5 t80 176.73 -50.53 0.0 OUTLIER Pre-proline 0 C--N 1.303 -1.449 0 C-N-CA 122.853 0.461 . . . . 0.0 110.392 -174.578 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.551 ' HD3' ' HB3' ' A' ' 68' ' ' PHE . 24.8 Cg_exo -67.58 131.69 25.15 Favored 'Trans proline' 0 N--CA 1.436 -1.876 0 N-CA-C 109.046 -1.175 . . . . 0.0 109.046 174.386 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -73.7 64.58 1.84 Allowed Glycine 0 C--N 1.306 -1.102 0 O-C-N 123.439 0.462 . . . . 0.0 113.045 -177.275 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.496 ' HB3' ' HG3' ' A' ' 89' ' ' PRO . 12.7 t70 177.43 -39.65 0.01 OUTLIER 'General case' 0 C--O 1.21 -0.978 0 N-CA-C 107.737 -1.208 . . . . 0.0 107.737 179.379 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.66 ' O ' ' HB ' ' A' ' 73' ' ' THR . . . -46.48 166.28 0.02 OUTLIER 'General case' 0 N--CA 1.506 2.365 0 C-N-CA 124.273 1.029 . . . . 0.0 112.753 174.624 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.66 ' HB ' ' O ' ' A' ' 72' ' ' ALA 0.254 1.5 m 88.11 26.22 0.03 OUTLIER 'General case' 0 C--N 1.367 1.346 0 CA-C-O 125.071 2.367 . . . . 0.0 109.665 -178.97 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 40.7 m-80 -82.23 163.88 21.57 Favored 'General case' 0 N--CA 1.411 -2.376 0 CA-C-N 113.725 -1.58 . . . . 0.0 111.033 177.404 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.496 ' H ' ' HB3' ' A' ' 58' ' ' LEU . 33.7 t80 -134.52 95.6 3.41 Favored 'General case' 0 C--N 1.274 -2.702 0 CA-C-N 115.151 -0.932 . . . . 0.0 111.923 -168.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.498 ' O ' HD22 ' A' ' 84' ' ' LEU . 41.0 mm-40 -115.89 153.46 31.5 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 173.667 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 69.0 t80 -146.08 114.47 6.71 Favored 'General case' 0 C--N 1.29 -1.98 0 O-C-N 122.046 -0.409 . . . . 0.0 110.04 -177.023 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.658 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 31.7 m-20 -88.67 148.95 23.75 Favored 'General case' 0 CA--C 1.459 -2.535 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 175.622 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -82.37 -41.18 20.31 Favored 'General case' 1 C--N 1.24 -4.172 0 CA-C-N 114.796 -1.093 . . . . 0.0 111.916 179.307 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.401 ' HG3' ' N ' ' A' ' 81' ' ' THR . 8.7 pt-20 -61.84 -41.7 98.14 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-O 122.236 1.017 . . . . 0.0 109.332 178.331 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.658 ' HB ' ' HB2' ' A' ' 78' ' ' ASP . 46.2 m -70.76 -51.31 27.9 Favored 'General case' 0 N--CA 1.412 -2.374 0 CA-C-N 113.799 -1.546 . . . . 0.0 108.045 177.14 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 80.0 tttt 68.2 9.01 6.95 Favored 'General case' 0 C--N 1.348 0.533 0 C-N-CA 126.144 1.778 . . . . 0.0 110.398 178.563 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.792 ' HG2' HG22 ' A' ' 109' ' ' THR . 75.5 tttt -117.7 133.86 55.51 Favored 'General case' 0 N--CA 1.409 -2.505 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 179.363 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.498 HD22 ' O ' ' A' ' 76' ' ' GLU . 2.7 tm? -64.44 133.76 53.15 Favored 'General case' 0 C--N 1.317 -0.841 0 C-N-CA 123.101 0.561 . . . . 0.0 110.149 -172.554 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.509 ' HB ' HG23 ' A' ' 109' ' ' THR . 6.0 t -117.1 111.44 19.51 Favored 'General case' 0 N--CA 1.412 -2.372 0 CA-C-O 122.128 0.966 . . . . 0.0 111.577 -177.593 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 58.0 t -92.87 126.01 45.37 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.272 0 CA-C-N 114.89 -1.05 . . . . 0.0 108.433 177.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.51 ' HA ' ' O ' ' A' ' 106' ' ' THR . 1.9 pp -105.02 124.4 49.46 Favored 'General case' 0 N--CA 1.408 -2.572 0 CA-C-N 115.242 -0.89 . . . . 0.0 112.16 178.276 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 3.0 mp -110.06 125.04 31.93 Favored Pre-proline 0 C--N 1.293 -1.855 0 CA-C-N 114.063 -1.426 . . . . 0.0 109.089 178.453 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.496 ' HG3' ' HB3' ' A' ' 71' ' ' ASP . 2.6 Cg_endo -52.23 98.59 0.04 OUTLIER 'Trans proline' 0 C--N 1.363 1.306 0 C-N-CA 123.395 2.73 . . . . 0.0 112.206 173.216 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . 0.612 ' HB2' ' HB2' ' A' ' 168' ' ' ASP . 43.3 t 74.03 141.56 0.07 Allowed 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 124.326 1.05 . . . . 0.0 112.512 -179.534 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.532 HD11 ' HG3' ' A' ' 103' ' ' LYS . 0.0 OUTLIER -76.49 108.37 9.08 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.132 0 CA-C-N 114.999 -1.0 . . . . 0.0 109.005 176.644 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 25.1 p -91.83 127.22 37.21 Favored 'General case' 0 N--CA 1.431 -1.419 0 CA-C-N 114.838 -1.074 . . . . 0.0 110.56 -179.756 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -107.8 159.59 16.38 Favored 'General case' 0 C--O 1.244 0.766 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.25 -179.374 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.574 ' O ' ' HA ' ' A' ' 101' ' ' VAL . 2.6 p -156.95 109.01 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.141 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 -178.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.552 ' HA2' ' O ' ' A' ' 100' ' ' SER . . . . . . . . 0 N--CA 1.423 -2.233 0 C-N-CA 119.022 -1.561 . . . . 0.0 114.239 -178.114 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . 0.552 ' O ' ' HA2' ' A' ' 95' ' ' GLY . 54.3 m . . . . . 0 N--CA 1.429 -1.524 0 CA-C-O 120.634 0.254 . . . . 0.0 110.945 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.574 ' HA ' ' O ' ' A' ' 94' ' ' VAL . 11.3 p -117.27 132.97 65.49 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.507 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 171.771 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.41 ' HG ' ' HA ' ' A' ' 125' ' ' THR . 6.8 tt -152.78 145.41 24.24 Favored 'General case' 0 N--CA 1.405 -2.702 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 -175.642 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.532 ' HG3' HD11 ' A' ' 91' ' ' ILE . 39.8 ttmt -129.99 121.1 25.87 Favored 'General case' 0 C--N 1.291 -1.965 0 N-CA-C 111.937 0.347 . . . . 0.0 111.937 -177.331 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -95.36 103.6 15.47 Favored 'General case' 0 N--CA 1.439 -1.008 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 175.293 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 41.1 m -70.82 149.74 46.53 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 109.889 -0.411 . . . . 0.0 109.889 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . 0.51 ' O ' ' HA ' ' A' ' 87' ' ' LEU . 37.8 p -54.07 -53.75 48.88 Favored 'General case' 0 C--O 1.216 -0.691 0 CA-C-O 121.666 0.746 . . . . 0.0 110.985 -178.26 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 7.5 m -113.73 93.54 4.43 Favored 'General case' 0 N--CA 1.399 -2.994 0 CA-C-N 115.056 -0.974 . . . . 0.0 109.619 -176.408 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.471 HG11 ' CD1' ' A' ' 123' ' ' ILE . 15.1 m -99.46 155.59 4.03 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.546 177.531 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.792 HG22 ' HG2' ' A' ' 83' ' ' LYS . 0.4 OUTLIER -137.24 128.73 28.35 Favored 'General case' 0 N--CA 1.398 -3.072 0 N-CA-C 106.05 -1.833 . . . . 0.0 106.05 -173.831 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . 0.453 ' HA2' ' O ' ' A' ' 119' ' ' ASP . . . -151.12 -174.57 22.15 Favored Glycine 0 C--N 1.286 -2.208 0 C-N-CA 119.979 -1.105 . . . . 0.0 113.714 -175.706 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' HIS . . . . . 0.463 ' O ' HD12 ' A' ' 117' ' ' LEU . 45.0 t60 -91.33 117.93 30.08 Favored 'General case' 0 C--N 1.294 -1.821 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 179.727 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -99.92 117.91 35.22 Favored 'General case' 0 CA--C 1.479 -1.752 0 CA-C-O 121.014 0.435 . . . . 0.0 110.879 -171.132 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -126.74 138.34 53.37 Favored 'General case' 0 CA--C 1.45 -2.881 0 CA-C-N 115.094 -0.957 . . . . 0.0 108.894 167.04 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 6.0 tmtt? -73.47 100.88 3.36 Favored 'General case' 0 N--CA 1.389 -3.482 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 -175.482 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . 0.543 ' O ' HG23 ' A' ' 138' ' ' THR . . . 135.78 -37.63 1.88 Allowed Glycine 0 N--CA 1.419 -2.461 0 N-CA-C 110.169 -1.172 . . . . 0.0 110.169 -176.203 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.559 ' O ' ' HD2' ' A' ' 116' ' ' LYS . 0.0 OUTLIER -154.06 136.96 15.39 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.27 0.628 . . . . 0.0 111.984 -179.441 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.463 HD12 ' O ' ' A' ' 111' ' ' HIS . 64.1 tp -111.43 107.05 16.14 Favored 'General case' 0 C--N 1.308 -1.2 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 -177.274 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 68.1 p -105.56 176.11 5.27 Favored 'General case' 0 C--N 1.296 -1.735 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.637 -179.023 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . 0.453 ' O ' ' HA2' ' A' ' 110' ' ' GLY . 16.2 m-20 56.59 48.66 16.1 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.259 0.623 . . . . 0.0 111.722 172.61 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.454 HG23 ' O ' ' A' ' 133' ' ' VAL . 3.3 m -81.93 96.18 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.656 0 CA-C-O 122.662 1.22 . . . . 0.0 112.29 -176.253 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -75.94 94.12 3.34 Favored 'General case' 0 N--CA 1.401 -2.886 0 CA-C-N 113.253 -1.794 . . . . 0.0 108.438 -178.56 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 134.7 -4.85 4.39 Favored Glycine 0 C--N 1.285 -2.299 0 CA-C-N 115.063 -0.971 . . . . 0.0 111.816 177.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.471 ' CD1' HG11 ' A' ' 108' ' ' VAL . 48.9 mm -99.91 99.58 8.78 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.229 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 177.039 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 53.4 mtmt -93.44 119.26 32.32 Favored 'General case' 0 N--CA 1.411 -2.382 0 CA-C-N 114.355 -1.293 . . . . 0.0 108.605 -179.092 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.41 ' HA ' ' HG ' ' A' ' 102' ' ' LEU . 99.1 m -128.1 131.87 49.01 Favored 'General case' 0 N--CA 1.422 -1.852 0 CA-C-N 114.771 -1.104 . . . . 0.0 112.918 -167.782 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.619 ' C ' ' HD3' ' A' ' 126' ' ' LYS . 0.2 OUTLIER -123.05 119.71 31.16 Favored 'General case' 0 N--CA 1.418 -2.068 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 170.825 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.441 HG23 ' H ' ' A' ' 128' ' ' MET . 4.8 m -139.17 -56.57 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.031 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.388 176.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . 0.441 ' H ' HG23 ' A' ' 127' ' ' VAL . 26.8 ttt -99.57 -34.96 10.02 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 178.168 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . 0.565 ' CD1' ' H ' ' A' ' 130' ' ' TRP . 0.3 OUTLIER -162.57 -177.71 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.418 -2.074 0 N-CA-C 103.499 -2.778 . . . . 0.0 103.499 176.615 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' TRP . . . . . 0.565 ' H ' ' CD1' ' A' ' 129' ' ' ILE . 88.4 t90 -92.29 123.76 35.85 Favored 'General case' 0 C--N 1.296 -1.733 0 CA-C-N 119.55 1.068 . . . . 0.0 109.797 -179.658 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.626 HG12 ' H ' ' A' ' 133' ' ' VAL . 61.1 t -131.55 136.69 56.85 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.08 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 179.631 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . 0.617 ' HD3' ' H ' ' A' ' 132' ' ' LYS . 0.0 OUTLIER -98.89 21.77 11.11 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-O 121.019 0.437 . . . . 0.0 111.237 -178.056 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.626 ' H ' HG12 ' A' ' 131' ' ' VAL . 51.5 t -132.05 -78.73 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.251 0 CA-C-N 116.214 -0.448 . . . . 0.0 109.959 -175.689 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 40.0 p 51.86 -167.01 0.05 OUTLIER 'General case' 0 CA--C 1.555 1.155 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 -177.068 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 27.6 p -164.04 150.39 11.33 Favored 'General case' 0 N--CA 1.429 -1.52 0 C-N-CA 122.637 0.375 . . . . 0.0 110.146 -179.43 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 7.5 tt -105.7 97.41 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.884 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 173.502 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 60.6 p -97.58 142.63 29.16 Favored 'General case' 0 N--CA 1.405 -2.686 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.997 -177.011 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . 0.543 HG23 ' O ' ' A' ' 115' ' ' GLY . 5.8 t -165.08 175.07 9.72 Favored 'General case' 0 N--CA 1.399 -2.988 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 -177.794 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -110.71 28.52 8.61 Favored 'General case' 0 C--N 1.285 -2.23 0 N-CA-C 106.306 -1.739 . . . . 0.0 106.306 176.669 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . 61.46 44.06 9.72 Favored 'General case' 0 C--N 1.348 0.529 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 -171.115 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 30.8 t -174.96 -80.29 0.01 OUTLIER 'General case' 0 CA--C 1.555 1.149 0 CA-C-N 114.783 -1.099 . . . . 0.0 110.973 -171.52 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -83.96 128.6 34.66 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 179.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.421 HG11 HG12 ' A' ' 160' ' ' VAL . 88.8 t -105.49 127.83 60.01 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.973 0 CA-C-O 121.516 0.674 . . . . 0.0 112.093 -171.001 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 26.7 m-85 -118.41 141.25 48.74 Favored 'General case' 0 N--CA 1.426 -1.64 0 CA-C-N 115.318 -0.855 . . . . 0.0 111.138 179.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . 0.433 ' HB2' ' H ' ' A' ' 151' ' ' LYS . 42.9 m-85 -93.21 98.75 11.48 Favored 'General case' 0 N--CA 1.408 -2.525 0 CA-C-N 114.382 -1.281 . . . . 0.0 108.371 171.377 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . 0.259 2.5 p -98.42 99.71 10.91 Favored 'General case' 0 N--CA 1.406 -2.639 0 N-CA-C 115.061 1.504 . . . . 0.0 115.061 -176.221 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -130.35 29.62 4.84 Favored 'General case' 0 C--N 1.312 -1.031 0 N-CA-C 105.445 -2.057 . . . . 0.0 105.445 174.524 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 133.99 -69.33 0.53 Allowed Glycine 0 N--CA 1.413 -2.847 0 N-CA-C 104.016 -3.633 . . . . 0.0 104.016 -171.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 27.7 ttt 173.3 82.86 0.0 OUTLIER 'General case' 0 C--N 1.314 -0.971 0 C-N-CA 125.885 1.674 . . . . 0.0 108.147 169.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . 0.404 ' HG3' ' CG2' ' A' ' 127' ' ' VAL . 29.4 mmtt -88.84 -88.74 0.15 Allowed 'General case' 0 C--N 1.308 -1.196 0 N-CA-C 115.09 1.515 . . . . 0.0 115.09 -179.513 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . 0.433 ' H ' ' HB2' ' A' ' 145' ' ' PHE . 98.7 mttt -110.26 149.1 30.65 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 113.354 0.872 . . . . 0.0 113.354 -172.469 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 20.3 m -132.64 137.77 47.12 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.818 -176.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.28 162.84 40.78 Favored 'General case' 0 CA--C 1.477 -1.849 0 CA-C-O 121.317 0.58 . . . . 0.0 111.661 175.129 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 46.4 m -90.18 139.85 30.24 Favored 'General case' 0 C--N 1.274 -2.689 0 CA-C-N 115.284 -0.871 . . . . 0.0 108.858 179.12 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' ARG . . . . . . . . . . . . 0.407 0.0 OUTLIER -58.68 -18.54 31.81 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 114.28 1.215 . . . . 0.0 114.28 -179.783 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -50.06 -32.4 15.46 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 124.632 1.173 . . . . 0.0 111.489 178.494 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -68.04 -54.05 21.26 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 116.576 -0.283 . . . . 0.0 110.827 179.708 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 1.1 t80 177.95 21.6 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.0 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 177.205 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . 0.4 ' HA2' ' HB ' ' A' ' 65' ' ' ILE . . . 88.71 -99.41 2.54 Favored Glycine 0 N--CA 1.419 -2.472 0 C-N-CA 119.779 -1.201 . . . . 0.0 111.098 -174.08 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.566 HG22 ' O ' ' A' ' 67' ' ' ILE . 4.2 m -103.09 128.79 55.74 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.304 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 49.9 mt-30 -94.02 92.13 7.19 Favored 'General case' 0 C--N 1.294 -1.824 0 C-N-CA 119.176 -1.01 . . . . 0.0 111.151 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . 0.522 ' CG ' HG11 ' A' ' 94' ' ' VAL . 21.0 tpp180 -152.49 112.2 3.95 Favored 'General case' 0 N--CA 1.414 -2.228 0 N-CA-C 106.857 -1.534 . . . . 0.0 106.857 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 83.7 m-20 -77.05 105.97 8.46 Favored 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 -174.402 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -118.76 -178.22 16.81 Favored Glycine 0 C--N 1.3 -1.434 0 N-CA-C 110.18 -1.168 . . . . 0.0 110.18 176.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.526 ' O ' HD22 ' A' ' 165' ' ' LEU . 0.0 OUTLIER -141.55 131.74 24.89 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 177.431 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . 0.483 ' HD3' ' HB3' ' A' ' 69' ' ' PRO . 9.5 mtm180 -96.05 111.1 23.21 Favored 'General case' 0 CA--C 1.482 -1.667 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 -179.788 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . 0.414 HG13 HD23 ' A' ' 165' ' ' LEU 0.287 2.6 m -80.84 65.92 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.103 0 CA-C-O 122.906 1.336 . . . . 0.0 111.181 173.32 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . 0.612 ' HB2' ' HB2' ' A' ' 90' ' ' SER . 21.7 t70 -160.87 -27.49 0.06 Allowed 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 112.33 -2.214 . . . . 0.0 108.426 -177.293 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' LYS . . . . . 0.412 ' H ' ' H ' ' A' ' 168' ' ' ASP . 21.6 pttp -74.85 149.51 39.54 Favored 'General case' 0 C--O 1.244 0.796 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.863 -173.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' PHE . . . . . . . . . . . . . 16.9 p90 . . . . . 0 C--N 1.297 -1.698 0 CA-C-O 118.189 -0.91 . . . . 0.0 110.039 -179.785 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 9.3 mp . . . . . 0 CA--C 1.476 -1.892 0 N-CA-C 116.92 2.193 . . . . 0.0 116.92 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.553 ' O ' ' HG2' ' A' ' 59' ' ' LYS . 25.8 Cg_exo -60.71 -15.53 37.95 Favored 'Trans proline' 0 N--CA 1.45 -1.079 0 C-N-CA 121.613 1.542 . . . . 0.0 111.92 -171.643 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.478 ' O ' ' HB2' ' A' ' 60' ' ' GLU . 22.6 mm-40 -80.27 -37.09 33.55 Favored 'General case' 0 N--CA 1.419 -1.989 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 179.553 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.507 ' HA ' ' HB3' ' A' ' 60' ' ' GLU . 9.3 mp -75.63 -34.27 60.53 Favored 'General case' 0 N--CA 1.438 -1.074 0 N-CA-C 113.557 0.947 . . . . 0.0 113.557 -177.412 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.421 HD12 ' N ' ' A' ' 58' ' ' LEU . 3.5 mp -63.14 -45.74 90.5 Favored 'General case' 0 N--CA 1.499 2.025 0 C-N-CA 119.29 -0.964 . . . . 0.0 109.365 -178.618 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.553 ' HG2' ' O ' ' A' ' 55' ' ' PRO . 0.0 OUTLIER -75.77 -25.85 56.82 Favored 'General case' 0 C--N 1.297 -1.689 0 CA-C-N 114.833 -1.076 . . . . 0.0 112.33 176.395 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.507 ' HB3' ' HA ' ' A' ' 57' ' ' LEU . 9.3 tp10 -63.18 -54.47 37.01 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 179.46 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 86.8 m-85 -74.23 3.89 6.54 Favored 'General case' 0 CA--C 1.511 -0.53 0 CA-C-O 121.839 0.828 . . . . 0.0 111.688 -178.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.548 ' HB3' ' O ' ' A' ' 59' ' ' LYS . 9.2 t70 -88.85 -177.03 5.41 Favored 'General case' 0 C--N 1.276 -2.626 0 CA-C-N 113.998 -1.455 . . . . 0.0 109.659 178.651 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.739 ' HB2' HD12 ' A' ' 65' ' ' ILE . 3.0 mt -80.2 -168.35 0.17 Allowed Pre-proline 0 CA--C 1.582 2.2 0 N-CA-C 106.215 -1.772 . . . . 0.0 106.215 178.454 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.651 ' HG3' ' N ' ' A' ' 141' ' ' SER . 41.8 Cg_endo -94.26 6.62 2.5 Favored 'Trans proline' 0 N--CA 1.442 -1.505 0 CA-C-N 121.991 1.747 . . . . 0.0 111.539 -176.836 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.739 HD12 ' HB2' ' A' ' 63' ' ' LEU . 0.1 OUTLIER -69.45 -46.65 75.78 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.874 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 179.801 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.507 ' H ' HD13 ' A' ' 65' ' ' ILE . . . 57.06 9.55 4.14 Favored Glycine 0 N--CA 1.482 1.735 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.57 -174.286 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.702 ' H ' HG12 ' A' ' 65' ' ' ILE . 68.3 mt 58.11 -70.66 0.07 OUTLIER 'Isoleucine or valine' 0 C--O 1.189 -2.129 0 C-N-CA 128.135 2.574 . . . . 0.0 111.405 -171.25 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.464 ' HB3' ' HD3' ' A' ' 69' ' ' PRO . 77.4 t80 -177.7 -55.83 0.0 OUTLIER Pre-proline 0 C--N 1.306 -1.289 0 CA-C-N 117.805 0.275 . . . . 0.0 111.146 -175.476 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.464 ' HD3' ' HB3' ' A' ' 68' ' ' PHE . 8.5 Cg_endo -96.91 -172.2 0.18 Allowed 'Trans proline' 0 N--CA 1.442 -1.558 0 C-N-CA 122.508 2.139 . . . . 0.0 112.187 -175.683 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -104.17 12.72 52.16 Favored Glycine 0 N--CA 1.436 -1.316 0 N-CA-C 110.62 -0.992 . . . . 0.0 110.62 175.294 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.425 ' H ' ' HB2' ' A' ' 69' ' ' PRO . 1.8 p30 -101.19 -56.68 2.25 Favored 'General case' 0 N--CA 1.419 -2.012 0 CA-C-N 115.422 -0.389 . . . . 0.0 110.421 179.678 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.41 ' O ' ' HB ' ' A' ' 73' ' ' THR . . . -67.37 167.46 12.48 Favored 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 123.379 0.672 . . . . 0.0 111.209 172.366 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.591 ' O ' HG22 ' A' ' 73' ' ' THR . 96.7 m 87.88 27.97 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.813 0 CA-C-O 124.518 2.104 . . . . 0.0 111.128 175.366 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.593 ' O ' ' HA ' ' A' ' 86' ' ' VAL . 0.8 OUTLIER -76.0 145.65 40.11 Favored 'General case' 0 C--N 1.267 -3.017 0 CA-C-N 114.575 -1.193 . . . . 0.0 109.456 174.721 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 42.6 t80 -121.25 98.57 6.04 Favored 'General case' 0 C--N 1.282 -2.341 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.633 -169.206 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 32.8 mm-40 -128.12 115.63 18.71 Favored 'General case' 0 C--O 1.212 -0.878 0 C-N-CA 123.35 0.66 . . . . 0.0 110.151 178.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.403 ' HA ' ' HA ' ' A' ' 84' ' ' LEU . 36.1 p90 -123.04 143.17 50.13 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 -178.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.61 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 10.5 m-20 -96.27 169.36 9.99 Favored 'General case' 0 CA--C 1.487 -1.452 0 C-N-CA 118.876 -1.13 . . . . 0.0 108.955 178.604 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -79.75 -64.01 1.28 Allowed 'General case' 0 C--N 1.279 -2.477 0 CA-C-N 114.644 -1.162 . . . . 0.0 111.396 -176.543 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -68.21 -45.5 73.17 Favored 'General case' 0 CA--C 1.498 -1.054 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.575 -177.104 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.61 ' HB ' ' HB2' ' A' ' 78' ' ' ASP . 10.5 m -57.68 -49.45 76.45 Favored 'General case' 0 N--CA 1.419 -2.021 0 CA-C-N 114.232 -1.349 . . . . 0.0 111.823 -176.58 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.414 ' HD3' ' HA ' ' A' ' 82' ' ' LYS . 74.2 mmtt 65.35 16.19 10.4 Favored 'General case' 0 N--CA 1.488 1.453 0 CA-C-O 121.916 0.865 . . . . 0.0 111.493 -176.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.597 ' HB3' HG22 ' A' ' 81' ' ' THR . 39.4 ttpt -115.18 131.08 57.04 Favored 'General case' 0 N--CA 1.42 -1.953 0 N-CA-C 106.299 -1.741 . . . . 0.0 106.299 177.607 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.552 ' O ' ' HA ' ' A' ' 109' ' ' THR . 7.0 tt -103.59 142.79 33.69 Favored 'General case' 0 C--N 1.284 -2.25 0 O-C-N 123.68 0.612 . . . . 0.0 109.901 -175.657 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.446 ' HA ' ' O ' ' A' ' 108' ' ' VAL . 9.3 t -113.42 121.3 43.92 Favored 'General case' 0 N--CA 1.406 -2.661 0 CA-C-O 121.879 0.847 . . . . 0.0 110.429 178.803 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.593 ' HA ' ' O ' ' A' ' 74' ' ' ASN . 86.7 t -93.34 118.99 40.36 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.746 0 CA-C-N 114.905 -1.043 . . . . 0.0 108.438 174.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 5.4 mp -80.95 116.2 20.8 Favored 'General case' 0 C--O 1.249 1.056 0 O-C-N 123.711 0.632 . . . . 0.0 110.389 -179.094 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.58 ' O ' ' HA ' ' A' ' 106' ' ' THR . 42.1 mm -108.12 128.4 25.8 Favored Pre-proline 0 C--N 1.285 -2.201 0 N-CA-C 106.593 -1.632 . . . . 0.0 106.593 176.614 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -58.84 111.74 0.98 Allowed 'Trans proline' 0 N--CA 1.45 -1.083 0 C-N-CA 122.062 1.841 . . . . 0.0 111.351 176.531 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 22.7 t 67.42 -169.01 0.2 Allowed 'General case' 0 N--CA 1.443 -0.812 0 O-C-N 124.117 0.886 . . . . 0.0 110.847 178.01 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.489 HD11 ' HD2' ' A' ' 103' ' ' LYS . 10.3 tt -112.2 109.4 28.4 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.278 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 176.481 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' CYS . . . . . 0.639 ' SG ' ' HB2' ' A' ' 104' ' ' PHE . 16.1 p -108.89 124.84 51.28 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-N 115.723 -0.672 . . . . 0.0 112.55 -174.057 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.445 ' OE2' HG12 ' A' ' 91' ' ' ILE . 4.9 mp0 -107.27 156.94 18.32 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 174.194 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 3.4 p -128.76 111.9 24.62 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.756 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 173.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.435 -1.417 0 N-CA-C 110.448 -1.061 . . . . 0.0 110.448 -179.826 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 47.4 t . . . . . 0 N--CA 1.43 -1.431 0 N-CA-C 107.102 -1.444 . . . . 0.0 107.102 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 94.5 t -128.28 127.87 67.86 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 -179.745 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -158.0 166.88 31.43 Favored 'General case' 0 C--N 1.309 -1.17 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 -175.084 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.489 ' HD2' HD11 ' A' ' 91' ' ' ILE . 38.5 ttpt -132.92 133.56 43.39 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.304 -175.707 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.639 ' HB2' ' SG ' ' A' ' 92' ' ' CYS . 77.9 m-85 -117.2 110.38 18.07 Favored 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 107.567 -1.271 . . . . 0.0 107.567 175.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 12.9 t -88.99 171.57 9.76 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 -177.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . 0.58 ' HA ' ' O ' ' A' ' 88' ' ' ILE . 32.5 m -58.49 -50.31 74.21 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 112.919 0.711 . . . . 0.0 112.919 -175.249 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 23.3 p -116.78 94.36 4.57 Favored 'General case' 0 C--N 1.296 -1.719 0 C-N-CA 119.414 -0.914 . . . . 0.0 112.458 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.446 ' O ' ' HA ' ' A' ' 85' ' ' THR . 43.5 t -93.16 125.45 45.72 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.486 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 175.437 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.552 ' HA ' ' O ' ' A' ' 84' ' ' LEU . 8.1 p -107.81 154.1 22.03 Favored 'General case' 0 N--CA 1.4 -2.941 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.48 -177.088 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 175.28 -173.98 46.54 Favored Glycine 0 C--N 1.283 -2.364 0 N-CA-C 110.506 -1.038 . . . . 0.0 110.506 178.327 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 59.9 m-70 -99.25 91.53 5.01 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 178.182 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.468 ' HB3' HD13 ' A' ' 84' ' ' LEU . 5.3 tt -97.7 112.56 24.4 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 -175.121 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -116.21 160.25 20.67 Favored 'General case' 0 CA--C 1.458 -2.584 0 CA-C-N 114.9 -1.046 . . . . 0.0 108.569 175.504 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 2.3 tmtp? -71.51 103.72 3.05 Favored 'General case' 0 C--N 1.255 -3.503 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 -177.062 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 116.15 -10.07 17.77 Favored Glycine 0 C--O 1.186 -2.872 0 C-N-CA 120.516 -0.85 . . . . 0.0 111.944 -178.285 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -174.88 134.77 0.36 Allowed 'General case' 0 N--CA 1.488 1.465 0 CA-C-N 118.088 0.944 . . . . 0.0 111.888 176.768 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.405 ' HA ' ' HA ' ' A' ' 112' ' ' LEU . 2.3 tt -110.6 114.98 28.79 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 105.772 -1.936 . . . . 0.0 105.772 175.552 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.404 ' HA ' ' HB3' ' A' ' 135' ' ' SER . 75.1 p -103.35 135.06 45.68 Favored 'General case' 0 C--N 1.278 -2.539 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 -177.079 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . 0.394 4.0 p-10 48.61 97.47 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 115.878 1.807 . . . . 0.0 115.878 -178.63 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.446 HG22 ' O ' ' A' ' 134' ' ' THR . 13.0 m -87.44 118.02 32.54 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.086 0 CA-C-N 114.637 -1.165 . . . . 0.0 110.334 -179.687 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -97.08 92.36 6.02 Favored 'General case' 0 C--N 1.252 -3.67 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 179.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 140.92 -15.93 2.82 Favored Glycine 0 C--N 1.302 -1.323 0 C-N-CA 119.968 -1.111 . . . . 0.0 112.932 177.268 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 80.4 mt -100.37 104.81 16.68 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 CA-C-O 121.767 0.794 . . . . 0.0 111.235 -179.282 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -86.45 121.24 28.72 Favored 'General case' 0 N--CA 1.433 -1.312 0 N-CA-C 106.104 -1.813 . . . . 0.0 106.104 176.447 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 12.8 t -133.37 162.3 32.21 Favored 'General case' 0 N--CA 1.412 -2.347 0 CA-C-O 121.515 0.674 . . . . 0.0 110.644 -176.398 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.469 ' C ' ' HD3' ' A' ' 126' ' ' LYS . 1.0 OUTLIER -126.1 119.92 28.83 Favored 'General case' 0 N--CA 1.396 -3.137 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 173.051 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 59.9 t -109.38 -78.38 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.838 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 179.202 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -96.93 -35.75 10.78 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 105.636 -1.987 . . . . 0.0 105.636 171.771 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . 0.498 HG13 ' H ' ' A' ' 130' ' ' TRP . 9.6 tp -146.98 176.06 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.419 -1.981 0 N-CA-C 106.636 -1.616 . . . . 0.0 106.636 176.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' TRP . . . . . 0.498 ' H ' HG13 ' A' ' 129' ' ' ILE . 6.2 m-90 -74.81 132.61 41.69 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 122.767 0.427 . . . . 0.0 111.041 -177.189 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.495 HG22 ' H ' ' A' ' 133' ' ' VAL . 8.4 p -149.64 147.09 16.61 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.09 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 175.227 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 57.7 pttt -111.09 -4.23 15.15 Favored 'General case' 0 C--N 1.31 -1.128 0 C-N-CA 119.537 -0.865 . . . . 0.0 111.774 178.189 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.495 ' H ' HG22 ' A' ' 131' ' ' VAL . 7.4 p -123.79 103.8 13.25 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 CA-C-O 122.001 0.905 . . . . 0.0 110.862 178.746 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . 0.446 ' O ' HG22 ' A' ' 120' ' ' VAL . 8.3 t -144.91 169.95 17.09 Favored 'General case' 0 C--N 1.293 -1.863 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 -179.494 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . 0.404 ' HB3' ' HA ' ' A' ' 118' ' ' THR . 26.9 m -122.65 168.64 11.94 Favored 'General case' 0 N--CA 1.409 -2.508 0 N-CA-C 109.924 -0.398 . . . . 0.0 109.924 178.678 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 11.8 tt -134.92 98.05 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.767 0 CA-C-O 122.382 1.087 . . . . 0.0 108.797 175.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 73.9 p -89.93 158.67 17.3 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-N 114.608 -1.178 . . . . 0.0 110.453 -176.634 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . 0.658 HG21 ' HB3' ' A' ' 63' ' ' LEU . 9.8 t -166.01 178.56 6.33 Favored 'General case' 0 N--CA 1.418 -2.069 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 -179.638 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -118.66 26.93 9.23 Favored 'General case' 0 C--N 1.273 -2.718 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 175.187 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . 60.65 36.56 19.58 Favored 'General case' 0 C--N 1.354 0.793 0 CA-C-N 114.379 -1.282 . . . . 0.0 108.274 -173.371 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . 0.651 ' N ' ' HG3' ' A' ' 64' ' ' PRO . 46.8 t -171.01 -78.68 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 114.092 -1.413 . . . . 0.0 109.825 -173.248 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . 0.483 ' H ' ' HD3' ' A' ' 142' ' ' LYS . 0.0 OUTLIER -90.1 130.34 36.28 Favored 'General case' 0 CA--C 1.498 -1.029 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 176.352 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.511 ' HB ' ' O ' ' A' ' 153' ' ' ARG . 42.4 t -108.35 143.2 19.15 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 CA-C-O 121.108 0.48 . . . . 0.0 111.47 -171.336 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 91.1 m-85 -135.82 123.32 22.11 Favored 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 178.018 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 42.8 t80 -93.61 117.16 29.73 Favored 'General case' 0 C--N 1.288 -2.088 0 N-CA-C 106.708 -1.59 . . . . 0.0 106.708 -178.493 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.42 ' C ' ' H ' ' A' ' 148' ' ' GLY . 62.9 p -76.24 -89.87 0.03 OUTLIER 'General case' 0 N--CA 1.425 -1.701 0 N-CA-C 114.94 1.459 . . . . 0.0 114.94 -169.164 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . 67.17 -42.59 0.43 Allowed 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 125.244 1.418 . . . . 0.0 112.047 -175.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . 0.42 ' H ' ' C ' ' A' ' 146' ' ' THR . . . 177.94 44.9 0.07 OUTLIER Glycine 0 N--CA 1.412 -2.937 0 N-CA-C 107.349 -2.3 . . . . 0.0 107.349 178.437 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 65.6 mtt 58.22 40.14 25.1 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 124.003 0.921 . . . . 0.0 109.715 -176.278 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -89.03 -48.55 7.34 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 115.805 1.78 . . . . 0.0 115.805 -169.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . 0.472 ' HE2' ' HA ' ' A' ' 151' ' ' LYS . 8.2 mmpt? -125.44 162.86 23.91 Favored 'General case' 0 N--CA 1.483 1.216 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 -172.227 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 57.3 p -119.73 158.34 26.71 Favored 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 174.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' ARG . . . . . 0.511 ' O ' ' HB ' ' A' ' 143' ' ' VAL . 3.8 tpm_? -149.92 120.5 7.47 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 109.082 -0.711 . . . . 0.0 109.082 -178.028 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 17.8 m -87.91 143.78 26.93 Favored 'General case' 0 C--N 1.308 -1.226 0 C-N-CA 120.122 -0.631 . . . . 0.0 110.835 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' ARG . . . . . 0.522 ' HD3' ' HB2' ' A' ' 64' ' ' PRO . 32.6 ttp180 -70.67 -34.5 72.08 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 115.608 -0.723 . . . . 0.0 110.121 179.06 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -45.85 -40.82 10.4 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 116.706 2.113 . . . . 0.0 116.706 -170.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -70.95 -56.43 6.22 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 119.019 -1.072 . . . . 0.0 112.077 -174.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 67.9 m-85 -171.63 19.16 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.765 0 C-N-CA 124.556 1.143 . . . . 0.0 108.934 -179.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . 0.444 ' HA3' ' O ' ' A' ' 65' ' ' ILE . . . 84.76 -97.19 2.1 Favored Glycine 0 N--CA 1.427 -1.942 0 C-N-CA 119.011 -1.566 . . . . 0.0 110.224 -171.704 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.547 HG23 ' HB ' ' A' ' 65' ' ' ILE . 90.2 t -127.65 113.41 31.31 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.521 0 CA-C-O 121.828 0.823 . . . . 0.0 110.651 -178.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -121.71 107.06 11.91 Favored 'General case' 0 C--N 1.295 -1.804 0 C-N-CA 119.424 -0.91 . . . . 0.0 113.167 -176.005 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 30.4 mmm180 -130.66 137.49 49.6 Favored 'General case' 0 C--N 1.292 -1.92 0 N-CA-C 106.337 -1.727 . . . . 0.0 106.337 172.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -77.25 74.53 3.82 Favored 'General case' 0 C--N 1.289 -2.056 0 N-CA-C 113.699 1.0 . . . . 0.0 113.699 -172.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -111.59 129.02 8.92 Favored Glycine 0 N--CA 1.424 -2.136 0 N-CA-C 109.25 -1.54 . . . . 0.0 109.25 176.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -91.56 112.65 24.65 Favored 'General case' 0 N--CA 1.42 -1.963 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 -177.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . 0.409 ' HA ' ' HB3' ' A' ' 92' ' ' CYS . 65.9 mtt85 -79.45 102.58 8.84 Favored 'General case' 0 N--CA 1.417 -2.12 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 179.027 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 25.2 t -66.01 82.55 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 O-C-N 124.077 0.861 . . . . 0.0 110.063 -178.422 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 22.1 t70 176.74 -24.65 0.0 OUTLIER 'General case' 0 C--N 1.287 -2.114 0 N-CA-C 106.236 -1.765 . . . . 0.0 106.236 -171.422 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 2.9 tppp? -79.2 106.48 11.26 Favored 'General case' 0 N--CA 1.425 -1.678 0 CA-C-N 114.145 -1.389 . . . . 0.0 111.899 179.312 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' PHE . . . . . . . . . . . . . 47.3 p90 . . . . . 0 C--N 1.293 -1.888 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 173.632 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.569 ' N ' ' HD3' ' A' ' 55' ' ' PRO . 10.2 mp . . . . . 0 N--CA 1.443 -0.805 0 N-CA-C 116.904 2.187 . . . . 0.0 116.904 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.742 ' HA ' ' CD1' ' A' ' 58' ' ' LEU . 7.6 Cg_exo -66.08 -15.12 47.38 Favored 'Trans proline' 0 N--CA 1.425 -2.507 0 CA-C-N 121.134 1.441 . . . . 0.0 115.568 -161.018 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 32.3 mm-40 -79.34 -29.69 42.36 Favored 'General case' 0 N--CA 1.425 -1.691 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.718 ' O ' ' HB3' ' A' ' 60' ' ' GLU . 10.6 mt -76.41 -31.66 58.06 Favored 'General case' 0 C--O 1.207 -1.14 0 CA-C-N 114.652 -1.158 . . . . 0.0 110.061 -177.582 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.742 ' CD1' ' HA ' ' A' ' 55' ' ' PRO . 8.2 mt -70.41 -54.32 12.87 Favored 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 -174.383 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.636 ' HG2' ' O ' ' A' ' 55' ' ' PRO . 17.1 ptpt -64.02 -25.08 67.96 Favored 'General case' 0 C--O 1.191 -2.009 0 CA-C-N 114.885 -1.052 . . . . 0.0 111.398 176.76 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.718 ' HB3' ' O ' ' A' ' 57' ' ' LEU . 7.1 tp10 -54.95 -56.4 20.11 Favored 'General case' 0 C--N 1.295 -1.773 0 O-C-N 121.954 -0.467 . . . . 0.0 111.13 172.361 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 45.2 m-85 -78.54 -40.2 35.68 Favored 'General case' 0 CA--C 1.489 -1.375 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 -175.321 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.424 ' OD2' ' HG ' ' A' ' 112' ' ' LEU . 5.9 m-20 -87.42 18.34 3.9 Favored 'General case' 0 C--N 1.294 -1.833 0 CA-C-N 113.686 -1.597 . . . . 0.0 113.262 -174.256 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.623 HD21 ' H ' ' A' ' 115' ' ' GLY . 21.5 mt 79.79 151.24 0.12 Allowed Pre-proline 0 N--CA 1.475 0.82 0 C-N-CA 125.184 1.393 . . . . 0.0 112.703 174.303 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.429 ' HB2' ' HD2' ' A' ' 155' ' ' ARG . 7.4 Cg_endo -80.65 15.07 1.86 Allowed 'Trans proline' 0 N--CA 1.443 -1.468 0 C-N-CA 122.697 2.265 . . . . 0.0 113.546 -166.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.587 ' O ' ' HA3' ' A' ' 159' ' ' GLY . 0.2 OUTLIER -69.5 -36.73 72.68 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.811 0 N-CA-C 106.753 -1.573 . . . . 0.0 106.753 173.029 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 54.34 8.68 1.24 Allowed Glycine 0 C--N 1.339 0.731 0 CA-C-N 114.771 -1.104 . . . . 0.0 115.287 175.149 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.736 ' O ' ' HB ' ' A' ' 160' ' ' VAL 0.252 27.7 mt 72.71 -45.66 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.031 0 N-CA-C 114.527 1.306 . . . . 0.0 114.527 -179.9 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.546 ' HB2' ' O ' ' A' ' 67' ' ' ILE . 40.2 t80 164.99 -56.4 0.0 OUTLIER Pre-proline 0 CA--C 1.54 0.574 0 C-N-CA 124.155 0.982 . . . . 0.0 110.597 173.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -102.07 -160.31 0.04 OUTLIER 'Trans proline' 0 N--CA 1.43 -2.246 0 C-N-CA 122.533 2.155 . . . . 0.0 113.123 -169.58 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -100.96 29.08 13.28 Favored Glycine 0 N--CA 1.428 -1.868 0 N-CA-C 109.656 -1.378 . . . . 0.0 109.656 174.102 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.48 ' OD1' ' HD3' ' A' ' 89' ' ' PRO . 8.8 t0 -140.84 176.67 8.61 Favored 'General case' 0 N--CA 1.42 -1.949 0 N-CA-C 102.928 -2.99 . . . . 0.0 102.928 177.111 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.561 ' O ' HG22 ' A' ' 73' ' ' THR . . . 57.8 -177.73 0.07 Allowed 'General case' 0 N--CA 1.483 1.185 0 CA-C-N 118.977 0.808 . . . . 0.0 109.871 -170.635 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.561 HG22 ' O ' ' A' ' 72' ' ' ALA . 5.2 t 65.36 16.7 10.67 Favored 'General case' 0 N--CA 1.515 2.775 0 C-N-CA 125.06 1.344 . . . . 0.0 109.523 172.256 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.623 ' O ' ' HA ' ' A' ' 86' ' ' VAL . 37.3 m-80 -68.45 135.8 52.25 Favored 'General case' 0 N--CA 1.414 -2.25 0 CA-C-N 113.366 -1.743 . . . . 0.0 114.127 -176.154 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.514 ' CD2' HD11 ' A' ' 84' ' ' LEU . 48.3 t80 -98.88 106.22 18.46 Favored 'General case' 0 C--N 1.272 -2.797 0 CA-C-N 113.247 -1.797 . . . . 0.0 109.949 -177.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.454 ' HB2' HG23 ' A' ' 85' ' ' THR . 8.9 mm-40 -137.81 141.34 40.83 Favored 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 176.583 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 48.1 p90 -144.49 150.95 38.44 Favored 'General case' 0 C--N 1.301 -1.512 0 C-N-CA 120.283 -0.567 . . . . 0.0 110.675 -177.283 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.642 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 11.0 m-20 -97.1 170.72 8.94 Favored 'General case' 0 CA--C 1.486 -1.489 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 174.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -79.81 -71.46 0.45 Allowed 'General case' 0 C--N 1.278 -2.53 0 CA-C-N 115.283 -0.871 . . . . 0.0 113.021 -175.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -72.94 -42.27 63.62 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 121.583 0.706 . . . . 0.0 110.654 -175.088 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.642 ' HB ' ' HB2' ' A' ' 78' ' ' ASP . 19.8 m -55.7 -41.15 73.38 Favored 'General case' 0 N--CA 1.431 -1.41 0 CA-C-N 114.645 -1.161 . . . . 0.0 110.9 179.54 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 71.8 mmtt 59.85 9.9 1.89 Allowed 'General case' 0 N--CA 1.482 1.165 0 N-CA-C 113.04 0.756 . . . . 0.0 113.04 178.714 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.416 ' HE3' HG21 ' A' ' 109' ' ' THR . 27.8 pttt -98.77 134.12 42.11 Favored 'General case' 0 N--CA 1.402 -2.85 0 N-CA-C 105.13 -2.174 . . . . 0.0 105.13 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.514 HD11 ' CD2' ' A' ' 75' ' ' TYR . 6.9 tt -89.36 143.24 26.98 Favored 'General case' 0 C--N 1.282 -2.33 0 C-N-CA 120.142 -0.623 . . . . 0.0 109.492 -174.22 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.507 ' N ' HD23 ' A' ' 84' ' ' LEU . 2.7 t -116.5 107.19 14.45 Favored 'General case' 0 N--CA 1.415 -2.199 0 CA-C-O 121.692 0.758 . . . . 0.0 111.722 -179.61 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.623 ' HA ' ' O ' ' A' ' 74' ' ' ASN . 73.0 t -89.84 108.96 19.95 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.224 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 173.76 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.438 HD12 ' HB2' ' A' ' 74' ' ' ASN 0.272 0.8 OUTLIER -96.71 118.2 32.66 Favored 'General case' 0 N--CA 1.394 -3.262 0 CA-C-O 122.605 1.193 . . . . 0.0 111.852 -179.79 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.412 HG23 ' HB2' ' A' ' 72' ' ' ALA . 55.9 mt -97.46 142.42 24.52 Favored Pre-proline 0 C--N 1.277 -2.577 0 N-CA-C 104.399 -2.445 . . . . 0.0 104.399 178.178 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.48 ' HD3' ' OD1' ' A' ' 71' ' ' ASP . 30.9 Cg_endo -59.53 -18.04 44.7 Favored 'Trans proline' 0 C--N 1.328 -0.532 0 C-N-CA 122.968 2.446 . . . . 0.0 112.914 -178.077 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 6.5 m -154.44 167.42 30.08 Favored 'General case' 0 N--CA 1.422 -1.843 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 -172.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.483 HD11 ' HD3' ' A' ' 103' ' ' LYS . 14.2 tt -85.74 108.49 17.41 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.295 0 N-CA-C 105.968 -1.864 . . . . 0.0 105.968 166.614 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' CYS . . . . . 0.52 ' SG ' ' HA3' ' A' ' 164' ' ' GLY . 48.2 t -119.19 123.38 44.19 Favored 'General case' 0 C--N 1.292 -1.916 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 -176.358 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.448 ' CB ' ' HA ' ' A' ' 103' ' ' LYS . 12.7 pt-20 -119.49 150.6 39.97 Favored 'General case' 0 C--N 1.284 -2.277 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.908 -174.182 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.504 ' CG1' ' H ' ' A' ' 163' ' ' ASN . 34.5 m -130.29 102.2 6.67 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.485 0 CA-C-O 121.871 0.843 . . . . 0.0 111.385 179.807 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.51 ' HA2' ' O ' ' A' ' 100' ' ' SER . . . . . . . . 0 CA--C 1.48 -2.117 0 N-CA-C 108.121 -1.992 . . . . 0.0 108.121 172.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . 0.51 ' O ' ' HA2' ' A' ' 95' ' ' GLY . 34.2 t . . . . . 0 N--CA 1.409 -2.523 0 CA-C-O 121.342 0.592 . . . . 0.0 109.677 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 48.2 t -109.33 99.56 8.93 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 CA-C-N 115.084 -0.962 . . . . 0.0 109.491 176.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.452 ' HG ' ' HA ' ' A' ' 125' ' ' THR . 7.8 mp -110.07 127.93 55.14 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.157 179.617 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.483 ' HD3' HD11 ' A' ' 91' ' ' ILE . 23.8 ttmm -106.5 109.01 20.81 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 177.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 78.9 m-85 -94.81 105.68 17.63 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-N 116.068 -0.514 . . . . 0.0 109.788 179.469 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 49.7 m -61.75 151.37 34.21 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 115.276 -0.875 . . . . 0.0 111.006 178.585 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 7.3 m -51.5 -43.69 62.31 Favored 'General case' 0 C--O 1.215 -0.748 0 C-N-CA 125.241 1.417 . . . . 0.0 110.289 179.344 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 85.5 m -120.21 101.19 7.64 Favored 'General case' 0 N--CA 1.423 -1.777 0 CA-C-O 121.137 0.494 . . . . 0.0 109.761 178.46 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 13.5 m -108.71 114.77 47.65 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.059 0 CA-C-O 121.951 0.881 . . . . 0.0 111.176 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.511 ' HA ' ' O ' ' A' ' 84' ' ' LEU . 20.9 p -107.76 166.42 10.71 Favored 'General case' 0 N--CA 1.405 -2.693 0 CA-C-N 114.449 -1.251 . . . . 0.0 111.02 -176.528 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 167.84 -164.06 37.65 Favored Glycine 0 N--CA 1.41 -3.054 0 C-N-CA 120.323 -0.941 . . . . 0.0 111.565 177.052 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 52.0 t60 -103.3 99.81 9.67 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.424 ' HG ' ' OD2' ' A' ' 62' ' ' ASP . 3.0 tm? -103.55 125.29 50.0 Favored 'General case' 0 CA--C 1.483 -1.611 0 CA-C-N 115.635 -0.712 . . . . 0.0 110.2 -172.675 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -122.41 149.24 44.09 Favored 'General case' 0 N--CA 1.402 -2.871 0 CA-C-N 114.75 -1.113 . . . . 0.0 108.994 172.259 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -68.95 100.59 1.23 Allowed 'General case' 0 N--CA 1.402 -2.866 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 -179.091 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . 0.623 ' H ' HD21 ' A' ' 63' ' ' LEU . . . 135.52 -45.44 1.1 Allowed Glycine 0 C--N 1.282 -2.459 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 -175.738 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.48 ' HD3' HG23 ' A' ' 118' ' ' THR . 0.7 OUTLIER -150.2 133.5 16.37 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 114.074 1.139 . . . . 0.0 114.074 -178.382 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.524 ' O ' ' HB2' ' A' ' 135' ' ' SER . 40.6 tp -97.51 113.52 25.24 Favored 'General case' 0 C--N 1.309 -1.163 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 175.549 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.48 HG23 ' HD3' ' A' ' 116' ' ' LYS . 19.8 p -114.71 140.81 48.56 Favored 'General case' 0 C--N 1.285 -2.225 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.547 -178.593 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 66.18 100.61 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.93 0.892 . . . . 0.0 111.097 179.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.431 HG11 HD12 ' A' ' 123' ' ' ILE . 4.1 m -107.37 103.25 15.18 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.674 0 N-CA-C 113.974 1.102 . . . . 0.0 113.974 -177.355 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -84.66 84.26 7.74 Favored 'General case' 0 C--N 1.29 -2.013 0 CA-C-N 114.632 -1.167 . . . . 0.0 108.534 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 133.6 -12.4 4.87 Favored Glycine 0 N--CA 1.435 -1.384 0 CA-C-N 115.289 -0.869 . . . . 0.0 113.038 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.431 HD12 HG11 ' A' ' 120' ' ' VAL . 71.7 mt -100.28 99.95 9.46 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.112 0 CA-C-O 121.817 0.818 . . . . 0.0 109.716 179.213 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -91.18 118.18 30.24 Favored 'General case' 0 C--N 1.29 -2.004 0 CA-C-N 114.791 -1.095 . . . . 0.0 108.429 -177.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.452 ' HA ' ' HG ' ' A' ' 102' ' ' LEU . 62.1 m -115.46 113.53 23.83 Favored 'General case' 0 N--CA 1.426 -1.64 0 N-CA-C 112.913 0.708 . . . . 0.0 112.913 -173.137 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.433 ' O ' ' HA ' ' A' ' 100' ' ' SER . 39.0 tttp -105.13 121.82 44.61 Favored 'General case' 0 N--CA 1.415 -2.203 0 C-N-CA 119.137 -1.025 . . . . 0.0 108.644 169.676 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.437 ' O ' ' HB3' ' A' ' 128' ' ' MET . 27.2 t -144.76 104.09 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.278 -2.534 0 N-CA-C 103.29 -2.856 . . . . 0.0 103.29 170.547 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . 0.437 ' HB3' ' O ' ' A' ' 127' ' ' VAL . 26.3 ttt 74.17 -52.29 0.69 Allowed 'General case' 0 C--N 1.321 -0.658 0 O-C-N 124.487 1.117 . . . . 0.0 109.55 -172.241 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 8.7 tp -136.88 152.96 29.2 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 N-CA-C 109.063 -0.718 . . . . 0.0 109.063 175.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' TRP . . . . . 0.431 ' HA ' ' HA ' ' A' ' 126' ' ' LYS . 20.4 t-105 -81.49 117.8 22.2 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 123.526 0.731 . . . . 0.0 109.863 -177.028 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.533 HG12 ' H ' ' A' ' 133' ' ' VAL . 41.4 t -138.09 120.48 18.85 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.129 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 178.728 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 65.7 pttt -91.46 11.34 24.29 Favored 'General case' 0 C--N 1.312 -1.029 0 O-C-N 121.738 -0.601 . . . . 0.0 111.599 -177.2 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.533 ' H ' HG12 ' A' ' 131' ' ' VAL . 34.1 m -120.59 -1.59 8.21 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.107 0 C-N-CA 119.647 -0.821 . . . . 0.0 112.885 -175.586 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . 0.694 ' O ' ' HB ' ' A' ' 146' ' ' THR . 18.2 p -74.13 101.63 3.99 Favored 'General case' 0 N--CA 1.425 -1.709 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 176.5 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . 0.524 ' HB2' ' O ' ' A' ' 117' ' ' LEU . 12.4 p -94.48 170.03 9.78 Favored 'General case' 0 N--CA 1.412 -2.338 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 -177.665 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . 0.424 HD11 HG21 ' A' ' 65' ' ' ILE . 15.2 tt -100.77 122.35 52.68 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.155 0 CA-C-O 121.685 0.755 . . . . 0.0 111.555 -170.355 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 25.9 m -109.32 147.4 32.74 Favored 'General case' 0 N--CA 1.433 -1.297 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.023 -177.726 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . 0.535 HG22 ' H ' ' A' ' 141' ' ' SER . 33.0 m -146.85 174.03 11.86 Favored 'General case' 0 C--N 1.295 -1.787 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 -174.671 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -110.24 28.75 8.32 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 172.396 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . 59.79 43.74 14.86 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 -172.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . 0.535 ' H ' HG22 ' A' ' 138' ' ' THR . 35.1 t 176.78 -82.57 0.0 OUTLIER 'General case' 0 CA--C 1.545 0.77 0 CA-C-N 114.755 -1.111 . . . . 0.0 110.338 -173.59 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 24.7 pttm -89.29 150.91 22.39 Favored 'General case' 0 CA--C 1.503 -0.858 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.515 HG12 ' HB2' ' A' ' 155' ' ' ARG . 13.8 p -131.52 149.38 33.01 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.337 0 N-CA-C 114.281 1.215 . . . . 0.0 114.281 -168.656 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -112.44 143.48 43.51 Favored 'General case' 0 N--CA 1.428 -1.528 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 169.063 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 48.7 t80 -67.87 165.58 17.31 Favored 'General case' 0 C--N 1.305 -1.353 0 C-N-CA 122.93 0.492 . . . . 0.0 109.987 -173.18 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.694 ' HB ' ' O ' ' A' ' 134' ' ' THR . 41.6 p -50.88 -53.16 34.88 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 120.985 0.421 . . . . 0.0 111.531 -176.511 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -84.95 97.33 9.73 Favored 'General case' 0 N--CA 1.424 -1.754 0 N-CA-C 105.735 -1.95 . . . . 0.0 105.735 170.227 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -81.71 -18.0 69.19 Favored Glycine 0 CA--C 1.466 -2.978 0 CA-C-O 121.66 0.589 . . . . 0.0 111.666 -167.136 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 66.3 mtt -97.43 5.43 49.74 Favored 'General case' 0 C--N 1.281 -2.389 0 CA-C-N 114.666 -0.767 . . . . 0.0 110.718 178.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . 0.552 ' HE2' ' HA ' ' A' ' 150' ' ' LYS . 6.7 mmpt? -116.4 -49.69 2.66 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.509 -179.396 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 42.4 mmtm -146.14 165.08 30.18 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.3 0.571 . . . . 0.0 112.514 -175.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 42.2 p -130.03 160.37 33.9 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 174.073 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' ARG . . . . . 0.44 ' NE ' ' HA ' ' A' ' 153' ' ' ARG . 3.3 tpm_? -135.95 149.3 48.85 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 106.976 -1.491 . . . . 0.0 106.976 -177.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 8.2 m -88.64 117.37 27.55 Favored 'General case' 0 N--CA 1.436 -1.126 0 C-N-CA 120.212 -0.595 . . . . 0.0 111.763 -175.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' ARG . . . . . 0.639 ' HA ' ' HA2' ' A' ' 159' ' ' GLY . 0.0 OUTLIER -69.75 -31.08 68.85 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 105.457 -2.053 . . . . 0.0 105.457 174.505 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -45.46 -53.99 8.03 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 113.592 -1.64 . . . . 0.0 113.791 -179.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -66.47 -53.21 37.83 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 120.799 0.333 . . . . 0.0 111.476 -177.727 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -148.43 -32.89 0.24 Allowed 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.689 -178.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . 0.639 ' HA2' ' HA ' ' A' ' 155' ' ' ARG . . . 130.54 -95.0 0.33 Allowed Glycine 0 CA--C 1.463 -3.215 0 N-CA-C 107.992 -2.043 . . . . 0.0 107.992 -168.627 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.736 ' HB ' ' O ' ' A' ' 67' ' ' ILE . 41.3 t -98.72 125.25 52.17 Favored 'Isoleucine or valine' 0 N--CA 1.398 -3.046 0 N-CA-C 107.273 -1.381 . . . . 0.0 107.273 171.244 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' GLN . . . . . 0.407 ' HB2' ' HD3' ' A' ' 153' ' ' ARG . 46.8 mt-30 -90.78 101.38 14.13 Favored 'General case' 0 C--N 1.294 -1.824 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 -176.094 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . 0.433 HH21 HG23 ' A' ' 67' ' ' ILE . 20.2 mmt180 -90.86 152.89 20.57 Favored 'General case' 0 C--N 1.278 -2.501 0 CA-C-N 113.584 -1.644 . . . . 0.0 114.151 -172.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' ASN . . . . . 0.504 ' H ' ' CG1' ' A' ' 94' ' ' VAL . 46.7 m-80 -136.82 31.69 2.74 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 104.789 -2.301 . . . . 0.0 104.789 173.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . 0.52 ' HA3' ' SG ' ' A' ' 92' ' ' CYS . . . -110.67 149.34 17.7 Favored Glycine 0 N--CA 1.433 -1.508 0 CA-C-N 114.051 -1.432 . . . . 0.0 113.587 -171.399 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -110.01 117.16 33.03 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 175.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . 0.41 HH11 ' HD2' ' A' ' 166' ' ' ARG . 30.0 mtt180 -78.73 102.14 7.92 Favored 'General case' 0 N--CA 1.422 -1.83 0 N-CA-C 107.378 -1.341 . . . . 0.0 107.378 -178.416 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 40.0 t -75.72 90.6 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 CA-C-O 121.189 0.519 . . . . 0.0 110.848 -177.638 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 21.0 t70 172.85 -33.87 0.0 OUTLIER 'General case' 0 CA--C 1.484 -1.57 0 N-CA-C 106.665 -1.605 . . . . 0.0 106.665 -178.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 15.5 ptmt -157.38 -164.26 1.54 Allowed 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 113.675 -1.602 . . . . 0.0 110.75 -172.792 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' PHE . . . . . . . . . . . . . 89.1 t80 . . . . . 0 N--CA 1.427 -1.578 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 171.576 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.53 ' O ' ' HG ' ' A' ' 58' ' ' LEU . 14.9 tp . . . . . 0 C--O 1.214 -0.798 0 N-CA-C 114.573 1.323 . . . . 0.0 114.573 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.435 ' O ' ' HE3' ' A' ' 59' ' ' LYS . 0.9 OUTLIER -52.4 -26.41 27.86 Favored 'Trans proline' 0 C--N 1.362 1.253 0 C-N-CA 123.303 2.669 . . . . 0.0 110.952 176.922 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 20.0 mm-40 -82.7 -41.48 19.27 Favored 'General case' 0 N--CA 1.4 -2.928 0 CA-C-N 115.201 -0.909 . . . . 0.0 109.367 -178.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.489 ' HA ' ' HB3' ' A' ' 60' ' ' GLU . 3.8 mm? -75.35 -37.38 60.71 Favored 'General case' 0 N--CA 1.44 -0.973 0 N-CA-C 113.47 0.915 . . . . 0.0 113.47 -176.056 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.582 HD22 ' ND2' ' A' ' 74' ' ' ASN 0.261 1.8 pp -58.84 -43.58 90.78 Favored 'General case' 0 C--O 1.217 -0.614 0 C-N-CA 120.088 -0.645 . . . . 0.0 112.179 178.908 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.493 ' N ' HD12 ' A' ' 58' ' ' LEU . 20.8 pttp -77.49 -26.81 51.58 Favored 'General case' 0 C--O 1.208 -1.119 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 175.454 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.489 ' HB3' ' HA ' ' A' ' 57' ' ' LEU . 8.7 tp10 -61.97 -49.03 77.72 Favored 'General case' 0 C--N 1.313 -0.999 0 C-N-CA 123.895 0.878 . . . . 0.0 111.34 177.402 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 72.5 m-85 -73.62 5.5 3.85 Favored 'General case' 0 C--O 1.243 0.725 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.332 179.181 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -125.4 -162.93 1.15 Allowed 'General case' 0 C--N 1.292 -1.918 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.737 ' HB2' HD12 ' A' ' 65' ' ' ILE . 2.5 mt -79.11 173.86 7.04 Favored Pre-proline 0 CA--C 1.563 1.467 0 N-CA-C 106.988 -1.486 . . . . 0.0 106.988 -176.421 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -85.8 6.41 5.57 Favored 'Trans proline' 0 CA--C 1.505 -0.967 0 C-N-CA 121.68 1.587 . . . . 0.0 112.103 -171.131 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.737 HD12 ' HB2' ' A' ' 63' ' ' LEU . 0.2 OUTLIER -71.26 -45.46 70.34 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.816 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 179.578 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.415 ' H ' HD13 ' A' ' 65' ' ' ILE . . . 58.27 8.91 5.36 Favored Glycine 0 CA--C 1.528 0.885 0 CA-C-N 115.735 -0.666 . . . . 0.0 113.531 -178.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.544 ' O ' ' HB ' ' A' ' 160' ' ' VAL . 48.0 mt 68.58 -68.07 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.832 0 C-N-CA 125.494 1.517 . . . . 0.0 112.364 -176.791 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.542 ' HB3' ' HD3' ' A' ' 69' ' ' PRO . 76.7 t80 178.67 -56.99 0.0 OUTLIER Pre-proline 0 C--N 1.303 -1.417 0 C-N-CA 122.324 0.25 . . . . 0.0 111.078 -177.625 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.542 ' HD3' ' HB3' ' A' ' 68' ' ' PHE . 20.0 Cg_endo -98.15 145.64 0.64 Allowed 'Trans proline' 0 N--CA 1.432 -2.134 0 C-N-CA 122.285 1.99 . . . . 0.0 112.364 -177.026 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -78.57 64.34 3.59 Favored Glycine 0 N--CA 1.442 -0.934 0 N-CA-C 110.517 -1.033 . . . . 0.0 110.517 178.124 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -163.06 -27.38 0.04 OUTLIER 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 -177.471 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.43 ' HA ' ' CD ' ' A' ' 89' ' ' PRO . . . -83.2 170.52 14.62 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.663 0.785 . . . . 0.0 109.339 173.239 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.56 ' O ' HG22 ' A' ' 73' ' ' THR . 84.1 m 76.8 28.46 0.68 Allowed 'General case' 0 CA--C 1.56 1.339 0 CA-C-O 124.878 2.275 . . . . 0.0 110.866 172.117 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.686 ' O ' ' HA ' ' A' ' 86' ' ' VAL . 0.9 OUTLIER -73.74 108.21 6.44 Favored 'General case' 0 C--N 1.257 -3.439 0 CA-C-N 113.947 -1.479 . . . . 0.0 112.712 -178.175 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.576 ' HB2' HD21 ' A' ' 84' ' ' LEU . 31.3 p90 -79.34 108.71 13.06 Favored 'General case' 0 C--N 1.271 -2.815 0 CA-C-O 122.095 0.95 . . . . 0.0 113.37 -173.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.582 ' HB2' ' O ' ' A' ' 85' ' ' THR . 8.4 mm-40 -105.02 158.35 16.61 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 174.638 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 60.0 t80 -152.87 147.43 25.99 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 -175.274 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.638 ' O ' ' HA ' ' A' ' 82' ' ' LYS . 12.0 m-20 -130.3 -176.46 3.96 Favored 'General case' 0 CA--C 1.489 -1.393 0 CA-C-O 121.325 0.584 . . . . 0.0 111.665 -179.811 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.753 ' O ' ' HB2' ' A' ' 82' ' ' LYS . 45.8 mt-10 -83.88 -62.57 1.54 Allowed 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 117.042 2.238 . . . . 0.0 117.042 175.141 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -80.6 -34.43 35.17 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 122.775 1.274 . . . . 0.0 108.257 177.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.589 ' C ' ' H ' ' A' ' 83' ' ' LYS . 24.7 m -92.63 30.58 1.51 Allowed 'General case' 0 C--N 1.291 -1.969 0 C-N-CA 126.877 2.071 . . . . 0.0 107.496 176.478 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.753 ' HB2' ' O ' ' A' ' 79' ' ' GLU . 72.5 tttt -57.33 32.0 0.0 OUTLIER 'General case' 0 CA--C 1.565 1.542 0 C-N-CA 127.996 2.518 . . . . 0.0 112.617 -179.737 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.676 ' HG3' HG22 ' A' ' 109' ' ' THR . 53.9 pttt -117.96 133.67 55.69 Favored 'General case' 0 N--CA 1.393 -3.315 0 C-N-CA 125.943 1.697 . . . . 0.0 107.179 176.219 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.576 HD21 ' HB2' ' A' ' 75' ' ' TYR . 1.2 tm? -59.82 127.24 30.99 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-O 121.569 0.699 . . . . 0.0 110.743 -171.368 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.582 ' O ' ' HB2' ' A' ' 76' ' ' GLU . 6.2 t -126.77 114.28 17.75 Favored 'General case' 0 N--CA 1.405 -2.687 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.37 -179.851 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.686 ' HA ' ' O ' ' A' ' 74' ' ' ASN . 15.7 m -92.41 140.16 16.7 Favored 'Isoleucine or valine' 0 CA--C 1.474 -1.96 0 O-C-N 121.007 -1.058 . . . . 0.0 111.304 178.542 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.543 ' HA ' ' H ' ' A' ' 107' ' ' THR 0.339 2.0 pp -101.59 103.7 14.54 Favored 'General case' 0 N--CA 1.391 -3.423 0 CA-C-O 122.593 1.187 . . . . 0.0 109.979 176.892 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 35.0 mt -88.65 117.37 68.25 Favored Pre-proline 0 N--CA 1.405 -2.715 0 CA-C-N 113.683 -1.599 . . . . 0.0 107.23 -178.223 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.455 ' HB2' ' HD2' ' A' ' 166' ' ' ARG . 55.1 Cg_exo -55.78 104.15 0.12 Allowed 'Trans proline' 0 N--CA 1.451 -0.992 0 C-N-CA 123.442 2.761 . . . . 0.0 111.737 -178.059 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . 0.512 ' OG ' ' HB ' ' A' ' 167' ' ' VAL . 25.7 t 71.66 170.22 0.32 Allowed 'General case' 0 N--CA 1.44 -0.942 0 O-C-N 124.715 1.259 . . . . 0.0 110.832 -179.134 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 79.4 mt -85.88 116.78 29.49 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.921 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.227 177.409 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' CYS . . . . . 0.597 ' SG ' ' HB2' ' A' ' 104' ' ' PHE . 12.0 p -109.91 129.05 55.7 Favored 'General case' 0 C--N 1.292 -1.92 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 174.615 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -120.41 120.34 35.66 Favored 'General case' 0 CA--C 1.461 -2.463 0 N-CA-C 108.787 -0.819 . . . . 0.0 108.787 -175.5 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.719 ' O ' ' HA ' ' A' ' 101' ' ' VAL . 49.1 t -111.06 115.79 50.8 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.156 0 CA-C-N 114.443 -1.253 . . . . 0.0 109.398 -172.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.309 -0.944 0 N-CA-C 110.939 -0.864 . . . . 0.0 110.939 179.325 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 39.9 m . . . . . 0 N--CA 1.43 -1.466 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.719 ' HA ' ' O ' ' A' ' 94' ' ' VAL . 9.3 p -94.81 116.37 35.97 Favored 'Isoleucine or valine' 0 C--O 1.244 0.765 0 CA-C-O 122.01 0.909 . . . . 0.0 113.021 -175.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.427 ' CD1' HG23 ' A' ' 125' ' ' THR . 1.5 mm? -110.2 133.23 53.43 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 177.202 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 22.6 ttmm -103.39 105.23 15.44 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 177.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.597 ' HB2' ' SG ' ' A' ' 92' ' ' CYS . 99.3 m-85 -90.15 98.18 11.62 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 176.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 28.0 m -85.81 155.94 20.78 Favored 'General case' 0 C--N 1.296 -1.737 0 CA-C-N 114.686 -1.143 . . . . 0.0 111.062 -175.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 27.0 m -68.79 121.29 16.22 Favored 'General case' 0 N--CA 1.417 -2.094 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 175.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.543 ' H ' ' HA ' ' A' ' 87' ' ' LEU . 23.3 m 71.98 79.56 0.15 Allowed 'General case' 0 C--N 1.317 -0.807 0 C-N-CA 124.212 1.005 . . . . 0.0 110.656 179.238 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.506 ' O ' ' HA ' ' A' ' 85' ' ' THR . 14.9 m -109.25 121.21 61.93 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 CA-C-N 114.995 -1.002 . . . . 0.0 109.45 177.306 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.676 HG22 ' HG3' ' A' ' 83' ' ' LYS . 25.7 m -106.57 124.22 49.28 Favored 'General case' 0 N--CA 1.409 -2.492 0 CA-C-N 114.977 -1.01 . . . . 0.0 111.657 -167.599 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -157.1 -168.69 20.02 Favored Glycine 0 C--N 1.309 -0.947 0 C-N-CA 120.452 -0.88 . . . . 0.0 113.733 -179.295 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 12.9 t-80 -99.64 119.62 38.39 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 105.752 -1.944 . . . . 0.0 105.752 179.632 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.559 HD23 ' HG ' ' A' ' 84' ' ' LEU . 60.7 tp -124.11 118.51 27.08 Favored 'General case' 0 CA--C 1.457 -2.62 0 CA-C-O 121.338 0.59 . . . . 0.0 111.594 -167.496 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 8.1 mp0 -121.04 146.57 46.58 Favored 'General case' 1 N--CA 1.37 -4.459 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 175.323 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 21.2 tptm -66.2 101.14 0.68 Allowed 'General case' 0 C--N 1.291 -1.959 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 179.148 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 137.07 -48.95 0.88 Allowed Glycine 0 C--O 1.192 -2.478 0 N-CA-C 108.361 -1.896 . . . . 0.0 108.361 -173.294 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.63 ' HD3' HG23 ' A' ' 118' ' ' THR . 0.0 OUTLIER -148.71 144.22 26.95 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 114.006 1.113 . . . . 0.0 114.006 179.935 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.666 ' O ' ' HB2' ' A' ' 135' ' ' SER . 49.1 tp -110.65 100.91 9.61 Favored 'General case' 0 C--N 1.31 -1.124 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 177.029 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.63 HG23 ' HD3' ' A' ' 116' ' ' LYS . 6.9 p -100.95 138.16 38.37 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 113.064 0.765 . . . . 0.0 113.064 -176.528 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . 0.418 ' H ' ' HB3' ' A' ' 135' ' ' SER . 29.3 t70 64.09 124.52 0.02 OUTLIER 'General case' 0 CA--C 1.45 -2.866 0 C-N-CA 124.882 1.273 . . . . 0.0 111.348 -176.414 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.431 HG21 HD12 ' A' ' 123' ' ' ILE . 0.8 OUTLIER -145.99 145.16 20.37 Favored 'Isoleucine or valine' 1 N--CA 1.351 -5.388 0 C-N-CA 116.475 -2.09 . . . . 0.0 111.082 -169.659 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.466 ' HB3' ' HB ' ' A' ' 109' ' ' THR . 14.9 tp10 -111.42 102.87 11.21 Favored 'General case' 0 C--N 1.283 -2.283 0 CA-C-N 115.13 -0.941 . . . . 0.0 109.199 -176.567 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 116.22 -4.85 20.0 Favored Glycine 0 N--CA 1.439 -1.161 0 C-N-CA 119.392 -1.385 . . . . 0.0 114.225 173.294 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.431 HD12 HG21 ' A' ' 120' ' ' VAL . 61.4 mt -99.35 105.4 17.39 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.99 0 C-N-CA 118.737 -1.185 . . . . 0.0 110.052 179.746 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 58.0 tttm -85.37 119.67 25.99 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 179.019 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.523 ' O ' ' HA ' ' A' ' 130' ' ' TRP . 92.1 m -116.46 124.08 49.08 Favored 'General case' 0 C--N 1.271 -2.813 0 CA-C-N 114.951 -1.022 . . . . 0.0 110.116 -176.365 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.482 ' HA ' ' O ' ' A' ' 129' ' ' ILE . 0.7 OUTLIER -122.83 100.25 6.81 Favored 'General case' 0 N--CA 1.424 -1.762 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 174.077 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 11.8 p -102.59 -26.84 3.38 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.138 0 CA-C-O 122.255 1.026 . . . . 0.0 109.511 178.299 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 26.6 ttt -161.32 -33.6 0.05 OUTLIER 'General case' 0 C--N 1.282 -2.335 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 -178.089 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . 0.516 ' H ' HD13 ' A' ' 129' ' ' ILE . 0.2 OUTLIER -139.46 165.62 22.59 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 N-CA-C 104.436 -2.431 . . . . 0.0 104.436 176.759 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' TRP . . . . . 0.523 ' HA ' ' O ' ' A' ' 125' ' ' THR . 60.8 p-90 -108.42 127.82 54.24 Favored 'General case' 0 N--CA 1.418 -2.058 0 C-N-CA 118.928 -1.109 . . . . 0.0 111.661 -178.479 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.595 HG12 ' H ' ' A' ' 133' ' ' VAL . 43.0 t -127.99 154.02 38.06 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.914 0 N-CA-C 105.751 -1.944 . . . . 0.0 105.751 177.354 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -115.98 18.71 15.43 Favored 'General case' 0 C--N 1.3 -1.579 0 CA-C-O 121.627 0.727 . . . . 0.0 111.238 -176.441 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.595 ' H ' HG12 ' A' ' 131' ' ' VAL . 33.5 m -138.11 0.2 0.71 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.637 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.962 -178.464 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . 0.463 ' OG1' ' HB ' ' A' ' 125' ' ' THR . 1.2 p -64.65 120.61 12.73 Favored 'General case' 0 N--CA 1.418 -2.063 0 CA-C-O 122.065 0.936 . . . . 0.0 110.917 178.074 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . 0.666 ' HB2' ' O ' ' A' ' 117' ' ' LEU . 19.7 p -78.61 171.25 15.4 Favored 'General case' 0 N--CA 1.407 -2.608 0 CA-C-N 113.778 -1.555 . . . . 0.0 114.049 -173.03 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 10.4 tt -119.18 127.54 75.84 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.099 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 175.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 37.9 m -129.45 131.23 46.68 Favored 'General case' 0 C--N 1.293 -1.886 0 C-N-CA 120.351 -0.54 . . . . 0.0 110.995 -174.422 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . 0.516 ' HB ' ' O ' ' A' ' 142' ' ' LYS . 59.6 p -118.2 176.13 5.37 Favored 'General case' 0 C--N 1.29 -1.983 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 177.182 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -99.93 21.64 12.35 Favored 'General case' 0 C--N 1.281 -2.398 0 N-CA-C 106.185 -1.783 . . . . 0.0 106.185 173.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . 61.71 40.42 13.15 Favored 'General case' 0 C--N 1.352 0.683 0 N-CA-C 107.367 -1.346 . . . . 0.0 107.367 -168.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 35.6 t -174.78 -79.69 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 114.222 -1.354 . . . . 0.0 109.483 -174.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . 0.516 ' O ' ' HB ' ' A' ' 138' ' ' THR . 99.5 mttt -85.41 167.2 15.74 Favored 'General case' 0 CA--C 1.497 -1.095 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 177.141 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.449 ' HA ' HG22 ' A' ' 138' ' ' THR . 10.4 p -126.33 127.7 70.84 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.741 0 N-CA-C 113.484 0.92 . . . . 0.0 113.484 -173.105 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 45.8 m-85 -113.68 147.14 38.71 Favored 'General case' 0 CA--C 1.487 -1.465 0 CA-C-N 115.244 -0.889 . . . . 0.0 109.982 176.041 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . 0.505 ' HB2' ' HB2' ' A' ' 151' ' ' LYS . 93.9 m-85 -99.19 99.85 10.89 Favored 'General case' 0 C--N 1.263 -3.174 0 CA-C-N 114.456 -1.247 . . . . 0.0 107.922 175.738 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . 0.363 17.7 p -82.34 69.76 9.15 Favored 'General case' 0 N--CA 1.425 -1.686 0 N-CA-C 115.315 1.598 . . . . 0.0 115.315 -175.215 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . 0.411 ' HB2' HG21 ' A' ' 125' ' ' THR . . . -123.85 74.35 1.27 Allowed 'General case' 0 N--CA 1.424 -1.728 0 N-CA-C 104.68 -2.341 . . . . 0.0 104.68 170.869 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 77.64 16.25 80.4 Favored Glycine 0 N--CA 1.433 -1.567 0 N-CA-C 109.071 -1.611 . . . . 0.0 109.071 -171.271 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 27.5 ptt? 49.03 24.39 0.88 Allowed 'General case' 0 N--CA 1.502 2.149 0 C-N-CA 126.578 1.951 . . . . 0.0 111.416 -173.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 59.5 mttp -62.77 -36.79 84.23 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 115.021 1.489 . . . . 0.0 115.021 -174.099 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . 0.547 ' HE2' ' HA ' ' A' ' 151' ' ' LYS . 6.1 mmpt? -106.3 132.8 51.91 Favored 'General case' 0 C--N 1.319 -0.74 0 C-N-CA 120.473 -0.491 . . . . 0.0 110.897 178.144 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 19.7 m -132.46 128.21 36.96 Favored 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 -179.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 25.2 mmm180 -140.99 172.95 11.97 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-O 121.232 0.539 . . . . 0.0 111.954 -178.138 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 17.8 m -101.15 142.26 32.85 Favored 'General case' 0 N--CA 1.432 -1.331 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 176.434 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' ARG . . . . . 0.531 ' HD3' ' C ' ' A' ' 155' ' ' ARG . 0.2 OUTLIER -78.58 -25.02 45.21 Favored 'General case' 0 C--N 1.299 -1.606 0 CA-C-O 121.255 0.55 . . . . 0.0 109.89 178.976 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -44.17 -36.37 2.62 Favored 'General case' 0 C--N 1.316 -0.854 0 C-N-CA 125.455 1.502 . . . . 0.0 114.905 -175.277 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -66.44 -53.81 31.23 Favored 'General case' 0 CA--C 1.546 0.797 0 N-CA-C 114.277 1.214 . . . . 0.0 114.277 -174.107 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -149.66 5.15 0.6 Allowed 'General case' 0 N--CA 1.491 1.603 0 CA-C-N 117.597 0.18 . . . . 0.0 111.364 -175.411 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . 0.518 ' HA2' ' HG2' ' A' ' 155' ' ' ARG . . . 96.31 -91.55 1.29 Allowed Glycine 0 CA--C 1.461 -3.33 0 N-CA-C 106.231 -2.748 . . . . 0.0 106.231 -166.772 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.544 ' HB ' ' O ' ' A' ' 67' ' ' ILE . 57.7 t -104.96 127.45 59.49 Favored 'Isoleucine or valine' 1 N--CA 1.369 -4.512 0 N-CA-C 105.16 -2.163 . . . . 0.0 105.16 165.1 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 -88.34 106.59 18.34 Favored 'General case' 0 C--N 1.273 -2.754 0 N-CA-C 106.396 -1.705 . . . . 0.0 106.396 -177.055 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . 0.446 ' HD2' ' O ' ' A' ' 164' ' ' GLY . 0.0 OUTLIER -148.64 158.69 44.31 Favored 'General case' 0 N--CA 1.389 -3.519 0 C-N-CA 118.384 -1.326 . . . . 0.0 114.523 -167.359 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -106.29 -24.1 12.38 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 115.073 -0.967 . . . . 0.0 108.792 172.657 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . 0.446 ' O ' ' HD2' ' A' ' 162' ' ' ARG . . . -58.65 118.61 14.33 Favored Glycine 0 CA--C 1.498 -0.994 0 CA-C-N 115.258 -0.883 . . . . 0.0 112.282 -178.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 2.8 pp -108.7 153.74 23.01 Favored 'General case' 0 N--CA 1.418 -2.047 0 CA-C-O 120.667 0.27 . . . . 0.0 111.161 -174.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . 0.455 ' HD2' ' HB2' ' A' ' 89' ' ' PRO . 58.6 mtm180 -79.12 117.4 20.11 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 178.17 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . 0.512 ' HB ' ' OG ' ' A' ' 90' ' ' SER . 43.6 t -62.28 -18.0 19.26 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.627 0 CA-C-O 121.64 0.733 . . . . 0.0 109.692 176.056 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -56.1 -41.44 75.21 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 124.739 1.215 . . . . 0.0 111.101 176.736 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 1.9 tmmm? -86.59 109.58 19.23 Favored 'General case' 0 N--CA 1.429 -1.499 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 -178.478 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' PHE . . . . . . . . . . . . . 87.9 t80 . . . . . 0 N--CA 1.423 -1.822 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 178.414 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.676 ' O ' ' HG ' ' A' ' 58' ' ' LEU . 23.3 mt . . . . . 0 C--O 1.208 -1.088 0 CA-C-O 118.826 -0.607 . . . . 0.0 112.068 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.569 ' HA ' ' CD1' ' A' ' 58' ' ' LEU . 36.7 Cg_endo -60.34 -34.96 93.04 Favored 'Trans proline' 0 C--N 1.377 2.063 0 C-N-CA 120.899 1.066 . . . . 0.0 113.768 -169.729 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -78.21 -30.27 48.8 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-O 121.242 0.544 . . . . 0.0 110.633 179.324 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 45.5 tp -74.02 -29.39 61.91 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.242 176.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.676 ' HG ' ' O ' ' A' ' 54' ' ' LEU . 59.6 mt -57.48 -45.9 84.3 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-O 121.375 0.607 . . . . 0.0 110.3 -177.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.431 ' HD3' ' HA3' ' A' ' 66' ' ' GLY . 1.9 pptp? -73.57 -25.0 60.16 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 114.894 -1.048 . . . . 0.0 110.577 -179.183 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -90.48 -22.83 21.17 Favored 'General case' 0 CA--C 1.556 1.181 0 N-CA-C 113.482 0.919 . . . . 0.0 113.482 -174.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.558 ' CD2' ' HA ' ' A' ' 58' ' ' LEU . 34.1 m-85 -41.31 -41.08 1.83 Allowed 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 115.193 1.553 . . . . 0.0 115.193 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.493 ' OD2' ' HA ' ' A' ' 114' ' ' LYS . 10.4 t70 -125.96 -82.96 0.63 Allowed 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 117.746 -1.582 . . . . 0.0 112.205 -172.647 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.554 ' H ' HD12 ' A' ' 63' ' ' LEU . 0.0 OUTLIER -90.94 161.07 36.56 Favored Pre-proline 0 N--CA 1.444 -0.752 0 N-CA-C 106.619 -1.623 . . . . 0.0 106.619 -179.742 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -100.55 14.17 0.45 Allowed 'Trans proline' 0 N--CA 1.435 -1.936 0 C-N-CA 122.778 2.319 . . . . 0.0 112.803 -176.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.56 HG12 ' H ' ' A' ' 67' ' ' ILE . 0.2 OUTLIER -67.09 -47.5 81.75 Favored 'Isoleucine or valine' 0 CA--C 1.484 -1.59 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 177.146 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.524 ' HA2' HG21 ' A' ' 73' ' ' THR . . . 49.91 8.7 0.15 Allowed Glycine 0 N--CA 1.472 1.043 0 CA-C-N 114.903 -1.044 . . . . 0.0 113.849 -173.13 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.56 ' H ' HG12 ' A' ' 65' ' ' ILE . 16.6 mm 69.38 -69.34 0.16 Allowed 'Isoleucine or valine' 0 C--O 1.177 -2.739 0 C-N-CA 125.549 1.54 . . . . 0.0 108.555 -173.142 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.577 ' HB3' ' HD3' ' A' ' 69' ' ' PRO . 65.3 t80 -167.4 -56.75 0.01 OUTLIER Pre-proline 0 C--N 1.293 -1.851 0 C-N-CA 120.917 -0.313 . . . . 0.0 110.64 -177.78 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.577 ' HD3' ' HB3' ' A' ' 68' ' ' PHE . 56.0 Cg_endo -102.71 178.91 0.15 Allowed 'Trans proline' 0 N--CA 1.424 -2.61 0 C-N-CA 121.721 1.614 . . . . 0.0 111.108 -179.651 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -102.99 19.32 46.98 Favored Glycine 0 N--CA 1.43 -1.76 0 N-CA-C 109.756 -1.338 . . . . 0.0 109.756 175.381 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -100.93 -44.43 5.75 Favored 'General case' 0 N--CA 1.432 -1.353 0 N-CA-C 106.401 -1.703 . . . . 0.0 106.401 -178.368 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.451 ' HA ' ' HD2' ' A' ' 89' ' ' PRO . . . -80.6 168.04 19.36 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 114.653 -1.158 . . . . 0.0 109.156 167.059 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.559 ' O ' HG22 ' A' ' 73' ' ' THR . 22.3 m 81.8 28.84 0.15 Allowed 'General case' 0 CA--C 1.513 -0.462 0 CA-C-O 123.764 1.745 . . . . 0.0 111.198 171.556 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.687 HD22 ' N ' ' A' ' 74' ' ' ASN . 0.7 OUTLIER -70.47 148.26 48.49 Favored 'General case' 0 C--N 1.262 -3.212 0 CA-C-N 114.264 -1.335 . . . . 0.0 110.01 -179.725 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 40.5 t80 -115.01 91.32 3.58 Favored 'General case' 0 C--N 1.275 -2.644 0 C-N-CA 119.847 -0.741 . . . . 0.0 111.834 -166.556 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.5 ' O ' HD22 ' A' ' 84' ' ' LEU . 39.6 mm-40 -113.53 153.77 28.19 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.018 177.165 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 46.0 p90 -163.35 147.77 10.95 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 178.409 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.574 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 11.7 m-20 -74.99 165.11 25.79 Favored 'General case' 0 CA--C 1.478 -1.818 0 C-N-CA 119.827 -0.749 . . . . 0.0 109.235 179.77 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -80.78 -62.73 1.58 Allowed 'General case' 0 C--N 1.265 -3.087 0 CA-C-N 114.775 -1.102 . . . . 0.0 111.599 -179.169 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.494 ' CD ' ' H ' ' A' ' 80' ' ' GLU . 0.0 OUTLIER -80.98 -35.15 32.42 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.271 -176.293 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.574 ' HB ' ' HB2' ' A' ' 78' ' ' ASP . 56.8 m -80.49 -40.83 25.4 Favored 'General case' 0 N--CA 1.423 -1.822 0 CA-C-N 115.076 -0.965 . . . . 0.0 110.992 -178.598 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.423 ' H ' ' HB2' ' A' ' 78' ' ' ASP . 61.9 mttp 66.23 13.72 9.3 Favored 'General case' 0 N--CA 1.483 1.184 0 N-CA-C 114.206 1.187 . . . . 0.0 114.206 178.554 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 36.6 ttpt -71.54 116.46 11.91 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 176.336 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.5 HD22 ' O ' ' A' ' 76' ' ' GLU . 2.1 tm? -75.03 131.39 40.57 Favored 'General case' 0 N--CA 1.443 -0.817 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 -176.447 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.572 ' HA ' ' O ' ' A' ' 108' ' ' VAL . 27.4 p -126.66 116.59 21.23 Favored 'General case' 0 N--CA 1.412 -2.353 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.127 177.428 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.565 ' HA ' ' O ' ' A' ' 74' ' ' ASN . 63.2 t -91.92 131.84 37.94 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.054 0 N-CA-C 106.86 -1.533 . . . . 0.0 106.86 173.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.633 ' HA ' ' O ' ' A' ' 106' ' ' THR 0.361 2.1 pp -111.08 114.9 28.51 Favored 'General case' 0 N--CA 1.393 -3.28 0 CA-C-O 122.161 0.981 . . . . 0.0 111.869 178.642 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.474 ' O ' HG23 ' A' ' 106' ' ' THR . 70.3 mt -95.88 125.71 47.67 Favored Pre-proline 0 N--CA 1.419 -2.008 0 CA-C-N 113.647 -1.615 . . . . 0.0 109.771 -176.472 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.451 ' HD2' ' HA ' ' A' ' 72' ' ' ALA . 9.6 Cg_endo -53.89 95.43 0.04 OUTLIER 'Trans proline' 0 CA--C 1.534 0.489 0 C-N-CA 124.129 3.219 . . . . 0.0 112.492 177.696 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . 0.533 ' OG ' ' HB ' ' A' ' 167' ' ' VAL . 22.9 t 75.7 158.14 0.2 Allowed 'General case' 0 C--O 1.236 0.387 0 C-N-CA 125.452 1.501 . . . . 0.0 110.394 -177.804 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.476 HD11 ' HD3' ' A' ' 103' ' ' LYS . 15.9 tt -78.57 108.22 11.77 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.598 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 173.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' CYS . . . . . 0.683 ' SG ' ' HG2' ' A' ' 166' ' ' ARG . 32.0 m -98.76 127.03 44.56 Favored 'General case' 0 C--N 1.29 -1.99 0 CA-C-N 114.932 -1.031 . . . . 0.0 110.725 -170.817 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -116.79 147.71 41.84 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-N 116.661 -0.245 . . . . 0.0 110.461 -178.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.577 ' O ' ' HA ' ' A' ' 101' ' ' VAL . 6.4 p -137.74 114.11 11.39 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 CA-C-O 120.91 0.386 . . . . 0.0 111.198 -178.745 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.854 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 176.613 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 36.1 p . . . . . 0 N--CA 1.414 -2.27 0 CA-C-O 121.329 0.585 . . . . 0.0 109.973 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.577 ' HA ' ' O ' ' A' ' 94' ' ' VAL . 11.6 p -123.22 119.64 58.17 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 N-CA-C 106.681 -1.599 . . . . 0.0 106.681 174.477 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.506 HD23 ' H ' ' A' ' 126' ' ' LYS . 59.1 mt -124.83 144.12 50.46 Favored 'General case' 0 C--N 1.282 -2.356 0 C-N-CA 120.03 -0.668 . . . . 0.0 110.688 -170.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.476 ' HD3' HD11 ' A' ' 91' ' ' ILE . 23.0 ttmm -121.28 104.96 10.11 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 179.551 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -89.92 101.83 14.53 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.767 -178.31 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 82.5 m -60.97 153.09 25.99 Favored 'General case' 0 C--N 1.306 -1.317 0 C-N-CA 124.46 1.104 . . . . 0.0 110.652 177.11 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . 0.633 ' O ' ' HA ' ' A' ' 87' ' ' LEU . 88.4 m -71.65 -69.24 0.4 Allowed 'General case' 0 C--O 1.205 -1.242 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.302 -174.634 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.412 HG22 ' HB3' ' A' ' 87' ' ' LEU . 32.3 p -99.08 101.71 13.17 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 178.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.723 HG21 HG12 ' A' ' 123' ' ' ILE . 4.7 p -112.41 138.42 41.56 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.769 0 C-N-CA 119.27 -0.972 . . . . 0.0 111.751 -177.236 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.426 HG22 HG22 ' A' ' 85' ' ' THR . 76.4 p -94.29 153.07 18.21 Favored 'General case' 0 N--CA 1.413 -2.311 0 CA-C-N 115.344 -0.843 . . . . 0.0 109.666 -177.599 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . 0.478 ' HA2' ' O ' ' A' ' 119' ' ' ASP . . . -169.8 167.92 40.92 Favored Glycine 0 N--CA 1.423 -2.201 0 C-N-CA 120.787 -0.72 . . . . 0.0 111.979 -179.381 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 9.6 t60 -92.97 108.65 20.17 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 178.31 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -91.52 125.42 36.25 Favored 'General case' 0 C--N 1.296 -1.718 0 CA-C-O 121.075 0.464 . . . . 0.0 110.363 -178.37 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . 0.562 ' HG3' ' HG3' ' A' ' 116' ' ' LYS . 10.5 pt-20 -142.33 136.57 29.8 Favored 'General case' 0 N--CA 1.425 -1.675 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 171.133 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.493 ' HA ' ' OD2' ' A' ' 62' ' ' ASP . 2.3 tmtp? -52.08 117.82 3.04 Favored 'General case' 0 C--O 1.248 0.991 0 CA-C-O 121.726 0.775 . . . . 0.0 111.774 -169.599 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . 0.671 ' O ' ' HB ' ' A' ' 138' ' ' THR . . . 106.53 -28.47 13.32 Favored Glycine 0 N--CA 1.409 -3.126 0 CA-C-N 114.66 -1.155 . . . . 0.0 112.421 176.559 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.562 ' HG3' ' HG3' ' A' ' 113' ' ' GLU . 12.4 ptmm? -147.11 115.38 6.62 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-O 121.784 0.802 . . . . 0.0 111.676 -174.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 59.4 tp -93.55 103.57 15.74 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 106.656 -1.609 . . . . 0.0 106.656 177.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.411 HG21 ' NZ ' ' A' ' 116' ' ' LYS . 39.7 p -103.64 140.38 37.64 Favored 'General case' 0 N--CA 1.403 -2.801 0 N-CA-C 113.572 0.953 . . . . 0.0 113.572 -171.787 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . 0.478 ' O ' ' HA2' ' A' ' 110' ' ' GLY . 12.9 m-20 60.09 85.51 0.11 Allowed 'General case' 0 CA--C 1.493 -1.215 0 CA-C-N 114.611 -1.177 . . . . 0.0 113.788 -179.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.8 m -88.02 87.77 2.8 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.985 0 CA-C-N 115.038 -0.983 . . . . 0.0 109.327 174.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -68.51 93.89 0.53 Allowed 'General case' 0 N--CA 1.418 -2.066 0 CA-C-N 113.813 -1.539 . . . . 0.0 108.495 -177.434 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 137.84 -11.26 3.67 Favored Glycine 0 N--CA 1.418 -2.52 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.597 178.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.723 HG12 HG21 ' A' ' 108' ' ' VAL . 36.1 mm -96.64 112.46 28.8 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.176 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 178.779 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.413 ' HA ' ' HA ' ' A' ' 132' ' ' LYS . 46.6 mtpt -86.35 118.97 26.12 Favored 'General case' 0 N--CA 1.414 -2.253 0 CA-C-N 114.954 -1.021 . . . . 0.0 109.279 -177.282 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.419 HG23 HD22 ' A' ' 102' ' ' LEU . 86.5 m -122.9 130.66 53.12 Favored 'General case' 0 N--CA 1.407 -2.604 0 CA-C-N 114.159 -1.382 . . . . 0.0 110.604 -173.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.617 ' C ' ' HD3' ' A' ' 126' ' ' LYS . 0.3 OUTLIER -107.72 125.64 51.63 Favored 'General case' 0 N--CA 1.41 -2.454 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 173.705 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.638 HG23 ' H ' ' A' ' 128' ' ' MET . 4.0 m -119.29 -81.0 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.09 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.498 175.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . 0.638 ' H ' HG23 ' A' ' 127' ' ' VAL . 1.1 tmt? -103.1 -20.2 14.26 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 106.277 -1.749 . . . . 0.0 106.277 171.722 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 1.1 pp -152.21 -176.41 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 C-N-CA 126.758 2.023 . . . . 0.0 108.564 -178.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 91.2 m95 -95.28 139.84 31.02 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.06 0.457 . . . . 0.0 111.567 178.585 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.57 HG12 ' H ' ' A' ' 133' ' ' VAL . 31.9 t -138.65 135.43 43.47 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.955 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 174.428 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . 0.593 ' H ' ' HD2' ' A' ' 132' ' ' LYS . 0.0 OUTLIER -93.03 13.31 21.16 Favored 'General case' 0 N--CA 1.487 1.403 0 CA-C-N 118.426 0.557 . . . . 0.0 111.024 -178.029 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.57 ' H ' HG12 ' A' ' 131' ' ' VAL . 5.5 p -166.43 96.31 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.31 -1.129 0 CA-C-O 122.364 1.078 . . . . 0.0 111.578 -172.539 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . 0.413 ' O ' ' HA ' ' A' ' 119' ' ' ASP . 21.8 p -99.03 -172.8 2.35 Favored 'General case' 0 N--CA 1.404 -2.742 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.289 176.334 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 28.4 t -147.97 134.53 19.8 Favored 'General case' 0 C--N 1.282 -2.344 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 -173.569 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 60.9 mt -105.27 103.79 15.92 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.875 0 CA-C-O 121.197 0.522 . . . . 0.0 109.979 -178.415 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 56.3 p -96.54 110.8 23.13 Favored 'General case' 0 N--CA 1.428 -1.549 0 CA-C-O 121.233 0.54 . . . . 0.0 109.597 179.107 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . 0.671 ' HB ' ' O ' ' A' ' 115' ' ' GLY . 75.5 m -128.44 159.65 34.74 Favored 'General case' 0 C--N 1.274 -2.694 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 -177.591 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -105.72 39.35 1.78 Allowed 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 109.786 -0.449 . . . . 0.0 109.786 175.576 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . 58.74 34.82 24.03 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 115.243 -0.89 . . . . 0.0 109.602 -177.152 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . 0.452 ' H ' HG22 ' A' ' 138' ' ' THR . 33.5 t 179.45 -78.16 0.01 OUTLIER 'General case' 0 CA--C 1.547 0.859 0 CA-C-N 114.7 -1.137 . . . . 0.0 110.081 -174.634 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -80.67 134.97 35.95 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 110.152 -0.314 . . . . 0.0 110.152 179.392 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.413 ' CG2' HG22 ' A' ' 65' ' ' ILE . 20.3 t -110.22 140.19 30.32 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 N-CA-C 112.793 0.664 . . . . 0.0 112.793 -168.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -133.51 151.84 51.82 Favored 'General case' 0 CA--C 1.483 -1.605 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 170.013 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . 0.526 ' HB2' ' HB2' ' A' ' 151' ' ' LYS . 55.4 m-85 -113.11 99.58 7.94 Favored 'General case' 0 C--N 1.275 -2.659 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.744 179.297 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 16.8 p -84.81 85.72 7.43 Favored 'General case' 0 N--CA 1.408 -2.538 0 CA-C-N 115.133 -0.939 . . . . 0.0 110.97 177.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -113.03 70.52 0.72 Allowed 'General case' 0 N--CA 1.428 -1.559 0 N-CA-C 106.33 -1.73 . . . . 0.0 106.33 174.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 72.64 27.03 70.1 Favored Glycine 0 N--CA 1.439 -1.125 0 N-CA-C 108.619 -1.792 . . . . 0.0 108.619 -171.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 26.8 ttt 60.42 97.51 0.03 OUTLIER 'General case' 0 C--N 1.355 0.807 0 C-N-CA 124.621 1.169 . . . . 0.0 109.3 -171.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.19 -52.54 0.32 Allowed 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 114.9 1.444 . . . . 0.0 114.9 -174.766 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . 0.526 ' HB2' ' HB2' ' A' ' 145' ' ' PHE . 35.2 mmtp -121.96 163.9 18.52 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 114.236 1.199 . . . . 0.0 114.236 -171.292 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 55.7 p -128.51 160.01 33.67 Favored 'General case' 0 N--CA 1.439 -0.977 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 175.362 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 14.6 tpp180 -154.96 132.84 11.49 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.132 0.491 . . . . 0.0 111.709 179.7 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 9.2 m -88.64 137.38 32.37 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 177.311 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' ARG . . . . . 0.677 ' O ' ' HD3' ' A' ' 155' ' ' ARG . 2.4 tmt_? -70.12 -22.25 63.03 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 110.282 -0.266 . . . . 0.0 110.282 -176.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -50.86 -25.25 4.29 Favored 'General case' 0 N--CA 1.5 2.052 0 C-N-CA 123.482 0.713 . . . . 0.0 112.552 177.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.59 ' HB1' ' HG2' ' A' ' 161' ' ' GLN . . . -76.42 4.01 9.93 Favored 'General case' 0 C--N 1.306 -1.286 0 C-N-CA 124.924 1.29 . . . . 0.0 113.393 -178.311 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 86.7 m-85 91.53 23.46 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.147 0 C-N-CA 126.186 1.794 . . . . 0.0 109.51 -175.489 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . 0.464 ' HA3' ' O ' ' A' ' 65' ' ' ILE . . . 101.64 -94.4 1.22 Allowed Glycine 0 N--CA 1.398 -3.867 0 N-CA-C 109.224 -1.551 . . . . 0.0 109.224 -175.458 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.553 HG23 ' HB ' ' A' ' 65' ' ' ILE . 79.7 t -128.92 113.74 30.09 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.337 0 CA-C-O 121.505 0.669 . . . . 0.0 111.029 -178.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' GLN . . . . . 0.59 ' HG2' ' HB1' ' A' ' 157' ' ' ALA 0.315 10.0 pt20 -110.52 92.87 4.21 Favored 'General case' 0 C--N 1.302 -1.472 0 C-N-CA 117.203 -1.799 . . . . 0.0 114.54 179.278 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 26.0 tpt180 -146.22 102.14 3.58 Favored 'General case' 0 C--N 1.274 -2.708 0 N-CA-C 101.789 -3.411 . . . . 0.0 101.789 168.454 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 47.8 m-80 -110.67 123.03 49.23 Favored 'General case' 0 C--N 1.292 -1.93 0 N-CA-C 113.453 0.909 . . . . 0.0 113.453 -169.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . 0.459 ' CA ' ' HB ' ' A' ' 94' ' ' VAL . . . -95.11 -169.5 36.35 Favored Glycine 0 N--CA 1.42 -2.422 0 N-CA-C 108.823 -1.711 . . . . 0.0 108.823 172.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.616 ' H ' HD23 ' A' ' 165' ' ' LEU . 1.9 pt? -91.37 112.0 23.72 Favored 'General case' 0 C--N 1.296 -1.736 0 C-N-CA 119.113 -1.035 . . . . 0.0 109.648 -178.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . 0.683 ' HG2' ' SG ' ' A' ' 92' ' ' CYS . 78.9 mtt85 -82.74 101.16 10.7 Favored 'General case' 0 CA--C 1.48 -1.738 0 N-CA-C 106.447 -1.686 . . . . 0.0 106.447 174.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . 0.533 ' HB ' ' OG ' ' A' ' 90' ' ' SER . 52.4 t -68.59 -27.84 37.86 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.803 0 CA-C-N 114.942 -1.026 . . . . 0.0 112.25 -175.366 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . 0.42 ' HB2' ' HB2' ' A' ' 90' ' ' SER . 18.0 t70 -90.84 69.69 6.48 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-O 121.975 0.893 . . . . 0.0 110.432 -177.642 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 39.3 ttpt 177.92 130.54 0.06 Allowed 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 113.474 -1.694 . . . . 0.0 106.81 175.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' PHE . . . . . . . . . . . . . 64.0 m-85 . . . . . 0 C--N 1.288 -2.098 0 CA-C-O 119.148 -0.453 . . . . 0.0 110.302 -175.159 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.471 ' O ' ' HG ' ' A' ' 58' ' ' LEU . 18.4 mt . . . . . 0 N--CA 1.437 -1.115 0 CA-C-O 119.087 -0.482 . . . . 0.0 111.597 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.514 ' HA ' ' CD1' ' A' ' 58' ' ' LEU . 38.6 Cg_exo -58.59 -38.47 89.41 Favored 'Trans proline' 0 C--N 1.384 2.409 0 C-N-CA 121.209 1.273 . . . . 0.0 113.572 -172.059 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.406 ' O ' ' HG3' ' A' ' 59' ' ' LYS . 11.0 pt-20 -70.13 -30.13 67.24 Favored 'General case' 0 C--O 1.214 -0.765 0 CA-C-O 120.826 0.346 . . . . 0.0 110.815 178.317 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 62.4 tp -69.66 -33.38 72.51 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.371 177.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.514 ' CD1' ' HA ' ' A' ' 55' ' ' PRO . 6.3 mt -65.58 -52.59 51.08 Favored 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 -179.042 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.462 ' O ' ' HA ' ' A' ' 64' ' ' PRO . 15.3 ptpt -63.04 -24.04 67.73 Favored 'General case' 0 C--O 1.187 -2.213 0 CA-C-N 114.897 -1.047 . . . . 0.0 113.296 177.149 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -82.53 -54.77 4.92 Favored 'General case' 0 C--N 1.292 -1.898 0 O-C-N 121.848 -0.533 . . . . 0.0 112.283 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 54.0 t80 -56.96 -31.26 64.83 Favored 'General case' 0 C--O 1.245 0.827 0 C-N-CA 124.287 1.035 . . . . 0.0 110.68 -173.719 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.624 ' OD1' ' HB3' ' A' ' 75' ' ' TYR . 3.4 m-20 -108.56 25.69 11.4 Favored 'General case' 0 C--N 1.283 -2.32 0 CA-C-N 114.19 -1.368 . . . . 0.0 111.681 -172.312 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.641 HD21 ' H ' ' A' ' 115' ' ' GLY . 34.5 mt 80.91 143.33 0.08 OUTLIER Pre-proline 0 N--CA 1.477 0.89 0 C-N-CA 125.056 1.342 . . . . 0.0 108.936 -178.408 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.462 ' HA ' ' O ' ' A' ' 59' ' ' LYS . 10.2 Cg_endo -84.2 21.5 1.06 Allowed 'Trans proline' 0 N--CA 1.439 -1.733 0 C-N-CA 122.837 2.358 . . . . 0.0 113.239 -161.797 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.596 ' O ' ' HA3' ' A' ' 159' ' ' GLY . 0.2 OUTLIER -72.93 -38.13 55.7 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.913 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 175.338 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 55.07 8.64 1.57 Allowed Glycine 0 N--CA 1.473 1.106 0 CA-C-N 114.988 -1.005 . . . . 0.0 114.329 178.099 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.749 ' O ' ' HB ' ' A' ' 160' ' ' VAL . 37.9 mt 70.77 -31.93 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 C-N-CA 125.578 1.551 . . . . 0.0 113.911 -179.132 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.525 ' HB2' ' O ' ' A' ' 67' ' ' ILE . 55.6 t80 167.04 -56.89 0.0 OUTLIER Pre-proline 0 C--N 1.312 -1.046 0 C-N-CA 124.743 1.217 . . . . 0.0 108.936 175.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.476 ' HD3' ' HB3' ' A' ' 68' ' ' PHE . 19.3 Cg_endo -110.4 -16.73 0.03 OUTLIER 'Trans proline' 0 CA--C 1.569 2.225 0 C-N-CA 122.777 2.318 . . . . 0.0 116.877 -171.701 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.474 ' H ' ' HD2' ' A' ' 69' ' ' PRO . . . 84.09 7.19 85.66 Favored Glycine 0 CA--C 1.533 1.161 0 C-N-CA 119.732 -1.223 . . . . 0.0 110.395 -171.155 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.465 ' HB3' ' HG2' ' A' ' 69' ' ' PRO . 30.0 t70 -82.36 -50.62 8.71 Favored 'General case' 0 CA--C 1.497 -1.086 0 N-CA-C 106.314 -1.735 . . . . 0.0 106.314 177.395 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.42 ' HB1' HG13 ' A' ' 88' ' ' ILE . . . -83.03 176.73 9.02 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 113.732 -1.577 . . . . 0.0 107.48 166.049 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.561 ' O ' HG22 ' A' ' 73' ' ' THR . 89.4 m 82.0 27.86 0.15 Allowed 'General case' 0 N--CA 1.492 1.633 0 CA-C-O 124.363 2.03 . . . . 0.0 109.8 176.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.594 HD22 ' N ' ' A' ' 74' ' ' ASN . 0.8 OUTLIER -87.84 123.53 32.71 Favored 'General case' 0 C--N 1.257 -3.447 0 CA-C-N 114.417 -1.265 . . . . 0.0 110.464 179.434 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.624 ' HB3' ' OD1' ' A' ' 62' ' ' ASP . 46.2 p90 -82.17 141.53 32.97 Favored 'General case' 0 C--N 1.295 -1.771 0 O-C-N 124.243 0.964 . . . . 0.0 112.506 -178.639 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 32.0 mm-40 -159.39 136.84 9.88 Favored 'General case' 0 C--O 1.203 -1.347 0 C-N-CA 126.537 1.935 . . . . 0.0 107.266 174.409 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 49.9 p90 -134.7 148.32 50.28 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 118.538 0.608 . . . . 0.0 110.995 -177.163 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.619 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 4.6 m-20 -89.39 169.88 11.02 Favored 'General case' 0 CA--C 1.478 -1.827 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 177.477 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -81.41 -62.07 1.76 Allowed 'General case' 0 C--N 1.267 -3.013 0 CA-C-N 114.426 -1.261 . . . . 0.0 111.337 177.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.32 -33.59 49.17 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 115.398 -0.819 . . . . 0.0 112.502 -176.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.619 ' HB ' ' HB2' ' A' ' 78' ' ' ASP . 90.1 m -81.46 -47.6 12.97 Favored 'General case' 0 C--N 1.288 -2.093 0 CA-C-N 115.192 -0.913 . . . . 0.0 111.844 178.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.401 ' H ' ' HB2' ' A' ' 78' ' ' ASP . 65.5 mttp 61.73 -5.55 0.14 Allowed 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 115.345 1.609 . . . . 0.0 115.345 -179.238 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.775 ' HG2' HG22 ' A' ' 109' ' ' THR . 32.6 ttmt -75.2 110.22 9.35 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 173.071 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.543 HD11 ' HB2' ' A' ' 75' ' ' TYR . 5.8 tt -66.23 134.02 51.82 Favored 'General case' 0 C--N 1.299 -1.6 0 CA-C-N 114.756 -1.111 . . . . 0.0 111.41 -174.067 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 15.0 t -108.02 126.93 53.31 Favored 'General case' 0 N--CA 1.397 -3.093 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.238 -179.288 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.582 ' HA ' ' O ' ' A' ' 74' ' ' ASN . 79.0 t -96.9 132.24 41.8 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.672 -179.359 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.9 mp -95.4 114.63 26.42 Favored 'General case' 0 N--CA 1.423 -1.787 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.721 -179.444 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.42 HG13 ' HB1' ' A' ' 72' ' ' ALA . 2.4 mp -104.83 110.27 64.22 Favored Pre-proline 0 C--N 1.299 -1.616 0 N-CA-C 105.77 -1.937 . . . . 0.0 105.77 171.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.625 ' O ' ' HB2' ' A' ' 166' ' ' ARG . 51.8 Cg_exo -56.17 94.07 0.05 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.498 0 C-N-CA 122.782 2.321 . . . . 0.0 112.215 178.164 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . 0.491 ' HB2' ' HB2' ' A' ' 168' ' ' ASP . 40.9 t 74.95 141.53 0.07 Allowed 'General case' 0 C--N 1.343 0.323 0 C-N-CA 125.217 1.407 . . . . 0.0 111.813 -176.777 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.419 HD11 ' HD2' ' A' ' 103' ' ' LYS . 4.5 tt -69.08 121.35 18.27 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.504 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.894 177.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 12.7 p -107.58 145.16 33.59 Favored 'General case' 0 C--N 1.298 -1.657 0 CA-C-N 114.524 -1.216 . . . . 0.0 109.634 176.511 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.475 ' O ' ' HA3' ' A' ' 164' ' ' GLY . 2.2 mp0 -118.1 132.65 56.33 Favored 'General case' 0 CA--C 1.471 -2.087 0 N-CA-C 105.969 -1.863 . . . . 0.0 105.969 178.585 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.661 HG13 ' H ' ' A' ' 163' ' ' ASN . 16.7 t -108.8 104.19 16.69 Favored 'Isoleucine or valine' 0 N--CA 1.398 -3.046 0 C-N-CA 119.366 -0.934 . . . . 0.0 109.132 -178.628 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.404 -3.477 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 -179.102 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . 0.44 ' HA ' ' O ' ' A' ' 126' ' ' LYS . 46.4 t . . . . . 0 N--CA 1.419 -2.01 0 N-CA-C 104.816 -2.29 . . . . 0.0 104.816 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 54.3 t -126.03 131.21 71.97 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 179.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.539 ' HB2' ' HB ' ' A' ' 94' ' ' VAL . 2.7 mp -126.81 148.42 49.95 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 118.145 0.429 . . . . 0.0 110.126 -177.61 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.419 ' HD2' HD11 ' A' ' 91' ' ' ILE . 39.5 ttpt -138.67 123.73 19.01 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 174.811 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -120.77 108.05 13.49 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 178.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 12.4 t -81.47 -177.35 6.47 Favored 'General case' 0 N--CA 1.432 -1.339 0 CA-C-O 121.133 0.492 . . . . 0.0 111.266 -178.431 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 39.4 p -66.07 -58.71 4.87 Favored 'General case' 0 C--N 1.301 -1.538 0 C-N-CA 124.833 1.253 . . . . 0.0 112.595 -172.376 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 6.4 m -122.54 97.32 5.4 Favored 'General case' 0 N--CA 1.41 -2.455 0 CA-C-O 121.535 0.683 . . . . 0.0 109.866 -175.571 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 18.1 m -99.02 141.11 17.09 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 CA-C-N 114.978 -1.01 . . . . 0.0 109.545 179.301 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.775 HG22 ' HG2' ' A' ' 83' ' ' LYS . 2.9 m -114.62 119.91 38.36 Favored 'General case' 0 N--CA 1.403 -2.783 0 N-CA-C 104.748 -2.316 . . . . 0.0 104.748 -174.336 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . 0.734 ' HA2' ' O ' ' A' ' 119' ' ' ASP . . . -141.74 159.56 26.9 Favored Glycine 0 N--CA 1.435 -1.38 0 C-N-CA 120.037 -1.078 . . . . 0.0 115.169 -174.258 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 6.8 t60 -88.06 109.28 19.73 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 177.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 65.3 tp -106.96 120.99 43.55 Favored 'General case' 0 C--N 1.302 -1.461 0 C-N-CA 119.885 -0.726 . . . . 0.0 112.458 -175.099 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -115.1 158.05 22.71 Favored 'General case' 0 CA--C 1.448 -2.971 0 N-CA-C 107.505 -1.294 . . . . 0.0 107.505 169.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 2.4 tmtm? -82.25 99.12 9.12 Favored 'General case' 2 N--CA 1.375 -4.202 0 N-CA-C 107.135 -1.432 . . . . 0.0 107.135 -175.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . 0.641 ' H ' HD21 ' A' ' 63' ' ' LEU . . . 131.28 -20.24 4.74 Favored Glycine 0 C--O 1.19 -2.631 0 N-CA-C 109.978 -1.249 . . . . 0.0 109.978 -177.257 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -163.23 135.8 5.38 Favored 'General case' 0 C--N 1.314 -0.953 0 O-C-N 122.109 -0.642 . . . . 0.0 110.864 -177.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 3.1 tt -116.8 114.54 24.08 Favored 'General case' 0 C--N 1.286 -2.168 0 N-CA-C 106.246 -1.761 . . . . 0.0 106.246 178.002 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.452 ' HA ' ' CB ' ' A' ' 135' ' ' SER . 49.9 p -116.52 175.77 5.41 Favored 'General case' 0 C--N 1.279 -2.48 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.424 -176.016 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . 0.734 ' O ' ' HA2' ' A' ' 110' ' ' GLY . 7.0 m-20 54.91 83.84 0.08 Allowed 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.629 0.772 . . . . 0.0 111.2 174.85 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.431 ' CG2' ' HB ' ' A' ' 123' ' ' ILE . 13.6 m -119.3 108.47 23.86 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.8 0 CA-C-O 122.303 1.049 . . . . 0.0 112.321 -172.469 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -79.9 100.24 7.95 Favored 'General case' 0 C--N 1.268 -2.943 0 CA-C-N 114.331 -1.304 . . . . 0.0 110.204 174.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 123.94 -14.08 8.01 Favored Glycine 0 N--CA 1.435 -1.428 0 C-N-CA 120.722 -0.751 . . . . 0.0 113.161 176.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.431 ' HB ' ' CG2' ' A' ' 120' ' ' VAL . 63.5 mt -102.46 116.09 45.53 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.914 0 CA-C-O 121.536 0.684 . . . . 0.0 110.116 179.555 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -124.21 141.23 52.24 Favored 'General case' 0 C--N 1.294 -1.847 0 CA-C-N 114.795 -1.093 . . . . 0.0 109.053 178.474 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.433 ' OG1' ' HG ' ' A' ' 102' ' ' LEU . 11.1 t -152.48 162.67 40.88 Favored 'General case' 0 C--O 1.245 0.847 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 178.495 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.454 ' HE2' ' N ' ' A' ' 128' ' ' MET . 8.3 tmtt? -131.18 129.59 41.91 Favored 'General case' 0 N--CA 1.426 -1.635 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.656 176.261 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.408 ' O ' ' HB3' ' A' ' 128' ' ' MET . 41.8 t -150.02 112.81 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.481 -1.699 0 N-CA-C 104.31 -2.478 . . . . 0.0 104.31 172.764 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . 0.454 ' N ' ' HE2' ' A' ' 126' ' ' LYS . 45.9 ttm 69.48 -54.95 0.58 Allowed 'General case' 0 N--CA 1.473 0.696 0 O-C-N 124.031 0.832 . . . . 0.0 109.978 -172.054 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 8.0 tp -139.18 162.89 27.21 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.716 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 178.38 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 69.5 p-90 -92.67 137.72 32.12 Favored 'General case' 0 N--CA 1.423 -1.823 0 CA-C-O 121.064 0.459 . . . . 0.0 110.861 -178.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 53.4 t -134.31 121.83 38.38 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.154 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 179.343 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 60.1 pttt -98.29 3.16 48.73 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.157 0.503 . . . . 0.0 111.955 -176.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 34.4 m -124.22 25.02 3.47 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.204 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 176.545 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 9.4 t -55.24 113.24 1.31 Allowed 'General case' 0 N--CA 1.441 -0.906 0 CA-C-N 113.258 -1.792 . . . . 0.0 113.249 -173.178 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . 0.46 ' O ' ' HA ' ' A' ' 146' ' ' THR . 26.3 p -100.1 149.94 22.99 Favored 'General case' 0 N--CA 1.405 -2.72 0 C-N-CA 119.72 -0.792 . . . . 0.0 113.033 -177.38 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . 0.527 ' HB ' HG22 ' A' ' 146' ' ' THR . 13.2 tt -100.9 138.46 25.05 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.71 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 -179.109 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 14.7 t -120.55 142.71 49.09 Favored 'General case' 0 N--CA 1.408 -2.567 0 N-CA-C 107.052 -1.462 . . . . 0.0 107.052 -178.479 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . 0.453 ' HB ' HD13 ' A' ' 63' ' ' LEU . 33.2 m -149.02 175.5 11.25 Favored 'General case' 0 C--N 1.27 -2.882 0 N-CA-C 106.523 -1.658 . . . . 0.0 106.523 -176.768 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -118.05 30.45 7.23 Favored 'General case' 0 C--N 1.277 -2.583 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 174.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . 0.499 ' HA ' HD22 ' A' ' 63' ' ' LEU . . . 60.26 36.56 20.75 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-N 114.745 -1.116 . . . . 0.0 110.145 -177.045 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . 0.407 ' H ' HG22 ' A' ' 138' ' ' THR . 41.4 t 174.38 -82.68 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 114.283 -1.326 . . . . 0.0 108.353 -172.607 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 23.0 pttm -77.56 136.79 38.32 Favored 'General case' 0 CA--C 1.505 -0.758 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 177.62 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.409 HG21 HG21 ' A' ' 65' ' ' ILE . 12.4 p -109.95 156.58 10.79 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.889 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 -171.23 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -128.98 154.16 46.86 Favored 'General case' 0 N--CA 1.428 -1.539 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 174.613 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 33.9 t80 -73.96 162.92 28.55 Favored 'General case' 0 C--N 1.309 -1.152 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 -175.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.527 HG22 ' HB ' ' A' ' 136' ' ' ILE . 70.9 p -71.7 -172.73 0.85 Allowed 'General case' 0 N--CA 1.42 -1.966 0 CA-C-O 121.512 0.672 . . . . 0.0 112.609 -175.358 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . 74.78 -29.54 0.19 Allowed 'General case' 0 N--CA 1.463 0.192 0 C-N-CA 126.018 1.727 . . . . 0.0 113.317 177.267 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 147.74 43.63 0.03 OUTLIER Glycine 0 CA--C 1.477 -2.319 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 178.008 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 65.3 mtt 60.96 40.14 15.76 Favored 'General case' 0 C--N 1.344 0.369 0 O-C-N 124.196 0.586 . . . . 0.0 110.224 -177.409 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . 0.6 ' HE2' ' HA ' ' A' ' 150' ' ' LYS . 9.5 mmpt? -65.53 -16.76 64.0 Favored 'General case' 0 N--CA 1.483 1.199 0 CA-C-O 120.816 0.341 . . . . 0.0 111.415 -178.766 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . 0.543 ' HA ' ' HE3' ' A' ' 151' ' ' LYS . 0.0 OUTLIER -147.27 163.43 36.42 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 176.962 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 9.0 p -131.34 111.65 12.04 Favored 'General case' 0 C--N 1.292 -1.904 0 CA-C-O 121.391 0.615 . . . . 0.0 110.483 176.502 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 33.5 mmt180 -113.87 160.51 18.68 Favored 'General case' 0 CA--C 1.501 -0.914 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.001 -179.085 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 51.2 m -96.05 140.49 30.7 Favored 'General case' 0 N--CA 1.42 -1.93 0 CA-C-N 116.253 -0.43 . . . . 0.0 109.905 177.068 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' ARG . . . . . 0.574 ' HG3' ' HA2' ' A' ' 159' ' ' GLY . 9.0 ttp180 -74.99 -21.2 59.28 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.051 175.625 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -34.92 -49.6 0.45 Allowed 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 126.315 1.846 . . . . 0.0 114.806 -174.144 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -77.44 -55.37 5.45 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 113.635 0.976 . . . . 0.0 113.635 -176.198 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -153.52 16.02 0.52 Allowed 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.981 -0.449 . . . . 0.0 111.836 -176.01 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . 0.596 ' HA3' ' O ' ' A' ' 65' ' ' ILE . . . 84.88 -89.35 1.6 Allowed Glycine 0 CA--C 1.466 -2.989 0 C-N-CA 119.646 -1.264 . . . . 0.0 110.735 -174.501 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.749 ' HB ' ' O ' ' A' ' 67' ' ' ILE . 39.1 t -99.6 148.5 6.39 Favored 'Isoleucine or valine' 0 N--CA 1.4 -2.931 0 C-N-CA 119.491 -0.884 . . . . 0.0 109.102 177.575 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 74.8 mt-30 -113.74 108.98 17.84 Favored 'General case' 0 N--CA 1.416 -2.158 0 N-CA-C 106.393 -1.706 . . . . 0.0 106.393 -172.082 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . 0.537 ' HD2' ' C ' ' A' ' 162' ' ' ARG . 5.2 ppt_? -125.9 163.15 23.57 Favored 'General case' 0 C--N 1.275 -2.668 0 CA-C-N 115.167 -0.924 . . . . 0.0 112.919 -169.76 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' ASN . . . . . 0.661 ' H ' HG13 ' A' ' 94' ' ' VAL . 3.1 m-20 -110.4 -59.65 1.91 Allowed 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.875 175.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . 0.503 ' O ' ' HD3' ' A' ' 162' ' ' ARG . . . -61.0 147.38 47.03 Favored Glycine 0 CA--C 1.501 -0.782 0 CA-C-N 115.877 -0.601 . . . . 0.0 113.033 -179.635 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 65.6 tp -107.83 139.23 42.73 Favored 'General case' 0 N--CA 1.422 -1.827 0 CA-C-O 121.169 0.509 . . . . 0.0 109.851 -177.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . 0.625 ' HB2' ' O ' ' A' ' 89' ' ' PRO . 6.5 ptp85 -85.84 103.49 14.64 Favored 'General case' 0 C--N 1.287 -2.146 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 176.471 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 4.8 t -102.9 70.98 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.788 0 CA-C-N 115.184 -0.916 . . . . 0.0 112.46 -170.52 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . 0.491 ' HB2' ' HB2' ' A' ' 90' ' ' SER . 15.8 t70 -109.14 -39.2 5.33 Favored 'General case' 0 CA--C 1.475 -1.918 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 175.304 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' LYS . . . . . 0.645 ' HD3' ' H ' ' A' ' 169' ' ' LYS . 0.0 OUTLIER -93.1 149.65 21.08 Favored 'General case' 0 C--N 1.287 -2.128 0 CA-C-N 113.48 -1.691 . . . . 0.0 109.634 -174.146 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' PHE . . . . . . . . . . . . . 81.6 t80 . . . . . 0 C--N 1.288 -2.082 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 179.719 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.645 ' HB3' ' HD3' ' A' ' 55' ' ' PRO . 10.5 tp . . . . . 0 C--O 1.203 -1.349 0 N-CA-C 110.213 -0.292 . . . . 0.0 110.213 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.645 ' HD3' ' HB3' ' A' ' 54' ' ' LEU . 8.1 Cg_exo -50.73 -38.2 55.81 Favored 'Trans proline' 0 C--N 1.388 2.608 0 C-N-CA 123.536 2.824 . . . . 0.0 112.671 -177.444 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -76.95 -31.84 56.88 Favored 'General case' 0 N--CA 1.432 -1.365 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.069 -179.299 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.564 ' HG ' ' O ' ' A' ' 54' ' ' LEU . 2.0 pp -75.74 -28.67 58.59 Favored 'General case' 0 C--O 1.204 -1.293 0 C-N-CA 119.669 -0.812 . . . . 0.0 108.984 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.639 ' HG ' ' O ' ' A' ' 54' ' ' LEU . 63.0 mt -57.34 -48.76 78.14 Favored 'General case' 0 C--O 1.199 -1.571 0 O-C-N 123.938 0.774 . . . . 0.0 110.809 -177.123 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 55.2 mtpt -64.88 -29.53 70.49 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-O 121.846 0.832 . . . . 0.0 110.627 -177.68 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -96.71 1.71 51.25 Favored 'General case' 0 C--N 1.297 -1.686 0 CA-C-N 114.692 -1.14 . . . . 0.0 111.424 -178.214 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.437 ' HB3' ' CD2' ' A' ' 75' ' ' TYR . 41.2 t80 -57.15 -42.88 81.86 Favored 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 112.776 0.658 . . . . 0.0 112.776 -170.542 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.566 ' OD1' ' HA ' ' A' ' 114' ' ' LYS . 11.2 t70 -139.67 -74.56 0.36 Allowed 'General case' 0 C--N 1.315 -0.916 0 C-N-CA 120.031 -0.667 . . . . 0.0 109.989 -177.41 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.559 HD21 ' H ' ' A' ' 115' ' ' GLY . 20.3 mt -96.29 150.17 36.82 Favored Pre-proline 0 N--CA 1.445 -0.719 0 N-CA-C 106.23 -1.767 . . . . 0.0 106.23 175.489 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_endo -99.9 18.22 0.35 Allowed 'Trans proline' 0 N--CA 1.443 -1.497 0 C-N-CA 123.77 2.98 . . . . 0.0 113.539 -169.391 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.517 ' HB ' HG23 ' A' ' 160' ' ' VAL . 0.2 OUTLIER -69.78 -45.01 78.6 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.872 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 176.743 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 52.83 9.53 0.8 Allowed Glycine 0 N--CA 1.486 2.011 0 CA-C-N 114.908 -1.042 . . . . 0.0 114.266 178.401 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.667 ' HA ' ' CG2' ' A' ' 160' ' ' VAL 0.288 20.2 mt 62.17 -68.37 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 C-N-CA 126.413 1.885 . . . . 0.0 112.835 -170.948 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.418 ' HB3' ' HD3' ' A' ' 69' ' ' PRO . 69.6 t80 177.97 -55.41 0.0 OUTLIER Pre-proline 0 C--N 1.301 -1.528 0 O-C-N 123.69 0.619 . . . . 0.0 111.674 -177.787 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.418 ' HD3' ' HB3' ' A' ' 68' ' ' PHE . 2.9 Cg_endo -82.9 -70.35 0.01 OUTLIER 'Trans proline' 0 C--N 1.369 1.647 0 C-N-CA 121.763 1.642 . . . . 0.0 113.003 -175.402 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 153.73 -40.53 0.67 Allowed Glycine 0 CA--C 1.492 -1.38 0 N-CA-C 110.092 -1.203 . . . . 0.0 110.092 -176.114 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.442 ' HB3' ' HG3' ' A' ' 89' ' ' PRO . 3.2 t70 -74.84 -55.25 6.01 Favored 'General case' 0 C--O 1.184 -2.352 0 N-CA-C 104.745 -2.317 . . . . 0.0 104.745 175.757 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.432 ' HA ' HG12 ' A' ' 88' ' ' ILE . . . -66.08 99.57 0.52 Allowed 'General case' 0 C--N 1.31 -1.132 0 C-N-CA 117.082 -1.847 . . . . 0.0 107.556 163.216 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . 1.619 6.3 m 115.26 30.8 0.0 OUTLIER 'General case' 0 N--CA 1.439 -1.012 1 N-CA-C 123.299 4.555 . . . . 0.0 123.299 -178.542 . . . . . . . . 3 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.582 ' O ' HG22 ' A' ' 86' ' ' VAL . 3.5 p30 -89.11 178.28 6.42 Favored 'General case' 0 C--N 1.293 -1.882 0 CA-C-N 114.708 -1.133 . . . . 0.0 108.003 167.419 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.504 ' HB3' HD21 ' A' ' 84' ' ' LEU . 93.4 m-85 -136.73 101.56 4.64 Favored 'General case' 0 C--N 1.281 -2.395 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 -178.248 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -108.59 114.15 27.72 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 -178.253 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 87.8 t80 -112.94 126.73 55.8 Favored 'General case' 0 C--N 1.282 -2.363 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 -176.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.671 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 7.3 m-20 -91.09 164.44 13.94 Favored 'General case' 0 CA--C 1.478 -1.799 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 177.001 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -80.27 -64.77 1.11 Allowed 'General case' 0 C--N 1.278 -2.515 0 CA-C-N 115.055 -0.975 . . . . 0.0 112.662 -175.541 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -71.91 -30.36 65.28 Favored 'General case' 0 CA--C 1.506 -0.736 0 CA-C-O 121.437 0.637 . . . . 0.0 110.538 -176.033 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.671 ' HB ' ' HB2' ' A' ' 78' ' ' ASP . 17.7 m -66.29 -46.81 75.7 Favored 'General case' 0 N--CA 1.417 -2.125 0 CA-C-N 115.082 -0.963 . . . . 0.0 110.295 -178.218 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 97.3 mttt 64.58 17.59 10.96 Favored 'General case' 0 N--CA 1.486 1.363 0 CA-C-O 121.982 0.896 . . . . 0.0 111.486 178.345 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.485 ' HB3' HG22 ' A' ' 81' ' ' THR . 47.0 tptt -116.03 124.62 50.91 Favored 'General case' 0 N--CA 1.394 -3.248 0 N-CA-C 105.242 -2.133 . . . . 0.0 105.242 -178.607 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.504 HD21 ' HB3' ' A' ' 75' ' ' TYR . 3.1 tm? -76.46 137.38 39.64 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 179.794 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.447 ' N ' HD13 ' A' ' 84' ' ' LEU . 54.1 p -125.94 144.8 50.54 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.582 HG22 ' O ' ' A' ' 74' ' ' ASN . 92.9 t -112.98 130.39 66.92 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.512 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 172.337 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 18.5 mt -96.4 102.16 13.91 Favored 'General case' 0 C--N 1.282 -2.355 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 -179.447 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.432 HG12 ' HA ' ' A' ' 72' ' ' ALA . 62.6 mt -104.15 135.1 19.39 Favored Pre-proline 0 C--N 1.306 -1.313 0 N-CA-C 109.63 -0.508 . . . . 0.0 109.63 -178.378 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.442 ' HG3' ' HB3' ' A' ' 71' ' ' ASP . 37.9 Cg_endo -84.04 110.34 1.54 Allowed 'Trans proline' 0 N--CA 1.43 -2.264 0 C-N-CA 122.548 2.165 . . . . 0.0 110.483 177.606 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 59.9 m 71.41 156.25 0.16 Allowed 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 122.146 0.974 . . . . 0.0 113.181 -179.748 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.511 HG12 ' HA ' ' A' ' 105' ' ' THR . 96.5 mt -80.72 125.69 39.4 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.861 0 CA-C-N 114.807 -1.088 . . . . 0.0 110.038 177.058 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 8.9 p -118.13 145.92 44.54 Favored 'General case' 0 C--N 1.293 -1.87 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 173.292 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -131.18 130.84 43.53 Favored 'General case' 0 C--N 1.282 -2.334 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 -174.099 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.614 HG13 ' H ' ' A' ' 163' ' ' ASN . 55.7 t -118.67 109.43 26.92 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.296 0 CA-C-O 121.266 0.555 . . . . 0.0 111.87 -173.779 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.408 -3.209 0 N-CA-C 109.357 -1.497 . . . . 0.0 109.357 175.306 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . 0.646 ' HB3' ' O ' ' A' ' 126' ' ' LYS . 23.3 m . . . . . 0 N--CA 1.402 -2.856 0 CA-C-O 120.512 0.196 . . . . 0.0 110.489 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 86.6 t -128.68 102.64 8.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 N-CA-C 107.313 -1.365 . . . . 0.0 107.313 175.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.657 HD22 HG23 ' A' ' 125' ' ' THR . 55.2 mt -109.39 130.86 55.48 Favored 'General case' 0 C--N 1.285 -2.205 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.989 -171.144 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.443 ' HE3' HD13 ' A' ' 91' ' ' ILE . 35.2 tttp -103.63 115.57 30.74 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 110.237 -0.282 . . . . 0.0 110.237 -175.391 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -96.89 95.73 8.05 Favored 'General case' 0 N--CA 1.413 -2.285 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 173.303 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.636 ' H ' HG22 ' A' ' 123' ' ' ILE . 19.6 m -66.35 179.56 0.97 Allowed 'General case' 0 N--CA 1.423 -1.803 0 CA-C-N 113.587 -1.642 . . . . 0.0 110.186 177.318 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . 0.631 ' H ' HG22 ' A' ' 105' ' ' THR . 22.1 p -79.56 -74.09 0.31 Allowed 'General case' 0 C--N 1.301 -1.527 0 C-N-CA 123.814 0.846 . . . . 0.0 112.408 -173.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 11.5 p -96.04 101.59 13.28 Favored 'General case' 0 N--CA 1.406 -2.642 0 CA-C-O 121.295 0.569 . . . . 0.0 110.25 -178.412 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.444 ' CG2' HG23 ' A' ' 123' ' ' ILE . 1.1 p -97.45 159.01 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.03 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 -179.778 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.483 HG22 ' HG2' ' A' ' 83' ' ' LYS . 63.6 m -144.71 120.38 10.47 Favored 'General case' 0 C--N 1.293 -1.876 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 -173.103 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . 0.55 ' HA3' ' O ' ' A' ' 119' ' ' ASP . . . -160.69 -157.45 8.71 Favored Glycine 0 C--O 1.202 -1.897 0 C-N-CA 121.091 -0.576 . . . . 0.0 113.88 -174.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 36.4 m80 -124.64 117.34 24.06 Favored 'General case' 0 C--N 1.305 -1.358 0 O-C-N 122.269 -0.548 . . . . 0.0 109.687 177.277 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.478 HD22 ' CD1' ' A' ' 75' ' ' TYR . 67.0 tp -100.68 129.61 46.61 Favored 'General case' 0 C--N 1.293 -1.885 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.267 -177.605 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -127.32 153.29 46.36 Favored 'General case' 0 CA--C 1.441 -3.239 0 CA-C-N 115.018 -0.992 . . . . 0.0 109.507 174.115 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.566 ' HA ' ' OD1' ' A' ' 62' ' ' ASP . 56.6 tptt -67.54 101.52 1.01 Allowed 'General case' 0 N--CA 1.388 -3.539 0 O-C-N 124.672 1.233 . . . . 0.0 107.896 176.816 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . 0.573 ' O ' ' HB ' ' A' ' 138' ' ' THR . . . 135.78 -55.3 0.72 Allowed Glycine 0 N--CA 1.401 -3.657 0 N-CA-C 109.272 -1.531 . . . . 0.0 109.272 -175.209 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.611 ' HD3' HG23 ' A' ' 118' ' ' THR . 0.0 OUTLIER -148.98 152.73 36.84 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 -177.485 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.521 ' O ' ' HB2' ' A' ' 135' ' ' SER . 47.9 tp -108.47 102.77 11.83 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-N 115.337 -0.847 . . . . 0.0 108.96 177.616 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.611 HG23 ' HD3' ' A' ' 116' ' ' LYS . 6.1 p -103.22 167.09 10.05 Favored 'General case' 0 C--N 1.299 -1.619 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.048 178.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . 0.55 ' O ' ' HA3' ' A' ' 110' ' ' GLY . 5.8 m-20 67.94 107.22 0.05 OUTLIER 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.665 0.786 . . . . 0.0 109.12 -176.041 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.527 ' HB ' HG12 ' A' ' 123' ' ' ILE 0.354 4.1 m -125.7 72.79 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.401 -2.92 0 N-CA-C 114.243 1.201 . . . . 0.0 114.243 179.514 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -82.04 86.39 6.58 Favored 'General case' 0 N--CA 1.425 -1.682 0 CA-C-N 114.271 -1.331 . . . . 0.0 110.449 176.121 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 161.92 -40.77 0.39 Allowed Glycine 0 C--N 1.262 -3.533 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 175.141 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.636 HG22 ' H ' ' A' ' 105' ' ' THR . 25.2 pt -100.12 152.2 4.83 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.737 0 C-N-CA 119.09 -1.044 . . . . 0.0 108.813 -178.041 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.423 ' NZ ' ' HB2' ' A' ' 124' ' ' LYS . 4.1 ttmp? -128.79 138.0 51.83 Favored 'General case' 0 C--N 1.27 -2.854 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 -176.468 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.657 HG23 HD22 ' A' ' 102' ' ' LEU . 13.3 m -124.13 115.45 21.16 Favored 'General case' 0 C--N 1.283 -2.296 0 CA-C-N 115.517 -0.765 . . . . 0.0 112.928 -169.561 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.646 ' O ' ' HB3' ' A' ' 100' ' ' SER . 0.2 OUTLIER -100.85 115.66 30.89 Favored 'General case' 0 N--CA 1.413 -2.289 0 N-CA-C 107.154 -1.424 . . . . 0.0 107.154 169.572 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.647 HG13 ' SD ' ' A' ' 128' ' ' MET 0.25 1.0 OUTLIER -120.47 -78.46 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.128 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.353 176.739 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . 0.647 ' SD ' HG13 ' A' ' 127' ' ' VAL . 0.0 OUTLIER -103.69 -9.15 19.36 Favored 'General case' 0 N--CA 1.412 -2.362 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 176.67 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . 0.411 HG23 HG13 ' A' ' 131' ' ' VAL . 8.9 tp -164.06 164.48 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.41 -2.437 0 N-CA-C 106.297 -1.742 . . . . 0.0 106.297 177.834 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 31.0 t90 -85.33 114.93 22.77 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 -178.436 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.411 HG13 HG23 ' A' ' 129' ' ' ILE . 15.7 m -148.74 -175.27 0.38 Allowed 'Isoleucine or valine' 0 C--O 1.211 -0.953 0 C-N-CA 125.125 1.37 . . . . 0.0 109.452 -176.381 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . 0.505 ' HG3' ' N ' ' A' ' 133' ' ' VAL . 38.6 pttt -131.06 -36.62 1.32 Allowed 'General case' 0 C--N 1.305 -1.334 0 C-N-CA 120.227 -0.589 . . . . 0.0 112.038 176.163 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.505 ' N ' ' HG3' ' A' ' 132' ' ' LYS . 25.6 m -69.81 -8.0 9.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 N-CA-C 115.389 1.626 . . . . 0.0 115.389 -165.484 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . 0.416 ' O ' ' HB ' ' A' ' 146' ' ' THR . 37.9 p -75.57 90.3 2.77 Favored 'General case' 0 N--CA 1.42 -1.951 0 CA-C-O 121.767 0.794 . . . . 0.0 110.48 179.464 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . 0.521 ' HB2' ' O ' ' A' ' 117' ' ' LEU . 30.0 p -86.13 174.27 9.27 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-N 114.404 -1.271 . . . . 0.0 112.757 -175.554 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 9.4 tt -98.33 122.46 50.01 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.798 0 CA-C-O 122.027 0.918 . . . . 0.0 111.889 -171.38 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 34.0 p -96.56 148.11 23.17 Favored 'General case' 0 N--CA 1.417 -2.113 0 CA-C-N 114.886 -1.052 . . . . 0.0 108.69 176.473 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . 0.573 ' HB ' ' O ' ' A' ' 115' ' ' GLY . 93.6 m -154.03 164.09 39.03 Favored 'General case' 0 C--N 1.289 -2.043 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 -172.565 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 63.7 m-20 -99.64 22.97 10.13 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 172.457 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . 0.549 ' N ' HG22 ' A' ' 138' ' ' THR . . . 58.86 36.36 24.62 Favored 'General case' 0 C--N 1.351 0.661 0 N-CA-C 106.525 -1.657 . . . . 0.0 106.525 -167.331 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . 0.481 ' H ' HG22 ' A' ' 138' ' ' THR . 35.3 t -167.54 -75.36 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.841 0 CA-C-N 113.741 -1.572 . . . . 0.0 110.341 -170.124 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . 0.513 ' O ' HG23 ' A' ' 138' ' ' THR . 96.7 mttt -98.65 163.58 12.59 Favored 'General case' 0 N--CA 1.484 1.268 0 CA-C-N 117.924 0.329 . . . . 0.0 110.581 -179.306 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 92.1 t -106.7 135.14 46.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-O 121.431 0.634 . . . . 0.0 111.1 -178.389 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 62.5 m-85 -119.76 156.53 30.4 Favored 'General case' 0 C--N 1.296 -1.732 0 CA-C-N 115.483 -0.781 . . . . 0.0 109.501 179.143 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 46.9 p90 -42.03 133.17 3.04 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 124.558 1.143 . . . . 0.0 113.92 -176.288 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.495 ' HA ' ' O ' ' A' ' 135' ' ' SER . 74.5 p -78.71 -40.46 33.66 Favored 'General case' 0 N--CA 1.433 -1.311 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.101 177.699 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . 0.433 ' CB ' HG11 ' A' ' 127' ' ' VAL . . . -112.09 157.71 20.47 Favored 'General case' 0 N--CA 1.433 -1.292 0 CA-C-N 115.091 -0.958 . . . . 0.0 108.739 178.618 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -67.41 -27.78 73.57 Favored Glycine 0 C--N 1.309 -0.945 0 O-C-N 123.543 0.527 . . . . 0.0 113.153 -176.266 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 1.6 tmt? -78.25 -24.27 46.99 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-O 121.271 0.558 . . . . 0.0 110.429 178.259 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . 0.523 ' HE2' ' CG2' ' A' ' 127' ' ' VAL . 21.5 ttmm -80.14 166.45 21.46 Favored 'General case' 0 N--CA 1.433 -1.317 0 CA-C-N 115.289 -0.869 . . . . 0.0 110.155 -176.03 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -110.49 161.92 15.2 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 -177.381 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 44.2 m -76.17 155.41 34.58 Favored 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 176.136 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 24.4 tpt180 -142.77 138.69 30.63 Favored 'General case' 0 N--CA 1.435 -1.187 0 C-N-CA 119.104 -1.039 . . . . 0.0 112.077 -172.001 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 28.5 p -68.25 118.62 11.6 Favored 'General case' 0 N--CA 1.44 -0.958 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.668 177.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' ARG . . . . . 0.547 ' HB2' ' O ' ' A' ' 159' ' ' GLY 0.315 0.0 OUTLIER -83.35 -20.6 33.99 Favored 'General case' 0 C--O 1.204 -1.336 0 C-N-CA 119.357 -0.937 . . . . 0.0 113.476 -178.787 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . 0.413 ' HA ' HH21 ' A' ' 155' ' ' ARG . 22.7 t70 -43.78 -32.03 0.95 Allowed 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 124.774 1.23 . . . . 0.0 113.425 -178.676 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -61.53 -38.53 87.76 Favored 'General case' 0 CA--C 1.553 1.095 0 N-CA-C 113.647 0.98 . . . . 0.0 113.647 -179.739 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 41.1 m-85 -152.55 -21.69 0.17 Allowed 'General case' 0 N--CA 1.504 2.238 0 CA-C-N 118.363 0.529 . . . . 0.0 111.507 -177.432 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . 0.547 ' O ' ' HB2' ' A' ' 155' ' ' ARG . . . 106.34 -91.33 0.72 Allowed Glycine 0 CA--C 1.464 -3.149 0 N-CA-C 105.585 -3.006 . . . . 0.0 105.585 -166.413 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.667 ' CG2' ' HA ' ' A' ' 67' ' ' ILE . 88.9 t -100.66 141.68 17.04 Favored 'Isoleucine or valine' 0 N--CA 1.388 -3.534 0 N-CA-C 105.984 -1.858 . . . . 0.0 105.984 167.291 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 65.5 mt-30 -94.47 92.12 6.97 Favored 'General case' 0 CA--C 1.453 -2.755 0 N-CA-C 106.425 -1.695 . . . . 0.0 106.425 -170.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . 0.61 ' O ' ' HD2' ' A' ' 162' ' ' ARG . 0.0 OUTLIER -101.24 135.89 41.98 Favored 'General case' 1 N--CA 1.379 -4.016 0 CA-C-N 114.573 -1.194 . . . . 0.0 111.648 -170.685 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' ASN . . . . . 0.614 ' H ' HG13 ' A' ' 94' ' ' VAL . 7.5 t30 -114.77 -13.63 12.03 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 177.537 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . 0.446 ' O ' ' HD3' ' A' ' 162' ' ' ARG . . . -100.38 157.78 19.43 Favored Glycine 0 N--CA 1.428 -1.863 0 CA-C-N 114.225 -1.352 . . . . 0.0 110.609 178.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.416 ' O ' HD12 ' A' ' 165' ' ' LEU . 2.1 pp -121.38 153.78 37.35 Favored 'General case' 0 C--N 1.287 -2.144 0 C-N-CA 123.234 0.614 . . . . 0.0 109.935 -177.234 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . 0.401 ' HG2' ' HG2' ' A' ' 89' ' ' PRO . 0.0 OUTLIER -71.38 129.75 39.61 Favored 'General case' 0 N--CA 1.432 -1.326 0 N-CA-C 106.856 -1.535 . . . . 0.0 106.856 173.899 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 46.8 t -57.54 -29.65 34.55 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 CA-C-O 121.444 0.64 . . . . 0.0 109.684 174.557 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -70.29 -34.6 72.95 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 123.475 0.71 . . . . 0.0 111.378 178.054 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 64.8 tttp -96.99 109.63 22.34 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 113.248 0.832 . . . . 0.0 113.248 -174.462 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 . . . . . 0 C--N 1.293 -1.885 0 N-CA-C 107.099 -1.445 . . . . 0.0 107.099 173.914 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.515 ' HB3' ' HD3' ' A' ' 55' ' ' PRO . 14.8 tp . . . . . 0 C--O 1.199 -1.59 0 CA-C-O 118.895 -0.574 . . . . 0.0 111.65 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.515 ' HD3' ' HB3' ' A' ' 54' ' ' LEU . 0.1 OUTLIER -38.3 -45.58 2.2 Favored 'Trans proline' 0 C--N 1.388 2.613 0 C-N-CA 124.143 3.229 . . . . 0.0 113.476 177.185 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.435 ' HA ' ' HE2' ' A' ' 59' ' ' LYS . 12.3 pt-20 -69.76 -37.9 76.56 Favored 'General case' 0 N--CA 1.438 -1.069 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.668 179.68 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.421 ' HG ' ' CE1' ' A' ' 61' ' ' TYR . 3.7 tt -75.64 -35.4 60.45 Favored 'General case' 0 N--CA 1.436 -1.166 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.845 -177.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.519 HD22 HD22 ' A' ' 74' ' ' ASN . 4.0 pp -66.88 -41.11 87.8 Favored 'General case' 0 C--N 1.314 -0.937 0 C-N-CA 120.412 -0.515 . . . . 0.0 112.276 -178.273 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.499 ' N ' HD12 ' A' ' 58' ' ' LEU . 62.0 pttt -75.13 -26.0 58.84 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.788 0.804 . . . . 0.0 109.823 176.649 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -66.27 -53.8 32.54 Favored 'General case' 0 N--CA 1.439 -0.979 0 CA-C-N 115.146 -0.934 . . . . 0.0 111.393 176.57 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.421 ' CE1' ' HG ' ' A' ' 57' ' ' LEU . 14.5 m-85 -60.34 -52.96 63.04 Favored 'General case' 0 CA--C 1.504 -0.815 0 N-CA-C 114.681 1.363 . . . . 0.0 114.681 -178.847 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.566 ' O ' HD13 ' A' ' 63' ' ' LEU . 19.6 m-20 -79.91 -98.04 0.03 OUTLIER 'General case' 0 C--N 1.316 -0.86 0 C-N-CA 118.918 -1.113 . . . . 0.0 110.44 -179.737 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.613 ' HB2' HD12 ' A' ' 65' ' ' ILE . 0.8 OUTLIER -142.41 158.68 60.21 Favored Pre-proline 0 N--CA 1.43 -1.426 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 -177.723 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.528 ' HB2' ' NH1' ' A' ' 155' ' ' ARG . 12.9 Cg_endo -93.27 28.68 0.31 Allowed 'Trans proline' 0 N--CA 1.439 -1.679 0 C-N-CA 123.47 2.78 . . . . 0.0 112.176 -173.565 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.613 HD12 ' HB2' ' A' ' 63' ' ' LEU . 0.2 OUTLIER -69.96 -29.92 42.16 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.343 0 N-CA-C 107.764 -1.199 . . . . 0.0 107.764 173.863 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 62.01 -9.71 0.11 Allowed Glycine 0 CA--C 1.54 1.651 0 CA-C-N 114.515 -1.22 . . . . 0.0 115.268 177.596 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.607 ' O ' ' HB ' ' A' ' 160' ' ' VAL . 38.4 mt 76.33 -38.53 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.51 -0.592 0 C-N-CA 125.171 1.389 . . . . 0.0 113.217 179.315 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.518 ' HB2' ' O ' ' A' ' 67' ' ' ILE . 39.0 t80 166.07 -57.72 0.0 OUTLIER Pre-proline 0 C--N 1.321 -0.636 0 C-N-CA 125.009 1.323 . . . . 0.0 109.007 173.131 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.454 ' HD3' ' HB3' ' A' ' 68' ' ' PHE . 19.6 Cg_endo -102.56 -16.85 0.09 OUTLIER 'Trans proline' 0 C--N 1.378 2.129 0 C-N-CA 122.209 1.94 . . . . 0.0 114.985 -172.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.433 ' H ' ' HD2' ' A' ' 69' ' ' PRO . . . 80.36 9.72 86.2 Favored Glycine 0 N--CA 1.441 -0.986 0 C-N-CA 119.924 -1.132 . . . . 0.0 111.633 -173.565 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.658 ' OD1' ' HG3' ' A' ' 89' ' ' PRO . 10.4 t70 -92.0 -43.56 9.36 Favored 'General case' 0 C--O 1.201 -1.455 0 N-CA-C 106.474 -1.676 . . . . 0.0 106.474 176.304 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.44 ' O ' ' HB ' ' A' ' 73' ' ' THR . . . -72.02 -178.77 2.5 Favored 'General case' 0 CA--C 1.552 1.043 0 CA-C-N 114.537 -1.21 . . . . 0.0 108.104 165.195 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.501 ' O ' HG22 ' A' ' 73' ' ' THR . 56.8 m 83.52 26.97 0.1 Allowed 'General case' 0 N--CA 1.498 1.948 0 CA-C-O 123.469 1.604 . . . . 0.0 108.398 179.28 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.519 HD22 HD22 ' A' ' 58' ' ' LEU . 3.5 m120 -81.7 111.15 17.69 Favored 'General case' 0 N--CA 1.41 -2.474 0 C-N-CA 118.528 -1.269 . . . . 0.0 110.962 -175.601 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 66.1 t80 -71.71 94.2 1.34 Allowed 'General case' 0 C--N 1.293 -1.874 0 CA-C-N 114.074 -1.421 . . . . 0.0 112.081 -176.195 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.448 ' O ' HD22 ' A' ' 84' ' ' LEU . 23.5 mm-40 -110.62 111.57 22.88 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 171.692 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.412 ' HB2' HD23 ' A' ' 84' ' ' LEU . 81.4 t80 -125.76 127.28 45.92 Favored 'General case' 0 C--N 1.291 -1.966 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.985 -170.495 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.554 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 3.3 m-20 -91.32 163.48 14.2 Favored 'General case' 0 CA--C 1.475 -1.933 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 178.238 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -81.67 -58.38 3.03 Favored 'General case' 0 C--N 1.26 -3.29 0 CA-C-N 114.237 -1.347 . . . . 0.0 113.176 -178.548 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -75.97 -46.92 27.14 Favored 'General case' 0 N--CA 1.429 -1.499 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.596 -176.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.554 ' HB ' ' HB2' ' A' ' 78' ' ' ASP . 96.8 m -67.98 -52.08 39.9 Favored 'General case' 0 C--N 1.293 -1.882 0 CA-C-N 114.4 -1.273 . . . . 0.0 112.369 -177.677 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 99.4 mttt 66.6 3.76 3.06 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 114.501 1.297 . . . . 0.0 114.501 178.334 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.698 ' HG2' ' OG1' ' A' ' 109' ' ' THR . 38.2 ttpt -91.17 92.49 8.69 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-O 121.856 0.836 . . . . 0.0 109.24 176.485 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.506 ' HB2' ' HB2' ' A' ' 112' ' ' LEU . 3.0 tm? -51.21 135.1 26.65 Favored 'General case' 0 C--N 1.32 -0.706 0 C-N-CA 126.376 1.87 . . . . 0.0 111.728 -173.82 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.467 ' HA ' ' O ' ' A' ' 108' ' ' VAL . 46.1 p -117.34 110.04 17.57 Favored 'General case' 0 N--CA 1.419 -1.981 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.021 179.805 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.423 HG23 ' CD1' ' A' ' 84' ' ' LEU . 53.5 t -91.9 127.44 44.18 Favored 'Isoleucine or valine' 0 CA--C 1.478 -1.822 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 172.574 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.507 ' H ' HD13 ' A' ' 87' ' ' LEU 0.286 0.0 OUTLIER -114.57 129.85 56.71 Favored 'General case' 0 N--CA 1.392 -3.349 0 CA-C-N 115.105 -0.952 . . . . 0.0 111.227 178.902 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.458 ' O ' HG23 ' A' ' 106' ' ' THR . 3.1 mp -95.69 136.21 22.5 Favored Pre-proline 0 C--N 1.275 -2.66 0 CA-C-N 114.069 -1.423 . . . . 0.0 108.411 178.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.658 ' HG3' ' OD1' ' A' ' 71' ' ' ASP . 7.1 Cg_exo -25.3 -55.45 0.08 OUTLIER 'Trans proline' 0 C--N 1.374 1.878 1 C-N-CA 125.719 4.279 . . . . 0.0 114.065 174.825 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . 0.582 ' HB2' ' HB2' ' A' ' 168' ' ' ASP . 45.1 t -154.1 161.45 41.89 Favored 'General case' 0 N--CA 1.426 -1.631 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 177.179 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.431 HD11 ' HD2' ' A' ' 103' ' ' LYS . 10.0 tt -64.64 114.65 2.48 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 O-C-N 123.939 0.774 . . . . 0.0 110.524 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' CYS . . . . . 0.513 ' HB2' ' HA ' ' A' ' 166' ' ' ARG . 44.2 t -116.03 123.08 47.06 Favored 'General case' 0 N--CA 1.417 -2.122 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.01 -179.161 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -99.05 169.82 9.14 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.25 -179.148 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.416 ' HB ' HH11 ' A' ' 162' ' ' ARG . 3.5 p -148.31 106.08 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.674 0 C-N-CA 123.325 0.65 . . . . 0.0 110.073 174.372 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.296 -1.686 0 N-CA-C 108.643 -1.783 . . . . 0.0 108.643 175.831 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 43.6 p . . . . . 0 N--CA 1.411 -2.388 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 96.1 t -94.68 115.96 34.8 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.993 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.776 176.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.415 ' HG ' ' HA ' ' A' ' 125' ' ' THR . 6.9 tt -137.66 134.83 35.91 Favored 'General case' 0 C--N 1.286 -2.195 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 -178.199 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.431 ' HD2' HD11 ' A' ' 91' ' ' ILE . 39.0 ttpt -110.11 106.51 16.0 Favored 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 178.62 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.444 ' HA ' HD12 ' A' ' 123' ' ' ILE . 14.1 t80 -96.36 96.83 9.01 Favored 'General case' 0 N--CA 1.421 -1.904 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 -177.579 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.498 HG22 ' H ' ' A' ' 106' ' ' THR . 10.6 m -57.98 172.29 0.43 Allowed 'General case' 0 CA--C 1.568 1.66 0 C-N-CA 126.415 1.886 . . . . 0.0 112.307 -178.777 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . 0.498 ' H ' HG22 ' A' ' 105' ' ' THR . 38.4 m -78.29 -72.41 0.37 Allowed 'General case' 0 C--N 1.316 -0.887 0 C-N-CA 123.562 0.745 . . . . 0.0 111.79 -173.445 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 43.9 m -103.62 110.34 22.36 Favored 'General case' 0 N--CA 1.431 -1.412 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 179.498 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.815 HG21 HG12 ' A' ' 123' ' ' ILE . 3.6 p -109.03 167.08 4.31 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.419 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 178.48 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.698 ' OG1' ' HG2' ' A' ' 83' ' ' LYS . 15.1 t -139.39 131.94 28.74 Favored 'General case' 0 N--CA 1.4 -2.945 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 -175.788 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -147.32 172.18 27.8 Favored Glycine 0 N--CA 1.413 -2.86 0 C-N-CA 119.273 -1.441 . . . . 0.0 113.162 -177.65 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 35.8 m80 -77.35 121.57 23.93 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 -179.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.506 ' HB2' ' HB2' ' A' ' 84' ' ' LEU . 3.2 tm? -94.57 110.71 22.5 Favored 'General case' 0 N--CA 1.422 -1.845 0 CA-C-O 121.213 0.53 . . . . 0.0 110.532 -174.214 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -128.18 130.15 47.59 Favored 'General case' 0 CA--C 1.439 -3.307 0 CA-C-N 114.549 -1.205 . . . . 0.0 108.913 168.221 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 54.8 tptt -66.47 116.37 7.39 Favored 'General case' 0 N--CA 1.38 -3.962 0 CA-C-N 114.54 -1.209 . . . . 0.0 109.142 -178.209 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . 0.477 ' C ' ' HE2' ' A' ' 116' ' ' LYS . . . 118.42 -27.56 7.23 Favored Glycine 0 C--O 1.177 -3.459 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 -174.169 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.739 ' N ' ' HE2' ' A' ' 116' ' ' LYS . 0.0 OUTLIER -165.19 122.23 1.51 Allowed 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 117.393 0.597 . . . . 0.0 111.898 -178.246 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 64.4 tp -93.6 105.44 17.49 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 176.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 34.2 p -105.9 134.64 48.71 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 114.094 1.146 . . . . 0.0 114.094 -172.534 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 67.1 88.15 0.11 Allowed 'General case' 0 CA--C 1.49 -1.327 0 C-N-CA 124.871 1.268 . . . . 0.0 112.887 178.211 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.43 HG22 ' O ' ' A' ' 134' ' ' THR . 12.4 m -95.78 92.35 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.302 0 CA-C-O 122.912 1.339 . . . . 0.0 108.679 178.824 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -73.57 99.76 3.14 Favored 'General case' 0 C--N 1.264 -3.145 0 CA-C-N 113.072 -1.876 . . . . 0.0 111.769 -174.307 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 145.67 -8.62 1.58 Allowed Glycine 0 N--CA 1.423 -2.194 0 CA-C-N 114.41 -1.268 . . . . 0.0 111.631 177.011 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.815 HG12 HG21 ' A' ' 108' ' ' VAL . 46.4 mm -100.21 118.46 46.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-O 121.623 0.725 . . . . 0.0 111.18 -178.171 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt -85.4 119.31 25.63 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 106.294 -1.743 . . . . 0.0 106.294 175.169 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.481 ' HB ' ' HB ' ' A' ' 131' ' ' VAL . 89.5 m -125.47 128.07 47.48 Favored 'General case' 0 C--N 1.283 -2.299 0 CA-C-N 115.764 -0.653 . . . . 0.0 112.526 -169.624 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.525 ' C ' ' HD3' ' A' ' 126' ' ' LYS . 0.5 OUTLIER -137.85 123.45 19.75 Favored 'General case' 0 N--CA 1.428 -1.561 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 168.82 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.458 ' N ' ' HD3' ' A' ' 126' ' ' LYS . 7.1 p -150.55 -44.52 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.284 -2.266 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 177.556 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 15.5 tpt -103.72 -42.7 5.55 Favored 'General case' 0 N--CA 1.416 -2.16 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 173.371 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 9.3 tp -164.51 175.33 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.889 0 N-CA-C 105.808 -1.923 . . . . 0.0 105.808 178.507 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' TRP . . . . . 0.469 ' CE3' ' HB2' ' A' ' 126' ' ' LYS . 97.7 m95 -69.66 122.81 19.85 Favored 'General case' 0 C--O 1.241 0.642 0 CA-C-O 121.716 0.769 . . . . 0.0 112.285 178.725 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.481 ' HB ' ' HB ' ' A' ' 125' ' ' THR . 97.0 t -130.96 149.03 33.08 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.031 0 C-N-CA 125.481 1.512 . . . . 0.0 107.348 179.347 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 18.0 ptmt -122.75 -12.37 8.07 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-O 121.381 0.61 . . . . 0.0 110.71 177.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 15.8 m -138.39 75.28 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 CA-C-O 122.115 0.96 . . . . 0.0 110.266 -178.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . 0.43 ' O ' HG22 ' A' ' 120' ' ' VAL . 7.7 t -84.01 168.92 15.49 Favored 'General case' 0 N--CA 1.414 -2.265 0 CA-C-N 115.062 -0.972 . . . . 0.0 109.328 179.022 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 16.6 p -131.47 151.69 51.35 Favored 'General case' 0 N--CA 1.387 -3.593 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 14.1 tt -118.28 97.61 5.55 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.272 0 CA-C-O 122.253 1.025 . . . . 0.0 108.768 176.405 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . 0.487 ' OG ' ' HB2' ' A' ' 144' ' ' TYR . 36.2 p -91.44 152.48 20.36 Favored 'General case' 0 N--CA 1.407 -2.577 0 CA-C-N 115.019 -0.991 . . . . 0.0 110.575 -177.204 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . 0.413 HG23 ' O ' ' A' ' 115' ' ' GLY . 4.4 t -165.42 178.08 7.05 Favored 'General case' 0 N--CA 1.396 -3.137 0 N-CA-C 107.337 -1.356 . . . . 0.0 107.337 -176.378 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -112.7 28.43 8.79 Favored 'General case' 0 C--N 1.269 -2.891 0 N-CA-C 106.848 -1.538 . . . . 0.0 106.848 174.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . 71.44 35.76 1.44 Allowed 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 114.284 -1.325 . . . . 0.0 109.569 -175.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 39.3 t 177.66 -80.9 0.0 OUTLIER 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 114.299 -1.319 . . . . 0.0 109.37 -178.17 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -78.26 135.94 37.66 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 -178.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 47.7 t -105.48 144.5 14.96 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 -165.062 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . 0.487 ' HB2' ' OG ' ' A' ' 137' ' ' SER . 83.6 m-85 -119.69 121.42 39.18 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 106.499 -1.667 . . . . 0.0 106.499 173.826 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 32.3 t80 -96.86 99.13 10.71 Favored 'General case' 0 C--N 1.286 -2.163 0 CA-C-O 121.812 0.815 . . . . 0.0 109.117 -173.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 15.2 p -97.95 31.35 2.71 Favored 'General case' 0 C--N 1.298 -1.668 0 CA-C-N 115.288 -0.869 . . . . 0.0 112.571 -175.137 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -76.13 82.45 2.96 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-O 121.856 0.836 . . . . 0.0 111.265 178.364 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 94.79 -58.13 1.84 Allowed Glycine 0 CA--C 1.477 -2.34 0 N-CA-C 108.749 -1.74 . . . . 0.0 108.749 178.213 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 19.6 ttt 169.93 88.93 0.0 OUTLIER 'General case' 0 N--CA 1.435 -1.214 0 C-N-CA 126.518 1.927 . . . . 0.0 107.351 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . 0.448 ' HA ' ' HD3' ' A' ' 150' ' ' LYS . 63.2 mmtt -133.07 176.32 8.6 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 113.64 0.978 . . . . 0.0 113.64 178.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -85.59 161.34 19.34 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.296 -0.866 . . . . 0.0 112.205 -173.716 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 53.6 p -78.31 160.8 27.66 Favored 'General case' 0 N--CA 1.438 -1.058 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.189 -179.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 30.4 ttm180 -145.7 152.09 39.05 Favored 'General case' 0 N--CA 1.438 -1.073 0 CA-C-O 121.014 0.435 . . . . 0.0 110.257 -176.074 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 61.8 p -89.11 135.05 33.77 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 177.186 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' ARG . . . . . 0.528 ' NH1' ' HB2' ' A' ' 64' ' ' PRO . 15.1 ptt180 -78.45 -19.18 53.71 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 120.091 -0.644 . . . . 0.0 110.449 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -48.68 -30.54 5.61 Favored 'General case' 0 C--N 1.316 -0.858 0 C-N-CA 124.375 1.07 . . . . 0.0 112.837 -177.647 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -75.33 -53.83 8.08 Favored 'General case' 0 N--CA 1.441 -0.902 0 C-N-CA 120.838 -0.345 . . . . 0.0 111.043 178.422 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 0.51 ' HB2' ' HB3' ' A' ' 161' ' ' GLN . 95.4 m-85 -157.1 -5.25 0.1 Allowed 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 111.592 0.219 . . . . 0.0 111.592 -178.417 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . 0.518 ' HA3' ' O ' ' A' ' 65' ' ' ILE . . . 79.14 -84.71 1.24 Allowed Glycine 0 CA--C 1.475 -2.446 0 N-CA-C 109.01 -1.636 . . . . 0.0 109.01 -169.47 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.607 ' HB ' ' O ' ' A' ' 67' ' ' ILE . 16.3 t -109.85 134.11 53.02 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.505 0 N-CA-C 107.513 -1.292 . . . . 0.0 107.513 174.297 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' GLN . . . . . 0.51 ' HB3' ' HB2' ' A' ' 158' ' ' TYR . 1.1 pp0? -148.17 116.39 6.51 Favored 'General case' 0 N--CA 1.416 -2.169 0 CA-C-O 121.497 0.665 . . . . 0.0 110.721 -175.002 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . 0.513 ' NH1' ' HA3' ' A' ' 164' ' ' GLY . 1.9 ppt_? -154.74 162.32 41.16 Favored 'General case' 0 C--N 1.266 -3.034 0 CA-C-N 113.935 -1.484 . . . . 0.0 109.074 175.57 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -76.8 91.98 3.56 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 121.716 0.77 . . . . 0.0 112.718 -177.478 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . 0.513 ' HA3' ' NH1' ' A' ' 162' ' ' ARG . . . -146.25 142.4 10.48 Favored Glycine 0 N--CA 1.421 -2.312 0 CA-C-N 115.67 -0.696 . . . . 0.0 111.591 178.128 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.471 ' H ' HD23 ' A' ' 165' ' ' LEU . 1.5 pt? -117.7 112.05 19.95 Favored 'General case' 0 N--CA 1.416 -2.133 0 N-CA-C 106.802 -1.555 . . . . 0.0 106.802 173.575 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . 0.513 ' HA ' ' HB2' ' A' ' 92' ' ' CYS . 10.8 ptp180 -80.02 110.21 15.2 Favored 'General case' 0 N--CA 1.416 -2.161 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 -179.06 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . 0.452 HG22 ' H ' ' A' ' 167' ' ' VAL . 5.7 m -69.88 26.31 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.292 -1.897 0 N-CA-C 116.082 1.882 . . . . 0.0 116.082 -171.537 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . 0.582 ' HB2' ' HB2' ' A' ' 90' ' ' SER . 31.7 t70 -135.37 69.15 1.44 Allowed 'General case' 0 CA--C 1.497 -1.092 0 N-CA-C 108.064 -1.088 . . . . 0.0 108.064 170.183 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' LYS . . . . . 0.426 ' HB2' ' O ' ' A' ' 168' ' ' ASP . 25.0 ttpp 167.87 145.86 0.02 OUTLIER 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 113.878 -1.51 . . . . 0.0 107.344 179.465 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' PHE . . . . . . . . . . . . . 74.5 t80 . . . . . 0 N--CA 1.412 -2.346 0 N-CA-C 105.37 -2.085 . . . . 0.0 105.37 170.378 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.404 ' HB2' ' HD3' ' A' ' 55' ' ' PRO . 3.4 mm? . . . . . 0 CA--C 1.491 -1.301 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.404 ' HD3' ' HB2' ' A' ' 54' ' ' LEU . 27.3 Cg_endo -60.82 -14.97 35.09 Favored 'Trans proline' 0 N--CA 1.434 -2.017 0 C-N-CA 121.914 1.743 . . . . 0.0 113.129 -170.789 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -76.26 -34.4 59.16 Favored 'General case' 0 CA--C 1.493 -1.228 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 -179.597 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.471 ' HA ' ' HB3' ' A' ' 60' ' ' GLU . 88.1 mt -74.44 -36.52 63.4 Favored 'General case' 0 N--CA 1.42 -1.971 0 CA-C-N 114.946 -1.025 . . . . 0.0 109.48 178.459 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 8.3 mp -62.59 -42.11 99.37 Favored 'General case' 0 CA--C 1.494 -1.187 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -178.088 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.416 ' HD2' ' N ' ' A' ' 60' ' ' GLU . 0.0 OUTLIER -75.39 -28.1 59.32 Favored 'General case' 0 N--CA 1.435 -1.204 0 C-N-CA 118.839 -1.144 . . . . 0.0 110.375 176.228 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.471 ' HB3' ' HA ' ' A' ' 57' ' ' LEU . 7.5 tt0 -60.47 -38.64 84.86 Favored 'General case' 0 C--O 1.25 1.094 0 CA-C-N 114.952 -1.022 . . . . 0.0 113.124 178.835 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 73.8 m-85 -60.43 -42.24 95.64 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.944 0.72 . . . . 0.0 112.944 179.39 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . 0.265 24.8 m-20 -121.64 -82.77 0.65 Allowed 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 115.92 1.822 . . . . 0.0 115.92 -174.416 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.524 ' HB2' HD12 ' A' ' 65' ' ' ILE . 0.0 OUTLIER -114.04 138.72 22.99 Favored Pre-proline 0 C--N 1.318 -0.793 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 -177.747 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 63' ' ' LEU . 32.2 Cg_endo -98.93 27.94 0.15 Allowed 'Trans proline' 0 N--CA 1.431 -2.178 0 C-N-CA 123.858 3.038 . . . . 0.0 111.753 -170.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.678 ' O ' ' HA3' ' A' ' 159' ' ' GLY . 0.2 OUTLIER -61.63 -39.59 83.69 Favored 'Isoleucine or valine' 0 CA--C 1.484 -1.592 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 173.787 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 54.83 8.79 1.49 Allowed Glycine 0 CA--C 1.547 2.086 0 CA-C-N 115.263 -0.88 . . . . 0.0 113.737 -177.66 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.483 ' O ' ' HB ' ' A' ' 160' ' ' VAL . 47.8 mt 62.35 -68.15 0.12 Allowed 'Isoleucine or valine' 0 C--O 1.193 -1.904 0 C-N-CA 126.669 1.988 . . . . 0.0 113.812 -177.307 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 89.2 t80 -176.74 -54.19 0.0 OUTLIER Pre-proline 0 C--N 1.307 -1.273 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -173.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -92.05 -2.9 4.08 Favored 'Trans proline' 0 C--N 1.366 1.447 0 C-N-CA 121.74 1.626 . . . . 0.0 113.085 -172.507 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 82.77 -2.64 85.78 Favored Glycine 0 N--CA 1.429 -1.773 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.15 -179.196 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -102.75 -71.06 0.73 Allowed 'General case' 0 CA--C 1.497 -1.083 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 179.297 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.435 ' HB2' HG23 ' A' ' 88' ' ' ILE . . . -49.77 137.78 15.66 Favored 'General case' 0 CA--C 1.509 -0.604 0 CA-C-N 115.037 -0.983 . . . . 0.0 108.812 173.25 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 8.1 t 118.53 4.19 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.167 0 C-N-CA 126.735 2.014 . . . . 0.0 108.475 -169.112 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.516 ' O ' HG13 ' A' ' 86' ' ' VAL . 18.5 m-80 -72.31 -173.13 1.03 Allowed 'General case' 0 CA--C 1.497 -1.081 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 174.667 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.568 ' HB2' HD11 ' A' ' 84' ' ' LEU . 50.5 p90 -170.87 143.46 2.06 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 114.286 1.217 . . . . 0.0 114.286 178.326 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.563 ' HG3' HD12 ' A' ' 87' ' ' LEU . 52.8 mt-10 -133.11 173.34 11.53 Favored 'General case' 0 C--N 1.288 -2.074 0 C-N-CA 127.479 2.312 . . . . 0.0 105.021 174.393 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 47.2 p90 -148.45 149.54 31.89 Favored 'General case' 0 C--N 1.29 -2.017 0 CA-C-N 118.904 0.775 . . . . 0.0 110.544 178.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.739 ' OD1' ' HB ' ' A' ' 81' ' ' THR . 5.5 p30 -87.91 158.07 18.79 Favored 'General case' 0 C--N 1.306 -1.301 0 C-N-CA 119.682 -0.807 . . . . 0.0 111.109 174.507 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -82.59 -66.86 0.84 Allowed 'General case' 0 C--N 1.28 -2.454 0 N-CA-C 115.915 1.82 . . . . 0.0 115.915 -170.815 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.434 ' CD ' ' H ' ' A' ' 80' ' ' GLU . 0.0 OUTLIER -69.69 -21.3 63.52 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.832 -173.074 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.739 ' HB ' ' OD1' ' A' ' 78' ' ' ASP . 85.0 m -101.57 -51.01 3.56 Favored 'General case' 0 N--CA 1.408 -2.546 0 CA-C-N 114.973 -1.012 . . . . 0.0 110.52 -178.212 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.561 ' HA ' ' O ' ' A' ' 78' ' ' ASP . 39.6 mtpt 77.39 31.13 0.48 Allowed 'General case' 0 C--O 1.243 0.757 0 C-N-CA 125.959 1.703 . . . . 0.0 112.438 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.492 ' CG ' HG22 ' A' ' 109' ' ' THR . 16.4 tptm -88.8 139.3 30.6 Favored 'General case' 0 N--CA 1.404 -2.767 0 N-CA-C 106.007 -1.849 . . . . 0.0 106.007 175.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.634 ' O ' ' HA ' ' A' ' 109' ' ' THR . 16.0 tp -76.07 135.57 39.89 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 -176.587 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.506 HG23 ' HB2' ' A' ' 76' ' ' GLU . 3.0 t -124.86 111.57 15.64 Favored 'General case' 0 C--N 1.272 -2.777 0 CA-C-O 121.927 0.87 . . . . 0.0 109.915 178.073 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.516 HG13 ' O ' ' A' ' 74' ' ' ASN . 86.7 t -92.01 124.65 44.57 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.691 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.675 -177.501 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.656 ' H ' HD13 ' A' ' 87' ' ' LEU . 0.0 OUTLIER -90.48 117.77 29.43 Favored 'General case' 0 N--CA 1.398 -3.064 0 CA-C-N 114.944 -1.026 . . . . 0.0 108.754 176.497 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.644 HG22 ' NH1' ' A' ' 166' ' ' ARG . 48.8 mt -117.82 120.29 32.94 Favored Pre-proline 0 C--N 1.277 -2.576 0 CA-C-N 114.122 -1.399 . . . . 0.0 107.926 -175.629 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.419 ' HD2' ' HA ' ' A' ' 88' ' ' ILE . 18.8 Cg_endo -58.19 91.36 0.06 OUTLIER 'Trans proline' 0 C--N 1.358 1.053 0 C-N-CA 123.794 2.996 . . . . 0.0 113.475 -177.752 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 70.0 m 73.39 -169.92 0.12 Allowed 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.003 0.921 . . . . 0.0 112.205 -179.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.548 HG12 ' HA ' ' A' ' 105' ' ' THR . 66.5 mt -102.58 150.04 6.67 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.12 0 CA-C-O 120.722 0.296 . . . . 0.0 110.344 178.677 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 23.5 p -141.4 141.44 33.76 Favored 'General case' 0 CA--C 1.48 -1.734 0 N-CA-C 105.715 -1.957 . . . . 0.0 105.715 168.296 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.531 ' HB3' ' HA ' ' A' ' 103' ' ' LYS . 7.9 pt-20 -150.16 168.19 24.68 Favored 'General case' 0 C--N 1.259 -3.356 0 O-C-N 123.508 0.505 . . . . 0.0 111.022 177.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.511 ' O ' ' HA ' ' A' ' 101' ' ' VAL . 5.2 p -137.33 123.9 28.51 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.158 0 C-N-CA 120.587 -0.445 . . . . 0.0 111.34 -172.637 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.433 -1.542 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 177.306 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 20.3 m . . . . . 0 N--CA 1.406 -2.626 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.511 ' HA ' ' O ' ' A' ' 94' ' ' VAL . 7.6 p -113.69 103.13 14.9 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.355 0 CA-C-O 121.889 0.852 . . . . 0.0 110.497 176.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.526 ' HG ' HG23 ' A' ' 125' ' ' THR . 4.3 mp -116.92 134.15 55.12 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 114.698 -1.137 . . . . 0.0 109.001 -177.587 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.531 ' HA ' ' HB3' ' A' ' 93' ' ' GLU . 4.4 ttmp? -103.01 111.95 24.55 Favored 'General case' 0 C--N 1.312 -1.046 0 N-CA-C 109.57 -0.529 . . . . 0.0 109.57 175.824 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.45 ' O ' ' HA ' ' A' ' 91' ' ' ILE . 98.3 m-85 -95.34 101.45 13.18 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 176.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.548 ' HA ' HG12 ' A' ' 91' ' ' ILE . 14.7 t -87.56 179.7 6.49 Favored 'General case' 0 N--CA 1.443 -0.784 0 O-C-N 123.63 0.581 . . . . 0.0 111.612 -173.732 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . 0.434 ' HA ' ' O ' ' A' ' 88' ' ' ILE . 37.3 p -67.6 -35.66 79.4 Favored 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 124.051 0.94 . . . . 0.0 113.293 -176.322 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 27.8 p -133.13 110.2 10.01 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-O 120.811 0.339 . . . . 0.0 111.14 178.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 61.5 t -109.6 131.38 60.65 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.699 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 176.067 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.634 ' HA ' ' O ' ' A' ' 84' ' ' LEU . 11.5 m -114.15 122.01 45.52 Favored 'General case' 0 N--CA 1.42 -1.962 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 -172.094 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . 0.563 ' HA3' ' O ' ' A' ' 119' ' ' ASP . . . -155.16 -158.42 8.74 Favored Glycine 0 N--CA 1.442 -0.904 0 C-N-CA 120.305 -0.95 . . . . 0.0 114.058 -175.654 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 78.7 t60 -120.09 127.17 52.3 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-O 121.337 0.589 . . . . 0.0 110.532 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.539 ' HA ' HD22 ' A' ' 117' ' ' LEU . 1.2 tt -95.35 128.08 41.91 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 115.542 -0.753 . . . . 0.0 109.675 -174.571 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . 0.527 ' HB2' ' O ' ' A' ' 116' ' ' LYS . 35.1 mm-40 -131.04 165.31 23.5 Favored 'General case' 0 CA--C 1.495 -1.144 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 171.736 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 57.2 tptt -84.15 101.36 11.78 Favored 'General case' 0 N--CA 1.414 -2.243 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 178.401 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . 0.701 ' O ' ' HB ' ' A' ' 138' ' ' THR . . . 120.18 -56.54 0.59 Allowed Glycine 0 N--CA 1.418 -2.51 0 C-N-CA 120.027 -1.082 . . . . 0.0 111.494 179.547 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.527 ' O ' ' HB2' ' A' ' 113' ' ' GLU . 0.0 OUTLIER -126.23 127.51 45.76 Favored 'General case' 0 C--N 1.298 -1.654 0 CA-C-O 121.577 0.704 . . . . 0.0 112.542 -177.663 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.539 HD22 ' HA ' ' A' ' 112' ' ' LEU . 1.8 tm? -100.95 107.54 19.05 Favored 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 106.989 -1.485 . . . . 0.0 106.989 -176.69 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.574 ' HA ' ' HB2' ' A' ' 135' ' ' SER . 12.4 p -110.47 153.63 24.78 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 -178.559 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . 0.563 ' O ' ' HA3' ' A' ' 110' ' ' GLY . 20.7 m-20 69.53 115.92 0.04 OUTLIER 'General case' 0 C--O 1.206 -1.224 0 C-N-CA 124.379 1.071 . . . . 0.0 109.828 -174.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 8.5 m -140.37 85.38 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.115 0 CA-C-O 122.398 1.094 . . . . 0.0 111.312 179.258 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -79.05 101.95 8.11 Favored 'General case' 0 C--N 1.289 -2.026 0 CA-C-N 114.474 -1.239 . . . . 0.0 107.8 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 139.38 -22.48 2.88 Favored Glycine 0 C--N 1.297 -1.608 0 N-CA-C 110.525 -1.03 . . . . 0.0 110.525 -177.371 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 89.9 mt -100.09 107.71 21.45 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.059 0 CA-C-O 121.918 0.866 . . . . 0.0 109.403 178.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 57.5 mttp -107.1 122.9 47.41 Favored 'General case' 0 C--N 1.288 -2.104 0 CA-C-N 114.304 -1.317 . . . . 0.0 108.756 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.526 HG23 ' HG ' ' A' ' 102' ' ' LEU . 72.1 m -130.89 130.04 43.03 Favored 'General case' 0 N--CA 1.431 -1.385 0 O-C-N 123.851 0.72 . . . . 0.0 112.633 -172.298 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.541 ' C ' ' HD3' ' A' ' 126' ' ' LYS . 0.4 OUTLIER -113.48 126.52 55.41 Favored 'General case' 0 N--CA 1.42 -1.962 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 167.996 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.567 HG13 ' SD ' ' A' ' 128' ' ' MET . 2.3 p -135.74 -65.05 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.873 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.517 177.239 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . 0.567 ' SD ' HG13 ' A' ' 127' ' ' VAL . 0.0 OUTLIER -106.59 -29.76 9.44 Favored 'General case' 0 N--CA 1.399 -3.017 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 177.556 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 42.5 mm -148.92 162.31 5.05 Favored 'Isoleucine or valine' 0 C--O 1.248 1.0 0 N-CA-C 104.315 -2.476 . . . . 0.0 104.315 177.135 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 87.4 t90 -81.47 117.46 21.91 Favored 'General case' 0 N--CA 1.443 -0.786 0 N-CA-C 108.234 -1.025 . . . . 0.0 108.234 175.208 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.575 HG12 ' H ' ' A' ' 133' ' ' VAL . 47.5 t -123.04 141.64 42.62 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.903 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 -177.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 64.4 pttt -100.85 21.95 12.84 Favored 'General case' 0 C--N 1.306 -1.306 0 C-N-CA 119.326 -0.949 . . . . 0.0 111.876 -177.552 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.575 ' H ' HG12 ' A' ' 131' ' ' VAL . 61.5 t -133.82 -82.12 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 C-N-CA 120.712 -0.395 . . . . 0.0 110.548 176.768 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . 0.48 ' O ' ' HB ' ' A' ' 146' ' ' THR . 70.5 p 49.9 76.93 0.12 Allowed 'General case' 0 CA--C 1.536 0.414 0 CA-C-O 121.619 0.724 . . . . 0.0 111.097 -171.184 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . 0.593 ' O ' ' HA ' ' A' ' 146' ' ' THR . 12.5 p -83.15 153.85 24.59 Favored 'General case' 0 N--CA 1.431 -1.391 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 -176.257 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . 0.428 ' HB ' HG22 ' A' ' 146' ' ' THR . 14.5 tt -100.84 128.89 52.53 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.396 0 CA-C-O 121.891 0.853 . . . . 0.0 112.259 -170.617 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 19.8 m -101.3 147.52 26.21 Favored 'General case' 0 N--CA 1.421 -1.894 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 178.081 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . 0.701 ' HB ' ' O ' ' A' ' 115' ' ' GLY . 98.8 m -155.77 152.31 28.32 Favored 'General case' 0 C--N 1.284 -2.247 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 -178.301 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 73.5 m-20 -87.36 23.07 1.97 Allowed 'General case' 0 N--CA 1.482 1.162 0 O-C-N 121.597 -0.69 . . . . 0.0 109.965 176.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . 61.47 35.95 17.39 Favored 'General case' 0 C--N 1.351 0.631 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 -170.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . 0.426 ' HA ' ' HG2' ' A' ' 64' ' ' PRO . 43.3 t -173.87 -79.18 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 113.972 -1.467 . . . . 0.0 109.492 -173.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . 0.453 ' O ' HG23 ' A' ' 138' ' ' THR . 97.9 mttt -88.0 151.46 22.76 Favored 'General case' 0 CA--C 1.509 -0.631 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 -179.48 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.506 HG22 HG22 ' A' ' 65' ' ' ILE . 24.4 t -105.97 136.78 38.99 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 O-C-N 123.545 0.528 . . . . 0.0 111.442 -167.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . 0.402 ' HD2' ' HG ' ' A' ' 152' ' ' SER . 87.9 m-85 -124.5 155.56 38.74 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-O 120.833 0.349 . . . . 0.0 111.527 -177.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 35.3 p90 -45.93 148.34 0.83 Allowed 'General case' 0 C--O 1.243 0.737 0 N-CA-C 115.346 1.609 . . . . 0.0 115.346 -178.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.593 ' HA ' ' O ' ' A' ' 135' ' ' SER . 69.3 p -93.05 -16.02 25.47 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-N 114.915 -1.038 . . . . 0.0 110.973 179.176 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -136.36 149.17 48.23 Favored 'General case' 0 N--CA 1.441 -0.876 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 -177.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -83.04 74.71 2.49 Favored Glycine 0 CA--C 1.497 -1.037 0 N-CA-C 111.289 -0.725 . . . . 0.0 111.289 -176.67 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 1.3 tmt? 174.5 -36.27 0.0 OUTLIER 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 105.87 -1.9 . . . . 0.0 105.87 -177.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 22.8 ttmm -75.43 168.49 19.9 Favored 'General case' 0 N--CA 1.411 -2.425 0 CA-C-N 112.469 -2.15 . . . . 0.0 109.074 -179.141 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 61.0 mttp -119.92 164.03 16.67 Favored 'General case' 0 C--N 1.31 -1.133 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 -171.738 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' SER . . . . . 0.453 ' HB3' ' O ' ' A' ' 143' ' ' VAL . 35.6 m -85.82 160.86 19.36 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 115.398 -0.819 . . . . 0.0 112.806 -175.69 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' ARG . . . . . 0.51 ' HG2' ' H ' ' A' ' 161' ' ' GLN . 12.0 mpt_? -126.56 164.2 21.73 Favored 'General case' 0 CA--C 1.516 -0.351 0 C-N-CA 123.571 0.748 . . . . 0.0 111.282 -179.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 35.0 m -94.38 145.3 24.86 Favored 'General case' 0 C--N 1.296 -1.748 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.784 177.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -61.16 -37.46 82.98 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 176.47 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -58.3 -26.16 62.69 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 123.749 0.82 . . . . 0.0 111.656 177.445 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.431 ' HB1' ' HG3' ' A' ' 161' ' ' GLN . . . -79.56 1.21 26.77 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 115.692 -0.685 . . . . 0.0 112.017 -177.608 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 88.7 m-85 93.54 20.94 0.02 OUTLIER 'General case' 0 CA--C 1.493 -1.241 0 C-N-CA 125.888 1.675 . . . . 0.0 111.189 -176.432 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . 0.678 ' HA3' ' O ' ' A' ' 65' ' ' ILE . . . 87.04 -86.04 1.54 Allowed Glycine 0 N--CA 1.408 -3.219 0 CA-C-N 114.757 -1.111 . . . . 0.0 113.115 175.645 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.483 ' HB ' ' O ' ' A' ' 67' ' ' ILE . 6.8 t -104.57 116.48 48.44 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.138 0 C-N-CA 119.849 -0.74 . . . . 0.0 109.686 -174.758 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' GLN . . . . . 0.51 ' H ' ' HG2' ' A' ' 153' ' ' ARG . 12.5 mm-40 -116.33 99.87 7.5 Favored 'General case' 0 CA--C 1.486 -1.505 0 N-CA-C 116.521 2.045 . . . . 0.0 116.521 -174.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . 0.635 ' NE ' ' HA ' ' A' ' 162' ' ' ARG . 1.5 tpm_? -152.66 105.23 2.96 Favored 'General case' 0 N--CA 1.4 -2.933 0 N-CA-C 105.504 -2.035 . . . . 0.0 105.504 170.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 19.0 m120 -45.63 104.12 0.04 OUTLIER 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 115.875 1.806 . . . . 0.0 115.875 -172.403 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -151.66 156.21 26.56 Favored Glycine 0 N--CA 1.435 -1.425 0 N-CA-C 108.449 -1.86 . . . . 0.0 108.449 176.18 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -128.19 135.47 49.77 Favored 'General case' 0 N--CA 1.429 -1.508 0 CA-C-N 118.025 0.913 . . . . 0.0 109.929 -179.296 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . 0.644 ' NH1' HG22 ' A' ' 88' ' ' ILE . 3.1 mmp_? -65.76 122.44 17.31 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 106.496 -1.668 . . . . 0.0 106.496 179.541 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 25.1 t -74.18 61.99 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.559 1.308 0 CA-C-O 122.615 1.197 . . . . 0.0 109.596 175.256 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -165.83 -33.82 0.03 OUTLIER 'General case' 0 C--N 1.296 -1.735 0 C-N-CA 126.457 1.903 . . . . 0.0 106.742 -177.237 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 16.4 tppt? -76.37 110.47 10.93 Favored 'General case' 0 N--CA 1.434 -1.25 0 CA-C-N 114.349 -1.296 . . . . 0.0 111.932 -177.153 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' PHE . . . . . . . . . . . . . 69.7 t80 . . . . . 0 N--CA 1.432 -1.352 0 N-CA-C 106.456 -1.683 . . . . 0.0 106.456 176.588 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.565 ' HB3' ' HD3' ' A' ' 55' ' ' PRO . 14.0 tp . . . . . 0 N--CA 1.495 1.778 0 N-CA-C 113.373 0.879 . . . . 0.0 113.373 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.565 ' HD3' ' HB3' ' A' ' 54' ' ' LEU . 80.6 Cg_exo -59.22 -19.99 52.69 Favored 'Trans proline' 0 C--N 1.369 1.607 0 C-N-CA 123.086 2.524 . . . . 0.0 111.544 -178.183 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.461 ' HA ' ' HE2' ' A' ' 59' ' ' LYS . 21.3 mm-40 -81.1 -32.03 34.05 Favored 'General case' 0 N--CA 1.413 -2.312 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 -175.614 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.455 ' HA ' ' HG2' ' A' ' 60' ' ' GLU . 3.8 mm? -75.34 -49.23 19.76 Favored 'General case' 0 CA--C 1.483 -1.617 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.695 177.168 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.47 ' HA ' ' CD1' ' A' ' 75' ' ' TYR 0.323 2.5 pp -61.77 -38.95 89.93 Favored 'General case' 0 C--O 1.21 -1.0 0 C-N-CA 119.375 -0.93 . . . . 0.0 113.032 -176.162 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.461 ' HE2' ' HA ' ' A' ' 56' ' ' GLU . 63.7 pttt -75.5 -26.97 58.57 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 120.017 -0.673 . . . . 0.0 111.002 -179.867 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.455 ' HG2' ' HA ' ' A' ' 57' ' ' LEU . 11.2 pt-20 -79.78 -28.48 40.32 Favored 'General case' 0 C--N 1.351 0.65 0 C-N-CA 119.892 -0.723 . . . . 0.0 110.866 -177.896 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 78.5 m-85 -86.33 -1.58 57.64 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 118.799 -1.16 . . . . 0.0 112.269 175.336 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.517 ' HB2' HG23 ' A' ' 73' ' ' THR . 15.4 t70 -93.2 -171.91 2.8 Favored 'General case' 0 C--N 1.306 -1.308 0 C-N-CA 125.709 1.603 . . . . 0.0 108.607 178.079 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.617 ' HB2' HD12 ' A' ' 65' ' ' ILE . 17.0 mt -85.47 -153.84 0.0 OUTLIER Pre-proline 0 CA--C 1.576 1.969 0 N-CA-C 103.488 -2.782 . . . . 0.0 103.488 174.175 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.573 ' O ' ' HD2' ' A' ' 155' ' ' ARG . 17.7 Cg_endo -100.87 8.78 0.58 Allowed 'Trans proline' 0 N--CA 1.436 -1.883 0 CA-C-N 123.998 2.464 . . . . 0.0 111.241 176.125 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.824 HG12 ' H ' ' A' ' 67' ' ' ILE . 0.1 OUTLIER -78.69 -38.21 21.5 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.461 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 -176.641 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.419 ' H ' HD13 ' A' ' 65' ' ' ILE . . . 60.08 9.39 10.93 Favored Glycine 0 N--CA 1.48 1.579 0 CA-C-O 122.517 1.065 . . . . 0.0 110.702 -176.16 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.824 ' H ' HG12 ' A' ' 65' ' ' ILE . 48.7 mt 63.51 -68.73 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.41 -2.442 0 C-N-CA 128.136 2.574 . . . . 0.0 110.349 -172.516 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.425 ' CD2' ' HD3' ' A' ' 162' ' ' ARG . 91.0 t80 -177.53 -55.72 0.0 OUTLIER Pre-proline 0 C--N 1.308 -1.231 0 N-CA-C 113.702 1.001 . . . . 0.0 113.702 -175.83 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.412 ' HB2' ' OD2' ' A' ' 71' ' ' ASP . 10.8 Cg_endo -91.93 -29.31 0.13 Allowed 'Trans proline' 0 C--N 1.361 1.215 0 C-N-CA 121.573 1.516 . . . . 0.0 115.396 -170.083 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 94.22 -16.97 59.82 Favored Glycine 0 N--CA 1.442 -0.943 0 N-CA-C 110.012 -1.235 . . . . 0.0 110.012 -172.009 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.465 ' CB ' ' HG2' ' A' ' 89' ' ' PRO . 30.0 m-20 -78.84 -38.56 37.71 Favored 'General case' 0 CA--C 1.506 -0.726 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 177.617 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.6 ' O ' ' HB ' ' A' ' 73' ' ' THR . . . -78.53 178.61 7.64 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 114.282 -1.326 . . . . 0.0 108.063 170.41 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.6 ' HB ' ' O ' ' A' ' 72' ' ' ALA . 3.0 m 85.25 6.42 0.47 Allowed 'General case' 0 N--CA 1.483 1.182 0 CA-C-O 123.739 1.733 . . . . 0.0 111.534 175.1 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.563 ' O ' ' HA ' ' A' ' 86' ' ' VAL . 0.8 OUTLIER -64.93 132.97 50.78 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-N 114.079 -1.418 . . . . 0.0 110.307 177.603 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.52 ' HB2' HD21 ' A' ' 84' ' ' LEU . 11.5 p90 -108.94 99.21 8.58 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 113.385 0.883 . . . . 0.0 113.385 -173.487 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 58.9 mm-40 -117.69 133.49 55.89 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 174.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 41.2 p90 -144.57 145.24 31.71 Favored 'General case' 0 C--N 1.295 -1.795 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 -179.205 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.612 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 35.3 m-20 -96.02 173.97 7.16 Favored 'General case' 0 CA--C 1.476 -1.87 0 C-N-CA 119.623 -0.831 . . . . 0.0 109.357 178.028 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -79.27 -65.37 1.01 Allowed 'General case' 0 C--N 1.283 -2.319 0 CA-C-N 114.784 -1.098 . . . . 0.0 111.843 -176.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.406 ' H ' ' CD ' ' A' ' 80' ' ' GLU . 0.1 OUTLIER -74.91 -29.75 61.07 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.112 -175.451 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.612 ' HB ' ' HB2' ' A' ' 78' ' ' ASP . 17.5 m -65.41 -43.27 91.1 Favored 'General case' 0 N--CA 1.428 -1.526 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.581 179.605 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 46.6 mmtm 61.16 14.49 5.55 Favored 'General case' 0 N--CA 1.495 1.778 0 C-N-CA 123.409 0.684 . . . . 0.0 112.098 -177.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.601 ' CD ' HG22 ' A' ' 109' ' ' THR . 31.5 ttmt -116.38 128.4 55.48 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-O 121.247 0.546 . . . . 0.0 110.531 -176.13 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.52 HD21 ' HB2' ' A' ' 75' ' ' TYR . 2.0 tm? -84.65 126.67 33.56 Favored 'General case' 0 C--N 1.296 -1.72 0 CA-C-N 114.388 -1.278 . . . . 0.0 109.163 -173.625 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.528 ' HA ' ' O ' ' A' ' 108' ' ' VAL . 68.1 p -107.06 115.08 29.56 Favored 'General case' 0 N--CA 1.409 -2.483 0 CA-C-N 115.474 -0.785 . . . . 0.0 109.41 178.327 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.563 ' HA ' ' O ' ' A' ' 74' ' ' ASN . 58.6 t -92.57 120.69 42.3 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 179.384 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 5.3 mp -83.34 103.14 12.49 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-O 121.472 0.653 . . . . 0.0 109.467 -179.823 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.514 ' O ' ' HA ' ' A' ' 106' ' ' THR . 46.7 mm -83.34 115.2 58.0 Favored Pre-proline 0 N--CA 1.412 -2.338 0 N-CA-C 104.793 -2.299 . . . . 0.0 104.793 171.915 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.465 ' HG2' ' CB ' ' A' ' 71' ' ' ASP . 1.0 OUTLIER -37.46 -41.18 0.91 Allowed 'Trans proline' 0 N--CA 1.485 1.017 0 C-N-CA 125.146 3.897 . . . . 0.0 115.715 -175.047 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . 0.512 ' HB2' ' HB2' ' A' ' 168' ' ' ASP . 47.9 t -157.15 166.1 34.17 Favored 'General case' 0 C--N 1.284 -2.268 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.439 HG13 ' HD3' ' A' ' 103' ' ' LYS . 6.0 tt -71.81 119.83 19.0 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.336 0 CA-C-O 121.642 0.734 . . . . 0.0 109.883 179.763 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' CYS . . . . . 0.452 ' SG ' ' HB2' ' A' ' 104' ' ' PHE . 19.0 p -115.97 123.42 47.99 Favored 'General case' 0 C--N 1.29 -1.995 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 174.383 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -103.66 111.33 23.76 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 107.019 -1.475 . . . . 0.0 107.019 175.532 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.615 HG21 ' HA ' ' A' ' 162' ' ' ARG . 5.2 p -108.5 102.65 14.3 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.03 0 C-N-CA 118.812 -1.155 . . . . 0.0 113.925 -178.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.431 -1.639 0 N-CA-C 108.102 -1.999 . . . . 0.0 108.102 176.075 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 14.1 m . . . . . 0 N--CA 1.42 -1.958 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 46.3 t -105.62 116.22 48.97 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.085 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 179.154 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.566 ' HG ' ' CG2' ' A' ' 125' ' ' THR . 5.5 mp -114.42 121.16 42.71 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 110.198 -0.297 . . . . 0.0 110.198 -176.54 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.439 ' HD3' HG13 ' A' ' 91' ' ' ILE . 0.4 OUTLIER -111.32 109.12 18.98 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-O 121.571 0.701 . . . . 0.0 110.95 178.677 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.452 ' HB2' ' SG ' ' A' ' 92' ' ' CYS . 94.5 m-85 -91.02 125.33 35.78 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 114.825 -1.079 . . . . 0.0 108.5 179.28 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.479 ' O ' HG13 ' A' ' 108' ' ' VAL . 13.2 m -100.16 147.32 25.82 Favored 'General case' 0 C--N 1.294 -1.817 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.642 -175.155 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . 0.514 ' HA ' ' O ' ' A' ' 88' ' ' ILE . 14.9 m -56.81 120.82 8.52 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 172.65 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 39.0 m 66.14 78.28 0.27 Allowed 'General case' 0 C--N 1.308 -1.198 0 CA-C-O 122.038 0.923 . . . . 0.0 111.676 -177.461 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.528 ' O ' ' HA ' ' A' ' 85' ' ' THR . 3.7 m -93.45 133.17 35.46 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.161 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.391 175.146 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.601 HG22 ' CD ' ' A' ' 83' ' ' LYS 0.26 7.8 m -105.56 118.0 35.46 Favored 'General case' 0 N--CA 1.406 -2.626 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 -168.239 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . 0.552 ' HA3' HG12 ' A' ' 120' ' ' VAL . . . -157.97 167.88 34.38 Favored Glycine 0 CA--C 1.494 -1.27 0 C-N-CA 119.945 -1.122 . . . . 0.0 113.316 -177.73 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 14.2 t-80 -90.91 101.89 14.65 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 179.788 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 68.0 tp -96.73 109.02 21.76 Favored 'General case' 0 CA--C 1.484 -1.577 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.739 -174.762 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -106.15 156.5 18.38 Favored 'General case' 0 CA--C 1.448 -2.96 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 173.037 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 1.6 tmtm? -79.55 100.7 7.89 Favored 'General case' 0 N--CA 1.384 -3.772 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 -176.344 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 138.31 -51.8 0.76 Allowed Glycine 0 C--N 1.296 -1.691 0 N-CA-C 108.419 -1.872 . . . . 0.0 108.419 -174.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.564 ' HB2' ' HA ' ' A' ' 137' ' ' SER . 0.0 OUTLIER -140.83 137.28 33.16 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-O 121.43 0.633 . . . . 0.0 112.149 -179.013 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.528 ' O ' ' HB3' ' A' ' 135' ' ' SER . 46.3 tp -102.25 105.8 16.51 Favored 'General case' 0 C--N 1.305 -1.326 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 175.275 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.515 ' HA ' ' HB3' ' A' ' 135' ' ' SER . 27.7 p -120.53 145.93 46.81 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 112.505 0.557 . . . . 0.0 112.505 -173.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . 0.532 ' O ' ' HA2' ' A' ' 110' ' ' GLY . 34.5 t70 64.4 87.96 0.11 Allowed 'General case' 0 C--O 1.215 -0.715 0 O-C-N 124.117 0.885 . . . . 0.0 110.096 -179.468 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.552 HG12 ' HA3' ' A' ' 110' ' ' GLY . 3.1 m -124.89 104.31 13.48 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.489 0 CA-C-O 122.671 1.224 . . . . 0.0 112.081 -172.779 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -86.41 100.88 12.65 Favored 'General case' 0 C--N 1.26 -3.313 0 CA-C-N 113.292 -1.776 . . . . 0.0 108.401 178.344 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 139.7 -15.5 3.12 Favored Glycine 0 N--CA 1.428 -1.871 0 CA-C-N 115.209 -0.905 . . . . 0.0 112.347 178.729 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 65.3 mt -99.28 102.76 13.83 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.23 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 178.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.412 ' HA ' ' HA ' ' A' ' 132' ' ' LYS . 95.3 mttt -106.13 119.26 38.75 Favored 'General case' 0 C--N 1.282 -2.352 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 -176.51 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.566 ' CG2' ' HG ' ' A' ' 102' ' ' LEU . 49.7 m -139.64 148.43 42.43 Favored 'General case' 0 C--N 1.293 -1.878 0 CA-C-N 115.429 -0.805 . . . . 0.0 112.671 -168.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.468 ' HA ' ' HA ' ' A' ' 130' ' ' TRP . 40.9 tttp -108.11 122.24 46.49 Favored 'General case' 0 N--CA 1.424 -1.74 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 172.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.438 ' CG1' ' HB3' ' A' ' 150' ' ' LYS . 15.9 t -138.56 101.15 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.208 0 N-CA-C 104.142 -2.54 . . . . 0.0 104.142 169.663 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER 73.67 -52.88 0.7 Allowed 'General case' 0 CA--C 1.544 0.729 0 O-C-N 124.305 1.003 . . . . 0.0 108.594 -171.075 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 9.0 tp -137.51 158.65 34.8 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.264 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 176.615 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' TRP . . . . . 0.468 ' HA ' ' HA ' ' A' ' 126' ' ' LYS . 42.6 t-105 -78.2 122.31 25.51 Favored 'General case' 0 C--O 1.241 0.644 0 CA-C-O 121.185 0.517 . . . . 0.0 110.708 -179.135 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 48.5 t -125.06 132.05 71.76 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 177.619 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . 0.412 ' HA ' ' HA ' ' A' ' 124' ' ' LYS . 63.1 pttt -88.85 28.6 1.13 Allowed 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 112.268 0.47 . . . . 0.0 112.268 -176.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 44.7 t -132.74 -78.09 0.15 Allowed 'Isoleucine or valine' 0 C--O 1.214 -0.812 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 -179.059 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 38.5 p 46.89 80.21 0.05 Allowed 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 113.615 0.968 . . . . 0.0 113.615 -179.499 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . 0.528 ' HB3' ' O ' ' A' ' 117' ' ' LEU . 28.3 m -84.68 153.61 23.0 Favored 'General case' 0 N--CA 1.424 -1.729 0 CA-C-N 115.898 -0.592 . . . . 0.0 112.036 -177.653 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 67.5 mt -100.67 97.91 6.3 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.231 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . 0.619 ' O ' ' HB2' ' A' ' 144' ' ' TYR . 29.1 t -119.89 126.86 51.96 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-N 115.914 -0.584 . . . . 0.0 109.569 -174.187 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 9.3 t -162.12 177.58 9.56 Favored 'General case' 0 N--CA 1.424 -1.747 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 -173.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -109.9 75.02 0.92 Allowed 'General case' 0 C--N 1.306 -1.324 0 C-N-CA 120.389 -0.524 . . . . 0.0 109.906 176.356 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . 27.43 72.42 0.04 OUTLIER 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 125.603 1.561 . . . . 0.0 113.994 177.303 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 40.2 t 177.68 -63.59 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 -177.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -95.09 -169.65 2.03 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 179.31 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 13.2 p -142.66 123.04 10.52 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.347 0 CA-C-O 121.365 0.603 . . . . 0.0 109.894 177.087 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . 0.619 ' HB2' ' O ' ' A' ' 137' ' ' SER . 94.0 m-85 -128.97 155.61 45.09 Favored 'General case' 0 CA--C 1.487 -1.473 0 CA-C-O 121.41 0.624 . . . . 0.0 110.574 -179.587 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . 0.437 ' HB2' ' HB2' ' A' ' 151' ' ' LYS . 81.7 m-85 -112.72 113.81 26.1 Favored 'General case' 0 N--CA 1.407 -2.579 0 CA-C-N 114.565 -1.198 . . . . 0.0 109.145 176.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.464 ' CG2' ' HB2' ' A' ' 135' ' ' SER . 9.1 t -79.82 33.41 0.27 Allowed 'General case' 0 CA--C 1.56 1.337 0 CA-C-O 122.115 0.96 . . . . 0.0 111.404 -174.512 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -75.48 -19.67 59.26 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.349 179.368 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 134.02 50.54 0.08 OUTLIER Glycine 0 CA--C 1.475 -2.428 0 N-CA-C 108.987 -1.645 . . . . 0.0 108.987 179.09 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 66.5 mtt 63.64 12.08 6.25 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.102 0.961 . . . . 0.0 111.787 -177.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . 0.438 ' HB3' ' CG1' ' A' ' 127' ' ' VAL . 47.7 mmtm -69.16 -29.83 67.94 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 115.375 -0.83 . . . . 0.0 112.564 -176.585 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . 0.437 ' HB2' ' HB2' ' A' ' 145' ' ' PHE . 39.9 mmtm -143.88 122.58 12.59 Favored 'General case' 0 CA--C 1.509 -0.629 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 178.557 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 43.8 m -132.46 128.27 37.07 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 106.136 -1.802 . . . . 0.0 106.136 175.232 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' ARG . . . . . 0.464 ' HG2' ' CG ' ' A' ' 161' ' ' GLN . 26.9 tpt180 -146.6 160.41 42.2 Favored 'General case' 0 N--CA 1.429 -1.491 0 C-N-CA 119.084 -1.046 . . . . 0.0 110.942 -172.814 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 13.6 m -90.47 130.25 36.55 Favored 'General case' 0 N--CA 1.419 -1.992 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 174.378 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' ARG . . . . . 0.573 ' HD2' ' O ' ' A' ' 64' ' ' PRO . 8.6 ttp180 -68.29 -24.92 64.92 Favored 'General case' 0 C--N 1.297 -1.678 0 C-N-CA 123.517 0.727 . . . . 0.0 110.455 179.675 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -42.29 -45.71 4.29 Favored 'General case' 0 C--N 1.313 -0.996 0 N-CA-C 115.257 1.577 . . . . 0.0 115.257 -172.106 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -71.55 -52.62 17.25 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 114.438 1.273 . . . . 0.0 114.438 -173.507 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 -141.89 3.8 1.64 Allowed 'General case' 0 N--CA 1.483 1.18 0 N-CA-C 113.029 0.751 . . . . 0.0 113.029 -174.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 90.85 -88.49 1.43 Allowed Glycine 0 C--N 1.304 -1.223 0 N-CA-C 108.935 -1.666 . . . . 0.0 108.935 -173.078 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.671 HG12 ' O ' ' A' ' 67' ' ' ILE . 11.5 p -98.64 177.03 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.556 1.193 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 171.712 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' GLN . . . . . 0.509 ' H ' HG22 ' A' ' 160' ' ' VAL . 14.3 mm100 -108.36 99.29 8.71 Favored 'General case' 0 CA--C 1.463 -2.378 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 -175.553 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . 0.615 ' HA ' HG21 ' A' ' 94' ' ' VAL . 0.0 OUTLIER -132.1 173.18 11.49 Favored 'General case' 0 N--CA 1.393 -3.287 0 C-N-CA 119.283 -0.967 . . . . 0.0 113.148 -174.722 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 21.9 t-20 -152.76 -48.69 0.1 Allowed 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 106.359 -1.719 . . . . 0.0 106.359 179.55 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -64.0 147.27 50.73 Favored Glycine 0 C--O 1.254 1.373 0 CA-C-N 114.566 -1.197 . . . . 0.0 110.546 170.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.514 ' H ' HD23 ' A' ' 165' ' ' LEU . 1.9 pt? -124.65 154.9 40.05 Favored 'General case' 0 C--N 1.291 -1.973 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 -176.874 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . 0.523 ' HD2' ' N ' ' A' ' 166' ' ' ARG . 5.2 mpt_? -76.43 114.98 15.74 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 -179.219 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 18.2 m -80.75 54.07 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.286 -2.191 0 CA-C-O 122.479 1.133 . . . . 0.0 112.827 -177.335 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . 0.512 ' HB2' ' HB2' ' A' ' 90' ' ' SER . 14.8 t70 -109.94 -39.32 5.1 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 114.069 -1.423 . . . . 0.0 107.766 176.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 27.8 ttpp -107.22 8.92 30.23 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 114.012 -1.449 . . . . 0.0 108.749 -177.05 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 170' ' ' PHE . . . . . . . . . . . . . 84.5 t80 . . . . . 0 C--N 1.306 -1.291 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 -178.464 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.55 ' O ' HD13 ' A' ' 58' ' ' LEU . 28.8 mt . . . . . 0 CA--C 1.51 -0.581 0 CA-C-O 119.484 -0.294 . . . . 0.0 110.902 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.415 ' HD3' ' HB2' ' A' ' 54' ' ' LEU . 13.8 Cg_exo -64.9 -31.42 56.76 Favored 'Trans proline' 0 N--CA 1.428 -2.366 0 C-N-CA 120.791 0.994 . . . . 0.0 111.88 -170.509 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -75.86 -32.33 59.68 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.282 178.753 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 63.7 tp -69.33 -34.3 74.42 Favored 'General case' 0 CA--C 1.508 -0.656 0 C-N-CA 120.503 -0.479 . . . . 0.0 110.157 178.634 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.62 ' HA ' ' CD1' ' A' ' 75' ' ' TYR . 6.2 mp -61.7 -41.47 97.65 Favored 'General case' 0 CA--C 1.49 -1.334 0 C-N-CA 120.128 -0.629 . . . . 0.0 112.421 179.669 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.48 ' HD2' ' N ' ' A' ' 60' ' ' GLU . 0.1 OUTLIER -76.86 -26.5 54.32 Favored 'General case' 0 C--N 1.298 -1.658 0 CA-C-O 121.491 0.662 . . . . 0.0 112.722 178.477 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.534 ' C ' ' H ' ' A' ' 62' ' ' ASP . 8.5 tp10 -82.51 -41.53 19.58 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 115.344 -0.843 . . . . 0.0 113.145 -171.08 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 56.2 t80 -68.44 3.85 1.6 Allowed 'General case' 0 N--CA 1.494 1.727 0 CA-C-O 122.095 0.95 . . . . 0.0 110.108 -178.303 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.534 ' H ' ' C ' ' A' ' 60' ' ' GLU . 27.9 t70 -109.02 -153.8 0.52 Allowed 'General case' 0 C--N 1.287 -2.113 0 CA-C-N 113.888 -1.505 . . . . 0.0 109.024 -174.783 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.708 ' HB2' HD12 ' A' ' 65' ' ' ILE . 0.1 OUTLIER -100.54 -167.98 0.15 Allowed Pre-proline 0 CA--C 1.576 1.961 0 N-CA-C 106.187 -1.783 . . . . 0.0 106.187 -177.362 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.477 ' O ' ' HD2' ' A' ' 155' ' ' ARG . 18.2 Cg_endo -100.4 11.49 0.56 Allowed 'Trans proline' 0 C--N 1.368 1.576 0 CA-C-N 122.943 2.087 . . . . 0.0 112.593 -176.292 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.708 HD12 ' HB2' ' A' ' 63' ' ' LEU . 0.2 OUTLIER -73.03 -43.07 59.21 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.959 0 CA-C-N 115.846 -0.616 . . . . 0.0 109.62 179.53 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.432 ' H ' HD13 ' A' ' 65' ' ' ILE . . . 56.94 9.14 3.56 Favored Glycine 0 N--CA 1.484 1.846 0 CA-C-O 121.351 0.417 . . . . 0.0 113.201 -177.582 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.524 ' H ' HG12 ' A' ' 65' ' ' ILE . 52.1 mt 67.39 -67.63 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.421 0 C-N-CA 125.877 1.671 . . . . 0.0 112.04 -175.61 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.478 ' HB2' ' O ' ' A' ' 67' ' ' ILE . 26.0 t80 175.01 -56.16 0.0 OUTLIER Pre-proline 0 C--N 1.318 -0.782 0 CA-C-O 119.68 -0.2 . . . . 0.0 111.281 -178.314 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.463 ' HD3' ' HB3' ' A' ' 68' ' ' PHE . 8.4 Cg_exo -73.51 -35.37 4.84 Favored 'Trans proline' 0 C--N 1.379 2.163 0 C-N-CA 121.934 1.756 . . . . 0.0 113.108 -172.226 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 97.28 -17.55 58.93 Favored Glycine 0 N--CA 1.44 -1.069 0 C-N-CA 120.193 -1.004 . . . . 0.0 111.048 -176.253 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -84.93 -48.11 9.62 Favored 'General case' 0 C--O 1.195 -1.769 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 176.808 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.647 ' O ' ' HB ' ' A' ' 73' ' ' THR . . . -57.7 171.87 0.43 Allowed 'General case' 0 CA--C 1.55 0.981 0 C-N-CA 124.53 1.132 . . . . 0.0 111.675 174.888 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.647 ' HB ' ' O ' ' A' ' 72' ' ' ALA . 8.9 m 94.49 -10.65 0.12 Allowed 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 124.022 0.929 . . . . 0.0 112.035 177.804 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.542 ' HA ' ' HB3' ' A' ' 58' ' ' LEU . 35.5 m-80 -46.4 103.25 0.04 OUTLIER 'General case' 0 CA--C 1.45 -2.879 0 C-N-CA 125.062 1.345 . . . . 0.0 113.657 -179.463 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.62 ' CD1' ' HA ' ' A' ' 58' ' ' LEU . 8.3 p90 -92.81 144.0 25.72 Favored 'General case' 1 C--N 1.241 -4.144 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.493 -176.787 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.629 ' HB2' ' O ' ' A' ' 85' ' ' THR . 10.9 mm-40 -136.2 161.78 34.78 Favored 'General case' 0 C--N 1.278 -2.534 0 N-CA-C 105.872 -1.899 . . . . 0.0 105.872 171.522 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 38.8 p90 -162.95 146.83 11.15 Favored 'General case' 0 C--N 1.293 -1.875 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 177.682 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.709 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 25.5 m-20 -105.17 162.31 13.51 Favored 'General case' 0 CA--C 1.459 -2.529 0 C-N-CA 118.955 -1.098 . . . . 0.0 108.799 176.12 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -81.24 -44.47 17.71 Favored 'General case' 0 C--N 1.262 -3.201 0 CA-C-N 114.161 -1.382 . . . . 0.0 111.094 -179.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -69.17 -47.45 64.9 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 178.213 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.709 ' HB ' ' HB2' ' A' ' 78' ' ' ASP . 31.8 m -63.75 -51.74 63.55 Favored 'General case' 0 N--CA 1.418 -2.056 0 CA-C-N 113.93 -1.486 . . . . 0.0 111.951 -178.45 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 99.1 mttt 66.27 18.63 10.96 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-O 121.818 0.818 . . . . 0.0 111.117 -177.042 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.617 ' HB3' HG22 ' A' ' 81' ' ' THR . 35.5 ttmt -111.83 135.88 51.86 Favored 'General case' 0 CA--C 1.491 -1.298 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.205 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.592 ' O ' ' HA ' ' A' ' 109' ' ' THR . 1.5 tm? -76.65 124.71 28.06 Favored 'General case' 0 N--CA 1.421 -1.897 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 -179.757 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.629 ' O ' ' HB2' ' A' ' 76' ' ' GLU . 3.8 t -126.82 109.39 11.95 Favored 'General case' 0 C--N 1.265 -3.097 0 CA-C-N 115.844 -0.617 . . . . 0.0 109.622 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.606 ' O ' ' HA ' ' A' ' 107' ' ' THR . 31.0 m -91.84 151.08 3.61 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.943 0 O-C-N 121.375 -0.828 . . . . 0.0 110.575 -179.483 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.535 ' HA ' ' O ' ' A' ' 106' ' ' THR 0.299 1.5 pp -115.59 103.64 10.93 Favored 'General case' 0 N--CA 1.396 -3.153 0 CA-C-O 122.655 1.217 . . . . 0.0 109.736 174.35 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 40.0 mm -89.82 139.01 27.61 Favored Pre-proline 0 C--N 1.289 -2.044 0 CA-C-N 114.08 -1.418 . . . . 0.0 108.37 -174.293 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -54.14 87.5 0.03 OUTLIER 'Trans proline' 0 C--N 1.354 0.868 0 C-N-CA 123.475 2.783 . . . . 0.0 112.431 173.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . 0.533 ' OG ' ' HB ' ' A' ' 167' ' ' VAL . 22.6 t 66.73 -169.15 0.2 Allowed 'General case' 0 N--CA 1.44 -0.955 0 C-N-CA 124.421 1.088 . . . . 0.0 110.811 178.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -93.05 137.36 22.59 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 177.022 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' CYS . . . . . 0.578 ' SG ' ' HG2' ' A' ' 166' ' ' ARG . 33.3 m -129.57 138.61 51.39 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 -176.882 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.621 ' O ' ' HA2' ' A' ' 164' ' ' GLY . 45.6 mt-10 -120.25 135.71 54.9 Favored 'General case' 0 CA--C 1.469 -2.167 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 177.511 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.734 HG13 ' H ' ' A' ' 163' ' ' ASN . 20.3 t -117.91 107.81 22.94 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.482 0 C-N-CA 120.224 -0.59 . . . . 0.0 112.349 -172.215 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.426 -1.988 0 N-CA-C 108.166 -1.974 . . . . 0.0 108.166 169.536 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 67.0 m . . . . . 0 CA--C 1.513 -0.446 0 N-CA-C 105.818 -1.919 . . . . 0.0 105.818 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.42 ' HA ' ' O ' ' A' ' 94' ' ' VAL . 59.9 t -147.59 129.88 7.16 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.919 0 CA-C-N 114.759 -1.11 . . . . 0.0 108.065 177.632 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -126.61 167.37 15.76 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 177.629 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.62 ' HB3' ' HB3' ' A' ' 124' ' ' LYS . 39.0 ttmt -148.54 128.97 13.91 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-O 120.768 0.318 . . . . 0.0 110.462 174.689 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -104.6 123.73 48.08 Favored 'General case' 0 C--N 1.293 -1.87 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 174.31 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.417 HG22 HG22 ' A' ' 108' ' ' VAL . 14.4 t -91.09 168.98 11.24 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 179.464 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . 0.535 ' O ' ' HA ' ' A' ' 87' ' ' LEU . 46.1 m -64.94 -27.97 69.21 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 112.229 0.455 . . . . 0.0 112.229 -175.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.606 ' HA ' ' O ' ' A' ' 86' ' ' VAL . 29.1 m -138.66 108.35 6.25 Favored 'General case' 0 C--N 1.306 -1.314 0 O-C-N 121.687 -0.633 . . . . 0.0 110.74 -179.4 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.493 ' O ' ' HA ' ' A' ' 85' ' ' THR . 34.1 t -108.72 135.97 45.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 N-CA-C 108.631 -0.878 . . . . 0.0 108.631 -179.303 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.592 ' HA ' ' O ' ' A' ' 84' ' ' LEU . 44.5 p -122.43 132.95 54.6 Favored 'General case' 0 N--CA 1.414 -2.237 0 C-N-CA 122.755 0.422 . . . . 0.0 110.785 -173.51 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . 0.659 ' HA3' ' O ' ' A' ' 119' ' ' ASP . . . -168.69 -158.26 12.44 Favored Glycine 0 C--N 1.308 -0.985 0 C-N-CA 121.373 -0.442 . . . . 0.0 113.234 -178.748 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 46.2 m80 -110.65 119.57 39.59 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-O 121.0 0.428 . . . . 0.0 110.562 -178.281 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.427 ' HB2' ' HG ' ' A' ' 84' ' ' LEU . 2.5 tm? -89.88 120.78 31.41 Favored 'General case' 0 C--N 1.308 -1.198 0 C-N-CA 123.905 0.882 . . . . 0.0 111.192 -176.264 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -139.56 175.37 9.62 Favored 'General case' 0 CA--C 1.475 -1.928 0 CA-C-N 115.274 -0.876 . . . . 0.0 109.303 170.692 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 1.8 tmtm? -103.81 131.9 50.57 Favored 'General case' 0 N--CA 1.393 -3.287 0 N-CA-C 107.262 -1.385 . . . . 0.0 107.262 -175.494 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 97.13 -25.77 25.58 Favored Glycine 0 C--O 1.189 -2.686 0 N-CA-C 109.862 -1.295 . . . . 0.0 109.862 -176.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . 0.341 0.0 OUTLIER -164.12 134.76 4.3 Favored 'General case' 0 C--N 1.291 -1.952 0 N-CA-C 114.316 1.228 . . . . 0.0 114.316 177.928 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -103.49 109.53 21.21 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 104.932 -2.248 . . . . 0.0 104.932 179.053 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 33.5 p -95.99 136.97 35.73 Favored 'General case' 0 C--N 1.284 -2.27 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.221 -176.49 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . 0.659 ' O ' ' HA3' ' A' ' 110' ' ' GLY . 15.1 m-20 69.03 107.22 0.05 Allowed 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 124.623 1.169 . . . . 0.0 111.621 178.608 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.405 HG22 ' O ' ' A' ' 134' ' ' THR . 7.6 m -119.66 86.39 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.901 0 CA-C-O 122.168 0.985 . . . . 0.0 111.129 173.082 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -74.25 100.9 3.84 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-N 114.48 -1.236 . . . . 0.0 109.464 -177.19 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 128.66 -7.86 6.53 Favored Glycine 0 C--N 1.299 -1.482 0 C-N-CA 120.017 -1.087 . . . . 0.0 111.736 177.744 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 66.5 mt -99.3 115.85 41.01 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.699 0 CA-C-O 121.869 0.843 . . . . 0.0 109.525 178.547 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.62 ' HB3' ' HB3' ' A' ' 103' ' ' LYS . 86.7 tttt -84.2 128.06 34.33 Favored 'General case' 0 CA--C 1.475 -1.936 0 CA-C-N 114.317 -1.31 . . . . 0.0 107.711 -176.146 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.479 HG21 ' HB1' ' A' ' 147' ' ' ALA . 92.1 m -130.16 127.28 39.39 Favored 'General case' 0 N--CA 1.388 -3.571 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.715 -176.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.512 ' HG2' ' N ' ' A' ' 127' ' ' VAL . 85.2 tttt -139.11 143.12 38.13 Favored 'General case' 0 N--CA 1.407 -2.609 0 CA-C-O 121.344 0.592 . . . . 0.0 110.184 167.178 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.514 HG21 ' HG3' ' A' ' 150' ' ' LYS . 7.0 p -158.84 -37.66 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 N-CA-C 106.286 -1.746 . . . . 0.0 106.286 177.02 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -120.28 -52.83 2.15 Favored 'General case' 0 N--CA 1.381 -3.903 0 CA-C-N 112.173 -2.285 . . . . 0.0 106.531 -177.484 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 9.6 tp -153.04 164.43 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.386 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 177.095 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 62.6 t90 -70.81 117.66 12.6 Favored 'General case' 0 C--N 1.317 -0.826 0 C-N-CA 123.339 0.656 . . . . 0.0 111.406 178.151 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.464 HG12 ' H ' ' A' ' 133' ' ' VAL . 21.5 t -138.86 119.44 15.37 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 175.696 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 14.8 ptmm? -102.09 17.53 23.05 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-O 121.316 0.579 . . . . 0.0 110.936 -179.123 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.464 ' H ' HG12 ' A' ' 131' ' ' VAL . 13.7 m -138.33 74.63 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 CA-C-N 114.866 -1.061 . . . . 0.0 110.324 178.612 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . 0.405 ' O ' HG22 ' A' ' 120' ' ' VAL . 35.2 p -111.49 -165.97 1.04 Allowed 'General case' 0 C--N 1.288 -2.102 0 CA-C-N 115.166 -0.925 . . . . 0.0 110.374 -177.271 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 38.3 m -151.65 167.71 27.28 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 176.623 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 11.7 tt -135.11 136.01 52.0 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.234 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 179.375 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 36.6 p -123.51 168.26 12.82 Favored 'General case' 0 N--CA 1.427 -1.579 0 CA-C-O 121.858 0.837 . . . . 0.0 112.885 -177.056 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . 0.486 HG23 ' H ' ' A' ' 140' ' ' ALA . 5.0 t -165.7 177.53 7.22 Favored 'General case' 0 N--CA 1.413 -2.312 0 N-CA-C 106.97 -1.492 . . . . 0.0 106.97 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -115.22 32.95 5.72 Favored 'General case' 0 C--N 1.265 -3.101 0 N-CA-C 105.352 -2.092 . . . . 0.0 105.352 175.062 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . 0.486 ' H ' HG23 ' A' ' 138' ' ' THR . . . 60.91 42.78 12.51 Favored 'General case' 0 C--N 1.366 1.309 0 CA-C-N 113.759 -1.564 . . . . 0.0 108.97 -172.466 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 47.6 t -173.4 -65.61 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 115.432 -0.803 . . . . 0.0 111.645 -172.735 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . 0.462 ' HA ' ' HE2' ' A' ' 142' ' ' LYS . 9.1 mmpt? -82.4 -154.46 0.13 Allowed 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 -179.599 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 14.6 p -155.25 119.3 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.055 0 CA-C-O 121.408 0.623 . . . . 0.0 110.136 170.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -114.55 155.99 25.46 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-O 121.964 0.888 . . . . 0.0 112.98 -172.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 35.0 p90 -72.78 137.66 45.95 Favored 'General case' 0 N--CA 1.431 -1.388 0 CA-C-N 113.931 -1.486 . . . . 0.0 113.379 178.216 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 25.9 m -157.72 28.73 0.27 Allowed 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 106.451 -1.685 . . . . 0.0 106.451 172.419 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . 0.479 ' HB1' HG21 ' A' ' 125' ' ' THR . . . -132.44 92.62 3.11 Favored 'General case' 0 N--CA 1.422 -1.859 0 C-N-CA 119.552 -0.859 . . . . 0.0 113.227 -173.459 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 66.9 32.28 80.56 Favored Glycine 0 CA--C 1.5 -0.852 0 CA-C-N 115.803 -0.635 . . . . 0.0 112.815 175.707 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 49.5 ttm 60.12 80.13 0.21 Allowed 'General case' 0 C--O 1.236 0.386 0 CA-C-O 122.019 0.914 . . . . 0.0 109.689 -177.065 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . 0.742 ' HG2' ' H ' ' A' ' 151' ' ' LYS . 35.4 ttmt -120.8 -160.32 0.84 Allowed 'General case' 0 C--N 1.297 -1.698 0 CA-C-N 114.915 -1.039 . . . . 0.0 108.995 -174.181 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . 0.742 ' H ' ' HG2' ' A' ' 150' ' ' LYS . 96.4 mttt -121.64 165.12 16.21 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 124.078 0.951 . . . . 0.0 110.016 -178.415 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 22.3 p -83.66 160.11 21.41 Favored 'General case' 0 C--N 1.301 -1.51 0 C-N-CA 123.275 0.63 . . . . 0.0 110.587 177.527 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 4.2 mpt_? -128.18 174.65 9.07 Favored 'General case' 0 CA--C 1.506 -0.736 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 177.272 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 14.7 m -98.9 116.23 30.66 Favored 'General case' 0 N--CA 1.422 -1.862 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 173.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' ARG . . . . . 0.635 ' HG2' ' HA2' ' A' ' 159' ' ' GLY . 0.2 OUTLIER -63.15 -22.98 67.22 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.461 0.648 . . . . 0.0 109.598 -179.559 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -46.51 -37.55 8.07 Favored 'General case' 0 C--N 1.318 -0.797 0 C-N-CA 125.346 1.458 . . . . 0.0 114.476 -177.626 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -69.92 -56.63 6.53 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 119.708 -0.797 . . . . 0.0 112.372 -174.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 58.5 m-85 -165.1 20.52 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 124.025 0.93 . . . . 0.0 110.08 -178.317 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . 0.646 ' HA3' ' O ' ' A' ' 65' ' ' ILE . . . 92.36 -92.79 1.72 Allowed Glycine 0 CA--C 1.47 -2.736 0 C-N-CA 120.016 -1.088 . . . . 0.0 111.195 -174.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.522 ' HB ' ' O ' ' A' ' 67' ' ' ILE . 11.5 t -103.42 172.53 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.41 -2.457 0 N-CA-C 106.947 -1.501 . . . . 0.0 106.947 179.102 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' GLN . . . . . 0.423 ' H ' HG12 ' A' ' 160' ' ' VAL . 46.6 mt-30 -123.09 92.9 3.8 Favored 'General case' 0 CA--C 1.483 -1.62 0 CA-C-N 118.973 0.806 . . . . 0.0 109.233 -175.147 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.33 161.83 17.96 Favored 'General case' 0 N--CA 1.401 -2.902 0 C-N-CA 119.012 -1.075 . . . . 0.0 113.251 -176.409 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' ASN . . . . . 0.734 ' H ' HG13 ' A' ' 94' ' ' VAL . 57.7 t30 -129.75 16.56 5.82 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 105.678 -1.971 . . . . 0.0 105.678 172.671 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . 0.621 ' HA2' ' O ' ' A' ' 93' ' ' GLU . . . -58.19 123.09 31.98 Favored Glycine 0 CA--C 1.475 -2.449 0 CA-C-N 113.469 -1.696 . . . . 0.0 112.991 -176.149 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.585 ' O ' HD12 ' A' ' 165' ' ' LEU . 3.9 pp -94.16 121.96 36.2 Favored 'General case' 1 N--CA 1.374 -4.25 0 N-CA-C 105.661 -1.977 . . . . 0.0 105.661 -178.349 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . 0.578 ' HG2' ' SG ' ' A' ' 92' ' ' CYS . 16.0 mtm180 -84.94 129.09 34.86 Favored 'General case' 0 N--CA 1.391 -3.396 0 N-CA-C 105.886 -1.894 . . . . 0.0 105.886 179.483 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . 0.533 ' HB ' ' OG ' ' A' ' 90' ' ' SER . 66.8 t -58.93 -14.98 5.4 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.737 0 CA-C-O 122.104 0.954 . . . . 0.0 110.249 171.679 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . 0.466 ' HB2' ' HB2' ' A' ' 90' ' ' SER . 11.1 t70 -76.25 -13.0 60.18 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 125.795 1.638 . . . . 0.0 109.986 173.162 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 169' ' ' LYS . . . . . 0.478 ' HG2' ' N ' ' A' ' 170' ' ' PHE . 56.1 tttm -134.29 176.99 8.1 Favored 'General case' 0 C--N 1.297 -1.699 0 C-N-CA 124.167 0.987 . . . . 0.0 108.497 -174.247 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 170' ' ' PHE . . . . . 0.478 ' N ' ' HG2' ' A' ' 169' ' ' LYS . 79.4 t80 . . . . . 0 C--N 1.295 -1.762 0 N-CA-C 106.656 -1.609 . . . . 0.0 106.656 170.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.404 ' HB2' ' HD3' ' A' ' 55' ' ' PRO . 3.4 mm? . . . . . 0 CA--C 1.484 -1.569 0 N-CA-C 113.872 1.064 . . . . 0.0 113.872 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.655 ' O ' ' HG2' ' A' ' 59' ' ' LYS . 19.3 Cg_endo -55.38 -25.74 49.56 Favored 'Trans proline' 0 N--CA 1.429 -2.301 0 C-N-CA 121.94 1.76 . . . . 0.0 113.657 -168.023 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.414 ' HA ' ' CG ' ' A' ' 59' ' ' LYS . 14.0 pt-20 -81.36 -29.51 34.05 Favored 'General case' 0 CA--C 1.479 -1.763 0 CA-C-O 121.093 0.473 . . . . 0.0 110.867 -177.353 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.596 ' O ' ' HB3' ' A' ' 60' ' ' GLU . 93.8 mt -74.29 -31.54 62.54 Favored 'General case' 0 N--CA 1.417 -2.104 0 CA-C-N 115.736 -0.666 . . . . 0.0 109.973 174.867 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.581 ' HB3' ' H ' ' A' ' 75' ' ' TYR . 4.8 mp -69.76 -35.32 74.83 Favored 'General case' 0 CA--C 1.504 -0.82 0 C-N-CA 118.988 -1.085 . . . . 0.0 110.017 177.852 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.655 ' HG2' ' O ' ' A' ' 55' ' ' PRO 0.279 41.5 pttt -75.1 -25.25 58.36 Favored 'General case' 0 N--CA 1.439 -1.011 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 172.405 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.596 ' HB3' ' O ' ' A' ' 57' ' ' LEU . 7.4 tp10 -59.4 -49.13 78.98 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-O 121.247 0.546 . . . . 0.0 109.98 171.098 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 85.6 m-85 -68.93 -4.28 15.98 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-O 121.313 0.578 . . . . 0.0 111.202 176.468 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.624 ' HB3' ' O ' ' A' ' 59' ' ' LYS . 21.1 t70 -84.65 166.52 17.01 Favored 'General case' 0 C--N 1.298 -1.671 0 CA-C-N 115.102 -0.954 . . . . 0.0 111.813 -176.117 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.696 ' HB2' HD12 ' A' ' 65' ' ' ILE . 3.5 mt -85.67 -151.47 0.0 OUTLIER Pre-proline 0 CA--C 1.602 2.95 0 N-CA-C 104.936 -2.246 . . . . 0.0 104.936 178.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.647 ' HG3' ' N ' ' A' ' 141' ' ' SER . 71.3 Cg_endo -101.54 5.07 0.57 Allowed 'Trans proline' 0 N--CA 1.449 -1.114 0 CA-C-N 123.531 2.297 . . . . 0.0 112.125 176.188 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.72 HG12 ' H ' ' A' ' 67' ' ' ILE . 0.1 OUTLIER -70.04 -42.06 79.35 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.832 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.534 -177.435 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.436 ' H ' HD13 ' A' ' 65' ' ' ILE . . . 57.79 8.91 4.63 Favored Glycine 0 N--CA 1.5 2.958 0 CA-C-O 122.228 0.904 . . . . 0.0 112.441 -174.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.72 ' H ' HG12 ' A' ' 65' ' ' ILE . 61.1 mt 58.13 -72.47 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 C-N-CA 129.191 2.997 . . . . 0.0 113.162 -174.358 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.471 ' HB3' ' HD3' ' A' ' 69' ' ' PRO . 80.0 t80 171.8 -53.26 0.0 OUTLIER Pre-proline 0 N--CA 1.485 1.303 0 N-CA-C 113.497 0.925 . . . . 0.0 113.497 -172.687 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.471 ' HD3' ' HB3' ' A' ' 68' ' ' PHE . 6.9 Cg_exo -74.1 -28.53 10.8 Favored 'Trans proline' 0 C--N 1.366 1.496 0 C-N-CA 121.288 1.325 . . . . 0.0 113.094 -174.1 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 86.84 -12.7 60.99 Favored Glycine 0 C--N 1.31 -0.905 0 N-CA-C 110.309 -1.117 . . . . 0.0 110.309 -174.274 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -93.12 -53.47 4.11 Favored 'General case' 0 CA--C 1.48 -1.739 0 N-CA-C 106.512 -1.662 . . . . 0.0 106.512 178.374 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.652 ' O ' ' HB ' ' A' ' 73' ' ' THR . . . -52.06 173.37 0.03 OUTLIER 'General case' 0 C--N 1.361 1.079 0 CA-C-N 114.671 -1.15 . . . . 0.0 110.549 169.916 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.652 ' HB ' ' O ' ' A' ' 72' ' ' ALA . 10.6 m 87.63 27.13 0.03 OUTLIER 'General case' 0 CA--C 1.558 1.251 0 CA-C-O 125.331 2.491 . . . . 0.0 109.246 -174.814 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.62 ' O ' ' HA ' ' A' ' 86' ' ' VAL . 37.2 m-80 -83.81 75.12 10.12 Favored 'General case' 0 C--N 1.275 -2.67 0 CA-C-N 113.685 -1.598 . . . . 0.0 112.021 177.77 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.581 ' H ' ' HB3' ' A' ' 58' ' ' LEU . 2.9 m-85 -70.89 98.12 1.53 Allowed 'General case' 0 C--N 1.258 -3.375 0 CA-C-N 113.377 -1.738 . . . . 0.0 113.56 -179.073 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -106.43 115.29 29.95 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 105.452 -2.055 . . . . 0.0 105.452 176.672 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.4 ' HB2' HD12 ' A' ' 84' ' ' LEU . 76.2 t80 -131.35 127.59 37.94 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 112.465 0.543 . . . . 0.0 112.465 -172.842 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.62 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 19.6 m-20 -94.22 160.45 14.68 Favored 'General case' 0 CA--C 1.483 -1.607 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 173.248 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 13.5 tp10 -80.14 -63.38 1.42 Allowed 'General case' 0 C--N 1.264 -3.125 0 CA-C-N 114.94 -1.027 . . . . 0.0 112.436 -175.455 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -67.08 -40.05 86.92 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.582 0.706 . . . . 0.0 110.088 -173.638 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.62 ' HB ' ' HB2' ' A' ' 78' ' ' ASP . 62.7 m -62.77 -40.85 98.57 Favored 'General case' 0 C--N 1.289 -2.049 0 CA-C-N 114.679 -1.146 . . . . 0.0 111.648 -179.71 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt 65.0 6.83 3.64 Favored 'General case' 0 N--CA 1.484 1.247 0 N-CA-C 113.308 0.855 . . . . 0.0 113.308 -179.249 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.431 ' HB3' HG22 ' A' ' 81' ' ' THR . 87.0 tttt -116.14 109.64 17.75 Favored 'General case' 0 N--CA 1.399 -2.991 0 CA-C-O 121.54 0.686 . . . . 0.0 109.21 -179.059 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.537 ' O ' ' HA ' ' A' ' 109' ' ' THR . 3.4 tt -82.41 150.03 27.33 Favored 'General case' 0 C--N 1.289 -2.055 0 CA-C-N 114.044 -1.435 . . . . 0.0 110.121 -178.415 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.437 ' HA ' ' O ' ' A' ' 108' ' ' VAL . 7.1 t -126.14 131.27 52.09 Favored 'General case' 0 N--CA 1.405 -2.72 0 N-CA-C 106.667 -1.605 . . . . 0.0 106.667 174.38 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.62 ' HA ' ' O ' ' A' ' 74' ' ' ASN . 9.8 p -107.13 134.26 49.35 Favored 'Isoleucine or valine' 0 N--CA 1.398 -3.03 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 -177.57 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 5.1 mp -86.98 116.65 25.18 Favored 'General case' 0 C--N 1.293 -1.851 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.439 178.033 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 48.7 mm -103.37 126.8 31.16 Favored Pre-proline 0 C--N 1.274 -2.715 0 N-CA-C 106.418 -1.697 . . . . 0.0 106.418 173.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.41 ' HG2' ' HG2' ' A' ' 166' ' ' ARG . 1.2 Cg_endo -40.33 -42.54 3.74 Favored 'Trans proline' 0 C--N 1.372 1.784 0 C-N-CA 124.44 3.426 . . . . 0.0 113.739 -178.432 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 66.5 m -161.79 161.73 29.24 Favored 'General case' 0 CA--C 1.482 -1.664 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 176.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.457 ' HA ' ' O ' ' A' ' 104' ' ' PHE . 0.0 OUTLIER -71.15 108.91 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.148 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 174.683 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' CYS . . . . . 0.494 ' SG ' ' HB2' ' A' ' 104' ' ' PHE . 14.2 p -97.42 124.0 41.46 Favored 'General case' 0 N--CA 1.425 -1.689 0 N-CA-C 108.442 -0.948 . . . . 0.0 108.442 175.642 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -116.47 123.7 48.13 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 177.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.642 ' O ' ' HA ' ' A' ' 101' ' ' VAL . 33.5 m -113.62 130.61 67.37 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.348 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 -179.759 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.511 ' HA2' ' O ' ' A' ' 100' ' ' SER . . . . . . . . 0 C--N 1.3 -1.466 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.232 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . 0.511 ' O ' ' HA2' ' A' ' 95' ' ' GLY . 18.2 m . . . . . 0 N--CA 1.411 -2.378 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.642 ' HA ' ' O ' ' A' ' 94' ' ' VAL . 93.8 t -127.11 117.74 48.31 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.19 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 173.891 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.504 HD12 ' C ' ' A' ' 101' ' ' VAL . 5.6 mp -134.47 142.32 47.04 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 -178.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 39.6 ttmt -133.5 121.04 21.6 Favored 'General case' 0 C--N 1.291 -1.968 0 CA-C-O 121.002 0.43 . . . . 0.0 110.249 179.175 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.494 ' HB2' ' SG ' ' A' ' 92' ' ' CYS . 94.1 m-85 -101.25 109.24 21.07 Favored 'General case' 0 C--N 1.291 -1.965 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 174.804 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 43.9 m -72.58 151.96 42.08 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.484 -177.147 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 17.1 p -50.28 -42.87 52.97 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 124.134 0.974 . . . . 0.0 112.375 -179.367 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 41.4 p -127.42 93.76 3.81 Favored 'General case' 0 N--CA 1.424 -1.768 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.344 178.324 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.551 HG11 HG13 ' A' ' 123' ' ' ILE . 45.7 t -87.33 144.09 9.98 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.115 0 N-CA-C 106.372 -1.714 . . . . 0.0 106.372 175.479 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.537 ' HA ' ' O ' ' A' ' 84' ' ' LEU . 10.1 t -144.45 134.45 23.98 Favored 'General case' 0 N--CA 1.399 -2.998 0 CA-C-N 118.614 0.643 . . . . 0.0 110.891 -176.205 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -167.22 -166.97 27.2 Favored Glycine 0 N--CA 1.434 -1.491 0 N-CA-C 111.353 -0.699 . . . . 0.0 111.353 179.652 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 45.8 m80 -83.98 143.32 29.88 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 117.696 0.748 . . . . 0.0 110.741 -177.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.568 ' HA ' HD22 ' A' ' 117' ' ' LEU . 0.5 OUTLIER -103.42 118.19 36.2 Favored 'General case' 0 N--CA 1.434 -1.23 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 -174.524 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -132.75 140.23 47.96 Favored 'General case' 0 CA--C 1.461 -2.469 0 O-C-N 123.897 0.748 . . . . 0.0 109.038 167.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 2.5 tmtm? -78.31 100.4 6.71 Favored 'General case' 0 C--N 1.268 -2.964 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 -174.723 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . 0.584 ' H ' HD22 ' A' ' 63' ' ' LEU . . . 135.02 -63.3 0.6 Allowed Glycine 0 N--CA 1.433 -1.559 0 N-CA-C 108.201 -1.96 . . . . 0.0 108.201 -175.071 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.547 ' H ' ' HD3' ' A' ' 116' ' ' LYS . 0.1 OUTLIER -122.08 130.0 52.88 Favored 'General case' 0 C--N 1.291 -1.945 0 O-C-N 121.848 -0.795 . . . . 0.0 110.492 179.407 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.568 HD22 ' HA ' ' A' ' 112' ' ' LEU . 0.3 OUTLIER -108.19 105.34 15.02 Favored 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 105.165 -2.161 . . . . 0.0 105.165 -179.502 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 48.1 p -106.05 166.75 10.28 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 113.103 0.779 . . . . 0.0 113.103 -172.748 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 28.0 m-20 64.43 40.53 6.27 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.976 0.91 . . . . 0.0 109.75 175.109 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.479 ' CG1' HD12 ' A' ' 117' ' ' LEU . 15.6 m -83.83 83.07 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.415 -2.197 0 CA-C-O 122.216 1.007 . . . . 0.0 112.117 -172.595 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -68.63 96.39 0.71 Allowed 'General case' 0 N--CA 1.406 -2.64 0 CA-C-N 113.742 -1.572 . . . . 0.0 109.004 176.054 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 147.53 -15.11 1.43 Allowed Glycine 0 C--N 1.292 -1.87 0 C-N-CA 120.28 -0.962 . . . . 0.0 112.059 177.753 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.551 HG13 HG11 ' A' ' 108' ' ' VAL . 93.2 mt -100.17 99.52 8.64 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.833 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 176.636 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.489 ' HA ' ' O ' ' A' ' 131' ' ' VAL . 47.9 mtpt -107.23 148.63 28.69 Favored 'General case' 0 N--CA 1.419 -1.99 0 CA-C-N 113.999 -1.455 . . . . 0.0 109.666 -173.145 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.458 HG22 HG21 ' A' ' 134' ' ' THR . 13.3 t -154.76 157.62 38.27 Favored 'General case' 0 C--N 1.285 -2.23 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 176.236 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.61 ' HD3' ' N ' ' A' ' 127' ' ' VAL . 0.5 OUTLIER -128.8 138.02 51.84 Favored 'General case' 0 N--CA 1.385 -3.713 0 N-CA-C 106.686 -1.598 . . . . 0.0 106.686 172.184 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.61 ' N ' ' HD3' ' A' ' 126' ' ' LYS . 7.4 p -160.21 -38.04 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.289 -2.054 0 N-CA-C 105.766 -1.939 . . . . 0.0 105.766 177.327 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 13.8 tpt -115.74 -50.62 2.69 Favored 'General case' 0 N--CA 1.39 -3.434 0 CA-C-N 112.605 -2.089 . . . . 0.0 108.129 177.711 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 8.7 tp -162.25 172.71 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 N-CA-C 105.511 -2.033 . . . . 0.0 105.511 174.815 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 14.3 m-90 -71.66 117.38 13.17 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 118.834 0.743 . . . . 0.0 110.344 177.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.489 ' O ' ' HA ' ' A' ' 124' ' ' LYS . 45.9 t -122.84 133.01 70.21 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.661 0 N-CA-C 106.559 -1.645 . . . . 0.0 106.559 174.691 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 62.8 pttt -108.61 5.24 24.81 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 -173.293 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 35.8 m -126.05 14.94 4.02 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 N-CA-C 112.439 0.533 . . . . 0.0 112.439 -177.538 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . 0.458 HG21 HG22 ' A' ' 125' ' ' THR . 38.4 p -51.58 102.13 0.04 OUTLIER 'General case' 0 C--N 1.347 0.458 0 CA-C-O 121.502 0.668 . . . . 0.0 112.059 179.682 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 38.5 m -86.54 152.44 22.63 Favored 'General case' 0 N--CA 1.418 -2.038 0 CA-C-N 115.073 -0.967 . . . . 0.0 111.669 -174.747 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 11.5 tt -110.27 132.32 58.93 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.513 0 CA-C-N 114.973 -1.012 . . . . 0.0 109.558 -179.256 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . 0.416 ' HB2' ' OG1' ' A' ' 146' ' ' THR . 26.0 t -122.13 116.95 25.12 Favored 'General case' 0 N--CA 1.426 -1.657 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 -179.812 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . 0.457 HG21 HG23 ' A' ' 65' ' ' ILE . 3.0 t -136.35 114.62 11.62 Favored 'General case' 0 C--N 1.277 -2.57 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 178.393 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -78.33 73.06 4.89 Favored 'General case' 0 C--N 1.305 -1.369 0 C-N-CA 119.16 -1.016 . . . . 0.0 111.586 -174.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . 49.86 32.23 5.28 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 125.482 1.513 . . . . 0.0 112.039 178.479 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . 0.647 ' N ' ' HG3' ' A' ' 64' ' ' PRO . 22.9 t -176.96 -76.73 0.01 OUTLIER 'General case' 0 C--O 1.215 -0.727 0 CA-C-O 120.886 0.374 . . . . 0.0 111.102 -175.902 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . 0.433 ' O ' ' HA ' ' A' ' 138' ' ' THR . 93.3 mttt -98.48 150.47 21.63 Favored 'General case' 0 C--N 1.306 -1.291 0 O-C-N 122.287 -0.258 . . . . 0.0 110.443 -172.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.685 ' HB ' ' O ' ' A' ' 153' ' ' ARG . 47.9 t -106.16 136.06 42.08 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 CA-C-O 121.143 0.497 . . . . 0.0 111.697 -172.772 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . 0.43 ' HA ' ' OG ' ' A' ' 152' ' ' SER . 75.5 m-85 -135.71 143.29 45.3 Favored 'General case' 0 C--O 1.25 1.11 0 C-N-CA 123.894 0.878 . . . . 0.0 109.244 179.488 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 55.5 p90 -64.14 141.28 58.83 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-O 121.423 0.63 . . . . 0.0 112.564 178.575 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.416 ' OG1' ' HB2' ' A' ' 137' ' ' SER . 91.4 m -108.63 -28.77 9.09 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 167.56 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . 0.563 ' HB3' ' HB3' ' A' ' 150' ' ' LYS . . . -60.33 129.46 41.76 Favored 'General case' 0 N--CA 1.441 -0.925 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 172.445 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -84.22 -15.61 68.91 Favored Glycine 0 CA--C 1.48 -2.097 0 C-N-CA 119.956 -1.116 . . . . 0.0 112.584 -169.616 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 58.5 mtt -101.45 2.13 39.01 Favored 'General case' 0 C--N 1.291 -1.974 0 CA-C-O 121.453 0.644 . . . . 0.0 110.021 -176.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . 0.563 ' HB3' ' HB3' ' A' ' 147' ' ' ALA . 17.3 tppt? -121.28 -178.03 3.67 Favored 'General case' 0 CA--C 1.561 1.374 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 -174.398 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . 0.516 ' H ' ' HG3' ' A' ' 150' ' ' LYS . 75.0 mmtt -137.32 164.52 28.39 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 123.491 0.716 . . . . 0.0 109.071 -172.562 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' SER . . . . . 0.457 ' C ' ' HD2' ' A' ' 153' ' ' ARG . 42.5 m -76.04 153.6 36.31 Favored 'General case' 0 C--N 1.306 -1.326 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 -174.758 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' ARG . . . . . 0.685 ' O ' ' HB ' ' A' ' 143' ' ' VAL . 3.1 mpt_? -126.18 149.98 48.63 Favored 'General case' 0 CA--C 1.494 -1.177 0 N-CA-C 106.18 -1.785 . . . . 0.0 106.18 173.635 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 41.4 m -93.63 142.22 27.59 Favored 'General case' 0 C--N 1.281 -2.382 0 C-N-CA 120.497 -0.481 . . . . 0.0 110.625 -178.352 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 19.1 ttp180 -58.5 -30.38 66.99 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-O 120.66 0.267 . . . . 0.0 111.184 178.541 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -53.44 -21.03 5.37 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 124.058 0.943 . . . . 0.0 112.71 179.531 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -64.96 -53.63 43.3 Favored 'General case' 0 N--CA 1.432 -1.332 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 178.605 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 0.404 ' H ' ' H ' ' A' ' 159' ' ' GLY . 10.7 t80 170.72 23.57 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 106.744 -1.576 . . . . 0.0 106.744 177.49 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . 0.404 ' H ' ' H ' ' A' ' 158' ' ' TYR . . . 95.89 -92.52 1.44 Allowed Glycine 0 N--CA 1.416 -2.689 0 C-N-CA 119.082 -1.532 . . . . 0.0 109.376 -170.159 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.536 HG23 ' HB ' ' A' ' 65' ' ' ILE . 2.4 t -130.26 114.5 29.18 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.758 0 N-CA-C 106.333 -1.728 . . . . 0.0 106.333 176.289 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 5.3 pp0? -134.51 130.66 36.96 Favored 'General case' 0 N--CA 1.414 -2.25 0 C-N-CA 117.194 -1.802 . . . . 0.0 115.338 -172.46 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . 0.428 ' HG2' HG21 ' A' ' 94' ' ' VAL . 19.8 tpt180 -152.81 138.68 18.02 Favored 'General case' 0 C--N 1.27 -2.875 0 N-CA-C 104.694 -2.335 . . . . 0.0 104.694 168.102 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -69.81 95.27 0.89 Allowed 'General case' 0 CA--C 1.505 -0.768 0 CA-C-O 121.621 0.724 . . . . 0.0 112.777 -175.579 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -145.6 159.27 27.89 Favored Glycine 0 N--CA 1.423 -2.17 0 N-CA-C 109.2 -1.56 . . . . 0.0 109.2 176.572 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.426 ' H ' HD23 ' A' ' 165' ' ' LEU . 2.0 pt? -130.77 143.74 50.95 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-O 120.992 0.425 . . . . 0.0 110.451 -178.075 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . 0.507 ' HD2' ' N ' ' A' ' 166' ' ' ARG . 4.2 mpt_? -96.85 106.34 18.63 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 178.897 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 43.3 t -37.52 -46.26 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.562 1.44 0 N-CA-C 115.674 1.731 . . . . 0.0 115.674 -172.054 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -60.45 -35.55 76.11 Favored 'General case' 0 N--CA 1.486 1.326 0 CA-C-O 121.178 0.513 . . . . 0.0 111.729 -178.534 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 31.5 tttm -96.22 -81.17 0.42 Allowed 'General case' 0 C--N 1.3 -1.572 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.678 -179.756 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 170' ' ' PHE . . . . . 0.421 ' OXT' ' HB2' ' A' ' 165' ' ' LEU . 68.6 t80 . . . . . 0 N--CA 1.432 -1.35 0 N-CA-C 101.802 -3.407 . . . . 0.0 101.802 -175.545 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.433 ' HB2' ' HD3' ' A' ' 55' ' ' PRO . 33.0 mt . . . . . 0 CA--C 1.505 -0.754 0 N-CA-C 112.793 0.664 . . . . 0.0 112.793 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.512 ' O ' ' HG2' ' A' ' 59' ' ' LYS . 7.5 Cg_exo -69.65 -14.34 36.29 Favored 'Trans proline' 0 N--CA 1.427 -2.432 0 C-N-CA 121.61 1.54 . . . . 0.0 112.282 -169.356 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -71.52 -39.88 70.48 Favored 'General case' 0 CA--C 1.49 -1.359 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 -174.069 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.451 ' HA ' ' HB3' ' A' ' 60' ' ' GLU . 10.4 mp -68.62 -30.48 69.22 Favored 'General case' 0 N--CA 1.44 -0.925 0 CA-C-N 114.808 -1.087 . . . . 0.0 111.988 178.932 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 6.2 mp -64.5 -48.82 73.74 Favored 'General case' 0 CA--C 1.495 -1.153 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 179.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.512 ' HG2' ' O ' ' A' ' 55' ' ' PRO . 32.3 pttt -75.19 -26.84 59.33 Favored 'General case' 0 C--N 1.299 -1.59 0 CA-C-N 115.143 -0.935 . . . . 0.0 112.986 177.399 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.451 ' HB3' ' HA ' ' A' ' 57' ' ' LEU . 8.3 tp10 -59.82 -51.81 68.15 Favored 'General case' 0 C--N 1.306 -1.313 0 C-N-CA 123.927 0.891 . . . . 0.0 111.221 175.018 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 63.4 t80 -68.59 -10.26 54.78 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.6 -176.519 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.589 ' OD2' HG23 ' A' ' 73' ' ' THR . 22.4 t0 -94.71 -179.37 4.84 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.473 -178.495 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.738 ' HB2' HD12 ' A' ' 65' ' ' ILE . 2.5 mt -76.36 169.03 22.9 Favored Pre-proline 0 CA--C 1.559 1.299 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 -178.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.463 ' HB2' ' HG3' ' A' ' 155' ' ' ARG . 10.9 Cg_endo -91.97 25.7 0.46 Allowed 'Trans proline' 0 N--CA 1.441 -1.576 0 C-N-CA 122.596 2.197 . . . . 0.0 110.853 -176.725 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.738 HD12 ' HB2' ' A' ' 63' ' ' LEU . 0.2 OUTLIER -73.89 -29.09 25.12 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.432 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 176.915 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 53.11 1.66 0.07 OUTLIER Glycine 0 CA--C 1.544 1.887 0 CA-C-N 114.972 -1.013 . . . . 0.0 115.133 178.086 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.683 ' O ' ' HB ' ' A' ' 160' ' ' VAL . 48.6 mt 67.08 -42.35 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.189 0 C-N-CA 126.441 1.896 . . . . 0.0 114.099 -179.575 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.514 ' HB2' ' O ' ' A' ' 67' ' ' ILE . 71.3 t80 158.0 -51.37 0.0 OUTLIER Pre-proline 0 N--CA 1.489 1.494 0 C-N-CA 125.354 1.462 . . . . 0.0 110.498 177.729 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.464 ' HB2' ' OD2' ' A' ' 71' ' ' ASP . 9.5 Cg_endo -95.82 -24.82 0.12 Allowed 'Trans proline' 0 C--N 1.374 1.878 0 C-N-CA 121.87 1.713 . . . . 0.0 115.052 -172.479 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 82.48 -7.89 63.44 Favored Glycine 0 CA--C 1.526 0.738 0 C-N-CA 120.454 -0.879 . . . . 0.0 111.629 -174.707 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.464 ' OD2' ' HB2' ' A' ' 69' ' ' PRO . 23.2 m-20 -86.16 -30.99 22.05 Favored 'General case' 0 CA--C 1.495 -1.148 0 N-CA-C 106.26 -1.755 . . . . 0.0 106.26 178.062 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.527 ' O ' ' HB ' ' A' ' 73' ' ' THR . . . -82.62 -172.26 3.95 Favored 'General case' 0 N--CA 1.442 -0.825 0 CA-C-N 113.556 -1.657 . . . . 0.0 107.103 171.81 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.589 HG23 ' OD2' ' A' ' 62' ' ' ASP . 60.7 m 79.94 27.35 0.32 Allowed 'General case' 0 N--CA 1.474 0.742 0 CA-C-O 124.807 2.241 . . . . 0.0 109.483 175.015 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 35.8 m-80 -84.48 -177.3 6.58 Favored 'General case' 0 N--CA 1.386 -3.641 0 CA-C-N 113.759 -1.564 . . . . 0.0 110.479 178.786 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 42.6 t80 -149.21 94.9 2.3 Favored 'General case' 0 C--N 1.276 -2.628 0 C-N-CA 119.352 -0.939 . . . . 0.0 110.935 -169.784 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.665 ' OE1' ' HG ' ' A' ' 87' ' ' LEU . 4.2 mp0 -107.26 96.09 6.17 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 176.777 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.431 ' HB2' HD23 ' A' ' 84' ' ' LEU . 81.9 t80 -102.73 124.31 48.03 Favored 'General case' 0 C--N 1.297 -1.704 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.255 -176.264 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.724 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 10.4 m-20 -93.9 155.77 16.99 Favored 'General case' 0 CA--C 1.47 -2.1 0 C-N-CA 118.819 -1.152 . . . . 0.0 108.712 175.017 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -80.43 -53.35 6.68 Favored 'General case' 0 C--N 1.25 -3.756 0 CA-C-N 113.412 -1.722 . . . . 0.0 109.026 179.323 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -66.77 -21.33 66.06 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 113.726 -1.579 . . . . 0.0 110.754 -176.498 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.724 ' HB ' ' HB2' ' A' ' 78' ' ' ASP . 27.2 m -101.63 -53.01 3.07 Favored 'General case' 0 N--CA 1.41 -2.455 0 CA-C-N 115.0 -1.0 . . . . 0.0 111.192 -174.612 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 99.7 mttt 70.26 4.15 4.74 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 123.85 0.86 . . . . 0.0 111.995 -174.616 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.719 ' HG2' HG22 ' A' ' 109' ' ' THR . 36.2 ttmt -104.91 107.41 18.36 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 176.655 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.431 HD23 ' HB2' ' A' ' 77' ' ' PHE . 3.1 tm? -68.01 133.73 49.52 Favored 'General case' 0 C--N 1.292 -1.929 0 CA-C-N 113.833 -1.53 . . . . 0.0 110.447 -175.56 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.503 HG23 ' HB2' ' A' ' 76' ' ' GLU . 8.9 t -120.85 137.79 54.38 Favored 'General case' 0 N--CA 1.403 -2.812 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 177.422 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 61.0 t -111.32 118.62 57.88 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 C-N-CA 123.811 0.844 . . . . 0.0 109.44 -179.205 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.665 ' HG ' ' OE1' ' A' ' 76' ' ' GLU 0.293 0.5 OUTLIER -79.44 124.41 28.43 Favored 'General case' 0 N--CA 1.403 -2.82 0 CA-C-O 122.578 1.18 . . . . 0.0 112.37 172.879 . . . . . . . . 4 4 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.437 HG23 ' HE ' ' A' ' 166' ' ' ARG . 50.4 mm -102.36 125.8 35.18 Favored Pre-proline 0 C--N 1.279 -2.482 0 CA-C-N 113.711 -1.586 . . . . 0.0 107.805 178.638 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -59.61 96.93 0.1 Allowed 'Trans proline' 0 C--O 1.248 1.018 0 C-N-CA 122.62 2.214 . . . . 0.0 111.516 175.476 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . 0.485 ' OG ' ' HB2' ' A' ' 168' ' ' ASP . 68.4 m 65.21 176.74 0.2 Allowed 'General case' 0 C--O 1.236 0.356 0 C-N-CA 124.483 1.113 . . . . 0.0 112.844 -178.711 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.457 HG12 ' HA ' ' A' ' 105' ' ' THR . 39.7 mt -88.5 131.15 36.7 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.623 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.793 178.705 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' CYS . . . . . 0.461 ' SG ' ' HA3' ' A' ' 164' ' ' GLY . 16.0 t -116.16 122.71 45.87 Favored 'General case' 0 N--CA 1.41 -2.452 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 173.764 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -116.96 127.29 54.06 Favored 'General case' 0 C--N 1.29 -2.017 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 178.628 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 3.9 p -105.14 103.94 16.14 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.27 0 CA-C-O 122.024 0.916 . . . . 0.0 109.578 177.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.423 -2.229 0 N-CA-C 108.226 -1.95 . . . . 0.0 108.226 179.111 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 35.0 m . . . . . 0 N--CA 1.423 -1.789 0 CA-C-O 121.322 0.582 . . . . 0.0 109.645 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.459 ' C ' HD12 ' A' ' 102' ' ' LEU . 60.8 t -113.0 128.86 69.52 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.201 0 N-CA-C 108.142 -1.058 . . . . 0.0 108.142 176.374 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.464 ' HA ' ' O ' ' A' ' 124' ' ' LYS . 5.3 mp -129.9 136.2 49.23 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-O 120.746 0.308 . . . . 0.0 110.796 -178.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -112.43 110.09 20.08 Favored 'General case' 0 C--N 1.31 -1.146 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 177.132 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -89.82 103.5 16.15 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 176.862 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.457 ' HA ' HG12 ' A' ' 91' ' ' ILE . 35.1 m -82.41 157.81 23.54 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.967 -175.099 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 20.3 p -55.84 -38.13 69.64 Favored 'General case' 0 C--N 1.319 -0.725 0 C-N-CA 125.898 1.679 . . . . 0.0 113.037 -177.406 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 14.0 m -128.13 98.73 5.21 Favored 'General case' 0 N--CA 1.419 -1.983 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 -179.412 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 16.9 m -108.4 133.69 52.59 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 179.108 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.719 HG22 ' HG2' ' A' ' 83' ' ' LYS . 37.0 m -130.35 132.53 45.87 Favored 'General case' 0 N--CA 1.394 -3.268 0 CA-C-N 116.767 -0.197 . . . . 0.0 110.813 -164.338 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . 0.637 ' HA3' ' O ' ' A' ' 119' ' ' ASP . . . -161.98 -158.25 9.41 Favored Glycine 0 C--O 1.217 -0.916 0 C-N-CA 121.288 -0.482 . . . . 0.0 112.635 -177.274 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 53.3 m80 -117.56 108.06 15.02 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 122.165 -0.609 . . . . 0.0 109.606 176.038 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 5.9 tt -104.4 127.82 52.14 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.73 -172.071 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -131.59 168.1 18.27 Favored 'General case' 0 CA--C 1.464 -2.355 0 CA-C-N 115.243 -0.889 . . . . 0.0 109.71 173.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 54.2 tptt -84.35 101.11 11.71 Favored 'General case' 0 N--CA 1.389 -3.522 0 CA-C-N 115.179 -0.918 . . . . 0.0 108.809 -177.017 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . 0.479 ' H ' ' CD2' ' A' ' 63' ' ' LEU . . . 126.24 -11.68 7.22 Favored Glycine 0 C--O 1.205 -1.697 0 CA-C-N 115.159 -0.928 . . . . 0.0 111.164 -176.868 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 179.53 147.89 0.24 Allowed 'General case' 0 N--CA 1.487 1.393 0 CA-C-N 117.052 0.426 . . . . 0.0 111.219 178.295 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.6 tt -124.11 113.67 18.68 Favored 'General case' 0 N--CA 1.429 -1.497 0 N-CA-C 106.013 -1.847 . . . . 0.0 106.013 176.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 71.8 p -97.58 122.58 40.82 Favored 'General case' 0 C--N 1.265 -3.071 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.609 -177.829 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . 0.637 ' O ' ' HA3' ' A' ' 110' ' ' GLY . 31.3 m-20 73.13 129.76 0.04 OUTLIER 'General case' 0 C--O 1.207 -1.146 0 C-N-CA 125.484 1.514 . . . . 0.0 111.651 -179.155 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 10.8 m -135.5 78.75 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 CA-C-O 122.639 1.209 . . . . 0.0 108.72 173.744 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -67.17 111.53 3.97 Favored 'General case' 0 N--CA 1.424 -1.757 0 CA-C-N 113.668 -1.605 . . . . 0.0 108.85 -175.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 133.27 -13.75 4.89 Favored Glycine 0 N--CA 1.424 -2.1 0 C-N-CA 120.31 -0.948 . . . . 0.0 112.115 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.458 ' O ' ' HA ' ' A' ' 132' ' ' LYS . 67.5 mt -99.55 113.57 35.14 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.17 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 179.178 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.464 ' O ' ' HA ' ' A' ' 102' ' ' LEU . 23.1 tptm -85.07 117.9 24.31 Favored 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 104.967 -2.234 . . . . 0.0 104.967 -179.261 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 95.1 m -126.85 124.93 40.74 Favored 'General case' 0 C--N 1.288 -2.085 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 -170.347 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.522 ' HG2' ' N ' ' A' ' 127' ' ' VAL . 84.2 tttt -119.37 145.59 46.06 Favored 'General case' 0 N--CA 1.429 -1.499 0 CA-C-O 121.255 0.55 . . . . 0.0 110.203 169.548 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.522 ' N ' ' HG2' ' A' ' 126' ' ' LYS . 7.2 p -159.21 -35.68 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 175.782 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -125.25 -51.67 1.64 Allowed 'General case' 0 N--CA 1.399 -3.006 0 N-CA-C 105.621 -1.992 . . . . 0.0 105.621 -179.729 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 7.9 tp -149.94 169.9 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.285 0 N-CA-C 105.574 -2.01 . . . . 0.0 105.574 176.516 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' TRP . . . . . 0.433 ' CD1' ' HB2' ' A' ' 126' ' ' LYS . 30.6 m-90 -80.12 126.32 30.94 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-O 121.32 0.581 . . . . 0.0 111.241 177.52 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 7.3 p -137.35 137.0 46.51 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.247 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 176.636 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . 0.458 ' HA ' ' O ' ' A' ' 123' ' ' ILE . 0.0 OUTLIER -112.07 20.19 17.11 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 113.708 1.003 . . . . 0.0 113.708 -174.687 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.442 HG13 ' HD2' ' A' ' 132' ' ' LYS . 17.8 m -124.17 -60.55 1.86 Allowed 'Isoleucine or valine' 0 C--O 1.21 -1.014 0 CA-C-N 116.101 -0.499 . . . . 0.0 112.15 179.357 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . 0.466 ' O ' ' HA ' ' A' ' 119' ' ' ASP . 77.5 p 51.71 -171.64 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 124.118 0.967 . . . . 0.0 113.465 179.386 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 23.2 p -166.0 152.9 9.73 Favored 'General case' 0 N--CA 1.427 -1.612 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 176.06 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 14.1 tt -131.29 134.0 61.61 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.322 0 CA-C-O 121.254 0.549 . . . . 0.0 109.549 -179.264 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 39.9 t -124.81 159.61 30.62 Favored 'General case' 0 C--N 1.289 -2.041 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 -176.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . 0.53 HG23 ' H ' ' A' ' 140' ' ' ALA . 9.7 t -165.15 175.97 8.88 Favored 'General case' 0 N--CA 1.41 -2.436 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 -178.008 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -112.49 30.57 6.99 Favored 'General case' 0 C--N 1.275 -2.659 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 173.128 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . 0.53 ' H ' HG23 ' A' ' 138' ' ' THR . . . 62.84 38.37 11.56 Favored 'General case' 0 C--N 1.35 0.596 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 -172.462 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . 0.632 ' O ' ' HB3' ' A' ' 155' ' ' ARG . 46.9 t -174.57 -79.95 0.01 OUTLIER 'General case' 0 C--O 1.219 -0.527 0 CA-C-N 114.585 -1.189 . . . . 0.0 111.312 -175.064 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -75.53 134.94 40.63 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 -178.48 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 59.4 t -106.0 130.37 57.67 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.969 0 CA-C-O 120.998 0.428 . . . . 0.0 111.556 -170.155 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -131.76 150.17 52.24 Favored 'General case' 0 CA--C 1.481 -1.699 0 CA-C-O 121.589 0.709 . . . . 0.0 110.631 176.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . 0.456 ' HB2' ' HB2' ' A' ' 151' ' ' LYS . 60.7 m-85 -109.91 103.12 11.85 Favored 'General case' 0 C--N 1.268 -2.967 0 CA-C-N 115.026 -0.988 . . . . 0.0 111.424 179.205 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 6.6 p -81.75 19.69 1.04 Allowed 'General case' 0 C--N 1.305 -1.37 0 CA-C-N 115.073 -0.967 . . . . 0.0 113.269 -176.229 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -68.79 -15.4 63.49 Favored 'General case' 0 C--O 1.218 -0.574 0 CA-C-O 121.773 0.796 . . . . 0.0 109.812 175.209 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 166.39 29.53 0.02 OUTLIER Glycine 0 N--CA 1.43 -1.715 0 N-CA-C 108.868 -1.693 . . . . 0.0 108.868 175.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 15.6 tpt 57.59 23.5 9.38 Favored 'General case' 0 N--CA 1.486 1.328 0 CA-C-O 122.322 1.058 . . . . 0.0 108.498 -173.481 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . 0.462 ' CD ' HG11 ' A' ' 127' ' ' VAL . 0.0 OUTLIER -76.19 -9.46 58.65 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 115.942 1.83 . . . . 0.0 115.942 -169.492 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . 0.473 ' HE2' ' HA ' ' A' ' 151' ' ' LYS . 5.2 mmpt? -147.21 138.33 23.83 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 120.514 0.197 . . . . 0.0 111.278 178.556 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 72.2 p -126.53 132.41 51.37 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 174.343 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 22.8 tpt180 -147.91 157.37 43.49 Favored 'General case' 0 C--N 1.31 -1.148 0 N-CA-C 109.554 -0.535 . . . . 0.0 109.554 -176.82 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 68.3 m -98.1 143.71 28.36 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 108.434 -0.951 . . . . 0.0 108.434 173.019 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' ARG . . . . . 0.632 ' HB3' ' O ' ' A' ' 141' ' ' SER . 0.0 OUTLIER -67.44 -18.29 65.04 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 118.756 -1.177 . . . . 0.0 112.758 176.837 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -41.86 -56.97 2.54 Favored 'General case' 0 N--CA 1.482 1.174 0 N-CA-C 115.128 1.529 . . . . 0.0 115.128 -173.775 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -56.32 -37.96 70.65 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 112.012 0.375 . . . . 0.0 112.012 -176.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 6.7 t80 176.15 -26.25 0.0 OUTLIER 'General case' 0 CA--C 1.506 -0.731 0 N-CA-C 106.913 -1.514 . . . . 0.0 106.913 174.374 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . 0.695 ' HA3' ' O ' ' A' ' 65' ' ' ILE . . . 132.03 -87.33 0.28 Allowed Glycine 0 N--CA 1.407 -3.251 0 N-CA-C 110.506 -1.037 . . . . 0.0 110.506 -174.014 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.683 ' HB ' ' O ' ' A' ' 67' ' ' ILE . 12.0 t -98.54 116.91 42.6 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.238 0 C-N-CA 119.338 -0.945 . . . . 0.0 108.701 178.593 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 75.9 mm-40 -119.61 108.94 15.08 Favored 'General case' 0 CA--C 1.501 -0.931 0 N-CA-C 113.979 1.103 . . . . 0.0 113.979 -176.638 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 22.4 mmm180 -149.71 148.43 29.25 Favored 'General case' 0 C--N 1.308 -1.234 0 C-N-CA 125.508 1.523 . . . . 0.0 107.466 172.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -74.31 89.38 2.07 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-O 121.514 0.673 . . . . 0.0 110.874 -177.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . 0.461 ' HA3' ' SG ' ' A' ' 92' ' ' CYS . . . -122.8 168.05 15.12 Favored Glycine 0 N--CA 1.432 -1.568 0 CA-C-N 115.151 -0.931 . . . . 0.0 110.952 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 49.9 tp -141.19 114.58 8.77 Favored 'General case' 0 N--CA 1.414 -2.251 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 178.537 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . 0.439 ' HD2' ' HG3' ' A' ' 69' ' ' PRO . 81.3 mtt85 -87.4 103.97 16.0 Favored 'General case' 0 CA--C 1.476 -1.882 0 CA-C-O 122.07 0.938 . . . . 0.0 110.672 178.131 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 18.6 m -77.09 53.04 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.294 -1.809 0 CA-C-N 113.378 -1.737 . . . . 0.0 114.444 -173.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . 0.485 ' HB2' ' OG ' ' A' ' 90' ' ' SER . 32.8 t70 -135.36 -0.33 2.7 Favored 'General case' 0 N--CA 1.475 0.825 0 CA-C-O 122.271 1.034 . . . . 0.0 108.435 175.932 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -149.88 162.41 40.37 Favored 'General case' 0 N--CA 1.443 -0.817 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 -177.693 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 170' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 . . . . . 0 C--O 1.247 0.927 0 CA-C-O 118.958 -0.544 . . . . 0.0 110.162 176.784 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.661 ' O ' ' HG ' ' A' ' 58' ' ' LEU 0.261 7.9 mp . . . . . 0 CA--C 1.476 -1.886 0 N-CA-C 117.79 2.515 . . . . 0.0 117.79 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.617 ' O ' ' HE2' ' A' ' 59' ' ' LYS . 52.8 Cg_exo -57.44 -25.76 67.88 Favored 'Trans proline' 0 N--CA 1.445 -1.342 0 C-N-CA 121.52 1.48 . . . . 0.0 111.418 -176.371 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -81.74 -32.04 31.71 Favored 'General case' 0 N--CA 1.417 -2.124 0 CA-C-N 115.021 -0.99 . . . . 0.0 108.898 -178.279 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.543 ' HA ' ' HB3' ' A' ' 60' ' ' GLU . 15.4 mt -74.98 -29.69 60.97 Favored 'General case' 0 CA--C 1.487 -1.454 0 CA-C-N 115.004 -0.998 . . . . 0.0 110.333 -174.436 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.661 ' HG ' ' O ' ' A' ' 54' ' ' LEU . 15.5 mt -59.71 -52.4 65.67 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 -178.687 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.617 ' HE2' ' O ' ' A' ' 55' ' ' PRO . 49.5 mtmt -64.93 -23.91 67.36 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 113.955 -1.475 . . . . 0.0 110.57 177.689 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.543 ' HB3' ' HA ' ' A' ' 57' ' ' LEU . 28.3 tt0 -82.58 -19.09 39.14 Favored 'General case' 0 C--N 1.291 -1.976 0 C-N-CA 124.844 1.257 . . . . 0.0 111.679 178.456 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 36.6 m-85 -85.9 -33.21 21.28 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 113.56 0.948 . . . . 0.0 113.56 -177.669 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.514 ' OD2' HD13 ' A' ' 65' ' ' ILE . 4.6 p-10 -78.47 -165.19 0.66 Allowed 'General case' 0 C--N 1.292 -1.92 0 N-CA-C 113.116 0.784 . . . . 0.0 113.116 -167.458 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.703 ' HB2' HD12 ' A' ' 65' ' ' ILE . 6.6 mt -77.16 -154.23 0.0 OUTLIER Pre-proline 0 CA--C 1.599 2.845 0 N-CA-C 104.494 -2.41 . . . . 0.0 104.494 178.146 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.493 ' O ' ' HD2' ' A' ' 155' ' ' ARG . 7.5 Cg_endo -96.77 10.9 1.25 Allowed 'Trans proline' 0 N--CA 1.441 -1.585 0 CA-C-N 123.667 2.345 . . . . 0.0 111.067 177.127 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.703 HD12 ' HB2' ' A' ' 63' ' ' LEU . 0.2 OUTLIER -78.9 -40.31 22.77 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.92 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.68 -176.81 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 59.9 8.14 7.62 Favored Glycine 0 CA--C 1.542 1.73 0 CA-C-N 116.287 -0.415 . . . . 0.0 113.638 -177.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.635 ' H ' HG12 ' A' ' 65' ' ' ILE . 55.9 mt 59.01 -70.4 0.07 OUTLIER 'Isoleucine or valine' 0 C--O 1.211 -0.94 0 C-N-CA 127.418 2.287 . . . . 0.0 114.126 -178.72 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.597 ' HB3' ' HD3' ' A' ' 69' ' ' PRO . 34.3 t80 173.5 -56.57 0.0 OUTLIER Pre-proline 0 CA--C 1.563 1.446 0 CA-C-N 118.024 0.375 . . . . 0.0 110.571 -176.55 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.597 ' HD3' ' HB3' ' A' ' 68' ' ' PHE . 6.9 Cg_endo -98.89 157.97 0.67 Allowed 'Trans proline' 0 C--N 1.386 2.533 0 C-N-CA 123.205 2.603 . . . . 0.0 112.598 179.39 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -89.45 -8.24 68.39 Favored Glycine 0 CA--C 1.524 0.648 0 C-N-CA 121.379 -0.438 . . . . 0.0 112.39 179.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.565 ' OD2' ' HG3' ' A' ' 89' ' ' PRO . 20.8 t70 -89.6 -19.96 24.3 Favored 'General case' 0 C--O 1.213 -0.852 0 CA-C-O 122.17 0.986 . . . . 0.0 108.635 177.045 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.448 ' HB3' ' HD2' ' A' ' 69' ' ' PRO . . . -84.33 -166.13 1.35 Allowed 'General case' 0 CA--C 1.487 -1.48 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 167.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 18.2 p 67.71 18.06 9.81 Favored 'General case' 0 CA--C 1.47 -2.11 0 CA-C-O 123.582 1.658 . . . . 0.0 110.668 172.234 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.749 ' O ' ' HA ' ' A' ' 86' ' ' VAL . 1.6 m-80 -75.87 100.49 4.81 Favored 'General case' 2 N--CA 1.365 -4.694 0 CA-C-N 111.704 -2.498 . . . . 0.0 110.513 -178.639 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -99.03 91.86 5.22 Favored 'General case' 0 C--N 1.274 -2.71 0 CA-C-N 114.572 -1.194 . . . . 0.0 113.33 -176.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.599 ' HB2' HG23 ' A' ' 85' ' ' THR . 19.2 mm-40 -97.5 133.8 41.58 Favored 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 106.729 -1.582 . . . . 0.0 106.729 175.735 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.452 ' HB2' ' CD2' ' A' ' 84' ' ' LEU . 90.6 t80 -146.57 127.28 14.3 Favored 'General case' 0 C--N 1.301 -1.511 0 C-N-CA 120.256 -0.578 . . . . 0.0 112.193 -173.477 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.684 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 5.8 m-20 -95.2 156.5 16.29 Favored 'General case' 0 CA--C 1.472 -2.043 0 N-CA-C 105.44 -2.059 . . . . 0.0 105.44 170.184 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -80.1 -60.63 2.26 Favored 'General case' 0 C--N 1.255 -3.521 0 N-CA-C 113.557 0.947 . . . . 0.0 113.557 -175.027 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -71.04 -29.94 65.98 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-O 121.415 0.626 . . . . 0.0 111.1 -175.695 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.684 ' HB ' ' HB2' ' A' ' 78' ' ' ASP . 24.6 m -68.6 -45.13 72.77 Favored 'General case' 0 N--CA 1.421 -1.886 0 CA-C-N 114.898 -1.046 . . . . 0.0 109.873 179.561 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 99.6 mttt 68.12 8.13 6.33 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.139 0.976 . . . . 0.0 113.319 -179.016 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 1.9 mptm? -89.22 106.23 18.31 Favored 'General case' 0 CA--C 1.494 -1.193 0 CA-C-O 121.551 0.691 . . . . 0.0 110.662 173.712 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.461 ' HB2' ' HB2' ' A' ' 112' ' ' LEU . 2.1 tm? -81.81 126.4 31.81 Favored 'General case' 0 C--N 1.285 -2.229 0 N-CA-C 105.426 -2.064 . . . . 0.0 105.426 174.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.63 ' HA ' ' O ' ' A' ' 108' ' ' VAL . 9.5 t -116.5 127.42 54.54 Favored 'General case' 0 N--CA 1.392 -3.327 0 C-N-CA 120.196 -0.602 . . . . 0.0 110.632 -178.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.749 ' HA ' ' O ' ' A' ' 74' ' ' ASN . 32.3 t -104.75 122.65 58.06 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.108 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.404 -178.588 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.402 ' O ' ' HA ' ' A' ' 72' ' ' ALA . 5.6 mp -90.49 104.4 16.99 Favored 'General case' 0 C--N 1.29 -2.01 0 CA-C-N 114.981 -1.008 . . . . 0.0 109.328 177.352 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.423 HG12 ' HB3' ' A' ' 104' ' ' PHE . 3.5 mp -93.93 137.53 23.03 Favored Pre-proline 0 C--N 1.302 -1.489 0 N-CA-C 106.561 -1.644 . . . . 0.0 106.561 175.114 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.621 ' O ' ' HB2' ' A' ' 166' ' ' ARG . 43.4 Cg_exo -59.76 97.32 0.11 Allowed 'Trans proline' 0 N--CA 1.455 -0.781 0 C-N-CA 122.58 2.187 . . . . 0.0 110.34 176.364 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . 0.561 ' OG ' ' HB ' ' A' ' 167' ' ' VAL . 73.4 m 66.57 177.82 0.22 Allowed 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 123.654 0.781 . . . . 0.0 110.862 -174.531 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 14.8 tt -94.78 109.06 21.66 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.763 0 C-N-CA 119.792 -0.763 . . . . 0.0 109.185 175.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 27.1 p -98.77 149.15 23.17 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.366 -179.072 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -116.56 121.32 41.42 Favored 'General case' 0 CA--C 1.476 -1.88 0 N-CA-C 107.513 -1.291 . . . . 0.0 107.513 -179.053 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.595 HG13 ' H ' ' A' ' 163' ' ' ASN . 25.0 t -112.04 103.27 15.18 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.62 0 C-N-CA 119.614 -0.834 . . . . 0.0 111.293 -176.227 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.435 -1.426 0 N-CA-C 108.285 -1.926 . . . . 0.0 108.285 178.043 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . 0.425 ' HA ' ' O ' ' A' ' 126' ' ' LYS . 36.1 m . . . . . 0 N--CA 1.424 -1.746 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.482 ' HA ' ' O ' ' A' ' 94' ' ' VAL . 52.0 t -97.64 119.24 45.4 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.257 0 CA-C-N 115.23 -0.895 . . . . 0.0 110.653 -176.851 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.4 ' HG ' HG23 ' A' ' 125' ' ' THR . 6.5 mp -109.19 126.76 53.6 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 176.619 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.437 ' HB3' ' HB2' ' A' ' 124' ' ' LYS . 38.9 ttmt -109.46 115.16 29.41 Favored 'General case' 0 C--N 1.289 -2.035 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 -178.743 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.471 ' HA ' HD11 ' A' ' 123' ' ' ILE . 93.2 m-85 -89.95 97.06 10.97 Favored 'General case' 0 N--CA 1.426 -1.651 0 CA-C-N 115.949 -0.569 . . . . 0.0 112.264 -175.16 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 87.9 m -56.88 122.36 12.05 Favored 'General case' 0 N--CA 1.422 -1.844 0 CA-C-N 114.062 -1.426 . . . . 0.0 109.535 174.621 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 8.0 t -71.9 117.7 13.82 Favored 'General case' 0 N--CA 1.435 -1.197 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 -179.588 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 52.3 m 70.68 68.71 0.19 Allowed 'General case' 0 N--CA 1.439 -0.984 0 CA-C-O 122.76 1.266 . . . . 0.0 108.812 -173.353 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.63 ' O ' ' HA ' ' A' ' 85' ' ' THR . 9.8 p -103.93 159.83 4.89 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.127 0 CA-C-N 113.627 -1.624 . . . . 0.0 106.812 -179.124 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.401 ' HA ' ' O ' ' A' ' 84' ' ' LEU . 15.8 p -115.53 170.72 8.21 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-N 118.735 0.698 . . . . 0.0 111.504 -178.334 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 176.54 -175.59 47.59 Favored Glycine 0 N--CA 1.439 -1.107 0 N-CA-C 110.506 -1.038 . . . . 0.0 110.506 179.362 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 46.7 t-80 -105.77 131.39 53.18 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 -179.29 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.461 ' HB2' ' HB2' ' A' ' 84' ' ' LEU . 3.2 tm? -97.08 107.78 20.38 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-O 121.803 0.811 . . . . 0.0 112.678 -172.18 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -123.53 143.64 50.06 Favored 'General case' 0 CA--C 1.453 -2.756 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 171.064 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 3.7 tmtp? -92.01 101.06 13.6 Favored 'General case' 0 N--CA 1.384 -3.742 0 CA-C-O 122.321 1.058 . . . . 0.0 108.57 -171.556 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . 0.645 ' O ' ' HB ' ' A' ' 138' ' ' THR . . . 143.94 -58.53 0.53 Allowed Glycine 0 C--N 1.283 -2.397 0 N-CA-C 106.736 -2.546 . . . . 0.0 106.736 -175.163 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.5 ' HB2' ' HA ' ' A' ' 137' ' ' SER . 0.0 OUTLIER -132.72 130.37 39.94 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 178.989 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -91.92 105.57 17.8 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 105.569 -2.011 . . . . 0.0 105.569 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 21.4 p -99.26 175.33 5.92 Favored 'General case' 0 C--N 1.294 -1.839 0 C-N-CA 123.355 0.662 . . . . 0.0 112.069 -174.213 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 27.4 m-20 50.89 45.72 27.12 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 123.529 0.732 . . . . 0.0 111.125 173.6 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.469 ' CG2' ' HA ' ' A' ' 135' ' ' SER . 2.1 t -77.52 99.17 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.863 0 CA-C-O 122.416 1.103 . . . . 0.0 109.807 -169.863 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 46.6 tt0 -79.79 87.58 5.27 Favored 'General case' 0 N--CA 1.4 -2.928 0 CA-C-N 113.819 -1.537 . . . . 0.0 111.275 -173.641 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 126.39 7.61 5.26 Favored Glycine 0 N--CA 1.412 -2.957 0 C-N-CA 119.604 -1.284 . . . . 0.0 112.439 171.601 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.471 HD11 ' HA ' ' A' ' 104' ' ' PHE . 8.5 tp -98.09 116.62 41.25 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.271 0 C-N-CA 117.402 -1.719 . . . . 0.0 108.223 -176.488 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.437 ' HB2' ' HB3' ' A' ' 103' ' ' LYS . 96.5 mttt -85.73 117.65 24.74 Favored 'General case' 0 C--N 1.274 -2.68 0 CA-C-N 113.816 -1.538 . . . . 0.0 109.227 -177.155 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.4 HG23 ' HG ' ' A' ' 102' ' ' LEU . 80.8 m -136.02 126.95 27.65 Favored 'General case' 0 N--CA 1.415 -2.215 0 CA-C-N 114.756 -1.111 . . . . 0.0 110.914 -173.428 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.512 ' C ' ' HD3' ' A' ' 126' ' ' LYS . 0.4 OUTLIER -112.36 128.33 56.26 Favored 'General case' 0 N--CA 1.419 -1.986 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 171.255 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.461 ' N ' ' HD3' ' A' ' 126' ' ' LYS . 7.7 p -143.36 -45.58 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.805 0 CA-C-O 121.538 0.685 . . . . 0.0 109.164 176.84 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 26.5 ptm -120.5 -26.43 5.36 Favored 'General case' 0 N--CA 1.423 -1.808 0 CA-C-N 115.037 -0.983 . . . . 0.0 108.528 173.816 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 9.3 tp -164.13 171.51 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.416 -2.172 0 N-CA-C 104.249 -2.5 . . . . 0.0 104.249 177.324 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 88.6 t90 -85.21 120.26 26.5 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 179.57 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.545 HG12 ' H ' ' A' ' 133' ' ' VAL . 45.4 t -128.08 146.05 34.26 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 N-CA-C 107.262 -1.385 . . . . 0.0 107.262 178.724 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 22.5 pttp -111.71 31.3 6.27 Favored 'General case' 0 C--O 1.246 0.882 0 CA-C-O 121.76 0.79 . . . . 0.0 110.731 -179.646 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.545 ' H ' HG12 ' A' ' 131' ' ' VAL . 21.9 t -131.27 -80.1 0.14 Allowed 'Isoleucine or valine' 0 C--O 1.208 -1.102 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 178.834 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 41.3 p 47.57 -156.41 0.05 Allowed 'General case' 0 C--O 1.258 1.551 0 C-N-CA 123.639 0.776 . . . . 0.0 112.602 179.363 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . 0.469 ' HA ' ' CG2' ' A' ' 120' ' ' VAL . 34.1 t -170.42 144.16 2.42 Favored 'General case' 0 N--CA 1.419 -1.993 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 -179.571 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 12.2 tt -99.64 96.95 5.33 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.28 0 N-CA-C 105.318 -2.105 . . . . 0.0 105.318 172.13 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . 0.5 ' HA ' ' HB2' ' A' ' 116' ' ' LYS . 25.6 m -90.55 142.95 27.22 Favored 'General case' 0 N--CA 1.389 -3.509 0 CA-C-N 113.588 -1.642 . . . . 0.0 109.303 -174.533 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . 0.645 ' HB ' ' O ' ' A' ' 115' ' ' GLY . 92.4 m -153.89 147.66 25.35 Favored 'General case' 0 C--N 1.256 -3.478 0 N-CA-C 105.743 -1.947 . . . . 0.0 105.743 -179.013 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -95.62 28.9 2.8 Favored 'General case' 0 C--N 1.276 -2.596 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 177.351 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . 0.458 ' N ' HG22 ' A' ' 138' ' ' THR . . . 58.16 39.54 25.86 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 -171.433 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 24.6 t -168.67 -70.95 0.02 OUTLIER 'General case' 0 N--CA 1.441 -0.876 0 CA-C-N 114.625 -1.17 . . . . 0.0 110.803 -175.287 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . 0.433 ' O ' HG23 ' A' ' 138' ' ' THR . 40.1 mmtm -106.42 159.7 15.95 Favored 'General case' 0 CA--C 1.51 -0.588 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 -179.45 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 48.0 t -106.21 139.32 27.93 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 CA-C-O 121.111 0.482 . . . . 0.0 110.855 -174.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 38.3 m-85 -129.5 150.28 50.91 Favored 'General case' 0 CA--C 1.498 -1.052 0 CA-C-O 122.089 0.947 . . . . 0.0 111.657 177.169 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -108.72 103.03 12.04 Favored 'General case' 0 C--N 1.277 -2.555 0 CA-C-N 113.723 -1.58 . . . . 0.0 108.98 178.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.441 ' OG1' ' HB3' ' A' ' 135' ' ' SER . 36.7 p -104.46 104.83 14.75 Favored 'General case' 0 N--CA 1.41 -2.438 0 N-CA-C 114.212 1.19 . . . . 0.0 114.212 -175.132 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -111.5 26.6 10.48 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 104.888 -2.264 . . . . 0.0 104.888 169.553 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 140.92 -74.28 0.36 Allowed Glycine 0 N--CA 1.399 -3.789 1 N-CA-C 103.049 -4.02 . . . . 0.0 103.049 -169.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 28.2 ttt -175.15 88.13 0.04 OUTLIER 'General case' 0 C--N 1.315 -0.934 0 C-N-CA 124.703 1.201 . . . . 0.0 108.103 170.352 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . 0.282 72.4 mmtt -106.42 -93.23 0.38 Allowed 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 116.1 1.889 . . . . 0.0 116.1 -177.605 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -93.42 161.59 14.32 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 113.7 1.0 . . . . 0.0 113.7 -172.188 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 33.0 t -133.72 156.64 47.58 Favored 'General case' 0 C--N 1.31 -1.126 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 175.561 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 20.4 tpt180 -149.62 151.13 33.27 Favored 'General case' 0 N--CA 1.441 -0.899 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 178.618 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 20.2 m -73.59 133.54 43.53 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 176.687 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' ARG . . . . . 0.51 ' HG3' ' HA2' ' A' ' 159' ' ' GLY . 14.9 ttp85 -75.88 -21.43 57.17 Favored 'General case' 0 C--N 1.299 -1.597 0 CA-C-O 121.617 0.722 . . . . 0.0 109.534 176.72 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -35.11 -47.64 0.39 Allowed 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 116.923 2.194 . . . . 0.0 116.923 -172.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -76.38 -53.45 8.15 Favored 'General case' 0 CA--C 1.548 0.878 0 N-CA-C 115.041 1.497 . . . . 0.0 115.041 -171.86 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -140.39 7.14 2.15 Favored 'General case' 0 N--CA 1.484 1.257 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -178.03 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . 0.684 ' HA3' ' O ' ' A' ' 65' ' ' ILE . . . 96.07 -81.88 0.8 Allowed Glycine 0 CA--C 1.462 -3.223 0 N-CA-C 108.712 -1.755 . . . . 0.0 108.712 -172.004 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.566 HG23 ' HB ' ' A' ' 65' ' ' ILE . 17.8 t -111.62 135.02 52.17 Favored 'Isoleucine or valine' 0 N--CA 1.401 -2.916 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 172.275 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -84.76 91.68 8.03 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 -177.601 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . 0.551 ' HD3' HG21 ' A' ' 94' ' ' VAL . 3.5 mmp_? -106.59 140.79 38.91 Favored 'General case' 0 C--N 1.29 -1.978 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.897 -176.816 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' ASN . . . . . 0.595 ' H ' HG13 ' A' ' 94' ' ' VAL . 16.8 m120 -127.3 5.91 6.36 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 114.762 -1.108 . . . . 0.0 111.011 -174.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -81.47 167.29 48.63 Favored Glycine 0 CA--C 1.498 -1.019 0 C-N-CA 120.343 -0.932 . . . . 0.0 111.912 -175.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.485 ' H ' HD23 ' A' ' 165' ' ' LEU . 1.2 pt? -116.92 112.34 20.9 Favored 'General case' 0 N--CA 1.417 -2.106 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 -179.873 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . 0.621 ' HB2' ' O ' ' A' ' 89' ' ' PRO . 5.8 ptp85 -82.91 118.84 23.74 Favored 'General case' 0 N--CA 1.41 -2.461 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 -177.095 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . 0.561 ' HB ' ' OG ' ' A' ' 90' ' ' SER . 41.1 t -51.61 -46.52 37.55 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 CA-C-N 115.107 -0.951 . . . . 0.0 111.484 -179.776 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -79.31 81.32 5.59 Favored 'General case' 0 CA--C 1.498 -1.05 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 171.224 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 27.0 tptp -99.57 106.63 18.64 Favored 'General case' 0 C--N 1.279 -2.475 0 N-CA-C 114.046 1.128 . . . . 0.0 114.046 -179.377 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 170' ' ' PHE . . . . . . . . . . . . . 79.5 t80 . . . . . 0 N--CA 1.424 -1.765 0 N-CA-C 106.311 -1.737 . . . . 0.0 106.311 173.173 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 8.9 mp . . . . . 0 CA--C 1.498 -1.027 0 N-CA-C 116.377 1.992 . . . . 0.0 116.377 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -62.29 -12.86 29.15 Favored 'Trans proline' 0 N--CA 1.449 -1.095 0 C-N-CA 122.336 2.024 . . . . 0.0 112.462 -170.584 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 17.8 mm-40 -72.52 -32.4 66.11 Favored 'General case' 0 N--CA 1.418 -2.028 0 N-CA-C 107.513 -1.291 . . . . 0.0 107.513 -178.491 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.466 ' O ' ' HG2' ' A' ' 60' ' ' GLU . 3.5 mm? -74.48 -44.28 52.22 Favored 'General case' 0 N--CA 1.423 -1.805 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 175.743 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.456 ' HG ' ' CE2' ' A' ' 75' ' ' TYR . 6.9 mp -59.05 -38.55 79.63 Favored 'General case' 0 CA--C 1.495 -1.15 0 CA-C-N 114.842 -1.072 . . . . 0.0 111.646 -176.563 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.442 ' HD2' ' N ' ' A' ' 60' ' ' GLU . 0.0 OUTLIER -76.14 -29.12 57.67 Favored 'General case' 0 N--CA 1.419 -2.005 0 C-N-CA 119.345 -0.942 . . . . 0.0 112.697 177.842 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.466 ' HG2' ' O ' ' A' ' 57' ' ' LEU . 11.6 pt-20 -77.68 -27.09 50.71 Favored 'General case' 0 N--CA 1.445 -0.706 0 C-N-CA 119.212 -0.995 . . . . 0.0 111.321 -175.595 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 58.6 m-85 -57.02 -47.71 80.25 Favored 'General case' 0 C--O 1.242 0.667 0 C-N-CA 120.17 -0.612 . . . . 0.0 112.515 176.455 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -108.78 -86.05 0.52 Allowed 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 114.722 1.378 . . . . 0.0 114.722 -174.348 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.634 ' HB2' HD12 ' A' ' 65' ' ' ILE . 0.0 OUTLIER -115.31 137.58 23.13 Favored Pre-proline 0 C--N 1.317 -0.81 0 C-N-CA 118.489 -1.284 . . . . 0.0 107.751 -179.215 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 63' ' ' LEU . 9.4 Cg_endo -91.49 21.26 0.8 Allowed 'Trans proline' 0 N--CA 1.429 -2.313 0 C-N-CA 123.653 2.902 . . . . 0.0 111.257 -170.332 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.706 ' HB ' HG23 ' A' ' 160' ' ' VAL . 0.2 OUTLIER -58.9 -40.33 79.96 Favored 'Isoleucine or valine' 0 CA--C 1.473 -2.007 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 176.544 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 59.2 -0.29 0.59 Allowed Glycine 0 N--CA 1.483 1.794 0 CA-C-N 114.363 -1.29 . . . . 0.0 112.182 -176.176 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.579 ' H ' HG12 ' A' ' 65' ' ' ILE . 56.4 mt 62.73 -69.36 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.414 -2.238 0 C-N-CA 127.539 2.336 . . . . 0.0 111.076 -171.606 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 75.1 t80 -177.54 -52.87 0.0 OUTLIER Pre-proline 0 C--N 1.306 -1.287 0 N-CA-C 113.541 0.941 . . . . 0.0 113.541 -174.451 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.453 ' HB2' ' OD1' ' A' ' 71' ' ' ASP . 18.6 Cg_endo -90.21 -28.0 0.27 Allowed 'Trans proline' 0 N--CA 1.444 -1.432 0 C-N-CA 121.073 1.182 . . . . 0.0 115.136 -170.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 94.68 -18.42 57.19 Favored Glycine 0 C--O 1.216 -0.993 0 N-CA-C 110.537 -1.025 . . . . 0.0 110.537 -174.108 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.613 ' HB3' ' HG2' ' A' ' 89' ' ' PRO . 8.2 m-20 -75.48 -50.73 14.84 Favored 'General case' 0 N--CA 1.437 -1.11 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 177.272 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.421 ' HA ' ' O ' ' A' ' 87' ' ' LEU . . . -73.86 170.86 14.48 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 114.106 -1.406 . . . . 0.0 109.95 174.082 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.584 ' O ' HG22 ' A' ' 73' ' ' THR . 28.8 m 89.79 28.46 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.836 0 CA-C-O 124.11 1.909 . . . . 0.0 112.559 170.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.517 ' HB2' ' HB2' ' A' ' 87' ' ' LEU . 27.5 m-80 -91.25 -174.9 4.1 Favored 'General case' 0 C--N 1.247 -3.855 0 CA-C-N 114.823 -1.08 . . . . 0.0 109.973 178.133 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.551 ' HB2' HD21 ' A' ' 84' ' ' LEU . 28.4 p90 -148.9 136.14 20.13 Favored 'General case' 0 C--N 1.3 -1.545 0 C-N-CA 119.206 -0.998 . . . . 0.0 113.299 -179.387 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.575 ' HB2' HG23 ' A' ' 85' ' ' THR . 70.5 mm-40 -144.13 146.07 32.53 Favored 'General case' 0 C--N 1.306 -1.322 0 C-N-CA 126.251 1.82 . . . . 0.0 106.784 175.324 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 50.2 p90 -149.65 150.93 32.91 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-N 118.249 0.477 . . . . 0.0 111.95 -176.572 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.612 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 11.5 m-20 -95.35 163.1 13.39 Favored 'General case' 0 CA--C 1.489 -1.378 0 N-CA-C 106.857 -1.534 . . . . 0.0 106.857 173.814 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -81.11 -62.43 1.66 Allowed 'General case' 0 C--N 1.278 -2.524 0 N-CA-C 113.633 0.975 . . . . 0.0 113.633 -178.202 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -77.56 -40.39 42.63 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 121.309 0.576 . . . . 0.0 109.519 -176.236 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.612 ' HB ' ' HB2' ' A' ' 78' ' ' ASP . 81.5 m -66.67 -38.54 87.03 Favored 'General case' 0 N--CA 1.429 -1.521 0 CA-C-N 114.949 -1.023 . . . . 0.0 111.892 178.638 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 98.8 mttt 61.54 7.5 1.86 Allowed 'General case' 0 N--CA 1.5 2.036 0 N-CA-C 114.037 1.125 . . . . 0.0 114.037 177.3 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.496 ' HD3' ' HB ' ' A' ' 109' ' ' THR . 35.8 ttmt -83.26 113.33 20.61 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 108.847 -0.798 . . . . 0.0 108.847 178.74 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.551 HD21 ' HB2' ' A' ' 75' ' ' TYR . 2.2 tm? -79.87 134.64 36.32 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 -176.194 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.628 ' HA ' ' O ' ' A' ' 108' ' ' VAL . 8.9 t -120.91 129.7 53.59 Favored 'General case' 0 N--CA 1.403 -2.823 0 CA-C-O 121.643 0.735 . . . . 0.0 110.309 178.763 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.402 HG13 ' O ' ' A' ' 74' ' ' ASN . 98.8 t -102.92 134.07 44.98 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.611 -177.28 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.517 ' HB2' ' HB2' ' A' ' 74' ' ' ASN . 2.5 mm? -81.95 115.92 21.34 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-N 114.676 -1.147 . . . . 0.0 110.819 -179.76 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.617 ' O ' ' HA ' ' A' ' 106' ' ' THR . 64.0 mt -124.8 103.81 30.83 Favored Pre-proline 0 C--N 1.29 -1.982 0 N-CA-C 107.375 -1.343 . . . . 0.0 107.375 173.91 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.613 ' HG2' ' HB3' ' A' ' 71' ' ' ASP . 70.9 Cg_exo -56.63 110.9 0.65 Allowed 'Trans proline' 0 C--O 1.199 -1.45 0 C-N-CA 123.136 2.557 . . . . 0.0 111.814 178.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . 0.429 ' HB2' ' O ' ' A' ' 89' ' ' PRO . 36.7 m 75.34 149.47 0.1 Allowed 'General case' 0 CA--C 1.485 -1.52 0 CA-C-O 122.091 0.948 . . . . 0.0 113.324 -175.511 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.458 HD12 HG23 ' A' ' 106' ' ' THR . 3.3 mp -80.79 120.7 32.93 Favored 'Isoleucine or valine' 0 N--CA 1.392 -3.33 0 N-CA-C 107.594 -1.261 . . . . 0.0 107.594 173.582 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 40.4 t -96.15 121.57 38.06 Favored 'General case' 0 N--CA 1.405 -2.688 0 N-CA-C 106.625 -1.62 . . . . 0.0 106.625 171.594 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.445 ' HG3' HG22 ' A' ' 91' ' ' ILE . 49.9 mt-10 -116.82 121.6 42.0 Favored 'General case' 0 CA--C 1.466 -2.267 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 177.263 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.401 HG23 HD23 ' A' ' 102' ' ' LEU . 33.3 m -115.28 103.63 15.58 Favored 'Isoleucine or valine' 0 C--N 1.267 -2.989 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 177.754 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.756 ' HA2' ' O ' ' A' ' 100' ' ' SER . . . . . . . . 0 CA--C 1.478 -2.226 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 -178.851 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . 0.756 ' O ' ' HA2' ' A' ' 95' ' ' GLY . 69.3 p . . . . . 0 N--CA 1.41 -2.456 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 60.5 t -115.72 99.72 9.02 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.237 0 CA-C-O 121.23 0.538 . . . . 0.0 109.755 175.817 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.554 HD13 HG23 ' A' ' 125' ' ' THR . 1.8 mm? -111.79 129.62 56.07 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 178.693 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -116.51 107.2 14.45 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-O 120.924 0.392 . . . . 0.0 111.106 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -93.06 102.36 14.69 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 107.518 -1.289 . . . . 0.0 107.518 176.69 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.534 ' O ' ' HB ' ' A' ' 88' ' ' ILE . 13.5 t -77.07 -178.37 4.96 Favored 'General case' 0 CA--C 1.551 1.019 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.532 -175.697 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . 0.617 ' HA ' ' O ' ' A' ' 88' ' ' ILE . 15.0 p -84.13 -50.32 8.04 Favored 'General case' 0 C--N 1.309 -1.162 0 C-N-CA 123.513 0.725 . . . . 0.0 111.716 -173.9 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 26.3 p -115.82 84.76 2.16 Favored 'General case' 0 N--CA 1.406 -2.644 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 175.251 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.628 ' O ' ' HA ' ' A' ' 85' ' ' THR . 14.7 p -81.58 129.58 37.27 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.296 0 CA-C-N 114.94 -1.027 . . . . 0.0 109.922 -177.317 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.496 ' HB ' ' HD3' ' A' ' 83' ' ' LYS . 17.5 p -104.98 149.0 26.12 Favored 'General case' 0 N--CA 1.4 -2.955 0 CA-C-N 116.191 -0.459 . . . . 0.0 109.771 -176.05 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 178.98 -159.41 24.3 Favored Glycine 0 N--CA 1.424 -2.135 0 N-CA-C 110.944 -0.862 . . . . 0.0 110.944 -179.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' HIS . . . . . 0.432 ' HB2' ' O ' ' A' ' 118' ' ' THR . 74.1 m80 -123.68 121.22 34.96 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 177.593 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.538 ' HB3' ' HG ' ' A' ' 84' ' ' LEU . 6.4 tt -123.43 136.58 54.68 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-O 121.277 0.56 . . . . 0.0 110.427 -171.717 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -130.67 171.09 13.47 Favored 'General case' 0 CA--C 1.456 -2.64 0 CA-C-N 114.941 -1.027 . . . . 0.0 110.189 177.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 2.7 tmtm? -86.24 100.84 12.53 Favored 'General case' 1 N--CA 1.376 -4.155 0 N-CA-C 103.779 -2.674 . . . . 0.0 103.779 173.461 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . 0.631 ' O ' HG23 ' A' ' 138' ' ' THR . . . 143.2 -62.09 0.51 Allowed Glycine 0 C--N 1.273 -2.96 0 N-CA-C 109.252 -1.539 . . . . 0.0 109.252 -174.85 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.433 ' HG2' HG23 ' A' ' 118' ' ' THR . 0.0 OUTLIER -151.02 164.7 35.8 Favored 'General case' 0 CA--C 1.508 -0.647 0 C-N-CA 122.766 0.426 . . . . 0.0 110.087 -179.697 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 3.7 tt -121.31 109.76 15.3 Favored 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 106.252 -1.758 . . . . 0.0 106.252 176.608 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.611 ' HA ' ' OG ' ' A' ' 135' ' ' SER . 66.9 p -112.14 131.22 55.58 Favored 'General case' 0 C--N 1.277 -2.566 0 N-CA-C 114.109 1.151 . . . . 0.0 114.109 -177.263 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . 0.504 ' H ' ' HB2' ' A' ' 135' ' ' SER . 17.5 t70 70.42 107.81 0.06 Allowed 'General case' 0 CA--C 1.507 -0.71 0 N-CA-C 114.294 1.22 . . . . 0.0 114.294 175.215 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 35.8 m -112.58 166.07 6.92 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.194 0 CA-C-N 115.002 -0.999 . . . . 0.0 110.566 177.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.472 ' HB3' ' OG1' ' A' ' 109' ' ' THR . 12.0 tp10 -127.75 -8.32 5.59 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.747 -178.316 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -105.7 -19.11 10.65 Favored Glycine 0 N--CA 1.432 -1.587 0 C-N-CA 119.706 -1.235 . . . . 0.0 112.39 -173.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.496 HG13 ' CG2' ' A' ' 108' ' ' VAL . 96.2 mt -100.82 100.6 10.71 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.62 0 CA-C-O 121.98 0.895 . . . . 0.0 111.272 -178.553 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -86.27 141.89 28.94 Favored 'General case' 0 C--N 1.295 -1.77 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 172.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.554 HG23 HD13 ' A' ' 102' ' ' LEU . 17.9 m -150.5 143.04 24.47 Favored 'General case' 0 N--CA 1.421 -1.925 0 N-CA-C 112.998 0.74 . . . . 0.0 112.998 -172.561 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.539 ' C ' ' HD3' ' A' ' 126' ' ' LYS . 0.4 OUTLIER -131.07 105.24 7.58 Favored 'General case' 0 N--CA 1.423 -1.798 0 N-CA-C 105.3 -2.111 . . . . 0.0 105.3 168.56 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 7.4 p -113.47 -53.58 5.01 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.441 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 179.193 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 45.5 ttm -114.29 -27.49 7.59 Favored 'General case' 0 N--CA 1.398 -3.059 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 172.295 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . 0.404 HD12 ' HA ' ' A' ' 129' ' ' ILE . 8.5 tp -161.51 171.13 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.551 1.008 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 173.77 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 8.5 m-90 -70.66 117.52 12.28 Favored 'General case' 0 CA--C 1.509 -0.605 0 CA-C-N 118.572 0.623 . . . . 0.0 110.431 179.309 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.436 HG12 HG12 ' A' ' 133' ' ' VAL . 88.6 t -147.94 111.04 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.139 0 C-N-CA 122.956 0.502 . . . . 0.0 109.783 179.62 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 54.6 pttt -106.78 114.33 28.36 Favored 'General case' 0 N--CA 1.442 -0.841 0 C-N-CA 119.31 -0.956 . . . . 0.0 109.364 173.523 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.436 HG12 HG12 ' A' ' 131' ' ' VAL . 13.5 p 173.57 -21.23 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.296 -1.755 0 N-CA-C 107.362 -1.347 . . . . 0.0 107.362 -178.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . 0.577 HG22 ' HA3' ' A' ' 148' ' ' GLY . 66.4 p -7.51 88.84 0.0 OUTLIER 'General case' 0 C--N 1.366 1.295 0 C-N-CA 127.921 2.488 . . . . 0.0 114.345 177.89 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . 0.611 ' OG ' ' HA ' ' A' ' 118' ' ' THR . 30.2 t -101.64 146.43 27.73 Favored 'General case' 0 N--CA 1.408 -2.571 0 CA-C-N 114.252 -1.34 . . . . 0.0 109.978 -176.505 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 8.9 tt -115.36 122.85 70.14 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.567 0 O-C-N 124.136 0.897 . . . . 0.0 109.681 179.464 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 34.7 p -105.77 135.96 46.25 Favored 'General case' 0 N--CA 1.398 -3.051 0 CA-C-O 122.239 1.018 . . . . 0.0 110.306 178.382 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . 0.631 HG23 ' O ' ' A' ' 115' ' ' GLY . 3.0 t -151.08 175.68 11.88 Favored 'General case' 0 N--CA 1.385 -3.724 0 N-CA-C 105.7 -1.963 . . . . 0.0 105.7 -179.599 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -122.2 33.76 5.37 Favored 'General case' 0 C--N 1.271 -2.827 0 N-CA-C 106.272 -1.751 . . . . 0.0 106.272 177.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . 63.33 46.15 4.59 Favored 'General case' 0 C--N 1.351 0.646 0 CA-C-N 113.971 -1.468 . . . . 0.0 109.274 -176.751 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 36.2 t -178.45 -78.87 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 114.878 -1.055 . . . . 0.0 110.065 -177.702 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 66.2 mttm -88.91 143.72 26.68 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 -178.44 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.528 ' HB ' ' O ' ' A' ' 153' ' ' ARG . 47.6 t -106.86 138.4 32.81 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 CA-C-O 120.899 0.381 . . . . 0.0 111.693 -173.569 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 57.6 m-85 -136.11 141.58 44.19 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 178.463 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 51.5 p90 -66.94 161.87 23.16 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.531 0.681 . . . . 0.0 112.19 177.683 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.497 ' HB ' ' O ' ' A' ' 135' ' ' SER . 92.7 m -149.0 -58.87 0.22 Allowed 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.298 174.9 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . 0.485 ' HB3' ' HA ' ' A' ' 134' ' ' THR . . . -141.38 137.04 32.01 Favored 'General case' 0 CA--C 1.507 -0.691 0 N-CA-C 110.062 -0.348 . . . . 0.0 110.062 178.803 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . 0.577 ' HA3' HG22 ' A' ' 134' ' ' THR . . . 79.89 -54.59 4.45 Favored Glycine 0 C--O 1.219 -0.817 0 O-C-N 123.539 0.524 . . . . 0.0 113.129 177.585 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 26.4 ttt -60.98 -48.49 81.57 Favored 'General case' 0 C--N 1.3 -1.577 0 C-N-CA 123.159 0.584 . . . . 0.0 109.799 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . 0.257 27.3 mtpp 49.0 17.46 0.16 Allowed 'General case' 0 N--CA 1.486 1.348 0 N-CA-C 115.985 1.846 . . . . 0.0 115.985 177.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -143.95 140.98 29.97 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 175.608 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 20.6 p -87.72 111.28 21.16 Favored 'General case' 0 N--CA 1.421 -1.916 0 CA-C-O 121.392 0.615 . . . . 0.0 110.119 177.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' ARG . . . . . 0.528 ' O ' ' HB ' ' A' ' 143' ' ' VAL . 2.6 tpm_? -105.9 105.77 15.97 Favored 'General case' 0 N--CA 1.432 -1.361 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 176.657 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 48.1 m -68.71 146.23 53.14 Favored 'General case' 0 C--N 1.285 -2.209 0 C-N-CA 120.841 -0.344 . . . . 0.0 111.742 -177.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' ARG . . . . . 0.509 ' HA ' ' HA2' ' A' ' 159' ' ' GLY . 29.0 tpt180 -57.81 -31.01 66.17 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-O 121.278 0.561 . . . . 0.0 109.532 175.732 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -47.16 -41.85 18.58 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 114.298 -1.319 . . . . 0.0 112.084 175.583 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -82.41 -53.87 5.66 Favored 'General case' 0 N--CA 1.437 -1.097 0 C-N-CA 120.692 -0.403 . . . . 0.0 111.622 -179.321 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -152.99 -18.97 0.15 Allowed 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 112.815 0.672 . . . . 0.0 112.815 -175.588 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . 0.509 ' HA2' ' HA ' ' A' ' 155' ' ' ARG . . . 107.99 -93.16 0.79 Allowed Glycine 0 N--CA 1.418 -2.555 0 N-CA-C 108.062 -2.015 . . . . 0.0 108.062 -165.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.706 HG23 ' HB ' ' A' ' 65' ' ' ILE . 83.8 t -133.57 115.86 23.32 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 CA-C-O 121.705 0.764 . . . . 0.0 110.399 -179.761 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' GLN . . . . . 0.471 ' H ' ' HG2' ' A' ' 153' ' ' ARG . 2.5 mm-40 -134.99 135.31 41.31 Favored 'General case' 0 N--CA 1.412 -2.36 0 N-CA-C 115.158 1.54 . . . . 0.0 115.158 -177.767 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 10.9 tpt180 -150.53 110.52 4.11 Favored 'General case' 0 C--N 1.263 -3.183 0 N-CA-C 101.72 -3.437 . . . . 0.0 101.72 170.197 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -43.71 95.29 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 113.975 1.102 . . . . 0.0 113.975 -169.519 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -157.39 161.09 31.04 Favored Glycine 0 N--CA 1.433 -1.552 0 CA-C-N 114.302 -1.317 . . . . 0.0 110.439 -178.54 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.487 ' O ' HD12 ' A' ' 165' ' ' LEU . 3.5 pp -141.37 139.09 33.44 Favored 'General case' 0 N--CA 1.411 -2.399 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 178.216 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . 0.53 ' HB3' ' O ' ' A' ' 89' ' ' PRO . 0.0 OUTLIER -70.49 134.76 48.03 Favored 'General case' 0 C--N 1.295 -1.778 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 175.869 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 32.7 t -62.11 -31.36 51.13 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.845 0 O-C-N 123.755 0.66 . . . . 0.0 112.681 176.577 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -73.83 77.49 1.61 Allowed 'General case' 0 N--CA 1.485 1.308 0 CA-C-O 122.25 1.024 . . . . 0.0 111.114 174.753 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 169' ' ' LYS . . . . . 0.404 ' HB3' ' HE3' ' A' ' 169' ' ' LYS . 19.3 ttpp -152.95 156.39 38.8 Favored 'General case' 0 C--N 1.276 -2.606 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 -178.619 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 170' ' ' PHE . . . . . . . . . . . . . 28.3 p90 . . . . . 0 C--N 1.304 -1.378 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 174.321 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.628 ' O ' ' HG ' ' A' ' 58' ' ' LEU . 3.5 mm? . . . . . 0 N--CA 1.498 1.935 0 N-CA-C 116.658 2.096 . . . . 0.0 116.658 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.717 ' HA ' HD11 ' A' ' 58' ' ' LEU . 26.2 Cg_exo -59.65 -21.09 61.2 Favored 'Trans proline' 0 N--CA 1.426 -2.464 0 C-N-CA 121.275 1.317 . . . . 0.0 112.029 -172.19 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -84.3 -41.39 16.89 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 123.456 0.702 . . . . 0.0 110.73 -179.196 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -69.7 -51.42 34.57 Favored 'General case' 0 CA--C 1.488 -1.407 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.962 178.214 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.717 HD11 ' HA ' ' A' ' 55' ' ' PRO 0.294 1.7 pp -62.19 -26.77 68.54 Favored 'General case' 0 C--O 1.208 -1.082 0 C-N-CA 119.745 -0.782 . . . . 0.0 111.029 179.284 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.458 ' HB2' ' O ' ' A' ' 55' ' ' PRO . 37.1 ttmt -69.45 -41.52 76.14 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 114.671 -1.15 . . . . 0.0 111.842 174.785 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -80.18 -16.18 55.41 Favored 'General case' 0 N--CA 1.441 -0.908 0 C-N-CA 119.418 -0.913 . . . . 0.0 109.122 -179.49 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 26.0 m-85 -84.29 -31.92 24.64 Favored 'General case' 0 C--N 1.321 -0.644 0 C-N-CA 119.437 -0.905 . . . . 0.0 111.456 177.665 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.517 ' HA ' HD11 ' A' ' 112' ' ' LEU . 20.7 t70 -87.11 -155.46 0.28 Allowed 'General case' 0 CA--C 1.545 0.773 0 N-CA-C 106.486 -1.672 . . . . 0.0 106.486 173.09 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.491 ' HB2' HD12 ' A' ' 65' ' ' ILE . 13.4 mt -84.03 155.4 64.14 Favored Pre-proline 0 C--N 1.299 -1.618 0 N-CA-C 107.248 -1.39 . . . . 0.0 107.248 -178.685 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -80.61 10.21 3.4 Favored 'Trans proline' 0 N--CA 1.453 -0.868 0 C-N-CA 122.2 1.933 . . . . 0.0 113.27 -166.102 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.744 HG12 ' H ' ' A' ' 67' ' ' ILE . 0.2 OUTLIER -81.34 -26.22 10.31 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.311 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 179.708 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 68.42 9.98 59.22 Favored Glycine 0 C--N 1.357 1.742 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.29 179.808 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.744 ' H ' HG12 ' A' ' 65' ' ' ILE . 55.8 mt 64.3 -68.01 0.14 Allowed 'Isoleucine or valine' 0 C--O 1.181 -2.506 0 C-N-CA 126.259 1.824 . . . . 0.0 111.653 -171.845 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.525 ' HB2' HG22 ' A' ' 160' ' ' VAL . 39.7 t80 -170.58 -57.81 0.0 OUTLIER Pre-proline 0 C--N 1.275 -2.632 0 CA-C-N 118.078 0.399 . . . . 0.0 111.177 -175.409 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.524 ' HD3' ' HB3' ' A' ' 68' ' ' PHE . 8.6 Cg_endo -100.57 -10.41 0.27 Allowed 'Trans proline' 0 N--CA 1.449 -1.116 0 C-N-CA 122.505 2.137 . . . . 0.0 114.793 -172.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 73.83 10.65 80.59 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.369 -0.92 . . . . 0.0 111.561 -175.2 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.455 ' HB2' ' CG ' ' A' ' 89' ' ' PRO . 13.3 p30 -95.96 -50.3 4.93 Favored 'General case' 0 N--CA 1.421 -1.905 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 178.438 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.555 ' O ' ' HB ' ' A' ' 73' ' ' THR . . . -64.01 178.45 0.65 Allowed 'General case' 0 C--N 1.318 -0.77 0 C-N-CA 124.302 1.041 . . . . 0.0 109.08 164.028 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.555 ' HB ' ' O ' ' A' ' 72' ' ' ALA . 65.0 m 84.33 27.89 0.08 Allowed 'General case' 0 C--N 1.349 0.578 0 CA-C-O 124.052 1.882 . . . . 0.0 109.773 171.217 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.651 HD22 ' N ' ' A' ' 74' ' ' ASN . 0.5 OUTLIER -80.93 176.33 9.91 Favored 'General case' 0 C--N 1.288 -2.072 0 C-N-CA 118.002 -1.479 . . . . 0.0 109.803 -178.768 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.458 ' CD2' HD11 ' A' ' 84' ' ' LEU . 13.7 t80 -147.12 109.84 4.66 Favored 'General case' 0 C--N 1.289 -2.051 0 C-N-CA 119.273 -0.971 . . . . 0.0 111.498 -171.387 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.402 ' O ' ' HG ' ' A' ' 84' ' ' LEU . 37.9 mt-10 -131.24 116.99 18.37 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.988 172.568 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 88.5 t80 -115.03 132.6 56.55 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.007 -173.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.506 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 26.1 m-20 -92.02 178.71 5.8 Favored 'General case' 0 CA--C 1.488 -1.436 0 CA-C-O 121.387 0.613 . . . . 0.0 111.048 -179.447 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -79.74 -74.11 0.31 Allowed 'General case' 0 C--N 1.294 -1.819 0 CA-C-N 114.503 -1.226 . . . . 0.0 112.244 -177.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -92.1 -22.35 19.95 Favored 'General case' 0 CA--C 1.503 -0.862 0 CA-C-N 115.823 -0.626 . . . . 0.0 112.402 -174.798 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.506 ' HB ' ' HB2' ' A' ' 78' ' ' ASP . 59.7 m -68.64 -51.7 39.27 Favored 'General case' 0 N--CA 1.427 -1.602 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.535 178.677 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 98.0 mttt 63.18 2.77 1.15 Allowed 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 124.16 0.984 . . . . 0.0 113.255 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.613 ' HG2' HG22 ' A' ' 109' ' ' THR . 35.6 ttmt -94.45 94.53 8.29 Favored 'General case' 0 N--CA 1.427 -1.598 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 173.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.458 HD11 ' CD2' ' A' ' 75' ' ' TYR . 6.9 tt -66.15 144.11 56.87 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-N 113.191 -1.822 . . . . 0.0 111.845 -172.37 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.444 ' HA ' ' O ' ' A' ' 108' ' ' VAL . 10.1 t -110.03 125.54 53.03 Favored 'General case' 0 N--CA 1.411 -2.38 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.148 179.212 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 86.1 t -99.53 127.85 51.89 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.363 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.265 178.116 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.507 ' HA ' ' O ' ' A' ' 106' ' ' THR . 1.2 mm? -97.25 142.11 29.54 Favored 'General case' 0 N--CA 1.418 -2.055 0 CA-C-N 113.707 -1.588 . . . . 0.0 109.507 -177.235 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 58.8 mt -137.28 119.96 11.44 Favored Pre-proline 0 C--N 1.252 -3.633 0 CA-C-N 112.854 -1.975 . . . . 0.0 105.685 174.413 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.455 ' CG ' ' HB2' ' A' ' 71' ' ' ASP . 6.2 Cg_exo -22.41 -52.72 0.04 OUTLIER 'Trans proline' 0 C--N 1.37 1.691 1 C-N-CA 126.133 4.555 . . . . 0.0 116.445 -178.769 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . 0.436 ' HB3' ' HB3' ' A' ' 166' ' ' ARG . 41.3 t -151.55 165.35 34.53 Favored 'General case' 0 N--CA 1.425 -1.695 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 -179.743 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.541 HD11 ' HD2' ' A' ' 103' ' ' LYS . 6.1 tt -72.3 112.38 7.88 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.979 0 CA-C-O 121.647 0.737 . . . . 0.0 110.37 178.41 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' CYS . . . . . 0.524 ' HB3' ' CE2' ' A' ' 104' ' ' PHE . 48.0 t -118.09 128.54 54.85 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 178.625 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -122.33 139.32 53.95 Favored 'General case' 0 C--N 1.292 -1.931 0 C-N-CA 119.218 -0.993 . . . . 0.0 110.158 176.614 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 34.4 m -124.28 106.67 17.2 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.168 -175.219 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.317 -0.518 0 C-N-CA 120.035 -1.079 . . . . 0.0 113.153 176.527 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . 0.441 ' HA ' ' O ' ' A' ' 126' ' ' LYS . 73.6 p . . . . . 0 N--CA 1.394 -3.248 0 CA-C-O 121.221 0.534 . . . . 0.0 110.692 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 65.1 t -93.65 105.39 16.8 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.069 0 N-CA-C 107.03 -1.47 . . . . 0.0 107.03 172.02 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.437 HD23 ' H ' ' A' ' 126' ' ' LYS . 83.3 mt -118.53 114.63 23.11 Favored 'General case' 0 C--N 1.286 -2.187 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.99 -173.678 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.541 ' HD2' HD11 ' A' ' 91' ' ' ILE . 34.9 ttpt -103.55 113.17 26.47 Favored 'General case' 0 N--CA 1.427 -1.576 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.091 -179.313 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.524 ' CE2' ' HB3' ' A' ' 92' ' ' CYS 0.288 38.9 p90 -111.07 107.72 17.19 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-O 122.191 0.996 . . . . 0.0 112.538 179.467 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.609 ' H ' HG22 ' A' ' 123' ' ' ILE . 12.2 t -72.11 -175.74 1.57 Allowed 'General case' 0 N--CA 1.436 -1.151 0 CA-C-N 113.843 -1.526 . . . . 0.0 111.958 -177.378 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . 0.507 ' O ' ' HA ' ' A' ' 87' ' ' LEU . 4.7 t -93.18 -27.64 16.76 Favored 'General case' 0 C--N 1.288 -2.102 0 CA-C-N 114.624 -1.171 . . . . 0.0 112.682 -173.26 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 25.0 m -139.73 95.35 2.9 Favored 'General case' 0 C--N 1.275 -2.672 0 N-CA-C 107.672 -1.232 . . . . 0.0 107.672 -178.478 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.444 ' O ' ' HA ' ' A' ' 85' ' ' THR . 3.4 p -103.83 160.36 4.73 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.52 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 -177.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.613 HG22 ' HG2' ' A' ' 83' ' ' LYS . 61.1 m -132.4 120.56 22.18 Favored 'General case' 0 N--CA 1.415 -2.219 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 -169.769 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -163.83 -159.43 10.8 Favored Glycine 0 C--O 1.208 -1.517 0 C-N-CA 120.474 -0.87 . . . . 0.0 113.097 -178.543 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 41.0 m80 -114.59 122.75 47.48 Favored 'General case' 0 CA--C 1.482 -1.664 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 178.47 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.517 HD11 ' HA ' ' A' ' 62' ' ' ASP . 5.2 tt -102.47 110.41 22.35 Favored 'General case' 0 C--N 1.285 -2.228 0 C-N-CA 119.965 -0.694 . . . . 0.0 109.278 -176.237 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -118.77 157.98 26.49 Favored 'General case' 0 CA--C 1.455 -2.678 0 CA-C-O 121.827 0.823 . . . . 0.0 109.445 174.122 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.468 ' HA ' ' HD3' ' A' ' 114' ' ' LYS . 16.5 mmtp -75.31 101.47 4.72 Favored 'General case' 0 C--N 1.245 -3.936 0 CA-C-O 122.687 1.232 . . . . 0.0 112.567 -178.492 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 121.59 -11.91 9.55 Favored Glycine 0 N--CA 1.411 -2.982 0 CA-C-N 113.195 -1.82 . . . . 0.0 110.021 -177.033 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -172.37 129.94 0.57 Allowed 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 113.363 0.875 . . . . 0.0 113.363 177.752 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.413 ' HB3' ' CG2' ' A' ' 136' ' ' ILE . 59.7 tp -97.39 104.23 16.23 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 106.46 -1.682 . . . . 0.0 106.46 172.664 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.458 ' HA ' ' CB ' ' A' ' 135' ' ' SER . 82.4 p -104.0 172.25 6.9 Favored 'General case' 0 C--N 1.311 -1.074 0 N-CA-C 111.803 0.297 . . . . 0.0 111.803 -173.301 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 57.76 46.17 17.59 Favored 'General case' 0 CA--C 1.496 -1.115 0 O-C-N 123.997 0.811 . . . . 0.0 110.7 172.71 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.415 HG21 HD11 ' A' ' 123' ' ' ILE 0.263 8.5 m -84.52 77.01 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.414 -2.266 0 CA-C-O 123.224 1.488 . . . . 0.0 111.962 -173.413 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -73.38 89.03 1.59 Allowed 'General case' 0 N--CA 1.394 -3.246 0 CA-C-N 112.287 -2.233 . . . . 0.0 110.293 -177.678 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 160.85 -22.91 0.24 Allowed Glycine 0 N--CA 1.413 -2.895 0 CA-C-N 115.085 -0.961 . . . . 0.0 110.801 176.504 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.609 HG22 ' H ' ' A' ' 105' ' ' THR . 18.6 pt -110.53 141.1 26.85 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.313 0 C-N-CA 119.62 -0.832 . . . . 0.0 111.657 -179.768 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -101.92 126.88 48.92 Favored 'General case' 0 C--N 1.294 -1.821 0 CA-C-N 114.795 -1.093 . . . . 0.0 110.331 177.479 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.401 HG23 HD22 ' A' ' 102' ' ' LEU . 97.4 m -115.49 109.74 18.27 Favored 'General case' 0 C--N 1.281 -2.394 0 CA-C-N 114.797 -1.092 . . . . 0.0 109.575 -178.297 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.441 ' O ' ' HA ' ' A' ' 100' ' ' SER . 6.6 tmtt? -114.56 134.73 54.82 Favored 'General case' 0 N--CA 1.421 -1.878 0 C-N-CA 120.441 -0.503 . . . . 0.0 110.45 174.102 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 89.7 t -130.19 -57.74 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.289 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 176.242 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 16.9 tpt -115.66 -34.86 4.71 Favored 'General case' 0 C--N 1.291 -1.971 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 173.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 7.8 tp -138.55 155.01 27.73 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.933 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.303 177.016 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 72.6 m95 -79.43 117.51 20.46 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 123.095 0.558 . . . . 0.0 110.872 179.343 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 17.5 m -129.93 157.16 42.54 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 174.107 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 48.0 pttt -126.84 28.48 5.83 Favored 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 -174.348 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 46.1 t -122.07 -83.07 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.15 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 175.472 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . 0.431 ' HB ' ' H ' ' A' ' 135' ' ' SER . 33.8 p 42.6 -161.71 0.01 OUTLIER 'General case' 0 CA--C 1.559 1.324 0 N-CA-C 114.288 1.218 . . . . 0.0 114.288 -178.54 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . 0.458 ' CB ' ' HA ' ' A' ' 118' ' ' THR . 89.6 p -171.81 157.75 4.66 Favored 'General case' 0 N--CA 1.414 -2.24 0 N-CA-C 106.801 -1.555 . . . . 0.0 106.801 176.167 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . 0.413 ' CG2' ' HB3' ' A' ' 117' ' ' LEU . 9.7 tt -100.44 113.02 34.87 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.94 0 N-CA-C 106.12 -1.808 . . . . 0.0 106.12 173.284 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 23.3 m -105.04 155.08 19.3 Favored 'General case' 0 N--CA 1.418 -2.074 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.676 -172.115 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . 0.489 HG21 ' HB3' ' A' ' 63' ' ' LEU . 9.4 t -164.09 166.19 21.57 Favored 'General case' 0 C--N 1.282 -2.333 0 N-CA-C 106.922 -1.51 . . . . 0.0 106.922 178.59 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -111.86 64.77 0.62 Allowed 'General case' 0 C--N 1.268 -2.94 0 C-N-CA 117.682 -1.607 . . . . 0.0 106.808 170.296 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . 0.41 ' H ' HG23 ' A' ' 138' ' ' THR . . . 50.88 41.64 27.03 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 113.568 -1.651 . . . . 0.0 111.69 -178.036 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . 0.564 ' O ' ' HD2' ' A' ' 155' ' ' ARG . 47.4 t 171.05 -84.78 0.0 OUTLIER 'General case' 0 C--N 1.346 0.447 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.387 -175.486 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 61.5 pttt -78.91 135.58 37.02 Favored 'General case' 0 CA--C 1.491 -1.326 0 C-N-CA 120.158 -0.617 . . . . 0.0 109.881 -177.31 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.433 ' HB ' HG21 ' A' ' 65' ' ' ILE . 5.3 p -105.52 147.02 11.75 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.91 0 CA-C-O 121.122 0.487 . . . . 0.0 111.474 -166.377 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -139.17 155.91 47.49 Favored 'General case' 0 CA--C 1.499 -0.983 0 CA-C-N 115.417 -0.81 . . . . 0.0 109.935 -179.058 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . 0.547 ' HB2' ' HB2' ' A' ' 151' ' ' LYS . 62.7 m-85 -105.8 114.67 28.96 Favored 'General case' 0 C--N 1.282 -2.345 0 CA-C-N 115.195 -0.912 . . . . 0.0 110.006 172.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.403 HG21 ' OG ' ' A' ' 135' ' ' SER . 8.8 t -70.44 2.79 3.52 Favored 'General case' 0 CA--C 1.554 1.115 0 CA-C-N 114.739 -1.119 . . . . 0.0 113.051 -172.089 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -63.16 -17.04 61.95 Favored 'General case' 0 C--O 1.221 -0.407 0 CA-C-O 121.332 0.587 . . . . 0.0 111.0 -178.259 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 156.3 31.53 0.03 OUTLIER Glycine 0 CA--C 1.492 -1.399 0 N-CA-C 110.107 -1.197 . . . . 0.0 110.107 172.505 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 53.1 ttm 58.83 19.72 7.26 Favored 'General case' 0 C--N 1.361 1.081 0 CA-C-O 122.42 1.105 . . . . 0.0 108.482 -173.099 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . 0.472 ' O ' ' HE3' ' A' ' 151' ' ' LYS . 17.5 ptpt -85.13 1.78 46.43 Favored 'General case' 0 N--CA 1.44 -0.972 0 CA-C-N 114.628 -1.169 . . . . 0.0 113.634 -172.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . 0.547 ' HB2' ' HB2' ' A' ' 145' ' ' PHE . 5.1 mmpt? -147.16 118.34 7.78 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 123.218 0.607 . . . . 0.0 109.818 176.247 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 23.7 p -133.01 132.96 42.47 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 177.081 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' ARG . . . . . 0.425 HH11 ' HD3' ' A' ' 153' ' ' ARG . 25.4 mmt180 -138.7 155.18 48.46 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 122.154 0.181 . . . . 0.0 110.539 179.499 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 70.1 p -79.11 119.91 22.9 Favored 'General case' 0 C--O 1.25 1.086 0 N-CA-C 113.528 0.936 . . . . 0.0 113.528 -175.552 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' ARG . . . . . 0.564 ' HD2' ' O ' ' A' ' 141' ' ' SER . 28.7 ttt180 -71.07 -35.92 72.08 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.073 0.463 . . . . 0.0 111.021 176.327 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -50.11 -41.81 49.22 Favored 'General case' 0 C--N 1.314 -0.943 0 C-N-CA 123.721 0.809 . . . . 0.0 112.528 -175.694 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -71.1 -52.36 19.79 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.921 -178.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 0.502 ' HB2' HE22 ' A' ' 161' ' ' GLN . 99.1 m-85 -149.36 -23.13 0.29 Allowed 'General case' 0 N--CA 1.484 1.254 0 N-CA-C 112.028 0.381 . . . . 0.0 112.028 -179.191 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . 0.419 ' HA2' ' HA ' ' A' ' 155' ' ' ARG . . . 128.73 -90.41 0.32 Allowed Glycine 0 N--CA 1.446 -0.646 0 N-CA-C 109.008 -1.637 . . . . 0.0 109.008 -172.901 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.608 HG22 ' O ' ' A' ' 67' ' ' ILE . 22.8 m -98.45 144.78 10.97 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.764 0 N-CA-C 106.285 -1.746 . . . . 0.0 106.285 173.194 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 161' ' ' GLN . . . . . 0.502 HE22 ' HB2' ' A' ' 158' ' ' TYR . 27.1 mm-40 -113.62 90.1 3.26 Favored 'General case' 0 C--N 1.3 -1.572 0 C-N-CA 119.022 -1.071 . . . . 0.0 111.447 -176.526 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -154.75 150.03 27.14 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 173.5 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 50.0 t30 -88.61 104.81 17.2 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-O 121.254 0.55 . . . . 0.0 110.553 177.566 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -142.63 150.51 22.27 Favored Glycine 0 CA--C 1.484 -1.876 0 N-CA-C 108.937 -1.665 . . . . 0.0 108.937 177.561 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -142.74 118.98 10.8 Favored 'General case' 0 N--CA 1.419 -2.018 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 176.784 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . 0.436 ' HB3' ' HB3' ' A' ' 90' ' ' SER . 0.0 OUTLIER -58.05 136.13 57.1 Favored 'General case' 0 N--CA 1.427 -1.577 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 173.31 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 48.6 t -53.28 -40.66 40.37 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.925 0 O-C-N 123.947 0.78 . . . . 0.0 110.148 175.127 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -86.07 70.79 10.62 Favored 'General case' 0 CA--C 1.503 -0.832 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.598 174.535 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 169' ' ' LYS . . . . . 0.411 ' O ' ' HB2' ' A' ' 170' ' ' PHE . 59.7 tttp -152.93 119.09 5.49 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.411 177.491 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 170' ' ' PHE . . . . . 0.411 ' HB2' ' O ' ' A' ' 169' ' ' LYS . 59.4 t80 . . . . . 0 C--O 1.252 1.194 0 N-CA-C 106.667 -1.605 . . . . 0.0 106.667 174.366 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.679 ' O ' ' HG ' ' A' ' 58' ' ' LEU . 1.8 mm? . . . . . 0 CA--C 1.495 -1.163 0 CA-C-O 118.938 -0.553 . . . . 0.0 111.139 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.579 ' HA ' HD11 ' A' ' 58' ' ' LEU . 24.7 Cg_exo -60.84 -25.44 81.23 Favored 'Trans proline' 0 C--N 1.386 2.53 0 C-N-CA 121.103 1.202 . . . . 0.0 111.185 -172.581 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -76.18 -47.69 23.23 Favored 'General case' 0 N--CA 1.433 -1.303 0 CA-C-N 114.884 -1.053 . . . . 0.0 109.031 179.681 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.5 ' HA ' ' HG2' ' A' ' 60' ' ' GLU . 52.1 tp -63.83 -48.86 75.11 Favored 'General case' 0 C--N 1.313 -1.021 0 C-N-CA 124.562 1.145 . . . . 0.0 111.497 -179.164 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.679 ' HG ' ' O ' ' A' ' 54' ' ' LEU 0.339 2.4 pp -67.1 -33.85 76.36 Favored 'General case' 0 N--CA 1.428 -1.547 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 -177.995 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.499 ' HG2' ' O ' ' A' ' 55' ' ' PRO . 23.1 pttp -76.56 -30.9 57.26 Favored 'General case' 0 C--O 1.222 -0.367 0 C-N-CA 119.442 -0.903 . . . . 0.0 111.875 175.363 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.5 ' HG2' ' HA ' ' A' ' 57' ' ' LEU . 12.7 pt-20 -76.69 -40.18 49.65 Favored 'General case' 0 CA--C 1.509 -0.601 0 C-N-CA 120.038 -0.665 . . . . 0.0 111.737 -177.368 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 27.7 m-85 -68.64 -19.37 64.41 Favored 'General case' 0 C--O 1.24 0.582 0 C-N-CA 119.0 -1.08 . . . . 0.0 113.035 174.3 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.483 ' O ' ' HE3' ' A' ' 114' ' ' LYS . 12.1 t0 -95.39 176.12 6.31 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.132 178.267 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.727 ' HB2' HD12 ' A' ' 65' ' ' ILE . 13.8 mt -71.39 179.81 0.88 Allowed Pre-proline 0 CA--C 1.577 1.985 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 -177.184 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_endo -88.03 12.66 2.79 Favored 'Trans proline' 0 N--CA 1.45 -1.035 0 C-N-CA 122.211 1.941 . . . . 0.0 111.801 -175.613 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.747 HG12 ' H ' ' A' ' 67' ' ' ILE . 0.2 OUTLIER -68.84 -42.02 82.46 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 178.017 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 58.87 8.79 6.16 Favored Glycine 0 N--CA 1.496 2.644 0 CA-C-O 121.956 0.753 . . . . 0.0 112.163 -176.412 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.747 ' H ' HG12 ' A' ' 65' ' ' ILE . 62.6 mt 56.63 -70.05 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.192 -1.973 0 C-N-CA 128.294 2.638 . . . . 0.0 112.307 -173.544 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.494 ' HB3' ' HD3' ' A' ' 69' ' ' PRO . 88.2 t80 175.2 -61.24 0.0 OUTLIER Pre-proline 0 CA--C 1.543 0.692 0 N-CA-C 112.762 0.653 . . . . 0.0 112.762 -174.539 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.494 ' HD3' ' HB3' ' A' ' 68' ' ' PHE . 3.4 Cg_endo -84.49 -21.23 3.62 Favored 'Trans proline' 0 N--CA 1.447 -1.232 0 C-N-CA 121.409 1.406 . . . . 0.0 114.584 -168.004 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 83.38 -11.5 55.28 Favored Glycine 0 C--O 1.224 -0.497 0 N-CA-C 111.006 -0.837 . . . . 0.0 111.006 -175.576 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.579 ' HB3' ' HG2' ' A' ' 89' ' ' PRO . 20.1 m-20 -83.21 -42.0 17.77 Favored 'General case' 0 N--CA 1.438 -1.038 0 N-CA-C 105.587 -2.005 . . . . 0.0 105.587 177.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.52 ' O ' ' HB ' ' A' ' 73' ' ' THR . . . -75.89 -178.35 4.27 Favored 'General case' 0 CA--C 1.546 0.793 0 CA-C-N 113.695 -1.593 . . . . 0.0 109.719 175.217 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.522 ' O ' HG22 ' A' ' 73' ' ' THR . 41.3 m 84.44 26.11 0.09 Allowed 'General case' 0 N--CA 1.49 1.554 0 CA-C-O 124.544 2.116 . . . . 0.0 110.178 175.131 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.612 HD22 ' N ' ' A' ' 74' ' ' ASN . 0.7 OUTLIER -81.07 136.86 36.0 Favored 'General case' 0 C--N 1.272 -2.791 0 CA-C-N 114.527 -1.215 . . . . 0.0 110.16 -178.988 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 43.1 t80 -113.11 90.2 3.28 Favored 'General case' 0 C--N 1.277 -2.552 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.693 -169.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.505 ' O ' HD22 ' A' ' 84' ' ' LEU . 13.2 mm-40 -122.85 150.98 42.16 Favored 'General case' 0 C--O 1.202 -1.415 0 N-CA-C 106.934 -1.506 . . . . 0.0 106.934 179.073 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 46.8 p90 -146.89 144.26 29.13 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-N 119.514 1.052 . . . . 0.0 111.334 176.804 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.588 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 10.8 m-20 -92.01 165.83 13.0 Favored 'General case' 0 CA--C 1.481 -1.705 0 CA-C-O 121.258 0.551 . . . . 0.0 109.542 -178.341 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.425 ' O ' ' HG3' ' A' ' 82' ' ' LYS . 48.8 mt-10 -82.35 -43.79 16.98 Favored 'General case' 0 C--N 1.281 -2.383 0 CA-C-N 114.859 -1.064 . . . . 0.0 112.414 176.25 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -65.25 -33.09 75.18 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 122.62 1.2 . . . . 0.0 109.424 -179.81 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.588 ' HB ' ' HB2' ' A' ' 78' ' ' ASP . 29.7 m -85.23 -52.96 5.55 Favored 'General case' 0 N--CA 1.404 -2.766 0 CA-C-N 113.04 -1.891 . . . . 0.0 110.54 -178.056 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.425 ' HG3' ' O ' ' A' ' 79' ' ' GLU . 62.9 mttp 64.16 8.85 4.32 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 124.211 1.004 . . . . 0.0 109.892 -173.152 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.539 ' HG2' ' CG2' ' A' ' 81' ' ' THR 0.25 14.1 pttt -117.48 146.99 43.14 Favored 'General case' 0 N--CA 1.404 -2.773 0 CA-C-N 114.612 -1.176 . . . . 0.0 109.156 -177.459 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.505 HD22 ' O ' ' A' ' 76' ' ' GLU . 1.8 tm? -73.96 130.19 39.37 Favored 'General case' 0 C--N 1.279 -2.481 0 CA-C-N 115.288 -0.869 . . . . 0.0 111.82 -167.26 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.422 ' HA ' ' O ' ' A' ' 108' ' ' VAL . 74.5 p -111.3 111.95 23.37 Favored 'General case' 0 N--CA 1.411 -2.399 0 CA-C-N 114.892 -1.049 . . . . 0.0 109.063 177.549 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.584 ' HA ' ' O ' ' A' ' 74' ' ' ASN . 86.2 t -91.19 122.46 42.62 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.253 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 177.546 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.532 ' HA ' ' O ' ' A' ' 106' ' ' THR 0.388 1.0 OUTLIER -104.04 102.46 12.22 Favored 'General case' 0 N--CA 1.389 -3.483 0 CA-C-O 122.923 1.344 . . . . 0.0 112.782 -179.042 . . . . . . . . 4 4 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.48 ' O ' HG23 ' A' ' 106' ' ' THR . 69.0 mt -85.56 128.54 58.62 Favored Pre-proline 0 C--N 1.279 -2.487 0 CA-C-N 113.038 -1.892 . . . . 0.0 108.888 -176.824 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.579 ' HG2' ' HB3' ' A' ' 71' ' ' ASP . 50.6 Cg_exo -61.97 109.71 0.86 Allowed 'Trans proline' 0 CA--C 1.504 -0.988 0 C-N-CA 122.708 2.272 . . . . 0.0 110.563 177.926 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 30.4 t 69.26 179.55 0.24 Allowed 'General case' 0 CA--C 1.552 1.037 0 O-C-N 124.019 0.824 . . . . 0.0 110.357 -177.494 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.583 HD11 ' HG3' ' A' ' 103' ' ' LYS . 0.0 OUTLIER -112.58 132.35 61.58 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.784 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.007 177.692 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' CYS . . . . . 0.623 ' SG ' ' HB2' ' A' ' 104' ' ' PHE . 28.1 p -112.28 124.42 52.42 Favored 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 175.618 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.448 ' OE1' ' HE2' ' A' ' 103' ' ' LYS . 35.9 tt0 -124.2 129.72 51.29 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 178.823 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.505 ' O ' ' HA ' ' A' ' 101' ' ' VAL . 20.8 m -122.36 114.63 43.31 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.994 0 CA-C-O 121.234 0.54 . . . . 0.0 111.074 179.132 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.427 -1.941 0 N-CA-C 108.332 -1.907 . . . . 0.0 108.332 178.107 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 31.1 p . . . . . 0 N--CA 1.398 -3.039 0 CA-C-O 121.221 0.534 . . . . 0.0 110.555 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.507 ' O ' ' HA ' ' A' ' 125' ' ' THR . 17.2 m -125.9 101.09 7.62 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 CA-C-N 115.079 -0.964 . . . . 0.0 108.89 172.154 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.606 ' HG ' ' OG1' ' A' ' 125' ' ' THR . 5.4 mp -123.45 125.69 45.4 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.829 -173.467 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.583 ' HG3' HD11 ' A' ' 91' ' ' ILE . 39.3 ttmt -112.46 113.1 25.11 Favored 'General case' 0 C--N 1.317 -0.82 0 O-C-N 123.127 0.267 . . . . 0.0 110.371 176.738 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.623 ' HB2' ' SG ' ' A' ' 92' ' ' CYS . 96.1 m-85 -103.67 98.94 8.73 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 175.315 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 87.1 m -74.37 159.96 31.66 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 115.095 -0.957 . . . . 0.0 111.378 -178.173 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . 0.532 ' O ' ' HA ' ' A' ' 87' ' ' LEU . 90.2 m -57.93 -67.94 0.29 Allowed 'General case' 0 N--CA 1.431 -1.381 0 C-N-CA 124.665 1.186 . . . . 0.0 111.373 178.616 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 37.4 p -96.12 90.23 5.45 Favored 'General case' 0 N--CA 1.431 -1.4 0 C-N-CA 119.512 -0.875 . . . . 0.0 111.961 179.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.422 ' O ' ' HA ' ' A' ' 85' ' ' THR . 17.6 m -95.17 132.21 39.82 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 CA-C-N 115.538 -0.756 . . . . 0.0 109.649 176.443 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 30.3 m -114.94 120.06 38.64 Favored 'General case' 0 N--CA 1.413 -2.29 0 N-CA-C 108.712 -0.848 . . . . 0.0 108.712 -173.648 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . 0.549 ' HA2' ' O ' ' A' ' 119' ' ' ASP . . . -150.99 161.79 29.18 Favored Glycine 0 N--CA 1.435 -1.393 0 C-N-CA 121.132 -0.556 . . . . 0.0 111.967 -177.626 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 84.2 t60 -84.81 90.8 7.84 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 178.524 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.542 ' HB2' HD13 ' A' ' 117' ' ' LEU . 5.4 tt -89.52 107.81 19.29 Favored 'General case' 0 N--CA 1.417 -2.1 0 N-CA-C 106.649 -1.611 . . . . 0.0 106.649 179.218 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -108.36 153.12 23.72 Favored 'General case' 0 N--CA 1.385 -3.705 0 N-CA-C 104.655 -2.35 . . . . 0.0 104.655 174.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.483 ' HE3' ' O ' ' A' ' 62' ' ' ASP . 21.4 tptm -75.2 101.5 4.65 Favored 'General case' 0 C--N 1.277 -2.566 0 C-N-CA 117.781 -1.568 . . . . 0.0 109.015 -176.221 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . 0.441 ' O ' HG23 ' A' ' 138' ' ' THR . . . 140.64 -24.42 2.62 Favored Glycine 0 C--O 1.19 -2.649 0 CA-C-N 114.043 -1.435 . . . . 0.0 110.236 -175.228 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 19.7 ptmt -173.98 151.2 1.71 Allowed 'General case' 0 N--CA 1.492 1.632 0 CA-C-N 117.643 0.721 . . . . 0.0 111.919 -179.038 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.542 HD13 ' HB2' ' A' ' 112' ' ' LEU . 27.3 tp -118.07 105.35 11.76 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 178.729 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 33.4 p -109.31 144.84 36.93 Favored 'General case' 0 C--N 1.295 -1.787 0 N-CA-C 113.681 0.993 . . . . 0.0 113.681 -176.26 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . 0.549 ' O ' ' HA2' ' A' ' 110' ' ' GLY . 31.5 m-20 60.81 94.06 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 124.885 1.274 . . . . 0.0 111.131 177.447 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 11.2 m -116.53 91.09 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.425 -1.715 0 CA-C-O 122.493 1.139 . . . . 0.0 113.009 -173.284 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -66.77 103.43 1.11 Allowed 'General case' 0 C--N 1.29 -1.999 0 CA-C-N 113.785 -1.552 . . . . 0.0 110.251 175.697 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 139.6 -20.68 2.92 Favored Glycine 0 N--CA 1.432 -1.607 0 CA-C-N 115.11 -0.95 . . . . 0.0 112.008 178.736 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 73.9 mt -101.56 108.17 23.02 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 CA-C-O 120.937 0.399 . . . . 0.0 110.267 -179.333 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 29.0 ttpp -101.23 130.93 47.44 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 176.033 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.606 ' OG1' ' HG ' ' A' ' 102' ' ' LEU . 15.1 t -157.53 163.81 38.01 Favored 'General case' 0 C--N 1.302 -1.498 0 C-N-CA 120.27 -0.572 . . . . 0.0 110.217 -175.822 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.42 ' HB2' ' CD1' ' A' ' 130' ' ' TRP . 74.3 tttt -127.51 142.83 51.28 Favored 'General case' 0 C--N 1.276 -2.609 0 CA-C-N 115.52 -0.763 . . . . 0.0 109.354 174.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.447 HG11 ' HB2' ' A' ' 150' ' ' LYS . 83.6 t -110.92 -78.93 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.421 -1.918 0 N-CA-C 107.227 -1.398 . . . . 0.0 107.227 167.679 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . 0.482 ' C ' HD12 ' A' ' 129' ' ' ILE . 26.3 ttt -105.49 -32.16 8.65 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 176.287 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . 0.482 HD12 ' C ' ' A' ' 128' ' ' MET . 2.7 mp -130.83 154.42 40.66 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.747 0 N-CA-C 107.057 -1.461 . . . . 0.0 107.057 175.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' TRP . . . . . 0.42 ' CD1' ' HB2' ' A' ' 126' ' ' LYS . 12.7 m-90 -70.95 134.12 46.95 Favored 'General case' 0 C--O 1.242 0.696 0 CA-C-O 120.845 0.355 . . . . 0.0 110.969 178.895 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 3.7 m -135.34 162.5 37.7 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 C-N-CA 123.803 0.841 . . . . 0.0 111.282 177.79 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -137.77 9.87 2.86 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 112.265 0.468 . . . . 0.0 112.265 -175.673 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 59.1 t -118.12 -69.12 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 C-N-CA 120.307 -0.557 . . . . 0.0 110.04 178.664 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 76.4 p 54.96 -178.6 0.03 OUTLIER 'General case' 0 C--O 1.247 0.944 0 N-CA-C 114.987 1.477 . . . . 0.0 114.987 177.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 36.1 p -164.96 146.84 7.94 Favored 'General case' 0 N--CA 1.422 -1.861 0 CA-C-N 114.955 -1.02 . . . . 0.0 109.056 177.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . 0.478 ' CG2' ' HB3' ' A' ' 117' ' ' LEU . 10.7 tt -113.68 107.95 24.25 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 175.377 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 33.3 p -100.6 148.93 24.27 Favored 'General case' 0 N--CA 1.398 -3.042 0 CA-C-O 121.713 0.768 . . . . 0.0 110.926 -177.166 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . 0.441 HG23 ' O ' ' A' ' 115' ' ' GLY . 6.1 t -165.31 176.12 8.61 Favored 'General case' 0 N--CA 1.4 -2.958 0 N-CA-C 106.765 -1.569 . . . . 0.0 106.765 -176.778 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -115.26 29.05 8.28 Favored 'General case' 0 C--N 1.277 -2.544 0 N-CA-C 105.859 -1.904 . . . . 0.0 105.859 172.567 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . 66.04 54.72 0.97 Allowed 'General case' 0 C--O 1.242 0.685 0 CA-C-N 113.886 -1.507 . . . . 0.0 107.321 -171.497 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 44.4 t -168.0 -81.41 0.02 OUTLIER 'General case' 0 N--CA 1.443 -0.785 0 CA-C-N 114.405 -1.271 . . . . 0.0 111.327 -174.772 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -95.59 150.03 20.79 Favored 'General case' 0 C--O 1.203 -1.383 0 C-N-CA 122.913 0.485 . . . . 0.0 110.477 -176.429 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.668 ' HB ' ' O ' ' A' ' 153' ' ' ARG . 67.8 t -105.65 114.48 45.19 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.118 0 CA-C-O 121.749 0.785 . . . . 0.0 112.477 -173.081 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 82.0 m-85 -117.89 113.29 21.53 Favored 'General case' 0 N--CA 1.422 -1.858 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 174.469 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 69.2 t80 -83.37 106.7 15.34 Favored 'General case' 0 C--N 1.288 -2.08 0 N-CA-C 108.582 -0.895 . . . . 0.0 108.582 -177.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . 0.406 5.6 p -86.52 78.1 9.28 Favored 'General case' 0 N--CA 1.389 -3.517 0 N-CA-C 116.658 2.095 . . . . 0.0 116.658 -173.802 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -126.7 76.17 1.61 Allowed 'General case' 0 N--CA 1.417 -2.124 0 N-CA-C 104.737 -2.32 . . . . 0.0 104.737 168.115 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 78.75 7.12 88.38 Favored Glycine 0 N--CA 1.441 -1.027 0 CA-C-N 114.195 -1.366 . . . . 0.0 111.274 -174.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' MET . . . . . 0.423 ' O ' ' HG2' ' A' ' 149' ' ' MET . 27.3 ttt 63.67 15.75 9.19 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 124.538 1.135 . . . . 0.0 109.397 -175.682 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . 0.447 ' HB2' HG11 ' A' ' 127' ' ' VAL . 64.3 mttp -66.21 -26.95 67.62 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 114.993 -1.003 . . . . 0.0 113.476 -175.24 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . 0.636 ' HE2' ' HA ' ' A' ' 151' ' ' LYS . 8.2 mmpt? -114.13 136.73 52.61 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.012 0.434 . . . . 0.0 110.472 179.247 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 43.3 m -132.18 126.26 33.18 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 178.58 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' ARG . . . . . 0.668 ' O ' ' HB ' ' A' ' 143' ' ' VAL . 7.0 tpm_? -133.37 108.46 8.71 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 -176.86 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 16.2 m -61.08 128.96 38.99 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 175.524 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' ARG . . . . . 0.442 ' HD3' ' C ' ' A' ' 155' ' ' ARG . 2.5 tmt_? -59.24 -29.47 67.56 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 123.516 0.727 . . . . 0.0 109.299 -179.664 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -41.1 -41.12 1.66 Allowed 'General case' 0 C--N 1.314 -0.936 0 C-N-CA 125.615 1.566 . . . . 0.0 113.735 178.286 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -57.45 -53.11 61.84 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -176.397 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -178.88 20.46 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.172 0 N-CA-C 107.721 -1.214 . . . . 0.0 107.721 -179.202 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . 0.562 ' HA3' ' O ' ' A' ' 65' ' ' ILE . . . 95.85 -98.21 2.19 Favored Glycine 0 N--CA 1.405 -3.429 0 N-CA-C 108.901 -1.679 . . . . 0.0 108.901 -170.631 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.546 HG23 ' HB ' ' A' ' 65' ' ' ILE . 3.5 t -121.99 114.14 41.61 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.769 0 N-CA-C 105.793 -1.928 . . . . 0.0 105.793 176.385 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 161' ' ' GLN . . . . . 0.416 ' HG2' ' CE1' ' A' ' 68' ' ' PHE . 0.8 OUTLIER -132.51 98.3 4.32 Favored 'General case' 0 C--N 1.29 -2.02 0 C-N-CA 118.033 -1.467 . . . . 0.0 110.295 -171.012 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 39.8 ttm180 -153.26 100.61 2.47 Favored 'General case' 0 N--CA 1.428 -1.544 0 C-N-CA 120.441 -0.504 . . . . 0.0 109.89 170.816 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 51.41 -33.55 0.01 OUTLIER 'General case' 0 N--CA 1.509 2.477 0 N-CA-C 119.179 3.029 . . . . 0.0 119.179 171.415 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -60.75 111.39 3.7 Favored Glycine 0 C--N 1.315 -0.637 0 N-CA-C 115.647 1.019 . . . . 0.0 115.647 -173.637 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 44.9 tp -124.22 118.78 27.61 Favored 'General case' 0 N--CA 1.425 -1.681 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 176.859 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . 0.44 ' HB3' ' O ' ' A' ' 89' ' ' PRO . 6.3 mpt_? -78.14 117.6 19.58 Favored 'General case' 0 CA--C 1.479 -1.771 0 CA-C-O 121.112 0.482 . . . . 0.0 110.196 -177.531 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 4.3 m -78.05 62.34 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.947 0 CA-C-O 122.3 1.048 . . . . 0.0 113.233 179.145 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -111.65 -21.7 11.57 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 106.871 -1.529 . . . . 0.0 106.871 172.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 23.7 ttmm -91.12 101.92 14.66 Favored 'General case' 0 N--CA 1.425 -1.715 0 CA-C-N 113.551 -1.658 . . . . 0.0 110.413 -175.642 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 170' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 . . . . . 0 C--N 1.309 -1.193 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 177.268 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.52 ' O ' HD13 ' A' ' 58' ' ' LEU . 19.0 mt . . . . . 0 N--CA 1.475 0.789 0 N-CA-C 113.724 1.009 . . . . 0.0 113.724 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_exo -62.98 -15.57 48.64 Favored 'Trans proline' 0 C--N 1.372 1.795 0 C-N-CA 121.577 1.518 . . . . 0.0 113.068 -168.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 15.2 mm-40 -78.9 -36.97 41.14 Favored 'General case' 0 N--CA 1.423 -1.813 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 -174.083 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -76.05 -32.58 59.38 Favored 'General case' 0 N--CA 1.431 -1.397 0 CA-C-N 115.019 -0.991 . . . . 0.0 110.74 176.699 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.551 ' HG ' ' CE1' ' A' ' 75' ' ' TYR 0.253 4.6 mp -71.12 -44.21 66.08 Favored 'General case' 0 CA--C 1.487 -1.462 0 C-N-CA 120.346 -0.542 . . . . 0.0 111.722 -177.824 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.41 -25.79 66.93 Favored 'General case' 0 C--O 1.218 -0.579 0 CA-C-O 122.536 1.16 . . . . 0.0 109.972 176.432 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 18.5 tt0 -71.97 -28.58 63.52 Favored 'General case' 0 N--CA 1.428 -1.562 0 CA-C-N 114.024 -1.444 . . . . 0.0 112.251 175.807 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 72.6 t80 -83.74 -36.31 23.75 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 176.084 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 55.4 t0 -78.4 -171.05 2.27 Favored 'General case' 0 C--O 1.255 1.363 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 177.698 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.729 ' HB2' HD12 ' A' ' 65' ' ' ILE . 7.0 mt -82.82 -178.9 1.29 Allowed Pre-proline 0 CA--C 1.575 1.923 0 N-CA-C 106.384 -1.709 . . . . 0.0 106.384 179.4 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.442 ' HD3' ' HB3' ' A' ' 63' ' ' LEU . 3.4 Cg_endo -89.66 16.74 1.69 Allowed 'Trans proline' 0 N--CA 1.451 -1.011 0 CA-C-N 121.752 1.662 . . . . 0.0 110.669 -173.485 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.729 HD12 ' HB2' ' A' ' 63' ' ' LEU . 0.2 OUTLIER -72.64 -38.05 57.76 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.867 0 CA-C-N 114.73 -1.123 . . . . 0.0 109.29 -179.107 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.405 ' H ' HD13 ' A' ' 65' ' ' ILE . . . 59.09 4.34 2.35 Favored Glycine 0 N--CA 1.484 1.839 0 CA-C-N 115.495 -0.775 . . . . 0.0 112.769 -177.661 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.664 ' H ' HG12 ' A' ' 65' ' ' ILE . 20.3 mt 65.66 -68.65 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.224 0 C-N-CA 127.663 2.385 . . . . 0.0 112.025 -176.837 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.553 ' HA ' ' CD2' ' A' ' 158' ' ' TYR . 70.5 t80 169.34 -52.87 0.0 OUTLIER Pre-proline 0 C--N 1.322 -0.619 0 C-N-CA 124.013 0.925 . . . . 0.0 110.192 179.657 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.51 ' HD3' ' HB3' ' A' ' 68' ' ' PHE . 7.1 Cg_exo -81.29 143.48 13.97 Favored 'Trans proline' 0 C--N 1.369 1.637 0 C-N-CA 121.636 1.558 . . . . 0.0 110.229 177.444 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -71.85 -17.13 76.64 Favored Glycine 0 C--N 1.314 -0.644 0 C-N-CA 121.177 -0.535 . . . . 0.0 113.061 -177.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -90.7 -10.69 42.16 Favored 'General case' 0 C--O 1.201 -1.449 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 179.531 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.605 ' HA ' ' O ' ' A' ' 87' ' ' LEU . . . -82.89 -171.48 3.57 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.147 173.21 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.59 HG22 ' O ' ' A' ' 72' ' ' ALA . 6.0 t 72.39 26.9 2.54 Favored 'General case' 0 N--CA 1.501 2.121 0 C-N-CA 126.184 1.794 . . . . 0.0 109.53 169.2 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.445 ' HA ' ' HB3' ' A' ' 58' ' ' LEU . 28.2 m-80 -87.53 -169.48 2.62 Favored 'General case' 0 N--CA 1.417 -2.076 0 CA-C-N 113.599 -1.637 . . . . 0.0 108.852 -179.746 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.667 ' HB2' HD11 ' A' ' 84' ' ' LEU . 49.9 p90 -158.98 119.71 3.25 Favored 'General case' 0 C--N 1.311 -1.106 0 C-N-CA 118.889 -1.125 . . . . 0.0 113.649 -176.623 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.675 ' O ' HG22 ' A' ' 85' ' ' THR . 51.8 mt-10 -146.55 92.2 2.13 Favored 'General case' 0 CA--C 1.577 2.001 0 N-CA-C 114.58 1.326 . . . . 0.0 114.58 175.365 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.662 ' HB2' ' HA ' ' A' ' 84' ' ' LEU 0.437 30.3 m-85 -169.45 154.76 5.84 Favored 'General case' 0 N--CA 1.506 2.362 0 C-N-CA 128.105 2.562 . . . . 0.0 110.894 165.859 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.487 ' HB2' ' HB ' ' A' ' 81' ' ' THR 0.259 8.3 m-20 -50.99 142.96 11.06 Favored 'General case' 0 CA--C 1.48 -1.748 0 CA-C-O 122.074 0.94 . . . . 0.0 110.42 -179.874 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -81.11 -31.23 34.37 Favored 'General case' 1 C--N 1.24 -4.185 0 CA-C-N 113.867 -1.515 . . . . 0.0 111.753 178.493 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.413 ' HG2' ' HB3' ' A' ' 78' ' ' ASP . 12.9 pt-20 -65.9 -30.08 70.62 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 122.227 1.013 . . . . 0.0 108.626 177.227 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.487 ' HB ' ' HB2' ' A' ' 78' ' ' ASP . 95.5 m -78.73 -39.13 37.13 Favored 'General case' 0 N--CA 1.414 -2.268 0 CA-C-N 113.5 -1.682 . . . . 0.0 109.571 177.546 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.68 ' HE2' ' HA ' ' A' ' 82' ' ' LYS . 3.3 mmpt? 71.95 15.29 5.7 Favored 'General case' 0 CA--C 1.494 -1.188 0 C-N-CA 124.067 0.947 . . . . 0.0 112.864 -177.492 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.423 ' C ' ' HB2' ' A' ' 77' ' ' PHE . 37.2 ttpt -93.81 173.02 7.88 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 104.212 -2.514 . . . . 0.0 104.212 172.299 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.679 HD23 HD13 ' A' ' 112' ' ' LEU . 20.8 tp 176.24 121.93 0.03 OUTLIER 'General case' 0 CA--C 1.475 -1.912 0 CA-C-N 119.134 0.879 . . . . 0.0 108.99 -169.181 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.675 HG22 ' O ' ' A' ' 76' ' ' GLU . 14.5 t -92.2 129.93 38.03 Favored 'General case' 0 N--CA 1.392 -3.344 0 C-N-CA 118.976 -1.09 . . . . 0.0 108.252 174.537 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 62.3 t -103.92 116.61 48.01 Favored 'Isoleucine or valine' 0 N--CA 1.4 -2.975 0 CA-C-N 115.264 -0.88 . . . . 0.0 108.655 179.623 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.605 ' O ' ' HA ' ' A' ' 72' ' ' ALA . 2.0 mm? -75.1 123.16 24.72 Favored 'General case' 0 N--CA 1.41 -2.456 0 CA-C-N 113.783 -1.553 . . . . 0.0 110.673 -176.337 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 74.8 mt -107.51 137.16 19.6 Favored Pre-proline 0 C--N 1.281 -2.375 0 N-CA-C 105.225 -2.139 . . . . 0.0 105.225 170.881 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.465 ' O ' ' HB2' ' A' ' 166' ' ' ARG . 17.9 Cg_endo -58.21 84.87 0.05 OUTLIER 'Trans proline' 0 CA--C 1.541 0.825 0 C-N-CA 123.275 2.65 . . . . 0.0 112.523 178.175 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . 0.438 ' HB3' ' HB ' ' A' ' 167' ' ' VAL . 24.2 m 69.33 163.89 0.24 Allowed 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 125.489 1.516 . . . . 0.0 112.46 -179.385 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 9.3 tt -62.82 135.34 27.34 Favored 'Isoleucine or valine' 0 C--O 1.242 0.69 0 CA-C-O 121.361 0.601 . . . . 0.0 109.864 177.383 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' CYS . . . . . 0.528 ' SG ' ' HB2' ' A' ' 104' ' ' PHE . 3.7 p -132.76 139.17 47.45 Favored 'General case' 0 C--N 1.282 -2.332 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.916 -179.295 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -119.79 142.41 48.62 Favored 'General case' 0 CA--C 1.454 -2.735 0 N-CA-C 106.048 -1.834 . . . . 0.0 106.048 178.637 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.411 ' HB ' ' CD2' ' A' ' 102' ' ' LEU . 17.9 t -118.49 104.38 16.0 Favored 'Isoleucine or valine' 0 N--CA 1.392 -3.365 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 -175.649 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.418 -2.549 0 N-CA-C 109.469 -1.453 . . . . 0.0 109.469 176.875 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 36.4 t . . . . . 0 N--CA 1.408 -2.566 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 9.5 p -119.23 140.4 43.31 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 177.818 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.47 ' CB ' ' HA ' ' A' ' 125' ' ' THR . 0.4 OUTLIER -151.72 167.08 29.32 Favored 'General case' 0 C--N 1.294 -1.843 0 N-CA-C 112.641 0.608 . . . . 0.0 112.641 -171.364 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -142.59 129.13 20.22 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.413 0.625 . . . . 0.0 111.63 -175.703 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.528 ' HB2' ' SG ' ' A' ' 92' ' ' CYS . 61.0 m-85 -109.86 122.03 46.6 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 178.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.492 HG22 ' H ' ' A' ' 107' ' ' THR . 32.0 m -71.23 151.7 44.04 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 178.623 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 8.3 m -52.47 -38.5 59.53 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.967 0.907 . . . . 0.0 109.838 176.52 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.492 ' H ' HG22 ' A' ' 105' ' ' THR . 68.2 p -121.42 99.66 6.6 Favored 'General case' 0 N--CA 1.425 -1.678 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.144 179.021 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.542 ' O ' ' HA ' ' A' ' 85' ' ' THR . 61.9 t -99.65 138.22 24.69 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.285 0 N-CA-C 106.779 -1.563 . . . . 0.0 106.779 174.137 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.452 ' HA ' ' O ' ' A' ' 84' ' ' LEU . 9.1 t -125.8 137.13 53.76 Favored 'General case' 0 N--CA 1.395 -3.222 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 -175.814 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -157.16 176.98 34.24 Favored Glycine 0 N--CA 1.403 -3.529 0 C-N-CA 119.834 -1.174 . . . . 0.0 112.053 179.674 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' HIS . . . . . 0.524 ' HA ' ' O ' ' A' ' 82' ' ' LYS . 10.5 t60 -86.81 93.24 9.23 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 178.808 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.679 HD13 HD23 ' A' ' 84' ' ' LEU . 7.2 tt -97.98 120.41 38.32 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-O 121.656 0.741 . . . . 0.0 110.841 -174.062 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . 0.504 ' OE1' ' HE2' ' A' ' 116' ' ' LYS . 44.4 mt-10 -123.41 -177.06 3.6 Favored 'General case' 0 CA--C 1.457 -2.611 0 CA-C-N 114.667 -1.151 . . . . 0.0 108.973 175.05 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.493 ' HA ' ' HD3' ' A' ' 114' ' ' LYS . 29.4 mmtt -83.07 101.84 11.4 Favored 'General case' 1 N--CA 1.371 -4.412 0 CA-C-N 114.834 -1.076 . . . . 0.0 113.536 179.926 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 125.27 -45.1 1.19 Allowed Glycine 0 N--CA 1.406 -3.336 0 CA-C-N 113.148 -1.842 . . . . 0.0 110.425 178.1 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.504 ' HE2' ' OE1' ' A' ' 113' ' ' GLU . 0.3 OUTLIER -135.2 147.59 49.41 Favored 'General case' 0 C--N 1.313 -0.984 0 C-N-CA 123.102 0.561 . . . . 0.0 112.492 -178.151 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.445 ' HA ' ' HA ' ' A' ' 112' ' ' LEU . 1.2 tt -120.64 105.06 10.43 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 105.346 -2.094 . . . . 0.0 105.346 178.079 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.513 ' HA ' ' OG ' ' A' ' 135' ' ' SER . 44.9 p -100.89 135.53 42.19 Favored 'General case' 0 C--N 1.267 -2.995 0 N-CA-C 114.465 1.283 . . . . 0.0 114.465 -172.174 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 64.92 97.47 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 125.235 1.414 . . . . 0.0 111.586 -179.887 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 6.1 m -104.52 93.53 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.018 0 CA-C-O 122.764 1.269 . . . . 0.0 111.348 -177.041 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -82.86 95.03 7.81 Favored 'General case' 0 N--CA 1.397 -3.107 0 CA-C-N 113.26 -1.791 . . . . 0.0 108.829 -179.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 145.91 -14.58 1.74 Allowed Glycine 0 C--N 1.305 -1.154 0 CA-C-N 114.375 -1.284 . . . . 0.0 111.188 -178.519 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.532 HG13 HG11 ' A' ' 108' ' ' VAL . 86.8 mt -100.64 99.41 8.38 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.25 0 CA-C-O 121.81 0.814 . . . . 0.0 111.042 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -89.18 127.71 35.76 Favored 'General case' 0 N--CA 1.433 -1.295 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 178.103 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.47 ' HA ' ' CB ' ' A' ' 102' ' ' LEU . 9.0 t -140.77 152.75 45.48 Favored 'General case' 0 C--N 1.278 -2.536 0 C-N-CA 119.734 -0.786 . . . . 0.0 111.002 -177.754 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.511 ' C ' ' HD3' ' A' ' 126' ' ' LYS . 3.8 tmtt? -140.85 127.17 19.81 Favored 'General case' 0 N--CA 1.389 -3.51 0 CA-C-N 115.168 -0.924 . . . . 0.0 108.695 175.055 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.513 HG13 ' H ' ' A' ' 128' ' ' MET . 2.6 p -135.55 -57.42 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 CA-C-N 114.709 -1.132 . . . . 0.0 109.057 -179.017 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . 0.513 ' H ' HG13 ' A' ' 127' ' ' VAL . 24.3 ttt -101.19 -57.92 1.99 Allowed 'General case' 0 N--CA 1.421 -1.876 0 N-CA-C 106.293 -1.743 . . . . 0.0 106.293 176.495 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 2.2 pp -132.9 -179.48 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.637 0 CA-C-N 113.508 -1.678 . . . . 0.0 108.721 177.537 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 85.7 t90 -88.13 126.61 35.21 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 123.652 0.595 . . . . 0.0 110.518 -175.236 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 44.3 t -132.3 137.43 54.49 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 178.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 25.2 pttm -102.62 -24.54 13.76 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 112.328 0.492 . . . . 0.0 112.328 179.156 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 19.1 m -130.37 103.69 8.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-O 121.845 0.831 . . . . 0.0 111.417 -179.43 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 23.3 p -109.09 -165.5 1.02 Allowed 'General case' 0 C--N 1.292 -1.908 0 CA-C-N 115.342 -0.845 . . . . 0.0 109.166 177.091 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . 0.513 ' OG ' ' HA ' ' A' ' 118' ' ' THR . 27.5 t -144.96 158.64 43.74 Favored 'General case' 0 N--CA 1.422 -1.837 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 176.715 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 68.1 mt -126.32 96.82 3.8 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 179.749 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . 0.58 ' O ' ' HB2' ' A' ' 144' ' ' TYR . 46.9 t -121.48 136.53 54.95 Favored 'General case' 0 C--N 1.298 -1.663 0 O-C-N 121.816 -0.553 . . . . 0.0 110.324 -175.755 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 8.8 t -165.16 178.33 7.05 Favored 'General case' 0 N--CA 1.42 -1.935 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 -174.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -110.25 68.33 0.67 Allowed 'General case' 0 C--N 1.312 -1.045 0 C-N-CA 119.215 -0.994 . . . . 0.0 112.599 -179.263 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . 48.79 33.35 4.28 Favored 'General case' 0 N--CA 1.496 1.848 0 C-N-CA 124.586 1.154 . . . . 0.0 113.828 173.009 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . 0.471 ' O ' ' HG3' ' A' ' 155' ' ' ARG . 48.1 t -154.32 -67.03 0.14 Allowed 'General case' 0 C--N 1.307 -1.265 0 C-N-CA 120.342 -0.543 . . . . 0.0 110.378 -174.717 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 55.3 mtpt -89.87 -162.79 0.92 Allowed 'General case' 0 CA--C 1.507 -0.709 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 179.125 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.516 HG11 ' O ' ' A' ' 159' ' ' GLY . 8.8 p -144.42 145.34 21.56 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 176.211 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . 0.58 ' HB2' ' O ' ' A' ' 137' ' ' SER . 91.6 m-85 -143.04 144.62 32.34 Favored 'General case' 0 CA--C 1.483 -1.6 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 174.219 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . 0.485 ' HB2' ' HA ' ' A' ' 151' ' ' LYS . 26.5 m-85 -95.53 156.37 16.35 Favored 'General case' 0 CA--C 1.454 -2.733 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 173.775 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 19.0 m -137.03 93.92 2.89 Favored 'General case' 1 N--CA 1.374 -4.226 0 C-N-CA 119.799 -0.761 . . . . 0.0 109.477 174.595 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . 0.491 ' HB3' ' HG3' ' A' ' 150' ' ' LYS . . . -111.56 6.99 20.43 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.168 -0.924 . . . . 0.0 109.361 177.783 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . 0.52 ' O ' ' HG2' ' A' ' 150' ' ' LYS . . . 111.98 75.41 0.75 Allowed Glycine 0 CA--C 1.48 -2.103 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 -179.377 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER 74.31 -33.72 0.26 Allowed 'General case' 0 N--CA 1.494 1.755 0 C-N-CA 125.145 1.378 . . . . 0.0 110.534 -176.754 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . 0.52 ' HG2' ' O ' ' A' ' 148' ' ' GLY . 12.0 pttm -79.88 121.22 25.15 Favored 'General case' 0 C--N 1.315 -0.904 0 C-N-CA 124.292 1.037 . . . . 0.0 112.047 179.518 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . 0.485 ' HA ' ' HB2' ' A' ' 145' ' ' PHE . 21.4 pttm -148.38 119.88 7.95 Favored 'General case' 0 N--CA 1.419 -1.983 0 CA-C-N 114.262 -1.335 . . . . 0.0 110.479 -175.074 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 42.9 m -110.41 111.82 23.34 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 106.54 -1.652 . . . . 0.0 106.54 173.53 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' ARG . . . . . 0.46 ' HB2' HG13 ' A' ' 143' ' ' VAL . 0.0 OUTLIER -154.69 99.57 2.17 Favored 'General case' 0 N--CA 1.435 -1.184 0 N-CA-C 116.397 1.999 . . . . 0.0 116.397 -165.745 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 4.9 m -108.99 109.57 20.65 Favored 'General case' 0 C--N 1.261 -3.279 0 O-C-N 121.423 -0.798 . . . . 0.0 109.051 165.489 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' ARG . . . . . 0.556 ' O ' ' HD3' ' A' ' 155' ' ' ARG . 0.2 OUTLIER -72.75 -23.45 60.83 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 120.633 1.561 . . . . 0.0 107.055 173.329 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -48.13 -43.72 31.46 Favored 'General case' 0 C--N 1.298 -1.666 0 C-N-CA 126.859 2.064 . . . . 0.0 115.536 -178.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.526 ' HB3' ' NE2' ' A' ' 161' ' ' GLN . . . -79.28 -19.5 50.38 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 113.318 0.859 . . . . 0.0 113.318 -175.893 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 0.553 ' CD2' ' HA ' ' A' ' 68' ' ' PHE . 44.0 t80 176.51 -34.49 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 CA-C-O 121.297 0.57 . . . . 0.0 109.831 178.482 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . 0.577 ' HA3' ' O ' ' A' ' 65' ' ' ILE . . . 150.52 -88.92 0.14 Allowed Glycine 0 CA--C 1.464 -3.134 0 N-CA-C 109.168 -1.573 . . . . 0.0 109.168 -172.194 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.558 HG23 ' HB ' ' A' ' 65' ' ' ILE . 10.9 t -98.06 153.39 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.642 0 N-CA-C 107.146 -1.428 . . . . 0.0 107.146 178.772 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 161' ' ' GLN . . . . . 0.526 ' NE2' ' HB3' ' A' ' 157' ' ' ALA . 79.3 mm-40 -116.32 90.05 3.25 Favored 'General case' 0 CA--C 1.453 -2.755 0 CA-C-O 122.435 1.112 . . . . 0.0 110.823 -172.469 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.28 147.59 24.9 Favored 'General case' 0 N--CA 1.387 -3.603 0 CA-C-N 112.555 -2.111 . . . . 0.0 108.828 179.327 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 9.4 t30 -113.13 -86.12 0.57 Allowed 'General case' 0 C--N 1.29 -2.014 0 C-N-CA 119.544 -0.862 . . . . 0.0 109.693 173.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 73.02 164.93 8.65 Favored Glycine 0 CA--C 1.502 -0.765 0 C-N-CA 120.424 -0.893 . . . . 0.0 113.256 179.088 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.525 ' O ' HD22 ' A' ' 165' ' ' LEU . 0.0 OUTLIER -100.95 114.69 28.82 Favored 'General case' 0 N--CA 1.413 -2.316 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 177.367 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . 0.465 ' HB2' ' O ' ' A' ' 89' ' ' PRO . 6.2 ptp180 -90.03 105.67 17.96 Favored 'General case' 0 N--CA 1.412 -2.369 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 -179.694 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . 0.438 ' HB ' ' HB3' ' A' ' 90' ' ' SER . 57.5 t -43.83 -28.19 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 C-N-CA 124.333 1.053 . . . . 0.0 112.812 -177.662 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -49.64 -43.06 46.57 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 124.242 1.017 . . . . 0.0 111.813 177.042 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -128.49 8.79 5.96 Favored 'General case' 0 CA--C 1.546 0.825 0 CA-C-O 121.635 0.731 . . . . 0.0 110.887 -176.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 170' ' ' PHE . . . . . . . . . . . . . 67.3 t80 . . . . . 0 C--N 1.303 -1.439 0 N-CA-C 108.771 -0.825 . . . . 0.0 108.771 178.603 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.624 ' HG ' ' HD3' ' A' ' 55' ' ' PRO 0.352 0.5 OUTLIER . . . . . 0 N--CA 1.439 -1.003 0 N-CA-C 113.384 0.883 . . . . 0.0 113.384 . . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.624 ' HD3' ' HG ' ' A' ' 54' ' ' LEU . 88.9 Cg_exo -55.33 -35.33 91.34 Favored 'Trans proline' 0 C--N 1.362 1.238 0 C-N-CA 123.376 2.717 . . . . 0.0 112.461 -176.88 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -66.33 -30.88 71.37 Favored 'General case' 0 C--O 1.217 -0.615 0 C-N-CA 120.389 -0.525 . . . . 0.0 110.349 179.392 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.401 ' HA ' ' HB3' ' A' ' 60' ' ' GLU . 59.8 tp -74.8 -31.77 61.8 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.017 178.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.454 ' HB3' ' H ' ' A' ' 75' ' ' TYR . 7.9 mp -58.39 -49.8 75.96 Favored 'General case' 0 CA--C 1.482 -1.657 0 CA-C-O 121.675 0.75 . . . . 0.0 109.484 178.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.484 ' HG2' ' O ' ' A' ' 55' ' ' PRO . 17.2 ptmt -74.64 -26.63 60.0 Favored 'General case' 0 C--N 1.28 -2.425 0 CA-C-N 114.089 -1.414 . . . . 0.0 112.41 179.653 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.401 ' HB3' ' HA ' ' A' ' 57' ' ' LEU . 9.1 tp10 -70.75 -35.14 72.51 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.934 178.819 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 61.5 m-85 -48.46 -22.6 0.75 Allowed 'General case' 0 N--CA 1.5 2.072 0 CA-C-O 120.944 0.402 . . . . 0.0 111.442 174.494 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.436 ' CG ' ' H ' ' A' ' 63' ' ' LEU . 17.1 t70 -107.25 -156.38 0.58 Allowed 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 -172.799 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.644 HD21 ' H ' ' A' ' 115' ' ' GLY . 53.3 mt -91.71 172.8 6.01 Favored Pre-proline 0 CA--C 1.568 1.651 0 O-C-N 121.394 -0.816 . . . . 0.0 110.419 -174.773 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.428 ' HD3' ' HB3' ' A' ' 63' ' ' LEU . 3.5 Cg_endo -88.12 19.8 1.27 Allowed 'Trans proline' 0 C--N 1.356 0.968 0 C-N-CA 123.335 2.69 . . . . 0.0 111.367 -172.21 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.734 ' O ' ' HA3' ' A' ' 159' ' ' GLY . 0.2 OUTLIER -73.25 -37.92 53.07 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.708 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.401 179.69 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 55.58 8.51 1.95 Allowed Glycine 0 N--CA 1.49 2.25 0 CA-C-N 115.489 -0.778 . . . . 0.0 113.351 -178.804 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.667 ' O ' ' HB ' ' A' ' 160' ' ' VAL . 40.6 mt 69.37 -63.89 0.23 Allowed 'Isoleucine or valine' 0 C--O 1.197 -1.682 0 C-N-CA 126.053 1.741 . . . . 0.0 113.627 -178.726 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.495 ' HB2' ' O ' ' A' ' 67' ' ' ILE . 63.7 t80 171.24 -48.0 0.0 OUTLIER Pre-proline 0 C--N 1.314 -0.944 0 C-N-CA 122.729 0.412 . . . . 0.0 110.637 -177.446 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.592 ' HB3' ' HD3' ' A' ' 166' ' ' ARG . 17.1 Cg_exo -74.61 -31.62 6.75 Favored 'Trans proline' 0 C--N 1.377 2.035 0 C-N-CA 121.388 1.392 . . . . 0.0 112.109 179.666 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 88.37 -29.16 5.8 Favored Glycine 0 N--CA 1.437 -1.281 0 C-N-CA 120.448 -0.882 . . . . 0.0 110.999 -175.22 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.426 ' HB3' ' HG3' ' A' ' 89' ' ' PRO . 17.5 t70 -81.86 -19.02 41.83 Favored 'General case' 0 C--O 1.2 -1.545 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 177.52 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.511 ' HB2' ' HD2' ' A' ' 89' ' ' PRO . . . -78.25 175.04 10.57 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 114.95 -1.023 . . . . 0.0 110.375 170.511 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.501 ' HB ' ' O ' ' A' ' 72' ' ' ALA . 51.9 m 86.29 21.27 0.08 Allowed 'General case' 0 C--N 1.355 0.836 0 CA-C-O 124.069 1.89 . . . . 0.0 110.763 172.451 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.556 ' O ' ' HA ' ' A' ' 86' ' ' VAL . 37.3 m-80 -80.33 158.9 25.96 Favored 'General case' 0 C--N 1.272 -2.793 0 CA-C-N 114.641 -1.163 . . . . 0.0 112.632 -179.572 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.454 ' H ' ' HB3' ' A' ' 58' ' ' LEU . 53.5 t80 -118.38 123.1 44.44 Favored 'General case' 0 C--N 1.284 -2.266 0 CA-C-N 114.716 -1.129 . . . . 0.0 112.998 -169.748 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.598 ' O ' HD12 ' A' ' 84' ' ' LEU . 26.7 mm-40 -146.59 151.2 36.91 Favored 'General case' 0 C--O 1.215 -0.73 0 C-N-CA 125.984 1.714 . . . . 0.0 108.165 173.254 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 52.4 p90 -139.28 150.58 45.61 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-N 118.228 0.467 . . . . 0.0 110.651 -178.501 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.478 ' CB ' ' HB ' ' A' ' 81' ' ' THR . 21.6 m-20 -78.56 164.39 24.72 Favored 'General case' 0 CA--C 1.48 -1.729 0 CA-C-O 121.589 0.709 . . . . 0.0 110.227 179.002 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -80.82 -65.87 0.96 Allowed 'General case' 0 C--N 1.279 -2.476 0 CA-C-N 114.312 -1.313 . . . . 0.0 110.835 -179.629 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -81.06 -33.22 33.63 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.378 -176.604 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.478 ' HB ' ' CB ' ' A' ' 78' ' ' ASP . 91.6 m -82.67 -29.03 30.24 Favored 'General case' 0 N--CA 1.425 -1.715 0 CA-C-N 115.048 -0.978 . . . . 0.0 111.64 -176.794 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt 58.88 15.41 3.86 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 113.021 0.749 . . . . 0.0 113.021 178.173 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.437 ' CG ' ' HB ' ' A' ' 109' ' ' THR . 16.4 tppt? -88.54 141.76 28.26 Favored 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 -177.635 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.598 HD12 ' O ' ' A' ' 76' ' ' GLU . 37.5 tp -75.96 138.72 41.15 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.26 177.037 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.406 HG23 ' HB2' ' A' ' 76' ' ' GLU . 9.4 t -126.31 116.97 22.06 Favored 'General case' 0 N--CA 1.412 -2.351 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 173.269 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.556 ' HA ' ' O ' ' A' ' 74' ' ' ASN . 74.2 t -92.92 127.01 45.29 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.808 0 CA-C-N 115.133 -0.94 . . . . 0.0 110.781 -178.463 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.469 ' HB2' ' HB2' ' A' ' 74' ' ' ASN . 3.9 mp -88.6 109.54 20.18 Favored 'General case' 0 N--CA 1.433 -1.294 0 CA-C-N 115.287 -0.87 . . . . 0.0 109.596 179.844 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 65.7 mt -96.86 137.93 21.35 Favored Pre-proline 0 C--N 1.286 -2.186 0 N-CA-C 105.957 -1.868 . . . . 0.0 105.957 171.073 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.61 ' O ' ' HB2' ' A' ' 166' ' ' ARG . 41.5 Cg_endo -63.19 107.44 0.66 Allowed 'Trans proline' 0 N--CA 1.437 -1.842 0 C-N-CA 122.109 1.873 . . . . 0.0 110.14 175.849 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . 0.653 ' HB2' ' HB2' ' A' ' 168' ' ' ASP . 33.2 t 63.65 -163.92 0.26 Allowed 'General case' 0 CA--C 1.557 1.248 0 CA-C-O 121.272 0.558 . . . . 0.0 110.891 179.614 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 5.7 tt -106.06 119.63 55.71 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 CA-C-O 121.52 0.676 . . . . 0.0 109.496 177.854 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' CYS . . . . . 0.467 ' O ' ' HB2' ' A' ' 104' ' ' PHE . 21.0 p -117.47 124.59 49.15 Favored 'General case' 0 C--N 1.296 -1.753 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 -179.441 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -116.41 166.17 12.38 Favored 'General case' 0 C--N 1.306 -1.31 0 O-C-N 122.072 -0.392 . . . . 0.0 111.775 -174.045 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.449 ' HB ' ' HB2' ' A' ' 163' ' ' ASN . 3.0 p -149.95 104.93 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.609 177.757 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.68 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.994 176.627 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . 0.455 ' HA ' ' O ' ' A' ' 126' ' ' LYS . 34.8 t . . . . . 0 N--CA 1.411 -2.391 0 N-CA-C 106.696 -1.594 . . . . 0.0 106.696 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.444 ' C ' HD12 ' A' ' 102' ' ' LEU . 97.9 t -130.45 119.35 45.89 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.108 0 CA-C-N 114.633 -1.167 . . . . 0.0 108.414 177.22 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.48 ' HG ' ' HA ' ' A' ' 125' ' ' THR . 4.8 mp -124.6 138.59 54.31 Favored 'General case' 0 N--CA 1.424 -1.759 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.346 -179.645 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 27.3 ttpp -117.19 110.35 18.03 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.33 177.759 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.579 ' HA ' HD12 ' A' ' 123' ' ' ILE . 51.1 m-85 -91.13 97.14 10.97 Favored 'General case' 0 N--CA 1.422 -1.871 0 CA-C-O 122.19 0.995 . . . . 0.0 111.756 177.764 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 31.6 m -56.05 146.4 22.85 Favored 'General case' 0 N--CA 1.424 -1.762 0 CA-C-N 112.276 -2.238 . . . . 0.0 110.916 177.325 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 66.9 m -56.95 -67.8 0.28 Allowed 'General case' 0 C--O 1.218 -0.593 0 C-N-CA 123.738 0.815 . . . . 0.0 111.123 -179.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.412 ' HA ' ' O ' ' A' ' 86' ' ' VAL . 7.3 p -107.56 99.88 9.34 Favored 'General case' 0 N--CA 1.423 -1.825 0 CA-C-O 121.654 0.74 . . . . 0.0 110.054 176.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.781 HG21 HG12 ' A' ' 123' ' ' ILE . 4.3 p -110.07 148.38 13.69 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.433 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.805 -176.894 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.535 ' HA ' ' O ' ' A' ' 84' ' ' LEU . 35.6 p -97.95 156.26 16.7 Favored 'General case' 0 N--CA 1.432 -1.369 0 N-CA-C 112.895 0.702 . . . . 0.0 112.895 -176.131 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . 0.667 ' HA2' ' O ' ' A' ' 119' ' ' ASP . . . -172.99 174.42 45.86 Favored Glycine 0 CA--C 1.52 0.353 0 N-CA-C 111.714 -0.554 . . . . 0.0 111.714 -179.84 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 34.2 t-80 -109.75 121.96 46.41 Favored 'General case' 0 CA--C 1.508 -0.658 0 N-CA-C 107.934 -1.135 . . . . 0.0 107.934 177.347 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.572 ' HB2' HD22 ' A' ' 84' ' ' LEU . 2.9 tt -91.99 116.86 29.28 Favored 'General case' 0 C--N 1.307 -1.261 0 C-N-CA 120.324 -0.55 . . . . 0.0 110.395 -172.541 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -127.57 143.99 51.12 Favored 'General case' 0 CA--C 1.459 -2.542 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 171.748 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 42.7 tptt -80.15 100.24 8.16 Favored 'General case' 0 N--CA 1.387 -3.581 0 CA-C-O 122.194 0.997 . . . . 0.0 108.911 -171.627 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . 0.644 ' H ' HD21 ' A' ' 63' ' ' LEU . . . 136.5 -31.92 2.53 Favored Glycine 0 N--CA 1.426 -1.999 0 N-CA-C 108.245 -1.942 . . . . 0.0 108.245 -176.681 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -157.87 127.0 5.77 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 121.379 0.609 . . . . 0.0 111.985 -178.744 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -94.59 107.14 19.14 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 105.656 -1.979 . . . . 0.0 105.656 174.72 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.438 ' HA ' ' CB ' ' A' ' 135' ' ' SER . 49.4 p -109.61 172.44 6.85 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.963 -175.188 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . 0.667 ' O ' ' HA2' ' A' ' 110' ' ' GLY . 12.2 m-20 56.97 63.14 2.0 Favored 'General case' 0 CA--C 1.473 -1.983 0 O-C-N 124.468 1.105 . . . . 0.0 109.55 178.531 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.423 HG23 ' O ' ' A' ' 134' ' ' THR . 4.5 t -86.75 78.1 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.399 -2.98 0 C-N-CA 117.983 -1.487 . . . . 0.0 108.335 -175.798 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.409 ' HB3' ' OG1' ' A' ' 109' ' ' THR . 11.6 tp10 -68.92 96.47 0.77 Allowed 'General case' 0 N--CA 1.414 -2.252 0 CA-C-N 113.011 -1.904 . . . . 0.0 110.601 -174.39 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 130.56 -2.18 5.69 Favored Glycine 0 N--CA 1.424 -2.104 0 C-N-CA 120.152 -1.023 . . . . 0.0 112.995 174.864 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.781 HG12 HG21 ' A' ' 108' ' ' VAL . 26.6 mm -99.2 112.25 30.93 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 176.743 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -84.3 119.38 25.0 Favored 'General case' 0 N--CA 1.429 -1.51 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 -178.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.48 ' HA ' ' HG ' ' A' ' 102' ' ' LEU . 58.9 m -131.38 119.44 21.68 Favored 'General case' 0 N--CA 1.405 -2.716 0 CA-C-N 114.976 -1.011 . . . . 0.0 111.33 -175.889 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.455 ' O ' ' HA ' ' A' ' 100' ' ' SER . 83.1 tttt -110.08 141.94 42.22 Favored 'General case' 0 N--CA 1.41 -2.451 0 C-N-CA 119.083 -1.047 . . . . 0.0 109.452 168.225 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.443 HG11 ' HE2' ' A' ' 150' ' ' LYS . 7.5 p -149.01 -35.0 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.296 -1.757 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 175.431 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . 0.466 ' HG3' HG22 ' A' ' 129' ' ' ILE . 26.4 ptm -137.52 -29.23 0.88 Allowed 'General case' 0 N--CA 1.404 -2.758 0 CA-C-N 113.922 -1.49 . . . . 0.0 107.986 -176.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . 0.466 HG22 ' HG3' ' A' ' 128' ' ' MET . 7.0 tp -161.97 159.52 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.565 0 N-CA-C 103.684 -2.71 . . . . 0.0 103.684 175.278 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 63.6 p-90 -83.82 126.52 33.02 Favored 'General case' 0 N--CA 1.409 -2.476 0 CA-C-O 121.351 0.596 . . . . 0.0 109.547 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.503 HG22 ' H ' ' A' ' 133' ' ' VAL . 13.1 p -130.92 149.01 33.07 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.147 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 179.022 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 20.8 pttp -103.48 12.94 34.52 Favored 'General case' 0 C--N 1.308 -1.201 0 C-N-CA 120.536 -0.466 . . . . 0.0 110.99 -179.643 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.503 ' H ' HG22 ' A' ' 131' ' ' VAL . 10.8 m -146.92 94.17 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.936 0.874 . . . . 0.0 112.529 -174.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . 0.476 HG21 HG21 ' A' ' 125' ' ' THR . 25.5 p -107.59 -160.73 0.74 Allowed 'General case' 0 N--CA 1.404 -2.73 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 174.026 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . 0.438 ' CB ' ' HA ' ' A' ' 118' ' ' THR . 51.8 p -173.35 142.66 1.01 Allowed 'General case' 0 N--CA 1.44 -0.941 0 N-CA-C 111.327 0.121 . . . . 0.0 111.327 -178.352 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . 0.437 HG13 ' O ' ' A' ' 144' ' ' TYR . 10.1 tt -103.18 111.23 32.18 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 CA-C-O 121.397 0.618 . . . . 0.0 109.396 177.574 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . 0.443 ' O ' ' HB2' ' A' ' 144' ' ' TYR . 43.5 m -111.75 139.35 47.29 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.739 -178.279 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . 0.437 HG23 ' H ' ' A' ' 140' ' ' ALA . 7.5 t -166.09 178.11 6.56 Favored 'General case' 0 N--CA 1.428 -1.559 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 -177.709 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -83.61 28.69 0.55 Allowed 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 176.441 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . 0.484 ' HA ' HD22 ' A' ' 63' ' ' LEU . . . 60.23 35.73 20.91 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.352 0.661 . . . . 0.0 109.598 -174.246 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . 0.468 ' O ' ' HG3' ' A' ' 155' ' ' ARG . 33.4 t -153.62 -65.73 0.15 Allowed 'General case' 0 C--O 1.214 -0.784 0 CA-C-N 115.795 -0.638 . . . . 0.0 111.426 -171.505 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 51.2 mtpt -80.11 -169.16 1.92 Allowed 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 179.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.609 HG22 HG22 ' A' ' 65' ' ' ILE . 91.7 t -135.71 119.77 25.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-O 121.663 0.744 . . . . 0.0 112.673 179.11 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . 0.443 ' HB2' ' O ' ' A' ' 137' ' ' SER . 96.2 m-85 -113.64 114.59 26.64 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 106.297 -1.742 . . . . 0.0 106.297 171.13 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . 0.419 ' HB3' ' HB2' ' A' ' 151' ' ' LYS . 29.5 t80 -59.35 143.2 50.22 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 114.866 -1.061 . . . . 0.0 111.701 -169.12 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.43 ' C ' ' HB ' ' A' ' 134' ' ' THR . 75.1 p -46.88 104.27 0.05 OUTLIER 'General case' 0 C--O 1.245 0.823 0 N-CA-C 115.553 1.686 . . . . 0.0 115.553 -169.795 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . 0.492 ' HB3' ' HG3' ' A' ' 150' ' ' LYS . . . 161.23 -65.47 0.0 OUTLIER 'General case' 0 CA--C 1.487 -1.457 0 C-N-CA 129.674 3.19 . . . . 0.0 104.824 174.036 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 154.57 -75.22 0.23 Allowed Glycine 0 CA--C 1.48 -2.139 0 C-N-CA 119.557 -1.306 . . . . 0.0 112.282 170.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 27.3 ptt? -97.36 -11.59 23.81 Favored 'General case' 0 C--N 1.29 -1.992 0 CA-C-N 115.396 -0.402 . . . . 0.0 111.938 -175.585 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . 0.492 ' HG3' ' HB3' ' A' ' 147' ' ' ALA 0.352 0.0 OUTLIER -77.37 -28.71 52.97 Favored 'General case' 0 C--O 1.213 -0.823 0 N-CA-C 116.656 2.095 . . . . 0.0 116.656 -170.597 . . . . . . . . 4 4 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . 0.565 ' HE2' ' HA ' ' A' ' 151' ' ' LYS . 4.8 mmpt? -147.52 129.32 15.24 Favored 'General case' 0 CA--C 1.503 -0.829 0 CA-C-N 118.074 0.397 . . . . 0.0 110.767 179.453 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 40.6 p -106.72 145.91 31.46 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 175.461 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' ARG . . . . . 0.413 ' HG2' ' HB2' ' A' ' 145' ' ' PHE . 4.1 mmp_? -130.75 166.69 20.23 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 -179.313 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 19.0 m -101.15 121.76 42.41 Favored 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 177.201 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' ARG . . . . . 0.468 ' HG3' ' O ' ' A' ' 141' ' ' SER . 1.6 tmm_? -63.19 -25.79 68.5 Favored 'General case' 0 C--O 1.206 -1.198 0 N-CA-C 106.898 -1.519 . . . . 0.0 106.898 178.548 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -52.7 -25.94 12.47 Favored 'General case' 0 C--N 1.302 -1.499 0 C-N-CA 126.339 1.855 . . . . 0.0 113.009 -179.665 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -71.76 -32.66 67.93 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 120.703 0.287 . . . . 0.0 111.192 -179.268 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 44.0 t80 169.39 -31.94 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 106.333 -1.729 . . . . 0.0 106.333 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . 0.734 ' HA3' ' O ' ' A' ' 65' ' ' ILE . . . 156.87 -90.11 0.12 Allowed Glycine 0 N--CA 1.4 -3.729 0 N-CA-C 108.299 -1.92 . . . . 0.0 108.299 -173.361 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.667 ' HB ' ' O ' ' A' ' 67' ' ' ILE . 11.1 t -103.35 148.17 8.74 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.756 0 N-CA-C 105.372 -2.084 . . . . 0.0 105.372 179.231 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -137.07 102.69 4.92 Favored 'General case' 0 N--CA 1.408 -2.566 0 C-N-CA 118.102 -1.439 . . . . 0.0 109.179 -173.251 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 34.7 ptt85 -152.78 173.76 14.9 Favored 'General case' 0 C--N 1.275 -2.632 0 CA-C-N 113.214 -1.812 . . . . 0.0 106.515 -177.102 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 163' ' ' ASN . . . . . 0.449 ' HB2' ' HB ' ' A' ' 94' ' ' VAL . 4.4 m-20 -67.63 126.03 28.06 Favored 'General case' 0 C--O 1.248 1.007 0 C-N-CA 119.087 -1.045 . . . . 0.0 108.475 169.254 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -159.23 60.9 0.31 Allowed Glycine 0 N--CA 1.411 -3.032 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.311 -179.651 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.429 HD12 HH21 ' A' ' 166' ' ' ARG . 47.1 tp -81.62 111.54 18.0 Favored 'General case' 0 N--CA 1.418 -2.038 0 N-CA-C 105.509 -2.034 . . . . 0.0 105.509 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . 0.65 ' H ' ' NE ' ' A' ' 166' ' ' ARG . 0.0 OUTLIER -84.15 105.94 15.4 Favored 'General case' 0 N--CA 1.398 -3.055 0 C-N-CA 118.382 -1.327 . . . . 0.0 110.788 -178.189 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 4.8 m -74.74 63.93 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.29 -2.012 0 CA-C-O 122.833 1.301 . . . . 0.0 111.204 176.505 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . 0.653 ' HB2' ' HB2' ' A' ' 90' ' ' SER . 35.6 t70 -133.49 -32.69 1.14 Allowed 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 112.772 -2.013 . . . . 0.0 107.724 -177.635 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 21.7 ttpp -140.03 -67.19 0.44 Allowed 'General case' 0 N--CA 1.427 -1.584 0 CA-C-N 113.764 -1.562 . . . . 0.0 107.763 -177.172 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 170' ' ' PHE . . . . . . . . . . . . . 68.3 t80 . . . . . 0 C--O 1.249 1.026 0 N-CA-C 105.004 -2.221 . . . . 0.0 105.004 -178.82 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 25.6 m . . . . . 0 N--CA 1.444 -0.737 0 N-CA-C 109.225 -0.658 . . . . 0.0 109.225 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -141.14 138.17 33.27 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.396 0.617 . . . . 0.0 112.1 -177.174 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -146.3 27.45 1.14 Allowed 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 177.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 10.3 tt -72.0 127.67 34.2 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 CA-C-N 115.3 -0.864 . . . . 0.0 112.068 -176.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 34.3 p90 -145.12 112.04 5.93 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.683 177.037 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 44.3 t-20 -126.69 99.17 5.67 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 179.196 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -96.56 122.89 39.96 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-N 115.235 -0.893 . . . . 0.0 109.294 -178.167 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.7 p -110.09 126.19 67.32 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.833 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 176.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -88.84 153.59 23.95 Favored Glycine 0 N--CA 1.427 -1.929 0 C-N-CA 120.798 -0.715 . . . . 0.0 111.692 -178.48 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 32.5 t -135.38 124.31 24.13 Favored 'General case' 0 C--N 1.292 -1.906 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 179.108 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -108.8 156.53 19.53 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 178.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 71.3 t-105 -137.76 131.53 31.4 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-O 121.273 0.558 . . . . 0.0 111.56 179.217 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -144.51 145.42 31.84 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-N 115.072 -0.967 . . . . 0.0 109.58 175.01 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -132.05 105.02 0.59 Allowed Glycine 0 N--CA 1.434 -1.485 0 C-N-CA 120.205 -0.997 . . . . 0.0 111.971 -177.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 16.9 mp0 -73.48 108.67 6.47 Favored 'General case' 0 C--N 1.308 -1.196 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 179.27 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -111.71 114.29 27.21 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.77 178.053 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -155.03 146.6 23.17 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -149.96 127.8 11.77 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-O 121.077 0.465 . . . . 0.0 111.586 -179.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -139.68 103.63 4.72 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.207 175.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -126.42 95.0 4.22 Favored 'General case' 0 C--N 1.292 -1.906 0 CA-C-O 121.836 0.827 . . . . 0.0 111.734 -178.67 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 88.9 t80 -100.0 127.33 46.22 Favored 'General case' 0 C--N 1.296 -1.735 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.515 179.085 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -127.2 165.83 18.88 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 174.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 32.0 t -124.47 136.98 54.46 Favored 'General case' 0 C--N 1.297 -1.688 0 CA-C-O 120.989 0.423 . . . . 0.0 110.461 -175.328 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 55.7 t -92.49 128.06 44.29 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.092 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 -179.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -98.06 170.23 24.75 Favored Glycine 0 N--CA 1.437 -1.276 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.671 -178.073 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 29.9 p-10 -153.34 153.86 33.41 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 177.534 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -128.42 157.85 39.92 Favored 'General case' 0 C--N 1.305 -1.337 0 C-N-CA 120.612 -0.435 . . . . 0.0 110.987 -179.397 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 89.8 mt -96.34 153.47 17.8 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.491 -177.18 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 28.8 p-10 -141.43 131.73 25.05 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.995 -179.173 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 38.0 t -161.27 111.03 1.64 Allowed 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 179.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 28.6 m -127.68 130.83 70.36 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-N 116.281 -0.418 . . . . 0.0 109.899 178.436 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 46.1 m -155.38 152.12 28.7 Favored 'General case' 0 C--N 1.31 -1.134 0 O-C-N 122.304 -0.248 . . . . 0.0 110.376 -177.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 10.2 t -161.14 176.21 11.55 Favored 'General case' 0 C--O 1.246 0.882 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 177.272 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 32.1 t -163.96 158.62 19.89 Favored 'General case' 0 N--CA 1.438 -1.044 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 -179.635 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 29.8 pt -133.56 -177.12 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.953 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 178.408 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -131.04 134.4 46.62 Favored 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 179.02 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -156.03 48.43 0.48 Allowed Glycine 0 C--N 1.308 -1.024 0 N-CA-C 111.115 -0.794 . . . . 0.0 111.115 -179.012 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -78.48 -36.19 30.8 Favored Glycine 0 N--CA 1.442 -0.962 0 C-N-CA 121.138 -0.553 . . . . 0.0 112.024 -177.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 29.1 p -84.88 121.06 27.2 Favored 'General case' 0 N--CA 1.429 -1.524 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 177.535 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -143.65 107.07 4.57 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-O 121.053 0.454 . . . . 0.0 111.155 -177.483 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 28.9 p-90 -150.09 100.85 2.96 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 115.045 -0.979 . . . . 0.0 111.461 179.1 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.644 HD23 ' H ' ' A' ' 42' ' ' LEU . 2.0 pt? -79.78 -12.32 59.79 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 121.801 0.81 . . . . 0.0 110.142 179.387 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 34.5 m -104.02 138.67 27.63 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.806 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 175.026 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 5.6 p30 -111.0 85.7 2.17 Favored 'General case' 0 C--N 1.295 -1.763 0 CA-C-O 122.307 1.051 . . . . 0.0 111.505 179.028 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 58.8 tptt -105.72 101.73 11.23 Favored 'General case' 0 N--CA 1.418 -2.062 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 178.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 10.0 tt -64.52 89.95 0.08 OUTLIER 'Isoleucine or valine' 0 C--O 1.248 1.018 0 CA-C-O 122.301 1.048 . . . . 0.0 113.11 -174.652 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 50.0 tptt -173.07 151.78 2.19 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 105.546 -2.02 . . . . 0.0 105.546 178.339 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -75.26 54.74 2.76 Favored Glycine 0 CA--C 1.525 0.691 0 C-N-CA 121.62 -0.324 . . . . 0.0 113.782 -176.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -135.32 -35.38 0.83 Allowed 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 177.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 1.8 mpt? 66.88 -87.3 0.03 OUTLIER 'General case' 0 C--O 1.242 0.676 0 CA-C-N 114.692 -1.14 . . . . 0.0 109.891 -174.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -143.52 -0.18 1.1 Allowed 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 120.671 0.272 . . . . 0.0 111.32 177.151 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.419 ' HB3' ' HG ' ' A' ' 54' ' ' LEU . 75.3 mmtt -136.81 155.22 76.63 Favored Pre-proline 0 C--O 1.208 -1.106 0 CA-C-O 120.513 0.197 . . . . 0.0 110.528 -178.249 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -84.14 28.2 0.58 Allowed 'Trans proline' 0 C--O 1.241 0.625 0 C-N-CA 122.864 2.376 . . . . 0.0 111.246 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.419 ' HG ' ' HB3' ' A' ' 52' ' ' LYS . 42.0 mt -74.63 -45.24 5.51 Favored Pre-proline 0 C--N 1.307 -1.262 0 N-CA-C 114.602 1.334 . . . . 0.0 114.602 -174.646 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.519 ' O ' ' HG2' ' A' ' 59' ' ' LYS . 20.9 Cg_exo -61.76 -15.93 45.61 Favored 'Trans proline' 0 C--N 1.374 1.907 0 C-N-CA 121.73 1.62 . . . . 0.0 113.412 -165.149 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 31.1 mm-40 -80.35 -30.74 38.01 Favored 'General case' 0 CA--C 1.485 -1.542 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 -178.008 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.555 ' HA ' ' HB3' ' A' ' 60' ' ' GLU . 72.6 mt -75.28 -35.06 61.37 Favored 'General case' 0 N--CA 1.418 -2.054 0 CA-C-N 114.648 -1.16 . . . . 0.0 110.572 -179.218 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.653 ' HB3' ' H ' ' A' ' 75' ' ' TYR . 5.2 mp -64.46 -50.93 65.57 Favored 'General case' 0 CA--C 1.493 -1.229 0 C-N-CA 119.668 -0.813 . . . . 0.0 110.047 -178.28 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.519 ' HG2' ' O ' ' A' ' 55' ' ' PRO . 18.0 ptpt -62.55 -26.48 68.6 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 114.923 -1.035 . . . . 0.0 111.041 175.478 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.555 ' HB3' ' HA ' ' A' ' 57' ' ' LEU . 15.5 tt0 -69.71 -39.44 76.86 Favored 'General case' 0 C--N 1.317 -0.823 0 C-N-CA 123.89 0.876 . . . . 0.0 112.345 176.884 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -74.89 -26.14 59.44 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 120.459 -0.497 . . . . 0.0 110.301 176.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -77.17 -162.22 0.27 Allowed 'General case' 0 CA--C 1.565 1.545 0 CA-C-N 115.206 -0.906 . . . . 0.0 108.563 178.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.779 ' HB2' HD12 ' A' ' 65' ' ' ILE . 1.5 mt -95.02 -178.64 0.82 Allowed Pre-proline 0 CA--C 1.569 1.704 0 N-CA-C 106.809 -1.552 . . . . 0.0 106.809 -175.591 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_endo -92.45 14.85 1.63 Allowed 'Trans proline' 0 C--N 1.361 1.202 0 C-N-CA 122.36 2.04 . . . . 0.0 111.547 -174.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.779 HD12 ' HB2' ' A' ' 63' ' ' LEU . 0.2 OUTLIER -76.12 -42.15 37.93 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.704 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 179.497 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.402 ' H ' HD13 ' A' ' 65' ' ' ILE . . . 57.75 8.55 4.27 Favored Glycine 0 N--CA 1.481 1.645 0 CA-C-N 115.925 -0.58 . . . . 0.0 112.771 -178.155 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.623 ' H ' HG12 ' A' ' 65' ' ' ILE . 61.6 mt 64.95 -67.39 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.562 0 C-N-CA 126.201 1.8 . . . . 0.0 112.471 -176.623 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.403 ' HB3' ' HD3' ' A' ' 69' ' ' PRO . 53.3 t80 179.61 -56.63 0.0 OUTLIER Pre-proline 0 C--N 1.31 -1.119 0 N-CA-C 112.268 0.47 . . . . 0.0 112.268 -177.672 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.489 ' HB2' ' OD2' ' A' ' 71' ' ' ASP . 3.2 Cg_endo -87.67 -22.68 1.5 Allowed 'Trans proline' 0 C--N 1.365 1.416 0 C-N-CA 121.556 1.504 . . . . 0.0 114.185 -170.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 88.8 -8.55 79.23 Favored Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 120.525 -0.845 . . . . 0.0 111.456 -175.338 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.496 ' HB2' ' HG3' ' A' ' 89' ' ' PRO . 21.6 m-20 -81.78 -46.65 13.91 Favored 'General case' 0 CA--C 1.501 -0.926 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 177.537 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.512 ' HB1' HD12 ' A' ' 67' ' ' ILE . . . -71.27 178.15 3.51 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 114.164 -1.38 . . . . 0.0 110.273 172.798 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.541 ' O ' HG22 ' A' ' 73' ' ' THR . 81.3 m 83.24 27.86 0.1 Allowed 'General case' 0 C--N 1.354 0.775 0 CA-C-O 124.429 2.062 . . . . 0.0 110.018 174.496 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.689 ' O ' ' HA ' ' A' ' 86' ' ' VAL . 0.7 OUTLIER -81.82 137.76 35.22 Favored 'General case' 0 C--N 1.275 -2.635 0 CA-C-N 114.206 -1.361 . . . . 0.0 109.726 177.706 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.653 ' H ' ' HB3' ' A' ' 58' ' ' LEU . 37.5 t80 -106.73 104.94 14.75 Favored 'General case' 0 C--N 1.273 -2.756 0 CA-C-N 115.234 -0.894 . . . . 0.0 110.074 -173.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.676 ' O ' ' HG ' ' A' ' 84' ' ' LEU . 10.8 mm-40 -137.73 163.33 31.59 Favored 'General case' 0 C--N 1.307 -1.258 0 C-N-CA 124.112 0.965 . . . . 0.0 108.882 177.202 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 50.9 p90 -147.75 150.47 34.33 Favored 'General case' 0 C--N 1.289 -2.035 0 N-CA-C 108.064 -1.088 . . . . 0.0 108.064 177.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.728 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 12.7 m-20 -99.16 165.26 11.8 Favored 'General case' 0 CA--C 1.479 -1.767 0 C-N-CA 118.001 -1.48 . . . . 0.0 110.282 178.549 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -79.55 -59.66 2.66 Favored 'General case' 0 C--N 1.272 -2.802 0 CA-C-N 114.159 -1.382 . . . . 0.0 112.947 -177.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -72.41 -30.41 64.62 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-O 121.58 0.705 . . . . 0.0 110.292 -177.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.728 ' HB ' ' HB2' ' A' ' 78' ' ' ASP . 21.8 m -78.49 -51.07 10.52 Favored 'General case' 0 N--CA 1.411 -2.424 0 CA-C-N 114.824 -1.08 . . . . 0.0 110.48 -178.158 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 65.0 mttp 65.88 12.0 8.06 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.626 0.77 . . . . 0.0 112.172 -177.567 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 5.0 tppp? -100.59 141.97 32.72 Favored 'General case' 0 N--CA 1.428 -1.548 0 N-CA-C 104.449 -2.426 . . . . 0.0 104.449 175.445 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.676 ' HG ' ' O ' ' A' ' 76' ' ' GLU . 9.3 tt -80.83 145.83 31.21 Favored 'General case' 0 C--N 1.295 -1.782 0 C-N-CA 119.39 -0.924 . . . . 0.0 110.488 -178.428 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.438 ' HB ' HG22 ' A' ' 109' ' ' THR . 10.7 t -126.47 123.84 38.75 Favored 'General case' 0 N--CA 1.4 -2.964 0 CA-C-O 121.896 0.855 . . . . 0.0 111.035 -179.529 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.689 ' HA ' ' O ' ' A' ' 74' ' ' ASN . 98.5 t -96.84 126.81 49.47 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 CA-C-N 114.932 -1.031 . . . . 0.0 108.4 175.36 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.6 mp -91.64 120.37 32.35 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-O 121.63 0.728 . . . . 0.0 111.046 -179.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 2.1 mp -100.69 132.74 21.85 Favored Pre-proline 0 C--N 1.286 -2.191 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 172.335 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.496 ' HG3' ' HB2' ' A' ' 71' ' ' ASP . 12.4 Cg_endo -51.06 -36.28 53.96 Favored 'Trans proline' 0 C--N 1.356 0.938 0 C-N-CA 124.637 3.558 . . . . 0.0 114.357 -176.131 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.637 ' HB2' ' HB2' ' A' ' 168' ' ' ASP . 47.9 t -161.99 157.65 23.96 Favored 'General case' 0 CA--C 1.493 -1.221 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.408 ' CD1' ' HG3' ' A' ' 93' ' ' GLU . 0.0 OUTLIER -70.4 116.13 11.13 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.711 0 O-C-N 123.991 0.807 . . . . 0.0 109.28 179.993 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 41.3 t -112.77 123.51 50.46 Favored 'General case' 0 N--CA 1.427 -1.587 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.934 179.377 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.408 ' HG3' ' CD1' ' A' ' 91' ' ' ILE . 41.4 mt-10 -106.57 114.66 28.9 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 174.782 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 5.8 p -111.66 118.15 56.86 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.726 0 CA-C-O 121.192 0.52 . . . . 0.0 111.283 -176.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.466 ' HA2' ' HA ' ' A' ' 101' ' ' VAL . . . -131.26 140.28 11.65 Favored Glycine 0 N--CA 1.43 -1.703 0 C-N-CA 120.463 -0.875 . . . . 0.0 112.016 179.155 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 0.401 ' C ' ' H ' ' A' ' 98' ' ' ASP . 51.9 t80 -159.98 175.16 13.34 Favored 'General case' 0 N--CA 1.402 -2.868 0 N-CA-C 102.791 -3.04 . . . . 0.0 102.791 179.224 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.99 1.75 2.5 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 118.755 0.707 . . . . 0.0 111.305 177.543 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.401 ' H ' ' C ' ' A' ' 96' ' ' TYR . 9.4 t70 -45.26 -52.33 9.74 Favored 'General case' 0 CA--C 1.502 -0.898 0 C-N-CA 125.362 1.465 . . . . 0.0 110.07 176.449 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.443 ' OG ' ' HD2' ' A' ' 151' ' ' LYS . 45.1 m -146.89 -68.52 0.26 Allowed 'General case' 0 N--CA 1.408 -2.563 0 N-CA-C 106.653 -1.61 . . . . 0.0 106.653 175.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 48.8 m -164.15 -74.19 0.04 OUTLIER 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 176.014 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.466 ' HA ' ' HA2' ' A' ' 95' ' ' GLY . 13.8 p -166.85 147.63 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.796 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 -178.354 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.524 HD23 ' H ' ' A' ' 126' ' ' LYS . 51.6 mt -134.86 133.95 40.25 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 -176.205 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.446 ' O ' ' HA ' ' A' ' 123' ' ' ILE . 27.4 ttpp -110.28 114.05 27.22 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 112.195 0.442 . . . . 0.0 112.195 -177.112 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.405 ' O ' ' HA ' ' A' ' 91' ' ' ILE . 95.5 m-85 -101.65 104.54 15.39 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.721 176.696 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 89.4 m -79.59 165.0 23.39 Favored 'General case' 0 CA--C 1.557 1.215 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.618 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 12.0 p -69.57 -69.68 0.33 Allowed 'General case' 0 N--CA 1.438 -1.063 0 C-N-CA 124.93 1.292 . . . . 0.0 112.886 -175.014 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 25.6 m -96.3 88.51 4.79 Favored 'General case' 0 N--CA 1.416 -2.173 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 -178.195 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.683 HG21 HG13 ' A' ' 123' ' ' ILE . 5.0 p -101.48 144.18 13.43 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.103 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.18 -176.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.592 ' OG1' ' HB3' ' A' ' 121' ' ' GLU . 11.6 p -109.33 165.06 11.92 Favored 'General case' 0 C--N 1.287 -2.139 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 178.183 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 173.39 172.58 38.99 Favored Glycine 0 N--CA 1.427 -1.914 0 N-CA-C 111.485 -0.646 . . . . 0.0 111.485 179.68 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 47.4 t-80 -93.2 106.47 18.43 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 178.016 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.52 ' HB3' HD13 ' A' ' 84' ' ' LEU . 2.9 tm? -94.42 136.51 34.63 Favored 'General case' 0 CA--C 1.466 -2.261 0 N-CA-C 106.838 -1.542 . . . . 0.0 106.838 -175.388 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.43 ' N ' HD13 ' A' ' 112' ' ' LEU . 0.3 OUTLIER -142.49 153.01 43.26 Favored 'General case' 0 N--CA 1.383 -3.777 0 N-CA-C 105.275 -2.12 . . . . 0.0 105.275 177.837 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 8.1 mmtt -67.92 101.06 1.04 Allowed 'General case' 0 C--N 1.302 -1.464 0 CA-C-O 121.898 0.856 . . . . 0.0 111.691 -178.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . 0.685 ' O ' ' HB ' ' A' ' 138' ' ' THR . . . 131.0 -54.24 0.79 Allowed Glycine 0 N--CA 1.41 -3.049 0 CA-C-N 114.342 -1.299 . . . . 0.0 109.927 -178.765 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.491 ' HD3' HG23 ' A' ' 118' ' ' THR . 0.0 OUTLIER -136.51 141.93 43.47 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 114.006 1.113 . . . . 0.0 114.006 -176.811 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.68 ' O ' ' HB2' ' A' ' 135' ' ' SER . 58.1 tp -104.82 106.82 17.47 Favored 'General case' 0 C--N 1.311 -1.067 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 177.704 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.491 HG23 ' HD3' ' A' ' 116' ' ' LYS . 42.1 p -106.19 142.93 35.06 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 -175.594 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 28.6 m-20 54.74 98.78 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 125.156 1.382 . . . . 0.0 113.031 177.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 4.3 m -100.58 172.54 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.587 0 CA-C-O 120.983 0.42 . . . . 0.0 110.907 179.529 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.592 ' HB3' ' OG1' ' A' ' 109' ' ' THR . 14.9 tp10 -140.84 82.77 1.86 Allowed 'General case' 0 N--CA 1.416 -2.165 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.382 178.705 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . 0.412 ' HA3' HG23 ' A' ' 108' ' ' VAL . . . 150.96 -19.7 0.97 Allowed Glycine 0 C--N 1.308 -1.012 0 CA-C-N 115.153 -0.931 . . . . 0.0 111.979 177.14 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.683 HG13 HG21 ' A' ' 108' ' ' VAL . 96.1 mt -99.61 100.17 9.93 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.63 0 CA-C-O 121.383 0.611 . . . . 0.0 109.514 -179.087 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.461 ' HA ' ' HA ' ' A' ' 132' ' ' LYS . 39.7 ttmt -86.65 119.19 26.62 Favored 'General case' 0 N--CA 1.428 -1.565 0 N-CA-C 107.613 -1.255 . . . . 0.0 107.613 -179.617 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.601 ' HB ' ' OG1' ' A' ' 134' ' ' THR . 89.9 m -121.33 125.14 46.28 Favored 'General case' 0 C--N 1.268 -2.95 0 CA-C-N 114.477 -1.238 . . . . 0.0 110.962 -172.19 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.612 ' C ' ' HD3' ' A' ' 126' ' ' LYS . 0.2 OUTLIER -117.99 105.78 12.24 Favored 'General case' 0 N--CA 1.412 -2.347 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 173.026 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 33.3 m -107.7 -27.61 2.95 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.102 0 CA-C-O 121.872 0.844 . . . . 0.0 110.08 176.314 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . 0.482 ' C ' HD12 ' A' ' 129' ' ' ILE . 27.3 ttt -158.94 -35.55 0.06 Allowed 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 106.971 -1.492 . . . . 0.0 106.971 -175.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.482 HD12 ' C ' ' A' ' 128' ' ' MET . 2.8 mp -134.94 151.65 31.46 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.72 0 N-CA-C 104.271 -2.492 . . . . 0.0 104.271 171.356 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 16.2 p90 -90.53 116.68 28.62 Favored 'General case' 0 N--CA 1.425 -1.711 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 178.375 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.623 HG12 ' H ' ' A' ' 133' ' ' VAL . 36.0 t -137.69 146.58 27.25 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 -175.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . 0.461 ' HA ' ' HA ' ' A' ' 124' ' ' LYS . 58.9 pttt -103.23 12.0 36.17 Favored 'General case' 0 C--N 1.315 -0.917 0 C-N-CA 120.165 -0.614 . . . . 0.0 111.448 -178.797 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.623 ' H ' HG12 ' A' ' 131' ' ' VAL . 33.5 m -125.55 -1.43 5.14 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.006 0 C-N-CA 120.396 -0.522 . . . . 0.0 111.778 -175.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . 0.601 ' OG1' ' HB ' ' A' ' 125' ' ' THR . 1.3 p -60.35 111.16 1.45 Allowed 'General case' 0 N--CA 1.43 -1.425 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 175.636 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . 0.68 ' HB2' ' O ' ' A' ' 117' ' ' LEU . 23.2 p -106.79 172.2 6.95 Favored 'General case' 0 N--CA 1.41 -2.471 0 N-CA-C 114.93 1.455 . . . . 0.0 114.93 -169.166 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . 0.406 ' HB ' ' CG2' ' A' ' 146' ' ' THR . 12.2 tt -101.16 105.23 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.491 0 CA-C-N 114.81 -1.086 . . . . 0.0 110.869 -173.406 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 45.7 p -91.54 114.36 26.87 Favored 'General case' 0 N--CA 1.414 -2.269 0 CA-C-N 115.157 -0.928 . . . . 0.0 109.685 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . 0.685 ' HB ' ' O ' ' A' ' 115' ' ' GLY . 46.6 m -119.54 153.87 34.74 Favored 'General case' 0 C--N 1.279 -2.476 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 -179.791 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -106.41 35.36 2.98 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 178.326 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . 57.54 34.87 25.15 Favored 'General case' 0 C--N 1.355 0.805 0 CA-C-N 115.046 -0.979 . . . . 0.0 109.065 -177.389 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 47.2 t -173.1 -77.96 0.01 OUTLIER 'General case' 0 C--O 1.211 -0.935 0 CA-C-N 114.731 -1.122 . . . . 0.0 109.683 -174.234 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 81.6 mttt -89.93 150.97 21.94 Favored 'General case' 0 CA--C 1.497 -1.068 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 179.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 13.1 p -118.93 142.91 31.71 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.067 0 CA-C-O 121.416 0.627 . . . . 0.0 111.686 -175.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -121.55 114.9 21.86 Favored 'General case' 0 N--CA 1.423 -1.799 0 N-CA-C 106.163 -1.791 . . . . 0.0 106.163 171.475 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . 0.545 ' HB3' ' HB2' ' A' ' 151' ' ' LYS . 65.0 t80 -53.74 156.2 2.85 Favored 'General case' 0 C--O 1.252 1.223 0 C-N-CA 124.539 1.135 . . . . 0.0 113.094 -171.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.516 ' O ' HG21 ' A' ' 125' ' ' THR . 33.7 p -51.1 93.65 0.01 OUTLIER 'General case' 0 C--N 1.35 0.609 0 C-N-CA 125.181 1.392 . . . . 0.0 113.793 -175.573 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.521 ' HA ' ' HB ' ' A' ' 134' ' ' THR . . . 163.27 -35.71 0.0 OUTLIER 'General case' 0 CA--C 1.497 -1.061 0 C-N-CA 127.171 2.188 . . . . 0.0 106.31 178.676 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 100.63 79.07 1.4 Allowed Glycine 0 N--CA 1.434 -1.493 0 CA-C-N 114.963 -1.017 . . . . 0.0 111.807 179.016 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 16.3 tpt 72.51 -10.24 0.96 Allowed 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 123.877 0.871 . . . . 0.0 112.698 177.155 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -62.38 -30.53 71.27 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 121.062 0.458 . . . . 0.0 110.023 -179.014 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.545 ' HB2' ' HB3' ' A' ' 145' ' ' PHE . 10.0 mmpt? -121.86 118.76 29.75 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 106.521 -1.659 . . . . 0.0 106.521 175.122 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 32.1 p -91.39 111.66 23.24 Favored 'General case' 0 C--N 1.297 -1.708 0 CA-C-O 120.617 0.246 . . . . 0.0 111.174 -177.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 37.6 mmt180 -134.88 137.3 43.09 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 179.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 20.0 m -90.2 132.47 35.47 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 111.504 0.187 . . . . 0.0 111.504 -176.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' ARG . . . . . 0.481 ' HG2' ' HA2' ' A' ' 159' ' ' GLY . 2.0 tmt_? -65.01 -26.5 68.31 Favored 'General case' 0 N--CA 1.483 1.196 0 CA-C-O 121.107 0.479 . . . . 0.0 109.898 177.494 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -38.04 -48.11 1.17 Allowed 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 126.102 1.761 . . . . 0.0 115.576 -175.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -79.33 -54.92 5.47 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 113.899 1.074 . . . . 0.0 113.899 -173.212 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 0.577 ' HB2' ' NE2' ' A' ' 161' ' ' GLN . 98.3 m-85 -153.19 24.5 0.55 Allowed 'General case' 0 N--CA 1.482 1.151 0 O-C-N 122.242 -0.286 . . . . 0.0 110.536 -176.658 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . 0.634 ' HA3' ' O ' ' A' ' 65' ' ' ILE . . . 87.78 -92.41 1.8 Allowed Glycine 0 CA--C 1.475 -2.46 0 C-N-CA 119.672 -1.252 . . . . 0.0 111.618 -177.597 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.566 ' HB ' ' O ' ' A' ' 67' ' ' ILE . 28.6 t -98.58 121.92 49.68 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.191 0 C-N-CA 119.67 -0.812 . . . . 0.0 108.91 -179.797 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' GLN . . . . . 0.577 ' NE2' ' HB2' ' A' ' 158' ' ' TYR . 25.7 mm-40 -103.88 92.95 4.63 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 115.78 1.77 . . . . 0.0 115.78 -175.188 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 17.0 mmm180 -152.66 150.27 29.29 Favored 'General case' 0 CA--C 1.501 -0.93 0 C-N-CA 125.624 1.57 . . . . 0.0 108.754 170.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 19.7 m120 -89.88 97.69 11.33 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-O 120.964 0.412 . . . . 0.0 111.415 -178.491 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -136.57 156.07 22.91 Favored Glycine 0 C--N 1.308 -1.025 0 N-CA-C 110.615 -0.994 . . . . 0.0 110.615 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -135.83 116.63 14.07 Favored 'General case' 0 N--CA 1.425 -1.703 0 CA-C-O 121.38 0.609 . . . . 0.0 109.5 178.355 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . 0.604 ' H ' ' HD2' ' A' ' 166' ' ' ARG . 3.3 mpt_? -81.3 105.83 12.79 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 106.39 -1.707 . . . . 0.0 106.39 178.63 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.4 HG22 ' H ' ' A' ' 167' ' ' VAL . 9.2 m -71.43 77.08 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.925 0 N-CA-C 114.976 1.473 . . . . 0.0 114.976 -174.25 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . 0.637 ' HB2' ' HB2' ' A' ' 90' ' ' SER . 15.4 t70 -144.41 -34.01 0.38 Allowed 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 114.072 -1.422 . . . . 0.0 107.279 177.588 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' LYS . . . . . 0.407 ' H ' ' H ' ' A' ' 168' ' ' ASP . 39.1 ttpt -111.86 157.4 20.66 Favored 'General case' 0 N--CA 1.439 -1.015 0 CA-C-N 114.543 -1.208 . . . . 0.0 108.039 178.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' PHE . . . . . . . . . . . . . 16.0 p90 . . . . . 0 C--N 1.305 -1.366 0 O-C-N 123.248 0.342 . . . . 0.0 111.349 179.405 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 20.4 m . . . . . 0 N--CA 1.44 -0.955 0 N-CA-C 109.022 -0.732 . . . . 0.0 109.022 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 57.74 79.63 0.19 Allowed 'General case' 0 C--O 1.248 1.026 0 C-N-CA 123.396 0.678 . . . . 0.0 111.18 179.357 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 52.9 mt-30 -85.07 106.06 16.27 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-N 115.516 -0.766 . . . . 0.0 111.354 -176.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 7.0 tt -145.14 118.68 2.69 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.816 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.282 178.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 30.8 p90 -147.14 106.35 3.88 Favored 'General case' 0 C--N 1.298 -1.66 0 CA-C-O 121.411 0.624 . . . . 0.0 110.145 -179.063 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 28.3 p-10 -160.73 149.42 16.57 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.325 -178.547 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.13 92.46 2.49 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-O 121.8 0.809 . . . . 0.0 111.575 178.007 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 9.6 p -101.64 145.35 11.77 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 CA-C-N 115.01 -0.995 . . . . 0.0 108.773 178.248 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 95.87 31.66 7.24 Favored Glycine 0 N--CA 1.435 -1.381 0 N-CA-C 110.564 -1.014 . . . . 0.0 110.564 -178.223 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 28.1 t -93.3 101.55 13.8 Favored 'General case' 0 N--CA 1.42 -1.948 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 -179.522 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 90.3 m-85 -106.38 103.06 12.43 Favored 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 109.414 -0.588 . . . . 0.0 109.414 179.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 85.5 t90 -99.66 120.04 39.06 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.468 -178.642 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -160.76 154.75 22.76 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 107.783 -1.192 . . . . 0.0 107.783 177.191 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 159.53 46.63 0.01 OUTLIER Glycine 0 N--CA 1.433 -1.513 0 C-N-CA 119.768 -1.206 . . . . 0.0 112.947 178.335 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -86.73 95.68 9.9 Favored 'General case' 0 C--N 1.312 -1.051 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 177.062 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -119.44 104.2 10.13 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 115.925 -0.579 . . . . 0.0 109.683 -178.26 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -93.16 96.72 10.2 Favored 'General case' 0 C--N 1.296 -1.735 0 CA-C-O 121.11 0.481 . . . . 0.0 109.841 178.125 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -116.09 105.0 12.12 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.147 -179.424 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 37.8 ttpt -119.04 101.76 8.26 Favored 'General case' 0 C--N 1.292 -1.907 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.127 -176.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -136.3 108.78 7.39 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.645 -176.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 48.8 p90 -155.98 148.24 23.53 Favored 'General case' 0 C--N 1.292 -1.91 0 N-CA-C 106.505 -1.665 . . . . 0.0 106.505 175.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -118.74 99.04 6.52 Favored 'General case' 0 C--N 1.292 -1.908 0 C-N-CA 120.125 -0.63 . . . . 0.0 109.705 -177.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 54.3 p -76.79 96.62 4.3 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.572 -178.135 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 12.6 p -151.08 148.98 14.54 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 178.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 130.16 78.13 0.19 Allowed Glycine 0 N--CA 1.435 -1.43 0 N-CA-C 110.86 -0.896 . . . . 0.0 110.86 -179.625 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -112.75 114.68 27.35 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 -178.617 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 31.8 m-20 -85.03 115.86 23.09 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-O 121.23 0.538 . . . . 0.0 110.88 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 89.3 mt -123.91 144.78 49.56 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.44 178.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 32.7 p30 -156.84 155.83 32.16 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.245 177.232 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 21.4 m -114.85 162.72 16.52 Favored 'General case' 0 C--N 1.295 -1.799 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.4 -178.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 58.6 t -88.52 110.49 21.25 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.244 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 -178.411 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 42.1 t -104.52 112.07 24.98 Favored 'General case' 0 C--N 1.311 -1.104 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 177.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 8.7 t -156.95 154.89 30.42 Favored 'General case' 0 N--CA 1.428 -1.571 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 9.5 t -163.32 90.95 0.68 Allowed 'General case' 0 N--CA 1.424 -1.729 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 176.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 62.0 mt -111.77 112.34 40.11 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 177.708 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -146.22 159.71 42.96 Favored 'General case' 0 C--N 1.293 -1.878 0 C-N-CA 120.55 -0.46 . . . . 0.0 110.126 -178.174 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -165.89 -154.28 8.1 Favored Glycine 0 N--CA 1.42 -2.386 0 N-CA-C 110.665 -0.974 . . . . 0.0 110.665 179.43 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -133.32 -174.88 13.71 Favored Glycine 0 N--CA 1.419 -2.445 0 N-CA-C 111.656 -0.578 . . . . 0.0 111.656 -178.339 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 9.3 t -145.05 176.35 9.56 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 59.9 mttp -63.08 119.81 10.22 Favored 'General case' 0 C--N 1.322 -0.59 0 O-C-N 123.424 0.452 . . . . 0.0 110.16 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 57.1 t90 -68.55 -77.89 0.07 Allowed 'General case' 0 C--N 1.306 -1.324 0 CA-C-N 115.204 -0.907 . . . . 0.0 112.396 -176.425 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.4 tt -170.76 34.72 0.02 OUTLIER 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 104.48 -2.415 . . . . 0.0 104.48 -175.138 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 12.6 p -70.02 146.17 12.5 Favored 'Isoleucine or valine' 0 C--O 1.245 0.835 0 CA-C-N 115.072 -0.967 . . . . 0.0 111.46 -173.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 57.8 t30 76.73 11.33 2.59 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 125.079 1.352 . . . . 0.0 110.022 -179.033 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 28.1 mtpp -145.19 128.4 16.72 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.242 -0.89 . . . . 0.0 108.896 -179.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -137.55 163.03 31.79 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.17 0 O-C-N 122.005 -0.434 . . . . 0.0 111.295 178.615 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -139.79 155.36 47.33 Favored 'General case' 0 C--N 1.312 -1.043 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 176.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -178.36 151.61 10.72 Favored Glycine 0 N--CA 1.43 -1.758 0 C-N-CA 119.755 -1.212 . . . . 0.0 112.242 177.713 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 58.9 tptt -104.82 -51.11 3.12 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 106.66 -1.607 . . . . 0.0 106.66 175.069 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 26.3 ttt -146.05 80.4 1.57 Allowed 'General case' 0 N--CA 1.432 -1.372 0 CA-C-N 114.654 -1.157 . . . . 0.0 108.793 177.319 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER 72.53 -46.86 0.66 Allowed 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 124.872 1.269 . . . . 0.0 111.291 179.782 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 25.0 ttmm 75.07 92.24 0.05 OUTLIER Pre-proline 0 C--O 1.219 -0.504 0 C-N-CA 125.117 1.367 . . . . 0.0 108.146 -174.582 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -68.7 3.68 2.15 Favored 'Trans proline' 0 N--CA 1.481 0.776 0 C-N-CA 123.593 2.862 . . . . 0.0 115.506 -170.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 8.4 mp -54.75 -47.05 99.16 Favored Pre-proline 0 CA--C 1.489 -1.383 0 N-CA-C 117.272 2.323 . . . . 0.0 117.272 -177.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.567 ' HA ' ' HG ' ' A' ' 58' ' ' LEU . 13.1 Cg_exo -66.39 -14.51 44.46 Favored 'Trans proline' 0 N--CA 1.416 -3.05 0 CA-C-N 120.183 1.101 . . . . 0.0 111.857 -175.131 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -74.05 -32.19 63.2 Favored 'General case' 0 N--CA 1.426 -1.644 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 -179.532 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.525 ' HA ' ' HG2' ' A' ' 60' ' ' GLU . 3.7 mm? -73.88 -41.73 61.75 Favored 'General case' 0 N--CA 1.423 -1.825 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 175.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.567 ' HG ' ' HA ' ' A' ' 55' ' ' PRO . 52.0 mt -58.2 -48.08 81.43 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.735 -177.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 7.4 mtpm? -70.84 -26.58 63.34 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 115.296 -0.865 . . . . 0.0 112.319 -178.036 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.525 ' HG2' ' HA ' ' A' ' 57' ' ' LEU . 8.6 pt-20 -83.84 -18.49 37.39 Favored 'General case' 0 N--CA 1.444 -0.762 0 C-N-CA 118.957 -1.097 . . . . 0.0 109.854 177.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 61.2 m-85 -89.08 -13.91 37.52 Favored 'General case' 0 C--O 1.24 0.604 0 C-N-CA 119.095 -1.042 . . . . 0.0 112.119 175.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.449 ' HB3' HG23 ' A' ' 73' ' ' THR . 23.5 t70 -91.93 -153.95 0.35 Allowed 'General case' 0 C--O 1.253 1.27 0 N-CA-C 105.782 -1.933 . . . . 0.0 105.782 172.698 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.632 ' HB2' HD12 ' A' ' 65' ' ' ILE . 5.1 mt -95.16 158.17 35.26 Favored Pre-proline 0 C--N 1.298 -1.661 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 -178.057 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -93.86 26.6 0.34 Allowed 'Trans proline' 0 N--CA 1.448 -1.19 0 C-N-CA 122.849 2.366 . . . . 0.0 111.143 -168.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.686 HG12 ' H ' ' A' ' 67' ' ' ILE . 0.2 OUTLIER -95.11 -21.58 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.778 0 CA-C-N 115.331 -0.849 . . . . 0.0 108.966 -177.995 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 67.64 8.92 54.33 Favored Glycine 0 C--N 1.353 1.481 0 CA-C-N 115.501 -0.772 . . . . 0.0 112.195 179.548 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.686 ' H ' HG12 ' A' ' 65' ' ' ILE . 73.0 mt 57.79 -70.78 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.203 -1.344 0 C-N-CA 127.184 2.193 . . . . 0.0 112.613 -173.044 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.551 ' HB3' ' HD3' ' A' ' 69' ' ' PRO . 79.5 t80 176.73 -50.53 0.0 OUTLIER Pre-proline 0 C--N 1.303 -1.449 0 C-N-CA 122.853 0.461 . . . . 0.0 110.392 -174.578 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.551 ' HD3' ' HB3' ' A' ' 68' ' ' PHE . 24.8 Cg_exo -67.58 131.69 25.15 Favored 'Trans proline' 0 N--CA 1.436 -1.876 0 N-CA-C 109.046 -1.175 . . . . 0.0 109.046 174.386 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -73.7 64.58 1.84 Allowed Glycine 0 C--N 1.306 -1.102 0 O-C-N 123.439 0.462 . . . . 0.0 113.045 -177.275 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.496 ' HB3' ' HG3' ' A' ' 89' ' ' PRO . 12.7 t70 177.43 -39.65 0.01 OUTLIER 'General case' 0 C--O 1.21 -0.978 0 N-CA-C 107.737 -1.208 . . . . 0.0 107.737 179.379 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.66 ' O ' ' HB ' ' A' ' 73' ' ' THR . . . -46.48 166.28 0.02 OUTLIER 'General case' 0 N--CA 1.506 2.365 0 C-N-CA 124.273 1.029 . . . . 0.0 112.753 174.624 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.66 ' HB ' ' O ' ' A' ' 72' ' ' ALA 0.254 1.5 m 88.11 26.22 0.03 OUTLIER 'General case' 0 C--N 1.367 1.346 0 CA-C-O 125.071 2.367 . . . . 0.0 109.665 -178.97 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 40.7 m-80 -82.23 163.88 21.57 Favored 'General case' 0 N--CA 1.411 -2.376 0 CA-C-N 113.725 -1.58 . . . . 0.0 111.033 177.404 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.496 ' H ' ' HB3' ' A' ' 58' ' ' LEU . 33.7 t80 -134.52 95.6 3.41 Favored 'General case' 0 C--N 1.274 -2.702 0 CA-C-N 115.151 -0.932 . . . . 0.0 111.923 -168.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.498 ' O ' HD22 ' A' ' 84' ' ' LEU . 41.0 mm-40 -115.89 153.46 31.5 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 173.667 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 69.0 t80 -146.08 114.47 6.71 Favored 'General case' 0 C--N 1.29 -1.98 0 O-C-N 122.046 -0.409 . . . . 0.0 110.04 -177.023 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.658 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 31.7 m-20 -88.67 148.95 23.75 Favored 'General case' 0 CA--C 1.459 -2.535 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 175.622 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -82.37 -41.18 20.31 Favored 'General case' 1 C--N 1.24 -4.172 0 CA-C-N 114.796 -1.093 . . . . 0.0 111.916 179.307 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.401 ' HG3' ' N ' ' A' ' 81' ' ' THR . 8.7 pt-20 -61.84 -41.7 98.14 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-O 122.236 1.017 . . . . 0.0 109.332 178.331 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.658 ' HB ' ' HB2' ' A' ' 78' ' ' ASP . 46.2 m -70.76 -51.31 27.9 Favored 'General case' 0 N--CA 1.412 -2.374 0 CA-C-N 113.799 -1.546 . . . . 0.0 108.045 177.14 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 80.0 tttt 68.2 9.01 6.95 Favored 'General case' 0 C--N 1.348 0.533 0 C-N-CA 126.144 1.778 . . . . 0.0 110.398 178.563 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.792 ' HG2' HG22 ' A' ' 109' ' ' THR . 75.5 tttt -117.7 133.86 55.51 Favored 'General case' 0 N--CA 1.409 -2.505 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 179.363 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.498 HD22 ' O ' ' A' ' 76' ' ' GLU . 2.7 tm? -64.44 133.76 53.15 Favored 'General case' 0 C--N 1.317 -0.841 0 C-N-CA 123.101 0.561 . . . . 0.0 110.149 -172.554 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.509 ' HB ' HG23 ' A' ' 109' ' ' THR . 6.0 t -117.1 111.44 19.51 Favored 'General case' 0 N--CA 1.412 -2.372 0 CA-C-O 122.128 0.966 . . . . 0.0 111.577 -177.593 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 58.0 t -92.87 126.01 45.37 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.272 0 CA-C-N 114.89 -1.05 . . . . 0.0 108.433 177.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.51 ' HA ' ' O ' ' A' ' 106' ' ' THR . 1.9 pp -105.02 124.4 49.46 Favored 'General case' 0 N--CA 1.408 -2.572 0 CA-C-N 115.242 -0.89 . . . . 0.0 112.16 178.276 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 3.0 mp -110.06 125.04 31.93 Favored Pre-proline 0 C--N 1.293 -1.855 0 CA-C-N 114.063 -1.426 . . . . 0.0 109.089 178.453 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.496 ' HG3' ' HB3' ' A' ' 71' ' ' ASP . 2.6 Cg_endo -52.23 98.59 0.04 OUTLIER 'Trans proline' 0 C--N 1.363 1.306 0 C-N-CA 123.395 2.73 . . . . 0.0 112.206 173.216 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.612 ' HB2' ' HB2' ' A' ' 168' ' ' ASP . 43.3 t 74.03 141.56 0.07 Allowed 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 124.326 1.05 . . . . 0.0 112.512 -179.534 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.532 HD11 ' HG3' ' A' ' 103' ' ' LYS . 0.0 OUTLIER -76.49 108.37 9.08 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.132 0 CA-C-N 114.999 -1.0 . . . . 0.0 109.005 176.644 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 25.1 p -91.83 127.22 37.21 Favored 'General case' 0 N--CA 1.431 -1.419 0 CA-C-N 114.838 -1.074 . . . . 0.0 110.56 -179.756 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -107.8 159.59 16.38 Favored 'General case' 0 C--O 1.244 0.766 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.25 -179.374 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.574 ' O ' ' HA ' ' A' ' 101' ' ' VAL . 2.6 p -156.95 109.01 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.141 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 -178.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.552 ' HA2' ' O ' ' A' ' 100' ' ' SER . . . -145.94 170.89 27.04 Favored Glycine 0 N--CA 1.423 -2.233 0 C-N-CA 119.022 -1.561 . . . . 0.0 114.239 -178.114 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 87.6 m-85 -127.22 -157.1 0.79 Allowed 'General case' 0 N--CA 1.404 -2.741 0 N-CA-C 102.776 -3.046 . . . . 0.0 102.776 170.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.15 -11.72 61.05 Favored 'General case' 0 C--N 1.293 -1.861 0 C-N-CA 118.675 -1.21 . . . . 0.0 111.158 175.414 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 25.9 t70 177.93 -53.93 0.01 OUTLIER 'General case' 0 C--N 1.382 1.998 0 N-CA-C 114.33 1.233 . . . . 0.0 114.33 177.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 49.9 m -44.98 -28.52 0.69 Allowed 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 115.201 1.556 . . . . 0.0 115.201 -168.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . 0.552 ' O ' ' HA2' ' A' ' 95' ' ' GLY . 54.3 m -152.77 83.53 1.22 Allowed 'General case' 0 C--N 1.287 -2.143 0 C-N-CA 120.952 -0.299 . . . . 0.0 110.945 177.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.574 ' HA ' ' O ' ' A' ' 94' ' ' VAL . 11.3 p -117.27 132.97 65.49 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.507 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 171.771 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.41 ' HG ' ' HA ' ' A' ' 125' ' ' THR . 6.8 tt -152.78 145.41 24.24 Favored 'General case' 0 N--CA 1.405 -2.702 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 -175.642 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.532 ' HG3' HD11 ' A' ' 91' ' ' ILE . 39.8 ttmt -129.99 121.1 25.87 Favored 'General case' 0 C--N 1.291 -1.965 0 N-CA-C 111.937 0.347 . . . . 0.0 111.937 -177.331 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -95.36 103.6 15.47 Favored 'General case' 0 N--CA 1.439 -1.008 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 175.293 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 41.1 m -70.82 149.74 46.53 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 109.889 -0.411 . . . . 0.0 109.889 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.51 ' O ' ' HA ' ' A' ' 87' ' ' LEU . 37.8 p -54.07 -53.75 48.88 Favored 'General case' 0 C--O 1.216 -0.691 0 CA-C-O 121.666 0.746 . . . . 0.0 110.985 -178.26 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 7.5 m -113.73 93.54 4.43 Favored 'General case' 0 N--CA 1.399 -2.994 0 CA-C-N 115.056 -0.974 . . . . 0.0 109.619 -176.408 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.471 HG11 ' CD1' ' A' ' 123' ' ' ILE . 15.1 m -99.46 155.59 4.03 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.546 177.531 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.792 HG22 ' HG2' ' A' ' 83' ' ' LYS . 0.4 OUTLIER -137.24 128.73 28.35 Favored 'General case' 0 N--CA 1.398 -3.072 0 N-CA-C 106.05 -1.833 . . . . 0.0 106.05 -173.831 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.453 ' HA2' ' O ' ' A' ' 119' ' ' ASP . . . -151.12 -174.57 22.15 Favored Glycine 0 C--N 1.286 -2.208 0 C-N-CA 119.979 -1.105 . . . . 0.0 113.714 -175.706 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . 0.463 ' O ' HD12 ' A' ' 117' ' ' LEU . 45.0 t60 -91.33 117.93 30.08 Favored 'General case' 0 C--N 1.294 -1.821 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 179.727 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -99.92 117.91 35.22 Favored 'General case' 0 CA--C 1.479 -1.752 0 CA-C-O 121.014 0.435 . . . . 0.0 110.879 -171.132 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -126.74 138.34 53.37 Favored 'General case' 0 CA--C 1.45 -2.881 0 CA-C-N 115.094 -0.957 . . . . 0.0 108.894 167.04 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 6.0 tmtt? -73.47 100.88 3.36 Favored 'General case' 0 N--CA 1.389 -3.482 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 -175.482 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . 0.543 ' O ' HG23 ' A' ' 138' ' ' THR . . . 135.78 -37.63 1.88 Allowed Glycine 0 N--CA 1.419 -2.461 0 N-CA-C 110.169 -1.172 . . . . 0.0 110.169 -176.203 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.559 ' O ' ' HD2' ' A' ' 116' ' ' LYS . 0.0 OUTLIER -154.06 136.96 15.39 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.27 0.628 . . . . 0.0 111.984 -179.441 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.463 HD12 ' O ' ' A' ' 111' ' ' HIS . 64.1 tp -111.43 107.05 16.14 Favored 'General case' 0 C--N 1.308 -1.2 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 -177.274 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 68.1 p -105.56 176.11 5.27 Favored 'General case' 0 C--N 1.296 -1.735 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.637 -179.023 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . 0.453 ' O ' ' HA2' ' A' ' 110' ' ' GLY . 16.2 m-20 56.59 48.66 16.1 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.259 0.623 . . . . 0.0 111.722 172.61 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.454 HG23 ' O ' ' A' ' 133' ' ' VAL . 3.3 m -81.93 96.18 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.656 0 CA-C-O 122.662 1.22 . . . . 0.0 112.29 -176.253 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -75.94 94.12 3.34 Favored 'General case' 0 N--CA 1.401 -2.886 0 CA-C-N 113.253 -1.794 . . . . 0.0 108.438 -178.56 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 134.7 -4.85 4.39 Favored Glycine 0 C--N 1.285 -2.299 0 CA-C-N 115.063 -0.971 . . . . 0.0 111.816 177.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.471 ' CD1' HG11 ' A' ' 108' ' ' VAL . 48.9 mm -99.91 99.58 8.78 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.229 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 177.039 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 53.4 mtmt -93.44 119.26 32.32 Favored 'General case' 0 N--CA 1.411 -2.382 0 CA-C-N 114.355 -1.293 . . . . 0.0 108.605 -179.092 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.41 ' HA ' ' HG ' ' A' ' 102' ' ' LEU . 99.1 m -128.1 131.87 49.01 Favored 'General case' 0 N--CA 1.422 -1.852 0 CA-C-N 114.771 -1.104 . . . . 0.0 112.918 -167.782 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.619 ' C ' ' HD3' ' A' ' 126' ' ' LYS . 0.2 OUTLIER -123.05 119.71 31.16 Favored 'General case' 0 N--CA 1.418 -2.068 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 170.825 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.441 HG23 ' H ' ' A' ' 128' ' ' MET . 4.8 m -139.17 -56.57 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.031 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.388 176.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . 0.441 ' H ' HG23 ' A' ' 127' ' ' VAL . 26.8 ttt -99.57 -34.96 10.02 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 178.168 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.565 ' CD1' ' H ' ' A' ' 130' ' ' TRP . 0.3 OUTLIER -162.57 -177.71 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.418 -2.074 0 N-CA-C 103.499 -2.778 . . . . 0.0 103.499 176.615 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' TRP . . . . . 0.565 ' H ' ' CD1' ' A' ' 129' ' ' ILE . 88.4 t90 -92.29 123.76 35.85 Favored 'General case' 0 C--N 1.296 -1.733 0 CA-C-N 119.55 1.068 . . . . 0.0 109.797 -179.658 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.626 HG12 ' H ' ' A' ' 133' ' ' VAL . 61.1 t -131.55 136.69 56.85 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.08 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 179.631 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . 0.617 ' HD3' ' H ' ' A' ' 132' ' ' LYS . 0.0 OUTLIER -98.89 21.77 11.11 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-O 121.019 0.437 . . . . 0.0 111.237 -178.056 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.626 ' H ' HG12 ' A' ' 131' ' ' VAL . 51.5 t -132.05 -78.73 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.251 0 CA-C-N 116.214 -0.448 . . . . 0.0 109.959 -175.689 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 40.0 p 51.86 -167.01 0.05 OUTLIER 'General case' 0 CA--C 1.555 1.155 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 -177.068 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 27.6 p -164.04 150.39 11.33 Favored 'General case' 0 N--CA 1.429 -1.52 0 C-N-CA 122.637 0.375 . . . . 0.0 110.146 -179.43 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 7.5 tt -105.7 97.41 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.884 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 173.502 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 60.6 p -97.58 142.63 29.16 Favored 'General case' 0 N--CA 1.405 -2.686 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.997 -177.011 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . 0.543 HG23 ' O ' ' A' ' 115' ' ' GLY . 5.8 t -165.08 175.07 9.72 Favored 'General case' 0 N--CA 1.399 -2.988 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 -177.794 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -110.71 28.52 8.61 Favored 'General case' 0 C--N 1.285 -2.23 0 N-CA-C 106.306 -1.739 . . . . 0.0 106.306 176.669 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . 61.46 44.06 9.72 Favored 'General case' 0 C--N 1.348 0.529 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 -171.115 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 30.8 t -174.96 -80.29 0.01 OUTLIER 'General case' 0 CA--C 1.555 1.149 0 CA-C-N 114.783 -1.099 . . . . 0.0 110.973 -171.52 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -83.96 128.6 34.66 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 179.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.421 HG11 HG12 ' A' ' 160' ' ' VAL . 88.8 t -105.49 127.83 60.01 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.973 0 CA-C-O 121.516 0.674 . . . . 0.0 112.093 -171.001 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 26.7 m-85 -118.41 141.25 48.74 Favored 'General case' 0 N--CA 1.426 -1.64 0 CA-C-N 115.318 -0.855 . . . . 0.0 111.138 179.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . 0.433 ' HB2' ' H ' ' A' ' 151' ' ' LYS . 42.9 m-85 -93.21 98.75 11.48 Favored 'General case' 0 N--CA 1.408 -2.525 0 CA-C-N 114.382 -1.281 . . . . 0.0 108.371 171.377 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . 0.259 2.5 p -98.42 99.71 10.91 Favored 'General case' 0 N--CA 1.406 -2.639 0 N-CA-C 115.061 1.504 . . . . 0.0 115.061 -176.221 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -130.35 29.62 4.84 Favored 'General case' 0 C--N 1.312 -1.031 0 N-CA-C 105.445 -2.057 . . . . 0.0 105.445 174.524 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 133.99 -69.33 0.53 Allowed Glycine 0 N--CA 1.413 -2.847 0 N-CA-C 104.016 -3.633 . . . . 0.0 104.016 -171.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 27.7 ttt 173.3 82.86 0.0 OUTLIER 'General case' 0 C--N 1.314 -0.971 0 C-N-CA 125.885 1.674 . . . . 0.0 108.147 169.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . 0.404 ' HG3' ' CG2' ' A' ' 127' ' ' VAL . 29.4 mmtt -88.84 -88.74 0.15 Allowed 'General case' 0 C--N 1.308 -1.196 0 N-CA-C 115.09 1.515 . . . . 0.0 115.09 -179.513 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.433 ' H ' ' HB2' ' A' ' 145' ' ' PHE . 98.7 mttt -110.26 149.1 30.65 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 113.354 0.872 . . . . 0.0 113.354 -172.469 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 20.3 m -132.64 137.77 47.12 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.818 -176.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.28 162.84 40.78 Favored 'General case' 0 CA--C 1.477 -1.849 0 CA-C-O 121.317 0.58 . . . . 0.0 111.661 175.129 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 46.4 m -90.18 139.85 30.24 Favored 'General case' 0 C--N 1.274 -2.689 0 CA-C-N 115.284 -0.871 . . . . 0.0 108.858 179.12 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . 0.407 0.0 OUTLIER -58.68 -18.54 31.81 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 114.28 1.215 . . . . 0.0 114.28 -179.783 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -50.06 -32.4 15.46 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 124.632 1.173 . . . . 0.0 111.489 178.494 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -68.04 -54.05 21.26 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 116.576 -0.283 . . . . 0.0 110.827 179.708 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 1.1 t80 177.95 21.6 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.0 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 177.205 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . 0.4 ' HA2' ' HB ' ' A' ' 65' ' ' ILE . . . 88.71 -99.41 2.54 Favored Glycine 0 N--CA 1.419 -2.472 0 C-N-CA 119.779 -1.201 . . . . 0.0 111.098 -174.08 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.566 HG22 ' O ' ' A' ' 67' ' ' ILE . 4.2 m -103.09 128.79 55.74 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.304 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 49.9 mt-30 -94.02 92.13 7.19 Favored 'General case' 0 C--N 1.294 -1.824 0 C-N-CA 119.176 -1.01 . . . . 0.0 111.151 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . 0.522 ' CG ' HG11 ' A' ' 94' ' ' VAL . 21.0 tpp180 -152.49 112.2 3.95 Favored 'General case' 0 N--CA 1.414 -2.228 0 N-CA-C 106.857 -1.534 . . . . 0.0 106.857 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 83.7 m-20 -77.05 105.97 8.46 Favored 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 -174.402 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -118.76 -178.22 16.81 Favored Glycine 0 C--N 1.3 -1.434 0 N-CA-C 110.18 -1.168 . . . . 0.0 110.18 176.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.526 ' O ' HD22 ' A' ' 165' ' ' LEU . 0.0 OUTLIER -141.55 131.74 24.89 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 177.431 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . 0.483 ' HD3' ' HB3' ' A' ' 69' ' ' PRO . 9.5 mtm180 -96.05 111.1 23.21 Favored 'General case' 0 CA--C 1.482 -1.667 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 -179.788 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.414 HG13 HD23 ' A' ' 165' ' ' LEU 0.287 2.6 m -80.84 65.92 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.103 0 CA-C-O 122.906 1.336 . . . . 0.0 111.181 173.32 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . 0.612 ' HB2' ' HB2' ' A' ' 90' ' ' SER . 21.7 t70 -160.87 -27.49 0.06 Allowed 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 112.33 -2.214 . . . . 0.0 108.426 -177.293 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' LYS . . . . . 0.412 ' H ' ' H ' ' A' ' 168' ' ' ASP . 21.6 pttp -74.85 149.51 39.54 Favored 'General case' 0 C--O 1.244 0.796 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.863 -173.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' PHE . . . . . . . . . . . . . 16.9 p90 . . . . . 0 C--N 1.297 -1.698 0 CA-C-O 118.189 -0.91 . . . . 0.0 110.039 -179.785 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 39.5 t . . . . . 0 N--CA 1.452 -0.344 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -88.96 101.24 13.88 Favored 'General case' 0 CA--C 1.495 -1.157 0 CA-C-O 120.807 0.337 . . . . 0.0 110.11 179.668 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 29.2 tt0 -155.52 85.86 1.06 Allowed 'General case' 0 N--CA 1.422 -1.828 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 177.053 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 7.1 tp -151.42 87.83 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 CA-C-O 122.414 1.102 . . . . 0.0 109.505 177.716 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 86.0 m-85 -112.65 126.5 55.44 Favored 'General case' 0 C--N 1.293 -1.889 0 CA-C-N 114.971 -1.013 . . . . 0.0 109.604 -177.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 43.8 t30 -77.39 92.72 3.98 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 177.493 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 35.1 mmtp -95.18 107.79 19.89 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.433 -179.467 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 6.0 p -80.94 118.6 29.0 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.244 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.685 177.665 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -91.69 150.97 20.62 Favored Glycine 0 N--CA 1.427 -1.913 0 N-CA-C 110.918 -0.873 . . . . 0.0 110.918 179.285 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 19.9 m -66.95 131.76 46.55 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 179.505 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 42.5 p90 -100.5 102.19 13.31 Favored 'General case' 0 N--CA 1.433 -1.288 0 CA-C-O 121.674 0.75 . . . . 0.0 110.868 179.028 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 14.8 m-90 -83.3 146.23 28.64 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 178.39 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -137.62 146.32 43.8 Favored 'General case' 0 C--N 1.302 -1.458 0 C-N-CA 120.396 -0.522 . . . . 0.0 111.597 -175.184 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -88.76 67.19 3.02 Favored Glycine 0 N--CA 1.433 -1.549 0 N-CA-C 110.746 -0.942 . . . . 0.0 110.746 178.256 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -82.89 166.84 18.59 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-O 120.759 0.314 . . . . 0.0 111.499 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 61.3 mttp 63.66 64.48 0.79 Allowed 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.37 -177.143 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -95.89 91.22 5.92 Favored 'General case' 0 N--CA 1.418 -2.048 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 175.276 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -92.76 139.5 30.49 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.155 -177.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.476 ' N ' ' HD3' ' A' ' 19' ' ' LYS . 0.1 OUTLIER -139.08 154.56 48.19 Favored 'General case' 0 C--N 1.29 -2.009 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 -177.151 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -144.12 100.24 3.52 Favored 'General case' 0 C--N 1.287 -2.133 0 N-CA-C 106.026 -1.842 . . . . 0.0 106.026 176.169 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 47.0 p90 -70.0 138.6 52.36 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-O 121.22 0.533 . . . . 0.0 111.939 -174.491 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -82.05 144.2 30.99 Favored 'General case' 0 C--N 1.291 -1.961 0 CA-C-N 115.397 -0.819 . . . . 0.0 108.854 178.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 33.1 m -128.2 101.78 6.41 Favored 'General case' 0 C--N 1.281 -2.382 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 179.771 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 41.9 t -101.13 154.02 4.76 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 -179.476 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -75.0 61.18 2.6 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 121.683 -0.294 . . . . 0.0 112.577 -179.436 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 -98.28 77.13 2.36 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-O 121.125 0.488 . . . . 0.0 109.81 -179.472 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.406 ' CG ' ' H ' ' A' ' 28' ' ' LEU . 21.6 t70 -172.67 -168.2 0.49 Allowed 'General case' 0 C--N 1.31 -1.149 0 N-CA-C 105.856 -1.905 . . . . 0.0 105.856 -179.209 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.406 ' H ' ' CG ' ' A' ' 27' ' ' ASP . 54.7 tp 62.77 82.7 0.17 Allowed 'General case' 0 C--O 1.237 0.398 0 CA-C-O 121.885 0.85 . . . . 0.0 109.907 -176.509 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -121.48 -173.75 2.7 Favored 'General case' 0 C--N 1.294 -1.817 0 CA-C-N 115.099 -0.955 . . . . 0.0 110.264 -176.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 20.3 m -92.42 125.88 37.27 Favored 'General case' 0 C--N 1.299 -1.627 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.031 179.132 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 64.5 t -79.78 100.68 4.42 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 174.639 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 48.2 p -79.72 -25.65 41.08 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.658 -174.731 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 11.7 t -159.91 144.93 15.12 Favored 'General case' 0 N--CA 1.424 -1.754 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 179.528 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 20.4 m -112.54 111.28 21.99 Favored 'General case' 0 C--N 1.294 -1.832 0 N-CA-C 106.574 -1.639 . . . . 0.0 106.574 175.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 63.0 mt -76.04 108.75 8.85 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 CA-C-O 120.949 0.404 . . . . 0.0 111.355 -174.013 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -113.18 163.74 14.39 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.548 179.063 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 149.94 -176.39 28.62 Favored Glycine 0 N--CA 1.427 -1.963 0 N-CA-C 109.102 -1.599 . . . . 0.0 109.102 -178.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 167.02 -130.83 2.2 Favored Glycine 0 N--CA 1.426 -2.028 0 C-N-CA 119.357 -1.402 . . . . 0.0 112.889 179.034 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 48.1 m 67.19 87.51 0.12 Allowed 'General case' 0 C--N 1.312 -1.026 0 C-N-CA 123.91 0.884 . . . . 0.0 110.029 -175.144 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 18.1 ptpt -90.36 125.75 35.64 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 115.096 -0.956 . . . . 0.0 109.55 178.36 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 25.2 m-90 -85.8 99.22 11.21 Favored 'General case' 0 C--N 1.304 -1.406 0 CA-C-O 122.011 0.91 . . . . 0.0 112.093 -177.254 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 80.3 mt -100.85 -166.53 1.32 Allowed 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 114.581 -1.19 . . . . 0.0 108.205 178.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 70.2 t 73.19 93.81 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.244 0.77 0 CA-C-O 121.542 0.687 . . . . 0.0 109.411 -178.646 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 51.5 t-20 -140.52 124.81 17.66 Favored 'General case' 0 C--N 1.308 -1.239 0 CA-C-N 115.423 -0.808 . . . . 0.0 108.978 -175.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 64.2 mttp -123.74 -178.6 4.09 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-O 120.77 0.319 . . . . 0.0 111.723 179.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.445 HD11 ' OE1' ' A' ' 60' ' ' GLU . 62.0 mt 75.88 122.95 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 C-N-CA 125.482 1.513 . . . . 0.0 111.216 179.626 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 4.0 mptp? -86.14 -60.54 1.98 Allowed 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 108.542 -0.911 . . . . 0.0 108.542 174.646 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 116.94 144.66 7.94 Favored Glycine 0 N--CA 1.428 -1.891 0 C-N-CA 120.349 -0.929 . . . . 0.0 111.206 -179.553 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.459 ' HB3' ' HG2' ' A' ' 51' ' ' GLN . 1.0 OUTLIER -112.02 138.33 48.81 Favored 'General case' 0 C--N 1.298 -1.643 0 C-N-CA 122.514 0.326 . . . . 0.0 110.185 179.986 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 27.0 ptt? -90.19 -0.89 57.83 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-O 121.4 0.619 . . . . 0.0 110.363 -178.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.459 ' HG2' ' HB3' ' A' ' 49' ' ' LYS . 13.5 pt20 -97.43 34.22 1.85 Allowed 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 175.754 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 97.1 mttt 84.79 134.6 0.04 OUTLIER Pre-proline 0 N--CA 1.468 0.436 0 C-N-CA 126.133 1.773 . . . . 0.0 109.744 -172.383 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -78.66 4.55 6.31 Favored 'Trans proline' 0 CA--C 1.511 -0.651 0 C-N-CA 122.571 2.181 . . . . 0.0 112.898 -178.553 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 9.3 mp -53.54 -51.92 71.62 Favored Pre-proline 0 CA--C 1.476 -1.892 0 N-CA-C 116.92 2.193 . . . . 0.0 116.92 -176.371 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.553 ' O ' ' HG2' ' A' ' 59' ' ' LYS . 25.8 Cg_exo -60.71 -15.53 37.95 Favored 'Trans proline' 0 N--CA 1.45 -1.079 0 C-N-CA 121.613 1.542 . . . . 0.0 111.92 -171.643 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.478 ' O ' ' HB2' ' A' ' 60' ' ' GLU . 22.6 mm-40 -80.27 -37.09 33.55 Favored 'General case' 0 N--CA 1.419 -1.989 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 179.553 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.507 ' HA ' ' HB3' ' A' ' 60' ' ' GLU . 9.3 mp -75.63 -34.27 60.53 Favored 'General case' 0 N--CA 1.438 -1.074 0 N-CA-C 113.557 0.947 . . . . 0.0 113.557 -177.412 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.421 HD12 ' N ' ' A' ' 58' ' ' LEU . 3.5 mp -63.14 -45.74 90.5 Favored 'General case' 0 N--CA 1.499 2.025 0 C-N-CA 119.29 -0.964 . . . . 0.0 109.365 -178.618 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.553 ' HG2' ' O ' ' A' ' 55' ' ' PRO . 0.0 OUTLIER -75.77 -25.85 56.82 Favored 'General case' 0 C--N 1.297 -1.689 0 CA-C-N 114.833 -1.076 . . . . 0.0 112.33 176.395 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.507 ' HB3' ' HA ' ' A' ' 57' ' ' LEU . 9.3 tp10 -63.18 -54.47 37.01 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 179.46 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 86.8 m-85 -74.23 3.89 6.54 Favored 'General case' 0 CA--C 1.511 -0.53 0 CA-C-O 121.839 0.828 . . . . 0.0 111.688 -178.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.548 ' HB3' ' O ' ' A' ' 59' ' ' LYS . 9.2 t70 -88.85 -177.03 5.41 Favored 'General case' 0 C--N 1.276 -2.626 0 CA-C-N 113.998 -1.455 . . . . 0.0 109.659 178.651 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.739 ' HB2' HD12 ' A' ' 65' ' ' ILE . 3.0 mt -80.2 -168.35 0.17 Allowed Pre-proline 0 CA--C 1.582 2.2 0 N-CA-C 106.215 -1.772 . . . . 0.0 106.215 178.454 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.651 ' HG3' ' N ' ' A' ' 141' ' ' SER . 41.8 Cg_endo -94.26 6.62 2.5 Favored 'Trans proline' 0 N--CA 1.442 -1.505 0 CA-C-N 121.991 1.747 . . . . 0.0 111.539 -176.836 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.739 HD12 ' HB2' ' A' ' 63' ' ' LEU . 0.1 OUTLIER -69.45 -46.65 75.78 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.874 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 179.801 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.507 ' H ' HD13 ' A' ' 65' ' ' ILE . . . 57.06 9.55 4.14 Favored Glycine 0 N--CA 1.482 1.735 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.57 -174.286 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.702 ' H ' HG12 ' A' ' 65' ' ' ILE . 68.3 mt 58.11 -70.66 0.07 OUTLIER 'Isoleucine or valine' 0 C--O 1.189 -2.129 0 C-N-CA 128.135 2.574 . . . . 0.0 111.405 -171.25 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.464 ' HB3' ' HD3' ' A' ' 69' ' ' PRO . 77.4 t80 -177.7 -55.83 0.0 OUTLIER Pre-proline 0 C--N 1.306 -1.289 0 CA-C-N 117.805 0.275 . . . . 0.0 111.146 -175.476 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.464 ' HD3' ' HB3' ' A' ' 68' ' ' PHE . 8.5 Cg_endo -96.91 -172.2 0.18 Allowed 'Trans proline' 0 N--CA 1.442 -1.558 0 C-N-CA 122.508 2.139 . . . . 0.0 112.187 -175.683 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -104.17 12.72 52.16 Favored Glycine 0 N--CA 1.436 -1.316 0 N-CA-C 110.62 -0.992 . . . . 0.0 110.62 175.294 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.425 ' H ' ' HB2' ' A' ' 69' ' ' PRO . 1.8 p30 -101.19 -56.68 2.25 Favored 'General case' 0 N--CA 1.419 -2.012 0 CA-C-N 115.422 -0.389 . . . . 0.0 110.421 179.678 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.41 ' O ' ' HB ' ' A' ' 73' ' ' THR . . . -67.37 167.46 12.48 Favored 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 123.379 0.672 . . . . 0.0 111.209 172.366 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.591 ' O ' HG22 ' A' ' 73' ' ' THR . 96.7 m 87.88 27.97 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.813 0 CA-C-O 124.518 2.104 . . . . 0.0 111.128 175.366 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.593 ' O ' ' HA ' ' A' ' 86' ' ' VAL . 0.8 OUTLIER -76.0 145.65 40.11 Favored 'General case' 0 C--N 1.267 -3.017 0 CA-C-N 114.575 -1.193 . . . . 0.0 109.456 174.721 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 42.6 t80 -121.25 98.57 6.04 Favored 'General case' 0 C--N 1.282 -2.341 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.633 -169.206 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 32.8 mm-40 -128.12 115.63 18.71 Favored 'General case' 0 C--O 1.212 -0.878 0 C-N-CA 123.35 0.66 . . . . 0.0 110.151 178.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.403 ' HA ' ' HA ' ' A' ' 84' ' ' LEU . 36.1 p90 -123.04 143.17 50.13 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 -178.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.61 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 10.5 m-20 -96.27 169.36 9.99 Favored 'General case' 0 CA--C 1.487 -1.452 0 C-N-CA 118.876 -1.13 . . . . 0.0 108.955 178.604 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -79.75 -64.01 1.28 Allowed 'General case' 0 C--N 1.279 -2.477 0 CA-C-N 114.644 -1.162 . . . . 0.0 111.396 -176.543 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -68.21 -45.5 73.17 Favored 'General case' 0 CA--C 1.498 -1.054 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.575 -177.104 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.61 ' HB ' ' HB2' ' A' ' 78' ' ' ASP . 10.5 m -57.68 -49.45 76.45 Favored 'General case' 0 N--CA 1.419 -2.021 0 CA-C-N 114.232 -1.349 . . . . 0.0 111.823 -176.58 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.414 ' HD3' ' HA ' ' A' ' 82' ' ' LYS . 74.2 mmtt 65.35 16.19 10.4 Favored 'General case' 0 N--CA 1.488 1.453 0 CA-C-O 121.916 0.865 . . . . 0.0 111.493 -176.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.597 ' HB3' HG22 ' A' ' 81' ' ' THR . 39.4 ttpt -115.18 131.08 57.04 Favored 'General case' 0 N--CA 1.42 -1.953 0 N-CA-C 106.299 -1.741 . . . . 0.0 106.299 177.607 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.552 ' O ' ' HA ' ' A' ' 109' ' ' THR . 7.0 tt -103.59 142.79 33.69 Favored 'General case' 0 C--N 1.284 -2.25 0 O-C-N 123.68 0.612 . . . . 0.0 109.901 -175.657 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.446 ' HA ' ' O ' ' A' ' 108' ' ' VAL . 9.3 t -113.42 121.3 43.92 Favored 'General case' 0 N--CA 1.406 -2.661 0 CA-C-O 121.879 0.847 . . . . 0.0 110.429 178.803 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.593 ' HA ' ' O ' ' A' ' 74' ' ' ASN . 86.7 t -93.34 118.99 40.36 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.746 0 CA-C-N 114.905 -1.043 . . . . 0.0 108.438 174.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 5.4 mp -80.95 116.2 20.8 Favored 'General case' 0 C--O 1.249 1.056 0 O-C-N 123.711 0.632 . . . . 0.0 110.389 -179.094 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.58 ' O ' ' HA ' ' A' ' 106' ' ' THR . 42.1 mm -108.12 128.4 25.8 Favored Pre-proline 0 C--N 1.285 -2.201 0 N-CA-C 106.593 -1.632 . . . . 0.0 106.593 176.614 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -58.84 111.74 0.98 Allowed 'Trans proline' 0 N--CA 1.45 -1.083 0 C-N-CA 122.062 1.841 . . . . 0.0 111.351 176.531 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 22.7 t 67.42 -169.01 0.2 Allowed 'General case' 0 N--CA 1.443 -0.812 0 O-C-N 124.117 0.886 . . . . 0.0 110.847 178.01 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.489 HD11 ' HD2' ' A' ' 103' ' ' LYS . 10.3 tt -112.2 109.4 28.4 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.278 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 176.481 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' CYS . . . . . 0.639 ' SG ' ' HB2' ' A' ' 104' ' ' PHE . 16.1 p -108.89 124.84 51.28 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-N 115.723 -0.672 . . . . 0.0 112.55 -174.057 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.445 ' OE2' HG12 ' A' ' 91' ' ' ILE . 4.9 mp0 -107.27 156.94 18.32 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 174.194 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 3.4 p -128.76 111.9 24.62 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.756 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 173.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -103.42 154.7 18.0 Favored Glycine 0 N--CA 1.435 -1.417 0 N-CA-C 110.448 -1.061 . . . . 0.0 110.448 -179.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 44.9 t80 -159.16 -172.47 3.78 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 105.579 -2.008 . . . . 0.0 105.579 -174.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.406 ' O ' ' HB3' ' A' ' 98' ' ' ASP . 10.9 ptmt -64.1 -13.19 45.89 Favored 'General case' 0 N--CA 1.483 1.208 0 CA-C-N 119.108 0.867 . . . . 0.0 109.266 175.473 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.406 ' HB3' ' O ' ' A' ' 97' ' ' LYS 0.294 25.6 t70 92.11 100.03 0.02 OUTLIER 'General case' 0 N--CA 1.427 -1.59 0 C-N-CA 126.487 1.915 . . . . 0.0 113.724 -179.421 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 20.3 m -149.77 -39.79 0.14 Allowed 'General case' 0 C--N 1.286 -2.18 0 N-CA-C 104.761 -2.311 . . . . 0.0 104.761 177.117 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 47.4 t -146.02 104.28 3.82 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-N 113.765 -1.561 . . . . 0.0 107.102 174.003 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 94.5 t -128.28 127.87 67.86 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 -179.745 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -158.0 166.88 31.43 Favored 'General case' 0 C--N 1.309 -1.17 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 -175.084 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.489 ' HD2' HD11 ' A' ' 91' ' ' ILE . 38.5 ttpt -132.92 133.56 43.39 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.304 -175.707 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.639 ' HB2' ' SG ' ' A' ' 92' ' ' CYS . 77.9 m-85 -117.2 110.38 18.07 Favored 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 107.567 -1.271 . . . . 0.0 107.567 175.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 12.9 t -88.99 171.57 9.76 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 -177.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.58 ' HA ' ' O ' ' A' ' 88' ' ' ILE . 32.5 m -58.49 -50.31 74.21 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 112.919 0.711 . . . . 0.0 112.919 -175.249 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 23.3 p -116.78 94.36 4.57 Favored 'General case' 0 C--N 1.296 -1.719 0 C-N-CA 119.414 -0.914 . . . . 0.0 112.458 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.446 ' O ' ' HA ' ' A' ' 85' ' ' THR . 43.5 t -93.16 125.45 45.72 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.486 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 175.437 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.552 ' HA ' ' O ' ' A' ' 84' ' ' LEU . 8.1 p -107.81 154.1 22.03 Favored 'General case' 0 N--CA 1.4 -2.941 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.48 -177.088 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 175.28 -173.98 46.54 Favored Glycine 0 C--N 1.283 -2.364 0 N-CA-C 110.506 -1.038 . . . . 0.0 110.506 178.327 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 59.9 m-70 -99.25 91.53 5.01 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 178.182 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.468 ' HB3' HD13 ' A' ' 84' ' ' LEU . 5.3 tt -97.7 112.56 24.4 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 -175.121 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -116.21 160.25 20.67 Favored 'General case' 0 CA--C 1.458 -2.584 0 CA-C-N 114.9 -1.046 . . . . 0.0 108.569 175.504 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 2.3 tmtp? -71.51 103.72 3.05 Favored 'General case' 0 C--N 1.255 -3.503 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 -177.062 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 116.15 -10.07 17.77 Favored Glycine 0 C--O 1.186 -2.872 0 C-N-CA 120.516 -0.85 . . . . 0.0 111.944 -178.285 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -174.88 134.77 0.36 Allowed 'General case' 0 N--CA 1.488 1.465 0 CA-C-N 118.088 0.944 . . . . 0.0 111.888 176.768 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.405 ' HA ' ' HA ' ' A' ' 112' ' ' LEU . 2.3 tt -110.6 114.98 28.79 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 105.772 -1.936 . . . . 0.0 105.772 175.552 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.404 ' HA ' ' HB3' ' A' ' 135' ' ' SER . 75.1 p -103.35 135.06 45.68 Favored 'General case' 0 C--N 1.278 -2.539 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 -177.079 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . 0.394 4.0 p-10 48.61 97.47 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 115.878 1.807 . . . . 0.0 115.878 -178.63 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.446 HG22 ' O ' ' A' ' 134' ' ' THR . 13.0 m -87.44 118.02 32.54 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.086 0 CA-C-N 114.637 -1.165 . . . . 0.0 110.334 -179.687 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -97.08 92.36 6.02 Favored 'General case' 0 C--N 1.252 -3.67 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 179.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 140.92 -15.93 2.82 Favored Glycine 0 C--N 1.302 -1.323 0 C-N-CA 119.968 -1.111 . . . . 0.0 112.932 177.268 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 80.4 mt -100.37 104.81 16.68 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 CA-C-O 121.767 0.794 . . . . 0.0 111.235 -179.282 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -86.45 121.24 28.72 Favored 'General case' 0 N--CA 1.433 -1.312 0 N-CA-C 106.104 -1.813 . . . . 0.0 106.104 176.447 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 12.8 t -133.37 162.3 32.21 Favored 'General case' 0 N--CA 1.412 -2.347 0 CA-C-O 121.515 0.674 . . . . 0.0 110.644 -176.398 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.469 ' C ' ' HD3' ' A' ' 126' ' ' LYS . 1.0 OUTLIER -126.1 119.92 28.83 Favored 'General case' 0 N--CA 1.396 -3.137 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 173.051 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 59.9 t -109.38 -78.38 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.838 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 179.202 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -96.93 -35.75 10.78 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 105.636 -1.987 . . . . 0.0 105.636 171.771 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.498 HG13 ' H ' ' A' ' 130' ' ' TRP . 9.6 tp -146.98 176.06 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.419 -1.981 0 N-CA-C 106.636 -1.616 . . . . 0.0 106.636 176.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' TRP . . . . . 0.498 ' H ' HG13 ' A' ' 129' ' ' ILE . 6.2 m-90 -74.81 132.61 41.69 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 122.767 0.427 . . . . 0.0 111.041 -177.189 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.495 HG22 ' H ' ' A' ' 133' ' ' VAL . 8.4 p -149.64 147.09 16.61 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.09 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 175.227 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 57.7 pttt -111.09 -4.23 15.15 Favored 'General case' 0 C--N 1.31 -1.128 0 C-N-CA 119.537 -0.865 . . . . 0.0 111.774 178.189 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.495 ' H ' HG22 ' A' ' 131' ' ' VAL . 7.4 p -123.79 103.8 13.25 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 CA-C-O 122.001 0.905 . . . . 0.0 110.862 178.746 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . 0.446 ' O ' HG22 ' A' ' 120' ' ' VAL . 8.3 t -144.91 169.95 17.09 Favored 'General case' 0 C--N 1.293 -1.863 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 -179.494 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . 0.404 ' HB3' ' HA ' ' A' ' 118' ' ' THR . 26.9 m -122.65 168.64 11.94 Favored 'General case' 0 N--CA 1.409 -2.508 0 N-CA-C 109.924 -0.398 . . . . 0.0 109.924 178.678 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 11.8 tt -134.92 98.05 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.767 0 CA-C-O 122.382 1.087 . . . . 0.0 108.797 175.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 73.9 p -89.93 158.67 17.3 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-N 114.608 -1.178 . . . . 0.0 110.453 -176.634 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . 0.658 HG21 ' HB3' ' A' ' 63' ' ' LEU . 9.8 t -166.01 178.56 6.33 Favored 'General case' 0 N--CA 1.418 -2.069 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 -179.638 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -118.66 26.93 9.23 Favored 'General case' 0 C--N 1.273 -2.718 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 175.187 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . 60.65 36.56 19.58 Favored 'General case' 0 C--N 1.354 0.793 0 CA-C-N 114.379 -1.282 . . . . 0.0 108.274 -173.371 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . 0.651 ' N ' ' HG3' ' A' ' 64' ' ' PRO . 46.8 t -171.01 -78.68 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 114.092 -1.413 . . . . 0.0 109.825 -173.248 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.483 ' H ' ' HD3' ' A' ' 142' ' ' LYS . 0.0 OUTLIER -90.1 130.34 36.28 Favored 'General case' 0 CA--C 1.498 -1.029 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 176.352 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.511 ' HB ' ' O ' ' A' ' 153' ' ' ARG . 42.4 t -108.35 143.2 19.15 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 CA-C-O 121.108 0.48 . . . . 0.0 111.47 -171.336 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 91.1 m-85 -135.82 123.32 22.11 Favored 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 178.018 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 42.8 t80 -93.61 117.16 29.73 Favored 'General case' 0 C--N 1.288 -2.088 0 N-CA-C 106.708 -1.59 . . . . 0.0 106.708 -178.493 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.42 ' C ' ' H ' ' A' ' 148' ' ' GLY . 62.9 p -76.24 -89.87 0.03 OUTLIER 'General case' 0 N--CA 1.425 -1.701 0 N-CA-C 114.94 1.459 . . . . 0.0 114.94 -169.164 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . 67.17 -42.59 0.43 Allowed 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 125.244 1.418 . . . . 0.0 112.047 -175.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . 0.42 ' H ' ' C ' ' A' ' 146' ' ' THR . . . 177.94 44.9 0.07 OUTLIER Glycine 0 N--CA 1.412 -2.937 0 N-CA-C 107.349 -2.3 . . . . 0.0 107.349 178.437 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 65.6 mtt 58.22 40.14 25.1 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 124.003 0.921 . . . . 0.0 109.715 -176.278 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -89.03 -48.55 7.34 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 115.805 1.78 . . . . 0.0 115.805 -169.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.472 ' HE2' ' HA ' ' A' ' 151' ' ' LYS . 8.2 mmpt? -125.44 162.86 23.91 Favored 'General case' 0 N--CA 1.483 1.216 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 -172.227 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 57.3 p -119.73 158.34 26.71 Favored 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 174.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' ARG . . . . . 0.511 ' O ' ' HB ' ' A' ' 143' ' ' VAL . 3.8 tpm_? -149.92 120.5 7.47 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 109.082 -0.711 . . . . 0.0 109.082 -178.028 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 17.8 m -87.91 143.78 26.93 Favored 'General case' 0 C--N 1.308 -1.226 0 C-N-CA 120.122 -0.631 . . . . 0.0 110.835 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' ARG . . . . . 0.522 ' HD3' ' HB2' ' A' ' 64' ' ' PRO . 32.6 ttp180 -70.67 -34.5 72.08 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 115.608 -0.723 . . . . 0.0 110.121 179.06 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -45.85 -40.82 10.4 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 116.706 2.113 . . . . 0.0 116.706 -170.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -70.95 -56.43 6.22 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 119.019 -1.072 . . . . 0.0 112.077 -174.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 67.9 m-85 -171.63 19.16 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.765 0 C-N-CA 124.556 1.143 . . . . 0.0 108.934 -179.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . 0.444 ' HA3' ' O ' ' A' ' 65' ' ' ILE . . . 84.76 -97.19 2.1 Favored Glycine 0 N--CA 1.427 -1.942 0 C-N-CA 119.011 -1.566 . . . . 0.0 110.224 -171.704 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.547 HG23 ' HB ' ' A' ' 65' ' ' ILE . 90.2 t -127.65 113.41 31.31 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.521 0 CA-C-O 121.828 0.823 . . . . 0.0 110.651 -178.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -121.71 107.06 11.91 Favored 'General case' 0 C--N 1.295 -1.804 0 C-N-CA 119.424 -0.91 . . . . 0.0 113.167 -176.005 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 30.4 mmm180 -130.66 137.49 49.6 Favored 'General case' 0 C--N 1.292 -1.92 0 N-CA-C 106.337 -1.727 . . . . 0.0 106.337 172.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -77.25 74.53 3.82 Favored 'General case' 0 C--N 1.289 -2.056 0 N-CA-C 113.699 1.0 . . . . 0.0 113.699 -172.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -111.59 129.02 8.92 Favored Glycine 0 N--CA 1.424 -2.136 0 N-CA-C 109.25 -1.54 . . . . 0.0 109.25 176.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -91.56 112.65 24.65 Favored 'General case' 0 N--CA 1.42 -1.963 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 -177.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . 0.409 ' HA ' ' HB3' ' A' ' 92' ' ' CYS . 65.9 mtt85 -79.45 102.58 8.84 Favored 'General case' 0 N--CA 1.417 -2.12 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 179.027 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 25.2 t -66.01 82.55 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 O-C-N 124.077 0.861 . . . . 0.0 110.063 -178.422 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 22.1 t70 176.74 -24.65 0.0 OUTLIER 'General case' 0 C--N 1.287 -2.114 0 N-CA-C 106.236 -1.765 . . . . 0.0 106.236 -171.422 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 2.9 tppp? -79.2 106.48 11.26 Favored 'General case' 0 N--CA 1.425 -1.678 0 CA-C-N 114.145 -1.389 . . . . 0.0 111.899 179.312 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' PHE . . . . . . . . . . . . . 47.3 p90 . . . . . 0 C--N 1.293 -1.888 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 173.632 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 33.8 t . . . . . 0 CA--C 1.531 0.228 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -150.73 155.18 38.77 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-O 121.067 0.46 . . . . 0.0 110.621 -178.388 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 25.8 pt20 -159.13 126.96 4.97 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 175.582 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 28.7 pt -108.34 97.94 6.34 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.104 0 CA-C-O 122.37 1.081 . . . . 0.0 112.707 -177.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -132.34 21.07 4.38 Favored 'General case' 0 C--N 1.294 -1.817 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 177.014 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 22.8 p-10 -98.82 147.54 24.81 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 114.579 -1.191 . . . . 0.0 110.677 -178.373 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 87.6 tttt 71.49 124.41 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 125.043 1.337 . . . . 0.0 113.175 178.348 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 8.4 p -83.51 136.12 23.44 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.213 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 175.249 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -80.16 56.23 4.61 Favored Glycine 0 N--CA 1.445 -0.708 0 C-N-CA 121.44 -0.41 . . . . 0.0 112.787 -178.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 36.0 m -130.65 97.52 4.39 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 177.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 88.5 t80 -137.41 129.23 28.8 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 -178.316 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 79.4 m95 -95.7 95.92 8.65 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 179.03 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 60.5 tp -73.2 131.16 41.66 Favored 'General case' 0 C--O 1.25 1.127 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 179.266 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 93.48 86.43 1.6 Allowed Glycine 0 N--CA 1.423 -2.21 0 N-CA-C 110.504 -1.039 . . . . 0.0 110.504 -179.04 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 47.2 tt0 -69.95 -29.18 66.24 Favored 'General case' 0 C--O 1.246 0.879 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 -179.169 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 28.0 tptp 71.6 84.04 0.13 Allowed 'General case' 0 N--CA 1.441 -0.882 0 CA-C-N 114.727 -1.124 . . . . 0.0 110.32 -177.538 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -138.9 122.18 17.04 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-N 114.274 -1.33 . . . . 0.0 107.468 178.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -95.55 111.65 23.52 Favored 'General case' 0 C--N 1.291 -1.964 0 CA-C-O 121.101 0.477 . . . . 0.0 110.558 -174.392 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -113.55 118.58 34.82 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.518 -178.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 51.3 tt0 -129.64 140.64 51.1 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 178.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -88.44 86.43 7.04 Favored 'General case' 0 N--CA 1.435 -1.177 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 175.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 -78.74 111.31 14.73 Favored 'General case' 0 C--N 1.299 -1.6 0 CA-C-N 114.531 -1.213 . . . . 0.0 111.328 -176.259 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 32.0 m -82.4 99.53 9.46 Favored 'General case' 0 N--CA 1.423 -1.786 0 CA-C-N 114.944 -1.025 . . . . 0.0 109.923 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 35.8 m -88.66 -17.74 8.25 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.935 0 CA-C-O 120.866 0.365 . . . . 0.0 110.674 179.455 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -170.64 178.38 43.26 Favored Glycine 0 N--CA 1.43 -1.742 0 N-CA-C 110.927 -0.869 . . . . 0.0 110.927 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 36.2 t30 67.46 98.66 0.05 Allowed 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.43 1.092 . . . . 0.0 112.628 179.439 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -105.52 87.64 2.65 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 178.301 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.9 mm? 57.19 19.18 4.67 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 123.787 0.835 . . . . 0.0 112.337 179.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -90.72 110.41 21.6 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-O 121.007 0.432 . . . . 0.0 111.258 -174.173 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 29.6 t -82.38 103.68 12.13 Favored 'General case' 0 N--CA 1.418 -2.026 0 N-CA-C 107.864 -1.161 . . . . 0.0 107.864 177.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 7.3 p -103.18 109.46 26.95 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.188 0 CA-C-O 121.659 0.743 . . . . 0.0 110.424 -179.411 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 20.2 m -133.64 98.05 4.09 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 179.592 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 87.7 m -64.8 127.82 33.16 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.385 -179.571 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 13.5 p -74.19 106.86 6.04 Favored 'General case' 0 N--CA 1.425 -1.676 0 CA-C-O 121.391 0.615 . . . . 0.0 110.472 178.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 46.9 mm -62.25 127.09 21.65 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 115.097 -0.956 . . . . 0.0 111.427 -176.449 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -70.05 101.76 1.89 Allowed 'General case' 0 N--CA 1.435 -1.221 0 CA-C-N 114.869 -1.06 . . . . 0.0 109.538 -178.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -83.55 -28.16 36.7 Favored Glycine 0 CA--C 1.494 -1.268 0 N-CA-C 110.959 -0.856 . . . . 0.0 110.959 -178.448 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -80.3 59.25 4.6 Favored Glycine 0 N--CA 1.436 -1.344 0 N-CA-C 111.961 -0.455 . . . . 0.0 111.961 179.419 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 10.1 t -68.3 124.76 24.38 Favored 'General case' 0 N--CA 1.433 -1.317 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 178.436 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -97.01 108.85 21.67 Favored 'General case' 0 N--CA 1.438 -1.045 0 N-CA-C 112.984 0.735 . . . . 0.0 112.984 -174.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 83.0 m95 -118.48 84.69 2.22 Favored 'General case' 0 N--CA 1.427 -1.582 0 CA-C-N 114.89 -1.05 . . . . 0.0 108.939 173.461 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 5.5 mp -96.57 75.47 2.83 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 176.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.6 p -172.93 132.53 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.426 -1.634 0 CA-C-N 114.099 -1.41 . . . . 0.0 108.951 -176.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 43.7 t30 -148.12 92.66 2.07 Favored 'General case' 0 C--N 1.29 -1.985 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 175.165 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -92.58 102.73 15.17 Favored 'General case' 0 N--CA 1.418 -2.053 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 -177.311 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 25.5 pt -98.89 160.76 3.18 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.772 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.245 177.167 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 64.87 81.62 0.2 Allowed 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.012 0.82 . . . . 0.0 110.225 -175.039 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -124.4 37.68 2.57 Favored Glycine 0 N--CA 1.428 -1.876 0 C-N-CA 120.412 -0.899 . . . . 0.0 112.093 -177.562 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 55.5 pttt -141.62 19.65 2.19 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-O 121.288 0.566 . . . . 0.0 110.903 178.255 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 23.2 ptt? -92.64 83.91 4.96 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 122.368 1.08 . . . . 0.0 112.969 -178.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 80.7 mt-30 -156.07 -58.53 0.1 Allowed 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 105.848 -1.908 . . . . 0.0 105.848 177.362 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.412 ' HG2' ' CD1' ' A' ' 54' ' ' LEU . 0.0 OUTLIER -161.13 112.92 1.27 Allowed Pre-proline 0 N--CA 1.43 -1.469 0 N-CA-C 105.632 -1.988 . . . . 0.0 105.632 174.775 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_endo -67.69 81.9 0.44 Allowed 'Trans proline' 0 N--CA 1.457 -0.618 0 C-N-CA 122.324 2.016 . . . . 0.0 116.846 -174.054 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.569 ' N ' ' HD3' ' A' ' 55' ' ' PRO . 10.2 mp -82.07 -33.2 0.62 Allowed Pre-proline 0 C--N 1.296 -1.743 0 N-CA-C 116.904 2.187 . . . . 0.0 116.904 169.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.742 ' HA ' ' CD1' ' A' ' 58' ' ' LEU . 7.6 Cg_exo -66.08 -15.12 47.38 Favored 'Trans proline' 0 N--CA 1.425 -2.507 0 CA-C-N 121.134 1.441 . . . . 0.0 115.568 -161.018 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 32.3 mm-40 -79.34 -29.69 42.36 Favored 'General case' 0 N--CA 1.425 -1.691 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.718 ' O ' ' HB3' ' A' ' 60' ' ' GLU . 10.6 mt -76.41 -31.66 58.06 Favored 'General case' 0 C--O 1.207 -1.14 0 CA-C-N 114.652 -1.158 . . . . 0.0 110.061 -177.582 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.742 ' CD1' ' HA ' ' A' ' 55' ' ' PRO . 8.2 mt -70.41 -54.32 12.87 Favored 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 -174.383 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.636 ' HG2' ' O ' ' A' ' 55' ' ' PRO . 17.1 ptpt -64.02 -25.08 67.96 Favored 'General case' 0 C--O 1.191 -2.009 0 CA-C-N 114.885 -1.052 . . . . 0.0 111.398 176.76 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.718 ' HB3' ' O ' ' A' ' 57' ' ' LEU . 7.1 tp10 -54.95 -56.4 20.11 Favored 'General case' 0 C--N 1.295 -1.773 0 O-C-N 121.954 -0.467 . . . . 0.0 111.13 172.361 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 45.2 m-85 -78.54 -40.2 35.68 Favored 'General case' 0 CA--C 1.489 -1.375 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 -175.321 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.424 ' OD2' ' HG ' ' A' ' 112' ' ' LEU . 5.9 m-20 -87.42 18.34 3.9 Favored 'General case' 0 C--N 1.294 -1.833 0 CA-C-N 113.686 -1.597 . . . . 0.0 113.262 -174.256 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.623 HD21 ' H ' ' A' ' 115' ' ' GLY . 21.5 mt 79.79 151.24 0.12 Allowed Pre-proline 0 N--CA 1.475 0.82 0 C-N-CA 125.184 1.393 . . . . 0.0 112.703 174.303 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.429 ' HB2' ' HD2' ' A' ' 155' ' ' ARG . 7.4 Cg_endo -80.65 15.07 1.86 Allowed 'Trans proline' 0 N--CA 1.443 -1.468 0 C-N-CA 122.697 2.265 . . . . 0.0 113.546 -166.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.587 ' O ' ' HA3' ' A' ' 159' ' ' GLY . 0.2 OUTLIER -69.5 -36.73 72.68 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.811 0 N-CA-C 106.753 -1.573 . . . . 0.0 106.753 173.029 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 54.34 8.68 1.24 Allowed Glycine 0 C--N 1.339 0.731 0 CA-C-N 114.771 -1.104 . . . . 0.0 115.287 175.149 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.736 ' O ' ' HB ' ' A' ' 160' ' ' VAL 0.252 27.7 mt 72.71 -45.66 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.031 0 N-CA-C 114.527 1.306 . . . . 0.0 114.527 -179.9 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.546 ' HB2' ' O ' ' A' ' 67' ' ' ILE . 40.2 t80 164.99 -56.4 0.0 OUTLIER Pre-proline 0 CA--C 1.54 0.574 0 C-N-CA 124.155 0.982 . . . . 0.0 110.597 173.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -102.07 -160.31 0.04 OUTLIER 'Trans proline' 0 N--CA 1.43 -2.246 0 C-N-CA 122.533 2.155 . . . . 0.0 113.123 -169.58 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -100.96 29.08 13.28 Favored Glycine 0 N--CA 1.428 -1.868 0 N-CA-C 109.656 -1.378 . . . . 0.0 109.656 174.102 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.48 ' OD1' ' HD3' ' A' ' 89' ' ' PRO . 8.8 t0 -140.84 176.67 8.61 Favored 'General case' 0 N--CA 1.42 -1.949 0 N-CA-C 102.928 -2.99 . . . . 0.0 102.928 177.111 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.561 ' O ' HG22 ' A' ' 73' ' ' THR . . . 57.8 -177.73 0.07 Allowed 'General case' 0 N--CA 1.483 1.185 0 CA-C-N 118.977 0.808 . . . . 0.0 109.871 -170.635 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.561 HG22 ' O ' ' A' ' 72' ' ' ALA . 5.2 t 65.36 16.7 10.67 Favored 'General case' 0 N--CA 1.515 2.775 0 C-N-CA 125.06 1.344 . . . . 0.0 109.523 172.256 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.623 ' O ' ' HA ' ' A' ' 86' ' ' VAL . 37.3 m-80 -68.45 135.8 52.25 Favored 'General case' 0 N--CA 1.414 -2.25 0 CA-C-N 113.366 -1.743 . . . . 0.0 114.127 -176.154 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.514 ' CD2' HD11 ' A' ' 84' ' ' LEU . 48.3 t80 -98.88 106.22 18.46 Favored 'General case' 0 C--N 1.272 -2.797 0 CA-C-N 113.247 -1.797 . . . . 0.0 109.949 -177.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.454 ' HB2' HG23 ' A' ' 85' ' ' THR . 8.9 mm-40 -137.81 141.34 40.83 Favored 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 176.583 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 48.1 p90 -144.49 150.95 38.44 Favored 'General case' 0 C--N 1.301 -1.512 0 C-N-CA 120.283 -0.567 . . . . 0.0 110.675 -177.283 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.642 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 11.0 m-20 -97.1 170.72 8.94 Favored 'General case' 0 CA--C 1.486 -1.489 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 174.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -79.81 -71.46 0.45 Allowed 'General case' 0 C--N 1.278 -2.53 0 CA-C-N 115.283 -0.871 . . . . 0.0 113.021 -175.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -72.94 -42.27 63.62 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 121.583 0.706 . . . . 0.0 110.654 -175.088 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.642 ' HB ' ' HB2' ' A' ' 78' ' ' ASP . 19.8 m -55.7 -41.15 73.38 Favored 'General case' 0 N--CA 1.431 -1.41 0 CA-C-N 114.645 -1.161 . . . . 0.0 110.9 179.54 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 71.8 mmtt 59.85 9.9 1.89 Allowed 'General case' 0 N--CA 1.482 1.165 0 N-CA-C 113.04 0.756 . . . . 0.0 113.04 178.714 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.416 ' HE3' HG21 ' A' ' 109' ' ' THR . 27.8 pttt -98.77 134.12 42.11 Favored 'General case' 0 N--CA 1.402 -2.85 0 N-CA-C 105.13 -2.174 . . . . 0.0 105.13 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.514 HD11 ' CD2' ' A' ' 75' ' ' TYR . 6.9 tt -89.36 143.24 26.98 Favored 'General case' 0 C--N 1.282 -2.33 0 C-N-CA 120.142 -0.623 . . . . 0.0 109.492 -174.22 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.507 ' N ' HD23 ' A' ' 84' ' ' LEU . 2.7 t -116.5 107.19 14.45 Favored 'General case' 0 N--CA 1.415 -2.199 0 CA-C-O 121.692 0.758 . . . . 0.0 111.722 -179.61 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.623 ' HA ' ' O ' ' A' ' 74' ' ' ASN . 73.0 t -89.84 108.96 19.95 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.224 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 173.76 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.438 HD12 ' HB2' ' A' ' 74' ' ' ASN 0.272 0.8 OUTLIER -96.71 118.2 32.66 Favored 'General case' 0 N--CA 1.394 -3.262 0 CA-C-O 122.605 1.193 . . . . 0.0 111.852 -179.79 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.412 HG23 ' HB2' ' A' ' 72' ' ' ALA . 55.9 mt -97.46 142.42 24.52 Favored Pre-proline 0 C--N 1.277 -2.577 0 N-CA-C 104.399 -2.445 . . . . 0.0 104.399 178.178 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.48 ' HD3' ' OD1' ' A' ' 71' ' ' ASP . 30.9 Cg_endo -59.53 -18.04 44.7 Favored 'Trans proline' 0 C--N 1.328 -0.532 0 C-N-CA 122.968 2.446 . . . . 0.0 112.914 -178.077 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 6.5 m -154.44 167.42 30.08 Favored 'General case' 0 N--CA 1.422 -1.843 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 -172.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.483 HD11 ' HD3' ' A' ' 103' ' ' LYS . 14.2 tt -85.74 108.49 17.41 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.295 0 N-CA-C 105.968 -1.864 . . . . 0.0 105.968 166.614 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' CYS . . . . . 0.52 ' SG ' ' HA3' ' A' ' 164' ' ' GLY . 48.2 t -119.19 123.38 44.19 Favored 'General case' 0 C--N 1.292 -1.916 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 -176.358 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.448 ' CB ' ' HA ' ' A' ' 103' ' ' LYS . 12.7 pt-20 -119.49 150.6 39.97 Favored 'General case' 0 C--N 1.284 -2.277 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.908 -174.182 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.504 ' CG1' ' H ' ' A' ' 163' ' ' ASN . 34.5 m -130.29 102.2 6.67 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.485 0 CA-C-O 121.871 0.843 . . . . 0.0 111.385 179.807 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.51 ' HA2' ' O ' ' A' ' 100' ' ' SER . . . -148.2 122.62 1.54 Allowed Glycine 0 CA--C 1.48 -2.117 0 N-CA-C 108.121 -1.992 . . . . 0.0 108.121 172.757 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 62.9 t80 -152.29 -67.03 0.17 Allowed 'General case' 0 CA--C 1.46 -2.503 0 C-N-CA 116.388 -2.125 . . . . 0.0 111.1 -178.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.46 ' O ' ' HD2' ' A' ' 97' ' ' LYS . 2.0 tmmm? -86.46 -37.31 18.42 Favored 'General case' 1 N--CA 1.378 -4.051 0 CA-C-N 113.625 -1.625 . . . . 0.0 113.002 -164.276 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -157.35 83.23 0.91 Allowed 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 115.718 1.747 . . . . 0.0 115.718 -169.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 50.3 m 64.09 -27.98 0.09 Allowed 'General case' 0 N--CA 1.481 1.112 0 N-CA-C 115.679 1.733 . . . . 0.0 115.679 169.177 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . 0.51 ' O ' ' HA2' ' A' ' 95' ' ' GLY . 34.2 t -79.07 86.46 4.9 Favored 'General case' 0 N--CA 1.409 -2.523 0 C-N-CA 123.463 0.705 . . . . 0.0 109.677 -179.394 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 48.2 t -109.33 99.56 8.93 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 CA-C-N 115.084 -0.962 . . . . 0.0 109.491 176.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.452 ' HG ' ' HA ' ' A' ' 125' ' ' THR . 7.8 mp -110.07 127.93 55.14 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.157 179.617 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.483 ' HD3' HD11 ' A' ' 91' ' ' ILE . 23.8 ttmm -106.5 109.01 20.81 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 177.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 78.9 m-85 -94.81 105.68 17.63 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-N 116.068 -0.514 . . . . 0.0 109.788 179.469 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 49.7 m -61.75 151.37 34.21 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 115.276 -0.875 . . . . 0.0 111.006 178.585 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 7.3 m -51.5 -43.69 62.31 Favored 'General case' 0 C--O 1.215 -0.748 0 C-N-CA 125.241 1.417 . . . . 0.0 110.289 179.344 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 85.5 m -120.21 101.19 7.64 Favored 'General case' 0 N--CA 1.423 -1.777 0 CA-C-O 121.137 0.494 . . . . 0.0 109.761 178.46 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 13.5 m -108.71 114.77 47.65 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.059 0 CA-C-O 121.951 0.881 . . . . 0.0 111.176 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.511 ' HA ' ' O ' ' A' ' 84' ' ' LEU . 20.9 p -107.76 166.42 10.71 Favored 'General case' 0 N--CA 1.405 -2.693 0 CA-C-N 114.449 -1.251 . . . . 0.0 111.02 -176.528 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 167.84 -164.06 37.65 Favored Glycine 0 N--CA 1.41 -3.054 0 C-N-CA 120.323 -0.941 . . . . 0.0 111.565 177.052 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 52.0 t60 -103.3 99.81 9.67 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.424 ' HG ' ' OD2' ' A' ' 62' ' ' ASP . 3.0 tm? -103.55 125.29 50.0 Favored 'General case' 0 CA--C 1.483 -1.611 0 CA-C-N 115.635 -0.712 . . . . 0.0 110.2 -172.675 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -122.41 149.24 44.09 Favored 'General case' 0 N--CA 1.402 -2.871 0 CA-C-N 114.75 -1.113 . . . . 0.0 108.994 172.259 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -68.95 100.59 1.23 Allowed 'General case' 0 N--CA 1.402 -2.866 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 -179.091 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . 0.623 ' H ' HD21 ' A' ' 63' ' ' LEU . . . 135.52 -45.44 1.1 Allowed Glycine 0 C--N 1.282 -2.459 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 -175.738 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.48 ' HD3' HG23 ' A' ' 118' ' ' THR . 0.7 OUTLIER -150.2 133.5 16.37 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 114.074 1.139 . . . . 0.0 114.074 -178.382 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.524 ' O ' ' HB2' ' A' ' 135' ' ' SER . 40.6 tp -97.51 113.52 25.24 Favored 'General case' 0 C--N 1.309 -1.163 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 175.549 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.48 HG23 ' HD3' ' A' ' 116' ' ' LYS . 19.8 p -114.71 140.81 48.56 Favored 'General case' 0 C--N 1.285 -2.225 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.547 -178.593 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 66.18 100.61 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.93 0.892 . . . . 0.0 111.097 179.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.431 HG11 HD12 ' A' ' 123' ' ' ILE . 4.1 m -107.37 103.25 15.18 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.674 0 N-CA-C 113.974 1.102 . . . . 0.0 113.974 -177.355 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -84.66 84.26 7.74 Favored 'General case' 0 C--N 1.29 -2.013 0 CA-C-N 114.632 -1.167 . . . . 0.0 108.534 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 133.6 -12.4 4.87 Favored Glycine 0 N--CA 1.435 -1.384 0 CA-C-N 115.289 -0.869 . . . . 0.0 113.038 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.431 HD12 HG11 ' A' ' 120' ' ' VAL . 71.7 mt -100.28 99.95 9.46 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.112 0 CA-C-O 121.817 0.818 . . . . 0.0 109.716 179.213 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -91.18 118.18 30.24 Favored 'General case' 0 C--N 1.29 -2.004 0 CA-C-N 114.791 -1.095 . . . . 0.0 108.429 -177.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.452 ' HA ' ' HG ' ' A' ' 102' ' ' LEU . 62.1 m -115.46 113.53 23.83 Favored 'General case' 0 N--CA 1.426 -1.64 0 N-CA-C 112.913 0.708 . . . . 0.0 112.913 -173.137 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.433 ' O ' ' HA ' ' A' ' 100' ' ' SER . 39.0 tttp -105.13 121.82 44.61 Favored 'General case' 0 N--CA 1.415 -2.203 0 C-N-CA 119.137 -1.025 . . . . 0.0 108.644 169.676 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.437 ' O ' ' HB3' ' A' ' 128' ' ' MET . 27.2 t -144.76 104.09 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.278 -2.534 0 N-CA-C 103.29 -2.856 . . . . 0.0 103.29 170.547 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . 0.437 ' HB3' ' O ' ' A' ' 127' ' ' VAL . 26.3 ttt 74.17 -52.29 0.69 Allowed 'General case' 0 C--N 1.321 -0.658 0 O-C-N 124.487 1.117 . . . . 0.0 109.55 -172.241 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 8.7 tp -136.88 152.96 29.2 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 N-CA-C 109.063 -0.718 . . . . 0.0 109.063 175.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' TRP . . . . . 0.431 ' HA ' ' HA ' ' A' ' 126' ' ' LYS . 20.4 t-105 -81.49 117.8 22.2 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 123.526 0.731 . . . . 0.0 109.863 -177.028 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.533 HG12 ' H ' ' A' ' 133' ' ' VAL . 41.4 t -138.09 120.48 18.85 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.129 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 178.728 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 65.7 pttt -91.46 11.34 24.29 Favored 'General case' 0 C--N 1.312 -1.029 0 O-C-N 121.738 -0.601 . . . . 0.0 111.599 -177.2 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.533 ' H ' HG12 ' A' ' 131' ' ' VAL . 34.1 m -120.59 -1.59 8.21 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.107 0 C-N-CA 119.647 -0.821 . . . . 0.0 112.885 -175.586 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . 0.694 ' O ' ' HB ' ' A' ' 146' ' ' THR . 18.2 p -74.13 101.63 3.99 Favored 'General case' 0 N--CA 1.425 -1.709 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 176.5 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . 0.524 ' HB2' ' O ' ' A' ' 117' ' ' LEU . 12.4 p -94.48 170.03 9.78 Favored 'General case' 0 N--CA 1.412 -2.338 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 -177.665 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . 0.424 HD11 HG21 ' A' ' 65' ' ' ILE . 15.2 tt -100.77 122.35 52.68 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.155 0 CA-C-O 121.685 0.755 . . . . 0.0 111.555 -170.355 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 25.9 m -109.32 147.4 32.74 Favored 'General case' 0 N--CA 1.433 -1.297 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.023 -177.726 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . 0.535 HG22 ' H ' ' A' ' 141' ' ' SER . 33.0 m -146.85 174.03 11.86 Favored 'General case' 0 C--N 1.295 -1.787 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 -174.671 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -110.24 28.75 8.32 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 172.396 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . 59.79 43.74 14.86 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 -172.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . 0.535 ' H ' HG22 ' A' ' 138' ' ' THR . 35.1 t 176.78 -82.57 0.0 OUTLIER 'General case' 0 CA--C 1.545 0.77 0 CA-C-N 114.755 -1.111 . . . . 0.0 110.338 -173.59 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 24.7 pttm -89.29 150.91 22.39 Favored 'General case' 0 CA--C 1.503 -0.858 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.515 HG12 ' HB2' ' A' ' 155' ' ' ARG . 13.8 p -131.52 149.38 33.01 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.337 0 N-CA-C 114.281 1.215 . . . . 0.0 114.281 -168.656 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -112.44 143.48 43.51 Favored 'General case' 0 N--CA 1.428 -1.528 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 169.063 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 48.7 t80 -67.87 165.58 17.31 Favored 'General case' 0 C--N 1.305 -1.353 0 C-N-CA 122.93 0.492 . . . . 0.0 109.987 -173.18 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.694 ' HB ' ' O ' ' A' ' 134' ' ' THR . 41.6 p -50.88 -53.16 34.88 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 120.985 0.421 . . . . 0.0 111.531 -176.511 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -84.95 97.33 9.73 Favored 'General case' 0 N--CA 1.424 -1.754 0 N-CA-C 105.735 -1.95 . . . . 0.0 105.735 170.227 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -81.71 -18.0 69.19 Favored Glycine 0 CA--C 1.466 -2.978 0 CA-C-O 121.66 0.589 . . . . 0.0 111.666 -167.136 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 66.3 mtt -97.43 5.43 49.74 Favored 'General case' 0 C--N 1.281 -2.389 0 CA-C-N 114.666 -0.767 . . . . 0.0 110.718 178.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . 0.552 ' HE2' ' HA ' ' A' ' 150' ' ' LYS . 6.7 mmpt? -116.4 -49.69 2.66 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.509 -179.396 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 42.4 mmtm -146.14 165.08 30.18 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.3 0.571 . . . . 0.0 112.514 -175.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 42.2 p -130.03 160.37 33.9 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 174.073 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' ARG . . . . . 0.44 ' NE ' ' HA ' ' A' ' 153' ' ' ARG . 3.3 tpm_? -135.95 149.3 48.85 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 106.976 -1.491 . . . . 0.0 106.976 -177.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 8.2 m -88.64 117.37 27.55 Favored 'General case' 0 N--CA 1.436 -1.126 0 C-N-CA 120.212 -0.595 . . . . 0.0 111.763 -175.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' ARG . . . . . 0.639 ' HA ' ' HA2' ' A' ' 159' ' ' GLY . 0.0 OUTLIER -69.75 -31.08 68.85 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 105.457 -2.053 . . . . 0.0 105.457 174.505 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -45.46 -53.99 8.03 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 113.592 -1.64 . . . . 0.0 113.791 -179.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -66.47 -53.21 37.83 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 120.799 0.333 . . . . 0.0 111.476 -177.727 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -148.43 -32.89 0.24 Allowed 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.689 -178.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . 0.639 ' HA2' ' HA ' ' A' ' 155' ' ' ARG . . . 130.54 -95.0 0.33 Allowed Glycine 0 CA--C 1.463 -3.215 0 N-CA-C 107.992 -2.043 . . . . 0.0 107.992 -168.627 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.736 ' HB ' ' O ' ' A' ' 67' ' ' ILE . 41.3 t -98.72 125.25 52.17 Favored 'Isoleucine or valine' 0 N--CA 1.398 -3.046 0 N-CA-C 107.273 -1.381 . . . . 0.0 107.273 171.244 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' GLN . . . . . 0.407 ' HB2' ' HD3' ' A' ' 153' ' ' ARG . 46.8 mt-30 -90.78 101.38 14.13 Favored 'General case' 0 C--N 1.294 -1.824 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 -176.094 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . 0.433 HH21 HG23 ' A' ' 67' ' ' ILE . 20.2 mmt180 -90.86 152.89 20.57 Favored 'General case' 0 C--N 1.278 -2.501 0 CA-C-N 113.584 -1.644 . . . . 0.0 114.151 -172.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' ASN . . . . . 0.504 ' H ' ' CG1' ' A' ' 94' ' ' VAL . 46.7 m-80 -136.82 31.69 2.74 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 104.789 -2.301 . . . . 0.0 104.789 173.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . 0.52 ' HA3' ' SG ' ' A' ' 92' ' ' CYS . . . -110.67 149.34 17.7 Favored Glycine 0 N--CA 1.433 -1.508 0 CA-C-N 114.051 -1.432 . . . . 0.0 113.587 -171.399 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -110.01 117.16 33.03 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 175.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . 0.41 HH11 ' HD2' ' A' ' 166' ' ' ARG . 30.0 mtt180 -78.73 102.14 7.92 Favored 'General case' 0 N--CA 1.422 -1.83 0 N-CA-C 107.378 -1.341 . . . . 0.0 107.378 -178.416 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 40.0 t -75.72 90.6 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 CA-C-O 121.189 0.519 . . . . 0.0 110.848 -177.638 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 21.0 t70 172.85 -33.87 0.0 OUTLIER 'General case' 0 CA--C 1.484 -1.57 0 N-CA-C 106.665 -1.605 . . . . 0.0 106.665 -178.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 15.5 ptmt -157.38 -164.26 1.54 Allowed 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 113.675 -1.602 . . . . 0.0 110.75 -172.792 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' PHE . . . . . . . . . . . . . 89.1 t80 . . . . . 0 N--CA 1.427 -1.578 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 171.576 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 33.3 m . . . . . 0 N--CA 1.443 -0.782 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -85.27 149.01 25.78 Favored 'General case' 0 C--N 1.31 -1.141 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 178.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 -131.3 89.9 2.79 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-O 121.284 0.564 . . . . 0.0 110.675 -177.496 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.536 ' O ' HD12 ' A' ' 4' ' ' ILE . 2.4 pp -126.4 113.88 35.66 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.265 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.089 177.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -138.2 108.26 6.38 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-O 121.228 0.537 . . . . 0.0 110.836 -178.156 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -135.8 94.74 3.11 Favored 'General case' 0 C--N 1.293 -1.853 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 178.575 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 24.7 ttmm -90.96 116.13 28.52 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 178.127 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 8.7 p -80.45 130.22 36.3 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.678 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 177.643 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 178.51 80.06 0.06 OUTLIER Glycine 0 N--CA 1.439 -1.137 0 C-N-CA 120.303 -0.951 . . . . 0.0 112.322 -178.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 14.9 p -93.66 104.93 17.0 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-O 121.428 0.632 . . . . 0.0 109.835 177.119 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 76.9 t80 -84.16 101.29 11.73 Favored 'General case' 0 N--CA 1.434 -1.269 0 CA-C-O 121.466 0.651 . . . . 0.0 111.936 -174.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 68.5 p-90 -155.09 160.29 40.87 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 107.686 -1.228 . . . . 0.0 107.686 173.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.568 ' H ' HD23 ' A' ' 13' ' ' LEU . 1.9 pt? -116.93 156.36 27.53 Favored 'General case' 0 C--N 1.305 -1.368 0 C-N-CA 120.649 -0.421 . . . . 0.0 111.267 -175.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -103.63 20.22 42.45 Favored Glycine 0 N--CA 1.446 -0.66 0 N-CA-C 111.577 -0.609 . . . . 0.0 111.577 -179.394 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 84.1 mm-40 -115.37 127.85 55.67 Favored 'General case' 0 C--N 1.309 -1.16 0 C-N-CA 122.72 0.408 . . . . 0.0 110.136 179.191 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 60.7 pttt -121.79 153.95 37.63 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 178.256 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -112.67 93.07 4.25 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-O 120.917 0.389 . . . . 0.0 111.984 -177.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 -135.86 112.6 10.15 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-O 121.807 0.813 . . . . 0.0 110.754 177.552 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.602 ' HA ' ' HE3' ' A' ' 19' ' ' LYS . 0.5 OUTLIER -140.89 105.29 4.85 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 115.197 -0.911 . . . . 0.0 108.997 178.703 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 9.0 pm0 -83.57 101.87 11.76 Favored 'General case' 0 N--CA 1.424 -1.743 0 CA-C-O 121.532 0.682 . . . . 0.0 109.77 178.17 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 73.8 t80 -118.18 110.33 17.45 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.702 -177.519 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -125.73 108.32 11.4 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-O 121.494 0.664 . . . . 0.0 110.276 178.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 47.6 m -155.39 127.28 7.53 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 109.038 -0.726 . . . . 0.0 109.038 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.521 HG23 ' H ' ' A' ' 26' ' ' ASN . 32.3 m -90.02 -24.44 5.81 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-O 121.236 0.541 . . . . 0.0 110.281 179.226 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 103.07 -25.44 27.27 Favored Glycine 0 CA--C 1.499 -0.952 0 CA-C-N 115.751 -0.658 . . . . 0.0 112.055 176.13 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.521 ' H ' HG23 ' A' ' 24' ' ' VAL . 58.0 t30 -103.04 7.79 38.95 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-O 122.294 1.045 . . . . 0.0 108.93 179.703 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.441 ' OD2' ' HB2' ' A' ' 29' ' ' ASN . 9.4 p-10 -93.12 153.28 18.75 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.54 178.616 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 93.0 mt -66.88 102.38 0.95 Allowed 'General case' 0 CA--C 1.499 -0.995 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 175.028 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.441 ' HB2' ' OD2' ' A' ' 27' ' ' ASP . 45.4 t-20 -141.08 139.45 34.04 Favored 'General case' 0 N--CA 1.416 -2.127 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.763 -170.646 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 32.5 t -74.72 -152.02 0.03 OUTLIER 'General case' 0 CA--C 1.557 1.222 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 175.068 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.497 ' HB ' ' O ' ' A' ' 42' ' ' LEU . 7.4 p -69.29 90.91 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 CA-C-O 122.15 0.976 . . . . 0.0 112.323 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 33.0 p -76.35 103.8 6.54 Favored 'General case' 0 N--CA 1.42 -1.931 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 174.672 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 53.5 p -80.02 80.12 6.47 Favored 'General case' 0 N--CA 1.432 -1.373 0 N-CA-C 113.271 0.841 . . . . 0.0 113.271 -174.508 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 22.3 p -83.4 -61.2 1.91 Allowed 'General case' 0 N--CA 1.431 -1.401 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 175.487 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 51.1 mm -98.7 -69.06 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 175.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -169.72 -63.85 0.02 OUTLIER 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 -179.111 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 133.62 -33.1 2.61 Favored Glycine 0 N--CA 1.437 -1.242 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.864 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 142.38 -128.16 3.44 Favored Glycine 0 CA--C 1.495 -1.185 0 N-CA-C 108.63 -1.788 . . . . 0.0 108.63 -177.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 7.9 t -70.4 -32.22 69.77 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 106.983 -1.488 . . . . 0.0 106.983 171.663 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 53.55 88.04 0.04 OUTLIER 'General case' 0 N--CA 1.439 -0.976 0 C-N-CA 125.82 1.648 . . . . 0.0 114.241 173.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 82.2 m95 -94.6 -53.68 3.79 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 104.739 -2.319 . . . . 0.0 104.739 167.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.497 ' O ' ' HB ' ' A' ' 31' ' ' VAL . 4.2 tt -107.88 -53.98 2.55 Favored 'General case' 0 C--O 1.21 -1.025 0 N-CA-C 103.389 -2.819 . . . . 0.0 103.389 168.869 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.484 HG13 ' H ' ' A' ' 44' ' ' ASN . 7.4 p -165.29 -68.5 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.86 0 CA-C-N 114.998 -1.001 . . . . 0.0 110.575 174.787 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.484 ' H ' HG13 ' A' ' 43' ' ' VAL . 54.0 t30 -169.0 86.05 0.16 Allowed 'General case' 0 C--O 1.236 0.363 0 CA-C-O 121.114 0.483 . . . . 0.0 110.987 178.47 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 4.4 mptp? -132.33 149.2 52.41 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 115.903 -0.59 . . . . 0.0 109.918 177.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 29.0 pt -121.36 -51.34 3.22 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.709 175.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 35.0 mmtp 60.33 174.39 0.09 Allowed 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 124.404 1.082 . . . . 0.0 112.77 177.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 131.32 123.54 2.49 Favored Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 119.319 -1.419 . . . . 0.0 115.901 173.169 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 12.7 mptt -144.63 159.77 42.26 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 107.1 -1.444 . . . . 0.0 107.1 171.354 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 1.1 mpt? -83.15 -167.81 1.83 Allowed 'General case' 0 C--N 1.305 -1.335 0 O-C-N 123.026 0.204 . . . . 0.0 110.559 176.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . 0.268 11.6 pt20 -76.21 75.26 3.03 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 115.948 1.833 . . . . 0.0 115.948 -173.565 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.659 ' HB2' ' HD3' ' A' ' 53' ' ' PRO . 98.9 mttt -135.93 -58.66 0.02 OUTLIER Pre-proline 0 C--N 1.315 -0.903 0 CA-C-N 114.352 -1.294 . . . . 0.0 108.228 169.684 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.659 ' HD3' ' HB2' ' A' ' 52' ' ' LYS . 1.4 Cg_endo -95.72 29.88 0.2 Allowed 'Trans proline' 0 C--N 1.383 2.376 0 C-N-CA 122.879 2.386 . . . . 0.0 108.609 174.436 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.53 ' O ' ' HG ' ' A' ' 58' ' ' LEU . 14.9 tp -54.23 -39.96 78.54 Favored Pre-proline 0 C--N 1.303 -1.435 0 N-CA-C 114.573 1.323 . . . . 0.0 114.573 -171.504 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.435 ' O ' ' HE3' ' A' ' 59' ' ' LYS . 0.9 OUTLIER -52.4 -26.41 27.86 Favored 'Trans proline' 0 C--N 1.362 1.253 0 C-N-CA 123.303 2.669 . . . . 0.0 110.952 176.922 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.402 ' HB2' ' O ' ' A' ' 53' ' ' PRO . 20.0 mm-40 -82.7 -41.48 19.27 Favored 'General case' 0 N--CA 1.4 -2.928 0 CA-C-N 115.201 -0.909 . . . . 0.0 109.367 -178.648 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.489 ' HA ' ' HB3' ' A' ' 60' ' ' GLU . 3.8 mm? -75.35 -37.38 60.71 Favored 'General case' 0 N--CA 1.44 -0.973 0 N-CA-C 113.47 0.915 . . . . 0.0 113.47 -176.056 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.582 HD22 ' ND2' ' A' ' 74' ' ' ASN 0.261 1.8 pp -58.84 -43.58 90.78 Favored 'General case' 0 C--O 1.217 -0.614 0 C-N-CA 120.088 -0.645 . . . . 0.0 112.179 178.908 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.493 ' N ' HD12 ' A' ' 58' ' ' LEU . 20.8 pttp -77.49 -26.81 51.58 Favored 'General case' 0 C--O 1.208 -1.119 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 175.454 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.489 ' HB3' ' HA ' ' A' ' 57' ' ' LEU . 8.7 tp10 -61.97 -49.03 77.72 Favored 'General case' 0 C--N 1.313 -0.999 0 C-N-CA 123.895 0.878 . . . . 0.0 111.34 177.402 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 72.5 m-85 -73.62 5.5 3.85 Favored 'General case' 0 C--O 1.243 0.725 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.332 179.181 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -125.4 -162.93 1.15 Allowed 'General case' 0 C--N 1.292 -1.918 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.737 ' HB2' HD12 ' A' ' 65' ' ' ILE . 2.5 mt -79.11 173.86 7.04 Favored Pre-proline 0 CA--C 1.563 1.467 0 N-CA-C 106.988 -1.486 . . . . 0.0 106.988 -176.421 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -85.8 6.41 5.57 Favored 'Trans proline' 0 CA--C 1.505 -0.967 0 C-N-CA 121.68 1.587 . . . . 0.0 112.103 -171.131 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.737 HD12 ' HB2' ' A' ' 63' ' ' LEU . 0.2 OUTLIER -71.26 -45.46 70.34 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.816 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 179.578 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.415 ' H ' HD13 ' A' ' 65' ' ' ILE . . . 58.27 8.91 5.36 Favored Glycine 0 CA--C 1.528 0.885 0 CA-C-N 115.735 -0.666 . . . . 0.0 113.531 -178.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.544 ' O ' ' HB ' ' A' ' 160' ' ' VAL . 48.0 mt 68.58 -68.07 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.832 0 C-N-CA 125.494 1.517 . . . . 0.0 112.364 -176.791 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.542 ' HB3' ' HD3' ' A' ' 69' ' ' PRO . 76.7 t80 178.67 -56.99 0.0 OUTLIER Pre-proline 0 C--N 1.303 -1.417 0 C-N-CA 122.324 0.25 . . . . 0.0 111.078 -177.625 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.542 ' HD3' ' HB3' ' A' ' 68' ' ' PHE . 20.0 Cg_endo -98.15 145.64 0.64 Allowed 'Trans proline' 0 N--CA 1.432 -2.134 0 C-N-CA 122.285 1.99 . . . . 0.0 112.364 -177.026 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -78.57 64.34 3.59 Favored Glycine 0 N--CA 1.442 -0.934 0 N-CA-C 110.517 -1.033 . . . . 0.0 110.517 178.124 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -163.06 -27.38 0.04 OUTLIER 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 -177.471 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.43 ' HA ' ' CD ' ' A' ' 89' ' ' PRO . . . -83.2 170.52 14.62 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.663 0.785 . . . . 0.0 109.339 173.239 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.56 ' O ' HG22 ' A' ' 73' ' ' THR . 84.1 m 76.8 28.46 0.68 Allowed 'General case' 0 CA--C 1.56 1.339 0 CA-C-O 124.878 2.275 . . . . 0.0 110.866 172.117 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.686 ' O ' ' HA ' ' A' ' 86' ' ' VAL . 0.9 OUTLIER -73.74 108.21 6.44 Favored 'General case' 0 C--N 1.257 -3.439 0 CA-C-N 113.947 -1.479 . . . . 0.0 112.712 -178.175 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.576 ' HB2' HD21 ' A' ' 84' ' ' LEU . 31.3 p90 -79.34 108.71 13.06 Favored 'General case' 0 C--N 1.271 -2.815 0 CA-C-O 122.095 0.95 . . . . 0.0 113.37 -173.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.582 ' HB2' ' O ' ' A' ' 85' ' ' THR . 8.4 mm-40 -105.02 158.35 16.61 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 174.638 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 60.0 t80 -152.87 147.43 25.99 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 -175.274 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.638 ' O ' ' HA ' ' A' ' 82' ' ' LYS . 12.0 m-20 -130.3 -176.46 3.96 Favored 'General case' 0 CA--C 1.489 -1.393 0 CA-C-O 121.325 0.584 . . . . 0.0 111.665 -179.811 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.753 ' O ' ' HB2' ' A' ' 82' ' ' LYS . 45.8 mt-10 -83.88 -62.57 1.54 Allowed 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 117.042 2.238 . . . . 0.0 117.042 175.141 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -80.6 -34.43 35.17 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 122.775 1.274 . . . . 0.0 108.257 177.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.589 ' C ' ' H ' ' A' ' 83' ' ' LYS . 24.7 m -92.63 30.58 1.51 Allowed 'General case' 0 C--N 1.291 -1.969 0 C-N-CA 126.877 2.071 . . . . 0.0 107.496 176.478 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.753 ' HB2' ' O ' ' A' ' 79' ' ' GLU . 72.5 tttt -57.33 32.0 0.0 OUTLIER 'General case' 0 CA--C 1.565 1.542 0 C-N-CA 127.996 2.518 . . . . 0.0 112.617 -179.737 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.676 ' HG3' HG22 ' A' ' 109' ' ' THR . 53.9 pttt -117.96 133.67 55.69 Favored 'General case' 0 N--CA 1.393 -3.315 0 C-N-CA 125.943 1.697 . . . . 0.0 107.179 176.219 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.576 HD21 ' HB2' ' A' ' 75' ' ' TYR . 1.2 tm? -59.82 127.24 30.99 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-O 121.569 0.699 . . . . 0.0 110.743 -171.368 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.582 ' O ' ' HB2' ' A' ' 76' ' ' GLU . 6.2 t -126.77 114.28 17.75 Favored 'General case' 0 N--CA 1.405 -2.687 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.37 -179.851 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.686 ' HA ' ' O ' ' A' ' 74' ' ' ASN . 15.7 m -92.41 140.16 16.7 Favored 'Isoleucine or valine' 0 CA--C 1.474 -1.96 0 O-C-N 121.007 -1.058 . . . . 0.0 111.304 178.542 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.543 ' HA ' ' H ' ' A' ' 107' ' ' THR 0.339 2.0 pp -101.59 103.7 14.54 Favored 'General case' 0 N--CA 1.391 -3.423 0 CA-C-O 122.593 1.187 . . . . 0.0 109.979 176.892 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 35.0 mt -88.65 117.37 68.25 Favored Pre-proline 0 N--CA 1.405 -2.715 0 CA-C-N 113.683 -1.599 . . . . 0.0 107.23 -178.223 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.455 ' HB2' ' HD2' ' A' ' 166' ' ' ARG . 55.1 Cg_exo -55.78 104.15 0.12 Allowed 'Trans proline' 0 N--CA 1.451 -0.992 0 C-N-CA 123.442 2.761 . . . . 0.0 111.737 -178.059 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.512 ' OG ' ' HB ' ' A' ' 167' ' ' VAL . 25.7 t 71.66 170.22 0.32 Allowed 'General case' 0 N--CA 1.44 -0.942 0 O-C-N 124.715 1.259 . . . . 0.0 110.832 -179.134 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 79.4 mt -85.88 116.78 29.49 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.921 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.227 177.409 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' CYS . . . . . 0.597 ' SG ' ' HB2' ' A' ' 104' ' ' PHE . 12.0 p -109.91 129.05 55.7 Favored 'General case' 0 C--N 1.292 -1.92 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 174.615 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -120.41 120.34 35.66 Favored 'General case' 0 CA--C 1.461 -2.463 0 N-CA-C 108.787 -0.819 . . . . 0.0 108.787 -175.5 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.719 ' O ' ' HA ' ' A' ' 101' ' ' VAL . 49.1 t -111.06 115.79 50.8 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.156 0 CA-C-N 114.443 -1.253 . . . . 0.0 109.398 -172.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -137.99 -168.57 11.36 Favored Glycine 0 C--N 1.309 -0.944 0 N-CA-C 110.939 -0.864 . . . . 0.0 110.939 179.325 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 56.4 t80 -141.34 -91.38 0.15 Allowed 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 179.137 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -88.33 -35.41 17.21 Favored 'General case' 0 N--CA 1.434 -1.249 0 C-N-CA 119.401 -0.92 . . . . 0.0 109.013 171.012 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 15.9 t70 177.42 -67.38 0.01 OUTLIER 'General case' 0 C--N 1.353 0.733 0 CA-C-N 115.327 -0.851 . . . . 0.0 111.804 -178.371 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.474 ' HB3' ' O ' ' A' ' 127' ' ' VAL . 29.6 m -77.98 44.56 0.48 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 122.089 0.947 . . . . 0.0 112.935 -171.821 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 39.9 m -149.72 25.23 0.85 Allowed 'General case' 0 C--N 1.287 -2.129 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 175.485 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.719 ' HA ' ' O ' ' A' ' 94' ' ' VAL . 9.3 p -94.81 116.37 35.97 Favored 'Isoleucine or valine' 0 C--O 1.244 0.765 0 CA-C-O 122.01 0.909 . . . . 0.0 113.021 -175.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.427 ' CD1' HG23 ' A' ' 125' ' ' THR . 1.5 mm? -110.2 133.23 53.43 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 177.202 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 22.6 ttmm -103.39 105.23 15.44 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 177.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.597 ' HB2' ' SG ' ' A' ' 92' ' ' CYS . 99.3 m-85 -90.15 98.18 11.62 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 176.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 28.0 m -85.81 155.94 20.78 Favored 'General case' 0 C--N 1.296 -1.737 0 CA-C-N 114.686 -1.143 . . . . 0.0 111.062 -175.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 27.0 m -68.79 121.29 16.22 Favored 'General case' 0 N--CA 1.417 -2.094 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 175.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.543 ' H ' ' HA ' ' A' ' 87' ' ' LEU . 23.3 m 71.98 79.56 0.15 Allowed 'General case' 0 C--N 1.317 -0.807 0 C-N-CA 124.212 1.005 . . . . 0.0 110.656 179.238 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.506 ' O ' ' HA ' ' A' ' 85' ' ' THR . 14.9 m -109.25 121.21 61.93 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 CA-C-N 114.995 -1.002 . . . . 0.0 109.45 177.306 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.676 HG22 ' HG3' ' A' ' 83' ' ' LYS . 25.7 m -106.57 124.22 49.28 Favored 'General case' 0 N--CA 1.409 -2.492 0 CA-C-N 114.977 -1.01 . . . . 0.0 111.657 -167.599 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -157.1 -168.69 20.02 Favored Glycine 0 C--N 1.309 -0.947 0 C-N-CA 120.452 -0.88 . . . . 0.0 113.733 -179.295 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 12.9 t-80 -99.64 119.62 38.39 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 105.752 -1.944 . . . . 0.0 105.752 179.632 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.559 HD23 ' HG ' ' A' ' 84' ' ' LEU . 60.7 tp -124.11 118.51 27.08 Favored 'General case' 0 CA--C 1.457 -2.62 0 CA-C-O 121.338 0.59 . . . . 0.0 111.594 -167.496 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 8.1 mp0 -121.04 146.57 46.58 Favored 'General case' 1 N--CA 1.37 -4.459 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 175.323 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 21.2 tptm -66.2 101.14 0.68 Allowed 'General case' 0 C--N 1.291 -1.959 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 179.148 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 137.07 -48.95 0.88 Allowed Glycine 0 C--O 1.192 -2.478 0 N-CA-C 108.361 -1.896 . . . . 0.0 108.361 -173.294 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.63 ' HD3' HG23 ' A' ' 118' ' ' THR . 0.0 OUTLIER -148.71 144.22 26.95 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 114.006 1.113 . . . . 0.0 114.006 179.935 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.666 ' O ' ' HB2' ' A' ' 135' ' ' SER . 49.1 tp -110.65 100.91 9.61 Favored 'General case' 0 C--N 1.31 -1.124 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 177.029 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.63 HG23 ' HD3' ' A' ' 116' ' ' LYS . 6.9 p -100.95 138.16 38.37 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 113.064 0.765 . . . . 0.0 113.064 -176.528 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . 0.418 ' H ' ' HB3' ' A' ' 135' ' ' SER . 29.3 t70 64.09 124.52 0.02 OUTLIER 'General case' 0 CA--C 1.45 -2.866 0 C-N-CA 124.882 1.273 . . . . 0.0 111.348 -176.414 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.431 HG21 HD12 ' A' ' 123' ' ' ILE . 0.8 OUTLIER -145.99 145.16 20.37 Favored 'Isoleucine or valine' 1 N--CA 1.351 -5.388 0 C-N-CA 116.475 -2.09 . . . . 0.0 111.082 -169.659 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.466 ' HB3' ' HB ' ' A' ' 109' ' ' THR . 14.9 tp10 -111.42 102.87 11.21 Favored 'General case' 0 C--N 1.283 -2.283 0 CA-C-N 115.13 -0.941 . . . . 0.0 109.199 -176.567 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 116.22 -4.85 20.0 Favored Glycine 0 N--CA 1.439 -1.161 0 C-N-CA 119.392 -1.385 . . . . 0.0 114.225 173.294 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.431 HD12 HG21 ' A' ' 120' ' ' VAL . 61.4 mt -99.35 105.4 17.39 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.99 0 C-N-CA 118.737 -1.185 . . . . 0.0 110.052 179.746 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 58.0 tttm -85.37 119.67 25.99 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 179.019 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.523 ' O ' ' HA ' ' A' ' 130' ' ' TRP . 92.1 m -116.46 124.08 49.08 Favored 'General case' 0 C--N 1.271 -2.813 0 CA-C-N 114.951 -1.022 . . . . 0.0 110.116 -176.365 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.482 ' HA ' ' O ' ' A' ' 129' ' ' ILE . 0.7 OUTLIER -122.83 100.25 6.81 Favored 'General case' 0 N--CA 1.424 -1.762 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 174.077 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.474 ' O ' ' HB3' ' A' ' 99' ' ' SER . 11.8 p -102.59 -26.84 3.38 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.138 0 CA-C-O 122.255 1.026 . . . . 0.0 109.511 178.299 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 26.6 ttt -161.32 -33.6 0.05 OUTLIER 'General case' 0 C--N 1.282 -2.335 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 -178.089 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.516 ' H ' HD13 ' A' ' 129' ' ' ILE . 0.2 OUTLIER -139.46 165.62 22.59 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 N-CA-C 104.436 -2.431 . . . . 0.0 104.436 176.759 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' TRP . . . . . 0.523 ' HA ' ' O ' ' A' ' 125' ' ' THR . 60.8 p-90 -108.42 127.82 54.24 Favored 'General case' 0 N--CA 1.418 -2.058 0 C-N-CA 118.928 -1.109 . . . . 0.0 111.661 -178.479 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.595 HG12 ' H ' ' A' ' 133' ' ' VAL . 43.0 t -127.99 154.02 38.06 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.914 0 N-CA-C 105.751 -1.944 . . . . 0.0 105.751 177.354 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -115.98 18.71 15.43 Favored 'General case' 0 C--N 1.3 -1.579 0 CA-C-O 121.627 0.727 . . . . 0.0 111.238 -176.441 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.595 ' H ' HG12 ' A' ' 131' ' ' VAL . 33.5 m -138.11 0.2 0.71 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.637 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.962 -178.464 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . 0.463 ' OG1' ' HB ' ' A' ' 125' ' ' THR . 1.2 p -64.65 120.61 12.73 Favored 'General case' 0 N--CA 1.418 -2.063 0 CA-C-O 122.065 0.936 . . . . 0.0 110.917 178.074 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . 0.666 ' HB2' ' O ' ' A' ' 117' ' ' LEU . 19.7 p -78.61 171.25 15.4 Favored 'General case' 0 N--CA 1.407 -2.608 0 CA-C-N 113.778 -1.555 . . . . 0.0 114.049 -173.03 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 10.4 tt -119.18 127.54 75.84 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.099 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 175.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 37.9 m -129.45 131.23 46.68 Favored 'General case' 0 C--N 1.293 -1.886 0 C-N-CA 120.351 -0.54 . . . . 0.0 110.995 -174.422 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . 0.516 ' HB ' ' O ' ' A' ' 142' ' ' LYS . 59.6 p -118.2 176.13 5.37 Favored 'General case' 0 C--N 1.29 -1.983 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 177.182 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -99.93 21.64 12.35 Favored 'General case' 0 C--N 1.281 -2.398 0 N-CA-C 106.185 -1.783 . . . . 0.0 106.185 173.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . 61.71 40.42 13.15 Favored 'General case' 0 C--N 1.352 0.683 0 N-CA-C 107.367 -1.346 . . . . 0.0 107.367 -168.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 35.6 t -174.78 -79.69 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 114.222 -1.354 . . . . 0.0 109.483 -174.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.516 ' O ' ' HB ' ' A' ' 138' ' ' THR . 99.5 mttt -85.41 167.2 15.74 Favored 'General case' 0 CA--C 1.497 -1.095 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 177.141 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.449 ' HA ' HG22 ' A' ' 138' ' ' THR . 10.4 p -126.33 127.7 70.84 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.741 0 N-CA-C 113.484 0.92 . . . . 0.0 113.484 -173.105 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 45.8 m-85 -113.68 147.14 38.71 Favored 'General case' 0 CA--C 1.487 -1.465 0 CA-C-N 115.244 -0.889 . . . . 0.0 109.982 176.041 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . 0.505 ' HB2' ' HB2' ' A' ' 151' ' ' LYS . 93.9 m-85 -99.19 99.85 10.89 Favored 'General case' 0 C--N 1.263 -3.174 0 CA-C-N 114.456 -1.247 . . . . 0.0 107.922 175.738 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . 0.363 17.7 p -82.34 69.76 9.15 Favored 'General case' 0 N--CA 1.425 -1.686 0 N-CA-C 115.315 1.598 . . . . 0.0 115.315 -175.215 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.411 ' HB2' HG21 ' A' ' 125' ' ' THR . . . -123.85 74.35 1.27 Allowed 'General case' 0 N--CA 1.424 -1.728 0 N-CA-C 104.68 -2.341 . . . . 0.0 104.68 170.869 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 77.64 16.25 80.4 Favored Glycine 0 N--CA 1.433 -1.567 0 N-CA-C 109.071 -1.611 . . . . 0.0 109.071 -171.271 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 27.5 ptt? 49.03 24.39 0.88 Allowed 'General case' 0 N--CA 1.502 2.149 0 C-N-CA 126.578 1.951 . . . . 0.0 111.416 -173.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 59.5 mttp -62.77 -36.79 84.23 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 115.021 1.489 . . . . 0.0 115.021 -174.099 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.547 ' HE2' ' HA ' ' A' ' 151' ' ' LYS . 6.1 mmpt? -106.3 132.8 51.91 Favored 'General case' 0 C--N 1.319 -0.74 0 C-N-CA 120.473 -0.491 . . . . 0.0 110.897 178.144 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 19.7 m -132.46 128.21 36.96 Favored 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 -179.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 25.2 mmm180 -140.99 172.95 11.97 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-O 121.232 0.539 . . . . 0.0 111.954 -178.138 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 17.8 m -101.15 142.26 32.85 Favored 'General case' 0 N--CA 1.432 -1.331 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 176.434 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' ARG . . . . . 0.531 ' HD3' ' C ' ' A' ' 155' ' ' ARG . 0.2 OUTLIER -78.58 -25.02 45.21 Favored 'General case' 0 C--N 1.299 -1.606 0 CA-C-O 121.255 0.55 . . . . 0.0 109.89 178.976 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -44.17 -36.37 2.62 Favored 'General case' 0 C--N 1.316 -0.854 0 C-N-CA 125.455 1.502 . . . . 0.0 114.905 -175.277 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -66.44 -53.81 31.23 Favored 'General case' 0 CA--C 1.546 0.797 0 N-CA-C 114.277 1.214 . . . . 0.0 114.277 -174.107 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -149.66 5.15 0.6 Allowed 'General case' 0 N--CA 1.491 1.603 0 CA-C-N 117.597 0.18 . . . . 0.0 111.364 -175.411 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . 0.518 ' HA2' ' HG2' ' A' ' 155' ' ' ARG . . . 96.31 -91.55 1.29 Allowed Glycine 0 CA--C 1.461 -3.33 0 N-CA-C 106.231 -2.748 . . . . 0.0 106.231 -166.772 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.544 ' HB ' ' O ' ' A' ' 67' ' ' ILE . 57.7 t -104.96 127.45 59.49 Favored 'Isoleucine or valine' 1 N--CA 1.369 -4.512 0 N-CA-C 105.16 -2.163 . . . . 0.0 105.16 165.1 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 -88.34 106.59 18.34 Favored 'General case' 0 C--N 1.273 -2.754 0 N-CA-C 106.396 -1.705 . . . . 0.0 106.396 -177.055 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . 0.446 ' HD2' ' O ' ' A' ' 164' ' ' GLY . 0.0 OUTLIER -148.64 158.69 44.31 Favored 'General case' 0 N--CA 1.389 -3.519 0 C-N-CA 118.384 -1.326 . . . . 0.0 114.523 -167.359 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -106.29 -24.1 12.38 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 115.073 -0.967 . . . . 0.0 108.792 172.657 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . 0.446 ' O ' ' HD2' ' A' ' 162' ' ' ARG . . . -58.65 118.61 14.33 Favored Glycine 0 CA--C 1.498 -0.994 0 CA-C-N 115.258 -0.883 . . . . 0.0 112.282 -178.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 2.8 pp -108.7 153.74 23.01 Favored 'General case' 0 N--CA 1.418 -2.047 0 CA-C-O 120.667 0.27 . . . . 0.0 111.161 -174.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . 0.455 ' HD2' ' HB2' ' A' ' 89' ' ' PRO . 58.6 mtm180 -79.12 117.4 20.11 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 178.17 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.512 ' HB ' ' OG ' ' A' ' 90' ' ' SER . 43.6 t -62.28 -18.0 19.26 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.627 0 CA-C-O 121.64 0.733 . . . . 0.0 109.692 176.056 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -56.1 -41.44 75.21 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 124.739 1.215 . . . . 0.0 111.101 176.736 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 1.9 tmmm? -86.59 109.58 19.23 Favored 'General case' 0 N--CA 1.429 -1.499 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 -178.478 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' PHE . . . . . . . . . . . . . 87.9 t80 . . . . . 0 N--CA 1.423 -1.822 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 178.414 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 44.1 m . . . . . 0 N--CA 1.443 -0.813 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -90.43 94.09 9.58 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-O 122.1 0.952 . . . . 0.0 111.8 -177.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 29.6 tt0 -114.18 100.4 8.34 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 178.055 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.1 mp -78.61 127.76 38.69 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.094 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.261 -175.48 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -102.45 157.22 17.07 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.61 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 83.8 m-20 -112.25 165.4 12.2 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 177.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.598 ' HD3' ' H ' ' A' ' 7' ' ' LYS . 0.1 OUTLIER -83.55 83.07 8.03 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-O 121.958 0.885 . . . . 0.0 111.193 178.885 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 29.9 m -137.17 169.7 19.17 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 CA-C-N 115.146 -0.934 . . . . 0.0 109.105 179.422 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -103.49 150.31 17.59 Favored Glycine 0 N--CA 1.418 -2.553 0 N-CA-C 107.477 -2.249 . . . . 0.0 107.477 172.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 32.1 t -66.23 159.14 27.12 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-N 117.957 0.879 . . . . 0.0 109.235 -179.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 37.9 p90 -63.11 129.77 41.75 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-O 120.917 0.389 . . . . 0.0 110.688 -177.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 12.3 p90 -92.44 137.09 32.66 Favored 'General case' 0 C--N 1.304 -1.392 0 C-N-CA 120.411 -0.516 . . . . 0.0 110.257 177.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 53.5 tp -154.37 100.73 2.31 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 109.101 -0.704 . . . . 0.0 109.101 -179.294 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -92.68 115.57 4.89 Favored Glycine 0 N--CA 1.43 -1.715 0 N-CA-C 111.185 -0.766 . . . . 0.0 111.185 -179.54 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -136.95 153.21 50.76 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 18.0 ptpt -125.06 82.52 2.06 Favored 'General case' 0 C--N 1.292 -1.898 0 CA-C-O 122.143 0.973 . . . . 0.0 110.686 173.486 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -136.29 91.95 2.73 Favored 'General case' 0 N--CA 1.426 -1.662 0 CA-C-N 114.43 -1.259 . . . . 0.0 107.635 178.271 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 46.1 t30 -72.48 108.36 5.51 Favored 'General case' 0 C--N 1.299 -1.62 0 CA-C-N 115.085 -0.961 . . . . 0.0 111.517 -175.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 6.0 tmtm? -84.72 -60.23 2.12 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 104.683 -2.34 . . . . 0.0 104.683 171.752 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -168.36 75.71 0.12 Allowed 'General case' 0 N--CA 1.435 -1.223 0 CA-C-N 115.197 -0.91 . . . . 0.0 109.492 173.132 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -93.83 90.53 6.56 Favored 'General case' 0 CA--C 1.496 -1.125 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.61 178.102 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -109.63 -25.82 10.22 Favored 'General case' 0 C--N 1.291 -1.968 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 176.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 38.4 t 68.71 159.63 0.17 Allowed 'General case' 0 C--N 1.349 0.574 0 C-N-CA 124.578 1.151 . . . . 0.0 111.04 179.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 47.0 t -90.52 102.36 13.26 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.78 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 176.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -54.34 114.95 4.71 Favored Glycine 0 CA--C 1.506 -0.507 0 O-C-N 124.187 0.929 . . . . 0.0 113.278 -175.381 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -83.27 131.41 35.09 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 -179.109 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -96.19 134.96 38.64 Favored 'General case' 0 C--N 1.295 -1.794 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 175.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . 0.334 1.0 OUTLIER -77.58 72.67 4.13 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 115.607 1.706 . . . . 0.0 115.607 -175.693 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -91.82 131.25 37.31 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.446 177.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 47.3 t -140.95 101.91 4.15 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 -179.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 40.4 t -123.45 74.28 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 178.453 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 26.8 t 173.37 95.56 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 124.608 1.163 . . . . 0.0 108.075 177.086 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 7.1 t -131.18 91.2 2.99 Favored 'General case' 0 C--N 1.295 -1.796 0 CA-C-O 122.117 0.96 . . . . 0.0 110.148 179.037 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 61.7 m -157.8 153.3 26.23 Favored 'General case' 0 N--CA 1.44 -0.966 0 CA-C-N 115.069 -0.969 . . . . 0.0 109.134 179.623 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 6.4 tp -136.84 112.2 11.18 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 175.412 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -120.7 -172.69 2.43 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 113.005 0.743 . . . . 0.0 113.005 -175.685 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -140.95 142.11 11.91 Favored Glycine 0 N--CA 1.415 -2.735 0 N-CA-C 108.952 -1.659 . . . . 0.0 108.952 176.082 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -82.29 69.01 3.41 Favored Glycine 0 C--N 1.302 -1.321 0 N-CA-C 110.935 -0.866 . . . . 0.0 110.935 179.557 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 7.4 t -160.5 158.35 29.11 Favored 'General case' 0 N--CA 1.426 -1.658 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 -178.336 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 55.7 tptt -87.67 -14.06 40.93 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-O 121.409 0.623 . . . . 0.0 109.546 178.081 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 87.5 t90 -91.16 100.83 13.59 Favored 'General case' 0 N--CA 1.437 -1.086 0 CA-C-O 121.205 0.526 . . . . 0.0 109.649 179.169 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.482 ' O ' HD12 ' A' ' 42' ' ' LEU 0.261 2.3 pp -157.5 108.55 2.28 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-O 121.952 0.882 . . . . 0.0 111.37 176.578 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 8.5 p -165.23 138.29 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.97 0 CA-C-N 114.921 -1.036 . . . . 0.0 109.45 -178.424 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 37.6 t30 -101.25 107.36 18.72 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 179.03 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -98.98 107.7 20.2 Favored 'General case' 0 C--N 1.308 -1.218 0 C-N-CA 120.227 -0.589 . . . . 0.0 111.155 -177.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 63.8 mt -112.84 94.41 3.11 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 173.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 54.6 tttp -87.07 114.36 23.61 Favored 'General case' 0 C--N 1.309 -1.167 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 -176.575 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.457 ' HA2' ' HB2' ' A' ' 51' ' ' GLN . . . -99.48 25.16 29.33 Favored Glycine 0 C--N 1.302 -1.32 0 C-N-CA 121.188 -0.529 . . . . 0.0 113.346 -176.406 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 61.8 tttm -77.48 -52.72 8.61 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 178.522 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 27.9 ttt -126.79 82.37 2.08 Favored 'General case' 0 C--N 1.308 -1.196 0 N-CA-C 106.163 -1.791 . . . . 0.0 106.163 171.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.457 ' HB2' ' HA2' ' A' ' 48' ' ' GLY . 53.1 tt0 -89.44 -63.09 1.34 Allowed 'General case' 0 C--N 1.302 -1.489 0 CA-C-N 114.999 -1.0 . . . . 0.0 112.146 -170.783 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 68.7 mttm 68.12 132.45 0.04 OUTLIER Pre-proline 0 N--CA 1.467 0.424 0 O-C-N 124.389 1.055 . . . . 0.0 110.212 -171.338 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -78.28 -13.28 15.36 Favored 'Trans proline' 0 N--CA 1.454 -0.844 0 C-N-CA 121.506 1.47 . . . . 0.0 111.482 179.28 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.676 ' O ' ' HG ' ' A' ' 58' ' ' LEU . 23.3 mt -57.08 -59.09 13.74 Favored Pre-proline 0 C--O 1.208 -1.088 0 CA-C-N 115.535 -0.757 . . . . 0.0 112.068 -174.786 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.569 ' HA ' ' CD1' ' A' ' 58' ' ' LEU . 36.7 Cg_endo -60.34 -34.96 93.04 Favored 'Trans proline' 0 C--N 1.377 2.063 0 C-N-CA 120.899 1.066 . . . . 0.0 113.768 -169.729 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -78.21 -30.27 48.8 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-O 121.242 0.544 . . . . 0.0 110.633 179.324 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 45.5 tp -74.02 -29.39 61.91 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.242 176.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.676 ' HG ' ' O ' ' A' ' 54' ' ' LEU . 59.6 mt -57.48 -45.9 84.3 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-O 121.375 0.607 . . . . 0.0 110.3 -177.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.431 ' HD3' ' HA3' ' A' ' 66' ' ' GLY . 1.9 pptp? -73.57 -25.0 60.16 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 114.894 -1.048 . . . . 0.0 110.577 -179.183 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -90.48 -22.83 21.17 Favored 'General case' 0 CA--C 1.556 1.181 0 N-CA-C 113.482 0.919 . . . . 0.0 113.482 -174.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.558 ' CD2' ' HA ' ' A' ' 58' ' ' LEU . 34.1 m-85 -41.31 -41.08 1.83 Allowed 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 115.193 1.553 . . . . 0.0 115.193 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.493 ' OD2' ' HA ' ' A' ' 114' ' ' LYS . 10.4 t70 -125.96 -82.96 0.63 Allowed 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 117.746 -1.582 . . . . 0.0 112.205 -172.647 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.554 ' H ' HD12 ' A' ' 63' ' ' LEU . 0.0 OUTLIER -90.94 161.07 36.56 Favored Pre-proline 0 N--CA 1.444 -0.752 0 N-CA-C 106.619 -1.623 . . . . 0.0 106.619 -179.742 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -100.55 14.17 0.45 Allowed 'Trans proline' 0 N--CA 1.435 -1.936 0 C-N-CA 122.778 2.319 . . . . 0.0 112.803 -176.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.56 HG12 ' H ' ' A' ' 67' ' ' ILE . 0.2 OUTLIER -67.09 -47.5 81.75 Favored 'Isoleucine or valine' 0 CA--C 1.484 -1.59 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 177.146 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.524 ' HA2' HG21 ' A' ' 73' ' ' THR . . . 49.91 8.7 0.15 Allowed Glycine 0 N--CA 1.472 1.043 0 CA-C-N 114.903 -1.044 . . . . 0.0 113.849 -173.13 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.56 ' H ' HG12 ' A' ' 65' ' ' ILE . 16.6 mm 69.38 -69.34 0.16 Allowed 'Isoleucine or valine' 0 C--O 1.177 -2.739 0 C-N-CA 125.549 1.54 . . . . 0.0 108.555 -173.142 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.577 ' HB3' ' HD3' ' A' ' 69' ' ' PRO . 65.3 t80 -167.4 -56.75 0.01 OUTLIER Pre-proline 0 C--N 1.293 -1.851 0 C-N-CA 120.917 -0.313 . . . . 0.0 110.64 -177.78 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.577 ' HD3' ' HB3' ' A' ' 68' ' ' PHE . 56.0 Cg_endo -102.71 178.91 0.15 Allowed 'Trans proline' 0 N--CA 1.424 -2.61 0 C-N-CA 121.721 1.614 . . . . 0.0 111.108 -179.651 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -102.99 19.32 46.98 Favored Glycine 0 N--CA 1.43 -1.76 0 N-CA-C 109.756 -1.338 . . . . 0.0 109.756 175.381 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -100.93 -44.43 5.75 Favored 'General case' 0 N--CA 1.432 -1.353 0 N-CA-C 106.401 -1.703 . . . . 0.0 106.401 -178.368 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.451 ' HA ' ' HD2' ' A' ' 89' ' ' PRO . . . -80.6 168.04 19.36 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 114.653 -1.158 . . . . 0.0 109.156 167.059 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.559 ' O ' HG22 ' A' ' 73' ' ' THR . 22.3 m 81.8 28.84 0.15 Allowed 'General case' 0 CA--C 1.513 -0.462 0 CA-C-O 123.764 1.745 . . . . 0.0 111.198 171.556 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.687 HD22 ' N ' ' A' ' 74' ' ' ASN . 0.7 OUTLIER -70.47 148.26 48.49 Favored 'General case' 0 C--N 1.262 -3.212 0 CA-C-N 114.264 -1.335 . . . . 0.0 110.01 -179.725 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 40.5 t80 -115.01 91.32 3.58 Favored 'General case' 0 C--N 1.275 -2.644 0 C-N-CA 119.847 -0.741 . . . . 0.0 111.834 -166.556 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.5 ' O ' HD22 ' A' ' 84' ' ' LEU . 39.6 mm-40 -113.53 153.77 28.19 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.018 177.165 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 46.0 p90 -163.35 147.77 10.95 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 178.409 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.574 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 11.7 m-20 -74.99 165.11 25.79 Favored 'General case' 0 CA--C 1.478 -1.818 0 C-N-CA 119.827 -0.749 . . . . 0.0 109.235 179.77 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -80.78 -62.73 1.58 Allowed 'General case' 0 C--N 1.265 -3.087 0 CA-C-N 114.775 -1.102 . . . . 0.0 111.599 -179.169 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.494 ' CD ' ' H ' ' A' ' 80' ' ' GLU . 0.0 OUTLIER -80.98 -35.15 32.42 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.271 -176.293 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.574 ' HB ' ' HB2' ' A' ' 78' ' ' ASP . 56.8 m -80.49 -40.83 25.4 Favored 'General case' 0 N--CA 1.423 -1.822 0 CA-C-N 115.076 -0.965 . . . . 0.0 110.992 -178.598 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.423 ' H ' ' HB2' ' A' ' 78' ' ' ASP . 61.9 mttp 66.23 13.72 9.3 Favored 'General case' 0 N--CA 1.483 1.184 0 N-CA-C 114.206 1.187 . . . . 0.0 114.206 178.554 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 36.6 ttpt -71.54 116.46 11.91 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 176.336 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.5 HD22 ' O ' ' A' ' 76' ' ' GLU . 2.1 tm? -75.03 131.39 40.57 Favored 'General case' 0 N--CA 1.443 -0.817 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 -176.447 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.572 ' HA ' ' O ' ' A' ' 108' ' ' VAL . 27.4 p -126.66 116.59 21.23 Favored 'General case' 0 N--CA 1.412 -2.353 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.127 177.428 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.565 ' HA ' ' O ' ' A' ' 74' ' ' ASN . 63.2 t -91.92 131.84 37.94 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.054 0 N-CA-C 106.86 -1.533 . . . . 0.0 106.86 173.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.633 ' HA ' ' O ' ' A' ' 106' ' ' THR 0.361 2.1 pp -111.08 114.9 28.51 Favored 'General case' 0 N--CA 1.393 -3.28 0 CA-C-O 122.161 0.981 . . . . 0.0 111.869 178.642 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.474 ' O ' HG23 ' A' ' 106' ' ' THR . 70.3 mt -95.88 125.71 47.67 Favored Pre-proline 0 N--CA 1.419 -2.008 0 CA-C-N 113.647 -1.615 . . . . 0.0 109.771 -176.472 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.451 ' HD2' ' HA ' ' A' ' 72' ' ' ALA . 9.6 Cg_endo -53.89 95.43 0.04 OUTLIER 'Trans proline' 0 CA--C 1.534 0.489 0 C-N-CA 124.129 3.219 . . . . 0.0 112.492 177.696 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.533 ' OG ' ' HB ' ' A' ' 167' ' ' VAL . 22.9 t 75.7 158.14 0.2 Allowed 'General case' 0 C--O 1.236 0.387 0 C-N-CA 125.452 1.501 . . . . 0.0 110.394 -177.804 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.476 HD11 ' HD3' ' A' ' 103' ' ' LYS . 15.9 tt -78.57 108.22 11.77 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.598 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 173.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' CYS . . . . . 0.683 ' SG ' ' HG2' ' A' ' 166' ' ' ARG . 32.0 m -98.76 127.03 44.56 Favored 'General case' 0 C--N 1.29 -1.99 0 CA-C-N 114.932 -1.031 . . . . 0.0 110.725 -170.817 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -116.79 147.71 41.84 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-N 116.661 -0.245 . . . . 0.0 110.461 -178.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.577 ' O ' ' HA ' ' A' ' 101' ' ' VAL . 6.4 p -137.74 114.11 11.39 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 CA-C-O 120.91 0.386 . . . . 0.0 111.198 -178.745 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -145.43 163.31 28.19 Favored Glycine 0 N--CA 1.443 -0.854 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 176.613 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 78.1 t80 -171.1 -79.49 0.01 OUTLIER 'General case' 0 CA--C 1.522 -0.11 0 CA-C-N 118.102 0.951 . . . . 0.0 111.263 179.113 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.404 ' HE3' ' HB2' ' A' ' 97' ' ' LYS . 13.0 ptmt -85.84 -16.25 39.27 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 112.316 0.487 . . . . 0.0 112.316 -176.692 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 23.0 t70 75.25 106.33 0.07 Allowed 'General case' 0 N--CA 1.471 0.578 0 O-C-N 124.304 1.003 . . . . 0.0 112.702 -175.08 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 66.0 m 172.45 -29.87 0.0 OUTLIER 'General case' 0 C--N 1.31 -1.121 0 C-N-CA 128.235 2.614 . . . . 0.0 105.872 -178.325 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 36.1 p -147.92 102.53 3.41 Favored 'General case' 0 N--CA 1.414 -2.27 0 CA-C-N 114.033 -1.44 . . . . 0.0 109.973 178.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.577 ' HA ' ' O ' ' A' ' 94' ' ' VAL . 11.6 p -123.22 119.64 58.17 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 N-CA-C 106.681 -1.599 . . . . 0.0 106.681 174.477 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.506 HD23 ' H ' ' A' ' 126' ' ' LYS . 59.1 mt -124.83 144.12 50.46 Favored 'General case' 0 C--N 1.282 -2.356 0 C-N-CA 120.03 -0.668 . . . . 0.0 110.688 -170.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.476 ' HD3' HD11 ' A' ' 91' ' ' ILE . 23.0 ttmm -121.28 104.96 10.11 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 179.551 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -89.92 101.83 14.53 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.767 -178.31 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 82.5 m -60.97 153.09 25.99 Favored 'General case' 0 C--N 1.306 -1.317 0 C-N-CA 124.46 1.104 . . . . 0.0 110.652 177.11 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.633 ' O ' ' HA ' ' A' ' 87' ' ' LEU . 88.4 m -71.65 -69.24 0.4 Allowed 'General case' 0 C--O 1.205 -1.242 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.302 -174.634 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.412 HG22 ' HB3' ' A' ' 87' ' ' LEU . 32.3 p -99.08 101.71 13.17 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 178.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.723 HG21 HG12 ' A' ' 123' ' ' ILE . 4.7 p -112.41 138.42 41.56 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.769 0 C-N-CA 119.27 -0.972 . . . . 0.0 111.751 -177.236 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.426 HG22 HG22 ' A' ' 85' ' ' THR . 76.4 p -94.29 153.07 18.21 Favored 'General case' 0 N--CA 1.413 -2.311 0 CA-C-N 115.344 -0.843 . . . . 0.0 109.666 -177.599 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.478 ' HA2' ' O ' ' A' ' 119' ' ' ASP . . . -169.8 167.92 40.92 Favored Glycine 0 N--CA 1.423 -2.201 0 C-N-CA 120.787 -0.72 . . . . 0.0 111.979 -179.381 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 9.6 t60 -92.97 108.65 20.17 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 178.31 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -91.52 125.42 36.25 Favored 'General case' 0 C--N 1.296 -1.718 0 CA-C-O 121.075 0.464 . . . . 0.0 110.363 -178.37 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.562 ' HG3' ' HG3' ' A' ' 116' ' ' LYS . 10.5 pt-20 -142.33 136.57 29.8 Favored 'General case' 0 N--CA 1.425 -1.675 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 171.133 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.493 ' HA ' ' OD2' ' A' ' 62' ' ' ASP . 2.3 tmtp? -52.08 117.82 3.04 Favored 'General case' 0 C--O 1.248 0.991 0 CA-C-O 121.726 0.775 . . . . 0.0 111.774 -169.599 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . 0.671 ' O ' ' HB ' ' A' ' 138' ' ' THR . . . 106.53 -28.47 13.32 Favored Glycine 0 N--CA 1.409 -3.126 0 CA-C-N 114.66 -1.155 . . . . 0.0 112.421 176.559 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.562 ' HG3' ' HG3' ' A' ' 113' ' ' GLU . 12.4 ptmm? -147.11 115.38 6.62 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-O 121.784 0.802 . . . . 0.0 111.676 -174.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 59.4 tp -93.55 103.57 15.74 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 106.656 -1.609 . . . . 0.0 106.656 177.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.411 HG21 ' NZ ' ' A' ' 116' ' ' LYS . 39.7 p -103.64 140.38 37.64 Favored 'General case' 0 N--CA 1.403 -2.801 0 N-CA-C 113.572 0.953 . . . . 0.0 113.572 -171.787 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . 0.478 ' O ' ' HA2' ' A' ' 110' ' ' GLY . 12.9 m-20 60.09 85.51 0.11 Allowed 'General case' 0 CA--C 1.493 -1.215 0 CA-C-N 114.611 -1.177 . . . . 0.0 113.788 -179.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.8 m -88.02 87.77 2.8 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.985 0 CA-C-N 115.038 -0.983 . . . . 0.0 109.327 174.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -68.51 93.89 0.53 Allowed 'General case' 0 N--CA 1.418 -2.066 0 CA-C-N 113.813 -1.539 . . . . 0.0 108.495 -177.434 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 137.84 -11.26 3.67 Favored Glycine 0 N--CA 1.418 -2.52 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.597 178.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.723 HG12 HG21 ' A' ' 108' ' ' VAL . 36.1 mm -96.64 112.46 28.8 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.176 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 178.779 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.413 ' HA ' ' HA ' ' A' ' 132' ' ' LYS . 46.6 mtpt -86.35 118.97 26.12 Favored 'General case' 0 N--CA 1.414 -2.253 0 CA-C-N 114.954 -1.021 . . . . 0.0 109.279 -177.282 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.419 HG23 HD22 ' A' ' 102' ' ' LEU . 86.5 m -122.9 130.66 53.12 Favored 'General case' 0 N--CA 1.407 -2.604 0 CA-C-N 114.159 -1.382 . . . . 0.0 110.604 -173.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.617 ' C ' ' HD3' ' A' ' 126' ' ' LYS . 0.3 OUTLIER -107.72 125.64 51.63 Favored 'General case' 0 N--CA 1.41 -2.454 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 173.705 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.638 HG23 ' H ' ' A' ' 128' ' ' MET . 4.0 m -119.29 -81.0 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.09 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.498 175.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . 0.638 ' H ' HG23 ' A' ' 127' ' ' VAL . 1.1 tmt? -103.1 -20.2 14.26 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 106.277 -1.749 . . . . 0.0 106.277 171.722 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 1.1 pp -152.21 -176.41 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 C-N-CA 126.758 2.023 . . . . 0.0 108.564 -178.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 91.2 m95 -95.28 139.84 31.02 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.06 0.457 . . . . 0.0 111.567 178.585 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.57 HG12 ' H ' ' A' ' 133' ' ' VAL . 31.9 t -138.65 135.43 43.47 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.955 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 174.428 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . 0.593 ' H ' ' HD2' ' A' ' 132' ' ' LYS . 0.0 OUTLIER -93.03 13.31 21.16 Favored 'General case' 0 N--CA 1.487 1.403 0 CA-C-N 118.426 0.557 . . . . 0.0 111.024 -178.029 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.57 ' H ' HG12 ' A' ' 131' ' ' VAL . 5.5 p -166.43 96.31 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.31 -1.129 0 CA-C-O 122.364 1.078 . . . . 0.0 111.578 -172.539 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . 0.413 ' O ' ' HA ' ' A' ' 119' ' ' ASP . 21.8 p -99.03 -172.8 2.35 Favored 'General case' 0 N--CA 1.404 -2.742 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.289 176.334 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 28.4 t -147.97 134.53 19.8 Favored 'General case' 0 C--N 1.282 -2.344 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 -173.569 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 60.9 mt -105.27 103.79 15.92 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.875 0 CA-C-O 121.197 0.522 . . . . 0.0 109.979 -178.415 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 56.3 p -96.54 110.8 23.13 Favored 'General case' 0 N--CA 1.428 -1.549 0 CA-C-O 121.233 0.54 . . . . 0.0 109.597 179.107 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . 0.671 ' HB ' ' O ' ' A' ' 115' ' ' GLY . 75.5 m -128.44 159.65 34.74 Favored 'General case' 0 C--N 1.274 -2.694 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 -177.591 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -105.72 39.35 1.78 Allowed 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 109.786 -0.449 . . . . 0.0 109.786 175.576 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . 58.74 34.82 24.03 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 115.243 -0.89 . . . . 0.0 109.602 -177.152 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . 0.452 ' H ' HG22 ' A' ' 138' ' ' THR . 33.5 t 179.45 -78.16 0.01 OUTLIER 'General case' 0 CA--C 1.547 0.859 0 CA-C-N 114.7 -1.137 . . . . 0.0 110.081 -174.634 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -80.67 134.97 35.95 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 110.152 -0.314 . . . . 0.0 110.152 179.392 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.413 ' CG2' HG22 ' A' ' 65' ' ' ILE . 20.3 t -110.22 140.19 30.32 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 N-CA-C 112.793 0.664 . . . . 0.0 112.793 -168.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -133.51 151.84 51.82 Favored 'General case' 0 CA--C 1.483 -1.605 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 170.013 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . 0.526 ' HB2' ' HB2' ' A' ' 151' ' ' LYS . 55.4 m-85 -113.11 99.58 7.94 Favored 'General case' 0 C--N 1.275 -2.659 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.744 179.297 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 16.8 p -84.81 85.72 7.43 Favored 'General case' 0 N--CA 1.408 -2.538 0 CA-C-N 115.133 -0.939 . . . . 0.0 110.97 177.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -113.03 70.52 0.72 Allowed 'General case' 0 N--CA 1.428 -1.559 0 N-CA-C 106.33 -1.73 . . . . 0.0 106.33 174.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 72.64 27.03 70.1 Favored Glycine 0 N--CA 1.439 -1.125 0 N-CA-C 108.619 -1.792 . . . . 0.0 108.619 -171.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 26.8 ttt 60.42 97.51 0.03 OUTLIER 'General case' 0 C--N 1.355 0.807 0 C-N-CA 124.621 1.169 . . . . 0.0 109.3 -171.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.19 -52.54 0.32 Allowed 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 114.9 1.444 . . . . 0.0 114.9 -174.766 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.526 ' HB2' ' HB2' ' A' ' 145' ' ' PHE . 35.2 mmtp -121.96 163.9 18.52 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 114.236 1.199 . . . . 0.0 114.236 -171.292 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 55.7 p -128.51 160.01 33.67 Favored 'General case' 0 N--CA 1.439 -0.977 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 175.362 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 14.6 tpp180 -154.96 132.84 11.49 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.132 0.491 . . . . 0.0 111.709 179.7 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 9.2 m -88.64 137.38 32.37 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 177.311 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' ARG . . . . . 0.677 ' O ' ' HD3' ' A' ' 155' ' ' ARG . 2.4 tmt_? -70.12 -22.25 63.03 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 110.282 -0.266 . . . . 0.0 110.282 -176.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -50.86 -25.25 4.29 Favored 'General case' 0 N--CA 1.5 2.052 0 C-N-CA 123.482 0.713 . . . . 0.0 112.552 177.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.59 ' HB1' ' HG2' ' A' ' 161' ' ' GLN . . . -76.42 4.01 9.93 Favored 'General case' 0 C--N 1.306 -1.286 0 C-N-CA 124.924 1.29 . . . . 0.0 113.393 -178.311 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 86.7 m-85 91.53 23.46 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.147 0 C-N-CA 126.186 1.794 . . . . 0.0 109.51 -175.489 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . 0.464 ' HA3' ' O ' ' A' ' 65' ' ' ILE . . . 101.64 -94.4 1.22 Allowed Glycine 0 N--CA 1.398 -3.867 0 N-CA-C 109.224 -1.551 . . . . 0.0 109.224 -175.458 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.553 HG23 ' HB ' ' A' ' 65' ' ' ILE . 79.7 t -128.92 113.74 30.09 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.337 0 CA-C-O 121.505 0.669 . . . . 0.0 111.029 -178.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' GLN . . . . . 0.59 ' HG2' ' HB1' ' A' ' 157' ' ' ALA 0.315 10.0 pt20 -110.52 92.87 4.21 Favored 'General case' 0 C--N 1.302 -1.472 0 C-N-CA 117.203 -1.799 . . . . 0.0 114.54 179.278 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 26.0 tpt180 -146.22 102.14 3.58 Favored 'General case' 0 C--N 1.274 -2.708 0 N-CA-C 101.789 -3.411 . . . . 0.0 101.789 168.454 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 47.8 m-80 -110.67 123.03 49.23 Favored 'General case' 0 C--N 1.292 -1.93 0 N-CA-C 113.453 0.909 . . . . 0.0 113.453 -169.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . 0.459 ' CA ' ' HB ' ' A' ' 94' ' ' VAL . . . -95.11 -169.5 36.35 Favored Glycine 0 N--CA 1.42 -2.422 0 N-CA-C 108.823 -1.711 . . . . 0.0 108.823 172.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.616 ' H ' HD23 ' A' ' 165' ' ' LEU . 1.9 pt? -91.37 112.0 23.72 Favored 'General case' 0 C--N 1.296 -1.736 0 C-N-CA 119.113 -1.035 . . . . 0.0 109.648 -178.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . 0.683 ' HG2' ' SG ' ' A' ' 92' ' ' CYS . 78.9 mtt85 -82.74 101.16 10.7 Favored 'General case' 0 CA--C 1.48 -1.738 0 N-CA-C 106.447 -1.686 . . . . 0.0 106.447 174.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.533 ' HB ' ' OG ' ' A' ' 90' ' ' SER . 52.4 t -68.59 -27.84 37.86 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.803 0 CA-C-N 114.942 -1.026 . . . . 0.0 112.25 -175.366 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . 0.42 ' HB2' ' HB2' ' A' ' 90' ' ' SER . 18.0 t70 -90.84 69.69 6.48 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-O 121.975 0.893 . . . . 0.0 110.432 -177.642 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 39.3 ttpt 177.92 130.54 0.06 Allowed 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 113.474 -1.694 . . . . 0.0 106.81 175.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' PHE . . . . . . . . . . . . . 64.0 m-85 . . . . . 0 C--N 1.288 -2.098 0 CA-C-O 119.148 -0.453 . . . . 0.0 110.302 -175.159 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 26.0 t . . . . . 0 N--CA 1.445 -0.719 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -118.05 97.54 5.86 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-O 121.27 0.557 . . . . 0.0 112.417 -177.548 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 93.9 mt-30 -122.75 113.72 19.57 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 174.083 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.423 ' N ' HD12 ' A' ' 4' ' ' ILE . 2.4 mp -85.22 110.76 19.79 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.936 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 -179.402 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 47.8 p90 -122.56 118.18 27.63 Favored 'General case' 0 N--CA 1.421 -1.878 0 CA-C-O 121.653 0.739 . . . . 0.0 110.646 179.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 63.4 t30 -105.09 19.67 20.19 Favored 'General case' 0 C--N 1.291 -1.96 0 N-CA-C 106.209 -1.774 . . . . 0.0 106.209 176.089 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -72.1 106.81 4.48 Favored 'General case' 0 N--CA 1.436 -1.143 0 CA-C-N 113.34 -1.755 . . . . 0.0 110.584 -178.474 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.7 p -149.73 100.94 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 CA-C-O 122.479 1.133 . . . . 0.0 111.695 178.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -109.64 27.21 12.59 Favored Glycine 0 N--CA 1.432 -1.577 0 CA-C-N 114.782 -1.099 . . . . 0.0 110.381 177.573 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 20.4 m -84.22 90.9 7.6 Favored 'General case' 0 N--CA 1.427 -1.598 0 CA-C-O 121.233 0.54 . . . . 0.0 110.402 -179.469 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -106.47 96.46 6.48 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 177.465 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 59.2 p-90 -80.78 147.15 30.63 Favored 'General case' 0 C--N 1.297 -1.694 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.357 -174.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.482 ' O ' HD12 ' A' ' 13' ' ' LEU . 1.9 pp -113.28 115.49 28.25 Favored 'General case' 0 C--N 1.29 -2.011 0 CA-C-O 121.753 0.787 . . . . 0.0 111.84 179.301 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -160.56 48.53 0.38 Allowed Glycine 0 N--CA 1.431 -1.683 0 N-CA-C 110.761 -0.936 . . . . 0.0 110.761 -179.259 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.432 ' H ' ' NE2' ' A' ' 15' ' ' GLN . 0.4 OUTLIER -128.22 131.01 48.84 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 -179.849 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 28.2 tptp -92.55 -28.42 16.77 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.648 -177.635 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 59.22 83.92 0.12 Allowed 'General case' 0 C--O 1.236 0.394 0 CA-C-O 122.024 0.916 . . . . 0.0 111.147 -178.445 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 42.0 t30 -139.52 102.7 4.53 Favored 'General case' 0 C--N 1.295 -1.791 0 CA-C-N 115.183 -0.917 . . . . 0.0 109.129 -178.25 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -147.24 124.01 11.21 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.399 -177.349 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -93.51 122.97 36.49 Favored 'General case' 0 N--CA 1.42 -1.948 0 N-CA-C 104.73 -2.322 . . . . 0.0 104.73 167.136 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 49.2 p90 -94.08 139.38 31.05 Favored 'General case' 0 C--N 1.289 -2.026 0 C-N-CA 119.626 -0.829 . . . . 0.0 111.21 -174.472 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -119.43 80.82 1.62 Allowed 'General case' 0 C--N 1.286 -2.158 0 CA-C-O 122.175 0.988 . . . . 0.0 110.154 176.156 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 20.2 m -148.67 87.73 1.58 Allowed 'General case' 0 N--CA 1.428 -1.546 0 CA-C-N 113.858 -1.519 . . . . 0.0 108.02 -179.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.401 HG12 ' N ' ' A' ' 25' ' ' GLY . 41.0 t -137.98 170.95 16.36 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.268 0 N-CA-C 105.973 -1.862 . . . . 0.0 105.973 -177.256 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.401 ' N ' HG12 ' A' ' 24' ' ' VAL . . . -51.54 119.9 9.15 Favored Glycine 0 C--O 1.245 0.824 0 N-CA-C 110.861 -0.896 . . . . 0.0 110.861 176.121 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 40.2 m-80 -61.29 143.59 55.4 Favored 'General case' 0 C--O 1.247 0.958 0 CA-C-O 120.954 0.406 . . . . 0.0 110.973 -177.075 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -78.82 84.61 4.87 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 122.031 0.919 . . . . 0.0 110.762 -179.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -169.29 -47.32 0.02 OUTLIER 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 104.711 -2.329 . . . . 0.0 104.711 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 41.0 m-80 64.48 90.46 0.09 Allowed 'General case' 0 CA--C 1.5 -0.952 0 CA-C-N 114.162 -1.381 . . . . 0.0 112.04 176.456 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 34.7 t -72.63 -65.87 0.73 Allowed 'General case' 0 N--CA 1.431 -1.418 0 N-CA-C 106.408 -1.701 . . . . 0.0 106.408 174.486 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 29.7 m 44.67 -171.92 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 N-CA-C 116.074 1.879 . . . . 0.0 116.074 172.102 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 27.1 t 70.5 16.65 6.98 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 114.533 -1.212 . . . . 0.0 110.618 176.217 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 40.2 p -72.04 -16.99 62.05 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 122.361 1.077 . . . . 0.0 110.1 -179.754 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.58 ' HB3' ' OE1' ' A' ' 79' ' ' GLU . 70.7 m -147.72 171.24 15.98 Favored 'General case' 0 N--CA 1.416 -2.155 0 N-CA-C 107.219 -1.4 . . . . 0.0 107.219 176.107 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 32.8 pt -94.59 -25.25 4.69 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.283 0 C-N-CA 120.475 -0.49 . . . . 0.0 111.075 -178.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 32.5 mm-40 68.92 177.1 0.27 Allowed 'General case' 0 C--O 1.239 0.552 0 C-N-CA 123.808 0.843 . . . . 0.0 112.555 178.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -74.14 107.65 2.31 Favored Glycine 0 N--CA 1.434 -1.492 0 N-CA-C 110.667 -0.973 . . . . 0.0 110.667 177.37 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -95.66 -2.29 61.55 Favored Glycine 0 N--CA 1.441 -0.994 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.169 -177.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.458 ' HB ' ' OE1' ' A' ' 76' ' ' GLU . 11.8 t -81.11 129.31 34.5 Favored 'General case' 0 N--CA 1.424 -1.742 0 CA-C-O 121.663 0.744 . . . . 0.0 111.081 -179.385 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -144.46 11.96 1.51 Allowed 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 115.11 -0.95 . . . . 0.0 109.876 177.193 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 41.0 t-105 66.92 91.7 0.08 Allowed 'General case' 0 C--O 1.243 0.741 0 C-N-CA 124.306 1.042 . . . . 0.0 112.319 -178.131 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 81.3 mt -90.29 110.3 21.36 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-N 114.751 -1.113 . . . . 0.0 108.701 177.189 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 59.6 t -72.75 -46.97 51.84 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.278 0 CA-C-N 115.738 -0.665 . . . . 0.0 109.572 179.167 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 78.4 m-20 67.14 83.55 0.17 Allowed 'General case' 0 CA--C 1.511 -0.522 0 CA-C-N 114.808 -1.087 . . . . 0.0 109.756 -177.404 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 20.5 ptmt -88.82 95.85 10.45 Favored 'General case' 0 C--N 1.297 -1.692 0 CA-C-N 115.093 -0.958 . . . . 0.0 111.876 -175.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 6.1 tp 179.82 -52.91 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.31 -1.119 0 CA-C-N 114.915 -1.038 . . . . 0.0 109.586 177.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt 65.46 94.69 0.06 Allowed 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 124.216 1.006 . . . . 0.0 109.76 -175.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -94.66 178.72 36.74 Favored Glycine 0 N--CA 1.426 -2.008 0 C-N-CA 120.351 -0.928 . . . . 0.0 111.041 -179.095 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -76.21 -25.45 55.12 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-O 121.299 0.571 . . . . 0.0 109.64 178.197 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 65.3 mtm -89.92 99.32 12.36 Favored 'General case' 0 N--CA 1.439 -0.985 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 175.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 62.3 tt0 -106.63 -37.74 6.35 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.469 -177.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 66.6 mttm 73.88 148.38 0.12 Allowed Pre-proline 0 CA--C 1.551 1.001 0 C-N-CA 124.507 1.123 . . . . 0.0 110.281 -177.484 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -71.76 37.35 0.33 Allowed 'Trans proline' 0 N--CA 1.496 1.647 0 C-N-CA 123.568 2.845 . . . . 0.0 113.34 -177.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.471 ' O ' ' HG ' ' A' ' 58' ' ' LEU . 18.4 mt -71.29 -48.44 12.96 Favored Pre-proline 0 C--N 1.291 -1.971 0 CA-C-O 119.087 -0.482 . . . . 0.0 111.597 -177.088 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.514 ' HA ' ' CD1' ' A' ' 58' ' ' LEU . 38.6 Cg_exo -58.59 -38.47 89.41 Favored 'Trans proline' 0 C--N 1.384 2.409 0 C-N-CA 121.209 1.273 . . . . 0.0 113.572 -172.059 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.406 ' O ' ' HG3' ' A' ' 59' ' ' LYS . 11.0 pt-20 -70.13 -30.13 67.24 Favored 'General case' 0 C--O 1.214 -0.765 0 CA-C-O 120.826 0.346 . . . . 0.0 110.815 178.317 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 62.4 tp -69.66 -33.38 72.51 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.371 177.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.514 ' CD1' ' HA ' ' A' ' 55' ' ' PRO . 6.3 mt -65.58 -52.59 51.08 Favored 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 -179.042 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.462 ' O ' ' HA ' ' A' ' 64' ' ' PRO . 15.3 ptpt -63.04 -24.04 67.73 Favored 'General case' 0 C--O 1.187 -2.213 0 CA-C-N 114.897 -1.047 . . . . 0.0 113.296 177.149 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -82.53 -54.77 4.92 Favored 'General case' 0 C--N 1.292 -1.898 0 O-C-N 121.848 -0.533 . . . . 0.0 112.283 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 54.0 t80 -56.96 -31.26 64.83 Favored 'General case' 0 C--O 1.245 0.827 0 C-N-CA 124.287 1.035 . . . . 0.0 110.68 -173.719 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.624 ' OD1' ' HB3' ' A' ' 75' ' ' TYR . 3.4 m-20 -108.56 25.69 11.4 Favored 'General case' 0 C--N 1.283 -2.32 0 CA-C-N 114.19 -1.368 . . . . 0.0 111.681 -172.312 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.641 HD21 ' H ' ' A' ' 115' ' ' GLY . 34.5 mt 80.91 143.33 0.08 OUTLIER Pre-proline 0 N--CA 1.477 0.89 0 C-N-CA 125.056 1.342 . . . . 0.0 108.936 -178.408 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.462 ' HA ' ' O ' ' A' ' 59' ' ' LYS . 10.2 Cg_endo -84.2 21.5 1.06 Allowed 'Trans proline' 0 N--CA 1.439 -1.733 0 C-N-CA 122.837 2.358 . . . . 0.0 113.239 -161.797 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.596 ' O ' ' HA3' ' A' ' 159' ' ' GLY . 0.2 OUTLIER -72.93 -38.13 55.7 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.913 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 175.338 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 55.07 8.64 1.57 Allowed Glycine 0 N--CA 1.473 1.106 0 CA-C-N 114.988 -1.005 . . . . 0.0 114.329 178.099 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.749 ' O ' ' HB ' ' A' ' 160' ' ' VAL . 37.9 mt 70.77 -31.93 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 C-N-CA 125.578 1.551 . . . . 0.0 113.911 -179.132 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.525 ' HB2' ' O ' ' A' ' 67' ' ' ILE . 55.6 t80 167.04 -56.89 0.0 OUTLIER Pre-proline 0 C--N 1.312 -1.046 0 C-N-CA 124.743 1.217 . . . . 0.0 108.936 175.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.476 ' HD3' ' HB3' ' A' ' 68' ' ' PHE . 19.3 Cg_endo -110.4 -16.73 0.03 OUTLIER 'Trans proline' 0 CA--C 1.569 2.225 0 C-N-CA 122.777 2.318 . . . . 0.0 116.877 -171.701 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.474 ' H ' ' HD2' ' A' ' 69' ' ' PRO . . . 84.09 7.19 85.66 Favored Glycine 0 CA--C 1.533 1.161 0 C-N-CA 119.732 -1.223 . . . . 0.0 110.395 -171.155 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.465 ' HB3' ' HG2' ' A' ' 69' ' ' PRO . 30.0 t70 -82.36 -50.62 8.71 Favored 'General case' 0 CA--C 1.497 -1.086 0 N-CA-C 106.314 -1.735 . . . . 0.0 106.314 177.395 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.42 ' HB1' HG13 ' A' ' 88' ' ' ILE . . . -83.03 176.73 9.02 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 113.732 -1.577 . . . . 0.0 107.48 166.049 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.561 ' O ' HG22 ' A' ' 73' ' ' THR . 89.4 m 82.0 27.86 0.15 Allowed 'General case' 0 N--CA 1.492 1.633 0 CA-C-O 124.363 2.03 . . . . 0.0 109.8 176.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.594 HD22 ' N ' ' A' ' 74' ' ' ASN . 0.8 OUTLIER -87.84 123.53 32.71 Favored 'General case' 0 C--N 1.257 -3.447 0 CA-C-N 114.417 -1.265 . . . . 0.0 110.464 179.434 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.624 ' HB3' ' OD1' ' A' ' 62' ' ' ASP . 46.2 p90 -82.17 141.53 32.97 Favored 'General case' 0 C--N 1.295 -1.771 0 O-C-N 124.243 0.964 . . . . 0.0 112.506 -178.639 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.458 ' OE1' ' HB ' ' A' ' 39' ' ' THR . 32.0 mm-40 -159.39 136.84 9.88 Favored 'General case' 0 C--O 1.203 -1.347 0 C-N-CA 126.537 1.935 . . . . 0.0 107.266 174.409 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 49.9 p90 -134.7 148.32 50.28 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 118.538 0.608 . . . . 0.0 110.995 -177.163 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.619 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 4.6 m-20 -89.39 169.88 11.02 Favored 'General case' 0 CA--C 1.478 -1.827 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 177.477 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.58 ' OE1' ' HB3' ' A' ' 34' ' ' SER . 44.7 mt-10 -81.41 -62.07 1.76 Allowed 'General case' 0 C--N 1.267 -3.013 0 CA-C-N 114.426 -1.261 . . . . 0.0 111.337 177.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.32 -33.59 49.17 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 115.398 -0.819 . . . . 0.0 112.502 -176.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.619 ' HB ' ' HB2' ' A' ' 78' ' ' ASP . 90.1 m -81.46 -47.6 12.97 Favored 'General case' 0 C--N 1.288 -2.093 0 CA-C-N 115.192 -0.913 . . . . 0.0 111.844 178.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.401 ' H ' ' HB2' ' A' ' 78' ' ' ASP . 65.5 mttp 61.73 -5.55 0.14 Allowed 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 115.345 1.609 . . . . 0.0 115.345 -179.238 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.775 ' HG2' HG22 ' A' ' 109' ' ' THR . 32.6 ttmt -75.2 110.22 9.35 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 173.071 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.543 HD11 ' HB2' ' A' ' 75' ' ' TYR . 5.8 tt -66.23 134.02 51.82 Favored 'General case' 0 C--N 1.299 -1.6 0 CA-C-N 114.756 -1.111 . . . . 0.0 111.41 -174.067 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 15.0 t -108.02 126.93 53.31 Favored 'General case' 0 N--CA 1.397 -3.093 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.238 -179.288 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.582 ' HA ' ' O ' ' A' ' 74' ' ' ASN . 79.0 t -96.9 132.24 41.8 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.672 -179.359 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.9 mp -95.4 114.63 26.42 Favored 'General case' 0 N--CA 1.423 -1.787 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.721 -179.444 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.42 HG13 ' HB1' ' A' ' 72' ' ' ALA . 2.4 mp -104.83 110.27 64.22 Favored Pre-proline 0 C--N 1.299 -1.616 0 N-CA-C 105.77 -1.937 . . . . 0.0 105.77 171.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.625 ' O ' ' HB2' ' A' ' 166' ' ' ARG . 51.8 Cg_exo -56.17 94.07 0.05 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.498 0 C-N-CA 122.782 2.321 . . . . 0.0 112.215 178.164 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.491 ' HB2' ' HB2' ' A' ' 168' ' ' ASP . 40.9 t 74.95 141.53 0.07 Allowed 'General case' 0 C--N 1.343 0.323 0 C-N-CA 125.217 1.407 . . . . 0.0 111.813 -176.777 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.419 HD11 ' HD2' ' A' ' 103' ' ' LYS . 4.5 tt -69.08 121.35 18.27 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.504 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.894 177.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 12.7 p -107.58 145.16 33.59 Favored 'General case' 0 C--N 1.298 -1.657 0 CA-C-N 114.524 -1.216 . . . . 0.0 109.634 176.511 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.475 ' O ' ' HA3' ' A' ' 164' ' ' GLY . 2.2 mp0 -118.1 132.65 56.33 Favored 'General case' 0 CA--C 1.471 -2.087 0 N-CA-C 105.969 -1.863 . . . . 0.0 105.969 178.585 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.661 HG13 ' H ' ' A' ' 163' ' ' ASN . 16.7 t -108.8 104.19 16.69 Favored 'Isoleucine or valine' 0 N--CA 1.398 -3.046 0 C-N-CA 119.366 -0.934 . . . . 0.0 109.132 -178.628 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -138.45 -157.79 7.53 Favored Glycine 0 N--CA 1.404 -3.477 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 -179.102 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 0.44 ' C ' ' H ' ' A' ' 98' ' ' ASP . 72.4 t80 76.22 -44.38 0.49 Allowed 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 124.57 1.148 . . . . 0.0 110.293 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.496 ' HB2' ' NZ ' ' A' ' 97' ' ' LYS . 0.0 OUTLIER -72.48 11.03 0.68 Allowed 'General case' 0 C--N 1.31 -1.147 0 C-N-CA 127.003 2.121 . . . . 0.0 111.292 177.298 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.44 ' H ' ' C ' ' A' ' 96' ' ' TYR . 25.1 t70 -36.42 90.46 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 117.397 2.369 . . . . 0.0 117.397 -169.563 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 31.4 t -152.26 10.53 0.52 Allowed 'General case' 0 C--N 1.281 -2.391 0 N-CA-C 103.024 -2.954 . . . . 0.0 103.024 169.405 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . 0.44 ' HA ' ' O ' ' A' ' 126' ' ' LYS . 46.4 t 170.6 139.97 0.03 OUTLIER 'General case' 0 N--CA 1.419 -2.01 0 C-N-CA 127.528 2.331 . . . . 0.0 104.816 -174.394 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 54.3 t -126.03 131.21 71.97 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 179.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.539 ' HB2' ' HB ' ' A' ' 94' ' ' VAL . 2.7 mp -126.81 148.42 49.95 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 118.145 0.429 . . . . 0.0 110.126 -177.61 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.419 ' HD2' HD11 ' A' ' 91' ' ' ILE . 39.5 ttpt -138.67 123.73 19.01 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 174.811 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -120.77 108.05 13.49 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 178.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 12.4 t -81.47 -177.35 6.47 Favored 'General case' 0 N--CA 1.432 -1.339 0 CA-C-O 121.133 0.492 . . . . 0.0 111.266 -178.431 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 39.4 p -66.07 -58.71 4.87 Favored 'General case' 0 C--N 1.301 -1.538 0 C-N-CA 124.833 1.253 . . . . 0.0 112.595 -172.376 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 6.4 m -122.54 97.32 5.4 Favored 'General case' 0 N--CA 1.41 -2.455 0 CA-C-O 121.535 0.683 . . . . 0.0 109.866 -175.571 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 18.1 m -99.02 141.11 17.09 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 CA-C-N 114.978 -1.01 . . . . 0.0 109.545 179.301 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.775 HG22 ' HG2' ' A' ' 83' ' ' LYS . 2.9 m -114.62 119.91 38.36 Favored 'General case' 0 N--CA 1.403 -2.783 0 N-CA-C 104.748 -2.316 . . . . 0.0 104.748 -174.336 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.734 ' HA2' ' O ' ' A' ' 119' ' ' ASP . . . -141.74 159.56 26.9 Favored Glycine 0 N--CA 1.435 -1.38 0 C-N-CA 120.037 -1.078 . . . . 0.0 115.169 -174.258 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 6.8 t60 -88.06 109.28 19.73 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 177.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 65.3 tp -106.96 120.99 43.55 Favored 'General case' 0 C--N 1.302 -1.461 0 C-N-CA 119.885 -0.726 . . . . 0.0 112.458 -175.099 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -115.1 158.05 22.71 Favored 'General case' 0 CA--C 1.448 -2.971 0 N-CA-C 107.505 -1.294 . . . . 0.0 107.505 169.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 2.4 tmtm? -82.25 99.12 9.12 Favored 'General case' 2 N--CA 1.375 -4.202 0 N-CA-C 107.135 -1.432 . . . . 0.0 107.135 -175.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . 0.641 ' H ' HD21 ' A' ' 63' ' ' LEU . . . 131.28 -20.24 4.74 Favored Glycine 0 C--O 1.19 -2.631 0 N-CA-C 109.978 -1.249 . . . . 0.0 109.978 -177.257 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -163.23 135.8 5.38 Favored 'General case' 0 C--N 1.314 -0.953 0 O-C-N 122.109 -0.642 . . . . 0.0 110.864 -177.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 3.1 tt -116.8 114.54 24.08 Favored 'General case' 0 C--N 1.286 -2.168 0 N-CA-C 106.246 -1.761 . . . . 0.0 106.246 178.002 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.452 ' HA ' ' CB ' ' A' ' 135' ' ' SER . 49.9 p -116.52 175.77 5.41 Favored 'General case' 0 C--N 1.279 -2.48 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.424 -176.016 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . 0.734 ' O ' ' HA2' ' A' ' 110' ' ' GLY . 7.0 m-20 54.91 83.84 0.08 Allowed 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.629 0.772 . . . . 0.0 111.2 174.85 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.431 ' CG2' ' HB ' ' A' ' 123' ' ' ILE . 13.6 m -119.3 108.47 23.86 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.8 0 CA-C-O 122.303 1.049 . . . . 0.0 112.321 -172.469 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -79.9 100.24 7.95 Favored 'General case' 0 C--N 1.268 -2.943 0 CA-C-N 114.331 -1.304 . . . . 0.0 110.204 174.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 123.94 -14.08 8.01 Favored Glycine 0 N--CA 1.435 -1.428 0 C-N-CA 120.722 -0.751 . . . . 0.0 113.161 176.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.431 ' HB ' ' CG2' ' A' ' 120' ' ' VAL . 63.5 mt -102.46 116.09 45.53 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.914 0 CA-C-O 121.536 0.684 . . . . 0.0 110.116 179.555 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -124.21 141.23 52.24 Favored 'General case' 0 C--N 1.294 -1.847 0 CA-C-N 114.795 -1.093 . . . . 0.0 109.053 178.474 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.433 ' OG1' ' HG ' ' A' ' 102' ' ' LEU . 11.1 t -152.48 162.67 40.88 Favored 'General case' 0 C--O 1.245 0.847 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 178.495 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.454 ' HE2' ' N ' ' A' ' 128' ' ' MET . 8.3 tmtt? -131.18 129.59 41.91 Favored 'General case' 0 N--CA 1.426 -1.635 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.656 176.261 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.408 ' O ' ' HB3' ' A' ' 128' ' ' MET . 41.8 t -150.02 112.81 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.481 -1.699 0 N-CA-C 104.31 -2.478 . . . . 0.0 104.31 172.764 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . 0.454 ' N ' ' HE2' ' A' ' 126' ' ' LYS . 45.9 ttm 69.48 -54.95 0.58 Allowed 'General case' 0 N--CA 1.473 0.696 0 O-C-N 124.031 0.832 . . . . 0.0 109.978 -172.054 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 8.0 tp -139.18 162.89 27.21 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.716 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 178.38 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 69.5 p-90 -92.67 137.72 32.12 Favored 'General case' 0 N--CA 1.423 -1.823 0 CA-C-O 121.064 0.459 . . . . 0.0 110.861 -178.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 53.4 t -134.31 121.83 38.38 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.154 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 179.343 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 60.1 pttt -98.29 3.16 48.73 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.157 0.503 . . . . 0.0 111.955 -176.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 34.4 m -124.22 25.02 3.47 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.204 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 176.545 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 9.4 t -55.24 113.24 1.31 Allowed 'General case' 0 N--CA 1.441 -0.906 0 CA-C-N 113.258 -1.792 . . . . 0.0 113.249 -173.178 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . 0.46 ' O ' ' HA ' ' A' ' 146' ' ' THR . 26.3 p -100.1 149.94 22.99 Favored 'General case' 0 N--CA 1.405 -2.72 0 C-N-CA 119.72 -0.792 . . . . 0.0 113.033 -177.38 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . 0.527 ' HB ' HG22 ' A' ' 146' ' ' THR . 13.2 tt -100.9 138.46 25.05 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.71 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 -179.109 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 14.7 t -120.55 142.71 49.09 Favored 'General case' 0 N--CA 1.408 -2.567 0 N-CA-C 107.052 -1.462 . . . . 0.0 107.052 -178.479 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . 0.453 ' HB ' HD13 ' A' ' 63' ' ' LEU . 33.2 m -149.02 175.5 11.25 Favored 'General case' 0 C--N 1.27 -2.882 0 N-CA-C 106.523 -1.658 . . . . 0.0 106.523 -176.768 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -118.05 30.45 7.23 Favored 'General case' 0 C--N 1.277 -2.583 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 174.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.499 ' HA ' HD22 ' A' ' 63' ' ' LEU . . . 60.26 36.56 20.75 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-N 114.745 -1.116 . . . . 0.0 110.145 -177.045 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . 0.407 ' H ' HG22 ' A' ' 138' ' ' THR . 41.4 t 174.38 -82.68 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 114.283 -1.326 . . . . 0.0 108.353 -172.607 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 23.0 pttm -77.56 136.79 38.32 Favored 'General case' 0 CA--C 1.505 -0.758 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 177.62 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.409 HG21 HG21 ' A' ' 65' ' ' ILE . 12.4 p -109.95 156.58 10.79 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.889 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 -171.23 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -128.98 154.16 46.86 Favored 'General case' 0 N--CA 1.428 -1.539 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 174.613 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 33.9 t80 -73.96 162.92 28.55 Favored 'General case' 0 C--N 1.309 -1.152 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 -175.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.527 HG22 ' HB ' ' A' ' 136' ' ' ILE . 70.9 p -71.7 -172.73 0.85 Allowed 'General case' 0 N--CA 1.42 -1.966 0 CA-C-O 121.512 0.672 . . . . 0.0 112.609 -175.358 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . 74.78 -29.54 0.19 Allowed 'General case' 0 N--CA 1.463 0.192 0 C-N-CA 126.018 1.727 . . . . 0.0 113.317 177.267 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 147.74 43.63 0.03 OUTLIER Glycine 0 CA--C 1.477 -2.319 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 178.008 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 65.3 mtt 60.96 40.14 15.76 Favored 'General case' 0 C--N 1.344 0.369 0 O-C-N 124.196 0.586 . . . . 0.0 110.224 -177.409 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . 0.6 ' HE2' ' HA ' ' A' ' 150' ' ' LYS . 9.5 mmpt? -65.53 -16.76 64.0 Favored 'General case' 0 N--CA 1.483 1.199 0 CA-C-O 120.816 0.341 . . . . 0.0 111.415 -178.766 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.543 ' HA ' ' HE3' ' A' ' 151' ' ' LYS . 0.0 OUTLIER -147.27 163.43 36.42 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 176.962 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 9.0 p -131.34 111.65 12.04 Favored 'General case' 0 C--N 1.292 -1.904 0 CA-C-O 121.391 0.615 . . . . 0.0 110.483 176.502 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 33.5 mmt180 -113.87 160.51 18.68 Favored 'General case' 0 CA--C 1.501 -0.914 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.001 -179.085 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 51.2 m -96.05 140.49 30.7 Favored 'General case' 0 N--CA 1.42 -1.93 0 CA-C-N 116.253 -0.43 . . . . 0.0 109.905 177.068 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' ARG . . . . . 0.574 ' HG3' ' HA2' ' A' ' 159' ' ' GLY . 9.0 ttp180 -74.99 -21.2 59.28 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.051 175.625 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -34.92 -49.6 0.45 Allowed 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 126.315 1.846 . . . . 0.0 114.806 -174.144 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -77.44 -55.37 5.45 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 113.635 0.976 . . . . 0.0 113.635 -176.198 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -153.52 16.02 0.52 Allowed 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.981 -0.449 . . . . 0.0 111.836 -176.01 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . 0.596 ' HA3' ' O ' ' A' ' 65' ' ' ILE . . . 84.88 -89.35 1.6 Allowed Glycine 0 CA--C 1.466 -2.989 0 C-N-CA 119.646 -1.264 . . . . 0.0 110.735 -174.501 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.749 ' HB ' ' O ' ' A' ' 67' ' ' ILE . 39.1 t -99.6 148.5 6.39 Favored 'Isoleucine or valine' 0 N--CA 1.4 -2.931 0 C-N-CA 119.491 -0.884 . . . . 0.0 109.102 177.575 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 74.8 mt-30 -113.74 108.98 17.84 Favored 'General case' 0 N--CA 1.416 -2.158 0 N-CA-C 106.393 -1.706 . . . . 0.0 106.393 -172.082 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . 0.537 ' HD2' ' C ' ' A' ' 162' ' ' ARG . 5.2 ppt_? -125.9 163.15 23.57 Favored 'General case' 0 C--N 1.275 -2.668 0 CA-C-N 115.167 -0.924 . . . . 0.0 112.919 -169.76 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' ASN . . . . . 0.661 ' H ' HG13 ' A' ' 94' ' ' VAL . 3.1 m-20 -110.4 -59.65 1.91 Allowed 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.875 175.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . 0.503 ' O ' ' HD3' ' A' ' 162' ' ' ARG . . . -61.0 147.38 47.03 Favored Glycine 0 CA--C 1.501 -0.782 0 CA-C-N 115.877 -0.601 . . . . 0.0 113.033 -179.635 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 65.6 tp -107.83 139.23 42.73 Favored 'General case' 0 N--CA 1.422 -1.827 0 CA-C-O 121.169 0.509 . . . . 0.0 109.851 -177.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . 0.625 ' HB2' ' O ' ' A' ' 89' ' ' PRO . 6.5 ptp85 -85.84 103.49 14.64 Favored 'General case' 0 C--N 1.287 -2.146 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 176.471 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 4.8 t -102.9 70.98 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.788 0 CA-C-N 115.184 -0.916 . . . . 0.0 112.46 -170.52 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . 0.491 ' HB2' ' HB2' ' A' ' 90' ' ' SER . 15.8 t70 -109.14 -39.2 5.33 Favored 'General case' 0 CA--C 1.475 -1.918 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 175.304 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' LYS . . . . . 0.645 ' HD3' ' H ' ' A' ' 169' ' ' LYS . 0.0 OUTLIER -93.1 149.65 21.08 Favored 'General case' 0 C--N 1.287 -2.128 0 CA-C-N 113.48 -1.691 . . . . 0.0 109.634 -174.146 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' PHE . . . . . . . . . . . . . 81.6 t80 . . . . . 0 C--N 1.288 -2.082 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 179.719 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 25.2 p . . . . . 0 N--CA 1.442 -0.844 0 CA-C-O 121.279 0.562 . . . . 0.0 111.095 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -133.7 103.92 6.1 Favored 'General case' 0 CA--C 1.498 -1.056 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 179.238 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -82.99 86.48 6.98 Favored 'General case' 0 C--N 1.309 -1.166 0 C-N-CA 118.575 -1.25 . . . . 0.0 112.223 179.62 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 8.1 tt -140.21 95.74 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.149 0 CA-C-N 113.734 -1.575 . . . . 0.0 106.757 176.171 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 62.9 t80 -142.49 139.6 31.58 Favored 'General case' 0 C--N 1.299 -1.629 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.167 -173.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -146.91 154.99 41.95 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 178.4 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -120.79 132.53 55.08 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 176.005 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.5 p -122.39 103.14 12.9 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.721 0 CA-C-O 121.906 0.86 . . . . 0.0 112.9 -175.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -114.9 109.39 2.11 Favored Glycine 0 N--CA 1.427 -1.905 0 N-CA-C 109.309 -1.516 . . . . 0.0 109.309 175.383 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 48.5 m -83.31 128.18 34.28 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-O 120.888 0.375 . . . . 0.0 111.1 -177.473 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -130.44 104.57 7.32 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 177.182 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 37.6 p90 -116.51 149.87 38.86 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 -178.541 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 5.3 tt 179.99 -50.64 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 -179.684 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 105.67 42.79 1.65 Allowed Glycine 0 N--CA 1.436 -1.358 0 CA-C-N 115.384 -0.825 . . . . 0.0 111.588 -179.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 47.2 mt-30 -79.98 154.92 27.91 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-O 120.59 0.233 . . . . 0.0 110.607 -179.695 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 95.5 mttt 65.83 -176.73 0.18 Allowed 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 124.122 0.969 . . . . 0.0 111.835 178.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 62.65 26.96 15.95 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.557 0.743 . . . . 0.0 111.222 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 52.6 m-80 -86.75 -171.7 3.65 Favored 'General case' 0 C--O 1.244 0.812 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.642 -178.553 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.6 tmmm? -69.49 108.17 3.67 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 179.572 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -108.65 109.24 20.38 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 84.0 t80 -154.22 117.81 4.62 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 -179.093 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -94.95 -69.47 0.75 Allowed 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 176.23 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 34.2 t -168.58 151.92 5.48 Favored 'General case' 0 N--CA 1.442 -0.841 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 179.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 17.4 m -98.53 90.97 2.24 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.913 0 CA-C-O 121.78 0.8 . . . . 0.0 112.18 178.04 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -115.96 84.87 0.38 Allowed Glycine 0 N--CA 1.436 -1.309 0 N-CA-C 110.409 -1.076 . . . . 0.0 110.409 178.249 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -145.16 111.91 5.87 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-O 120.89 0.376 . . . . 0.0 110.376 -178.239 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -129.33 143.53 50.88 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 115.467 -0.788 . . . . 0.0 108.928 -178.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 50.8 tp -88.77 145.53 25.55 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-O 120.806 0.336 . . . . 0.0 110.399 -177.681 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 28.2 p-10 -93.26 179.79 5.31 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.388 179.411 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 21.1 m 72.12 175.45 0.28 Allowed 'General case' 0 C--O 1.248 1.018 0 C-N-CA 124.667 1.187 . . . . 0.0 111.137 -179.476 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 23.8 m -86.77 83.36 2.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-O 122.407 1.099 . . . . 0.0 113.115 -177.098 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 49.9 m -157.62 138.73 13.45 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 177.25 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 39.4 p -79.1 110.96 14.84 Favored 'General case' 0 C--N 1.308 -1.212 0 C-N-CA 120.939 -0.304 . . . . 0.0 111.054 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 24.6 t -160.25 92.53 0.99 Allowed 'General case' 0 N--CA 1.435 -1.2 0 CA-C-O 121.475 0.655 . . . . 0.0 110.874 179.321 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 54.9 mt 56.66 84.33 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.241 0.64 0 C-N-CA 126.025 1.73 . . . . 0.0 114.311 176.463 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.513 ' O ' ' HA ' ' A' ' 97' ' ' LYS . 0.4 OUTLIER -176.29 112.62 0.11 Allowed 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 106.272 -1.751 . . . . 0.0 106.272 175.733 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -109.89 39.24 2.97 Favored Glycine 0 C--O 1.215 -1.041 0 C-N-CA 120.376 -0.916 . . . . 0.0 113.915 -176.302 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 84.2 0.5 89.54 Favored Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 120.565 -0.826 . . . . 0.0 112.139 177.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 23.8 m 58.65 90.54 0.05 OUTLIER 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 124.912 1.285 . . . . 0.0 112.471 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.427 ' NZ ' ' HB3' ' A' ' 40' ' ' LYS . 0.0 OUTLIER -169.81 136.51 1.57 Allowed 'General case' 0 CA--C 1.508 -0.66 0 CA-C-O 120.941 0.401 . . . . 0.0 110.116 174.179 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 28.3 m-90 -108.52 95.4 5.63 Favored 'General case' 0 C--N 1.287 -2.134 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 175.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 48.0 tp -74.35 95.93 2.76 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-N 115.189 -0.914 . . . . 0.0 111.904 -174.563 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 6.5 p -103.01 84.73 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.421 -1.887 0 CA-C-O 122.719 1.247 . . . . 0.0 109.069 175.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -141.32 102.25 4.18 Favored 'General case' 0 C--N 1.295 -1.776 0 CA-C-N 114.298 -1.319 . . . . 0.0 108.698 -178.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 63.0 pttt -117.42 129.61 55.96 Favored 'General case' 0 C--N 1.292 -1.891 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 179.204 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.422 HD12 ' N ' ' A' ' 46' ' ' ILE . 2.8 mp -81.72 -56.14 6.69 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.05 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 179.372 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 23.1 tptm 46.37 83.11 0.03 OUTLIER 'General case' 0 C--O 1.245 0.864 0 O-C-N 124.966 1.416 . . . . 0.0 110.551 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -63.62 141.72 45.92 Favored Glycine 0 N--CA 1.444 -0.779 0 CA-C-N 115.157 -0.929 . . . . 0.0 114.237 -173.275 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -112.39 157.13 21.41 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 177.533 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 28.0 ttt 66.19 16.11 10.33 Favored 'General case' 0 N--CA 1.482 1.174 0 CA-C-O 122.5 1.143 . . . . 0.0 110.497 177.655 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -109.05 170.43 8.06 Favored 'General case' 0 N--CA 1.432 -1.336 0 CA-C-N 115.107 -0.952 . . . . 0.0 109.166 178.097 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.504 ' O ' ' HD2' ' A' ' 55' ' ' PRO . 59.6 tptt -64.46 123.96 84.45 Favored Pre-proline 0 N--CA 1.435 -1.221 0 N-CA-C 106.021 -1.844 . . . . 0.0 106.021 174.342 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -77.86 18.1 0.91 Allowed 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 122.162 1.908 . . . . 0.0 113.823 -175.592 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.645 ' HB3' ' HD3' ' A' ' 55' ' ' PRO . 10.5 tp -72.36 -56.7 3.98 Favored Pre-proline 0 C--O 1.203 -1.349 0 C-N-CA 120.367 -0.533 . . . . 0.0 110.213 -179.363 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.645 ' HD3' ' HB3' ' A' ' 54' ' ' LEU . 8.1 Cg_exo -50.73 -38.2 55.81 Favored 'Trans proline' 0 C--N 1.388 2.608 0 C-N-CA 123.536 2.824 . . . . 0.0 112.671 -177.444 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -76.95 -31.84 56.88 Favored 'General case' 0 N--CA 1.432 -1.365 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.069 -179.299 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.564 ' HG ' ' O ' ' A' ' 54' ' ' LEU . 2.0 pp -75.74 -28.67 58.59 Favored 'General case' 0 C--O 1.204 -1.293 0 C-N-CA 119.669 -0.812 . . . . 0.0 108.984 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.639 ' HG ' ' O ' ' A' ' 54' ' ' LEU . 63.0 mt -57.34 -48.76 78.14 Favored 'General case' 0 C--O 1.199 -1.571 0 O-C-N 123.938 0.774 . . . . 0.0 110.809 -177.123 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 55.2 mtpt -64.88 -29.53 70.49 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-O 121.846 0.832 . . . . 0.0 110.627 -177.68 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -96.71 1.71 51.25 Favored 'General case' 0 C--N 1.297 -1.686 0 CA-C-N 114.692 -1.14 . . . . 0.0 111.424 -178.214 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.437 ' HB3' ' CD2' ' A' ' 75' ' ' TYR . 41.2 t80 -57.15 -42.88 81.86 Favored 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 112.776 0.658 . . . . 0.0 112.776 -170.542 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.566 ' OD1' ' HA ' ' A' ' 114' ' ' LYS . 11.2 t70 -139.67 -74.56 0.36 Allowed 'General case' 0 C--N 1.315 -0.916 0 C-N-CA 120.031 -0.667 . . . . 0.0 109.989 -177.41 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.559 HD21 ' H ' ' A' ' 115' ' ' GLY . 20.3 mt -96.29 150.17 36.82 Favored Pre-proline 0 N--CA 1.445 -0.719 0 N-CA-C 106.23 -1.767 . . . . 0.0 106.23 175.489 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_endo -99.9 18.22 0.35 Allowed 'Trans proline' 0 N--CA 1.443 -1.497 0 C-N-CA 123.77 2.98 . . . . 0.0 113.539 -169.391 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.517 ' HB ' HG23 ' A' ' 160' ' ' VAL . 0.2 OUTLIER -69.78 -45.01 78.6 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.872 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 176.743 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 52.83 9.53 0.8 Allowed Glycine 0 N--CA 1.486 2.011 0 CA-C-N 114.908 -1.042 . . . . 0.0 114.266 178.401 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.667 ' HA ' ' CG2' ' A' ' 160' ' ' VAL 0.288 20.2 mt 62.17 -68.37 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 C-N-CA 126.413 1.885 . . . . 0.0 112.835 -170.948 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.418 ' HB3' ' HD3' ' A' ' 69' ' ' PRO . 69.6 t80 177.97 -55.41 0.0 OUTLIER Pre-proline 0 C--N 1.301 -1.528 0 O-C-N 123.69 0.619 . . . . 0.0 111.674 -177.787 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.418 ' HD3' ' HB3' ' A' ' 68' ' ' PHE . 2.9 Cg_endo -82.9 -70.35 0.01 OUTLIER 'Trans proline' 0 C--N 1.369 1.647 0 C-N-CA 121.763 1.642 . . . . 0.0 113.003 -175.402 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 153.73 -40.53 0.67 Allowed Glycine 0 CA--C 1.492 -1.38 0 N-CA-C 110.092 -1.203 . . . . 0.0 110.092 -176.114 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.442 ' HB3' ' HG3' ' A' ' 89' ' ' PRO . 3.2 t70 -74.84 -55.25 6.01 Favored 'General case' 0 C--O 1.184 -2.352 0 N-CA-C 104.745 -2.317 . . . . 0.0 104.745 175.757 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.432 ' HA ' HG12 ' A' ' 88' ' ' ILE . . . -66.08 99.57 0.52 Allowed 'General case' 0 C--N 1.31 -1.132 0 C-N-CA 117.082 -1.847 . . . . 0.0 107.556 163.216 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . 1.619 6.3 m 115.26 30.8 0.0 OUTLIER 'General case' 0 N--CA 1.439 -1.012 1 N-CA-C 123.299 4.555 . . . . 0.0 123.299 -178.542 . . . . . . . . 3 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.582 ' O ' HG22 ' A' ' 86' ' ' VAL . 3.5 p30 -89.11 178.28 6.42 Favored 'General case' 0 C--N 1.293 -1.882 0 CA-C-N 114.708 -1.133 . . . . 0.0 108.003 167.419 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.504 ' HB3' HD21 ' A' ' 84' ' ' LEU . 93.4 m-85 -136.73 101.56 4.64 Favored 'General case' 0 C--N 1.281 -2.395 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 -178.248 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -108.59 114.15 27.72 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 -178.253 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 87.8 t80 -112.94 126.73 55.8 Favored 'General case' 0 C--N 1.282 -2.363 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 -176.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.671 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 7.3 m-20 -91.09 164.44 13.94 Favored 'General case' 0 CA--C 1.478 -1.799 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 177.001 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -80.27 -64.77 1.11 Allowed 'General case' 0 C--N 1.278 -2.515 0 CA-C-N 115.055 -0.975 . . . . 0.0 112.662 -175.541 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -71.91 -30.36 65.28 Favored 'General case' 0 CA--C 1.506 -0.736 0 CA-C-O 121.437 0.637 . . . . 0.0 110.538 -176.033 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.671 ' HB ' ' HB2' ' A' ' 78' ' ' ASP . 17.7 m -66.29 -46.81 75.7 Favored 'General case' 0 N--CA 1.417 -2.125 0 CA-C-N 115.082 -0.963 . . . . 0.0 110.295 -178.218 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 97.3 mttt 64.58 17.59 10.96 Favored 'General case' 0 N--CA 1.486 1.363 0 CA-C-O 121.982 0.896 . . . . 0.0 111.486 178.345 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.485 ' HB3' HG22 ' A' ' 81' ' ' THR . 47.0 tptt -116.03 124.62 50.91 Favored 'General case' 0 N--CA 1.394 -3.248 0 N-CA-C 105.242 -2.133 . . . . 0.0 105.242 -178.607 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.504 HD21 ' HB3' ' A' ' 75' ' ' TYR . 3.1 tm? -76.46 137.38 39.64 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 179.794 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.447 ' N ' HD13 ' A' ' 84' ' ' LEU . 54.1 p -125.94 144.8 50.54 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.582 HG22 ' O ' ' A' ' 74' ' ' ASN . 92.9 t -112.98 130.39 66.92 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.512 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 172.337 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 18.5 mt -96.4 102.16 13.91 Favored 'General case' 0 C--N 1.282 -2.355 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 -179.447 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.432 HG12 ' HA ' ' A' ' 72' ' ' ALA . 62.6 mt -104.15 135.1 19.39 Favored Pre-proline 0 C--N 1.306 -1.313 0 N-CA-C 109.63 -0.508 . . . . 0.0 109.63 -178.378 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.442 ' HG3' ' HB3' ' A' ' 71' ' ' ASP . 37.9 Cg_endo -84.04 110.34 1.54 Allowed 'Trans proline' 0 N--CA 1.43 -2.264 0 C-N-CA 122.548 2.165 . . . . 0.0 110.483 177.606 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 59.9 m 71.41 156.25 0.16 Allowed 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 122.146 0.974 . . . . 0.0 113.181 -179.748 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.511 HG12 ' HA ' ' A' ' 105' ' ' THR . 96.5 mt -80.72 125.69 39.4 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.861 0 CA-C-N 114.807 -1.088 . . . . 0.0 110.038 177.058 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 8.9 p -118.13 145.92 44.54 Favored 'General case' 0 C--N 1.293 -1.87 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 173.292 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -131.18 130.84 43.53 Favored 'General case' 0 C--N 1.282 -2.334 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 -174.099 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.614 HG13 ' H ' ' A' ' 163' ' ' ASN . 55.7 t -118.67 109.43 26.92 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.296 0 CA-C-O 121.266 0.555 . . . . 0.0 111.87 -173.779 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -145.76 -169.31 13.78 Favored Glycine 0 N--CA 1.408 -3.209 0 N-CA-C 109.357 -1.497 . . . . 0.0 109.357 175.306 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 44.4 t80 79.23 -50.76 0.43 Allowed 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.341 1.056 . . . . 0.0 112.062 168.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.548 ' HD2' ' C ' ' A' ' 97' ' ' LYS . 0.1 OUTLIER -71.79 -22.48 61.57 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 177.439 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.409 ' N ' ' HD2' ' A' ' 97' ' ' LYS . 16.0 t70 -99.57 -82.98 0.43 Allowed 'General case' 0 N--CA 1.42 -1.955 0 CA-C-N 114.375 -1.284 . . . . 0.0 112.626 -169.82 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 51.9 p 170.26 -38.14 0.0 OUTLIER 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 106.375 -1.713 . . . . 0.0 106.375 -176.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . 0.646 ' HB3' ' O ' ' A' ' 126' ' ' LYS . 23.3 m -96.02 176.85 5.95 Favored 'General case' 0 N--CA 1.402 -2.856 0 CA-C-N 113.053 -1.885 . . . . 0.0 110.489 -179.2 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 86.6 t -128.68 102.64 8.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 N-CA-C 107.313 -1.365 . . . . 0.0 107.313 175.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.657 HD22 HG23 ' A' ' 125' ' ' THR . 55.2 mt -109.39 130.86 55.48 Favored 'General case' 0 C--N 1.285 -2.205 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.989 -171.144 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.443 ' HE3' HD13 ' A' ' 91' ' ' ILE . 35.2 tttp -103.63 115.57 30.74 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 110.237 -0.282 . . . . 0.0 110.237 -175.391 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -96.89 95.73 8.05 Favored 'General case' 0 N--CA 1.413 -2.285 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 173.303 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.636 ' H ' HG22 ' A' ' 123' ' ' ILE . 19.6 m -66.35 179.56 0.97 Allowed 'General case' 0 N--CA 1.423 -1.803 0 CA-C-N 113.587 -1.642 . . . . 0.0 110.186 177.318 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.631 ' H ' HG22 ' A' ' 105' ' ' THR . 22.1 p -79.56 -74.09 0.31 Allowed 'General case' 0 C--N 1.301 -1.527 0 C-N-CA 123.814 0.846 . . . . 0.0 112.408 -173.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 11.5 p -96.04 101.59 13.28 Favored 'General case' 0 N--CA 1.406 -2.642 0 CA-C-O 121.295 0.569 . . . . 0.0 110.25 -178.412 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.444 ' CG2' HG23 ' A' ' 123' ' ' ILE . 1.1 p -97.45 159.01 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.03 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 -179.778 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.483 HG22 ' HG2' ' A' ' 83' ' ' LYS . 63.6 m -144.71 120.38 10.47 Favored 'General case' 0 C--N 1.293 -1.876 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 -173.103 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.55 ' HA3' ' O ' ' A' ' 119' ' ' ASP . . . -160.69 -157.45 8.71 Favored Glycine 0 C--O 1.202 -1.897 0 C-N-CA 121.091 -0.576 . . . . 0.0 113.88 -174.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 36.4 m80 -124.64 117.34 24.06 Favored 'General case' 0 C--N 1.305 -1.358 0 O-C-N 122.269 -0.548 . . . . 0.0 109.687 177.277 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.478 HD22 ' CD1' ' A' ' 75' ' ' TYR . 67.0 tp -100.68 129.61 46.61 Favored 'General case' 0 C--N 1.293 -1.885 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.267 -177.605 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -127.32 153.29 46.36 Favored 'General case' 0 CA--C 1.441 -3.239 0 CA-C-N 115.018 -0.992 . . . . 0.0 109.507 174.115 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.566 ' HA ' ' OD1' ' A' ' 62' ' ' ASP . 56.6 tptt -67.54 101.52 1.01 Allowed 'General case' 0 N--CA 1.388 -3.539 0 O-C-N 124.672 1.233 . . . . 0.0 107.896 176.816 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . 0.573 ' O ' ' HB ' ' A' ' 138' ' ' THR . . . 135.78 -55.3 0.72 Allowed Glycine 0 N--CA 1.401 -3.657 0 N-CA-C 109.272 -1.531 . . . . 0.0 109.272 -175.209 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.611 ' HD3' HG23 ' A' ' 118' ' ' THR . 0.0 OUTLIER -148.98 152.73 36.84 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 -177.485 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.521 ' O ' ' HB2' ' A' ' 135' ' ' SER . 47.9 tp -108.47 102.77 11.83 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-N 115.337 -0.847 . . . . 0.0 108.96 177.616 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.611 HG23 ' HD3' ' A' ' 116' ' ' LYS . 6.1 p -103.22 167.09 10.05 Favored 'General case' 0 C--N 1.299 -1.619 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.048 178.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . 0.55 ' O ' ' HA3' ' A' ' 110' ' ' GLY . 5.8 m-20 67.94 107.22 0.05 OUTLIER 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.665 0.786 . . . . 0.0 109.12 -176.041 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.527 ' HB ' HG12 ' A' ' 123' ' ' ILE 0.354 4.1 m -125.7 72.79 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.401 -2.92 0 N-CA-C 114.243 1.201 . . . . 0.0 114.243 179.514 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -82.04 86.39 6.58 Favored 'General case' 0 N--CA 1.425 -1.682 0 CA-C-N 114.271 -1.331 . . . . 0.0 110.449 176.121 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 161.92 -40.77 0.39 Allowed Glycine 0 C--N 1.262 -3.533 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 175.141 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.636 HG22 ' H ' ' A' ' 105' ' ' THR . 25.2 pt -100.12 152.2 4.83 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.737 0 C-N-CA 119.09 -1.044 . . . . 0.0 108.813 -178.041 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.423 ' NZ ' ' HB2' ' A' ' 124' ' ' LYS . 4.1 ttmp? -128.79 138.0 51.83 Favored 'General case' 0 C--N 1.27 -2.854 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 -176.468 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.657 HG23 HD22 ' A' ' 102' ' ' LEU . 13.3 m -124.13 115.45 21.16 Favored 'General case' 0 C--N 1.283 -2.296 0 CA-C-N 115.517 -0.765 . . . . 0.0 112.928 -169.561 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.646 ' O ' ' HB3' ' A' ' 100' ' ' SER . 0.2 OUTLIER -100.85 115.66 30.89 Favored 'General case' 0 N--CA 1.413 -2.289 0 N-CA-C 107.154 -1.424 . . . . 0.0 107.154 169.572 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.647 HG13 ' SD ' ' A' ' 128' ' ' MET 0.25 1.0 OUTLIER -120.47 -78.46 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.128 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.353 176.739 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . 0.647 ' SD ' HG13 ' A' ' 127' ' ' VAL . 0.0 OUTLIER -103.69 -9.15 19.36 Favored 'General case' 0 N--CA 1.412 -2.362 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 176.67 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.411 HG23 HG13 ' A' ' 131' ' ' VAL . 8.9 tp -164.06 164.48 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.41 -2.437 0 N-CA-C 106.297 -1.742 . . . . 0.0 106.297 177.834 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 31.0 t90 -85.33 114.93 22.77 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 -178.436 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.411 HG13 HG23 ' A' ' 129' ' ' ILE . 15.7 m -148.74 -175.27 0.38 Allowed 'Isoleucine or valine' 0 C--O 1.211 -0.953 0 C-N-CA 125.125 1.37 . . . . 0.0 109.452 -176.381 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . 0.505 ' HG3' ' N ' ' A' ' 133' ' ' VAL . 38.6 pttt -131.06 -36.62 1.32 Allowed 'General case' 0 C--N 1.305 -1.334 0 C-N-CA 120.227 -0.589 . . . . 0.0 112.038 176.163 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.505 ' N ' ' HG3' ' A' ' 132' ' ' LYS . 25.6 m -69.81 -8.0 9.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 N-CA-C 115.389 1.626 . . . . 0.0 115.389 -165.484 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . 0.416 ' O ' ' HB ' ' A' ' 146' ' ' THR . 37.9 p -75.57 90.3 2.77 Favored 'General case' 0 N--CA 1.42 -1.951 0 CA-C-O 121.767 0.794 . . . . 0.0 110.48 179.464 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . 0.521 ' HB2' ' O ' ' A' ' 117' ' ' LEU . 30.0 p -86.13 174.27 9.27 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-N 114.404 -1.271 . . . . 0.0 112.757 -175.554 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 9.4 tt -98.33 122.46 50.01 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.798 0 CA-C-O 122.027 0.918 . . . . 0.0 111.889 -171.38 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 34.0 p -96.56 148.11 23.17 Favored 'General case' 0 N--CA 1.417 -2.113 0 CA-C-N 114.886 -1.052 . . . . 0.0 108.69 176.473 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . 0.573 ' HB ' ' O ' ' A' ' 115' ' ' GLY . 93.6 m -154.03 164.09 39.03 Favored 'General case' 0 C--N 1.289 -2.043 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 -172.565 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 63.7 m-20 -99.64 22.97 10.13 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 172.457 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.549 ' N ' HG22 ' A' ' 138' ' ' THR . . . 58.86 36.36 24.62 Favored 'General case' 0 C--N 1.351 0.661 0 N-CA-C 106.525 -1.657 . . . . 0.0 106.525 -167.331 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . 0.481 ' H ' HG22 ' A' ' 138' ' ' THR . 35.3 t -167.54 -75.36 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.841 0 CA-C-N 113.741 -1.572 . . . . 0.0 110.341 -170.124 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.513 ' O ' HG23 ' A' ' 138' ' ' THR . 96.7 mttt -98.65 163.58 12.59 Favored 'General case' 0 N--CA 1.484 1.268 0 CA-C-N 117.924 0.329 . . . . 0.0 110.581 -179.306 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 92.1 t -106.7 135.14 46.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-O 121.431 0.634 . . . . 0.0 111.1 -178.389 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 62.5 m-85 -119.76 156.53 30.4 Favored 'General case' 0 C--N 1.296 -1.732 0 CA-C-N 115.483 -0.781 . . . . 0.0 109.501 179.143 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 46.9 p90 -42.03 133.17 3.04 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 124.558 1.143 . . . . 0.0 113.92 -176.288 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.495 ' HA ' ' O ' ' A' ' 135' ' ' SER . 74.5 p -78.71 -40.46 33.66 Favored 'General case' 0 N--CA 1.433 -1.311 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.101 177.699 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.433 ' CB ' HG11 ' A' ' 127' ' ' VAL . . . -112.09 157.71 20.47 Favored 'General case' 0 N--CA 1.433 -1.292 0 CA-C-N 115.091 -0.958 . . . . 0.0 108.739 178.618 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -67.41 -27.78 73.57 Favored Glycine 0 C--N 1.309 -0.945 0 O-C-N 123.543 0.527 . . . . 0.0 113.153 -176.266 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 1.6 tmt? -78.25 -24.27 46.99 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-O 121.271 0.558 . . . . 0.0 110.429 178.259 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . 0.523 ' HE2' ' CG2' ' A' ' 127' ' ' VAL . 21.5 ttmm -80.14 166.45 21.46 Favored 'General case' 0 N--CA 1.433 -1.317 0 CA-C-N 115.289 -0.869 . . . . 0.0 110.155 -176.03 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -110.49 161.92 15.2 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 -177.381 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 44.2 m -76.17 155.41 34.58 Favored 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 176.136 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 24.4 tpt180 -142.77 138.69 30.63 Favored 'General case' 0 N--CA 1.435 -1.187 0 C-N-CA 119.104 -1.039 . . . . 0.0 112.077 -172.001 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 28.5 p -68.25 118.62 11.6 Favored 'General case' 0 N--CA 1.44 -0.958 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.668 177.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' ARG . . . . . 0.547 ' HB2' ' O ' ' A' ' 159' ' ' GLY 0.315 0.0 OUTLIER -83.35 -20.6 33.99 Favored 'General case' 0 C--O 1.204 -1.336 0 C-N-CA 119.357 -0.937 . . . . 0.0 113.476 -178.787 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . 0.413 ' HA ' HH21 ' A' ' 155' ' ' ARG . 22.7 t70 -43.78 -32.03 0.95 Allowed 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 124.774 1.23 . . . . 0.0 113.425 -178.676 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -61.53 -38.53 87.76 Favored 'General case' 0 CA--C 1.553 1.095 0 N-CA-C 113.647 0.98 . . . . 0.0 113.647 -179.739 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 41.1 m-85 -152.55 -21.69 0.17 Allowed 'General case' 0 N--CA 1.504 2.238 0 CA-C-N 118.363 0.529 . . . . 0.0 111.507 -177.432 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . 0.547 ' O ' ' HB2' ' A' ' 155' ' ' ARG . . . 106.34 -91.33 0.72 Allowed Glycine 0 CA--C 1.464 -3.149 0 N-CA-C 105.585 -3.006 . . . . 0.0 105.585 -166.413 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.667 ' CG2' ' HA ' ' A' ' 67' ' ' ILE . 88.9 t -100.66 141.68 17.04 Favored 'Isoleucine or valine' 0 N--CA 1.388 -3.534 0 N-CA-C 105.984 -1.858 . . . . 0.0 105.984 167.291 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 65.5 mt-30 -94.47 92.12 6.97 Favored 'General case' 0 CA--C 1.453 -2.755 0 N-CA-C 106.425 -1.695 . . . . 0.0 106.425 -170.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . 0.61 ' O ' ' HD2' ' A' ' 162' ' ' ARG . 0.0 OUTLIER -101.24 135.89 41.98 Favored 'General case' 1 N--CA 1.379 -4.016 0 CA-C-N 114.573 -1.194 . . . . 0.0 111.648 -170.685 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' ASN . . . . . 0.614 ' H ' HG13 ' A' ' 94' ' ' VAL . 7.5 t30 -114.77 -13.63 12.03 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 177.537 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . 0.446 ' O ' ' HD3' ' A' ' 162' ' ' ARG . . . -100.38 157.78 19.43 Favored Glycine 0 N--CA 1.428 -1.863 0 CA-C-N 114.225 -1.352 . . . . 0.0 110.609 178.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.416 ' O ' HD12 ' A' ' 165' ' ' LEU . 2.1 pp -121.38 153.78 37.35 Favored 'General case' 0 C--N 1.287 -2.144 0 C-N-CA 123.234 0.614 . . . . 0.0 109.935 -177.234 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . 0.401 ' HG2' ' HG2' ' A' ' 89' ' ' PRO . 0.0 OUTLIER -71.38 129.75 39.61 Favored 'General case' 0 N--CA 1.432 -1.326 0 N-CA-C 106.856 -1.535 . . . . 0.0 106.856 173.899 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 46.8 t -57.54 -29.65 34.55 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 CA-C-O 121.444 0.64 . . . . 0.0 109.684 174.557 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -70.29 -34.6 72.95 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 123.475 0.71 . . . . 0.0 111.378 178.054 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 64.8 tttp -96.99 109.63 22.34 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 113.248 0.832 . . . . 0.0 113.248 -174.462 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 . . . . . 0 C--N 1.293 -1.885 0 N-CA-C 107.099 -1.445 . . . . 0.0 107.099 173.914 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 40.8 m . . . . . 0 C--O 1.241 0.645 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 66.29 -173.96 0.19 Allowed 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.42 0.688 . . . . 0.0 110.853 -178.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 63.01 18.61 11.05 Favored 'General case' 0 C--O 1.238 0.499 0 C-N-CA 123.589 0.755 . . . . 0.0 111.419 179.125 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 12.2 tt -84.22 142.2 13.7 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.208 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 -178.424 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 51.1 p90 -149.6 166.4 29.36 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 -178.016 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -153.48 115.51 4.32 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-O 120.883 0.373 . . . . 0.0 110.957 176.653 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.35 95.41 1.24 Allowed 'General case' 0 C--N 1.309 -1.161 0 CA-C-O 121.665 0.745 . . . . 0.0 110.76 171.231 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 13.2 p -73.62 150.95 7.57 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.097 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 177.63 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -78.32 68.26 2.94 Favored Glycine 0 N--CA 1.439 -1.129 0 C-N-CA 120.979 -0.629 . . . . 0.0 113.879 -176.341 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 33.0 t -76.79 -33.99 57.99 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 106.59 -1.633 . . . . 0.0 106.59 174.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 83.9 t80 -82.04 100.92 10.02 Favored 'General case' 0 N--CA 1.425 -1.693 0 CA-C-N 114.494 -1.23 . . . . 0.0 108.672 174.744 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 68.7 p-90 -113.77 148.86 35.77 Favored 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 177.145 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -149.22 153.19 37.25 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 179.388 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 93.11 71.33 1.16 Allowed Glycine 0 N--CA 1.424 -2.133 0 C-N-CA 120.256 -0.973 . . . . 0.0 111.953 178.693 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -81.49 118.73 22.96 Favored 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 174.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.621 ' HE3' ' HA ' ' A' ' 16' ' ' LYS . 0.3 OUTLIER 63.83 77.34 0.32 Allowed 'General case' 0 C--N 1.326 -0.435 0 O-C-N 124.096 0.872 . . . . 0.0 108.761 -174.293 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -133.44 90.65 2.75 Favored 'General case' 0 N--CA 1.433 -1.29 0 CA-C-O 121.629 0.728 . . . . 0.0 111.497 -178.404 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -128.62 85.67 2.36 Favored 'General case' 0 C--N 1.29 -1.984 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 176.009 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 47.2 mtmt -84.53 88.33 7.31 Favored 'General case' 0 CA--C 1.502 -0.882 0 C-N-CA 119.883 -0.727 . . . . 0.0 111.207 -176.36 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -145.44 92.91 2.29 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-N 114.801 -1.09 . . . . 0.0 109.717 177.333 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 43.4 p90 -159.27 156.95 29.67 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-N 115.177 -0.92 . . . . 0.0 108.537 -178.388 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -102.82 -71.97 0.71 Allowed 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 177.329 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 23.0 t 66.48 -59.41 0.35 Allowed 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 124.603 1.161 . . . . 0.0 111.12 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 7.5 p -115.41 107.06 21.76 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.531 0 CA-C-O 121.84 0.829 . . . . 0.0 109.33 177.296 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 177.93 164.43 31.21 Favored Glycine 0 N--CA 1.424 -2.111 0 N-CA-C 109.92 -1.272 . . . . 0.0 109.92 -178.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 6.2 t30 57.84 83.75 0.11 Allowed 'General case' 0 C--O 1.24 0.605 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 -175.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -89.13 128.04 35.75 Favored 'General case' 0 C--N 1.29 -1.999 0 CA-C-O 121.903 0.859 . . . . 0.0 112.817 -172.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 48.5 tp -147.66 98.09 2.92 Favored 'General case' 0 C--N 1.293 -1.851 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 171.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 38.3 m-80 -133.99 97.59 3.92 Favored 'General case' 0 C--N 1.288 -2.069 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 -179.291 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 32.2 t -145.72 88.97 1.87 Allowed 'General case' 0 N--CA 1.413 -2.318 0 CA-C-O 121.608 0.718 . . . . 0.0 109.506 179.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 57.3 t -126.18 -64.56 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 N-CA-C 106.037 -1.838 . . . . 0.0 106.037 175.08 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 37.2 m -103.62 104.01 14.01 Favored 'General case' 0 N--CA 1.414 -2.236 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 175.61 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 37.1 p -77.98 84.73 4.24 Favored 'General case' 0 N--CA 1.429 -1.495 0 CA-C-O 122.091 0.948 . . . . 0.0 110.603 179.203 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 38.1 m -122.85 121.78 37.05 Favored 'General case' 0 N--CA 1.418 -2.07 0 CA-C-N 114.536 -1.211 . . . . 0.0 108.268 178.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 51.1 mm -89.65 112.95 25.2 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.765 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 -178.308 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 68.77 -62.76 0.38 Allowed 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 124.551 1.14 . . . . 0.0 112.386 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 132.45 -150.62 19.71 Favored Glycine 0 N--CA 1.422 -2.241 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 -176.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -117.0 3.85 18.96 Favored Glycine 0 C--N 1.299 -1.521 0 C-N-CA 120.752 -0.737 . . . . 0.0 111.746 178.343 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 23.7 p -109.22 103.47 12.45 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-O 121.365 0.602 . . . . 0.0 112.622 -179.512 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -90.26 -42.98 10.68 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 106.082 -1.821 . . . . 0.0 106.082 172.237 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 32.5 p90 -159.3 165.39 33.54 Favored 'General case' 0 N--CA 1.434 -1.264 0 N-CA-C 106.317 -1.734 . . . . 0.0 106.317 175.389 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 56.0 tp -136.77 108.71 7.13 Favored 'General case' 0 C--N 1.292 -1.926 0 C-N-CA 120.322 -0.551 . . . . 0.0 110.836 -179.135 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 61.3 t -86.9 116.34 29.24 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.029 0 N-CA-C 106.934 -1.506 . . . . 0.0 106.934 175.257 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 40.7 t30 -78.08 91.03 4.25 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-O 121.772 0.796 . . . . 0.0 112.436 -175.521 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 41.0 ttmt -126.65 75.26 1.54 Allowed 'General case' 0 N--CA 1.424 -1.774 0 CA-C-N 115.093 -0.958 . . . . 0.0 108.467 175.141 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 7.4 tp -176.2 -47.04 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 CA-C-N 113.444 -1.707 . . . . 0.0 106.48 -178.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 96.1 mttt 67.66 168.55 0.26 Allowed 'General case' 0 C--N 1.346 0.422 0 C-N-CA 125.008 1.323 . . . . 0.0 113.279 175.492 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -85.05 36.8 3.02 Favored Glycine 0 N--CA 1.438 -1.226 0 C-N-CA 121.053 -0.594 . . . . 0.0 114.405 -174.048 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.482 ' HG3' ' SD ' ' A' ' 50' ' ' MET . 62.8 pttt -90.84 -16.82 27.59 Favored 'General case' 0 C--N 1.318 -0.786 0 C-N-CA 120.03 -0.668 . . . . 0.0 109.797 176.736 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . 0.482 ' SD ' ' HG3' ' A' ' 49' ' ' LYS . 1.7 mpt? -94.36 126.91 39.91 Favored 'General case' 0 N--CA 1.441 -0.91 0 N-CA-C 106.613 -1.625 . . . . 0.0 106.613 171.614 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 28.3 pt20 -74.19 131.89 41.68 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-O 121.588 0.708 . . . . 0.0 112.272 -176.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.492 ' O ' ' HD2' ' A' ' 55' ' ' PRO . 68.6 mttm -129.39 168.72 15.26 Favored Pre-proline 0 C--N 1.302 -1.457 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 179.084 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -84.76 15.55 2.17 Favored 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 122.25 1.967 . . . . 0.0 111.551 175.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.515 ' HB3' ' HD3' ' A' ' 55' ' ' PRO . 14.8 tp -80.02 -49.53 1.26 Allowed Pre-proline 0 C--O 1.199 -1.59 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.65 -179.83 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.515 ' HD3' ' HB3' ' A' ' 54' ' ' LEU . 0.1 OUTLIER -38.3 -45.58 2.2 Favored 'Trans proline' 0 C--N 1.388 2.613 0 C-N-CA 124.143 3.229 . . . . 0.0 113.476 177.185 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.435 ' HA ' ' HE2' ' A' ' 59' ' ' LYS . 12.3 pt-20 -69.76 -37.9 76.56 Favored 'General case' 0 N--CA 1.438 -1.069 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.668 179.68 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.421 ' HG ' ' CE1' ' A' ' 61' ' ' TYR . 3.7 tt -75.64 -35.4 60.45 Favored 'General case' 0 N--CA 1.436 -1.166 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.845 -177.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.519 HD22 HD22 ' A' ' 74' ' ' ASN . 4.0 pp -66.88 -41.11 87.8 Favored 'General case' 0 C--N 1.314 -0.937 0 C-N-CA 120.412 -0.515 . . . . 0.0 112.276 -178.273 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.499 ' N ' HD12 ' A' ' 58' ' ' LEU . 62.0 pttt -75.13 -26.0 58.84 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.788 0.804 . . . . 0.0 109.823 176.649 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -66.27 -53.8 32.54 Favored 'General case' 0 N--CA 1.439 -0.979 0 CA-C-N 115.146 -0.934 . . . . 0.0 111.393 176.57 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.421 ' CE1' ' HG ' ' A' ' 57' ' ' LEU . 14.5 m-85 -60.34 -52.96 63.04 Favored 'General case' 0 CA--C 1.504 -0.815 0 N-CA-C 114.681 1.363 . . . . 0.0 114.681 -178.847 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.566 ' O ' HD13 ' A' ' 63' ' ' LEU . 19.6 m-20 -79.91 -98.04 0.03 OUTLIER 'General case' 0 C--N 1.316 -0.86 0 C-N-CA 118.918 -1.113 . . . . 0.0 110.44 -179.737 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.613 ' HB2' HD12 ' A' ' 65' ' ' ILE . 0.8 OUTLIER -142.41 158.68 60.21 Favored Pre-proline 0 N--CA 1.43 -1.426 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 -177.723 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.528 ' HB2' ' NH1' ' A' ' 155' ' ' ARG . 12.9 Cg_endo -93.27 28.68 0.31 Allowed 'Trans proline' 0 N--CA 1.439 -1.679 0 C-N-CA 123.47 2.78 . . . . 0.0 112.176 -173.565 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.613 HD12 ' HB2' ' A' ' 63' ' ' LEU . 0.2 OUTLIER -69.96 -29.92 42.16 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.343 0 N-CA-C 107.764 -1.199 . . . . 0.0 107.764 173.863 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 62.01 -9.71 0.11 Allowed Glycine 0 CA--C 1.54 1.651 0 CA-C-N 114.515 -1.22 . . . . 0.0 115.268 177.596 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.607 ' O ' ' HB ' ' A' ' 160' ' ' VAL . 38.4 mt 76.33 -38.53 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.51 -0.592 0 C-N-CA 125.171 1.389 . . . . 0.0 113.217 179.315 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.518 ' HB2' ' O ' ' A' ' 67' ' ' ILE . 39.0 t80 166.07 -57.72 0.0 OUTLIER Pre-proline 0 C--N 1.321 -0.636 0 C-N-CA 125.009 1.323 . . . . 0.0 109.007 173.131 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.454 ' HD3' ' HB3' ' A' ' 68' ' ' PHE . 19.6 Cg_endo -102.56 -16.85 0.09 OUTLIER 'Trans proline' 0 C--N 1.378 2.129 0 C-N-CA 122.209 1.94 . . . . 0.0 114.985 -172.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.433 ' H ' ' HD2' ' A' ' 69' ' ' PRO . . . 80.36 9.72 86.2 Favored Glycine 0 N--CA 1.441 -0.986 0 C-N-CA 119.924 -1.132 . . . . 0.0 111.633 -173.565 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.658 ' OD1' ' HG3' ' A' ' 89' ' ' PRO . 10.4 t70 -92.0 -43.56 9.36 Favored 'General case' 0 C--O 1.201 -1.455 0 N-CA-C 106.474 -1.676 . . . . 0.0 106.474 176.304 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.44 ' O ' ' HB ' ' A' ' 73' ' ' THR . . . -72.02 -178.77 2.5 Favored 'General case' 0 CA--C 1.552 1.043 0 CA-C-N 114.537 -1.21 . . . . 0.0 108.104 165.195 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.501 ' O ' HG22 ' A' ' 73' ' ' THR . 56.8 m 83.52 26.97 0.1 Allowed 'General case' 0 N--CA 1.498 1.948 0 CA-C-O 123.469 1.604 . . . . 0.0 108.398 179.28 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.519 HD22 HD22 ' A' ' 58' ' ' LEU . 3.5 m120 -81.7 111.15 17.69 Favored 'General case' 0 N--CA 1.41 -2.474 0 C-N-CA 118.528 -1.269 . . . . 0.0 110.962 -175.601 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 66.1 t80 -71.71 94.2 1.34 Allowed 'General case' 0 C--N 1.293 -1.874 0 CA-C-N 114.074 -1.421 . . . . 0.0 112.081 -176.195 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.448 ' O ' HD22 ' A' ' 84' ' ' LEU . 23.5 mm-40 -110.62 111.57 22.88 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 171.692 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.412 ' HB2' HD23 ' A' ' 84' ' ' LEU . 81.4 t80 -125.76 127.28 45.92 Favored 'General case' 0 C--N 1.291 -1.966 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.985 -170.495 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.554 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 3.3 m-20 -91.32 163.48 14.2 Favored 'General case' 0 CA--C 1.475 -1.933 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 178.238 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -81.67 -58.38 3.03 Favored 'General case' 0 C--N 1.26 -3.29 0 CA-C-N 114.237 -1.347 . . . . 0.0 113.176 -178.548 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -75.97 -46.92 27.14 Favored 'General case' 0 N--CA 1.429 -1.499 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.596 -176.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.554 ' HB ' ' HB2' ' A' ' 78' ' ' ASP . 96.8 m -67.98 -52.08 39.9 Favored 'General case' 0 C--N 1.293 -1.882 0 CA-C-N 114.4 -1.273 . . . . 0.0 112.369 -177.677 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 99.4 mttt 66.6 3.76 3.06 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 114.501 1.297 . . . . 0.0 114.501 178.334 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.698 ' HG2' ' OG1' ' A' ' 109' ' ' THR . 38.2 ttpt -91.17 92.49 8.69 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-O 121.856 0.836 . . . . 0.0 109.24 176.485 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.506 ' HB2' ' HB2' ' A' ' 112' ' ' LEU . 3.0 tm? -51.21 135.1 26.65 Favored 'General case' 0 C--N 1.32 -0.706 0 C-N-CA 126.376 1.87 . . . . 0.0 111.728 -173.82 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.467 ' HA ' ' O ' ' A' ' 108' ' ' VAL . 46.1 p -117.34 110.04 17.57 Favored 'General case' 0 N--CA 1.419 -1.981 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.021 179.805 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.423 HG23 ' CD1' ' A' ' 84' ' ' LEU . 53.5 t -91.9 127.44 44.18 Favored 'Isoleucine or valine' 0 CA--C 1.478 -1.822 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 172.574 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.507 ' H ' HD13 ' A' ' 87' ' ' LEU 0.286 0.0 OUTLIER -114.57 129.85 56.71 Favored 'General case' 0 N--CA 1.392 -3.349 0 CA-C-N 115.105 -0.952 . . . . 0.0 111.227 178.902 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.458 ' O ' HG23 ' A' ' 106' ' ' THR . 3.1 mp -95.69 136.21 22.5 Favored Pre-proline 0 C--N 1.275 -2.66 0 CA-C-N 114.069 -1.423 . . . . 0.0 108.411 178.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.658 ' HG3' ' OD1' ' A' ' 71' ' ' ASP . 7.1 Cg_exo -25.3 -55.45 0.08 OUTLIER 'Trans proline' 0 C--N 1.374 1.878 1 C-N-CA 125.719 4.279 . . . . 0.0 114.065 174.825 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.582 ' HB2' ' HB2' ' A' ' 168' ' ' ASP . 45.1 t -154.1 161.45 41.89 Favored 'General case' 0 N--CA 1.426 -1.631 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 177.179 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.431 HD11 ' HD2' ' A' ' 103' ' ' LYS . 10.0 tt -64.64 114.65 2.48 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 O-C-N 123.939 0.774 . . . . 0.0 110.524 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' CYS . . . . . 0.513 ' HB2' ' HA ' ' A' ' 166' ' ' ARG . 44.2 t -116.03 123.08 47.06 Favored 'General case' 0 N--CA 1.417 -2.122 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.01 -179.161 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -99.05 169.82 9.14 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.25 -179.148 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.416 ' HB ' HH11 ' A' ' 162' ' ' ARG . 3.5 p -148.31 106.08 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.674 0 C-N-CA 123.325 0.65 . . . . 0.0 110.073 174.372 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -145.77 114.71 0.77 Allowed Glycine 0 C--N 1.296 -1.686 0 N-CA-C 108.643 -1.783 . . . . 0.0 108.643 175.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 0.526 ' CD2' ' HG3' ' A' ' 97' ' ' LYS . 12.1 t80 -139.78 -156.67 0.7 Allowed 'General case' 0 N--CA 1.414 -2.253 0 N-CA-C 106.048 -1.834 . . . . 0.0 106.048 -176.607 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.526 ' HG3' ' CD2' ' A' ' 96' ' ' TYR . 0.1 OUTLIER -72.63 -6.07 41.76 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-O 122.185 0.993 . . . . 0.0 111.049 -175.442 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.496 ' OD1' ' HB3' ' A' ' 96' ' ' TYR . 5.9 m-20 -74.38 -15.01 60.94 Favored 'General case' 0 N--CA 1.422 -1.868 0 CA-C-N 113.486 -1.688 . . . . 0.0 111.704 -175.488 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 34.5 t 77.62 -10.0 1.42 Allowed 'General case' 0 C--O 1.238 0.449 0 C-N-CA 124.476 1.111 . . . . 0.0 111.86 177.658 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 43.6 p -82.9 93.71 7.56 Favored 'General case' 0 N--CA 1.411 -2.388 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 176.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 96.1 t -94.68 115.96 34.8 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.993 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.776 176.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.415 ' HG ' ' HA ' ' A' ' 125' ' ' THR . 6.9 tt -137.66 134.83 35.91 Favored 'General case' 0 C--N 1.286 -2.195 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 -178.199 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.431 ' HD2' HD11 ' A' ' 91' ' ' ILE . 39.0 ttpt -110.11 106.51 16.0 Favored 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 178.62 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.444 ' HA ' HD12 ' A' ' 123' ' ' ILE . 14.1 t80 -96.36 96.83 9.01 Favored 'General case' 0 N--CA 1.421 -1.904 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 -177.579 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.498 HG22 ' H ' ' A' ' 106' ' ' THR . 10.6 m -57.98 172.29 0.43 Allowed 'General case' 0 CA--C 1.568 1.66 0 C-N-CA 126.415 1.886 . . . . 0.0 112.307 -178.777 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.498 ' H ' HG22 ' A' ' 105' ' ' THR . 38.4 m -78.29 -72.41 0.37 Allowed 'General case' 0 C--N 1.316 -0.887 0 C-N-CA 123.562 0.745 . . . . 0.0 111.79 -173.445 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 43.9 m -103.62 110.34 22.36 Favored 'General case' 0 N--CA 1.431 -1.412 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 179.498 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.815 HG21 HG12 ' A' ' 123' ' ' ILE . 3.6 p -109.03 167.08 4.31 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.419 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 178.48 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.698 ' OG1' ' HG2' ' A' ' 83' ' ' LYS . 15.1 t -139.39 131.94 28.74 Favored 'General case' 0 N--CA 1.4 -2.945 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 -175.788 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -147.32 172.18 27.8 Favored Glycine 0 N--CA 1.413 -2.86 0 C-N-CA 119.273 -1.441 . . . . 0.0 113.162 -177.65 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 35.8 m80 -77.35 121.57 23.93 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 -179.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.506 ' HB2' ' HB2' ' A' ' 84' ' ' LEU . 3.2 tm? -94.57 110.71 22.5 Favored 'General case' 0 N--CA 1.422 -1.845 0 CA-C-O 121.213 0.53 . . . . 0.0 110.532 -174.214 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -128.18 130.15 47.59 Favored 'General case' 0 CA--C 1.439 -3.307 0 CA-C-N 114.549 -1.205 . . . . 0.0 108.913 168.221 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 54.8 tptt -66.47 116.37 7.39 Favored 'General case' 0 N--CA 1.38 -3.962 0 CA-C-N 114.54 -1.209 . . . . 0.0 109.142 -178.209 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . 0.477 ' C ' ' HE2' ' A' ' 116' ' ' LYS . . . 118.42 -27.56 7.23 Favored Glycine 0 C--O 1.177 -3.459 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 -174.169 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.739 ' N ' ' HE2' ' A' ' 116' ' ' LYS . 0.0 OUTLIER -165.19 122.23 1.51 Allowed 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 117.393 0.597 . . . . 0.0 111.898 -178.246 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 64.4 tp -93.6 105.44 17.49 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 176.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 34.2 p -105.9 134.64 48.71 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 114.094 1.146 . . . . 0.0 114.094 -172.534 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 67.1 88.15 0.11 Allowed 'General case' 0 CA--C 1.49 -1.327 0 C-N-CA 124.871 1.268 . . . . 0.0 112.887 178.211 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.43 HG22 ' O ' ' A' ' 134' ' ' THR . 12.4 m -95.78 92.35 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.302 0 CA-C-O 122.912 1.339 . . . . 0.0 108.679 178.824 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -73.57 99.76 3.14 Favored 'General case' 0 C--N 1.264 -3.145 0 CA-C-N 113.072 -1.876 . . . . 0.0 111.769 -174.307 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 145.67 -8.62 1.58 Allowed Glycine 0 N--CA 1.423 -2.194 0 CA-C-N 114.41 -1.268 . . . . 0.0 111.631 177.011 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.815 HG12 HG21 ' A' ' 108' ' ' VAL . 46.4 mm -100.21 118.46 46.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-O 121.623 0.725 . . . . 0.0 111.18 -178.171 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt -85.4 119.31 25.63 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 106.294 -1.743 . . . . 0.0 106.294 175.169 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.481 ' HB ' ' HB ' ' A' ' 131' ' ' VAL . 89.5 m -125.47 128.07 47.48 Favored 'General case' 0 C--N 1.283 -2.299 0 CA-C-N 115.764 -0.653 . . . . 0.0 112.526 -169.624 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.525 ' C ' ' HD3' ' A' ' 126' ' ' LYS . 0.5 OUTLIER -137.85 123.45 19.75 Favored 'General case' 0 N--CA 1.428 -1.561 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 168.82 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.458 ' N ' ' HD3' ' A' ' 126' ' ' LYS . 7.1 p -150.55 -44.52 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.284 -2.266 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 177.556 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 15.5 tpt -103.72 -42.7 5.55 Favored 'General case' 0 N--CA 1.416 -2.16 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 173.371 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 9.3 tp -164.51 175.33 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.889 0 N-CA-C 105.808 -1.923 . . . . 0.0 105.808 178.507 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' TRP . . . . . 0.469 ' CE3' ' HB2' ' A' ' 126' ' ' LYS . 97.7 m95 -69.66 122.81 19.85 Favored 'General case' 0 C--O 1.241 0.642 0 CA-C-O 121.716 0.769 . . . . 0.0 112.285 178.725 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.481 ' HB ' ' HB ' ' A' ' 125' ' ' THR . 97.0 t -130.96 149.03 33.08 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.031 0 C-N-CA 125.481 1.512 . . . . 0.0 107.348 179.347 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 18.0 ptmt -122.75 -12.37 8.07 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-O 121.381 0.61 . . . . 0.0 110.71 177.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 15.8 m -138.39 75.28 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 CA-C-O 122.115 0.96 . . . . 0.0 110.266 -178.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . 0.43 ' O ' HG22 ' A' ' 120' ' ' VAL . 7.7 t -84.01 168.92 15.49 Favored 'General case' 0 N--CA 1.414 -2.265 0 CA-C-N 115.062 -0.972 . . . . 0.0 109.328 179.022 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 16.6 p -131.47 151.69 51.35 Favored 'General case' 0 N--CA 1.387 -3.593 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 14.1 tt -118.28 97.61 5.55 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.272 0 CA-C-O 122.253 1.025 . . . . 0.0 108.768 176.405 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . 0.487 ' OG ' ' HB2' ' A' ' 144' ' ' TYR . 36.2 p -91.44 152.48 20.36 Favored 'General case' 0 N--CA 1.407 -2.577 0 CA-C-N 115.019 -0.991 . . . . 0.0 110.575 -177.204 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . 0.413 HG23 ' O ' ' A' ' 115' ' ' GLY . 4.4 t -165.42 178.08 7.05 Favored 'General case' 0 N--CA 1.396 -3.137 0 N-CA-C 107.337 -1.356 . . . . 0.0 107.337 -176.378 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -112.7 28.43 8.79 Favored 'General case' 0 C--N 1.269 -2.891 0 N-CA-C 106.848 -1.538 . . . . 0.0 106.848 174.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . 71.44 35.76 1.44 Allowed 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 114.284 -1.325 . . . . 0.0 109.569 -175.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 39.3 t 177.66 -80.9 0.0 OUTLIER 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 114.299 -1.319 . . . . 0.0 109.37 -178.17 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -78.26 135.94 37.66 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 -178.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 47.7 t -105.48 144.5 14.96 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 -165.062 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . 0.487 ' HB2' ' OG ' ' A' ' 137' ' ' SER . 83.6 m-85 -119.69 121.42 39.18 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 106.499 -1.667 . . . . 0.0 106.499 173.826 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 32.3 t80 -96.86 99.13 10.71 Favored 'General case' 0 C--N 1.286 -2.163 0 CA-C-O 121.812 0.815 . . . . 0.0 109.117 -173.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 15.2 p -97.95 31.35 2.71 Favored 'General case' 0 C--N 1.298 -1.668 0 CA-C-N 115.288 -0.869 . . . . 0.0 112.571 -175.137 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -76.13 82.45 2.96 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-O 121.856 0.836 . . . . 0.0 111.265 178.364 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 94.79 -58.13 1.84 Allowed Glycine 0 CA--C 1.477 -2.34 0 N-CA-C 108.749 -1.74 . . . . 0.0 108.749 178.213 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 19.6 ttt 169.93 88.93 0.0 OUTLIER 'General case' 0 N--CA 1.435 -1.214 0 C-N-CA 126.518 1.927 . . . . 0.0 107.351 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . 0.448 ' HA ' ' HD3' ' A' ' 150' ' ' LYS . 63.2 mmtt -133.07 176.32 8.6 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 113.64 0.978 . . . . 0.0 113.64 178.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -85.59 161.34 19.34 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.296 -0.866 . . . . 0.0 112.205 -173.716 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 53.6 p -78.31 160.8 27.66 Favored 'General case' 0 N--CA 1.438 -1.058 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.189 -179.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 30.4 ttm180 -145.7 152.09 39.05 Favored 'General case' 0 N--CA 1.438 -1.073 0 CA-C-O 121.014 0.435 . . . . 0.0 110.257 -176.074 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 61.8 p -89.11 135.05 33.77 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 177.186 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' ARG . . . . . 0.528 ' NH1' ' HB2' ' A' ' 64' ' ' PRO . 15.1 ptt180 -78.45 -19.18 53.71 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 120.091 -0.644 . . . . 0.0 110.449 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -48.68 -30.54 5.61 Favored 'General case' 0 C--N 1.316 -0.858 0 C-N-CA 124.375 1.07 . . . . 0.0 112.837 -177.647 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -75.33 -53.83 8.08 Favored 'General case' 0 N--CA 1.441 -0.902 0 C-N-CA 120.838 -0.345 . . . . 0.0 111.043 178.422 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 0.51 ' HB2' ' HB3' ' A' ' 161' ' ' GLN . 95.4 m-85 -157.1 -5.25 0.1 Allowed 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 111.592 0.219 . . . . 0.0 111.592 -178.417 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . 0.518 ' HA3' ' O ' ' A' ' 65' ' ' ILE . . . 79.14 -84.71 1.24 Allowed Glycine 0 CA--C 1.475 -2.446 0 N-CA-C 109.01 -1.636 . . . . 0.0 109.01 -169.47 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.607 ' HB ' ' O ' ' A' ' 67' ' ' ILE . 16.3 t -109.85 134.11 53.02 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.505 0 N-CA-C 107.513 -1.292 . . . . 0.0 107.513 174.297 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' GLN . . . . . 0.51 ' HB3' ' HB2' ' A' ' 158' ' ' TYR . 1.1 pp0? -148.17 116.39 6.51 Favored 'General case' 0 N--CA 1.416 -2.169 0 CA-C-O 121.497 0.665 . . . . 0.0 110.721 -175.002 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . 0.513 ' NH1' ' HA3' ' A' ' 164' ' ' GLY . 1.9 ppt_? -154.74 162.32 41.16 Favored 'General case' 0 C--N 1.266 -3.034 0 CA-C-N 113.935 -1.484 . . . . 0.0 109.074 175.57 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -76.8 91.98 3.56 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 121.716 0.77 . . . . 0.0 112.718 -177.478 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . 0.513 ' HA3' ' NH1' ' A' ' 162' ' ' ARG . . . -146.25 142.4 10.48 Favored Glycine 0 N--CA 1.421 -2.312 0 CA-C-N 115.67 -0.696 . . . . 0.0 111.591 178.128 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.471 ' H ' HD23 ' A' ' 165' ' ' LEU . 1.5 pt? -117.7 112.05 19.95 Favored 'General case' 0 N--CA 1.416 -2.133 0 N-CA-C 106.802 -1.555 . . . . 0.0 106.802 173.575 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . 0.513 ' HA ' ' HB2' ' A' ' 92' ' ' CYS . 10.8 ptp180 -80.02 110.21 15.2 Favored 'General case' 0 N--CA 1.416 -2.161 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 -179.06 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.452 HG22 ' H ' ' A' ' 167' ' ' VAL . 5.7 m -69.88 26.31 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.292 -1.897 0 N-CA-C 116.082 1.882 . . . . 0.0 116.082 -171.537 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . 0.582 ' HB2' ' HB2' ' A' ' 90' ' ' SER . 31.7 t70 -135.37 69.15 1.44 Allowed 'General case' 0 CA--C 1.497 -1.092 0 N-CA-C 108.064 -1.088 . . . . 0.0 108.064 170.183 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' LYS . . . . . 0.426 ' HB2' ' O ' ' A' ' 168' ' ' ASP . 25.0 ttpp 167.87 145.86 0.02 OUTLIER 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 113.878 -1.51 . . . . 0.0 107.344 179.465 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' PHE . . . . . . . . . . . . . 74.5 t80 . . . . . 0 N--CA 1.412 -2.346 0 N-CA-C 105.37 -2.085 . . . . 0.0 105.37 170.378 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 46.7 t . . . . . 0 C--O 1.241 0.656 0 N-CA-C 110.214 -0.291 . . . . 0.0 110.214 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 58.47 178.15 0.07 Allowed 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 113.571 0.952 . . . . 0.0 113.571 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -172.21 130.19 0.6 Allowed 'General case' 0 C--N 1.311 -1.073 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 177.527 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 50.8 mm -83.28 92.06 2.69 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 C-N-CA 120.472 -0.491 . . . . 0.0 110.542 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -149.8 170.13 19.46 Favored 'General case' 0 C--N 1.312 -1.035 0 C-N-CA 124.68 1.192 . . . . 0.0 107.951 176.726 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 48.0 t30 -147.56 143.53 27.84 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 179.119 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 23.6 pttm -81.76 97.77 8.12 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-O 122.029 0.919 . . . . 0.0 109.731 175.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.2 p -145.4 138.46 21.34 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.699 0 CA-C-N 114.78 -1.1 . . . . 0.0 109.529 -176.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -165.03 82.25 0.11 Allowed Glycine 0 N--CA 1.426 -1.988 0 N-CA-C 110.137 -1.185 . . . . 0.0 110.137 179.468 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 23.6 p -83.08 80.03 9.18 Favored 'General case' 0 N--CA 1.429 -1.486 0 CA-C-O 121.683 0.754 . . . . 0.0 112.347 -178.435 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 55.1 p90 -145.13 156.81 44.1 Favored 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 106.452 -1.685 . . . . 0.0 106.452 177.463 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 76.6 t-105 -159.73 127.39 4.74 Favored 'General case' 0 C--N 1.307 -1.283 0 C-N-CA 119.74 -0.784 . . . . 0.0 112.72 -179.012 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 57.6 tp -134.11 94.19 3.2 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 107.141 -1.429 . . . . 0.0 107.141 172.613 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -88.13 -9.24 70.73 Favored Glycine 0 CA--C 1.498 -1.012 0 CA-C-N 115.416 -0.811 . . . . 0.0 112.367 -176.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 93.6 mt-30 -65.81 102.83 0.81 Allowed 'General case' 0 CA--C 1.502 -0.882 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 177.259 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 23.8 tptm -150.92 93.14 1.9 Allowed 'General case' 0 C--N 1.291 -1.962 0 N-CA-C 107.021 -1.474 . . . . 0.0 107.021 -178.517 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -151.5 121.85 7.3 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.241 -177.035 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 43.8 t30 -162.75 129.43 3.52 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 -179.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.451 ' HD3' ' H ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -128.41 95.73 4.22 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-O 121.904 0.859 . . . . 0.0 108.85 176.519 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 19.2 pt20 -95.64 82.84 3.66 Favored 'General case' 0 C--N 1.292 -1.927 0 CA-C-O 121.732 0.777 . . . . 0.0 112.289 -177.146 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 53.1 p90 -163.56 125.87 2.52 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-N 114.772 -1.103 . . . . 0.0 109.202 175.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -167.76 167.53 13.08 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 -179.155 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 34.3 m -67.77 124.68 23.97 Favored 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 110.081 -0.34 . . . . 0.0 110.081 179.342 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 35.7 m -81.56 153.4 4.15 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.09 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.662 -177.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -116.24 172.47 14.24 Favored Glycine 0 N--CA 1.429 -1.822 0 N-CA-C 110.825 -0.91 . . . . 0.0 110.825 -179.626 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 19.1 m120 -132.88 -179.86 5.74 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 -179.642 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 -72.98 104.45 4.1 Favored 'General case' 0 C--N 1.31 -1.143 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 177.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -109.53 110.51 21.63 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 105.831 -1.914 . . . . 0.0 105.831 -179.703 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 44.2 t30 -152.2 132.82 13.93 Favored 'General case' 0 C--N 1.307 -1.258 0 C-N-CA 120.626 -0.43 . . . . 0.0 111.333 -175.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 21.4 p -88.43 119.22 28.66 Favored 'General case' 0 N--CA 1.423 -1.793 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 175.006 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.453 ' O ' ' HB2' ' A' ' 32' ' ' SER . 51.4 t -74.82 -72.65 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.96 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 179.301 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.453 ' HB2' ' O ' ' A' ' 31' ' ' VAL . 20.9 t 169.1 126.87 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.172 0 O-C-N 124.128 0.892 . . . . 0.0 109.028 176.779 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 8.0 t -165.31 90.39 0.49 Allowed 'General case' 0 C--N 1.313 -1.012 0 CA-C-O 121.875 0.845 . . . . 0.0 109.18 175.614 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 69.1 m -155.36 120.34 4.84 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 112.748 0.647 . . . . 0.0 112.748 -175.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 47.9 mm 69.58 125.9 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 C-N-CA 124.897 1.279 . . . . 0.0 114.403 170.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -137.24 100.44 4.26 Favored 'General case' 0 N--CA 1.44 -0.965 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 175.055 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 178.84 167.81 37.05 Favored Glycine 0 C--N 1.308 -0.985 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.113 -178.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 157.93 171.84 24.36 Favored Glycine 0 N--CA 1.436 -1.332 0 N-CA-C 110.642 -0.983 . . . . 0.0 110.642 -179.443 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 18.0 p -76.35 97.19 4.17 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 112.826 0.676 . . . . 0.0 112.826 -179.478 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 29.4 mtpp -111.56 -39.9 4.5 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 172.131 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 12.7 m-90 -133.92 152.37 51.83 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 106.074 -1.824 . . . . 0.0 106.074 175.364 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 5.4 mp -90.5 146.58 24.0 Favored 'General case' 0 C--N 1.301 -1.5 0 C-N-CA 120.151 -0.62 . . . . 0.0 109.919 179.391 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 8.5 p -46.93 132.63 3.65 Favored 'Isoleucine or valine' 0 C--O 1.245 0.827 0 C-N-CA 124.3 1.04 . . . . 0.0 112.152 179.293 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -93.15 159.81 15.12 Favored 'General case' 0 C--N 1.297 -1.699 0 CA-C-N 115.4 -0.818 . . . . 0.0 108.908 -179.678 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 60.4 pttt -72.24 172.87 9.46 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 116.212 -0.449 . . . . 0.0 109.894 176.642 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 24.2 pt -67.05 160.69 4.07 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 N-CA-C 111.648 0.24 . . . . 0.0 111.648 -178.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 12.5 mptt 66.98 93.51 0.07 Allowed 'General case' 0 C--O 1.245 0.821 0 C-N-CA 123.883 0.873 . . . . 0.0 111.077 -173.195 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 137.67 -85.98 0.23 Allowed Glycine 0 N--CA 1.433 -1.559 0 N-CA-C 111.184 -0.766 . . . . 0.0 111.184 179.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 9.7 mptt -114.03 117.94 32.7 Favored 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 179.153 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 84.5 mtp -103.23 -64.28 1.1 Allowed 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 176.423 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.503 ' HG3' ' H ' ' A' ' 52' ' ' LYS . 23.1 tp60 -157.97 -179.63 8.32 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 106.429 -1.693 . . . . 0.0 106.429 -179.011 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.503 ' H ' ' HG3' ' A' ' 51' ' ' GLN . 31.6 mmmt -67.64 154.92 92.48 Favored Pre-proline 0 C--N 1.316 -0.866 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 -178.772 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -73.56 -4.9 16.21 Favored 'Trans proline' 0 N--CA 1.473 0.313 0 C-N-CA 122.532 2.154 . . . . 0.0 115.821 -176.08 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.404 ' HB2' ' HD3' ' A' ' 55' ' ' PRO . 3.4 mm? -79.03 -58.68 0.68 Allowed Pre-proline 0 C--N 1.301 -1.514 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 178.055 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.472 ' HD2' ' O ' ' A' ' 52' ' ' LYS . 27.3 Cg_endo -60.82 -14.97 35.09 Favored 'Trans proline' 0 N--CA 1.434 -2.017 0 C-N-CA 121.914 1.743 . . . . 0.0 113.129 -170.789 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -76.26 -34.4 59.16 Favored 'General case' 0 CA--C 1.493 -1.228 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 -179.597 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.471 ' HA ' ' HB3' ' A' ' 60' ' ' GLU . 88.1 mt -74.44 -36.52 63.4 Favored 'General case' 0 N--CA 1.42 -1.971 0 CA-C-N 114.946 -1.025 . . . . 0.0 109.48 178.459 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 8.3 mp -62.59 -42.11 99.37 Favored 'General case' 0 CA--C 1.494 -1.187 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -178.088 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.416 ' HD2' ' N ' ' A' ' 60' ' ' GLU . 0.0 OUTLIER -75.39 -28.1 59.32 Favored 'General case' 0 N--CA 1.435 -1.204 0 C-N-CA 118.839 -1.144 . . . . 0.0 110.375 176.228 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.471 ' HB3' ' HA ' ' A' ' 57' ' ' LEU . 7.5 tt0 -60.47 -38.64 84.86 Favored 'General case' 0 C--O 1.25 1.094 0 CA-C-N 114.952 -1.022 . . . . 0.0 113.124 178.835 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 73.8 m-85 -60.43 -42.24 95.64 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.944 0.72 . . . . 0.0 112.944 179.39 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . 0.265 24.8 m-20 -121.64 -82.77 0.65 Allowed 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 115.92 1.822 . . . . 0.0 115.92 -174.416 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.524 ' HB2' HD12 ' A' ' 65' ' ' ILE . 0.0 OUTLIER -114.04 138.72 22.99 Favored Pre-proline 0 C--N 1.318 -0.793 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 -177.747 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 63' ' ' LEU . 32.2 Cg_endo -98.93 27.94 0.15 Allowed 'Trans proline' 0 N--CA 1.431 -2.178 0 C-N-CA 123.858 3.038 . . . . 0.0 111.753 -170.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.678 ' O ' ' HA3' ' A' ' 159' ' ' GLY . 0.2 OUTLIER -61.63 -39.59 83.69 Favored 'Isoleucine or valine' 0 CA--C 1.484 -1.592 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 173.787 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 54.83 8.79 1.49 Allowed Glycine 0 CA--C 1.547 2.086 0 CA-C-N 115.263 -0.88 . . . . 0.0 113.737 -177.66 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.483 ' O ' ' HB ' ' A' ' 160' ' ' VAL . 47.8 mt 62.35 -68.15 0.12 Allowed 'Isoleucine or valine' 0 C--O 1.193 -1.904 0 C-N-CA 126.669 1.988 . . . . 0.0 113.812 -177.307 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 89.2 t80 -176.74 -54.19 0.0 OUTLIER Pre-proline 0 C--N 1.307 -1.273 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -173.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -92.05 -2.9 4.08 Favored 'Trans proline' 0 C--N 1.366 1.447 0 C-N-CA 121.74 1.626 . . . . 0.0 113.085 -172.507 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 82.77 -2.64 85.78 Favored Glycine 0 N--CA 1.429 -1.773 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.15 -179.196 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -102.75 -71.06 0.73 Allowed 'General case' 0 CA--C 1.497 -1.083 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 179.297 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.435 ' HB2' HG23 ' A' ' 88' ' ' ILE . . . -49.77 137.78 15.66 Favored 'General case' 0 CA--C 1.509 -0.604 0 CA-C-N 115.037 -0.983 . . . . 0.0 108.812 173.25 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 8.1 t 118.53 4.19 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.167 0 C-N-CA 126.735 2.014 . . . . 0.0 108.475 -169.112 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.516 ' O ' HG13 ' A' ' 86' ' ' VAL . 18.5 m-80 -72.31 -173.13 1.03 Allowed 'General case' 0 CA--C 1.497 -1.081 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 174.667 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.568 ' HB2' HD11 ' A' ' 84' ' ' LEU . 50.5 p90 -170.87 143.46 2.06 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 114.286 1.217 . . . . 0.0 114.286 178.326 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.563 ' HG3' HD12 ' A' ' 87' ' ' LEU . 52.8 mt-10 -133.11 173.34 11.53 Favored 'General case' 0 C--N 1.288 -2.074 0 C-N-CA 127.479 2.312 . . . . 0.0 105.021 174.393 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 47.2 p90 -148.45 149.54 31.89 Favored 'General case' 0 C--N 1.29 -2.017 0 CA-C-N 118.904 0.775 . . . . 0.0 110.544 178.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.739 ' OD1' ' HB ' ' A' ' 81' ' ' THR . 5.5 p30 -87.91 158.07 18.79 Favored 'General case' 0 C--N 1.306 -1.301 0 C-N-CA 119.682 -0.807 . . . . 0.0 111.109 174.507 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -82.59 -66.86 0.84 Allowed 'General case' 0 C--N 1.28 -2.454 0 N-CA-C 115.915 1.82 . . . . 0.0 115.915 -170.815 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.434 ' CD ' ' H ' ' A' ' 80' ' ' GLU . 0.0 OUTLIER -69.69 -21.3 63.52 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.832 -173.074 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.739 ' HB ' ' OD1' ' A' ' 78' ' ' ASP . 85.0 m -101.57 -51.01 3.56 Favored 'General case' 0 N--CA 1.408 -2.546 0 CA-C-N 114.973 -1.012 . . . . 0.0 110.52 -178.212 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.561 ' HA ' ' O ' ' A' ' 78' ' ' ASP . 39.6 mtpt 77.39 31.13 0.48 Allowed 'General case' 0 C--O 1.243 0.757 0 C-N-CA 125.959 1.703 . . . . 0.0 112.438 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.492 ' CG ' HG22 ' A' ' 109' ' ' THR . 16.4 tptm -88.8 139.3 30.6 Favored 'General case' 0 N--CA 1.404 -2.767 0 N-CA-C 106.007 -1.849 . . . . 0.0 106.007 175.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.634 ' O ' ' HA ' ' A' ' 109' ' ' THR . 16.0 tp -76.07 135.57 39.89 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 -176.587 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.506 HG23 ' HB2' ' A' ' 76' ' ' GLU . 3.0 t -124.86 111.57 15.64 Favored 'General case' 0 C--N 1.272 -2.777 0 CA-C-O 121.927 0.87 . . . . 0.0 109.915 178.073 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.516 HG13 ' O ' ' A' ' 74' ' ' ASN . 86.7 t -92.01 124.65 44.57 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.691 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.675 -177.501 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.656 ' H ' HD13 ' A' ' 87' ' ' LEU . 0.0 OUTLIER -90.48 117.77 29.43 Favored 'General case' 0 N--CA 1.398 -3.064 0 CA-C-N 114.944 -1.026 . . . . 0.0 108.754 176.497 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.644 HG22 ' NH1' ' A' ' 166' ' ' ARG . 48.8 mt -117.82 120.29 32.94 Favored Pre-proline 0 C--N 1.277 -2.576 0 CA-C-N 114.122 -1.399 . . . . 0.0 107.926 -175.629 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.419 ' HD2' ' HA ' ' A' ' 88' ' ' ILE . 18.8 Cg_endo -58.19 91.36 0.06 OUTLIER 'Trans proline' 0 C--N 1.358 1.053 0 C-N-CA 123.794 2.996 . . . . 0.0 113.475 -177.752 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 70.0 m 73.39 -169.92 0.12 Allowed 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.003 0.921 . . . . 0.0 112.205 -179.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.548 HG12 ' HA ' ' A' ' 105' ' ' THR . 66.5 mt -102.58 150.04 6.67 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.12 0 CA-C-O 120.722 0.296 . . . . 0.0 110.344 178.677 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 23.5 p -141.4 141.44 33.76 Favored 'General case' 0 CA--C 1.48 -1.734 0 N-CA-C 105.715 -1.957 . . . . 0.0 105.715 168.296 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.531 ' HB3' ' HA ' ' A' ' 103' ' ' LYS . 7.9 pt-20 -150.16 168.19 24.68 Favored 'General case' 0 C--N 1.259 -3.356 0 O-C-N 123.508 0.505 . . . . 0.0 111.022 177.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.511 ' O ' ' HA ' ' A' ' 101' ' ' VAL . 5.2 p -137.33 123.9 28.51 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.158 0 C-N-CA 120.587 -0.445 . . . . 0.0 111.34 -172.637 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -137.03 113.27 1.01 Allowed Glycine 0 N--CA 1.433 -1.542 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 177.306 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 48.7 t80 -149.4 -166.77 2.64 Favored 'General case' 0 N--CA 1.411 -2.414 0 N-CA-C 103.145 -2.909 . . . . 0.0 103.145 -176.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.41 ' HD2' ' C ' ' A' ' 97' ' ' LYS . 0.0 OUTLIER -79.55 6.62 9.99 Favored 'General case' 0 C--N 1.289 -2.04 0 CA-C-N 119.009 0.822 . . . . 0.0 109.743 174.861 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -68.05 -20.11 64.94 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-N 115.05 -0.977 . . . . 0.0 111.875 -174.216 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.649 ' O ' ' HA ' ' A' ' 127' ' ' VAL . 33.1 t 72.83 20.34 3.64 Favored 'General case' 0 C--N 1.347 0.458 0 C-N-CA 123.638 0.775 . . . . 0.0 109.498 177.509 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 20.3 m -126.31 94.75 4.16 Favored 'General case' 0 N--CA 1.406 -2.626 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 -179.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.511 ' HA ' ' O ' ' A' ' 94' ' ' VAL . 7.6 p -113.69 103.13 14.9 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.355 0 CA-C-O 121.889 0.852 . . . . 0.0 110.497 176.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.526 ' HG ' HG23 ' A' ' 125' ' ' THR . 4.3 mp -116.92 134.15 55.12 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 114.698 -1.137 . . . . 0.0 109.001 -177.587 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.531 ' HA ' ' HB3' ' A' ' 93' ' ' GLU . 4.4 ttmp? -103.01 111.95 24.55 Favored 'General case' 0 C--N 1.312 -1.046 0 N-CA-C 109.57 -0.529 . . . . 0.0 109.57 175.824 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.45 ' O ' ' HA ' ' A' ' 91' ' ' ILE . 98.3 m-85 -95.34 101.45 13.18 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 176.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.548 ' HA ' HG12 ' A' ' 91' ' ' ILE . 14.7 t -87.56 179.7 6.49 Favored 'General case' 0 N--CA 1.443 -0.784 0 O-C-N 123.63 0.581 . . . . 0.0 111.612 -173.732 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.434 ' HA ' ' O ' ' A' ' 88' ' ' ILE . 37.3 p -67.6 -35.66 79.4 Favored 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 124.051 0.94 . . . . 0.0 113.293 -176.322 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 27.8 p -133.13 110.2 10.01 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-O 120.811 0.339 . . . . 0.0 111.14 178.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 61.5 t -109.6 131.38 60.65 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.699 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 176.067 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.634 ' HA ' ' O ' ' A' ' 84' ' ' LEU . 11.5 m -114.15 122.01 45.52 Favored 'General case' 0 N--CA 1.42 -1.962 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 -172.094 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.563 ' HA3' ' O ' ' A' ' 119' ' ' ASP . . . -155.16 -158.42 8.74 Favored Glycine 0 N--CA 1.442 -0.904 0 C-N-CA 120.305 -0.95 . . . . 0.0 114.058 -175.654 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 78.7 t60 -120.09 127.17 52.3 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-O 121.337 0.589 . . . . 0.0 110.532 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.539 ' HA ' HD22 ' A' ' 117' ' ' LEU . 1.2 tt -95.35 128.08 41.91 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 115.542 -0.753 . . . . 0.0 109.675 -174.571 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.527 ' HB2' ' O ' ' A' ' 116' ' ' LYS . 35.1 mm-40 -131.04 165.31 23.5 Favored 'General case' 0 CA--C 1.495 -1.144 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 171.736 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 57.2 tptt -84.15 101.36 11.78 Favored 'General case' 0 N--CA 1.414 -2.243 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 178.401 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . 0.701 ' O ' ' HB ' ' A' ' 138' ' ' THR . . . 120.18 -56.54 0.59 Allowed Glycine 0 N--CA 1.418 -2.51 0 C-N-CA 120.027 -1.082 . . . . 0.0 111.494 179.547 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.527 ' O ' ' HB2' ' A' ' 113' ' ' GLU . 0.0 OUTLIER -126.23 127.51 45.76 Favored 'General case' 0 C--N 1.298 -1.654 0 CA-C-O 121.577 0.704 . . . . 0.0 112.542 -177.663 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.539 HD22 ' HA ' ' A' ' 112' ' ' LEU . 1.8 tm? -100.95 107.54 19.05 Favored 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 106.989 -1.485 . . . . 0.0 106.989 -176.69 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.574 ' HA ' ' HB2' ' A' ' 135' ' ' SER . 12.4 p -110.47 153.63 24.78 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 -178.559 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . 0.563 ' O ' ' HA3' ' A' ' 110' ' ' GLY . 20.7 m-20 69.53 115.92 0.04 OUTLIER 'General case' 0 C--O 1.206 -1.224 0 C-N-CA 124.379 1.071 . . . . 0.0 109.828 -174.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 8.5 m -140.37 85.38 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.115 0 CA-C-O 122.398 1.094 . . . . 0.0 111.312 179.258 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -79.05 101.95 8.11 Favored 'General case' 0 C--N 1.289 -2.026 0 CA-C-N 114.474 -1.239 . . . . 0.0 107.8 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 139.38 -22.48 2.88 Favored Glycine 0 C--N 1.297 -1.608 0 N-CA-C 110.525 -1.03 . . . . 0.0 110.525 -177.371 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 89.9 mt -100.09 107.71 21.45 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.059 0 CA-C-O 121.918 0.866 . . . . 0.0 109.403 178.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 57.5 mttp -107.1 122.9 47.41 Favored 'General case' 0 C--N 1.288 -2.104 0 CA-C-N 114.304 -1.317 . . . . 0.0 108.756 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.526 HG23 ' HG ' ' A' ' 102' ' ' LEU . 72.1 m -130.89 130.04 43.03 Favored 'General case' 0 N--CA 1.431 -1.385 0 O-C-N 123.851 0.72 . . . . 0.0 112.633 -172.298 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.541 ' C ' ' HD3' ' A' ' 126' ' ' LYS . 0.4 OUTLIER -113.48 126.52 55.41 Favored 'General case' 0 N--CA 1.42 -1.962 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 167.996 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.649 ' HA ' ' O ' ' A' ' 99' ' ' SER . 2.3 p -135.74 -65.05 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.873 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.517 177.239 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . 0.567 ' SD ' HG13 ' A' ' 127' ' ' VAL . 0.0 OUTLIER -106.59 -29.76 9.44 Favored 'General case' 0 N--CA 1.399 -3.017 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 177.556 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 42.5 mm -148.92 162.31 5.05 Favored 'Isoleucine or valine' 0 C--O 1.248 1.0 0 N-CA-C 104.315 -2.476 . . . . 0.0 104.315 177.135 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 87.4 t90 -81.47 117.46 21.91 Favored 'General case' 0 N--CA 1.443 -0.786 0 N-CA-C 108.234 -1.025 . . . . 0.0 108.234 175.208 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.575 HG12 ' H ' ' A' ' 133' ' ' VAL . 47.5 t -123.04 141.64 42.62 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.903 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 -177.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 64.4 pttt -100.85 21.95 12.84 Favored 'General case' 0 C--N 1.306 -1.306 0 C-N-CA 119.326 -0.949 . . . . 0.0 111.876 -177.552 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.575 ' H ' HG12 ' A' ' 131' ' ' VAL . 61.5 t -133.82 -82.12 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 C-N-CA 120.712 -0.395 . . . . 0.0 110.548 176.768 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . 0.48 ' O ' ' HB ' ' A' ' 146' ' ' THR . 70.5 p 49.9 76.93 0.12 Allowed 'General case' 0 CA--C 1.536 0.414 0 CA-C-O 121.619 0.724 . . . . 0.0 111.097 -171.184 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . 0.593 ' O ' ' HA ' ' A' ' 146' ' ' THR . 12.5 p -83.15 153.85 24.59 Favored 'General case' 0 N--CA 1.431 -1.391 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 -176.257 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . 0.428 ' HB ' HG22 ' A' ' 146' ' ' THR . 14.5 tt -100.84 128.89 52.53 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.396 0 CA-C-O 121.891 0.853 . . . . 0.0 112.259 -170.617 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 19.8 m -101.3 147.52 26.21 Favored 'General case' 0 N--CA 1.421 -1.894 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 178.081 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . 0.701 ' HB ' ' O ' ' A' ' 115' ' ' GLY . 98.8 m -155.77 152.31 28.32 Favored 'General case' 0 C--N 1.284 -2.247 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 -178.301 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 73.5 m-20 -87.36 23.07 1.97 Allowed 'General case' 0 N--CA 1.482 1.162 0 O-C-N 121.597 -0.69 . . . . 0.0 109.965 176.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . 61.47 35.95 17.39 Favored 'General case' 0 C--N 1.351 0.631 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 -170.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . 0.426 ' HA ' ' HG2' ' A' ' 64' ' ' PRO . 43.3 t -173.87 -79.18 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 113.972 -1.467 . . . . 0.0 109.492 -173.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.453 ' O ' HG23 ' A' ' 138' ' ' THR . 97.9 mttt -88.0 151.46 22.76 Favored 'General case' 0 CA--C 1.509 -0.631 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 -179.48 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.506 HG22 HG22 ' A' ' 65' ' ' ILE . 24.4 t -105.97 136.78 38.99 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 O-C-N 123.545 0.528 . . . . 0.0 111.442 -167.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . 0.402 ' HD2' ' HG ' ' A' ' 152' ' ' SER . 87.9 m-85 -124.5 155.56 38.74 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-O 120.833 0.349 . . . . 0.0 111.527 -177.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 35.3 p90 -45.93 148.34 0.83 Allowed 'General case' 0 C--O 1.243 0.737 0 N-CA-C 115.346 1.609 . . . . 0.0 115.346 -178.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.593 ' HA ' ' O ' ' A' ' 135' ' ' SER . 69.3 p -93.05 -16.02 25.47 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-N 114.915 -1.038 . . . . 0.0 110.973 179.176 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -136.36 149.17 48.23 Favored 'General case' 0 N--CA 1.441 -0.876 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 -177.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -83.04 74.71 2.49 Favored Glycine 0 CA--C 1.497 -1.037 0 N-CA-C 111.289 -0.725 . . . . 0.0 111.289 -176.67 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 1.3 tmt? 174.5 -36.27 0.0 OUTLIER 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 105.87 -1.9 . . . . 0.0 105.87 -177.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 22.8 ttmm -75.43 168.49 19.9 Favored 'General case' 0 N--CA 1.411 -2.425 0 CA-C-N 112.469 -2.15 . . . . 0.0 109.074 -179.141 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 61.0 mttp -119.92 164.03 16.67 Favored 'General case' 0 C--N 1.31 -1.133 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 -171.738 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . 0.453 ' HB3' ' O ' ' A' ' 143' ' ' VAL . 35.6 m -85.82 160.86 19.36 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 115.398 -0.819 . . . . 0.0 112.806 -175.69 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' ARG . . . . . 0.51 ' HG2' ' H ' ' A' ' 161' ' ' GLN . 12.0 mpt_? -126.56 164.2 21.73 Favored 'General case' 0 CA--C 1.516 -0.351 0 C-N-CA 123.571 0.748 . . . . 0.0 111.282 -179.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 35.0 m -94.38 145.3 24.86 Favored 'General case' 0 C--N 1.296 -1.748 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.784 177.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -61.16 -37.46 82.98 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 176.47 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -58.3 -26.16 62.69 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 123.749 0.82 . . . . 0.0 111.656 177.445 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.431 ' HB1' ' HG3' ' A' ' 161' ' ' GLN . . . -79.56 1.21 26.77 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 115.692 -0.685 . . . . 0.0 112.017 -177.608 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 88.7 m-85 93.54 20.94 0.02 OUTLIER 'General case' 0 CA--C 1.493 -1.241 0 C-N-CA 125.888 1.675 . . . . 0.0 111.189 -176.432 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . 0.678 ' HA3' ' O ' ' A' ' 65' ' ' ILE . . . 87.04 -86.04 1.54 Allowed Glycine 0 N--CA 1.408 -3.219 0 CA-C-N 114.757 -1.111 . . . . 0.0 113.115 175.645 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.483 ' HB ' ' O ' ' A' ' 67' ' ' ILE . 6.8 t -104.57 116.48 48.44 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.138 0 C-N-CA 119.849 -0.74 . . . . 0.0 109.686 -174.758 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' GLN . . . . . 0.51 ' H ' ' HG2' ' A' ' 153' ' ' ARG . 12.5 mm-40 -116.33 99.87 7.5 Favored 'General case' 0 CA--C 1.486 -1.505 0 N-CA-C 116.521 2.045 . . . . 0.0 116.521 -174.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . 0.635 ' NE ' ' HA ' ' A' ' 162' ' ' ARG . 1.5 tpm_? -152.66 105.23 2.96 Favored 'General case' 0 N--CA 1.4 -2.933 0 N-CA-C 105.504 -2.035 . . . . 0.0 105.504 170.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 19.0 m120 -45.63 104.12 0.04 OUTLIER 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 115.875 1.806 . . . . 0.0 115.875 -172.403 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -151.66 156.21 26.56 Favored Glycine 0 N--CA 1.435 -1.425 0 N-CA-C 108.449 -1.86 . . . . 0.0 108.449 176.18 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -128.19 135.47 49.77 Favored 'General case' 0 N--CA 1.429 -1.508 0 CA-C-N 118.025 0.913 . . . . 0.0 109.929 -179.296 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . 0.644 ' NH1' HG22 ' A' ' 88' ' ' ILE . 3.1 mmp_? -65.76 122.44 17.31 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 106.496 -1.668 . . . . 0.0 106.496 179.541 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 25.1 t -74.18 61.99 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.559 1.308 0 CA-C-O 122.615 1.197 . . . . 0.0 109.596 175.256 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -165.83 -33.82 0.03 OUTLIER 'General case' 0 C--N 1.296 -1.735 0 C-N-CA 126.457 1.903 . . . . 0.0 106.742 -177.237 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 16.4 tppt? -76.37 110.47 10.93 Favored 'General case' 0 N--CA 1.434 -1.25 0 CA-C-N 114.349 -1.296 . . . . 0.0 111.932 -177.153 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' PHE . . . . . . . . . . . . . 69.7 t80 . . . . . 0 N--CA 1.432 -1.352 0 N-CA-C 106.456 -1.683 . . . . 0.0 106.456 176.588 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 58.0 p . . . . . 0 C--O 1.247 0.966 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -137.94 89.78 2.43 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 116.7 -0.227 . . . . 0.0 111.031 179.27 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 5.5 pm0 -154.48 148.88 26.16 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 177.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 6.9 tp -139.47 118.85 13.12 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.181 0 CA-C-O 121.157 0.503 . . . . 0.0 110.009 178.101 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 83.7 m-85 -104.73 126.18 51.55 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.198 0.523 . . . . 0.0 111.074 -179.018 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -123.33 136.25 54.58 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 115.298 -0.865 . . . . 0.0 109.134 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -138.56 95.88 3.06 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-O 120.692 0.282 . . . . 0.0 111.35 -178.774 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 11.6 p 173.41 146.55 0.02 OUTLIER 'Isoleucine or valine' 0 C--O 1.237 0.425 0 C-N-CA 124.566 1.146 . . . . 0.0 108.501 177.209 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -137.84 -167.95 11.19 Favored Glycine 0 N--CA 1.429 -1.8 0 N-CA-C 110.125 -1.19 . . . . 0.0 110.125 178.549 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 41.6 t -84.19 100.62 11.29 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 178.556 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 76.2 t80 -131.66 100.58 5.17 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 -179.154 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 88.8 m95 -136.66 139.09 41.76 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.068 -177.269 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 5.6 mp -107.95 136.06 48.28 Favored 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 177.281 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -127.21 138.4 10.5 Favored Glycine 0 N--CA 1.432 -1.605 0 C-N-CA 120.648 -0.787 . . . . 0.0 111.56 179.768 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 16.3 tm0? -153.79 110.73 3.4 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 178.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 59.4 pttt -140.19 80.33 1.76 Allowed 'General case' 0 C--N 1.296 -1.751 0 CA-C-O 121.991 0.9 . . . . 0.0 109.549 175.078 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -147.48 88.81 1.73 Allowed 'General case' 0 C--N 1.299 -1.62 0 CA-C-N 115.009 -0.996 . . . . 0.0 109.777 -178.232 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -143.29 94.17 2.58 Favored 'General case' 0 C--N 1.286 -2.17 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 177.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 61.9 tttp -82.28 99.61 9.43 Favored 'General case' 0 N--CA 1.422 -1.847 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.642 -179.577 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 47.3 tt0 -58.1 -64.1 1.03 Allowed 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.257 -0.883 . . . . 0.0 109.754 177.784 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 85.6 t80 57.86 90.4 0.04 OUTLIER 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 114.966 1.469 . . . . 0.0 114.966 175.78 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -143.98 136.54 26.97 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 105.983 -1.858 . . . . 0.0 105.983 169.764 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 25.8 t -150.55 110.88 4.18 Favored 'General case' 0 C--N 1.293 -1.863 0 C-N-CA 120.275 -0.57 . . . . 0.0 110.382 -176.428 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 10.8 p -103.75 -17.03 7.4 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 CA-C-O 122.068 0.937 . . . . 0.0 108.507 177.54 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 90.55 -125.1 7.79 Favored Glycine 0 N--CA 1.419 -2.445 0 CA-C-N 114.885 -1.052 . . . . 0.0 111.367 -179.409 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -152.93 -62.16 0.15 Allowed 'General case' 0 C--N 1.31 -1.144 0 CA-C-O 119.744 -0.17 . . . . 0.0 110.839 179.581 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -153.53 -78.53 0.1 Allowed 'General case' 0 CA--C 1.518 -0.277 0 C-N-CA 119.774 -0.77 . . . . 0.0 112.872 177.436 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.484 ' O ' HD13 ' A' ' 28' ' ' LEU . 2.6 tm? -115.89 -28.9 6.53 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 -177.671 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 43.1 t-20 77.2 -55.01 0.55 Allowed 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 124.483 1.113 . . . . 0.0 111.991 176.204 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 25.4 m -71.33 109.55 5.41 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-O 121.315 0.578 . . . . 0.0 111.914 -177.732 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 12.3 p -109.02 -15.42 9.49 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.043 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 175.071 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 35.6 t 77.0 129.7 0.05 OUTLIER 'General case' 0 C--O 1.24 0.604 0 C-N-CA 125.468 1.507 . . . . 0.0 112.271 179.711 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 91.0 m -155.14 128.73 8.52 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.431 -0.804 . . . . 0.0 108.996 179.062 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 44.4 p -139.05 114.45 9.71 Favored 'General case' 0 C--N 1.311 -1.085 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 178.392 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 67.9 mt -128.48 119.19 49.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 O-C-N 122.416 -0.177 . . . . 0.0 110.546 -176.48 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -134.48 160.03 39.27 Favored 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 179.349 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -84.55 -70.8 1.33 Allowed Glycine 0 N--CA 1.428 -1.839 0 N-CA-C 108.433 -1.867 . . . . 0.0 108.433 172.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 108.33 -111.61 3.37 Favored Glycine 0 N--CA 1.426 -2.02 0 C-N-CA 120.806 -0.711 . . . . 0.0 113.073 175.25 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 27.3 p -81.15 146.83 30.34 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 -175.231 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 64.9 mttp -143.28 123.29 13.58 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 175.596 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.413 ' C ' HD12 ' A' ' 42' ' ' LEU . 88.6 t90 -125.99 126.96 45.16 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 179.883 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.413 HD12 ' C ' ' A' ' 41' ' ' TRP . 5.2 mp -131.68 152.3 50.98 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.2 p -108.15 130.77 60.12 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 175.6 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 56.9 t30 -165.08 168.91 16.83 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 -175.688 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 10.3 mtmp? 75.37 118.63 0.05 Allowed 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 125.124 1.37 . . . . 0.0 113.905 175.678 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 60.7 mt 67.64 102.7 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.244 0.777 0 C-N-CA 125.119 1.368 . . . . 0.0 112.207 178.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -128.49 130.11 47.04 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 -179.039 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -96.07 -156.71 31.43 Favored Glycine 0 C--O 1.243 0.707 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.617 -177.751 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -84.44 91.8 7.91 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.981 0.896 . . . . 0.0 110.066 178.364 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 84.7 mtp -90.69 88.83 7.25 Favored 'General case' 0 C--N 1.298 -1.655 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.405 -177.652 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 28.2 pt20 -128.9 -23.23 3.11 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-N 114.456 -1.247 . . . . 0.0 108.364 177.59 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 62.0 pttt -149.06 160.42 35.05 Favored Pre-proline 0 N--CA 1.425 -1.691 0 N-CA-C 106.251 -1.759 . . . . 0.0 106.251 175.718 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -77.35 -3.74 13.98 Favored 'Trans proline' 0 C--O 1.21 -0.906 0 C-N-CA 122.355 2.036 . . . . 0.0 115.764 -170.723 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.565 ' HB3' ' HD3' ' A' ' 55' ' ' PRO . 14.0 tp -53.5 -50.54 82.5 Favored Pre-proline 0 N--CA 1.495 1.778 0 N-CA-C 113.373 0.879 . . . . 0.0 113.373 -173.572 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.565 ' HD3' ' HB3' ' A' ' 54' ' ' LEU . 80.6 Cg_exo -59.22 -19.99 52.69 Favored 'Trans proline' 0 C--N 1.369 1.607 0 C-N-CA 123.086 2.524 . . . . 0.0 111.544 -178.183 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.461 ' HA ' ' HE2' ' A' ' 59' ' ' LYS . 21.3 mm-40 -81.1 -32.03 34.05 Favored 'General case' 0 N--CA 1.413 -2.312 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 -175.614 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.455 ' HA ' ' HG2' ' A' ' 60' ' ' GLU . 3.8 mm? -75.34 -49.23 19.76 Favored 'General case' 0 CA--C 1.483 -1.617 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.695 177.168 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.47 ' HA ' ' CD1' ' A' ' 75' ' ' TYR 0.323 2.5 pp -61.77 -38.95 89.93 Favored 'General case' 0 C--O 1.21 -1.0 0 C-N-CA 119.375 -0.93 . . . . 0.0 113.032 -176.162 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.461 ' HE2' ' HA ' ' A' ' 56' ' ' GLU . 63.7 pttt -75.5 -26.97 58.57 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 120.017 -0.673 . . . . 0.0 111.002 -179.867 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.455 ' HG2' ' HA ' ' A' ' 57' ' ' LEU . 11.2 pt-20 -79.78 -28.48 40.32 Favored 'General case' 0 C--N 1.351 0.65 0 C-N-CA 119.892 -0.723 . . . . 0.0 110.866 -177.896 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 78.5 m-85 -86.33 -1.58 57.64 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 118.799 -1.16 . . . . 0.0 112.269 175.336 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.517 ' HB2' HG23 ' A' ' 73' ' ' THR . 15.4 t70 -93.2 -171.91 2.8 Favored 'General case' 0 C--N 1.306 -1.308 0 C-N-CA 125.709 1.603 . . . . 0.0 108.607 178.079 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.617 ' HB2' HD12 ' A' ' 65' ' ' ILE . 17.0 mt -85.47 -153.84 0.0 OUTLIER Pre-proline 0 CA--C 1.576 1.969 0 N-CA-C 103.488 -2.782 . . . . 0.0 103.488 174.175 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.573 ' O ' ' HD2' ' A' ' 155' ' ' ARG . 17.7 Cg_endo -100.87 8.78 0.58 Allowed 'Trans proline' 0 N--CA 1.436 -1.883 0 CA-C-N 123.998 2.464 . . . . 0.0 111.241 176.125 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.824 HG12 ' H ' ' A' ' 67' ' ' ILE . 0.1 OUTLIER -78.69 -38.21 21.5 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.461 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 -176.641 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.419 ' H ' HD13 ' A' ' 65' ' ' ILE . . . 60.08 9.39 10.93 Favored Glycine 0 N--CA 1.48 1.579 0 CA-C-O 122.517 1.065 . . . . 0.0 110.702 -176.16 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.824 ' H ' HG12 ' A' ' 65' ' ' ILE . 48.7 mt 63.51 -68.73 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.41 -2.442 0 C-N-CA 128.136 2.574 . . . . 0.0 110.349 -172.516 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.425 ' CD2' ' HD3' ' A' ' 162' ' ' ARG . 91.0 t80 -177.53 -55.72 0.0 OUTLIER Pre-proline 0 C--N 1.308 -1.231 0 N-CA-C 113.702 1.001 . . . . 0.0 113.702 -175.83 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.412 ' HB2' ' OD2' ' A' ' 71' ' ' ASP . 10.8 Cg_endo -91.93 -29.31 0.13 Allowed 'Trans proline' 0 C--N 1.361 1.215 0 C-N-CA 121.573 1.516 . . . . 0.0 115.396 -170.083 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 94.22 -16.97 59.82 Favored Glycine 0 N--CA 1.442 -0.943 0 N-CA-C 110.012 -1.235 . . . . 0.0 110.012 -172.009 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.465 ' CB ' ' HG2' ' A' ' 89' ' ' PRO . 30.0 m-20 -78.84 -38.56 37.71 Favored 'General case' 0 CA--C 1.506 -0.726 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 177.617 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.6 ' O ' ' HB ' ' A' ' 73' ' ' THR . . . -78.53 178.61 7.64 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 114.282 -1.326 . . . . 0.0 108.063 170.41 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.6 ' HB ' ' O ' ' A' ' 72' ' ' ALA . 3.0 m 85.25 6.42 0.47 Allowed 'General case' 0 N--CA 1.483 1.182 0 CA-C-O 123.739 1.733 . . . . 0.0 111.534 175.1 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.563 ' O ' ' HA ' ' A' ' 86' ' ' VAL . 0.8 OUTLIER -64.93 132.97 50.78 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-N 114.079 -1.418 . . . . 0.0 110.307 177.603 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.52 ' HB2' HD21 ' A' ' 84' ' ' LEU . 11.5 p90 -108.94 99.21 8.58 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 113.385 0.883 . . . . 0.0 113.385 -173.487 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 58.9 mm-40 -117.69 133.49 55.89 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 174.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 41.2 p90 -144.57 145.24 31.71 Favored 'General case' 0 C--N 1.295 -1.795 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 -179.205 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.612 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 35.3 m-20 -96.02 173.97 7.16 Favored 'General case' 0 CA--C 1.476 -1.87 0 C-N-CA 119.623 -0.831 . . . . 0.0 109.357 178.028 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -79.27 -65.37 1.01 Allowed 'General case' 0 C--N 1.283 -2.319 0 CA-C-N 114.784 -1.098 . . . . 0.0 111.843 -176.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.406 ' H ' ' CD ' ' A' ' 80' ' ' GLU . 0.1 OUTLIER -74.91 -29.75 61.07 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.112 -175.451 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.612 ' HB ' ' HB2' ' A' ' 78' ' ' ASP . 17.5 m -65.41 -43.27 91.1 Favored 'General case' 0 N--CA 1.428 -1.526 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.581 179.605 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 46.6 mmtm 61.16 14.49 5.55 Favored 'General case' 0 N--CA 1.495 1.778 0 C-N-CA 123.409 0.684 . . . . 0.0 112.098 -177.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.601 ' CD ' HG22 ' A' ' 109' ' ' THR . 31.5 ttmt -116.38 128.4 55.48 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-O 121.247 0.546 . . . . 0.0 110.531 -176.13 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.52 HD21 ' HB2' ' A' ' 75' ' ' TYR . 2.0 tm? -84.65 126.67 33.56 Favored 'General case' 0 C--N 1.296 -1.72 0 CA-C-N 114.388 -1.278 . . . . 0.0 109.163 -173.625 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.528 ' HA ' ' O ' ' A' ' 108' ' ' VAL . 68.1 p -107.06 115.08 29.56 Favored 'General case' 0 N--CA 1.409 -2.483 0 CA-C-N 115.474 -0.785 . . . . 0.0 109.41 178.327 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.563 ' HA ' ' O ' ' A' ' 74' ' ' ASN . 58.6 t -92.57 120.69 42.3 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 179.384 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 5.3 mp -83.34 103.14 12.49 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-O 121.472 0.653 . . . . 0.0 109.467 -179.823 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.514 ' O ' ' HA ' ' A' ' 106' ' ' THR . 46.7 mm -83.34 115.2 58.0 Favored Pre-proline 0 N--CA 1.412 -2.338 0 N-CA-C 104.793 -2.299 . . . . 0.0 104.793 171.915 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.465 ' HG2' ' CB ' ' A' ' 71' ' ' ASP . 1.0 OUTLIER -37.46 -41.18 0.91 Allowed 'Trans proline' 0 N--CA 1.485 1.017 0 C-N-CA 125.146 3.897 . . . . 0.0 115.715 -175.047 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.512 ' HB2' ' HB2' ' A' ' 168' ' ' ASP . 47.9 t -157.15 166.1 34.17 Favored 'General case' 0 C--N 1.284 -2.268 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.439 HG13 ' HD3' ' A' ' 103' ' ' LYS . 6.0 tt -71.81 119.83 19.0 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.336 0 CA-C-O 121.642 0.734 . . . . 0.0 109.883 179.763 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' CYS . . . . . 0.452 ' SG ' ' HB2' ' A' ' 104' ' ' PHE . 19.0 p -115.97 123.42 47.99 Favored 'General case' 0 C--N 1.29 -1.995 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 174.383 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -103.66 111.33 23.76 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 107.019 -1.475 . . . . 0.0 107.019 175.532 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.615 HG21 ' HA ' ' A' ' 162' ' ' ARG . 5.2 p -108.5 102.65 14.3 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.03 0 C-N-CA 118.812 -1.155 . . . . 0.0 113.925 -178.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -144.82 113.0 0.69 Allowed Glycine 0 N--CA 1.431 -1.639 0 N-CA-C 108.102 -1.999 . . . . 0.0 108.102 176.075 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 43.2 t80 174.31 -51.02 0.01 OUTLIER 'General case' 0 CA--C 1.503 -0.861 0 CA-C-O 122.884 1.325 . . . . 0.0 108.34 -172.323 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.34 8.6 18.12 Favored 'General case' 0 C--N 1.294 -1.825 0 CA-C-N 112.865 -1.97 . . . . 0.0 113.644 -168.486 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -158.55 -79.09 0.07 Allowed 'General case' 0 C--N 1.315 -0.926 0 C-N-CA 119.583 -0.847 . . . . 0.0 111.86 -174.32 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 34.6 t 165.9 -38.66 0.0 OUTLIER 'General case' 0 C--N 1.31 -1.143 0 N-CA-C 104.296 -2.483 . . . . 0.0 104.296 -176.378 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 14.1 m -71.71 125.24 26.62 Favored 'General case' 0 N--CA 1.42 -1.958 0 CA-C-N 113.659 -1.61 . . . . 0.0 109.664 177.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 46.3 t -105.62 116.22 48.97 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.085 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 179.154 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.566 ' HG ' ' CG2' ' A' ' 125' ' ' THR . 5.5 mp -114.42 121.16 42.71 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 110.198 -0.297 . . . . 0.0 110.198 -176.54 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.439 ' HD3' HG13 ' A' ' 91' ' ' ILE . 0.4 OUTLIER -111.32 109.12 18.98 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-O 121.571 0.701 . . . . 0.0 110.95 178.677 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.452 ' HB2' ' SG ' ' A' ' 92' ' ' CYS . 94.5 m-85 -91.02 125.33 35.78 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 114.825 -1.079 . . . . 0.0 108.5 179.28 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.479 ' O ' HG13 ' A' ' 108' ' ' VAL . 13.2 m -100.16 147.32 25.82 Favored 'General case' 0 C--N 1.294 -1.817 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.642 -175.155 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.514 ' HA ' ' O ' ' A' ' 88' ' ' ILE . 14.9 m -56.81 120.82 8.52 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 172.65 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 39.0 m 66.14 78.28 0.27 Allowed 'General case' 0 C--N 1.308 -1.198 0 CA-C-O 122.038 0.923 . . . . 0.0 111.676 -177.461 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.528 ' O ' ' HA ' ' A' ' 85' ' ' THR . 3.7 m -93.45 133.17 35.46 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.161 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.391 175.146 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.601 HG22 ' CD ' ' A' ' 83' ' ' LYS 0.26 7.8 m -105.56 118.0 35.46 Favored 'General case' 0 N--CA 1.406 -2.626 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 -168.239 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.552 ' HA3' HG12 ' A' ' 120' ' ' VAL . . . -157.97 167.88 34.38 Favored Glycine 0 CA--C 1.494 -1.27 0 C-N-CA 119.945 -1.122 . . . . 0.0 113.316 -177.73 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 14.2 t-80 -90.91 101.89 14.65 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 179.788 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 68.0 tp -96.73 109.02 21.76 Favored 'General case' 0 CA--C 1.484 -1.577 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.739 -174.762 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -106.15 156.5 18.38 Favored 'General case' 0 CA--C 1.448 -2.96 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 173.037 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 1.6 tmtm? -79.55 100.7 7.89 Favored 'General case' 0 N--CA 1.384 -3.772 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 -176.344 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 138.31 -51.8 0.76 Allowed Glycine 0 C--N 1.296 -1.691 0 N-CA-C 108.419 -1.872 . . . . 0.0 108.419 -174.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.564 ' HB2' ' HA ' ' A' ' 137' ' ' SER . 0.0 OUTLIER -140.83 137.28 33.16 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-O 121.43 0.633 . . . . 0.0 112.149 -179.013 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.528 ' O ' ' HB3' ' A' ' 135' ' ' SER . 46.3 tp -102.25 105.8 16.51 Favored 'General case' 0 C--N 1.305 -1.326 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 175.275 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.515 ' HA ' ' HB3' ' A' ' 135' ' ' SER . 27.7 p -120.53 145.93 46.81 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 112.505 0.557 . . . . 0.0 112.505 -173.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . 0.532 ' O ' ' HA2' ' A' ' 110' ' ' GLY . 34.5 t70 64.4 87.96 0.11 Allowed 'General case' 0 C--O 1.215 -0.715 0 O-C-N 124.117 0.885 . . . . 0.0 110.096 -179.468 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.552 HG12 ' HA3' ' A' ' 110' ' ' GLY . 3.1 m -124.89 104.31 13.48 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.489 0 CA-C-O 122.671 1.224 . . . . 0.0 112.081 -172.779 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -86.41 100.88 12.65 Favored 'General case' 0 C--N 1.26 -3.313 0 CA-C-N 113.292 -1.776 . . . . 0.0 108.401 178.344 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 139.7 -15.5 3.12 Favored Glycine 0 N--CA 1.428 -1.871 0 CA-C-N 115.209 -0.905 . . . . 0.0 112.347 178.729 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 65.3 mt -99.28 102.76 13.83 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.23 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 178.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.412 ' HA ' ' HA ' ' A' ' 132' ' ' LYS . 95.3 mttt -106.13 119.26 38.75 Favored 'General case' 0 C--N 1.282 -2.352 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 -176.51 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.566 ' CG2' ' HG ' ' A' ' 102' ' ' LEU . 49.7 m -139.64 148.43 42.43 Favored 'General case' 0 C--N 1.293 -1.878 0 CA-C-N 115.429 -0.805 . . . . 0.0 112.671 -168.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.468 ' HA ' ' HA ' ' A' ' 130' ' ' TRP . 40.9 tttp -108.11 122.24 46.49 Favored 'General case' 0 N--CA 1.424 -1.74 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 172.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.438 ' CG1' ' HB3' ' A' ' 150' ' ' LYS . 15.9 t -138.56 101.15 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.208 0 N-CA-C 104.142 -2.54 . . . . 0.0 104.142 169.663 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER 73.67 -52.88 0.7 Allowed 'General case' 0 CA--C 1.544 0.729 0 O-C-N 124.305 1.003 . . . . 0.0 108.594 -171.075 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 9.0 tp -137.51 158.65 34.8 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.264 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 176.615 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' TRP . . . . . 0.468 ' HA ' ' HA ' ' A' ' 126' ' ' LYS . 42.6 t-105 -78.2 122.31 25.51 Favored 'General case' 0 C--O 1.241 0.644 0 CA-C-O 121.185 0.517 . . . . 0.0 110.708 -179.135 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 48.5 t -125.06 132.05 71.76 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 177.619 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . 0.412 ' HA ' ' HA ' ' A' ' 124' ' ' LYS . 63.1 pttt -88.85 28.6 1.13 Allowed 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 112.268 0.47 . . . . 0.0 112.268 -176.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 44.7 t -132.74 -78.09 0.15 Allowed 'Isoleucine or valine' 0 C--O 1.214 -0.812 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 -179.059 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 38.5 p 46.89 80.21 0.05 Allowed 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 113.615 0.968 . . . . 0.0 113.615 -179.499 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . 0.528 ' HB3' ' O ' ' A' ' 117' ' ' LEU . 28.3 m -84.68 153.61 23.0 Favored 'General case' 0 N--CA 1.424 -1.729 0 CA-C-N 115.898 -0.592 . . . . 0.0 112.036 -177.653 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 67.5 mt -100.67 97.91 6.3 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.231 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . 0.619 ' O ' ' HB2' ' A' ' 144' ' ' TYR . 29.1 t -119.89 126.86 51.96 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-N 115.914 -0.584 . . . . 0.0 109.569 -174.187 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 9.3 t -162.12 177.58 9.56 Favored 'General case' 0 N--CA 1.424 -1.747 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 -173.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -109.9 75.02 0.92 Allowed 'General case' 0 C--N 1.306 -1.324 0 C-N-CA 120.389 -0.524 . . . . 0.0 109.906 176.356 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . 27.43 72.42 0.04 OUTLIER 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 125.603 1.561 . . . . 0.0 113.994 177.303 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 40.2 t 177.68 -63.59 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 -177.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -95.09 -169.65 2.03 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 179.31 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 13.2 p -142.66 123.04 10.52 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.347 0 CA-C-O 121.365 0.603 . . . . 0.0 109.894 177.087 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . 0.619 ' HB2' ' O ' ' A' ' 137' ' ' SER . 94.0 m-85 -128.97 155.61 45.09 Favored 'General case' 0 CA--C 1.487 -1.473 0 CA-C-O 121.41 0.624 . . . . 0.0 110.574 -179.587 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . 0.437 ' HB2' ' HB2' ' A' ' 151' ' ' LYS . 81.7 m-85 -112.72 113.81 26.1 Favored 'General case' 0 N--CA 1.407 -2.579 0 CA-C-N 114.565 -1.198 . . . . 0.0 109.145 176.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.464 ' CG2' ' HB2' ' A' ' 135' ' ' SER . 9.1 t -79.82 33.41 0.27 Allowed 'General case' 0 CA--C 1.56 1.337 0 CA-C-O 122.115 0.96 . . . . 0.0 111.404 -174.512 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -75.48 -19.67 59.26 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.349 179.368 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 134.02 50.54 0.08 OUTLIER Glycine 0 CA--C 1.475 -2.428 0 N-CA-C 108.987 -1.645 . . . . 0.0 108.987 179.09 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 66.5 mtt 63.64 12.08 6.25 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.102 0.961 . . . . 0.0 111.787 -177.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . 0.438 ' HB3' ' CG1' ' A' ' 127' ' ' VAL . 47.7 mmtm -69.16 -29.83 67.94 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 115.375 -0.83 . . . . 0.0 112.564 -176.585 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.437 ' HB2' ' HB2' ' A' ' 145' ' ' PHE . 39.9 mmtm -143.88 122.58 12.59 Favored 'General case' 0 CA--C 1.509 -0.629 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 178.557 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 43.8 m -132.46 128.27 37.07 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 106.136 -1.802 . . . . 0.0 106.136 175.232 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' ARG . . . . . 0.464 ' HG2' ' CG ' ' A' ' 161' ' ' GLN . 26.9 tpt180 -146.6 160.41 42.2 Favored 'General case' 0 N--CA 1.429 -1.491 0 C-N-CA 119.084 -1.046 . . . . 0.0 110.942 -172.814 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 13.6 m -90.47 130.25 36.55 Favored 'General case' 0 N--CA 1.419 -1.992 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 174.378 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' ARG . . . . . 0.573 ' HD2' ' O ' ' A' ' 64' ' ' PRO . 8.6 ttp180 -68.29 -24.92 64.92 Favored 'General case' 0 C--N 1.297 -1.678 0 C-N-CA 123.517 0.727 . . . . 0.0 110.455 179.675 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -42.29 -45.71 4.29 Favored 'General case' 0 C--N 1.313 -0.996 0 N-CA-C 115.257 1.577 . . . . 0.0 115.257 -172.106 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -71.55 -52.62 17.25 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 114.438 1.273 . . . . 0.0 114.438 -173.507 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 -141.89 3.8 1.64 Allowed 'General case' 0 N--CA 1.483 1.18 0 N-CA-C 113.029 0.751 . . . . 0.0 113.029 -174.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 90.85 -88.49 1.43 Allowed Glycine 0 C--N 1.304 -1.223 0 N-CA-C 108.935 -1.666 . . . . 0.0 108.935 -173.078 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.671 HG12 ' O ' ' A' ' 67' ' ' ILE . 11.5 p -98.64 177.03 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.556 1.193 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 171.712 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' GLN . . . . . 0.509 ' H ' HG22 ' A' ' 160' ' ' VAL . 14.3 mm100 -108.36 99.29 8.71 Favored 'General case' 0 CA--C 1.463 -2.378 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 -175.553 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . 0.615 ' HA ' HG21 ' A' ' 94' ' ' VAL . 0.0 OUTLIER -132.1 173.18 11.49 Favored 'General case' 0 N--CA 1.393 -3.287 0 C-N-CA 119.283 -0.967 . . . . 0.0 113.148 -174.722 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 21.9 t-20 -152.76 -48.69 0.1 Allowed 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 106.359 -1.719 . . . . 0.0 106.359 179.55 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -64.0 147.27 50.73 Favored Glycine 0 C--O 1.254 1.373 0 CA-C-N 114.566 -1.197 . . . . 0.0 110.546 170.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.514 ' H ' HD23 ' A' ' 165' ' ' LEU . 1.9 pt? -124.65 154.9 40.05 Favored 'General case' 0 C--N 1.291 -1.973 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 -176.874 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . 0.523 ' HD2' ' N ' ' A' ' 166' ' ' ARG . 5.2 mpt_? -76.43 114.98 15.74 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 -179.219 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 18.2 m -80.75 54.07 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.286 -2.191 0 CA-C-O 122.479 1.133 . . . . 0.0 112.827 -177.335 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . 0.512 ' HB2' ' HB2' ' A' ' 90' ' ' SER . 14.8 t70 -109.94 -39.32 5.1 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 114.069 -1.423 . . . . 0.0 107.766 176.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 27.8 ttpp -107.22 8.92 30.23 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 114.012 -1.449 . . . . 0.0 108.749 -177.05 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' PHE . . . . . . . . . . . . . 84.5 t80 . . . . . 0 C--N 1.306 -1.291 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 -178.464 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 30.4 m . . . . . 0 C--O 1.237 0.432 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -128.08 99.31 5.43 Favored 'General case' 0 CA--C 1.5 -0.967 0 CA-C-O 120.722 0.296 . . . . 0.0 110.786 179.458 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -100.85 97.37 7.99 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 175.581 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.1 mp -89.84 104.96 15.64 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 177.352 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 44.0 p90 -120.44 120.65 36.52 Favored 'General case' 0 C--N 1.299 -1.613 0 CA-C-O 121.122 0.487 . . . . 0.0 110.743 -179.503 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 38.7 t30 -142.28 88.12 2.07 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-O 121.544 0.688 . . . . 0.0 110.504 178.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 54.2 mtpt -138.3 20.63 2.77 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 114.922 -1.036 . . . . 0.0 108.254 177.733 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 43.5 t -93.69 134.7 30.5 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.196 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.173 -176.224 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 102.86 117.18 4.29 Favored Glycine 0 N--CA 1.435 -1.387 0 C-N-CA 121.04 -0.6 . . . . 0.0 111.793 179.229 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 23.0 t -120.06 97.35 5.56 Favored 'General case' 0 N--CA 1.431 -1.404 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 178.542 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 81.3 t80 -101.56 127.59 48.2 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.103 -175.426 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 67.1 m95 -131.96 123.81 28.12 Favored 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 -178.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.524 HD23 ' H ' ' A' ' 15' ' ' GLN . 6.0 tt -83.36 110.83 18.47 Favored 'General case' 0 C--N 1.31 -1.132 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 179.32 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -118.01 35.04 4.21 Favored Glycine 0 N--CA 1.442 -0.966 0 CA-C-N 115.944 -0.571 . . . . 0.0 112.057 -176.714 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.524 ' H ' HD23 ' A' ' 13' ' ' LEU . 57.8 tt0 -83.69 115.86 22.38 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 177.216 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 63.2 tttp -105.81 94.95 5.47 Favored 'General case' 0 N--CA 1.424 -1.759 0 N-CA-C 109.797 -0.445 . . . . 0.0 109.797 179.362 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -88.72 90.83 8.57 Favored 'General case' 0 N--CA 1.436 -1.164 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 176.221 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -165.48 131.18 2.59 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 115.219 -0.9 . . . . 0.0 109.729 -176.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 25.0 pttm -129.85 176.56 7.94 Favored 'General case' 0 C--N 1.292 -1.921 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 178.179 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -115.4 150.84 35.75 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 -179.825 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 80.4 t80 76.63 108.14 0.08 Allowed 'General case' 0 C--O 1.236 0.359 0 C-N-CA 125.165 1.386 . . . . 0.0 112.303 179.641 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -146.42 125.29 12.7 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 115.228 -0.897 . . . . 0.0 108.781 175.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 49.5 m -154.32 174.35 14.94 Favored 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 179.242 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 34.6 m -68.21 144.39 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.939 0 N-CA-C 109.103 -0.702 . . . . 0.0 109.103 175.281 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 145.36 19.0 0.16 Allowed Glycine 0 C--N 1.292 -1.895 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.159 -178.035 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 27.7 p-10 -90.56 149.71 22.04 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 177.465 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -94.73 -29.4 14.81 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.597 -178.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 94.3 mt -138.33 154.83 48.98 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.079 178.782 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 47.8 t-20 -95.86 -47.27 6.22 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 174.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 33.9 m -85.83 93.01 8.8 Favored 'General case' 0 N--CA 1.429 -1.519 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 175.61 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 27.6 m -109.59 -179.45 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.738 -178.134 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 13.1 m -75.36 96.29 3.37 Favored 'General case' 0 N--CA 1.422 -1.831 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 177.477 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 20.1 p -83.5 172.86 11.98 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.854 -177.302 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 42.1 m -72.18 116.36 12.51 Favored 'General case' 0 N--CA 1.438 -1.06 0 CA-C-O 121.144 0.497 . . . . 0.0 110.803 -178.397 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 62.7 mt -124.78 93.82 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.971 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 179.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -76.06 110.16 10.31 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.188 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 175.67 -153.23 14.52 Favored Glycine 0 N--CA 1.442 -0.906 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.07 179.353 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -172.61 -42.95 0.04 OUTLIER Glycine 0 C--N 1.312 -0.772 0 N-CA-C 111.558 -0.617 . . . . 0.0 111.558 179.459 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 62.8 m 77.27 -38.8 0.3 Allowed 'General case' 0 CA--C 1.555 1.142 0 C-N-CA 124.661 1.185 . . . . 0.0 112.869 177.063 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 13.1 mptt -68.42 95.09 0.59 Allowed 'General case' 0 C--O 1.246 0.91 0 N-CA-C 113.547 0.943 . . . . 0.0 113.547 -178.533 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 21.4 t90 -168.68 132.66 1.5 Allowed 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 106.924 -1.51 . . . . 0.0 106.924 174.509 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 86.3 mt 72.28 93.68 0.08 Allowed 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 123.93 0.892 . . . . 0.0 110.716 -174.788 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 59.9 t -124.57 133.92 68.11 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 176.578 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -74.27 97.92 3.1 Favored 'General case' 0 C--N 1.311 -1.094 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 178.045 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 60.9 pttt -146.2 171.7 14.54 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 115.155 -0.929 . . . . 0.0 110.371 -174.138 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 63.1 mt 65.36 87.42 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.243 0.743 0 C-N-CA 124.114 0.966 . . . . 0.0 111.833 177.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -136.58 101.04 4.51 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 115.538 -0.756 . . . . 0.0 109.227 176.06 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -87.5 83.5 1.55 Allowed Glycine 0 N--CA 1.426 -1.973 0 C-N-CA 121.132 -0.556 . . . . 0.0 112.381 -177.613 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.62 ' HA ' ' HE3' ' A' ' 49' ' ' LYS . 0.8 OUTLIER -132.71 94.07 3.33 Favored 'General case' 0 C--N 1.294 -1.821 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 177.202 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 83.4 mtp -88.3 91.06 8.64 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-O 121.838 0.827 . . . . 0.0 111.51 179.535 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 7.2 tp60 -112.4 -62.63 1.55 Allowed 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 107.141 -1.429 . . . . 0.0 107.141 178.263 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 60.3 tttp -176.31 102.67 0.24 Allowed Pre-proline 0 N--CA 1.431 -1.393 0 N-CA-C 104.524 -2.399 . . . . 0.0 104.524 177.646 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -79.11 22.33 0.69 Allowed 'Trans proline' 0 CA--C 1.517 -0.325 0 C-N-CA 122.84 2.36 . . . . 0.0 116.352 -167.053 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.55 ' O ' HD13 ' A' ' 58' ' ' LEU . 28.8 mt -68.39 -57.23 9.02 Favored Pre-proline 0 C--N 1.31 -1.119 0 C-N-CA 119.252 -0.979 . . . . 0.0 110.902 179.572 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.415 ' HD3' ' HB2' ' A' ' 54' ' ' LEU . 13.8 Cg_exo -64.9 -31.42 56.76 Favored 'Trans proline' 0 N--CA 1.428 -2.366 0 C-N-CA 120.791 0.994 . . . . 0.0 111.88 -170.509 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -75.86 -32.33 59.68 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.282 178.753 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 63.7 tp -69.33 -34.3 74.42 Favored 'General case' 0 CA--C 1.508 -0.656 0 C-N-CA 120.503 -0.479 . . . . 0.0 110.157 178.634 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.62 ' HA ' ' CD1' ' A' ' 75' ' ' TYR . 6.2 mp -61.7 -41.47 97.65 Favored 'General case' 0 CA--C 1.49 -1.334 0 C-N-CA 120.128 -0.629 . . . . 0.0 112.421 179.669 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.48 ' HD2' ' N ' ' A' ' 60' ' ' GLU . 0.1 OUTLIER -76.86 -26.5 54.32 Favored 'General case' 0 C--N 1.298 -1.658 0 CA-C-O 121.491 0.662 . . . . 0.0 112.722 178.477 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.534 ' C ' ' H ' ' A' ' 62' ' ' ASP . 8.5 tp10 -82.51 -41.53 19.58 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 115.344 -0.843 . . . . 0.0 113.145 -171.08 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 56.2 t80 -68.44 3.85 1.6 Allowed 'General case' 0 N--CA 1.494 1.727 0 CA-C-O 122.095 0.95 . . . . 0.0 110.108 -178.303 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.534 ' H ' ' C ' ' A' ' 60' ' ' GLU . 27.9 t70 -109.02 -153.8 0.52 Allowed 'General case' 0 C--N 1.287 -2.113 0 CA-C-N 113.888 -1.505 . . . . 0.0 109.024 -174.783 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.708 ' HB2' HD12 ' A' ' 65' ' ' ILE . 0.1 OUTLIER -100.54 -167.98 0.15 Allowed Pre-proline 0 CA--C 1.576 1.961 0 N-CA-C 106.187 -1.783 . . . . 0.0 106.187 -177.362 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.477 ' O ' ' HD2' ' A' ' 155' ' ' ARG . 18.2 Cg_endo -100.4 11.49 0.56 Allowed 'Trans proline' 0 C--N 1.368 1.576 0 CA-C-N 122.943 2.087 . . . . 0.0 112.593 -176.292 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.708 HD12 ' HB2' ' A' ' 63' ' ' LEU . 0.2 OUTLIER -73.03 -43.07 59.21 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.959 0 CA-C-N 115.846 -0.616 . . . . 0.0 109.62 179.53 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.432 ' H ' HD13 ' A' ' 65' ' ' ILE . . . 56.94 9.14 3.56 Favored Glycine 0 N--CA 1.484 1.846 0 CA-C-O 121.351 0.417 . . . . 0.0 113.201 -177.582 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.524 ' H ' HG12 ' A' ' 65' ' ' ILE . 52.1 mt 67.39 -67.63 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.421 0 C-N-CA 125.877 1.671 . . . . 0.0 112.04 -175.61 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.478 ' HB2' ' O ' ' A' ' 67' ' ' ILE . 26.0 t80 175.01 -56.16 0.0 OUTLIER Pre-proline 0 C--N 1.318 -0.782 0 CA-C-O 119.68 -0.2 . . . . 0.0 111.281 -178.314 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.463 ' HD3' ' HB3' ' A' ' 68' ' ' PHE . 8.4 Cg_exo -73.51 -35.37 4.84 Favored 'Trans proline' 0 C--N 1.379 2.163 0 C-N-CA 121.934 1.756 . . . . 0.0 113.108 -172.226 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 97.28 -17.55 58.93 Favored Glycine 0 N--CA 1.44 -1.069 0 C-N-CA 120.193 -1.004 . . . . 0.0 111.048 -176.253 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -84.93 -48.11 9.62 Favored 'General case' 0 C--O 1.195 -1.769 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 176.808 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.647 ' O ' ' HB ' ' A' ' 73' ' ' THR . . . -57.7 171.87 0.43 Allowed 'General case' 0 CA--C 1.55 0.981 0 C-N-CA 124.53 1.132 . . . . 0.0 111.675 174.888 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.647 ' HB ' ' O ' ' A' ' 72' ' ' ALA . 8.9 m 94.49 -10.65 0.12 Allowed 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 124.022 0.929 . . . . 0.0 112.035 177.804 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.542 ' HA ' ' HB3' ' A' ' 58' ' ' LEU . 35.5 m-80 -46.4 103.25 0.04 OUTLIER 'General case' 0 CA--C 1.45 -2.879 0 C-N-CA 125.062 1.345 . . . . 0.0 113.657 -179.463 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.62 ' CD1' ' HA ' ' A' ' 58' ' ' LEU . 8.3 p90 -92.81 144.0 25.72 Favored 'General case' 1 C--N 1.241 -4.144 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.493 -176.787 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.629 ' HB2' ' O ' ' A' ' 85' ' ' THR . 10.9 mm-40 -136.2 161.78 34.78 Favored 'General case' 0 C--N 1.278 -2.534 0 N-CA-C 105.872 -1.899 . . . . 0.0 105.872 171.522 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 38.8 p90 -162.95 146.83 11.15 Favored 'General case' 0 C--N 1.293 -1.875 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 177.682 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.709 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 25.5 m-20 -105.17 162.31 13.51 Favored 'General case' 0 CA--C 1.459 -2.529 0 C-N-CA 118.955 -1.098 . . . . 0.0 108.799 176.12 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -81.24 -44.47 17.71 Favored 'General case' 0 C--N 1.262 -3.201 0 CA-C-N 114.161 -1.382 . . . . 0.0 111.094 -179.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -69.17 -47.45 64.9 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 178.213 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.709 ' HB ' ' HB2' ' A' ' 78' ' ' ASP . 31.8 m -63.75 -51.74 63.55 Favored 'General case' 0 N--CA 1.418 -2.056 0 CA-C-N 113.93 -1.486 . . . . 0.0 111.951 -178.45 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 99.1 mttt 66.27 18.63 10.96 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-O 121.818 0.818 . . . . 0.0 111.117 -177.042 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.617 ' HB3' HG22 ' A' ' 81' ' ' THR . 35.5 ttmt -111.83 135.88 51.86 Favored 'General case' 0 CA--C 1.491 -1.298 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.205 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.592 ' O ' ' HA ' ' A' ' 109' ' ' THR . 1.5 tm? -76.65 124.71 28.06 Favored 'General case' 0 N--CA 1.421 -1.897 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 -179.757 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.629 ' O ' ' HB2' ' A' ' 76' ' ' GLU . 3.8 t -126.82 109.39 11.95 Favored 'General case' 0 C--N 1.265 -3.097 0 CA-C-N 115.844 -0.617 . . . . 0.0 109.622 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.606 ' O ' ' HA ' ' A' ' 107' ' ' THR . 31.0 m -91.84 151.08 3.61 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.943 0 O-C-N 121.375 -0.828 . . . . 0.0 110.575 -179.483 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.535 ' HA ' ' O ' ' A' ' 106' ' ' THR 0.299 1.5 pp -115.59 103.64 10.93 Favored 'General case' 0 N--CA 1.396 -3.153 0 CA-C-O 122.655 1.217 . . . . 0.0 109.736 174.35 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 40.0 mm -89.82 139.01 27.61 Favored Pre-proline 0 C--N 1.289 -2.044 0 CA-C-N 114.08 -1.418 . . . . 0.0 108.37 -174.293 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -54.14 87.5 0.03 OUTLIER 'Trans proline' 0 C--N 1.354 0.868 0 C-N-CA 123.475 2.783 . . . . 0.0 112.431 173.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.533 ' OG ' ' HB ' ' A' ' 167' ' ' VAL . 22.6 t 66.73 -169.15 0.2 Allowed 'General case' 0 N--CA 1.44 -0.955 0 C-N-CA 124.421 1.088 . . . . 0.0 110.811 178.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -93.05 137.36 22.59 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 177.022 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' CYS . . . . . 0.578 ' SG ' ' HG2' ' A' ' 166' ' ' ARG . 33.3 m -129.57 138.61 51.39 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 -176.882 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.621 ' O ' ' HA2' ' A' ' 164' ' ' GLY . 45.6 mt-10 -120.25 135.71 54.9 Favored 'General case' 0 CA--C 1.469 -2.167 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 177.511 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.734 HG13 ' H ' ' A' ' 163' ' ' ASN . 20.3 t -117.91 107.81 22.94 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.482 0 C-N-CA 120.224 -0.59 . . . . 0.0 112.349 -172.215 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -112.15 111.79 2.92 Favored Glycine 0 N--CA 1.426 -1.988 0 N-CA-C 108.166 -1.974 . . . . 0.0 108.166 169.536 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 0.474 ' CD1' ' HB2' ' A' ' 163' ' ' ASN . 50.2 t80 -153.56 168.93 24.53 Favored 'General case' 0 N--CA 1.391 -3.416 0 N-CA-C 102.877 -3.008 . . . . 0.0 102.877 -178.829 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.45 ' HE2' ' CE2' ' A' ' 96' ' ' TYR . 0.0 OUTLIER -66.99 3.79 1.02 Allowed 'General case' 0 C--N 1.292 -1.934 0 O-C-N 123.262 0.351 . . . . 0.0 111.735 179.418 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.43 ' H ' ' C ' ' A' ' 96' ' ' TYR . 19.1 t70 -58.65 -74.21 0.07 Allowed 'General case' 0 N--CA 1.427 -1.577 0 CA-C-O 122.07 0.938 . . . . 0.0 110.983 -177.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.563 ' HB3' ' HB ' ' A' ' 127' ' ' VAL . 66.6 m -112.52 -69.93 0.84 Allowed 'General case' 0 C--N 1.281 -2.373 0 CA-C-N 114.565 -1.198 . . . . 0.0 108.942 -178.71 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 67.0 m -177.0 -73.87 0.01 OUTLIER 'General case' 0 C--N 1.31 -1.149 0 C-N-CA 126.577 1.951 . . . . 0.0 105.818 -179.326 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.42 ' HA ' ' O ' ' A' ' 94' ' ' VAL . 59.9 t -147.59 129.88 7.16 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.919 0 CA-C-N 114.759 -1.11 . . . . 0.0 108.065 177.632 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -126.61 167.37 15.76 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 177.629 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.62 ' HB3' ' HB3' ' A' ' 124' ' ' LYS . 39.0 ttmt -148.54 128.97 13.91 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-O 120.768 0.318 . . . . 0.0 110.462 174.689 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -104.6 123.73 48.08 Favored 'General case' 0 C--N 1.293 -1.87 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 174.31 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.417 HG22 HG22 ' A' ' 108' ' ' VAL . 14.4 t -91.09 168.98 11.24 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 179.464 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.535 ' O ' ' HA ' ' A' ' 87' ' ' LEU . 46.1 m -64.94 -27.97 69.21 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 112.229 0.455 . . . . 0.0 112.229 -175.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.606 ' HA ' ' O ' ' A' ' 86' ' ' VAL . 29.1 m -138.66 108.35 6.25 Favored 'General case' 0 C--N 1.306 -1.314 0 O-C-N 121.687 -0.633 . . . . 0.0 110.74 -179.4 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.493 ' O ' ' HA ' ' A' ' 85' ' ' THR . 34.1 t -108.72 135.97 45.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 N-CA-C 108.631 -0.878 . . . . 0.0 108.631 -179.303 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.592 ' HA ' ' O ' ' A' ' 84' ' ' LEU . 44.5 p -122.43 132.95 54.6 Favored 'General case' 0 N--CA 1.414 -2.237 0 C-N-CA 122.755 0.422 . . . . 0.0 110.785 -173.51 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.659 ' HA3' ' O ' ' A' ' 119' ' ' ASP . . . -168.69 -158.26 12.44 Favored Glycine 0 C--N 1.308 -0.985 0 C-N-CA 121.373 -0.442 . . . . 0.0 113.234 -178.748 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 46.2 m80 -110.65 119.57 39.59 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-O 121.0 0.428 . . . . 0.0 110.562 -178.281 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.427 ' HB2' ' HG ' ' A' ' 84' ' ' LEU . 2.5 tm? -89.88 120.78 31.41 Favored 'General case' 0 C--N 1.308 -1.198 0 C-N-CA 123.905 0.882 . . . . 0.0 111.192 -176.264 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -139.56 175.37 9.62 Favored 'General case' 0 CA--C 1.475 -1.928 0 CA-C-N 115.274 -0.876 . . . . 0.0 109.303 170.692 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 1.8 tmtm? -103.81 131.9 50.57 Favored 'General case' 0 N--CA 1.393 -3.287 0 N-CA-C 107.262 -1.385 . . . . 0.0 107.262 -175.494 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 97.13 -25.77 25.58 Favored Glycine 0 C--O 1.189 -2.686 0 N-CA-C 109.862 -1.295 . . . . 0.0 109.862 -176.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . 0.341 0.0 OUTLIER -164.12 134.76 4.3 Favored 'General case' 0 C--N 1.291 -1.952 0 N-CA-C 114.316 1.228 . . . . 0.0 114.316 177.928 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -103.49 109.53 21.21 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 104.932 -2.248 . . . . 0.0 104.932 179.053 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 33.5 p -95.99 136.97 35.73 Favored 'General case' 0 C--N 1.284 -2.27 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.221 -176.49 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . 0.659 ' O ' ' HA3' ' A' ' 110' ' ' GLY . 15.1 m-20 69.03 107.22 0.05 Allowed 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 124.623 1.169 . . . . 0.0 111.621 178.608 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.405 HG22 ' O ' ' A' ' 134' ' ' THR . 7.6 m -119.66 86.39 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.901 0 CA-C-O 122.168 0.985 . . . . 0.0 111.129 173.082 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -74.25 100.9 3.84 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-N 114.48 -1.236 . . . . 0.0 109.464 -177.19 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 128.66 -7.86 6.53 Favored Glycine 0 C--N 1.299 -1.482 0 C-N-CA 120.017 -1.087 . . . . 0.0 111.736 177.744 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 66.5 mt -99.3 115.85 41.01 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.699 0 CA-C-O 121.869 0.843 . . . . 0.0 109.525 178.547 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.62 ' HB3' ' HB3' ' A' ' 103' ' ' LYS . 86.7 tttt -84.2 128.06 34.33 Favored 'General case' 0 CA--C 1.475 -1.936 0 CA-C-N 114.317 -1.31 . . . . 0.0 107.711 -176.146 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.479 HG21 ' HB1' ' A' ' 147' ' ' ALA . 92.1 m -130.16 127.28 39.39 Favored 'General case' 0 N--CA 1.388 -3.571 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.715 -176.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.512 ' HG2' ' N ' ' A' ' 127' ' ' VAL . 85.2 tttt -139.11 143.12 38.13 Favored 'General case' 0 N--CA 1.407 -2.609 0 CA-C-O 121.344 0.592 . . . . 0.0 110.184 167.178 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.563 ' HB ' ' HB3' ' A' ' 99' ' ' SER . 7.0 p -158.84 -37.66 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 N-CA-C 106.286 -1.746 . . . . 0.0 106.286 177.02 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -120.28 -52.83 2.15 Favored 'General case' 0 N--CA 1.381 -3.903 0 CA-C-N 112.173 -2.285 . . . . 0.0 106.531 -177.484 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 9.6 tp -153.04 164.43 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.386 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 177.095 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 62.6 t90 -70.81 117.66 12.6 Favored 'General case' 0 C--N 1.317 -0.826 0 C-N-CA 123.339 0.656 . . . . 0.0 111.406 178.151 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.464 HG12 ' H ' ' A' ' 133' ' ' VAL . 21.5 t -138.86 119.44 15.37 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 175.696 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 14.8 ptmm? -102.09 17.53 23.05 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-O 121.316 0.579 . . . . 0.0 110.936 -179.123 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.464 ' H ' HG12 ' A' ' 131' ' ' VAL . 13.7 m -138.33 74.63 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 CA-C-N 114.866 -1.061 . . . . 0.0 110.324 178.612 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . 0.405 ' O ' HG22 ' A' ' 120' ' ' VAL . 35.2 p -111.49 -165.97 1.04 Allowed 'General case' 0 C--N 1.288 -2.102 0 CA-C-N 115.166 -0.925 . . . . 0.0 110.374 -177.271 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 38.3 m -151.65 167.71 27.28 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 176.623 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 11.7 tt -135.11 136.01 52.0 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.234 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 179.375 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 36.6 p -123.51 168.26 12.82 Favored 'General case' 0 N--CA 1.427 -1.579 0 CA-C-O 121.858 0.837 . . . . 0.0 112.885 -177.056 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . 0.486 HG23 ' H ' ' A' ' 140' ' ' ALA . 5.0 t -165.7 177.53 7.22 Favored 'General case' 0 N--CA 1.413 -2.312 0 N-CA-C 106.97 -1.492 . . . . 0.0 106.97 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -115.22 32.95 5.72 Favored 'General case' 0 C--N 1.265 -3.101 0 N-CA-C 105.352 -2.092 . . . . 0.0 105.352 175.062 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.486 ' H ' HG23 ' A' ' 138' ' ' THR . . . 60.91 42.78 12.51 Favored 'General case' 0 C--N 1.366 1.309 0 CA-C-N 113.759 -1.564 . . . . 0.0 108.97 -172.466 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 47.6 t -173.4 -65.61 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 115.432 -0.803 . . . . 0.0 111.645 -172.735 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.462 ' HA ' ' HE2' ' A' ' 142' ' ' LYS . 9.1 mmpt? -82.4 -154.46 0.13 Allowed 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 -179.599 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 14.6 p -155.25 119.3 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.055 0 CA-C-O 121.408 0.623 . . . . 0.0 110.136 170.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -114.55 155.99 25.46 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-O 121.964 0.888 . . . . 0.0 112.98 -172.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 35.0 p90 -72.78 137.66 45.95 Favored 'General case' 0 N--CA 1.431 -1.388 0 CA-C-N 113.931 -1.486 . . . . 0.0 113.379 178.216 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 25.9 m -157.72 28.73 0.27 Allowed 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 106.451 -1.685 . . . . 0.0 106.451 172.419 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.479 ' HB1' HG21 ' A' ' 125' ' ' THR . . . -132.44 92.62 3.11 Favored 'General case' 0 N--CA 1.422 -1.859 0 C-N-CA 119.552 -0.859 . . . . 0.0 113.227 -173.459 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 66.9 32.28 80.56 Favored Glycine 0 CA--C 1.5 -0.852 0 CA-C-N 115.803 -0.635 . . . . 0.0 112.815 175.707 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 49.5 ttm 60.12 80.13 0.21 Allowed 'General case' 0 C--O 1.236 0.386 0 CA-C-O 122.019 0.914 . . . . 0.0 109.689 -177.065 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . 0.742 ' HG2' ' H ' ' A' ' 151' ' ' LYS . 35.4 ttmt -120.8 -160.32 0.84 Allowed 'General case' 0 C--N 1.297 -1.698 0 CA-C-N 114.915 -1.039 . . . . 0.0 108.995 -174.181 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.742 ' H ' ' HG2' ' A' ' 150' ' ' LYS . 96.4 mttt -121.64 165.12 16.21 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 124.078 0.951 . . . . 0.0 110.016 -178.415 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 22.3 p -83.66 160.11 21.41 Favored 'General case' 0 C--N 1.301 -1.51 0 C-N-CA 123.275 0.63 . . . . 0.0 110.587 177.527 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' ARG . . . . . 0.425 HH21 ' CG ' ' A' ' 98' ' ' ASP . 4.2 mpt_? -128.18 174.65 9.07 Favored 'General case' 0 CA--C 1.506 -0.736 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 177.272 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 14.7 m -98.9 116.23 30.66 Favored 'General case' 0 N--CA 1.422 -1.862 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 173.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' ARG . . . . . 0.635 ' HG2' ' HA2' ' A' ' 159' ' ' GLY . 0.2 OUTLIER -63.15 -22.98 67.22 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.461 0.648 . . . . 0.0 109.598 -179.559 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -46.51 -37.55 8.07 Favored 'General case' 0 C--N 1.318 -0.797 0 C-N-CA 125.346 1.458 . . . . 0.0 114.476 -177.626 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -69.92 -56.63 6.53 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 119.708 -0.797 . . . . 0.0 112.372 -174.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 58.5 m-85 -165.1 20.52 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 124.025 0.93 . . . . 0.0 110.08 -178.317 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . 0.646 ' HA3' ' O ' ' A' ' 65' ' ' ILE . . . 92.36 -92.79 1.72 Allowed Glycine 0 CA--C 1.47 -2.736 0 C-N-CA 120.016 -1.088 . . . . 0.0 111.195 -174.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.522 ' HB ' ' O ' ' A' ' 67' ' ' ILE . 11.5 t -103.42 172.53 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.41 -2.457 0 N-CA-C 106.947 -1.501 . . . . 0.0 106.947 179.102 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' GLN . . . . . 0.423 ' H ' HG12 ' A' ' 160' ' ' VAL . 46.6 mt-30 -123.09 92.9 3.8 Favored 'General case' 0 CA--C 1.483 -1.62 0 CA-C-N 118.973 0.806 . . . . 0.0 109.233 -175.147 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.33 161.83 17.96 Favored 'General case' 0 N--CA 1.401 -2.902 0 C-N-CA 119.012 -1.075 . . . . 0.0 113.251 -176.409 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' ASN . . . . . 0.734 ' H ' HG13 ' A' ' 94' ' ' VAL . 57.7 t30 -129.75 16.56 5.82 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 105.678 -1.971 . . . . 0.0 105.678 172.671 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . 0.621 ' HA2' ' O ' ' A' ' 93' ' ' GLU . . . -58.19 123.09 31.98 Favored Glycine 0 CA--C 1.475 -2.449 0 CA-C-N 113.469 -1.696 . . . . 0.0 112.991 -176.149 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.585 ' O ' HD12 ' A' ' 165' ' ' LEU . 3.9 pp -94.16 121.96 36.2 Favored 'General case' 1 N--CA 1.374 -4.25 0 N-CA-C 105.661 -1.977 . . . . 0.0 105.661 -178.349 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . 0.578 ' HG2' ' SG ' ' A' ' 92' ' ' CYS . 16.0 mtm180 -84.94 129.09 34.86 Favored 'General case' 0 N--CA 1.391 -3.396 0 N-CA-C 105.886 -1.894 . . . . 0.0 105.886 179.483 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.533 ' HB ' ' OG ' ' A' ' 90' ' ' SER . 66.8 t -58.93 -14.98 5.4 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.737 0 CA-C-O 122.104 0.954 . . . . 0.0 110.249 171.679 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . 0.466 ' HB2' ' HB2' ' A' ' 90' ' ' SER . 11.1 t70 -76.25 -13.0 60.18 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 125.795 1.638 . . . . 0.0 109.986 173.162 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' LYS . . . . . 0.478 ' HG2' ' N ' ' A' ' 170' ' ' PHE . 56.1 tttm -134.29 176.99 8.1 Favored 'General case' 0 C--N 1.297 -1.699 0 C-N-CA 124.167 0.987 . . . . 0.0 108.497 -174.247 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' PHE . . . . . 0.478 ' N ' ' HG2' ' A' ' 169' ' ' LYS . 79.4 t80 . . . . . 0 C--N 1.295 -1.762 0 N-CA-C 106.656 -1.609 . . . . 0.0 106.656 170.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 48.9 m . . . . . 0 N--CA 1.44 -0.926 0 CA-C-O 120.662 0.268 . . . . 0.0 110.631 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -76.32 21.63 0.18 Allowed 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 114.953 1.464 . . . . 0.0 114.953 -173.087 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -86.01 -17.75 34.4 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.466 0.65 . . . . 0.0 109.458 175.313 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 45.3 mm -72.01 135.56 27.59 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.162 0 CA-C-N 115.101 -0.954 . . . . 0.0 108.976 -179.361 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -67.5 -60.55 2.47 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 178.579 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 51.7 t30 -159.77 129.96 5.56 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 177.289 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -86.83 135.44 33.34 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-O 120.956 0.408 . . . . 0.0 110.095 -179.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 11.1 p -110.84 144.09 19.49 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 CA-C-N 116.187 -0.46 . . . . 0.0 109.82 -179.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 159.32 177.03 32.04 Favored Glycine 0 N--CA 1.443 -0.892 0 N-CA-C 110.923 -0.871 . . . . 0.0 110.923 178.587 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 35.9 t -86.22 115.62 23.89 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 179.031 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -97.28 -0.88 45.84 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 112.902 0.704 . . . . 0.0 112.902 -176.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 73.4 t-105 -80.08 107.17 12.66 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 176.565 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 98.9 mt -94.82 164.58 12.87 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.323 -176.565 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -99.5 34.18 5.63 Favored Glycine 0 N--CA 1.44 -1.053 0 N-CA-C 111.172 -0.771 . . . . 0.0 111.172 179.647 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -89.72 110.96 21.82 Favored 'General case' 0 N--CA 1.438 -1.032 0 N-CA-C 105.039 -2.208 . . . . 0.0 105.039 177.756 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 61.3 pttt -137.04 172.36 13.13 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.533 -175.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -80.38 112.11 17.41 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 175.703 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 17.6 m120 -87.1 97.57 10.82 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.304 -177.536 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -155.74 119.47 4.45 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 116.057 -0.519 . . . . 0.0 109.654 179.03 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -135.64 153.29 51.68 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 104.377 -2.453 . . . . 0.0 104.377 177.27 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -64.95 117.99 8.42 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-O 121.373 0.606 . . . . 0.0 110.636 -179.599 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -86.93 -176.02 5.59 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 115.117 -0.947 . . . . 0.0 110.124 -178.194 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 35.1 p -54.38 116.3 2.57 Favored 'General case' 0 C--N 1.314 -0.941 0 C-N-CA 124.256 1.022 . . . . 0.0 113.631 -176.761 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 7.4 p -146.0 98.96 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.171 0 CA-C-O 121.803 0.811 . . . . 0.0 109.811 175.065 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -121.76 151.25 16.97 Favored Glycine 0 N--CA 1.434 -1.475 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.036 -179.393 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 29.2 p-10 -162.04 171.58 17.32 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 -179.312 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -102.32 -171.93 2.05 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 177.097 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.588 ' H ' HD23 ' A' ' 28' ' ' LEU . 1.7 pt? -76.05 78.82 2.9 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 121.642 0.734 . . . . 0.0 111.819 -178.745 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 52.1 t30 -165.89 162.98 18.61 Favored 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 -179.726 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 34.6 m -70.15 -40.5 74.72 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 118.016 0.371 . . . . 0.0 110.142 179.401 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . 0.259 7.1 p 42.58 99.48 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 C-N-CA 126.123 1.769 . . . . 0.0 115.521 176.109 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 55.2 m -145.36 109.94 5.02 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.062 179.446 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 35.5 p -86.63 130.06 34.63 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.258 178.579 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 32.4 m -82.01 94.13 7.11 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-O 121.322 0.582 . . . . 0.0 109.63 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 49.6 mm -116.0 113.93 44.67 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.322 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 -179.433 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -69.47 148.34 49.66 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 177.216 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 78.48 -104.02 2.01 Favored Glycine 0 N--CA 1.44 -1.05 0 N-CA-C 110.651 -0.98 . . . . 0.0 110.651 -178.504 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 138.23 -41.41 1.37 Allowed Glycine 0 N--CA 1.441 -0.985 0 C-N-CA 120.878 -0.677 . . . . 0.0 111.83 178.643 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 8.9 t -108.72 162.51 14.1 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 -179.019 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 55.1 tptt -113.06 123.82 51.17 Favored 'General case' 0 N--CA 1.433 -1.314 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.073 178.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 47.0 t90 -103.54 126.15 50.51 Favored 'General case' 0 C--N 1.301 -1.516 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.198 177.145 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 5.5 tt -84.45 124.73 31.66 Favored 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 106.663 -1.606 . . . . 0.0 106.663 177.647 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 39.7 t -72.0 91.6 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.138 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 -174.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 48.5 t-20 67.5 102.17 0.05 OUTLIER 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.985 1.314 . . . . 0.0 110.814 177.478 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 54.1 tptt -83.76 -37.01 23.17 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 115.384 -0.825 . . . . 0.0 112.542 -176.771 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 67.4 mt 66.43 91.72 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 -173.735 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 23.2 pttm -87.41 -19.56 27.9 Favored 'General case' 0 C--N 1.308 -1.225 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 -175.617 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -167.95 102.81 0.19 Allowed Glycine 0 CA--C 1.491 -1.45 0 C-N-CA 119.641 -1.266 . . . . 0.0 112.411 -179.501 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -177.16 105.76 0.06 Allowed 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 179.043 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 45.3 tpp -159.16 -64.89 0.08 Allowed 'General case' 0 C--N 1.316 -0.862 0 C-N-CA 120.779 -0.368 . . . . 0.0 111.883 -176.308 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 53.9 tt0 -140.65 82.66 1.86 Allowed 'General case' 0 N--CA 1.444 -0.765 0 C-N-CA 119.896 -0.722 . . . . 0.0 112.833 -177.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.635 ' O ' ' HG2' ' A' ' 56' ' ' GLU . 16.6 ptpt 173.44 78.39 0.05 OUTLIER Pre-proline 0 C--N 1.321 -0.647 0 C-N-CA 126.6 1.96 . . . . 0.0 109.315 172.469 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.433 ' O ' ' HG ' ' A' ' 57' ' ' LEU . 9.0 Cg_exo -31.29 -66.67 0.08 OUTLIER 'Trans proline' 0 C--N 1.373 1.822 1 C-N-CA 125.488 4.125 . . . . 0.0 116.792 -170.197 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.404 ' HB2' ' HD3' ' A' ' 55' ' ' PRO . 3.4 mm? -63.89 -67.15 1.15 Allowed Pre-proline 0 CA--C 1.484 -1.569 0 N-CA-C 113.872 1.064 . . . . 0.0 113.872 -175.088 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.655 ' O ' ' HG2' ' A' ' 59' ' ' LYS . 19.3 Cg_endo -55.38 -25.74 49.56 Favored 'Trans proline' 0 N--CA 1.429 -2.301 0 C-N-CA 121.94 1.76 . . . . 0.0 113.657 -168.023 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.635 ' HG2' ' O ' ' A' ' 52' ' ' LYS . 14.0 pt-20 -81.36 -29.51 34.05 Favored 'General case' 0 CA--C 1.479 -1.763 0 CA-C-O 121.093 0.473 . . . . 0.0 110.867 -177.353 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.596 ' O ' ' HB3' ' A' ' 60' ' ' GLU . 93.8 mt -74.29 -31.54 62.54 Favored 'General case' 0 N--CA 1.417 -2.104 0 CA-C-N 115.736 -0.666 . . . . 0.0 109.973 174.867 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.581 ' HB3' ' H ' ' A' ' 75' ' ' TYR . 4.8 mp -69.76 -35.32 74.83 Favored 'General case' 0 CA--C 1.504 -0.82 0 C-N-CA 118.988 -1.085 . . . . 0.0 110.017 177.852 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.655 ' HG2' ' O ' ' A' ' 55' ' ' PRO 0.279 41.5 pttt -75.1 -25.25 58.36 Favored 'General case' 0 N--CA 1.439 -1.011 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 172.405 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.596 ' HB3' ' O ' ' A' ' 57' ' ' LEU . 7.4 tp10 -59.4 -49.13 78.98 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-O 121.247 0.546 . . . . 0.0 109.98 171.098 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 85.6 m-85 -68.93 -4.28 15.98 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-O 121.313 0.578 . . . . 0.0 111.202 176.468 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.624 ' HB3' ' O ' ' A' ' 59' ' ' LYS . 21.1 t70 -84.65 166.52 17.01 Favored 'General case' 0 C--N 1.298 -1.671 0 CA-C-N 115.102 -0.954 . . . . 0.0 111.813 -176.117 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.696 ' HB2' HD12 ' A' ' 65' ' ' ILE . 3.5 mt -85.67 -151.47 0.0 OUTLIER Pre-proline 0 CA--C 1.602 2.95 0 N-CA-C 104.936 -2.246 . . . . 0.0 104.936 178.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.647 ' HG3' ' N ' ' A' ' 141' ' ' SER . 71.3 Cg_endo -101.54 5.07 0.57 Allowed 'Trans proline' 0 N--CA 1.449 -1.114 0 CA-C-N 123.531 2.297 . . . . 0.0 112.125 176.188 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.72 HG12 ' H ' ' A' ' 67' ' ' ILE . 0.1 OUTLIER -70.04 -42.06 79.35 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.832 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.534 -177.435 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.436 ' H ' HD13 ' A' ' 65' ' ' ILE . . . 57.79 8.91 4.63 Favored Glycine 0 N--CA 1.5 2.958 0 CA-C-O 122.228 0.904 . . . . 0.0 112.441 -174.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.72 ' H ' HG12 ' A' ' 65' ' ' ILE . 61.1 mt 58.13 -72.47 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 C-N-CA 129.191 2.997 . . . . 0.0 113.162 -174.358 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.471 ' HB3' ' HD3' ' A' ' 69' ' ' PRO . 80.0 t80 171.8 -53.26 0.0 OUTLIER Pre-proline 0 N--CA 1.485 1.303 0 N-CA-C 113.497 0.925 . . . . 0.0 113.497 -172.687 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.471 ' HD3' ' HB3' ' A' ' 68' ' ' PHE . 6.9 Cg_exo -74.1 -28.53 10.8 Favored 'Trans proline' 0 C--N 1.366 1.496 0 C-N-CA 121.288 1.325 . . . . 0.0 113.094 -174.1 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 86.84 -12.7 60.99 Favored Glycine 0 C--N 1.31 -0.905 0 N-CA-C 110.309 -1.117 . . . . 0.0 110.309 -174.274 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -93.12 -53.47 4.11 Favored 'General case' 0 CA--C 1.48 -1.739 0 N-CA-C 106.512 -1.662 . . . . 0.0 106.512 178.374 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.652 ' O ' ' HB ' ' A' ' 73' ' ' THR . . . -52.06 173.37 0.03 OUTLIER 'General case' 0 C--N 1.361 1.079 0 CA-C-N 114.671 -1.15 . . . . 0.0 110.549 169.916 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.652 ' HB ' ' O ' ' A' ' 72' ' ' ALA . 10.6 m 87.63 27.13 0.03 OUTLIER 'General case' 0 CA--C 1.558 1.251 0 CA-C-O 125.331 2.491 . . . . 0.0 109.246 -174.814 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.62 ' O ' ' HA ' ' A' ' 86' ' ' VAL . 37.2 m-80 -83.81 75.12 10.12 Favored 'General case' 0 C--N 1.275 -2.67 0 CA-C-N 113.685 -1.598 . . . . 0.0 112.021 177.77 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.581 ' H ' ' HB3' ' A' ' 58' ' ' LEU . 2.9 m-85 -70.89 98.12 1.53 Allowed 'General case' 0 C--N 1.258 -3.375 0 CA-C-N 113.377 -1.738 . . . . 0.0 113.56 -179.073 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -106.43 115.29 29.95 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 105.452 -2.055 . . . . 0.0 105.452 176.672 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.4 ' HB2' HD12 ' A' ' 84' ' ' LEU . 76.2 t80 -131.35 127.59 37.94 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 112.465 0.543 . . . . 0.0 112.465 -172.842 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.62 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 19.6 m-20 -94.22 160.45 14.68 Favored 'General case' 0 CA--C 1.483 -1.607 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 173.248 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 13.5 tp10 -80.14 -63.38 1.42 Allowed 'General case' 0 C--N 1.264 -3.125 0 CA-C-N 114.94 -1.027 . . . . 0.0 112.436 -175.455 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -67.08 -40.05 86.92 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.582 0.706 . . . . 0.0 110.088 -173.638 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.62 ' HB ' ' HB2' ' A' ' 78' ' ' ASP . 62.7 m -62.77 -40.85 98.57 Favored 'General case' 0 C--N 1.289 -2.049 0 CA-C-N 114.679 -1.146 . . . . 0.0 111.648 -179.71 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt 65.0 6.83 3.64 Favored 'General case' 0 N--CA 1.484 1.247 0 N-CA-C 113.308 0.855 . . . . 0.0 113.308 -179.249 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.431 ' HB3' HG22 ' A' ' 81' ' ' THR . 87.0 tttt -116.14 109.64 17.75 Favored 'General case' 0 N--CA 1.399 -2.991 0 CA-C-O 121.54 0.686 . . . . 0.0 109.21 -179.059 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.537 ' O ' ' HA ' ' A' ' 109' ' ' THR . 3.4 tt -82.41 150.03 27.33 Favored 'General case' 0 C--N 1.289 -2.055 0 CA-C-N 114.044 -1.435 . . . . 0.0 110.121 -178.415 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.437 ' HA ' ' O ' ' A' ' 108' ' ' VAL . 7.1 t -126.14 131.27 52.09 Favored 'General case' 0 N--CA 1.405 -2.72 0 N-CA-C 106.667 -1.605 . . . . 0.0 106.667 174.38 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.62 ' HA ' ' O ' ' A' ' 74' ' ' ASN . 9.8 p -107.13 134.26 49.35 Favored 'Isoleucine or valine' 0 N--CA 1.398 -3.03 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 -177.57 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 5.1 mp -86.98 116.65 25.18 Favored 'General case' 0 C--N 1.293 -1.851 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.439 178.033 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 48.7 mm -103.37 126.8 31.16 Favored Pre-proline 0 C--N 1.274 -2.715 0 N-CA-C 106.418 -1.697 . . . . 0.0 106.418 173.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.41 ' HG2' ' HG2' ' A' ' 166' ' ' ARG . 1.2 Cg_endo -40.33 -42.54 3.74 Favored 'Trans proline' 0 C--N 1.372 1.784 0 C-N-CA 124.44 3.426 . . . . 0.0 113.739 -178.432 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 66.5 m -161.79 161.73 29.24 Favored 'General case' 0 CA--C 1.482 -1.664 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 176.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.457 ' HA ' ' O ' ' A' ' 104' ' ' PHE . 0.0 OUTLIER -71.15 108.91 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.148 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 174.683 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' CYS . . . . . 0.494 ' SG ' ' HB2' ' A' ' 104' ' ' PHE . 14.2 p -97.42 124.0 41.46 Favored 'General case' 0 N--CA 1.425 -1.689 0 N-CA-C 108.442 -0.948 . . . . 0.0 108.442 175.642 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -116.47 123.7 48.13 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 177.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.642 ' O ' ' HA ' ' A' ' 101' ' ' VAL . 33.5 m -113.62 130.61 67.37 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.348 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 -179.759 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.511 ' HA2' ' O ' ' A' ' 100' ' ' SER . . . -144.63 158.61 27.6 Favored Glycine 0 C--N 1.3 -1.466 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.232 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 27.8 t80 -152.77 -78.72 0.11 Allowed 'General case' 0 CA--C 1.499 -1.001 0 C-N-CA 118.686 -1.206 . . . . 0.0 109.083 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.426 ' O ' ' HB2' ' A' ' 98' ' ' ASP . 50.4 mtpt -86.34 -41.32 14.63 Favored 'General case' 0 CA--C 1.491 -1.318 0 C-N-CA 119.639 -0.824 . . . . 0.0 108.931 178.134 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.426 ' HB2' ' O ' ' A' ' 97' ' ' LYS . 21.6 t70 143.31 -44.08 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.122 0 N-CA-C 105.954 -1.869 . . . . 0.0 105.954 -168.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 8.9 m -59.82 -30.14 68.72 Favored 'General case' 0 C--N 1.344 0.347 0 CA-C-N 113.796 -1.547 . . . . 0.0 110.858 -179.028 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . 0.511 ' O ' ' HA2' ' A' ' 95' ' ' GLY . 18.2 m -115.49 82.69 1.8 Allowed 'General case' 0 N--CA 1.411 -2.378 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.713 179.519 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.642 ' HA ' ' O ' ' A' ' 94' ' ' VAL . 93.8 t -127.11 117.74 48.31 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.19 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 173.891 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.504 HD12 ' C ' ' A' ' 101' ' ' VAL . 5.6 mp -134.47 142.32 47.04 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 -178.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 39.6 ttmt -133.5 121.04 21.6 Favored 'General case' 0 C--N 1.291 -1.968 0 CA-C-O 121.002 0.43 . . . . 0.0 110.249 179.175 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.494 ' HB2' ' SG ' ' A' ' 92' ' ' CYS . 94.1 m-85 -101.25 109.24 21.07 Favored 'General case' 0 C--N 1.291 -1.965 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 174.804 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 43.9 m -72.58 151.96 42.08 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.484 -177.147 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 17.1 p -50.28 -42.87 52.97 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 124.134 0.974 . . . . 0.0 112.375 -179.367 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 41.4 p -127.42 93.76 3.81 Favored 'General case' 0 N--CA 1.424 -1.768 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.344 178.324 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.551 HG11 HG13 ' A' ' 123' ' ' ILE . 45.7 t -87.33 144.09 9.98 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.115 0 N-CA-C 106.372 -1.714 . . . . 0.0 106.372 175.479 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.537 ' HA ' ' O ' ' A' ' 84' ' ' LEU . 10.1 t -144.45 134.45 23.98 Favored 'General case' 0 N--CA 1.399 -2.998 0 CA-C-N 118.614 0.643 . . . . 0.0 110.891 -176.205 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -167.22 -166.97 27.2 Favored Glycine 0 N--CA 1.434 -1.491 0 N-CA-C 111.353 -0.699 . . . . 0.0 111.353 179.652 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 45.8 m80 -83.98 143.32 29.88 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 117.696 0.748 . . . . 0.0 110.741 -177.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.568 ' HA ' HD22 ' A' ' 117' ' ' LEU . 0.5 OUTLIER -103.42 118.19 36.2 Favored 'General case' 0 N--CA 1.434 -1.23 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 -174.524 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -132.75 140.23 47.96 Favored 'General case' 0 CA--C 1.461 -2.469 0 O-C-N 123.897 0.748 . . . . 0.0 109.038 167.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 2.5 tmtm? -78.31 100.4 6.71 Favored 'General case' 0 C--N 1.268 -2.964 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 -174.723 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . 0.584 ' H ' HD22 ' A' ' 63' ' ' LEU . . . 135.02 -63.3 0.6 Allowed Glycine 0 N--CA 1.433 -1.559 0 N-CA-C 108.201 -1.96 . . . . 0.0 108.201 -175.071 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.547 ' H ' ' HD3' ' A' ' 116' ' ' LYS . 0.1 OUTLIER -122.08 130.0 52.88 Favored 'General case' 0 C--N 1.291 -1.945 0 O-C-N 121.848 -0.795 . . . . 0.0 110.492 179.407 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.568 HD22 ' HA ' ' A' ' 112' ' ' LEU . 0.3 OUTLIER -108.19 105.34 15.02 Favored 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 105.165 -2.161 . . . . 0.0 105.165 -179.502 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 48.1 p -106.05 166.75 10.28 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 113.103 0.779 . . . . 0.0 113.103 -172.748 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 28.0 m-20 64.43 40.53 6.27 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.976 0.91 . . . . 0.0 109.75 175.109 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.479 ' CG1' HD12 ' A' ' 117' ' ' LEU . 15.6 m -83.83 83.07 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.415 -2.197 0 CA-C-O 122.216 1.007 . . . . 0.0 112.117 -172.595 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -68.63 96.39 0.71 Allowed 'General case' 0 N--CA 1.406 -2.64 0 CA-C-N 113.742 -1.572 . . . . 0.0 109.004 176.054 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 147.53 -15.11 1.43 Allowed Glycine 0 C--N 1.292 -1.87 0 C-N-CA 120.28 -0.962 . . . . 0.0 112.059 177.753 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.551 HG13 HG11 ' A' ' 108' ' ' VAL . 93.2 mt -100.17 99.52 8.64 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.833 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 176.636 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.489 ' HA ' ' O ' ' A' ' 131' ' ' VAL . 47.9 mtpt -107.23 148.63 28.69 Favored 'General case' 0 N--CA 1.419 -1.99 0 CA-C-N 113.999 -1.455 . . . . 0.0 109.666 -173.145 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.458 HG22 HG21 ' A' ' 134' ' ' THR . 13.3 t -154.76 157.62 38.27 Favored 'General case' 0 C--N 1.285 -2.23 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 176.236 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.61 ' HD3' ' N ' ' A' ' 127' ' ' VAL . 0.5 OUTLIER -128.8 138.02 51.84 Favored 'General case' 0 N--CA 1.385 -3.713 0 N-CA-C 106.686 -1.598 . . . . 0.0 106.686 172.184 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.61 ' N ' ' HD3' ' A' ' 126' ' ' LYS . 7.4 p -160.21 -38.04 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.289 -2.054 0 N-CA-C 105.766 -1.939 . . . . 0.0 105.766 177.327 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 13.8 tpt -115.74 -50.62 2.69 Favored 'General case' 0 N--CA 1.39 -3.434 0 CA-C-N 112.605 -2.089 . . . . 0.0 108.129 177.711 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 8.7 tp -162.25 172.71 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 N-CA-C 105.511 -2.033 . . . . 0.0 105.511 174.815 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 14.3 m-90 -71.66 117.38 13.17 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 118.834 0.743 . . . . 0.0 110.344 177.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.489 ' O ' ' HA ' ' A' ' 124' ' ' LYS . 45.9 t -122.84 133.01 70.21 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.661 0 N-CA-C 106.559 -1.645 . . . . 0.0 106.559 174.691 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 62.8 pttt -108.61 5.24 24.81 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 -173.293 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 35.8 m -126.05 14.94 4.02 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 N-CA-C 112.439 0.533 . . . . 0.0 112.439 -177.538 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . 0.458 HG21 HG22 ' A' ' 125' ' ' THR . 38.4 p -51.58 102.13 0.04 OUTLIER 'General case' 0 C--N 1.347 0.458 0 CA-C-O 121.502 0.668 . . . . 0.0 112.059 179.682 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 38.5 m -86.54 152.44 22.63 Favored 'General case' 0 N--CA 1.418 -2.038 0 CA-C-N 115.073 -0.967 . . . . 0.0 111.669 -174.747 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 11.5 tt -110.27 132.32 58.93 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.513 0 CA-C-N 114.973 -1.012 . . . . 0.0 109.558 -179.256 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . 0.416 ' HB2' ' OG1' ' A' ' 146' ' ' THR . 26.0 t -122.13 116.95 25.12 Favored 'General case' 0 N--CA 1.426 -1.657 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 -179.812 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . 0.457 HG21 HG23 ' A' ' 65' ' ' ILE . 3.0 t -136.35 114.62 11.62 Favored 'General case' 0 C--N 1.277 -2.57 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 178.393 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -78.33 73.06 4.89 Favored 'General case' 0 C--N 1.305 -1.369 0 C-N-CA 119.16 -1.016 . . . . 0.0 111.586 -174.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . 49.86 32.23 5.28 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 125.482 1.513 . . . . 0.0 112.039 178.479 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . 0.647 ' N ' ' HG3' ' A' ' 64' ' ' PRO . 22.9 t -176.96 -76.73 0.01 OUTLIER 'General case' 0 C--O 1.215 -0.727 0 CA-C-O 120.886 0.374 . . . . 0.0 111.102 -175.902 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.433 ' O ' ' HA ' ' A' ' 138' ' ' THR . 93.3 mttt -98.48 150.47 21.63 Favored 'General case' 0 C--N 1.306 -1.291 0 O-C-N 122.287 -0.258 . . . . 0.0 110.443 -172.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.685 ' HB ' ' O ' ' A' ' 153' ' ' ARG . 47.9 t -106.16 136.06 42.08 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 CA-C-O 121.143 0.497 . . . . 0.0 111.697 -172.772 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . 0.43 ' HA ' ' OG ' ' A' ' 152' ' ' SER . 75.5 m-85 -135.71 143.29 45.3 Favored 'General case' 0 C--O 1.25 1.11 0 C-N-CA 123.894 0.878 . . . . 0.0 109.244 179.488 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 55.5 p90 -64.14 141.28 58.83 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-O 121.423 0.63 . . . . 0.0 112.564 178.575 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.416 ' OG1' ' HB2' ' A' ' 137' ' ' SER . 91.4 m -108.63 -28.77 9.09 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 167.56 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.563 ' HB3' ' HB3' ' A' ' 150' ' ' LYS . . . -60.33 129.46 41.76 Favored 'General case' 0 N--CA 1.441 -0.925 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 172.445 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -84.22 -15.61 68.91 Favored Glycine 0 CA--C 1.48 -2.097 0 C-N-CA 119.956 -1.116 . . . . 0.0 112.584 -169.616 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 58.5 mtt -101.45 2.13 39.01 Favored 'General case' 0 C--N 1.291 -1.974 0 CA-C-O 121.453 0.644 . . . . 0.0 110.021 -176.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . 0.563 ' HB3' ' HB3' ' A' ' 147' ' ' ALA . 17.3 tppt? -121.28 -178.03 3.67 Favored 'General case' 0 CA--C 1.561 1.374 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 -174.398 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.516 ' H ' ' HG3' ' A' ' 150' ' ' LYS . 75.0 mmtt -137.32 164.52 28.39 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 123.491 0.716 . . . . 0.0 109.071 -172.562 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . 0.457 ' C ' ' HD2' ' A' ' 153' ' ' ARG . 42.5 m -76.04 153.6 36.31 Favored 'General case' 0 C--N 1.306 -1.326 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 -174.758 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' ARG . . . . . 0.685 ' O ' ' HB ' ' A' ' 143' ' ' VAL . 3.1 mpt_? -126.18 149.98 48.63 Favored 'General case' 0 CA--C 1.494 -1.177 0 N-CA-C 106.18 -1.785 . . . . 0.0 106.18 173.635 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 41.4 m -93.63 142.22 27.59 Favored 'General case' 0 C--N 1.281 -2.382 0 C-N-CA 120.497 -0.481 . . . . 0.0 110.625 -178.352 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 19.1 ttp180 -58.5 -30.38 66.99 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-O 120.66 0.267 . . . . 0.0 111.184 178.541 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -53.44 -21.03 5.37 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 124.058 0.943 . . . . 0.0 112.71 179.531 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -64.96 -53.63 43.3 Favored 'General case' 0 N--CA 1.432 -1.332 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 178.605 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 0.404 ' H ' ' H ' ' A' ' 159' ' ' GLY . 10.7 t80 170.72 23.57 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 106.744 -1.576 . . . . 0.0 106.744 177.49 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . 0.404 ' H ' ' H ' ' A' ' 158' ' ' TYR . . . 95.89 -92.52 1.44 Allowed Glycine 0 N--CA 1.416 -2.689 0 C-N-CA 119.082 -1.532 . . . . 0.0 109.376 -170.159 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.536 HG23 ' HB ' ' A' ' 65' ' ' ILE . 2.4 t -130.26 114.5 29.18 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.758 0 N-CA-C 106.333 -1.728 . . . . 0.0 106.333 176.289 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 5.3 pp0? -134.51 130.66 36.96 Favored 'General case' 0 N--CA 1.414 -2.25 0 C-N-CA 117.194 -1.802 . . . . 0.0 115.338 -172.46 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . 0.428 ' HG2' HG21 ' A' ' 94' ' ' VAL . 19.8 tpt180 -152.81 138.68 18.02 Favored 'General case' 0 C--N 1.27 -2.875 0 N-CA-C 104.694 -2.335 . . . . 0.0 104.694 168.102 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -69.81 95.27 0.89 Allowed 'General case' 0 CA--C 1.505 -0.768 0 CA-C-O 121.621 0.724 . . . . 0.0 112.777 -175.579 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -145.6 159.27 27.89 Favored Glycine 0 N--CA 1.423 -2.17 0 N-CA-C 109.2 -1.56 . . . . 0.0 109.2 176.572 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.426 ' H ' HD23 ' A' ' 165' ' ' LEU . 2.0 pt? -130.77 143.74 50.95 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-O 120.992 0.425 . . . . 0.0 110.451 -178.075 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . 0.507 ' HD2' ' N ' ' A' ' 166' ' ' ARG . 4.2 mpt_? -96.85 106.34 18.63 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 178.897 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 43.3 t -37.52 -46.26 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.562 1.44 0 N-CA-C 115.674 1.731 . . . . 0.0 115.674 -172.054 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -60.45 -35.55 76.11 Favored 'General case' 0 N--CA 1.486 1.326 0 CA-C-O 121.178 0.513 . . . . 0.0 111.729 -178.534 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 31.5 tttm -96.22 -81.17 0.42 Allowed 'General case' 0 C--N 1.3 -1.572 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.678 -179.756 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' PHE . . . . . 0.421 ' OXT' ' HB2' ' A' ' 165' ' ' LEU . 68.6 t80 . . . . . 0 N--CA 1.432 -1.35 0 N-CA-C 101.802 -3.407 . . . . 0.0 101.802 -175.545 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 38.0 t . . . . . 0 N--CA 1.451 -0.38 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -127.68 91.01 3.21 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-O 121.107 0.48 . . . . 0.0 110.151 177.74 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 94.0 mt-30 -99.92 96.29 7.45 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 177.575 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.3 mp -84.95 109.63 18.25 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 -178.767 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 66.6 m-85 -107.38 107.68 18.69 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 176.354 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 53.0 t-20 -107.5 116.27 31.64 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 -178.251 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -100.97 99.74 10.26 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 109.392 -0.595 . . . . 0.0 109.392 177.628 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 28.6 m -95.17 152.7 3.63 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 CA-C-N 115.802 -0.635 . . . . 0.0 109.675 179.551 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 159.2 124.5 0.76 Allowed Glycine 0 N--CA 1.424 -2.164 0 C-N-CA 120.611 -0.804 . . . . 0.0 111.481 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 44.5 m -94.18 114.77 26.95 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 176.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -109.72 134.58 51.83 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-O 120.828 0.347 . . . . 0.0 111.395 -179.044 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 94.7 m95 -80.68 102.42 9.87 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.554 177.011 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.7 pp -131.11 170.05 15.05 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.803 178.121 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 96.43 24.51 13.96 Favored Glycine 0 C--N 1.299 -1.514 0 C-N-CA 120.512 -0.852 . . . . 0.0 111.354 -179.098 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 56.5 tt0 -78.14 105.91 9.67 Favored 'General case' 0 CA--C 1.504 -0.803 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 177.652 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 62.5 mttp -89.76 79.7 6.68 Favored 'General case' 0 C--N 1.294 -1.831 0 C-N-CA 118.7 -1.2 . . . . 0.0 111.798 178.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.493 ' HA ' HD12 ' A' ' 91' ' ' ILE . . . -82.63 86.42 6.83 Favored 'General case' 0 N--CA 1.431 -1.395 0 N-CA-C 105.222 -2.14 . . . . 0.0 105.222 171.548 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -108.28 114.32 28.09 Favored 'General case' 0 N--CA 1.418 -2.027 0 CA-C-N 114.998 -1.001 . . . . 0.0 112.486 -168.541 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.463 ' HE2' ' CE1' ' A' ' 21' ' ' PHE . 10.2 tmtt? -125.8 96.38 4.75 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 103.571 -2.752 . . . . 0.0 103.571 171.009 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -135.85 90.46 2.59 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 112.372 0.508 . . . . 0.0 112.372 -175.457 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.463 ' CE1' ' HE2' ' A' ' 19' ' ' LYS . 19.1 p90 -164.45 133.0 3.52 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 106.491 -1.67 . . . . 0.0 106.491 172.654 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -122.75 152.92 40.15 Favored 'General case' 0 C--N 1.285 -2.23 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 -179.206 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 35.6 t -83.19 80.35 9.09 Favored 'General case' 0 N--CA 1.422 -1.873 0 C-N-CA 119.622 -0.831 . . . . 0.0 109.203 176.483 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 77.5 t -114.46 -47.42 4.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-N 114.688 -1.142 . . . . 0.0 108.57 177.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 127.88 66.64 0.14 Allowed Glycine 0 N--CA 1.426 -1.979 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.094 178.54 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.436 HD21 HD13 ' A' ' 46' ' ' ILE . 7.1 t30 -58.17 127.0 29.9 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 176.479 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 35.8 m-20 -82.23 103.14 11.61 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 -174.529 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 85.1 mt -85.74 174.17 9.55 Favored 'General case' 0 C--N 1.309 -1.168 0 N-CA-C 106.446 -1.687 . . . . 0.0 106.446 169.751 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.419 ' CG ' ' H ' ' A' ' 30' ' ' SER . 55.1 t30 63.22 -164.45 0.25 Allowed 'General case' 0 N--CA 1.484 1.251 0 N-CA-C 106.544 -1.65 . . . . 0.0 106.544 -172.385 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.419 ' H ' ' CG ' ' A' ' 29' ' ' ASN . 35.4 t 72.37 116.13 0.05 Allowed 'General case' 0 C--O 1.244 0.766 0 CA-C-O 121.552 0.691 . . . . 0.0 111.718 175.3 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 7.3 p -63.13 125.23 19.25 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.906 0 CA-C-O 121.721 0.772 . . . . 0.0 111.346 179.098 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 51.1 m -113.7 93.48 4.4 Favored 'General case' 0 N--CA 1.42 -1.945 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 176.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 11.6 t -102.67 178.3 4.61 Favored 'General case' 0 C--N 1.295 -1.775 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.07 -177.233 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 40.2 m 73.87 -36.46 0.34 Allowed 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.595 1.158 . . . . 0.0 112.424 179.261 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 6.7 tp -81.62 84.57 1.57 Allowed 'Isoleucine or valine' 0 C--O 1.247 0.971 0 CA-C-O 122.299 1.047 . . . . 0.0 110.037 176.185 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -164.41 137.58 5.04 Favored 'General case' 0 C--N 1.31 -1.132 0 N-CA-C 104.983 -2.228 . . . . 0.0 104.983 -178.762 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -164.09 86.4 0.1 Allowed Glycine 0 N--CA 1.429 -1.811 0 C-N-CA 119.4 -1.381 . . . . 0.0 112.291 -179.68 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 58.87 -111.65 3.48 Favored Glycine 0 C--O 1.238 0.381 0 O-C-N 124.093 0.525 . . . . 0.0 112.751 178.281 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 8.8 t -107.52 116.47 31.99 Favored 'General case' 0 N--CA 1.427 -1.613 0 CA-C-O 121.745 0.783 . . . . 0.0 110.271 179.427 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 47.5 mmtm -133.79 109.93 9.44 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 115.17 -0.923 . . . . 0.0 109.188 179.452 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 36.2 p90 -83.2 89.16 6.93 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-O 122.01 0.909 . . . . 0.0 112.383 -178.766 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 57.4 tp -156.63 150.38 24.76 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 -179.659 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 11.2 p -66.6 142.54 16.58 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.051 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 175.378 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.421 ' ND2' ' HA ' ' A' ' 49' ' ' LYS . 50.6 t30 -76.93 88.7 3.5 Favored 'General case' 0 C--O 1.253 1.252 0 CA-C-O 121.697 0.761 . . . . 0.0 110.846 -177.476 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.516 ' C ' HD12 ' A' ' 46' ' ' ILE . 40.6 ttmt 70.34 -86.37 0.03 OUTLIER 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 113.989 -1.46 . . . . 0.0 109.623 -177.346 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.516 HD12 ' C ' ' A' ' 45' ' ' LYS . 3.1 mp -144.19 -74.26 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 N-CA-C 106.887 -1.523 . . . . 0.0 106.887 174.593 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt -144.95 15.28 1.54 Allowed 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.12 -0.946 . . . . 0.0 108.856 179.342 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -71.42 -43.97 52.51 Favored Glycine 0 N--CA 1.444 -0.809 0 CA-C-N 114.997 -1.001 . . . . 0.0 112.666 -175.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.421 ' HA ' ' ND2' ' A' ' 44' ' ' ASN . 39.7 ttmt 65.61 -83.25 0.03 OUTLIER 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 179.499 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 95.0 mmm 67.7 -62.87 0.33 Allowed 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 124.363 1.065 . . . . 0.0 109.033 -169.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 98.9 mt-30 -139.77 -177.69 5.08 Favored 'General case' 0 C--N 1.313 -0.981 0 C-N-CA 125.24 1.416 . . . . 0.0 107.924 177.697 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 51.5 mtmt 63.54 94.05 0.05 OUTLIER Pre-proline 0 N--CA 1.476 0.827 0 C-N-CA 123.943 0.897 . . . . 0.0 112.443 -179.544 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -80.24 25.98 0.59 Allowed 'Trans proline' 0 N--CA 1.477 0.519 0 C-N-CA 123.578 2.852 . . . . 0.0 112.582 -178.735 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.433 ' HB2' ' HD3' ' A' ' 55' ' ' PRO . 33.0 mt -54.77 -59.79 9.62 Favored Pre-proline 0 C--N 1.315 -0.927 0 N-CA-C 112.793 0.664 . . . . 0.0 112.793 -173.797 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.512 ' O ' ' HG2' ' A' ' 59' ' ' LYS . 7.5 Cg_exo -69.65 -14.34 36.29 Favored 'Trans proline' 0 N--CA 1.427 -2.432 0 C-N-CA 121.61 1.54 . . . . 0.0 112.282 -169.356 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -71.52 -39.88 70.48 Favored 'General case' 0 CA--C 1.49 -1.359 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 -174.069 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.451 ' HA ' ' HB3' ' A' ' 60' ' ' GLU . 10.4 mp -68.62 -30.48 69.22 Favored 'General case' 0 N--CA 1.44 -0.925 0 CA-C-N 114.808 -1.087 . . . . 0.0 111.988 178.932 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 6.2 mp -64.5 -48.82 73.74 Favored 'General case' 0 CA--C 1.495 -1.153 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 179.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.512 ' HG2' ' O ' ' A' ' 55' ' ' PRO . 32.3 pttt -75.19 -26.84 59.33 Favored 'General case' 0 C--N 1.299 -1.59 0 CA-C-N 115.143 -0.935 . . . . 0.0 112.986 177.399 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.451 ' HB3' ' HA ' ' A' ' 57' ' ' LEU . 8.3 tp10 -59.82 -51.81 68.15 Favored 'General case' 0 C--N 1.306 -1.313 0 C-N-CA 123.927 0.891 . . . . 0.0 111.221 175.018 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 63.4 t80 -68.59 -10.26 54.78 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.6 -176.519 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.589 ' OD2' HG23 ' A' ' 73' ' ' THR . 22.4 t0 -94.71 -179.37 4.84 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.473 -178.495 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.738 ' HB2' HD12 ' A' ' 65' ' ' ILE . 2.5 mt -76.36 169.03 22.9 Favored Pre-proline 0 CA--C 1.559 1.299 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 -178.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.463 ' HB2' ' HG3' ' A' ' 155' ' ' ARG . 10.9 Cg_endo -91.97 25.7 0.46 Allowed 'Trans proline' 0 N--CA 1.441 -1.576 0 C-N-CA 122.596 2.197 . . . . 0.0 110.853 -176.725 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.738 HD12 ' HB2' ' A' ' 63' ' ' LEU . 0.2 OUTLIER -73.89 -29.09 25.12 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.432 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 176.915 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 53.11 1.66 0.07 OUTLIER Glycine 0 CA--C 1.544 1.887 0 CA-C-N 114.972 -1.013 . . . . 0.0 115.133 178.086 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.683 ' O ' ' HB ' ' A' ' 160' ' ' VAL . 48.6 mt 67.08 -42.35 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.189 0 C-N-CA 126.441 1.896 . . . . 0.0 114.099 -179.575 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.514 ' HB2' ' O ' ' A' ' 67' ' ' ILE . 71.3 t80 158.0 -51.37 0.0 OUTLIER Pre-proline 0 N--CA 1.489 1.494 0 C-N-CA 125.354 1.462 . . . . 0.0 110.498 177.729 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.464 ' HB2' ' OD2' ' A' ' 71' ' ' ASP . 9.5 Cg_endo -95.82 -24.82 0.12 Allowed 'Trans proline' 0 C--N 1.374 1.878 0 C-N-CA 121.87 1.713 . . . . 0.0 115.052 -172.479 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 82.48 -7.89 63.44 Favored Glycine 0 CA--C 1.526 0.738 0 C-N-CA 120.454 -0.879 . . . . 0.0 111.629 -174.707 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.464 ' OD2' ' HB2' ' A' ' 69' ' ' PRO . 23.2 m-20 -86.16 -30.99 22.05 Favored 'General case' 0 CA--C 1.495 -1.148 0 N-CA-C 106.26 -1.755 . . . . 0.0 106.26 178.062 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.527 ' O ' ' HB ' ' A' ' 73' ' ' THR . . . -82.62 -172.26 3.95 Favored 'General case' 0 N--CA 1.442 -0.825 0 CA-C-N 113.556 -1.657 . . . . 0.0 107.103 171.81 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.589 HG23 ' OD2' ' A' ' 62' ' ' ASP . 60.7 m 79.94 27.35 0.32 Allowed 'General case' 0 N--CA 1.474 0.742 0 CA-C-O 124.807 2.241 . . . . 0.0 109.483 175.015 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 35.8 m-80 -84.48 -177.3 6.58 Favored 'General case' 0 N--CA 1.386 -3.641 0 CA-C-N 113.759 -1.564 . . . . 0.0 110.479 178.786 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 42.6 t80 -149.21 94.9 2.3 Favored 'General case' 0 C--N 1.276 -2.628 0 C-N-CA 119.352 -0.939 . . . . 0.0 110.935 -169.784 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.665 ' OE1' ' HG ' ' A' ' 87' ' ' LEU . 4.2 mp0 -107.26 96.09 6.17 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 176.777 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.431 ' HB2' HD23 ' A' ' 84' ' ' LEU . 81.9 t80 -102.73 124.31 48.03 Favored 'General case' 0 C--N 1.297 -1.704 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.255 -176.264 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.724 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 10.4 m-20 -93.9 155.77 16.99 Favored 'General case' 0 CA--C 1.47 -2.1 0 C-N-CA 118.819 -1.152 . . . . 0.0 108.712 175.017 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -80.43 -53.35 6.68 Favored 'General case' 0 C--N 1.25 -3.756 0 CA-C-N 113.412 -1.722 . . . . 0.0 109.026 179.323 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -66.77 -21.33 66.06 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 113.726 -1.579 . . . . 0.0 110.754 -176.498 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.724 ' HB ' ' HB2' ' A' ' 78' ' ' ASP . 27.2 m -101.63 -53.01 3.07 Favored 'General case' 0 N--CA 1.41 -2.455 0 CA-C-N 115.0 -1.0 . . . . 0.0 111.192 -174.612 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 99.7 mttt 70.26 4.15 4.74 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 123.85 0.86 . . . . 0.0 111.995 -174.616 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.719 ' HG2' HG22 ' A' ' 109' ' ' THR . 36.2 ttmt -104.91 107.41 18.36 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 176.655 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.431 HD23 ' HB2' ' A' ' 77' ' ' PHE . 3.1 tm? -68.01 133.73 49.52 Favored 'General case' 0 C--N 1.292 -1.929 0 CA-C-N 113.833 -1.53 . . . . 0.0 110.447 -175.56 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.503 HG23 ' HB2' ' A' ' 76' ' ' GLU . 8.9 t -120.85 137.79 54.38 Favored 'General case' 0 N--CA 1.403 -2.812 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 177.422 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 61.0 t -111.32 118.62 57.88 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 C-N-CA 123.811 0.844 . . . . 0.0 109.44 -179.205 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.665 ' HG ' ' OE1' ' A' ' 76' ' ' GLU 0.293 0.5 OUTLIER -79.44 124.41 28.43 Favored 'General case' 0 N--CA 1.403 -2.82 0 CA-C-O 122.578 1.18 . . . . 0.0 112.37 172.879 . . . . . . . . 4 4 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.437 HG23 ' HE ' ' A' ' 166' ' ' ARG . 50.4 mm -102.36 125.8 35.18 Favored Pre-proline 0 C--N 1.279 -2.482 0 CA-C-N 113.711 -1.586 . . . . 0.0 107.805 178.638 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -59.61 96.93 0.1 Allowed 'Trans proline' 0 C--O 1.248 1.018 0 C-N-CA 122.62 2.214 . . . . 0.0 111.516 175.476 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.485 ' OG ' ' HB2' ' A' ' 168' ' ' ASP . 68.4 m 65.21 176.74 0.2 Allowed 'General case' 0 C--O 1.236 0.356 0 C-N-CA 124.483 1.113 . . . . 0.0 112.844 -178.711 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.493 HD12 ' HA ' ' A' ' 17' ' ' ALA . 39.7 mt -88.5 131.15 36.7 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.623 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.793 178.705 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' CYS . . . . . 0.461 ' SG ' ' HA3' ' A' ' 164' ' ' GLY . 16.0 t -116.16 122.71 45.87 Favored 'General case' 0 N--CA 1.41 -2.452 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 173.764 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -116.96 127.29 54.06 Favored 'General case' 0 C--N 1.29 -2.017 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 178.628 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 3.9 p -105.14 103.94 16.14 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.27 0 CA-C-O 122.024 0.916 . . . . 0.0 109.578 177.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -130.53 131.37 6.49 Favored Glycine 0 N--CA 1.423 -2.229 0 N-CA-C 108.226 -1.95 . . . . 0.0 108.226 179.111 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . 0.286 4.9 t80 175.67 -53.41 0.01 OUTLIER 'General case' 0 CA--C 1.476 -1.879 0 N-CA-C 105.041 -2.207 . . . . 0.0 105.041 -171.899 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.603 ' HA ' ' HE3' ' A' ' 97' ' ' LYS . 0.4 OUTLIER -76.13 -18.72 59.02 Favored 'General case' 0 N--CA 1.403 -2.814 0 CA-C-N 110.806 -2.906 . . . . 0.0 112.185 -172.727 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 18.9 t70 70.1 -56.84 0.58 Allowed 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 113.912 1.079 . . . . 0.0 113.912 176.629 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 18.5 m -79.97 -9.97 59.73 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-O 121.661 0.744 . . . . 0.0 109.824 -177.421 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 35.0 m -140.57 89.37 2.27 Favored 'General case' 0 N--CA 1.423 -1.789 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.645 177.429 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.459 ' C ' HD12 ' A' ' 102' ' ' LEU . 60.8 t -113.0 128.86 69.52 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.201 0 N-CA-C 108.142 -1.058 . . . . 0.0 108.142 176.374 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.464 ' HA ' ' O ' ' A' ' 124' ' ' LYS . 5.3 mp -129.9 136.2 49.23 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-O 120.746 0.308 . . . . 0.0 110.796 -178.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -112.43 110.09 20.08 Favored 'General case' 0 C--N 1.31 -1.146 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 177.132 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -89.82 103.5 16.15 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 176.862 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.457 ' HA ' HG12 ' A' ' 91' ' ' ILE . 35.1 m -82.41 157.81 23.54 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.967 -175.099 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 20.3 p -55.84 -38.13 69.64 Favored 'General case' 0 C--N 1.319 -0.725 0 C-N-CA 125.898 1.679 . . . . 0.0 113.037 -177.406 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 14.0 m -128.13 98.73 5.21 Favored 'General case' 0 N--CA 1.419 -1.983 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 -179.412 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 16.9 m -108.4 133.69 52.59 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 179.108 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.719 HG22 ' HG2' ' A' ' 83' ' ' LYS . 37.0 m -130.35 132.53 45.87 Favored 'General case' 0 N--CA 1.394 -3.268 0 CA-C-N 116.767 -0.197 . . . . 0.0 110.813 -164.338 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.637 ' HA3' ' O ' ' A' ' 119' ' ' ASP . . . -161.98 -158.25 9.41 Favored Glycine 0 C--O 1.217 -0.916 0 C-N-CA 121.288 -0.482 . . . . 0.0 112.635 -177.274 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 53.3 m80 -117.56 108.06 15.02 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 122.165 -0.609 . . . . 0.0 109.606 176.038 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 5.9 tt -104.4 127.82 52.14 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.73 -172.071 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -131.59 168.1 18.27 Favored 'General case' 0 CA--C 1.464 -2.355 0 CA-C-N 115.243 -0.889 . . . . 0.0 109.71 173.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 54.2 tptt -84.35 101.11 11.71 Favored 'General case' 0 N--CA 1.389 -3.522 0 CA-C-N 115.179 -0.918 . . . . 0.0 108.809 -177.017 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . 0.479 ' H ' ' CD2' ' A' ' 63' ' ' LEU . . . 126.24 -11.68 7.22 Favored Glycine 0 C--O 1.205 -1.697 0 CA-C-N 115.159 -0.928 . . . . 0.0 111.164 -176.868 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 179.53 147.89 0.24 Allowed 'General case' 0 N--CA 1.487 1.393 0 CA-C-N 117.052 0.426 . . . . 0.0 111.219 178.295 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.6 tt -124.11 113.67 18.68 Favored 'General case' 0 N--CA 1.429 -1.497 0 N-CA-C 106.013 -1.847 . . . . 0.0 106.013 176.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 71.8 p -97.58 122.58 40.82 Favored 'General case' 0 C--N 1.265 -3.071 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.609 -177.829 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . 0.637 ' O ' ' HA3' ' A' ' 110' ' ' GLY . 31.3 m-20 73.13 129.76 0.04 OUTLIER 'General case' 0 C--O 1.207 -1.146 0 C-N-CA 125.484 1.514 . . . . 0.0 111.651 -179.155 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 10.8 m -135.5 78.75 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 CA-C-O 122.639 1.209 . . . . 0.0 108.72 173.744 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -67.17 111.53 3.97 Favored 'General case' 0 N--CA 1.424 -1.757 0 CA-C-N 113.668 -1.605 . . . . 0.0 108.85 -175.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 133.27 -13.75 4.89 Favored Glycine 0 N--CA 1.424 -2.1 0 C-N-CA 120.31 -0.948 . . . . 0.0 112.115 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.458 ' O ' ' HA ' ' A' ' 132' ' ' LYS . 67.5 mt -99.55 113.57 35.14 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.17 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 179.178 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.464 ' O ' ' HA ' ' A' ' 102' ' ' LEU . 23.1 tptm -85.07 117.9 24.31 Favored 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 104.967 -2.234 . . . . 0.0 104.967 -179.261 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 95.1 m -126.85 124.93 40.74 Favored 'General case' 0 C--N 1.288 -2.085 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 -170.347 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.522 ' HG2' ' N ' ' A' ' 127' ' ' VAL . 84.2 tttt -119.37 145.59 46.06 Favored 'General case' 0 N--CA 1.429 -1.499 0 CA-C-O 121.255 0.55 . . . . 0.0 110.203 169.548 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.522 ' N ' ' HG2' ' A' ' 126' ' ' LYS . 7.2 p -159.21 -35.68 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 175.782 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -125.25 -51.67 1.64 Allowed 'General case' 0 N--CA 1.399 -3.006 0 N-CA-C 105.621 -1.992 . . . . 0.0 105.621 -179.729 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 7.9 tp -149.94 169.9 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.285 0 N-CA-C 105.574 -2.01 . . . . 0.0 105.574 176.516 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' TRP . . . . . 0.433 ' CD1' ' HB2' ' A' ' 126' ' ' LYS . 30.6 m-90 -80.12 126.32 30.94 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-O 121.32 0.581 . . . . 0.0 111.241 177.52 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 7.3 p -137.35 137.0 46.51 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.247 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 176.636 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . 0.458 ' HA ' ' O ' ' A' ' 123' ' ' ILE . 0.0 OUTLIER -112.07 20.19 17.11 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 113.708 1.003 . . . . 0.0 113.708 -174.687 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.442 HG13 ' HD2' ' A' ' 132' ' ' LYS . 17.8 m -124.17 -60.55 1.86 Allowed 'Isoleucine or valine' 0 C--O 1.21 -1.014 0 CA-C-N 116.101 -0.499 . . . . 0.0 112.15 179.357 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . 0.466 ' O ' ' HA ' ' A' ' 119' ' ' ASP . 77.5 p 51.71 -171.64 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 124.118 0.967 . . . . 0.0 113.465 179.386 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 23.2 p -166.0 152.9 9.73 Favored 'General case' 0 N--CA 1.427 -1.612 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 176.06 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 14.1 tt -131.29 134.0 61.61 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.322 0 CA-C-O 121.254 0.549 . . . . 0.0 109.549 -179.264 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 39.9 t -124.81 159.61 30.62 Favored 'General case' 0 C--N 1.289 -2.041 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 -176.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . 0.53 HG23 ' H ' ' A' ' 140' ' ' ALA . 9.7 t -165.15 175.97 8.88 Favored 'General case' 0 N--CA 1.41 -2.436 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 -178.008 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -112.49 30.57 6.99 Favored 'General case' 0 C--N 1.275 -2.659 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 173.128 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.53 ' H ' HG23 ' A' ' 138' ' ' THR . . . 62.84 38.37 11.56 Favored 'General case' 0 C--N 1.35 0.596 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 -172.462 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . 0.632 ' O ' ' HB3' ' A' ' 155' ' ' ARG . 46.9 t -174.57 -79.95 0.01 OUTLIER 'General case' 0 C--O 1.219 -0.527 0 CA-C-N 114.585 -1.189 . . . . 0.0 111.312 -175.064 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -75.53 134.94 40.63 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 -178.48 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 59.4 t -106.0 130.37 57.67 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.969 0 CA-C-O 120.998 0.428 . . . . 0.0 111.556 -170.155 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -131.76 150.17 52.24 Favored 'General case' 0 CA--C 1.481 -1.699 0 CA-C-O 121.589 0.709 . . . . 0.0 110.631 176.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . 0.456 ' HB2' ' HB2' ' A' ' 151' ' ' LYS . 60.7 m-85 -109.91 103.12 11.85 Favored 'General case' 0 C--N 1.268 -2.967 0 CA-C-N 115.026 -0.988 . . . . 0.0 111.424 179.205 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 6.6 p -81.75 19.69 1.04 Allowed 'General case' 0 C--N 1.305 -1.37 0 CA-C-N 115.073 -0.967 . . . . 0.0 113.269 -176.229 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -68.79 -15.4 63.49 Favored 'General case' 0 C--O 1.218 -0.574 0 CA-C-O 121.773 0.796 . . . . 0.0 109.812 175.209 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 166.39 29.53 0.02 OUTLIER Glycine 0 N--CA 1.43 -1.715 0 N-CA-C 108.868 -1.693 . . . . 0.0 108.868 175.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 15.6 tpt 57.59 23.5 9.38 Favored 'General case' 0 N--CA 1.486 1.328 0 CA-C-O 122.322 1.058 . . . . 0.0 108.498 -173.481 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . 0.462 ' CD ' HG11 ' A' ' 127' ' ' VAL . 0.0 OUTLIER -76.19 -9.46 58.65 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 115.942 1.83 . . . . 0.0 115.942 -169.492 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.473 ' HE2' ' HA ' ' A' ' 151' ' ' LYS . 5.2 mmpt? -147.21 138.33 23.83 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 120.514 0.197 . . . . 0.0 111.278 178.556 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 72.2 p -126.53 132.41 51.37 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 174.343 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 22.8 tpt180 -147.91 157.37 43.49 Favored 'General case' 0 C--N 1.31 -1.148 0 N-CA-C 109.554 -0.535 . . . . 0.0 109.554 -176.82 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 68.3 m -98.1 143.71 28.36 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 108.434 -0.951 . . . . 0.0 108.434 173.019 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' ARG . . . . . 0.632 ' HB3' ' O ' ' A' ' 141' ' ' SER . 0.0 OUTLIER -67.44 -18.29 65.04 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 118.756 -1.177 . . . . 0.0 112.758 176.837 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -41.86 -56.97 2.54 Favored 'General case' 0 N--CA 1.482 1.174 0 N-CA-C 115.128 1.529 . . . . 0.0 115.128 -173.775 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -56.32 -37.96 70.65 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 112.012 0.375 . . . . 0.0 112.012 -176.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 6.7 t80 176.15 -26.25 0.0 OUTLIER 'General case' 0 CA--C 1.506 -0.731 0 N-CA-C 106.913 -1.514 . . . . 0.0 106.913 174.374 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . 0.695 ' HA3' ' O ' ' A' ' 65' ' ' ILE . . . 132.03 -87.33 0.28 Allowed Glycine 0 N--CA 1.407 -3.251 0 N-CA-C 110.506 -1.037 . . . . 0.0 110.506 -174.014 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.683 ' HB ' ' O ' ' A' ' 67' ' ' ILE . 12.0 t -98.54 116.91 42.6 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.238 0 C-N-CA 119.338 -0.945 . . . . 0.0 108.701 178.593 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 75.9 mm-40 -119.61 108.94 15.08 Favored 'General case' 0 CA--C 1.501 -0.931 0 N-CA-C 113.979 1.103 . . . . 0.0 113.979 -176.638 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 22.4 mmm180 -149.71 148.43 29.25 Favored 'General case' 0 C--N 1.308 -1.234 0 C-N-CA 125.508 1.523 . . . . 0.0 107.466 172.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -74.31 89.38 2.07 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-O 121.514 0.673 . . . . 0.0 110.874 -177.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . 0.461 ' HA3' ' SG ' ' A' ' 92' ' ' CYS . . . -122.8 168.05 15.12 Favored Glycine 0 N--CA 1.432 -1.568 0 CA-C-N 115.151 -0.931 . . . . 0.0 110.952 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 49.9 tp -141.19 114.58 8.77 Favored 'General case' 0 N--CA 1.414 -2.251 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 178.537 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . 0.439 ' HD2' ' HG3' ' A' ' 69' ' ' PRO . 81.3 mtt85 -87.4 103.97 16.0 Favored 'General case' 0 CA--C 1.476 -1.882 0 CA-C-O 122.07 0.938 . . . . 0.0 110.672 178.131 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 18.6 m -77.09 53.04 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.294 -1.809 0 CA-C-N 113.378 -1.737 . . . . 0.0 114.444 -173.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . 0.485 ' HB2' ' OG ' ' A' ' 90' ' ' SER . 32.8 t70 -135.36 -0.33 2.7 Favored 'General case' 0 N--CA 1.475 0.825 0 CA-C-O 122.271 1.034 . . . . 0.0 108.435 175.932 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -149.88 162.41 40.37 Favored 'General case' 0 N--CA 1.443 -0.817 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 -177.693 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 . . . . . 0 C--O 1.247 0.927 0 CA-C-O 118.958 -0.544 . . . . 0.0 110.162 176.784 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 42.5 m . . . . . 0 N--CA 1.446 -0.665 0 CA-C-O 120.624 0.25 . . . . 0.0 110.818 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 67.09 9.21 6.75 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 124.74 1.216 . . . . 0.0 113.364 174.761 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -90.79 106.9 18.83 Favored 'General case' 0 C--N 1.315 -0.892 0 C-N-CA 119.883 -0.727 . . . . 0.0 111.748 -177.349 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.541 HD13 ' H ' ' A' ' 4' ' ' ILE . 0.2 OUTLIER -116.35 91.84 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.836 0 CA-C-O 122.041 0.924 . . . . 0.0 111.133 179.347 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 44.3 p90 -140.42 113.7 8.51 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-N 115.004 -0.998 . . . . 0.0 109.295 178.54 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 38.1 t30 -160.68 91.31 0.9 Allowed 'General case' 0 C--N 1.299 -1.599 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.907 179.213 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.443 ' HD2' ' N ' ' A' ' 7' ' ' LYS . 0.3 OUTLIER -98.42 91.34 5.14 Favored 'General case' 0 C--N 1.291 -1.939 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 178.114 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.6 p -89.14 125.29 42.18 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 CA-C-N 115.168 -0.924 . . . . 0.0 110.662 -177.326 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -117.94 55.74 0.57 Allowed Glycine 0 N--CA 1.432 -1.588 0 C-N-CA 120.856 -0.688 . . . . 0.0 111.507 -178.576 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 51.0 m -79.05 125.11 28.97 Favored 'General case' 0 N--CA 1.435 -1.217 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 178.706 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.402 ' CZ ' ' HB3' ' A' ' 13' ' ' LEU . 83.2 t80 -106.33 125.76 51.4 Favored 'General case' 0 N--CA 1.425 -1.675 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.831 -175.857 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 45.1 p90 -144.84 98.24 3.15 Favored 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 171.323 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.402 ' HB3' ' CZ ' ' A' ' 11' ' ' TYR . 64.4 tp -163.24 107.7 1.06 Allowed 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.685 -176.012 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 159.59 -169.99 35.75 Favored Glycine 0 N--CA 1.429 -1.823 0 C-N-CA 120.239 -0.982 . . . . 0.0 111.411 178.823 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 27.6 pt20 -155.86 154.19 30.9 Favored 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 -179.584 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -86.79 113.33 22.53 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 107.956 -1.128 . . . . 0.0 107.956 176.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -76.42 98.82 4.68 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-N 115.976 -0.557 . . . . 0.0 111.072 -178.097 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 50.0 t-20 -87.69 93.58 9.48 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 106.606 -1.627 . . . . 0.0 106.606 174.377 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -99.85 105.81 17.6 Favored 'General case' 0 N--CA 1.419 -1.978 0 CA-C-N 115.956 -0.565 . . . . 0.0 109.557 -178.472 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -90.49 100.94 13.69 Favored 'General case' 0 N--CA 1.423 -1.809 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 177.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 56.6 t80 -100.12 96.38 7.46 Favored 'General case' 0 C--N 1.299 -1.595 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.934 -175.794 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 37.0 m-20 -97.12 85.35 3.69 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.01 179.469 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 32.7 t -169.57 135.56 1.55 Allowed 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 179.145 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 8.3 p -156.21 128.47 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 179.082 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -83.84 75.85 2.32 Favored Glycine 0 N--CA 1.431 -1.694 0 C-N-CA 120.68 -0.772 . . . . 0.0 113.123 -177.724 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -103.16 79.51 1.74 Allowed 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 174.028 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -174.97 152.74 1.54 Allowed 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.296 -177.023 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 58.3 tp 81.55 78.11 0.03 OUTLIER 'General case' 0 C--N 1.314 -0.945 0 C-N-CA 125.348 1.459 . . . . 0.0 112.318 178.722 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 53.1 t30 -159.67 89.02 0.87 Allowed 'General case' 0 C--N 1.305 -1.346 0 CA-C-N 114.19 -1.368 . . . . 0.0 107.669 175.387 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 53.1 p -90.97 93.63 9.28 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.78 -175.488 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 7.3 p -163.53 93.28 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.435 -1.212 0 CA-C-O 122.04 0.924 . . . . 0.0 110.54 178.209 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 33.3 t -86.41 -25.79 25.08 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 177.311 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 10.4 t -173.53 176.94 2.67 Favored 'General case' 0 N--CA 1.423 -1.822 0 N-CA-C 104.762 -2.31 . . . . 0.0 104.762 177.172 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 26.4 t -141.83 127.67 19.33 Favored 'General case' 0 N--CA 1.421 -1.924 0 C-N-CA 119.407 -0.917 . . . . 0.0 110.484 179.746 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 32.8 pt -104.99 -4.5 9.7 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 175.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -69.71 109.55 4.43 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-N 114.377 -1.283 . . . . 0.0 108.153 178.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 145.76 57.17 0.02 OUTLIER Glycine 0 C--N 1.293 -1.834 0 C-N-CA 119.57 -1.3 . . . . 0.0 111.763 -179.487 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -139.06 54.42 0.68 Allowed Glycine 0 N--CA 1.426 -2.012 0 N-CA-C 110.433 -1.067 . . . . 0.0 110.433 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.3 t -85.89 100.99 12.47 Favored 'General case' 0 N--CA 1.425 -1.682 0 CA-C-O 121.771 0.796 . . . . 0.0 110.444 -179.851 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -87.58 130.78 34.62 Favored 'General case' 0 N--CA 1.423 -1.805 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.278 -178.74 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 77.0 t-105 -128.93 103.52 7.07 Favored 'General case' 0 N--CA 1.422 -1.834 0 N-CA-C 106.96 -1.496 . . . . 0.0 106.96 177.682 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 52.2 tp -87.92 -18.54 28.91 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.812 -174.412 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 47.5 t 70.66 93.2 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.241 0.64 0 C-N-CA 123.996 0.919 . . . . 0.0 110.254 -178.259 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 -92.38 70.39 5.12 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-O 121.455 0.645 . . . . 0.0 110.463 178.746 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 87.5 tttt 176.61 93.95 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.724 0 C-N-CA 125.431 1.493 . . . . 0.0 107.542 179.773 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 7.2 tp -91.0 77.25 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 CA-C-O 122.174 0.988 . . . . 0.0 111.251 -178.157 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp -135.93 92.96 2.86 Favored 'General case' 0 N--CA 1.438 -1.06 0 CA-C-N 114.363 -1.289 . . . . 0.0 109.179 178.646 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -123.56 -71.4 0.24 Allowed Glycine 0 N--CA 1.42 -2.368 0 N-CA-C 109.792 -1.323 . . . . 0.0 109.792 178.122 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 67.3 mttm 51.24 91.3 0.02 OUTLIER 'General case' 0 CA--C 1.511 -0.556 0 C-N-CA 124.487 1.115 . . . . 0.0 112.166 179.467 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 26.4 ptt? -82.36 83.06 7.6 Favored 'General case' 0 C--N 1.299 -1.615 0 C-N-CA 118.78 -1.168 . . . . 0.0 111.471 -179.219 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 43.7 mt-30 -79.71 108.94 13.66 Favored 'General case' 0 N--CA 1.421 -1.882 0 N-CA-C 105.827 -1.916 . . . . 0.0 105.827 174.53 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 96.0 mttt 78.87 140.9 0.07 OUTLIER Pre-proline 0 CA--C 1.536 0.425 0 O-C-N 125.229 1.581 . . . . 0.0 108.152 -168.231 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.512 ' O ' ' HG ' ' A' ' 57' ' ' LEU . 43.9 Cg_endo -70.65 27.17 0.2 Allowed 'Trans proline' 0 N--CA 1.488 1.206 0 C-N-CA 123.081 2.521 . . . . 0.0 113.924 -177.408 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.661 ' O ' ' HG ' ' A' ' 58' ' ' LEU 0.261 7.9 mp -53.98 -48.71 93.05 Favored Pre-proline 0 CA--C 1.476 -1.886 0 N-CA-C 117.79 2.515 . . . . 0.0 117.79 -174.159 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.617 ' O ' ' HE2' ' A' ' 59' ' ' LYS . 52.8 Cg_exo -57.44 -25.76 67.88 Favored 'Trans proline' 0 N--CA 1.445 -1.342 0 C-N-CA 121.52 1.48 . . . . 0.0 111.418 -176.371 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -81.74 -32.04 31.71 Favored 'General case' 0 N--CA 1.417 -2.124 0 CA-C-N 115.021 -0.99 . . . . 0.0 108.898 -178.279 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.543 ' HA ' ' HB3' ' A' ' 60' ' ' GLU . 15.4 mt -74.98 -29.69 60.97 Favored 'General case' 0 CA--C 1.487 -1.454 0 CA-C-N 115.004 -0.998 . . . . 0.0 110.333 -174.436 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.661 ' HG ' ' O ' ' A' ' 54' ' ' LEU . 15.5 mt -59.71 -52.4 65.67 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 -178.687 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.617 ' HE2' ' O ' ' A' ' 55' ' ' PRO . 49.5 mtmt -64.93 -23.91 67.36 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 113.955 -1.475 . . . . 0.0 110.57 177.689 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.543 ' HB3' ' HA ' ' A' ' 57' ' ' LEU . 28.3 tt0 -82.58 -19.09 39.14 Favored 'General case' 0 C--N 1.291 -1.976 0 C-N-CA 124.844 1.257 . . . . 0.0 111.679 178.456 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 36.6 m-85 -85.9 -33.21 21.28 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 113.56 0.948 . . . . 0.0 113.56 -177.669 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.514 ' OD2' HD13 ' A' ' 65' ' ' ILE . 4.6 p-10 -78.47 -165.19 0.66 Allowed 'General case' 0 C--N 1.292 -1.92 0 N-CA-C 113.116 0.784 . . . . 0.0 113.116 -167.458 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.703 ' HB2' HD12 ' A' ' 65' ' ' ILE . 6.6 mt -77.16 -154.23 0.0 OUTLIER Pre-proline 0 CA--C 1.599 2.845 0 N-CA-C 104.494 -2.41 . . . . 0.0 104.494 178.146 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.493 ' O ' ' HD2' ' A' ' 155' ' ' ARG . 7.5 Cg_endo -96.77 10.9 1.25 Allowed 'Trans proline' 0 N--CA 1.441 -1.585 0 CA-C-N 123.667 2.345 . . . . 0.0 111.067 177.127 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.703 HD12 ' HB2' ' A' ' 63' ' ' LEU . 0.2 OUTLIER -78.9 -40.31 22.77 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.92 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.68 -176.81 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 59.9 8.14 7.62 Favored Glycine 0 CA--C 1.542 1.73 0 CA-C-N 116.287 -0.415 . . . . 0.0 113.638 -177.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.635 ' H ' HG12 ' A' ' 65' ' ' ILE . 55.9 mt 59.01 -70.4 0.07 OUTLIER 'Isoleucine or valine' 0 C--O 1.211 -0.94 0 C-N-CA 127.418 2.287 . . . . 0.0 114.126 -178.72 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.597 ' HB3' ' HD3' ' A' ' 69' ' ' PRO . 34.3 t80 173.5 -56.57 0.0 OUTLIER Pre-proline 0 CA--C 1.563 1.446 0 CA-C-N 118.024 0.375 . . . . 0.0 110.571 -176.55 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.597 ' HD3' ' HB3' ' A' ' 68' ' ' PHE . 6.9 Cg_endo -98.89 157.97 0.67 Allowed 'Trans proline' 0 C--N 1.386 2.533 0 C-N-CA 123.205 2.603 . . . . 0.0 112.598 179.39 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -89.45 -8.24 68.39 Favored Glycine 0 CA--C 1.524 0.648 0 C-N-CA 121.379 -0.438 . . . . 0.0 112.39 179.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.565 ' OD2' ' HG3' ' A' ' 89' ' ' PRO . 20.8 t70 -89.6 -19.96 24.3 Favored 'General case' 0 C--O 1.213 -0.852 0 CA-C-O 122.17 0.986 . . . . 0.0 108.635 177.045 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.448 ' HB3' ' HD2' ' A' ' 69' ' ' PRO . . . -84.33 -166.13 1.35 Allowed 'General case' 0 CA--C 1.487 -1.48 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 167.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 18.2 p 67.71 18.06 9.81 Favored 'General case' 0 CA--C 1.47 -2.11 0 CA-C-O 123.582 1.658 . . . . 0.0 110.668 172.234 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.749 ' O ' ' HA ' ' A' ' 86' ' ' VAL . 1.6 m-80 -75.87 100.49 4.81 Favored 'General case' 2 N--CA 1.365 -4.694 0 CA-C-N 111.704 -2.498 . . . . 0.0 110.513 -178.639 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -99.03 91.86 5.22 Favored 'General case' 0 C--N 1.274 -2.71 0 CA-C-N 114.572 -1.194 . . . . 0.0 113.33 -176.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.599 ' HB2' HG23 ' A' ' 85' ' ' THR . 19.2 mm-40 -97.5 133.8 41.58 Favored 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 106.729 -1.582 . . . . 0.0 106.729 175.735 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.452 ' HB2' ' CD2' ' A' ' 84' ' ' LEU . 90.6 t80 -146.57 127.28 14.3 Favored 'General case' 0 C--N 1.301 -1.511 0 C-N-CA 120.256 -0.578 . . . . 0.0 112.193 -173.477 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.684 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 5.8 m-20 -95.2 156.5 16.29 Favored 'General case' 0 CA--C 1.472 -2.043 0 N-CA-C 105.44 -2.059 . . . . 0.0 105.44 170.184 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -80.1 -60.63 2.26 Favored 'General case' 0 C--N 1.255 -3.521 0 N-CA-C 113.557 0.947 . . . . 0.0 113.557 -175.027 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -71.04 -29.94 65.98 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-O 121.415 0.626 . . . . 0.0 111.1 -175.695 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.684 ' HB ' ' HB2' ' A' ' 78' ' ' ASP . 24.6 m -68.6 -45.13 72.77 Favored 'General case' 0 N--CA 1.421 -1.886 0 CA-C-N 114.898 -1.046 . . . . 0.0 109.873 179.561 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 99.6 mttt 68.12 8.13 6.33 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.139 0.976 . . . . 0.0 113.319 -179.016 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 1.9 mptm? -89.22 106.23 18.31 Favored 'General case' 0 CA--C 1.494 -1.193 0 CA-C-O 121.551 0.691 . . . . 0.0 110.662 173.712 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.461 ' HB2' ' HB2' ' A' ' 112' ' ' LEU . 2.1 tm? -81.81 126.4 31.81 Favored 'General case' 0 C--N 1.285 -2.229 0 N-CA-C 105.426 -2.064 . . . . 0.0 105.426 174.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.63 ' HA ' ' O ' ' A' ' 108' ' ' VAL . 9.5 t -116.5 127.42 54.54 Favored 'General case' 0 N--CA 1.392 -3.327 0 C-N-CA 120.196 -0.602 . . . . 0.0 110.632 -178.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.749 ' HA ' ' O ' ' A' ' 74' ' ' ASN . 32.3 t -104.75 122.65 58.06 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.108 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.404 -178.588 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.402 ' O ' ' HA ' ' A' ' 72' ' ' ALA . 5.6 mp -90.49 104.4 16.99 Favored 'General case' 0 C--N 1.29 -2.01 0 CA-C-N 114.981 -1.008 . . . . 0.0 109.328 177.352 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.423 HG12 ' HB3' ' A' ' 104' ' ' PHE . 3.5 mp -93.93 137.53 23.03 Favored Pre-proline 0 C--N 1.302 -1.489 0 N-CA-C 106.561 -1.644 . . . . 0.0 106.561 175.114 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.621 ' O ' ' HB2' ' A' ' 166' ' ' ARG . 43.4 Cg_exo -59.76 97.32 0.11 Allowed 'Trans proline' 0 N--CA 1.455 -0.781 0 C-N-CA 122.58 2.187 . . . . 0.0 110.34 176.364 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.561 ' OG ' ' HB ' ' A' ' 167' ' ' VAL . 73.4 m 66.57 177.82 0.22 Allowed 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 123.654 0.781 . . . . 0.0 110.862 -174.531 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 14.8 tt -94.78 109.06 21.66 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.763 0 C-N-CA 119.792 -0.763 . . . . 0.0 109.185 175.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 27.1 p -98.77 149.15 23.17 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.366 -179.072 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -116.56 121.32 41.42 Favored 'General case' 0 CA--C 1.476 -1.88 0 N-CA-C 107.513 -1.291 . . . . 0.0 107.513 -179.053 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.595 HG13 ' H ' ' A' ' 163' ' ' ASN . 25.0 t -112.04 103.27 15.18 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.62 0 C-N-CA 119.614 -0.834 . . . . 0.0 111.293 -176.227 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -144.81 -156.93 7.01 Favored Glycine 0 N--CA 1.435 -1.426 0 N-CA-C 108.285 -1.926 . . . . 0.0 108.285 178.043 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 91.2 t80 75.84 -21.21 0.32 Allowed 'General case' 0 N--CA 1.492 1.631 0 CA-C-N 117.749 0.774 . . . . 0.0 112.989 173.33 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.441 ' HD3' ' OD1' ' A' ' 163' ' ' ASN . 20.9 pttp -86.61 -15.8 38.67 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-O 122.181 0.991 . . . . 0.0 108.914 179.02 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.509 ' CG ' ' H ' ' A' ' 99' ' ' SER . 17.9 t70 -177.43 -151.69 0.03 OUTLIER 'General case' 0 N--CA 1.42 -1.953 0 N-CA-C 104.403 -2.443 . . . . 0.0 104.403 -167.846 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.509 ' H ' ' CG ' ' A' ' 98' ' ' ASP . 25.5 m -123.76 -18.28 6.1 Favored 'General case' 0 C--N 1.265 -3.102 0 C-N-CA 123.839 0.856 . . . . 0.0 109.718 -175.244 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . 0.425 ' HA ' ' O ' ' A' ' 126' ' ' LYS . 36.1 m -74.09 96.42 2.71 Favored 'General case' 0 N--CA 1.424 -1.746 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 173.805 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.482 ' HA ' ' O ' ' A' ' 94' ' ' VAL . 52.0 t -97.64 119.24 45.4 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.257 0 CA-C-N 115.23 -0.895 . . . . 0.0 110.653 -176.851 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.4 ' HG ' HG23 ' A' ' 125' ' ' THR . 6.5 mp -109.19 126.76 53.6 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 176.619 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.437 ' HB3' ' HB2' ' A' ' 124' ' ' LYS . 38.9 ttmt -109.46 115.16 29.41 Favored 'General case' 0 C--N 1.289 -2.035 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 -178.743 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.471 ' HA ' HD11 ' A' ' 123' ' ' ILE . 93.2 m-85 -89.95 97.06 10.97 Favored 'General case' 0 N--CA 1.426 -1.651 0 CA-C-N 115.949 -0.569 . . . . 0.0 112.264 -175.16 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 87.9 m -56.88 122.36 12.05 Favored 'General case' 0 N--CA 1.422 -1.844 0 CA-C-N 114.062 -1.426 . . . . 0.0 109.535 174.621 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 8.0 t -71.9 117.7 13.82 Favored 'General case' 0 N--CA 1.435 -1.197 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 -179.588 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 52.3 m 70.68 68.71 0.19 Allowed 'General case' 0 N--CA 1.439 -0.984 0 CA-C-O 122.76 1.266 . . . . 0.0 108.812 -173.353 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.63 ' O ' ' HA ' ' A' ' 85' ' ' THR . 9.8 p -103.93 159.83 4.89 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.127 0 CA-C-N 113.627 -1.624 . . . . 0.0 106.812 -179.124 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.401 ' HA ' ' O ' ' A' ' 84' ' ' LEU . 15.8 p -115.53 170.72 8.21 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-N 118.735 0.698 . . . . 0.0 111.504 -178.334 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 176.54 -175.59 47.59 Favored Glycine 0 N--CA 1.439 -1.107 0 N-CA-C 110.506 -1.038 . . . . 0.0 110.506 179.362 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 46.7 t-80 -105.77 131.39 53.18 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 -179.29 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.461 ' HB2' ' HB2' ' A' ' 84' ' ' LEU . 3.2 tm? -97.08 107.78 20.38 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-O 121.803 0.811 . . . . 0.0 112.678 -172.18 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -123.53 143.64 50.06 Favored 'General case' 0 CA--C 1.453 -2.756 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 171.064 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 3.7 tmtp? -92.01 101.06 13.6 Favored 'General case' 0 N--CA 1.384 -3.742 0 CA-C-O 122.321 1.058 . . . . 0.0 108.57 -171.556 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . 0.645 ' O ' ' HB ' ' A' ' 138' ' ' THR . . . 143.94 -58.53 0.53 Allowed Glycine 0 C--N 1.283 -2.397 0 N-CA-C 106.736 -2.546 . . . . 0.0 106.736 -175.163 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.5 ' HB2' ' HA ' ' A' ' 137' ' ' SER . 0.0 OUTLIER -132.72 130.37 39.94 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 178.989 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -91.92 105.57 17.8 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 105.569 -2.011 . . . . 0.0 105.569 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 21.4 p -99.26 175.33 5.92 Favored 'General case' 0 C--N 1.294 -1.839 0 C-N-CA 123.355 0.662 . . . . 0.0 112.069 -174.213 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 27.4 m-20 50.89 45.72 27.12 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 123.529 0.732 . . . . 0.0 111.125 173.6 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.469 ' CG2' ' HA ' ' A' ' 135' ' ' SER . 2.1 t -77.52 99.17 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.863 0 CA-C-O 122.416 1.103 . . . . 0.0 109.807 -169.863 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 46.6 tt0 -79.79 87.58 5.27 Favored 'General case' 0 N--CA 1.4 -2.928 0 CA-C-N 113.819 -1.537 . . . . 0.0 111.275 -173.641 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 126.39 7.61 5.26 Favored Glycine 0 N--CA 1.412 -2.957 0 C-N-CA 119.604 -1.284 . . . . 0.0 112.439 171.601 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.471 HD11 ' HA ' ' A' ' 104' ' ' PHE . 8.5 tp -98.09 116.62 41.25 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.271 0 C-N-CA 117.402 -1.719 . . . . 0.0 108.223 -176.488 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.437 ' HB2' ' HB3' ' A' ' 103' ' ' LYS . 96.5 mttt -85.73 117.65 24.74 Favored 'General case' 0 C--N 1.274 -2.68 0 CA-C-N 113.816 -1.538 . . . . 0.0 109.227 -177.155 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.4 HG23 ' HG ' ' A' ' 102' ' ' LEU . 80.8 m -136.02 126.95 27.65 Favored 'General case' 0 N--CA 1.415 -2.215 0 CA-C-N 114.756 -1.111 . . . . 0.0 110.914 -173.428 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.512 ' C ' ' HD3' ' A' ' 126' ' ' LYS . 0.4 OUTLIER -112.36 128.33 56.26 Favored 'General case' 0 N--CA 1.419 -1.986 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 171.255 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.461 ' N ' ' HD3' ' A' ' 126' ' ' LYS . 7.7 p -143.36 -45.58 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.805 0 CA-C-O 121.538 0.685 . . . . 0.0 109.164 176.84 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 26.5 ptm -120.5 -26.43 5.36 Favored 'General case' 0 N--CA 1.423 -1.808 0 CA-C-N 115.037 -0.983 . . . . 0.0 108.528 173.816 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 9.3 tp -164.13 171.51 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.416 -2.172 0 N-CA-C 104.249 -2.5 . . . . 0.0 104.249 177.324 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 88.6 t90 -85.21 120.26 26.5 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 179.57 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.545 HG12 ' H ' ' A' ' 133' ' ' VAL . 45.4 t -128.08 146.05 34.26 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 N-CA-C 107.262 -1.385 . . . . 0.0 107.262 178.724 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 22.5 pttp -111.71 31.3 6.27 Favored 'General case' 0 C--O 1.246 0.882 0 CA-C-O 121.76 0.79 . . . . 0.0 110.731 -179.646 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.545 ' H ' HG12 ' A' ' 131' ' ' VAL . 21.9 t -131.27 -80.1 0.14 Allowed 'Isoleucine or valine' 0 C--O 1.208 -1.102 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 178.834 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 41.3 p 47.57 -156.41 0.05 Allowed 'General case' 0 C--O 1.258 1.551 0 C-N-CA 123.639 0.776 . . . . 0.0 112.602 179.363 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . 0.469 ' HA ' ' CG2' ' A' ' 120' ' ' VAL . 34.1 t -170.42 144.16 2.42 Favored 'General case' 0 N--CA 1.419 -1.993 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 -179.571 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 12.2 tt -99.64 96.95 5.33 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.28 0 N-CA-C 105.318 -2.105 . . . . 0.0 105.318 172.13 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . 0.5 ' HA ' ' HB2' ' A' ' 116' ' ' LYS . 25.6 m -90.55 142.95 27.22 Favored 'General case' 0 N--CA 1.389 -3.509 0 CA-C-N 113.588 -1.642 . . . . 0.0 109.303 -174.533 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . 0.645 ' HB ' ' O ' ' A' ' 115' ' ' GLY . 92.4 m -153.89 147.66 25.35 Favored 'General case' 0 C--N 1.256 -3.478 0 N-CA-C 105.743 -1.947 . . . . 0.0 105.743 -179.013 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -95.62 28.9 2.8 Favored 'General case' 0 C--N 1.276 -2.596 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 177.351 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.458 ' N ' HG22 ' A' ' 138' ' ' THR . . . 58.16 39.54 25.86 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 -171.433 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 24.6 t -168.67 -70.95 0.02 OUTLIER 'General case' 0 N--CA 1.441 -0.876 0 CA-C-N 114.625 -1.17 . . . . 0.0 110.803 -175.287 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.433 ' O ' HG23 ' A' ' 138' ' ' THR . 40.1 mmtm -106.42 159.7 15.95 Favored 'General case' 0 CA--C 1.51 -0.588 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 -179.45 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 48.0 t -106.21 139.32 27.93 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 CA-C-O 121.111 0.482 . . . . 0.0 110.855 -174.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 38.3 m-85 -129.5 150.28 50.91 Favored 'General case' 0 CA--C 1.498 -1.052 0 CA-C-O 122.089 0.947 . . . . 0.0 111.657 177.169 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -108.72 103.03 12.04 Favored 'General case' 0 C--N 1.277 -2.555 0 CA-C-N 113.723 -1.58 . . . . 0.0 108.98 178.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.441 ' OG1' ' HB3' ' A' ' 135' ' ' SER . 36.7 p -104.46 104.83 14.75 Favored 'General case' 0 N--CA 1.41 -2.438 0 N-CA-C 114.212 1.19 . . . . 0.0 114.212 -175.132 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -111.5 26.6 10.48 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 104.888 -2.264 . . . . 0.0 104.888 169.553 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 140.92 -74.28 0.36 Allowed Glycine 0 N--CA 1.399 -3.789 1 N-CA-C 103.049 -4.02 . . . . 0.0 103.049 -169.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 28.2 ttt -175.15 88.13 0.04 OUTLIER 'General case' 0 C--N 1.315 -0.934 0 C-N-CA 124.703 1.201 . . . . 0.0 108.103 170.352 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . 0.282 72.4 mmtt -106.42 -93.23 0.38 Allowed 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 116.1 1.889 . . . . 0.0 116.1 -177.605 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -93.42 161.59 14.32 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 113.7 1.0 . . . . 0.0 113.7 -172.188 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 33.0 t -133.72 156.64 47.58 Favored 'General case' 0 C--N 1.31 -1.126 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 175.561 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 20.4 tpt180 -149.62 151.13 33.27 Favored 'General case' 0 N--CA 1.441 -0.899 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 178.618 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 20.2 m -73.59 133.54 43.53 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 176.687 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' ARG . . . . . 0.51 ' HG3' ' HA2' ' A' ' 159' ' ' GLY . 14.9 ttp85 -75.88 -21.43 57.17 Favored 'General case' 0 C--N 1.299 -1.597 0 CA-C-O 121.617 0.722 . . . . 0.0 109.534 176.72 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -35.11 -47.64 0.39 Allowed 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 116.923 2.194 . . . . 0.0 116.923 -172.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -76.38 -53.45 8.15 Favored 'General case' 0 CA--C 1.548 0.878 0 N-CA-C 115.041 1.497 . . . . 0.0 115.041 -171.86 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -140.39 7.14 2.15 Favored 'General case' 0 N--CA 1.484 1.257 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -178.03 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . 0.684 ' HA3' ' O ' ' A' ' 65' ' ' ILE . . . 96.07 -81.88 0.8 Allowed Glycine 0 CA--C 1.462 -3.223 0 N-CA-C 108.712 -1.755 . . . . 0.0 108.712 -172.004 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.566 HG23 ' HB ' ' A' ' 65' ' ' ILE . 17.8 t -111.62 135.02 52.17 Favored 'Isoleucine or valine' 0 N--CA 1.401 -2.916 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 172.275 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -84.76 91.68 8.03 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 -177.601 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . 0.551 ' HD3' HG21 ' A' ' 94' ' ' VAL . 3.5 mmp_? -106.59 140.79 38.91 Favored 'General case' 0 C--N 1.29 -1.978 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.897 -176.816 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' ASN . . . . . 0.595 ' H ' HG13 ' A' ' 94' ' ' VAL . 16.8 m120 -127.3 5.91 6.36 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 114.762 -1.108 . . . . 0.0 111.011 -174.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -81.47 167.29 48.63 Favored Glycine 0 CA--C 1.498 -1.019 0 C-N-CA 120.343 -0.932 . . . . 0.0 111.912 -175.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.485 ' H ' HD23 ' A' ' 165' ' ' LEU . 1.2 pt? -116.92 112.34 20.9 Favored 'General case' 0 N--CA 1.417 -2.106 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 -179.873 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . 0.621 ' HB2' ' O ' ' A' ' 89' ' ' PRO . 5.8 ptp85 -82.91 118.84 23.74 Favored 'General case' 0 N--CA 1.41 -2.461 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 -177.095 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.561 ' HB ' ' OG ' ' A' ' 90' ' ' SER . 41.1 t -51.61 -46.52 37.55 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 CA-C-N 115.107 -0.951 . . . . 0.0 111.484 -179.776 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -79.31 81.32 5.59 Favored 'General case' 0 CA--C 1.498 -1.05 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 171.224 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 27.0 tptp -99.57 106.63 18.64 Favored 'General case' 0 C--N 1.279 -2.475 0 N-CA-C 114.046 1.128 . . . . 0.0 114.046 -179.377 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' PHE . . . . . . . . . . . . . 79.5 t80 . . . . . 0 N--CA 1.424 -1.765 0 N-CA-C 106.311 -1.737 . . . . 0.0 106.311 173.173 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 36.9 m . . . . . 0 N--CA 1.446 -0.63 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -78.23 109.17 12.11 Favored 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 178.8 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.416 ' C ' HD12 ' A' ' 4' ' ' ILE . 64.2 tt0 -145.52 96.9 2.9 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.753 -177.457 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.416 HD12 ' C ' ' A' ' 3' ' ' GLN . 2.9 mp -128.56 120.8 53.58 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.964 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 178.347 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -106.96 84.8 2.04 Favored 'General case' 0 N--CA 1.432 -1.348 0 CA-C-O 120.955 0.407 . . . . 0.0 109.927 177.075 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 44.6 t30 -89.9 92.75 9.14 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 178.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.635 ' HD3' ' H ' ' A' ' 7' ' ' LYS . 0.0 OUTLIER -102.21 104.55 15.12 Favored 'General case' 0 C--N 1.295 -1.769 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.179 179.213 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 10.5 p -144.08 139.92 24.83 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 CA-C-N 115.171 -0.922 . . . . 0.0 108.996 -179.232 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -141.75 104.77 0.39 Allowed Glycine 0 N--CA 1.423 -2.195 0 N-CA-C 110.209 -1.156 . . . . 0.0 110.209 -179.569 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 47.7 m -75.5 86.45 2.61 Favored 'General case' 0 N--CA 1.426 -1.655 0 CA-C-O 121.575 0.703 . . . . 0.0 111.141 -178.61 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 80.8 t80 -117.76 116.47 27.08 Favored 'General case' 0 N--CA 1.42 -1.969 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 176.729 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . 0.507 ' CZ3' ' HA3' ' A' ' 14' ' ' GLY . 61.2 t90 -85.81 110.33 19.3 Favored 'General case' 0 C--N 1.289 -2.055 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 179.156 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 62.6 tp -83.3 98.17 9.29 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-O 121.318 0.58 . . . . 0.0 109.644 179.68 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.507 ' HA3' ' CZ3' ' A' ' 12' ' ' TRP . . . -127.44 105.2 0.73 Allowed Glycine 0 N--CA 1.42 -2.403 0 N-CA-C 110.143 -1.183 . . . . 0.0 110.143 178.134 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -79.65 93.05 5.44 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-O 121.153 0.501 . . . . 0.0 110.049 179.506 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 14.3 ptmm? -94.26 97.32 10.16 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 174.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -112.27 95.7 5.6 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-N 115.426 -0.807 . . . . 0.0 112.02 -174.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -152.88 77.07 1.15 Allowed 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 173.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 57.9 tptt -171.96 81.88 0.06 Allowed 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 115.095 -0.957 . . . . 0.0 108.499 179.538 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -144.42 141.01 29.35 Favored 'General case' 0 C--N 1.299 -1.608 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.735 179.816 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -131.41 116.28 17.31 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 177.716 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -83.11 119.62 24.74 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 178.166 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 52.3 p -132.5 143.55 49.83 Favored 'General case' 0 C--N 1.296 -1.733 0 C-N-CA 120.875 -0.33 . . . . 0.0 110.887 -178.22 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 34.7 m -84.41 166.09 2.19 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 CA-C-N 116.191 -0.459 . . . . 0.0 109.834 177.738 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 150.9 171.14 18.75 Favored Glycine 0 N--CA 1.431 -1.679 0 N-CA-C 110.852 -0.899 . . . . 0.0 110.852 -179.034 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -119.54 112.19 19.04 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-O 121.262 0.553 . . . . 0.0 112.091 -177.786 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -136.35 96.57 3.39 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-O 122.056 0.932 . . . . 0.0 109.27 174.099 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -152.68 106.68 3.11 Favored 'General case' 0 C--N 1.294 -1.824 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 -178.31 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 55.2 t-20 -139.86 104.29 4.84 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 178.742 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 47.5 m -92.08 74.44 5.51 Favored 'General case' 0 N--CA 1.438 -1.044 0 N-CA-C 112.953 0.723 . . . . 0.0 112.953 -176.235 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 10.6 p 176.46 103.32 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 C-N-CA 125.796 1.639 . . . . 0.0 108.14 175.373 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.477 ' H ' ' CD ' ' A' ' 76' ' ' GLU . 51.0 p -138.58 -52.6 0.59 Allowed 'General case' 0 C--N 1.282 -2.342 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.388 -175.416 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 17.2 m 63.5 38.95 9.47 Favored 'General case' 0 N--CA 1.442 -0.872 0 CA-C-O 122.568 1.175 . . . . 0.0 108.237 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 58.5 p -67.41 118.51 10.86 Favored 'General case' 0 N--CA 1.434 -1.232 0 CA-C-N 114.319 -1.31 . . . . 0.0 110.089 179.677 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 50.2 mm -81.12 86.33 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.146 0 CA-C-O 121.681 0.753 . . . . 0.0 109.413 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 32.2 mm-40 -120.9 165.5 15.12 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 114.468 -1.242 . . . . 0.0 109.63 -179.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 104.62 131.38 7.11 Favored Glycine 0 N--CA 1.425 -2.095 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.618 176.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 123.64 33.26 0.82 Allowed Glycine 0 C--N 1.298 -1.576 0 C-N-CA 121.043 -0.598 . . . . 0.0 112.015 178.28 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 10.7 m -94.34 109.51 21.34 Favored 'General case' 0 N--CA 1.438 -1.036 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.49 ' HD3' ' H ' ' A' ' 40' ' ' LYS . 0.0 OUTLIER -113.86 90.14 3.27 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-O 121.331 0.586 . . . . 0.0 111.862 -178.49 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 57.8 t-105 -114.71 -56.5 2.37 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.106 -179.297 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.4 HD23 ' N ' ' A' ' 43' ' ' VAL . 5.9 tt -157.45 137.79 12.81 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 106.522 -1.658 . . . . 0.0 106.522 -179.159 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.4 ' N ' HD23 ' A' ' 42' ' ' LEU . 62.1 t -82.47 -60.51 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 N-CA-C 111.901 0.334 . . . . 0.0 111.901 -177.03 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 57.3 t30 72.84 144.76 0.07 Allowed 'General case' 0 N--CA 1.504 2.245 0 C-N-CA 123.904 0.882 . . . . 0.0 111.682 177.657 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 10.2 mtmp? -92.22 88.94 6.67 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 -177.493 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.495 HG12 ' H ' ' A' ' 47' ' ' LYS . 15.2 tt 176.78 176.4 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.308 -1.199 0 N-CA-C 104.113 -2.551 . . . . 0.0 104.113 179.581 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.495 ' H ' HG12 ' A' ' 46' ' ' ILE . 0.0 OUTLIER -154.81 172.56 17.79 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 120.408 1.458 . . . . 0.0 111.469 -178.771 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 86.0 81.45 1.13 Allowed Glycine 0 N--CA 1.433 -1.55 0 CA-C-N 115.327 -0.851 . . . . 0.0 114.978 173.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.411 ' HA ' ' CE2' ' A' ' 170' ' ' PHE . 64.9 tttp -77.39 99.2 5.51 Favored 'General case' 0 N--CA 1.442 -0.859 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 172.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 49.1 ttm -65.37 103.61 0.84 Allowed 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 115.373 -0.83 . . . . 0.0 112.781 -172.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 14.8 mm-40 -100.97 -171.3 1.98 Allowed 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 176.661 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 48.8 mtpt -73.58 140.1 78.36 Favored Pre-proline 0 C--N 1.314 -0.966 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 176.829 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -60.92 30.02 0.05 OUTLIER 'Trans proline' 0 N--CA 1.51 2.479 0 C-N-CA 125.187 3.925 . . . . 0.0 117.576 -172.103 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 8.9 mp -65.86 -50.05 55.58 Favored Pre-proline 0 C--N 1.291 -1.972 0 N-CA-C 116.377 1.992 . . . . 0.0 116.377 178.777 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -62.29 -12.86 29.15 Favored 'Trans proline' 0 N--CA 1.449 -1.095 0 C-N-CA 122.336 2.024 . . . . 0.0 112.462 -170.584 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 17.8 mm-40 -72.52 -32.4 66.11 Favored 'General case' 0 N--CA 1.418 -2.028 0 N-CA-C 107.513 -1.291 . . . . 0.0 107.513 -178.491 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.466 ' O ' ' HG2' ' A' ' 60' ' ' GLU . 3.5 mm? -74.48 -44.28 52.22 Favored 'General case' 0 N--CA 1.423 -1.805 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 175.743 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.456 ' HG ' ' CE2' ' A' ' 75' ' ' TYR . 6.9 mp -59.05 -38.55 79.63 Favored 'General case' 0 CA--C 1.495 -1.15 0 CA-C-N 114.842 -1.072 . . . . 0.0 111.646 -176.563 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.442 ' HD2' ' N ' ' A' ' 60' ' ' GLU . 0.0 OUTLIER -76.14 -29.12 57.67 Favored 'General case' 0 N--CA 1.419 -2.005 0 C-N-CA 119.345 -0.942 . . . . 0.0 112.697 177.842 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.466 ' HG2' ' O ' ' A' ' 57' ' ' LEU . 11.6 pt-20 -77.68 -27.09 50.71 Favored 'General case' 0 N--CA 1.445 -0.706 0 C-N-CA 119.212 -0.995 . . . . 0.0 111.321 -175.595 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 58.6 m-85 -57.02 -47.71 80.25 Favored 'General case' 0 C--O 1.242 0.667 0 C-N-CA 120.17 -0.612 . . . . 0.0 112.515 176.455 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -108.78 -86.05 0.52 Allowed 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 114.722 1.378 . . . . 0.0 114.722 -174.348 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.634 ' HB2' HD12 ' A' ' 65' ' ' ILE . 0.0 OUTLIER -115.31 137.58 23.13 Favored Pre-proline 0 C--N 1.317 -0.81 0 C-N-CA 118.489 -1.284 . . . . 0.0 107.751 -179.215 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 63' ' ' LEU . 9.4 Cg_endo -91.49 21.26 0.8 Allowed 'Trans proline' 0 N--CA 1.429 -2.313 0 C-N-CA 123.653 2.902 . . . . 0.0 111.257 -170.332 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.706 ' HB ' HG23 ' A' ' 160' ' ' VAL . 0.2 OUTLIER -58.9 -40.33 79.96 Favored 'Isoleucine or valine' 0 CA--C 1.473 -2.007 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 176.544 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 59.2 -0.29 0.59 Allowed Glycine 0 N--CA 1.483 1.794 0 CA-C-N 114.363 -1.29 . . . . 0.0 112.182 -176.176 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.579 ' H ' HG12 ' A' ' 65' ' ' ILE . 56.4 mt 62.73 -69.36 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.414 -2.238 0 C-N-CA 127.539 2.336 . . . . 0.0 111.076 -171.606 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 75.1 t80 -177.54 -52.87 0.0 OUTLIER Pre-proline 0 C--N 1.306 -1.287 0 N-CA-C 113.541 0.941 . . . . 0.0 113.541 -174.451 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.453 ' HB2' ' OD1' ' A' ' 71' ' ' ASP . 18.6 Cg_endo -90.21 -28.0 0.27 Allowed 'Trans proline' 0 N--CA 1.444 -1.432 0 C-N-CA 121.073 1.182 . . . . 0.0 115.136 -170.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 94.68 -18.42 57.19 Favored Glycine 0 C--O 1.216 -0.993 0 N-CA-C 110.537 -1.025 . . . . 0.0 110.537 -174.108 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.613 ' HB3' ' HG2' ' A' ' 89' ' ' PRO . 8.2 m-20 -75.48 -50.73 14.84 Favored 'General case' 0 N--CA 1.437 -1.11 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 177.272 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.421 ' HA ' ' O ' ' A' ' 87' ' ' LEU . . . -73.86 170.86 14.48 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 114.106 -1.406 . . . . 0.0 109.95 174.082 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.584 ' O ' HG22 ' A' ' 73' ' ' THR . 28.8 m 89.79 28.46 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.836 0 CA-C-O 124.11 1.909 . . . . 0.0 112.559 170.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.517 ' HB2' ' HB2' ' A' ' 87' ' ' LEU . 27.5 m-80 -91.25 -174.9 4.1 Favored 'General case' 0 C--N 1.247 -3.855 0 CA-C-N 114.823 -1.08 . . . . 0.0 109.973 178.133 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.551 ' HB2' HD21 ' A' ' 84' ' ' LEU . 28.4 p90 -148.9 136.14 20.13 Favored 'General case' 0 C--N 1.3 -1.545 0 C-N-CA 119.206 -0.998 . . . . 0.0 113.299 -179.387 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.575 ' HB2' HG23 ' A' ' 85' ' ' THR . 70.5 mm-40 -144.13 146.07 32.53 Favored 'General case' 0 C--N 1.306 -1.322 0 C-N-CA 126.251 1.82 . . . . 0.0 106.784 175.324 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 50.2 p90 -149.65 150.93 32.91 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-N 118.249 0.477 . . . . 0.0 111.95 -176.572 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.612 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 11.5 m-20 -95.35 163.1 13.39 Favored 'General case' 0 CA--C 1.489 -1.378 0 N-CA-C 106.857 -1.534 . . . . 0.0 106.857 173.814 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -81.11 -62.43 1.66 Allowed 'General case' 0 C--N 1.278 -2.524 0 N-CA-C 113.633 0.975 . . . . 0.0 113.633 -178.202 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -77.56 -40.39 42.63 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 121.309 0.576 . . . . 0.0 109.519 -176.236 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.612 ' HB ' ' HB2' ' A' ' 78' ' ' ASP . 81.5 m -66.67 -38.54 87.03 Favored 'General case' 0 N--CA 1.429 -1.521 0 CA-C-N 114.949 -1.023 . . . . 0.0 111.892 178.638 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 98.8 mttt 61.54 7.5 1.86 Allowed 'General case' 0 N--CA 1.5 2.036 0 N-CA-C 114.037 1.125 . . . . 0.0 114.037 177.3 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.496 ' HD3' ' HB ' ' A' ' 109' ' ' THR . 35.8 ttmt -83.26 113.33 20.61 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 108.847 -0.798 . . . . 0.0 108.847 178.74 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.551 HD21 ' HB2' ' A' ' 75' ' ' TYR . 2.2 tm? -79.87 134.64 36.32 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 -176.194 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.628 ' HA ' ' O ' ' A' ' 108' ' ' VAL . 8.9 t -120.91 129.7 53.59 Favored 'General case' 0 N--CA 1.403 -2.823 0 CA-C-O 121.643 0.735 . . . . 0.0 110.309 178.763 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.402 HG13 ' O ' ' A' ' 74' ' ' ASN . 98.8 t -102.92 134.07 44.98 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.611 -177.28 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.517 ' HB2' ' HB2' ' A' ' 74' ' ' ASN . 2.5 mm? -81.95 115.92 21.34 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-N 114.676 -1.147 . . . . 0.0 110.819 -179.76 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.617 ' O ' ' HA ' ' A' ' 106' ' ' THR . 64.0 mt -124.8 103.81 30.83 Favored Pre-proline 0 C--N 1.29 -1.982 0 N-CA-C 107.375 -1.343 . . . . 0.0 107.375 173.91 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.613 ' HG2' ' HB3' ' A' ' 71' ' ' ASP . 70.9 Cg_exo -56.63 110.9 0.65 Allowed 'Trans proline' 0 C--O 1.199 -1.45 0 C-N-CA 123.136 2.557 . . . . 0.0 111.814 178.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.429 ' HB2' ' O ' ' A' ' 89' ' ' PRO . 36.7 m 75.34 149.47 0.1 Allowed 'General case' 0 CA--C 1.485 -1.52 0 CA-C-O 122.091 0.948 . . . . 0.0 113.324 -175.511 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.458 HD12 HG23 ' A' ' 106' ' ' THR . 3.3 mp -80.79 120.7 32.93 Favored 'Isoleucine or valine' 0 N--CA 1.392 -3.33 0 N-CA-C 107.594 -1.261 . . . . 0.0 107.594 173.582 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 40.4 t -96.15 121.57 38.06 Favored 'General case' 0 N--CA 1.405 -2.688 0 N-CA-C 106.625 -1.62 . . . . 0.0 106.625 171.594 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.445 ' HG3' HG22 ' A' ' 91' ' ' ILE . 49.9 mt-10 -116.82 121.6 42.0 Favored 'General case' 0 CA--C 1.466 -2.267 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 177.263 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.401 HG23 HD23 ' A' ' 102' ' ' LEU . 33.3 m -115.28 103.63 15.58 Favored 'Isoleucine or valine' 0 C--N 1.267 -2.989 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 177.754 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.756 ' HA2' ' O ' ' A' ' 100' ' ' SER . . . -145.35 148.63 20.49 Favored Glycine 0 CA--C 1.478 -2.226 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 -178.851 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -125.95 -89.12 0.57 Allowed 'General case' 0 CA--C 1.478 -1.809 0 C-N-CA 118.059 -1.456 . . . . 0.0 109.788 -178.258 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.487 ' O ' ' HB2' ' A' ' 98' ' ' ASP . 57.5 mtpt -87.47 -36.74 17.49 Favored 'General case' 0 N--CA 1.415 -2.186 0 C-N-CA 119.747 -0.781 . . . . 0.0 110.479 176.122 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.487 ' HB2' ' O ' ' A' ' 97' ' ' LYS . 31.3 t70 163.22 -40.62 0.0 OUTLIER 'General case' 0 C--N 1.364 1.238 0 O-C-N 124.21 0.944 . . . . 0.0 111.817 -176.023 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 19.4 m -72.68 15.47 0.19 Allowed 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.353 1.061 . . . . 0.0 113.475 -171.464 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . 0.756 ' O ' ' HA2' ' A' ' 95' ' ' GLY . 69.3 p -167.34 77.0 0.16 Allowed 'General case' 0 N--CA 1.41 -2.456 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 177.065 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 60.5 t -115.72 99.72 9.02 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.237 0 CA-C-O 121.23 0.538 . . . . 0.0 109.755 175.817 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.554 HD13 HG23 ' A' ' 125' ' ' THR . 1.8 mm? -111.79 129.62 56.07 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 178.693 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -116.51 107.2 14.45 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-O 120.924 0.392 . . . . 0.0 111.106 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -93.06 102.36 14.69 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 107.518 -1.289 . . . . 0.0 107.518 176.69 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.534 ' O ' ' HB ' ' A' ' 88' ' ' ILE . 13.5 t -77.07 -178.37 4.96 Favored 'General case' 0 CA--C 1.551 1.019 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.532 -175.697 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.617 ' HA ' ' O ' ' A' ' 88' ' ' ILE . 15.0 p -84.13 -50.32 8.04 Favored 'General case' 0 C--N 1.309 -1.162 0 C-N-CA 123.513 0.725 . . . . 0.0 111.716 -173.9 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 26.3 p -115.82 84.76 2.16 Favored 'General case' 0 N--CA 1.406 -2.644 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 175.251 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.628 ' O ' ' HA ' ' A' ' 85' ' ' THR . 14.7 p -81.58 129.58 37.27 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.296 0 CA-C-N 114.94 -1.027 . . . . 0.0 109.922 -177.317 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.496 ' HB ' ' HD3' ' A' ' 83' ' ' LYS . 17.5 p -104.98 149.0 26.12 Favored 'General case' 0 N--CA 1.4 -2.955 0 CA-C-N 116.191 -0.459 . . . . 0.0 109.771 -176.05 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 178.98 -159.41 24.3 Favored Glycine 0 N--CA 1.424 -2.135 0 N-CA-C 110.944 -0.862 . . . . 0.0 110.944 -179.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . 0.432 ' HB2' ' O ' ' A' ' 118' ' ' THR . 74.1 m80 -123.68 121.22 34.96 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 177.593 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.538 ' HB3' ' HG ' ' A' ' 84' ' ' LEU . 6.4 tt -123.43 136.58 54.68 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-O 121.277 0.56 . . . . 0.0 110.427 -171.717 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -130.67 171.09 13.47 Favored 'General case' 0 CA--C 1.456 -2.64 0 CA-C-N 114.941 -1.027 . . . . 0.0 110.189 177.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 2.7 tmtm? -86.24 100.84 12.53 Favored 'General case' 1 N--CA 1.376 -4.155 0 N-CA-C 103.779 -2.674 . . . . 0.0 103.779 173.461 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . 0.631 ' O ' HG23 ' A' ' 138' ' ' THR . . . 143.2 -62.09 0.51 Allowed Glycine 0 C--N 1.273 -2.96 0 N-CA-C 109.252 -1.539 . . . . 0.0 109.252 -174.85 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.433 ' HG2' HG23 ' A' ' 118' ' ' THR . 0.0 OUTLIER -151.02 164.7 35.8 Favored 'General case' 0 CA--C 1.508 -0.647 0 C-N-CA 122.766 0.426 . . . . 0.0 110.087 -179.697 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 3.7 tt -121.31 109.76 15.3 Favored 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 106.252 -1.758 . . . . 0.0 106.252 176.608 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.611 ' HA ' ' OG ' ' A' ' 135' ' ' SER . 66.9 p -112.14 131.22 55.58 Favored 'General case' 0 C--N 1.277 -2.566 0 N-CA-C 114.109 1.151 . . . . 0.0 114.109 -177.263 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . 0.504 ' H ' ' HB2' ' A' ' 135' ' ' SER . 17.5 t70 70.42 107.81 0.06 Allowed 'General case' 0 CA--C 1.507 -0.71 0 N-CA-C 114.294 1.22 . . . . 0.0 114.294 175.215 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 35.8 m -112.58 166.07 6.92 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.194 0 CA-C-N 115.002 -0.999 . . . . 0.0 110.566 177.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.472 ' HB3' ' OG1' ' A' ' 109' ' ' THR . 12.0 tp10 -127.75 -8.32 5.59 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.747 -178.316 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -105.7 -19.11 10.65 Favored Glycine 0 N--CA 1.432 -1.587 0 C-N-CA 119.706 -1.235 . . . . 0.0 112.39 -173.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.496 HG13 ' CG2' ' A' ' 108' ' ' VAL . 96.2 mt -100.82 100.6 10.71 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.62 0 CA-C-O 121.98 0.895 . . . . 0.0 111.272 -178.553 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -86.27 141.89 28.94 Favored 'General case' 0 C--N 1.295 -1.77 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 172.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.554 HG23 HD13 ' A' ' 102' ' ' LEU . 17.9 m -150.5 143.04 24.47 Favored 'General case' 0 N--CA 1.421 -1.925 0 N-CA-C 112.998 0.74 . . . . 0.0 112.998 -172.561 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.539 ' C ' ' HD3' ' A' ' 126' ' ' LYS . 0.4 OUTLIER -131.07 105.24 7.58 Favored 'General case' 0 N--CA 1.423 -1.798 0 N-CA-C 105.3 -2.111 . . . . 0.0 105.3 168.56 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 7.4 p -113.47 -53.58 5.01 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.441 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 179.193 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 45.5 ttm -114.29 -27.49 7.59 Favored 'General case' 0 N--CA 1.398 -3.059 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 172.295 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.404 HD12 ' HA ' ' A' ' 129' ' ' ILE . 8.5 tp -161.51 171.13 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.551 1.008 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 173.77 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 8.5 m-90 -70.66 117.52 12.28 Favored 'General case' 0 CA--C 1.509 -0.605 0 CA-C-N 118.572 0.623 . . . . 0.0 110.431 179.309 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.436 HG12 HG12 ' A' ' 133' ' ' VAL . 88.6 t -147.94 111.04 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.139 0 C-N-CA 122.956 0.502 . . . . 0.0 109.783 179.62 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 54.6 pttt -106.78 114.33 28.36 Favored 'General case' 0 N--CA 1.442 -0.841 0 C-N-CA 119.31 -0.956 . . . . 0.0 109.364 173.523 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.436 HG12 HG12 ' A' ' 131' ' ' VAL . 13.5 p 173.57 -21.23 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.296 -1.755 0 N-CA-C 107.362 -1.347 . . . . 0.0 107.362 -178.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . 0.577 HG22 ' HA3' ' A' ' 148' ' ' GLY . 66.4 p -7.51 88.84 0.0 OUTLIER 'General case' 0 C--N 1.366 1.295 0 C-N-CA 127.921 2.488 . . . . 0.0 114.345 177.89 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . 0.611 ' OG ' ' HA ' ' A' ' 118' ' ' THR . 30.2 t -101.64 146.43 27.73 Favored 'General case' 0 N--CA 1.408 -2.571 0 CA-C-N 114.252 -1.34 . . . . 0.0 109.978 -176.505 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 8.9 tt -115.36 122.85 70.14 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.567 0 O-C-N 124.136 0.897 . . . . 0.0 109.681 179.464 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 34.7 p -105.77 135.96 46.25 Favored 'General case' 0 N--CA 1.398 -3.051 0 CA-C-O 122.239 1.018 . . . . 0.0 110.306 178.382 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . 0.631 HG23 ' O ' ' A' ' 115' ' ' GLY . 3.0 t -151.08 175.68 11.88 Favored 'General case' 0 N--CA 1.385 -3.724 0 N-CA-C 105.7 -1.963 . . . . 0.0 105.7 -179.599 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -122.2 33.76 5.37 Favored 'General case' 0 C--N 1.271 -2.827 0 N-CA-C 106.272 -1.751 . . . . 0.0 106.272 177.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . 63.33 46.15 4.59 Favored 'General case' 0 C--N 1.351 0.646 0 CA-C-N 113.971 -1.468 . . . . 0.0 109.274 -176.751 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 36.2 t -178.45 -78.87 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 114.878 -1.055 . . . . 0.0 110.065 -177.702 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 66.2 mttm -88.91 143.72 26.68 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 -178.44 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.528 ' HB ' ' O ' ' A' ' 153' ' ' ARG . 47.6 t -106.86 138.4 32.81 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 CA-C-O 120.899 0.381 . . . . 0.0 111.693 -173.569 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 57.6 m-85 -136.11 141.58 44.19 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 178.463 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 51.5 p90 -66.94 161.87 23.16 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.531 0.681 . . . . 0.0 112.19 177.683 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.497 ' HB ' ' O ' ' A' ' 135' ' ' SER . 92.7 m -149.0 -58.87 0.22 Allowed 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.298 174.9 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.485 ' HB3' ' HA ' ' A' ' 134' ' ' THR . . . -141.38 137.04 32.01 Favored 'General case' 0 CA--C 1.507 -0.691 0 N-CA-C 110.062 -0.348 . . . . 0.0 110.062 178.803 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . 0.577 ' HA3' HG22 ' A' ' 134' ' ' THR . . . 79.89 -54.59 4.45 Favored Glycine 0 C--O 1.219 -0.817 0 O-C-N 123.539 0.524 . . . . 0.0 113.129 177.585 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 26.4 ttt -60.98 -48.49 81.57 Favored 'General case' 0 C--N 1.3 -1.577 0 C-N-CA 123.159 0.584 . . . . 0.0 109.799 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . 0.257 27.3 mtpp 49.0 17.46 0.16 Allowed 'General case' 0 N--CA 1.486 1.348 0 N-CA-C 115.985 1.846 . . . . 0.0 115.985 177.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -143.95 140.98 29.97 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 175.608 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 20.6 p -87.72 111.28 21.16 Favored 'General case' 0 N--CA 1.421 -1.916 0 CA-C-O 121.392 0.615 . . . . 0.0 110.119 177.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' ARG . . . . . 0.528 ' O ' ' HB ' ' A' ' 143' ' ' VAL . 2.6 tpm_? -105.9 105.77 15.97 Favored 'General case' 0 N--CA 1.432 -1.361 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 176.657 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 48.1 m -68.71 146.23 53.14 Favored 'General case' 0 C--N 1.285 -2.209 0 C-N-CA 120.841 -0.344 . . . . 0.0 111.742 -177.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' ARG . . . . . 0.509 ' HA ' ' HA2' ' A' ' 159' ' ' GLY . 29.0 tpt180 -57.81 -31.01 66.17 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-O 121.278 0.561 . . . . 0.0 109.532 175.732 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -47.16 -41.85 18.58 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 114.298 -1.319 . . . . 0.0 112.084 175.583 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -82.41 -53.87 5.66 Favored 'General case' 0 N--CA 1.437 -1.097 0 C-N-CA 120.692 -0.403 . . . . 0.0 111.622 -179.321 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -152.99 -18.97 0.15 Allowed 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 112.815 0.672 . . . . 0.0 112.815 -175.588 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . 0.509 ' HA2' ' HA ' ' A' ' 155' ' ' ARG . . . 107.99 -93.16 0.79 Allowed Glycine 0 N--CA 1.418 -2.555 0 N-CA-C 108.062 -2.015 . . . . 0.0 108.062 -165.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.706 HG23 ' HB ' ' A' ' 65' ' ' ILE . 83.8 t -133.57 115.86 23.32 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 CA-C-O 121.705 0.764 . . . . 0.0 110.399 -179.761 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' GLN . . . . . 0.471 ' H ' ' HG2' ' A' ' 153' ' ' ARG . 2.5 mm-40 -134.99 135.31 41.31 Favored 'General case' 0 N--CA 1.412 -2.36 0 N-CA-C 115.158 1.54 . . . . 0.0 115.158 -177.767 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 10.9 tpt180 -150.53 110.52 4.11 Favored 'General case' 0 C--N 1.263 -3.183 0 N-CA-C 101.72 -3.437 . . . . 0.0 101.72 170.197 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -43.71 95.29 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 113.975 1.102 . . . . 0.0 113.975 -169.519 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -157.39 161.09 31.04 Favored Glycine 0 N--CA 1.433 -1.552 0 CA-C-N 114.302 -1.317 . . . . 0.0 110.439 -178.54 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.487 ' O ' HD12 ' A' ' 165' ' ' LEU . 3.5 pp -141.37 139.09 33.44 Favored 'General case' 0 N--CA 1.411 -2.399 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 178.216 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . 0.53 ' HB3' ' O ' ' A' ' 89' ' ' PRO . 0.0 OUTLIER -70.49 134.76 48.03 Favored 'General case' 0 C--N 1.295 -1.778 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 175.869 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 32.7 t -62.11 -31.36 51.13 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.845 0 O-C-N 123.755 0.66 . . . . 0.0 112.681 176.577 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -73.83 77.49 1.61 Allowed 'General case' 0 N--CA 1.485 1.308 0 CA-C-O 122.25 1.024 . . . . 0.0 111.114 174.753 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' LYS . . . . . 0.468 ' HD2' ' HA ' ' A' ' 47' ' ' LYS . 19.3 ttpp -152.95 156.39 38.8 Favored 'General case' 0 C--N 1.276 -2.606 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 -178.619 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' PHE . . . . . 0.411 ' CE2' ' HA ' ' A' ' 49' ' ' LYS . 28.3 p90 . . . . . 0 C--N 1.304 -1.378 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 174.321 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 35.5 t . . . . . 0 N--CA 1.444 -0.734 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -129.47 102.65 6.49 Favored 'General case' 0 CA--C 1.5 -0.953 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 -179.166 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -93.55 94.91 8.91 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 10.6 tt -141.41 112.14 3.36 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 CA-C-O 121.514 0.673 . . . . 0.0 110.438 177.643 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -116.17 119.43 35.77 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 115.052 -0.976 . . . . 0.0 108.871 179.817 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 -102.17 113.33 26.51 Favored 'General case' 0 C--N 1.289 -2.058 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 -174.27 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 13.6 mptt -94.43 92.75 7.29 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 170.194 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 8.3 p -133.27 143.33 39.5 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.753 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 -177.665 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 176.42 72.45 0.05 OUTLIER Glycine 0 N--CA 1.429 -1.789 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.003 -179.243 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 60.5 m -100.06 108.85 21.13 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 177.562 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 40.3 m-85 -110.7 150.81 28.5 Favored 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 -177.398 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 52.0 p-90 -120.07 121.93 39.97 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 175.151 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.486 ' O ' HD12 ' A' ' 13' ' ' LEU 0.261 2.6 pp -82.73 122.18 27.84 Favored 'General case' 0 N--CA 1.428 -1.561 0 N-CA-C 113.592 0.96 . . . . 0.0 113.592 -174.128 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -103.91 35.55 4.96 Favored Glycine 0 N--CA 1.426 -1.989 0 CA-C-N 114.881 -1.054 . . . . 0.0 110.779 178.72 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 29.9 tt0 -83.3 78.77 9.57 Favored 'General case' 0 N--CA 1.436 -1.126 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 178.586 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.494 ' HD3' ' N ' ' A' ' 17' ' ' ALA . 9.5 tmtt? -174.87 133.76 0.35 Allowed 'General case' 0 N--CA 1.443 -0.804 0 N-CA-C 105.861 -1.903 . . . . 0.0 105.861 -177.143 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.494 ' N ' ' HD3' ' A' ' 16' ' ' LYS . . . -123.32 160.75 26.03 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 179.146 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -118.39 128.27 54.47 Favored 'General case' 0 C--N 1.308 -1.203 0 C-N-CA 120.14 -0.624 . . . . 0.0 111.669 -178.396 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 58.0 mttp -94.71 117.2 29.74 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 115.169 -0.923 . . . . 0.0 108.55 178.657 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -138.38 134.61 34.38 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-O 121.064 0.459 . . . . 0.0 111.098 -178.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 38.4 p90 -121.29 166.94 13.3 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.145 -177.476 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -125.89 108.68 11.67 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 176.769 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 58.2 p -142.08 104.47 4.48 Favored 'General case' 0 C--N 1.298 -1.635 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.601 -179.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 33.6 m -108.7 147.45 13.37 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.37 0 CA-C-O 120.72 0.295 . . . . 0.0 110.761 178.526 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -114.72 63.93 0.31 Allowed Glycine 0 N--CA 1.436 -1.321 0 N-CA-C 110.541 -1.024 . . . . 0.0 110.541 179.22 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 79.1 m-20 -94.71 14.33 21.54 Favored 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 -177.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -69.14 145.77 53.05 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 97.0 mt -124.01 111.42 15.97 Favored 'General case' 0 C--N 1.302 -1.478 0 CA-C-O 121.042 0.449 . . . . 0.0 111.205 -176.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 41.5 t30 -94.22 90.59 6.39 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 108.866 -0.791 . . . . 0.0 108.866 175.285 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 55.2 p -97.48 15.07 24.27 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.036 -178.284 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 45.9 t -76.47 90.39 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.054 0 CA-C-O 121.792 0.806 . . . . 0.0 109.827 -179.224 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 33.8 t -148.06 102.72 3.41 Favored 'General case' 0 N--CA 1.412 -2.325 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 178.837 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 39.4 p -115.86 -4.91 12.05 Favored 'General case' 0 C--N 1.294 -1.812 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.897 -179.614 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 42.1 t 65.88 22.31 11.38 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.301 -178.187 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 7.8 tp -61.05 138.4 21.96 Favored 'Isoleucine or valine' 0 C--O 1.244 0.788 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.906 179.422 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 72.77 16.27 4.64 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 124.078 0.951 . . . . 0.0 110.235 -177.174 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -57.71 -33.38 67.42 Favored Glycine 0 C--N 1.335 0.504 0 CA-C-N 115.611 -0.722 . . . . 0.0 112.817 -179.165 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -162.64 95.82 0.13 Allowed Glycine 0 N--CA 1.435 -1.426 0 N-CA-C 110.672 -0.971 . . . . 0.0 110.672 177.126 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 9.7 t -111.49 112.94 25.03 Favored 'General case' 0 N--CA 1.436 -1.143 0 CA-C-O 122.034 0.921 . . . . 0.0 111.318 -178.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 5.0 ttmp? -139.35 101.19 4.18 Favored 'General case' 0 N--CA 1.427 -1.597 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 178.499 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 19.1 p90 -101.78 86.01 2.83 Favored 'General case' 0 C--N 1.286 -2.168 0 C-N-CA 119.11 -1.036 . . . . 0.0 111.189 -178.243 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 93.6 mt -121.51 92.82 3.83 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-N 114.691 -1.14 . . . . 0.0 107.99 177.002 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 10.0 p -141.01 143.85 27.64 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.93 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.5 -178.454 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 -116.14 110.0 18.24 Favored 'General case' 0 C--N 1.295 -1.781 0 N-CA-C 107.926 -1.138 . . . . 0.0 107.926 179.098 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 8.1 tmtt? -75.08 88.68 2.43 Favored 'General case' 0 C--O 1.244 0.781 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 -177.84 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 9.0 tp 173.46 -28.23 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 C-N-CA 125.902 1.681 . . . . 0.0 106.743 -177.518 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -102.45 155.03 18.53 Favored 'General case' 0 N--CA 1.437 -1.082 0 N-CA-C 107.448 -1.316 . . . . 0.0 107.448 175.489 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 97.9 53.94 1.25 Allowed Glycine 0 N--CA 1.427 -1.918 0 N-CA-C 107.943 -2.063 . . . . 0.0 107.943 -172.412 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -74.53 142.22 44.78 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 114.435 -0.883 . . . . 0.0 110.988 -175.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 66.6 mtt -78.12 89.75 4.23 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-O 121.506 0.669 . . . . 0.0 110.021 176.814 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 49.4 mt-30 -105.04 151.5 23.88 Favored 'General case' 0 C--N 1.293 -1.85 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 176.657 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 4.8 ttmp? 73.92 132.15 0.04 OUTLIER Pre-proline 0 CA--C 1.556 1.199 0 O-C-N 124.478 1.112 . . . . 0.0 108.785 -176.182 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -68.5 -15.67 41.95 Favored 'Trans proline' 0 N--CA 1.487 1.09 0 C-N-CA 123.133 2.555 . . . . 0.0 116.943 -170.707 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.628 ' O ' ' HG ' ' A' ' 58' ' ' LEU . 3.5 mm? -53.55 -46.64 98.09 Favored Pre-proline 0 N--CA 1.498 1.935 0 N-CA-C 116.658 2.096 . . . . 0.0 116.658 -173.785 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.717 ' HA ' HD11 ' A' ' 58' ' ' LEU . 26.2 Cg_exo -59.65 -21.09 61.2 Favored 'Trans proline' 0 N--CA 1.426 -2.464 0 C-N-CA 121.275 1.317 . . . . 0.0 112.029 -172.19 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -84.3 -41.39 16.89 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 123.456 0.702 . . . . 0.0 110.73 -179.196 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -69.7 -51.42 34.57 Favored 'General case' 0 CA--C 1.488 -1.407 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.962 178.214 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.717 HD11 ' HA ' ' A' ' 55' ' ' PRO 0.294 1.7 pp -62.19 -26.77 68.54 Favored 'General case' 0 C--O 1.208 -1.082 0 C-N-CA 119.745 -0.782 . . . . 0.0 111.029 179.284 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.458 ' HB2' ' O ' ' A' ' 55' ' ' PRO . 37.1 ttmt -69.45 -41.52 76.14 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 114.671 -1.15 . . . . 0.0 111.842 174.785 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -80.18 -16.18 55.41 Favored 'General case' 0 N--CA 1.441 -0.908 0 C-N-CA 119.418 -0.913 . . . . 0.0 109.122 -179.49 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 26.0 m-85 -84.29 -31.92 24.64 Favored 'General case' 0 C--N 1.321 -0.644 0 C-N-CA 119.437 -0.905 . . . . 0.0 111.456 177.665 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.517 ' HA ' HD11 ' A' ' 112' ' ' LEU . 20.7 t70 -87.11 -155.46 0.28 Allowed 'General case' 0 CA--C 1.545 0.773 0 N-CA-C 106.486 -1.672 . . . . 0.0 106.486 173.09 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.491 ' HB2' HD12 ' A' ' 65' ' ' ILE . 13.4 mt -84.03 155.4 64.14 Favored Pre-proline 0 C--N 1.299 -1.618 0 N-CA-C 107.248 -1.39 . . . . 0.0 107.248 -178.685 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -80.61 10.21 3.4 Favored 'Trans proline' 0 N--CA 1.453 -0.868 0 C-N-CA 122.2 1.933 . . . . 0.0 113.27 -166.102 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.744 HG12 ' H ' ' A' ' 67' ' ' ILE . 0.2 OUTLIER -81.34 -26.22 10.31 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.311 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 179.708 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 68.42 9.98 59.22 Favored Glycine 0 C--N 1.357 1.742 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.29 179.808 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.744 ' H ' HG12 ' A' ' 65' ' ' ILE . 55.8 mt 64.3 -68.01 0.14 Allowed 'Isoleucine or valine' 0 C--O 1.181 -2.506 0 C-N-CA 126.259 1.824 . . . . 0.0 111.653 -171.845 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.525 ' HB2' HG22 ' A' ' 160' ' ' VAL . 39.7 t80 -170.58 -57.81 0.0 OUTLIER Pre-proline 0 C--N 1.275 -2.632 0 CA-C-N 118.078 0.399 . . . . 0.0 111.177 -175.409 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.524 ' HD3' ' HB3' ' A' ' 68' ' ' PHE . 8.6 Cg_endo -100.57 -10.41 0.27 Allowed 'Trans proline' 0 N--CA 1.449 -1.116 0 C-N-CA 122.505 2.137 . . . . 0.0 114.793 -172.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 73.83 10.65 80.59 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.369 -0.92 . . . . 0.0 111.561 -175.2 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.455 ' HB2' ' CG ' ' A' ' 89' ' ' PRO . 13.3 p30 -95.96 -50.3 4.93 Favored 'General case' 0 N--CA 1.421 -1.905 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 178.438 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.555 ' O ' ' HB ' ' A' ' 73' ' ' THR . . . -64.01 178.45 0.65 Allowed 'General case' 0 C--N 1.318 -0.77 0 C-N-CA 124.302 1.041 . . . . 0.0 109.08 164.028 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.555 ' HB ' ' O ' ' A' ' 72' ' ' ALA . 65.0 m 84.33 27.89 0.08 Allowed 'General case' 0 C--N 1.349 0.578 0 CA-C-O 124.052 1.882 . . . . 0.0 109.773 171.217 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.651 HD22 ' N ' ' A' ' 74' ' ' ASN . 0.5 OUTLIER -80.93 176.33 9.91 Favored 'General case' 0 C--N 1.288 -2.072 0 C-N-CA 118.002 -1.479 . . . . 0.0 109.803 -178.768 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.458 ' CD2' HD11 ' A' ' 84' ' ' LEU . 13.7 t80 -147.12 109.84 4.66 Favored 'General case' 0 C--N 1.289 -2.051 0 C-N-CA 119.273 -0.971 . . . . 0.0 111.498 -171.387 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.402 ' O ' ' HG ' ' A' ' 84' ' ' LEU . 37.9 mt-10 -131.24 116.99 18.37 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.988 172.568 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 88.5 t80 -115.03 132.6 56.55 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.007 -173.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.506 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 26.1 m-20 -92.02 178.71 5.8 Favored 'General case' 0 CA--C 1.488 -1.436 0 CA-C-O 121.387 0.613 . . . . 0.0 111.048 -179.447 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -79.74 -74.11 0.31 Allowed 'General case' 0 C--N 1.294 -1.819 0 CA-C-N 114.503 -1.226 . . . . 0.0 112.244 -177.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -92.1 -22.35 19.95 Favored 'General case' 0 CA--C 1.503 -0.862 0 CA-C-N 115.823 -0.626 . . . . 0.0 112.402 -174.798 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.506 ' HB ' ' HB2' ' A' ' 78' ' ' ASP . 59.7 m -68.64 -51.7 39.27 Favored 'General case' 0 N--CA 1.427 -1.602 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.535 178.677 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 98.0 mttt 63.18 2.77 1.15 Allowed 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 124.16 0.984 . . . . 0.0 113.255 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.613 ' HG2' HG22 ' A' ' 109' ' ' THR . 35.6 ttmt -94.45 94.53 8.29 Favored 'General case' 0 N--CA 1.427 -1.598 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 173.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.458 HD11 ' CD2' ' A' ' 75' ' ' TYR . 6.9 tt -66.15 144.11 56.87 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-N 113.191 -1.822 . . . . 0.0 111.845 -172.37 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.444 ' HA ' ' O ' ' A' ' 108' ' ' VAL . 10.1 t -110.03 125.54 53.03 Favored 'General case' 0 N--CA 1.411 -2.38 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.148 179.212 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 86.1 t -99.53 127.85 51.89 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.363 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.265 178.116 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.507 ' HA ' ' O ' ' A' ' 106' ' ' THR . 1.2 mm? -97.25 142.11 29.54 Favored 'General case' 0 N--CA 1.418 -2.055 0 CA-C-N 113.707 -1.588 . . . . 0.0 109.507 -177.235 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 58.8 mt -137.28 119.96 11.44 Favored Pre-proline 0 C--N 1.252 -3.633 0 CA-C-N 112.854 -1.975 . . . . 0.0 105.685 174.413 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.455 ' CG ' ' HB2' ' A' ' 71' ' ' ASP . 6.2 Cg_exo -22.41 -52.72 0.04 OUTLIER 'Trans proline' 0 C--N 1.37 1.691 1 C-N-CA 126.133 4.555 . . . . 0.0 116.445 -178.769 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.436 ' HB3' ' HB3' ' A' ' 166' ' ' ARG . 41.3 t -151.55 165.35 34.53 Favored 'General case' 0 N--CA 1.425 -1.695 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 -179.743 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.541 HD11 ' HD2' ' A' ' 103' ' ' LYS . 6.1 tt -72.3 112.38 7.88 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.979 0 CA-C-O 121.647 0.737 . . . . 0.0 110.37 178.41 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' CYS . . . . . 0.524 ' HB3' ' CE2' ' A' ' 104' ' ' PHE . 48.0 t -118.09 128.54 54.85 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 178.625 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -122.33 139.32 53.95 Favored 'General case' 0 C--N 1.292 -1.931 0 C-N-CA 119.218 -0.993 . . . . 0.0 110.158 176.614 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 34.4 m -124.28 106.67 17.2 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.168 -175.219 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -146.93 112.72 0.62 Allowed Glycine 0 C--N 1.317 -0.518 0 C-N-CA 120.035 -1.079 . . . . 0.0 113.153 176.527 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 72.7 m-85 -145.2 -107.75 0.1 Allowed 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 113.712 1.005 . . . . 0.0 113.712 175.568 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 1.7 pptp? -87.59 -2.0 58.32 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.974 0.731 . . . . 0.0 112.974 -175.775 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -81.89 -16.43 50.67 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-O 120.972 0.415 . . . . 0.0 110.737 -177.557 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 36.8 t 83.19 -10.94 0.97 Allowed 'General case' 0 CA--C 1.506 -0.747 0 C-N-CA 125.105 1.362 . . . . 0.0 109.801 -179.013 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . 0.441 ' HA ' ' O ' ' A' ' 126' ' ' LYS . 73.6 p -100.02 109.3 21.62 Favored 'General case' 0 N--CA 1.394 -3.248 0 CA-C-O 121.221 0.534 . . . . 0.0 110.692 179.532 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 65.1 t -93.65 105.39 16.8 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.069 0 N-CA-C 107.03 -1.47 . . . . 0.0 107.03 172.02 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.437 HD23 ' H ' ' A' ' 126' ' ' LYS . 83.3 mt -118.53 114.63 23.11 Favored 'General case' 0 C--N 1.286 -2.187 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.99 -173.678 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.541 ' HD2' HD11 ' A' ' 91' ' ' ILE . 34.9 ttpt -103.55 113.17 26.47 Favored 'General case' 0 N--CA 1.427 -1.576 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.091 -179.313 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.524 ' CE2' ' HB3' ' A' ' 92' ' ' CYS 0.288 38.9 p90 -111.07 107.72 17.19 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-O 122.191 0.996 . . . . 0.0 112.538 179.467 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.609 ' H ' HG22 ' A' ' 123' ' ' ILE . 12.2 t -72.11 -175.74 1.57 Allowed 'General case' 0 N--CA 1.436 -1.151 0 CA-C-N 113.843 -1.526 . . . . 0.0 111.958 -177.378 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.507 ' O ' ' HA ' ' A' ' 87' ' ' LEU . 4.7 t -93.18 -27.64 16.76 Favored 'General case' 0 C--N 1.288 -2.102 0 CA-C-N 114.624 -1.171 . . . . 0.0 112.682 -173.26 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 25.0 m -139.73 95.35 2.9 Favored 'General case' 0 C--N 1.275 -2.672 0 N-CA-C 107.672 -1.232 . . . . 0.0 107.672 -178.478 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.444 ' O ' ' HA ' ' A' ' 85' ' ' THR . 3.4 p -103.83 160.36 4.73 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.52 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 -177.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.613 HG22 ' HG2' ' A' ' 83' ' ' LYS . 61.1 m -132.4 120.56 22.18 Favored 'General case' 0 N--CA 1.415 -2.219 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 -169.769 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -163.83 -159.43 10.8 Favored Glycine 0 C--O 1.208 -1.517 0 C-N-CA 120.474 -0.87 . . . . 0.0 113.097 -178.543 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 41.0 m80 -114.59 122.75 47.48 Favored 'General case' 0 CA--C 1.482 -1.664 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 178.47 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.517 HD11 ' HA ' ' A' ' 62' ' ' ASP . 5.2 tt -102.47 110.41 22.35 Favored 'General case' 0 C--N 1.285 -2.228 0 C-N-CA 119.965 -0.694 . . . . 0.0 109.278 -176.237 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -118.77 157.98 26.49 Favored 'General case' 0 CA--C 1.455 -2.678 0 CA-C-O 121.827 0.823 . . . . 0.0 109.445 174.122 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.468 ' HA ' ' HD3' ' A' ' 114' ' ' LYS . 16.5 mmtp -75.31 101.47 4.72 Favored 'General case' 0 C--N 1.245 -3.936 0 CA-C-O 122.687 1.232 . . . . 0.0 112.567 -178.492 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 121.59 -11.91 9.55 Favored Glycine 0 N--CA 1.411 -2.982 0 CA-C-N 113.195 -1.82 . . . . 0.0 110.021 -177.033 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -172.37 129.94 0.57 Allowed 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 113.363 0.875 . . . . 0.0 113.363 177.752 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.413 ' HB3' ' CG2' ' A' ' 136' ' ' ILE . 59.7 tp -97.39 104.23 16.23 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 106.46 -1.682 . . . . 0.0 106.46 172.664 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.458 ' HA ' ' CB ' ' A' ' 135' ' ' SER . 82.4 p -104.0 172.25 6.9 Favored 'General case' 0 C--N 1.311 -1.074 0 N-CA-C 111.803 0.297 . . . . 0.0 111.803 -173.301 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 57.76 46.17 17.59 Favored 'General case' 0 CA--C 1.496 -1.115 0 O-C-N 123.997 0.811 . . . . 0.0 110.7 172.71 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.415 HG21 HD11 ' A' ' 123' ' ' ILE 0.263 8.5 m -84.52 77.01 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.414 -2.266 0 CA-C-O 123.224 1.488 . . . . 0.0 111.962 -173.413 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -73.38 89.03 1.59 Allowed 'General case' 0 N--CA 1.394 -3.246 0 CA-C-N 112.287 -2.233 . . . . 0.0 110.293 -177.678 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 160.85 -22.91 0.24 Allowed Glycine 0 N--CA 1.413 -2.895 0 CA-C-N 115.085 -0.961 . . . . 0.0 110.801 176.504 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.609 HG22 ' H ' ' A' ' 105' ' ' THR . 18.6 pt -110.53 141.1 26.85 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.313 0 C-N-CA 119.62 -0.832 . . . . 0.0 111.657 -179.768 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -101.92 126.88 48.92 Favored 'General case' 0 C--N 1.294 -1.821 0 CA-C-N 114.795 -1.093 . . . . 0.0 110.331 177.479 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.401 HG23 HD22 ' A' ' 102' ' ' LEU . 97.4 m -115.49 109.74 18.27 Favored 'General case' 0 C--N 1.281 -2.394 0 CA-C-N 114.797 -1.092 . . . . 0.0 109.575 -178.297 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.441 ' O ' ' HA ' ' A' ' 100' ' ' SER . 6.6 tmtt? -114.56 134.73 54.82 Favored 'General case' 0 N--CA 1.421 -1.878 0 C-N-CA 120.441 -0.503 . . . . 0.0 110.45 174.102 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 89.7 t -130.19 -57.74 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.289 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 176.242 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 16.9 tpt -115.66 -34.86 4.71 Favored 'General case' 0 C--N 1.291 -1.971 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 173.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 7.8 tp -138.55 155.01 27.73 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.933 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.303 177.016 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 72.6 m95 -79.43 117.51 20.46 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 123.095 0.558 . . . . 0.0 110.872 179.343 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 17.5 m -129.93 157.16 42.54 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 174.107 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 48.0 pttt -126.84 28.48 5.83 Favored 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 -174.348 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 46.1 t -122.07 -83.07 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.15 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 175.472 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . 0.431 ' HB ' ' H ' ' A' ' 135' ' ' SER . 33.8 p 42.6 -161.71 0.01 OUTLIER 'General case' 0 CA--C 1.559 1.324 0 N-CA-C 114.288 1.218 . . . . 0.0 114.288 -178.54 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . 0.458 ' CB ' ' HA ' ' A' ' 118' ' ' THR . 89.6 p -171.81 157.75 4.66 Favored 'General case' 0 N--CA 1.414 -2.24 0 N-CA-C 106.801 -1.555 . . . . 0.0 106.801 176.167 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . 0.413 ' CG2' ' HB3' ' A' ' 117' ' ' LEU . 9.7 tt -100.44 113.02 34.87 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.94 0 N-CA-C 106.12 -1.808 . . . . 0.0 106.12 173.284 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 23.3 m -105.04 155.08 19.3 Favored 'General case' 0 N--CA 1.418 -2.074 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.676 -172.115 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . 0.489 HG21 ' HB3' ' A' ' 63' ' ' LEU . 9.4 t -164.09 166.19 21.57 Favored 'General case' 0 C--N 1.282 -2.333 0 N-CA-C 106.922 -1.51 . . . . 0.0 106.922 178.59 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -111.86 64.77 0.62 Allowed 'General case' 0 C--N 1.268 -2.94 0 C-N-CA 117.682 -1.607 . . . . 0.0 106.808 170.296 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.41 ' H ' HG23 ' A' ' 138' ' ' THR . . . 50.88 41.64 27.03 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 113.568 -1.651 . . . . 0.0 111.69 -178.036 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . 0.564 ' O ' ' HD2' ' A' ' 155' ' ' ARG . 47.4 t 171.05 -84.78 0.0 OUTLIER 'General case' 0 C--N 1.346 0.447 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.387 -175.486 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 61.5 pttt -78.91 135.58 37.02 Favored 'General case' 0 CA--C 1.491 -1.326 0 C-N-CA 120.158 -0.617 . . . . 0.0 109.881 -177.31 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.433 ' HB ' HG21 ' A' ' 65' ' ' ILE . 5.3 p -105.52 147.02 11.75 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.91 0 CA-C-O 121.122 0.487 . . . . 0.0 111.474 -166.377 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -139.17 155.91 47.49 Favored 'General case' 0 CA--C 1.499 -0.983 0 CA-C-N 115.417 -0.81 . . . . 0.0 109.935 -179.058 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . 0.547 ' HB2' ' HB2' ' A' ' 151' ' ' LYS . 62.7 m-85 -105.8 114.67 28.96 Favored 'General case' 0 C--N 1.282 -2.345 0 CA-C-N 115.195 -0.912 . . . . 0.0 110.006 172.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.403 HG21 ' OG ' ' A' ' 135' ' ' SER . 8.8 t -70.44 2.79 3.52 Favored 'General case' 0 CA--C 1.554 1.115 0 CA-C-N 114.739 -1.119 . . . . 0.0 113.051 -172.089 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -63.16 -17.04 61.95 Favored 'General case' 0 C--O 1.221 -0.407 0 CA-C-O 121.332 0.587 . . . . 0.0 111.0 -178.259 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 156.3 31.53 0.03 OUTLIER Glycine 0 CA--C 1.492 -1.399 0 N-CA-C 110.107 -1.197 . . . . 0.0 110.107 172.505 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 53.1 ttm 58.83 19.72 7.26 Favored 'General case' 0 C--N 1.361 1.081 0 CA-C-O 122.42 1.105 . . . . 0.0 108.482 -173.099 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . 0.472 ' O ' ' HE3' ' A' ' 151' ' ' LYS . 17.5 ptpt -85.13 1.78 46.43 Favored 'General case' 0 N--CA 1.44 -0.972 0 CA-C-N 114.628 -1.169 . . . . 0.0 113.634 -172.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.547 ' HB2' ' HB2' ' A' ' 145' ' ' PHE . 5.1 mmpt? -147.16 118.34 7.78 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 123.218 0.607 . . . . 0.0 109.818 176.247 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 23.7 p -133.01 132.96 42.47 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 177.081 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' ARG . . . . . 0.425 HH11 ' HD3' ' A' ' 153' ' ' ARG . 25.4 mmt180 -138.7 155.18 48.46 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 122.154 0.181 . . . . 0.0 110.539 179.499 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 70.1 p -79.11 119.91 22.9 Favored 'General case' 0 C--O 1.25 1.086 0 N-CA-C 113.528 0.936 . . . . 0.0 113.528 -175.552 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' ARG . . . . . 0.564 ' HD2' ' O ' ' A' ' 141' ' ' SER . 28.7 ttt180 -71.07 -35.92 72.08 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.073 0.463 . . . . 0.0 111.021 176.327 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -50.11 -41.81 49.22 Favored 'General case' 0 C--N 1.314 -0.943 0 C-N-CA 123.721 0.809 . . . . 0.0 112.528 -175.694 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -71.1 -52.36 19.79 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.921 -178.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 0.502 ' HB2' HE22 ' A' ' 161' ' ' GLN . 99.1 m-85 -149.36 -23.13 0.29 Allowed 'General case' 0 N--CA 1.484 1.254 0 N-CA-C 112.028 0.381 . . . . 0.0 112.028 -179.191 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . 0.419 ' HA2' ' HA ' ' A' ' 155' ' ' ARG . . . 128.73 -90.41 0.32 Allowed Glycine 0 N--CA 1.446 -0.646 0 N-CA-C 109.008 -1.637 . . . . 0.0 109.008 -172.901 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.608 HG22 ' O ' ' A' ' 67' ' ' ILE . 22.8 m -98.45 144.78 10.97 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.764 0 N-CA-C 106.285 -1.746 . . . . 0.0 106.285 173.194 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' GLN . . . . . 0.502 HE22 ' HB2' ' A' ' 158' ' ' TYR . 27.1 mm-40 -113.62 90.1 3.26 Favored 'General case' 0 C--N 1.3 -1.572 0 C-N-CA 119.022 -1.071 . . . . 0.0 111.447 -176.526 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -154.75 150.03 27.14 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 173.5 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 50.0 t30 -88.61 104.81 17.2 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-O 121.254 0.55 . . . . 0.0 110.553 177.566 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -142.63 150.51 22.27 Favored Glycine 0 CA--C 1.484 -1.876 0 N-CA-C 108.937 -1.665 . . . . 0.0 108.937 177.561 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -142.74 118.98 10.8 Favored 'General case' 0 N--CA 1.419 -2.018 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 176.784 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . 0.436 ' HB3' ' HB3' ' A' ' 90' ' ' SER . 0.0 OUTLIER -58.05 136.13 57.1 Favored 'General case' 0 N--CA 1.427 -1.577 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 173.31 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 48.6 t -53.28 -40.66 40.37 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.925 0 O-C-N 123.947 0.78 . . . . 0.0 110.148 175.127 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -86.07 70.79 10.62 Favored 'General case' 0 CA--C 1.503 -0.832 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.598 174.535 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' LYS . . . . . 0.411 ' O ' ' HB2' ' A' ' 170' ' ' PHE . 59.7 tttp -152.93 119.09 5.49 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.411 177.491 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' PHE . . . . . 0.411 ' HB2' ' O ' ' A' ' 169' ' ' LYS . 59.4 t80 . . . . . 0 C--O 1.252 1.194 0 N-CA-C 106.667 -1.605 . . . . 0.0 106.667 174.366 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 27.3 p . . . . . 0 N--CA 1.443 -0.818 0 CA-C-O 120.581 0.229 . . . . 0.0 111.242 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -136.3 94.33 3.01 Favored 'General case' 0 CA--C 1.494 -1.183 0 O-C-N 122.245 -0.284 . . . . 0.0 110.49 -179.339 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -96.51 90.38 5.35 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 174.518 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.428 HD13 ' N ' ' A' ' 5' ' ' PHE . 0.0 OUTLIER -136.18 133.77 50.15 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.096 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 -177.483 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.428 ' N ' HD13 ' A' ' 4' ' ' ILE . 43.4 p90 -150.61 134.39 16.64 Favored 'General case' 0 C--N 1.292 -1.93 0 CA-C-O 120.902 0.382 . . . . 0.0 110.703 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -101.83 82.59 2.28 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 173.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -126.86 102.65 7.11 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 -177.201 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 8.4 p -161.31 137.58 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.563 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.957 -178.215 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -153.15 84.58 0.15 Allowed Glycine 0 N--CA 1.424 -2.15 0 N-CA-C 110.436 -1.066 . . . . 0.0 110.436 178.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 18.8 m -79.73 88.17 5.21 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-O 121.112 0.482 . . . . 0.0 110.409 -179.161 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 54.4 p90 -151.63 146.69 26.0 Favored 'General case' 0 N--CA 1.438 -1.073 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 177.401 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 40.8 p90 -161.47 166.74 26.75 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 -179.523 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 4.0 tt -98.92 116.06 30.3 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 -178.082 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -152.08 60.0 0.41 Allowed Glycine 0 N--CA 1.438 -1.187 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 178.088 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -117.69 0.43 12.02 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-O 121.632 0.73 . . . . 0.0 110.633 -174.14 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -108.93 121.61 45.47 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.404 -178.818 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -168.26 168.88 11.24 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 123.704 0.801 . . . . 0.0 109.441 177.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 18.6 m120 62.45 72.95 0.48 Allowed 'General case' 0 C--O 1.243 0.746 0 C-N-CA 124.565 1.146 . . . . 0.0 113.393 178.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 14.6 ptmm? -164.0 120.07 1.62 Allowed 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 115.117 -0.947 . . . . 0.0 109.231 176.505 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -135.38 -70.0 0.49 Allowed 'General case' 0 C--N 1.312 -1.025 0 CA-C-O 121.005 0.431 . . . . 0.0 109.95 -178.466 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 45.2 p90 -139.62 149.04 43.29 Favored 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 108.442 -0.948 . . . . 0.0 108.442 178.591 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -97.79 154.51 17.57 Favored 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 -178.394 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 16.5 m 64.39 102.94 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.245 1.018 . . . . 0.0 113.361 174.434 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 55.4 t -93.16 103.22 14.46 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 177.116 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -149.59 133.04 4.26 Favored Glycine 0 N--CA 1.431 -1.694 0 N-CA-C 110.76 -0.936 . . . . 0.0 110.76 -179.497 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 46.4 m-80 -141.51 167.67 21.61 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-N 116.73 0.265 . . . . 0.0 110.662 -178.156 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 26.4 m-20 -83.86 165.72 18.52 Favored 'General case' 0 C--N 1.313 -1.0 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 177.451 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 90.0 mt -80.76 115.96 20.52 Favored 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 176.607 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -66.41 117.59 8.86 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.12 179.858 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 21.0 m -102.85 158.39 16.3 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 -179.508 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 54.3 t -84.06 -48.37 17.06 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 175.801 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 50.0 m 69.05 -35.25 0.3 Allowed 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 124.584 1.154 . . . . 0.0 113.411 177.792 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 23.3 m -69.09 -10.81 59.47 Favored 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 123.831 0.852 . . . . 0.0 109.968 178.449 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 19.1 m -64.17 104.83 0.79 Allowed 'General case' 0 N--CA 1.436 -1.152 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.954 179.422 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.524 ' O ' ' HE2' ' A' ' 52' ' ' LYS . 9.2 tp -120.53 -33.79 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 174.838 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 57.64 15.36 2.83 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 124.479 1.112 . . . . 0.0 112.517 177.858 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.452 ' HA3' ' HG2' ' A' ' 52' ' ' LYS . . . -96.91 114.8 5.07 Favored Glycine 0 N--CA 1.423 -2.202 0 N-CA-C 111.617 -0.593 . . . . 0.0 111.617 -178.699 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -75.65 138.36 22.99 Favored Glycine 0 N--CA 1.431 -1.682 0 N-CA-C 110.64 -0.984 . . . . 0.0 110.64 178.638 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 41.1 m -80.62 87.95 5.74 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-O 121.749 0.785 . . . . 0.0 110.395 -178.804 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 5.2 tmtm? -145.87 100.28 3.39 Favored 'General case' 0 C--N 1.311 -1.104 0 N-CA-C 106.384 -1.71 . . . . 0.0 106.384 179.759 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 40.9 p90 -88.73 115.51 26.32 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-O 121.855 0.836 . . . . 0.0 111.187 -177.529 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 61.4 tp -106.53 -40.24 5.62 Favored 'General case' 0 C--N 1.297 -1.685 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.575 -179.221 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 58.3 t -84.57 103.78 12.12 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.968 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.79 -178.84 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 -93.09 83.61 4.71 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-O 121.27 0.557 . . . . 0.0 109.662 178.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 10.5 tmtt? -160.28 106.45 1.54 Allowed 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 105.428 -2.064 . . . . 0.0 105.428 178.103 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 2.3 pp -80.29 148.94 5.37 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 N-CA-C 113.889 1.07 . . . . 0.0 113.889 -174.783 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 60.2 tttm 61.02 87.87 0.09 Allowed 'General case' 0 C--O 1.25 1.094 0 C-N-CA 124.651 1.181 . . . . 0.0 111.803 178.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 162.46 -161.3 33.5 Favored Glycine 0 N--CA 1.434 -1.494 0 N-CA-C 110.371 -1.092 . . . . 0.0 110.371 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -86.48 95.36 9.68 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 108.542 -0.911 . . . . 0.0 108.542 179.481 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 82.8 mtp -98.08 -79.52 0.47 Allowed 'General case' 0 C--N 1.293 -1.885 0 CA-C-O 121.363 0.601 . . . . 0.0 111.117 -175.362 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 52.6 mt-30 -151.93 -156.8 0.74 Allowed 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 -174.777 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.524 ' HE2' ' O ' ' A' ' 35' ' ' ILE . 50.3 tptt -57.92 137.48 83.51 Favored Pre-proline 0 CA--C 1.556 1.199 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 176.528 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.432 ' HD2' ' HD2' ' A' ' 52' ' ' LYS . 19.6 Cg_endo -61.39 32.53 0.06 OUTLIER 'Trans proline' 0 N--CA 1.499 1.827 0 C-N-CA 124.385 3.39 . . . . 0.0 117.72 -174.325 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.679 ' O ' ' HG ' ' A' ' 58' ' ' LEU . 1.8 mm? -63.85 -54.47 41.04 Favored Pre-proline 0 CA--C 1.495 -1.163 0 CA-C-N 119.427 1.012 . . . . 0.0 111.139 178.368 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.579 ' HA ' HD11 ' A' ' 58' ' ' LEU . 24.7 Cg_exo -60.84 -25.44 81.23 Favored 'Trans proline' 0 C--N 1.386 2.53 0 C-N-CA 121.103 1.202 . . . . 0.0 111.185 -172.581 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -76.18 -47.69 23.23 Favored 'General case' 0 N--CA 1.433 -1.303 0 CA-C-N 114.884 -1.053 . . . . 0.0 109.031 179.681 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.5 ' HA ' ' HG2' ' A' ' 60' ' ' GLU . 52.1 tp -63.83 -48.86 75.11 Favored 'General case' 0 C--N 1.313 -1.021 0 C-N-CA 124.562 1.145 . . . . 0.0 111.497 -179.164 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.679 ' HG ' ' O ' ' A' ' 54' ' ' LEU 0.339 2.4 pp -67.1 -33.85 76.36 Favored 'General case' 0 N--CA 1.428 -1.547 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 -177.995 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.499 ' HG2' ' O ' ' A' ' 55' ' ' PRO . 23.1 pttp -76.56 -30.9 57.26 Favored 'General case' 0 C--O 1.222 -0.367 0 C-N-CA 119.442 -0.903 . . . . 0.0 111.875 175.363 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.5 ' HG2' ' HA ' ' A' ' 57' ' ' LEU . 12.7 pt-20 -76.69 -40.18 49.65 Favored 'General case' 0 CA--C 1.509 -0.601 0 C-N-CA 120.038 -0.665 . . . . 0.0 111.737 -177.368 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 27.7 m-85 -68.64 -19.37 64.41 Favored 'General case' 0 C--O 1.24 0.582 0 C-N-CA 119.0 -1.08 . . . . 0.0 113.035 174.3 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.483 ' O ' ' HE3' ' A' ' 114' ' ' LYS . 12.1 t0 -95.39 176.12 6.31 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.132 178.267 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.727 ' HB2' HD12 ' A' ' 65' ' ' ILE . 13.8 mt -71.39 179.81 0.88 Allowed Pre-proline 0 CA--C 1.577 1.985 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 -177.184 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_endo -88.03 12.66 2.79 Favored 'Trans proline' 0 N--CA 1.45 -1.035 0 C-N-CA 122.211 1.941 . . . . 0.0 111.801 -175.613 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.747 HG12 ' H ' ' A' ' 67' ' ' ILE . 0.2 OUTLIER -68.84 -42.02 82.46 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 178.017 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 58.87 8.79 6.16 Favored Glycine 0 N--CA 1.496 2.644 0 CA-C-O 121.956 0.753 . . . . 0.0 112.163 -176.412 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.747 ' H ' HG12 ' A' ' 65' ' ' ILE . 62.6 mt 56.63 -70.05 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.192 -1.973 0 C-N-CA 128.294 2.638 . . . . 0.0 112.307 -173.544 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.494 ' HB3' ' HD3' ' A' ' 69' ' ' PRO . 88.2 t80 175.2 -61.24 0.0 OUTLIER Pre-proline 0 CA--C 1.543 0.692 0 N-CA-C 112.762 0.653 . . . . 0.0 112.762 -174.539 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.494 ' HD3' ' HB3' ' A' ' 68' ' ' PHE . 3.4 Cg_endo -84.49 -21.23 3.62 Favored 'Trans proline' 0 N--CA 1.447 -1.232 0 C-N-CA 121.409 1.406 . . . . 0.0 114.584 -168.004 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 83.38 -11.5 55.28 Favored Glycine 0 C--O 1.224 -0.497 0 N-CA-C 111.006 -0.837 . . . . 0.0 111.006 -175.576 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.579 ' HB3' ' HG2' ' A' ' 89' ' ' PRO . 20.1 m-20 -83.21 -42.0 17.77 Favored 'General case' 0 N--CA 1.438 -1.038 0 N-CA-C 105.587 -2.005 . . . . 0.0 105.587 177.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.52 ' O ' ' HB ' ' A' ' 73' ' ' THR . . . -75.89 -178.35 4.27 Favored 'General case' 0 CA--C 1.546 0.793 0 CA-C-N 113.695 -1.593 . . . . 0.0 109.719 175.217 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.522 ' O ' HG22 ' A' ' 73' ' ' THR . 41.3 m 84.44 26.11 0.09 Allowed 'General case' 0 N--CA 1.49 1.554 0 CA-C-O 124.544 2.116 . . . . 0.0 110.178 175.131 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.612 HD22 ' N ' ' A' ' 74' ' ' ASN . 0.7 OUTLIER -81.07 136.86 36.0 Favored 'General case' 0 C--N 1.272 -2.791 0 CA-C-N 114.527 -1.215 . . . . 0.0 110.16 -178.988 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 43.1 t80 -113.11 90.2 3.28 Favored 'General case' 0 C--N 1.277 -2.552 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.693 -169.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.505 ' O ' HD22 ' A' ' 84' ' ' LEU . 13.2 mm-40 -122.85 150.98 42.16 Favored 'General case' 0 C--O 1.202 -1.415 0 N-CA-C 106.934 -1.506 . . . . 0.0 106.934 179.073 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 46.8 p90 -146.89 144.26 29.13 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-N 119.514 1.052 . . . . 0.0 111.334 176.804 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.588 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 10.8 m-20 -92.01 165.83 13.0 Favored 'General case' 0 CA--C 1.481 -1.705 0 CA-C-O 121.258 0.551 . . . . 0.0 109.542 -178.341 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.425 ' O ' ' HG3' ' A' ' 82' ' ' LYS . 48.8 mt-10 -82.35 -43.79 16.98 Favored 'General case' 0 C--N 1.281 -2.383 0 CA-C-N 114.859 -1.064 . . . . 0.0 112.414 176.25 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -65.25 -33.09 75.18 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 122.62 1.2 . . . . 0.0 109.424 -179.81 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.588 ' HB ' ' HB2' ' A' ' 78' ' ' ASP . 29.7 m -85.23 -52.96 5.55 Favored 'General case' 0 N--CA 1.404 -2.766 0 CA-C-N 113.04 -1.891 . . . . 0.0 110.54 -178.056 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.425 ' HG3' ' O ' ' A' ' 79' ' ' GLU . 62.9 mttp 64.16 8.85 4.32 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 124.211 1.004 . . . . 0.0 109.892 -173.152 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.539 ' HG2' ' CG2' ' A' ' 81' ' ' THR 0.25 14.1 pttt -117.48 146.99 43.14 Favored 'General case' 0 N--CA 1.404 -2.773 0 CA-C-N 114.612 -1.176 . . . . 0.0 109.156 -177.459 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.505 HD22 ' O ' ' A' ' 76' ' ' GLU . 1.8 tm? -73.96 130.19 39.37 Favored 'General case' 0 C--N 1.279 -2.481 0 CA-C-N 115.288 -0.869 . . . . 0.0 111.82 -167.26 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.422 ' HA ' ' O ' ' A' ' 108' ' ' VAL . 74.5 p -111.3 111.95 23.37 Favored 'General case' 0 N--CA 1.411 -2.399 0 CA-C-N 114.892 -1.049 . . . . 0.0 109.063 177.549 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.584 ' HA ' ' O ' ' A' ' 74' ' ' ASN . 86.2 t -91.19 122.46 42.62 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.253 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 177.546 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.532 ' HA ' ' O ' ' A' ' 106' ' ' THR 0.388 1.0 OUTLIER -104.04 102.46 12.22 Favored 'General case' 0 N--CA 1.389 -3.483 0 CA-C-O 122.923 1.344 . . . . 0.0 112.782 -179.042 . . . . . . . . 4 4 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.48 ' O ' HG23 ' A' ' 106' ' ' THR . 69.0 mt -85.56 128.54 58.62 Favored Pre-proline 0 C--N 1.279 -2.487 0 CA-C-N 113.038 -1.892 . . . . 0.0 108.888 -176.824 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.579 ' HG2' ' HB3' ' A' ' 71' ' ' ASP . 50.6 Cg_exo -61.97 109.71 0.86 Allowed 'Trans proline' 0 CA--C 1.504 -0.988 0 C-N-CA 122.708 2.272 . . . . 0.0 110.563 177.926 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 30.4 t 69.26 179.55 0.24 Allowed 'General case' 0 CA--C 1.552 1.037 0 O-C-N 124.019 0.824 . . . . 0.0 110.357 -177.494 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.583 HD11 ' HG3' ' A' ' 103' ' ' LYS . 0.0 OUTLIER -112.58 132.35 61.58 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.784 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.007 177.692 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' CYS . . . . . 0.623 ' SG ' ' HB2' ' A' ' 104' ' ' PHE . 28.1 p -112.28 124.42 52.42 Favored 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 175.618 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.448 ' OE1' ' HE2' ' A' ' 103' ' ' LYS . 35.9 tt0 -124.2 129.72 51.29 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 178.823 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.505 ' O ' ' HA ' ' A' ' 101' ' ' VAL . 20.8 m -122.36 114.63 43.31 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.994 0 CA-C-O 121.234 0.54 . . . . 0.0 111.074 179.132 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -143.77 152.9 24.57 Favored Glycine 0 N--CA 1.427 -1.941 0 N-CA-C 108.332 -1.907 . . . . 0.0 108.332 178.107 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 18.9 t80 175.97 -60.24 0.01 OUTLIER 'General case' 0 CA--C 1.481 -1.678 0 N-CA-C 106.429 -1.693 . . . . 0.0 106.429 -174.609 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.615 ' HA ' ' HE3' ' A' ' 97' ' ' LYS . 0.1 OUTLIER -87.11 -6.81 58.54 Favored 'General case' 0 N--CA 1.409 -2.491 0 CA-C-N 111.327 -2.67 . . . . 0.0 112.055 -172.629 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.457 ' O ' ' HD3' ' A' ' 126' ' ' LYS . 17.3 t70 71.81 -43.86 0.57 Allowed 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 124.407 1.083 . . . . 0.0 112.947 179.765 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 27.3 m -64.01 -30.6 71.66 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 176.576 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 31.1 p -117.31 91.07 3.47 Favored 'General case' 0 N--CA 1.398 -3.039 0 CA-C-N 114.612 -1.177 . . . . 0.0 110.555 177.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.507 ' O ' ' HA ' ' A' ' 125' ' ' THR . 17.2 m -125.9 101.09 7.62 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 CA-C-N 115.079 -0.964 . . . . 0.0 108.89 172.154 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.606 ' HG ' ' OG1' ' A' ' 125' ' ' THR . 5.4 mp -123.45 125.69 45.4 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.829 -173.467 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.583 ' HG3' HD11 ' A' ' 91' ' ' ILE . 39.3 ttmt -112.46 113.1 25.11 Favored 'General case' 0 C--N 1.317 -0.82 0 O-C-N 123.127 0.267 . . . . 0.0 110.371 176.738 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.623 ' HB2' ' SG ' ' A' ' 92' ' ' CYS . 96.1 m-85 -103.67 98.94 8.73 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 175.315 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 87.1 m -74.37 159.96 31.66 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 115.095 -0.957 . . . . 0.0 111.378 -178.173 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.532 ' O ' ' HA ' ' A' ' 87' ' ' LEU . 90.2 m -57.93 -67.94 0.29 Allowed 'General case' 0 N--CA 1.431 -1.381 0 C-N-CA 124.665 1.186 . . . . 0.0 111.373 178.616 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 37.4 p -96.12 90.23 5.45 Favored 'General case' 0 N--CA 1.431 -1.4 0 C-N-CA 119.512 -0.875 . . . . 0.0 111.961 179.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.422 ' O ' ' HA ' ' A' ' 85' ' ' THR . 17.6 m -95.17 132.21 39.82 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 CA-C-N 115.538 -0.756 . . . . 0.0 109.649 176.443 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 30.3 m -114.94 120.06 38.64 Favored 'General case' 0 N--CA 1.413 -2.29 0 N-CA-C 108.712 -0.848 . . . . 0.0 108.712 -173.648 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.549 ' HA2' ' O ' ' A' ' 119' ' ' ASP . . . -150.99 161.79 29.18 Favored Glycine 0 N--CA 1.435 -1.393 0 C-N-CA 121.132 -0.556 . . . . 0.0 111.967 -177.626 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 84.2 t60 -84.81 90.8 7.84 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 178.524 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.542 ' HB2' HD13 ' A' ' 117' ' ' LEU . 5.4 tt -89.52 107.81 19.29 Favored 'General case' 0 N--CA 1.417 -2.1 0 N-CA-C 106.649 -1.611 . . . . 0.0 106.649 179.218 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -108.36 153.12 23.72 Favored 'General case' 0 N--CA 1.385 -3.705 0 N-CA-C 104.655 -2.35 . . . . 0.0 104.655 174.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.483 ' HE3' ' O ' ' A' ' 62' ' ' ASP . 21.4 tptm -75.2 101.5 4.65 Favored 'General case' 0 C--N 1.277 -2.566 0 C-N-CA 117.781 -1.568 . . . . 0.0 109.015 -176.221 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . 0.441 ' O ' HG23 ' A' ' 138' ' ' THR . . . 140.64 -24.42 2.62 Favored Glycine 0 C--O 1.19 -2.649 0 CA-C-N 114.043 -1.435 . . . . 0.0 110.236 -175.228 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 19.7 ptmt -173.98 151.2 1.71 Allowed 'General case' 0 N--CA 1.492 1.632 0 CA-C-N 117.643 0.721 . . . . 0.0 111.919 -179.038 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.542 HD13 ' HB2' ' A' ' 112' ' ' LEU . 27.3 tp -118.07 105.35 11.76 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 178.729 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 33.4 p -109.31 144.84 36.93 Favored 'General case' 0 C--N 1.295 -1.787 0 N-CA-C 113.681 0.993 . . . . 0.0 113.681 -176.26 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . 0.549 ' O ' ' HA2' ' A' ' 110' ' ' GLY . 31.5 m-20 60.81 94.06 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 124.885 1.274 . . . . 0.0 111.131 177.447 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 11.2 m -116.53 91.09 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.425 -1.715 0 CA-C-O 122.493 1.139 . . . . 0.0 113.009 -173.284 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -66.77 103.43 1.11 Allowed 'General case' 0 C--N 1.29 -1.999 0 CA-C-N 113.785 -1.552 . . . . 0.0 110.251 175.697 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 139.6 -20.68 2.92 Favored Glycine 0 N--CA 1.432 -1.607 0 CA-C-N 115.11 -0.95 . . . . 0.0 112.008 178.736 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 73.9 mt -101.56 108.17 23.02 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 CA-C-O 120.937 0.399 . . . . 0.0 110.267 -179.333 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 29.0 ttpp -101.23 130.93 47.44 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 176.033 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.606 ' OG1' ' HG ' ' A' ' 102' ' ' LEU . 15.1 t -157.53 163.81 38.01 Favored 'General case' 0 C--N 1.302 -1.498 0 C-N-CA 120.27 -0.572 . . . . 0.0 110.217 -175.822 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.457 ' HD3' ' O ' ' A' ' 98' ' ' ASP . 74.3 tttt -127.51 142.83 51.28 Favored 'General case' 0 C--N 1.276 -2.609 0 CA-C-N 115.52 -0.763 . . . . 0.0 109.354 174.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.447 HG11 ' HB2' ' A' ' 150' ' ' LYS . 83.6 t -110.92 -78.93 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.421 -1.918 0 N-CA-C 107.227 -1.398 . . . . 0.0 107.227 167.679 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . 0.482 ' C ' HD12 ' A' ' 129' ' ' ILE . 26.3 ttt -105.49 -32.16 8.65 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 176.287 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.482 HD12 ' C ' ' A' ' 128' ' ' MET . 2.7 mp -130.83 154.42 40.66 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.747 0 N-CA-C 107.057 -1.461 . . . . 0.0 107.057 175.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' TRP . . . . . 0.42 ' CD1' ' HB2' ' A' ' 126' ' ' LYS . 12.7 m-90 -70.95 134.12 46.95 Favored 'General case' 0 C--O 1.242 0.696 0 CA-C-O 120.845 0.355 . . . . 0.0 110.969 178.895 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 3.7 m -135.34 162.5 37.7 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 C-N-CA 123.803 0.841 . . . . 0.0 111.282 177.79 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -137.77 9.87 2.86 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 112.265 0.468 . . . . 0.0 112.265 -175.673 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 59.1 t -118.12 -69.12 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 C-N-CA 120.307 -0.557 . . . . 0.0 110.04 178.664 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 76.4 p 54.96 -178.6 0.03 OUTLIER 'General case' 0 C--O 1.247 0.944 0 N-CA-C 114.987 1.477 . . . . 0.0 114.987 177.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 36.1 p -164.96 146.84 7.94 Favored 'General case' 0 N--CA 1.422 -1.861 0 CA-C-N 114.955 -1.02 . . . . 0.0 109.056 177.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . 0.478 ' CG2' ' HB3' ' A' ' 117' ' ' LEU . 10.7 tt -113.68 107.95 24.25 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 175.377 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 33.3 p -100.6 148.93 24.27 Favored 'General case' 0 N--CA 1.398 -3.042 0 CA-C-O 121.713 0.768 . . . . 0.0 110.926 -177.166 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . 0.441 HG23 ' O ' ' A' ' 115' ' ' GLY . 6.1 t -165.31 176.12 8.61 Favored 'General case' 0 N--CA 1.4 -2.958 0 N-CA-C 106.765 -1.569 . . . . 0.0 106.765 -176.778 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -115.26 29.05 8.28 Favored 'General case' 0 C--N 1.277 -2.544 0 N-CA-C 105.859 -1.904 . . . . 0.0 105.859 172.567 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . 66.04 54.72 0.97 Allowed 'General case' 0 C--O 1.242 0.685 0 CA-C-N 113.886 -1.507 . . . . 0.0 107.321 -171.497 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 44.4 t -168.0 -81.41 0.02 OUTLIER 'General case' 0 N--CA 1.443 -0.785 0 CA-C-N 114.405 -1.271 . . . . 0.0 111.327 -174.772 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -95.59 150.03 20.79 Favored 'General case' 0 C--O 1.203 -1.383 0 C-N-CA 122.913 0.485 . . . . 0.0 110.477 -176.429 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.668 ' HB ' ' O ' ' A' ' 153' ' ' ARG . 67.8 t -105.65 114.48 45.19 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.118 0 CA-C-O 121.749 0.785 . . . . 0.0 112.477 -173.081 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 82.0 m-85 -117.89 113.29 21.53 Favored 'General case' 0 N--CA 1.422 -1.858 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 174.469 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 69.2 t80 -83.37 106.7 15.34 Favored 'General case' 0 C--N 1.288 -2.08 0 N-CA-C 108.582 -0.895 . . . . 0.0 108.582 -177.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . 0.406 5.6 p -86.52 78.1 9.28 Favored 'General case' 0 N--CA 1.389 -3.517 0 N-CA-C 116.658 2.095 . . . . 0.0 116.658 -173.802 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -126.7 76.17 1.61 Allowed 'General case' 0 N--CA 1.417 -2.124 0 N-CA-C 104.737 -2.32 . . . . 0.0 104.737 168.115 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 78.75 7.12 88.38 Favored Glycine 0 N--CA 1.441 -1.027 0 CA-C-N 114.195 -1.366 . . . . 0.0 111.274 -174.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' MET . . . . . 0.423 ' O ' ' HG2' ' A' ' 149' ' ' MET . 27.3 ttt 63.67 15.75 9.19 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 124.538 1.135 . . . . 0.0 109.397 -175.682 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . 0.447 ' HB2' HG11 ' A' ' 127' ' ' VAL . 64.3 mttp -66.21 -26.95 67.62 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 114.993 -1.003 . . . . 0.0 113.476 -175.24 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.636 ' HE2' ' HA ' ' A' ' 151' ' ' LYS . 8.2 mmpt? -114.13 136.73 52.61 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.012 0.434 . . . . 0.0 110.472 179.247 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 43.3 m -132.18 126.26 33.18 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 178.58 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' ARG . . . . . 0.668 ' O ' ' HB ' ' A' ' 143' ' ' VAL . 7.0 tpm_? -133.37 108.46 8.71 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 -176.86 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 16.2 m -61.08 128.96 38.99 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 175.524 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' ARG . . . . . 0.442 ' HD3' ' C ' ' A' ' 155' ' ' ARG . 2.5 tmt_? -59.24 -29.47 67.56 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 123.516 0.727 . . . . 0.0 109.299 -179.664 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -41.1 -41.12 1.66 Allowed 'General case' 0 C--N 1.314 -0.936 0 C-N-CA 125.615 1.566 . . . . 0.0 113.735 178.286 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -57.45 -53.11 61.84 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -176.397 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -178.88 20.46 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.172 0 N-CA-C 107.721 -1.214 . . . . 0.0 107.721 -179.202 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . 0.562 ' HA3' ' O ' ' A' ' 65' ' ' ILE . . . 95.85 -98.21 2.19 Favored Glycine 0 N--CA 1.405 -3.429 0 N-CA-C 108.901 -1.679 . . . . 0.0 108.901 -170.631 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.546 HG23 ' HB ' ' A' ' 65' ' ' ILE . 3.5 t -121.99 114.14 41.61 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.769 0 N-CA-C 105.793 -1.928 . . . . 0.0 105.793 176.385 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' GLN . . . . . 0.416 ' HG2' ' CE1' ' A' ' 68' ' ' PHE . 0.8 OUTLIER -132.51 98.3 4.32 Favored 'General case' 0 C--N 1.29 -2.02 0 C-N-CA 118.033 -1.467 . . . . 0.0 110.295 -171.012 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 39.8 ttm180 -153.26 100.61 2.47 Favored 'General case' 0 N--CA 1.428 -1.544 0 C-N-CA 120.441 -0.504 . . . . 0.0 109.89 170.816 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 51.41 -33.55 0.01 OUTLIER 'General case' 0 N--CA 1.509 2.477 0 N-CA-C 119.179 3.029 . . . . 0.0 119.179 171.415 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -60.75 111.39 3.7 Favored Glycine 0 C--N 1.315 -0.637 0 N-CA-C 115.647 1.019 . . . . 0.0 115.647 -173.637 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 44.9 tp -124.22 118.78 27.61 Favored 'General case' 0 N--CA 1.425 -1.681 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 176.859 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . 0.44 ' HB3' ' O ' ' A' ' 89' ' ' PRO . 6.3 mpt_? -78.14 117.6 19.58 Favored 'General case' 0 CA--C 1.479 -1.771 0 CA-C-O 121.112 0.482 . . . . 0.0 110.196 -177.531 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 4.3 m -78.05 62.34 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.947 0 CA-C-O 122.3 1.048 . . . . 0.0 113.233 179.145 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -111.65 -21.7 11.57 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 106.871 -1.529 . . . . 0.0 106.871 172.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 23.7 ttmm -91.12 101.92 14.66 Favored 'General case' 0 N--CA 1.425 -1.715 0 CA-C-N 113.551 -1.658 . . . . 0.0 110.413 -175.642 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 170' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 . . . . . 0 C--N 1.309 -1.193 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 177.268 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 23.1 m . . . . . 0 N--CA 1.45 -0.425 0 CA-C-O 121.115 0.483 . . . . 0.0 110.103 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -99.39 147.75 24.91 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.143 -175.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 -150.37 152.74 34.86 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 106.465 -1.68 . . . . 0.0 106.465 175.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 73.6 mt -92.96 102.31 13.51 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.722 0 C-N-CA 120.082 -0.647 . . . . 0.0 110.821 -179.535 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -113.97 93.1 4.21 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 173.799 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 32.0 t30 -145.16 119.66 9.7 Favored 'General case' 0 C--N 1.29 -2.004 0 CA-C-O 121.25 0.547 . . . . 0.0 110.583 -178.13 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -116.98 130.71 56.87 Favored 'General case' 0 C--N 1.287 -2.148 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 175.639 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.3 p -73.28 110.24 6.45 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 CA-C-O 121.745 0.784 . . . . 0.0 110.121 178.041 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -92.32 51.57 2.75 Favored Glycine 0 N--CA 1.421 -2.322 0 CA-C-N 115.547 -0.751 . . . . 0.0 112.808 -175.681 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 24.8 p -87.11 97.32 10.68 Favored 'General case' 0 N--CA 1.42 -1.933 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 175.192 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 70.9 m-85 -101.9 112.55 25.21 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.782 -173.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 72.6 t-105 -117.98 100.56 7.64 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.289 176.268 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 5.1 mp -112.67 96.52 6.02 Favored 'General case' 0 N--CA 1.428 -1.544 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 175.529 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 178.78 149.82 8.44 Favored Glycine 0 N--CA 1.423 -2.227 0 N-CA-C 109.159 -1.576 . . . . 0.0 109.159 -178.526 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -152.5 126.96 9.33 Favored 'General case' 0 C--N 1.292 -1.897 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 -178.248 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 60.2 mttp -88.04 96.93 10.7 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-O 121.52 0.676 . . . . 0.0 110.178 -179.859 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -123.42 129.51 51.38 Favored 'General case' 0 N--CA 1.428 -1.567 0 CA-C-N 115.117 -0.947 . . . . 0.0 109.737 -178.427 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -87.52 147.51 25.33 Favored 'General case' 0 C--N 1.308 -1.2 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 178.352 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -87.51 99.36 11.97 Favored 'General case' 0 N--CA 1.428 -1.566 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 179.517 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -84.86 81.01 9.07 Favored 'General case' 0 N--CA 1.429 -1.512 0 CA-C-O 122.079 0.943 . . . . 0.0 109.742 176.74 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 44.8 t80 -135.89 89.76 2.52 Favored 'General case' 0 N--CA 1.419 -1.989 0 CA-C-N 115.046 -0.979 . . . . 0.0 108.414 179.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -136.31 169.56 17.45 Favored 'General case' 0 C--N 1.281 -2.378 0 N-CA-C 108.042 -1.095 . . . . 0.0 108.042 -178.595 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 23.4 m -109.33 147.95 31.87 Favored 'General case' 0 C--N 1.281 -2.384 0 CA-C-O 120.764 0.316 . . . . 0.0 110.213 -176.755 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 54.2 t -83.6 92.42 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.394 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 177.767 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -100.79 56.02 0.78 Allowed Glycine 0 N--CA 1.429 -1.826 0 N-CA-C 110.897 -0.881 . . . . 0.0 110.897 -178.51 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -58.77 120.3 8.72 Favored 'General case' 0 C--N 1.317 -0.823 0 O-C-N 123.928 0.428 . . . . 0.0 109.972 -179.339 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -79.08 94.3 5.3 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-O 121.219 0.533 . . . . 0.0 111.822 -176.842 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.7 tt 176.48 113.81 0.02 OUTLIER 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 104.376 -2.453 . . . . 0.0 104.376 179.286 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -66.77 109.67 2.97 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 121.341 0.591 . . . . 0.0 111.001 -177.006 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 32.2 t -153.88 -168.12 2.87 Favored 'General case' 0 N--CA 1.419 -1.986 0 N-CA-C 106.437 -1.69 . . . . 0.0 106.437 -178.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 60.7 t -86.26 85.25 2.33 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 CA-C-O 121.508 0.671 . . . . 0.0 109.593 178.605 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 52.3 p -151.49 98.57 2.53 Favored 'General case' 0 N--CA 1.427 -1.601 0 CA-C-N 114.973 -1.012 . . . . 0.0 109.255 -179.618 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 21.3 p -82.5 115.7 21.61 Favored 'General case' 0 N--CA 1.423 -1.814 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.549 -179.674 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 37.2 p -88.98 -18.21 27.88 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-O 121.392 0.615 . . . . 0.0 110.799 -179.459 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 12.0 tt -131.11 149.38 33.36 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 179.097 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -76.92 132.17 38.94 Favored 'General case' 0 N--CA 1.436 -1.134 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 176.319 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -92.2 17.06 58.21 Favored Glycine 0 C--N 1.308 -1.023 0 C-N-CA 121.2 -0.524 . . . . 0.0 112.178 -177.734 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.467 ' HA3' ' CD1' ' A' ' 41' ' ' TRP . . . 152.01 -158.48 27.82 Favored Glycine 0 N--CA 1.416 -2.649 0 N-CA-C 111.226 -0.75 . . . . 0.0 111.226 178.759 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 35.9 p -113.83 -70.75 0.78 Allowed 'General case' 0 C--N 1.302 -1.493 0 CA-C-O 121.124 0.488 . . . . 0.0 110.901 179.599 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 66.6 mttm -99.49 10.13 41.95 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.009 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.467 ' CD1' ' HA3' ' A' ' 38' ' ' GLY . 28.5 p90 -128.62 147.93 50.76 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.173 -178.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 7.1 mp 69.28 114.67 0.04 OUTLIER 'General case' 0 CA--C 1.515 -0.385 0 C-N-CA 125.123 1.369 . . . . 0.0 111.401 -174.649 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 31.3 m -80.56 88.47 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.077 0 CA-C-O 122.541 1.162 . . . . 0.0 110.898 178.663 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -85.26 149.48 25.46 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-N 114.276 -1.329 . . . . 0.0 109.656 -177.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.498 ' HD2' ' N ' ' A' ' 45' ' ' LYS . 11.0 mptt -99.08 101.39 12.73 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 106.838 -1.541 . . . . 0.0 106.838 178.664 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 64.4 mt -111.57 140.61 30.2 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 N-CA-C 113.489 0.922 . . . . 0.0 113.489 -167.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.47 83.25 1.71 Allowed 'General case' 0 N--CA 1.436 -1.175 0 CA-C-N 114.245 -1.343 . . . . 0.0 107.954 168.181 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -160.43 165.32 34.9 Favored Glycine 0 C--N 1.309 -0.937 0 N-CA-C 110.038 -1.225 . . . . 0.0 110.038 -176.361 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 98.8 mttt 63.06 81.43 0.2 Allowed 'General case' 0 CA--C 1.51 -0.586 0 CA-C-O 121.929 0.871 . . . . 0.0 108.826 -173.194 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . 0.434 ' SD ' ' HA ' ' A' ' 53' ' ' PRO . 50.7 mtt -120.72 132.85 55.29 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-N 114.604 -1.18 . . . . 0.0 110.944 -170.851 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 50.1 tt0 -83.44 -39.63 20.33 Favored 'General case' 0 C--N 1.31 -1.126 0 N-CA-C 104.047 -2.575 . . . . 0.0 104.047 168.146 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 53.2 mtmt -133.89 143.13 46.15 Favored Pre-proline 0 N--CA 1.433 -1.296 0 N-CA-C 106.168 -1.79 . . . . 0.0 106.168 173.521 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.434 ' HA ' ' SD ' ' A' ' 50' ' ' MET . 4.3 Cg_exo -77.85 -20.04 12.11 Favored 'Trans proline' 0 CA--C 1.519 -0.239 0 C-N-CA 121.908 1.739 . . . . 0.0 112.589 -179.013 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.52 ' O ' HD13 ' A' ' 58' ' ' LEU . 19.0 mt -53.7 -51.49 75.99 Favored Pre-proline 0 N--CA 1.475 0.789 0 N-CA-C 113.724 1.009 . . . . 0.0 113.724 -173.213 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_exo -62.98 -15.57 48.64 Favored 'Trans proline' 0 C--N 1.372 1.795 0 C-N-CA 121.577 1.518 . . . . 0.0 113.068 -168.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 15.2 mm-40 -78.9 -36.97 41.14 Favored 'General case' 0 N--CA 1.423 -1.813 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 -174.083 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -76.05 -32.58 59.38 Favored 'General case' 0 N--CA 1.431 -1.397 0 CA-C-N 115.019 -0.991 . . . . 0.0 110.74 176.699 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.551 ' HG ' ' CE1' ' A' ' 75' ' ' TYR 0.253 4.6 mp -71.12 -44.21 66.08 Favored 'General case' 0 CA--C 1.487 -1.462 0 C-N-CA 120.346 -0.542 . . . . 0.0 111.722 -177.824 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.41 -25.79 66.93 Favored 'General case' 0 C--O 1.218 -0.579 0 CA-C-O 122.536 1.16 . . . . 0.0 109.972 176.432 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 18.5 tt0 -71.97 -28.58 63.52 Favored 'General case' 0 N--CA 1.428 -1.562 0 CA-C-N 114.024 -1.444 . . . . 0.0 112.251 175.807 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 72.6 t80 -83.74 -36.31 23.75 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 176.084 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 55.4 t0 -78.4 -171.05 2.27 Favored 'General case' 0 C--O 1.255 1.363 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 177.698 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.729 ' HB2' HD12 ' A' ' 65' ' ' ILE . 7.0 mt -82.82 -178.9 1.29 Allowed Pre-proline 0 CA--C 1.575 1.923 0 N-CA-C 106.384 -1.709 . . . . 0.0 106.384 179.4 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.442 ' HD3' ' HB3' ' A' ' 63' ' ' LEU . 3.4 Cg_endo -89.66 16.74 1.69 Allowed 'Trans proline' 0 N--CA 1.451 -1.011 0 CA-C-N 121.752 1.662 . . . . 0.0 110.669 -173.485 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.729 HD12 ' HB2' ' A' ' 63' ' ' LEU . 0.2 OUTLIER -72.64 -38.05 57.76 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.867 0 CA-C-N 114.73 -1.123 . . . . 0.0 109.29 -179.107 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.405 ' H ' HD13 ' A' ' 65' ' ' ILE . . . 59.09 4.34 2.35 Favored Glycine 0 N--CA 1.484 1.839 0 CA-C-N 115.495 -0.775 . . . . 0.0 112.769 -177.661 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.664 ' H ' HG12 ' A' ' 65' ' ' ILE . 20.3 mt 65.66 -68.65 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.224 0 C-N-CA 127.663 2.385 . . . . 0.0 112.025 -176.837 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.553 ' HA ' ' CD2' ' A' ' 158' ' ' TYR . 70.5 t80 169.34 -52.87 0.0 OUTLIER Pre-proline 0 C--N 1.322 -0.619 0 C-N-CA 124.013 0.925 . . . . 0.0 110.192 179.657 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.51 ' HD3' ' HB3' ' A' ' 68' ' ' PHE . 7.1 Cg_exo -81.29 143.48 13.97 Favored 'Trans proline' 0 C--N 1.369 1.637 0 C-N-CA 121.636 1.558 . . . . 0.0 110.229 177.444 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -71.85 -17.13 76.64 Favored Glycine 0 C--N 1.314 -0.644 0 C-N-CA 121.177 -0.535 . . . . 0.0 113.061 -177.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -90.7 -10.69 42.16 Favored 'General case' 0 C--O 1.201 -1.449 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 179.531 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.605 ' HA ' ' O ' ' A' ' 87' ' ' LEU . . . -82.89 -171.48 3.57 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.147 173.21 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.59 HG22 ' O ' ' A' ' 72' ' ' ALA . 6.0 t 72.39 26.9 2.54 Favored 'General case' 0 N--CA 1.501 2.121 0 C-N-CA 126.184 1.794 . . . . 0.0 109.53 169.2 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.445 ' HA ' ' HB3' ' A' ' 58' ' ' LEU . 28.2 m-80 -87.53 -169.48 2.62 Favored 'General case' 0 N--CA 1.417 -2.076 0 CA-C-N 113.599 -1.637 . . . . 0.0 108.852 -179.746 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.667 ' HB2' HD11 ' A' ' 84' ' ' LEU . 49.9 p90 -158.98 119.71 3.25 Favored 'General case' 0 C--N 1.311 -1.106 0 C-N-CA 118.889 -1.125 . . . . 0.0 113.649 -176.623 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.675 ' O ' HG22 ' A' ' 85' ' ' THR . 51.8 mt-10 -146.55 92.2 2.13 Favored 'General case' 0 CA--C 1.577 2.001 0 N-CA-C 114.58 1.326 . . . . 0.0 114.58 175.365 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.662 ' HB2' ' HA ' ' A' ' 84' ' ' LEU 0.437 30.3 m-85 -169.45 154.76 5.84 Favored 'General case' 0 N--CA 1.506 2.362 0 C-N-CA 128.105 2.562 . . . . 0.0 110.894 165.859 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.487 ' HB2' ' HB ' ' A' ' 81' ' ' THR 0.259 8.3 m-20 -50.99 142.96 11.06 Favored 'General case' 0 CA--C 1.48 -1.748 0 CA-C-O 122.074 0.94 . . . . 0.0 110.42 -179.874 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -81.11 -31.23 34.37 Favored 'General case' 1 C--N 1.24 -4.185 0 CA-C-N 113.867 -1.515 . . . . 0.0 111.753 178.493 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.413 ' HG2' ' HB3' ' A' ' 78' ' ' ASP . 12.9 pt-20 -65.9 -30.08 70.62 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 122.227 1.013 . . . . 0.0 108.626 177.227 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.487 ' HB ' ' HB2' ' A' ' 78' ' ' ASP . 95.5 m -78.73 -39.13 37.13 Favored 'General case' 0 N--CA 1.414 -2.268 0 CA-C-N 113.5 -1.682 . . . . 0.0 109.571 177.546 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.68 ' HE2' ' HA ' ' A' ' 82' ' ' LYS . 3.3 mmpt? 71.95 15.29 5.7 Favored 'General case' 0 CA--C 1.494 -1.188 0 C-N-CA 124.067 0.947 . . . . 0.0 112.864 -177.492 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.423 ' C ' ' HB2' ' A' ' 77' ' ' PHE . 37.2 ttpt -93.81 173.02 7.88 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 104.212 -2.514 . . . . 0.0 104.212 172.299 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.679 HD23 HD13 ' A' ' 112' ' ' LEU . 20.8 tp 176.24 121.93 0.03 OUTLIER 'General case' 0 CA--C 1.475 -1.912 0 CA-C-N 119.134 0.879 . . . . 0.0 108.99 -169.181 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.675 HG22 ' O ' ' A' ' 76' ' ' GLU . 14.5 t -92.2 129.93 38.03 Favored 'General case' 0 N--CA 1.392 -3.344 0 C-N-CA 118.976 -1.09 . . . . 0.0 108.252 174.537 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 62.3 t -103.92 116.61 48.01 Favored 'Isoleucine or valine' 0 N--CA 1.4 -2.975 0 CA-C-N 115.264 -0.88 . . . . 0.0 108.655 179.623 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.605 ' O ' ' HA ' ' A' ' 72' ' ' ALA . 2.0 mm? -75.1 123.16 24.72 Favored 'General case' 0 N--CA 1.41 -2.456 0 CA-C-N 113.783 -1.553 . . . . 0.0 110.673 -176.337 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 74.8 mt -107.51 137.16 19.6 Favored Pre-proline 0 C--N 1.281 -2.375 0 N-CA-C 105.225 -2.139 . . . . 0.0 105.225 170.881 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.465 ' O ' ' HB2' ' A' ' 166' ' ' ARG . 17.9 Cg_endo -58.21 84.87 0.05 OUTLIER 'Trans proline' 0 CA--C 1.541 0.825 0 C-N-CA 123.275 2.65 . . . . 0.0 112.523 178.175 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.438 ' HB3' ' HB ' ' A' ' 167' ' ' VAL . 24.2 m 69.33 163.89 0.24 Allowed 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 125.489 1.516 . . . . 0.0 112.46 -179.385 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 9.3 tt -62.82 135.34 27.34 Favored 'Isoleucine or valine' 0 C--O 1.242 0.69 0 CA-C-O 121.361 0.601 . . . . 0.0 109.864 177.383 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' CYS . . . . . 0.528 ' SG ' ' HB2' ' A' ' 104' ' ' PHE . 3.7 p -132.76 139.17 47.45 Favored 'General case' 0 C--N 1.282 -2.332 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.916 -179.295 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -119.79 142.41 48.62 Favored 'General case' 0 CA--C 1.454 -2.735 0 N-CA-C 106.048 -1.834 . . . . 0.0 106.048 178.637 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.411 ' HB ' ' CD2' ' A' ' 102' ' ' LEU . 17.9 t -118.49 104.38 16.0 Favored 'Isoleucine or valine' 0 N--CA 1.392 -3.365 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 -175.649 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -126.2 112.79 1.69 Allowed Glycine 0 N--CA 1.418 -2.549 0 N-CA-C 109.469 -1.453 . . . . 0.0 109.469 176.875 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 74.1 t80 -158.85 -47.61 0.06 Allowed 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 -177.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.625 ' HE2' ' HA ' ' A' ' 97' ' ' LYS . 7.7 mmpt? -74.43 -21.55 59.56 Favored 'General case' 0 CA--C 1.475 -1.91 0 CA-C-N 115.272 -0.876 . . . . 0.0 109.803 176.404 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 18.1 t70 74.74 -47.85 0.63 Allowed 'General case' 0 C--O 1.219 -0.531 0 O-C-N 124.927 1.392 . . . . 0.0 112.599 169.631 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 37.9 m -84.35 -4.96 59.2 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 175.525 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 36.4 t -135.2 92.46 2.86 Favored 'General case' 0 N--CA 1.408 -2.566 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 173.834 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 9.5 p -119.23 140.4 43.31 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 177.818 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.47 ' CB ' ' HA ' ' A' ' 125' ' ' THR . 0.4 OUTLIER -151.72 167.08 29.32 Favored 'General case' 0 C--N 1.294 -1.843 0 N-CA-C 112.641 0.608 . . . . 0.0 112.641 -171.364 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -142.59 129.13 20.22 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.413 0.625 . . . . 0.0 111.63 -175.703 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.528 ' HB2' ' SG ' ' A' ' 92' ' ' CYS . 61.0 m-85 -109.86 122.03 46.6 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 178.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.492 HG22 ' H ' ' A' ' 107' ' ' THR . 32.0 m -71.23 151.7 44.04 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 178.623 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 8.3 m -52.47 -38.5 59.53 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.967 0.907 . . . . 0.0 109.838 176.52 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.492 ' H ' HG22 ' A' ' 105' ' ' THR . 68.2 p -121.42 99.66 6.6 Favored 'General case' 0 N--CA 1.425 -1.678 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.144 179.021 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.542 ' O ' ' HA ' ' A' ' 85' ' ' THR . 61.9 t -99.65 138.22 24.69 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.285 0 N-CA-C 106.779 -1.563 . . . . 0.0 106.779 174.137 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.452 ' HA ' ' O ' ' A' ' 84' ' ' LEU . 9.1 t -125.8 137.13 53.76 Favored 'General case' 0 N--CA 1.395 -3.222 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 -175.814 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -157.16 176.98 34.24 Favored Glycine 0 N--CA 1.403 -3.529 0 C-N-CA 119.834 -1.174 . . . . 0.0 112.053 179.674 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . 0.524 ' HA ' ' O ' ' A' ' 82' ' ' LYS . 10.5 t60 -86.81 93.24 9.23 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 178.808 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.679 HD13 HD23 ' A' ' 84' ' ' LEU . 7.2 tt -97.98 120.41 38.32 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-O 121.656 0.741 . . . . 0.0 110.841 -174.062 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.504 ' OE1' ' HE2' ' A' ' 116' ' ' LYS . 44.4 mt-10 -123.41 -177.06 3.6 Favored 'General case' 0 CA--C 1.457 -2.611 0 CA-C-N 114.667 -1.151 . . . . 0.0 108.973 175.05 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.493 ' HA ' ' HD3' ' A' ' 114' ' ' LYS . 29.4 mmtt -83.07 101.84 11.4 Favored 'General case' 1 N--CA 1.371 -4.412 0 CA-C-N 114.834 -1.076 . . . . 0.0 113.536 179.926 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 125.27 -45.1 1.19 Allowed Glycine 0 N--CA 1.406 -3.336 0 CA-C-N 113.148 -1.842 . . . . 0.0 110.425 178.1 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.504 ' HE2' ' OE1' ' A' ' 113' ' ' GLU . 0.3 OUTLIER -135.2 147.59 49.41 Favored 'General case' 0 C--N 1.313 -0.984 0 C-N-CA 123.102 0.561 . . . . 0.0 112.492 -178.151 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.445 ' HA ' ' HA ' ' A' ' 112' ' ' LEU . 1.2 tt -120.64 105.06 10.43 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 105.346 -2.094 . . . . 0.0 105.346 178.079 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.513 ' HA ' ' OG ' ' A' ' 135' ' ' SER . 44.9 p -100.89 135.53 42.19 Favored 'General case' 0 C--N 1.267 -2.995 0 N-CA-C 114.465 1.283 . . . . 0.0 114.465 -172.174 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 64.92 97.47 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 125.235 1.414 . . . . 0.0 111.586 -179.887 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 6.1 m -104.52 93.53 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.018 0 CA-C-O 122.764 1.269 . . . . 0.0 111.348 -177.041 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -82.86 95.03 7.81 Favored 'General case' 0 N--CA 1.397 -3.107 0 CA-C-N 113.26 -1.791 . . . . 0.0 108.829 -179.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 145.91 -14.58 1.74 Allowed Glycine 0 C--N 1.305 -1.154 0 CA-C-N 114.375 -1.284 . . . . 0.0 111.188 -178.519 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.532 HG13 HG11 ' A' ' 108' ' ' VAL . 86.8 mt -100.64 99.41 8.38 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.25 0 CA-C-O 121.81 0.814 . . . . 0.0 111.042 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -89.18 127.71 35.76 Favored 'General case' 0 N--CA 1.433 -1.295 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 178.103 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.47 ' HA ' ' CB ' ' A' ' 102' ' ' LEU . 9.0 t -140.77 152.75 45.48 Favored 'General case' 0 C--N 1.278 -2.536 0 C-N-CA 119.734 -0.786 . . . . 0.0 111.002 -177.754 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.511 ' C ' ' HD3' ' A' ' 126' ' ' LYS . 3.8 tmtt? -140.85 127.17 19.81 Favored 'General case' 0 N--CA 1.389 -3.51 0 CA-C-N 115.168 -0.924 . . . . 0.0 108.695 175.055 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.513 HG13 ' H ' ' A' ' 128' ' ' MET . 2.6 p -135.55 -57.42 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 CA-C-N 114.709 -1.132 . . . . 0.0 109.057 -179.017 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . 0.513 ' H ' HG13 ' A' ' 127' ' ' VAL . 24.3 ttt -101.19 -57.92 1.99 Allowed 'General case' 0 N--CA 1.421 -1.876 0 N-CA-C 106.293 -1.743 . . . . 0.0 106.293 176.495 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 2.2 pp -132.9 -179.48 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.637 0 CA-C-N 113.508 -1.678 . . . . 0.0 108.721 177.537 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 85.7 t90 -88.13 126.61 35.21 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 123.652 0.595 . . . . 0.0 110.518 -175.236 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 44.3 t -132.3 137.43 54.49 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 178.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 25.2 pttm -102.62 -24.54 13.76 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 112.328 0.492 . . . . 0.0 112.328 179.156 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 19.1 m -130.37 103.69 8.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-O 121.845 0.831 . . . . 0.0 111.417 -179.43 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 23.3 p -109.09 -165.5 1.02 Allowed 'General case' 0 C--N 1.292 -1.908 0 CA-C-N 115.342 -0.845 . . . . 0.0 109.166 177.091 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . 0.513 ' OG ' ' HA ' ' A' ' 118' ' ' THR . 27.5 t -144.96 158.64 43.74 Favored 'General case' 0 N--CA 1.422 -1.837 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 176.715 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 68.1 mt -126.32 96.82 3.8 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 179.749 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . 0.58 ' O ' ' HB2' ' A' ' 144' ' ' TYR . 46.9 t -121.48 136.53 54.95 Favored 'General case' 0 C--N 1.298 -1.663 0 O-C-N 121.816 -0.553 . . . . 0.0 110.324 -175.755 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 8.8 t -165.16 178.33 7.05 Favored 'General case' 0 N--CA 1.42 -1.935 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 -174.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -110.25 68.33 0.67 Allowed 'General case' 0 C--N 1.312 -1.045 0 C-N-CA 119.215 -0.994 . . . . 0.0 112.599 -179.263 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . 48.79 33.35 4.28 Favored 'General case' 0 N--CA 1.496 1.848 0 C-N-CA 124.586 1.154 . . . . 0.0 113.828 173.009 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . 0.471 ' O ' ' HG3' ' A' ' 155' ' ' ARG . 48.1 t -154.32 -67.03 0.14 Allowed 'General case' 0 C--N 1.307 -1.265 0 C-N-CA 120.342 -0.543 . . . . 0.0 110.378 -174.717 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 55.3 mtpt -89.87 -162.79 0.92 Allowed 'General case' 0 CA--C 1.507 -0.709 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 179.125 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.516 HG11 ' O ' ' A' ' 159' ' ' GLY . 8.8 p -144.42 145.34 21.56 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 176.211 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . 0.58 ' HB2' ' O ' ' A' ' 137' ' ' SER . 91.6 m-85 -143.04 144.62 32.34 Favored 'General case' 0 CA--C 1.483 -1.6 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 174.219 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . 0.485 ' HB2' ' HA ' ' A' ' 151' ' ' LYS . 26.5 m-85 -95.53 156.37 16.35 Favored 'General case' 0 CA--C 1.454 -2.733 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 173.775 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 19.0 m -137.03 93.92 2.89 Favored 'General case' 1 N--CA 1.374 -4.226 0 C-N-CA 119.799 -0.761 . . . . 0.0 109.477 174.595 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.491 ' HB3' ' HG3' ' A' ' 150' ' ' LYS . . . -111.56 6.99 20.43 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.168 -0.924 . . . . 0.0 109.361 177.783 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . 0.52 ' O ' ' HG2' ' A' ' 150' ' ' LYS . . . 111.98 75.41 0.75 Allowed Glycine 0 CA--C 1.48 -2.103 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 -179.377 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER 74.31 -33.72 0.26 Allowed 'General case' 0 N--CA 1.494 1.755 0 C-N-CA 125.145 1.378 . . . . 0.0 110.534 -176.754 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . 0.52 ' HG2' ' O ' ' A' ' 148' ' ' GLY . 12.0 pttm -79.88 121.22 25.15 Favored 'General case' 0 C--N 1.315 -0.904 0 C-N-CA 124.292 1.037 . . . . 0.0 112.047 179.518 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.485 ' HA ' ' HB2' ' A' ' 145' ' ' PHE . 21.4 pttm -148.38 119.88 7.95 Favored 'General case' 0 N--CA 1.419 -1.983 0 CA-C-N 114.262 -1.335 . . . . 0.0 110.479 -175.074 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 42.9 m -110.41 111.82 23.34 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 106.54 -1.652 . . . . 0.0 106.54 173.53 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' ARG . . . . . 0.46 ' HB2' HG13 ' A' ' 143' ' ' VAL . 0.0 OUTLIER -154.69 99.57 2.17 Favored 'General case' 0 N--CA 1.435 -1.184 0 N-CA-C 116.397 1.999 . . . . 0.0 116.397 -165.745 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 4.9 m -108.99 109.57 20.65 Favored 'General case' 0 C--N 1.261 -3.279 0 O-C-N 121.423 -0.798 . . . . 0.0 109.051 165.489 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' ARG . . . . . 0.556 ' O ' ' HD3' ' A' ' 155' ' ' ARG . 0.2 OUTLIER -72.75 -23.45 60.83 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 120.633 1.561 . . . . 0.0 107.055 173.329 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -48.13 -43.72 31.46 Favored 'General case' 0 C--N 1.298 -1.666 0 C-N-CA 126.859 2.064 . . . . 0.0 115.536 -178.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.526 ' HB3' ' NE2' ' A' ' 161' ' ' GLN . . . -79.28 -19.5 50.38 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 113.318 0.859 . . . . 0.0 113.318 -175.893 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 0.553 ' CD2' ' HA ' ' A' ' 68' ' ' PHE . 44.0 t80 176.51 -34.49 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 CA-C-O 121.297 0.57 . . . . 0.0 109.831 178.482 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . 0.577 ' HA3' ' O ' ' A' ' 65' ' ' ILE . . . 150.52 -88.92 0.14 Allowed Glycine 0 CA--C 1.464 -3.134 0 N-CA-C 109.168 -1.573 . . . . 0.0 109.168 -172.194 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.558 HG23 ' HB ' ' A' ' 65' ' ' ILE . 10.9 t -98.06 153.39 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.642 0 N-CA-C 107.146 -1.428 . . . . 0.0 107.146 178.772 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' GLN . . . . . 0.526 ' NE2' ' HB3' ' A' ' 157' ' ' ALA . 79.3 mm-40 -116.32 90.05 3.25 Favored 'General case' 0 CA--C 1.453 -2.755 0 CA-C-O 122.435 1.112 . . . . 0.0 110.823 -172.469 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.28 147.59 24.9 Favored 'General case' 0 N--CA 1.387 -3.603 0 CA-C-N 112.555 -2.111 . . . . 0.0 108.828 179.327 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 9.4 t30 -113.13 -86.12 0.57 Allowed 'General case' 0 C--N 1.29 -2.014 0 C-N-CA 119.544 -0.862 . . . . 0.0 109.693 173.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 73.02 164.93 8.65 Favored Glycine 0 CA--C 1.502 -0.765 0 C-N-CA 120.424 -0.893 . . . . 0.0 113.256 179.088 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.525 ' O ' HD22 ' A' ' 165' ' ' LEU . 0.0 OUTLIER -100.95 114.69 28.82 Favored 'General case' 0 N--CA 1.413 -2.316 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 177.367 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . 0.465 ' HB2' ' O ' ' A' ' 89' ' ' PRO . 6.2 ptp180 -90.03 105.67 17.96 Favored 'General case' 0 N--CA 1.412 -2.369 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 -179.694 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.438 ' HB ' ' HB3' ' A' ' 90' ' ' SER . 57.5 t -43.83 -28.19 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 C-N-CA 124.333 1.053 . . . . 0.0 112.812 -177.662 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -49.64 -43.06 46.57 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 124.242 1.017 . . . . 0.0 111.813 177.042 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -128.49 8.79 5.96 Favored 'General case' 0 CA--C 1.546 0.825 0 CA-C-O 121.635 0.731 . . . . 0.0 110.887 -176.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 170' ' ' PHE . . . . . . . . . . . . . 67.3 t80 . . . . . 0 C--N 1.303 -1.439 0 N-CA-C 108.771 -0.825 . . . . 0.0 108.771 178.603 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 27.7 m . . . . . 0 N--CA 1.443 -0.775 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -92.73 103.43 15.8 Favored 'General case' 0 C--N 1.311 -1.094 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 -179.177 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -117.56 118.49 32.28 Favored 'General case' 0 C--N 1.307 -1.246 0 C-N-CA 120.54 -0.464 . . . . 0.0 111.518 -179.142 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 10.5 tt -137.14 108.21 5.91 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 CA-C-O 121.668 0.747 . . . . 0.0 110.078 174.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 76.5 t80 -109.58 104.32 13.33 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 178.601 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -125.41 99.09 5.89 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-O 121.179 0.514 . . . . 0.0 112.323 -175.389 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 63.8 mttp -133.63 95.94 3.59 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 174.409 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 42.7 t -107.83 138.14 35.72 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 -176.387 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -76.84 71.16 2.2 Favored Glycine 0 N--CA 1.439 -1.134 0 N-CA-C 111.929 -0.468 . . . . 0.0 111.929 179.187 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 17.0 m -83.84 87.35 7.08 Favored 'General case' 0 N--CA 1.425 -1.719 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 178.516 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 50.3 p90 -139.1 135.41 34.09 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.084 179.238 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 30.4 m-90 -132.88 104.85 6.78 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 178.633 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 56.2 tp -90.63 104.9 17.43 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.132 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -97.63 -168.38 32.49 Favored Glycine 0 N--CA 1.437 -1.291 0 C-N-CA 120.786 -0.721 . . . . 0.0 111.855 -179.63 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -93.96 98.61 11.15 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-O 121.537 0.684 . . . . 0.0 110.536 179.53 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.663 ' HD3' ' H ' ' A' ' 16' ' ' LYS . 0.2 OUTLIER -80.69 121.31 25.72 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.871 -179.285 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -165.6 98.26 0.68 Allowed 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.961 178.792 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 44.9 t-20 -147.12 94.78 2.46 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 109.573 -0.528 . . . . 0.0 109.573 178.307 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -138.44 118.66 13.59 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 176.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -83.69 96.85 8.82 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-O 121.53 0.681 . . . . 0.0 112.259 -177.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 33.7 p90 -121.8 96.62 5.14 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-O 121.678 0.752 . . . . 0.0 109.028 175.359 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -151.98 156.75 40.65 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.885 -177.112 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 17.3 m -71.4 127.37 32.35 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-O 120.86 0.362 . . . . 0.0 111.297 -177.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 7.7 p -60.73 138.43 21.64 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.807 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.849 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -89.81 98.3 2.43 Favored Glycine 0 CA--C 1.498 -1.0 0 N-CA-C 110.864 -0.895 . . . . 0.0 110.864 179.78 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 43.7 t30 -76.74 98.36 4.76 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-O 121.502 0.668 . . . . 0.0 112.329 -176.397 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -111.96 116.66 30.96 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 107.143 -1.429 . . . . 0.0 107.143 176.438 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.9 pp -124.53 3.77 8.32 Favored 'General case' 0 C--N 1.31 -1.13 0 N-CA-C 114.574 1.324 . . . . 0.0 114.574 -175.125 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 46.2 t30 -118.45 101.86 8.48 Favored 'General case' 0 C--N 1.314 -0.953 0 C-N-CA 120.334 -0.547 . . . . 0.0 109.902 178.473 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 36.3 p -135.35 14.15 3.5 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 116.145 -0.48 . . . . 0.0 112.29 -178.139 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 20.6 m -76.45 118.57 23.08 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 CA-C-O 121.498 0.666 . . . . 0.0 112.157 179.353 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 40.1 t -141.06 146.68 37.47 Favored 'General case' 0 C--N 1.313 -1.006 0 N-CA-C 108.388 -0.968 . . . . 0.0 108.388 -179.156 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 9.9 t -160.33 138.85 10.25 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-O 121.232 0.539 . . . . 0.0 112.306 -178.268 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 67.5 m -158.18 103.78 1.84 Allowed 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 107.097 -1.446 . . . . 0.0 107.097 174.218 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 11.7 tt -125.24 104.54 13.62 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 N-CA-C 114.2 1.185 . . . . 0.0 114.2 -172.348 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -102.6 122.29 44.1 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 172.819 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -66.09 127.96 30.66 Favored Glycine 0 N--CA 1.439 -1.147 0 N-CA-C 111.098 -0.801 . . . . 0.0 111.098 -179.556 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -61.12 100.94 0.27 Allowed Glycine 0 CA--C 1.5 -0.884 0 N-CA-C 111.131 -0.788 . . . . 0.0 111.131 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 17.1 m -97.61 70.13 2.21 Favored 'General case' 0 N--CA 1.414 -2.241 0 CA-C-O 122.031 0.92 . . . . 0.0 110.535 -176.284 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 63.3 tttm -145.3 22.05 1.53 Allowed 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 103.621 -2.733 . . . . 0.0 103.621 174.657 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 29.2 t90 -92.51 168.0 11.57 Favored 'General case' 0 N--CA 1.426 -1.666 0 CA-C-N 111.413 -2.63 . . . . 0.0 108.391 -174.189 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.623 HD23 ' H ' ' A' ' 42' ' ' LEU . 2.2 pt? -74.39 176.51 6.69 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 -178.349 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 43.3 t -45.97 120.69 0.6 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.559 0 C-N-CA 124.69 1.196 . . . . 0.0 112.039 -177.127 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 35.5 p30 -93.72 178.08 5.8 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.848 177.152 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.673 ' HE2' ' HA ' ' A' ' 45' ' ' LYS . 10.1 mmpt? -87.09 -34.72 19.04 Favored 'General case' 0 C--N 1.311 -1.085 0 C-N-CA 120.83 -0.348 . . . . 0.0 110.534 -177.447 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . 0.285 7.9 tp 42.76 78.48 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.248 1.02 0 C-N-CA 124.85 1.26 . . . . 0.0 113.124 -177.512 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -87.28 161.25 18.08 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-N 114.96 -1.018 . . . . 0.0 109.599 178.31 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 80.87 59.56 2.44 Favored Glycine 0 N--CA 1.425 -2.037 0 N-CA-C 110.088 -1.205 . . . . 0.0 110.088 -176.751 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 3.7 mptp? -63.29 -41.33 98.97 Favored 'General case' 0 CA--C 1.502 -0.886 0 C-N-CA 122.987 0.515 . . . . 0.0 109.958 -179.297 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . 0.47 ' HB2' ' HD3' ' A' ' 59' ' ' LYS . 27.5 ttt -175.55 148.75 0.94 Allowed 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 106.339 -1.726 . . . . 0.0 106.339 177.875 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 79.3 mm-40 -72.69 144.46 47.71 Favored 'General case' 0 C--N 1.296 -1.757 0 C-N-CA 120.463 -0.495 . . . . 0.0 110.983 -178.077 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.586 ' O ' ' HD2' ' A' ' 55' ' ' PRO . 11.3 mptt 76.32 135.42 0.05 OUTLIER Pre-proline 0 CA--C 1.543 0.688 0 C-N-CA 125.507 1.523 . . . . 0.0 109.851 -171.933 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -69.23 -26.52 29.99 Favored 'Trans proline' 0 C--O 1.24 0.58 0 C-N-CA 122.61 2.206 . . . . 0.0 114.91 -173.864 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.68 ' H ' HD23 ' A' ' 54' ' ' LEU 0.352 0.5 OUTLIER -69.87 -56.42 7.56 Favored Pre-proline 0 C--N 1.307 -1.27 0 C-N-CA 119.367 -0.933 . . . . 0.0 113.384 175.587 . . . . . . . . 4 4 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.624 ' HD3' ' HG ' ' A' ' 54' ' ' LEU . 88.9 Cg_exo -55.33 -35.33 91.34 Favored 'Trans proline' 0 C--N 1.362 1.238 0 C-N-CA 123.376 2.717 . . . . 0.0 112.461 -176.88 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -66.33 -30.88 71.37 Favored 'General case' 0 C--O 1.217 -0.615 0 C-N-CA 120.389 -0.525 . . . . 0.0 110.349 179.392 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.401 ' HA ' ' HB3' ' A' ' 60' ' ' GLU . 59.8 tp -74.8 -31.77 61.8 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.017 178.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.454 ' HB3' ' H ' ' A' ' 75' ' ' TYR . 7.9 mp -58.39 -49.8 75.96 Favored 'General case' 0 CA--C 1.482 -1.657 0 CA-C-O 121.675 0.75 . . . . 0.0 109.484 178.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.484 ' HG2' ' O ' ' A' ' 55' ' ' PRO . 17.2 ptmt -74.64 -26.63 60.0 Favored 'General case' 0 C--N 1.28 -2.425 0 CA-C-N 114.089 -1.414 . . . . 0.0 112.41 179.653 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.401 ' HB3' ' HA ' ' A' ' 57' ' ' LEU . 9.1 tp10 -70.75 -35.14 72.51 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.934 178.819 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 61.5 m-85 -48.46 -22.6 0.75 Allowed 'General case' 0 N--CA 1.5 2.072 0 CA-C-O 120.944 0.402 . . . . 0.0 111.442 174.494 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.436 ' CG ' ' H ' ' A' ' 63' ' ' LEU . 17.1 t70 -107.25 -156.38 0.58 Allowed 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 -172.799 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.644 HD21 ' H ' ' A' ' 115' ' ' GLY . 53.3 mt -91.71 172.8 6.01 Favored Pre-proline 0 CA--C 1.568 1.651 0 O-C-N 121.394 -0.816 . . . . 0.0 110.419 -174.773 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.428 ' HD3' ' HB3' ' A' ' 63' ' ' LEU . 3.5 Cg_endo -88.12 19.8 1.27 Allowed 'Trans proline' 0 C--N 1.356 0.968 0 C-N-CA 123.335 2.69 . . . . 0.0 111.367 -172.21 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.734 ' O ' ' HA3' ' A' ' 159' ' ' GLY . 0.2 OUTLIER -73.25 -37.92 53.07 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.708 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.401 179.69 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 55.58 8.51 1.95 Allowed Glycine 0 N--CA 1.49 2.25 0 CA-C-N 115.489 -0.778 . . . . 0.0 113.351 -178.804 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.667 ' O ' ' HB ' ' A' ' 160' ' ' VAL . 40.6 mt 69.37 -63.89 0.23 Allowed 'Isoleucine or valine' 0 C--O 1.197 -1.682 0 C-N-CA 126.053 1.741 . . . . 0.0 113.627 -178.726 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.495 ' HB2' ' O ' ' A' ' 67' ' ' ILE . 63.7 t80 171.24 -48.0 0.0 OUTLIER Pre-proline 0 C--N 1.314 -0.944 0 C-N-CA 122.729 0.412 . . . . 0.0 110.637 -177.446 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.592 ' HB3' ' HD3' ' A' ' 166' ' ' ARG . 17.1 Cg_exo -74.61 -31.62 6.75 Favored 'Trans proline' 0 C--N 1.377 2.035 0 C-N-CA 121.388 1.392 . . . . 0.0 112.109 179.666 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 88.37 -29.16 5.8 Favored Glycine 0 N--CA 1.437 -1.281 0 C-N-CA 120.448 -0.882 . . . . 0.0 110.999 -175.22 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.426 ' HB3' ' HG3' ' A' ' 89' ' ' PRO . 17.5 t70 -81.86 -19.02 41.83 Favored 'General case' 0 C--O 1.2 -1.545 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 177.52 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.511 ' HB2' ' HD2' ' A' ' 89' ' ' PRO . . . -78.25 175.04 10.57 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 114.95 -1.023 . . . . 0.0 110.375 170.511 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.501 ' HB ' ' O ' ' A' ' 72' ' ' ALA . 51.9 m 86.29 21.27 0.08 Allowed 'General case' 0 C--N 1.355 0.836 0 CA-C-O 124.069 1.89 . . . . 0.0 110.763 172.451 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.556 ' O ' ' HA ' ' A' ' 86' ' ' VAL . 37.3 m-80 -80.33 158.9 25.96 Favored 'General case' 0 C--N 1.272 -2.793 0 CA-C-N 114.641 -1.163 . . . . 0.0 112.632 -179.572 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.454 ' H ' ' HB3' ' A' ' 58' ' ' LEU . 53.5 t80 -118.38 123.1 44.44 Favored 'General case' 0 C--N 1.284 -2.266 0 CA-C-N 114.716 -1.129 . . . . 0.0 112.998 -169.748 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.598 ' O ' HD12 ' A' ' 84' ' ' LEU . 26.7 mm-40 -146.59 151.2 36.91 Favored 'General case' 0 C--O 1.215 -0.73 0 C-N-CA 125.984 1.714 . . . . 0.0 108.165 173.254 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 52.4 p90 -139.28 150.58 45.61 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-N 118.228 0.467 . . . . 0.0 110.651 -178.501 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.478 ' CB ' ' HB ' ' A' ' 81' ' ' THR . 21.6 m-20 -78.56 164.39 24.72 Favored 'General case' 0 CA--C 1.48 -1.729 0 CA-C-O 121.589 0.709 . . . . 0.0 110.227 179.002 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -80.82 -65.87 0.96 Allowed 'General case' 0 C--N 1.279 -2.476 0 CA-C-N 114.312 -1.313 . . . . 0.0 110.835 -179.629 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -81.06 -33.22 33.63 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.378 -176.604 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.478 ' HB ' ' CB ' ' A' ' 78' ' ' ASP . 91.6 m -82.67 -29.03 30.24 Favored 'General case' 0 N--CA 1.425 -1.715 0 CA-C-N 115.048 -0.978 . . . . 0.0 111.64 -176.794 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt 58.88 15.41 3.86 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 113.021 0.749 . . . . 0.0 113.021 178.173 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.437 ' CG ' ' HB ' ' A' ' 109' ' ' THR . 16.4 tppt? -88.54 141.76 28.26 Favored 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 -177.635 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.598 HD12 ' O ' ' A' ' 76' ' ' GLU . 37.5 tp -75.96 138.72 41.15 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.26 177.037 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.406 HG23 ' HB2' ' A' ' 76' ' ' GLU . 9.4 t -126.31 116.97 22.06 Favored 'General case' 0 N--CA 1.412 -2.351 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 173.269 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.556 ' HA ' ' O ' ' A' ' 74' ' ' ASN . 74.2 t -92.92 127.01 45.29 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.808 0 CA-C-N 115.133 -0.94 . . . . 0.0 110.781 -178.463 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.469 ' HB2' ' HB2' ' A' ' 74' ' ' ASN . 3.9 mp -88.6 109.54 20.18 Favored 'General case' 0 N--CA 1.433 -1.294 0 CA-C-N 115.287 -0.87 . . . . 0.0 109.596 179.844 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 65.7 mt -96.86 137.93 21.35 Favored Pre-proline 0 C--N 1.286 -2.186 0 N-CA-C 105.957 -1.868 . . . . 0.0 105.957 171.073 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.61 ' O ' ' HB2' ' A' ' 166' ' ' ARG . 41.5 Cg_endo -63.19 107.44 0.66 Allowed 'Trans proline' 0 N--CA 1.437 -1.842 0 C-N-CA 122.109 1.873 . . . . 0.0 110.14 175.849 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.653 ' HB2' ' HB2' ' A' ' 168' ' ' ASP . 33.2 t 63.65 -163.92 0.26 Allowed 'General case' 0 CA--C 1.557 1.248 0 CA-C-O 121.272 0.558 . . . . 0.0 110.891 179.614 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 5.7 tt -106.06 119.63 55.71 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 CA-C-O 121.52 0.676 . . . . 0.0 109.496 177.854 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' CYS . . . . . 0.467 ' O ' ' HB2' ' A' ' 104' ' ' PHE . 21.0 p -117.47 124.59 49.15 Favored 'General case' 0 C--N 1.296 -1.753 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 -179.441 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -116.41 166.17 12.38 Favored 'General case' 0 C--N 1.306 -1.31 0 O-C-N 122.072 -0.392 . . . . 0.0 111.775 -174.045 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.449 ' HB ' ' HB2' ' A' ' 163' ' ' ASN . 3.0 p -149.95 104.93 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.609 177.757 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -145.4 151.24 23.46 Favored Glycine 0 N--CA 1.446 -0.68 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.994 176.627 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 78.2 m-85 -161.58 -60.49 0.05 Allowed 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 124.19 0.996 . . . . 0.0 108.508 179.067 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.564 ' HA ' ' HE3' ' A' ' 97' ' ' LYS . 0.4 OUTLIER -71.25 -13.43 61.9 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 114.262 -1.336 . . . . 0.0 110.955 -177.128 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 22.5 t70 71.89 -36.58 0.36 Allowed 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 123.962 0.905 . . . . 0.0 112.145 -179.638 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 68.4 m -77.76 -7.88 57.19 Favored 'General case' 0 N--CA 1.44 -0.937 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 172.399 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . 0.455 ' HA ' ' O ' ' A' ' 126' ' ' LYS . 34.8 t -132.25 91.59 2.97 Favored 'General case' 0 N--CA 1.411 -2.391 0 N-CA-C 106.696 -1.594 . . . . 0.0 106.696 173.824 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.444 ' C ' HD12 ' A' ' 102' ' ' LEU . 97.9 t -130.45 119.35 45.89 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.108 0 CA-C-N 114.633 -1.167 . . . . 0.0 108.414 177.22 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.48 ' HG ' ' HA ' ' A' ' 125' ' ' THR . 4.8 mp -124.6 138.59 54.31 Favored 'General case' 0 N--CA 1.424 -1.759 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.346 -179.645 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 27.3 ttpp -117.19 110.35 18.03 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.33 177.759 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.579 ' HA ' HD12 ' A' ' 123' ' ' ILE . 51.1 m-85 -91.13 97.14 10.97 Favored 'General case' 0 N--CA 1.422 -1.871 0 CA-C-O 122.19 0.995 . . . . 0.0 111.756 177.764 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 31.6 m -56.05 146.4 22.85 Favored 'General case' 0 N--CA 1.424 -1.762 0 CA-C-N 112.276 -2.238 . . . . 0.0 110.916 177.325 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 66.9 m -56.95 -67.8 0.28 Allowed 'General case' 0 C--O 1.218 -0.593 0 C-N-CA 123.738 0.815 . . . . 0.0 111.123 -179.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.412 ' HA ' ' O ' ' A' ' 86' ' ' VAL . 7.3 p -107.56 99.88 9.34 Favored 'General case' 0 N--CA 1.423 -1.825 0 CA-C-O 121.654 0.74 . . . . 0.0 110.054 176.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.781 HG21 HG12 ' A' ' 123' ' ' ILE . 4.3 p -110.07 148.38 13.69 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.433 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.805 -176.894 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.535 ' HA ' ' O ' ' A' ' 84' ' ' LEU . 35.6 p -97.95 156.26 16.7 Favored 'General case' 0 N--CA 1.432 -1.369 0 N-CA-C 112.895 0.702 . . . . 0.0 112.895 -176.131 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.667 ' HA2' ' O ' ' A' ' 119' ' ' ASP . . . -172.99 174.42 45.86 Favored Glycine 0 CA--C 1.52 0.353 0 N-CA-C 111.714 -0.554 . . . . 0.0 111.714 -179.84 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 34.2 t-80 -109.75 121.96 46.41 Favored 'General case' 0 CA--C 1.508 -0.658 0 N-CA-C 107.934 -1.135 . . . . 0.0 107.934 177.347 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.572 ' HB2' HD22 ' A' ' 84' ' ' LEU . 2.9 tt -91.99 116.86 29.28 Favored 'General case' 0 C--N 1.307 -1.261 0 C-N-CA 120.324 -0.55 . . . . 0.0 110.395 -172.541 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -127.57 143.99 51.12 Favored 'General case' 0 CA--C 1.459 -2.542 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 171.748 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 42.7 tptt -80.15 100.24 8.16 Favored 'General case' 0 N--CA 1.387 -3.581 0 CA-C-O 122.194 0.997 . . . . 0.0 108.911 -171.627 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . 0.644 ' H ' HD21 ' A' ' 63' ' ' LEU . . . 136.5 -31.92 2.53 Favored Glycine 0 N--CA 1.426 -1.999 0 N-CA-C 108.245 -1.942 . . . . 0.0 108.245 -176.681 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -157.87 127.0 5.77 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 121.379 0.609 . . . . 0.0 111.985 -178.744 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -94.59 107.14 19.14 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 105.656 -1.979 . . . . 0.0 105.656 174.72 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.438 ' HA ' ' CB ' ' A' ' 135' ' ' SER . 49.4 p -109.61 172.44 6.85 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.963 -175.188 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . 0.667 ' O ' ' HA2' ' A' ' 110' ' ' GLY . 12.2 m-20 56.97 63.14 2.0 Favored 'General case' 0 CA--C 1.473 -1.983 0 O-C-N 124.468 1.105 . . . . 0.0 109.55 178.531 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.423 HG23 ' O ' ' A' ' 134' ' ' THR . 4.5 t -86.75 78.1 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.399 -2.98 0 C-N-CA 117.983 -1.487 . . . . 0.0 108.335 -175.798 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.409 ' HB3' ' OG1' ' A' ' 109' ' ' THR . 11.6 tp10 -68.92 96.47 0.77 Allowed 'General case' 0 N--CA 1.414 -2.252 0 CA-C-N 113.011 -1.904 . . . . 0.0 110.601 -174.39 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 130.56 -2.18 5.69 Favored Glycine 0 N--CA 1.424 -2.104 0 C-N-CA 120.152 -1.023 . . . . 0.0 112.995 174.864 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.781 HG12 HG21 ' A' ' 108' ' ' VAL . 26.6 mm -99.2 112.25 30.93 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 176.743 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -84.3 119.38 25.0 Favored 'General case' 0 N--CA 1.429 -1.51 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 -178.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.48 ' HA ' ' HG ' ' A' ' 102' ' ' LEU . 58.9 m -131.38 119.44 21.68 Favored 'General case' 0 N--CA 1.405 -2.716 0 CA-C-N 114.976 -1.011 . . . . 0.0 111.33 -175.889 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.455 ' O ' ' HA ' ' A' ' 100' ' ' SER . 83.1 tttt -110.08 141.94 42.22 Favored 'General case' 0 N--CA 1.41 -2.451 0 C-N-CA 119.083 -1.047 . . . . 0.0 109.452 168.225 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.443 HG11 ' HE2' ' A' ' 150' ' ' LYS . 7.5 p -149.01 -35.0 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.296 -1.757 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 175.431 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . 0.466 ' HG3' HG22 ' A' ' 129' ' ' ILE . 26.4 ptm -137.52 -29.23 0.88 Allowed 'General case' 0 N--CA 1.404 -2.758 0 CA-C-N 113.922 -1.49 . . . . 0.0 107.986 -176.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.466 HG22 ' HG3' ' A' ' 128' ' ' MET . 7.0 tp -161.97 159.52 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.565 0 N-CA-C 103.684 -2.71 . . . . 0.0 103.684 175.278 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 63.6 p-90 -83.82 126.52 33.02 Favored 'General case' 0 N--CA 1.409 -2.476 0 CA-C-O 121.351 0.596 . . . . 0.0 109.547 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.503 HG22 ' H ' ' A' ' 133' ' ' VAL . 13.1 p -130.92 149.01 33.07 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.147 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 179.022 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 20.8 pttp -103.48 12.94 34.52 Favored 'General case' 0 C--N 1.308 -1.201 0 C-N-CA 120.536 -0.466 . . . . 0.0 110.99 -179.643 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.503 ' H ' HG22 ' A' ' 131' ' ' VAL . 10.8 m -146.92 94.17 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.936 0.874 . . . . 0.0 112.529 -174.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . 0.476 HG21 HG21 ' A' ' 125' ' ' THR . 25.5 p -107.59 -160.73 0.74 Allowed 'General case' 0 N--CA 1.404 -2.73 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 174.026 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . 0.438 ' CB ' ' HA ' ' A' ' 118' ' ' THR . 51.8 p -173.35 142.66 1.01 Allowed 'General case' 0 N--CA 1.44 -0.941 0 N-CA-C 111.327 0.121 . . . . 0.0 111.327 -178.352 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . 0.437 HG13 ' O ' ' A' ' 144' ' ' TYR . 10.1 tt -103.18 111.23 32.18 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 CA-C-O 121.397 0.618 . . . . 0.0 109.396 177.574 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . 0.443 ' O ' ' HB2' ' A' ' 144' ' ' TYR . 43.5 m -111.75 139.35 47.29 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.739 -178.279 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . 0.437 HG23 ' H ' ' A' ' 140' ' ' ALA . 7.5 t -166.09 178.11 6.56 Favored 'General case' 0 N--CA 1.428 -1.559 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 -177.709 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -83.61 28.69 0.55 Allowed 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 176.441 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.484 ' HA ' HD22 ' A' ' 63' ' ' LEU . . . 60.23 35.73 20.91 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.352 0.661 . . . . 0.0 109.598 -174.246 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . 0.468 ' O ' ' HG3' ' A' ' 155' ' ' ARG . 33.4 t -153.62 -65.73 0.15 Allowed 'General case' 0 C--O 1.214 -0.784 0 CA-C-N 115.795 -0.638 . . . . 0.0 111.426 -171.505 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 51.2 mtpt -80.11 -169.16 1.92 Allowed 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 179.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.609 HG22 HG22 ' A' ' 65' ' ' ILE . 91.7 t -135.71 119.77 25.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-O 121.663 0.744 . . . . 0.0 112.673 179.11 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . 0.443 ' HB2' ' O ' ' A' ' 137' ' ' SER . 96.2 m-85 -113.64 114.59 26.64 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 106.297 -1.742 . . . . 0.0 106.297 171.13 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . 0.419 ' HB3' ' HB2' ' A' ' 151' ' ' LYS . 29.5 t80 -59.35 143.2 50.22 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 114.866 -1.061 . . . . 0.0 111.701 -169.12 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.43 ' C ' ' HB ' ' A' ' 134' ' ' THR . 75.1 p -46.88 104.27 0.05 OUTLIER 'General case' 0 C--O 1.245 0.823 0 N-CA-C 115.553 1.686 . . . . 0.0 115.553 -169.795 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.492 ' HB3' ' HG3' ' A' ' 150' ' ' LYS . . . 161.23 -65.47 0.0 OUTLIER 'General case' 0 CA--C 1.487 -1.457 0 C-N-CA 129.674 3.19 . . . . 0.0 104.824 174.036 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 154.57 -75.22 0.23 Allowed Glycine 0 CA--C 1.48 -2.139 0 C-N-CA 119.557 -1.306 . . . . 0.0 112.282 170.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 27.3 ptt? -97.36 -11.59 23.81 Favored 'General case' 0 C--N 1.29 -1.992 0 CA-C-N 115.396 -0.402 . . . . 0.0 111.938 -175.585 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . 0.492 ' HG3' ' HB3' ' A' ' 147' ' ' ALA 0.352 0.0 OUTLIER -77.37 -28.71 52.97 Favored 'General case' 0 C--O 1.213 -0.823 0 N-CA-C 116.656 2.095 . . . . 0.0 116.656 -170.597 . . . . . . . . 4 4 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.565 ' HE2' ' HA ' ' A' ' 151' ' ' LYS . 4.8 mmpt? -147.52 129.32 15.24 Favored 'General case' 0 CA--C 1.503 -0.829 0 CA-C-N 118.074 0.397 . . . . 0.0 110.767 179.453 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 40.6 p -106.72 145.91 31.46 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 175.461 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' ARG . . . . . 0.413 ' HG2' ' HB2' ' A' ' 145' ' ' PHE . 4.1 mmp_? -130.75 166.69 20.23 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 -179.313 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 19.0 m -101.15 121.76 42.41 Favored 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 177.201 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' ARG . . . . . 0.468 ' HG3' ' O ' ' A' ' 141' ' ' SER . 1.6 tmm_? -63.19 -25.79 68.5 Favored 'General case' 0 C--O 1.206 -1.198 0 N-CA-C 106.898 -1.519 . . . . 0.0 106.898 178.548 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -52.7 -25.94 12.47 Favored 'General case' 0 C--N 1.302 -1.499 0 C-N-CA 126.339 1.855 . . . . 0.0 113.009 -179.665 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -71.76 -32.66 67.93 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 120.703 0.287 . . . . 0.0 111.192 -179.268 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 44.0 t80 169.39 -31.94 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 106.333 -1.729 . . . . 0.0 106.333 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . 0.734 ' HA3' ' O ' ' A' ' 65' ' ' ILE . . . 156.87 -90.11 0.12 Allowed Glycine 0 N--CA 1.4 -3.729 0 N-CA-C 108.299 -1.92 . . . . 0.0 108.299 -173.361 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.667 ' HB ' ' O ' ' A' ' 67' ' ' ILE . 11.1 t -103.35 148.17 8.74 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.756 0 N-CA-C 105.372 -2.084 . . . . 0.0 105.372 179.231 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -137.07 102.69 4.92 Favored 'General case' 0 N--CA 1.408 -2.566 0 C-N-CA 118.102 -1.439 . . . . 0.0 109.179 -173.251 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 34.7 ptt85 -152.78 173.76 14.9 Favored 'General case' 0 C--N 1.275 -2.632 0 CA-C-N 113.214 -1.812 . . . . 0.0 106.515 -177.102 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' ASN . . . . . 0.449 ' HB2' ' HB ' ' A' ' 94' ' ' VAL . 4.4 m-20 -67.63 126.03 28.06 Favored 'General case' 0 C--O 1.248 1.007 0 C-N-CA 119.087 -1.045 . . . . 0.0 108.475 169.254 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -159.23 60.9 0.31 Allowed Glycine 0 N--CA 1.411 -3.032 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.311 -179.651 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.429 HD12 HH21 ' A' ' 166' ' ' ARG . 47.1 tp -81.62 111.54 18.0 Favored 'General case' 0 N--CA 1.418 -2.038 0 N-CA-C 105.509 -2.034 . . . . 0.0 105.509 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . 0.65 ' H ' ' NE ' ' A' ' 166' ' ' ARG . 0.0 OUTLIER -84.15 105.94 15.4 Favored 'General case' 0 N--CA 1.398 -3.055 0 C-N-CA 118.382 -1.327 . . . . 0.0 110.788 -178.189 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 4.8 m -74.74 63.93 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.29 -2.012 0 CA-C-O 122.833 1.301 . . . . 0.0 111.204 176.505 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . 0.653 ' HB2' ' HB2' ' A' ' 90' ' ' SER . 35.6 t70 -133.49 -32.69 1.14 Allowed 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 112.772 -2.013 . . . . 0.0 107.724 -177.635 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 21.7 ttpp -140.03 -67.19 0.44 Allowed 'General case' 0 N--CA 1.427 -1.584 0 CA-C-N 113.764 -1.562 . . . . 0.0 107.763 -177.172 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 170' ' ' PHE . . . . . . . . . . . . . 68.3 t80 . . . . . 0 C--O 1.249 1.026 0 N-CA-C 105.004 -2.221 . . . . 0.0 105.004 -178.82 . . . . . . . . 0 0 . 1 stop_ save_